safetyreportid,receivedate,target_drug,patientonsetage,patientonsetageunit,age_years,patientsex,patientweight,serious,seriousnessdeath,seriousnesshospitalization,seriousnesslifethreatening,seriousnessdisabling,seriousnesscongenitalanomali,seriousnessother,drugname,all_drugs,num_drugs,drug_indication,reactions,num_reactions,reporter_qualification
10222779,20140606,Pembrolizumab,73,801,73.0,1,78.9,1,1,1,0,0,0,1,Pembrolizumab,SPIRONOLACTONE|RAMIPRIL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|RANITIDINE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PEMBROLIZUMAB|ALLOPURINOL|IPILIMUMAB|BISOPROLOL FUMARATE|FUROSEMIDE|NIVOLUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CALCIUM|METOPROLOL TARTRATE|METOPROLOL|SIMVASTATIN,28,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cardiomyopathy,1,3
10329607,20140721,Pembrolizumab,75,801,75.0,1,,1,0,1,0,0,0,0,Pembrolizumab,LEVOTHYROXINE SODIUM|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE,4,MALIGNANT MELANOMA STAGE IV,Pulmonary embolism|Asthenia|Urinary tract infection|Dyspnoea|Pulmonary embolism|Dehydration|Cystitis,7,3
10329852,20140721,Pembrolizumab,83,801,83.0,2,69.9,1,0,1,0,0,0,0,Pembrolizumab,VALSARTAN|VALSARTAN ORAL|PEMBROLIZUMAB|PEMBROLIZUMAB|AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE|GENTAMICIN SULFATE|PEMBROLIZUMAB|PEMBROLIZUMAB|METOPROLOL TARTRATE|METOPROLOL|PEMBROLIZUMAB|PEMBROLIZUMAB|AMLODIPINE|METOPROLOL TARTRATE|METOPROLOL|TORSEMIDE,18,HYPERTENSION|PAIN|HYPERTENSION|PANOPHTHALMITIS|MALIGNANT MELANOMA|HYPERTENSION|CONSTIPATION|ATRIAL FIBRILLATION|ACTINIC KERATOSIS|HYPERTENSION|HYPERTENSION|HYPERTENSION|PRURITUS,Hypothyroidism|Adrenal insufficiency,2,1
10329858,20140721,Pembrolizumab,46,801,46.0,1,73,1,0,1,0,0,0,0,Pembrolizumab,"PEMBROLIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ALLOPURINOL|PEMBROLIZUMAB|LENALIDOMIDE|PREDNISONE|LENALIDOMIDE|CLOBETASOL PROPIONATE|CLOBETASOL PROPIONATE OINTMENT USP, 0.05%|LACTULOSE|MAGNESIUM HYDROXIDE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|PEMBROLIZUMAB|LENALIDOMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",16,PLASMA CELL MYELOMA|HYPERURICAEMIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PRURITUS|PRURITUS|CONSTIPATION|CONSTIPATION|INFECTION PROPHYLAXIS|THROMBOSIS PROPHYLAXIS,Tumour lysis syndrome|Renal failure,2,1
10329882,20140721,Pembrolizumab,64,801,64.0,2,73.1,1,0,0,1,0,0,1,Pembrolizumab,LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ROSUVASTATIN|PANTOPRAZOLE SODIUM|PEMBROLIZUMAB|PEMBROLIZUMAB,7,DIARRHOEA|HYPERCHOLESTEROLAEMIA|DIARRHOEA|PROPHYLAXIS|MALIGNANT MELANOMA|ARTHRALGIA,Type 1 diabetes mellitus,1,1
10330020,20140721,Pembrolizumab,39,801,39.0,2,89,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|PEMBROLIZUMAB|PREGABALIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,10,MALIGNANT MELANOMA|HYPOTHYROIDISM|PAIN IN EXTREMITY|PAIN IN EXTREMITY|FIBROMYALGIA|DRY SKIN|HYPOCALCAEMIA|DEPRESSION|DEPRESSION,Metabolic disorder|Oesophagitis,2,1
10330075,20140721,Pembrolizumab,79,801,79.0,1,,1,0,1,0,0,0,0,Pembrolizumab,METOPROLOL TARTRATE|METOPROLOL|ENOXAPARIN SODIUM|TERBINAFINE HYDROCHLORIDE|TERBINAFINE,5,ADRENAL INSUFFICIENCY|ATRIAL FIBRILLATION|METASTATIC MALIGNANT MELANOMA|DEEP VEIN THROMBOSIS|TINEA INFECTION,Pyrexia,1,3
10330249,20140721,Pembrolizumab,78,801,78.0,1,81.6,1,0,1,0,0,0,1,Pembrolizumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|AMLODIPINE|SIMVASTATIN,6,CARDIAC DISORDER|MALIGNANT MELANOMA|HYPERTENSION|BLOOD CHOLESTEROL INCREASED,Colitis|Colitis,2,1
10330254,20140721,Pembrolizumab,77,801,77.0,1,91,1,0,1,0,0,0,0,Pembrolizumab,AMLODIPINE BESYLATE|DOXAZOSIN MESYLATE|SIMVASTATIN|PEMBROLIZUMAB|GUAIFENESIN|ALISKIREN HEMIFUMARATE|CLONIDINE HYDROCHLORIDE|CLONIDINE|PEMBROLIZUMAB|FINASTERIDE|VALSARTAN|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|PREDNISONE,16,HYPERTENSION|HYPERTENSION|HYPERCHOLESTEROLAEMIA|COUGH|ROUTINE HEALTH MAINTENANCE|COUGH|HYPERTENSION|HYPERTENSION|MALIGNANT MELANOMA|BENIGN PROSTATIC HYPERPLASIA|PAIN|HYPERTENSION|COUGH|VIRAL INFECTION|COUGH,Generalised oedema,1,1
10330263,20140721,Pembrolizumab,83,801,83.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Hypothyroidism|Fatigue|Diarrhoea|Pruritus,4,5
10330289,20140722,Pembrolizumab,58,801,58.0,1,,1,1,1,0,0,0,0,Pembrolizumab,,1,MALIGNANT MELANOMA,Dehydration|Disease progression|Anaemia,3,5
10330460,20140722,Pembrolizumab,72,801,72.0,1,,1,0,0,0,0,0,0,Pembrolizumab,,1,MALIGNANT MELANOMA,Fatigue|Weight increased|Decreased appetite|Back pain,4,3
10330618,20140722,Pembrolizumab,41,801,41.0,2,61.1,1,0,1,0,0,0,0,Pembrolizumab,HYDROMORPHONE HYDROCHLORIDE|MELATONIN|METHADONE HYDROCHLORIDE|METHADONE|MORPHINE SULFATE|ZOLEDRONIC ACID|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR,14,ABDOMINAL PAIN|INSOMNIA|VOMITING|ABDOMINAL PAIN|PAIN|CONSTIPATION|HYPOMAGNESAEMIA|ABDOMINAL PAIN|HYPERCALCAEMIA|HYPOMAGNESAEMIA|VOMITING|NAUSEA|SQUAMOUS CELL CARCINOMA OF THE CERVIX|NAUSEA,Abdominal pain,1,1
10330888,20140722,Pembrolizumab,77,801,77.0,1,90,1,0,1,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PEMBROLIZUMAB|PEMBROLIZUMAB,4,NAUSEA|MALIGNANT MELANOMA,Adrenal insufficiency|Peripheral motor neuropathy,2,1
10330890,20140722,Pembrolizumab,65,801,65.0,1,73,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PEMBROLIZUMAB|PANTOPRAZOLE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,12,MALIGNANT MELANOMA|CONSTIPATION|PAIN|METASTASES TO ADRENALS|HYPOPITUITARISM|HYPOPITUITARISM|CANCER PAIN|BRADYCARDIA|PAIN|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|METASTASES TO ADRENALS,Hypopituitarism|Gastrointestinal disorder,2,1
10331740,20140722,Pembrolizumab,31,801,31.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PANTOPRAZOLE SODIUM|POLYETHYLENE GLYCOL 3350|FUROSEMIDE|ESCITALOPRAM,9,ABDOMINAL DISCOMFORT|METASTATIC MALIGNANT MELANOMA|NAUSEA|VOMITING|CONSTIPATION|SWELLING|BLOOD POTASSIUM DECREASED|HYPERTENSION|ANXIETY,Aspartate aminotransferase increased|Blood bilirubin increased,2,3
10331744,20140722,Pembrolizumab,58,801,58.0,1,105.1,1,0,1,1,1,0,0,Pembrolizumab,LOSARTAN POTASSIUM|LOSARTAN|DOXAZOSIN MESYLATE|LEVETIRACETAM|PEMBROLIZUMAB|AMLODIPINE,5,HYPERTENSION|HYPERTENSION|EPILEPSY|MALIGNANT MELANOMA|HYPERTENSION,Drug-induced liver injury|Drug-induced liver injury|Guillain-Barre syndrome,3,1
10331835,20140722,Pembrolizumab,53,801,53.0,2,89,1,0,1,0,0,0,0,Pembrolizumab,"AMITRIPTYLINE HYDROCHLORIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PEMBROLIZUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOPROLOL TARTRATE|METOPROLOL|AMITRIPTYLINE HYDROCHLORIDE|LISINOPRIL|HYDROCHLOROTHIAZIDE|PANTOPRAZOLE",14,PAIN|PAIN|CANCER PAIN|CONSTIPATION PROPHYLAXIS|MALIGNANT MELANOMA|PAIN|ABDOMINAL PAIN|HYPOTHYROIDISM|HYPERTENSION|PAIN|INSOMNIA|HYPERTENSION|HYPERTENSION|PAIN,Autoimmune hepatitis|Iritis,2,1
10332810,20140722,Pembrolizumab,61,801,61.0,1,71,1,1,1,0,0,0,0,Pembrolizumab,RANITIDINE|INDOMETHACIN|CEFTRIAXONE SODIUM|FENTANYL|PEMBROLIZUMAB|FENTANYL,11,PROPHYLAXIS|TUMOUR ASSOCIATED FEVER|ABDOMINAL PAIN|INFECTION PROPHYLAXIS|BILE DUCT EXPLORATION|PAIN|NEOPLASM MALIGNANT|THROMBOSIS PROPHYLAXIS|ANAEMIA|ABDOMINAL PAIN|DYSPEPSIA,Autoimmune haemolytic anaemia|Malignant neoplasm progression,2,1
10332811,20140722,Pembrolizumab,47,801,47.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,5,METASTATIC MALIGNANT MELANOMA,Pneumonitis|Pyrexia,2,5
10332936,20140722,Pembrolizumab,82,801,82.0,1,,1,0,1,0,0,0,0,Pembrolizumab,"DIPHENHYDRAMINE HYDROCHLORIDE|CARVEDILOL|CLOPIDOGREL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|WARFARIN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PRAVASTATIN SODIUM|TRANDOLAPRIL|TRANDOLAPRIL TABLETS|PHENYTOIN|CLOPIDOGREL",16,PROPHYLAXIS|PROPHYLAXIS|HYPERTENSION|ROUTINE HEALTH MAINTENANCE|MALIGNANT MELANOMA|ROUTINE HEALTH MAINTENANCE|CORONARY ARTERY DISEASE|ROUTINE HEALTH MAINTENANCE|PULMONARY EMBOLISM|PROPHYLAXIS|HYPERLIPIDAEMIA|HYPERTENSION|CONVULSION|HYPERLIPIDAEMIA,Ventricular tachycardia|Acute myocardial infarction,2,5
10333197,20140722,Pembrolizumab,76,801,76.0,1,88.6,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|ROSUVASTATIN,6,SLEEP DISORDER|CONSTIPATION|MALIGNANT MELANOMA|DEPRESSION|HYPERCHOLESTEROLAEMIA|GASTROOESOPHAGEAL REFLUX DISEASE,Hypopituitarism,1,1
10333491,20140722,Pembrolizumab,61,801,61.0,1,121.2,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PREGABALIN|VALSARTAN|VALSARTAN ORAL|PEMBROLIZUMAB|PEMBROLIZUMAB|LEVODOPA|AMLODIPINE|METOPROLOL TARTRATE|METOPROLOL|HYDROCHLOROTHIAZIDE,16,PROPHYLAXIS|PAIN|HYPERTENSION|ORAL CANDIDIASIS|MUCOSAL INFLAMMATION|MALIGNANT MELANOMA|RESTLESS LEGS SYNDROME|HYPERTENSION|STEVENS-JOHNSON SYNDROME|HYPOTHYROIDISM|HYPERTENSION|HYPERTENSION|HYPERTENSION,Osteolysis|Lichenoid keratosis,2,1
10333494,20140722,Pembrolizumab,52,801,52.0,2,,1,0,0,0,0,0,0,Pembrolizumab,,1,METASTATIC MALIGNANT MELANOMA,Diarrhoea|Arthralgia|Headache,3,5
10333499,20140722,Pembrolizumab,70,801,70.0,2,42.5,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|OXYCODONE|PREGABALIN|LEVOTHYROXINE SODIUM|PANTOPRAZOLE SODIUM|CARBOXYMETHYLCELLULOSE SODIUM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|OXYCODONE HYDROCHLORIDE|TRAZODONE HYDROCHLORIDE|SENNOSIDES|SENNA LEAF|SENNA|LEVETIRACETAM|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,12,METASTATIC MALIGNANT MELANOMA,Fatigue|Somnolence|Eyelid oedema,3,3
10333502,20140722,Pembrolizumab,53,801,53.0,2,,1,0,0,0,0,0,0,Pembrolizumab,,1,MALIGNANT MELANOMA,Rash,1,5
10333509,20140722,Pembrolizumab,55,801,55.0,2,50.2,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|VENLAFAXINE HYDROCHLORIDE|VENLAFAXINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ERGOCALCIFEROL|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|PEMBROLIZUMAB|ZOLPIDEM TARTRATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALBUTEROL SULFATE|ALBUTEROL|BUDESONIDE|PEMBROLIZUMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,14,ASTHMA|BREAST CANCER|AFFECTIVE DISORDER|COUGH|HEADACHE|PROPHYLAXIS|ASTHMA|ANXIETY|PREMEDICATION|ASTHMA|ASTHMA|PREMEDICATION,Headache|Meningitis aseptic,2,1
10333512,20140722,Pembrolizumab,53,801,53.0,2,80,1,0,1,0,0,0,0,Pembrolizumab,SIMVASTATIN|PEMBROLIZUMAB|AMLODIPINE|MORPHINE|PEMBROLIZUMAB,10,HYPERCHOLESTEROLAEMIA|PLEURODESIS|PAIN|NON-SMALL CELL LUNG CANCER|PALLIATIVE CARE|PAIN|HYPERTENSION|ANALGESIC THERAPY|CANCER PAIN,Pneumonitis chemical,1,1
10333515,20140722,Pembrolizumab,67,801,67.0,1,70,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|LACTULOSE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|PHENYTOIN|ENOXAPARIN SODIUM|EXTENDED PHENYTOIN SODIUM|CITALOPRAM|CITALOPRAM HYDROBROMIDE|LACTULOSE|ENOXAPARIN SODIUM,10,NON-SMALL CELL LUNG CANCER|CONSTIPATION|INSOMNIA|ADVERSE EVENT|ADVERSE EVENT|DEEP VEIN THROMBOSIS|SEIZURE|DEPRESSION|ADVERSE EVENT|ADVERSE EVENT,Autoimmune haemolytic anaemia,1,1
10334246,20140723,Pembrolizumab,43,801,43.0,1,64.8,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|HYDROCORTISONE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|MESALAMINE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|PEMBROLIZUMAB|GANCICLOVIR SODIUM|GANCICLOVIR,13,MALIGNANT MELANOMA|PROPHYLAXIS|HYPOTHYROIDISM|COLITIS|MINERAL SUPPLEMENTATION|HYPOTHYROIDISM|COLITIS|COLITIS|COLITIS|COLITIS|INFECTION PROPHYLAXIS|CYTOMEGALOVIRUS INFECTION,Hepatic function abnormal,1,1
10334822,20140723,Pembrolizumab,73,801,73.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|FERROUS SULFATE|HYDROCHLOROTHIAZIDE|PREDNISONE,7,METASTATIC MALIGNANT MELANOMA,Fatigue|Fatigue,2,5
10334937,20140723,Pembrolizumab,77,801,77.0,1,60.2,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|MEGESTROL ACETATE|CELECOXIB|PEMBROLIZUMAB,5,COUGH|DECREASED APPETITE|CHEST PAIN|NON-SMALL CELL LUNG CANCER,Death,1,1
10334996,20140723,Pembrolizumab,76,801,76.0,2,59.6,1,0,1,0,0,0,0,Pembrolizumab,ZOLPIDEM TARTRATE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PEMBROLIZUMAB|PEMBROLIZUMAB|MAGNESIUM OXIDE|PANTOPRAZOLE SODIUM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS,10,SLEEP DISORDER|THYROID DISORDER|ATRIAL FIBRILLATION|MALIGNANT MELANOMA|ROUTINE HEALTH MAINTENANCE|PRODUCT USED FOR UNKNOWN INDICATION|PYREXIA|ERYTHEMA|ROUTINE HEALTH MAINTENANCE,Dehydration|Large intestine perforation,2,1
10335038,20140723,Pembrolizumab,32,801,32.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,METASTATIC MALIGNANT MELANOMA,Arthralgia|Rash|Alanine aminotransferase increased,3,5
10335142,20140723,Pembrolizumab,59,801,59.0,1,106,1,0,1,0,0,0,0,Pembrolizumab,PREGABALIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PEMBROLIZUMAB|SIMVASTATIN,7,PAIN|PAIN|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|NON-SMALL CELL LUNG CANCER|DYSLIPIDAEMIA|PAIN|HYPERTENSION,Muscle necrosis,1,1
10335184,20140723,Pembrolizumab,56,801,56.0,2,94,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|BUDESONIDE|PEMBROLIZUMAB|ASCORBIC ACID|FORMOTEROL FUMARATE|FORMOTEROL FUMARATE DIHYDRATE|PEMBROLIZUMAB|ENALAPRIL|INSULIN DETEMIR|SIMVASTATIN|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL,15,ASTHMA|DIABETES MELLITUS|OEDEMA|VITAMIN C DEFICIENCY|ASTHMA|DIABETES MELLITUS|PLATELET AGGREGATION INHIBITION|MALIGNANT MELANOMA|ESSENTIAL HYPERTENSION|ASTHMA|DIABETES MELLITUS|LIPID METABOLISM DISORDER|DIARRHOEA,Small intestinal perforation|Colitis,2,1
10335624,20140723,Pembrolizumab,74,801,74.0,1,77.4,1,0,1,0,0,0,0,Pembrolizumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,5,PAIN|MALIGNANT MELANOMA,Sepsis|Hyponatraemia|Rash,3,1
10336270,20140723,Pembrolizumab,61,801,61.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Rash|Pruritus,2,5
10336463,20140723,Pembrolizumab,74,801,74.0,1,75.28,1,0,1,0,0,0,1,Pembrolizumab,,2,MALIGNANT MELANOMA,Adrenal insufficiency|Myelodysplastic syndrome,2,1
10336705,20140723,Pembrolizumab,72,801,72.0,1,,1,0,1,0,0,0,0,Pembrolizumab,ATORVASTATIN CALCIUM,4,MALIGNANT MELANOMA STAGE IV,Diarrhoea|Enteritis|Nausea|Vomiting,4,3
10336923,20140723,Pembrolizumab,70,801,70.0,1,87.3,1,0,1,0,0,0,0,Pembrolizumab,"PEMBROLIZUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ALBUTEROL SULFATE|ALBUTEROL|PEMBROLIZUMAB|LOSARTAN POTASSIUM|CLONIDINE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIPHENHYDRAMINE HYDROCHLORIDE|DILTIAZEM HYDROCHLORIDE|OMEPRAZOLE MAGNESIUM|FOLIC ACID|ATORVASTATIN CALCIUM|DUTASTERIDE",22,NON-SMALL CELL LUNG CANCER|DIABETES MELLITUS|BENIGN PROSTATIC HYPERPLASIA|DIABETES MELLITUS|ROUTINE HEALTH MAINTENANCE|PROPHYLAXIS AGAINST BRONCHOSPASM|HYPERTENSION|HYPERTENSION|HYPERTENSION|COUGH|BACK PAIN|PROPHYLAXIS OF NAUSEA AND VOMITING|ANXIETY|INFLAMMATION|FLUSHING|HYPERTENSION|ANTACID THERAPY|FOLATE DEFICIENCY|PAIN|BLOOD CHOLESTEROL INCREASED|PROPHYLAXIS,Dyspnoea,1,1
10336928,20140723,Pembrolizumab,61,801,61.0,1,70.2,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|WARFARIN|WARFARIN,7,NON-SMALL CELL LUNG CANCER|COUGH|EMBOLISM|CONSTIPATION|BACK PAIN,Interstitial lung disease|Pneumonia aspiration|Pneumonia aspiration,3,1
10418319,20140829,Pembrolizumab,50,801,50.0,1,124,1,0,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB|CETIRIZINE HYDROCHLORIDE|PEMBROLIZUMAB,6,RENAL CELL CARCINOMA|RENAL CELL CARCINOMA|SEASONAL ALLERGY|HYPERTENSION|HYPERTENSION,Aspartate aminotransferase increased,1,1
10438550,20140908,Pembrolizumab,,,,0,,1,0,1,0,0,0,0,Pembrolizumab,PAZOPANIB|PAZOPANIB HYDROCHLORIDE,2,RENAL CELL CARCINOMA|RENAL CELL CARCINOMA,Atrioventricular block,1,1
10442698,20140909,Pembrolizumab,75,801,75.0,1,58.3,1,0,1,1,0,0,0,Pembrolizumab,PEMBROLIZUMAB|TIOTROPIUM BROMIDE|RANITIDINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SIMVASTATIN|ALBUTEROL SULFATE|ALBUTEROL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OXYGEN|0XYGEN,17,LUNG NEOPLASM MALIGNANT|ASTHMA|ABDOMINAL DISCOMFORT|ANTACID THERAPY|RASH|NAUSEA|ASTHMA|ANALGESIC THERAPY|GASTROOESOPHAGEAL REFLUX DISEASE|GASTROOESOPHAGEAL REFLUX DISEASE|PAIN|WEIGHT DECREASED|BLOOD CHOLESTEROL INCREASED|ASTHMA|ARTHRALGIA|DYSPNOEA|CONSTIPATION,Lung infiltration|Cholecystitis,2,1
10442739,20140909,Pembrolizumab,54,801,54.0,1,57,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|MORPHINE|MAGNESIUM OXIDE,13,NEOPLASM|PAIN IN EXTREMITY|ADVERSE EVENT|ADVERSE EVENT|PRE-EXISTING DISEASE|PRE-EXISTING DISEASE|PRE-EXISTING DISEASE|PAIN IN EXTREMITY|PRE-EXISTING DISEASE|ADVERSE EVENT|ADVERSE EVENT|PRE-EXISTING DISEASE,Sepsis|Pneumonitis,2,1
10442741,20140909,Pembrolizumab,67,801,67.0,1,65.5,1,0,0,0,0,0,1,Pembrolizumab,METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PEMBROLIZUMAB|PEMBROLIZUMAB|MORPHINE|MAGNESIUM OXIDE|MORPHINE SULFATE,6,NAUSEA|NEOPLASM MALIGNANT|PAIN|PROPHYLAXIS|PAIN,Thrombosis|Thrombocytopenia,2,1
10444313,20140910,Pembrolizumab,74,801,74.0,1,,1,0,1,0,0,0,0,Pembrolizumab,OLMESARTAN MEDOXOMIL|ENOXAPARIN SODIUM|PEMBROLIZUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|TIMOLOL MALEATE|TIMOLOL MALEATE OPHTHALMIC|OXYMETAZOLINE HYDROCHLORIDE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS,10,PRODUCT USED FOR UNKNOWN INDICATION|PULMONARY EMBOLISM|PRURITUS|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|HYPOPHYSITIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dehydration|Decreased appetite|Diarrhoea|Acute kidney injury,4,5
10444864,20140910,Pembrolizumab,44,801,44.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|AMMONIUM LACTATE|LEVETIRACETAM|AMMONIUM LACTATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,5,MALIGNANT MELANOMA|SKIN EXFOLIATION|SEIZURE|DRY SKIN|GASTROOESOPHAGEAL REFLUX DISEASE,Arthralgia,1,3
10445576,20140910,Pembrolizumab,48,801,48.0,2,,1,1,1,1,0,0,0,Pembrolizumab,"SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|PEMBROLIZUMAB|PANTOPRAZOLE SODIUM|ERGOCALCIFEROL",6,METASTATIC MALIGNANT MELANOMA,Asthenia|Liver function test abnormal|Occult blood positive|Disease progression|Anaemia,5,3
10445775,20140910,Pembrolizumab,69,801,69.0,2,55.3,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN AND CODEINE,4,MALIGNANT MELANOMA|GASTRITIS PROPHYLAXIS|PAIN MANAGEMENT,Haemorrhagic stroke|Facial bones fracture|Escherichia bacteraemia,3,1
10445867,20140910,Pembrolizumab,70,801,70.0,2,70,1,0,1,1,0,0,1,Pembrolizumab,PEMBROLIZUMAB|TRAMADOL HYDROCHLORIDE|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PEMBROLIZUMAB|SIMVASTATIN,8,MALIGNANT MELANOMA|OSTEOARTHRITIS|MUSCLE SPASMS|OSTEOARTHRITIS|UVEITIS|HYPERCHOLESTEROLAEMIA|MUSCLE SPASMS,Pulmonary embolism|Squamous cell carcinoma|Squamous cell carcinoma,3,1
10447220,20140911,Pembrolizumab,72,801,72.0,1,68,1,1,1,0,0,0,0,Pembrolizumab,DUTASTERIDE|PREGABALIN|LACTULOSE|MEGNESIUM OXIDE|ALPRAZOLAM|PEMBROLIZUMAB|PEMBROLIZUMAB|SPIRONOLACTONE,15,BENIGN PROSTATIC HYPERPLASIA|PAIN|CONSTIPATION|RECTAL HAEMORRHAGE|CONSTIPATION|HYPOMAGNESAEMIA|PAIN|ANXIETY|ADENOCARCINOMA OF COLON|RECTAL ADENOCARCINOMA|HYPOKALAEMIA|DIURETIC THERAPY|ABDOMINAL PAIN|INSOMNIA|PAIN,Hepatic failure|Malignant neoplasm progression,2,1
10447432,20140911,Pembrolizumab,78,801,78.0,1,70,1,0,1,1,0,0,0,Pembrolizumab,CANDESARTAN CILEXETIL|PEMBROLIZUMAB|PEMBROLIZUMAB|TORSEMIDE|PANTOPRAZOLE|TORSEMIDE|AMLODIPINE|METOPROLOL TARTRATE|METOPROLOL,11,HYPERTENSION|MALIGNANT MELANOMA|HYPERTENSION|PROPHYLAXIS|HYPERTENSION|BLADDER DYSFUNCTION|HYPERTENSION|HYPERTENSION|HYPOKALAEMIA,Adrenal insufficiency,1,1
10447618,20140911,Pembrolizumab,72,801,72.0,1,103.2,1,1,1,1,0,0,0,Pembrolizumab,SENNOSIDES|SENNA LEAF|SENNA|TRAMADOL HYDROCHLORIDE|SIMVASTATIN|PEMBROLIZUMAB,4,CONSTIPATION|PAIN|HYPERCHOLESTEROLAEMIA|NON-SMALL CELL LUNG CANCER,Pneumonia|Lower respiratory tract infection,2,3
10447659,20140911,Pembrolizumab,76,801,76.0,1,73,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|SIMVASTATIN|AMLODIPINE|ISOSORBIDE MONONITRATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|PEMBROLIZUMAB|PEMBROLIZUMAB,13,MALIGNANT MELANOMA|DEPRESSION|HYPERLIPIDAEMIA|HYPERTENSION|CORONARY ARTERY DISEASE|DIABETES MELLITUS|BENIGN PROSTATIC HYPERPLASIA|CARDIOVASCULAR EVENT PROPHYLAXIS|DIABETES MELLITUS|HYPERTENSION|HYPERLIPIDAEMIA,Tubulointerstitial nephritis,1,1
10447861,20140911,Pembrolizumab,58,801,58.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Diarrhoea,1,5
10447868,20140911,Pembrolizumab,45,801,45.0,1,,1,0,0,0,0,0,0,Pembrolizumab,LEVETIRACETAM|PEMBROLIZUMAB|METOCLOPRAMIDE HYDROCHLORIDE,4,RASH|SEIZURE|METASTATIC MALIGNANT MELANOMA|NAUSEA,Pyrexia,1,3
10447978,20140911,Pembrolizumab,71,801,71.0,1,65.7,1,0,1,0,0,0,0,Pembrolizumab,"PEMBROLIZUMAB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|PEMBROLIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",6,PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|CHEST PAIN|MUSCULOSKELETAL PAIN|HYPERCALCAEMIA OF MALIGNANCY,Alanine aminotransferase increased|Aspartate aminotransferase increased,2,3
10447985,20140911,Pembrolizumab,52,801,52.0,1,91,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PEMBROLIZUMAB,14,MUSCLE SPASMS|HYPERTENSION|CONSTIPATION|PAIN|PAIN|PAIN|PAIN|MALIGNANT MELANOMA|ANXIETY|MALNUTRITION|GASTRIC ULCER,Generalised oedema|Hypoalbuminaemia|Diarrhoea,3,1
10447987,20140911,Pembrolizumab,65,801,65.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Haemoptysis,1,3
10447989,20140911,Pembrolizumab,54,801,54.0,1,47.7,1,0,1,1,0,0,0,Pembrolizumab,PEMBROLIZUMAB|ESOMEPRAZOLE MAGNESIUM|PEMBROLIZUMAB,8,PRURITUS|PRURITUS|NASOPHARYNGEAL CANCER|NEOPLASM MALIGNANT|NECK PAIN|GASTROOESOPHAGEAL REFLUX PROPHYLAXIS,Hepatitis|Pneumonia,2,1
10448017,20140911,Pembrolizumab,72,801,72.0,1,73.5,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|FENTANYL CITRATE|GABAPENTIN|FENTANYL,14,HEAD AND NECK CANCER|INSOMNIA|PAIN|CONSTIPATION|PAIN|MYOCARDIAL ISCHAEMIA|PAIN|HYPERTENSION|PAIN|CONSTIPATION|PAIN|PAIN|DIABETES MELLITUS,Abscess neck,1,1
10448018,20140911,Pembrolizumab,45,801,45.0,2,60,1,0,1,0,0,0,0,Pembrolizumab,POLYETHYLENE GLYCOL|DIMETHICONE|BODY SHIELD|BODY CLEANSER|SKIN PROTECTANT|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PEMBROLIZUMAB,5,PAIN|CONSTIPATION|ABDOMINAL DISTENSION|NAUSEA|MALIGNANT MELANOMA,Anaemia|Hepatitis|Thrombocytopenia,3,5
10448095,20140911,Pembrolizumab,69,801,69.0,1,52.7,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,8,INSOMNIA|LARYNGEAL SQUAMOUS CELL CARCINOMA|HYPOCALCAEMIA|CONSTIPATION|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|HEAD AND NECK CANCER|HYPOTHYROIDISM|HYPOCALCAEMIA,Interstitial lung disease|Infection,2,1
10448214,20140911,Pembrolizumab,36,801,36.0,2,,1,0,1,0,1,0,0,Pembrolizumab,SUMATRIPTAN|SUMATRIPTAN SUCCINATE|PEMBROLIZUMAB|LORAZEPAM,4,MIGRAINE PROPHYLAXIS|MIGRAINE PROPHYLAXIS|METASTATIC MALIGNANT MELANOMA|INSOMNIA,Rectal haemorrhage|Nausea|Colitis|Fatigue|Rash|Diarrhoea haemorrhagic|Abdominal pain|Nausea|Fatigue|Haemorrhage,10,5
10448227,20140911,Pembrolizumab,27,801,27.0,1,,1,0,0,0,0,0,0,Pembrolizumab,ZOLPIDEM TARTRATE|PEMBROLIZUMAB,2,INSOMNIA|METASTATIC MALIGNANT MELANOMA,Alanine aminotransferase increased|Headache|Nausea|Hypotension|Tachycardia|Aspartate aminotransferase increased|Fatigue|Dizziness|Hot flush|Pain|Arthralgia|Feeling cold,12,3
10450301,20140912,Pembrolizumab,73,801,73.0,1,46.5,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|AMLODIPINE|TIOTROPIUM BROMIDE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|PEMBROLIZUMAB,8,HYPERTENSION|ROUTINE HEALTH MAINTENANCE|DYSPNOEA|DYSPNOEA|DYSPHAGIA|NON-SMALL CELL LUNG CANCER,Pneumonia|Chronic obstructive pulmonary disease,2,1
10450411,20140912,Pembrolizumab,69,801,69.0,2,64.2,1,0,1,0,0,0,0,Pembrolizumab,OXYCODONE HYDROCHLORIDE|MELOXICAM|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|PEMBROLIZUMAB,7,ADVERSE EVENT|ADVERSE EVENT|PAIN IN EXTREMITY|DEEP VEIN THROMBOSIS|FEMUR FRACTURE|PAIN IN EXTREMITY|NON-SMALL CELL LUNG CANCER,Pathological fracture|Pleural effusion|Thoracic vertebral fracture|Lymphangitis,4,3
10450419,20140912,Pembrolizumab,81,801,81.0,2,,1,0,1,0,0,0,0,Pembrolizumab,"PROMETHAZINE HYDROCHLORIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE HYDROCHLORIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|PEMBROLIZUMAB|FONDAPARINUX SODIUM|PROMETHAZINE HYDROCHLORIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|NALOXONE HYDROCHLORIDE NASAL|NALOXONE HYDROCHLORIDE|METRONIDAZOLE",21,NAUSEA|NAUSEA|VOMITING|PAIN|PAIN|NAUSEA|URINARY TRACT INFECTION|MALIGNANT MELANOMA|VOMITING|VOMITING|PAIN,Adrenal insufficiency,1,5
10450804,20140912,Pembrolizumab,61,801,61.0,1,,1,0,1,0,0,0,1,Pembrolizumab,"CLOBETASOL PROPIONATE|CLOBETASOL PROPIONATE OINTMENT USP, 0.05%|ZOLPIDEM TARTRATE|GUAIFENESIN|CEPHALEXIN|METHADONE HYDROCHLORIDE|METHADONE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|PEMBROLIZUMAB|GABAPENTIN|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|OXYCODONE|HYDROCORTISONE SODIUM SUCCINATE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",18,COUGH|NAUSEA|METASTATIC MALIGNANT MELANOMA|PAIN|MALAISE,Pyrexia|Diarrhoea|Diarrhoea|Vomiting|Nausea|Colitis|Nausea|Diarrhoea|Pyrexia|Vomiting,10,5
10451253,20140912,Pembrolizumab,78,801,78.0,2,89.34,1,0,0,0,0,0,0,Pembrolizumab,"PREDNISONE|OXYCODONE|PEMBROLIZUMAB|LORATADINE|LORATADINE TABLET|LANSOPRAZOLE|PEMBROLIZUMAB|POTASSIUM CHLORIDE|RIVAROXABAN|SIMVASTATIN|VENLAFAXINE HYDROCHLORIDE|PREDNISONE|LOSARTAN POTASSIUM|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|METHYLPREDNISOLONE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE|VENLAFAXINE HYDROCHLORIDE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE",23,LOCAL SWELLING|ARTHRALGIA|MUSCULOSKELETAL DISCOMFORT|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|ASTHMA|BLOOD POTASSIUM DECREASED|THROMBOSIS PROPHYLAXIS|BLOOD CHOLESTEROL DECREASED|PROPHYLAXIS|PROPHYLAXIS|INFLAMMATION|HYPERTENSION|HYPERTENSION|HYPOTHYROIDISM|LOCAL SWELLING|ARTHRALGIA|SLEEP DISORDER THERAPY|DEPRESSION|ASTHMA|ROUTINE HEALTH MAINTENANCE,Infusion related reaction,1,1
10451260,20140912,Pembrolizumab,72,801,72.0,1,,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,HEAD AND NECK CANCER,Dyspnoea|Death,2,1
10451324,20140912,Pembrolizumab,79,801,79.0,2,64.4,1,0,1,0,0,0,0,Pembrolizumab,"ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE|ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES|SIMVASTATIN|METOPROLOL TARTRATE|METOPROLOL|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB",9,PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|HYPERCHOLESTEROLAEMIA|HYPERTROPHY|HYPERTROPHY|GLAUCOMA|MALIGNANT MELANOMA,Rectal cancer|Cholangitis,2,1
10451418,20140912,Pembrolizumab,40,801,40.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|LACTULOSE|PEMBROLIZUMAB|ESCITALOPRAM|PEMBROLIZUMAB|ZOLPIDEM TARTRATE|MORPHINE|OXYCODONE,8,CONSTIPATION|METASTATIC MALIGNANT MELANOMA|SLEEP DISORDER|PAIN|PAIN,Nausea|Abdominal pain|Vomiting|Pyrexia,4,3
10452073,20140915,Pembrolizumab,69,801,69.0,2,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PREDNISONE|PREDNISONE|LEVOTHYROXINE SODIUM,5,MALIGNANT MELANOMA STAGE IV|HYPOPITUITARISM|PROPHYLAXIS|HORMONE REPLACEMENT THERAPY|HYPOPITUITARISM,Fatigue|Diverticulitis|Leukocytosis|Pyrexia|Central nervous system neoplasm,5,5
10452586,20140915,Pembrolizumab,39,801,39.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS,3,HAEMATOLOGICAL MALIGNANCY|HEADACHE|DEHYDRATION,Pneumonia,1,1
10452700,20140915,Pembrolizumab,62,801,62.0,1,66,1,0,1,0,0,0,0,Pembrolizumab,TIOTROPIUM BROMIDE|PEMBROLIZUMAB|ZOLPIDEM TARTRATE|PEMBROLIZUMAB,8,CHRONIC OBSTRUCTIVE PULMONARY DISEASE|INSOMNIA|PAIN|NON-SMALL CELL LUNG CANCER|INSOMNIA|DYSPNOEA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Pneumonitis|Malignant neoplasm progression|Dyspnoea,3,1
10454153,20140915,Pembrolizumab,77,801,77.0,2,67.2,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|RAMIPRIL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|TRAMADOL HYDROCHLORIDE|TRAMADOL HYDROCHLORIDE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SIMVASTATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,17,LUNG NEOPLASM MALIGNANT|PROPHYLAXIS|HYPERTENSION|ANTACID THERAPY|ARTHRALGIA|ARTHRALGIA|PAIN IN EXTREMITY|MUSCULOSKELETAL PAIN|SEDATION|ROUTINE HEALTH MAINTENANCE|MUSCULOSKELETAL PAIN|ARTHRALGIA|MUSCULOSKELETAL PAIN|HYPERTENSION|HYPERCHOLESTEROLAEMIA|ARTHRALGIA|MUSCULOSKELETAL PAIN,Pleural effusion|Hyponatraemia|Adrenal insufficiency|Cardiac failure congestive|Hypothyroidism,5,3
10454417,20140915,Pembrolizumab,74,801,74.0,1,77.7,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,7,CONSTIPATION|PAIN IN EXTREMITY|MALIGNANT MELANOMA|NECK PAIN|CONGENITAL HYPERTHYROIDISM|GASTROOESOPHAGEAL REFLUX DISEASE,Autoimmune pancreatitis,1,1
10457016,20140916,Pembrolizumab,66,801,66.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Hepatotoxicity,1,1
10457024,20140916,Pembrolizumab,70,801,70.0,2,72,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|DENOSUMAB|BISOPROLOL FUMARATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PEMBROLIZUMAB,12,PAIN|HYPOTHYROIDISM|METASTASES TO BONE|HYPERTENSION|ROUTINE HEALTH MAINTENANCE|HYPERTENSION|PAIN|NON-SMALL CELL LUNG CANCER|ATRIAL FIBRILLATION|HYPERTENSION|ANXIETY,Gastritis|Gastrooesophageal reflux disease,2,1
10457384,20140916,Pembrolizumab,76,801,76.0,2,81.8,1,0,1,1,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,4,VITAMIN D DEFICIENCY|MYELODYSPLASTIC SYNDROME|THROMBOCYTOPENIA,Tumour lysis syndrome,1,1
10457531,20140916,Pembrolizumab,,,,1,67,1,1,1,0,0,0,0,Pembrolizumab,OXYCODONE HYDROCHLORIDE|IPILIMUMAB|PEMBROLIZUMAB|PREGABALIN|IPILIMUMAB,11,ANTI-EPITHELIAL ANTIBODY|METASTATIC MALIGNANT MELANOMA|NEURALGIA,Hepatitis cholestatic|Malignant neoplasm progression,2,5
10457532,20140916,Pembrolizumab,64,801,64.0,2,49.1,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|DIPHENHYDRAMINE HYDROCHLORIDE|CLONAZEPAM|PEMBROLIZUMAB,11,DIARRHOEA|TACHYCARDIA|ROUTINE HEALTH MAINTENANCE|DIARRHOEA|NAUSEA|PROPHYLAXIS|ANXIETY|MALIGNANT MELANOMA|PSORIASIS,Diarrhoea|Urinary retention|Arthritis|Intestinal obstruction,4,1
10457592,20140916,Pembrolizumab,72,801,72.0,1,,1,1,1,0,0,0,0,Pembrolizumab,LOSARTAN POTASSIUM|WARFARIN|DILTIAZEM HYDROCHLORIDE|HYDROCHLOROTHIAZIDE|PEMBROLIZUMAB|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|PEMBROLIZUMAB|PEMBROLIZUMAB,8,HYPERTENSION|AORTIC VALVE REPLACEMENT|HYPERTENSION|HYPERTENSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|METASTATIC MALIGNANT MELANOMA,Seizure|Malignant neoplasm progression,2,3
10457593,20140916,Pembrolizumab,71,801,71.0,1,115,1,0,1,0,0,0,0,Pembrolizumab,SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PEMBROLIZUMAB,6,PANCOAST^S SYNDROME|PREMEDICATION|NON-SMALL CELL LUNG CANCER|PANCOAST^S SYNDROME|CANCER PAIN|INFECTION PROPHYLAXIS,Confusional state|Fall,2,1
10457642,20140916,Pembrolizumab,,,,0,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,,Urticaria|Dyspnoea|Rash generalised,3,5
10457644,20140916,Pembrolizumab,47,801,47.0,1,,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|MORPHINE SULFATE|OXYGEN|0XYGEN|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FUROSEMIDE|OXYGEN|0XYGEN|MORPHINE|PEMBROLIZUMAB|IPRATROPIUM BROMIDE|MORPHINE SULFATE,24,PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|TUMOUR PAIN|PROPHYLAXIS|CONSTIPATION|PROPHYLAXIS|TUMOUR PAIN|OEDEMA PERIPHERAL|PROPHYLAXIS|PROPHYLAXIS|PNEUMONITIS|TUMOUR PAIN|TUMOUR PAIN|TUMOUR PAIN|TUMOUR PAIN|ASTHMA|ASTHMA|TUMOUR PAIN|TUMOUR PAIN|TUMOUR PAIN|PNEUMONITIS|TUMOUR PAIN,Pneumonitis|Pneumonitis,2,1
10457691,20140916,Pembrolizumab,84,801,84.0,1,90.5,1,0,1,0,0,0,0,Pembrolizumab,CELECOXIB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|PEMBROLIZUMAB|IRBESARTAN|LANSOPRAZOLE|ERGOCALCIFEROL|AMLODIPINE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PEMBROLIZUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LANSOPRAZOLE|IRBESARTAN|HYDROCHLOROTHIAZIDE|CELECOXIB|ERGOCALCIFEROL,22,OSTEOARTHRITIS|CARDIOVASCULAR EVENT PROPHYLAXIS|ADVERSE EVENT|NON-SMALL CELL LUNG CANCER|HYPERTENSION|GASTROOESOPHAGEAL REFLUX DISEASE|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|HYPERTENSION|ROUTINE HEALTH MAINTENANCE|CARDIOVASCULAR EVENT PROPHYLAXIS|CARDIOVASCULAR EVENT PROPHYLAXIS|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION|HYPERTENSION|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|PAIN|ROUTINE HEALTH MAINTENANCE,Syncope|Blood creatine phosphokinase increased,2,3
10457693,20140916,Pembrolizumab,40,801,40.0,2,49.9,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|MAGNESIUM OXIDE,21,VOMITING|CANDIDA INFECTION|INSOMNIA|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS AGAINST DIARRHOEA|COUGH|ADVERSE EVENT|COUGH|COUGH|HEADACHE|NAUSEA|HEADACHE|SKIN FISSURES|DECREASED APPETITE|ADVERSE EVENT|DERMATITIS|ABDOMINAL PAIN|ECZEMA|DEPRESSION|DERMATITIS|CONSTIPATION,Muscular weakness|Dysuria,2,3
10459217,20140917,Pembrolizumab,48,801,48.0,2,114.8,1,0,1,1,0,0,0,Pembrolizumab,METHADONE HYDROCHLORIDE|METHADONE|HYDROMORPHONE HYDROCHLORIDE|HYDROMORPHONE HYDROCHLORIDE|METHADONE HYDROCHLORIDE|METHADONE|PEMBROLIZUMAB|ALLOPURINOL|FUROSEMIDE|ASCORBIC ACID,12,PAIN IN EXTREMITY|ROUTINE HEALTH MAINTENANCE|DIABETES MELLITUS|BACK PAIN|HYPERTENSION|DYSPNOEA|PAIN IN EXTREMITY|BACK PAIN|SQUAMOUS CELL CARCINOMA OF THE CERVIX|BLOOD URIC ACID INCREASED|URINE URIC ACID|ROUTINE HEALTH MAINTENANCE,Rash|Cellulitis|Hyperbilirubinaemia,3,1
10459830,20140917,Pembrolizumab,42,801,42.0,2,,1,0,1,0,0,0,0,Pembrolizumab,"BUPRENORPHINE|PREGABALIN|OFLOXACIN|OFLOXACIN OTIC|OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3%|OFLOXACIN OTIC SOLUTION|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PREGABALIN",10,PAIN|PAIN|PAIN|PAIN|GENITAL INFECTION|METASTATIC MALIGNANT MELANOMA,Myoclonus,1,5
10459930,20140917,Pembrolizumab,52,801,52.0,2,98,1,0,1,0,0,0,1,Pembrolizumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DIVALPROEX SODIUM|PEMBROLIZUMAB|PEMBROLIZUMAB,6,ARTHRALGIA|ARTHRALGIA|AFFECTIVE DISORDER|MALIGNANT MELANOMA|ARTHRALGIA,Thrombocytopenia|Thrombocytopenia,2,1
10460045,20140917,Pembrolizumab,42,801,42.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,MALIGNANT MELANOMA,Fatigue|Fatigue|Fatigue,3,5
10460252,20140917,Pembrolizumab,46,801,46.0,2,,1,0,0,0,0,0,0,Pembrolizumab,"BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|DESONIDE|ZOLMITRIPTAN|METOPROLOL SUCCINATE|DIPHENHYDRAMINE HYDROCHLORIDE|PEMBROLIZUMAB|ESOMEPRAZOLE MAGNESIUM|ALPRAZOLAM|CETIRIZINE HYDROCHLORIDE|CARISOPRODOL|MEDROXYPROGESTERONE ACETATE|AMLODIPINE BESYLATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",15,ASTHMA|RASH|MIGRAINE|HYPERTENSION|PRURITUS|METASTATIC MALIGNANT MELANOMA|GASTROOESOPHAGEAL REFLUX DISEASE|ANXIETY|PRURITUS|PAIN|HYPERSENSITIVITY|CONTRACEPTION|HYPERTENSION|ASTHMA|PAIN,Anaemia|Nasopharyngitis|Pain|Dyspnoea|Headache|Vision blurred|Cough,7,5
10460472,20140918,Pembrolizumab,56,801,56.0,2,,1,0,1,0,0,0,1,Pembrolizumab,"FERROUS SULFATE|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|PEMBROLIZUMAB|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|ENOXAPARIN SODIUM|LORATADINE|LORATADINE TABLET|PEMBROLIZUMAB|ASCORBIC ACID",11,VITAMIN SUPPLEMENTATION|PAIN|URINARY TRACT INFECTION|VITAMIN SUPPLEMENTATION|ANTICOAGULANT THERAPY|VITAMIN SUPPLEMENTATION|SEASONAL ALLERGY|PAIN|METASTATIC MALIGNANT MELANOMA|VITAMIN SUPPLEMENTATION,Nausea|Abdominal pain|Vomiting,3,1
10460692,20140918,Pembrolizumab,79,801,79.0,1,,1,0,0,0,0,0,0,Pembrolizumab,DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|PEMBROLIZUMAB|NITROGLYCERIN|FOLIC ACID|ERGOCALCIFEROL|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|INSULIN GLARGINE|INSULIN LISPRO|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CYANOCOBALAMIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,16,BLOOD CHOLESTEROL|CONSTIPATION|MALIGNANT MELANOMA|VITAMIN SUPPLEMENTATION|DIABETES MELLITUS|DIABETES MELLITUS|DIABETES MELLITUS|VITAMIN SUPPLEMENTATION|PAIN|VITAMIN SUPPLEMENTATION|ROUTINE HEALTH MAINTENANCE,Fatigue|Fatigue|Vomiting,3,5
10461951,20140918,Pembrolizumab,71,801,71.0,1,93.15,1,0,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB|ERGOCALCIFEROL|PREDNISOLONE ACETATE|SERTRALINE HYDROCHLORIDE|PEMBROLIZUMAB,7,MALIGNANT MELANOMA|ROUTINE HEALTH MAINTENANCE|SCLERITIS|HYPERLIPIDAEMIA|DEPRESSION|ROUTINE HEALTH MAINTENANCE,Sinusitis,1,1
10461953,20140918,Pembrolizumab,86,801,86.0,1,71,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|REPAGLINIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CLOPIDOGREL|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,19,MALIGNANT MELANOMA|TYPE 2 DIABETES MELLITUS|BENIGN PROSTATIC HYPERPLASIA|HYPERGLYCAEMIA|DIARRHOEA|MYOCARDIAL ISCHAEMIA|MYOCARDIAL INFARCTION|MYOCARDIAL ISCHAEMIA|PRURITUS|MYOCARDIAL ISCHAEMIA|SLEEP DISORDER|HYPERTENSION|DIARRHOEA|PROPHYLAXIS,Pneumonia|Diarrhoea|Pneumonia,3,1
10462021,20140918,Pembrolizumab,80,801,80.0,1,66,1,1,1,1,0,0,0,Pembrolizumab,PEMBROLIZUMAB|FLUVASTATIN SODIUM|PEMBROLIZUMAB|CLOPIDOGREL|PEMBROLIZUMAB,16,PRURITUS|BACK PAIN|HYPERTENSION|DYSLIPIDAEMIA|ATRIAL FIBRILLATION|ISCHAEMIC STROKE|ATRIAL FIBRILLATION|MALIGNANT MELANOMA|PRURITUS|ATRIAL FIBRILLATION|HYPERTENSION|BACK PAIN|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|BACK PAIN,Lung infection|Pulmonary embolism,2,1
10462022,20140918,Pembrolizumab,67,801,67.0,1,100,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|BRINZOLAMIDE|PEMBROLIZUMAB|PEMBROLIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE,16,RETINAL VEIN OCCLUSION|RETINAL VEIN OCCLUSION|DIARRHOEA|DRY SKIN|HYPERTENSION|DIARRHOEA|MALIGNANT MELANOMA|ARTHRALGIA|ABDOMINAL PAIN|OESOPHAGITIS|DYSLIPIDAEMIA|HYPOKALAEMIA|DIARRHOEA,Colitis|Hypokalaemia|Colitis,3,1
10462029,20140918,Pembrolizumab,80,801,80.0,1,70,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|CLOPIDOGREL|FLUVASTATIN SODIUM|PEMBROLIZUMAB,12,HYPERTENSION|SALIVARY GLAND PAIN|HYPERTENSION|CONSTIPATION PROPHYLAXIS|PRURITUS|BACK PAIN|ISCHAEMIC STROKE|PRURITUS|DYSLIPIDAEMIA|MALIGNANT MELANOMA,Atrial fibrillation|Hepatitis,2,1
10462484,20140918,Pembrolizumab,72,801,72.0,1,91.16,1,0,1,0,0,0,0,Pembrolizumab,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|SERTRALINE HYDROCHLORIDE|PREDNISOLONE ACETATE|DIPHENHYDRAMINE HYDROCHLORIDE|PEMBROLIZUMAB|PEMBROLIZUMAB|ERGOCALCIFEROL|GUAIFENESIN",11,MYALGIA|HYPERLIPIDAEMIA|DEPRESSION|SCLERITIS|NASAL CONGESTION|ROUTINE HEALTH MAINTENANCE|MALIGNANT MELANOMA|ROUTINE HEALTH MAINTENANCE|COUGH|ANTIALLERGIC THERAPY,Autoimmune hepatitis,1,1
10462645,20140918,Pembrolizumab,55,801,55.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Anaemia,1,5
10462657,20140918,Pembrolizumab,70,801,70.0,1,83.2,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|PEMBROLIZUMAB|PEMBROLIZUMAB,7,NON-SMALL CELL LUNG CANCER|ROUTINE HEALTH MAINTENANCE|PROSTATOMEGALY|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION,Vasculitis|Viral infection|Lower respiratory tract infection|Hypophysitis,4,3
10462728,20140918,Pembrolizumab,55,801,55.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,5,METASTATIC MALIGNANT MELANOMA|PAIN|CONVULSION PROPHYLAXIS|GASTROOESOPHAGEAL REFLUX DISEASE,Dehydration,1,1
10463761,20140919,Pembrolizumab,66,801,66.0,2,,1,0,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB,3,METASTASES TO CENTRAL NERVOUS SYSTEM|METASTATIC MALIGNANT MELANOMA,Central nervous system lesion|Fatigue,2,5
10463882,20140919,Pembrolizumab,70,801,70.0,1,54.5,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|ROSUVASTATIN,18,HYPERTONIC BLADDER|CHRONIC GASTRITIS|CONSTIPATION|NON-SMALL CELL LUNG CANCER|COUGH|NAUSEA|RASH|INSOMNIA|RASH|COUGH|PROSTATOMEGALY|PYREXIA|COUGH|DYSLIPIDAEMIA|CHRONIC GASTRITIS|GASTROINTESTINAL INJURY,Diverticulitis,1,1
10464302,20140919,Pembrolizumab,53,801,53.0,2,50.2,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|CLONAZEPAM|MORPHINE|OXYCODONE|MORPHINE|PEMBROLIZUMAB|MORPHINE SULFATE|OXYCODONE|GABAPENTIN|LEVETIRACETAM|NICOTINE POLACRILEX|NICOTINE|NICOTINE POLACRILEX MINI|NICOTINE POLARILEX|DOCUSATE CALCIUM|STOOL SOFTENER|MORPHINE|GABAPENTIN|PEMBROLIZUMAB|CLONAZEPAM|CITALOPRAM|MORPHINE SULFATE,18,DEPRESSION|PAIN|LUNG NEOPLASM MALIGNANT|PAIN|PAIN|PAIN|SEIZURE|EX-TOBACCO USER|CONSTIPATION|PAIN|ANXIETY|DEPRESSION|PAIN,Nausea|Vomiting|Drug withdrawal maintenance therapy|Nausea,4,1
10464424,20140919,Pembrolizumab,74,801,74.0,2,59.6,1,0,1,0,0,0,0,Pembrolizumab,LORAZEPAM|ERGOCALCIFEROL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|GRANISETRON|GRANISETRON HYDROCHLORIDE|PROMETHAZINE|PEMBROLIZUMAB|PEMBROLIZUMAB,13,PROPHYLAXIS OF NAUSEA AND VOMITING|ROUTINE HEALTH MAINTENANCE|THROMBOSIS|ADVERSE EVENT|MUSCULOSKELETAL PAIN|ROUTINE HEALTH MAINTENANCE|ADVERSE EVENT|ADVERSE EVENT|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING|NON-SMALL CELL LUNG CANCER|THROMBOSIS PROPHYLAXIS,Adrenal insufficiency,1,3
10464935,20140919,Pembrolizumab,81,801,81.0,1,75.8,1,0,1,0,0,0,0,Pembrolizumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PEMBROLIZUMAB|TRAMADOL HYDROCHLORIDE|PEMBROLIZUMAB|FOLIC ACID,11,ROUTINE HEALTH MAINTENANCE|PAIN|GASTROOESOPHAGEAL REFLUX PROPHYLAXIS|ROUTINE HEALTH MAINTENANCE|NON-SMALL CELL LUNG CANCER|PAIN|ROUTINE HEALTH MAINTENANCE|THROMBOSIS PROPHYLAXIS|ROUTINE HEALTH MAINTENANCE|PRODUCT USED FOR UNKNOWN INDICATION,Pleural effusion|Lung infection,2,3
10465744,20140919,Pembrolizumab,74,801,74.0,2,50.3,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,3,MALIGNANT MELANOMA|ASTHMA EXERCISE INDUCED,Interstitial lung disease,1,1
10466052,20140922,Pembrolizumab,74,801,74.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|HYDROCORTISONE SODIUM SUCCINATE|ZOLPIDEM TARTRATE|METOPROLOL TARTRATE|METOPROLOL,7,METASTATIC MALIGNANT MELANOMA,Rash maculo-papular|Alanine aminotransferase increased|Aspartate aminotransferase increased,3,3
10466794,20140922,Pembrolizumab,63,801,63.0,1,100.6,1,0,1,0,1,0,0,Pembrolizumab,"DIAZEPAM|METHYLPREDNISOLONE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|PEMBROLIZUMAB|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|ESOMEPRAZOLE MAGNESIUM|DIPHENHYDRAMINE HYDROCHLORIDE|STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM|SALMETEROL XINAFOATE|LEVOTHYROXINE SODIUM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",14,METASTATIC MALIGNANT MELANOMA|PAIN,Muscular weakness|Pollakiuria|Haematuria|Peripheral sensory neuropathy|Nausea|Vomiting|Constipation,7,5
10467195,20140922,Pembrolizumab,66,801,66.0,1,53.2,1,1,1,0,0,0,0,Pembrolizumab,MORPHINE SULFATE|LACTULOSE|PEMBROLIZUMAB|MAGNESIUM OXIDE|LACTULOSE|MORPHINE SULFATE|PREGABALIN|MORPHINE SULFATE|PEMBROLIZUMAB|PEMBROLIZUMAB|FUROSEMIDE|AMOXICILLIN AND CLAVULANATE POTASSIUM|AMOXICILLIN AND CLAVULANATE POTASSIUM|LACTULOSE,25,CONSTIPATION PROPHYLAXIS|CONSTIPATION|TUMOUR PAIN|ANXIETY|TUMOUR PAIN|FAECAL INCONTINENCE|ADVERSE EVENT|PROPHYLAXIS AGAINST DEHYDRATION|TUMOUR PAIN|PROPHYLAXIS|NEOPLASM MALIGNANT|ADVERSE EVENT|INFECTION PROPHYLAXIS|ADVERSE EVENT|ADVERSE EVENT|COUGH|CONSTIPATION|DIARRHOEA|PROPHYLAXIS AGAINST DEHYDRATION,Constipation|Interstitial lung disease,2,1
10467312,20140922,Pembrolizumab,53,801,53.0,1,85,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|DABRAFENIB|PEMBROLIZUMAB|DENOSUMAB,7,VITAMIN SUPPLEMENTATION|MALIGNANT MELANOMA|MALIGNANT MELANOMA|MUSCULOSKELETAL PAIN|PROPHYLAXIS,Cough,1,1
10467421,20140922,Pembrolizumab,54,801,54.0,1,95,1,0,0,1,0,0,0,Pembrolizumab,PEMBROLIZUMAB|BISOPROLOL FUMARATE|PEMBROLIZUMAB,9,PRURITUS|ANXIETY|HYPERGLYCAEMIA|HYPERTENSION|HYPERTENSION|MALIGNANT MELANOMA|HYPERTENSION|HYPOTHYROIDISM,Anaphylactic reaction,1,1
10467503,20140922,Pembrolizumab,61,801,61.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|FERROUS SULFATE|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,7,METASTATIC MALIGNANT MELANOMA|ANAEMIA,Squamous cell carcinoma of skin|Rash maculo-papular|Neoplasm malignant|Rash maculo-papular|Diarrhoea|Rash maculo-papular|Vitiligo,7,3
10467504,20140922,Pembrolizumab,64,801,64.0,2,,1,0,1,0,0,0,0,Pembrolizumab,LEVOTHYROXINE SODIUM|PEMBROLIZUMAB,2,HYPOTHYROIDISM|MALIGNANT MELANOMA,Pneumonitis,1,3
10467612,20140922,Pembrolizumab,54,801,54.0,1,,1,0,1,0,1,0,0,Pembrolizumab,PEMBROLIZUMAB|CLOPIDOGREL|CLOPIDOGREL BISULFATE|LOSARTAN POTASSIUM|LOSARTAN|PEMBROLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DESLORATADINE|PEMBROLIZUMAB,9,CORONARY ARTERY DISEASE|HYPERTENSION|ABDOMINAL PAIN|ABDOMINAL PAIN UPPER|PRURITUS|HYPERLIPIDAEMIA|MALIGNANT MELANOMA STAGE IV,Polyneuropathy|Pancreatitis|Arthralgia|Myalgia|Iridocyclitis,5,1
10467819,20140922,Pembrolizumab,43,801,43.0,2,71,1,0,1,1,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,4,NEOPLASM MALIGNANT|TACHYCARDIA|ANXIETY|BREAST CANCER,Septic shock|Pleural effusion|Pericardial effusion,3,1
10467917,20140922,Pembrolizumab,61,801,61.0,1,81.6,1,0,1,0,0,0,0,Pembrolizumab,IPILIMUMAB|IPILIMUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|SIMVASTATIN|METHIMAZOLE|SITAGLIPTIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,10,RENAL CELL CARCINOMA|RENAL CELL CARCINOMA|BLOOD CHOLESTEROL|HYPERTHYROIDISM|DIABETES MELLITUS|ROUTINE HEALTH MAINTENANCE|DIABETES MELLITUS|PAIN,Hyperthyroidism|Pancreatic enzymes increased,2,1
10468263,20140922,Pembrolizumab,53,801,53.0,2,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|CEFUROXIME|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,3,METASTATIC MALIGNANT MELANOMA|INFECTION|ADRENAL INSUFFICIENCY,Hypophysitis|General physical health deterioration,2,1
10469537,20140923,Pembrolizumab,63,801,63.0,2,60.4,1,0,1,1,0,0,0,Pembrolizumab,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PEMBROLIZUMAB|PEMBROLIZUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|DIFLUPREDNATE OPHTHALMIC|DIFLUPREDNATE|NEPAFENAC|BUPROPION HYDROCHLORIDE|LORAZEPAM|TIOTROPIUM BROMIDE|DIPHENHYDRAMINE HYDROCHLORIDE|LEVOTHYROXINE SODIUM|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|METOPROLOL TARTRATE|METOPROLOL|ALBUTEROL SULFATE|ALBUTEROL|IPRATROPIUM BROMIDE|OXYCODONE|DIPHENHYDRAMINE HYDROCHLORIDE,21,DYSPNOEA|NAUSEA|NON-SMALL CELL LUNG CANCER|CONSTIPATION|PROPHYLAXIS URINARY TRACT INFECTION|CATARACT OPERATION|CATARACT OPERATION|PROPHYLAXIS|ANXIETY|DYSPNOEA|PITYRIASIS ROSEA|HYPOTHYROIDISM|ATRIAL FIBRILLATION|DYSPNOEA|ROUTINE HEALTH MAINTENANCE|DYSPNOEA|DYSPNOEA|PAIN|PITYRIASIS ROSEA,Dyspnoea,1,3
10469833,20140923,Pembrolizumab,58,801,58.0,2,71.4,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|GABAPENTIN|PEMBROLIZUMAB,5,NEOPLASM MALIGNANT|NEURALGIA|NEURALGIA|NEURALGIA,Cytokine release syndrome,1,1
10470292,20140923,Pembrolizumab,55,801,55.0,2,81.8,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|ERGOCALCIFEROL,5,NEOPLASM MALIGNANT|HYPOTHYROIDISM|VITAMIN SUPPLEMENTATION,Dermatitis,1,1
10470441,20140923,Pembrolizumab,73,801,73.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,METASTATIC MALIGNANT MELANOMA,Hypothyroidism,1,5
10470531,20140923,Pembrolizumab,67,801,67.0,2,,1,0,0,0,0,0,0,Pembrolizumab,OXYCODONE|PEMBROLIZUMAB,3,ROUTINE HEALTH MAINTENANCE|PAIN|MALIGNANT MELANOMA,Fatigue,1,5
10470534,20140923,Pembrolizumab,79,801,79.0,2,75.5,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|ATENOLOL|PEMBROLIZUMAB|PEMBROLIZUMAB,11,HYPERTENSION|SCIATICA|HYPOKALAEMIA|MALIGNANT MELANOMA|CATARACT|SCIATICA|CONSTIPATION|PROPHYLAXIS|THROMBOSIS PROPHYLAXIS,Blood corticotrophin decreased,1,1
10471100,20140923,Pembrolizumab,65,801,65.0,1,80.91,1,0,1,0,0,0,1,Pembrolizumab,"FAMOTIDINE|LOSARTAN POTASSIUM|KETOCONAZOLE|KETOCONAZOLE FOAM|KETOCONAZOLE CREAM, 2%|OMEPRAZOLE MAGNESIUM|MONTELUKAST SODIUM|FLUOCINONIDE|FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|FERROUS SULFATE|FINASTERIDE|CLOBETASOL PROPIONATE|CLOBETASOL PROPIONATE OINTMENT USP, 0.05%|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FERROUS SULFATE|PEMBROLIZUMAB|FLUOXETINE HYDROCHLORIDE|CAMPHOR AND MENTHOL|PRAMOXINE HYDROCHLORIDE|COLLOIDAL OATMEAL|PRAMOXINE HYDROCHLORIDE, MENTHOL|ASCORBIC ACID",17,GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION|DRY SKIN|GASTROOESOPHAGEAL REFLUX DISEASE|PRURITUS|DIABETES MELLITUS|ANAEMIA|DRY SKIN|ADVERSE EVENT|PROPHYLAXIS|MALIGNANT MELANOMA|DEPRESSION|ADVERSE EVENT|SUPPLEMENTATION THERAPY|ADVERSE EVENT,Psoriatic arthropathy|Abscess limb,2,3
10471208,20140923,Pembrolizumab,44,801,44.0,2,72.5,1,0,1,0,0,0,0,Pembrolizumab,"LORAZEPAM|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS",6,ANXIETY|NEOPLASM MALIGNANT|NECK PAIN|HYPOTHYROIDISM,Acute kidney injury|Cough,2,1
10471300,20140923,Pembrolizumab,68,801,68.0,1,,1,1,1,0,0,0,0,Pembrolizumab,ONDANSETRON HYDROCHLORIDE|SERTRALINE HYDROCHLORIDE|PEMBROLIZUMAB|ACETAMINOPHEN AND CODEINE|LORAZEPAM|LANSOPRAZOLE|LORAZEPAM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE,12,NAUSEA|DEPRESSION|METASTATIC MALIGNANT MELANOMA|COUGH|ANXIETY|PAIN|ANTIBIOTIC THERAPY|ROUTINE HEALTH MAINTENANCE|DYSPEPSIA|INSOMNIA|CONSTIPATION|SEIZURE,Vomiting|Disease progression|Aspartate aminotransferase increased|Nausea|Diarrhoea,5,5
10471303,20140923,Pembrolizumab,82,801,82.0,2,,1,1,1,0,0,0,0,Pembrolizumab,ESCITALOPRAM|PEMBROLIZUMAB|GLIMEPIRIDE|LANSOPRAZOLE|INSULIN GLARGINE|TRAZODONE HYDROCHLORIDE|LOSARTAN POTASSIUM|CYANOCOBALAMIN|MAGNESIUM HYDROXIDE|POLYETHYLENE GLYCOL 3350|INSULIN LISPRO|PEMBROLIZUMAB|LORATADINE|LORATADINE TABLET|TRAMADOL HYDROCHLORIDE|SITAGLIPTIN|PEMBROLIZUMAB|PEMBROLIZUMAB|ATORVASTATIN CALCIUM,19,DEPRESSION|METASTATIC MALIGNANT MELANOMA|TYPE 2 DIABETES MELLITUS|GASTROOESOPHAGEAL REFLUX DISEASE|SINUS CONGESTION|TYPE 2 DIABETES MELLITUS|DEPRESSION|HYPERTENSION|VITAMIN B12 DEFICIENCY|CONSTIPATION|TYPE 2 DIABETES MELLITUS|SINUS CONGESTION|PAIN|COUGH|TYPE 2 DIABETES MELLITUS|HYPERLIPIDAEMIA,Vomiting|Pruritus|Dehydration|Pruritus|Dry mouth|Anaemia|Dry skin|Vomiting|Vomiting|Nausea|Disease progression|Dyspnoea|Nausea,13,5
10471473,20140923,Pembrolizumab,60,801,60.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Aspartate aminotransferase increased|Blood alkaline phosphatase increased|Blood bilirubin increased|Alanine aminotransferase increased,4,5
10471479,20140923,Pembrolizumab,54,801,54.0,1,,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,HEAD AND NECK CANCER,Staphylococcal bacteraemia|Death,2,1
10471480,20140923,Pembrolizumab,60,801,60.0,2,44,1,0,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|CYANOCOBALAMIN|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|PEMBROLIZUMAB|PEMBROLIZUMAB|ACETYLCYSTEINE,10,ANAEMIA|HYPERTHYROIDISM|NEOPLASM MALIGNANT|COUGH,Iridocyclitis|Iridocyclitis|Iridocyclitis,3,1
10471538,20140923,Pembrolizumab,53,801,53.0,2,,1,0,0,0,0,0,0,Pembrolizumab,LEVETIRACETAM|MEMANTINE|MEMANTINE HYDROCHLORIDE|ALPRAZOLAM|PEMBROLIZUMAB,4,METASTATIC MALIGNANT MELANOMA,Colitis|Hypophysitis,2,5
10472769,20140924,Pembrolizumab,75,801,75.0,1,80,1,0,1,0,0,0,0,Pembrolizumab,CLOPIDOGREL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|PEMBROLIZUMAB|PEMBROLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,11,HYPERTENSION|HYPERTENSION|TYPE 2 DIABETES MELLITUS|MALIGNANT MELANOMA|RHINITIS|HYPERTENSION|TYPE 2 DIABETES MELLITUS|ABDOMINAL PAIN UPPER|INSOMNIA|HYPOMAGNESAEMIA,Hydrocephalus|Renal failure,2,1
10472772,20140924,Pembrolizumab,74,801,74.0,1,,1,1,1,0,0,0,1,Pembrolizumab,FUROSEMIDE|FINASTERIDE|FUROSEMIDE|LORAZEPAM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ASCORBIC ACID|METHYLPHENIDATE HYDROCHLORIDE|PEMBROLIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,13,HEART RATE ABNORMAL|HYPERTENSION|BENIGN PROSTATIC HYPERPLASIA|FLUID RETENTION|ANXIETY|STOMATITIS|VITAMIN SUPPLEMENTATION|VITAMIN SUPPLEMENTATION|COAGULOPATHY|MINERAL SUPPLEMENTATION|ASTHENIA|METASTATIC MALIGNANT MELANOMA|OEDEMA,Pleural effusion,1,5
10473270,20140924,Pembrolizumab,74,801,74.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,5,METASTATIC MALIGNANT MELANOMA,Enteritis|Rash maculo-papular|Lymphocyte count decreased|Mucosal inflammation,4,5
10473373,20140924,Pembrolizumab,64,801,64.0,2,57.1,1,0,1,0,0,0,0,Pembrolizumab,"CALCIUM CARBONATE|ANTACID|PEMBROLIZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PROCHLORPERAZINE|CLONAZEPAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SERTRALINE HYDROCHLORIDE|FOLIC ACID|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CYANOCOBALAMIN",11,ROUTINE HEALTH MAINTENANCE|NON-SMALL CELL LUNG CANCER|NAUSEA|ANXIETY|NAUSEA|DEPRESSION|ADVERSE EVENT|PAIN|ROUTINE HEALTH MAINTENANCE|SLEEP DISORDER,Fatigue|Infusion related reaction,2,3
10473810,20140924,Pembrolizumab,80,801,80.0,1,,1,1,1,1,0,0,1,Pembrolizumab,ACYCLOVIR|PEMBROLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|FOLIC ACID,6,ANTIVIRAL TREATMENT|RASH|METASTATIC MALIGNANT MELANOMA|GASTROOESOPHAGEAL REFLUX DISEASE|HYPOTHYROIDISM|ROUTINE HEALTH MAINTENANCE,Stomatitis|Mucosal inflammation|Death|Rash maculo-papular|Sepsis,5,3
10473872,20140924,Pembrolizumab,42,801,42.0,1,,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Hyponatraemia|Death|Anaemia|Nausea|Vomiting|Constipation,6,5
10473876,20140924,Pembrolizumab,34,801,34.0,1,77,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|OXYCODONE HYDROCHLORIDE,5,MALIGNANT MELANOMA STAGE IV|ANALGESIC THERAPY|ANALGESIC THERAPY|ANALGESIC THERAPY,Thrombocytopenic purpura|Malignant neoplasm progression,2,3
10474333,20140924,Pembrolizumab,,,,1,60,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|CLOPIDOGREL|PEMBROLIZUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PEMBROLIZUMAB|CLOPIDOGREL|OXYCODONE HYDROCHLORIDE|ATENOLOL|TRAMADOL HYDROCHLORIDE,18,CAROTID ARTERY STENOSIS|HYPERTENSION|LUNG NEOPLASM MALIGNANT|PROPHYLAXIS|ADVERSE EVENT|ADVERSE EVENT|PROPHYLAXIS|ADVERSE EVENT|ARTHRITIS|HYPERTENSION|PROPHYLAXIS|HYPERTENSION|ADVERSE EVENT|HYPERCHOLESTEROLAEMIA,General physical health deterioration|Rectal haemorrhage,2,3
10474431,20140924,Pembrolizumab,79,801,79.0,1,,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CYANOCOBALAMIN|METOPROLOL TARTRATE|METOPROLOL|DIGITALIS|METOPROLOL TARTRATE|METOPROLOL|METOPROLOL TARTRATE|METOPROLOL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METRONIDAZOLE|METRONIDAZOLE TOPICAL,16,METASTATIC MALIGNANT MELANOMA|DIABETES MELLITUS|ANAEMIA MACROCYTIC|BLOOD CHOLESTEROL|HYPERTENSION|ATRIAL FIBRILLATION|ATRIAL FIBRILLATION|HYPERTENSION|ANTIBIOTIC THERAPY|ANTIBIOTIC THERAPY,Cellulitis|Face oedema|Failure to thrive|Fatigue|Fatigue|Anaemia|Failure to thrive|Malignant neoplasm progression,8,5
10474456,20140924,Pembrolizumab,69,801,69.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Platelet count decreased,1,5
10474458,20140924,Pembrolizumab,71,801,71.0,1,,1,0,0,0,0,0,0,Pembrolizumab,LACOSAMIDE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|OXYCODONE|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM,7,PROPHYLAXIS|METASTATIC MALIGNANT MELANOMA|HYPOTHYROIDISM,Rash|Rash,2,3
10474655,20140925,Pembrolizumab,,,,1,,1,0,0,0,0,0,0,Pembrolizumab,IPILIMUMAB|VEMURAFENIB|PEMBROLIZUMAB|TEMOZOLOMIDE,4,METASTATIC MALIGNANT MELANOMA,Unevaluable event|Disease progression,2,5
10475693,20140925,Pembrolizumab,64,801,64.0,1,,1,0,0,0,0,0,0,Pembrolizumab,LEVOTHYROXINE SODIUM|PEMBROLIZUMAB|ALENDRONATE SODIUM,3,METASTATIC MALIGNANT MELANOMA,Aspartate aminotransferase increased|Alanine aminotransferase increased,2,5
10475694,20140925,Pembrolizumab,78,801,78.0,1,,1,0,0,0,0,0,0,Pembrolizumab,"TAMSULOSIN HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PEMBROLIZUMAB|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|INSULIN ASPART|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,",11,HYPERTENSION|ROUTINE HEALTH MAINTENANCE|GASTROOESOPHAGEAL REFLUX DISEASE|MALIGNANT MELANOMA|HYPERTENSION|COLOSTOMY|DIABETES MELLITUS|DIARRHOEA|DIABETES MELLITUS|DIABETES MELLITUS|PCO2 DECREASED,Diarrhoea,1,5
10476097,20140925,Pembrolizumab,76,801,76.0,1,62.1,1,1,1,0,0,0,0,Pembrolizumab,CYANOCOBALAMIN|NIACINAMIDE|OXYCODONE HYDROCHLORIDE|ACETYLCYSTEINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PEMBROLIZUMAB|ASCORBIC ACID|FOLIC ACID|TENOFOVIR DISOPROXIL FUMARATE|TENOFOVIR DISOPROXIL FUMARATE TABLETS,15,ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|ADVERSE EVENT|ROUTINE HEALTH MAINTENANCE|PAIN|PULMONARY EMBOLISM|NON-SMALL CELL LUNG CANCER|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|ADVERSE EVENT|ROUTINE HEALTH MAINTENANCE|PROPHYLAXIS|ADVERSE EVENT,Cardio-respiratory arrest|Lethargy|Lower respiratory tract infection,3,3
10476309,20140925,Pembrolizumab,56,801,56.0,2,,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,4,METASTATIC MALIGNANT MELANOMA,Blood alkaline phosphatase increased|Malignant neoplasm progression|Oedema peripheral|Stomatitis|Stomatitis,5,5
10476313,20140925,Pembrolizumab,47,801,47.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Blood alkaline phosphatase increased,1,5
10476358,20140925,Pembrolizumab,38,801,38.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Arthralgia,1,5
10477916,20140926,Pembrolizumab,79,801,79.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,4,MALIGNANT MELANOMA,Pruritus|Blood bilirubin increased|Diarrhoea|Hyperglycaemia,4,3
10478270,20140926,Pembrolizumab,63,801,63.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,MALIGNANT MELANOMA,Rash maculo-papular|Pruritus,2,5
10478542,20140926,Pembrolizumab,63,801,63.0,1,,1,0,1,0,0,0,0,Pembrolizumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SIMVASTATIN|PEMBROLIZUMAB,4,HYPERTENSION|HYPERLIPIDAEMIA|METASTATIC MALIGNANT MELANOMA|ASTHMA,Cellulitis|Pyrexia,2,5
10478551,20140926,Pembrolizumab,37,801,37.0,1,85,1,0,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,5,MALIGNANT MELANOMA,Alanine aminotransferase increased|Aspartate aminotransferase increased,2,1
10478770,20140926,Pembrolizumab,61,801,61.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|IPILIMUMAB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Dyspnoea exertional|Fatigue|Decreased appetite|Visual impairment|Headache,5,5
10478976,20140926,Pembrolizumab,47,801,47.0,1,,1,1,1,0,0,0,0,Pembrolizumab,METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|CYANOCOBALAMIN|AMOXICILLIN|METHADONE HYDROCHLORIDE|METHADONE|LACTULOSE|PEMBROLIZUMAB|ALBUTEROL SULFATE|OMEPRAZOLE MAGNESIUM|MILK THISTLE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|LIDOCAINE / PRILOCAINE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|LORAZEPAM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,26,VOMITING|PAIN|ROUTINE HEALTH MAINTENANCE|NAUSEA|PAIN|MALIGNANT MELANOMA|ROUTINE HEALTH MAINTENANCE|CONSTIPATION|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|ANXIETY|NAUSEA|VOMITING,Dehydration|Fall|Anaemia|Asthenia|Renal failure acute|Neoplasm malignant|Abdominal pain,7,5
10478979,20140926,Pembrolizumab,62,801,62.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Fatigue,1,5
10478980,20140926,Pembrolizumab,55,801,55.0,2,,1,0,0,0,0,0,0,Pembrolizumab,ALPRAZOLAM|METOPROLOL SUCCINATE|SPIRONOLACTONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM,10,HYPERSENSITIVITY|ANXIETY|ROUTINE HEALTH MAINTENANCE|HYPERTENSION|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|METASTATIC MALIGNANT MELANOMA|HYPOTHYROIDISM,Fatigue|Rash maculo-papular,2,5
10479324,20140926,Pembrolizumab,41,801,41.0,2,,1,0,1,1,0,0,0,Pembrolizumab,ERGOCALCIFEROL|ASCORBIC ACID|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS,5,ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|METASTATIC MALIGNANT MELANOMA|HYPOTHYROIDISM|ROUTINE HEALTH MAINTENANCE,Diabetic ketoacidosis,1,5
10479378,20140926,Pembrolizumab,61,801,61.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Diarrhoea|Decreased appetite,2,5
10479410,20140926,Pembrolizumab,60,801,60.0,1,113.2,1,0,1,0,0,0,0,Pembrolizumab,"ALBUTEROL SULFATE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|SERTRALINE HYDROCHLORIDE|CLONAZEPAM|FERROUS SULFATE|PEMBROLIZUMAB|ENOXAPARIN SODIUM|PANTOPRAZOLE|PEMBROLIZUMAB|ALBUTEROL SULFATE|RANITIDINE HYDROCHLORIDE|ACYCLOVIR|SERTRALINE HYDROCHLORIDE|CYANOCOBALAMIN|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|SENNOSIDES",20,DYSPNOEA|DYSPNOEA|HYPOTHYROIDISM|ANXIETY|ANAEMIA|THROMBOSIS PROPHYLAXIS|GASTROOESOPHAGEAL REFLUX DISEASE|PROPHYLAXIS|NON-HODGKIN^S LYMPHOMA|WHEEZING|GASTROOESOPHAGEAL REFLUX DISEASE|INFECTION PROPHYLAXIS|DYSPNOEA|DEPRESSION|ANAEMIA|HYPERSENSITIVITY|CONSTIPATION,Vertigo,1,3
10479501,20140926,Pembrolizumab,68,801,68.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Metastases to central nervous system,1,5
10479865,20140929,Pembrolizumab,57,801,57.0,2,,1,0,1,0,0,0,0,Pembrolizumab,"PEMBROLIZUMAB|ALPRAZOLAM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",5,METASTATIC MALIGNANT MELANOMA|ANXIETY|HERPES SIMPLEX|PAIN|PAIN,Pyrexia,1,5
10480068,20140929,Pembrolizumab,,,,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Pruritus|Rash,2,5
10480250,20140929,Pembrolizumab,54,801,54.0,2,,1,0,0,0,0,0,0,Pembrolizumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PEMBROLIZUMAB",2,PAIN|MALIGNANT MELANOMA,Abdominal pain upper|Back pain|Pruritus,3,5
10480288,20140929,Pembrolizumab,,,,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Hypoaesthesia,1,5
10480290,20140929,Pembrolizumab,48,801,48.0,1,,1,0,1,0,0,0,0,Pembrolizumab,DEXTROMETHORPHAN|PEMBROLIZUMAB,3,COUGH|MALIGNANT MELANOMA|INFLUENZA LIKE ILLNESS,Rhabdomyolysis|Liver disorder,2,5
10480297,20140929,Pembrolizumab,67,801,67.0,1,,1,0,1,0,0,0,0,Pembrolizumab,OXYCODONE HYDROCHLORIDE|PEMBROLIZUMAB|PEMBROLIZUMAB,3,PAIN|METASTATIC MALIGNANT MELANOMA,Autoimmune hepatitis,1,5
10480330,20140929,Pembrolizumab,74,801,74.0,1,139.5,1,0,1,0,0,0,1,Pembrolizumab,ALBUTEROL SULFATE|PEMBROLIZUMAB|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|ARNICA MONTANA|ARNICA|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|METOPROLOL TARTRATE|METOPROLOL|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|PEMBROLIZUMAB|VITAMIN E|PEMBROLIZUMAB,13,ASTHMA|ATRIAL FIBRILLATION|SKIN LESION|RASH|HYPERTENSION|HYPOTHYROIDISM|ASTHMA|MALIGNANT MELANOMA|HYPERTENSION|RASH,Gout|Cholecystitis|Sepsis,3,1
10481013,20140929,Pembrolizumab,62,801,62.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|ROSUVASTATIN|LORATADINE|LORATADINE ORAL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ERGOCALCIFEROL,6,METASTATIC MALIGNANT MELANOMA|HYPERCHOLESTEROLAEMIA|HYPERSENSITIVITY|DIABETES MELLITUS|SUPPLEMENTATION THERAPY,Diarrhoea|Colitis,2,3
10481860,20140929,Pembrolizumab,42,801,42.0,1,56,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,7,NON-SMALL CELL LUNG CANCER|TUMOUR PAIN|ABDOMINAL PAIN UPPER|TUMOUR PAIN|TUMOUR PAIN,Interstitial lung disease,1,3
10481861,20140929,Pembrolizumab,60,801,60.0,2,66,1,0,1,0,0,0,0,Pembrolizumab,"PEMBROLIZUMAB|POLYETHYLENE GLYCOL|PEMBROLIZUMAB|ZOLPIDEM TARTRATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",8,MALIGNANT MELANOMA|NAUSEA|CONSTIPATION|SLEEP DISORDER THERAPY|PLATELET COUNT INCREASED|COUGH|PAIN,Meningitis|Peripheral motor neuropathy,2,1
10482233,20140929,Pembrolizumab,75,801,75.0,1,53.2,1,0,1,0,0,0,0,Pembrolizumab,SITAGLIPTIN|PEMBROLIZUMAB|ESOMEPRAZOLE MAGNESIUM,11,HYPERTENSION|DIABETES MELLITUS|DIABETES MELLITUS|HYPERTHERMIA MALIGNANT|NON-SMALL CELL LUNG CANCER|INSOMNIA|LUNG NEOPLASM MALIGNANT|PROPHYLAXIS|PROPHYLAXIS|DRY SKIN|HYPERTENSION,Interstitial lung disease,1,1
10482695,20140929,Pembrolizumab,54,801,54.0,1,98,1,0,1,0,0,0,0,Pembrolizumab,HYDROCORTISONE|PEMBROLIZUMAB|PEMBROLIZUMAB|GRANISETRON|GRANISETRON HYDROCHLORIDE|UNCARIA TOMENTOSA,15,BREAST PAIN|RASH MACULO-PAPULAR|MALIGNANT MELANOMA|PROPHYLAXIS|PROPHYLAXIS|APHTHOUS STOMATITIS|PROPHYLAXIS OF NAUSEA AND VOMITING|NAUSEA|ARTHROPOD BITE|ROUTINE HEALTH MAINTENANCE|PROPHYLAXIS|RASH|COUGH|IMMUNISATION,Pancreatitis,1,1
10483948,20140930,Pembrolizumab,,,,2,,1,0,0,0,0,0,0,Pembrolizumab,,1,MALIGNANT MELANOMA,Tumour pain|Neoplasm,2,5
10484578,20140930,Pembrolizumab,66,801,66.0,1,77.4,1,0,1,0,0,0,1,Pembrolizumab,ROSUVASTATIN CALCIUM|NITROGLYCERIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PEMBROLIZUMAB|PEMBROLIZUMAB,6,ANGINA PECTORIS|ANGINA PECTORIS|ANGINA PECTORIS|ANGINA PECTORIS|NON-SMALL CELL LUNG CANCER,Pneumonia viral|Pneumothorax|Blood bilirubin increased,3,1
10484655,20140930,Pembrolizumab,72,801,72.0,1,76.2,1,0,1,0,0,0,0,Pembrolizumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARBOPLATIN|DOXAZOSIN MESYLATE|TIOTROPIUM BROMIDE|FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE|TURMERIC|FOLIC ACID|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMETREXED|PEMETREXED DISODIUM|DILTIAZEM HYDROCHLORIDE|ALISKIREN|ALISKIREN HEMIFUMARATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|VALSARTAN|PEMETREXED|PEMETREXED DISODIUM|CYANOCOBALAMIN|ALPRAZOLAM|CARBOPLATIN,20,PREMEDICATION|HYPERTENSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|NON-SMALL CELL LUNG CANCER|HYPERTENSION|BLOOD CHOLESTEROL INCREASED|HYPERTENSION|GLUCOSE TOLERANCE IMPAIRED|HYPERTENSION|NON-SMALL CELL LUNG CANCER|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|ANXIETY|NON-SMALL CELL LUNG CANCER,Atrial fibrillation|Colitis,2,1
10484660,20140930,Pembrolizumab,64,801,64.0,2,,1,0,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Thyroid disorder|Rash|Fatigue|Metastases to central nervous system|Arthralgia,5,3
10484663,20140930,Pembrolizumab,65,801,65.0,2,55.2,1,0,1,0,0,0,0,Pembrolizumab,"PROMETHAZINE|MAGNESIUM OXIDE|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|PROMETHAZINE|ZINC SULFATE|ZINC SULFATE INJECTION,|ZINC SULFATE INJECTION|PEMBROLIZUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",10,VOMITING|HYPOMAGNESAEMIA|DEHYDRATION|HYPERTHYROIDISM|NAUSEA|DECREASED APPETITE|NEOPLASM MALIGNANT|ARTHRALGIA|PAIN,Streptococcal sepsis|Pyrexia|Hyperbilirubinaemia,3,1
10484732,20140930,Pembrolizumab,,,,1,,1,0,1,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB,1,,Liver function test abnormal|Sepsis|Pneumonia|Adverse event,4,3
10484888,20140930,Pembrolizumab,45,801,45.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Alopecia|Dry mouth|Malaise,3,1
10484977,20140930,Pembrolizumab,71,801,71.0,2,66,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|POVIDONE-IODINE|PEMBROLIZUMAB|CANDESARTAN|BISOPROLOL FUMARATE|PEMBROLIZUMAB,6,MALIGNANT MELANOMA|SKIN ULCER|HYPERTENSION|HYPERTENSION,Pain in extremity|Cardiac failure|Pneumonia,3,1
10484978,20140930,Pembrolizumab,76,801,76.0,1,110.5,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|PEMBROLIZUMAB|PEMBROLIZUMAB|ROSUVASTATIN CALCIUM|TRANDOLAPRIL|TRANDOLAPRIL TABLETS,9,MALIGNANT MELANOMA|HYPERTHYROIDISM|ANALGESIC THERAPY|ANALGESIC THERAPY|HYPERCHOLESTEROLAEMIA|HYPERTENSION|HYPERTENSION,Hypopituitarism,1,1
10485059,20140930,Pembrolizumab,61,801,61.0,1,71,1,1,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
10485065,20140930,Pembrolizumab,47,801,47.0,2,63,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|OXYCODONE HYDROCHLORIDE|PREGABALIN,4,NEOPLASM MALIGNANT|PAIN|PAIN|PAIN,Guillain-Barre syndrome,1,1
10485310,20140930,Pembrolizumab,63,801,63.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|TIOTROPIUM BROMIDE|HYDROCHLOROTHIAZIDE|ALBUTEROL SULFATE|VALSARTAN,9,MALIGNANT MELANOMA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PAIN|HYPERTENSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|BLOOD CHOLESTEROL INCREASED|HYPERTENSION,Hyperkalaemia|Haemorrhage intracranial|Convulsion|Neurological symptom,4,5
10485355,20140930,Pembrolizumab,66,801,66.0,1,,1,0,0,0,0,0,0,Pembrolizumab,"OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FINASTERIDE|CLOBETASOL PROPIONATE|CLOBETASOL PROPIONATE OINTMENT USP, 0.05%|TERAZOSIN HYDROCHLORIDE|PEMBROLIZUMAB",12,GASTROOESOPHAGEAL REFLUX DISEASE|PROPHYLAXIS|PAIN|DIARRHOEA|BENIGN PROSTATIC HYPERPLASIA|PROPHYLAXIS|DIARRHOEA|RASH|DERMATITIS|HYPERCHOLESTEROLAEMIA|BENIGN PROSTATIC HYPERPLASIA|METASTATIC MALIGNANT MELANOMA,Asthenia|Skin hypopigmentation|Pruritus|Lymphocyte count decreased|Alanine aminotransferase decreased|Fatigue|Diarrhoea|Hyperglycaemia|Eosinophil count increased,9,5
10485357,20140930,Pembrolizumab,67,801,67.0,2,,1,0,0,0,0,0,0,Pembrolizumab,"CLOBETASOL PROPIONATE|CLOBETASOL PROPIONATE OINTMENT USP, 0.05%|RANITIDINE|ALPRAZOLAM|PEMBROLIZUMAB|PSYLLIUM HUSK|LEVOTHYROXINE SODIUM|ATENOLOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",10,PRURITUS|ANXIETY|VITAMIN SUPPLEMENTATION|METASTATIC MALIGNANT MELANOMA,Hypothyroidism,1,3
10485360,20140930,Pembrolizumab,52,801,52.0,2,49.8,1,0,1,0,0,0,0,Pembrolizumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PEMBROLIZUMAB|PEMBROLIZUMAB|LORATADINE|LORATADINE TABLET",4,PAIN|NEOPLASM MALIGNANT|RHINITIS ALLERGIC,Aspartate aminotransferase increased|Alanine aminotransferase increased|Hepatitis,3,1
10485362,20140930,Pembrolizumab,35,801,35.0,2,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Aspartate aminotransferase increased|Chills|Fatigue|Fatigue|Alanine aminotransferase increased|Oropharyngeal pain|Dyspnoea|Pleuritic pain,8,5
10487419,20141001,Pembrolizumab,74,801,74.0,1,77.7,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ACETAMINOPHEN AND CODEINE,5,GASTROOESOPHAGEAL REFLUX DISEASE|MALIGNANT MELANOMA|CONGENITAL HYPERTHYROIDISM|PAIN,Liver abscess,1,1
10487721,20141001,Pembrolizumab,64,801,64.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,MALIGNANT MELANOMA,Fatigue,1,5
10487778,20141001,Pembrolizumab,42,801,42.0,2,55,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PREGABALIN|DULOXETINE HYDROCHLORIDE|PEMBROLIZUMAB|PEMBROLIZUMAB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE,10,PELVIC PAIN|PELVIC PAIN|PELVIC PAIN|ABDOMINAL PAIN|ANXIETY|DIARRHOEA|NEOPLASM|DIARRHOEA,Lung infection|Diarrhoea,2,1
10487875,20141001,Pembrolizumab,44,801,44.0,1,50,1,0,1,0,0,0,0,Pembrolizumab,GABAPENTIN|PEMBROLIZUMAB|PREGABALIN|PEMBROLIZUMAB|MEPERIDINE HYDROCHLORIDE|MORPHINE SULFATE,16,BRONCHIOLITIS|NEUROPATHY PERIPHERAL|HEAD AND NECK CANCER|FACIAL PAIN|BRONCHIOLITIS|HYPERCALCAEMIA|WOUND INFECTION|NEUTROPENIA|NEUROPATHY PERIPHERAL|FACIAL PAIN|FACIAL PAIN|BRONCHIOLITIS|WOUND INFECTION|FACIAL PAIN|WOUND INFECTION,Neutropenia,1,1
10487922,20141001,Pembrolizumab,64,801,64.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,3,MALIGNANT MELANOMA STAGE IV,White blood cell count decreased|Lymphocyte count decreased|Lymphocyte count decreased|Dry eye,4,5
10488022,20141001,Pembrolizumab,77,801,77.0,1,,1,0,0,0,0,0,0,Pembrolizumab,MOMETASONE FUROATE|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|FOLIC ACID|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CYANOCOBALAMIN|CETIRIZINE HYDROCHLORIDE|NIACIN|PEMBROLIZUMAB|FINASTERIDE|DOXAZOSIN MESYLATE,11,ASTHMA|ASTHMA|ROUTINE HEALTH MAINTENANCE|DIABETES MELLITUS|ROUTINE HEALTH MAINTENANCE|ASTHMA|ROUTINE HEALTH MAINTENANCE|METASTATIC MALIGNANT MELANOMA|BENIGN PROSTATIC HYPERPLASIA|HYPERTENSION|HYPERTENSION,Neuropathy peripheral,1,5
10488537,20141002,Pembrolizumab,69,801,69.0,2,,1,0,1,0,0,0,0,Pembrolizumab,"HYPROMELLOSE|LORAZEPAM|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|FAMOTIDINE|PROCHLORPERAZINE|PROCHLORPERAZINE|BIOTIN|ENOXAPARIN SODIUM|PEMBROLIZUMAB|OXYCODONE HYDROCHLORIDE|OXYCODONE",15,ROUTINE HEALTH MAINTENANCE|ANXIETY|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|GASTROOESOPHAGEAL REFLUX DISEASE|IMMUNISATION|ROUTINE HEALTH MAINTENANCE|VOMITING|NAUSEA|ROUTINE HEALTH MAINTENANCE|COAGULOPATHY|METASTATIC MALIGNANT MELANOMA|ROUTINE HEALTH MAINTENANCE|PAIN,Dysphagia|Pyrexia,2,5
10488680,20141002,Pembrolizumab,68,801,68.0,1,,1,1,1,1,1,0,1,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Staphylococcus test positive|Death|Dyspnoea,3,5
10489422,20141002,Pembrolizumab,50,801,50.0,2,,1,0,1,0,1,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Headache|Hydrocephalus,2,3
10489597,20141002,Pembrolizumab,46,801,46.0,1,70.9,1,0,1,0,0,0,0,Pembrolizumab,CHLORHEXIDINE GLUCONATE|ANTISEPTIC SKIN CLEANSER|PEMBROLIZUMAB|MORPHINE|MORPHINE|MORPHINE SULFATE|PEMBROLIZUMAB|PEMBROLIZUMAB|LORAZEPAM,8,PROPHYLAXIS|ORAL PAIN|ORAL PAIN|ORAL PAIN|HEAD AND NECK CANCER|ANXIETY,Agitation|Swelling face|Confusional state,3,1
10489854,20141002,Pembrolizumab,52,801,52.0,1,,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Gastrointestinal haemorrhage|Dehydration|Anaemia|Malignant neoplasm progression|Dyspnoea,5,5
10489864,20141002,Pembrolizumab,76,801,76.0,1,107.2,1,0,1,0,0,0,0,Pembrolizumab,GLYBURIDE|TEMAZEPAM|FAMOTIDINE|PEMBROLIZUMAB|FENTANYL|PRAVASTATIN SODIUM|PEMBROLIZUMAB|ONDANSETRON HYDROCHLORIDE|LOSARTAN POTASSIUM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|FENTANYL|AMLODIPINE,13,TYPE 2 DIABETES MELLITUS|INSOMNIA|GASTROOESOPHAGEAL REFLUX DISEASE|NON-SMALL CELL LUNG CANCER|PAIN|CORONARY ARTERY DISEASE|NAUSEA|HYPERTENSION|TYPE 2 DIABETES MELLITUS|HYPERTENSION,Syncope|Haemoptysis,2,1
10489951,20141002,Pembrolizumab,65,801,65.0,1,89.36,1,0,0,0,0,0,1,Pembrolizumab,"IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|PEMBROLIZUMAB|PEMBROLIZUMAB|SIMVASTATIN|ENALAPRIL MALEATE|ENALAPRIL",5,ARTHRALGIA|MALIGNANT MELANOMA|HYPERTENSION|HYPERTENSION,Alveolitis allergic,1,1
10490470,20141002,Pembrolizumab,50,801,50.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Aspartate aminotransferase increased|Fatigue|Alanine aminotransferase increased|Abdominal pain|Diarrhoea|Pyrexia|Neck pain,7,5
10492779,20141002,Pembrolizumab,57,801,57.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Chills|Fatigue|Vitiligo|Decreased appetite,4,5
10493883,20141003,Pembrolizumab,49,801,49.0,2,,1,0,1,1,0,0,1,Pembrolizumab,LORAZEPAM|PEMBROLIZUMAB|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS,6,NAUSEA|METASTATIC MALIGNANT MELANOMA|DEPRESSION|ROUTINE HEALTH MAINTENANCE|THYROID HORMONE REPLACEMENT THERAPY,Micturition disorder|Anaemia|Melaena|Small intestinal obstruction,4,5
10494590,20141003,Pembrolizumab,85,801,85.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Pruritus|Rash|Pruritus,3,5
10495014,20141003,Pembrolizumab,72,801,72.0,2,,1,0,1,0,0,0,0,Pembrolizumab,IOHEXOL|IOHEXOL|IOHEXOL|IOHEXOL|BISOPROLOL FUMARATE|IOHEXOL|PEMBROLIZUMAB|IOHEXOL,10,HYPOTHYROIDISM|DIAGNOSTIC PROCEDURE|MALIGNANT MELANOMA|NEOPLASM MALIGNANT,Renal failure,1,3
10495379,20141003,Pembrolizumab,57,801,57.0,1,70,1,0,1,0,0,0,0,Pembrolizumab,PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PEMBROLIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PEMBROLIZUMAB|PEMBROLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PEMBROLIZUMAB|DICLOFENAC|DICLOFENAC SODIUM,11,PAIN|PROPHYLAXIS|MALIGNANT MELANOMA|PORTAL VEIN THROMBOSIS|PAIN,Secondary adrenocortical insufficiency|Pancreatitis|Pancreatitis|Pancreatitis,4,1
10495382,20141003,Pembrolizumab,63,801,63.0,1,69.3,1,0,1,0,0,0,0,Pembrolizumab,SITAGLIPTIN|PEMBROLIZUMAB|MAGNESIUM OXIDE|ROSUVASTATIN|PEMBROLIZUMAB,13,DIABETES MELLITUS|DIABETES MELLITUS|LAXATIVE SUPPORTIVE CARE|DIABETES MELLITUS|LUNG NEOPLASM MALIGNANT|DIABETES MELLITUS|LAXATIVE SUPPORTIVE CARE|PROPHYLAXIS OF NAUSEA AND VOMITING|HEPATIC FUNCTION ABNORMAL|DYSLIPIDAEMIA|HYPERTENSION|NON-SMALL CELL LUNG CANCER,Diabetes mellitus,1,1
10495989,20141003,Pembrolizumab,77,801,77.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|MORPHINE|LISINOPRIL,5,METASTATIC MALIGNANT MELANOMA|ROUTINE HEALTH MAINTENANCE|PAIN|BLOOD PRESSURE|ROUTINE HEALTH MAINTENANCE,Diarrhoea|Hypotension|Hypoalbuminaemia|Fatigue,4,5
10496240,20141003,Pembrolizumab,81,801,81.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Hyperthyroidism,1,5
10500731,20141007,Pembrolizumab,,,,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Urticaria,1,1
10501635,20141007,Pembrolizumab,74,801,74.0,2,67.3,1,0,1,0,0,0,0,Pembrolizumab,"PEMBROLIZUMAB|HYDROMORPHONE HYDROCHLORIDE|LIDOCAINE PATCH 5%|PAROXETINE HYDROCHLORIDE|FENTANYL|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PEMBROLIZUMAB|ENOXAPARIN SODIUM|FENTANYL",12,PAIN|MALIGNANT MELANOMA|PAIN,Fall,1,3
10501741,20141007,Pembrolizumab,,,,0,,1,0,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB,1,,Brain oedema,1,5
10502324,20141007,Pembrolizumab,47,801,47.0,1,75,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,6,MALIGNANT MELANOMA|CHEMOTHERAPY|MITRAL VALVE STENOSIS|ARRHYTHMIA|PREMEDICATION,Encephalitis,1,1
10502493,20141007,Pembrolizumab,57,801,57.0,2,61.15,1,1,1,1,0,0,0,Pembrolizumab,AMOXICILLIN AND CLAVULANATE POTASSIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LUBIPROSTONE|PREGABALIN|BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|BUPIVACAINE HYDROCHLORIDE|PEMBROLIZUMAB|FENTANYL|FENTANYL|FENTANYL,18,BREAST CELLULITIS|PAIN|ANAEMIA|PAIN|NAUSEA|VOMITING|CONSTIPATION|PAIN|PROPHYLAXIS|PAIN|HYPERCHLORHYDRIA|PAIN|BREAST CANCER|PAIN|NAUSEA|PAIN|PAIN|PAIN,Disseminated intravascular coagulation|Anaemia|Blood fibrinogen decreased,3,1
10505093,20141008,Pembrolizumab,51,801,51.0,2,65.6,1,0,1,0,0,0,0,Pembrolizumab,SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ACETAMINOPHEN AND CODEINE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PEMBROLIZUMAB|PEMBROLIZUMAB|MIRTAZAPINE|MEROPENEM|FUROSEMIDE,10,HEPATIC PAIN|DEHYDRATION|MALIGNANT MELANOMA|DIARRHOEA|ANXIETY|THROMBOSIS|BACTERIAL SEPSIS|DIARRHOEA,Diarrhoea|Abdominal distension|Bacterial sepsis|Hypotension,4,1
10505466,20141008,Pembrolizumab,63,801,63.0,1,,1,0,1,1,0,0,0,Pembrolizumab,ROSUVASTATIN CALCIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|PEMBROLIZUMAB|METOPROLOL TARTRATE|METOPROLOL|FUROSEMIDE|FUROSEMIDE|PEMBROLIZUMAB,10,HYPERLIPIDAEMIA|PAIN|DIABETES MELLITUS|DIABETES MELLITUS|HYPERTENSION|CONSTIPATION PROPHYLAXIS|SINGLE FUNCTIONAL KIDNEY|HYPERTENSION|NON-SMALL CELL LUNG CANCER,Pulmonary embolism|Pleural effusion|Deep vein thrombosis,3,1
10505471,20141008,Pembrolizumab,65,801,65.0,1,70.1,1,0,1,0,0,0,0,Pembrolizumab,"DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ZOLPIDEM TARTRATE|DIPHENHYDRAMINE HYDROCHLORIDE|OXYCODONE|PEMBROLIZUMAB|ALBUTEROL SULFATE|ALBUTEROL SULFATE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|TIOTROPIUM BROMIDE|MEGESTROL ACETATE|PEMBROLIZUMAB|FENTANYL",19,CONSTIPATION|NAUSEA|VOMITING|BRONCHITIS CHRONIC|HYPOTHYROIDISM|INSOMNIA|BACK PAIN|BACK PAIN|HYPOPHYSITIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|AXILLARY PAIN|BRONCHITIS CHRONIC|BACK PAIN|BRONCHITIS CHRONIC|DECREASED APPETITE|MALIGNANT MELANOMA|BACK PAIN|NECK PAIN,Hyponatraemia,1,1
10505474,20141008,Pembrolizumab,67,801,67.0,2,,1,1,1,0,0,0,0,Pembrolizumab,LISINOPRIL|PEMBROLIZUMAB|ZOLPIDEM TARTRATE|POLYETHYLENE GLYCOL 3350|SENNOSIDES|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|LABETALOL HYDROCHLORIDE|LABETALOL|LORAZEPAM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PROCHLORPERAZINE MALEATE|LORAZEPAM|LORAZEPAM|AMLODIPINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|LORAZEPAM,16,HYPERTENSION|METASTATIC MALIGNANT MELANOMA|INSOMNIA|CONSTIPATION|CONSTIPATION|CONSTIPATION|HYPERTENSION|INSOMNIA|PAIN|NAUSEA|NAUSEA|VOMITING|HYPERTENSION|PYREXIA|CONSTIPATION|ANXIETY,Malignant neoplasm progression|Failure to thrive,2,5
10505483,20141008,Pembrolizumab,74,801,74.0,1,97.1,1,0,1,0,0,0,0,Pembrolizumab,ATORVASTATIN CALCIUM|PEMBROLIZUMAB|PEMBROLIZUMAB,3,HYPERCHOLESTEROLAEMIA|MALIGNANT MELANOMA,Myasthenia gravis,1,1
10505494,20141008,Pembrolizumab,66,801,66.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Urinary retention|Pruritus|Arthralgia|Fatigue,4,5
10505496,20141008,Pembrolizumab,70,801,70.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Decreased appetite|Nausea,2,5
10505502,20141008,Pembrolizumab,50,801,50.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Pruritus,1,5
10505544,20141008,Pembrolizumab,31,801,31.0,1,,1,0,1,0,0,0,0,Pembrolizumab,NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|PEMBROLIZUMAB,3,ANALGESIC THERAPY|METASTATIC MALIGNANT MELANOMA,Proctitis|Pain in extremity,2,5
10506556,20141009,Pembrolizumab,74,801,74.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Diarrhoea,1,3
10506896,20141009,Pembrolizumab,42,801,42.0,2,139.9,1,0,1,0,0,0,0,Pembrolizumab,TEMAZEPAM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PEMBROLIZUMAB|ERGOCALCIFEROL|PROMETHAZINE|ASCORBIC ACID|LORATADINE|LORATADINE ORAL|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|HYDROCORTISONE ACETATE|AMITRIPTYLINE HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS,22,ROUTINE HEALTH MAINTENANCE|CONTRACEPTION|EAR PAIN|INSOMNIA|PROPHYLAXIS OF NAUSEA AND VOMITING|PSORIASIS|ROUTINE HEALTH MAINTENANCE|PSORIASIS|RASH|ROUTINE HEALTH MAINTENANCE|RASH|MALIGNANT MELANOMA|ANXIETY|RASH|EAR PAIN|ROUTINE HEALTH MAINTENANCE|PSORIASIS|PSORIASIS,Autoimmune hepatitis,1,1
10508145,20141009,Pembrolizumab,,,,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,,Adverse event,1,1
10508153,20141009,Pembrolizumab,55,801,55.0,2,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Acidosis|Hyperglycaemia,2,3
10508565,20141009,Pembrolizumab,18,801,18.0,1,,1,0,1,0,0,0,1,Pembrolizumab,"NAPROXEN|NAPROXEN SODIUM|PEMBROLIZUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PEMBROLIZUMAB",4,HEADACHE|HEADACHE|METASTATIC MALIGNANT MELANOMA,Thyroxine free decreased|Rash maculo-papular|Headache|Tri-iodothyronine free decreased|Hypopituitarism|Blood corticotrophin increased,6,5
10508659,20141009,Pembrolizumab,58,801,58.0,2,,1,0,1,0,0,0,0,Pembrolizumab,"CYCLOSPORINE|HYDROCORTISONE SODIUM SUCCINATE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|PEMBROLIZUMAB|DESONIDE|LORAZEPAM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LANSOPRAZOLE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL",13,METASTATIC MALIGNANT MELANOMA,Gait disturbance|Nausea|Vomiting|Dizziness,4,3
10509019,20141009,Pembrolizumab,54,801,54.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Decreased appetite|Fatigue|Balance disorder|Headache|Muscular weakness|Nervous system disorder|Vertigo,7,5
10509106,20141009,Pembrolizumab,61,801,61.0,1,85,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|TRAMADOL HYDROCHLORIDE|RIVAROXABAN|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,10,MALIGNANT MELANOMA|BACK PAIN|HYPERTENSION|ANTITHROMBIN III|HYPERTENSION|BACK PAIN|BACK PAIN,Acute kidney injury,1,1
10510761,20141010,Pembrolizumab,61,801,61.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Fatigue,1,5
10511084,20141010,Pembrolizumab,,,,2,68.9,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,,Drug ineffective|Disease progression,2,5
10511847,20141010,Pembrolizumab,52,801,52.0,1,73.5,1,0,1,1,0,0,0,Pembrolizumab,LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|FENTANYL|PEMBROLIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OXYCODONE,5,HYPOTHYROIDISM|PAIN|HEAD AND NECK CANCER|NECK PAIN|NECK PAIN,Respiratory distress|Swelling face|Sepsis,3,1
10511856,20141010,Pembrolizumab,64,801,64.0,1,95,1,0,1,0,0,0,0,Pembrolizumab,"ALLOPURINOL|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|CELECOXIB|ALBUTEROL SULFATE|ALBUTEROL|SENNOSIDES|SENNA LEAF|SENNA|PANTOPRAZOLE|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PEMBROLIZUMAB|PEMBROLIZUMAB|AMLODIPINE",15,HYPERTENSION|GOUT|TRANSIENT ISCHAEMIC ATTACK|PROPHYLAXIS|GOUT|COUGH|CONSTIPATION|PROPHYLAXIS|SEIZURE|TRANSIENT ISCHAEMIC ATTACK|HYPOKALAEMIA|HYPERTENSION|MALIGNANT MELANOMA|HYPERTENSION,Haemorrhage intracranial,1,1
10512142,20141010,Pembrolizumab,48,801,48.0,2,90.8,1,0,1,0,0,0,0,Pembrolizumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|AMITRIPTYLINE HYDROCHLORIDE|PEMBROLIZUMAB|RAMIPRIL|PEMBROLIZUMAB|PEMBROLIZUMAB,10,PAIN|ADVERSE DRUG REACTION|PAIN|CONSTIPATION|HYPERTENSION|PAIN|MALIGNANT MELANOMA|PROPHYLAXIS,Acute kidney injury|Hyponatraemia,2,3
10512147,20141010,Pembrolizumab,61,801,61.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,4,METASTATIC MALIGNANT MELANOMA,Fatigue|Rash maculo-papular,2,5
10512210,20141010,Pembrolizumab,63,801,63.0,2,,1,0,0,0,0,0,1,Pembrolizumab,"FLUOXETINE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|FLUOXETINE HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|PEMBROLIZUMAB|OXYCODONE HYDROCHLORIDE|VALSARTAN|CYANOCOBALAMIN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|LEVOTHYROXINE SODIUM|PREGABALIN|HYDROMORPHONE HYDROCHLORIDE|LIOTHYRONINE SODIUM|LIOTHYRONINE SODIUM|METHYLPHENIDATE HYDROCHLORIDE",24,METASTATIC MALIGNANT MELANOMA|PAIN|DIALYSIS,Pneumonitis,1,5
10512614,20141011,Pembrolizumab,84,801,84.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Asthenia|Dyspnoea,2,5
10512640,20141012,Pembrolizumab,73,801,73.0,1,,1,0,1,0,0,0,0,Pembrolizumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|SENNOSIDES|SENNA LEAF|SENNA|GABAPENTIN|PEMBROLIZUMAB|ZONISAMIDE",5,PAIN|CONSTIPATION|NEUROPATHY PERIPHERAL|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Lethargy|Mental status changes|Confusional state|Pyrexia,4,5
10513867,20141013,Pembrolizumab,70,801,70.0,1,100,1,0,1,0,0,0,0,Pembrolizumab,"PEMBROLIZUMAB|LENALIDOMIDE|LENALIDOMIDE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|INSULIN GLARGINE|PEMBROLIZUMAB|PEMBROLIZUMAB|LENALIDOMIDE|ALLOPURINOL|TADALAFIL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE|ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES",19,HYPOKALAEMIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|MUSCULOSKELETAL CHEST PAIN|THROMBOSIS PROPHYLAXIS|HYPERGLYCAEMIA|HYPERGLYCAEMIA|HYPERURICAEMIA|ERECTILE DYSFUNCTION|HYPERGLYCAEMIA|PLASMA CELL MYELOMA|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER,Renal failure|Pneumonia,2,1
10514348,20141013,Pembrolizumab,82,801,82.0,2,53,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE SODIUM SUCCINATE|OXYCODONE HYDROCHLORIDE|MORPHINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,13,PAIN PROPHYLAXIS|PAIN PROPHYLAXIS|PAIN PROPHYLAXIS|NEOPLASM MALIGNANT|PAIN PROPHYLAXIS|PAIN PROPHYLAXIS|DYSURIA|CONSTIPATION PROPHYLAXIS|PAIN PROPHYLAXIS|PRURITUS|PAIN PROPHYLAXIS|PREMEDICATION,General physical health deterioration,1,1
10514476,20141013,Pembrolizumab,48,801,48.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,RETINAL MELANOMA,Pyrexia|Nausea|Nausea|Fatigue,4,5
10515446,20141014,Pembrolizumab,,,,0,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,,Urticaria|Nausea,2,5
10515991,20141014,Pembrolizumab,64,801,64.0,1,,1,1,1,1,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,METASTATIC MALIGNANT MELANOMA,Cardiac arrest|Dyspnoea|Atrial fibrillation,3,5
10516147,20141014,Pembrolizumab,64,801,64.0,1,,1,1,1,1,1,0,1,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Death|Cardiac arrest,2,3
10516644,20141014,Pembrolizumab,69,801,69.0,1,65.3,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|FAMOTIDINE|PEMBROLIZUMAB,15,CANCER PAIN|CONSTIPATION|CANCER PAIN|CANCER PAIN|CONSTIPATION|NAUSEA|CANCER PAIN|CANCER PAIN|GASTRITIS PROPHYLAXIS|NEOPLASM MALIGNANT|CANCER PAIN|CONSTIPATION|INSOMNIA|HYPERTENSION,Pemphigoid,1,1
10516645,20141014,Pembrolizumab,61,801,61.0,1,94.3,1,0,1,1,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|CANDESARTAN CILEXETIL,8,MALIGNANT MELANOMA|INFUSION RELATED REACTION|INFUSION RELATED REACTION|HYPERTENSION|HYPERTENSION,Colitis|Hypokalaemia|Ileus,3,1
10517081,20141014,Pembrolizumab,,,,2,60,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Disease progression,1,1
10517398,20141014,Pembrolizumab,65,801,65.0,1,78.5,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|ZOLPIDEM TARTRATE|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET,5,NON-SMALL CELL LUNG CANCER|NASOPHARYNGITIS|INSOMNIA|PAIN,Pain|Pneumonia,2,3
10517873,20141015,Pembrolizumab,82,801,82.0,2,,1,0,1,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB|LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE|ASCORBIC ACID|SIMVASTATIN|MECLIZINE HCL 12.5 MG|MECLIZINE|MECLIZINE HYDROCHLORIDE|MECLIZINE HCL 25MG|MECLIZINE HCL 12.5MG|OXYCODONE|PEMBROLIZUMAB|LORAZEPAM|PEMBROLIZUMAB|VALSARTAN,11,METASTASES TO LUNG|METASTATIC MALIGNANT MELANOMA|METASTASES TO LIVER,Heart rate increased|Blood creatinine increased|Fatigue|Bone neoplasm|Anaemia|Hypotension|Post procedural haemorrhage|Femur fracture,8,2
10519012,20141015,Pembrolizumab,59,801,59.0,2,50,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,NON-SMALL CELL LUNG CANCER,Respiratory tract infection|Pain,2,1
10519934,20141015,Pembrolizumab,46,801,46.0,1,81,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|OMEPRAZOLE MAGNESIUM|PEMBROLIZUMAB|LORAZEPAM,5,GASTROOESOPHAGEAL REFLUX DISEASE|ROUTINE HEALTH MAINTENANCE|NON-SMALL CELL LUNG CANCER|ANXIETY,Cardiac tamponade,1,3
10520076,20141015,Pembrolizumab,46,801,46.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,3,PAIN|PAIN|METASTATIC MALIGNANT MELANOMA,Seizure,1,5
10520082,20141015,Pembrolizumab,79,801,79.0,1,82.9,1,0,1,0,0,0,0,Pembrolizumab,ERGOCALCIFEROL|GARLIC|ASCORBIC ACID|PEMBROLIZUMAB|CYANOCOBALAMIN|ROSUVASTATIN,12,NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|MALIGNANT MELANOMA|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|HYPERCHOLESTEROLAEMIA|NUTRITIONAL SUPPLEMENTATION,Hepatitis|Pneumonitis,2,1
10520084,20141015,Pembrolizumab,35,801,35.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,2,METASTATIC MALIGNANT MELANOMA|URINARY TRACT INFECTION,Dehydration|Urinary tract infection|Pyrexia,3,5
10520539,20141015,Pembrolizumab,43,801,43.0,2,63.2,1,0,1,0,0,0,0,Pembrolizumab,"PEMBROLIZUMAB|ERIBULIN MESYLATE|CAMPHOR AND MENTHOL|PRAMOXINE HYDROCHLORIDE|COLLOIDAL OATMEAL|PRAMOXINE HYDROCHLORIDE, MENTHOL|DIPHENHYDRAMINE HYDROCHLORIDE|CAMPHOR AND MENTHOL|PRAMOXINE HYDROCHLORIDE|COLLOIDAL OATMEAL|PRAMOXINE HYDROCHLORIDE, MENTHOL|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|DALTEPARIN SODIUM|DIPHENHYDRAMINE HYDROCHLORIDE|TURMERIC",14,BREAST CANCER|NEOPLASM MALIGNANT|PRURITUS|ARTHRALGIA|PRODUCTIVE COUGH|DRY SKIN|HYPOTHYROIDISM|CONSTIPATION|HEADACHE|THROMBOSIS PROPHYLAXIS|RASH PRURITIC|VITAMIN SUPPLEMENTATION|PRODUCTIVE COUGH,Joint effusion|Diarrhoea|Enterocolitis,3,1
10520673,20141015,Pembrolizumab,64,801,64.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PREDNISONE,3,METASTATIC MALIGNANT MELANOMA|RASH,Rash maculo-papular|Rash maculo-papular|Pruritus|Rash maculo-papular|Rash maculo-papular,5,5
10520970,20141016,Pembrolizumab,,,,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,NEOPLASM MALIGNANT,Abdominal discomfort,1,5
10521692,20141016,Pembrolizumab,88,801,88.0,1,,1,1,1,1,0,0,0,Pembrolizumab,HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|LEVOTHYROXINE SODIUM|SIMVASTATIN|PEMBROLIZUMAB|LATANOPROST|BRIMONIDINE TARTRATE,9,ADRENAL INSUFFICIENCY|ADRENAL INSUFFICIENCY|PNEUMONIA|HYPOTHYROIDISM|BLOOD CHOLESTEROL|GLAUCOMA|METASTATIC MALIGNANT MELANOMA|GLAUCOMA|GLAUCOMA,Pyrexia|Depressed level of consciousness|Malignant neoplasm progression,3,5
10521915,20141016,Pembrolizumab,71,801,71.0,2,,1,0,1,0,0,0,0,Pembrolizumab,LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ESOMEPRAZOLE MAGNESIUM|PEMBROLIZUMAB|MORPHINE SULFATE,5,HYPOTHYROIDISM|PROPHYLAXIS OF NAUSEA AND VOMITING|GASTROOESOPHAGEAL REFLUX DISEASE|METASTATIC MALIGNANT MELANOMA|PAIN,Nausea,1,5
10522015,20141016,Pembrolizumab,56,801,56.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PREGABALIN|HYDROMORPHONE HYDROCHLORIDE,3,METASTATIC MALIGNANT MELANOMA,Flank pain|Nausea|Intestinal mass|Arthralgia|Surgery|Fatigue,6,5
10522548,20141016,Pembrolizumab,72,801,72.0,2,,1,1,0,0,0,0,0,Pembrolizumab,DULOXETINE HYDROCHLORIDE|PEMBROLIZUMAB,6,METASTATIC MALIGNANT MELANOMA,Pneumonia|Renal failure,2,5
10522667,20141016,Pembrolizumab,75,801,75.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PRAVASTATIN SODIUM|PEMBROLIZUMAB|ALLOPURINOL,3,METASTATIC MALIGNANT MELANOMA,Anaemia,1,3
10522827,20141016,Pembrolizumab,62,801,62.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Papule,1,5
10524680,20141017,Pembrolizumab,73,801,73.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,3,MALIGNANT MELANOMA,Adrenal insufficiency|Pyrexia|Back pain|Anaemia|Decreased appetite|Fatigue|Oedema,7,3
10525965,20141017,Pembrolizumab,65,801,65.0,1,67.3,1,0,1,0,0,0,0,Pembrolizumab,"OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|DUTASTERIDE|PEMBROLIZUMAB|PEMBROLIZUMAB|ENALAPRIL MALEATE|ENALAPRIL",8,PROPHYLAXIS|PAIN|HYPOTHYROIDISM|BENIGN PROSTATIC HYPERPLASIA|MALIGNANT MELANOMA|HYPERTENSION,Renal failure,1,1
10527061,20141020,Pembrolizumab,66,801,66.0,2,68,1,0,1,0,0,0,0,Pembrolizumab,"SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PEMBROLIZUMAB|MORPHINE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|OXYCODONE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|LACTULOSE|MORPHINE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PEMBROLIZUMAB|OXYCODONE HYDROCHLORIDE|OXYCODONE",16,NAUSEA|DEHYDRATION|NEOPLASM MALIGNANT|CONSTIPATION|CONSTIPATION|ABDOMINAL PAIN|HEADACHE|PAIN|HYPOTHYROIDISM|CONSTIPATION|CONSTIPATION|HYPOKALAEMIA|BONE DISORDER|PAIN|NAUSEA,Gastritis|Gastroenteritis radiation|Helicobacter infection,3,1
10528186,20141020,Pembrolizumab,48,801,48.0,2,55.5,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|ESTRADIOL AND NORETHINDRONE ACETATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,6,MALIGNANT MELANOMA|HORMONE REPLACEMENT THERAPY|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE,Lichen planus,1,1
10528352,20141020,Pembrolizumab,40,801,40.0,2,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,,Pulmonary embolism,1,5
10528477,20141020,Pembrolizumab,61,801,61.0,1,83,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|PEMBROLIZUMAB,6,MALIGNANT MELANOMA|EMBOLISM|DIARRHOEA|NUTRITIONAL SUPPLEMENTATION|NAUSEA,Prerenal failure|Hepatitis,2,1
10529186,20141020,Pembrolizumab,61,801,61.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,4,METASTATIC MALIGNANT MELANOMA,Eczema|Rash maculo-papular|Alopecia|Pruritus|Arthralgia|Fatigue|Rash maculo-papular|Pruritus,8,5
10529217,20141020,Pembrolizumab,51,801,51.0,1,63.9,1,0,1,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB|OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PEMBROLIZUMAB|PEMBROLIZUMAB,7,PELVIC PAIN|PELVIC PAIN|MYOCARDIAL ISCHAEMIA|PELVIC PAIN|NON-SMALL CELL LUNG CANCER,Synovitis|Faecaloma,2,1
10530657,20141021,Pembrolizumab,59,801,59.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Diarrhoea,1,3
10530659,20141021,Pembrolizumab,69,801,69.0,2,44.8,1,0,0,0,0,0,1,Pembrolizumab,ERGOCALCIFEROL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CYANOCOBALAMIN|PEMBROLIZUMAB|ALBUTEROL SULFATE|PEMBROLIZUMAB,9,HYPERTENSION|ROUTINE HEALTH MAINTENANCE|PAIN|DYSPNOEA|ROUTINE HEALTH MAINTENANCE|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS,Gastrointestinal disorder,1,1
10531030,20141021,Pembrolizumab,67,801,67.0,1,,1,0,0,0,0,0,0,Pembrolizumab,"PEMBROLIZUMAB|QUINAPRIL HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OMEPRAZOLE MAGNESIUM|METOPROLOL SUCCINATE|SILDENAFIL CITRATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",11,METASTATIC MALIGNANT MELANOMA|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|HYPERTENSION|CARDIOVASCULAR EVENT PROPHYLAXIS|GASTROOESOPHAGEAL REFLUX DISEASE|SEXUAL DYSFUNCTION|HYPERTENSION|ROUTINE HEALTH MAINTENANCE|SEXUAL DYSFUNCTION|PAIN,Rash maculo-papular|Nausea|Fatigue|Arthralgia,4,5
10531250,20141021,Pembrolizumab,43,801,43.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Fatigue|Pyrexia|Pruritus|Platelet count decreased|Rash maculo-papular,5,5
10531255,20141021,Pembrolizumab,71,801,71.0,2,112,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PAZOPANIB|PAZOPANIB HYDROCHLORIDE,2,RENAL CELL CARCINOMA|RENAL CELL CARCINOMA,Atrioventricular block,1,5
10531588,20141021,Pembrolizumab,64,801,64.0,2,60,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|FENOFIBRATE|PEPPERMINT|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CITALOPRAM|CITALOPRAM HYDROBROMIDE|MIRTAZAPINE|INDAPAMIDE|PEMBROLIZUMAB|CITALOPRAM|CITALOPRAM HYDROBROMIDE,31,MALIGNANT MELANOMA|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|GROIN PAIN|HYPOTHYROIDISM|HYPOTHYROIDISM|HYPOTENSION|HYPERTRIGLYCERIDAEMIA|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|HYPERTENSION|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|CEREBROVASCULAR ACCIDENT PROPHYLAXIS|PANIC DISORDER|ANXIETY|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|HYPERTENSION|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|ANXIETY|NAUSEA|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|HYPERTENSION,Pancreatitis,1,1
10531730,20141021,Pembrolizumab,44,801,44.0,1,61.5,1,1,0,0,0,0,0,Pembrolizumab,SENNOSIDES|PEMBROLIZUMAB|PROCHLORPERAZINE|FENTANYL|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS,8,CONSTIPATION PROPHYLAXIS|PAIN|HEAD AND NECK CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING|PAIN|HYPOTHYROIDISM|INFECTION PROPHYLAXIS|BACK PAIN,Death,1,3
10531869,20141021,Pembrolizumab,,,,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,,General physical health deterioration,1,5
10531879,20141021,Pembrolizumab,74,801,74.0,2,105.9,1,0,1,0,0,0,0,Pembrolizumab,"PACLITAXEL|PEMBROLIZUMAB|CARBOPLATIN|METOPROLOL TARTRATE|METOPROLOL|NAPROXEN SODIUM|SIMVASTATIN|PEMBROLIZUMAB|PACLITAXEL|DIPHENHYDRAMINE HYDROCHLORIDE|RALOXIFENE|CYANOCOBALAMIN|PEMBROLIZUMAB|OMEPRAZOLE MAGNESIUM|CARBOPLATIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PACLITAXEL|CARBOPLATIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PEMBROLIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIPHENHYDRAMINE HYDROCHLORIDE|FAMOTIDINE",31,NAUSEA|VOMITING|PROPHYLAXIS|VOMITING|NAUSEA|HYPERTENSION|ARTHRITIS|DYSLIPIDAEMIA|ROUTINE HEALTH MAINTENANCE|NON-SMALL CELL LUNG CANCER|HYPERSENSITIVITY|HYPERTENSION|OSTEOPENIA|ROUTINE HEALTH MAINTENANCE|GASTROOESOPHAGEAL REFLUX DISEASE|ROUTINE HEALTH MAINTENANCE|BACK PAIN|NON-SMALL CELL LUNG CANCER|BACK PAIN|CARDIOVASCULAR EVENT PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|ALLERGY PROPHYLAXIS|ALLERGY PROPHYLAXIS|GASTROOESOPHAGEAL REFLUX DISEASE,Urticaria|Febrile neutropenia|Febrile neutropenia,3,1
10534031,20141022,Pembrolizumab,51,801,51.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Rash maculo-papular|Pruritus,2,5
10534166,20141022,Pembrolizumab,74,801,74.0,1,,1,0,0,0,0,0,0,Pembrolizumab,ENOXAPARIN SODIUM|OLMESARTAN MEDOXOMIL|PEMBROLIZUMAB|OXYMETAZOLINE HYDROCHLORIDE|TIMOLOL MALEATE|TIMOLOL MALEATE OPHTHALMIC|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PREDNISONE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|SIMVASTATIN,11,PULMONARY EMBOLISM|MALIGNANT MELANOMA|HYPOPHYSITIS|PRURITUS|ADRENAL INSUFFICIENCY,Pruritus|Rash,2,3
10534171,20141022,Pembrolizumab,68,801,68.0,1,,1,0,1,0,0,0,0,Pembrolizumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ERGOCALCIFEROL|PANTOPRAZOLE|INSULIN GLARGINE|TIOTROPIUM BROMIDE|AMLODIPINE|PANTOPRAZOLE|PEMBROLIZUMAB|ATORVASTATIN CALCIUM,16,CARDIOVASCULAR DISORDER|VITAMIN D DECREASED|GASTROOESOPHAGEAL REFLUX DISEASE|DIABETES MELLITUS|BLOOD GLUCOSE|ASTHMA|CARDIOVASCULAR DISORDER|BLOOD CHOLESTEROL|HYPERTENSION|RANULA|GASTROOESOPHAGEAL REFLUX DISEASE|METASTATIC MALIGNANT MELANOMA|BLOOD GLUCOSE|BLOOD CHOLESTEROL INCREASED|CARDIOVASCULAR DISORDER|PROSTATISM,Hypopituitarism,1,5
10534176,20141022,Pembrolizumab,55,801,55.0,2,,1,0,0,0,0,0,0,Pembrolizumab,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PEMBROLIZUMAB",2,HEADACHE|METASTATIC MALIGNANT MELANOMA,Rash,1,5
10534178,20141022,Pembrolizumab,71,801,71.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|TEMOZOLOMIDE,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Blood bilirubin increased|Hypotension|Nausea|Fatigue|Blood alkaline phosphatase increased|Gastrointestinal haemorrhage|Sepsis|Pain in extremity|Alanine aminotransferase increased|Acute kidney injury|Aspartate aminotransferase increased|Acute respiratory failure,12,5
10534682,20141022,Pembrolizumab,51,801,51.0,2,77.98,1,0,1,0,0,0,0,Pembrolizumab,CLONAZEPAM|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|ALBUTEROL SULFATE|NAPROXEN|NAPROXEN SODIUM|PEMBROLIZUMAB|LORATADINE|LORATADINE TABLET|ACETAMINOPHEN|ALPRAZOLAM|FLUCONAZOLE|PEMBROLIZUMAB|FOLIC ACID|DULOXETINE HYDROCHLORIDE|PREDNISONE|NAPROXEN|NAPROXEN SODIUM|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|NEBIVOLOL HYDROCHLORIDE|TEMAZEPAM|OMEPRAZOLE MAGNESIUM|CLOTRIMAZOLE|DRS. CLOTRIMAZOLE|FAMILY WELLNESS CLOTRIMAZOLE|CLOTRIMAZOLE TOPICAL|ACETAMINOPHEN|TRAMADOL HYDROCHLORIDE,28,INSOMNIA|DYSPNOEA|DYSPNOEA|OSTEOARTHRITIS|ARTHRALGIA|PAIN|NON-SMALL CELL LUNG CANCER|RHINITIS ALLERGIC|OSTEOARTHRITIS|DYSPNOEA|SKIN IRRITATION|ANXIETY|CANDIDA INFECTION|ROUTINE HEALTH MAINTENANCE|DEPRESSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|BACK PAIN|ANXIETY|HYPERTENSION|INSOMNIA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|DYSPEPSIA|ROUTINE HEALTH MAINTENANCE|CANDIDA INFECTION|PAIN|ARTHRALGIA|PREMEDICATION,Bronchospasm,1,3
10535087,20141022,Pembrolizumab,67,801,67.0,2,62.3,1,0,1,0,0,0,0,Pembrolizumab,PROPOFOL|PEMBROLIZUMAB|AMLODIPINE|PEMBROLIZUMAB,13,CHEST PAIN|ENDOSCOPY UPPER GASTROINTESTINAL TRACT|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PAIN|CHEST PAIN|NON-SMALL CELL LUNG CANCER|HYPERTENSION|PROPHYLAXIS|VOMITING|PAIN|HYPOTHYROIDISM|CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Atrial fibrillation,1,1
10538252,20141023,Pembrolizumab,66,801,66.0,1,,1,1,1,0,0,0,0,Pembrolizumab,DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|ATORVASTATIN CALCIUM|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LORAZEPAM|PREDNISONE|TESTOSTERONE|LEVETIRACETAM|ATENOLOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|PREDNISONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LORAZEPAM,17,CONSTIPATION|HYPERTENSION|METASTATIC MALIGNANT MELANOMA|HYPOTHYROIDISM|PROPHYLAXIS|PAIN|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|ROUTINE HEALTH MAINTENANCE|ANXIETY|GAIT DISTURBANCE|ANDROGEN DEFICIENCY|SEIZURE|HYPERTENSION|PROPHYLAXIS|APHASIA|APHASIA|INSOMNIA,Asthenia|Malignant neoplasm progression,2,3
10538347,20141023,Pembrolizumab,72,801,72.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,METASTATIC MALIGNANT MELANOMA,Pneumonitis|Pneumonitis,2,5
10538352,20141023,Pembrolizumab,69,801,69.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Fatigue,1,5
10538907,20141023,Pembrolizumab,54,801,54.0,1,76.7,1,0,1,0,0,0,1,Pembrolizumab,FOLIC ACID|CARBOPLATIN|CLOPIDOGREL|CITALOPRAM|CITALOPRAM HYDROBROMIDE|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|SIMVASTATIN|PEMBROLIZUMAB|PEMETREXED|PEMETREXED DISODIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,12,PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|ANXIETY DISORDER|CORONARY ARTERY DISEASE|HYPERLIPIDAEMIA|NAUSEA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|PROPHYLAXIS|NAUSEA,Toxic epidermal necrolysis,1,1
10539296,20141023,Pembrolizumab,88,801,88.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Asthenia|Nausea,2,5
10539931,20141024,Pembrolizumab,54,801,54.0,2,,1,0,1,0,1,0,0,Pembrolizumab,LEVETIRACETAM|PANTOPRAZOLE SODIUM|TRAZODONE HYDROCHLORIDE|VENLAFAXINE HYDROCHLORIDE|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|CLONAZEPAM|ESOMEPRAZOLE MAGNESIUM,10,METASTASES TO CENTRAL NERVOUS SYSTEM|PROPHYLAXIS|GASTROOESOPHAGEAL REFLUX DISEASE|INSOMNIA|DEPRESSION|ROUTINE HEALTH MAINTENANCE|MALIGNANT MELANOMA|HYPOTHYROIDISM|ANXIETY|GASTROOESOPHAGEAL REFLUX DISEASE,Gait disturbance|Diarrhoea|Mental status changes,3,5
10539998,20141024,Pembrolizumab,59,801,59.0,1,,1,0,0,0,0,0,0,Pembrolizumab,"PEMBROLIZUMAB|OXYCODONE|LATANOPROST|LOSARTAN POTASSIUM|PEMBROLIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|TIMOLOL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",10,PAIN|GLAUCOMA|GLAUCOMA|HYPERTENSION|METASTATIC MALIGNANT MELANOMA|ROUTINE HEALTH MAINTENANCE|PAIN|GLAUCOMA|PAIN,Oedema peripheral|Oedema genital,2,5
10540907,20141024,Pembrolizumab,66,801,66.0,1,90.7,1,0,0,0,0,0,1,Pembrolizumab,PITAVASTATIN CALCIUM|DESONIDE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|FLECAINIDE ACETATE TABLET|FLECAINIDE ACETATE|DILTIAZEM HYDROCHLORIDE|DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS|DILTIAZEM HYDROCHLORIDE|DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS|ATORVASTATIN CALCIUM|PEMBROLIZUMAB,12,HYPERTENSION|HYPERCHOLESTEROLAEMIA|ADVERSE EVENT|ADVERSE EVENT|HYPOTHYROIDISM|ATRIAL FIBRILLATION|ROUTINE HEALTH MAINTENANCE|ATRIAL FIBRILLATION|ADVERSE EVENT|HYPERTENSION|HYPERTENSION|MALIGNANT MELANOMA,Pemphigoid,1,1
10541085,20141024,Pembrolizumab,65,801,65.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Skin hypopigmentation|Vitiligo,2,5
10541090,20141024,Pembrolizumab,66,801,66.0,1,59.6,1,0,1,0,0,0,0,Pembrolizumab,RAMELTEON|PEMBROLIZUMAB|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|PEMBROLIZUMAB,9,PRODUCTIVE COUGH|INSOMNIA|PRODUCTIVE COUGH|COUGH|PROPHYLAXIS|HAEMORRHAGE PROPHYLAXIS|HAEMORRHAGE PROPHYLAXIS|NON-SMALL CELL LUNG CANCER,Organising pneumonia,1,1
10542219,20141024,Pembrolizumab,72,801,72.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|FINASTERIDE|LABETALOL HYDROCHLORIDE|LABETALOL|ENALAPRIL MALEATE|ENALAPRIL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DOXAZOSIN MESYLATE|ASCORBIC ACID|PEMBROLIZUMAB|PEMBROLIZUMAB|DILTIAZEM HYDROCHLORIDE|DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,20,METASTATIC MALIGNANT MELANOMA,Fatigue,1,5
10543009,20141027,Pembrolizumab,55,801,55.0,1,,1,0,1,0,0,0,0,Pembrolizumab,METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|CLOPIDOGREL|PEMBROLIZUMAB|SIMVASTATIN|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|OXYCODONE,7,HYPERTENSION|CORONARY ARTERY DISEASE|METASTATIC MALIGNANT MELANOMA|HYPERLIPIDAEMIA|CORONARY ARTERY DISEASE|ATRIAL FIBRILLATION|TUMOUR PAIN,Pyrexia|Small intestinal obstruction|Atrial fibrillation|Abdominal pain,4,1
10543759,20141027,Pembrolizumab,66,801,66.0,1,77,1,0,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|IPILIMUMAB,4,MALIGNANT MELANOMA|HYPOTHYROIDISM|MALIGNANT MELANOMA,Type 1 diabetes mellitus,1,1
10544030,20141027,Pembrolizumab,61,801,61.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Pruritus|Pruritus|Rash,3,3
10544231,20141027,Pembrolizumab,62,801,62.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Rash,1,3
10544476,20141027,Pembrolizumab,60,801,60.0,1,,1,0,1,0,0,0,0,Pembrolizumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|LEVETIRACETAM|METOPROLOL TARTRATE|METOPROLOL|VALSARTAN|VITAMIN E|FERROUS SULFATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PEMBROLIZUMAB",11,PAIN|CONVULSION PROPHYLAXIS|HYPERTENSION|HYPERTENSION|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|BENIGN PROSTATIC HYPERPLASIA|PAIN|NAUSEA|MALIGNANT MELANOMA,Anaemia|Small intestinal perforation|Pyrexia|Pyrexia|Fatigue,5,5
10545216,20141027,Pembrolizumab,,,,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PREDNISONE|CARVEDILOL|AMLODIPINE,5,MALIGNANT MELANOMA,Drug ineffective|Disease progression,2,5
10545282,20141027,Pembrolizumab,58,801,58.0,2,78,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|GABAPENTIN|PEMBROLIZUMAB|PEMBROLIZUMAB,12,NEURALGIA|VAGINAL INFECTION|VAGINAL INFECTION|PROPHYLAXIS OF NAUSEA AND VOMITING|VAGINAL INFECTION|NEURALGIA|NEOPLASM MALIGNANT|HYPOMAGNESAEMIA|VAGINAL INFECTION,Intestinal ischaemia|Colitis|Food intolerance|Device related sepsis,4,1
10545371,20141027,Pembrolizumab,61,801,61.0,1,,1,0,0,0,0,0,0,Pembrolizumab,FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|NEBIVOLOL HYDROCHLORIDE|PEMBROLIZUMAB|MOMETASONE FUROATE|ROSUVASTATIN|COLCHICINE|OMEPRAZOLE MAGNESIUM,7,ASTHMA|HYPERTENSION|METASTATIC MALIGNANT MELANOMA|HYPERSENSITIVITY|HYPOCHOLESTEROLAEMIA|GOUT|GASTROOESOPHAGEAL REFLUX DISEASE,Alanine aminotransferase increased|Aspartate aminotransferase increased|Arthralgia,3,5
10545950,20141027,Pembrolizumab,65,801,65.0,1,,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|OLANZAPINE|PROCHLORPERAZINE|MAGNESIUM OXIDE|SITAGLIPTIN|PEMBROLIZUMAB|PREGABALIN|RABEPRAZOLE SODIUM|RABEPRAZOLE|NABILONE,11,METASTATIC MALIGNANT MELANOMA,Cardiopulmonary failure,1,5
10548330,20141028,Pembrolizumab,,,,0,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,,Autoimmune hepatitis,1,3
10549192,20141028,Pembrolizumab,88,801,88.0,1,,1,0,1,0,0,0,0,Pembrolizumab,FUROSEMIDE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|FERROUS SULFATE|PSYLLIUM HUSK|DILTIAZEM HYDROCHLORIDE|DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS|LEVETIRACETAM|PEMBROLIZUMAB|ATENOLOL,8,HYPERTENSION|HYPOTHYROIDISM|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|HYPERTENSION|SEIZURE|METASTATIC MALIGNANT MELANOMA|ATRIAL FIBRILLATION,Syncope|Hypophysitis,2,5
10549576,20141028,Pembrolizumab,67,801,67.0,1,76.3,1,0,1,0,0,0,0,Pembrolizumab,"OXYCODONE|ACETAMINOPHEN AND CODEINE|TRAZODONE HYDROCHLORIDE|VENLAFAXINE HYDROCHLORIDE|VENLAFAXINE|DILTIAZEM HYDROCHLORIDE|DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|GLIPIZIDE|RANITIDINE|CALCITRIOL|CALCITRIOL CAPSULES 0.25 MCG|CALCITRIOL CAPSULES 0.5 MCG|TRAZODONE HYDROCHLORIDE|PEMBROLIZUMAB|OXYCODONE|ZOLEDRONIC ACID",17,PYREXIA|VITAMIN SUPPLEMENTATION|ABDOMINAL PAIN|HYPOKALAEMIA|DEPRESSION|DEPRESSION|VITAMIN SUPPLEMENTATION|HYPERTENSION|RASH PRURITIC|DIABETES MELLITUS|GASTROOESOPHAGEAL REFLUX DISEASE|VITAMIN SUPPLEMENTATION|ANXIETY|ANAEMIA|TRANSITIONAL CELL CARCINOMA|ABDOMINAL PAIN|HYPERCALCAEMIA,Myositis|Neuromyopathy|Rhabdomyolysis,3,1
10550079,20141028,Pembrolizumab,65,801,65.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,METASTATIC MALIGNANT MELANOMA,Pruritus|Rash maculo-papular,2,5
10550080,20141028,Pembrolizumab,76,801,76.0,2,,1,0,0,0,0,0,0,Pembrolizumab,"PEMBROLIZUMAB|BETAMETHASONE DIPROPIONATE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED",3,METASTATIC MALIGNANT MELANOMA,Pruritus|Blood thyroid stimulating hormone decreased,2,5
10550532,20141029,Pembrolizumab,62,801,62.0,1,,1,0,1,0,0,0,0,Pembrolizumab,AMOXICILLIN AND CLAVULANATE POTASSIUM|MELATONIN|PEMBROLIZUMAB,6,INFECTION|HEADACHE|SLEEP DISORDER THERAPY|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|METASTATIC MALIGNANT MELANOMA,Transaminases increased|Systemic inflammatory response syndrome|Anaemia,3,5
10552106,20141029,Pembrolizumab,52,801,52.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Fatigue|Nausea|Arthralgia|Vomiting|Headache|Fatigue,6,5
10552115,20141029,Pembrolizumab,,,,1,,1,1,0,1,1,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Death,1,3
10552243,20141029,Pembrolizumab,63,801,63.0,1,56.8,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,NON-SMALL CELL LUNG CANCER,General physical health deterioration,1,1
10552394,20141029,Pembrolizumab,31,801,31.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|METHADONE HYDROCHLORIDE|METHADONE,2,METASTATIC MALIGNANT MELANOMA|PAIN,Pneumonitis,1,5
10552402,20141029,Pembrolizumab,78,801,78.0,1,,1,0,0,0,0,0,0,Pembrolizumab,ERGOCALCIFEROL|PEMBROLIZUMAB|ACARBOSE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LOSARTAN POTASSIUM|LOSARTAN|SIMVASTATIN|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS,9,ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|MALIGNANT MELANOMA|DIABETES MELLITUS MANAGEMENT|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|HYPERTENSION|HYPERCHOLESTEROLAEMIA|HYPOTHYROIDISM,Pain in extremity|Hyponatraemia|Pruritus|Fatigue,4,5
10552522,20141029,Pembrolizumab,68,801,68.0,2,51.9,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|MORPHINE|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|PREGABALIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ZOLPIDEM TARTRATE|PEMBROLIZUMAB,9,NON-SMALL CELL LUNG CANCER|DIABETES MELLITUS|CHEST PAIN|DEPRESSION|CHEST PAIN|CHEST PAIN|INSOMNIA|CONSTIPATION,Dyspnoea,1,1
10553392,20141030,Pembrolizumab,71,801,71.0,1,,1,1,0,0,0,0,0,Pembrolizumab,TEMOZOLOMIDE|PEMBROLIZUMAB,2,MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Hepatotoxicity|Hepatic enzyme increased,2,1
10553881,20141030,Pembrolizumab,79,801,79.0,1,,1,0,1,0,0,0,0,Pembrolizumab,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PREGABALIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PEMBROLIZUMAB|DOXAZOSIN MESYLATE|DOXAZOSIN",6,METASTATIC MALIGNANT MELANOMA,Pneumonia,1,5
10554589,20141030,Pembrolizumab,51,801,51.0,1,73,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FLECAINIDE ACETATE TABLET|FLECAINIDE ACETATE|PEMBROLIZUMAB|CALCITRIOL|CALCITRIOL CAPSULES 0.25 MCG|CALCITRIOL CAPSULES 0.5 MCG|CALCIUM CARBONATE|ANTACID,9,NEOPLASM MALIGNANT|THYROID HORMONE REPLACEMENT THERAPY|THROMBOSIS PROPHYLAXIS|PROPHYLAXIS|ARRHYTHMIA PROPHYLAXIS|SALIVARY GLAND CANCER|PARATHYROIDECTOMY|HYPOCALCAEMIA|THYROID HORMONE REPLACEMENT THERAPY,Hepatitis,1,1
10554592,20141030,Pembrolizumab,71,801,71.0,2,,1,0,1,0,0,0,0,Pembrolizumab,"PREGABALIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METOPROLOL TARTRATE|PEMBROLIZUMAB|FOLIC ACID|OXYCODONE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CONJUGATED ESTROGENS|ESTROGENS, CONJUGATED",12,POST HERPETIC NEURALGIA|PROPHYLAXIS|ROUTINE HEALTH MAINTENANCE|GOUT|DIABETES MELLITUS|HYPERTENSION|MALIGNANT MELANOMA|ROUTINE HEALTH MAINTENANCE|POST HERPETIC NEURALGIA|NAUSEA|PAIN|ROUTINE HEALTH MAINTENANCE,Haemolytic anaemia,1,5
10554597,20141030,Pembrolizumab,57,801,57.0,1,84.1,1,0,1,0,0,0,0,Pembrolizumab,"DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|OXYCODONE|PEMBROLIZUMAB|OXYCODONE HYDROCHLORIDE|CYANOCOBALAMIN|NIFEDIPINE|PEMBROLIZUMAB",11,ARTHRITIS|INSOMNIA|ARTHRALGIA|ARTHRALGIA|ARTHRALGIA|ROUTINE HEALTH MAINTENANCE|HYPERTENSION|NEOPLASM MALIGNANT|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE,Renal failure,1,1
10554906,20141030,Pembrolizumab,71,801,71.0,2,111.6,1,0,1,0,0,0,1,Pembrolizumab,,3,RENAL CELL CARCINOMA|RENAL CELL CARCINOMA,Cardiac failure congestive,1,1
10555359,20141030,Pembrolizumab,19,801,19.0,1,,1,1,1,1,0,0,0,Pembrolizumab,PHENYTOIN|PEMBROLIZUMAB,3,CONVULSION PROPHYLAXIS|METASTATIC MALIGNANT MELANOMA|PAIN,Hyperlipasaemia|Lipase increased|Pyrexia|Malignant neoplasm progression|Diarrhoea|Anaemia,6,1
10555675,20141030,Pembrolizumab,31,801,31.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|METHADONE HYDROCHLORIDE|METHADONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREDNISONE,5,METASTATIC MALIGNANT MELANOMA|PAIN|PNEUMONITIS,Nausea|Vomiting|Abdominal pain,3,3
10556409,20141031,Pembrolizumab,40,801,40.0,2,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Ketoacidosis,1,5
10556545,20141031,Pembrolizumab,,,,0,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,RHABDOMYOSARCOMA,Bone pain|Off label use|Platelet count abnormal|Anaemia|Adverse event|Blood lactate dehydrogenase increased|Transfusion|Platelet transfusion,8,1
10557141,20141031,Pembrolizumab,65,801,65.0,1,,1,1,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB,1,NEUROENDOCRINE CARCINOMA OF THE SKIN,Hepatic failure|Dialysis,2,5
10557158,20141031,Pembrolizumab,65,801,65.0,1,100.68,1,0,1,1,0,0,0,Pembrolizumab,NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|PEMBROLIZUMAB|PEMBROLIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,5,PAIN|ROUTINE HEALTH MAINTENANCE|MALIGNANT MELANOMA|PAIN,Autoimmune hepatitis,1,3
10557575,20141031,Pembrolizumab,40,801,40.0,2,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,MALIGNANT MELANOMA,Hepatitis|Pleural effusion,2,5
10560232,20141103,Pembrolizumab,71,801,71.0,2,111.6,1,0,1,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB|PAZOPANIB|PAZOPANIB HYDROCHLORIDE|PAZOPANIB|PAZOPANIB HYDROCHLORIDE,3,RENAL CELL CARCINOMA|RENAL CELL CARCINOMA,Cardiac failure congestive,1,5
10560424,20141103,Pembrolizumab,76,801,76.0,1,117.91,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Headache|Rash|Malaise|Fatigue,4,5
10560636,20141103,Pembrolizumab,,,,1,,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Death,1,3
10561337,20141103,Pembrolizumab,69,801,69.0,2,,1,0,1,0,0,0,0,Pembrolizumab,"BIOTIN|CELECOXIB|FOLIC ACID|LEVETIRACETAM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CALCIUM CARBONATE|METHOTREXATE|METHOTREXATE SODIUM|ZOLPIDEM TARTRATE|LEVETIRACETAM|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM",13,ALOPECIA|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|DRY EYE|SEIZURE|PAIN|DYSPEPSIA|RHEUMATOID ARTHRITIS|INSOMNIA|GASTROOESOPHAGEAL REFLUX DISEASE|METASTATIC MALIGNANT MELANOMA|HYPOTHYROIDISM,Pyrexia|Arthralgia|Decreased appetite|Stomatitis|Hypotension|Nausea|Anaemia|Joint swelling|Fatigue|Fatigue|Pneumonitis,11,5
10561339,20141103,Pembrolizumab,63,801,63.0,2,57,1,0,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB|EXTENDED PHENYTOIN SODIUM|PEMBROLIZUMAB|PEMBROLIZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PEMBROLIZUMAB|PEMBROLIZUMAB,10,RASH|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|PROPHYLAXIS|MALIGNANT MELANOMA|NAUSEA,Intraocular pressure decreased|Hearing impaired|Uveitis,3,1
10561341,20141103,Pembrolizumab,71,801,71.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Transaminases increased,1,5
10561922,20141104,Pembrolizumab,47,801,47.0,1,,1,0,1,0,0,0,0,Pembrolizumab,NEBIVOLOL HYDROCHLORIDE|OLMESARTAN MEDOXOMIL|PEMBROLIZUMAB|PRAVASTATIN SODIUM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|METHIMAZOLE,6,HYPERTENSION|HYPERTENSION|METASTATIC MALIGNANT MELANOMA|HYPERCHOLESTEROLAEMIA|TYPE 2 DIABETES MELLITUS|HYPERTHYROIDISM,Pyrexia,1,5
10562042,20141104,Pembrolizumab,37,801,37.0,2,,1,1,1,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC OCULAR MELANOMA,Metastatic ocular melanoma|Off label use,2,5
10562430,20141104,Pembrolizumab,54,801,54.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Abdominal pain,1,5
10563136,20141104,Pembrolizumab,58,801,58.0,1,75.9,1,0,1,0,0,0,0,Pembrolizumab,GABAPENTIN|CETIRIZINE HYDROCHLORIDE|OXYCODONE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|PEMBROLIZUMAB|LORAZEPAM|PEMBROLIZUMAB|DEXLANSOPRAZOLE|FLUCONAZOLE|PEMBROLIZUMAB,11,NEURALGIA|ARTHRALGIA|PROPHYLAXIS|HYPERSENSITIVITY|ANXIETY|MYELODYSPLASTIC SYNDROME|GASTROOESOPHAGEAL REFLUX DISEASE,Constipation|Febrile neutropenia|Febrile neutropenia|Febrile neutropenia|Febrile neutropenia|Clostridium difficile colitis,6,1
10563812,20141104,Pembrolizumab,51,801,51.0,1,73.47,1,0,1,0,0,0,0,Pembrolizumab,"METOPROLOL TARTRATE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|FUROSEMIDE|FUROSEMIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LANSOPRAZOLE|LORAZEPAM|TESTOSTERONE|TESTOSTERONE,|PEMBROLIZUMAB|PEMBROLIZUMAB|LORAZEPAM|ERGOCALCIFEROL|SIMVASTATIN|ALLOPURINOL|LACTULOSE|ZOLPIDEM TARTRATE",17,HYPERTENSION|CONSTIPATION|OEDEMA PERIPHERAL|NAUSEA|ABDOMINAL PAIN|GASTROOESOPHAGEAL REFLUX DISEASE|INSOMNIA|BLOOD TESTOSTERONE DECREASED|MALIGNANT MELANOMA|ANXIETY|VITAMIN D DECREASED|HYPERLIPIDAEMIA|BLOOD URIC ACID INCREASED|HYPERKALAEMIA|INSOMNIA,Acute kidney injury,1,1
10564045,20141104,Pembrolizumab,71,801,71.0,1,,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Pneumonia|Disease progression|Pneumonitis,3,5
10565020,20141105,Pembrolizumab,,,,1,,1,1,0,1,0,0,1,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,DISEASE PROGRESSION|METASTATIC MALIGNANT MELANOMA,Death|Central nervous system haemorrhage|Metastases to central nervous system|Unresponsive to stimuli|Lymphoedema,5,3
10565680,20141105,Pembrolizumab,35,801,35.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Decreased appetite|Pyrexia|Muscular weakness|Nausea|Diarrhoea,5,1
10566368,20141105,Pembrolizumab,62,801,62.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Pruritus,1,5
10566619,20141105,Pembrolizumab,72,801,72.0,1,71,1,1,1,1,0,0,1,Pembrolizumab,LORAZEPAM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LORAZEPAM|PEMBROLIZUMAB|ATORVASTATIN CALCIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PEMBROLIZUMAB|LORAZEPAM|ATENOLOL|PEMBROLIZUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|GABAPENTIN|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,22,NAUSEA|ROUTINE HEALTH MAINTENANCE|ARTHRITIS|FLUSHING|ANXIETY|ERECTILE DYSFUNCTION|DYSLIPIDAEMIA|FLUID REPLACEMENT|SLEEP DISORDER|HYPERTENSION|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|PERIPHERAL SENSORY NEUROPATHY|HYPERTENSION|ROUTINE HEALTH MAINTENANCE|TRANSITIONAL CELL CARCINOMA|ROUTINE HEALTH MAINTENANCE,Hypercalcaemia|Myositis|Histiocytosis haematophagic|Renal tubular necrosis|Sepsis,5,3
10566649,20141105,Pembrolizumab,66,801,66.0,2,54.6,1,0,1,0,0,0,0,Pembrolizumab,,2,RENAL CELL CARCINOMA|RENAL CELL CARCINOMA,Aspartate aminotransferase increased|Blood bilirubin increased|Alanine aminotransferase increased,3,1
10566974,20141105,Pembrolizumab,55,801,55.0,2,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|HYDROCHLOROTHIAZIDE|MORPHINE SULFATE|HYDROXYCHLOROQUINE SULFATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FOLIC ACID|SULFASALAZINE|PROCHLORPERAZINE MALEATE,9,METASTATIC MALIGNANT MELANOMA|HYPERTENSION|PAIN|RHEUMATOID ARTHRITIS|NAUSEA|VITAMIN SUPPLEMENTATION|RHEUMATOID ARTHRITIS|PAIN|NAUSEA,Constipation|Abdominal pain|Vomiting|Nausea,4,5
10567070,20141105,Pembrolizumab,54,801,54.0,1,,1,0,1,0,0,0,0,Pembrolizumab,"DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|PEMBROLIZUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|TRAMADOL HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|PEMBROLIZUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|MORPHINE SULFATE|GABAPENTIN|PEMBROLIZUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",19,CONSTIPATION|PAIN|NAUSEA|PAIN|PAIN|VOMITING|NAUSEA|CONSTIPATION|PRURITUS|VOMITING|PAIN|PAIN|NEURALGIA|NAUSEA|VOMITING|METASTATIC MALIGNANT MELANOMA|SWELLING,Metastases to lung|Metastatic malignant melanoma|Amnesia|Headache|Metastases to central nervous system,5,5
10567230,20141105,Pembrolizumab,64,801,64.0,2,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Anaemia|Dyspnoea,2,5
10568293,20141106,Pembrolizumab,61,801,61.0,1,87.89,1,0,0,0,0,0,1,Pembrolizumab,"PEMBROLIZUMAB|ENOXAPARIN SODIUM|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|TOPIRAMATE|TOPIRAMATE SPINKLE|PEMBROLIZUMAB|PROCHLORPERAZINE MALEATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PEMBROLIZUMAB|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE",11,RENAL CELL CARCINOMA|DEEP VEIN THROMBOSIS|DIARRHOEA|MIGRAINE WITH AURA|NAUSEA|MIGRAINE WITH AURA|RENAL CELL CARCINOMA|ANXIETY,Personality change|Agitation,2,1
10568534,20141106,Pembrolizumab,63,801,63.0,1,93,1,0,1,0,0,0,0,Pembrolizumab,"PEMBROLIZUMAB|SENNOSIDES|SENNA LEAF|SENNA|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|ALLOPURINOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PEMBROLIZUMAB|PEMBROLIZUMAB|AMLODIPINE",13,CONSTIPATION|SEIZURE|PROPHYLAXIS|GOUT|TRANSIENT ISCHAEMIC ATTACK|HYPOKALAEMIA|HYPERTENSION|MALIGNANT MELANOMA|HYPERTENSION|HYPERTENSION|TRANSIENT ISCHAEMIC ATTACK,Confusional state,1,1
10568876,20141106,Pembrolizumab,25,801,25.0,1,91,1,0,1,1,0,0,0,Pembrolizumab,SULFAMETHOXAZOLE AND TRIMETHOPRIM|OXYCODONE HYDROCHLORIDE|PEMBROLIZUMAB|PHYTONADIONE|PEMBROLIZUMAB|MORPHINE,13,ANTIBIOTIC THERAPY|HYPERTENSION|ANTIINFLAMMATORY THERAPY|HERPES SIMPLEX|ANTICOAGULANT THERAPY|BACK PAIN|ANALGESIC THERAPY|HODGKIN^S DISEASE|FACTOR VII DEFICIENCY|FUNGAL INFECTION|AXILLARY PAIN|HEREDITARY DISORDER,Axillary pain|Hypoxia|Urinary retention|Dyspnoea,4,1
10569020,20141106,Pembrolizumab,75,801,75.0,2,86,1,0,1,0,0,0,0,Pembrolizumab,METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|PEMBROLIZUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PEMBROLIZUMAB,8,TYPE 2 DIABETES MELLITUS|HYPERTENSION|HYPERTENSION|THROMBOSIS PROPHYLAXIS|PROPHYLAXIS|ATRIAL FIBRILLATION|MALIGNANT MELANOMA,Erysipelas|Neuropathy peripheral,2,1
10569095,20141106,Pembrolizumab,70,801,70.0,1,78.7,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PACLITAXEL|PACLITAXEL|CARBOPLATIN|PEMBROLIZUMAB|CARBOPLATIN,6,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Diverticular perforation,1,1
10569171,20141106,Pembrolizumab,,,,0,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,NON-SMALL CELL LUNG CANCER,Urticaria|Throat irritation,2,5
10569465,20141106,Pembrolizumab,54,801,54.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,3,MALIGNANT MELANOMA,Fatigue,1,3
10570835,20141107,Pembrolizumab,45,801,45.0,1,122,1,0,1,0,0,0,0,Pembrolizumab,"PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|LOSARTAN POTASSIUM|LINAGLIPTIN|DOCUSATE SODIUM|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|LEVETIRACETAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|PRAVASTATIN SODIUM",14,NASAL CONGESTION|ANXIETY|HYPERTENSION|DIABETES MELLITUS|CONSTIPATION|CANCER PAIN|HYPERLIPIDAEMIA|COUGH|NUTRITIONAL SUPPLEMENTATION|CONVULSION PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|DEPRESSION|HYPERLIPIDAEMIA,Pneumonia,1,3
10571155,20141107,Pembrolizumab,55,801,55.0,1,,1,0,0,0,0,0,0,Pembrolizumab,SIMVASTATIN|CARVEDILOL|PEMBROLIZUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ALPRAZOLAM,8,MALIGNANT MELANOMA,Injection site mass|Fatigue|Musculoskeletal stiffness|Arthralgia|Joint stiffness|Pain in extremity,6,1
10571258,20141107,Pembrolizumab,,,,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,,Malaise,1,5
10571423,20141107,Pembrolizumab,71,801,71.0,1,59.8,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,6,BENIGN PROSTATIC HYPERPLASIA|NEOPLASM MALIGNANT|BENIGN PROSTATIC HYPERPLASIA|ABDOMINAL DISCOMFORT,Enteritis,1,1
10571498,20141107,Pembrolizumab,71,801,71.0,2,111.6,1,0,1,0,0,0,0,Pembrolizumab,LORAZEPAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LORAZEPAM,8,NAUSEA|VOMITING|NAUSEA|RENAL CELL CARCINOMA|RENAL CELL CARCINOMA|NAUSEA|VOMITING|VOMITING,Nausea|Vomiting,2,1
10571629,20141107,Pembrolizumab,63,801,63.0,1,104,1,0,1,0,0,0,0,Pembrolizumab,"FOLIC ACID|PEMBROLIZUMAB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PEMBROLIZUMAB",9,ANAEMIA|NON-SMALL CELL LUNG CANCER|TYPE 2 DIABETES MELLITUS|HYPOKALAEMIA|ARRHYTHMIA|VENTRICULAR TACHYCARDIA|HYPERTENSION|THROMBOSIS PROPHYLAXIS,Empyema,1,1
10571709,20141107,Pembrolizumab,34,801,34.0,2,,1,0,0,0,0,0,1,Pembrolizumab,PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|PEMBROLIZUMAB|PEMBROLIZUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE,7,HYPOPITUITARISM|HYPOTHYROIDISM|METASTATIC MALIGNANT MELANOMA|CONVULSION PROPHYLAXIS,Hyperprolactinaemia|Diarrhoea,2,5
10571798,20141107,Pembrolizumab,36,801,36.0,2,,1,0,0,0,0,0,0,Pembrolizumab,LEVOTHYROXINE SODIUM|PEMBROLIZUMAB,2,HYPOTHYROIDISM|MALIGNANT MELANOMA,Diarrhoea|Myalgia|Nausea|Constipation|Decreased appetite|Hypothyroidism|Lip ulceration|Pruritus|Fatigue|Headache,10,5
10572358,20141109,Pembrolizumab,66,801,66.0,1,,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Renal failure|Acute kidney injury,2,5
10572593,20141110,Pembrolizumab,69,801,69.0,1,,1,1,1,0,0,0,0,Pembrolizumab,ENALAPRIL MALEATE|ENALAPRIL|AMLODIPINE|PEMBROLIZUMAB|WARFARIN|PRAVASTATIN SODIUM|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ATENOLOL,7,BLOOD PRESSURE ABNORMAL|BLOOD PRESSURE ABNORMAL|METASTATIC MALIGNANT MELANOMA|ANTICOAGULANT THERAPY|BLOOD CHOLESTEROL ABNORMAL|DIARRHOEA|BLOOD PRESSURE ABNORMAL,Death|Diarrhoea|Angiopathy|Red blood cell count decreased,4,3
10573194,20141110,Pembrolizumab,55,801,55.0,1,169,1,1,1,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Cancer pain|Metastatic malignant melanoma|Urinary retention|Delirium|Cancer pain|Agitation|Restlessness,7,5
10573195,20141110,Pembrolizumab,75,801,75.0,1,84.6,1,1,1,1,0,0,0,Pembrolizumab,"OXYGEN|0XYGEN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PEMBROLIZUMAB",7,DYSPNOEA|TUMOUR PAIN|ANAEMIA|OEDEMA PERIPHERAL|INSOMNIA|MALIGNANT MELANOMA|INSOMNIA,Pelvic pain|Dyspnoea|Upper gastrointestinal haemorrhage|Death,4,5
10573310,20141110,Pembrolizumab,,,,2,,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Disease progression,1,5
10574090,20141110,Pembrolizumab,,,,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Herpes zoster|Inappropriate schedule of drug administration,2,5
10574107,20141110,Pembrolizumab,,,,2,,1,1,0,0,0,0,0,Pembrolizumab,,1,,Respiratory failure,1,5
10574380,20141110,Pembrolizumab,71,801,71.0,1,113.8,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|OMEPRAZOLE MAGNESIUM|LORAZEPAM|GABAPENTIN|PEMBROLIZUMAB|ALBUTEROL SULFATE|PREDNISONE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|PEMBROLIZUMAB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|OMEPRAZOLE MAGNESIUM,18,NAUSEA|GASTROOESOPHAGEAL REFLUX DISEASE|SLEEP DISORDER THERAPY|NEUROPATHY PERIPHERAL|ASTHMA|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|MYALGIA|PAIN PROPHYLAXIS|ROUTINE HEALTH MAINTENANCE|ASTHMA|GASTRIC CANCER|ROUTINE HEALTH MAINTENANCE|DIARRHOEA|ABDOMINAL PAIN LOWER,Tracheomalacia|Hypoxia,2,1
10574424,20141110,Pembrolizumab,,,,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Tracheal disorder,1,5
10574544,20141110,Pembrolizumab,68,801,68.0,1,74.3,1,0,1,0,0,0,0,Pembrolizumab,"PEMBROLIZUMAB|HYDROCODONE BITARTRATE AND ACETAMINOPHEN|MESALAMINE|CELECOXIB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DEXLANSOPRAZOLE|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|ERGOCALCIFEROL|MORPHINE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|MORPHINE SULFATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|CALCIUM CARBONATE|ANTACID|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PEMBROLIZUMAB|PEMBROLIZUMAB|CITALOPRAM|CITALOPRAM HYDROBROMIDE",18,PAIN|PROCTITIS ULCERATIVE|BONE PAIN|BLOOD CREATININE INCREASED|GASTROOESOPHAGEAL REFLUX DISEASE|CONSTIPATION PROPHYLAXIS|ROUTINE HEALTH MAINTENANCE|PAIN|BONE PAIN|CONSTIPATION PROPHYLAXIS|BONE PAIN|PAIN|ROUTINE HEALTH MAINTENANCE|GASTRIC CANCER|ANXIETY,Pleural effusion,1,1
10574551,20141110,Pembrolizumab,,,,0,,1,1,0,1,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Death|General physical health deterioration,2,5
10574552,20141110,Pembrolizumab,51,801,51.0,2,,1,0,1,0,0,0,0,Pembrolizumab,OXYCODONE|PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS,5,NAUSEA|ROUTINE HEALTH MAINTENANCE|PAIN|METASTATIC MALIGNANT MELANOMA|HYPOTHYROIDISM,Oedema peripheral,1,3
10574609,20141110,Pembrolizumab,49,801,49.0,1,,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,METASTASES TO CENTRAL NERVOUS SYSTEM|METASTATIC MALIGNANT MELANOMA,Death|Tremor|Delirium|Confusional state,4,3
10574612,20141110,Pembrolizumab,51,801,51.0,1,77.3,1,0,1,0,0,0,0,Pembrolizumab,"DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|OXYCODONE|PEMBROLIZUMAB|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|PREDNISONE|PEMBROLIZUMAB|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|HYDROCORTISONE ACETATE",9,CONSTIPATION|PAIN|HEAD AND NECK CANCER|ORAL PAIN|ANXIETY|OSTEOARTHRITIS|INFECTION|RASH,Tongue oedema|Lip swelling,2,1
10574640,20141110,Pembrolizumab,44,801,44.0,2,40.59,1,0,1,0,0,0,0,Pembrolizumab,METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|METHADONE HYDROCHLORIDE|METHADONE|SENNOSIDES|DICLOFENAC|DICLOFENAC SODIUM|OXYCODONE HYDROCHLORIDE|OXYCODONE|POLYETHYLENE GLYCOL 3350|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|PEMBROLIZUMAB,12,NAUSEA|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERSENSITIVITY|GASTROOESOPHAGEAL REFLUX DISEASE|PYREXIA|PAIN|CONSTIPATION|ACTINIC KERATOSIS|ANALGESIC THERAPY|CONSTIPATION|HYPERSENSITIVITY|HEAD AND NECK CANCER,Pneumonitis,1,1
10577096,20141111,Pembrolizumab,72,801,72.0,2,57.6,1,0,1,0,0,0,0,Pembrolizumab,"PEMBROLIZUMAB|CYCLOBENZAPRINE HYDROCHLORIDE|CYCLOBENZAPRINE|LORAZEPAM|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|PEMBROLIZUMAB|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|PEMBROLIZUMAB|DENOSUMAB|CHLORHEXIDINE GLUCONATE|ANTISEPTIC SKIN CLEANSER",11,EYE DISORDER|HEADACHE|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|DRY EYE|FLUID REPLACEMENT|DENTAL DISORDER PROPHYLAXIS,Hyponatraemia|Nausea,2,1
10577442,20141111,Pembrolizumab,73,801,73.0,1,,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|POLYETHYLENE GLYCOL 3350|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|FENTANYL|LEVOTHYROXINE SODIUM|OMEPRAZOLE MAGNESIUM|GABAPENTIN|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|FENTANYL|LACTULOSE|SENNOSIDES|SENNA LEAF|SENNA|ROSUVASTATIN|LEVOTHYROXINE SODIUM|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|OXYCODONE,16,METASTATIC MALIGNANT MELANOMA|CONSTIPATION|NASAL CONGESTION|CONSTIPATION|BLOOD CHOLESTEROL|NEURALGIA|ORAL CANDIDIASIS|PAIN|CONSTIPATION|CONSTIPATION|BLOOD CHOLESTEROL|HYPOTHYROIDISM|ADRENAL DISORDER|PAIN,Fatigue|Disease progression|Haemoptysis|Dyspnoea,4,5
10577503,20141111,Pembrolizumab,53,801,53.0,2,88.8,1,0,1,0,0,0,0,Pembrolizumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PEMBROLIZUMAB|IPILIMUMAB|ACETAMINOPHEN AND CODEINE|PEMBROLIZUMAB,5,MIGRAINE|MALIGNANT MELANOMA|MIGRAINE|MALIGNANT MELANOMA,Drug-induced liver injury|Pneumonitis|Autoimmune hepatitis,3,1
10577596,20141111,Pembrolizumab,62,801,62.0,1,54.5,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|SIMVASTATIN|PEMBROLIZUMAB|PREGABALIN,18,TUMOUR PAIN|HYPERLIPIDAEMIA|PHYTOTHERAPY|HYPERTENSION|ANXIETY|VITAMIN SUPPLEMENTATION|TUMOUR PAIN|DEPRESSION|TUMOUR PAIN|HYPERTENSION|MESENTERIC ARTERY THROMBOSIS|THROMBOCYTOPENIA|TRANSITIONAL CELL CARCINOMA|CONSTIPATION|SLEEP DISORDER|TUMOUR PAIN,Toxic encephalopathy|Intestinal obstruction,2,1
10578901,20141112,Pembrolizumab,70,801,70.0,1,,1,1,1,1,0,0,0,Pembrolizumab,PEMBROLIZUMAB|METOPROLOL TARTRATE|METOPROLOL|PRAVASTATIN SODIUM|AMLODIPINE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE,8,METASTATIC MALIGNANT MELANOMA|NAUSEA|HYPERTENSION|HYPERCHOLESTEROLAEMIA|ROUTINE HEALTH MAINTENANCE|HYPERTENSION,Malignant neoplasm progression|Vomiting|Decreased appetite|Nausea,4,3
10579795,20141112,Pembrolizumab,33,801,33.0,2,61.2,1,0,0,0,0,0,1,Pembrolizumab,METHYLPREDNISOLONE|TEMAZEPAM|FAMOTIDINE|OXYCODONE|ALPRAZOLAM|DIPHENHYDRAMINE HYDROCHLORIDE|FENTANYL|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|SENNOSIDES|SENNA LEAF|SENNA|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE,18,MIGRAINE|INSOMNIA|PROPHYLAXIS|PAIN|ANXIETY|NAUSEA|PROPHYLAXIS|PAIN|MIGRAINE|MIGRAINE|MIGRAINE|CONSTIPATION|MALIGNANT MELANOMA|MIGRAINE|MIGRAINE|MIGRAINE,Meningitis noninfective,1,1
10579798,20141112,Pembrolizumab,67,801,67.0,2,,1,0,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Rash|Swelling face|Pharyngeal oedema,3,5
10579944,20141112,Pembrolizumab,65,801,65.0,1,74.6,1,0,1,1,0,0,0,Pembrolizumab,"PEMBROLIZUMAB|ATORVASTATIN CALCIUM|OMEPRAZOLE MAGNESIUM|TRAMADOL HYDROCHLORIDE|LORATADINE|LORATADINE TABLET|BENAZEPRIL HYDROCHLORIDE|PEMBROLIZUMAB|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|FERROUS SULFATE|LEVOTHYROXINE SODIUM|CYANOCOBALAMIN|LORAZEPAM",17,NON-SMALL CELL LUNG CANCER|BLOOD CHOLESTEROL ABNORMAL|VITAMIN SUPPLEMENTATION|GASTROOESOPHAGEAL REFLUX DISEASE|PAIN|RASH PUSTULAR|HYPERTENSION|VITAMIN SUPPLEMENTATION|BACK PAIN|HYPERTENSION|VITAMIN SUPPLEMENTATION|VOMITING|VITAMIN SUPPLEMENTATION|HYPOTHYROIDISM|VITAMIN SUPPLEMENTATION|NAUSEA,Diabetic ketoacidosis|Hypertriglyceridaemia,2,1
10580068,20141112,Pembrolizumab,72,801,72.0,1,,1,1,1,1,0,0,1,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Malignant melanoma,1,5
10580160,20141112,Pembrolizumab,,,,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Fatigue,1,5
10580401,20141112,Pembrolizumab,,,,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,,Colitis,1,5
10580738,20141113,Pembrolizumab,,,,0,,1,1,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Metastatic malignant melanoma,1,5
10581674,20141113,Pembrolizumab,79,801,79.0,2,60.4,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,3,NEOPLASM MALIGNANT,Autoimmune hepatitis,1,1
10581779,20141113,Pembrolizumab,76,801,76.0,1,76.5,1,0,1,0,0,0,0,Pembrolizumab,METOPROLOL TARTRATE|METOPROLOL|NITROGLYCERIN|PEMBROLIZUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|SIMVASTATIN|ATORVASTATIN CALCIUM|PEMBROLIZUMAB|CANDESARTAN CILEXETIL,10,HYPERTENSION|CHEST PAIN|MALIGNANT MELANOMA|DIABETES MELLITUS|CORONARY ARTERY DISEASE|HYPERCHOLESTEROLAEMIA|HYPERTENSION|CORONARY ARTERY DISEASE|HYPERTENSION,Aspartate aminotransferase increased|Blood bilirubin increased|Alanine aminotransferase increased,3,1
10581785,20141113,Pembrolizumab,88,801,88.0,1,,1,1,1,0,0,0,0,Pembrolizumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|OLMESARTAN MEDOXOMIL|ZOLPIDEM TARTRATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FUROSEMIDE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|FINASTERIDE|POLYETHYLENE GLYCOL 3350|SIMETHICONE|DIMETHICONE|PEMBROLIZUMAB|METOCLOPRAMIDE HYDROCHLORIDE",14,PAIN|INSOMNIA|HYPERTENSION|INSOMNIA|PAIN|HEPATIC FAILURE|CONSTIPATION|HYPERTENSION|PROSTATOMEGALY|PAIN|CONSTIPATION|FLATULENCE|METASTATIC MALIGNANT MELANOMA|DYSPEPSIA,Multi-organ failure|Hypophagia|Abdominal pain,3,5
10581979,20141113,Pembrolizumab,64,801,64.0,2,80,1,1,0,0,0,0,1,Pembrolizumab,FUROSEMIDE|PEMBROLIZUMAB|IPILIMUMAB|FUROSEMIDE,4,INTERSTITIAL LUNG DISEASE|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PLEURAL EFFUSION,Malignant pleural effusion|Respiratory disorder|Lung disorder,3,1
10582070,20141113,Pembrolizumab,61,801,61.0,1,78.6,1,0,1,0,0,0,0,Pembrolizumab,"DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|GABAPENTIN|PEMBROLIZUMAB|PEMBROLIZUMAB|LORAZEPAM|TAMSULOSIN HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|TRAMADOL HYDROCHLORIDE|PEMBROLIZUMAB|AMLODIPINE|OMEPRAZOLE MAGNESIUM",17,PRODUCT USED FOR UNKNOWN INDICATION|PERIPHERAL SENSORY NEUROPATHY|RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|RENAL CELL CARCINOMA|ANXIETY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ROUTINE HEALTH MAINTENANCE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia|Depression,2,1
10582372,20141113,Pembrolizumab,71,801,71.0,1,49.1,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,NON-SMALL CELL LUNG CANCER,Pneumonia|Pneumonia,2,3
10583558,20141114,Pembrolizumab,83,801,83.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Pruritus,1,3
10585299,20141114,Pembrolizumab,83,801,83.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Nausea|Rash|Platelet count decreased,3,5
10587583,20141117,Pembrolizumab,66,801,66.0,1,88,1,0,1,0,0,0,0,Pembrolizumab,AMLODIPINE BESYLATE|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,5,HYPERTENSION|MALIGNANT MELANOMA|HYPERTHYROIDISM,Chest pain,1,1
10588012,20141117,Pembrolizumab,50,801,50.0,2,49,1,0,1,0,0,0,0,Pembrolizumab,LEVETIRACETAM|PEMBROLIZUMAB,2,EPILEPSY|METASTATIC MALIGNANT MELANOMA,Hepatitis acute,1,1
10588066,20141117,Pembrolizumab,61,801,61.0,2,42.4,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|FAMOTIDINE|PEMBROLIZUMAB|GABAPENTIN|MORPHINE SULFATE,13,ANXIETY|TUMOUR ASSOCIATED FEVER|HEAD AND NECK CANCER|COUGH|DECREASED APPETITE|GASTRITIS PROPHYLAXIS|CANCER PAIN|CANCER PAIN|CANCER PAIN|CONSTIPATION|CANCER PAIN,Stomatitis,1,1
10588076,20141117,Pembrolizumab,69,801,69.0,1,76.2,1,1,1,1,0,0,0,Pembrolizumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PEMBROLIZUMAB|LATANOPROST|TIOTROPIUM BROMIDE|LANSOPRAZOLE|METOPROLOL TARTRATE|ALLOPURINOL|ALLOPURINOL,12,PERIPHERAL VASCULAR DISORDER|HYPERLIPIDAEMIA|NON-SMALL CELL LUNG CANCER|GLAUCOMA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION|HYPERTENSION|PROPHYLAXIS|ROUTINE HEALTH MAINTENANCE|HYPERURICAEMIA|ROUTINE HEALTH MAINTENANCE,Pneumonia|Pneumonia|Hypoxia|Pneumonitis|Malignant neoplasm progression|Pneumonitis|Rash generalised,7,1
10588327,20141117,Pembrolizumab,63,801,63.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Decreased appetite|Fatigue,2,5
10588335,20141117,Pembrolizumab,41,801,41.0,1,89.5,1,0,0,0,0,0,0,Pembrolizumab,"ROSUVASTATIN CALCIUM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|PEMBROLIZUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|BISOPROLOL FUMARATE|PEMBROLIZUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACETAMINOPHEN",9,HYPERCHOLESTEROLAEMIA|ANTIFUNGAL PROPHYLAXIS|INFECTION PROPHYLAXIS|BACK PAIN|TACHYCARDIA|HODGKIN^S DISEASE|CARDIOVASCULAR EVENT PROPHYLAXIS|BACK PAIN,Blood creatinine increased|Blood creatinine increased,2,1
10588533,20141117,Pembrolizumab,59,801,59.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Fatigue|Pruritus|Chills|Pyrexia,4,5
10588893,20141117,Pembrolizumab,,,,1,,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,METASTASES TO PERITONEUM|BLADDER CANCER,Disease progression|Vomiting|Nausea,3,5
10588894,20141117,Pembrolizumab,,,,2,,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,,Death,1,5
10589126,20141118,Pembrolizumab,,,,2,,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,OVARIAN CANCER,Death,1,5
10590119,20141118,Pembrolizumab,,,,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Disease progression|Incorrect route of drug administration,2,5
10590287,20141118,Pembrolizumab,,,,2,,1,1,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB,1,GASTRIC CANCER,Death|Pulmonary endarterectomy|Inappropriate schedule of drug administration|Pulmonary embolism,4,5
10590297,20141118,Pembrolizumab,,,,0,,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,,Death,1,5
10590425,20141118,Pembrolizumab,,,,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,NEOPLASM MALIGNANT,Colitis,1,5
10590893,20141118,Pembrolizumab,56,801,56.0,1,68.5,1,0,1,0,0,0,0,Pembrolizumab,OXYCODONE|POLYETHYLENE GLYCOL|LORAZEPAM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PEMBROLIZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LORAZEPAM|PEMBROLIZUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|METRONIDAZOLE|NICOTINE POLACRILEX|NICOTINE|NICOTINE POLACRILEX MINI|NICOTINE POLARILEX,13,FACIAL PAIN|CONSTIPATION|INSOMNIA|STOMATITIS|FLUID REPLACEMENT|DYSPEPSIA|NAUSEA|ANXIETY|HEAD AND NECK CANCER|CONSTIPATION|WOUND|EX-TOBACCO USER,Face oedema,1,1
10591314,20141118,Pembrolizumab,40,801,40.0,1,,1,1,1,1,1,0,1,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Deep vein thrombosis|Adverse event|Pulmonary embolism|Thrombosis|Death,5,3
10591384,20141118,Pembrolizumab,71,801,71.0,1,108,1,0,1,0,0,0,0,Pembrolizumab,"BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE|MELATONIN|CETIRIZINE HYDROCHLORIDE|PEMBROLIZUMAB|BRIMONIDINE TARTRATE|LOSARTAN POTASSIUM|HYOSCYAMINE SULFATE|IBUPROFEN|IBUPROFEN AND DIPHENHYDRAMINE CITRATE|ZOLEDRONIC ACID|PEMBROLIZUMAB|BRIMONIDINE TARTRATE|VENLAFAXINE HYDROCHLORIDE|ATORVASTATIN CALCIUM|ESOMEPRAZOLE MAGNESIUM|PEMBROLIZUMAB|COLESTIPOL HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE",20,HEADACHE|HEADACHE|INSOMNIA|HYPERSENSITIVITY|GLAUCOMA|HYPERTENSION|ABDOMINAL PAIN|PAIN|OSTEOPOROSIS|NEOPLASM MALIGNANT|ROSACEA|DEPRESSION|HYPERCHOLESTEROLAEMIA|ROUTINE HEALTH MAINTENANCE|GASTROOESOPHAGEAL REFLUX DISEASE|FAECAL INCONTINENCE|ANORECTAL DISCOMFORT|DIARRHOEA,Polyneuropathy,1,1
10591939,20141119,Pembrolizumab,65,801,65.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Aspartate aminotransferase increased|Alanine aminotransferase increased,2,3
10592430,20141119,Pembrolizumab,58,801,58.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Neutrophil count decreased|White blood cell count decreased,2,3
10593390,20141119,Pembrolizumab,67,801,67.0,1,82.2,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CARBOPLATIN|SIMVASTATIN|PEMBROLIZUMAB|ENOXAPARIN SODIUM|CARBOPLATIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PACLITAXEL|FAMOTIDINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PACLITAXEL|MAGNESIUM HYDROXIDE,22,CHEST PAIN|HYPERTENSION|NAUSEA|NON-SMALL CELL LUNG CANCER|ROUTINE HEALTH MAINTENANCE|DEEP VEIN THROMBOSIS|BLOOD CHOLESTEROL INCREASED|NON-SMALL CELL LUNG CANCER|DEEP VEIN THROMBOSIS|PREMEDICATION|CORONARY ARTERY DISEASE|HYPERTENSION|GASTROOESOPHAGEAL REFLUX DISEASE|VOMITING|NAUSEA|NON-SMALL CELL LUNG CANCER|CONSTIPATION|VOMITING|CHEST PAIN,Anaemia|Diarrhoea haemorrhagic,2,1
10593400,20141119,Pembrolizumab,51,801,51.0,1,58.5,1,1,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB,1,,Metastatic malignant melanoma,1,1
10593475,20141119,Pembrolizumab,70,801,70.0,1,,1,0,1,0,0,0,1,Pembrolizumab,TAMSULOSIN HYDROCHLORIDE|PEMBROLIZUMAB|BISOPROLOL FUMARATE|FLECAINIDE ACETATE TABLET|FLECAINIDE ACETATE,4,BENIGN PROSTATIC HYPERPLASIA|METASTATIC MALIGNANT MELANOMA|ATRIAL FIBRILLATION|ATRIAL FIBRILLATION,Pneumonitis,1,5
10593481,20141119,Pembrolizumab,,,,2,,1,1,0,0,0,0,0,Pembrolizumab,,1,,Death,1,5
10593885,20141119,Pembrolizumab,45,801,45.0,2,58.6,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|CARBOPLATIN|CARBOPLATIN|PACLITAXEL|PACLITAXEL,6,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pneumonia,1,1
10594217,20141119,Pembrolizumab,38,801,38.0,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,2,METASTATIC MALIGNANT MELANOMA,Hyperglycaemia,1,5
10594557,20141120,Pembrolizumab,53,801,53.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,3,METASTATIC MALIGNANT MELANOMA,Dry skin|Lymphoedema|Fatigue|Constipation|Hypokalaemia|Anaemia|Hyponatraemia,7,3
10596308,20141120,Pembrolizumab,45,801,45.0,2,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Pancreatitis|Hyperthyroidism,2,5
10596483,20141120,Pembrolizumab,78,801,78.0,1,99.77,1,0,0,0,0,0,1,Pembrolizumab,"ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL|PEMBROLIZUMAB|PEMBROLIZUMAB|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|FENOFIBRATE|THYROID, PORCINE|METOPROLOL SUCCINATE|OMEPRAZOLE MAGNESIUM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LORATADINE|LORATADINE TABLET|TRAMADOL HYDROCHLORIDE|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE",20,ROUTINE HEALTH MAINTENANCE|SEASONAL ALLERGY|ROUTINE HEALTH MAINTENANCE|INFECTION PROPHYLAXIS|MALIGNANT MELANOMA|GASTROOESOPHAGEAL REFLUX DISEASE|ROUTINE HEALTH MAINTENANCE|PAIN|HYPERLIPIDAEMIA|ROUTINE HEALTH MAINTENANCE|HYPOTHYROIDISM|BUNDLE BRANCH BLOCK|PAIN|ROUTINE HEALTH MAINTENANCE|HYPERLIPIDAEMIA|SEASONAL ALLERGY|PAIN|GASTROOESOPHAGEAL REFLUX DISEASE,Colitis microscopic|Hypothyroidism,2,3
10596946,20141120,Pembrolizumab,65,801,65.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Myalgia|Fatigue|Fatigue|Fatigue|Headache,5,1
10596957,20141120,Pembrolizumab,36,801,36.0,1,,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,2,ANAPLASTIC ASTROCYTOMA,Death,1,5
10597128,20141121,Pembrolizumab,72,801,72.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Pruritus,1,5
10597271,20141121,Pembrolizumab,66,801,66.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,METASTATIC MALIGNANT MELANOMA,Fatigue,1,5
10597304,20141121,Pembrolizumab,64,801,64.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Anaemia,1,3
10598346,20141121,Pembrolizumab,79,801,79.0,1,72.6,1,0,1,0,0,0,0,Pembrolizumab,TAMSULOSIN HYDROCHLORIDE|PREDNISONE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|PEMBROLIZUMAB,4,METASTATIC MALIGNANT MELANOMA,Pyrexia|Confusional state|Aspartate aminotransferase increased|Alanine aminotransferase increased,4,1
10599510,20141121,Pembrolizumab,48,801,48.0,1,,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,3,HYPERTENSION|METASTATIC MALIGNANT MELANOMA,Cerebral haemorrhage,1,5
10599682,20141121,Pembrolizumab,68,801,68.0,1,77.7,1,0,0,0,0,0,1,Pembrolizumab,,3,RENAL CELL CARCINOMA|RENAL CELL CARCINOMA,Lipase increased,1,1
10599738,20141121,Pembrolizumab,68,801,68.0,1,90.5,1,0,1,0,0,0,1,Pembrolizumab,"PEMBROLIZUMAB|ALLOPURINOL|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|OXYCODONE|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL|FOLIC ACID|ROSUVASTATIN|PEMBROLIZUMAB|ASCORBIC ACID|HYDROXYUREA|RAMIPRIL|ANAGRELIDE HYDROCHLORIDE|ALLOPURINOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASCORBIC ACID|CLOPIDOGREL|VALSARTAN|ROSUVASTATIN CALCIUM|ERGOCALCIFEROL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ERGOCALCIFEROL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FOLIC ACID",27,RHINITIS|HYPERTENSION|ANALGESIC THERAPY|HYPERSENSITIVITY|ROUTINE HEALTH MAINTENANCE|BLOOD CHOLESTEROL INCREASED|NON-SMALL CELL LUNG CANCER|ROUTINE HEALTH MAINTENANCE|POLYCYTHAEMIA VERA|HYPERTENSION|POLYCYTHAEMIA|GOUT|THROMBOCYTOSIS|PROPHYLAXIS|DECREASED APPETITE|HYPERTENSION|ROUTINE HEALTH MAINTENANCE|GASTROOESOPHAGEAL REFLUX DISEASE|PROPHYLAXIS|GASTROOESOPHAGEAL REFLUX DISEASE|ROUTINE HEALTH MAINTENANCE|PROPHYLAXIS,Acute myocardial infarction|Angina unstable,2,3
10600358,20141123,Pembrolizumab,43,801,43.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Fatigue|Nausea,2,5
10601059,20141124,Pembrolizumab,57,801,57.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Adrenal insufficiency,1,5
10601064,20141124,Pembrolizumab,67,801,67.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Adrenal insufficiency,1,5
10601374,20141124,Pembrolizumab,54,801,54.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,5,METASTATIC MALIGNANT MELANOMA,Lymphocyte count decreased|Diarrhoea|Lymphopenia|Gastrooesophageal reflux disease|Hyperglycaemia|Anaemia|Constipation|Lymphocyte count decreased,8,3
10601381,20141124,Pembrolizumab,61,801,61.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Myalgia|Hyponatraemia|Hyperglycaemia|Lymphocyte count decreased|Nausea|Anaemia|Hyperglycaemia|Hyponatraemia|Anaemia|Hyponatraemia|Hyperglycaemia|Anaemia|Lymphocyte count decreased|Anaemia|Haematuria,15,5
10601987,20141124,Pembrolizumab,66,801,66.0,1,119.1,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|CARBOPLATIN|CARBOPLATIN|PACLITAXEL|PACLITAXEL,6,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Dyspnoea|Infectious pleural effusion|Pneumonia|Peptic ulcer|Dyspnoea,5,1
10602455,20141124,Pembrolizumab,78,801,78.0,2,,1,1,1,1,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,NON-SMALL CELL LUNG CANCER,Embolism,1,3
10602901,20141124,Pembrolizumab,62,801,62.0,1,108.39,1,0,0,0,0,0,1,Pembrolizumab,"NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|PROPYLENE GLYCOL|TIMOLOL MALEATE|TIMOLOL MALEATE OPHTHALMIC|AMLODIPINE|BENZONATATE|PEMBROLIZUMAB|PEMBROLIZUMAB|ALLOPURINOL|LOTEPREDNOL ETABONATE AND TOBRAMYCIN|PEMBROLIZUMAB|PANTOPRAZOLE|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|LOTEPREDNOL ETABONATE",17,PRURITUS|CEREBROVASCULAR ACCIDENT|PROPHYLAXIS|HYPERTENSION|COUGH|COUGH|MALIGNANT MELANOMA|GOUT|CEREBROVASCULAR ACCIDENT|ROUTINE HEALTH MAINTENANCE|CEREBROVASCULAR ACCIDENT|GASTROOESOPHAGEAL REFLUX DISEASE|PRURITUS|HYPERTENSION|CEREBROVASCULAR ACCIDENT,Autoimmune hepatitis,1,1
10602986,20141124,Pembrolizumab,66,801,66.0,1,85,1,0,1,1,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,4,MALIGNANT MELANOMA|DRY EYE|OSTEOARTHRITIS,Drug hypersensitivity,1,3
10603209,20141124,Pembrolizumab,71,801,71.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,5,METASTATIC MALIGNANT MELANOMA,Fatigue|Anaemia|Diarrhoea|Rash maculo-papular|Blood alkaline phosphatase increased|Hyponatraemia|Hyperglycaemia|Blood alkaline phosphatase increased|Anaemia|Blood alkaline phosphatase increased|Dyspnoea|Nausea|Anaemia,13,5
10605365,20141124,Pembrolizumab,,,,1,,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|LEVOTHYROXINE SODIUM|ZOLPIDEM TARTRATE|LEVETIRACETAM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,6,MALIGNANT MELANOMA,Malignant neoplasm progression,1,5
10605576,20141124,Pembrolizumab,78,801,78.0,1,,1,0,0,0,0,0,0,Pembrolizumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PEMBROLIZUMAB|OXYBUTYNIN|PREDNISOLONE ACETATE|MOMETASONE FUROATE|FINASTERIDE,9,METASTATIC MALIGNANT MELANOMA,Plasma cell myeloma,1,5
10606172,20141125,Pembrolizumab,,,,0,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,,Blood lactate dehydrogenase increased|Hypothyroidism,2,1
10606507,20141125,Pembrolizumab,62,801,62.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|CALCIUM POLYCARBOPHIL|OMEPRAZOLE MAGNESIUM|DIPHENHYDRAMINE HYDROCHLORIDE,8,NAUSEA|METASTATIC MALIGNANT MELANOMA|CONSTIPATION|PRURITUS|PRURITUS|PRURITUS|GASTROOESOPHAGEAL REFLUX DISEASE|PRURITUS,Vitiligo,1,5
10606577,20141125,Pembrolizumab,,,,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,,Mucosal inflammation,1,5
10606580,20141125,Pembrolizumab,73,801,73.0,1,67,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|FENTANYL|FENTANYL|PEMBROLIZUMAB,10,HEAD AND NECK CANCER|PAIN IN JAW|PAIN IN JAW|NUTRITIONAL SUPPLEMENTATION|PROPHYLAXIS|PAIN IN JAW|HYPERTENSION|PAIN IN JAW|HYPERTENSION,Pneumonia aspiration|Pain in jaw,2,1
10606834,20141125,Pembrolizumab,59,801,59.0,2,,1,0,1,0,0,0,0,Pembrolizumab,"DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE|GABAPENTIN|MORPHINE|BRIMONIDINE TARTRATE|BRIMONIDINE TARTRATE, TIMOLOL MALEATE|LEVETIRACETAM|MORPHINE SULFATE|LEVOTHYROXINE SODIUM|PREDNISOLONE ACETATE|DALTEPARIN SODIUM|ESCITALOPRAM|PEMBROLIZUMAB|PREDNISONE",14,GLAUCOMA|PAIN|PAIN|GLAUCOMA|GLAUCOMA|CONVULSION PROPHYLAXIS|NAUSEA|PAIN|HYPOTHYROIDISM|GLAUCOMA|PULMONARY EMBOLISM|ANTIDEPRESSANT THERAPY|METASTATIC MALIGNANT MELANOMA|PROPHYLAXIS,Diarrhoea|Adrenal insufficiency|Acute kidney injury|Hyperkalaemia|Anaemia|Hypotension,6,3
10606939,20141125,Pembrolizumab,43,801,43.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|LORAZEPAM|OXYCODONE|LORAZEPAM|MORPHINE SULFATE|ONDANSETRON HYDROCHLORIDE,7,METASTATIC MALIGNANT MELANOMA|ANXIETY|DYSPEPSIA|PAIN|ANXIETY|PAIN|NAUSEA,Anaemia|Platelet count decreased|Thrombocytopenia|Hypothyroidism,4,3
10608207,20141125,Pembrolizumab,40,801,40.0,1,55,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Disease progression,1,1
10608579,20141125,Pembrolizumab,17,801,17.0,2,,1,1,0,0,0,0,0,Pembrolizumab,OXYCODONE HYDROCHLORIDE|LEVOTHYROXINE SODIUM|PEMBROLIZUMAB|ESCITALOPRAM|LORAZEPAM|PEMBROLIZUMAB,9,MALIGNANT MELANOMA,Malignant neoplasm progression,1,3
10608580,20141125,Pembrolizumab,59,801,59.0,2,103.3,1,0,1,0,0,0,0,Pembrolizumab,"CITALOPRAM|CITALOPRAM HYDROBROMIDE|SIMVASTATIN|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|TRAMADOL HYDROCHLORIDE|AMITRIPTYLINE HYDROCHLORIDE|PEMBROLIZUMAB|RANITIDINE|PEMBROLIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|RAMIPRIL",14,STRESS|CARDIOVASCULAR DISORDER|CONSTIPATION|CHEST PAIN|INSOMNIA|GASTROINTESTINAL DISORDER|ANALGESIC THERAPY|NON-SMALL CELL LUNG CANCER|HYPERTENSION|CONSTIPATION|CHEST PAIN|ANALGESIC THERAPY|CARDIOVASCULAR DISORDER,Dysphagia|Dyspnoea,2,1
10610289,20141126,Pembrolizumab,61,801,61.0,2,63.4,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|TRAMADOL HYDROCHLORIDE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|GABAPENTIN|ACETAMINOPHEN AND CODEINE,9,NEOPLASM MALIGNANT|RASH|SKIN LESION|HYPOTENSION|PAIN|RASH|PAIN|PAIN,Cellulitis,1,1
10610388,20141126,Pembrolizumab,,,,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Myocardial necrosis marker increased|Fatigue|Blood creatine phosphokinase MB increased|Chest pain,4,5
10611598,20141126,Pembrolizumab,76,801,76.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Blood alkaline phosphatase increased|Lymphocyte count decreased|Diarrhoea|Nausea|Anaemia|Headache|Abdominal pain|Vomiting|Faecal incontinence|Confusional state|Urinary incontinence|Hyponatraemia|Somnolence|Hyperglycaemia,14,5
10612739,20141127,Pembrolizumab,,,,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Cytokine storm,1,5
10612777,20141127,Pembrolizumab,,,,1,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,,Haematemesis,1,5
10612863,20141127,Pembrolizumab,8,801,8.0,2,,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,HEAD AND NECK CANCER METASTATIC,Therapeutic response unexpected|Pyrexia|Therapeutic response delayed|Death,4,1
10612951,20141127,Pembrolizumab,,,,2,50,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,GASTRIC CANCER,Death,1,1
10613182,20141128,Pembrolizumab,43,801,43.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Pain,1,5
10613183,20141128,Pembrolizumab,31,801,31.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Dyspnoea exertional|Agitation|Insomnia|Restless legs syndrome,4,5
10613607,20141128,Pembrolizumab,56,801,56.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Hyperglycaemia,1,3
10613667,20141128,Pembrolizumab,,,,0,,1,0,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB,1,MALIGNANT MELANOMA,Pancreatitis acute,1,5
10613903,20141128,Pembrolizumab,,,,0,,1,0,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB,1,,Pancytopenia,1,1
10614808,20141201,Pembrolizumab,70,801,70.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,METASTATIC MALIGNANT MELANOMA,Pruritus|Pruritus|Oral pain,3,5
10615314,20141201,Pembrolizumab,,,,2,,1,1,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,,Death,1,1
10615650,20141201,Pembrolizumab,59,801,59.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Fatigue|Vitiligo,2,3
10616385,20141201,Pembrolizumab,47,801,47.0,2,72.2,1,0,0,0,0,0,1,Pembrolizumab,ZOLPIDEM TARTRATE|PEMBROLIZUMAB,3,INSOMNIA|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER,Neuralgia,1,3
10617391,20141201,Pembrolizumab,74,801,74.0,1,94.9,1,0,0,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB|ATORVASTATIN CALCIUM|PEMBROLIZUMAB|PEMBROLIZUMAB,6,MALIGNANT MELANOMA|ADVERSE EVENT|HYPERCHOLESTEROLAEMIA|HYPERCHOLESTEROLAEMIA,Basal cell carcinoma|Squamous cell carcinoma|Squamous cell carcinoma,3,3
10617396,20141201,Pembrolizumab,73,801,73.0,2,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,9,HYPERCHOLESTEROLAEMIA|METASTATIC MALIGNANT MELANOMA,Myocarditis|Ejection fraction decreased|Arrhythmia,3,1
10617407,20141201,Pembrolizumab,55,801,55.0,2,,1,0,1,0,0,0,1,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,2,,Pneumonia|Sepsis|Infection|Malignant neoplasm progression,4,5
10618094,20141202,Pembrolizumab,76,801,76.0,1,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Pruritus,1,5
10618534,20141202,Pembrolizumab,49,801,49.0,1,88,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,3,NON-SMALL CELL LUNG CANCER|COUGH,Pericardial effusion,1,1
10618958,20141202,Pembrolizumab,83,801,83.0,2,70.3,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|GENTAMICIN SULFATE|PEMBROLIZUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|VALSARTAN|VALSARTAN ORAL|VALSARTAN|VALSARTAN ORAL|TADALAFIL|METOPROLOL TARTRATE|METOPROLOL|AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE|TADALAFIL|TORSEMIDE|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION,23,PANOPHTHALMITIS|ATRIAL FIBRILLATION|PAIN|MALIGNANT MELANOMA|BLOOD CORTISOL DECREASED|HYPERTENSION|HYPERTENSION|CONSTIPATION|EYE PAIN|PULMONARY HYPERTENSION|HYPERTENSION|HYPERTENSION|PULMONARY HYPERTENSION|HYPOTHYROIDISM|PRURITUS|DRY EYE|PRURITUS|HYPERTENSION|HYPERKERATOSIS|PAIN|PROPHYLAXIS,Epilepsy,1,1
10619248,20141202,Pembrolizumab,65,801,65.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Alanine aminotransferase increased|Hypokalaemia|Aspartate aminotransferase increased|Hypokalaemia|Hypocalcaemia,5,5
10619575,20141202,Pembrolizumab,72,801,72.0,2,,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB,5,PRURITUS|ROUTINE HEALTH MAINTENANCE|METASTATIC MALIGNANT MELANOMA|ROUTINE HEALTH MAINTENANCE,Muscular weakness|Tremor,2,1
10619741,20141202,Pembrolizumab,30,801,30.0,1,,1,1,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Disease progression|Diarrhoea|Nausea|Anaemia|General physical health deterioration,5,5
10620681,20141202,Pembrolizumab,33,801,33.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB,1,METASTATIC MALIGNANT MELANOMA,Arthralgia|Pruritus|Nausea|Sinusitis,4,5
10622309,20141201,Pembrolizumab,57,801,57.0,1,77.5,1,0,0,1,0,0,1,Pembrolizumab,OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE HYDROCHLORIDE|LORAZEPAM|CHLORPROMAZINE|PEMBROLIZUMAB|MORPHINE SULFATE|HYDROMORPHONE HYDROCHLORIDE,12,METASTATIC MALIGNANT MELANOMA,Fatigue|Blood lactate dehydrogenase increased|Decreased appetite|Weight decreased|Abdominal pain upper|Blood bilirubin increased|Nausea|Hyponatraemia|Cholestasis,9,
10622330,20141203,Pembrolizumab,70,801,70.0,2,,1,0,0,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PEMBROLIZUMAB,3,MALIGNANT MELANOMA,Arthralgia,1,5
10622440,20141203,Pembrolizumab,72,801,72.0,1,150,1,0,1,0,0,0,0,Pembrolizumab,PEMBROLIZUMAB|PEMBROLIZUMAB|PREGABALIN|ROSUVASTATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ENOXAPARIN SODIUM,13,MALIGNANT MELANOMA|PAIN IN EXTREMITY|PAIN IN EXTREMITY|DYSLIPIDAEMIA|INTERTRIGO|CONSTIPATION|HYPERTENSION|CONSTIPATION|HYPERTENSION|PAIN IN EXTREMITY|THROMBOSIS PROPHYLAXIS|ANAEMIA,General physical health deterioration,1,1
10006507,20140313,Nivolumab,60,801,60.0,1,119.2,1,0,1,0,0,0,0,Nivolumab,"ADVIL PM|DIPHENHYDRAMINE HCL, IBUPROFEN|IBUPROFEN AND DIPHENHYDRAMINE CITRATE|DIPHENHYDRAMINE CITRATE AND IBUPROFEN|NIVOLUMAB|PROMETHAZINE HYDROCHLORIDE|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|PRAVASTATIN SODIUM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|IPILIMUMAB",8,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Adrenal insufficiency,1,3
10011787,20140314,Nivolumab,63,801,63.0,2,72.9,1,0,1,1,0,0,1,Nivolumab,NIVOLUMAB|IPILIMUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PANTOPRAZOLE|LEVOTHYROXINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,11,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Intestinal perforation|Ileus paralytic|Pneumonitis|Lung infiltration|Renal failure|Pneumothorax|Pulmonary embolism,7,3
10016256,20140317,Nivolumab,59,801,59.0,2,77.1,1,0,1,0,0,0,0,Nivolumab,"ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CALCIUM POLYCARBOPHIL|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|NIVOLUMAB|IPILIMUMAB|CEFTRIAXONE|CEFTRIAXONE SODIUM",8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,3
10023086,20140319,Nivolumab,66,801,66.0,1,168,1,0,1,1,0,0,1,Nivolumab,"IPILIMUMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|METRONIDAZOLE|METRONIDAZOLE TOPICAL|PANTOPRAZOLE|NIVOLUMAB|INSULIN LISPRO|PENICILLIN G POTASSIUM|PENICILLIN G|CARBOXYMETHYLCELLULOSE SODIUM|PROCHLORPERAZINE|SODIUM PHOSPHATE|AZTREONAM|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHYLPREDNISOLONE SODIUM SUCCINATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LORAZEPAM|POLYETHYLENE GLYCOL 3350|PREDNISONE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|LOSARTAN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|ALBUTEROL SULFATE|ALBUTEROL|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MICONAZOLE|MICONAZOLE NITRATE|FUROSEMIDE|SENNOSIDES|SENNA LEAF|SENNA|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350",44,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Necrotising fasciitis|Septic shock|Adrenal insufficiency,3,3
10026298,20140320,Nivolumab,69,801,69.0,2,101,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|LEVOTHYROXINE SODIUM|SENNOSIDES|SENNA LEAF|SENNA|NIVOLUMAB|METOPROLOL TARTRATE|METOPROLOL|RIVAROXABAN|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES,10,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia,1,3
10027866,20140321,Nivolumab,87,801,87.0,1,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|LISINOPRIL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|HYPERTENSION,Hypotension|Incorrect dose administered,2,1
10029149,20140321,Nivolumab,62,801,62.0,1,82.1,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB|AMLODIPINE BESYLATE AND VALSARTAN|DICLOFENAC|DICLOFENAC SODIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|IPILIMUMAB|BETAMETHASONE DIPROPIONATE|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE,14,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Hypertension|Constipation|Paraparesis|VIIth nerve paralysis,4,3
10042644,20140327,Nivolumab,51,801,51.0,1,108,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB|BUPROPION|RISPERIDONE|METHYLPREDNISOLONE|LEVOTHYROXINE|FLUCONAZOLE|PANTOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,13,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Gastritis|Diarrhoea,2,3
10045414,20140328,Nivolumab,61,801,61.0,1,62,1,0,1,0,0,0,0,Nivolumab,RABEPRAZOLE SODIUM|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|CETIRIZINE HYDROCHLORIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|WARFARIN|DIPHENHYDRAMINE HYDROCHLORIDE|POLYETHYLENE GLYCOL 3350|LEVOTHYROXINE|NIVOLUMAB|CROMOLYN SODIUM|ATOVAQUONE|ATOVAQUONE ORAL SUSPENSION|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|IPILIMUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|PREDNISONE|ATOVAQUONE|LORAZEPAM|DIGOXIN|MORPHINE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|SENNOSIDES|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG,46,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HYPERSENSITIVITY|PRODUCT USED FOR UNKNOWN INDICATION|HYPOTHYROIDISM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PNEUMOCYSTIS JIROVECII PNEUMONIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CANDIDA INFECTION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Fatigue|Drug-induced liver injury|Dysphagia|Pyrexia|Confusional state,5,3
10048480,20140331,Nivolumab,56,801,56.0,1,125.9,1,0,1,0,0,0,0,Nivolumab,"NIVOLUMAB|IPILIMUMAB|AMLODIPINE|CARVEDILOL|VALSARTAN|FENOFIBRATE|OSELTAMIVIR PHOSPHATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|OXYCODONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",14,RENAL CELL CARCINOMA|RENAL CELL CARCINOMA,Pyrexia,1,3
10048686,20140331,Nivolumab,54,801,54.0,2,68,1,0,1,0,0,0,0,Nivolumab,CALCIUM CARBONATE|ANTACID|CEFUROXIME|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|METHYLPREDNISOLONE|NIVOLUMAB|IPILIMUMAB,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|NEOPLASM,Colitis,1,3
10051029,20140401,Nivolumab,33,801,33.0,1,86.5,1,0,1,1,0,0,0,Nivolumab,"FLUCONAZOLE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BUDESONIDE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|CITALOPRAM|CITALOPRAM HYDROBROMIDE|CALCIUM|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|IPILIMUMAB|NIVOLUMAB|PANTOPRAZOLE",25,METASTASES TO BONE|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pulmonary embolism,1,3
10055185,20140402,Nivolumab,69,801,69.0,1,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Abdominal pain,1,3
10057516,20140403,Nivolumab,71,801,71.0,2,,1,0,0,0,0,0,1,Nivolumab,"QUINAPRIL|QUINAPRIL HYDROCHLORIDE|DIGOXIN|METOPROLOL SUCCINATE|ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE|NIVOLUMAB|IPILIMUMAB",7,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Lipase increased,1,3
10061149,20140406,Nivolumab,74,801,74.0,2,59.9,1,0,1,0,0,0,1,Nivolumab,PANTOPRAZOLE|CEFTRIAXONE|CEFTRIAXONE SODIUM|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|NIVOLUMAB|HYDROCORTISONE CREAM|HYDROCORTISONE|PREDNISONE|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|IPILIMUMAB|FERROUS SULFATE,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis,1,5
10062982,20140407,Nivolumab,68,801,68.0,1,87,1,1,1,0,0,0,1,Nivolumab,"BRIMONIDINE TARTRATE, TIMOLOL MALEATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METOPROLOL TARTRATE|METOPROLOL|FENOFIBRATE|LINAGLIPTIN|POLYETHYLENE GLYCOL 3350|ROSUVASTATIN|BIMATOPROST|IPILIMUMAB|NIVOLUMAB|GLIMEPIRIDE|BRINZOLAMIDE|OXYCODONE",15,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Myocardial infarction,1,3
10096137,20140422,Nivolumab,56,801,56.0,1,92.1,1,0,1,0,0,0,0,Nivolumab,"NIVOLUMAB|IPILIMUMAB|MULTIVITAMIN|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|ERGOCALCIFEROL|DIPHENHYDRAMINE HYDROCHLORIDE|HYDROCORTISONE CREAM|HYDROCORTISONE|FLUOCINONIDE|FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%",11,RENAL CELL CARCINOMA|RENAL CELL CARCINOMA,Hyperthyroidism,1,3
10100754,20140423,Nivolumab,26,801,26.0,2,55.78,1,0,1,0,0,0,0,Nivolumab,"ZOLPIDEM TARTRATE|LORATADINE|LORATADINE TABLET|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PANTOPRAZOLE SODIUM|ALBUTEROL SULFATE|ALBUTEROL|FLUCONAZOLE|NIVOLUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PREDNISONE|IPILIMUMAB",12,RENAL CELL CARCINOMA|RENAL CELL CARCINOMA,Pyrexia,1,3
10126315,20140427,Nivolumab,76,801,76.0,1,74,1,1,1,0,0,0,1,Nivolumab,BRIMONIDINE TARTRATE|DIPHENHYDRAMINE HYDROCHLORIDE|OMEPRAZOLE MAGNESIUM|PREDNISONE|RAMIPRIL|METHYLPREDNISOLONE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|IPILIMUMAB|LATANOPROST|PANTOPRAZOLE|NIVOLUMAB|ATENOLOL|METHAZOLAMIDE|ESOMEPRAZOLE MAGNESIUM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|HYDROCHLOROTHIAZIDE|ENOXAPARIN SODIUM,24,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Pneumonitis,2,3
10151072,20140502,Nivolumab,63,801,63.0,1,94.5,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METHYLPREDNISOLONE|PANTOPRAZOLE|LORATADINE|LORATADINE ORAL,8,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pemphigoid|Transaminases increased,2,3
10155796,20140506,Nivolumab,53,801,53.0,1,161.45,1,0,1,0,0,0,0,Nivolumab,"DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|HYDROMORPHONE HYDROCHLORIDE|IPILIMUMAB|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|POLYETHYLENE GLYCOL 3350|PREDNISONE|NIVOLUMAB|ALPRAZOLAM|OXYCODONE HYDROCHLORIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|ATENOLOL|LEVOTHYROXINE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ZOLPIDEM TARTRATE|DAPSONE GEL, 5%|DAPSONE|DASPONE|LORAZEPAM|STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM|METOCLOPRAMIDE HYDROCHLORIDE",27,METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA,Diplopia,1,3
10160756,20140508,Nivolumab,44,801,44.0,2,89.7,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB|LEVETIRACETAM|METHYLPREDNISOLONE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LORAZEPAM|ZONISAMIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ALPRAZOLAM,16,GLIOBLASTOMA MULTIFORME|GLIOBLASTOMA MULTIFORME|PAIN|ANXIETY,Diabetic ketoacidosis|Pancreatitis|Hyperglycaemia,3,3
10173815,20140425,Nivolumab,,,,0,,1,0,0,0,0,0,0,Nivolumab,VEMURAFENIB|NIVOLUMAB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Rash generalised,1,
10174096,20140515,Nivolumab,55,801,55.0,1,83,1,0,1,0,0,0,1,Nivolumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LORAZEPAM|DESONIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OSELTAMIVIR PHOSPHATE|OXYGEN|0XYGEN|NIVOLUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|IPILIMUMAB|PREDNISONE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|METHYLPREDNISOLONE|AMPICILLIN SODIUM AND SULBACTAM SODIUM|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|BENZONATATE|AMOXICILLIN AND CLAVULANATE POTASSIUM|SULFAMETHOXAZOLE AND TRIMETHOPRIM,22,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Lung infection|Hypoxia|Chills|Pyrexia|Tumour flare,5,3
10177317,20140516,Nivolumab,31,801,31.0,1,,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Headache|Sinusitis|Pneumonia,3,3
10182058,20140519,Nivolumab,51,801,51.0,1,97.9,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,3,METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION,Blood creatinine increased,1,5
10192563,20140523,Nivolumab,70,801,70.0,1,,1,0,1,0,0,0,0,Nivolumab,PARICALCITOL|NIVOLUMAB|NIVOLUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ZOLEDRONIC ACID|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|CARVEDILOL|HYDRALAZINE HYDROCHLORIDE|LEVOTHYROXINE|LISINOPRIL|MULTIVITAMIN|NIFEDIPINE|LACTULOSE|SIMVASTATIN,16,PREMEDICATION|RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypercalcaemia,1,3
10199667,20140527,Nivolumab,70,801,70.0,1,117.41,1,0,1,0,0,0,1,Nivolumab,"FENOFIBRATE|ZOLPIDEM TARTRATE|METRONIDAZOLE|INFLIXIMAB|SILDENAFIL CITRATE|SILDENAFIL|SILDENAFIL POWDER,|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|PREDNISONE|IPILIMUMAB|INSULIN LISPRO|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|IPILIMUMAB|MIRTAZAPINE|METHYLPREDNISOLONE|NIVOLUMAB|SIMVASTATIN|NIVOLUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LOSARTAN",29,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia|Colitis|Enterocolitis infectious,3,5
10200172,20140527,Nivolumab,55,801,55.0,2,89.5,1,0,1,0,0,0,0,Nivolumab,PREDNISONE|ERGOCALCIFEROL|LORAZEPAM|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|PREDNISONE|IPILIMUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PANTOPRAZOLE SODIUM|PREDNISONE|NIVOLUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|ALCLOMETASONE DIPROPIONATE|PREDNISONE|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE|INSULIN ASPART|PREDNISONE|PREDNISONE|PREDNISONE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|PREDNISONE|PREDNISONE|PREDNISONE|INSULIN GLARGINE|DIPHENHYDRAMINE HYDROCHLORIDE|PREDNISONE,31,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Transaminases increased,2,5
10200337,20140527,Nivolumab,57,801,57.0,2,77,1,0,1,0,0,0,0,Nivolumab,METHYLPREDNISOLONE|IPILIMUMAB|LEVETIRACETAM|HYDROCORTISONE CREAM|HYDROCORTISONE|NIVOLUMAB,5,PRODUCT USED FOR UNKNOWN INDICATION|GLIOBLASTOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GLIOBLASTOMA,Confusional state,1,3
10226688,20140609,Nivolumab,55,801,55.0,2,80.54,1,0,1,0,0,0,0,Nivolumab,"DIPHENHYDRAMINE HYDROCHLORIDE|METHYLPREDNISOLONE|ENOXAPARIN SODIUM|AZTREONAM|LEVOTHYROXINE|NIVOLUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ERGOCALCIFEROL|OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE|RANITIDINE|PREDNISONE|FOLIC ACID|MULTIVITAMIN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|SULFAMETHOXAZOLE AND TRIMETHOPRIM|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|PANTOPRAZOLE|IPILIMUMAB|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|ATENOLOL|METRONIDAZOLE|PANTOPRAZOLE SODIUM",30,METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA,Upper gastrointestinal haemorrhage|Gastritis erosive|Erosive duodenitis|Pyrexia|Lower gastrointestinal haemorrhage|Anaemia,6,3
10231084,20140611,Nivolumab,68,801,68.0,2,54.6,1,1,1,0,0,0,1,Nivolumab,"DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|FENTANYL|IPILIMUMAB|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|LACOSAMIDE|SENNOSIDES|SENNA LEAF|SENNA|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|NIVOLUMAB|PANTOPRAZOLE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LACTULOSE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MAGNESIUM|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|CALCIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|IPRATROPIUM BROMIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SIMVASTATIN|ATOVAQUONE|ATOVAQUONE ORAL SUSPENSION|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|POLYETHYLENE GLYCOL|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM",32,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GLIOBLASTOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GLIOBLASTOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Sepsis|Confusional state|Lethargy|Hypocalcaemia|Alanine aminotransferase increased|Sinus tachycardia|Malignant neoplasm progression|Cholecystitis|Dermatitis bullous|Hypomagnesaemia|Hypotension|Aspartate aminotransferase increased|Pyrexia|Hyperthyroidism|Blood bilirubin increased,15,3
10231657,20140611,Nivolumab,54,801,54.0,1,168.7,1,0,1,0,0,0,0,Nivolumab,"IPILIMUMAB|OXYCODONE|ALPRAZOLAM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|NIVOLUMAB|LEVOTHYROXINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED",12,METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA,Pyrexia,1,3
10234417,20140612,Nivolumab,72,801,72.0,2,53,1,0,1,0,0,0,0,Nivolumab,"NIVOLUMAB|BRIMONIDINE TARTRATE|IPILIMUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PANCRELIPASE|HYDROCHLOROTHIAZIDE|IMIPENEM AND CILASTATIN SODIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PANTOPRAZOLE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|METHYLPREDNISOLONE|CEFEPIME HYDROCHLORIDE|CEFEPIME",15,NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|HYPOTENSION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia,1,5
10250885,20140620,Nivolumab,79,801,79.0,1,78.2,1,0,1,0,0,0,0,Nivolumab,"SELENIUM|METHYLPREDNISOLONE|PRAVASTATIN SODIUM|FUROSEMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|VITAMIN E|CLOPIDOGREL|MULTIVITAMIN|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|IPILIMUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|ZINC|ZINC GLUCONATE|ZINC CHLORIDE",22,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pneumonia|Pneumonitis,2,3
10256629,20140624,Nivolumab,54,801,54.0,1,168,1,0,1,0,0,0,0,Nivolumab,"DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|AZTREONAM|ALPRAZOLAM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|NIVOLUMAB|IPILIMUMAB|LEVOTHYROXINE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE|CEFTRIAXONE|CEFTRIAXONE SODIUM|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FENTANYL CITRATE",17,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypotension,1,5
10277380,20140703,Nivolumab,61,801,61.0,1,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Ileus paralytic|Diarrhoea|Colitis|Abdominal pain,4,3
10277462,20140703,Nivolumab,73,801,73.0,1,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Hyperglycaemia|Alanine aminotransferase increased|Renal failure acute,3,3
10281003,20140707,Nivolumab,64,801,64.0,0,,1,0,1,0,0,0,0,Nivolumab,VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|ACYCLOVIR|NIVOLUMAB|IPILIMUMAB,5,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pyrexia|Myalgia|Fatigue|Headache|Nausea,5,3
10285415,20140708,Nivolumab,55,801,55.0,2,89.5,1,0,1,0,0,0,0,Nivolumab,ALCLOMETASONE DIPROPIONATE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|NIVOLUMAB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|LORAZEPAM|CETIRIZINE HYDROCHLORIDE|INSULIN GLARGINE|IPILIMUMAB|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|INSULIN ASPART|PREDNISONE|ERGOCALCIFEROL|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|PANTOPRAZOLE SODIUM|IRON|DIPHENHYDRAMINE HYDROCHLORIDE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES,23,PREMEDICATION|RENAL CELL CARCINOMA|PREMEDICATION|PREMEDICATION|PREMEDICATION|RENAL CELL CARCINOMA|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION,Hypotension|Pyrexia,2,3
10296807,20140710,Nivolumab,54,801,54.0,1,92.7,1,1,1,0,0,0,0,Nivolumab,MAGNESIUM HYDROXIDE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|POLYETHYLENE GLYCOL|CYCLOBENZAPRINE|SENNOSIDES|SENNA LEAF|SENNA|NIVOLUMAB|GABAPENTIN|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|IPILIMUMAB,11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER,Encephalopathy|Rash|Malignant neoplasm progression|Pyrexia,4,3
10299098,20140711,Nivolumab,42,801,42.0,2,80.4,1,0,1,0,0,0,0,Nivolumab,"METOPROLOL TARTRATE|METOPROLOL|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|HYDROCODONE BITARTRATE AND ACETAMINOPHEN|IPILIMUMAB|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|DEXTROSE MONOHYDRATE|DEXTROSE|MELATONIN|PREDNISONE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|RANITIDINE|LEVOTHYROXINE SODIUM|AMLODIPINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|METOPROLOL TARTRATE|METOPROLOL|PREDNISONE|LEVOTHYROXINE SODIUM|LEVETIRACETAM|SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE|SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE|SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE|SODIUM CHLORIDE, SOLDIUM LACTATE, POTASSIUM CHLORIDE AND CALCIUM CHLORIDE|NIVOLUMAB|METOPROLOL TARTRATE|METOPROLOL|MAGNESIUM OXIDE|PANTOPRAZOLE|PREDNISONE|METHYLPREDNISOLONE|PROMETHAZINE HYDROCHLORIDE|PREDNISONE|PREDNISONE|METHYLPREDNISOLONE SODIUM SUCCINATE|HYDRALAZINE HYDROCHLORIDE",37,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GLIOBLASTOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GLIOBLASTOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Decreased appetite|Hypothyroidism,3,5
10300518,20140713,Nivolumab,50,801,50.0,2,79.6,1,0,1,0,0,0,0,Nivolumab,"OXYCODONE|PROMETHAZINE HYDROCHLORIDE|LORAZEPAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|NIVOLUMAB|ZOLPIDEM TARTRATE|IPILIMUMAB|GABAPENTIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|FISH OIL|HYDROXYZINE|ESTRADIOL|ESTRADIOL GEL 0.1%|ESTRADIOL TRANSDERMAL|ESTRADIOL,|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FUROSEMIDE|COSYNTROPIN|OXCARBAZEPINE|DIPHENHYDRAMINE HYDROCHLORIDE",21,RASH|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Cardiac failure|Adrenal insufficiency,2,3
10312142,20140717,Nivolumab,69,801,69.0,1,55,1,0,1,0,0,0,1,Nivolumab,PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METHYLPREDNISOLONE|MEROPENEM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CITALOPRAM|CITALOPRAM HYDROBROMIDE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|AMIKACIN|GENTAMICIN|GENTAMICIN SULFATE|LANSOPRAZOLE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|NIVOLUMAB|INSULIN GLARGINE|PHYTONADIONE|IPILIMUMAB|PANCRELIPASE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,36,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Biliary tract infection|Alanine aminotransferase increased|Ascites|Thrombocytopenia|Hyperbilirubinaemia,5,5
10331900,20140722,Nivolumab,47,801,47.0,2,53.88,1,0,1,0,0,0,1,Nivolumab,"SULFAMETHOXAZOLE AND TRIMETHOPRIM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|NIVOLUMAB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CALCIUM|PHENYLEPHRINE HCL|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|MAGNESIUM|IPILIMUMAB|LORAZEPAM|LEVOTHYROXINE|PREDNISONE|PROCHLORPERAZINE MALEATE|PROCHLORPERAZINE EDISYLATE|DALTEPARIN SODIUM|METOCLOPRAMIDE HYDROCHLORIDE|METRONIDAZOLE|CEFEPIME HYDROCHLORIDE|CEFEPIME|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|POLYETHYLENE GLYCOL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CALCIUM GLUCONATE|MELATONIN|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|DOPAMINE HYDROCHLORIDE|DOPAMINE|SODIUM PHOSPHATE|ERGOCALCIFEROL|DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM|HYDROMORPHONE HYDROCHLORIDE|MORPHINE|COSYNTROPIN",49,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Headache|Hypotension|Nausea|Diarrhoea|Vomiting,5,3
10332197,20140722,Nivolumab,81,801,81.0,2,,1,1,1,0,0,0,0,Nivolumab,ALBUTEROL SULFATE|ERGOCALCIFEROL|ZOLPIDEM TARTRATE|ENOXAPARIN SODIUM|FERROUS SULFATE|IPILIMUMAB|NIVOLUMAB,11,PRODUCT USED FOR UNKNOWN INDICATION|WHEEZING|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|WHEEZING|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER,Rash|Pulmonary haemorrhage|Hypotension|Acute kidney injury|Dyspnoea,5,3
10346977,20140729,Nivolumab,64,801,64.0,1,83.3,1,1,1,0,0,0,1,Nivolumab,"AZACITIDINE|METHADONE|DIPHENHYDRAMINE HYDROCHLORIDE|ADVIL PM|DIPHENHYDRAMINE HCL, IBUPROFEN|IBUPROFEN AND DIPHENHYDRAMINE CITRATE|DIPHENHYDRAMINE CITRATE AND IBUPROFEN|OXYCODONE|FLUOXETINE HYDROCHLORIDE|NIVOLUMAB|ZOLPIDEM TARTRATE|OXYGEN|0XYGEN|AMLODIPINE",14,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pleural effusion|Confusional state|Death|Non-small cell lung cancer metastatic|Dizziness,5,3
10353277,20140730,Nivolumab,66,801,66.0,1,84.8,1,0,1,0,0,0,0,Nivolumab,LORAZEPAM|MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|NIVOLUMAB|IPILIMUMAB|PROCHLORPERAZINE,6,SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER,Encephalitis|Hyponatraemia,2,3
10358404,20140801,Nivolumab,,,,0,,1,0,1,0,0,0,1,Nivolumab,PANTOPRAZOLE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|INSULIN ASPART|LISINOPRIL|NADOLOL|NIVOLUMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|IPILIMUMAB|LACOSAMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,16,DIABETES MELLITUS|PROPHYLAXIS|HYPERLIPIDAEMIA|CONSTIPATION|DIABETES MELLITUS|PRODUCT USED FOR UNKNOWN INDICATION|VITAMIN SUPPLEMENTATION|PRODUCT USED FOR UNKNOWN INDICATION|HYPERTENSION|HYPERTENSION|GLIOBLASTOMA|PROPHYLAXIS|DEPRESSION|GLIOBLASTOMA|SEIZURE|BRAIN OEDEMA,Headache|Hyperglycaemia|Hemiparesis|Vomiting,4,3
10358663,20140803,Nivolumab,63,801,63.0,1,96.3,1,0,1,0,0,0,0,Nivolumab,"LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ZOLPIDEM TARTRATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|IPILIMUMAB|PREDNISONE|LORAZEPAM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|MULTIVITAMIN|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL|SIMVASTATIN|FISH OIL|HYDROCHLOROTHIAZIDE",16,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pneumonitis,1,3
10358665,20140803,Nivolumab,51,801,51.0,1,98,1,0,1,0,0,0,0,Nivolumab,"SENNOSIDES|SENNA LEAF|SENNA|METOPROLOL TARTRATE|METOPROLOL|PREDNISONE|PANTOPRAZOLE|LEVOTHYROXINE|ENOXAPARIN SODIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LORAZEPAM|NIVOLUMAB|IPILIMUMAB|POLYETHYLENE GLYCOL 3350|BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE|ZOLPIDEM TARTRATE",17,NEOPLASM|NEOPLASM,Hyponatraemia,1,3
10358667,20140803,Nivolumab,90,801,90.0,2,,1,0,1,0,0,0,0,Nivolumab,"NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|AMMONIUM LACTATE|AMLODIPINE BESYLATE|ATORVASTATIN CALCIUM|CALCIUM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|NIVOLUMAB",9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA,Diarrhoea|Vomiting,2,3
10381935,20140813,Nivolumab,64,801,64.0,1,76.2,1,1,1,1,0,0,1,Nivolumab,NIVOLUMAB|IPILIMUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|NALOXONE|PROCHLORPERAZINE MALEATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|AZITHROMYCIN DIHYDRATE|ENOXAPARIN SODIUM|OXYCODONE|ENOXAPARIN SODIUM|FAMOTIDINE|MORPHINE|POLYETHYLENE GLYCOL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|PROCHLORPERAZINE|LORAZEPAM|FUROSEMIDE|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|TRAZODONE HYDROCHLORIDE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL,33,COLON CANCER|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pulmonary embolism,1,3
10383220,20140813,Nivolumab,64,801,64.0,1,100.7,1,0,1,0,0,0,0,Nivolumab,PITAVASTATIN CALCIUM|PITAVASTATIN|LEVOTHYROXINE SODIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|IPILIMUMAB|LORAZEPAM|NASAL|SALINE|(SALINE)|GABAPENTIN|LIRAGLUTIDE|NIVOLUMAB|ALLOPURINOL|FEXOFENADINE HCL|LISINOPRIL|BUPROPION|HYDROCHLOROTHIAZIDE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|OXYMETAZOLINE,16,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Blood creatinine increased,1,3
10383221,20140813,Nivolumab,72,801,72.0,1,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Embolism|Dyspnoea,2,5
10383222,20140813,Nivolumab,55,801,55.0,1,80.4,1,0,1,0,0,0,0,Nivolumab,OMEPRAZOLE MAGNESIUM|IPILIMUMAB|NIVOLUMAB|MORPHINE SULFATE,5,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Dysphagia|Oesophageal fistula|Dehydration,3,3
10394305,20140819,Nivolumab,70,801,70.0,1,91.8,1,1,1,0,0,0,1,Nivolumab,VASOPRESSIN|DEXMEDETOMIDINE HYDROCHLORIDE|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|DOPAMINE HYDROCHLORIDE|DOPAMINE|NIVOLUMAB|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|PANTOPRAZOLE|ALBUTEROL SULFATE|ALBUTEROL|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISONE|NOREPINEPHRINE BITARTRATE|PROPOFOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PYRIDOSTIGMINE BROMIDE|IPILIMUMAB|CEFUROXIME|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,19,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Atrioventricular block complete|Myasthenia gravis|Duodenal ulcer haemorrhage|Sepsis,4,3
10399718,20140821,Nivolumab,42,801,42.0,2,80.4,1,0,0,0,0,0,1,Nivolumab,"METHYLPREDNISOLONE|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|PREDNISONE|PANTOPRAZOLE|HYDRALAZINE HYDROCHLORIDE|IPILIMUMAB|PROMETHAZINE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RANITIDINE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|NIVOLUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|AMLODIPINE|LEVOTHYROXINE SODIUM|METOPROLOL TARTRATE|METOPROLOL|MELATONIN",21,GLIOBLASTOMA|GLIOBLASTOMA,Lipase increased,1,5
10401382,20140822,Nivolumab,67,801,67.0,1,,1,0,1,1,0,0,1,Nivolumab,ACETAMINOPHEN|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|IPILIMUMAB|TEMAZEPAM|ATORVASTATIN CALCIUM|NIVOLUMAB|FLUTICASONE PROPIONATE AND SALMETEROL|ENOXAPARIN SODIUM,11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|COUGH|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis|Malignant neoplasm progression,2,3
10403630,20140822,Nivolumab,76,801,76.0,1,,1,1,1,1,0,0,1,Nivolumab,IPILIMUMAB|NIVOLUMAB|ZINC|ZINC GLUCONATE|ZINC CHLORIDE|ERGOCALCIFEROL,9,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Atrioventricular block|Dehydration|Respiratory failure|Pneumonitis,5,5
10406931,20140825,Nivolumab,73,801,73.0,1,83.8,1,0,1,0,0,0,0,Nivolumab,"ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METOPROLOL TARTRATE|METOPROLOL|NITROGLYCERIN|CLOBETASOL PROPIONATE|CLOBETASOL PROPIONATE OINTMENT USP, 0.05%|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|PREDNISONE|CEFTRIAXONE|CEFTRIAXONE SODIUM|NIVOLUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|IPILIMUMAB|OXYCODONE",14,CHEST PAIN|RASH|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Epididymitis|Pneumonitis,2,3
10408113,20140825,Nivolumab,52,801,52.0,1,70,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SPIRONOLACTONE|IPILIMUMAB|DEXTROSE ANHYDROUS|FERRIC CARBOXYMALTOSE,14,COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia,1,3
10413141,20140827,Nivolumab,36,801,36.0,2,64.1,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB|SUCRALFATE|PANTOPRAZOLE SODIUM|CALCIUM CARBONATE|ANTACID|MICONAZOLE|MICONAZOLE NITRATE,8,BREAST CANCER|BREAST CANCER,Neutropenia|Pyrexia,2,3
10420098,20140829,Nivolumab,57,801,57.0,2,64.2,1,1,1,0,0,0,0,Nivolumab,NIVOLUMAB|TEMAZEPAM|IPILIMUMAB,4,BREAST CANCER|INSOMNIA|BREAST CANCER,Myasthenic syndrome|Hypopituitarism|Malignant neoplasm progression,3,3
10425631,20140902,Nivolumab,52,801,52.0,1,,1,0,1,0,0,0,0,Nivolumab,CLARITHROMYCIN|IPILIMUMAB|NIVOLUMAB|AMOXICILLIN AND CLAVULANATE POTASSIUM,5,COLON CANCER METASTATIC|COLON CANCER METASTATIC,Cough|Bronchitis,2,3
10425632,20140902,Nivolumab,35,801,35.0,2,58.5,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|IPILIMUMAB|METHYLPREDNISOLONE|MORPHINE|NIVOLUMAB|INFLIXIMAB|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN,15,COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis|Bacteraemia,2,5
10427875,20140903,Nivolumab,63,801,63.0,1,63,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|PROCHLORPERAZINE MALEATE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|IPILIMUMAB|ESOMEPRAZOLE MAGNESIUM|PREDNISONE,12,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Colitis,1,5
10445063,20140910,Nivolumab,64,801,64.0,2,67,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|HYDROCHLOROTHIAZIDE|CARVEDILOL|IPILIMUMAB|PRAVASTATIN SODIUM|VALSARTAN|VALSARTAN ORAL|PANTOPRAZOLE,12,NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Gastritis,1,3
10453189,20140915,Nivolumab,53,801,53.0,1,102,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|INSULIN GLARGINE|STANDARDIZED SENNA CONCENTRATE|IPILIMUMAB|ROSUVASTATIN|OXYCODONE HYDROCHLORIDE|ESOMEPRAZOLE MAGNESIUM|LACTULOSE|INSULIN DETEMIR|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|INSULIN GLULISINE,19,COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hyperglycaemia,1,5
10453247,20140915,Nivolumab,64,801,64.0,1,,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Adrenal insufficiency|Dehydration|Fatigue|Hypotension|Syncope,5,3
10462294,20140918,Nivolumab,67,801,67.0,2,,1,0,1,0,0,0,0,Nivolumab,"ESTRADIOL|ESTRADIOL GEL 0.1%|ESTRADIOL TRANSDERMAL|ESTRADIOL,|OXYCODONE HYDROCHLORIDE|PREDNISONE|CETIRIZINE HYDROCHLORIDE|NIVOLUMAB|MAGNESIUM HYDROXIDE|POLYETHYLENE GLYCOL 3350|IPILIMUMAB|CELECOXIB|ALPRAZOLAM|HYDROMORPHONE HYDROCHLORIDE|THYROID, PORCINE",14,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Facial nerve disorder,1,3
10468719,20140922,Nivolumab,65,801,65.0,1,89,1,0,0,0,0,0,1,Nivolumab,METOPROLOL TARTRATE|METOPROLOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|HYDROXYZINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|IPILIMUMAB|NIVOLUMAB|FENOFIBRATE|PANTOPRAZOLE,13,PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRURITUS|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hyperthyroidism,1,5
10471340,20140923,Nivolumab,60,801,60.0,1,,1,0,1,0,0,0,0,Nivolumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|NIVOLUMAB|IPILIMUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia|Rash,2,5
10482147,20140929,Nivolumab,61,801,61.0,1,77,1,0,1,0,0,0,1,Nivolumab,METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE|NIVOLUMAB|IPILIMUMAB,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA,Dehydration|Autoimmune colitis,2,5
10482154,20140929,Nivolumab,69,801,69.0,2,66,1,0,1,0,0,0,0,Nivolumab,METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|FLUCONAZOLE|GLIMEPIRIDE|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|LISINOPRIL|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISONE|OLOPATADINE HCL|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|NIVOLUMAB|IPILIMUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE),19,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Muscular weakness|Colitis|Hypopituitarism|Hyponatraemia,4,5
10488568,20141002,Nivolumab,71,801,71.0,1,92.7,1,0,1,0,0,0,1,Nivolumab,IPILIMUMAB|ENTECAVIR|ENTECAVIR ANHYDROUS|PREDNISONE|IPRATROPIUM BROMIDE|METHYLPREDNISOLONE|LORAZEPAM|PREDNISONE|NIVOLUMAB|LISINOPRIL AND HYDROCHLOROTHIAZIDE|LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|SULFAMETHOXAZOLE AND TRIMETHOPRIM,22,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypoxia|Pulmonary oedema|Pneumonitis|Pulmonary embolism|Aspartate aminotransferase increased|Alanine aminotransferase increased|Dyspnoea,7,5
10488569,20141002,Nivolumab,48,801,48.0,1,99.3,1,0,1,0,0,0,0,Nivolumab,METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ATROPINE SULFATE|ATROPINE|OXYCODONE|PANTOPRAZOLE|NIVOLUMAB|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|IPILIMUMAB|BUDESONIDE|DESLORATADINE,17,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,5
10505235,20141008,Nivolumab,63,801,63.0,1,80,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,4,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pyrexia,1,3
10509522,20141009,Nivolumab,40,801,40.0,1,76,1,0,1,0,0,0,0,Nivolumab,PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|NIVOLUMAB|IPILIMUMAB|LANSOPRAZOLE,5,COLON CANCER|COLON CANCER,Pyrexia,1,3
10512372,20141010,Nivolumab,64,801,64.0,1,101,1,1,1,0,0,0,1,Nivolumab,LEVOTHYROXINE SODIUM|NIVOLUMAB|IPILIMUMAB|LISINOPRIL|LIRAGLUTIDE|PITAVASTATIN CALCIUM|PITAVASTATIN|GABAPENTIN|LORAZEPAM|FEXOFENADINE HCL|HYDROCHLOROTHIAZIDE|BUPROPION|CITALOPRAM|CITALOPRAM HYDROBROMIDE|OXYMETAZOLINE HCL|OXYMETAZOLINE HYDROCHLORIDE|ALLOPURINOL,14,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Adrenocortical insufficiency acute|Blood creatinine increased|Hypopituitarism|Hypercalcaemia|Pneumonia aspiration|Confusional state|Dehydration,7,5
10512722,20141012,Nivolumab,77,801,77.0,2,62.7,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB|LEVOTHYROXINE SODIUM|METHYLPREDNISOLONE SODIUM SUCCINATE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|MICONAZOLE|MICONAZOLE NITRATE|METOPROLOL TARTRATE|METOPROLOL|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|FUROSEMIDE|PHYTONADIONE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|NITROFURANTOIN MACROCRYSTALS|PREDNISONE,18,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hepatitis|Pyrexia,2,5
10512723,20141012,Nivolumab,60,801,60.0,2,,1,0,1,0,0,0,1,Nivolumab,CLONAZEPAM|PREDNISONE|NICOTINE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|MIRTAZAPINE|ESCITALOPRAM|PANTOPRAZOLE SODIUM|PROMETHAZINE|NIVOLUMAB|IPILIMUMAB|POLYETHYLENE GLYCOL 3350|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CETIRIZINE HYDROCHLORIDE|OXYCODONE|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM,28,CONSTIPATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COUGH|RESPIRATORY TRACT CONGESTION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|DYSPEPSIA|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|CONSTIPATION|PYREXIA|CONSTIPATION|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|VOMITING|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Adrenal insufficiency|Autoimmune hepatitis|Hypophysitis|Pneumonitis,4,3
10517757,20141014,Nivolumab,62,801,62.0,1,,1,0,1,0,0,0,0,Nivolumab,DOXAZOSIN|DOXAZOSIN MESYLATE|NIVOLUMAB|IPILIMUMAB|FENOFIBRATE,5,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pyrexia|Pneumonitis,2,5
10519776,20141015,Nivolumab,54,801,54.0,1,74.8,1,0,1,0,0,0,0,Nivolumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CARBOPLATIN|PACLITAXEL|TRETINOIN|NIVOLUMAB|HYDROCORTISONE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE),10,NEOPLASM|NEOPLASM|NEOPLASM|NEOPLASM,Febrile neutropenia,1,3
10532415,20141021,Nivolumab,53,801,53.0,1,102.3,1,0,1,0,0,0,0,Nivolumab,"INSULIN GLARGINE|STANDARDIZED SENNA CONCENTRATE|ESOMEPRAZOLE MAGNESIUM|INSULIN DETEMIR|LACTULOSE|OXYCODONE HYDROCHLORIDE|ROSUVASTATIN|EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL|MOUTHWASH|MENTHOL, METHYL SALICYLATE, THYMOL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|NIVOLUMAB|IPILIMUMAB|INSULIN GLULISINE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|GENTAMICIN|GENTAMICIN SULFATE",23,COLON CANCER METASTATIC|COLON CANCER METASTATIC,Diarrhoea|Escherichia infection,2,3
10541451,20141024,Nivolumab,68,801,68.0,2,59.1,1,1,1,0,0,0,0,Nivolumab,"ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|AMLODIPINE|IPILIMUMAB|BACITRACIN ZINC|BACITRACIN|FUROSEMIDE|EPOETIN ALFA|OCTREOTIDE ACETATE|OCTREOTIDE|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|PREDNISONE|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE|FAMOTIDINE|NIVOLUMAB|OCTREOTIDE ACETATE|PANTOPRAZOLE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ENALAPRIL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|GLIPIZIDE|OXYCODONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ERYTHROPOIETIN|LEVOTHYROXINE|LISINOPRIL|LORAZEPAM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CEFTRIAXONE|CEFTRIAXONE SODIUM",31,SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER,Malignant neoplasm progression|Cardiomyopathy,2,3
10547234,20141027,Nivolumab,67,801,67.0,1,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|PANTOPRAZOLE SODIUM|IPILIMUMAB|CARBIDOPA AND LEVODOPA|SIMVASTATIN,6,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pleural effusion,1,5
10550692,20141029,Nivolumab,65,801,65.0,2,59,1,1,1,0,0,0,0,Nivolumab,METOCLOPRAMIDE HYDROCHLORIDE|PROMETHAZINE HYDROCHLORIDE|RANITIDINE|ALLOPURINOL|SIMVASTATIN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ACYCLOVIR|OXYCODONE|PANTOPRAZOLE|NIVOLUMAB|ERGOCALCIFEROL|PANTOPRAZOLE SODIUM|IPILIMUMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM,15,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HAEMATOLOGICAL MALIGNANCY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HAEMATOLOGICAL MALIGNANCY|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Vomiting|Nausea,3,3
10555081,20141030,Nivolumab,66,801,66.0,2,79,1,1,1,0,0,0,0,Nivolumab,"DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|MORPHINE SULFATE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|NIVOLUMAB|IPILIMUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|METHYLPREDNISOLONE|OXYCODONE HYDROCHLORIDE|OXYCODONE|PROCHLORPERAZINE|CALCIUM CARBONATE|ANTACID|METHYLPREDNISOLONE SODIUM SUCCINATE|PANTOPRAZOLE SODIUM|NOREPINEPHRINE BITARTRATE|DEXTROSE MONOHYDRATE|DEXTROSE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|HUMAN INSULIN|SIMVASTATIN|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|CONJUGATED ESTROGENS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS",26,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Acute respiratory failure|Hepatic enzyme increased,3,3
10555315,20141030,Nivolumab,59,801,59.0,1,,1,0,0,0,0,0,1,Nivolumab,"NIVOLUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FAMOTIDINE|OXYCODONE HYDROCHLORIDE|LEVETIRACETAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|IPILIMUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|OXYGEN|0XYGEN|LORAZEPAM|ZOLPIDEM TARTRATE",15,DYSPNOEA|NON-SMALL CELL LUNG CANCER|PAIN|NON-SMALL CELL LUNG CANCER|WHEEZING|ANXIETY|SLEEP DISORDER,Secondary adrenocortical insufficiency|Anaemia,2,3
10558499,20141031,Nivolumab,64,801,64.0,1,,1,0,1,0,0,0,0,Nivolumab,ERGOCALCIFEROL|IPILIMUMAB|NIVOLUMAB|FISH OIL|TADALAFIL,8,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ERECTILE DYSFUNCTION,Diabetes mellitus,1,5
10558501,20141031,Nivolumab,54,801,54.0,1,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|FUROSEMIDE|IPILIMUMAB|ZOLEDRONIC ACID|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS,5,GASTRIC CANCER|GASTRIC CANCER,Hypercalcaemia,1,3
10571640,20141107,Nivolumab,,,,0,64.2,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|PREDNISONE|METHYLPREDNISOLONE SODIUM SUCCINATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|IPILIMUMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|OXYCODONE,7,RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PAIN,Diarrhoea,1,3
10572402,20141109,Nivolumab,66,801,66.0,1,95,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Pyrexia,1,3
10583270,20141114,Nivolumab,51,801,51.0,1,,1,0,1,0,0,0,1,Nivolumab,IPILIMUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|NIVOLUMAB,3,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA,Diarrhoea|Colitis|Pyrexia,3,5
10600333,20141123,Nivolumab,39,801,39.0,1,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,2,HAEMATOLOGICAL MALIGNANCY|HAEMATOLOGICAL MALIGNANCY,Pyrexia,1,3
10605164,20141124,Nivolumab,45,801,45.0,1,76,1,0,1,0,0,0,0,Nivolumab,"GABAPENTIN|PREDNISONE|ENOXAPARIN SODIUM|IPILIMUMAB|MORPHINE|NIVOLUMAB|FUROSEMIDE|OXYCODONE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",13,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diabetic ketoacidosis,1,5
10611826,20141126,Nivolumab,75,801,75.0,2,65.3,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|BISMUTH SUBSALICYLATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|LEVOTHYROXINE|CALCIUM CARBONATE|ANTACID|LANSOPRAZOLE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DIPHENHYDRAMINE HYDROCHLORIDE|PHENAZOPYRIDINE|IPILIMUMAB,15,OESOPHAGEAL ADENOCARCINOMA|BLADDER SPASM|OESOPHAGEAL ADENOCARCINOMA,Cystitis|Transaminases increased,2,3
10614666,20141130,Nivolumab,41,801,41.0,1,90,1,0,1,0,0,0,0,Nivolumab,"SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|BUPROPION|HYDROMORPHONE HYDROCHLORIDE|PROMETHAZINE|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|NIVOLUMAB|DEXTROSE MONOHYDRATE|DEXTROSE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|INSULIN LISPRO|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PROCHLORPERAZINE|STANDARDIZED SENNA CONCENTRATE|EPINEPHRINE|ADRENALINUM|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE|INFLIXIMAB|ZOLPIDEM TARTRATE|LEVOTHYROXINE|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|BUPROPION HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|IPILIMUMAB|LAMOTRIGINE|LAMOTRIGINE EXTENDED-RELEASE|LAMOTRIGINE CHEWABLE DISPERSIBLE|LAMOTIRIGINE|METHYLPREDNISOLONE",33,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis|Vomiting|Polydipsia|Enterocolitis|Nausea|Gastritis|Dehydration,7,3
10616557,20141201,Nivolumab,63,801,63.0,1,99,1,0,1,0,0,0,0,Nivolumab,MAGNESIUM OXIDE|IPILIMUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|AMLODIPINE|OXYCODONE|NIVOLUMAB,9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM,Pyrexia,1,5
10616894,20141201,Nivolumab,64,801,64.0,1,72.3,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|IPILIMUMAB|PREDNISONE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METOPROLOL TARTRATE|METOPROLOL|ZOLPIDEM TARTRATE,9,PRODUCT USED FOR UNKNOWN INDICATION|RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Blood creatinine increased,1,3
10623437,20141203,Nivolumab,50,801,50.0,1,57,1,0,0,0,0,0,1,Nivolumab,"DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|MELATONIN|LORAZEPAM|ERGOCALCIFEROL|MELATONIN|NIVOLUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|KETOCONAZOLE|KETOCONAZOLE FOAM|KETOCONAZOLE CREAM, 2%|LEVETIRACETAM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|SERTRALINE|PREDNISONE|PANTOPRAZOLE SODIUM|IPILIMUMAB|SIMETHICONE|DIMETHICONE",18,GLIOBLASTOMA MULTIFORME|GLIOBLASTOMA MULTIFORME,Fall,1,3
10624648,20141203,Nivolumab,57,801,57.0,1,105,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB,4,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Vomiting|Pyrexia|Nausea,3,5
10647628,20141211,Nivolumab,63,801,63.0,1,98,1,0,1,0,0,0,0,Nivolumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|NIVOLUMAB|OXYCODONE|IPILIMUMAB|MAGNESIUM OXIDE|AMLODIPINE,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Fall|Muscular weakness,2,5
10660781,20141217,Nivolumab,62,801,62.0,2,104,1,0,1,0,0,0,1,Nivolumab,EZETIMIBE|CETIRIZINE HYDROCHLORIDE|AMLODIPINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SPIRONOLACTONE|IPILIMUMAB|PANTOPRAZOLE SODIUM|LEVOTHYROXINE SODIUM|ATENOLOL|DIPHENHYDRAMINE HYDROCHLORIDE|METHYLPREDNISOLONE|NIVOLUMAB|LORAZEPAM|DOXAZOSIN|DOXAZOSIN MESYLATE|CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE,20,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|NAUSEA,Adrenal insufficiency,1,3
10663128,20141218,Nivolumab,73,801,73.0,1,72.6,1,0,1,0,0,0,0,Nivolumab,CEFEPIME HYDROCHLORIDE|CEFEPIME|OXYCODONE|NIVOLUMAB|IPILIMUMAB|METHYLPREDNISOLONE|ZOLPIDEM TARTRATE|NITROGLYCERIN|HYDROCODONE BITARTRATE AND ACETAMINOPHEN,11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|TRANSITIONAL CELL CARCINOMA|TRANSITIONAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN,Polymyositis|Rhabdomyolysis|Aspartate aminotransferase increased,3,1
10669751,20141222,Nivolumab,44,801,44.0,1,78.8,1,1,1,0,0,0,1,Nivolumab,IPILIMUMAB|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|NALOXONE|DEXTROSE MONOHYDRATE|DEXTROSE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|NIVOLUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CEFEPIME HYDROCHLORIDE|CEFEPIME|FENTANYL CITRATE|HALOPERIDOL LACTATE|LINEZOLID,14,NEOPLASM|NEOPLASM,Vomiting|Pancreatitis|Acute kidney injury|Tumour lysis syndrome,4,3
10675684,20141224,Nivolumab,81,801,81.0,1,,1,1,1,0,0,0,0,Nivolumab,NIVOLUMAB|NITROGLYCERIN|POLYETHYLENE GLYCOL|IPILIMUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,6,NEOPLASM|NEOPLASM,Myocarditis,1,3
10676126,20141226,Nivolumab,48,801,48.0,2,,1,0,1,1,0,0,0,Nivolumab,DEXLANSOPRAZOLE|NIVOLUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OXYCODONE HYDROCHLORIDE|TRAZODONE HYDROCHLORIDE|PROCHLORPERAZINE|IPILIMUMAB|HYDROMORPHONE HYDROCHLORIDE,8,GASTROOESOPHAGEAL REFLUX DISEASE|MALIGNANT MELANOMA|NAUSEA|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|MALIGNANT MELANOMA|PAIN,Abdominal pain|Alanine aminotransferase increased|Diarrhoea|Aspartate aminotransferase increased,4,3
10676505,20141226,Nivolumab,74,801,74.0,1,89.4,1,1,1,1,0,0,1,Nivolumab,TIOTROPIUM BROMIDE|RAMIPRIL|NIVOLUMAB|SILODOSIN|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|FINASTERIDE|IPILIMUMAB|ATORVASTATIN CALCIUM,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Toxic epidermal necrolysis|Diarrhoea|Colitis ulcerative,3,3
10677327,20141226,Nivolumab,43,801,43.0,1,,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Syncope,1,3
10682520,20141229,Nivolumab,61,801,61.0,2,54.6,1,1,0,0,0,0,0,Nivolumab,"STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM|POLYETHYLENE GLYCOL 3350|LORAZEPAM|NIVOLUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|AZACITIDINE|AZACITIDINE FOR|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|MORPHINE SULFATE",13,,Fatigue|Drug intolerance|Performance status decreased|Non-small cell lung cancer|Asthenia,5,3
10683742,20141230,Nivolumab,55,801,55.0,2,45,1,0,1,0,0,0,0,Nivolumab,"FAMOTIDINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LEVOTHYROXINE|MORPHINE SULFATE|OXYCODONE|CALCIUM CARBONATE|ANTACID|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|LORAZEPAM|IPILIMUMAB|OLANZAPINE|OLANZAPINE PAMOATE|NIVOLUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pulmonary embolism|Hyperglycaemia|Hypophysitis,3,3
10686149,20141231,Nivolumab,62,801,62.0,2,50,1,0,1,0,0,0,1,Nivolumab,LORAZEPAM|LEVETIRACETAM|NIVOLUMAB|MAGNESIUM HYDROXIDE|LEVOTHYROXINE SODIUM|IPILIMUMAB|OXYCODONE|ENOXAPARIN SODIUM|PANTOPRAZOLE SODIUM,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BLADDER CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BLADDER CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Acute respiratory distress syndrome|Posterior reversible encephalopathy syndrome,2,3
10686846,20150101,Nivolumab,30,801,30.0,1,80.27,1,0,1,0,1,0,1,Nivolumab,HYDROMORPHONE HYDROCHLORIDE|PANTOPRAZOLE SODIUM|PEMBROLIZUMAB|PEMBROLIZUMAB|IPILIMUMAB|NIVOLUMAB|OXYCODONE|PROMETHAZINE HYDROCHLORIDE,10,TUMOUR PAIN|NAUSEA|MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|TUMOUR PAIN|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|TUMOUR PAIN|NAUSEA,Hypogonadism male|Hypothyroidism|Hypokalaemia|Hypomagnesaemia|Hypophysitis|Aplastic anaemia|Medical device discomfort|Hydronephrosis|Adrenal insufficiency|Pulmonary embolism|Cytokine release syndrome|Varicocele|Testicular pain|Fear of death|Urinary tract infection|Diarrhoea|Breast pain|Metastatic malignant melanoma|Small intestinal obstruction|Pleural effusion|Immunodeficiency|Cystitis|Dyspepsia|Constipation,24,5
10688826,20150103,Nivolumab,56,801,56.0,2,63,1,1,1,0,0,0,0,Nivolumab,CARBOPLATIN|AMOXICILLIN AND CLAVULANATE POTASSIUM|ETOPOSIDE|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|NIVOLUMAB|RITUXIMAB,20,DIFFUSE LARGE B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|DIFFUSE LARGE B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|DIFFUSE LARGE B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|DIFFUSE LARGE B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|DIFFUSE LARGE B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Encephalopathy|Multiple organ dysfunction syndrome|Malignant neoplasm progression,3,3
10688849,20150103,Nivolumab,61,801,61.0,2,,1,0,0,0,0,0,1,Nivolumab,IPILIMUMAB|NIVOLUMAB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Platelet count decreased|Aspartate aminotransferase increased|Alanine aminotransferase increased,3,5
10688855,20150103,Nivolumab,84,801,84.0,2,58,1,0,1,0,0,0,1,Nivolumab,"SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|SENNOSIDES|SENNA LEAF|SENNA|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISONE|OXYCODONE HYDROCHLORIDE|PROCHLORPERAZINE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|IPILIMUMAB|OXYCODONE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|SIMVASTATIN|RANITIDINE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|NIVOLUMAB|POLYETHYLENE GLYCOL 3350",23,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Enterocolitis|Diarrhoea,2,3
10692230,20150106,Nivolumab,57,801,57.0,1,,1,0,1,0,0,0,1,Nivolumab,"CALCIUM CARBONATE|NIVOLUMAB|CARBOPLATIN|PREDNISONE|ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE|PACLITAXEL",6,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER,Bandaemia|Lipase increased|Nausea|Colitis|Abdominal pain,5,3
10692637,20150106,Nivolumab,70,801,70.0,1,,1,0,1,0,0,0,0,Nivolumab,FLUCONAZOLE|FAMOTIDINE|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|DIGOXIN|LEVOTHYROXINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|INFLIXIMAB|NIVOLUMAB|IPILIMUMAB|ALLOPURINOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|PREDNISONE|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE,22,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,5
10694089,20150106,Nivolumab,71,801,71.0,1,77,1,0,1,0,0,0,0,Nivolumab,BENZONATATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|IPILIMUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LANSOPRAZOLE|HYOSCYAMINE SULFATE|LACTULOSE|PROMETHAZINE|NIVOLUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,20,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Vomiting|Nausea,2,5
10694094,20150106,Nivolumab,55,801,55.0,1,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB,1,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Pharyngeal oedema,1,3
10694230,20150106,Nivolumab,69,801,69.0,2,,1,0,1,1,0,0,0,Nivolumab,ATENOLOL|RIVAROXABAN|NIVOLUMAB,5,MALIGNANT MELANOMA,Infusion related reaction,1,1
10694335,20150107,Nivolumab,72,801,72.0,2,57,1,0,1,0,0,0,0,Nivolumab,TIOTROPIUM BROMIDE|ALPRAZOLAM|INSULIN GLARGINE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|VENLAFAXINE HYDROCHLORIDE|GABAPENTIN|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|FAMOTIDINE|DENOSUMAB|SENNOSIDES|SENNA LEAF|SENNA|POLYETHYLENE GLYCOL 3350|MUPIROCIN|MUPIROCIN CALCIUM|FENTANYL|OXYCODONE|OXYGEN|0XYGEN|PARICALCITOL|NIVOLUMAB|ZOLPIDEM TARTRATE,21,NON-SMALL CELL LUNG CANCER,Dyspnoea,1,5
10696136,20150107,Nivolumab,74,801,74.0,2,42,1,1,1,1,1,1,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB,6,Malignant melanoma,Diabetic ketoacidosis|Fulminant type 1 diabetes mellitus|Taste disorder|Pruritus|Chest discomfort|Leukoderma|Off label use,7,1
10696175,20150107,Nivolumab,80,801,80.0,2,73.3,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|HYDROXYZINE|CALCIUM|COLESEVELAM|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|ATENOLOL|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|CHLORTHALIDONE|ERGOCALCIFEROL|PREDNISONE|IPILIMUMAB|FENOFIBRATE|LEVOTHYROXINE|TRAVOPROST|TRAVOPROST (ISOMER FREE)|BIOTIN|ZOLPIDEM TARTRATE|METRONIDAZOLE|METRONIDAZOLE TOPICAL,26,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Hyponatraemia|Colitis,2,3
10698939,20150108,Nivolumab,51,801,51.0,1,87,1,0,1,0,0,0,0,Nivolumab,DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|ERGOCALCIFEROL|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|PREDNISONE|IPILIMUMAB|OXYCODONE|NIVOLUMAB|LORAZEPAM|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,15,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GASTROOESOPHAGEAL CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GASTROOESOPHAGEAL CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Vomiting|Nausea|Colitis|Dysphagia,4,3
10698940,20150108,Nivolumab,61,801,61.0,1,83,1,0,1,0,0,0,0,Nivolumab,HYDROMORPHONE HYDROCHLORIDE|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LACTULOSE|INSULIN ASPART|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|STANDARDIZED SENNA CONCENTRATE|BACLOFEN|POLYETHYLENE GLYCOL|NIVOLUMAB|MINERAL OIL|MORPHINE SULFATE|CHLORPROMAZINE|FENTANYL,23,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CONSTIPATION|PRODUCT USED FOR UNKNOWN INDICATION|DECREASED APPETITE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|CONSTIPATION|CONSTIPATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pain|Arthralgia,2,5
10699269,20150108,Nivolumab,46,801,46.0,2,74,1,0,1,0,0,0,0,Nivolumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DICLOFENAC POTASSIUM|DICLOFENAC POTASSIUM, FILM COATED|DICLOFENAC POTASSIUM TABLETS|NIVOLUMAB|POLYETHYLENE GLYCOL 3350|DAPSONE GEL, 5%|DAPSONE|DASPONE",8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HODGKIN^S DISEASE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction,1,3
10701785,20150109,Nivolumab,65,801,65.0,2,85,1,0,1,0,0,0,0,Nivolumab,"PREDNISONE|METRONIDAZOLE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|METHYLPREDNISOLONE|GABAPENTIN|DULOXETINE HYDROCHLORIDE|DULOXETINE|METHYLPREDNISOLONE SODIUM SUCCINATE|NIVOLUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LACTULOSE|SOLIFENACIN SUCCINATE|LORAZEPAM|PROMETHAZINE HYDROCHLORIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LORAZEPAM|DULOXETINE HYDROCHLORIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE",22,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Ileus|Enteritis,2,3
10702707,20150109,Nivolumab,48,801,48.0,2,100,1,1,1,0,0,0,0,Nivolumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|NIVOLUMAB|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|TAPENTADOL HYDROCHLORIDE|ATORVASTATIN CALCIUM|ESCITALOPRAM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXYCODONE HYDROCHLORIDE|OLANZAPINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LAMOTRIGINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,21,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Adrenal insufficiency|Sudden death|Hypophysitis,3,3
10702752,20150110,Nivolumab,51,801,51.0,1,,1,0,1,0,0,0,0,Nivolumab,"HYDROMORPHONE HYDROCHLORIDE|MORPHINE|NIVOLUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|RIVAROXABAN",6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pain,1,3
10702756,20150110,Nivolumab,70,801,70.0,1,75,1,1,0,1,0,0,0,Nivolumab,MAGNESIUM OXIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|NIACIN|METHYLPHENIDATE HYDROCHLORIDE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|NIFEDIPINE|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE|VENLAFAXINE HYDROCHLORIDE|VENLAFAXINE|NIVOLUMAB|MORPHINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LORAZEPAM|TIOTROPIUM BROMIDE,18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Respiratory failure|Malignant neoplasm progression|Pneumonia,3,5
10702966,20150110,Nivolumab,70,801,70.0,1,74.8,1,1,1,1,0,0,1,Nivolumab,FORMOTEROL FUMARATE DIHYDRATE|METHYLPREDNISOLONE SODIUM SUCCINATE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|FORMOTEROL FUMARATE DIHYDRATE|LORAZEPAM|MAGNESIUM OXIDE|NIFEDIPINE|METHYLPHENIDATE HYDROCHLORIDE|NIVOLUMAB|MORPHINE|TIOTROPIUM BROMIDE|LOSARTAN|VALACYCLOVIR HYDROCHLORIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISONE|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|LOSARTAN|CEFEPIME HYDROCHLORIDE|CEFEPIME|NIACIN|VENLAFAXINE HYDROCHLORIDE|VENLAFAXINE|BUDESONIDE|CYCLOBENZAPRINE,32,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PNEUMONITIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Chronic respiratory failure|Malignant neoplasm progression|Pneumonia|Interstitial lung disease,4,3
10703055,20150111,Nivolumab,,,,0,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,2,NEOPLASM|NEOPLASM,Abdominal pain,1,5
10703459,20150112,Nivolumab,51,801,51.0,1,87,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|LORAZEPAM|IPILIMUMAB|OXYCODONE|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|ERGOCALCIFEROL|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,11,OESOPHAGEAL ADENOCARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|OESOPHAGEAL ADENOCARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,3
10703720,20150112,Nivolumab,72,801,72.0,1,58,1,0,1,0,0,0,0,Nivolumab,ATORVASTATIN CALCIUM|LEVOTHYROXINE|NIVOLUMAB|PREDNISONE,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION,Hyponatraemia,1,3
10704920,20150112,Nivolumab,60,801,60.0,1,83,1,0,0,0,0,0,1,Nivolumab,NIVOLUMAB|IPILIMUMAB|METHYLPREDNISOLONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,4,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Autoimmune hepatitis,1,3
10704923,20150112,Nivolumab,64,801,64.0,1,125,1,0,1,0,0,0,0,Nivolumab,BUMETANIDE|FUROSEMIDE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|RAMIPRIL|METHYLPREDNISOLONE SODIUM SUCCINATE|DENOSUMAB|NIVOLUMAB|AMLODIPINE|METOPROLOL TARTRATE|OXYCODONE HYDROCHLORIDE|CLOPIDOGREL|BACLOFEN|PREDNISONE|OXYCODONE|ATOVAQUONE|ATOVAQUONE ORAL SUSPENSION|FISH OIL,24,RENAL CELL CARCINOMA,Pneumonitis,1,5
10705052,20150112,Nivolumab,62,801,62.0,1,51.5,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB|OXYCODONE|ESOMEPRAZOLE MAGNESIUM,4,OESOPHAGEAL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Oedema|Lung infection|Back pain,3,3
10705219,20150112,Nivolumab,61,801,61.0,1,,1,1,1,0,0,0,0,Nivolumab,NIVOLUMAB,11,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Hypercalcaemia,1,3
10705683,20150112,Nivolumab,59,801,59.0,1,64,1,0,1,0,0,0,0,Nivolumab,LOSARTAN|NIVOLUMAB|FLUCONAZOLE|PANTOPRAZOLE|LORAZEPAM|IPILIMUMAB|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|FENTANYL|SENNOSIDES|SENNA LEAF|SENNA|FILGRASTIM,16,PRODUCT USED FOR UNKNOWN INDICATION|HAEMATOLOGICAL MALIGNANCY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HAEMATOLOGICAL MALIGNANCY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Alanine aminotransferase increased|Rash maculo-papular|Aspartate aminotransferase increased|Pneumonitis|Blood bilirubin increased|Enterocolitis,6,5
10706267,20150113,Nivolumab,59,801,59.0,2,71,1,0,1,0,0,0,0,Nivolumab,"NIVOLUMAB|ACONITUM NAPELLUS, ARALIA QUINQUEFOLIA, CHININUM ARSENICOSUM, COFFEA CRUDA, COLCHICUM AUTUMNALE, CRATAEGUS OXYACANTHA FRUIT, ECHINACEA PURPUREA, ESCHSCHOLTZIA CALIFORNICA, HUMULUS LUPULUS, IGNATIA AMARA, LYCOPUS VIRGINICUS, NUX VOMICA, PASSIFLORA INCARNATA, SCUTELLARIA LATERIFLORA, STRYCHNINUM PHOSPHORICUM, THYROIDINUM, VISCUM ALBUM FRUITING TOP, YELLOW JASMINE ROOT|BETULA VERRUCOSA, BOS TAURUS ADRENAL GLAND, BOS TAURUS PITUITARUM POSTERIUM, CALCAREA IODATA, COCCULUS INDICUS, COLCHICUM AUTUMNALE, ELEUTHERO, EUROPEAN HORNBEAM FLOWER, EUROPEAN OLIVE, HYPOTHALAMUS, JUNIPERUS COMMUNIS STEM, KALI CARBONICUM, KALI PHOSPHORICUM, LAC CANINUM, NUX VOMICA, PASSIFLORA INCARNATA, ORNITHOGALUM UMBELLATUM, PHOSPHORICUM ACIDUM, RHAMNUS PURSHIANA, RIBES NIGRUM, SARCOLACTICUM ACIDUM, SEPIA, SOLIDAGO VIRGAUREA, SUS SCROFA PINEAL GLAND, TRYPTOPHAN, TYROSINE, YELLOW JASMINE",3,MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea,1,5
10706798,20150113,Nivolumab,27,801,27.0,2,56,1,0,1,0,0,0,1,Nivolumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|LORATADINE|LORATADINE TABLET|NIVOLUMAB|SUNITINIB MALATE|ZOLPIDEM TARTRATE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PANTOPRAZOLE SODIUM|ASCORBIC ACID|IPILIMUMAB",13,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RENAL CELL CARCINOMA|RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RENAL CELL CARCINOMA,Systemic inflammatory response syndrome,1,5
10708708,20150113,Nivolumab,74,801,74.0,1,77,1,0,1,0,0,0,0,Nivolumab,"SIMVASTATIN|IPILIMUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|METOPROLOL SUCCINATE|NIVOLUMAB|DUTASTERIDE",9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|CARDIAC DISORDER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Fatigue|Diarrhoea,2,5
10708724,20150113,Nivolumab,64,801,64.0,1,124.44,1,0,1,0,0,0,0,Nivolumab,RAMIPRIL|PREDNISONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|DENOSUMAB|OXYCODONE|PREDNISONE|PREDNISONE|FISH OIL|METOPROLOL TARTRATE|BACLOFEN|OXYGEN|0XYGEN|PREDNISONE|DENOSUMAB|CLOPIDOGREL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|PREDNISONE|PREDNISONE|BUMETANIDE|ATOVAQUONE|ATOVAQUONE ORAL SUSPENSION|PREDNISONE|NIVOLUMAB|PREDNISONE|PREDNISONE|PREDNISONE,34,METASTATIC RENAL CELL CARCINOMA,Pneumonitis,1,3
10709397,20150114,Nivolumab,67,801,67.0,1,79,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|MAGNESIUM OXIDE|NIVOLUMAB|MAGNESIUM|LISINOPRIL|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE,13,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pancreatitis acute,1,5
10709797,20150114,Nivolumab,70,801,70.0,1,82.6,1,1,1,0,0,0,1,Nivolumab,NIVOLUMAB|POLYETHYLENE GLYCOL 3350|FOLIC ACID|DENOSUMAB|GABAPENTIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PREDNISONE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|LORAZEPAM|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|ENOXAPARIN SODIUM|MORPHINE SULFATE,19,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Urinary retention|Adrenal insufficiency|Asthenia|Confusional state|Malignant neoplasm progression,5,5
10711261,20150114,Nivolumab,72,801,72.0,1,78.4,1,0,1,0,0,0,1,Nivolumab,"LACTULOSE|LORAZEPAM|PANTOPRAZOLE|DIPHENHYDRAMINE HYDROCHLORIDE|HYDROMORPHONE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|EPINEPHRINE|ADRENALINUM|METHYLPREDNISOLONE SODIUM SUCCINATE|SILDENAFIL CITRATE|CELECOXIB|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|TIZANIDINE|GABAPENTIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|NIVOLUMAB|IPILIMUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",31,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Guillain-Barre syndrome|Hyponatraemia,2,3
10711744,20150114,Nivolumab,70,801,70.0,1,85.2,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB|FISH OIL|GLYBURIDE|PROCHLORPERAZINE MALEATE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|OXYCODONE|ERGOCALCIFEROL|LATANOPROST|CALCIUM CARBONATE|ANTACID|LORAZEPAM|PREDNISONE|FEXOFENADINE HCL|PROCHLORPERAZINE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,23,NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Enteritis,1,5
10714633,20150115,Nivolumab,69,801,69.0,1,73,1,0,1,0,0,0,0,Nivolumab,"AMLODIPINE|CLARITHROMYCIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|INSULIN GLARGINE|CLOBETASOL PROPIONATE|CLOBETASOL PROPIONATE OINTMENT USP, 0.05%|LANSOPRAZOLE|METHYLPREDNISOLONE|NIVOLUMAB|TADALAFIL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",14,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Fatigue,1,5
10714634,20150115,Nivolumab,69,801,69.0,2,67,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|INFLIXIMAB|CITALOPRAM|CITALOPRAM HYDROBROMIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|METFORMIN HCL|FLUCONAZOLE|NIVOLUMAB|OLOPATADINE HCL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHYLPREDNISOLONE SODIUM SUCCINATE|GLIMEPIRIDE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|LISINOPRIL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE,20,MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea,1,5
10714656,20150115,Nivolumab,70,801,70.0,1,88,1,0,1,0,0,0,0,Nivolumab,"AMOXICILLIN|METHYLPREDNISOLONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|NIVOLUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|AMOXICILLIN|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|SPIRONOLACTONE|SILDENAFIL CITRATE|SILDENAFIL|SILDENAFIL POWDER,",12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Autoimmune hepatitis,1,5
10714657,20150115,Nivolumab,66,801,66.0,1,71.1,1,0,1,1,0,0,1,Nivolumab,"PREDNISONE|MEPERIDINE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|NIVOLUMAB|SIMVASTATIN|CHLORTHALIDONE|CLOPIDOGREL|CLOPIDOGREL BISULFATE|LISINOPRIL|LISINOPRIL|FISH OIL|METHYLPREDNISOLONE SODIUM SUCCINATE|FOLIC ACID|ATENOLOL|DIPHENHYDRAMINE HYDROCHLORIDE|FUROSEMIDE|ZINC|ZINC GLUCONATE|ZINC CHLORIDE|BIOTIN",24,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonia|Infusion related reaction|Troponin I increased,3,3
10715037,20150115,Nivolumab,68,801,68.0,1,78.7,1,0,1,0,0,0,1,Nivolumab,"METHYLPREDNISOLONE|METOPROLOL TARTRATE|METOPROLOL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|NIVOLUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|METRONIDAZOLE|METRONIDAZOLE TOPICAL|IPILIMUMAB|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|NIVOLUMAB|PANTOPRAZOLE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|IPILIMUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES",25,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Acute kidney injury|Hyponatraemia|Hyperglycaemia|Ischaemic neuropathy|Hypotension|Aspartate aminotransferase increased|Autoimmune pancreatitis|Blood bilirubin increased|Septic shock|Blood alkaline phosphatase increased|Pyrexia|Multiple organ dysfunction syndrome|Influenza like illness|Disseminated intravascular coagulation|Alanine aminotransferase increased,15,3
10715188,20150115,Nivolumab,42,801,42.0,1,99,1,0,1,0,0,0,0,Nivolumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|INSULIN GLARGINE|IPILIMUMAB|PROPRANOLOL HYDROCHLORIDE|INSULIN LISPRO|NIVOLUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION,Hyperglycaemia,1,5
10718152,20150117,Nivolumab,74,801,74.0,1,93,1,0,1,0,0,0,0,Nivolumab,METHYLPREDNISOLONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|AMLODIPINE|NIVOLUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BISOPROLOL FUMARATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|LANSOPRAZOLE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|IPILIMUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,22,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Hypophysitis,1,3
10718197,20150118,Nivolumab,66,801,66.0,2,91,1,0,1,0,0,0,0,Nivolumab,"NIVOLUMAB|DACARBAZINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|CEFOXITIN|CEFOXITIN SODIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CALCIUM GLUCONATE|DEXTROSE 5%|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PANTOPRAZOLE|FUROSEMIDE|BUDESONIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|METRONIDAZOLE|METRONIDAZOLE TOPICAL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALBUMIN HUMAN",34,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Lung infection|Skin infection|Atrial fibrillation,3,3
10718198,20150118,Nivolumab,63,801,63.0,2,78.9,1,0,1,0,0,0,1,Nivolumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ATOVAQUONE|ATOVAQUONE ORAL SUSPENSION|LEVOTHYROXINE SODIUM|NIVOLUMAB|ZOLPIDEM TARTRATE|METOPROLOL TARTRATE|METOPROLOL|NIVOLUMAB|IPILIMUMAB|HYDROCHLOROTHIAZIDE|PROMETHAZINE HYDROCHLORIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|MAGNESIUM",14,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Aspartate aminotransferase increased|Alanine aminotransferase increased,2,5
10718199,20150118,Nivolumab,37,801,37.0,2,82,1,0,1,0,0,0,0,Nivolumab,CEFUROXIME|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|MORPHINE SULFATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MORPHINE SULFATE|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|LORAZEPAM|METHYLPREDNISOLONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|MORPHINE SULFATE|PANTOPRAZOLE|NIVOLUMAB|AMOXICILLIN|FUROSEMIDE|METHYLPREDNISOLONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|IPILIMUMAB|BUMETANIDE|LANSOPRAZOLE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BUMETANIDE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CEFUROXIME|HYDROXYZINE|METHYLPREDNISOLONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,52,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Vomiting|Diarrhoea,2,3
10718208,20150118,Nivolumab,56,801,56.0,1,93.4,1,1,1,0,0,0,1,Nivolumab,"FOLIC ACID|FOLIC ACID|PANTOPRAZOLE|GABAPENTIN|PREDNISONE|PREDNISONE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|NIVOLUMAB|TESTOSTERONE|TESTOSTERONE,|INFLIXIMAB|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|NAPROXEN|NAPROXEN SODIUM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|MAGNESIUM OXIDE",18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis|Atrial flutter|Pulmonary embolism,3,5
10718213,20150118,Nivolumab,68,801,68.0,1,,1,1,1,0,0,0,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,6,MALIGNANT MELANOMA|INTERSTITIAL LUNG DISEASE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Interstitial lung disease|Gastric ulcer|Malignant neoplasm progression,3,5
10718305,20150118,Nivolumab,,,,2,71,1,0,1,0,0,0,1,Nivolumab,OXAZEPAM|GRANISETRON|GRANISETRON HYDROCHLORIDE|VALSARTAN AND HYDROCHLOROTHIAZIDE|FOLIC ACID|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|LORAZEPAM|METOPROLOL TARTRATE|METOPROLOL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|NIVOLUMAB,13,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Nausea|Pericardial effusion malignant,2,3
10720499,20150119,Nivolumab,65,801,65.0,1,,1,1,1,1,1,1,1,Nivolumab,OCTREOTIDE ACETATE|OCTREOTIDE ACETATE|OCTREOTIDE ACETATE|OCTREOTIDE ACETATE|OCTREOTIDE ACETATE|OCTREOTIDE ACETATE|OCTREOTIDE ACETATE|OCTREOTIDE ACETATE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM|RIVAROXABAN|NIVOLUMAB|DIMENHYDRINATE|ERGOCALCIFEROL|LATANOPROST,18,Carcinoid tumour|Carcinoid tumour|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Death|Weight decreased|Pancreatitis|Dehydration|Diarrhoea|Liver injury|Metastases to lung|Metastases to liver|Metastases to abdominal cavity|Metastases to kidney|Carcinoid tumour|Malignant neoplasm progression|Gastric disorder|Body temperature increased|Flushing|Haemoglobin decreased|Back pain|Nasopharyngitis|Nasal congestion|Blood pressure increased|Peripheral swelling|Joint swelling|Ocular hyperaemia|Eye swelling|Inguinal hernia|Groin pain|Sciatica|Oedema|Pain in extremity|Osteoarthritis|Oedema peripheral|Faeces soft|Fatigue|Diarrhoea|Nausea|Vomiting|Diarrhoea|Diarrhoea|Diarrhoea|Heart rate increased|Dizziness|Product dose omission issue|Product delivery mechanism issue,43,3
10724746,20150120,Nivolumab,47,801,47.0,1,106,1,0,1,0,0,0,0,Nivolumab,METHYLPREDNISOLONE|BENZONATATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|GUAIFENESIN AND DEXTROMETHORPHAN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OSELTAMIVIR PHOSPHATE|OSELTAMIVIR ACID|OSELTAMIVIR|PROCHLORPERAZINE|NIVOLUMAB|IPILIMUMAB|INFLIXIMAB,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION,Fatigue|Diarrhoea,2,5
10724757,20150120,Nivolumab,75,801,75.0,2,70,1,0,1,0,0,0,0,Nivolumab,ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|PREDNISONE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|SOTALOL HYDROCHLORIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|WARFARIN|FUROSEMIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SOTALOL HYDROCHLORIDE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|PREDNISONE|DIGOXIN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|DIGOXIN|NIVOLUMAB|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|WARFARIN,39,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,5
10725147,20150120,Nivolumab,72,801,72.0,1,,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pneumonia,1,5
10725278,20150120,Nivolumab,33,801,33.0,1,73,1,0,1,0,0,0,0,Nivolumab,SIMETHICONE|DIMETHICONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|NIVOLUMAB|HYDROMORPHONE HYDROCHLORIDE|CLONAZEPAM|ENOXAPARIN SODIUM|OXYCODONE HYDROCHLORIDE|LORAZEPAM,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea,1,5
10725480,20150121,Nivolumab,50,801,50.0,1,94,1,0,1,0,0,0,0,Nivolumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MORPHINE|PREGABALIN|DULOXETINE HYDROCHLORIDE|DULOXETINE|BETAMETHASONE VALERATE|BETAMETHASONE VALERATE FOAM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|CYCLOBENZAPRINE|HYDROMORPHONE HYDROCHLORIDE|LORAZEPAM|AMLODIPINE|HYDROMORPHONE HYDROCHLORIDE|PANTOPRAZOLE|DICLOFENAC SODIUM|CITALOPRAM|CITALOPRAM HYDROBROMIDE|LACTULOSE|NIVOLUMAB,26,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pain in extremity|Pain|Back pain,3,5
10727364,20150121,Nivolumab,80,801,80.0,1,88,1,0,1,0,0,0,0,Nivolumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIGOXIN|PANTOPRAZOLE|WARFARIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREGABALIN|PREGABALIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CORTISONE ACETATE,22,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypopituitarism,1,5
10727747,20150121,Nivolumab,51,801,51.0,1,131,1,0,1,0,0,0,1,Nivolumab,"ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CLONIDINE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|FERROUS SULFATE|HYDRALAZINE HYDROCHLORIDE|HYDROMORPHONE HYDROCHLORIDE|PANTOPRAZOLE|PROPOFOL|CITALOPRAM|CITALOPRAM HYDROBROMIDE|CARVEDILOL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ERGOCALCIFEROL|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|CARVEDILOL|HYDROMORPHONE HYDROCHLORIDE|GLYCOPYRROLATE|MANNITOL|GLIMEPIRIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CITALOPRAM|CITALOPRAM HYDROBROMIDE|PROCHLORPERAZINE|LORAZEPAM|BACITRACIN ZINC|BACITRACIN|FUROSEMIDE|NIVOLUMAB|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|POVIDONE-IODINE|CLONIDINE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LABETALOL|ROCURONIUM BROMIDE",45,RENAL CELL CARCINOMA,Oedema peripheral|Cough|Metastases to central nervous system|Fatigue|Decreased appetite,5,5
10729532,20150122,Nivolumab,52,801,52.0,1,,1,1,0,0,0,0,1,Nivolumab,NIVOLUMAB,1,MALIGNANT MELANOMA,Liver carcinoma ruptured|Malignant neoplasm progression|Hepatic function abnormal|Tumour lysis syndrome|Renal impairment,5,3
10730201,20150122,Nivolumab,52,801,52.0,1,85,1,1,1,0,0,0,0,Nivolumab,HYDROCORTISONE|LOPERAMIDE HYDROCHLORIDE|NIVOLUMAB|KETOPROFEN|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|OXYCODONE HYDROCHLORIDE,23,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Coma|Hypercalcaemia,3,5
10730977,20150122,Nivolumab,42,801,42.0,2,,1,1,1,1,0,0,1,Nivolumab,NIVOLUMAB,1,MALIGNANT MELANOMA,Thyroxine free decreased|Abdominal pain|Malignant neoplasm progression|Malignant pleural effusion|Respiratory failure|Pleural effusion|Alanine aminotransferase increased|Gamma-glutamyltransferase increased|Lymphangiosis carcinomatosa,9,5
10731124,20150122,Nivolumab,68,801,68.0,2,,1,0,1,0,0,0,1,Nivolumab,GABAPENTIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PHENYLEPHRINE HYDROCHLORIDE|NIVOLUMAB|SIMETHICONE AND CALCIUM CARBONATE|SIMETHICONE,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Gastrooesophageal reflux disease|Pulmonary embolism,2,5
10731473,20150123,Nivolumab,89,801,89.0,1,64,1,1,1,0,0,0,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|WARFARIN SODIUM|WARFARIN,17,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Lung disorder|Malignant neoplasm progression|Pleural effusion|Alanine aminotransferase increased|Psoriasis|Decreased appetite,6,3
10731564,20150123,Nivolumab,55,801,55.0,1,60,1,0,1,0,0,0,0,Nivolumab,"NIVOLUMAB|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|CEFEPIME HYDROCHLORIDE|CEFEPIME|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METRONIDAZOLE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|SODIUM PHOSPHATE|ALBUMIN HUMAN|THIAMINE HYDROCHLORIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|FENTANYL|GABAPENTIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MORPHINE SULFATE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM PHOSPHATE",22,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hyponatraemia,1,5
10732752,20150123,Nivolumab,61,801,61.0,2,81.6,1,0,1,0,0,0,0,Nivolumab,"NIVOLUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|LISINOPRIL|CHOLESTYRAMINE|LORATADINE|LORATADINE ORAL|IPILIMUMAB|SUMATRIPTAN|SUMATRIPTAN SUCCINATE|ACONITUM NAPELLUS, ARALIA QUINQUEFOLIA, CHININUM ARSENICOSUM, COFFEA CRUDA, COLCHICUM AUTUMNALE, CRATAEGUS OXYACANTHA FRUIT, ECHINACEA PURPUREA, ESCHSCHOLTZIA CALIFORNICA, HUMULUS LUPULUS, IGNATIA AMARA, LYCOPUS VIRGINICUS, NUX VOMICA, PASSIFLORA INCARNATA, SCUTELLARIA LATERIFLORA, STRYCHNINUM PHOSPHORICUM, THYROIDINUM, VISCUM ALBUM FRUITING TOP, YELLOW JASMINE ROOT|BETULA VERRUCOSA, BOS TAURUS ADRENAL GLAND, BOS TAURUS PITUITARUM POSTERIUM, CALCAREA IODATA, COCCULUS INDICUS, COLCHICUM AUTUMNALE, ELEUTHERO, EUROPEAN HORNBEAM FLOWER, EUROPEAN OLIVE, HYPOTHALAMUS, JUNIPERUS COMMUNIS STEM, KALI CARBONICUM, KALI PHOSPHORICUM, LAC CANINUM, NUX VOMICA, PASSIFLORA INCARNATA, ORNITHOGALUM UMBELLATUM, PHOSPHORICUM ACIDUM, RHAMNUS PURSHIANA, RIBES NIGRUM, SARCOLACTICUM ACIDUM, SEPIA, SOLIDAGO VIRGAUREA, SUS SCROFA PINEAL GLAND, TRYPTOPHAN, TYROSINE, YELLOW JASMINE|LEVOTHYROXINE|METHYLPREDNISOLONE|AMLODIPINE",19,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea,1,5
10733004,20150123,Nivolumab,57,801,57.0,1,136,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|PREDNISONE|IPILIMUMAB|LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE|ESCITALOPRAM|AMLODIPINE|HYDROCORTISONE CREAM|HYDROCORTISONE|PREDNISONE|ALFUZOSIN HCL|OXYCODONE|PREDNISONE|ZOLPIDEM TARTRATE|METOPROLOL TARTRATE|METOPROLOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ROSUVASTATIN|SILDENAFIL CITRATE|LEVOTHYROXINE SODIUM|PREDNISONE,20,METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Autoimmune hepatitis,1,3
10733005,20150123,Nivolumab,56,801,56.0,2,87.75,1,0,1,0,0,0,1,Nivolumab,LORATADINE|LORATADINE ORAL|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|LEVOTHYROXINE SODIUM|AMLODIPINE|POLYETHYLENE GLYCOL 3350|PROCHLORPERAZINE|NIVOLUMAB|ALLOPURINOL|FENTANYL|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|PREDNISONE|DULOXETINE HYDROCHLORIDE|DULOXETINE|FENTANYL|LACTULOSE|OXYCODONE|GABAPENTIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ESOMEPRAZOLE MAGNESIUM,28,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hyperuricaemia|Hyponatraemia|Dehydration|Acute kidney injury,4,3
10733008,20150123,Nivolumab,78,801,78.0,1,88,1,0,1,0,0,0,0,Nivolumab,"LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|METHYLPREDNISOLONE|PANTOPRAZOLE|NIVOLUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|IPILIMUMAB|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ESOMEPRAZOLE MAGNESIUM",19,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Fatigue|Colitis|Nausea|Diarrhoea,4,3
10733009,20150123,Nivolumab,40,801,40.0,1,90,1,0,1,0,0,0,0,Nivolumab,PREGABALIN|CELECOXIB|ALPRAZOLAM|NIVOLUMAB|CELECOXIB,16,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Spinal pain,1,3
10733181,20150123,Nivolumab,63,801,63.0,1,,1,1,1,1,0,0,1,Nivolumab,NIVOLUMAB|HYDROCORTISONE SODIUM SUCCINATE|NIVOLUMAB|SITAGLIPTIN|NIVOLUMAB,11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Multiple organ dysfunction syndrome|Hepatic function abnormal|Tumour lysis syndrome|Tri-iodothyronine free decreased|Malignant neoplasm progression|Hypoglycaemia|Acute kidney injury,7,5
10734142,20150123,Nivolumab,50,801,50.0,2,62,1,0,1,0,0,0,0,Nivolumab,METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|NIVOLUMAB,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Abdominal pain,1,5
10734769,20150123,Nivolumab,78,801,78.0,1,94,1,0,1,0,0,0,0,Nivolumab,HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|SIMVASTATIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|OSELTAMIVIR PHOSPHATE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|OSELTAMIVIR PHOSPHATE|OSELTAMIVIR ACID|OSELTAMIVIR|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|OSELTAMIVIR|OSELTAMIVIR PHOSPHATE|NIVOLUMAB|LISINOPRIL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|IPILIMUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BISOPROLOL FUMARATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,33,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis|Influenza like illness,2,5
10735085,20150124,Nivolumab,101,801,101.0,1,81,1,0,1,0,0,0,0,Nivolumab,METOPROLOL TARTRATE|METOPROLOL|LACTULOSE|ALLOPURINOL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|SIMVASTATIN|NIVOLUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Fatigue,1,3
10735128,20150125,Nivolumab,71,801,71.0,1,,1,0,0,0,0,0,0,Nivolumab,NIVOLUMAB|ATENOLOL|AMLODIPINE BESYLATE AND VALSARTAN|OXYCODONE HYDROCHLORIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,8,METASTATIC MALIGNANT MELANOMA,Back pain,1,2
10735366,20150125,Nivolumab,36,801,36.0,1,119.1,1,0,1,0,0,0,0,Nivolumab,GRANISETRON|GRANISETRON HYDROCHLORIDE|PREDNISONE|OXYCODONE HYDROCHLORIDE|METHYLPREDNISOLONE|PREGABALIN|PROMETHAZINE HYDROCHLORIDE|PREDNISONE|NIVOLUMAB|METHADONE|PREDNISONE|PREDNISONE|GRANISETRON|GRANISETRON HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|FENTANYL|DACARBAZINE|PREDNISONE,20,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA,Hepatic function abnormal,1,5
10737083,20150126,Nivolumab,70,801,70.0,1,85.7,1,0,1,0,1,0,0,Nivolumab,"DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|HYDROCORTISONE|PSYLLIUM HUSK|TESTOSTERONE|TESTOSTERONE,|DIPHENHYDRAMINE HYDROCHLORIDE|NIVOLUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|IPILIMUMAB|ROSUVASTATIN|DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM",14,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pain in extremity|Peripheral sensory neuropathy,2,5
10737634,20150126,Nivolumab,49,801,49.0,2,80.8,1,0,1,0,0,0,0,Nivolumab,DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METHYLPREDNISOLONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|LANSOPRAZOLE|METHYLPREDNISOLONE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE,25,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hepatitis,1,3
10737647,20150126,Nivolumab,57,801,57.0,2,87,1,0,1,0,0,0,0,Nivolumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RAMIPRIL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|NIVOLUMAB|DIGOXIN|RAMIPRIL|RAMIPRIL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BISOPROLOL FUMARATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METHYLPREDNISOLONE|PANTOPRAZOLE|IPILIMUMAB|WARFARIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SPIRONOLACTONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|FENTANYL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE,39,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea,1,3
10739530,20150126,Nivolumab,50,801,50.0,2,44,1,1,1,0,0,0,1,Nivolumab,IPILIMUMAB|NIVOLUMAB|NIVOLUMAB,4,MALIGNANT MELANOMA|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Arthralgia|Arrhythmia|Dysphagia|Infusion related reaction|Torticollis|Myositis|Malignant neoplasm progression|Off label use,8,3
10739599,20150126,Nivolumab,75,801,75.0,1,70,1,0,1,0,0,0,0,Nivolumab,ROSUVASTATIN|FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE|FOLIC ACID|WARFARIN|NIVOLUMAB,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER,Hyperglycaemia,1,5
10741448,20150127,Nivolumab,71,801,71.0,2,94,1,0,1,0,0,0,0,Nivolumab,PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|AMLODIPINE BESYLATE|GABAPENTIN|PREDNISONE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|OXYBUTYNIN|METHYLPREDNISOLONE SODIUM SUCCINATE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|IPILIMUMAB|PREDNISONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|INSULIN GLARGINE|PREDNISONE|INSULIN ASPART|IRBESARTAN|PREDNISONE|PREDNISONE|INFLIXIMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|SIMVASTATIN|PREDNISONE|PREDNISONE|LEVOTHYROXINE|NIVOLUMAB|PREDNISONE|IRON|MONTELUKAST SODIUM|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE,38,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Colitis,2,3
10742366,20150127,Nivolumab,74,801,74.0,1,67.1,1,0,1,0,0,0,0,Nivolumab,DARBEPOETIN ALFA|FUROSEMIDE|MINOCYCLINE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|NIVOLUMAB|DARBEPOETIN ALFA,25,NON-SMALL CELL LUNG CANCER,Rash papular,1,5
10742609,20150127,Nivolumab,69,801,69.0,2,66,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS,10,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumocystis jirovecii pneumonia,1,5
10742879,20150127,Nivolumab,73,801,73.0,1,78.2,1,0,1,0,0,0,1,Nivolumab,"POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|HYDROMORPHONE HYDROCHLORIDE|IPILIMUMAB|FAMOTIDINE|PANTOPRAZOLE SODIUM|METRONIDAZOLE|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|PROPOFOL|FLUCONAZOLE|FENTANYL|PREDNISONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|NIVOLUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|METOCLOPRAMIDE HYDROCHLORIDE",21,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis|Intestinal perforation,2,3
10742978,20150127,Nivolumab,50,801,50.0,1,86.4,1,0,0,0,0,0,1,Nivolumab,CLOPIDOGREL|CLOPIDOGREL BISULFATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ZINC|ZINC GLUCONATE|ZINC CHLORIDE|NIVOLUMAB|FOLIC ACID|PANTOPRAZOLE|ENALAPRIL|DIPYRIDAMOLE|TRAVOPROST|TRAVOPROST (ISOMER FREE),14,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cerebrovascular accident,1,3
10743304,20150127,Nivolumab,,,,0,,1,1,0,0,0,0,1,Nivolumab,IPILIMUMAB|OXYCODONE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|NIVOLUMAB,5,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Malignant neoplasm progression|Coagulopathy,2,1
10743667,20150128,Nivolumab,33,801,33.0,1,87,1,0,1,0,0,0,0,Nivolumab,"PANTOPRAZOLE|NIVOLUMAB|METHYLPREDNISOLONE|CEFUROXIME|INFLIXIMAB|INFLIXIMAB|INFLIXIMAB|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|FLUCONAZOLE|CALCIUM GLUCONATE|BUDESONIDE|FLUCONAZOLE|NIVOLUMAB|INFLIXIMAB|METRONIDAZOLE|METRONIDAZOLE TOPICAL|DENOSUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|IPILIMUMAB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|PREDNISONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|CITALOPRAM|CITALOPRAM HYDROBROMIDE|INFLIXIMAB|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|GANCICLOVIR SODIUM|GANCICLOVIR|GANCICLOVIR SODIUM|GANCICLOVIR",52,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,3
10745745,20150128,Nivolumab,28,801,28.0,1,54,1,1,0,0,0,0,1,Nivolumab,"LORAZEPAM|METHYLPHENIDATE HYDROCHLORIDE|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE|ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHYLPREDNISOLONE SODIUM SUCCINATE|NIVOLUMAB|METHYLPREDNISOLONE",9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Liver injury,2,5
10746091,20150128,Nivolumab,48,801,48.0,2,67.2,1,0,1,0,0,0,0,Nivolumab,FILGRASTIM|LANSOPRAZOLE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|GENTAMICIN|GENTAMICIN SULFATE|BUDESONIDE|METHYLPREDNISOLONE|PHYTONADIONE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|IPILIMUMAB|OXYGEN|0XYGEN|MEROPENEM|NIVOLUMAB,18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA,Febrile neutropenia,1,5
10748703,20150129,Nivolumab,37,801,37.0,1,64.7,1,1,1,0,0,0,0,Nivolumab,NIVOLUMAB|LANSOPRAZOLE|CEFUROXIME|METHYLPREDNISOLONE|OXYCODONE|METHYLPREDNISOLONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|LACTULOSE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|IPILIMUMAB|FLUCONAZOLE,12,NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis|Malignant neoplasm progression,2,5
10749452,20150129,Nivolumab,75,801,75.0,1,93,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB|IPILIMUMAB|ALLOPURINOL|PANTOPRAZOLE|CLOPIDOGREL BISULFATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|DICLOFENAC SODIUM|AMLODIPINE|SPIRONOLACTONE|VALSARTAN|VALSARTAN ORAL|SITAGLIPTIN,21,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hyperglycaemia|Hyperthyroidism,2,5
10749525,20150129,Nivolumab,72,801,72.0,1,81.1,1,0,1,0,0,0,1,Nivolumab,BISOPROLOL FUMARATE|FUROSEMIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CALCIUM|METOPROLOL TARTRATE|METOPROLOL|NIVOLUMAB|IPILIMUMAB|ALLOPURINOL|RAMIPRIL,23,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypophysitis,1,5
10750118,20150129,Nivolumab,84,801,84.0,1,,1,1,1,0,0,0,0,Nivolumab,NIVOLUMAB|NIVOLUMAB|TELMISARTAN,7,MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HYPERLIPIDAEMIA|PRODUCT USED FOR UNKNOWN INDICATION,Muscular weakness|Hepatic function abnormal|Myelodysplastic syndrome|Dyspnoea,4,5
10750553,20150130,Nivolumab,55,801,55.0,2,79.5,1,0,1,0,0,0,0,Nivolumab,"SODIUM PHOSPHATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PREDNISONE|PREDNISONE|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PANTOPRAZOLE|PREDNISONE|NIVOLUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|LORAZEPAM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETYLCYSTEINE|PREDNISONE|PREDNISONE|ACETYLCYSTEINE|LEVOTHYROXINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FISH OIL|FOLIC ACID|COSYNTROPIN|FENTANYL|LORAZEPAM|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ZOLPIDEM TARTRATE|FOLIC ACID|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|OXYCODONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",53,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Nausea,1,5
10750678,20150130,Nivolumab,70,801,70.0,1,77,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB|AMLODIPINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CYCLOSPORINE|GATIFLOXACIN|LOSARTAN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,10,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Acute kidney injury,1,3
10751108,20150130,Nivolumab,67,801,67.0,1,132.7,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|IPILIMUMAB|ESCITALOPRAM|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|IPILIMUMAB|FENTANYL|LISINOPRIL|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|GABAPENTIN|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|IPILIMUMAB|BACLOFEN|NIVOLUMAB|NIVOLUMAB|ATORVASTATIN CALCIUM|NIVOLUMAB|IPILIMUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB,35,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea,1,5
10751935,20150130,Nivolumab,66,801,66.0,2,,1,0,0,0,0,0,1,Nivolumab,IPILIMUMAB|NIVOLUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Lipase increased|Amylase increased,2,5
10752382,20150130,Nivolumab,53,801,53.0,1,68,1,0,1,0,0,0,0,Nivolumab,PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|NIVOLUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METRONIDAZOLE|METRONIDAZOLE TOPICAL|IPILIMUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,17,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER,Diarrhoea,1,3
10752385,20150130,Nivolumab,60,801,60.0,2,74.4,1,0,1,0,0,0,0,Nivolumab,PREDNISONE|ERGOCALCIFEROL|NIVOLUMAB|PREDNISONE|PREDNISONE|BIOTIN|PREDNISONE|MESALAMINE|ESCITALOPRAM|ESOMEPRAZOLE MAGNESIUM|MESALAMINE|IPILIMUMAB|PREDNISONE|MESALAMINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OXYCODONE HYDROCHLORIDE|PREDNISONE|PREDNISONE|ESCITALOPRAM OXALATE|ESCITALOPRAM|PREDNISONE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ESZOPICLONE|PREDNISONE|LORATADINE|LORATADINE ORAL,26,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,5
10752557,20150130,Nivolumab,60,801,60.0,2,74.4,1,0,1,0,0,0,0,Nivolumab,"ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|BIOTIN|LORATADINE|LORATADINE ORAL|CAMPHOR|MESALAMINE|PREDNISONE|PREDNISONE|MESALAMINE|PREDNISONE|ESZOPICLONE|PREDNISONE|NIVOLUMAB|IPILIMUMAB|ERGOCALCIFEROL|MENTHOL|MENTHOL, UNSPECIFIED FORM|COUGH SUPPRESSANT|MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE|AMISH ORIGINS MEDICATED|MAXIMUM STRENGTH MEDICATED FOOT POWDER|OXYCODONE HYDROCHLORIDE|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|ESCITALOPRAM OXALATE|ESCITALOPRAM|PREDNISONE|METHYLPREDNISOLONE SODIUM SUCCINATE",26,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,5
10752859,20150130,Nivolumab,60,801,60.0,2,,1,0,1,0,0,0,1,Nivolumab,LACTULOSE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|NIVOLUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|IPILIMUMAB,12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA,Nausea|Meningitis aseptic|Headache|Hepatitis,4,3
10753021,20150130,Nivolumab,80,801,80.0,2,69.1,1,0,1,0,0,0,1,Nivolumab,ZOLPIDEM TARTRATE|LOSARTAN POTASSIUM|LOSARTAN|ALPRAZOLAM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|NIVOLUMAB|LOSARTAN POTASSIUM|LOSARTAN|TEMAZEPAM|SODIUM PHOSPHATE|FISH OIL|HYDROCHLOROTHIAZIDE|ERGOCALCIFEROL|SENNOSIDES|SENNA LEAF|SENNA|METOPROLOL TARTRATE|METOPROLOL|OXYCODONE|PSYLLIUM HUSK|FOLIC ACID|MELOXICAM|PREDNISONE,21,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Autoimmune pancreatitis,1,3
10753251,20150130,Nivolumab,53,801,53.0,2,71,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,4,NEOPLASM|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea,1,3
10753477,20150131,Nivolumab,51,801,51.0,2,63.5,1,0,1,0,0,0,0,Nivolumab,METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METHYLPREDNISOLONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHYLPREDNISOLONE|METHYLPREDNISOLONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|NIVOLUMAB|IPILIMUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METHYLPREDNISOLONE|LEVOTHYROXINE,23,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pancreatitis|Autoimmune hepatitis,2,3
10756023,20150202,Nivolumab,40,801,40.0,1,,1,0,1,0,0,0,0,Nivolumab,POTASSIUM PHOSPHATE|TOBRAMYCIN|TOBRAMYCIN SULFATE|TOBRAMYCIN SOLUTION|NIVOLUMAB|MINOCYCLINE|PIMECROLIMUS|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|CLOBAZAM|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|OXYCODONE HCL,15,NON-SMALL CELL LUNG CANCER,Pneumonia,1,5
10756130,20150202,Nivolumab,71,801,71.0,2,84,1,0,1,1,0,0,0,Nivolumab,NIVOLUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MIRTAZAPINE|ALLOPURINOL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|NASAL|SALINE|(SALINE)|RIVAROXABAN|IPILIMUMAB|SIMVASTATIN|DICLOFENAC|DICLOFENAC SODIUM,19,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Acute kidney injury|Somnolence,2,3
10756390,20150202,Nivolumab,71,801,71.0,1,123,1,0,1,0,0,0,0,Nivolumab,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LEVETIRACETAM|SEVELAMER CARBONATE|LEVOTHYROXINE|TIOTROPIUM BROMIDE|CELECOXIB|BACLOFEN|PREDNISONE|MONTELUKAST|OXYGEN|0XYGEN|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|NIVOLUMAB|METOPROLOL TARTRATE|METOPROLOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Systemic inflammatory response syndrome,1,3
10756574,20150202,Nivolumab,88,801,88.0,1,76.3,1,1,1,0,0,0,1,Nivolumab,NIVOLUMAB|FLUCONAZOLE|ALLOPURINOL|BISOPROLOL FUMARATE|DICLOFENAC|DICLOFENAC SODIUM|GENTAMICIN|GENTAMICIN SULFATE,11,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Septic shock|Neutropenia,2,3
10757670,20150203,Nivolumab,47,801,47.0,1,,1,0,1,0,0,0,0,Nivolumab,FLUCONAZOLE|PREDNISONE|ACYCLOVIR|CEFTRIAXONE SODIUM|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CEFEPIME HYDROCHLORIDE|CEFEPIME|LENALIDOMIDE|MEROPENEM|TOBRAMYCIN|TOBRAMYCIN SULFATE|TOBRAMYCIN SOLUTION|NIVOLUMAB,11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HAEMATOLOGICAL MALIGNANCY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HAEMATOLOGICAL MALIGNANCY,Pyrexia,1,3
10759655,20150203,Nivolumab,73,801,73.0,1,78,1,0,1,0,0,0,0,Nivolumab,"IPILIMUMAB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|LORATADINE|LORATADINE ORAL|OXYCODONE|CEFTRIAXONE|CEFTRIAXONE SODIUM|NIVOLUMAB|RAMIPRIL",11,NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia|Infection|Sinusitis,3,5
10760523,20150204,Nivolumab,58,801,58.0,1,100.7,1,1,1,0,0,0,1,Nivolumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SENNOSIDES|SENNA LEAF|SENNA|LACTULOSE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OXYCODONE|ROSUVASTATIN|METOPROLOL TARTRATE|METOPROLOL|METHADONE|NIVOLUMAB|GENTAMICIN|GENTAMICIN SULFATE|IPILIMUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PANTOPRAZOLE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,16,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Alanine aminotransferase increased|Malignant neoplasm progression,2,3
10762354,20150204,Nivolumab,56,801,56.0,1,126,1,0,0,0,0,0,1,Nivolumab,GUAIFENESIN|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|ENOXAPARIN SODIUM|METHYLPREDNISOLONE|ALBUTEROL SULFATE|ALBUTEROL|RANITIDINE|BISOPROLOL FUMARATE|NIVOLUMAB|PREDNISONE|VORICONAZOLE|FLUCONAZOLE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|LEVOTHYROXINE SODIUM|OXYGEN|0XYGEN,23,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis,1,3
10762372,20150204,Nivolumab,52,801,52.0,1,74,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|AMOXICILLIN AND CLAVULANATE POTASSIUM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|CLARITHROMYCIN|IPILIMUMAB,8,COLON CANCER METASTATIC|COLON CANCER METASTATIC,Cough|Bronchitis,2,5
10764058,20150204,Nivolumab,54,801,54.0,1,64,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB|METHYLPREDNISOLONE|METRONIDAZOLE|METRONIDAZOLE TOPICAL,10,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea,1,3
10766306,20150205,Nivolumab,67,801,67.0,2,55,1,0,1,0,0,0,0,Nivolumab,"ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|LEVOTHYROXINE|NIVOLUMAB|LEVETIRACETAM|SPIRONOLACTONE",11,GLIOBLASTOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GLIOBLASTOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis|Confusional state,2,3
10767249,20150205,Nivolumab,,,,1,106.5,1,0,0,0,0,0,1,Nivolumab,COAL TAR|SIMVASTATIN|INDAPAMIDE|NIVOLUMAB|LOSARTAN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|AMLODIPINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|IPILIMUMAB|PREDNISOLONE ACETATE,14,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Ejaculation failure,1,3
10767974,20150205,Nivolumab,36,801,36.0,2,49,1,0,1,0,0,0,0,Nivolumab,ALPRAZOLAM|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|NIVOLUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|IPILIMUMAB,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia,1,5
10768228,20150206,Nivolumab,30,801,30.0,1,68,1,0,0,0,0,0,1,Nivolumab,TRAMETINIB|DABRAFENIB|METHYLPREDNISOLONE|ALPRAZOLAM|IPILIMUMAB|OXYCODONE|FENTANYL|NIVOLUMAB|DICLOFENAC|DICLOFENAC SODIUM|DENOSUMAB,15,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hepatitis,1,3
10768543,20150206,Nivolumab,50,801,50.0,2,60,1,1,1,1,0,0,1,Nivolumab,"PROCHLORPERAZINE|LORATADINE|LORATADINE ORAL|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL|CALCITRIOL|CALCITRIOL CAPSULES 0.25 MCG|CALCITRIOL CAPSULES 0.5 MCG|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|OXYCODONE HYDROCHLORIDE|SODIUM PHOSPHATE|BENZONATATE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|PANTOPRAZOLE|STANDARDIZED SENNA CONCENTRATE|SIMVASTATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DENOSUMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|POTASSIUM CHLORIDE|SIMETHICONE|DIMETHICONE|HYDROCODONE BITARTRATE AND ACETAMINOPHEN|POTASSIUM PHOSPHATE|LORAZEPAM|CYANOCOBALAMIN|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|NIVOLUMAB|FENTANYL|LIDOCAINE PATCH 5%|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",31,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Dyspnoea|Cellulitis|Pericardial effusion|Pleural effusion|Generalised oedema,6,5
10768570,20150206,Nivolumab,70,801,70.0,2,,1,1,0,0,0,0,0,Nivolumab,NIVOLUMAB|METHYLPREDNISOLONE|AMOXICILLIN AND CLAVULANATE POTASSIUM|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|SUFENTANIL|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,16,PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Multiple organ dysfunction syndrome,1,5
10769550,20150206,Nivolumab,35,801,35.0,2,65.3,1,0,1,0,0,0,0,Nivolumab,PANTOPRAZOLE|NIVOLUMAB|IPILIMUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OMEPRAZOLE MAGNESIUM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|PANTOPRAZOLE SODIUM,10,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Gastritis haemorrhagic,1,5
10770514,20150206,Nivolumab,48,801,48.0,2,,1,0,1,0,0,0,0,Nivolumab,PROCHLORPERAZINE MALEATE|NIVOLUMAB|IPILIMUMAB|MEMANTINE|MEMANTINE HYDROCHLORIDE|LAMOTRIGINE|SERTRALINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,7,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dehydration|Hyperthyroidism,2,5
10771607,20150206,Nivolumab,72,801,72.0,1,74,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,5,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dehydration,1,3
10771692,20150206,Nivolumab,68,801,68.0,1,84,1,0,1,0,0,0,0,Nivolumab,"IPILIMUMAB|LISINOPRIL|IRON|AMLODIPINE|TESTOSTERONE|TESTOSTERONE,|NIVOLUMAB|PANTOPRAZOLE",7,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Pancreatitis acute|Abdominal pain|Enteritis,3,3
10772043,20150206,Nivolumab,38,801,38.0,2,62,1,0,1,0,0,0,0,Nivolumab,"MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MAGNESIUM OXIDE|CETIRIZINE HYDROCHLORIDE|DROSPIRENONE AND ETHINYL ESTRADIOL|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|OXYCODONE|CELECOXIB|FOLIC ACID|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|VALACYCLOVIR HYDROCHLORIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CEFEPIME HYDROCHLORIDE|CEFEPIME|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|TRIMETHOPRIM|NIVOLUMAB|OMEPRAZOLE MAGNESIUM|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE",30,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HAEMATOLOGICAL MALIGNANCY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malaise|Cough|Pyrexia,3,3
10772044,20150206,Nivolumab,65,801,65.0,1,83,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|ENALAPRIL|NIVOLUMAB|ALLOPURINOL,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Dysuria|Transaminases increased,2,3
10772088,20150206,Nivolumab,66,801,66.0,2,52.8,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|NIVOLUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|INFLIXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CALCIUM|PANTOPRAZOLE|PROCHLORPERAZINE,14,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,3
10772244,20150206,Nivolumab,38,801,38.0,2,63.1,1,0,1,0,0,0,0,Nivolumab,"KETOCONAZOLE|KETOCONAZOLE FOAM|KETOCONAZOLE CREAM, 2%|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|NIVOLUMAB|ATOVAQUONE|ATOVAQUONE ORAL SUSPENSION|VALACYCLOVIR HYDROCHLORIDE|DROSPIRENONE AND ETHINYL ESTRADIOL|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|FOLIC ACID|VALACYCLOVIR HYDROCHLORIDE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|SIROLIMUS|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|LORATADINE|LORATADINE ORAL|CETIRIZINE HYDROCHLORIDE|CELECOXIB|OMEPRAZOLE MAGNESIUM|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LORAZEPAM",24,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HAEMATOLOGICAL MALIGNANCY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Chills|Vertigo|Vomiting,3,5
10775539,20150209,Nivolumab,,,,0,,1,0,0,0,0,0,1,Nivolumab,NIVOLUMAB,1,PLASMA CELL MYELOMA,Malignant neoplasm progression,1,1
10776000,20150209,Nivolumab,58,801,58.0,1,85,1,0,1,0,0,0,0,Nivolumab,AMLODIPINE BESYLATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|NIVOLUMAB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|SULFAMETHOXAZOLE AND TRIMETHOPRIM|DABRAFENIB,9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Autoimmune hepatitis,1,3
10776908,20150209,Nivolumab,59,801,59.0,1,92.5,1,0,1,0,0,0,0,Nivolumab,"LISINOPRIL|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|FISH OIL|SIMVASTATIN|NIVOLUMAB|IPILIMUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis|Diarrhoea,2,5
10777049,20150209,Nivolumab,72,801,72.0,2,69,1,0,1,0,0,0,0,Nivolumab,DESLORATADINE|IPILIMUMAB|NIVOLUMAB|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE,11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Confusional state,1,3
10777181,20150209,Nivolumab,68,801,68.0,1,133,1,0,1,0,0,0,0,Nivolumab,AMLODIPINE BESYLATE|IPRATROPIUM BROMIDE AND ALBUTEROL|ALPRAZOLAM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|INSULIN GLULISINE|MAGNESIUM OXIDE|RIVAROXABAN|NIVOLUMAB|PIOGLITAZONE|INSULIN GLARGINE|CARVEDILOL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM|AMLODIPINE AND ATORVASTATIN|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE,20,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Gait disturbance|Vestibular disorder,2,5
10777286,20150209,Nivolumab,56,801,56.0,1,78.5,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|LANSOPRAZOLE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|NIVOLUMAB|PEPPERMINT|METHYLPREDNISOLONE|SERTRALINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|INFLIXIMAB|NAPROXEN|NAPROXEN SODIUM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,23,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,5
10778077,20150209,Nivolumab,74,801,74.0,1,60,1,1,1,1,0,0,0,Nivolumab,"LEVOTHYROXINE SODIUM|ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE|METOPROLOL TARTRATE|METOPROLOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|FOLIC ACID|PRAVASTATIN SODIUM|ZOLPIDEM TARTRATE|NIVOLUMAB|AMLODIPINE",17,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Small intestinal obstruction|Pneumonia|Respiratory failure,3,5
10778458,20150209,Nivolumab,55,801,55.0,1,62,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|CANDESARTAN CILEXETIL|FEXOFENADINE HCL|NIVOLUMAB|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|PANTOPRAZOLE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,8,MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,5
10778468,20150209,Nivolumab,66,801,66.0,1,105.3,1,0,1,0,0,0,1,Nivolumab,"ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE|NIVOLUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|NIACIN|DIPHENHYDRAMINE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PROCHLORPERAZINE|PREDNISONE|INDOMETHACIN|BENZONATATE|FENOFIBRATE|ROSUVASTATIN|VALSARTAN|VALSARTAN ORAL",18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|HYPERSENSITIVITY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NASOPHARYNGITIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Tubulointerstitial nephritis,1,5
10778932,20150210,Nivolumab,66,801,66.0,1,,1,1,0,0,0,0,0,Nivolumab,NIVOLUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA,C-reactive protein increased|Pneumonia aspiration|Nausea,3,5
10782687,20150210,Nivolumab,63,801,63.0,1,85,1,0,1,0,0,0,0,Nivolumab,HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|IPILIMUMAB|LEVOTHYROXINE|PREDNISONE|PANTOPRAZOLE|NIVOLUMAB|GENTAMICIN|GENTAMICIN SULFATE|CEFUROXIME,8,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea,1,3
10783894,20150210,Nivolumab,82,801,82.0,1,63,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|IPILIMUMAB|NIVOLUMAB|PREDNISONE|METHYLPREDNISOLONE,5,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Acute kidney injury,1,5
10784169,20150211,Nivolumab,75,801,75.0,1,,1,1,1,0,0,0,0,Nivolumab,NIVOLUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA,Herpes zoster|Malignant neoplasm progression,2,5
10784254,20150211,Nivolumab,,,,0,,1,0,0,0,0,0,1,Nivolumab,NIVOLUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Accidental exposure to product|Wound,2,1
10785779,20150210,Nivolumab,61,801,61.0,1,88,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB,1,MALIGNANT MELANOMA,Incoherent|Confusional state|Gait disturbance,3,3
10785878,20150211,Nivolumab,61,801,61.0,1,83,1,0,1,0,0,0,0,Nivolumab,"FERRIC OXIDE RED, ZINC OXIDE, AND PRAMOXINE HYDROCHLORIDE|IPILIMUMAB|NIVOLUMAB|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|LEVOTHYROXINE",19,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypothyroidism|Colitis|Nephropathy toxic|Pyrexia|Confusional state,5,5
10786325,20150211,Nivolumab,59,801,59.0,1,112,1,0,0,0,0,0,1,Nivolumab,"LISINOPRIL|NIVOLUMAB|ALBUTEROL SULFATE|LOSARTAN POTASSIUM|DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN|DEXTROMETHORPHAN|ACETAMINOPHEN AND DEXTROMETHORPHAN HYDROBROMIDE|ROSUVASTATIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|IPILIMUMAB|TROPICAMIDE",16,PRODUCT USED FOR UNKNOWN INDICATION|ADENOCARCINOMA|COUGH|PRODUCT USED FOR UNKNOWN INDICATION|WHEEZING|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ADENOCARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BACK PAIN|PRODUCT USED FOR UNKNOWN INDICATION,Radiation necrosis,1,3
10786448,20150211,Nivolumab,81,801,81.0,1,81,1,0,1,0,0,0,1,Nivolumab,METHYLPREDNISOLONE|SIMVASTATIN|NIVOLUMAB|IPILIMUMAB,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Hyperthyroidism|Colitis|Aspartate aminotransferase increased,4,5
10787289,20150211,Nivolumab,40,801,40.0,2,78,1,0,1,0,0,0,0,Nivolumab,LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|LORAZEPAM|NIVOLUMAB,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GLIOBLASTOMA,Seizure|Tumour haemorrhage,2,5
10787420,20150212,Nivolumab,56,801,56.0,2,73,1,0,1,0,0,0,0,Nivolumab,PANTOPRAZOLE SODIUM|LEVETIRACETAM|NIVOLUMAB|POLYETHYLENE GLYCOL 3350|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GLIOBLASTOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Seizure,1,3
10790402,20150212,Nivolumab,56,801,56.0,2,73,1,0,1,0,0,0,0,Nivolumab,POLYETHYLENE GLYCOL 3350|LEVETIRACETAM|PANTOPRAZOLE SODIUM|NIVOLUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GLIOBLASTOMA|PRODUCT USED FOR UNKNOWN INDICATION,Seizure,1,5
10791951,20150213,Nivolumab,68,801,68.0,1,106,1,0,1,0,0,0,0,Nivolumab,"OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|IPILIMUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|NIVOLUMAB|POLYETHYLENE GLYCOL 3350|ZOLPIDEM TARTRATE",12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia,1,3
10793340,20150213,Nivolumab,65,801,65.0,1,44,1,1,0,0,0,0,1,Nivolumab,NIVOLUMAB,1,GASTRIC CANCER,Death,1,3
10793709,20150213,Nivolumab,53,801,53.0,1,64,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GASTRIC CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Decreased appetite,1,5
10794033,20150213,Nivolumab,,,,0,,1,0,0,0,0,0,1,Nivolumab,NIVOLUMAB|IPILIMUMAB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Musculoskeletal disorder,1,1
10795802,20150215,Nivolumab,76,801,76.0,1,89,1,1,1,0,0,0,1,Nivolumab,ALISKIREN HEMIFUMARATE|NIVOLUMAB|RIVAROXABAN,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Hepatotoxicity,2,3
10795843,20150216,Nivolumab,67,801,67.0,2,72,1,0,1,0,0,0,0,Nivolumab,ERGOCALCIFEROL|NIVOLUMAB|METHYLPREDNISOLONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METRONIDAZOLE|PREDNISONE,11,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypokalaemia|Pseudarthrosis|Colitis,3,5
10796247,20150216,Nivolumab,40,801,40.0,2,56.7,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|PREDNISONE|IPILIMUMAB|CLONAZEPAM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SERTRALINE,8,METASTATIC MALIGNANT MELANOMA|COLITIS|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Autoimmune arthritis|Colitis,2,5
10798758,20150216,Nivolumab,68,801,68.0,1,,1,0,0,0,0,0,0,Nivolumab,NIVOLUMAB,1,MALIGNANT MELANOMA,Oesophageal ulcer,1,5
10800671,20150216,Nivolumab,74,801,74.0,2,,1,0,0,0,0,0,1,Nivolumab,NIVOLUMAB|VALSARTAN|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|WARFARIN|NIVOLUMAB|NIVOLUMAB|ROSUVASTATIN,18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Myasthenia gravis|Hepatic function abnormal,2,1
10800923,20150216,Nivolumab,66,801,66.0,2,55,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|ERGOCALCIFEROL|NIVOLUMAB|CALCIUM,15,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hepatic enzyme increased,1,5
10801248,20150217,Nivolumab,70,801,70.0,2,,1,0,0,0,0,0,1,Nivolumab,NIVOLUMAB,1,MALIGNANT MELANOMA,Haemoglobin decreased,1,5
10801616,20150217,Nivolumab,68,801,68.0,1,62,1,1,1,1,1,1,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB,15,Malignant melanoma|Product used for unknown indication,Malignant neoplasm progression|Bursitis|Anaemia|Blood alkaline phosphatase increased|Gamma-glutamyltransferase increased|C-reactive protein increased|Blood bilirubin increased|White blood cell count increased|Off label use,9,1
10802045,20150217,Nivolumab,75,801,75.0,1,98,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|PREDNISONE,4,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis,1,5
10802109,20150217,Nivolumab,,,,1,90,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|LANSOPRAZOLE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|ATENOLOL|NAPROXEN|NAPROXEN SODIUM|AMLODIPINE,11,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Peripheral motor neuropathy,1,5
10803454,20150217,Nivolumab,71,801,71.0,2,85.3,1,0,1,0,0,0,0,Nivolumab,SPIRONOLACTONE|FUROSEMIDE|NIVOLUMAB|IPILIMUMAB,9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Colitis|Diarrhoea,2,3
10825816,20150219,Nivolumab,64,801,64.0,1,,1,0,1,0,0,0,0,Nivolumab,"CLONAZEPAM|DOXAZOSIN|DOXAZOSIN MESYLATE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|PANTOPRAZOLE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|IPILIMUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|NIVOLUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PROCHLORPERAZINE|LEVOTHYROXINE",15,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypopituitarism|Adrenal insufficiency|Pneumonia|Hypophysitis,4,3
10828062,20150219,Nivolumab,78,801,78.0,1,66,1,1,1,0,0,0,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|FUROSEMIDE|TOLVAPTAN|NIVOLUMAB|NIVOLUMAB|RIVAROXABAN,16,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|TYPE 2 DIABETES MELLITUS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Hypothyroidism|Cardiac failure|Off label use,4,3
10835427,20150219,Nivolumab,66,801,66.0,1,96.5,1,1,1,0,0,0,0,Nivolumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|NIVOLUMAB|OXYGEN|0XYGEN|CEFTRIAXONE|CEFTRIAXONE SODIUM,4,PRODUCT USED FOR UNKNOWN INDICATION|DIFFUSE LARGE B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia|Malignant neoplasm progression,2,5
10836063,20150219,Nivolumab,71,801,71.0,1,77.6,1,0,1,0,0,0,0,Nivolumab,LORAZEPAM|NIVOLUMAB|IPILIMUMAB|SIMVASTATIN|LISINOPRIL|NIFEDIPINE,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia,1,5
10837699,20150219,Nivolumab,78,801,78.0,1,,1,0,0,0,0,0,0,Nivolumab,NIVOLUMAB,1,METASTATIC MALIGNANT MELANOMA,Burning sensation|Arthralgia,2,5
10841324,20150220,Nivolumab,72,801,72.0,1,75,1,0,1,0,0,0,0,Nivolumab,LEVOTHYROXINE SODIUM|AMLODIPINE|SIMVASTATIN|PREDNISONE|AMOXICILLIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FENTANYL|PANTOPRAZOLE SODIUM|NIVOLUMAB|IPILIMUMAB|LISINOPRIL,15,PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Rash maculo-papular,1,5
10844776,20150220,Nivolumab,49,801,49.0,1,,1,1,1,0,0,0,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|NIVOLUMAB,3,MALIGNANT MELANOMA,Aspartate aminotransferase increased|Blood alkaline phosphatase increased|Malignant neoplasm progression|Haemoglobin decreased|Alanine aminotransferase increased|Gamma-glutamyltransferase increased,6,5
10844848,20150220,Nivolumab,63,801,63.0,2,,1,0,0,0,0,0,0,Nivolumab,NIVOLUMAB,2,MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Hypothyroidism,1,5
10846868,20150220,Nivolumab,64,801,64.0,1,58,1,1,1,0,0,0,1,Nivolumab,LEVOTHYROXINE|OXYCODONE|PANTOPRAZOLE|FLUCONAZOLE|NIVOLUMAB|PREDNISONE|CEFTAZIDIME|IPILIMUMAB|FENTANYL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHYLPREDNISOLONE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS,17,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ADENOCARCINOMA GASTRIC|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ADENOCARCINOMA GASTRIC|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Histiocytosis haematophagic|Pyrexia,3,3
10846983,20150220,Nivolumab,37,801,37.0,1,84.6,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|NIVOLUMAB|METHYLPREDNISOLONE|ALPRAZOLAM,19,COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Meningitis,1,3
10847238,20150220,Nivolumab,0,804,0.0,2,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB|LEVOTHYROXINE SODIUM|ALPRAZOLAM|OXYCODONE|TRIAMCINOLONE ACETONIDE,13,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ANXIETY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Radiation necrosis,1,3
10847290,20150220,Nivolumab,49,801,49.0,2,,1,0,1,0,0,0,0,Nivolumab,SODIUM HYALURONATE|CIMETIDINE|FLUOROMETHOLONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|NIVOLUMAB|PREDNISONE,6,EYE PAIN|PRODUCT USED FOR UNKNOWN INDICATION|EYE PAIN|EYE PAIN|ADENOID CYSTIC CARCINOMA OF SALIVARY GLAND|PRODUCT USED FOR UNKNOWN INDICATION,Brain neoplasm,1,3
10847360,20150220,Nivolumab,64,801,64.0,1,121,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|LORAZEPAM|DEXLANSOPRAZOLE|GRANISETRON|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|BUPROPION HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|LEVOTHYROXINE SODIUM|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|VILAZODONE HYDROCHLORIDE|FOLIC ACID|POLYETHYLENE GLYCOL 3350|IBUPROFEN|IBUPROFEN AND DIPHENHYDRAMINE CITRATE|GABAPENTIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LORATADINE|LORATADINE TABLET,23,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CONSTIPATION|HEADACHE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia|Cough,2,3
10849593,20150221,Nivolumab,,,,1,,1,1,0,0,0,0,0,Nivolumab,NIVOLUMAB,1,MALIGNANT MELANOMA,Malignant neoplasm progression,1,5
10852854,20150223,Nivolumab,72,801,72.0,1,,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Dyspnoea,1,5
10861905,20150224,Nivolumab,79,801,79.0,1,89.6,1,0,1,0,0,0,1,Nivolumab,ALLOPURINOL|AMLODIPINE|CARVEDILOL|INSULIN LISPRO|ERGOCALCIFEROL|LISINOPRIL|NIVOLUMAB|LORAZEPAM|IPILIMUMAB,11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Acidosis|Pancreatitis,2,5
10868351,20150225,Nivolumab,60,801,60.0,2,,1,0,1,0,0,0,0,Nivolumab,"SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|MIRTAZAPINE|METRONIDAZOLE|ALPRAZOLAM|NIVOLUMAB|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,",12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Chills,1,3
10869043,20150225,Nivolumab,48,801,48.0,1,81.5,1,0,1,0,0,0,1,Nivolumab,METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE|NIVOLUMAB|IPILIMUMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|METHYLPREDNISOLONE|FAMOTIDINE,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia|Transaminases increased,2,3
10872407,20150226,Nivolumab,54,801,54.0,2,44.5,1,0,1,0,0,0,0,Nivolumab,DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|NIVOLUMAB|LEVOTHYROXINE|IPILIMUMAB|MAGNESIUM OXIDE,9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypoxia,1,5
10872416,20150226,Nivolumab,37,801,37.0,1,98,1,0,1,0,0,0,1,Nivolumab,"AMOXICILLIN AND CLAVULANATE POTASSIUM|TOLTERODINE TARTRATE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|NIVOLUMAB|PREDNISONE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|NIVOLUMAB|CEFEPIME HYDROCHLORIDE|CEFEPIME|METHYLPREDNISOLONE SODIUM SUCCINATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE",15,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Cough,2,3
10872636,20150227,Nivolumab,66,801,66.0,2,69.4,1,0,1,0,0,0,0,Nivolumab,LEVOTHYROXINE SODIUM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|NIVOLUMAB,11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Polymyalgia rheumatica|Non-cardiac chest pain,2,5
10873923,20150227,Nivolumab,82,801,82.0,1,,1,1,0,0,0,0,1,Nivolumab,NIVOLUMAB,1,MALIGNANT MELANOMA,Malignant neoplasm progression|Hepatic rupture,2,5
10874356,20150227,Nivolumab,65,801,65.0,1,62.4,1,0,1,0,0,0,1,Nivolumab,"OXYCODONE HYDROCHLORIDE|NIVOLUMAB|TIOTROPIUM BROMIDE|ALPRAZOLAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FENTANYL|ALPRAZOLAM|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|PREGABALIN|POLYETHYLENE GLYCOL 3350|OXYCODONE",20,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|WHEEZING|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|ANXIETY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Ileus|Nausea|Abdominal pain|Vomiting|Mental status changes|Femoral neck fracture,6,3
10874679,20150227,Nivolumab,62,801,62.0,2,104.8,1,0,1,1,0,0,1,Nivolumab,DIPHENHYDRAMINE HYDROCHLORIDE|ESCITALOPRAM|NEBIVOLOL HYDROCHLORIDE|EPINEPHRINE|ADRENALINUM|IPILIMUMAB|NIVOLUMAB|ALBUTEROL SULFATE|RIZATRIPTAN BENZOATE|HYDROCORTISONE SODIUM SUCCINATE|VALSARTAN,14,PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION,Diabetic ketoacidosis,1,5
10874718,20150227,Nivolumab,54,801,54.0,1,176.5,1,0,1,0,0,0,1,Nivolumab,"HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PROCHLORPERAZINE|LEVOTHYROXINE|OXYCODONE|IPILIMUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|FUROSEMIDE|ALPRAZOLAM|NIVOLUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",16,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Systemic inflammatory response syndrome,1,3
10874809,20150227,Nivolumab,63,801,63.0,1,82,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|ROPINIROLE|IPILIMUMAB|CARBIDOPA AND LEVODOPA,7,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dermatomyositis,1,3
10876735,20150302,Nivolumab,,,,2,,1,0,0,0,0,0,0,Nivolumab,NIVOLUMAB,1,NON-SMALL CELL LUNG CANCER,Hypothyroidism,1,1
10880359,20150302,Nivolumab,56,801,56.0,1,,1,0,0,0,0,0,0,Nivolumab,NIVOLUMAB,1,RENAL CELL CARCINOMA,Arthralgia|Bone pain,2,1
10883637,20150303,Nivolumab,39,801,39.0,1,60,1,0,0,0,0,0,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB,6,MALIGNANT MELANOMA,Pyrexia|Asteatosis|Pruritus|Conjunctivitis|Malignant neoplasm progression|Vitiligo|Off label use,7,1
10883639,20150303,Nivolumab,75,801,75.0,2,70,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|NIVOLUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|BISOPROLOL FUMARATE,12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Renal failure,1,3
10883645,20150303,Nivolumab,66,801,66.0,1,87,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,2,NEOPLASM|NEOPLASM,Hyperbilirubinaemia,1,5
10883881,20150304,Nivolumab,54,801,54.0,2,,1,1,1,0,0,0,1,Nivolumab,LIDOCAINE PATCH 5%|MORPHINE|LACTULOSE|IPILIMUMAB|CITALOPRAM|CITALOPRAM HYDROBROMIDE|GABAPENTIN|CYANOCOBALAMIN|ROPINIROLE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|OXYCODONE|NIVOLUMAB|ZINC|ZINC GLUCONATE|ZINC CHLORIDE|ZOLPIDEM TARTRATE|BACLOFEN|CLONAZEPAM,18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pericardial effusion|Transaminases increased|Malignant neoplasm progression,3,3
10883936,20150304,Nivolumab,46,801,46.0,1,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Diarrhoea|Gastritis|Pyrexia|Rash maculo-papular|Nephritis|Adrenal insufficiency|Uveitis|Headache,8,3
10885761,20150304,Nivolumab,79,801,79.0,2,80,1,0,1,0,0,0,0,Nivolumab,METRONIDAZOLE|OLANZAPINE|OLANZAPINE PAMOATE|NIVOLUMAB|IPILIMUMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|NIVOLUMAB|PANTOPRAZOLE SODIUM|IPILIMUMAB|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|NIVOLUMAB|IPILIMUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|DULOXETINE HYDROCHLORIDE|LEVOTHYROXINE SODIUM|ZINC OXIDE|PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/LIGHT|ZINC OXIDE OINTMENT|PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/TAN|SKIN PROTECTANT|PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 NATURAL/MEDIUM|PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 COOL/DEEP|MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN|OXYCODONE,28,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RASH|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|DRY SKIN|PRODUCT USED FOR UNKNOWN INDICATION,Lung infiltration|Pyrexia|Diarrhoea,3,3
10885851,20150304,Nivolumab,57,801,57.0,1,73.5,1,0,1,0,0,0,0,Nivolumab,PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METOCLOPRAMIDE HYDROCHLORIDE|IPILIMUMAB|OXYCODONE|NIVOLUMAB|OMEPRAZOLE MAGNESIUM|LIDOCAINE PATCH 5%|METHIMAZOLE,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Fatigue|Blood bilirubin increased|Thyroiditis,3,3
10888176,20150304,Nivolumab,72,801,72.0,1,53,1,1,1,0,0,0,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|CEFEPIME HYDROCHLORIDE|NIVOLUMAB,7,MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Thyroiditis|Pneumonia bacterial|Adrenocorticotropic hormone deficiency|Off label use|Prescribed underdose|Malignant neoplasm progression|Secondary adrenocortical insufficiency,7,1
10888298,20150304,Nivolumab,44,801,44.0,1,,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Nausea|Colitis|Vomiting|Enterocolitis infectious,4,3
10888723,20150305,Nivolumab,55,801,55.0,2,,1,1,0,1,0,0,0,Nivolumab,NIVOLUMAB,2,MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Aspartate aminotransferase increased|Blood lactate dehydrogenase increased|Hepatic function abnormal|Pyrexia|Anaemia|Alanine aminotransferase increased|Malignant neoplasm progression|Pain|Hypothyroidism,9,5
10888852,20150305,Nivolumab,29,801,29.0,1,,1,1,1,0,0,0,1,Nivolumab,NIVOLUMAB|NIVOLUMAB,2,MALIGNANT MELANOMA,Aspartate aminotransferase increased|Respiratory failure|Malignant neoplasm progression|Hepatic pain|Alanine aminotransferase increased,5,5
10889663,20150305,Nivolumab,61,801,61.0,1,75.5,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|PANTOPRAZOLE|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FOLIC ACID|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|TEMAZEPAM|AMOXICILLIN AND CLAVULANATE POTASSIUM|CALCIUM|PROCHLORPERAZINE|PREDNISONE|METHYLPREDNISOLONE SODIUM SUCCINATE,20,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis,1,5
10890828,20150305,Nivolumab,70,801,70.0,1,,1,1,0,0,0,0,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|NIVOLUMAB,3,MALIGNANT MELANOMA,Angina pectoris|Alanine aminotransferase increased|Aspartate aminotransferase increased|Blood alkaline phosphatase increased|Malignant neoplasm progression|Gamma-glutamyltransferase increased,6,5
10892157,20150306,Nivolumab,37,801,37.0,1,,1,1,0,0,0,0,1,Nivolumab,NIVOLUMAB,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA,Brain oedema|Malignant neoplasm progression|Hypothyroidism|Hepatic function abnormal,4,5
10892899,20150306,Nivolumab,62,801,62.0,2,,1,1,0,0,0,0,1,Nivolumab,LEVETIRACETAM|NIVOLUMAB,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Embolism|Blood alkaline phosphatase increased|Malignant neoplasm progression|Aspartate aminotransferase increased|Gamma-glutamyltransferase increased|Alanine aminotransferase increased|Erythema multiforme|Dysgeusia,8,5
10893000,20150306,Nivolumab,71,801,71.0,1,,1,1,1,0,0,0,0,Nivolumab,NIVOLUMAB,2,PYREXIA|MALIGNANT MELANOMA,Thyroid disorder|Blood alkaline phosphatase increased|Aspartate aminotransferase increased|Gamma-glutamyltransferase increased|Alanine aminotransferase increased|Pleural effusion|Malignant neoplasm progression,7,5
10893744,20150306,Nivolumab,67,801,67.0,1,,1,0,0,0,0,0,1,Nivolumab,NIVOLUMAB,1,MALIGNANT MELANOMA,Oesophageal ulcer,1,5
10893749,20150306,Nivolumab,51,801,51.0,1,89,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB|IPILIMUMAB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pyrexia|Chills|Diarrhoea|Colitis,4,5
10895920,20150307,Nivolumab,50,801,50.0,1,,1,0,1,0,0,0,0,Nivolumab,METOPROLOL TARTRATE|METOPROLOL|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|IPILIMUMAB|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|NIVOLUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PROMETHAZINE|LORAZEPAM|NAPROXEN|NAPROXEN SODIUM,14,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Hypokalaemia|Dehydration,3,5
10896210,20150309,Nivolumab,78,801,78.0,2,,1,1,1,0,0,0,1,Nivolumab,NIVOLUMAB,2,MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Hepatic function abnormal|Myopathy|Myositis|Thyroid function test abnormal|Blood potassium decreased|Malignant melanoma|Rhabdomyolysis,7,5
10896301,20150309,Nivolumab,74,801,74.0,2,,1,0,1,1,0,0,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|DENOSUMAB|NIVOLUMAB|NIVOLUMAB,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Interstitial lung disease|Off label use|Acute respiratory distress syndrome,3,3
10901403,20150310,Nivolumab,67,801,67.0,1,75,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|NIVOLUMAB|ERYTHROMYCIN|METHYLPREDNISOLONE,6,NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonia aspiration|Nausea,2,5
10902027,20150310,Nivolumab,,,,1,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Sepsis,1,5
10903234,20150311,Nivolumab,,,,2,,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Vomiting|Nausea,2,3
10904764,20150311,Nivolumab,42,801,42.0,1,,1,1,1,1,0,0,1,Nivolumab,"MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|NIVOLUMAB|MORPHINE|IRON|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|LEVOTHYROXINE SODIUM|ALTEPLASE|LORAZEPAM|DIPHENHYDRAMINE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|PANTOPRAZOLE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METHYLPHENIDATE HYDROCHLORIDE|FOLIC ACID|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|MORPHINE SULFATE",25,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonia|Respiratory failure|Malignant neoplasm progression,3,3
10904765,20150311,Nivolumab,,,,0,,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB|NIVOLUMAB|IPILIMUMAB,4,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pyrexia,1,5
10905437,20150311,Nivolumab,42,801,42.0,2,55,1,1,1,0,0,0,0,Nivolumab,"RANITIDINE|MORPHINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|NIVOLUMAB|CHLORPROMAZINE|GLYCERIN SUPPOSITORY|KETOPROFEN|SCOPOLAMINE|HALOPERIDOL|HALOPERIDOL LACTATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Transaminases increased|Blood creatinine increased|Respiratory failure,3,5
10906175,20150311,Nivolumab,85,801,85.0,2,44,1,0,1,0,0,0,1,Nivolumab,PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|AMLODIPINE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|NIVOLUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,14,PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Bile duct stenosis|Cholangitis|Autoimmune haemolytic anaemia|Uveitis|Deafness neurosensory|Biliary stent placement|Tubulointerstitial nephritis|Transfusion,8,1
10906374,20150312,Nivolumab,69,801,69.0,2,,1,1,0,0,0,0,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB,7,MALIGNANT MELANOMA,Platelet count decreased|Malignant neoplasm progression|Underdose|Pancytopenia,4,5
10906375,20150312,Nivolumab,68,801,68.0,1,105.8,1,0,1,0,0,0,0,Nivolumab,"NIVOLUMAB|NIVOLUMAB|IPILIMUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|OMEPRAZOLE MAGNESIUM|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL|ZOLPIDEM TARTRATE|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|IPILIMUMAB|NIVOLUMAB|NIVOLUMAB|IPILIMUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|BRIMONIDINE TARTRATE, TIMOLOL MALEATE|VENLAFAXINE HYDROCHLORIDE|POLYETHYLENE GLYCOL 3350|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|BIMATOPROST|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|IPILIMUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|PANTOPRAZOLE",44,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Duodenal ulcer|Hypotension|Pyrexia|Muscular weakness|Hypopituitarism,5,3
10911397,20150313,Nivolumab,62,801,62.0,1,80,1,0,1,0,0,0,0,Nivolumab,METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|MEROPENEM|FENTANYL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|AMPICILLIN|AMPICILLIN SODIUM|AMPICILLIN INJECTION|IPILIMUMAB|NIVOLUMAB|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN,12,PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|NEOPLASM|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION,Meningitis aseptic,1,3
10913940,20150313,Nivolumab,50,801,50.0,1,62,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|NIVOLUMAB|PANTOPRAZOLE|ERGOCALCIFEROL,9,GLIOBLASTOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GLIOBLASTOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis|Diarrhoea,2,3
10914002,20150313,Nivolumab,72,801,72.0,1,,1,0,1,0,0,0,1,Nivolumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|NIVOLUMAB|CALCIUM GLUCONATE|RANITIDINE,5,PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypersensitivity,1,3
10915325,20150316,Nivolumab,50,801,50.0,2,109,1,1,0,0,0,0,1,Nivolumab,OXYCODONE HYDROCHLORIDE|NIVOLUMAB,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Coagulopathy|Malignant neoplasm progression,2,3
10915393,20150316,Nivolumab,53,801,53.0,1,110.5,1,0,1,0,0,0,0,Nivolumab,LISINOPRIL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ENOXAPARIN SODIUM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|PROCHLORPERAZINE|NIVOLUMAB|IPILIMUMAB|ATENOLOL|LORAZEPAM,15,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Vision blurred,1,3
10915715,20150316,Nivolumab,6,800,60.0,1,,1,0,0,0,0,0,0,Nivolumab,NIVOLUMAB,1,MALIGNANT MELANOMA,Rash,1,1
10916461,20150316,Nivolumab,,,,0,,1,0,0,0,0,0,0,Nivolumab,NIVOLUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia,1,1
10918932,20150316,Nivolumab,74,801,74.0,1,,1,1,1,0,0,0,0,Nivolumab,NIVOLUMAB|NIVOLUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|NIVOLUMAB,4,MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Pleural effusion|Malignant neoplasm progression,2,5
10919499,20150316,Nivolumab,79,801,79.0,1,,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Hyponatraemia,1,5
10920493,20150317,Nivolumab,52,801,52.0,2,62.1,1,1,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|MORPHINE,6,NEOPLASM|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Autoimmune thyroiditis|Ascites|Malignant neoplasm progression|Abdominal pain,4,5
10920988,20150317,Nivolumab,6,800,60.0,0,,1,0,0,0,0,0,0,Nivolumab,NIVOLUMAB,1,LUNG NEOPLASM MALIGNANT,Pyrexia,1,3
10921306,20150317,Nivolumab,,,,1,,1,1,0,0,0,0,0,Nivolumab,NIVOLUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10922299,20150317,Nivolumab,63,801,63.0,2,,1,1,0,0,0,0,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|NIVOLUMAB,3,MALIGNANT MELANOMA,Alanine aminotransferase increased|Aspartate aminotransferase increased|Acute kidney injury|Malignant neoplasm progression,4,5
10925238,20150318,Nivolumab,59,801,59.0,2,120,1,1,1,0,0,0,1,Nivolumab,IPILIMUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|NIVOLUMAB|SIMVASTATIN|NIVOLUMAB|ALPRAZOLAM|NIVOLUMAB,16,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Gamma-glutamyltransferase increased|C-reactive protein increased|Cholestasis|Cholangitis|Gastrointestinal toxicity|Malignant neoplasm progression|Jaundice cholestatic|Hepatocellular injury,8,5
10925668,20150318,Nivolumab,56,801,56.0,1,,1,1,1,0,0,0,1,Nivolumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|NIVOLUMAB|MOMETASONE FUROATE|MOMETASONE|FAMOTIDINE|NIVOLUMAB|ZOLPIDEM TARTRATE|NIVOLUMAB|NIVOLUMAB|TRANEXAMIC ACID|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|MONTELUKAST SODIUM|MONTELUKAST,18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Transfusion|Hepatic function abnormal|Epistaxis|Malignant neoplasm progression|Platelet count decreased|Thyroxine free decreased,6,5
10926406,20150318,Nivolumab,77,801,77.0,1,101.7,1,0,1,0,0,0,1,Nivolumab,"VALSARTAN AND HYDROCHLOROTHIAZIDE|WARFARIN|AMLODIPINE BESYLATE|NEBIVOLOL HYDROCHLORIDE|CAMPHOR AND MENTHOL|PRAMOXINE HYDROCHLORIDE|COLLOIDAL OATMEAL|PRAMOXINE HYDROCHLORIDE, MENTHOL|FOLIC ACID|NIVOLUMAB",9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RENAL CELL CARCINOMA,Organising pneumonia|Deep vein thrombosis,2,3
10926900,20150318,Nivolumab,41,801,41.0,2,55,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB,1,MALIGNANT MELANOMA,Colitis|Hypophysitis,2,1
10927687,20150319,Nivolumab,69,801,69.0,1,90,1,1,1,0,0,0,0,Nivolumab,CEFTRIAXONE|CEFTRIAXONE SODIUM|METHYLPREDNISOLONE|NIVOLUMAB,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression|Dyspnoea at rest|Lymphangiosis carcinomatosa,3,5
10931517,20150319,Nivolumab,80,801,80.0,1,55,1,1,1,1,1,1,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|OSELTAMIVIR PHOSPHATE|INSULIN LISPRO|ROSUVASTATIN|FUROSEMIDE|SPIRONOLACTONE|ALLOPURINOL|ISOSORBIDE DINITRATE,29,Malignant melanoma|Product used for unknown indication|Oral candidiasis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Autoimmune colitis|C-reactive protein increased|Hepatic enzyme increased|Influenza|Off label use,5,3
10932032,20150319,Nivolumab,63,801,63.0,2,53,1,1,1,1,1,1,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|INSULIN GLARGINE|INSULIN DEGLUDEC|LIRAGLUTIDE|LIRAGLUTIDE|LIRAGLUTIDE|LIRAGLUTIDE|LIRAGLUTIDE,21,Malignant melanoma|Fulminant type 1 diabetes mellitus|Fulminant type 1 diabetes mellitus|Fulminant type 1 diabetes mellitus|Metastases to spine|Product used for unknown indication,Fulminant type 1 diabetes mellitus|Malignant neoplasm progression|Liver disorder|Leukoderma|Off label use,5,1
10933034,20150320,Nivolumab,74,801,74.0,1,56,1,0,1,0,1,0,1,Nivolumab,MONTELUKAST SODIUM|MONTELUKAST|SITAGLIPTIN|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|NIVOLUMAB|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|NIVOLUMAB|FUROSEMIDE|GLIMEPIRIDE,18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION,Metastases to skin|Cough|Hypoxia|Blood glucose increased|Pleural effusion|Pyrexia|Respiratory failure|Cardiac failure acute|Hypertension|Cardiac hypertrophy|Eosinophil count increased|Lung disorder|Pulmonary oedema,13,5
10935301,20150320,Nivolumab,57,801,57.0,2,,1,0,1,0,0,0,1,Nivolumab,IPILIMUMAB|PANTOPRAZOLE SODIUM|LORAZEPAM|NIVOLUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM|PROPRANOLOL HYDROCHLORIDE,9,NON-SMALL CELL LUNG CANCER|CANCER PAIN|PRODUCT USED FOR UNKNOWN INDICATION|ANXIETY|NAUSEA|NON-SMALL CELL LUNG CANCER|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Petechiae|Diarrhoea|Urinary tract infection|Pneumonia|Pyrexia,5,5
10944071,20150323,Nivolumab,71,801,71.0,2,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB,1,MALIGNANT MELANOMA,Glomerulonephritis minimal lesion|Hypothyroidism|Photophobia|Alopecia|Leukoderma,5,1
10944112,20150323,Nivolumab,64,801,64.0,1,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Hyperthyroidism,1,5
10946373,20150323,Nivolumab,74,801,74.0,2,,1,1,1,1,0,0,1,Nivolumab,MESALAMINE|NIVOLUMAB|NIVOLUMAB|OXYCODONE HYDROCHLORIDE|OLANZAPINE|OLANZAPINE PAMOATE|PREGABALIN|NIVOLUMAB|KETOPROFEN,18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Melaena|Metastasis|Vomiting|Blood thyroid stimulating hormone increased|Malignant neoplasm progression|Dehydration|Blood lactate dehydrogenase increased|Tri-iodothyronine free decreased|Decreased appetite,9,5
10949258,20150324,Nivolumab,87,801,87.0,1,67,1,0,1,0,0,0,1,Nivolumab,"IPILIMUMAB|POLYETHYLENE GLYCOL 3350|IPILIMUMAB|FUROSEMIDE|FUROSEMIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|IPILIMUMAB|ATORVASTATIN CALCIUM|NIVOLUMAB|NIVOLUMAB|METOPROLOL TARTRATE|METOPROLOL TARTRATE|FINASTERIDE|PANTOPRAZOLE SODIUM|SENNOSIDES|SENNA LAXATIVE|SENNOSIDES 8.6 MG|NIVOLUMAB|FERROUS SULFATE|METOPROLOL TARTRATE|METOPROLOL",22,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|OEDEMA PERIPHERAL|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Back pain|Blood creatinine increased,3,3
10952174,20150325,Nivolumab,,,,0,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,2,HAEMATOLOGICAL MALIGNANCY|HAEMATOLOGICAL MALIGNANCY,Diarrhoea|Vomiting,2,3
10954351,20150325,Nivolumab,69,801,69.0,1,68,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB,5,ADVERSE EVENT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION,Haemoptysis,1,3
10954704,20150325,Nivolumab,60,801,60.0,1,67,1,0,0,0,0,0,1,Nivolumab,NIVOLUMAB|OXYCODONE HYDROCHLORIDE,14,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GASTRIC CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ADVERSE EVENT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,B-cell lymphoma,1,5
10954777,20150325,Nivolumab,65,801,65.0,1,77.3,1,0,1,0,0,0,1,Nivolumab,METRONIDAZOLE|METRONIDAZOLE TOPICAL|CALCIUM|MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LORAZEPAM|NIVOLUMAB|CELECOXIB|ZOLPIDEM TARTRATE|PHYTONADIONE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|WARFARIN|PANTOPRAZOLE|METHADONE,20,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SQUAMOUS CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Deep vein thrombosis|Allergic granulomatous angiitis,2,3
10955116,20150326,Nivolumab,51,801,51.0,1,74,1,0,1,0,1,0,1,Nivolumab,OXYCODONE|NIVOLUMAB|PREGABALIN,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Transaminases increased|Blood alkaline phosphatase increased|Pancytopenia|Cauda equina syndrome,4,5
10957674,20150326,Nivolumab,65,801,65.0,2,86.62,1,0,1,0,0,0,0,Nivolumab,"METHIMAZOLE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|CYANOCOBALAMIN|OXYCODONE HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|NIVOLUMAB|LORAZEPAM|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|METOCLOPRAMIDE HYDROCHLORIDE|CALCIUM|PREDNISONE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|CEFEPIME HYDROCHLORIDE|CEFEPIME|IPILIMUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS",26,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypotension|Diarrhoea|Failure to thrive,3,5
10957688,20150326,Nivolumab,56,801,56.0,2,80,1,0,1,0,0,0,1,Nivolumab,"ERGOCALCIFEROL|LORAZEPAM|FLUCONAZOLE|FISH OIL|FAMOTIDINE|NIVOLUMAB|IPILIMUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PROMETHAZINE HYDROCHLORIDE",13,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Syncope|Encephalopathy,2,3
10957930,20150326,Nivolumab,67,801,67.0,2,69.7,1,1,1,1,0,0,0,Nivolumab,LISINOPRIL|ESOMEPRAZOLE MAGNESIUM|ALPRAZOLAM|LATANOPROST|LORAZEPAM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|NIVOLUMAB|SERTRALINE HYDROCHLORIDE|LORAZEPAM|TIOTROPIUM BROMIDE|CARISOPRODOL|ALPRAZOLAM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PROMETHAZINE|HYDROCODONE BITARTRATE AND ACETAMINOPHEN|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,22,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonia|Malignant neoplasm progression,2,3
10958158,20150326,Nivolumab,60,801,60.0,2,102,1,0,1,0,0,0,1,Nivolumab,BUPROPION|METHYLPHENIDATE HYDROCHLORIDE|LEVOTHYROXINE SODIUM|NIVOLUMAB|BACLOFEN|NIVOLUMAB|IPILIMUMAB|NIVOLUMAB|IPILIMUMAB|LOSARTAN|ERGOCALCIFEROL|IPILIMUMAB|CARVEDILOL,19,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypovolaemic shock|Colitis|Enteritis|Renal failure,4,3
10958187,20150326,Nivolumab,37,801,37.0,2,65,1,0,1,0,0,0,0,Nivolumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CETIRIZINE HYDROCHLORIDE|IPILIMUMAB|PREDNISONE|LEVOTHYROXINE SODIUM|NIVOLUMAB|ZOLPIDEM TARTRATE|TERBINAFINE HYDROCHLORIDE,9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis|Headache,2,3
10958228,20150326,Nivolumab,67,801,67.0,2,65.6,1,1,1,1,0,0,1,Nivolumab,"COLLAGENASE SANTYL|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|NIVOLUMAB|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|MELATONIN|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|MIRTAZAPINE|CEFEPIME HYDROCHLORIDE|CEFEPIME|GABAPENTIN|OXYCODONE HYDROCHLORIDE|FUROSEMIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|POLYETHYLENE GLYCOL|IPILIMUMAB|OXYCODONE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|LINEZOLID|MEROPENEM|ZINC SULFATE|ZINC SULFATE INJECTION,|ZINC SULFATE INJECTION|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|ASCORBIC ACID",30,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Circulatory collapse|Pyrexia|Malignant neoplasm progression,3,3
10958271,20150326,Nivolumab,66,801,66.0,1,81,1,0,1,0,0,0,1,Nivolumab,"IPILIMUMAB|NIVOLUMAB|METHYLPREDNISOLONE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PREDNISONE",6,RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|HEADACHE|PRODUCT USED FOR UNKNOWN INDICATION,Lipase increased|Blood creatinine increased,2,3
10960392,20150327,Nivolumab,47,801,47.0,1,110,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|VEMURAFENIB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Renal failure|Retinal detachment|Vogt-Koyanagi-Harada syndrome|Blood potassium abnormal|Uveitis|Iridocyclitis|Alopecia areata,7,1
10960810,20150327,Nivolumab,55,801,55.0,2,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Infusion related reaction|Lower respiratory tract infection,2,3
10962405,20150327,Nivolumab,67,801,67.0,1,96,1,0,1,0,0,0,0,Nivolumab,METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|RIVAROXABAN|NIVOLUMAB|LEVOTHYROXINE SODIUM|ATORVASTATIN CALCIUM|FUROSEMIDE,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea,1,5
10962854,20150327,Nivolumab,71,801,71.0,1,92,1,0,1,0,0,0,1,Nivolumab,"PREDNISONE|FLUCONAZOLE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|IPILIMUMAB|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|AMOXICILLIN AND CLAVULANATE POTASSIUM|METHYLPREDNISOLONE SODIUM SUCCINATE|MICAFUNGIN|MICAFUNGIN SODIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|NIVOLUMAB|SENNOSIDES|SENNA LEAF|SENNA|METRONIDAZOLE|METRONIDAZOLE TOPICAL",18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Alanine aminotransferase increased|Wound infection|Aspartate aminotransferase increased,3,5
10963119,20150327,Nivolumab,65,801,65.0,1,111,1,1,1,0,0,0,1,Nivolumab,MORPHINE SULFATE|ZOLPIDEM TARTRATE|NIVOLUMAB|AMLODIPINE BESYLATE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|IPILIMUMAB|HYDROMORPHONE HYDROCHLORIDE|METHYLPREDNISOLONE SODIUM SUCCINATE,9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BLADDER CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BLADDER CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis,1,3
10963594,20150327,Nivolumab,62,801,62.0,1,67,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE,4,MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,3
10963596,20150327,Nivolumab,58,801,58.0,1,74,1,0,1,0,0,0,0,Nivolumab,"ZINC|ZINC GLUCONATE|ZINC CHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|TOPIRAMATE|TOPIRAMATE SPINKLE|NIVOLUMAB|STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM",10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Enteritis|Pancreatitis,2,5
10963610,20150328,Nivolumab,36,801,36.0,2,72,1,0,1,0,0,0,0,Nivolumab,"DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|TRIMETHOPRIM|BUPROPION HYDROCHLORIDE|CLONAZEPAM|BENZONATATE|GUAIFENESIN|CALCIUM CARBONATE|ANTACID|FISH OIL|IPILIMUMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|LANSOPRAZOLE|SENNOSIDES|SENNA LEAF|SENNA|CLOBETASOL PROPIONATE|CLOBETASOL PROPIONATE OINTMENT USP, 0.05%|NIVOLUMAB|ENOXAPARIN SODIUM",21,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis,1,5
10967039,20150330,Nivolumab,49,801,49.0,1,105,1,0,1,0,0,0,0,Nivolumab,"NIVOLUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|SENNOSIDES|SENNA LEAF|SENNA|IPILIMUMAB|DEXPANTHENOL",11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Meningitis|Pyrexia,2,3
10968670,20150330,Nivolumab,36,801,36.0,1,67,1,0,1,0,0,0,0,Nivolumab,OXYCODONE HYDROCHLORIDE|LEVETIRACETAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|NIVOLUMAB,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GLIOBLASTOMA|PRODUCT USED FOR UNKNOWN INDICATION,Headache,1,3
10970439,20150331,Nivolumab,49,801,49.0,1,102,1,0,1,0,0,0,1,Nivolumab,"NIVOLUMAB|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|IPILIMUMAB|METHYLPREDNISOLONE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Autoimmune hepatitis|Sepsis|Acute kidney injury,3,5
10970574,20150331,Nivolumab,58,801,58.0,1,120.1,1,0,1,0,0,0,0,Nivolumab,NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|NIVOLUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|IPILIMUMAB,6,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA,Colitis|Diarrhoea,2,3
10970739,20150331,Nivolumab,60,801,60.0,1,114,1,0,1,0,0,0,0,Nivolumab,PROPRANOLOL HYDROCHLORIDE|NIVOLUMAB|IPILIMUMAB|HYDROCORTISONE|IRBESARTAN|LANSOPRAZOLE|RANITIDINE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PANTOPRAZOLE|INFLIXIMAB,17,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Thyroiditis|Colitis,2,3
10970825,20150331,Nivolumab,82,801,82.0,2,84,1,1,1,1,0,0,0,Nivolumab,MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|SPIRONOLACTONE|ALPRAZOLAM|WARFARIN|HALOPERIDOL|HALOPERIDOL LACTATE|NIVOLUMAB|BISOPROLOL FUMARATE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|METHYLPREDNISOLONE|TRAZODONE HYDROCHLORIDE|PHYTONADIONE|BUMETANIDE,16,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis|Diverticular perforation|Non-cardiac chest pain,3,5
10971057,20150331,Nivolumab,58,801,58.0,1,87,1,0,1,0,0,0,0,Nivolumab,FERROUS SULFATE|IPILIMUMAB|NIVOLUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,3
10971795,20150331,Nivolumab,72,801,72.0,2,46,1,0,1,0,0,0,0,Nivolumab,METRONIDAZOLE|METRONIDAZOLE TOPICAL|INSULIN GLARGINE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|NIVOLUMAB,10,METASTATIC MALIGNANT MELANOMA,Malaise|Anaemia,2,3
10971796,20150331,Nivolumab,68,801,68.0,1,90,1,0,1,0,0,0,1,Nivolumab,TELMISARTAN|MANNITOL|METOPROLOL TARTRATE|METOPROLOL|PREDNISONE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|FLUCONAZOLE|NIVOLUMAB|CARBAMAZEPINE|DEXTROSE ANHYDROUS|IPILIMUMAB|HYDROXYZINE|CEFTRIAXONE|CEFTRIAXONE SODIUM,16,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Alanine aminotransferase increased,1,3
10971837,20150331,Nivolumab,73,801,73.0,2,,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|IPILIMUMAB|ENOXAPARIN SODIUM|METRONIDAZOLE,12,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Colitis,1,3
10971855,20150331,Nivolumab,81,801,81.0,2,90,1,0,1,0,0,0,1,Nivolumab,GABAPENTIN|ALENDRONATE SODIUM|ALENDRONATE SODIUM TABLET|CASPOFUNGIN ACETATE|DICLOFENAC|DICLOFENAC SODIUM|RAMIPRIL|FUROSEMIDE|NIVOLUMAB|ALLOPURINOL|IPILIMUMAB|AMLODIPINE|METHYLPREDNISOLONE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS,18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Tubulointerstitial nephritis|Pulmonary embolism,2,3
10971871,20150331,Nivolumab,77,801,77.0,2,66,1,0,0,0,0,0,1,Nivolumab,NIVOLUMAB|LISINOPRIL AND HYDROCHLOROTHIAZIDE|IPILIMUMAB|METHYLPREDNISOLONE,4,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Hypertransaminasaemia,1,3
10971872,20150331,Nivolumab,68,801,68.0,1,95,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB,10,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Thyroiditis,1,3
10971900,20150331,Nivolumab,74,801,74.0,1,89,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB|IPILIMUMAB|FUROSEMIDE|RANIBIZUMAB|METOPROLOL TARTRATE|METOPROLOL|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE,12,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Acute kidney injury|Atrial fibrillation|Diarrhoea,3,5
10972022,20150331,Nivolumab,66,801,66.0,1,,1,0,1,0,0,0,1,Nivolumab,"IPILIMUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PANTOPRAZOLE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|NIVOLUMAB|BISOPROLOL FUMARATE|SIMVASTATIN|RAMIPRIL",15,METASTATIC MALIGNANT MELANOMA|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis|Diarrhoea|Prerenal failure,3,3
10972468,20150331,Nivolumab,56,801,56.0,2,,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|LISINOPRIL AND HYDROCHLOROTHIAZIDE|LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS|PANTOPRAZOLE SODIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PITAVASTATIN CALCIUM|VENLAFAXINE HYDROCHLORIDE|BENZONATATE|NIVOLUMAB|ALPRAZOLAM,13,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Nausea,1,3
10972469,20150331,Nivolumab,56,801,56.0,2,77,1,0,1,0,0,0,1,Nivolumab,"LORAZEPAM|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE|NIVOLUMAB|PANTOPRAZOLE SODIUM|VENLAFAXINE HYDROCHLORIDE|ALPRAZOLAM|HYDROXYZINE|LISINOPRIL|LORATADINE|LORATADINE TABLET|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|PITAVASTATIN CALCIUM|DEXLANSOPRAZOLE|IPILIMUMAB|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)|FLUOCINONIDE|FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%|OXYCODONE|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|BENZONATATE|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|FLUCONAZOLE|FONDAPARINUX SODIUM|PANTOPRAZOLE",32,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Clostridium difficile colitis|Autoimmune colitis|Dehydration,3,3
10972472,20150331,Nivolumab,56,801,56.0,2,,1,0,1,0,0,0,0,Nivolumab,VENLAFAXINE HYDROCHLORIDE|DRONABINOL|PANTOPRAZOLE SODIUM|LORAZEPAM|IPILIMUMAB|ALPRAZOLAM|NIVOLUMAB|PITAVASTATIN CALCIUM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|LISINOPRIL AND HYDROCHLOROTHIAZIDE|LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS|HYDROXYZINE|PREDNISONE,17,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pyrexia,1,3
10972473,20150331,Nivolumab,55,801,55.0,2,66,1,0,0,0,0,0,1,Nivolumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|IPILIMUMAB|NIVOLUMAB,4,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Diarrhoea,1,3
10972484,20150331,Nivolumab,56,801,56.0,2,68.57,1,0,1,0,0,0,1,Nivolumab,"IPILIMUMAB|LISINOPRIL AND HYDROCHLOROTHIAZIDE|LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|ALPRAZOLAM|HYDROXYZINE|DRONABINOL|PITAVASTATIN CALCIUM|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|PANTOPRAZOLE SODIUM|NIVOLUMAB|LORAZEPAM|PREDNISONE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ENOXAPARIN SODIUM|VENLAFAXINE HYDROCHLORIDE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM",24,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Enterocolitis,1,3
10972488,20150331,Nivolumab,43,801,43.0,1,81,1,0,0,0,0,0,1,Nivolumab,IPILIMUMAB|NIVOLUMAB,5,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Hyperthyroidism,1,3
10972540,20150331,Nivolumab,44,801,44.0,1,84,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB|AMOXICILLIN AND CLAVULANATE POTASSIUM|DALTEPARIN SODIUM|METHYLPREDNISOLONE SODIUM SUCCINATE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|IPILIMUMAB,10,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Autoimmune hepatitis,1,3
10972589,20150331,Nivolumab,72,801,72.0,1,69,1,0,1,0,0,0,0,Nivolumab,ALPROSTADIL|NIVOLUMAB|IPILIMUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|SIMVASTATIN,9,PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypophysitis,1,5
10972645,20150331,Nivolumab,65,801,65.0,1,89.4,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|LORAZEPAM|AMOXICILLIN|AMLODIPINE|NIVOLUMAB|LATANOPROST|LOSARTAN POTASSIUM,12,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hepatocellular injury,1,5
10972646,20150331,Nivolumab,69,801,69.0,2,62.1,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Diarrhoea,1,3
10972648,20150331,Nivolumab,52,801,52.0,2,61,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|AMOXICILLIN AND CLAVULANATE POTASSIUM,5,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia,1,5
10972749,20150331,Nivolumab,61,801,61.0,2,56,1,0,1,0,0,0,0,Nivolumab,"NIVOLUMAB|CEFUROXIME|PREGABALIN|HYDROCORTISONE|IPILIMUMAB|PREGABALIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",9,METASTATIC MALIGNANT MELANOMA,Colitis,1,3
10972750,20150331,Nivolumab,66,801,66.0,1,84,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB|METHYLPREDNISOLONE|IPILIMUMAB,4,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Colitis|Autoimmune hepatitis,2,3
10973100,20150401,Nivolumab,,,,0,,1,1,0,0,0,0,1,Nivolumab,NIVOLUMAB,1,MALIGNANT MELANOMA,Interleukin level increased|CSF granulocyte count abnormal|Malignant neoplasm progression|Lung disorder|Hepatic function abnormal|White blood cell count increased,6,5
10973313,20150401,Nivolumab,,,,0,,1,0,0,0,0,0,0,Nivolumab,NIVOLUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Wrong technique in drug usage process,1,2
10974202,20150401,Nivolumab,44,801,44.0,1,75,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB|MAGNESIUM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,9,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Transaminases increased,1,5
10974245,20150401,Nivolumab,65,801,65.0,1,86.4,1,0,1,0,0,0,0,Nivolumab,AMLODIPINE|LOSARTAN POTASSIUM|LORAZEPAM|IPILIMUMAB|NIVOLUMAB|LATANOPROST,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Normochromic normocytic anaemia|Colitis,2,3
10974246,20150401,Nivolumab,57,801,57.0,1,80.9,1,1,1,0,0,0,1,Nivolumab,ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|NIVOLUMAB|DENOSUMAB|PREGABALIN|ERGOCALCIFEROL|OXYCODONE HYDROCHLORIDE,12,METASTATIC MALIGNANT MELANOMA,Malignant neoplasm progression|General physical health deterioration,2,3
10974324,20150401,Nivolumab,47,801,47.0,1,97,1,0,1,1,0,0,1,Nivolumab,"FUROSEMIDE|NIVOLUMAB|RASBURICASE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|AMOXICILLIN AND CLAVULANATE POTASSIUM|METHYLPREDNISOLONE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|IPILIMUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS",10,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Renal failure,1,3
10974327,20150401,Nivolumab,56,801,56.0,1,,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB|HYDROXYZINE,6,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Anaemia,1,5
10974352,20150401,Nivolumab,47,801,47.0,2,72,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB,5,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis|Hypokalaemia,2,5
10974353,20150401,Nivolumab,67,801,67.0,1,92.15,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|FINASTERIDE|WARFARIN|HYDRALAZINE HYDROCHLORIDE|MOMETASONE FUROATE|CLONIDINE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|METOPROLOL TARTRATE|DILTIAZEM HYDROCHLORIDE|VALSARTAN AND HYDROCHLOROTHIAZIDE|POTASSIUM CHLORIDE|FENOFIBRATE|DIGOXIN|NIVOLUMAB,16,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Colitis,1,3
10974432,20150401,Nivolumab,74,801,74.0,1,76,1,0,1,0,0,0,0,Nivolumab,AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM|AMLODIPINE AND ATORVASTATIN|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE|IPILIMUMAB|INFLIXIMAB|ATENOLOL|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|CARBAMAZEPINE|NIVOLUMAB,13,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Colitis,1,3
10974433,20150401,Nivolumab,68,801,68.0,2,84,1,0,1,0,0,0,1,Nivolumab,IPILIMUMAB|INSULIN LISPRO|TELMISARTAN|CAPTOPRIL|NIVOLUMAB|AMOXICILLIN AND CLAVULANATE POTASSIUM,12,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Autoimmune hepatitis,1,3
10974530,20150401,Nivolumab,71,801,71.0,1,82.9,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB|PROPRANOLOL HYDROCHLORIDE,9,METASTATIC MALIGNANT MELANOMA,Fatigue,1,3
10974557,20150401,Nivolumab,75,801,75.0,2,98.2,1,0,0,0,0,0,1,Nivolumab,"HYDROCODONE BITARTRATE AND ACETAMINOPHEN|OMEPRAZOLE MAGNESIUM|IPILIMUMAB|ALBUTEROL SULFATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|TIOTROPIUM BROMIDE|NIVOLUMAB",7,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pneumonitis,1,3
10974564,20150401,Nivolumab,52,801,52.0,2,57,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB|AMOXICILLIN|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|METHYLPREDNISOLONE,7,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Hypophysitis,1,3
10974676,20150401,Nivolumab,60,801,60.0,1,82,1,1,1,0,0,0,1,Nivolumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|IPILIMUMAB|FUROSEMIDE|CANDESARTAN|NIVOLUMAB,8,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA,Sudden death|Diarrhoea,2,3
10974680,20150401,Nivolumab,55,801,55.0,1,78,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB|PREDNISONE,3,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Hypophysitis,1,3
10974681,20150401,Nivolumab,86,801,86.0,1,60,1,0,1,0,0,0,0,Nivolumab,"NIVOLUMAB|RAMIPRIL|ALLOPURINOL|AMLODIPINE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|BISOPROLOL FUMARATE",10,METASTATIC MALIGNANT MELANOMA,Diarrhoea,1,3
10974696,20150401,Nivolumab,55,801,55.0,1,,1,0,0,0,0,0,1,Nivolumab,LOSARTAN|INDAPAMIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|SIMVASTATIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|AMLODIPINE|IPILIMUMAB|NIVOLUMAB|NIVOLUMAB,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Uveitis,1,3
10975476,20150401,Nivolumab,75,801,75.0,1,73.5,1,0,1,0,0,0,1,Nivolumab,CALCIUM|METHYLPREDNISOLONE|CEFUROXIME|MAGNESIUM|NIVOLUMAB,7,METASTATIC MALIGNANT MELANOMA,Hypoxia|Dyspnoea|Cough|Dermatitis exfoliative,4,3
10975542,20150401,Nivolumab,83,801,83.0,2,73,1,1,1,1,0,0,1,Nivolumab,DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ALPRAZOLAM|NIVOLUMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|CEFEPIME HYDROCHLORIDE|CEFEPIME,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Encephalitis toxic,1,3
10975600,20150401,Nivolumab,67,801,67.0,2,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,3,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis,1,3
10975703,20150401,Nivolumab,74,801,74.0,1,83.4,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|ZOLEDRONIC ACID|NIVOLUMAB|TEMAZEPAM|GENTAMICIN SULFATE,13,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pyrexia,1,3
10975761,20150401,Nivolumab,78,801,78.0,1,72,1,0,1,0,0,0,0,Nivolumab,MORPHINE|DABIGATRAN ETEXILATE|FENTANYL|GENTAMICIN|GENTAMICIN SULFATE|DILTIAZEM HYDROCHLORIDE|LACTULOSE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|IPILIMUMAB|NIVOLUMAB|FUROSEMIDE|DIGOXIN|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE,18,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Nausea|Orthostatic hypotension,2,3
10975811,20150401,Nivolumab,77,801,77.0,2,65,1,0,1,0,0,0,0,Nivolumab,TEMAZEPAM|NIVOLUMAB,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA,Pyrexia,1,3
10975950,20150401,Nivolumab,25,801,25.0,1,,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|MEROPENEM|NIVOLUMAB,6,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Rash generalised|Pyrexia,2,3
10975951,20150401,Nivolumab,78,801,78.0,1,73.8,1,1,1,0,0,0,1,Nivolumab,OXYCODONE HYDROCHLORIDE|TEMAZEPAM|NIVOLUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|LACTULOSE|IPILIMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIGOXIN,12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Fatigue|Malignant neoplasm progression|Pain,3,3
10976075,20150401,Nivolumab,76,801,76.0,2,76,1,1,0,0,0,0,1,Nivolumab,METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|RAMIPRIL|METOPROLOL TARTRATE|METOPROLOL|FENTANYL|IPILIMUMAB|DIMENHYDRINATE|NIVOLUMAB|ISOSORBIDE MONONITRATE,15,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Malignant neoplasm progression|Ischaemic stroke,2,3
10976219,20150401,Nivolumab,71,801,71.0,1,57.4,1,0,1,0,0,0,1,Nivolumab,"HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|IOHEXOL|NICOTINE POLACRILEX|NICOTINE|NICOTINE POLACRILEX MINI|NICOTINE POLARILEX|CALAMINE, ZINC OXIDE|FERRIC OXIDE RED|CALAMINE AND ZINC OXIDE|CALAMINE 8% AND ZINC OXIDE 8%|CALAMINE, PRAMOXINE HCL|CALAMINE, PRAMOXIND HCL|CALAMINE|GABAPENTIN|NIVOLUMAB|LEVOTHYROXINE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|MUPIROCIN|MUPIROCIN CALCIUM|IPILIMUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG",17,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypophysitis,1,3
10976919,20150402,Nivolumab,73,801,73.0,1,,1,1,1,1,1,0,1,Nivolumab,NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|DACARBAZINE|FUROSEMIDE|OCTREOTIDE ACETATE|NIVOLUMAB|FAMOTIDINE|CISPLATIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|NIVOLUMAB|NIVOLUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|MEROPENEM,36,MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cough|Nausea|Pruritus|Interstitial lung disease|Oesophageal stenosis|Alanine aminotransferase increased|Transfusion|Intestinal obstruction|Hypokalaemia|Fatigue|Hypoalbuminaemia|Gastrointestinal haemorrhage|Malignant neoplasm progression|Platelet count decreased|Malaise|Sepsis|Diarrhoea|Blood bilirubin increased|Loss of consciousness|Anaemia|Aspiration|Dizziness|Oedema peripheral|Blood alkaline phosphatase increased|Hyponatraemia|Aspartate aminotransferase increased,26,5
10977262,20150402,Nivolumab,62,801,62.0,2,,1,1,0,0,0,0,1,Nivolumab,NIVOLUMAB|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|NIVOLUMAB,6,PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Platelet count decreased|Urticaria,3,5
10978554,20150402,Nivolumab,75,801,75.0,1,95,1,0,1,0,0,0,0,Nivolumab,DOXEPIN|DOXEPIN HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|NIVOLUMAB|IPILIMUMAB|LORATADINE|LORATADINE ORAL|PREDNISONE,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Adrenal insufficiency,1,5
10978579,20150402,Nivolumab,70,801,70.0,1,91,1,0,1,0,0,0,1,Nivolumab,"AMOXICILLIN|NIVOLUMAB|SILDENAFIL CITRATE|SILDENAFIL|SILDENAFIL POWDER,",3,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Adrenal insufficiency,1,3
10978580,20150402,Nivolumab,64,801,64.0,2,66,1,0,1,0,0,0,1,Nivolumab,IPILIMUMAB|ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE|PROMETHAZINE HYDROCHLORIDE|NIVOLUMAB|PANTOPRAZOLE|TRIMETHOPRIM,11,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Autoimmune hepatitis,1,3
10978584,20150402,Nivolumab,26,801,26.0,1,60,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|NIVOLUMAB|NAPROXEN|NAPROXEN SODIUM|MORPHINE,6,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia,1,3
10978734,20150402,Nivolumab,51,801,51.0,1,84,1,1,1,0,0,0,0,Nivolumab,"PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|METRONIDAZOLE|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|DEXLANSOPRAZOLE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|STANDARDIZED SENNA CONCENTRATE|HYDROMORPHONE HYDROCHLORIDE|FENTANYL|DIMENHYDRINATE|NIVOLUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|LORAZEPAM|FENTANYL|LORAZEPAM",25,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dysphagia|Malignant neoplasm progression,2,3
10978796,20150402,Nivolumab,77,801,77.0,2,59,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|INFLIXIMAB,3,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,3
10978798,20150402,Nivolumab,76,801,76.0,1,97,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|CEFTRIAXONE|CEFTRIAXONE SODIUM|IPILIMUMAB|METHYLPREDNISOLONE,4,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Interstitial lung disease,1,5
10978824,20150402,Nivolumab,59,801,59.0,1,100,1,0,1,0,0,0,0,Nivolumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|NIVOLUMAB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|IPILIMUMAB|LANSOPRAZOLE|INFLIXIMAB,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dehydration|Colitis,2,3
10978887,20150402,Nivolumab,75,801,75.0,2,,1,1,1,0,0,0,1,Nivolumab,MORPHINE|METRONIDAZOLE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|NIVOLUMAB|FLUCONAZOLE,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression,1,3
10979312,20150402,Nivolumab,54,801,54.0,1,95,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB|PANTOPRAZOLE|IPILIMUMAB|CEFUROXIME,6,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Lobar pneumonia,1,3
10979407,20150402,Nivolumab,45,801,45.0,2,136.8,1,0,1,0,0,0,0,Nivolumab,"NIVOLUMAB|MORPHINE SULFATE|PREDNISONE|OXYCODONE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE|IPILIMUMAB|MORPHINE",12,PREMEDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|METASTATIC MALIGNANT MELANOMA|PREMEDICATION|PREMEDICATION|PREMEDICATION,Pyrexia|Headache,2,3
10979408,20150402,Nivolumab,81,801,81.0,1,63,1,0,1,0,0,0,0,Nivolumab,METHYLPREDNISOLONE|IPILIMUMAB|LEVOTHYROXINE|NIVOLUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,6,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypopituitarism,1,3
10979410,20150402,Nivolumab,78,801,78.0,1,92.2,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METHYLPREDNISOLONE|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RANITIDINE|FLUCONAZOLE|ERGOCALCIFEROL|PANTOPRAZOLE|METOPROLOL TARTRATE|METOPROLOL|IRBESARTAN,21,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Dehydration,1,3
10979493,20150402,Nivolumab,54,801,54.0,1,106,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|RANITIDINE|HYDROCODONE BITARTRATE AND ACETAMINOPHEN|PANTOPRAZOLE|NIVOLUMAB,7,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA,Diarrhoea,1,3
10979494,20150402,Nivolumab,74,801,74.0,1,78,1,0,1,0,0,0,0,Nivolumab,"DENOSUMAB|LEVOTHYROXINE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|ALPRAZOLAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|NIFEDIPINE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|LOSARTAN|PREDNISONE|NIVOLUMAB|IPILIMUMAB",16,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Cholecystitis acute,1,5
10979495,20150402,Nivolumab,46,801,46.0,1,,1,0,1,0,0,0,1,Nivolumab,METRONIDAZOLE|METRONIDAZOLE TOPICAL|PREDNISONE|IPILIMUMAB|NIVOLUMAB|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS,7,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Abdominal pain|Inferior vena caval occlusion,2,3
10979541,20150402,Nivolumab,,,,0,,1,0,1,0,0,0,1,Nivolumab,RANITIDINE|NIVOLUMAB|DALTEPARIN SODIUM,6,METASTATIC MALIGNANT MELANOMA,Renal failure,1,3
10979588,20150402,Nivolumab,64,801,64.0,1,111.7,1,0,1,0,0,0,1,Nivolumab,IPILIMUMAB|PREDNISONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DILTIAZEM HYDROCHLORIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LITHIUM|LITHIUM BROMATUM|GLYCERIN|GLYCERIN SUPPOSITORIES|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|NIVOLUMAB|PREDNISONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|MORPHINE,26,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Vomiting|Dehydration|Hypopituitarism|Acute kidney injury,4,3
10979591,20150402,Nivolumab,73,801,73.0,1,72,1,0,1,0,0,0,0,Nivolumab,INSULIN GLARGINE|NIVOLUMAB|SIMVASTATIN|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|IPILIMUMAB|PREDNISONE|ALLOPURINOL,10,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Diarrhoea,1,3
10979802,20150402,Nivolumab,65,801,65.0,2,74.2,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|NIVOLUMAB|PENICILLIN G BENZATHINE,11,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Dyspnoea,1,3
10979882,20150402,Nivolumab,63,801,63.0,2,69,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB|PREDNISONE,6,MALIGNANT MELANOMA|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,3
10979883,20150402,Nivolumab,46,801,46.0,2,92.6,1,0,1,0,0,0,0,Nivolumab,"METHYLPREDNISOLONE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|SIMVASTATIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|IPILIMUMAB|PREDNISONE|NIVOLUMAB",12,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Transaminases increased,1,3
10979887,20150402,Nivolumab,53,801,53.0,1,88.9,1,0,1,0,0,0,1,Nivolumab,IPILIMUMAB|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|NIVOLUMAB|FISH OIL,13,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Hepatitis acute,1,3
10979889,20150402,Nivolumab,70,801,70.0,1,93,1,1,1,0,0,0,1,Nivolumab,"GEMFIBROZIL|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|NIVOLUMAB|IPILIMUMAB|ALLOPURINOL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Sepsis,2,3
10979905,20150402,Nivolumab,27,801,27.0,1,73.5,1,0,0,0,0,0,1,Nivolumab,"IPILIMUMAB|PREDNISONE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|NIVOLUMAB|METHYLPREDNISOLONE",5,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Transaminases increased,1,3
10981565,20150402,Nivolumab,74,801,74.0,1,100,1,0,1,0,0,0,0,Nivolumab,HYDROCHLOROTHIAZIDE|IPILIMUMAB|AMLODIPINE|NIVOLUMAB|RAMIPRIL|CLOPIDOGREL BISULFATE|ALLOPURINOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SPIRONOLACTONE|METOPROLOL TARTRATE|METOPROLOL,14,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Lipase increased,1,3
10981785,20150402,Nivolumab,44,801,44.0,2,103,1,0,1,0,0,0,0,Nivolumab,CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|IPILIMUMAB|TRAZODONE HYDROCHLORIDE|NAPROXEN|NAPROXEN SODIUM|NIVOLUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ALPRAZOLAM|PREDNISONE,20,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pyrexia,1,3
10981843,20150402,Nivolumab,75,801,75.0,1,100,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|METOPROLOL TARTRATE|METOPROLOL|IPILIMUMAB|RAMIPRIL|PERMETHRIN|PERMETHRIN CREAM 5% W/W|ALLOPURINOL|CLOPIDOGREL BISULFATE|HYDROCHLOROTHIAZIDE|POLIDOCANOL|AMLODIPINE|SPIRONOLACTONE|UREA,22,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pruritus,1,5
10981847,20150402,Nivolumab,57,801,57.0,1,86,1,0,1,0,0,0,1,Nivolumab,"NIVOLUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|IPILIMUMAB",5,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Hepatotoxicity,1,5
10981851,20150402,Nivolumab,78,801,78.0,1,92.63,1,0,1,0,0,0,0,Nivolumab,PANTOPRAZOLE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METOPROLOL TARTRATE|METOPROLOL|NIVOLUMAB|RANITIDINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|IPILIMUMAB|IRBESARTAN|METHYLPREDNISOLONE,13,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Gastroenteritis,1,3
10981861,20150402,Nivolumab,48,801,48.0,1,92.4,1,0,1,0,0,0,0,Nivolumab,LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|NIVOLUMAB|TESTOSTERONE|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|IPILIMUMAB|PROCHLORPERAZINE,7,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Vomiting,1,3
10981863,20150402,Nivolumab,58,801,58.0,1,100,1,0,1,0,0,0,0,Nivolumab,METHYLCELLULOSE|NIVOLUMAB|IPILIMUMAB|PROCHLORPERAZINE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|LEVOTHYROXINE SODIUM|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE|AZITHROMYCIN DIHYDRATE,11,NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|RASH|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|NAUSEA|DIARRHOEA|PRODUCT USED FOR UNKNOWN INDICATION|RHINITIS ALLERGIC|SLEEP DISORDER|VIRAL UPPER RESPIRATORY TRACT INFECTION,Hyperglycaemia|Dehydration,2,3
10982111,20150403,Nivolumab,,,,0,,1,0,0,0,0,0,1,Nivolumab,NIVOLUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis,1,1
10982284,20150403,Nivolumab,69,801,69.0,1,90.3,1,0,1,0,0,0,0,Nivolumab,ROSUVASTATIN CALCIUM|METHYLPREDNISOLONE SODIUM SUCCINATE|NIVOLUMAB|PREDNISONE|NAPROXEN|NAPROXEN SODIUM|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|IPILIMUMAB|INFLIXIMAB,9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,5
10982285,20150403,Nivolumab,64,801,64.0,1,84,1,0,1,0,0,0,1,Nivolumab,"GLIMEPIRIDE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|TESTOSTERONE|TESTOSTERONE,|IPILIMUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|METHYLPREDNISOLONE SODIUM SUCCINATE|INDOMETHACIN|LEVOTHYROXINE SODIUM|TRAZODONE HYDROCHLORIDE|MORPHINE|LISINOPRIL|NIVOLUMAB|ALLOPURINOL|FLUCONAZOLE",20,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Polyneuropathy,1,3
10982466,20150403,Nivolumab,51,801,51.0,1,124.1,1,0,1,0,0,0,0,Nivolumab,LOSARTAN|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|NIVOLUMAB|CETIRIZINE HYDROCHLORIDE|METOPROLOL TARTRATE|METOPROLOL|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|IPILIMUMAB|ALLOPURINOL|COLCHICINE|PAROXETINE HYDROCHLORIDE|SIMVASTATIN|LEVOTHYROXINE|LEVOTHYROXINE SODIUM|INDOMETHACIN|LOSARTAN POTASSIUM|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|NIVOLUMAB|NIVOLUMAB|IPILIMUMAB|PREDNISONE,27,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Pneumocystis jirovecii pneumonia|Diarrhoea,2,3
10982467,20150403,Nivolumab,77,801,77.0,1,,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB|IPILIMUMAB|PREDNISONE,6,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Interstitial lung disease,1,3
10982484,20150403,Nivolumab,,,,0,,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|PROPRANOLOL HYDROCHLORIDE|IPILIMUMAB,4,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA,Hyperthyroidism,1,5
10982671,20150403,Nivolumab,74,801,74.0,2,74.7,1,0,1,0,0,0,1,Nivolumab,IPILIMUMAB|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|MOMETASONE FUROATE|NIVOLUMAB|FISH OIL|GENTAMICIN|GENTAMICIN SULFATE|CEFTRIAXONE|CEFTRIAXONE SODIUM,20,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Diarrhoea|Volvulus|Dehydration|Hyperthyroidism|Lethargy,5,3
10982672,20150403,Nivolumab,52,801,52.0,2,100.3,1,0,1,0,0,0,0,Nivolumab,CANDESARTAN CILEXETIL|IPILIMUMAB|PANTOPRAZOLE|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|PREDNISONE|TEMAZEPAM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PROPOFOL|NIVOLUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FENTANYL,23,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,3
10982686,20150403,Nivolumab,72,801,72.0,2,65.8,1,0,1,0,0,0,1,Nivolumab,SIMVASTATIN|LANSOPRAZOLE|NIVOLUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|NIVOLUMAB|LEVOTHYROXINE|CANDESARTAN,9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Adrenal insufficiency,1,3
10982687,20150403,Nivolumab,46,801,46.0,2,59.4,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|MORPHINE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,6,METASTATIC MALIGNANT MELANOMA,Atelectasis,1,3
10982688,20150403,Nivolumab,62,801,62.0,1,89.8,1,0,1,0,0,0,1,Nivolumab,CARVEDILOL|DABIGATRAN ETEXILATE|FUROSEMIDE|NIVOLUMAB|LOSARTAN|IPILIMUMAB,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia|Superior vena cava syndrome|Atrial flutter,3,3
10982741,20150403,Nivolumab,58,801,58.0,1,84.6,1,0,0,0,0,0,1,Nivolumab,NIVOLUMAB|PREDNISONE,2,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Transaminases increased,1,5
10982952,20150403,Nivolumab,61,801,61.0,2,,1,1,1,0,0,0,1,Nivolumab,NIVOLUMAB|AMOXICILLIN AND CLAVULANATE POTASSIUM,2,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Pneumonitis|Small intestinal obstruction,3,5
10982983,20150403,Nivolumab,71,801,71.0,2,91.5,1,0,1,0,0,0,0,Nivolumab,ALLOPURINOL|RIVAROXABAN|SIMVASTATIN|DICLOFENAC|DICLOFENAC SODIUM|NIVOLUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|IPILIMUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|MIRTAZAPINE,19,MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,General physical health deterioration,1,3
10982986,20150403,Nivolumab,78,801,78.0,1,98,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB|COAL TAR|PROMETHAZINE HYDROCHLORIDE|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|LORATADINE|LORATADINE ORAL,10,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Hypothyroidism,1,3
10983029,20150403,Nivolumab,64,801,64.0,2,65,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|IPILIMUMAB,3,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,General physical health deterioration,1,5
10983049,20150403,Nivolumab,45,801,45.0,1,108,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|CLONIDINE|DIPHENHYDRAMINE HYDROCHLORIDE|IPILIMUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|MORPHINE SULFATE|OXYCODONE|DIPHENHYDRAMINE HYDROCHLORIDE|PREDNISONE,12,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NASOPHARYNGITIS|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HYPERSENSITIVITY|PRODUCT USED FOR UNKNOWN INDICATION,Adrenal insufficiency,1,5
10983172,20150403,Nivolumab,57,801,57.0,2,83.6,1,0,0,0,0,0,1,Nivolumab,NIVOLUMAB|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|SENNOSIDES|PREDNISOLONE ACETATE|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|GLYCERIN|GLYCERIN SUPPOSITORIES|LEVOTHYROXINE SODIUM|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|DEXAMETHASONE,14,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Uveitis,1,5
10983294,20150403,Nivolumab,54,801,54.0,2,78,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB|ALBUTEROL SULFATE|NALOXONE|FISH OIL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ALBUTEROL SULFATE|LACTULOSE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|LORAZEPAM|OXYCODONE,21,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Diarrhoea,2,5
10983296,20150403,Nivolumab,26,801,26.0,1,69.8,1,0,1,0,0,0,0,Nivolumab,METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|NIVOLUMAB|IPILIMUMAB,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea,1,5
10983348,20150403,Nivolumab,74,801,74.0,1,88,1,0,1,0,0,0,0,Nivolumab,CALCIUM CARBONATE|ANTACID|CETIRIZINE HYDROCHLORIDE|DUTASTERIDE|LOSARTAN|DENOSUMAB|NIVOLUMAB|PREDNISONE|NIFEDIPINE|LEVOTHYROXINE|HYDROCODONE BITARTRATE AND ACETAMINOPHEN|IPILIMUMAB|ALPRAZOLAM,14,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,3
10983349,20150403,Nivolumab,75,801,75.0,2,72,1,0,1,0,0,0,0,Nivolumab,ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|DIGOXIN|WARFARIN|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|NIVOLUMAB|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|WARFARIN|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|SOTALOL HYDROCHLORIDE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|UREA|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SOTALOL HYDROCHLORIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,32,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypophysitis|Hypotension,2,3
10983354,20150403,Nivolumab,86,801,86.0,2,64,1,0,1,0,0,0,0,Nivolumab,NIVOLUMAB|OXYGEN|0XYGEN|IPILIMUMAB|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|MONTELUKAST SODIUM|METHYLPREDNISOLONE|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|LORATADINE|LORATADINE TABLET|AMOXICILLIN,16,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Asthma,1,5
10983365,20150403,Nivolumab,61,801,61.0,1,,1,0,1,0,0,0,1,Nivolumab,ALLOPURINOL|NIVOLUMAB|RAMIPRIL|PANTOPRAZOLE|IPILIMUMAB|BISOPROLOL FUMARATE|ROSUVASTATIN|OXYGEN|0XYGEN,15,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis|Hyperthyroidism,2,5
10983398,20150403,Nivolumab,62,801,62.0,2,77,1,0,1,0,0,0,0,Nivolumab,IPILIMUMAB|LISINOPRIL|SIMVASTATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SERTRALINE|HYDROCHLOROTHIAZIDE|ENOXAPARIN SODIUM|LORATADINE|LORATADINE ORAL|NIVOLUMAB|LEVOTHYROXINE|HYDROCORTISONE SODIUM SUCCINATE,15,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Endocrine disorder,1,5
10983399,20150403,Nivolumab,54,801,54.0,1,78,1,0,1,0,0,0,1,Nivolumab,NIVOLUMAB|MELOXICAM|LORATADINE|LORATADINE ORAL,4,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Autoimmune hepatitis,1,3
10983447,20150403,Nivolumab,63,801,63.0,1,74,1,0,1,0,0,0,0,Nivolumab,"ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|IPILIMUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|TEMAZEPAM|NIVOLUMAB|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL",11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea,1,3
10983515,20150403,Nivolumab,53,801,53.0,1,106,1,0,1,1,0,0,0,Nivolumab,METRONIDAZOLE|METRONIDAZOLE TOPICAL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|NIVOLUMAB|IPILIMUMAB|INFLIXIMAB|PREDNISONE,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,3
10057390,20140403,Atezolizumab,71,801,71.0,2,79.5,1,0,1,0,0,0,0,Atezolizumab,"INSULIN LISPRO|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|PREDNISONE|LEVOTHYROXINE SODIUM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|DIGOXIN|AMLODIPINE|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|LORAZEPAM|ZOLEDRONIC ACID|INSULIN GLARGINE|LORAZEPAM|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|LORAZEPAM|ATEZOLIZUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LORAZEPAM|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|PANTOPRAZOLE SODIUM|PREDNISONE|GLYBURIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE",32,PROPHYLAXIS|HEPATIC ENZYME INCREASED|NAUSEA|PROPHYLAXIS|HYPERTENSION|SUPRAVENTRICULAR TACHYCARDIA|ANXIETY|METASTASES TO BONE|INSOMNIA|HYPERCHOLESTEROLAEMIA|PAIN|NON-SMALL CELL LUNG CANCER|HYPERTENSION|SLEEP DISORDER|HYPERTENSION|PROPHYLAXIS|PRURITUS|HEPATIC ENZYME INCREASED,Fall|Syncope|Upper gastrointestinal haemorrhage,3,1
10253024,20140623,Atezolizumab,37,801,37.0,2,55.8,1,0,1,0,0,0,0,Atezolizumab,"BEVACIZUMAB|LEUCOVORIN CALCIUM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|POLYETHYLENE GLYCOL 3350|OXAZEPAM|ATEZOLIZUMAB|LORAZEPAM|LORAZEPAM|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|LORAZEPAM|LORAZEPAM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|OXALIPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OMEPRAZOLE MAGNESIUM|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|LORAZEPAM",25,NEOPLASM|NEOPLASM|CONSTIPATION|CONSTIPATION|BACK PAIN|CONSTIPATION|ANXIETY|NEOPLASM|ANXIETY|NEOPLASM|MYALGIA|NAUSEA|PNEUMOPERITONEUM|PAIN|BACK PAIN|MUCOSAL INFECTION|NEOPLASM|BACK PAIN|DYSPEPSIA|NEOPLASM|ANXIETY,Pneumoperitoneum,1,1
10436172,20140908,Atezolizumab,31,801,31.0,2,64.7,1,0,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|ALPRAZOLAM|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|METRONIDAZOLE|ALBUTEROL SULFATE|VEMURAFENIB|ALBUTEROL SULFATE|ALBUTEROL SULFATE|PREGABALIN|DOXYCYCLINE|DOXYCYCLINE HYCLATE|NAPROXEN SODIUM|NAPROXEN SODIUM 220MG|NAPROXEN SODIUM, COATED TABLETS|NAPROXEN SODIUM TABLET, COATED|SERTRALINE HYDROCHLORIDE|ALBUTEROL SULFATE|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|CYCLOBENZAPRINE|VEMURAFENIB|TRETINOIN|NAPROXEN SODIUM|NAPROXEN SODIUM 220MG|NAPROXEN SODIUM, COATED TABLETS|NAPROXEN SODIUM TABLET, COATED|VEMURAFENIB|TRETINOIN|VEMURAFENIB|METRONIDAZOLE",29,METASTATIC MALIGNANT MELANOMA|ANXIETY|PAIN|RASH|DYSPNOEA|METASTATIC MALIGNANT MELANOMA|MYALGIA|PAIN|HYPERSENSITIVITY|NASAL CONGESTION|TRIGEMINAL NEURALGIA|DERMATITIS ACNEIFORM|SEASONAL ALLERGY|HEADACHE|CONTRACEPTION|RASH|DEPRESSION|COUGH|HEADACHE|PAIN|ACNE|PAIN|PRURITUS|METASTATIC MALIGNANT MELANOMA|KERATOSIS PILARIS|RASH,Alanine aminotransferase increased|Diarrhoea,2,1
10738079,20150126,Atezolizumab,81,801,81.0,2,,1,0,0,0,0,0,1,Atezolizumab,ZOLPIDEM TARTRATE|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|LORAZEPAM|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROXYZINE HYDROCHLORIDE|HYDROXYZINE|HYDROXYZINE HYDROCHLORIDE ORAL|PACLITAXEL|CARBOPLATIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ERGOCALCIFEROL|LORAZEPAM|VALSARTAN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CHLORTHALIDONE|ALBUTEROL SULFATE|ALBUTEROL|MAGNESIUM OXIDE|PACLITAXEL|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|VALSARTAN|VALSARTAN ORAL|CARBOPLATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,28,INSOMNIA|HYPERTENSION|METASTATIC NEOPLASM|NAUSEA|RASH|PRURITUS|PRODUCT USED FOR UNKNOWN INDICATION|DYSPEPSIA|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION,Neutropenia,1,3
11039974,20150416,Atezolizumab,72,801,72.0,1,,1,0,1,0,0,0,0,Atezolizumab,"ATENOLOL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|GUAIFENESIN|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|PACLITAXEL|GABAPENTIN|CLOBETASOL PROPIONATE|CLOBETASOL PROPIONATE OINTMENT USP, 0.05%|DIPHENHYDRAMINE HYDROCHLORIDE|FINASTERIDE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|MAGNESIUM OXIDE|LORAZEPAM|CITALOPRAM|CITALOPRAM HYDROBROMIDE|FOLIC ACID|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|RANITIDINE HYDROCHLORIDE|CARBOPLATIN|ALLOPURINOL|LORAZEPAM|GABAPENTIN|OXYCODONE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES",32,HYPERTENSION|PAIN|NAUSEA|PRODUCTIVE COUGH|NEOPLASM|BENIGN PROSTATIC HYPERPLASIA|SEASONAL ALLERGY|FUNGAL SKIN INFECTION|NEOPLASM|BLADDER DISCOMFORT|DERMATITIS|HYPERSENSITIVITY|NAUSEA|BENIGN PROSTATIC HYPERPLASIA|CONSTIPATION|NUTRITIONAL SUPPLEMENTATION|ANXIETY|DEPRESSION|NUTRITIONAL SUPPLEMENTATION|DIABETES MELLITUS|GASTROOESOPHAGEAL REFLUX DISEASE|VOMITING|NEOPLASM|GOUT|NAUSEA|HYPERLIPIDAEMIA|NEUROPATHY PERIPHERAL|PAIN|FAECES HARD,Influenza|Urinary tract infection|Pneumonia|Urinary tract infection,4,1
11080074,20150430,Atezolizumab,67,801,67.0,2,,1,0,1,0,0,0,0,Atezolizumab,"ERGOCALCIFEROL|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)|BACITRACIN ZINC|BACITRACIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DENOSUMAB|ALBUTEROL SULFATE|ALBUTEROL|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MONTELUKAST|PACLITAXEL|BIMATOPROST|ZOLPIDEM TARTRATE|ATEZOLIZUMAB|MORPHINE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|PHENAZOPYRIDINE|PACLITAXEL",25,PRODUCT USED FOR UNKNOWN INDICATION|URINARY TRACT INFECTION|PYREXIA|INFECTION PROPHYLAXIS|HEADACHE|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|DYSPNOEA|DRY EYE|ASTHMA|COUGH|INFLUENZA|PYREXIA|DYSPNOEA|NEOPLASM|GLAUCOMA|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|HERPES SIMPLEX|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ANAESTHESIA|URINARY TRACT INFECTION|URINARY TRACT INFECTION,Pneumonia mycoplasmal,1,3
11088477,20150504,Atezolizumab,62,801,62.0,1,,1,0,1,0,0,0,0,Atezolizumab,"PROCHLORPERAZINE|MECLIZINE HYDROCHLORIDE|MECLIZINE HCL|MECLIZINE|MECLIZINE HYDROCLORIDE|OXYCODONE|LACTULOSE|OXYCODONE|SENNOSIDES|SENNA LEAF|SENNA|LACTULOSE|DENOSUMAB|PACLITAXEL|ERGOCALCIFEROL|PALONOSETRON HYDROCHLORIDE|SIMVASTATIN|SODIUM PHOSPHATE|CARBOPLATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|NAPROXEN SODIUM|NAPROXEN SODIUM 220MG|NAPROXEN SODIUM, COATED TABLETS|NAPROXEN SODIUM TABLET, COATED|CARBOPLATIN|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM",25,NAUSEA|DIZZINESS|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|CONSTIPATION|CONSTIPATION|PAIN IN EXTREMITY|SUPPLEMENTATION THERAPY|NEOPLASM|NUTRITIONAL SUPPLEMENTATION|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|DECREASED APPETITE|HYPERLIPIDAEMIA|HYPOPHOSPHATAEMIA|PREMEDICATION|PAIN IN EXTREMITY|NEOPLASM|GASTROOESOPHAGEAL REFLUX DISEASE|SEASONAL ALLERGY,Abdominal pain,1,1
11092105,20150505,Atezolizumab,59,801,59.0,1,105.78,1,0,1,0,0,0,0,Atezolizumab,"TRIAMTERENE CAPSULES|TRIAMTERENE|FLUOCINONIDE|FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%|NAFCILLIN SODIUM|NAFCILLIN|NAFCILLIN INJECTION|ATEZOLIZUMAB|ERGOCALCIFEROL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METOPROLOL TARTRATE|METOPROLOL|METOPROLOL TARTRATE|METOPROLOL|MORPHINE|POLYETHYLENE GLYCOL|BEVACIZUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG",20,CONSTIPATION|OEDEMA|RASH|BLOOD PRESSURE MEASUREMENT|STAPHYLOCOCCAL BACTERAEMIA|RASH|PROPHYLAXIS|RASH|RENAL CELL CARCINOMA|PROPHYLAXIS|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION|NOCTURIA|ATRIAL FLUTTER|PAIN|CONSTIPATION|RENAL CELL CARCINOMA|DIABETES MELLITUS|PAIN IN EXTREMITY,Neuropathic arthropathy|Haematuria|Staphylococcal infection,3,1
11100078,20150508,Atezolizumab,42,801,42.0,1,101.1,1,0,1,0,0,0,0,Atezolizumab,"DOCUSATE SODIUM,SENNOSIDES|MINOCYCLINE|ATEZOLIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|VEMURAFENIB|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL|MELATONIN|MORPHINE|COBIMETINIB|VEMURAFENIB|LEVOTHYROXINE SODIUM|COBIMETINIB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL|FAMOTIDINE",18,PAIN|METASTATIC MALIGNANT MELANOMA|PAIN|METASTATIC MALIGNANT MELANOMA|MUCOSAL INFLAMMATION|INSOMNIA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|HYPOTHYROIDISM|METASTATIC MALIGNANT MELANOMA|MOUTH ULCERATION,Cellulitis,1,1
11174420,20150609,Atezolizumab,75,801,75.0,1,96.25,1,1,1,0,0,0,0,Atezolizumab,"DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|MAGNESIUM HYDROXIDE|ATEZOLIZUMAB|WARFARIN SODIUM|WARFARIN|PREDNISONE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ENOXAPARIN SODIUM|HYDROMORPHONE HYDROCHLORIDE|TRAMADOL HYDROCHLORIDE|FUROSEMIDE|HYDROCODONE BITARTRATE AND ACETAMINOPHEN|ACETAMINOPHEN|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|PACLITAXEL|CARBOPLATIN|PREDNISONE|PREDNISONE|DEXAMETHASONE SODIUM PHOSPHATE|ONDANSETRON HYDROCHLORIDE|PREDNISONE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PALONOSETRON HYDROCHLORIDE|FOLIC ACID|FOSAPREPITANT DIMEGLUMINE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|TRAMADOL HYDROCHLORIDE|PANTOPRAZOLE SODIUM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",36,NAUSEA|PAIN|PREMEDICATION|CONSTIPATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|THROMBOSIS PROPHYLAXIS|DECREASED APPETITE|ASPARTATE AMINOTRANSFERASE INCREASED|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PAIN|OEDEMA PERIPHERAL|PREMEDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|CONSTIPATION|NEOPLASM|NEOPLASM|ALANINE AMINOTRANSFERASE INCREASED|PREMEDICATION|PAIN|NAUSEA|BACK PAIN|CHEST PAIN|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|CONSTIPATION|HYPERCHOLESTEROLAEMIA|BACK PAIN|PROPHYLAXIS|BACK PAIN,Hyperglycaemia|Asthenia|Mental status changes|Autoimmune hepatitis,4,1
11174421,20150609,Atezolizumab,75,801,75.0,1,41.51,1,1,1,0,0,0,0,Atezolizumab,"ONDANSETRON HYDROCHLORIDE|PREDNISONE|DEXAMETHASONE SODIUM PHOSPHATE|MAGNESIUM HYDROXIDE|PREDNISONE|HYDROMORPHONE HYDROCHLORIDE|FUROSEMIDE|FOSAPREPITANT DIMEGLUMINE|ATEZOLIZUMAB|CARBOPLATIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|TRAMADOL HYDROCHLORIDE|PREDNISONE|HYDROCODONE BITARTRATE AND ACETAMINOPHEN|WARFARIN SODIUM|WARFARIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PALONOSETRON HYDROCHLORIDE|ACETAMINOPHEN|ENOXAPARIN SODIUM|PACLITAXEL|TRAMADOL HYDROCHLORIDE|PANTOPRAZOLE SODIUM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FOLIC ACID",34,NAUSEA|ASPARTATE AMINOTRANSFERASE INCREASED|PREMEDICATION|CONSTIPATION|PAIN|PAIN|OEDEMA PERIPHERAL|PREMEDICATION|NEOPLASM|NEOPLASM|HYPERGLYCAEMIA|PREMEDICATION|NAUSEA|BACK PAIN|BACK PAIN|ALANINE AMINOTRANSFERASE INCREASED|PAIN|HYPERCHOLESTEROLAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PAIN|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PAIN|DECREASED APPETITE|PROPHYLAXIS|CONSTIPATION|BACK PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION,Autoimmune hepatitis|Mental status changes|Asthenia|Transaminases increased,4,1
11305918,20150723,Atezolizumab,73,801,73.0,2,99.2,1,0,0,0,0,0,1,Atezolizumab,"PACLITAXEL|PROCHLORPERAZINE MALEATE|MIRTAZAPINE|ONDANSETRON HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE|TIOTROPIUM BROMIDE|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|BRIMONIDINE TARTRATE|PACLITAXEL|CARBOPLATIN|CARBOPLATIN|CALCIUM CARBONATE, SIMETHICONE|SIMETHICONE|LORAZEPAM|MIRTAZAPINE|CARBOPLATIN|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|FILGRASTIM|ALBUTEROL SULFATE|ALBUTEROL",25,NAUSEA|NAUSEA|DIARRHOEA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|DIARRHOEA|NAUSEA|GLAUCOMA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ABDOMINAL DISTENSION|ANXIETY|NAUSEA|ANXIETY|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NEUTROPENIA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NAUSEA,Neutropenia|Thrombocytopenia|Anaemia|Thrombocytopenia|Anaemia|Neutropenia,6,1
11430764,20150828,Atezolizumab,39,801,39.0,2,72.6,1,0,0,0,0,0,1,Atezolizumab,DULOXETINE HYDROCHLORIDE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LORAZEPAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LORATADINE|LORATADINE TABLET|ATEZOLIZUMAB|PACLITAXEL|PACLITAXEL|LORAZEPAM|PROCHLORPERAZINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FILGRASTIM|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ATEZOLIZUMAB|ZOLPIDEM TARTRATE,20,DEPRESSION|PROPHYLACTIC CHEMOTHERAPY|NAUSEA|ANXIETY|PROPHYLACTIC CHEMOTHERAPY|PYREXIA|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|ANXIETY|NAUSEA|PYREXIA|NEUTROPENIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|INSOMNIA,Neutrophil count decreased|Neutrophil count decreased,2,3
11434861,20150831,Atezolizumab,56,801,56.0,2,,1,0,0,0,0,0,1,Atezolizumab,MULTIVITAMIN|APREPITANT|FOSAPREPITANT DIMEGLUMINE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ATEZOLIZUMAB|CARBOPLATIN|FISH OIL|PACLITAXEL,11,PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLACTIC CHEMOTHERAPY|DIARRHOEA|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|NEOPLASM|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION,Neutropenia,1,3
11457320,20150904,Atezolizumab,53,801,53.0,1,83.1,1,0,1,0,0,0,0,Atezolizumab,"BEVACIZUMAB|BEVACIZUMAB|LISINOPRIL|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ATEZOLIZUMAB|ATEZOLIZUMAB|LEVOTHYROXINE",9,RENAL CELL CARCINOMA|HYPERTENSION|INCISION SITE COMPLICATION|RENAL CELL CARCINOMA|HYPOTHYROIDISM|DEEP VEIN THROMBOSIS,Diverticulitis,1,1
11499791,20150914,Atezolizumab,61,801,61.0,1,83.4,1,0,1,1,0,0,0,Atezolizumab,BEVACIZUMAB|POLYETHYLENE GLYCOL 3350|ATEZOLIZUMAB|FENTANYL|NIFEDIPINE|HYDROMORPHONE HYDROCHLORIDE|PREGABALIN|PROCHLORPERAZINE|LORAZEPAM|FAMOTIDINE|ZOLPIDEM TARTRATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PACLITAXEL|ROSUVASTATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|LORAZEPAM|CARBOPLATIN|ESOMEPRAZOLE MAGNESIUM,26,NON-SMALL CELL LUNG CANCER|CONSTIPATION|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|PAIN|HYPERLIPIDAEMIA|RAYNAUD^S PHENOMENON|PAIN|PAIN|HYPERLIPIDAEMIA|NAUSEA|ANXIETY|PROPHYLAXIS|INSOMNIA|NAUSEA|NON-SMALL CELL LUNG CANCER|HYPERLIPIDAEMIA|NAUSEA|PROPHYLAXIS|NAUSEA|PROPHYLAXIS|PAIN|MUSCLE SPASMS|INSOMNIA|NON-SMALL CELL LUNG CANCER|GASTROOESOPHAGEAL REFLUX DISEASE,Seizure,1,1
11529716,20150921,Atezolizumab,78,801,78.0,1,72.1,1,0,1,1,1,0,0,Atezolizumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LOSARTAN POTASSIUM|ATEZOLIZUMAB|FINASTERIDE|LEVOTHYROXINE SODIUM|OMEPRAZOLE MAGNESIUM|SIMVASTATIN|AMLODIPINE BESYLATE|MAGNESIUM OXIDE|BEVACIZUMAB,15,DEHYDRATION|MUCOSAL INFLAMMATION|BLOOD PRESSURE INCREASED|RENAL CELL CARCINOMA|POLLAKIURIA|HYPOTHYROIDISM|GASTROOESOPHAGEAL REFLUX DISEASE|ANGIOPATHY|BLOOD PRESSURE INCREASED|MUCOSAL INFLAMMATION|BLOOD MAGNESIUM DECREASED|RENAL CELL CARCINOMA,Systemic inflammatory response syndrome,1,1
11591905,20151005,Atezolizumab,72,801,72.0,1,81.37,1,0,0,1,0,0,1,Atezolizumab,ROSUVASTATIN|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|FUROSEMIDE|INSULIN GLARGINE|BEVACIZUMAB|INSULIN GLARGINE|INSULIN GLARGINE|INSULIN LISPRO|FUROSEMIDE|FAMOTIDINE|ATEZOLIZUMAB|INSULIN LISPRO|FUROSEMIDE,18,HYPERLIPIDAEMIA|HYPERTENSION|OEDEMA|DECREASED APPETITE|RENAL CELL CARCINOMA|HYPERGLYCAEMIA|HYPERGLYCAEMIA|HYPERLIPIDAEMIA|RENAL CELL CARCINOMA|HYPERGLYCAEMIA,Hypercalcaemia|Hypophosphataemia|Hyperthyroidism|Immune-mediated hepatitis,4,1
11633573,20151015,Atezolizumab,46,801,46.0,2,55.8,1,0,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|FENTANYL|FENTANYL|CEFEPIME HYDROCHLORIDE|CEFEPIME|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PACLITAXEL|PACLITAXEL|FENTANYL|SERTRALINE HYDROCHLORIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|CEFEPIME HYDROCHLORIDE|CEFEPIME|CLONAZEPAM|FENTANYL|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|METHYLPHENIDATE|METHYLPHENIDATE HYDROCHLORIDE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|FENTANYL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|STANDARDIZED SENNA CONCENTRATE|METHYLPHENIDATE HYDROCHLORIDE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL",42,NEOPLASM|DEHYDRATION|PYREXIA|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|DEPRESSION|THROMBOSIS|HYPONATRAEMIA|PROPHYLAXIS|PYREXIA|ORAL CANDIDIASIS|PREMEDICATION|PYREXIA|ANXIETY|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CONSTIPATION|DEPRESSION|PAIN|PREMEDICATION|HYPOTENSION|PRODUCT USED FOR UNKNOWN INDICATION|MENTAL IMPAIRMENT|PRODUCT USED FOR UNKNOWN INDICATION,Anaemia,1,3
11732868,20151113,Atezolizumab,63,801,63.0,1,63.2,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROXYZINE|DOXYCYCLINE MONOHYDRATE|DOXYCYCLINE MONOHYDRATE|TELMISARTAN|DOXYCYCLINE MONOHYDRATE|HYDROXYZINE|ATEZOLIZUMAB|COBIMETINIB|TELMISARTAN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN,22,METASTATIC NEOPLASM|DIARRHOEA|RASH|RASH|PROPHYLAXIS|RASH|HYPERTENSION|DIARRHOEA|METASTATIC NEOPLASM|RASH|RASH,Cerebrovascular accident,1,1
11769792,20151123,Atezolizumab,61,801,61.0,1,75,1,0,1,0,0,0,0,Atezolizumab,RANITIDINE|COBIMETINIB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ATEZOLIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE,16,GASTRITIS PROPHYLAXIS|CONSTIPATION|NEOPLASM|HYPERGLYCAEMIA|DECREASED APPETITE|PRODUCTIVE COUGH|GASTRITIS PROPHYLAXIS|ASPARTATE AMINOTRANSFERASE INCREASED|NEOPLASM|PERIPHERAL SENSORY NEUROPATHY|PYREXIA|HYPERGLYCAEMIA|ALANINE AMINOTRANSFERASE INCREASED|FATIGUE|HYPERGLYCAEMIA,Pneumonia|Pneumonia pneumococcal,2,1
11776505,20151125,Atezolizumab,82,801,82.0,1,101.6,1,0,1,1,0,0,0,Atezolizumab,"VEMURAFENIB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RIVASTIGMINE|VEMURAFENIB|COBIMETINIB|GLIMEPIRIDE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|METOPROLOL TARTRATE|METOPROLOL|SIMVASTATIN|ASCORBIC ACID|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ATEZOLIZUMAB|COBIMETINIB",16,METASTATIC MALIGNANT MELANOMA|BACK PAIN|DEMENTIA|RASH MACULO-PAPULAR|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|GLUCOSE TOLERANCE IMPAIRED|CANDIDA INFECTION|BACK PAIN|HYPERTENSION|BLOOD CHOLESTEROL INCREASED|PROPHYLAXIS|ABSCESS LIMB|DEHYDRATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Diverticulitis|Gait disturbance|Sepsis|Clostridium difficile infection|Tremor,5,1
11780738,20151126,Atezolizumab,40,801,40.0,2,62.9,1,0,1,0,0,0,0,Atezolizumab,COBIMETINIB|SENNOSIDES|SENNA LEAF|SENNA|AMOXICILLIN AND CLAVULANATE POTASSIUM|ATEZOLIZUMAB|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|MORPHINE|LORAZEPAM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|MORPHINE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS,20,NEOPLASM|CONSTIPATION|UPPER RESPIRATORY TRACT INFECTION|NEOPLASM|INSOMNIA|DIARRHOEA|UPPER RESPIRATORY TRACT INFECTION|COUGH|PAIN|PYREXIA|VOMITING|DYSPNOEA|INSOMNIA|UPPER RESPIRATORY TRACT INFECTION|NAUSEA|PAIN|FLUSHING,Pleural effusion,1,1
11782051,20151126,Atezolizumab,59,801,59.0,2,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|ATEZOLIZUMAB|FUROSEMIDE|IPILIMUMAB|OXYCODONE|IPILIMUMAB|PANTOPRAZOLE,9,DYSPNOEA|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|NEOPLASM|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION,Infection|Pyrexia,2,1
11784197,20151128,Atezolizumab,61,801,61.0,1,,1,1,1,1,0,0,0,Atezolizumab,DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|PACLITAXEL|EZETIMIBE|DABIGATRAN ETEXILATE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|PACLITAXEL|CARBOPLATIN|ALBUTEROL SULFATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|LEVOTHYROXINE,16,HYPERLIPIDAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|DIARRHOEA|DEPRESSION|HYPERLIPIDAEMIA|NON-SMALL CELL LUNG CANCER|ATRIAL FIBRILLATION|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|EMPHYSEMA|DIARRHOEA|ATRIAL FIBRILLATION|DIABETES MELLITUS|HYPOTHYROIDISM,Cardiac arrest|White blood cell count decreased|Respiratory distress|Neutrophil count decreased|Hyperkalaemia|Renal failure,6,1
11784892,20151130,Atezolizumab,83,801,83.0,1,94.9,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|COBIMETINIB|FUROSEMIDE|PROPRANOLOL HYDROCHLORIDE|LEVOTHYROXINE SODIUM|FUROSEMIDE|SITAGLIPTIN|IBUPROFEN|IBUPROFEN AND DIPHENHYDRAMINE CITRATE|INDAPAMIDE|MINOCYCLINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,16,NEOPLASM|NEOPLASM|HYPOKALAEMIA|HYPERLIPIDAEMIA|HYPERTENSION|HYPERTENSION|HYPOTHYROIDISM|DIABETES MELLITUS|DIABETES MELLITUS|BACK PAIN|HYPERTENSION|DERMATITIS ACNEIFORM|DIABETES MELLITUS|BACK PAIN,Pulmonary embolism,1,1
11812005,20151208,Atezolizumab,60,801,60.0,1,64.8,1,0,1,0,0,0,0,Atezolizumab,PACLITAXEL|PACLITAXEL|CARBOPLATIN|CARBOPLATIN|PACLITAXEL|PACLITAXEL|CARBOPLATIN|PACLITAXEL,21,TINEA INFECTION|PROPHYLAXIS OF NAUSEA AND VOMITING|NON-SMALL CELL LUNG CANCER|TINEA INFECTION|PROPHYLAXIS OF NAUSEA AND VOMITING|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING|HEPATIC FUNCTION ABNORMAL,Influenza like illness|Influenza like illness|Influenza like illness|Influenza like illness|Pericardial effusion|Influenza like illness,6,3
11825836,20151211,Atezolizumab,63,801,63.0,1,,1,0,1,1,0,0,0,Atezolizumab,"NEBIVOLOL HYDROCHLORIDE|DIGOXIN|PRASUGREL HYDROCHLORIDE|LEVOTHYROXINE SODIUM|ATEZOLIZUMAB|ATEZOLIZUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DILTIAZEM HYDROCHLORIDE",11,HYPERTENSION|ATRIAL FIBRILLATION|THROMBOSIS PROPHYLAXIS|ATRIAL FIBRILLATION|NEOPLASM|HYPOTHYROIDISM|NEOPLASM|CHILLS,Hyperglycaemia,1,5
11839131,20151216,Atezolizumab,75,801,75.0,1,65.5,1,0,1,0,0,0,0,Atezolizumab,"ZOLEDRONIC ACID|BEVACIZUMAB|DENOSUMAB|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|ATEZOLIZUMAB|LANSOPRAZOLE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE",8,RENAL CELL CARCINOMA|METASTASES TO BONE|ACIDOSIS|RENAL CELL CARCINOMA|PAIN|ECZEMA,Renal impairment,1,1
11843816,20151217,Atezolizumab,60,801,60.0,1,85.9,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BEVACIZUMAB|AMLODIPINE|RAMIPRIL,6,RENAL CELL CARCINOMA|RENAL CELL CARCINOMA|HYPERTENSION|HYPERTENSION|DIARRHOEA,Pyrexia|Seizure,2,1
11855136,20151221,Atezolizumab,66,801,66.0,1,65.6,1,1,1,0,0,0,0,Atezolizumab,DOXYCYCLINE|DOXYCYCLINE HYCLATE|MEGESTROL ACETATE|ATENOLOL|COBIMETINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ATEZOLIZUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE,15,RASH|PAIN|HORMONE THERAPY|HYPERTENSION|COUGH|PYREXIA|MYALGIA|LOWER RESPIRATORY TRACT INFECTION|NEOPLASM|LIP DRY|DERMATITIS ACNEIFORM|NEOPLASM|RASH|LOWER RESPIRATORY TRACT INFECTION,Dyspnoea|Pneumonitis,2,1
11859097,20151222,Atezolizumab,57,801,57.0,2,51.2,1,0,1,1,0,0,0,Atezolizumab,"ATEZOLIZUMAB|CEFTRIAXONE|CEFTRIAXONE SODIUM|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|METRONIDAZOLE|METRONIDAZOLE TOPICAL|SPIRONOLACTONE|DEXTROSE MONOHYDRATE|DEXTROSE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|CEFAZOLIN SODIUM|CEFAZOLIN|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|FUROSEMIDE|FUROSEMIDE|CEFTRIAXONE|CEFTRIAXONE SODIUM|FLUCONAZOLE|OFLOXACIN|OFLOXACIN OTIC|OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3%|OFLOXACIN OTIC SOLUTION|DEXTROSE MONOHYDRATE|DEXTROSE|COBIMETINIB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|CARBOXYMETHYLCELLULOSE SODIUM",22,NEOPLASM|DIARRHOEA|OEDEMA|DIARRHOEA|OEDEMA|DECREASED APPETITE|OEDEMA|CELLULITIS|CELLULITIS|CELLULITIS|BLOOD URIC ACID INCREASED|PROPHYLAXIS|CELLULITIS|CELLULITIS|CELLULITIS|CELLULITIS|NEOPLASM|RASH|PROPHYLAXIS|DRY EYE,Asthenia,1,1
11864672,20151223,Atezolizumab,64,801,64.0,1,,1,0,1,1,0,0,1,Atezolizumab,"OXALIPLATIN|BEVACIZUMAB|BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|ATEZOLIZUMAB|OXALIPLATIN|ATEZOLIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",10,COLORECTAL CANCER STAGE III|COLORECTAL CANCER STAGE III|COLORECTAL CANCER STAGE III|METASTASES TO LIVER|COLORECTAL CANCER STAGE III|METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LIVER|COLORECTAL CANCER STAGE III|METASTASES TO LIVER,Anaemia|Cardiac failure|Bacterial infection|Cardiac disorder|Ejection fraction abnormal|Haemorrhage|Dyspnoea|Seizure|Pulmonary oedema|Rash|Swelling|Peripheral swelling,12,5
11867780,20151224,Atezolizumab,62,801,62.0,2,,1,0,1,0,0,0,0,Atezolizumab,SIMVASTATIN|PACLITAXEL|PACLITAXEL|SERTRALINE HYDROCHLORIDE,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION,Intracranial mass,1,3
11869812,20151228,Atezolizumab,55,801,55.0,2,109.7,1,0,1,0,0,0,0,Atezolizumab,"BEVACIZUMAB|OXYCODONE|OXYCODONE|MONTELUKAST|TRIAMTERENE AND HYDROCHLOROTHIAZIDE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|MELATONIN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETYLCYSTEINE|ACETYLCYSTEINE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|ACETYLCYSTEINE|OXYCODONE|ATEZOLIZUMAB|LEVOTHYROXINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM",23,RENAL CELL CARCINOMA|SEASONAL ALLERGY|CONSTIPATION|MYALGIA|PROCEDURAL PAIN|SEASONAL ALLERGY|HYPERTENSION|VITAMIN D DEFICIENCY|SEASONAL ALLERGY|DIARRHOEA|INSOMNIA|ARTHRALGIA|PROPHYLAXIS|CONSTIPATION|HEADACHE|RENAL CELL CARCINOMA|THROMBOSIS PROPHYLAXIS|HYPOTHYROIDISM|THROMBOSIS PROPHYLAXIS|RHINITIS ALLERGIC|PYELONEPHRITIS,Autoimmune hepatitis,1,1
11889660,20160105,Atezolizumab,56,801,56.0,2,,1,0,1,0,0,0,0,Atezolizumab,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PACLITAXEL,9,PAIN|BREAST CANCER METASTATIC|PAIN|RADIATION OESOPHAGITIS|NAUSEA|PROPHYLAXIS|CHEMOTHERAPY|BREAST CANCER METASTATIC|RADIATION OESOPHAGITIS,Spinal pain,1,3
11912215,20160112,Atezolizumab,73,801,73.0,2,,1,1,1,0,0,0,0,Atezolizumab,"PACLITAXEL|PEMETREXED|PEMETREXED DISODIUM|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|CARBOPLATIN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|LEVOTHYROXINE",10,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NAUSEA|COUGH|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NAUSEA|PAIN|HYPOTHYROIDISM,Dizziness|Confusional state|Cardiac arrest|Sepsis,4,3
11915593,20160114,Atezolizumab,40,801,40.0,2,,1,0,1,0,0,0,0,Atezolizumab,PROMETHAZINE HYDROCHLORIDE|MOMETASONE FUROATE|POLYETHYLENE GLYCOL 3350|LORAZEPAM|ALPRAZOLAM|GRANISETRON|PACLITAXEL|PACLITAXEL|OMEPRAZOLE MAGNESIUM|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RIZATRIPTAN BENZOATE|OXYCODONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|LEVOTHYROXINE SODIUM,21,PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|SEASONAL ALLERGY|CONSTIPATION|PREMEDICATION|ANXIETY|ANXIETY|NAUSEA|NEOPLASM|NEOPLASM|TUMOUR PAIN|DYSPEPSIA|DIARRHOEA|PREMEDICATION|MIGRAINE|TUMOUR PAIN|DIARRHOEA|PREMEDICATION|HYPOTHYROIDISM,Interstitial lung disease,1,3
11929087,20160120,Atezolizumab,79,801,79.0,1,101,1,1,1,1,0,0,1,Atezolizumab,"TIOTROPIUM BROMIDE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|INSULIN GLARGINE|VALSARTAN|VALSARTAN ORAL|ROSUVASTATIN|LORAZEPAM|PACLITAXEL|CARBOPLATIN|BISOPROLOL FUMARATE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|CEFTRIAXONE|CEFTRIAXONE SODIUM|PACLITAXEL|ROSUVASTATIN|LORAZEPAM|FLUCONAZOLE|VALSARTAN|VALSARTAN ORAL|DIMENHYDRINATE|DIMENHYDRINATE|CEFTRIAXONE|CEFTRIAXONE SODIUM|FLUCONAZOLE|CARBOPLATIN|BISOPROLOL FUMARATE",43,CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|DIABETES MELLITUS|NAUSEA|DYSLIPIDAEMIA|ATRIAL FLUTTER|VOMITING|VOMITING|PRODUCT USED FOR UNKNOWN INDICATION|CORONARY ARTERY DISEASE|VOMITING|VOMITING|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|NAUSEA|VOMITING|RENAL INJURY|PRODUCT USED FOR UNKNOWN INDICATION|VOMITING|VOMITING|VOMITING|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|SYSTEMIC CANDIDA|DIABETES MELLITUS|OROPHARYNGEAL DISCOMFORT|PRODUCT USED FOR UNKNOWN INDICATION|VOMITING|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|VOMITING|NON-SMALL CELL LUNG CANCER|DIABETES MELLITUS|NAUSEA|VOMITING|VOMITING,Oropharyngeal discomfort|Colitis,2,3
11937840,20160122,Atezolizumab,42,801,42.0,1,77,1,0,1,0,0,0,0,Atezolizumab,PACLITAXEL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MELOXICAM|CYANOCOBALAMIN|THEOPHYLLINE|THIAMINE HYDROCHLORIDE|ATEZOLIZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|BEVACIZUMAB|MELOXICAM|CARBOPLATIN|RANITIDINE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE,29,CHEST PAIN|NON-SMALL CELL LUNG CANCER|DYSPNOEA|PYREXIA|MYALGIA|PYREXIA|PERIPHERAL SENSORY NEUROPATHY|PERIPHERAL SENSORY NEUROPATHY|DYSPNOEA|PERIODONTAL DISEASE|PERIPHERAL SENSORY NEUROPATHY|NON-SMALL CELL LUNG CANCER|CHEST PAIN|COUGH|CHEST PAIN|CHEST PAIN|NON-SMALL CELL LUNG CANCER|ARTHRALGIA|NON-SMALL CELL LUNG CANCER|CHEST PAIN|PYREXIA|STOMATITIS,Anaemia,1,1
11957388,20160126,Atezolizumab,63,801,63.0,2,,1,0,0,0,0,0,0,Atezolizumab,MILK THISTLE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|GABAPENTIN|MELATONIN|FISH OIL|GABAPENTIN|PACLITAXEL|GABAPENTIN|LOSARTAN|GABAPENTIN,18,PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PROPHYLAXIS|DIABETES MELLITUS|NAUSEA|PERIPHERAL SENSORY NEUROPATHY|INSOMNIA|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|HYPERTENSION|PAIN,Onychomadesis,1,3
11985755,20160202,Atezolizumab,60,801,60.0,1,49,1,0,1,0,0,0,0,Atezolizumab,CARBOPLATIN|BEVACIZUMAB|PACLITAXEL|ATEZOLIZUMAB,9,NON-SMALL CELL LUNG CANCER|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CHEST PAIN|INSOMNIA|NON-SMALL CELL LUNG CANCER|CHEST PAIN|NON-SMALL CELL LUNG CANCER|CHEST PAIN|NON-SMALL CELL LUNG CANCER,Pyopneumothorax,1,1
11993440,20160203,Atezolizumab,74,801,74.0,2,73,1,0,1,0,0,0,1,Atezolizumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PACLITAXEL|CARBOPLATIN|PANTOPRAZOLE,13,HYPERTENSION|BACK PAIN|ANXIETY|ANAEMIA|TACHYCARDIA|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|COUGH|GASTROOESOPHAGEAL REFLUX DISEASE|INSOMNIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|GASTROOESOPHAGEAL REFLUX DISEASE,Asthenia|Pericardial effusion,2,3
12005583,20160204,Atezolizumab,68,801,68.0,1,83.3,1,0,1,0,0,0,0,Atezolizumab,"BEVACIZUMAB|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ACETYLCYSTEINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|AMLODIPINE|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL|ATEZOLIZUMAB|DOXAZOSIN|DOXAZOSIN MESYLATE|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|LISINOPRIL",25,RENAL CELL CARCINOMA|RHINORRHOEA|RHINORRHOEA|HYPONATRAEMIA|BLOOD BICARBONATE DECREASED|DIARRHOEA|PROPHYLAXIS|HYPERTENSION|MULTIPLE ALLERGIES|RHINORRHOEA|HYPERCHOLESTEROLAEMIA|VOMITING|HYPONATRAEMIA|HYPERTENSION|MULTIPLE ALLERGIES|NAUSEA|RENAL CELL CARCINOMA|DEHYDRATION|HYPERTENSION|HERPES ZOSTER|HYPOCALCAEMIA|HYPERKALAEMIA|HYPERGLYCAEMIA|HYPERTENSION,Acute kidney injury,1,1
12007987,20160205,Atezolizumab,68,801,68.0,1,68.6,1,1,0,0,0,0,0,Atezolizumab,ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE MAGNESIUM|ZOLEDRONIC ACID|BEVACIZUMAB|PACLITAXEL|ZOLEDRONIC ACID|ATEZOLIZUMAB|CARBOPLATIN,29,HYPERTENSION|MYALGIA|ARTHRALGIA|CANCER PAIN|GASTRITIS|GASTRITIS|PREMEDICATION|METASTASES TO BONE|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|CANCER PAIN|MYALGIA|CANCER PAIN|PREMEDICATION|CANCER PAIN|MYALGIA|CONSTIPATION|PREMEDICATION|GASTRITIS|INSOMNIA|INSOMNIA|MYALGIA|ARTHRALGIA|INSOMNIA|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|ARTHRALGIA|ARTHRALGIA,Aortic dissection,1,1
12050222,20160209,Atezolizumab,81,801,81.0,1,77.6,1,1,1,0,0,0,0,Atezolizumab,LEVOTHYROXINE|BEVACIZUMAB|AMLODIPINE BESYLATE|FINASTERIDE|ATEZOLIZUMAB|ATENOLOL|ATORVASTATIN CALCIUM,11,HYPOTHYROIDISM|RENAL CELL CARCINOMA|HYPERTENSION|BENIGN PROSTATIC HYPERPLASIA|BENIGN PROSTATIC HYPERPLASIA|RENAL CELL CARCINOMA|HYPERTENSION|POLLAKIURIA|BLOOD CHOLESTEROL INCREASED|HYPERTENSION,Acute kidney injury,1,1
12067192,20160211,Atezolizumab,,,,2,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|OXYCODONE|SENNOSIDES|SENNA LEAF|SENNA|PACLITAXEL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CARBOPLATIN|PEMETREXED|PEMETREXED DISODIUM,9,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|CONSTIPATION|NON-SMALL CELL LUNG CANCER|PAIN|PREMEDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Large intestinal obstruction|Off label use,2,5
12078123,20160215,Atezolizumab,65,801,65.0,2,,1,0,1,1,0,0,0,Atezolizumab,"PACLITAXEL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PACLITAXEL|SENNOSIDES|SENNA LEAF|SENNA|INDAPAMIDE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|ATEZOLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LINAGLIPTIN|ENALAPRIL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",23,BREAST CANCER METASTATIC|BLOOD CHOLESTEROL INCREASED|ARTHRALGIA|VOMITING|CONSTIPATION|SEPSIS|THROMBOSIS PROPHYLAXIS|ARTHRALGIA|ARTHRALGIA|SEPSIS|CONSTIPATION|HYPERTENSION|BLOOD MAGNESIUM DECREASED|CONSTIPATION|BLOOD POTASSIUM DECREASED|BREAST CANCER METASTATIC|PROPHYLAXIS|ARTHRALGIA|ARTHRALGIA|DIABETES MELLITUS|HYPERTENSION|PROPHYLAXIS,Supraventricular tachycardia|Supraventricular tachycardia|Post procedural complication,3,3
12104035,20160223,Atezolizumab,76,801,76.0,1,51.9,1,0,0,1,0,0,0,Atezolizumab,"FLURBIPROFEN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|INSULIN HUMAN|INSULIN HUMAN|HEPARIN SODIUM|INSULIN HUMAN|MAGNESIUM OXIDE|HEPARIN SODIUM|MIRTAZAPINE|INSULIN HUMAN|INSULIN HUMAN|INSULIN HUMAN|MAGNESIUM OXIDE|LANSOPRAZOLE|INSULIN HUMAN|ATEZOLIZUMAB|BEVACIZUMAB|CANDESARTAN CILEXETIL|CROTAMITON|INSULIN HUMAN|INSULIN HUMAN|INSULIN HUMAN|INSULIN HUMAN|INSULIN HUMAN|INSULIN HUMAN|CANDESARTAN CILEXETIL|SODIUM HYALURONATE",46,TRACHEITIS OBSTRUCTIVE|BACK PAIN|GAMMA-GLUTAMYLTRANSFERASE INCREASED|HYPOKALAEMIA|DIABETES MELLITUS|DIABETES MELLITUS|INSOMNIA|TRACHEITIS OBSTRUCTIVE|BLOOD ALKALINE PHOSPHATASE INCREASED|THROMBOSIS IN DEVICE|HYPOKALAEMIA|DIABETES MELLITUS|BLOOD ALKALINE PHOSPHATASE INCREASED|BLOOD ALKALINE PHOSPHATASE INCREASED|DELIRIUM|DIABETES MELLITUS|DIABETES MELLITUS|DIABETES MELLITUS|CONSTIPATION|GAMMA-GLUTAMYLTRANSFERASE INCREASED|DIABETES MELLITUS|FLUID REPLACEMENT|RENAL CELL CARCINOMA|RENAL CELL CARCINOMA|INSOMNIA|HYPERTENSION|PRURITUS|DIABETES MELLITUS|TRACHEITIS OBSTRUCTIVE|GAMMA-GLUTAMYLTRANSFERASE INCREASED|PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME|HYPERTENSION|HYPERTENSION|DIABETES MELLITUS|DIABETES MELLITUS|HYPERTENSION|DRY EYE,Systemic immune activation|Pneumonia,2,1
12113014,20160225,Atezolizumab,41,801,41.0,2,60.5,1,0,1,0,0,0,0,Atezolizumab,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PACLITAXEL|ATEZOLIZUMAB|OXYCODONE",12,PAIN|BREAST CANCER METASTATIC|PAIN|URINARY TRACT INFECTION|PRODUCT USED FOR UNKNOWN INDICATION|FLUID REPLACEMENT|BREAST CANCER METASTATIC|PAIN|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PAIN,Pleuritic pain|Rectal haemorrhage|Dyspnoea,3,3
12113018,20160225,Atezolizumab,71,801,71.0,2,,1,0,1,0,0,0,1,Atezolizumab,"CARBOPLATIN|DIPHENHYDRAMINE HYDROCHLORIDE|PACLITAXEL|ERGOCALCIFEROL|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PACLITAXEL|LEVETIRACETAM|DIPHENHYDRAMINE HYDROCHLORIDE",18,NON-SMALL CELL LUNG CANCER|PRURITUS|VOMITING|PRODUCT USED FOR UNKNOWN INDICATION|VOMITING|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|SEIZURE|PRODUCT USED FOR UNKNOWN INDICATION|RASH|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|HYPERLIPIDAEMIA|NAUSEA|NAUSEA,White blood cell count decreased|Platelet count decreased|Neutrophil count decreased|Hemiparesis|Brain oedema,5,3
12117669,20160226,Atezolizumab,71,801,71.0,2,42.7,1,0,1,0,0,0,0,Atezolizumab,"RANITIDINE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|RANITIDINE|PACLITAXEL|OXYCODONE|RANITIDINE|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|TRANEXAMIC ACID|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|ATEZOLIZUMAB|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|CARBOPLATIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|RANITIDINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|BEVACIZUMAB|ZOLPIDEM TARTRATE|RABEPRAZOLE SODIUM|RABEPRAZOLE|MAGNESIUM OXIDE",45,FEBRILE NEUTROPENIA|DECREASED APPETITE|GASTRITIS|DRY SKIN|NAUSEA|CONSTIPATION|HYPONATRAEMIA|NON-SMALL CELL LUNG CANCER STAGE IV|CANCER PAIN|GASTRITIS|CANCER PAIN|INSOMNIA|HYPERSENSITIVITY|GASTRITIS|CONSTIPATION|HAEMOPTYSIS|HAEMOPTYSIS|NAUSEA|FEBRILE NEUTROPENIA|NON-SMALL CELL LUNG CANCER STAGE IV|HEADACHE|CANCER PAIN|NAUSEA|PERIPHERAL SENSORY NEUROPATHY|OROPHARYNGEAL PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|CANCER PAIN|DECREASED APPETITE|CONSTIPATION|INFECTION PROPHYLAXIS|GASTRITIS PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|INSOMNIA|GASTRITIS|CONSTIPATION,Encephalitis,1,1
12118919,20160226,Atezolizumab,62,801,62.0,1,64.5,1,0,1,0,0,0,0,Atezolizumab,"LULICONAZOLE|CHLORPHENIRAMINE MALEATE|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|ALLOPURINOL|FAMOTIDINE|CHLORPHENIRAMINE MALEATE|APREPITANT|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LANSOPRAZOLE|APREPITANT|FENTANYL CITRATE|BEVACIZUMAB|PACLITAXEL|ZOLEDRONIC ACID|PREGABALIN|FAMOTIDINE|MAGNESIUM OXIDE|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|CARBOPLATIN|GRANISETRON HYDROCHLORIDE|GRANISETRON HYDROCHLORIDE|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|KETOPROFEN|ATEZOLIZUMAB|OLMESARTAN MEDOXOMIL",37,CANCER PAIN|FUNGAL SKIN INFECTION|CONSTIPATION|HYPERURICAEMIA|PREMEDICATION|PREMEDICATION|NAUSEA|ARTHRALGIA|GASTRIC ULCER|CONSTIPATION|PERIPHERAL SENSORY NEUROPATHY|CANCER PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CONSTIPATION|METASTASES TO BONE|PERIPHERAL SENSORY NEUROPATHY|CONSTIPATION|ENDOSCOPY UPPER GASTROINTESTINAL TRACT|INFLUENZA LIKE ILLNESS|HYPERLIPIDAEMIA|INFLUENZA LIKE ILLNESS|CHOLANGITIS|NON-SMALL CELL LUNG CANCER|CANCER PAIN|PREMEDICATION|ENDOSCOPY UPPER GASTROINTESTINAL TRACT|CONTUSION|NON-SMALL CELL LUNG CANCER|HYPERTENSION|OESOPHAGITIS,Cholangitis,1,1
12126151,20160229,Atezolizumab,41,801,41.0,2,56,1,0,1,0,0,0,0,Atezolizumab,"SUMATRIPTAN|SUMATRIPTAN SUCCINATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|GABAPENTIN|ATEZOLIZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|GABAPENTIN|PROPRANOLOL HYDROCHLORIDE|CHLORZOXAZONE|BEVACIZUMAB|GABAPENTIN|CHLORZOXAZONE|GABAPENTIN|GABAPENTIN|TRIAZOLAM",28,PERIPHERAL SENSORY NEUROPATHY|PERIPHERAL SENSORY NEUROPATHY|PAIN|PERIPHERAL SENSORY NEUROPATHY|MIGRAINE|PAIN|PERIPHERAL SENSORY NEUROPATHY|PERIPHERAL SENSORY NEUROPATHY|RENAL CELL CARCINOMA|NAUSEA|PERIPHERAL SENSORY NEUROPATHY|PERIPHERAL SENSORY NEUROPATHY|PERIPHERAL SENSORY NEUROPATHY|PERIPHERAL SENSORY NEUROPATHY|MIGRAINE|PAIN|PAIN|ULCER|PERIPHERAL SENSORY NEUROPATHY|RENAL CELL CARCINOMA|PERIPHERAL SENSORY NEUROPATHY|PAIN|NAUSEA|CYSTITIS|PERIPHERAL SENSORY NEUROPATHY|PERIPHERAL SENSORY NEUROPATHY|DIARRHOEA|INSOMNIA,Influenza like illness,1,1
12127542,20160229,Atezolizumab,40,801,40.0,2,,1,0,0,0,0,0,1,Atezolizumab,BEVACIZUMAB|ATEZOLIZUMAB|PREDNISONE|PREDNISONE|GRANISETRON|GRANISETRON HYDROCHLORIDE|PREDNISONE|PREDNISONE|ATEZOLIZUMAB|PACLITAXEL|FILGRASTIM|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS,18,PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|EMBOLISM|FULL BLOOD COUNT DECREASED|RASH|DIARRHOEA|ABDOMINAL DISTENSION|FLUID REPLACEMENT,Type 1 diabetes mellitus,1,3
12130286,20160301,Atezolizumab,45,801,45.0,2,63,1,0,1,0,0,0,0,Atezolizumab,CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|METRONIDAZOLE|METRONIDAZOLE TOPICAL|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ALPRAZOLAM|ESOMEPRAZOLE MAGNESIUM|MORPHINE SULFATE|POTASSIUM DIHYDROGEN PHOSPHATE|DEXTROMETHORPHAN|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|FENTANYL|GABAPENTIN|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|LEVOTHYROXINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|MORPHINE SULFATE|POTASSIUM DIHYDROGEN PHOSPHATE|ATEZOLIZUMAB|FAMOTIDINE|FAMOTIDINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ATEZOLIZUMAB|FAMOTIDINE|LEVOTHYROXINE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|MEROPENEM|COBIMETINIB|FENTANYL|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|ADENOSINE|MORPHINE SULFATE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|FAMOTIDINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|POTASSIUM DIHYDROGEN PHOSPHATE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|CARBOXYMETHYLCELLULOSE SODIUM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ALPRAZOLAM|SULFAMETHOXAZOLE AND TRIMETHOPRIM,79,ABDOMINAL SEPSIS|INFECTION PROPHYLAXIS|ORAL CANDIDIASIS|PAIN|HYPOPHOSPHATAEMIA|COUGH|HYPOTENSION|NEUROPATHY PERIPHERAL|HYPOTENSION|NASOPHARYNGEAL CANCER|PROPHYLAXIS|PAIN|INSOMNIA|HYPOPITUITARISM|INFECTION PROPHYLAXIS|INFECTION|NASOPHARYNGEAL CANCER|COUGH|INFECTION PROPHYLAXIS|HYPOPITUITARISM|SINUS TACHYCARDIA|SINUS TACHYCARDIA|DYSPNOEA|COUGH|HYPOPITUITARISM|OEDEMA PERIPHERAL|HYPOMAGNESAEMIA|DIARRHOEA|SUPPLEMENTATION THERAPY|INSOMNIA|COUGH|COUGH|ABDOMINAL SEPSIS|HYPOTENSION,Pericardial effusion,1,1
12143341,20160304,Atezolizumab,67,801,67.0,2,62.1,1,0,1,1,0,0,0,Atezolizumab,"COBIMETINIB|MORPHINE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SENNOSIDES|SENNA LEAF|SENNA|ATEZOLIZUMAB|LACTULOSE|LACTULOSE|OXYCODONE HYDROCHLORIDE|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|KETOPROFEN|PYRIDOSTIGMINE BROMIDE ORAL|COBIMETINIB|COBIMETINIB|PREGABALIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|AMLODIPINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|ATEZOLIZUMAB|KETOPROFEN|LACTULOSE|PREGABALIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|SENNOSIDES|SENNA LEAF|SENNA|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG",48,PAIN|VOMITING|SEPSIS|PROPHYLAXIS|CONSTIPATION|NAUSEA|DEEP VEIN THROMBOSIS|CONSTIPATION|PAIN|PAIN|PAIN|MYASTHENIA GRAVIS|NEOPLASM|NEURALGIA|HYPOTENSION|PROPHYLAXIS|URINARY TRACT INFECTION|PROPHYLAXIS|NEOPLASM|PROPHYLAXIS|VOMITING|NAUSEA|PAIN|PAIN|PAIN|VOMITING|DEEP VEIN THROMBOSIS|NAUSEA|CONSTIPATION|PAIN|DIABETES MELLITUS,Sepsis|Back pain,2,1
12147944,20160304,Atezolizumab,65,801,65.0,1,,1,0,1,0,0,0,0,Atezolizumab,PACLITAXEL|SITAGLIPTIN|TRIAMTERENE CAPSULES|TRIAMTERENE|AMLODIPINE|ATENOLOL|SIMVASTATIN|CARBOPLATIN|PREDNISONE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|LOSARTAN,13,NON-SMALL CELL LUNG CANCER|DIABETES MELLITUS|MULTIPLE ALLERGIES|OEDEMA|HYPERTENSION|HYPERTENSION|BLOOD CHOLESTEROL INCREASED|FULL BLOOD COUNT DECREASED|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|FATIGUE|DIABETES MELLITUS|DIABETES MELLITUS,Confusional state|Renal impairment,2,1
12157260,20160308,Atezolizumab,43,801,43.0,2,57.5,1,0,1,0,0,0,0,Atezolizumab,LORAZEPAM|COBIMETINIB|FUROSEMIDE|ATEZOLIZUMAB|COBIMETINIB|LEVOTHYROXINE SODIUM,9,INSOMNIA|ANAEMIA|ABDOMINAL PAIN UPPER|NEOPLASM|NEOPLASM|HYPERTHYROIDISM,Dyspnoea,1,1
12177437,20160315,Atezolizumab,68,801,68.0,1,63.8,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|BEVACIZUMAB|FUROSEMIDE|AMLODIPINE BESYLATE,6,PRURITUS|RENAL CELL CARCINOMA|RENAL CELL CARCINOMA|OEDEMA PERIPHERAL|HYPERKALAEMIA|HYPERTENSION,Acute kidney injury,1,1
12182555,20160316,Atezolizumab,61,801,61.0,1,54.1,1,0,1,1,0,0,1,Atezolizumab,"COBIMETINIB|FUROSEMIDE|IPRATROPIUM BROMIDE|IPRATROPIUM BROMIDE|ATEZOLIZUMAB|FENTANYL|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|IPRATROPIUM BROMIDE|POTASSIUM PHOSPHATE, MONOBASIC|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|HYDROCORTISONE SODIUM SUCCINATE|IPRATROPIUM BROMIDE",25,METASTATIC NEOPLASM|PROPHYLAXIS|PNEUMONIA ASPIRATION|ABDOMINAL PAIN|PROPHYLAXIS|BRONCHIOLITIS|BRONCHIOLITIS|ABDOMINAL PAIN|PNEUMONIA ASPIRATION|METASTATIC NEOPLASM|ABDOMINAL PAIN|BRONCHIOLITIS|ATELECTASIS|EMPHYSEMA|EMPHYSEMA|HYPOPHOSPHATAEMIA|PYREXIA|PROPHYLAXIS|EMPHYSEMA|ATELECTASIS|PNEUMONIA ASPIRATION|PROPHYLAXIS|ATELECTASIS,Stevens-Johnson syndrome|Ileal perforation,2,1
12190074,20160318,Atezolizumab,55,801,55.0,2,,1,0,1,0,0,0,0,Atezolizumab,PROCHLORPERAZINE|LORAZEPAM|NICOTINE POLACRILEX|NICOTINE|NICOTINE POLACRILEX MINI|NICOTINE POLARILEX|POLYETHYLENE GLYCOL|PANTOPRAZOLE|COBIMETINIB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PANTOPRAZOLE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|LORAZEPAM|ZOLPIDEM TARTRATE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|HALOPERIDOL|HALOPERIDOL LACTATE|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL|SENNOSIDES|SENNA LEAF|SENNA|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FUROSEMIDE|ATEZOLIZUMAB|OXYCODONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|LACTULOSE,27,NAUSEA|INSOMNIA|EX-TOBACCO USER|CONSTIPATION|GASTRITIS PROPHYLAXIS|HYPONATRAEMIA|METASTATIC NEOPLASM|NAUSEA|GASTRITIS|CLOSTRIDIUM DIFFICILE INFECTION|ANXIETY|FLATULENCE|INSOMNIA|GASTRITIS|ANXIETY|CONSTIPATION|GASTRITIS|CONSTIPATION|OEDEMA PERIPHERAL|VENA CAVA THROMBOSIS|METASTATIC NEOPLASM|ABDOMINAL PAIN|NUTRITIONAL SUPPLEMENTATION|INSOMNIA|CONSTIPATION,Small intestine ulcer,1,1
12196103,20160321,Atezolizumab,58,801,58.0,2,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METOPROLOL TARTRATE|METOPROLOL|DEXTROMETHORPHAN|IRON|PACLITAXEL|CARBOPLATIN|LORAZEPAM|ZOLEDRONIC ACID|ERGOCALCIFEROL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS,16,NON-SMALL CELL LUNG CANCER|PROPHYLAXIS AGAINST DIARRHOEA|NAUSEA|ATRIAL FIBRILLATION|NEUTROPENIA|THROMBOSIS PROPHYLAXIS|COUGH|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|NEUTROPENIA|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|PRERENAL FAILURE,Hyponatraemia|Hypokalaemia,2,3
12206132,20160324,Atezolizumab,26,801,26.0,1,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|OBINUTUZUMAB,13,DIFFUSE LARGE B-CELL LYMPHOMA|THROMBOSIS PROPHYLAXIS|DIFFUSE LARGE B-CELL LYMPHOMA|HAEMOPTYSIS|WHEEZING|LOWER RESPIRATORY TRACT INFECTION|LOWER RESPIRATORY TRACT INFECTION|PLEURAL EFFUSION|OROPHARYNGEAL PAIN|COUGH|WHEEZING|PLEURAL EFFUSION|PLEURAL EFFUSION,Pleural effusion|Lower respiratory tract infection,2,1
12209948,20160325,Atezolizumab,79,801,79.0,1,75.4,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|COBIMETINIB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,4,NEOPLASM|NEOPLASM|BACK PAIN|CONJUNCTIVITIS,Pruritus,1,1
12223534,20160330,Atezolizumab,69,801,69.0,2,,1,0,1,0,0,0,0,Atezolizumab,"CARBOPLATIN|BRINZOLAMIDE|LORAZEPAM|SIMVASTATIN|PACLITAXEL|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|ATEZOLIZUMAB|INDOMETHACIN|BIMATOPROST|MAGNESIUM OXIDE|BIOTIN|INDOMETHACIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALBUTEROL SULFATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PROCHLORPERAZINE MALEATE|COLCHICINE|VENLAFAXINE HYDROCHLORIDE",23,DRY SKIN|NON-SMALL CELL LUNG CANCER|GLAUCOMA|ANXIETY|HYPERLIPIDAEMIA|NON-SMALL CELL LUNG CANCER|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|DEPRESSION|NON-SMALL CELL LUNG CANCER|PAIN|GLAUCOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GOUT|HYPERTENSION|DYSPEPSIA|HYPERTENSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NAUSEA|PAIN|NAUSEA|GOUT|HYPERTENSION,Hypoxia,1,1
12240740,20160406,Atezolizumab,70,801,70.0,1,59,1,0,1,0,0,0,0,Atezolizumab,CLARITHROMYCIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|NASAL|SALINE|(SALINE)|CARBOPLATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|IPRATROPIUM BROMIDE|PREGABALIN|BEVACIZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATEZOLIZUMAB|PACLITAXEL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,35,GASTRITIS|INFUSION RELATED REACTION|C-REACTIVE PROTEIN INCREASED|PROPHYLAXIS|GENERAL PHYSICAL HEALTH DETERIORATION|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|PNEUMONIA|GENERAL PHYSICAL HEALTH DETERIORATION|GENERAL PHYSICAL HEALTH DETERIORATION|NON-SMALL CELL LUNG CANCER STAGE IV|ANAEMIA|DEHYDRATION|PROPHYLAXIS|GENERAL PHYSICAL HEALTH DETERIORATION|INFUSION RELATED REACTION|PROPHYLAXIS OF NAUSEA AND VOMITING|ANAEMIA|DEHYDRATION|DYSPNOEA|GASTRITIS|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|TYPE 2 DIABETES MELLITUS|HYPERGLYCAEMIA|INSOMNIA|C-REACTIVE PROTEIN INCREASED,Duodenal ulcer,1,1
12241108,20160406,Atezolizumab,71,801,71.0,2,47.7,1,0,1,0,0,0,0,Atezolizumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PACLITAXEL|SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE|SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE|SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE|SODIUM CHLORIDE, SOLDIUM LACTATE, POTASSIUM CHLORIDE AND CALCIUM CHLORIDE|CARBOPLATIN|RISEDRONATE SODIUM|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|HYDROCORTISONE ACETATE|HYDROCORTISONE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ATEZOLIZUMAB|STANDARDIZED SENNA CONCENTRATE|CEFIXIME|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|BEVACIZUMAB|AMLODIPINE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CEFTAZIDIME|PANTOPRAZOLE|ROSUVASTATIN|APREPITANT|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS",31,HYPERTENSION|FEBRILE NEUTROPENIA|INSOMNIA|NON-SMALL CELL LUNG CANCER STAGE IV|FEBRILE NEUTROPENIA|NON-SMALL CELL LUNG CANCER STAGE IV|OSTEOPOROSIS|DIARRHOEA|HAEMORRHOIDS|CONSTIPATION|PROPHYLAXIS OF NAUSEA AND VOMITING|UPPER RESPIRATORY TRACT INFECTION|STOMATITIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|CEREBROVASCULAR ACCIDENT PROPHYLAXIS|CONSTIPATION|UPPER RESPIRATORY TRACT INFECTION|STOMATITIS|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|UPPER RESPIRATORY TRACT INFECTION|FEBRILE NEUTROPENIA|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERLIPIDAEMIA|PROPHYLAXIS OF NAUSEA AND VOMITING|UPPER RESPIRATORY TRACT INFECTION|HYPOKALAEMIA,Acute kidney injury,1,1
12243389,20160406,Atezolizumab,34,801,34.0,2,,1,0,1,1,0,0,1,Atezolizumab,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PACLITAXEL|PACLITAXEL,8,HEADACHE|BREAST CANCER METASTATIC|DYSPNOEA|COUGH|NAUSEA|BREAST CANCER METASTATIC,Pulmonary embolism|Diplopia,2,3
12252882,20160411,Atezolizumab,34,801,34.0,2,,1,0,1,1,0,0,0,Atezolizumab,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CYCLOBENZAPRINE|PACLITAXEL|PACLITAXEL,8,BREAST CANCER METASTATIC|NAUSEA|DYSPNOEA|PAIN|BREAST CANCER METASTATIC|COUGH,Diplopia|Headache|Pulmonary embolism,3,3
12253813,20160411,Atezolizumab,69,801,69.0,2,,1,0,1,0,0,0,0,Atezolizumab,"BIOTIN|PACLITAXEL|ALBUTEROL SULFATE|LORAZEPAM|MAGNESIUM OXIDE|INDOMETHACIN|BRINZOLAMIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|SIMVASTATIN|OXYCODONE|INDOMETHACIN|CARBOPLATIN|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|COLCHICINE|VENLAFAXINE HYDROCHLORIDE|BIMATOPROST|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PROCHLORPERAZINE MALEATE|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN",27,HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|DEPRESSION|NON-SMALL CELL LUNG CANCER|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|ANXIETY|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|GLAUCOMA|PAIN|HYPERLIPIDAEMIA|PAIN|DRY SKIN|GOUT|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|GOUT|HYPERTENSION|GLAUCOMA|DYSPEPSIA|NAUSEA|NAUSEA|HYPOMAGNESAEMIA|POLLAKIURIA|PULMONARY EMBOLISM,Hypoxia,1,1
12265473,20160413,Atezolizumab,69,801,69.0,1,73.82,1,0,1,0,0,0,0,Atezolizumab,"PALONOSETRON HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FILGRASTIM|ACYCLOVIR|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FILGRASTIM|CARBOPLATIN|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|LORAZEPAM|NAPROXEN SODIUM|NAPROXEN SODIUM 220MG|NAPROXEN SODIUM, COATED TABLETS|NAPROXEN SODIUM TABLET, COATED|PROCHLORPERAZINE|PACLITAXEL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",16,INSOMNIA|PREMEDICATION|NAUSEA|NEUTROPENIA|HERPES ZOSTER|PREMEDICATION|PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|TACHYCARDIA|ANXIETY|HEADACHE|NAUSEA|NON-SMALL CELL LUNG CANCER|GASTROOESOPHAGEAL REFLUX DISEASE,Dizziness,1,3
12270926,20160415,Atezolizumab,74,801,74.0,1,76.2,1,0,0,1,0,0,1,Atezolizumab,"OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OXYCODONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|OXYGEN|0XYGEN|MORPHINE|LIDOCAINE HYDROCHLORIDE|LIDOCAINE HYDROCHLORIDE ANHYDROUS|MAGNESIUM HYDROXIDE|CARBOPLATIN|LORAZEPAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|ALUMINUM HYDROXIDE|PACLITAXEL|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|INSULIN LISPRO|BIMATOPROST|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PACLITAXEL|ALBUTEROL SULFATE|ALBUTEROL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|TIOTROPIUM BROMIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CARBOPLATIN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ERGOCALCIFEROL",35,PAIN|DYSPEPSIA|MUSCULOSKELETAL PAIN|PRODUCT USED FOR UNKNOWN INDICATION|CONSTIPATION|HYPOXIA|ANXIETY|MUSCULOSKELETAL PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|NUTRITIONAL SUPPLEMENTATION|ANXIETY|NAUSEA|HYPOMAGNESAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|DIABETES MELLITUS|DIABETES MELLITUS|OCULAR HYPERTENSION|DYSPEPSIA|NON-SMALL CELL LUNG CANCER|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CARDIAC DISORDER|HYPOTENSION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|VOMITING|STOMATITIS|DYSURIA|HYPOKALAEMIA|ANXIETY|NON-SMALL CELL LUNG CANCER|SUPPLEMENTATION THERAPY,Myocardial infarction|Pneumonia,2,3
12273667,20160415,Atezolizumab,38,801,38.0,2,,1,0,0,0,0,0,1,Atezolizumab,"PACLITAXEL|MORPHINE|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CEPHALEXIN|PACLITAXEL|DENOSUMAB|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|MORPHINE|GABAPENTIN|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|CYCLOBENZAPRINE|ERGOCALCIFEROL|LINEZOLID|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXYCODONE|CYCLOBENZAPRINE|LORAZEPAM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|CEFTRIAXONE|CEFTRIAXONE SODIUM|LINEZOLID|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|PROCHLORPERAZINE MALEATE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",38,NEOPLASM|METASTASES TO CENTRAL NERVOUS SYSTEM|CELLULITIS|SKIN INFECTION|NEOPLASM|OSTEOPOROSIS PROPHYLAXIS|CELLULITIS|PAIN|NEUROPATHY PERIPHERAL|CONSTIPATION|CELLULITIS|PAIN|MUSCLE SPASMS|BONE DISORDER|CELLULITIS|CELLULITIS|CELLULITIS|PAIN|MUSCULOSKELETAL PAIN|ANAEMIA|ANXIETY|CELLULITIS|CELLULITIS|ANAEMIA|NAUSEA|CELLULITIS,Pneumonitis,1,1
12281932,20160419,Atezolizumab,40,801,40.0,2,,1,0,0,0,0,0,0,Atezolizumab,"OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)|GRANISETRON|GRANISETRON HYDROCHLORIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ALTEPLASE|LORATADINE|LORATADINE ORAL|PACLITAXEL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|GUAIFENESIN|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|BUPROPION|MAGNESIUM HYDROXIDE|GUAIFENESIN|POLYETHYLENE GLYCOL",27,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CATHETER MANAGEMENT|URINARY TRACT INFECTION|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS OF NAUSEA AND VOMITING|DYSURIA|CATHETER MANAGEMENT|PRODUCT USED FOR UNKNOWN INDICATION|SINUS CONGESTION|BREAST CANCER METASTATIC|PAIN|THROMBOSIS PROPHYLAXIS|RHINITIS ALLERGIC|URINARY RETENTION|CONSTIPATION|NAUSEA|POLLAKIURIA|DEPRESSION|DEPRESSION|CONSTIPATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCTIVE COUGH|HEADACHE|PRODUCT USED FOR UNKNOWN INDICATION,Headache|Influenza like illness,2,1
12284224,20160420,Atezolizumab,50,801,50.0,2,80,1,0,1,0,0,0,0,Atezolizumab,"PACLITAXEL|MORPHINE SULFATE|PACLITAXEL|MORPHINE SULFATE|PROCHLORPERAZINE|FAMOTIDINE|OXYCODONE HYDROCHLORIDE|OXYCODONE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|SENNOSIDES|SENNA LEAF|SENNA|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ZOLPIDEM TARTRATE|DENOSUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED",19,BREAST CANCER METASTATIC|PAIN|NAUSEA|VOMITING|PAIN|RED MAN SYNDROME|CONSTIPATION|FOLLICULITIS|CONSTIPATION|PAIN|PAIN|INSOMNIA|BREAST CANCER METASTATIC|METASTASES TO BONE|ADVERSE DRUG REACTION|CONSTIPATION,Pleural effusion|Hypoxia|Dyspnoea exertional,3,3
12293680,20160421,Atezolizumab,79,801,79.0,2,83.2,1,0,1,0,0,0,0,Atezolizumab,LOSARTAN POTASSIUM|LOSARTAN|LEVOTHYROXINE SODIUM|BEVACIZUMAB|FUROSEMIDE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|MONTELUKAST SODIUM|PHYTONADIONE|ATEZOLIZUMAB|METOPROLOL TARTRATE|METOPROLOL|FOLIC ACID|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|SPIRONOLACTONE|LEVOTHYROXINE SODIUM,13,HYPERTENSION|NEOPLASM|OEDEMA PERIPHERAL|ASTHMA|ASTHMA|GASTROINTESTINAL HAEMORRHAGE|NEOPLASM|URINARY TRACT INFECTION|ASCITES|HYPOTHYROIDISM,Aspartate aminotransferase increased|Autoimmune hepatitis|Blood alkaline phosphatase increased|Bilirubin conjugated increased|Alanine aminotransferase increased|Blood bilirubin increased,6,1
12296491,20160422,Atezolizumab,57,801,57.0,1,,1,1,0,0,0,0,0,Atezolizumab,BISOPROLOL FUMARATE|CARBOPLATIN|ENOXAPARIN SODIUM|ATEZOLIZUMAB|PACLITAXEL|AMINOCAPROIC ACID,7,HYPERTENSION|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|ARRHYTHMIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
12304617,20160426,Atezolizumab,55,801,55.0,1,93.4,1,0,1,0,0,0,0,Atezolizumab,"VEMURAFENIB|COBIMETINIB|BUPROPION|ATEZOLIZUMAB|VEMURAFENIB|ATENOLOL|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|ESCITALOPRAM OXALATE|ESCITALOPRAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISONE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|COBIMETINIB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|VEMURAFENIB|TOPIRAMATE|TOPIRAMATE SPINKLE|PREDNISONE|PREDNISONE|COBIMETINIB|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|PREDNISONE",23,METASTATIC MALIGNANT MELANOMA|DEPRESSION|DIARRHOEA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|DIARRHOEA|HYPERTENSION|NAUSEA|DIARRHOEA|RHINITIS ALLERGIC|PAIN|METASTATIC MALIGNANT MELANOMA|RASH MACULO-PAPULAR|METASTATIC MALIGNANT MELANOMA,Blood creatine phosphokinase increased|Aspartate aminotransferase increased|Diarrhoea,3,1
12308610,20160427,Atezolizumab,73,801,73.0,2,100,1,0,1,0,0,0,0,Atezolizumab,OBINUTUZUMAB|ZOLPIDEM TARTRATE|METHYLPREDNISOLONE SODIUM SUCCINATE|ENOXAPARIN SODIUM|METHYLPREDNISOLONE SODIUM SUCCINATE|ATEZOLIZUMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM,23,DIFFUSE LARGE B-CELL LYMPHOMA|INSOMNIA|GASTROOESOPHAGEAL REFLUX DISEASE|INFECTION PROPHYLAXIS|VITAMIN SUPPLEMENTATION|PREMEDICATION|PROPHYLAXIS OF NAUSEA AND VOMITING|DYSLIPIDAEMIA|PREMEDICATION|OEDEMA PERIPHERAL|LYMPHADENOPATHY|PROPHYLAXIS|THROMBOSIS PROPHYLAXIS|PREMEDICATION|DIFFUSE LARGE B-CELL LYMPHOMA|PROPHYLAXIS OF NAUSEA AND VOMITING|PAIN IN EXTREMITY|OEDEMA PERIPHERAL|HYPERTENSION|INFECTION PROPHYLAXIS,Hyperthermia,1,1
12318568,20160429,Atezolizumab,62,801,62.0,2,,1,0,1,0,0,0,0,Atezolizumab,ENOXAPARIN SODIUM|ATEZOLIZUMAB|ALPRAZOLAM,7,NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM,Pneumonia,1,1
12328241,20160503,Atezolizumab,43,801,43.0,2,64.47,1,0,1,0,0,0,0,Atezolizumab,PACLITAXEL|OXYCODONE HYDROCHLORIDE|ALBUTEROL SULFATE|ALBUTEROL|PERFLUTREN|IBUPROFEN|IBUPROFEN AND DIPHENHYDRAMINE CITRATE|OMEPRAZOLE MAGNESIUM|FUROSEMIDE|LORATADINE|LORATADINE TABLET|PANTOPRAZOLE|CARBOPLATIN|OXYCODONE|IRON SUCROSE|IBUPROFEN|IBUPROFEN AND DIPHENHYDRAMINE CITRATE|MORPHINE|OXYCODONE|OXYCODONE|METOCLOPRAMIDE HYDROCHLORIDE|CLONAZEPAM|OXYCODONE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|METOCLOPRAMIDE HYDROCHLORIDE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|NICOTINE|FUROSEMIDE|OXYCODONE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE|PROMETHAZINE HYDROCHLORIDE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|PACLITAXEL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PHYTONADIONE,55,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COUGH|WHEEZING|PRODUCT USED FOR UNKNOWN INDICATION|PYREXIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COUGH|PRODUCT USED FOR UNKNOWN INDICATION|CONSTIPATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|COUGH|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypoxia|Dyspnoea,2,3
12335542,20160505,Atezolizumab,76,801,76.0,1,62,1,0,0,0,0,0,1,Atezolizumab,NIVOLUMAB|NIVOLUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|ATEZOLIZUMAB,6,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Interstitial lung disease,1,1
12343011,20160506,Atezolizumab,79,801,79.0,1,101,1,0,1,0,0,0,0,Atezolizumab,"PACLITAXEL|TIOTROPIUM BROMIDE|VALSARTAN|VALSARTAN ORAL|ROSUVASTATIN|LORAZEPAM|FLUCONAZOLE|METOPROLOL TARTRATE|METOPROLOL|CARBOPLATIN|CARBOPLATIN|ROSUVASTATIN|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|CEFTRIAXONE|CEFTRIAXONE SODIUM|INSULIN GLARGINE|LORAZEPAM|DIMENHYDRINATE|CEFTRIAXONE|CEFTRIAXONE SODIUM|BISOPROLOL FUMARATE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|DIMENHYDRINATE|PACLITAXEL|FLUCONAZOLE",42,OROPHARYNGEAL DISCOMFORT|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|HYPERTENSION|DYSLIPIDAEMIA|VOMITING|VOMITING|CORONARY ARTERY DISEASE|SYSTEMIC CANDIDA|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|VOMITING|PRODUCT USED FOR UNKNOWN INDICATION|VOMITING|PRODUCT USED FOR UNKNOWN INDICATION|VOMITING|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|DIABETES MELLITUS|VOMITING|ATRIAL FLUTTER|PRODUCT USED FOR UNKNOWN INDICATION|DIABETES MELLITUS|NAUSEA|VOMITING|PRODUCT USED FOR UNKNOWN INDICATION|VOMITING|VOMITING|VOMITING|VOMITING|NAUSEA|CORONARY ARTERY DISEASE|NAUSEA|RENAL INJURY|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|VOMITING,Bacterial colitis|Oropharyngeal discomfort,2,3
12353342,20160510,Atezolizumab,69,801,69.0,1,64.4,1,0,1,0,0,0,0,Atezolizumab,LANSOPRAZOLE|PANTOPRAZOLE|PROCHLORPERAZINE|ATEZOLIZUMAB|PROCHLORPERAZINE|METOPROLOL TARTRATE|METOPROLOL|HYDROCHLOROTHIAZIDE|LACTULOSE|BEVACIZUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SENNOSIDES|SENNA LEAF|SENNA,15,GASTROOESOPHAGEAL REFLUX DISEASE|GASTROOESOPHAGEAL REFLUX DISEASE|NAUSEA|INSOMNIA|RENAL CELL CARCINOMA|RENAL VEIN THROMBOSIS|VOMITING|HYPERTENSION|HYPERTENSION|CONSTIPATION|RENAL CELL CARCINOMA|DEHYDRATION|CARDIOVASCULAR DISORDER|HYPERTENSION|CONSTIPATION,Autoimmune hepatitis,1,1
12354993,20160511,Atezolizumab,69,801,69.0,1,,1,0,1,0,0,0,0,Atezolizumab,PRASUGREL HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXYCODONE HYDROCHLORIDE|ATEZOLIZUMAB|METOPROLOL TARTRATE|METOPROLOL|GEMFIBROZIL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|AMLODIPINE|CARBOPLATIN|ATEZOLIZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CARBOPLATIN|TIOTROPIUM BROMIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|NIFEDIPINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PACLITAXEL|NIFEDIPINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DOXYCYCLINE|DOXYCYCLINE HYCLATE|PACLITAXEL|NITROGLYCERIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PACLITAXEL|CARBOPLATIN|FUROSEMIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,47,PRODUCT USED FOR UNKNOWN INDICATION|GASTRIC DISORDER|MUSCULOSKELETAL CHEST PAIN|MUSCULOSKELETAL CHEST PAIN|ANGIOPATHY|GASTRIC ULCER|BLOOD CHOLESTEROL|BLOOD CHOLESTEROL|PYREXIA|DIARRHOEA|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|URINARY TRACT INFECTION|OSTEOPOROSIS PROPHYLAXIS|DYSPNOEA|INSOMNIA|PROPHYLAXIS OF NAUSEA AND VOMITING|GASTRIC DISORDER|SKIN DISORDER|HYPERTENSION|BRONCHITIS|URINARY TRACT INFECTION|NON-SMALL CELL LUNG CANCER|CONSTIPATION PROPHYLAXIS|CHEST PAIN|ANAEMIA|MUSCULOSKELETAL CHEST PAIN|PROPHYLAXIS AGAINST DEHYDRATION|NON-SMALL CELL LUNG CANCER|DYSPNOEA|TRANSFUSION|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLACTIC CHEMOTHERAPY,Hypomagnesaemia|Rectal haemorrhage|Febrile neutropenia|Rectal haemorrhage|Hypocalcaemia|Malaise|Hyponatraemia,7,3
12360507,20160512,Atezolizumab,75,801,75.0,2,,1,0,1,1,0,0,0,Atezolizumab,ATEZOLIZUMAB|CALCIUM|PACLITAXEL|ERGOCALCIFEROL|RAMIPRIL,13,BREAST CANCER METASTATIC|DEPRESSION|ATRIAL FLUTTER|DEPRESSION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|OEDEMA|NAUSEA|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|THYROID OPERATION|ATRIAL FLUTTER|PRODUCT USED FOR UNKNOWN INDICATION,Respiratory distress|Infective exacerbation of chronic obstructive airways disease,2,3
12378620,20160517,Atezolizumab,78,801,78.0,1,72,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|BEVACIZUMAB,21,HYPERCHOLESTEROLAEMIA|DIARRHOEA|URINARY TRACT INFECTION|HYPERTENSION|RENAL CELL CARCINOMA|CONSTIPATION|DYSPEPSIA|VITAMIN D DEFICIENCY|URINARY TRACT INFECTION|DIARRHOEA|HYPERTENSION|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION|DIARRHOEA|RENAL CELL CARCINOMA|HYPERTENSION|DIARRHOEA|CONSTIPATION,Hypotension,1,1
12386694,20160519,Atezolizumab,71,801,71.0,2,,1,0,1,0,0,0,0,Atezolizumab,"LOSARTAN|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|AMLODIPINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ATEZOLIZUMAB|CARBOPLATIN|PACLITAXEL|FLUOCINONIDE|FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%|CEFTAZIDIME|WARFARIN|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN",15,HYPERTENSION|DIARRHOEA|HYPERTENSION|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DYSPEPSIA|NON-SMALL CELL LUNG CANCER|RASH MACULO-PAPULAR|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Influenza like illness|Febrile neutropenia,2,3
12391929,20160523,Atezolizumab,76,801,76.0,1,103.3,1,0,1,0,0,0,0,Atezolizumab,ESCITALOPRAM|SIMVASTATIN|LORAZEPAM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OXYCODONE|OMEPRAZOLE MAGNESIUM|CEFEPIME HYDROCHLORIDE|CEFEPIME|ATEZOLIZUMAB|BEVACIZUMAB|GABAPENTIN|SOLIFENACIN SUCCINATE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN,14,DEPRESSION|HYPERCHOLESTEROLAEMIA|ANXIETY|DIABETES MELLITUS|URINARY TRACT OBSTRUCTION|BACK PAIN|ABDOMINAL PAIN LOWER|LUNG INFECTION|NEOPLASM|NEOPLASM|NEUROPATHY PERIPHERAL|URINARY TRACT OBSTRUCTION|LUNG INFECTION,Pneumonia,1,1
12395447,20160523,Atezolizumab,78,801,78.0,2,,1,0,1,0,0,0,0,Atezolizumab,"POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|MONTELUKAST|SERTRALINE HYDROCHLORIDE|PROCHLORPERAZINE|PEGFILGRASTIM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|GRANISETRON|GRANISETRON HYDROCHLORIDE|PACLITAXEL|GABAPENTIN|LORAZEPAM|EPOETIN ALFA|PALONOSETRON HYDROCHLORIDE|PACLITAXEL|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|OXYGEN|0XYGEN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|FLUCONAZOLE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",29,GASTROOESOPHAGEAL REFLUX DISEASE|DYSPNOEA|RHINITIS ALLERGIC|RHINITIS ALLERGIC|DEPRESSION|NAUSEA|NEUTROPENIA|NAUSEA|NAUSEA|NEUROPATHY PERIPHERAL|ANXIETY|ANAEMIA|PROPHYLAXIS OF NAUSEA AND VOMITING|TRIPLE NEGATIVE BREAST CANCER|CELLULITIS|HYPOTHYROIDISM|HYPERTENSION|HYPOXIA|DIARRHOEA|TRIPLE NEGATIVE BREAST CANCER|NUTRITIONAL SUPPLEMENTATION|INSOMNIA|ANTIBIOTIC PROPHYLAXIS|DIARRHOEA|PROPHYLAXIS,Dehydration|Acute respiratory failure|Hypokalaemia,3,1
12399220,20160524,Atezolizumab,66,801,66.0,1,101,1,1,1,1,0,0,0,Atezolizumab,ATEZOLIZUMAB,7,METASTATIC NEOPLASM|METASTATIC NEOPLASM,Acute kidney injury|Capillary leak syndrome,2,1
12400385,20160525,Atezolizumab,64,801,64.0,1,92,1,0,1,0,0,0,0,Atezolizumab,ROSUVASTATIN|ATEZOLIZUMAB|AMOXICILLIN AND CLAVULANATE POTASSIUM|CARBOPLATIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE,17,NON-SMALL CELL LUNG CANCER|HYPERCHOLESTEROLAEMIA|COUGH|HYPERCHOLESTEROLAEMIA|ORAL CANDIDIASIS|NON-SMALL CELL LUNG CANCER|COUGH|CARDIOVASCULAR EVENT PROPHYLAXIS|CHEST PAIN|COUGH|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|CARDIOVASCULAR EVENT PROPHYLAXIS|ORAL CANDIDIASIS|PROPHYLAXIS|HYPERTENSION|CHEST PAIN,Colitis,1,1
12400415,20160525,Atezolizumab,75,801,75.0,1,55.4,1,0,1,0,0,0,0,Atezolizumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|GRANISETRON|GRANISETRON HYDROCHLORIDE|DIGOXIN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LACTULOSE|CARBOPLATIN|AMOXICILLIN AND CLAVULANATE POTASSIUM|CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE|PACLITAXEL|CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|RANITIDINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SENNOSIDES|SENNA LEAF|SENNA|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ATEZOLIZUMAB,30,PROPHYLAXIS|PREMEDICATION|ATRIAL FIBRILLATION|DYSPNOEA|BRONCHITIS|COUGH|DRUG HYPERSENSITIVITY|VOMITING|CONSTIPATION|NON-SMALL CELL LUNG CANCER STAGE IV|DIARRHOEA|INFECTION|DYSPNOEA|NASAL CONGESTION|HYPERSENSITIVITY|NON-SMALL CELL LUNG CANCER STAGE IV|RHINORRHOEA|MYALGIA|UPPER RESPIRATORY TRACT INFECTION|PREMEDICATION|NAUSEA|NAUSEA|CONSTIPATION|PREMEDICATION|DRUG HYPERSENSITIVITY|NON-SMALL CELL LUNG CANCER STAGE IV|CONSTIPATION,Bronchitis|Enterocolitis infectious,2,1
12401449,20160525,Atezolizumab,73,801,73.0,2,,1,1,1,0,0,0,0,Atezolizumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PACLITAXEL|LEVOTHYROXINE|CARBOPLATIN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|CHLORHEXIDINE GLUCONATE|ANTISEPTIC SKIN CLEANSER|PEMETREXED|PEMETREXED DISODIUM",14,NAUSEA|VOMITING|PYREXIA|NON-SMALL CELL LUNG CANCER|HYPOTHYROIDISM|NON-SMALL CELL LUNG CANCER|PAIN|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|INFECTION PROPHYLAXIS|COUGH|FLUID REPLACEMENT|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Lung infection|Death|Sepsis,3,1
12401620,20160525,Atezolizumab,,,,0,,1,1,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis,1,5
12403167,20160525,Atezolizumab,69,801,69.0,1,87.7,1,0,1,0,0,0,0,Atezolizumab,OXYCODONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ATEZOLIZUMAB|LORAZEPAM|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|PROCHLORPERAZINE|SIMVASTATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350,20,BLADDER CANCER|BLADDER CANCER|URINARY TRACT INFECTION,Colitis|Anaemia,2,1
12403594,20160525,Atezolizumab,60,801,60.0,1,89,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|CARBOPLATIN,9,LUNG SQUAMOUS CELL CARCINOMA STAGE IV|EPILEPSY|THROMBOSIS PROPHYLAXIS|EPILEPSY|LUNG SQUAMOUS CELL CARCINOMA STAGE IV|THROMBOSIS PROPHYLAXIS|LUNG SQUAMOUS CELL CARCINOMA STAGE IV,Epistaxis,1,1
12405389,20160525,Atezolizumab,14,801,14.0,2,39.5,1,1,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ALPRAZOLAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|MORPHINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ATEZOLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LACTULOSE|LACTULOSE|MORPHINE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)",24,NEOPLASM RECURRENCE|PAIN|PAIN|PAIN|ANXIETY|HYPOKALAEMIA|PAIN|PROPHYLAXIS|PAIN|CONSTIPATION|PAIN|PAIN|CONSTIPATION|CONSTIPATION|PAIN,Cardio-respiratory arrest|Superior vena cava syndrome,2,1
12405581,20160526,Atezolizumab,77,801,77.0,2,58,1,0,1,0,0,0,1,Atezolizumab,BEVACIZUMAB|BEVACIZUMAB|CARBOPLATIN|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|PACLITAXEL|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|FAMOTIDINE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|SULFAMETHOXAZOLE AND TRIMETHOPRIM|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|ALPRAZOLAM|LORAZEPAM|VALACYCLOVIR HYDROCHLORIDE|ATEZOLIZUMAB|BUPROPION HYDROCHLORIDE|FOLIC ACID|SENNOSIDES|SENNA LEAF|SENNA|GABAPENTIN|AMLODIPINE BESYLATE|TRIAMTERENE CAPSULES|TRIAMTERENE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|LEVOTHYROXINE SODIUM|ATORVASTATIN CALCIUM|NEBIVOLOL HYDROCHLORIDE|MIRTAZAPINE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|ALBUTEROL SULFATE|ALBUTEROL|PEGFILGRASTIM|POLYETHYLENE GLYCOL 3350,42,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|CANDIDA INFECTION|NON-SMALL CELL LUNG CANCER STAGE IV|PREMEDICATION|PREMEDICATION|HYPOMAGNESAEMIA|URINARY TRACT INFECTION|PAIN|MYOSITIS|NAUSEA|URINARY TRACT INFECTION|VIRAL INFECTION|DEHYDRATION|PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|DEPRESSION|CONSTIPATION|NEURALGIA|HYPERTENSION|BACK PAIN|HYPERTENSION|PREMEDICATION|CONSTIPATION|HYPOTHYROIDISM|HYPERCHOLESTEROLAEMIA|MACULAR DEGENERATION|NAUSEA|HYPERTENSION|HYPERTENSION|INSOMNIA|DYSPEPSIA|PAIN|PARAINFLUENZAE VIRUS INFECTION|PREMEDICATION|PREMEDICATION|CONSTIPATION,Pneumonia|Transaminases increased|Pancreatitis,3,1
12405619,20160526,Atezolizumab,29,801,29.0,2,46.2,1,0,1,0,0,0,0,Atezolizumab,ESOMEPRAZOLE MAGNESIUM|ATEZOLIZUMAB,6,PROPHYLAXIS|PROPHYLAXIS|PNEUMOTHORAX|NEOPLASM,Thrombocytopenia,1,1
12405857,20160526,Atezolizumab,64,801,64.0,2,58,1,0,1,0,0,0,0,Atezolizumab,PACLITAXEL|ALENDRONATE SODIUM|ALENDRONATE SODIUM TABLET|RANITIDINE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|BEVACIZUMAB|LORATADINE|LORATADINE ORAL|CARBOPLATIN|ATEZOLIZUMAB|PALONOSETRON|PALONOSETRON HYDROCHLORIDE,14,NON-SMALL CELL LUNG CANCER|HYPERTENSION|PREMEDICATION|NON-SMALL CELL LUNG CANCER|PREMEDICATION|PAIN MANAGEMENT|NON-SMALL CELL LUNG CANCER|NEURALGIA|PAIN MANAGEMENT|NON-SMALL CELL LUNG CANCER|PREMEDICATION,Febrile neutropenia|Diarrhoea|Vomiting|Nausea,4,1
12405870,20160526,Atezolizumab,77,801,77.0,1,92,1,0,1,0,0,0,0,Atezolizumab,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATEZOLIZUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|SIMVASTATIN|FENTANYL|CARBOPLATIN,22,NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|DIABETES MELLITUS|DIABETES MELLITUS|DIABETES MELLITUS|METASTASES TO BONE|TUMOUR PAIN|PROPHYLAXIS|HYPERTENSIVE HEART DISEASE|HYPERTENSION|MUSCULOSKELETAL CHEST PAIN|NON-SMALL CELL LUNG CANCER|MUSCULOSKELETAL CHEST PAIN|LEUKOPENIA,Cholestasis,1,1
12405954,20160526,Atezolizumab,51,801,51.0,2,66.28,1,0,0,0,0,0,1,Atezolizumab,"OMEPRAZOLE MAGNESIUM|PROCHLORPERAZINE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|FLUCONAZOLE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|OXYGEN|0XYGEN|MAGNESIUM OXIDE|SODIUM PHOSPHATE|ALBUTEROL SULFATE|ALBUTEROL|ATEZOLIZUMAB|CETIRIZINE HYDROCHLORIDE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|METOPROLOL TARTRATE|METOPROLOL|MAGNESIUM HYDROXIDE|AMOXICILLIN AND CLAVULANATE POTASSIUM|CETIRIZINE HYDROCHLORIDE|GABAPENTIN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CLOTRIMAZOLE|DRS. CLOTRIMAZOLE|FAMILY WELLNESS CLOTRIMAZOLE|CLOTRIMAZOLE TOPICAL|HYDROMORPHONE HYDROCHLORIDE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|BENZONATATE|HYDROMORPHONE HYDROCHLORIDE|HYDROMORPHONE HYDROCHLORIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PROCHLORPERAZINE|GUAIFENESIN|GUAIFENESIN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|CARISOPRODOL|CETIRIZINE HYDROCHLORIDE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|MAGNESIUM OXIDE|DIAZEPAM|ERGOCALCIFEROL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OMEPRAZOLE MAGNESIUM|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|CARISOPRODOL|DRONABINOL",70,BREAST CANCER METASTATIC|DYSPHONIA|VOMITING|EPISTAXIS|PROCTITIS|INFECTION PROPHYLAXIS|PNEUMONIA|INFECTION PROPHYLAXIS|NUTRITIONAL SUPPLEMENTATION|EPISTAXIS|SINUS CONGESTION|SUPRAVENTRICULAR TACHYCARDIA|HYPOPHOSPHATAEMIA|DYSPNOEA|CONSTIPATION|BREAST CANCER METASTATIC|DYSPHONIA|PROPHYLAXIS OF NAUSEA AND VOMITING|NAUSEA|DYSPHAGIA|PNEUMONIA|SUPRAVENTRICULAR TACHYCARDIA|CONSTIPATION|PYREXIA|DYSPHONIA|SINUS CONGESTION|PERIPHERAL SENSORY NEUROPATHY|OROPHARYNGEAL PAIN|HYPOKALAEMIA|BACK PAIN|PNEUMONIA|ORAL CANDIDIASIS|BACK PAIN|VOMITING|EPIGLOTTITIS|INFECTION|HYPOMAGNESAEMIA|COUGH|BACK PAIN|BACK PAIN|BACK PAIN|COUGH|NAUSEA|SINUS CONGESTION|COUGH|HYPOTENSION|BACK PAIN|COUGH|OROPHARYNGEAL PAIN|HYPERSENSITIVITY|OROPHARYNGEAL PAIN|OROPHARYNGEAL PAIN|INFECTION PROPHYLAXIS|HYPOMAGNESAEMIA|ANXIETY|NUTRITIONAL SUPPLEMENTATION|URINARY TRACT INFECTION|BACK PAIN|PROCTITIS|GASTROOESOPHAGEAL REFLUX DISEASE|OROPHARYNGEAL PAIN|INFECTION PROPHYLAXIS|OROPHARYNGEAL PAIN|BACK PAIN|NAUSEA|PYREXIA,Adverse drug reaction,1,1
12405983,20160526,Atezolizumab,73,801,73.0,2,35.3,1,0,1,0,0,0,0,Atezolizumab,"ALPRAZOLAM|EPINASTINE HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ATEZOLIZUMAB|CARBOPLATIN|PACLITAXEL|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE|ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|FAMOTIDINE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|GLYCERINE|CANDESARTAN CILEXETIL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|MAGNESIUM OXIDE|PALONOSETRON HYDROCHLORIDE|CHLORPHENIRAMINE MALEATE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|NAPROXEN|NAPROXEN SODIUM|DULOXETINE HYDROCHLORIDE|DULOXETIN HYDROCHLORIDE|DULOXETINE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|HYDROXYZINE PAMOATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL",31,INSOMNIA|DRUG ERUPTION|HYPOKALAEMIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|GASTROOESOPHAGEAL REFLUX DISEASE|ARTHRALGIA|HYPERSENSITIVITY|NAUSEA|CONSTIPATION|HYPERTENSION|HYPONATRAEMIA|HYPERTENSION|CONSTIPATION|HYPOKALAEMIA|NAUSEA|HYPERSENSITIVITY|PRURITUS|TUMOUR ASSOCIATED FEVER|UPPER RESPIRATORY TRACT INFECTION|NEUROPATHY PERIPHERAL|COUGH|DRUG ERUPTION|NEUROPATHY PERIPHERAL|RASH|DRUG ERUPTION|DIARRHOEA,Pneumonia,1,1
12406494,20160526,Atezolizumab,41,801,41.0,1,75.9,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|BEVACIZUMAB|LACTULOSE,11,NIGHT SWEATS|PROCEDURAL PAIN|THROMBOSIS PROPHYLAXIS|NIGHT SWEATS|RENAL CELL CARCINOMA|RENAL CELL CARCINOMA,Systemic inflammatory response syndrome,1,1
12406767,20160526,Atezolizumab,47,801,47.0,2,93.7,1,0,0,0,0,0,1,Atezolizumab,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CAPECITABINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|BEVACIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATEZOLIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FERROUS SULFATE|HYDROXYZINE HYDROCHLORIDE|HYDROXYZINE|HYDROXYZINE HYDROCHLORIDE ORAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RAMIPRIL|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|HYDROXYZINE HYDROCHLORIDE|HYDROXYZINE|HYDROXYZINE HYDROCHLORIDE ORAL|HYDROXYZINE HYDROCHLORIDE|HYDROXYZINE|HYDROXYZINE HYDROCHLORIDE ORAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ERYTHROMYCIN,38,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|PROPHYLAXIS|HYPERTENSION|PRURITUS|PRURITUS|COUGH,Pulmonary embolism,1,1
12408597,20160526,Atezolizumab,13,801,13.0,1,40.1,1,0,1,0,0,0,1,Atezolizumab,ATEZOLIZUMAB|PHYTONADIONE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|METHYLPREDNISOLONE|METHYLPREDNISOLONE,22,PYREXIA|PAIN|NEOPLASM|DEHYDRATION|LYMPHOPENIA|PAIN|PYREXIA|PAIN|ANXIETY|ABDOMINAL PAIN|PAIN|PYREXIA|PYREXIA|NEOPLASM,Cholestasis|Pancreatitis|Transaminases increased,3,1
12408651,20160526,Atezolizumab,62,801,62.0,1,64,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,2,NON-SMALL CELL LUNG CANCER|ANXIETY,Tachycardia,1,1
12410142,20160527,Atezolizumab,41,801,41.0,2,59,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MAGNESIUM HYDROXIDE,8,ABDOMINAL PAIN|METASTATIC NEOPLASM|MYALGIA|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|ABDOMINAL PAIN,Hepatic enzyme increased,1,1
12410473,20160527,Atezolizumab,81,801,81.0,1,111,1,0,1,0,0,0,0,Atezolizumab,"POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE|MESALAMINE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|ATEZOLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",14,DIARRHOEA|HYPERTENSION|HYPERTENSION|HYPERTENSION|ENTEROCOLITIS HAEMORRHAGIC|MUCOSAL INFLAMMATION|HYPERKALAEMIA|BLADDER TRANSITIONAL CELL CARCINOMA|ENTEROCOLITIS HAEMORRHAGIC|VITAMIN D DEFICIENCY,Diabetes mellitus|Autoimmune colitis,2,1
12410502,20160527,Atezolizumab,56,801,56.0,1,61.1,1,1,1,0,0,0,0,Atezolizumab,BEVACIZUMAB|PACLITAXEL|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|CARBOPLATIN|RANITIDINE|ATEZOLIZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,10,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|PROPHYLACTIC CHEMOTHERAPY|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLACTIC CHEMOTHERAPY,Pneumonia|Haemoptysis,2,1
12410658,20160527,Atezolizumab,63,801,63.0,2,54.65,1,0,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|BROMFENAC SODIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|PREGABALIN|RANITIDINE HYDROCHLORIDE|GRANISETRON HYDROCHLORIDE|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE|ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES|RANITIDINE HYDROCHLORIDE|CHLORPHENIRAMINE MALEATE|RANITIDINE HYDROCHLORIDE|GRANISETRON HYDROCHLORIDE|GRANISETRON HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|CHLORPHENIRAMINE MALEATE|GRANISETRON HYDROCHLORIDE|CARBOPLATIN|PACLITAXEL|MAGNESIUM OXIDE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|PREGABALIN|PREGABALIN|SPIRONOLACTONE|KETOCONAZOLE",53,NON-SMALL CELL LUNG CANCER STAGE IV|CATARACT|NAUSEA|PERIPHERAL SENSORY NEUROPATHY|CONSTIPATION|GASTRITIS|ASPARTATE AMINOTRANSFERASE INCREASED|ANAPHYLACTIC REACTION|NAUSEA|GASTRITIS PROPHYLAXIS|GASTRITIS PROPHYLAXIS|GASTRITIS|MUCOSAL INFLAMMATION|ARTHRALGIA|NAUSEA|PYREXIA|PERIPHERAL SENSORY NEUROPATHY|DYSURIA|VOMITING|INFECTION|NAUSEA|VOMITING|RASH|ALANINE AMINOTRANSFERASE INCREASED|CHEILITIS|RASH|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|CONSTIPATION|ANAPHYLACTIC REACTION|HYPERSENSITIVITY|METASTASES TO BONE|GASTRITIS|PYREXIA|CONSTIPATION|CONSTIPATION|VOMITING|HERPES ZOSTER|OEDEMA|RASH,Hepatomegaly,1,1
12410865,20160527,Atezolizumab,64,801,64.0,1,65,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|ROSUVASTATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXYCODONE HYDROCHLORIDE|OXYCODONE|OXYCODONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ROSUVASTATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXYCODONE HYDROCHLORIDE|OXYCODONE,16,METASTATIC NEOPLASM|HYPERTENSION|METASTASES TO CENTRAL NERVOUS SYSTEM|HYPERTENSION|COUGH|PAIN IN EXTREMITY|PAIN|COUGH|COUGH|BLOOD CHOLESTEROL INCREASED|PAIN|METASTATIC NEOPLASM,Vision blurred,1,1
12411257,20160527,Atezolizumab,61,801,61.0,2,61,1,1,1,1,0,0,0,Atezolizumab,BEVACIZUMAB|PACLITAXEL|ATEZOLIZUMAB|PHYTONADIONE|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|CARBOPLATIN,13,PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|HAEMORRHAGE PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|DEPRESSION|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|COUGH|DEPRESSION,Infectious pleural effusion|Haemoptysis,2,1
12411967,20160527,Atezolizumab,69,801,69.0,1,82.8,1,0,1,0,0,0,0,Atezolizumab,OXYCODONE HYDROCHLORIDE|ATEZOLIZUMAB|FUROSEMIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|TIOTROPIUM BROMIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|CARBOPLATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|NITROGLYCERIN|PRASUGREL HYDROCHLORIDE|NIFEDIPINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|AMLODIPINE|CEFTRIAXONE|CEFTRIAXONE SODIUM|METOPROLOL TARTRATE|METOPROLOL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|GEMFIBROZIL,43,DIARRHOEA|MUSCULOSKELETAL CHEST PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|TRANSFUSION|PROPHYLAXIS OF NAUSEA AND VOMITING|DYSPNOEA|URINARY TRACT INFECTION|MUSCULOSKELETAL CHEST PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|DYSPNOEA|ANAEMIA|OSTEOPOROSIS PROPHYLAXIS|PROPHYLACTIC CHEMOTHERAPY|NON-SMALL CELL LUNG CANCER STAGE IV|CHEST PAIN|INSOMNIA|HYPERTENSION|PREMEDICATION|MUSCULOSKELETAL CHEST PAIN|PROPHYLAXIS|BLOOD CHOLESTEROL|PYREXIA|URINARY TRACT INFECTION|PROPHYLAXIS OF NAUSEA AND VOMITING|BRONCHITIS|CONSTIPATION PROPHYLAXIS|BLOOD CHOLESTEROL,Hypomagnesaemia|Febrile neutropenia|Malaise|Hypocalcaemia|Rectal haemorrhage|Rectal haemorrhage|Hyponatraemia,7,1
12413897,20160527,Atezolizumab,50,801,50.0,2,56,1,0,1,0,0,0,0,Atezolizumab,VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|AMOXICILLIN AND CLAVULANATE POTASSIUM|ATEZOLIZUMAB|VENLAFAXINE HYDROCHLORIDE|AMOXICILLIN AND CLAVULANATE POTASSIUM|GLYCERINE,21,DYSPEPSIA|PYELONEPHRITIS|PHARYNGITIS|CONSTIPATION|ALOPECIA|URINARY TRACT INFECTION|BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC|DEPRESSION|VITAMIN D DECREASED|DYSPEPSIA|HYPOKALAEMIA|PYELONEPHRITIS ACUTE|HYPERCHOLESTEROLAEMIA|HYPERCHOLESTEROLAEMIA|DEPRESSION|ANGINA PECTORIS|BACK PAIN|DEEP VEIN THROMBOSIS|CONSTIPATION,Subileus|Subileus|Abdominal pain|Escherichia pyelonephritis|Gastrointestinal disorder|Enteritis,6,1
12414977,20160530,Atezolizumab,70,801,70.0,1,83,1,0,1,0,1,0,0,Atezolizumab,ATEZOLIZUMAB,1,NON-SMALL CELL LUNG CANCER,Cognitive disorder,1,1
12415470,20160530,Atezolizumab,74,801,74.0,1,65,1,0,1,0,0,0,0,Atezolizumab,METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|BEVACIZUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|ATEZOLIZUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE,37,GASTROOESOPHAGEAL REFLUX DISEASE|COLORECTAL CANCER METASTATIC|SINUSITIS|COLORECTAL CANCER METASTATIC|NECK PAIN|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|BRONCHITIS|SINUSITIS|BRONCHITIS,Bronchitis,1,1
12415745,20160530,Atezolizumab,45,801,45.0,1,75.4,1,0,1,0,0,0,0,Atezolizumab,FOSAPREPITANT DIMEGLUMINE|LORAZEPAM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MAGNESIUM OXIDE|MAGNESIUM OXIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIMETHICONE|BODY SHIELD|BODY CLEANSER|SKIN PROTECTANT|CARBOPLATIN|PACLITAXEL|ATEZOLIZUMAB|MAGNESIUM OXIDE|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|MAGNESIUM OXIDE|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|FOSAPREPITANT DIMEGLUMINE|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL,33,PREMEDICATION|PYREXIA|INSOMNIA|PREMEDICATION|BACK PAIN|PYREXIA|PREMEDICATION|PREMEDICATION|PROPHYLAXIS|PREMEDICATION|CONSTIPATION PROPHYLAXIS|RASH|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER METASTATIC|COUGH|CONSTIPATION PROPHYLAXIS|PREMEDICATION|COUGH|CONSTIPATION PROPHYLAXIS|PREMEDICATION|PROPHYLAXIS|PREMEDICATION|CONSTIPATION,Pericardial effusion,1,1
12415808,20160530,Atezolizumab,44,801,44.0,1,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,2,NEOPLASM|NEOPLASM,Anaemia|Anaemia,2,1
12415900,20160530,Atezolizumab,70,801,70.0,1,86,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|ATEZOLIZUMAB|BISOPROLOL FUMARATE,11,PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM,Subdural haemorrhage|Sepsis,2,1
12421932,20160531,Atezolizumab,70,801,70.0,1,54,1,0,1,0,0,0,0,Atezolizumab,PACLITAXEL|ATEZOLIZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|BEVACIZUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CARBOPLATIN|PREGABALIN,21,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|INFUSION RELATED REACTION|PROPHYLAXIS|C-REACTIVE PROTEIN INCREASED|GENERAL PHYSICAL HEALTH DETERIORATION|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|TYPE 2 DIABETES MELLITUS|PROPHYLAXIS OF NAUSEA AND VOMITING|NON-SMALL CELL LUNG CANCER STAGE IV|DUODENAL ULCER|INSOMNIA|GENERAL PHYSICAL HEALTH DETERIORATION|GENERAL PHYSICAL HEALTH DETERIORATION|GENERAL PHYSICAL HEALTH DETERIORATION|DEHYDRATION|TYPE 2 DIABETES MELLITUS|INFUSION RELATED REACTION,Anaemia,1,1
12422089,20160531,Atezolizumab,79,801,79.0,2,46.5,1,0,0,0,0,0,1,Atezolizumab,PROCHLORPERAZINE MALEATE|ATEZOLIZUMAB|CARBOPLATIN|AMOXICILLIN|CETIRIZINE HYDROCHLORIDE|PROCHLORPERAZINE MALEATE|ALENDRONATE SODIUM,11,NAUSEA|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|PREMEDICATION|NAUSEA|TOOTH ABSCESS|HYPERSENSITIVITY|VOMITING|OSTEOPOROSIS|VOMITING|NON-SMALL CELL LUNG CANCER STAGE IV,Aspartate aminotransferase increased|Alanine aminotransferase increased|Neutrophil count decreased|Blood alkaline phosphatase increased|White blood cell count decreased,5,1
12422103,20160531,Atezolizumab,53,801,53.0,2,86,1,0,1,0,0,0,0,Atezolizumab,LEVOTHYROXINE SODIUM|BEVACIZUMAB|ATEZOLIZUMAB,17,ABDOMINAL PAIN LOWER|DYSPEPSIA|ABDOMINAL PAIN LOWER|HYPOTHYROIDISM|HYPERTENSION|INFECTION|PRURITUS|RENAL CELL CARCINOMA|HYPERTENSION|HYPERTENSION|HYPERTENSION|PRURITUS|DYSPEPSIA|RENAL CELL CARCINOMA|PAIN|HYPOKALAEMIA|URINARY TRACT INFECTION,Acute kidney injury|Urosepsis,2,1
12422418,20160601,Atezolizumab,57,801,57.0,2,45,1,0,1,0,0,0,0,Atezolizumab,ESOMEPRAZOLE MAGNESIUM|MAGNESIUM OXIDE|ALPRAZOLAM|CIMETIDINE|ATEZOLIZUMAB|GLYCERIN|GLYCERIN SUPPOSITORIES|ALPRAZOLAM|MORPHINE SULFATE|MORPHINE SULFATE,47,CONSTIPATION|PREMEDICATION|MUSCULOSKELETAL CHEST PAIN|MUSCULOSKELETAL CHEST PAIN|MUSCULOSKELETAL CHEST PAIN|PYREXIA|DYSPEPSIA|CONSTIPATION|CONSTIPATION|DYSPEPSIA|MUSCULOSKELETAL CHEST PAIN|MUSCULOSKELETAL CHEST PAIN|METASTATIC NEOPLASM|METASTATIC NEOPLASM|MUSCULOSKELETAL CHEST PAIN|CONSTIPATION|MUSCULOSKELETAL CHEST PAIN|PYREXIA|MUSCULOSKELETAL CHEST PAIN|DRY EYE|CONSTIPATION|DECREASED APPETITE|DYSPEPSIA|CONSTIPATION,Colitis ischaemic,1,1
12422458,20160601,Atezolizumab,74,801,74.0,2,45.8,1,0,1,0,0,0,0,Atezolizumab,DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|SENNOSIDES|SENNA LEAF|SENNA|CARBOPLATIN|ATEZOLIZUMAB|OXYCODONE HYDROCHLORIDE|POLYETHYLENE GLYCOL 3350,10,PAIN|CONSTIPATION|CONSTIPATION|NON-SMALL CELL LUNG CANCER STAGE IV|PREMEDICATION|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|PAIN|CONSTIPATION|GASTROOESOPHAGEAL REFLUX DISEASE,Large intestinal obstruction,1,1
12422543,20160601,Atezolizumab,50,801,50.0,2,51.4,1,0,1,0,0,0,0,Atezolizumab,"GRANISETRON|GRANISETRON HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ATEZOLIZUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ALBUTEROL SULFATE|ALBUTEROL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CARBAMAZEPINE|DEXTROMETHORPHAN HYDROBROMIDE",18,MYALGIA|INFUSION RELATED REACTION|INFUSION RELATED REACTION|INFUSION RELATED REACTION|NEOPLASM|PAIN|INFUSION RELATED REACTION|HYPOKALAEMIA|INSOMNIA|NEOPLASM|PROPHYLAXIS|INFLUENZA LIKE ILLNESS|INSOMNIA|INFUSION RELATED REACTION,Pneumonia,1,1
12422842,20160601,Atezolizumab,72,801,72.0,2,44,1,0,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|CARBOPLATIN|MORPHINE|MORPHINE|LORAZEPAM|PREGABALIN",14,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING|PREMEDICATION|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|ASTHMA|PAIN PROPHYLAXIS,Tracheobronchitis|Febrile neutropenia|Respiratory failure,3,1
12422892,20160601,Atezolizumab,75,801,75.0,1,59,1,1,0,0,0,0,0,Atezolizumab,SERTRALINE|PACLITAXEL|LORAZEPAM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|RANITIDINE|ATEZOLIZUMAB|CARBOPLATIN,19,ANXIETY|ANXIETY|NON-SMALL CELL LUNG CANCER STAGE IV|PREMEDICATION|COUGH|ANXIETY|PROPHYLAXIS|PROPHYLAXIS|SUPPORTIVE CARE|ANXIETY|SUPPORTIVE CARE|INSOMNIA|METASTASES TO BONE|SUPPORTIVE CARE|NON-SMALL CELL LUNG CANCER STAGE IV|ANXIETY|NON-SMALL CELL LUNG CANCER STAGE IV|BLADDER CATHETERISATION,Death,1,1
12423270,20160601,Atezolizumab,78,801,78.0,1,65.7,1,0,1,1,1,0,0,Atezolizumab,"TAFLUPROST|PANTOPRAZOLE|CARVEDILOL|FUROSEMIDE|ESCITALOPRAM OXALATE|ESCITALOPRAM|SPIRONOLACTONE|TAFLUPROST|ZOLPIDEM TARTRATE|CLOPIDOGREL BISULFATE|DIGOXIN|WARFARIN|MORPHINE SULFATE|POLYETHYLENE GLYCOL 3350|LORAZEPAM|TESTOSTERONE|TESTOSTERONE,|ATEZOLIZUMAB|TIOTROPIUM BROMIDE",18,DRY EYE|GASTROOESOPHAGEAL REFLUX DISEASE|PROPHYLAXIS|PROPHYLAXIS|DEPRESSION|PAIN|PROPHYLAXIS|DRY EYE|INSOMNIA|HEART RATE|PAIN|CONSTIPATION|ANXIETY|ERECTILE DYSFUNCTION|NON-SMALL CELL LUNG CANCER|DYSPNOEA,Acute respiratory distress syndrome|Hypoxia|Systemic inflammatory response syndrome,3,1
12427782,20160602,Atezolizumab,74,801,74.0,1,68,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|LATANOPROST|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CARBOPLATIN|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|OXYGEN|0XYGEN|PACLITAXEL,12,NON-SMALL CELL LUNG CANCER STAGE IV|DYSLIPIDAEMIA|ATRIAL FIBRILLATION|GLAUCOMA|PRURITUS|PRURITUS|PRURITUS|NON-SMALL CELL LUNG CANCER STAGE IV|ATRIAL FIBRILLATION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|DYSPNOEA|NON-SMALL CELL LUNG CANCER STAGE IV,Anaemia|Pneumonia,2,1
12427985,20160602,Atezolizumab,60,801,60.0,1,58.4,1,0,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FUROSEMIDE|PANTOPRAZOLE",11,NEOPLASM|NEOPLASM,Blood bilirubin increased|Hypotension,2,1
12428052,20160602,Atezolizumab,69,801,69.0,2,70.5,1,0,1,0,0,0,0,Atezolizumab,SIMVASTATIN|CARBOPLATIN|METOPROLOL TARTRATE|FOLIC ACID|NICOTINE|NISOLDIPINE|FENOFIBRATE|FLUOXETINE HYDROCHLORIDE|AMOXICILLIN AND CLAVULANATE POTASSIUM|LANSOPRAZOLE|ATEZOLIZUMAB|LOSARTAN POTASSIUM|FOLIC ACID,23,BLOOD CHOLESTEROL INCREASED|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|PAIN|DYSPEPSIA|PROPHYLAXIS OF NAUSEA AND VOMITING|NAUSEA|DERMATITIS|EX-TOBACCO USER|HYPERTENSION|VOMITING|BLOOD CHOLESTEROL INCREASED|DEPRESSION|PROPHYLAXIS OF NAUSEA AND VOMITING|URINARY TRACT INFECTION|NON-SMALL CELL LUNG CANCER|HYPERTENSION|DERMATITIS,Diarrhoea|Colitis,2,1
12428184,20160602,Atezolizumab,75,801,75.0,2,47,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|CARBOPLATIN|CARBOPLATIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|MIRTAZAPINE|NAPROXEN|NAPROXEN SODIUM,8,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|DEPRESSION|FLANK PAIN,Leukopenia,1,1
12428417,20160602,Atezolizumab,53,801,53.0,2,,1,0,0,0,1,0,0,Atezolizumab,"OXYCODONE HYDROCHLORIDE|ENOXAPARIN SODIUM|INSULIN ASPART|OXYCODONE HYDROCHLORIDE|ATEZOLIZUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|LORAZEPAM",12,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Encephalitis,1,1
12431099,20160603,Atezolizumab,65,801,65.0,1,80,1,0,1,0,1,0,0,Atezolizumab,CYCLOBENZAPRINE|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|ATEZOLIZUMAB|ATENOLOL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|SIMVASTATIN|METRONIDAZOLE|METRONIDAZOLE TOPICAL|CYCLOBENZAPRINE|WARFARIN,13,MUSCLE SPASMS|PNEUMONIA|NON-SMALL CELL LUNG CANCER|HYPERTENSION|CONSTIPATION|PNEUMONIA|HYPERLIPIDAEMIA|PAIN|WHEEZING|PNEUMONIA|COUGH|DECREASED APPETITE|PULMONARY EMBOLISM,Confusional state|Fatigue,2,1
12431815,20160603,Atezolizumab,68,801,68.0,2,41.7,1,0,1,0,0,0,0,Atezolizumab,BEVACIZUMAB|ATEZOLIZUMAB|ZOLEDRONIC ACID|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|DEXTROMETHORPHAN HYDROBROMIDE|KETOPROFEN,12,RENAL CELL CARCINOMA|DYSURIA|RENAL CELL CARCINOMA|DYSURIA|NASOPHARYNGITIS|NASOPHARYNGITIS|METASTASES TO BONE|DIARRHOEA|DIARRHOEA|NASOPHARYNGITIS|CONTUSION,Pyelonephritis,1,1
12431907,20160603,Atezolizumab,73,801,73.0,2,73.4,1,1,1,0,0,0,0,Atezolizumab,"CARBOPLATIN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|LEVOTHYROXINE|MORPHINE|MORPHINE|STANDARDIZED SENNA CONCENTRATE|MORPHINE|ATEZOLIZUMAB|STANDARDIZED SENNA CONCENTRATE|MORPHINE",24,VOMITING|NAUSEA|NON-SMALL CELL LUNG CANCER STAGE IV|THROMBOSIS PROPHYLAXIS|COUGH|PROPHYLAXIS|PAIN|PYREXIA|NON-SMALL CELL LUNG CANCER STAGE IV|HYPOTHYROIDISM|BREAKTHROUGH PAIN|CONSTIPATION|NAUSEA|NON-SMALL CELL LUNG CANCER STAGE IV|COUGH|PAIN|VOMITING,Sepsis|Lung infection,2,1
12432307,20160603,Atezolizumab,68,801,68.0,1,65.9,1,0,1,0,0,0,0,Atezolizumab,PACLITAXEL|ATEZOLIZUMAB|CARBOPLATIN,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Erythema multiforme,1,1
12434064,20160603,Atezolizumab,60,801,60.0,1,59,1,1,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|CARBOPLATIN|TIOTROPIUM BROMIDE,9,BACK PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|DEEP VEIN THROMBOSIS|NON-SMALL CELL LUNG CANCER STAGE IV|PAIN IN EXTREMITY|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|ABDOMINAL DISTENSION|BACK PAIN,Ventricular tachycardia|Pain,2,1
12434697,20160603,Atezolizumab,62,801,62.0,2,86.8,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|LANSOPRAZOLE,3,BLADDER TRANSITIONAL CELL CARCINOMA|PAIN,Hyperbilirubinaemia|Dyspnoea|Infusion related reaction,3,1
12436507,20160606,Atezolizumab,68,801,68.0,1,100.8,1,1,1,0,0,0,0,Atezolizumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PACLITAXEL|OXYGEN|0XYGEN|ZOLPIDEM TARTRATE|CARBOPLATIN|ATEZOLIZUMAB,30,DYSPEPSIA|FUNGAL INFECTION|ANXIETY|NEUROPATHY PERIPHERAL|THROMBOSIS PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|PROPHYLAXIS|DECREASED APPETITE|DYSPNOEA|INSOMNIA|NAUSEA|DYSPEPSIA|OROPHARYNGEAL PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|PAIN|ORAL FUNGAL INFECTION,Interstitial lung disease|Dyspnoea,2,1
12445347,20160607,Atezolizumab,69,801,69.0,1,69.2,1,0,1,0,0,0,0,Atezolizumab,"FENOFIBRATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CHLORPROMAZINE|CARBOPLATIN|GLIPIZIDE|ATEZOLIZUMAB|SIMVASTATIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ACETYLCYSTEINE|LOSARTAN|TESTOSTERONE|TESTOSTERONE,",13,HYPERLIPIDAEMIA|DIABETES MELLITUS|ABDOMINAL DISTENSION|NON-SMALL CELL LUNG CANCER STAGE IV|DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERLIPIDAEMIA|PRODUCTIVE COUGH|HYPERTENSION|PRODUCTIVE COUGH|NON-SMALL CELL LUNG CANCER STAGE IV|BLOOD TESTOSTERONE ABNORMAL,Febrile neutropenia,1,1
12446290,20160608,Atezolizumab,,,,2,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|LACTULOSE|HYDROMORPHONE HYDROCHLORIDE,5,TRIPLE NEGATIVE BREAST CANCER|TRIPLE NEGATIVE BREAST CANCER|CONSTIPATION|PAIN,Lung infection,1,1
12449552,20160609,Atezolizumab,76,801,76.0,1,63,1,0,1,0,1,0,0,Atezolizumab,FLUCONAZOLE|ATEZOLIZUMAB|CEFIXIME|PANTOPRAZOLE,10,EPILEPSY|HYPERTENSION|MUCOSAL INFLAMMATION|BLADDER TRANSITIONAL CELL CARCINOMA|PYREXIA|LUNG DISORDER|URINARY TRACT INFECTION|HYPERTENSION|PROPHYLAXIS|PULMONARY EMBOLISM,Myositis|Hepatocellular injury,2,1
12450171,20160609,Atezolizumab,39,801,39.0,2,98.7,1,0,1,0,0,0,0,Atezolizumab,"METOPROLOL TARTRATE|METOPROLOL|PAROXETINE HYDROCHLORIDE|FERROUS SULFATE|OXYCODONE|POLYETHYLENE GLYCOL 3350|DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE|DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE|DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG|DOCUSATE SODIUM, SENNOSIDES|DOCUSATE SODIUM, 50 MG SENNOSIDES, 8.6 MG|ATEZOLIZUMAB|MORPHINE|LORAZEPAM|ATEZOLIZUMAB|MORPHINE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|OXYCODONE|AMLODIPINE BESYLATE",23,HYPERTENSION|BACK PAIN|DEPRESSION|ANAEMIA|PAIN|CONSTIPATION|CERVIX CANCER METASTATIC|ATTENTION DEFICIT/HYPERACTIVITY DISORDER|VOMITING|CONSTIPATION|NAUSEA|CERVIX CANCER METASTATIC|CERVIX CANCER METASTATIC|BACK PAIN|CONSTIPATION|ANXIETY|CERVIX CANCER METASTATIC|BACK PAIN|HYPOMAGNESAEMIA|BACK PAIN|HYPERTENSION,Pleuritic pain,1,1
12450281,20160609,Atezolizumab,63,801,63.0,1,62,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|INDAPAMIDE|FENOFIBRATE,10,NEOPLASM|NEOPLASM,Fatigue,1,1
12450891,20160609,Atezolizumab,69,801,69.0,2,51.16,1,0,1,0,0,0,1,Atezolizumab,"ATEZOLIZUMAB|CETIRIZINE HYDROCHLORIDE|AMLODIPINE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|AMLODIPINE|HYDROMORPHONE HYDROCHLORIDE|TRIAMCINOLONE ACETONIDE|TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%|DIPHENHYDRAMINE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|SENNOSIDES|SENNA LEAF|SENNA|BEVACIZUMAB|AMLODIPINE|LEVOTHYROXINE|MORPHINE SULFATE|OXYCODONE HYDROCHLORIDE|AMLODIPINE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|BEVACIZUMAB|LISINOPRIL|FUROSEMIDE",26,RENAL CELL CARCINOMA|RHINITIS|HYPERTENSION|PAIN|HYPERTENSION|PAIN|CONSTIPATION|INFUSION RELATED REACTION|CONSTIPATION|RENAL CELL CARCINOMA|COUGH|HYPOTHYROIDISM|PAIN|CONSTIPATION|INFUSION RELATED REACTION|RENAL CELL CARCINOMA|HYPERTENSION|METASTASES TO BONE|OEDEMA|RASH,Proteinuria|Lethargy|Adrenal insufficiency,3,1
12454853,20160610,Atezolizumab,60,801,60.0,1,95.25,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER TRANSITIONAL CELL CARCINOMA,Dyspnoea,1,1
12454854,20160610,Atezolizumab,79,801,79.0,1,73.2,1,0,1,0,0,0,0,Atezolizumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LANSOPRAZOLE|PANTOPRAZOLE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|RAMIPRIL|MOMETASONE|LANSOPRAZOLE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|ATEZOLIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,19,DYSPEPSIA|PROPHYLAXIS|PROPHYLAXIS|ORAL CANDIDIASIS|ANALGESIC THERAPY|ANTIALLERGIC THERAPY|HYPERTENSION|HYPERTENSION|NASAL CONGESTION|NASAL CONGESTION|CONSTIPATION|BLADDER TRANSITIONAL CELL CARCINOMA|ANTICOAGULANT THERAPY|CHEMOTHERAPY|BLOOD POTASSIUM DECREASED|NUTRITIONAL SUPPLEMENTATION,Duodenal obstruction,1,1
12455538,20160610,Atezolizumab,57,801,57.0,1,85,1,0,1,0,0,0,1,Atezolizumab,"POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|SENNOSIDES|SENNA LEAF|SENNA|DEXTROSE ANHYDROUS|DOXYCYCLINE|DOXYCYCLINE HYCLATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SENNOSIDES|SENNA LEAF|SENNA|ATEZOLIZUMAB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|DOXYCYCLINE|DOXYCYCLINE HYCLATE",18,BLOOD POTASSIUM DECREASED|HYPOGLYCAEMIA|PAIN|PAIN|DEEP VEIN THROMBOSIS|PNEUMONIA|BLOOD SODIUM DECREASED|CONSTIPATION|BLADDER TRANSITIONAL CELL CARCINOMA|PAIN|PAIN|PAIN|INFECTION,Anaemia|Diabetic ketoacidosis|Colonic fistula|Diabetes mellitus,4,1
12455635,20160610,Atezolizumab,69,801,69.0,1,54,1,0,1,0,0,0,0,Atezolizumab,METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREGABALIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATEZOLIZUMAB|PACLITAXEL|BEVACIZUMAB|CARBOPLATIN,20,INFUSION RELATED REACTION|C-REACTIVE PROTEIN INCREASED|INSOMNIA|INFUSION RELATED REACTION|TYPE 2 DIABETES MELLITUS|TYPE 2 DIABETES MELLITUS|ALLERGY PROPHYLAXIS|GENERAL PHYSICAL HEALTH DETERIORATION|GENERAL PHYSICAL HEALTH DETERIORATION|DUODENAL ULCER|PROPHYLAXIS OF NAUSEA AND VOMITING|GENERAL PHYSICAL HEALTH DETERIORATION|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|GENERAL PHYSICAL HEALTH DETERIORATION|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Dehydration,1,1
12456056,20160610,Atezolizumab,70,801,70.0,1,103,1,0,1,0,0,0,0,Atezolizumab,GRANISETRON|GRANISETRON HYDROCHLORIDE|ALLOPURINOL|CARBOPLATIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|GLIMEPIRIDE|ATEZOLIZUMAB|ATENOLOL|INDAPAMIDE|IRBESARTAN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CLOPIDOGREL|CLOPIDOGREL BISULFATE,15,PROPHYLACTIC CHEMOTHERAPY|HYPERURICAEMIA|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|DIABETES MELLITUS|TYPE 2 DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|HYPERTENSION|HYPERTENSION|HYPERTENSION|DIABETES MELLITUS,Neutropenia|Renal failure|Autoimmune colitis|Autoimmune colitis,4,1
12456719,20160610,Atezolizumab,68,801,68.0,1,88.36,1,0,1,0,0,0,0,Atezolizumab,"OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|TIOTROPIUM BROMIDE|PREGABALIN|PACLITAXEL|PANTOPRAZOLE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CARBOPLATIN|OXYCODONE|CARBOPLATIN|OXYCODONE HYDROCHLORIDE|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|PACLITAXEL|OXYCODONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PANTOPRAZOLE|ATEZOLIZUMAB|OXYCODONE",22,BACK PAIN|ABDOMINAL PAIN|RESTLESS LEGS SYNDROME|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NEURALGIA|DEPRESSION|CONSTIPATION|VOMITING|HYPOKALAEMIA|NON-SMALL CELL LUNG CANCER|ARTHRALGIA|ARTHRALGIA|DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER|ABDOMINAL PAIN|NAUSEA|NAUSEA|NON-SMALL CELL LUNG CANCER|BACK PAIN|PAIN,Abdominal pain,1,1
12458311,20160613,Atezolizumab,61,801,61.0,1,70,1,0,1,1,0,0,1,Atezolizumab,SULFAMETHOXAZOLE AND TRIMETHOPRIM|ATEZOLIZUMAB|PROPOFOL|FUROSEMIDE|BEVACIZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|RAMIPRIL|DOXAZOSIN|DOXAZOSIN MESYLATE,28,COLORECTAL CANCER METASTATIC|PNEUMOCYSTIS JIROVECII INFECTION|HYPOACUSIS|COLORECTAL CANCER METASTATIC|PREMEDICATION|PROPHYLAXIS|HYPOACUSIS|CEREBROVASCULAR ACCIDENT|HYPOACUSIS|PNEUMOCYSTIS JIROVECII INFECTION|PROPHYLAXIS|COLORECTAL CANCER METASTATIC|PREMEDICATION|PREMEDICATION|HYPOCALCAEMIA|PNEUMOCYSTIS JIROVECII INFECTION|PNEUMOCYSTIS JIROVECII INFECTION|PROPHYLAXIS|HYPOACUSIS|PROPHYLAXIS|CEREBRAL ISCHAEMIA|COLORECTAL CANCER METASTATIC|PROPHYLAXIS,Respiratory failure|Deep vein thrombosis,2,1
12458888,20160613,Atezolizumab,79,801,79.0,1,73.2,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|MOMETASONE|PANTOPRAZOLE|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|SENNOSIDES|SENNA LEAF|SENNA|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FUROSEMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PANTOPRAZOLE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|RAMIPRIL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,43,BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC|NASAL CONGESTION|PROPHYLAXIS|PROPHYLAXIS|VOMITING|ARTHRALGIA|PAIN|NASAL CONGESTION|CONSTIPATION|NAUSEA|CHEMOTHERAPY|NAUSEA|ORAL CANDIDIASIS|BLOOD POTASSIUM DECREASED|CONSTIPATION|ERYSIPELAS|VOMITING|NAUSEA|NAUSEA|ABDOMINAL PAIN|NAUSEA|CONSTIPATION|DYSPEPSIA|HYPERTENSION|HYPERTENSION,Sepsis|Neutrophil count decreased,2,1
12460287,20160613,Atezolizumab,61,801,61.0,1,70.4,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|BEVACIZUMAB,3,RENAL CELL CARCINOMA|RENAL CELL CARCINOMA|HYPERTENSION,Influenza like illness,1,1
12463345,20160614,Atezolizumab,73,801,73.0,1,103.7,1,0,1,0,0,0,0,Atezolizumab,"AMLODIPINE BESYLATE|DIPHENHYDRAMINE HYDROCHLORIDE|ATEZOLIZUMAB|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|POLYETHYLENE GLYCOL 3350|NOREPINEPHRINE BITARTRATE|HYOSCYAMINE SULFATE|GUAIFENESIN|GUAIFENESIN|MAGNESIUM OXIDE|PROPOFOL|CALCIUM CARBONATE|GABAPENTIN|VITAMIN E|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|PANTOPRAZOLE SODIUM|PERFLUTREN|ALBUTEROL SULFATE|ALBUTEROL|GUAIFENESIN|BIMATOPROST|TIMOLOL MALEATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METRONIDAZOLE|LORAZEPAM|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|METOPROLOL SUCCINATE|LANSOPRAZOLE|TIOTROPIUM BROMIDE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE",43,HYPERTENSION|PAIN|BLADDER CANCER|ROSACEA|NAUSEA|CONSTIPATION|HYPOTENSION|ABDOMINAL PAIN|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|HYPOMAGNESAEMIA|DIARRHOEA|SIGMOIDOSCOPY|ROSACEA|DYSPEPSIA|NEUROPATHY PERIPHERAL|URINARY TRACT INFECTION|GASTROOESOPHAGEAL REFLUX DISEASE|COLITIS|TUBERCULIN TEST|DRY SKIN|URINARY TRACT INFECTION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|LOWER RESPIRATORY TRACT CONGESTION|GLAUCOMA|GLAUCOMA|FLUSHING|CLOSTRIDIUM DIFFICILE INFECTION|PROPHYLAXIS|ANXIETY|CLOSTRIDIUM DIFFICILE INFECTION|URINARY TRACT INFECTION|HYPERTENSION|GASTROOESOPHAGEAL REFLUX DISEASE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|HYPOXIA|HYPOALBUMINAEMIA|SIGMOIDOSCOPY,Pleural effusion|Hypoxia|Pericardial effusion,3,1
12463450,20160614,Atezolizumab,80,801,80.0,1,80,1,0,0,0,0,0,0,Atezolizumab,"ALLOPURINOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|CARVEDILOL|CARVEDILOL|DOXAZOSIN|DOXAZOSIN MESYLATE|LISINOPRIL|GRANISETRON|GRANISETRON HYDROCHLORIDE|CARVEDILOL|CARVEDILOL|DOXAZOSIN|DOXAZOSIN MESYLATE|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|BEVACIZUMAB|GRANISETRON|GRANISETRON HYDROCHLORIDE|ATEZOLIZUMAB|DOXAZOSIN|DOXAZOSIN MESYLATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|NITROGLYCERIN",47,BLOOD PRESSURE INCREASED|ARTHRALGIA|COLORECTAL CANCER METASTATIC|PROPHYLAXIS|BLOOD POTASSIUM DECREASED|DIARRHOEA|PROPHYLAXIS|HYPERTHYROIDISM|COLORECTAL CANCER METASTATIC|ARTHRALGIA|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Cardiovascular disorder,1,1
12463500,20160614,Atezolizumab,12,801,12.0,2,71.7,1,0,1,0,0,0,0,Atezolizumab,METHADONE|GRANISETRON|GRANISETRON HYDROCHLORIDE|NALOXONE|ATEZOLIZUMAB|MORPHINE|CELECOXIB|EPINEPHRINE,35,HYPOKALAEMIA|PAIN|NAUSEA|PAIN|NAUSEA|NAUSEA|CONSTIPATION|CONSTIPATION|PAIN|NEOPLASM|PAIN|PAIN|CONSTIPATION|PAIN|PAIN|PAIN|PAIN|CONSTIPATION|PAIN|PAIN|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|DIARRHOEA,Fatigue|Dehydration,2,1
12464225,20160614,Atezolizumab,84,801,84.0,2,61.6,1,0,1,0,0,0,0,Atezolizumab,"FERROUS SULFATE|AMLODIPINE BESYLATE|OMEPRAZOLE MAGNESIUM|MONTELUKAST SODIUM|ARFORMOTEROL TARTRATE|IPRATROPIUM BROMIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ENALAPRIL MALEATE|STANDARDIZED SENNA CONCENTRATE|ATEZOLIZUMAB|SIMVASTATIN",16,ANAEMIA|GASTROOESOPHAGEAL REFLUX DISEASE|VOMITING|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PAIN|NAUSEA|HYPERTENSION|CONSTIPATION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NAUSEA|BLADDER TRANSITIONAL CELL CARCINOMA|VOMITING,Blood creatinine increased,1,1
12464432,20160614,Atezolizumab,60,801,60.0,2,85.8,1,0,1,0,0,0,0,Atezolizumab,FERRIC CARBOXYMALTOSE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ATEZOLIZUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ATEZOLIZUMAB,21,ANAEMIA|ANAEMIA|DRY EYE|OVARIAN CANCER|PAIN|HYPERGLYCAEMIA|HYPERGLYCAEMIA|ANAEMIA|PROPHYLAXIS|HYPERGLYCAEMIA|ANAEMIA,Autoimmune haemolytic anaemia,1,1
12466581,20160615,Atezolizumab,50,801,50.0,2,54,1,0,1,0,0,0,0,Atezolizumab,ENOXAPARIN SODIUM|PREGABALIN|OXYCODONE HYDROCHLORIDE|PREGABALIN|OXYCODONE HYDROCHLORIDE|OXYCODONE|ATEZOLIZUMAB,18,THROMBOSIS PROPHYLAXIS|METASTATIC NEOPLASM|CHEST PAIN|TUMOUR PAIN|VOMITING|TUMOUR PAIN|ANAEMIA|NAUSEA|ANAEMIA|TUMOUR PAIN|INSOMNIA|METASTATIC NEOPLASM|TUMOUR PAIN|DEPRESSION|DIARRHOEA,Pleural effusion,1,1
12466671,20160615,Atezolizumab,73,801,73.0,2,72.57,1,0,1,0,0,0,0,Atezolizumab,ALPRAZOLAM|ATORVASTATIN CALCIUM|POLYETHYLENE GLYCOL 3350|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|PROCHLORPERAZINE|ALPRAZOLAM|ZOLPIDEM TARTRATE|MOMETASONE FUROATE|PANTOPRAZOLE SODIUM|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|ALPRAZOLAM|LEVOTHYROXINE SODIUM|SERTRALINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE|ATEZOLIZUMAB|BUPROPION HYDROCHLORIDE|OMEPRAZOLE MAGNESIUM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES,28,METASTASES TO BONE|ANXIETY|HYPERLIPIDAEMIA|CONSTIPATION|PAIN IN EXTREMITY|CHEST PAIN|PAIN IN EXTREMITY|NAUSEA|BACK PAIN|PAIN IN EXTREMITY|INSOMNIA|INSOMNIA|CHEST PAIN|BACK PAIN|METASTASES TO BONE|HYPOTHYROIDISM|DEPRESSION|CHEST PAIN|NEOPLASM MALIGNANT|DEPRESSION|PROPHYLAXIS|BACK PAIN|CONSTIPATION|PAIN,Dehydration|Diabetes mellitus,2,1
12467277,20160615,Atezolizumab,,,,1,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Hallucination,1,1
12469870,20160615,Atezolizumab,64,801,64.0,1,60.3,1,0,1,0,0,0,0,Atezolizumab,OXYCODONE|ATENOLOL|ATEZOLIZUMAB|LOSARTAN POTASSIUM|LOSARTAN|TAMSULOSIN HYDROCHLORIDE|NASAL|SALINE|(SALINE)|ZOLEDRONIC ACID|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|SIMVASTATIN|FILGRASTIM|CEFTRIAXONE|CEFTRIAXONE SODIUM|CARBOPLATIN|FILGRASTIM,30,MYOCARDIAL ISCHAEMIA|MUSCULOSKELETAL PAIN|MYOCARDIAL ISCHAEMIA|INSOMNIA|NON-SMALL CELL LUNG CANCER STAGE IV|MYOCARDIAL ISCHAEMIA|BENIGN PROSTATIC HYPERPLASIA|PYREXIA|PREMEDICATION|PREMEDICATION|INFECTION|PYREXIA|PYREXIA|PYREXIA|VITAMIN B12 DEFICIENCY|METASTASES TO BONE|STOMATITIS|PREMEDICATION|DIARRHOEA|HYPERLIPIDAEMIA|NEUTROPENIA|NEUTROPENIA|MUSCULOSKELETAL PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|MUSCULOSKELETAL PAIN|PYREXIA|NON-SMALL CELL LUNG CANCER STAGE IV|PREMEDICATION|PYREXIA|PYREXIA,Confusional state,1,1
12470406,20160616,Atezolizumab,76,801,76.0,1,51.6,1,1,1,0,0,0,0,Atezolizumab,BISOPROLOL FUMARATE|BISOPROLOL FUMARATE|ENOXAPARIN SODIUM|DIGOXIN|TRANEXAMIC ACID|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ATEZOLIZUMAB|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|ACETYLCYSTEINE|FAMOTIDINE|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|ENOXAPARIN SODIUM|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|BISOPROLOL FUMARATE|ENOXAPARIN SODIUM|ENOXAPARIN SODIUM|LACTULOSE|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN,28,ATRIAL FIBRILLATION|ATRIAL FIBRILLATION|HAEMOPTYSIS|ATRIAL FIBRILLATION|NON-SMALL CELL LUNG CANCER|PNEUMONIA|PAIN|ATRIAL FIBRILLATION|ATRIAL FIBRILLATION|PNEUMONIA|LUNG INFECTION|DEPRESSION|PRURITUS|PROPHYLAXIS|CONSTIPATION|PAIN|PNEUMONIA|PAIN|PRURITUS,Pneumonia|Pleural fistula|Pneumonia aspiration,3,1
12470829,20160616,Atezolizumab,67,801,67.0,1,99.5,1,0,0,0,0,0,1,Atezolizumab,"IRBESARTAN|OMEPRAZOLE MAGNESIUM|ATEZOLIZUMAB|IRBESARTAN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|CANAGLIFLOZIN|BEVACIZUMAB|SITAGLIPTIN|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|SITAGLIPTIN|HYDROCHLOROTHIAZIDE",15,HYPERTENSION|RENAL CELL CARCINOMA|HEADACHE|PAIN|MUCOSAL INFECTION|DIABETES MELLITUS|RENAL CELL CARCINOMA|DIABETES MELLITUS|DIARRHOEA|NAUSEA|HYPERTENSION|HYPERTENSION,Pancreatitis,1,1
12470937,20160616,Atezolizumab,59,801,59.0,1,54,1,0,1,0,0,0,0,Atezolizumab,AMOXICILLIN AND CLAVULANATE POTASSIUM|ATEZOLIZUMAB|AMOXICILLIN,7,PYREXIA|NON-SMALL CELL LUNG CANCER|PRURITUS GENERALISED|ANAEMIA|PYREXIA|XEROSIS,Pruritus generalised,1,1
12471080,20160616,Atezolizumab,64,801,64.0,1,67,1,1,1,0,0,0,0,Atezolizumab,PACLITAXEL|CARBOPLATIN|ATEZOLIZUMAB,4,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|COUGH|NON-SMALL CELL LUNG CANCER STAGE IV,Pneumonitis,1,1
12472524,20160616,Atezolizumab,61,801,61.0,1,88,1,0,1,0,0,0,0,Atezolizumab,LEVOTHYROXINE|LEVOTHYROXINE|LEVOTHYROXINE|LEVOTHYROXINE|LEVOTHYROXINE|ALLOPURINOL|LEVOTHYROXINE|LEVOTHYROXINE|ATEZOLIZUMAB|LEVOTHYROXINE|LEVOTHYROXINE|LEVOTHYROXINE|LEVOTHYROXINE|CEFTRIAXONE|CEFTRIAXONE SODIUM|LEVOTHYROXINE|ALLOPURINOL,18,BLADDER TRANSITIONAL CELL CARCINOMA|HYPOTHYROIDISM|PROPHYLAXIS|HYPERTENSION|HYPERURICAEMIA,Rhabdomyolysis,1,1
12472961,20160616,Atezolizumab,41,801,41.0,2,60.5,1,0,1,0,0,0,0,Atezolizumab,"PACLITAXEL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|CLARITHROMYCIN|ATEZOLIZUMAB|OXYCODONE",13,BREAST CANCER METASTATIC|PAIN|PROPHYLAXIS|URINARY TRACT INFECTION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PAIN|FLUID REPLACEMENT|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC|PAIN|PAIN,Pleuritic pain|Rectal haemorrhage|Dyspnoea exertional,3,3
12473595,20160616,Atezolizumab,76,801,76.0,1,77.6,1,1,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Acute respiratory failure|Renal failure,2,1
12474297,20160617,Atezolizumab,65,801,65.0,2,47,1,0,1,1,0,0,0,Atezolizumab,"SENNOSIDES|SENNA LEAF|SENNA|ERGOCALCIFEROL|DICLOFENAC POTASSIUM|DICLOFENAC POTASSIUM, FILM COATED|DICLOFENAC POTASSIUM TABLETS|SELENIUM|OXYBUTYNIN|FOLIC ACID|OXYCODONE HYDROCHLORIDE|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)|TURMERIC|ATEZOLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREGABALIN",22,CONSTIPATION|ANALGESIC THERAPY|ANALGESIC THERAPY|HYPERTONIC BLADDER|ANALGESIC THERAPY|URINARY TRACT INFECTION|ANALGESIC THERAPY|ANALGESIC THERAPY|ANALGESIC THERAPY|BLADDER TRANSITIONAL CELL CARCINOMA|THROMBOSIS|ANALGESIC THERAPY,Pulmonary embolism|Anaemia|Musculoskeletal pain,3,1
12479449,20160620,Atezolizumab,63,801,63.0,1,85,1,0,1,0,0,0,0,Atezolizumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ATEZOLIZUMAB,9,PAIN|PYREXIA|HYPERCALCAEMIA|BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC|PYREXIA,Anaemia|Pyrexia,2,1
12481488,20160620,Atezolizumab,58,801,58.0,2,47.7,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,6,RESPIRATORY TRACT INFECTION|NON-SMALL CELL LUNG CANCER|PREMEDICATION|COUGH|GASTRITIS|INFLUENZA LIKE ILLNESS,Influenza like illness,1,1
12482857,20160620,Atezolizumab,70,801,70.0,2,49.6,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|MORPHINE|MORPHINE,8,NEOPLASM|NEOPLASM,Thyroiditis,1,1
12483121,20160620,Atezolizumab,65,801,65.0,2,53,1,0,1,0,0,0,0,Atezolizumab,PREGABALIN|INSULIN GLARGINE|OXYGEN|0XYGEN|INSULIN GLULISINE|ATEZOLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,22,BONE PAIN|NEURALGIA|NAUSEA|VOMITING|VENOUS THROMBOSIS|CHEST PAIN|DEEP VEIN THROMBOSIS|DIABETES MELLITUS|DYSPNOEA|PROPHYLAXIS|ARTHRALGIA|OEDEMA PERIPHERAL|OPTIC NEURITIS|DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER|OEDEMA|PROPHYLAXIS,Hyperglycaemia,1,1
12483127,20160620,Atezolizumab,65,801,65.0,1,107.5,1,0,1,0,0,0,0,Atezolizumab,DOXAZOSIN|DOXAZOSIN MESYLATE|PANTOPRAZOLE|ATEZOLIZUMAB,8,NAUSEA|HYPERTENSION|DYSLIPIDAEMIA|CONSTIPATION|DYSPEPSIA|NON-SMALL CELL LUNG CANCER|CEREBROVASCULAR ACCIDENT|HYPERTENSION,Intestinal obstruction,1,1
12485709,20160621,Atezolizumab,62,801,62.0,1,,1,0,1,0,0,0,0,Atezolizumab,PACLITAXEL|LULICONAZOLE|ZOLEDRONIC ACID|BEVACIZUMAB|FAMOTIDINE|GRANISETRON HYDROCHLORIDE|APREPITANT|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|OXYCODONE HYDROCHLORIDE|OXYCODONE|PACLITAXEL|OLMESARTAN MEDOXOMIL|ALLOPURINOL|CHLORPHENIRAMINE MALEATE|APREPITANT|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|GRANISETRON HYDROCHLORIDE|ATEZOLIZUMAB|MAGNESIUM OXIDE|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|CARBOPLATIN|LANSOPRAZOLE|OXYCODONE HYDROCHLORIDE|OXYCODONE|BEVACIZUMAB|FAMOTIDINE|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|ATEZOLIZUMAB|CARBOPLATIN|CHLORPHENIRAMINE MALEATE,36,FUNGAL SKIN INFECTION|METASTASES TO BONE|NON-SMALL CELL LUNG CANCER|PREMEDICATION|PREMEDICATION|NAUSEA|CONSTIPATION|INFLUENZA LIKE ILLNESS|NON-SMALL CELL LUNG CANCER|HYPERTENSION|HYPERURICAEMIA|INFLUENZA LIKE ILLNESS|HYPERLIPIDAEMIA|NON-SMALL CELL LUNG CANCER|CONSTIPATION|OESOPHAGITIS|CONSTIPATION|ENDOSCOPY UPPER GASTROINTESTINAL TRACT|ENDOSCOPY UPPER GASTROINTESTINAL TRACT|GASTRIC ULCER|CANCER PAIN|CANCER PAIN|ARTHRALGIA|CONSTIPATION|NON-SMALL CELL LUNG CANCER|PREMEDICATION,Constipation|Nausea|Cholangitis|Influenza like illness,4,1
12486634,20160621,Atezolizumab,58,801,58.0,1,97.7,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|BEVACIZUMAB|PANTOPRAZOLE|PROCHLORPERAZINE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|OLANZAPINE,7,RENAL CELL CARCINOMA|RENAL CELL CARCINOMA|PROPHYLAXIS|DEEP VEIN THROMBOSIS|PROPHYLAXIS|DIARRHOEA|PROPHYLAXIS OF NAUSEA AND VOMITING,Hypothyroidism|Hepatic steatosis|Pyrexia,3,1
12487145,20160622,Atezolizumab,75,801,75.0,2,89.6,1,0,1,1,0,0,0,Atezolizumab,TRIMETHOPRIM|ATEZOLIZUMAB|ROSUVASTATIN|MORPHINE SULFATE|TRIMETHOPRIM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|TRANEXAMIC ACID|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,11,ARTHRALGIA|DYSURIA|BLADDER TRANSITIONAL CELL CARCINOMA|LOCAL ANAESTHESIA|ANALGESIC THERAPY|URINARY TRACT INFECTION|HYPOTHYROIDISM|RECTAL HAEMORRHAGE|PROPHYLAXIS,Thrombocytopenia,1,1
12487627,20160622,Atezolizumab,12,801,12.0,1,53.1,1,0,1,0,0,0,1,Atezolizumab,CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|ATEZOLIZUMAB,7,RASH MACULO-PAPULAR|NEOPLASM|RASH MACULO-PAPULAR|RASH MACULO-PAPULAR|BACK PAIN|CONSTIPATION,Pyrexia|Pleural effusion|Pyrexia,3,1
12494017,20160623,Atezolizumab,19,801,19.0,1,52.15,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|OXCARBAZEPINE,6,NEOPLASM|HEADACHE|COUGH|CHEST PAIN|EPILEPSY|CHEST PAIN,Dyspnoea|Chest pain|Influenza like illness,3,1
12495575,20160624,Atezolizumab,68,801,68.0,1,77.2,1,0,1,0,0,0,0,Atezolizumab,LORAZEPAM|ATEZOLIZUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS,3,TRANSITIONAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION,Impaired gastric emptying|Tachycardia,2,1
12498891,20160627,Atezolizumab,51,801,51.0,2,104.2,1,0,1,0,0,0,0,Atezolizumab,"ENOXAPARIN SODIUM|PHYTONADIONE|NICOTINE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|CARBOPLATIN|PACLITAXEL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATEZOLIZUMAB|RANITIDINE|NABILONE",17,ANXIETY|PROPHYLAXIS|PROPHYLAXIS|EX-TOBACCO USER|HYPOKALAEMIA|NAUSEA|TYPE 2 DIABETES MELLITUS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|CHEST PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|ANXIETY|CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Lung consolidation,1,1
12499098,20160627,Atezolizumab,5,801,5.0,1,17.1,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|MORPHINE,8,NEOPLASM|NAUSEA|NAUSEA|VOMITING|VOMITING|VOMITING|NAUSEA|ABDOMINAL PAIN,Anaemia,1,1
12500669,20160627,Atezolizumab,73,801,73.0,1,97.57,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|OXYMETAZOLINE|AMLODIPINE|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|CITALOPRAM|CITALOPRAM HYDROBROMIDE|LEVOTHYROXINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LORAZEPAM|EZETIMIBE,13,METASTATIC NEOPLASM|LICHENOID KERATOSIS|UPPER-AIRWAY COUGH SYNDROME|HYPERTENSION|PAIN|BLOOD PHOSPHORUS DECREASED|SEASONAL ALLERGY|DEPRESSION|HYPOTHYROIDISM|PAIN|BLOOD CHOLESTEROL INCREASED|PRURITUS,Hypoxia,1,1
12502504,20160627,Atezolizumab,65,801,65.0,2,49,1,0,1,0,0,0,1,Atezolizumab,"METOPROLOL SUCCINATE|EZETIMIBE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|FISH OIL|LORAZEPAM|OXYCODONE HYDROCHLORIDE|SERTRALINE HYDROCHLORIDE|AMOXICILLIN AND CLAVULANATE POTASSIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISONE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|ROSUVASTATIN|MEPERIDINE HYDROCHLORIDE|ATEZOLIZUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|TIOTROPIUM BROMIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LISINOPRIL",26,ASTHMA|HYPERTENSION|HYPERCHOLESTEROLAEMIA|ASTHMA|HYPERCHOLESTEROLAEMIA|PROPHYLAXIS|COUGH|BONE PAIN|DEPRESSION|PNEUMONIA|BONE PAIN|BONE PAIN|ANAEMIA|HYPERCHOLESTEROLAEMIA|COUGH|BONE DISORDER|BONE PAIN|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|ASTHMA|GASTROOESOPHAGEAL REFLUX DISEASE|BONE PAIN|COUGH|NAUSEA|HYPERTENSION,Dizziness|Pleural effusion,2,1
12502921,20160628,Atezolizumab,49,801,49.0,1,,1,0,0,1,1,0,0,Atezolizumab,RANITIDINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ASCORBIC ACID|RANITIDINE|RANITIDINE|CARBOPLATIN|PACLITAXEL|ATEZOLIZUMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,23,CHEST PAIN|BLOOD LACTATE DEHYDROGENASE INCREASED|CHEST PAIN|NAUSEA|PROPHYLAXIS|BACK PAIN|BACK PAIN|ASPARTATE AMINOTRANSFERASE INCREASED|PREMEDICATION|NAUSEA|VOMITING|PROPHYLAXIS|PREMEDICATION|VOMITING|BACK PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|CHEST PAIN|ASPARTATE AMINOTRANSFERASE INCREASED|NON-SMALL CELL LUNG CANCER STAGE IV|ANAESTHESIA|BLOOD LACTATE DEHYDROGENASE INCREASED|PREMEDICATION,Urinary retention|Nausea|Vomiting|Pulmonary oedema|Hallucination|Hypotension,6,1
12506653,20160628,Atezolizumab,58,801,58.0,1,77.8,1,0,0,0,0,0,1,Atezolizumab,CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|ATEZOLIZUMAB|BEVACIZUMAB,5,PYREXIA|HYPOTHYROIDISM|RENAL CELL CARCINOMA|RENAL CELL CARCINOMA|PYREXIA,Blood creatine phosphokinase increased,1,1
12506852,20160629,Atezolizumab,71,801,71.0,1,60.5,1,0,1,0,0,0,0,Atezolizumab,SENNOSIDES|ATEZOLIZUMAB|ZOLPIDEM TARTRATE|ZOLPIDEM TARTRATE|AMLODIPINE|PREGABALIN,23,XERODERMA|CONSTIPATION|NON-SMALL CELL LUNG CANCER METASTATIC|INSOMNIA|ANXIETY|ECZEMA|DIARRHOEA|ECZEMA|XERODERMA|GASTRITIS|ECZEMA|HYPERTENSION|METASTASES TO BONE|XERODERMA|GASTRITIS|GASTRITIS|CANCER PAIN|NEUROPATHY PERIPHERAL|COLITIS|COLITIS,Deep vein thrombosis,1,1
12507850,20160629,Atezolizumab,69,801,69.0,2,48.8,1,0,1,0,0,0,0,Atezolizumab,ENTECAVIR|ATEZOLIZUMAB,12,HYPONATRAEMIA|CHRONIC HEPATITIS B|PYREXIA|HEPATIC PAIN|NEOPLASM|BACK PAIN|TUMOUR PAIN|HEPATIC PAIN|PYREXIA|HEPATIC PAIN|HYPOMAGNESAEMIA,Hepatic pain|Hepatocellular injury,2,1
12508654,20160629,Atezolizumab,60,801,60.0,1,135.8,1,0,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|LORATADINE|LORATADINE ORAL|FISH OIL|LORATADINE PSEUDOEPHEDRINE SULFATE|LORATADINE AND PSEUDOEPHEDRINE SULFATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|TADALAFIL|LEVOTHYROXINE|FISH OIL",10,BLADDER TRANSITIONAL CELL CARCINOMA|SEASONAL ALLERGY|BACK PAIN|FLANK PAIN|NOCTURIA|HYPOTHYROIDISM|NUTRITIONAL SUPPLEMENTATION,Pulmonary embolism,1,1
12508776,20160629,Atezolizumab,63,801,63.0,1,57.2,1,1,0,0,0,0,0,Atezolizumab,BEVACIZUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ATEZOLIZUMAB|CARBOPLATIN|HYDROCHLOROTHIAZIDE|RANITIDINE|PACLITAXEL|ENALAPRIL|RANITIDINE,16,NON-SMALL CELL LUNG CANCER STAGE IV|DIABETES MELLITUS|NAUSEA|CONSTIPATION|NON-SMALL CELL LUNG CANCER STAGE IV|INSOMNIA|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|GASTRITIS|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|CHEST PAIN|HYPERSENSITIVITY,Respiratory failure,1,1
12511525,20160629,Atezolizumab,61,801,61.0,1,91.9,1,0,1,0,0,0,0,Atezolizumab,LEVOTHYROXINE|WARFARIN|PREDNISONE|PHENYTOIN|MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE|WARFARIN|PANTOPRAZOLE SODIUM|PHENYTOIN|ATEZOLIZUMAB|PHENYTOIN|CELECOXIB|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|OXYCODONE,14,HYPOTHYROIDISM|THROMBOSIS PROPHYLAXIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|GASTROOESOPHAGEAL REFLUX DISEASE|URINARY RETENTION|NON-SMALL CELL LUNG CANCER|NON-CARDIAC CHEST PAIN|DYSPNOEA|NON-CARDIAC CHEST PAIN,Tachypnoea,1,1
12519578,20160701,Atezolizumab,56,801,56.0,2,86.2,1,0,1,0,0,0,0,Atezolizumab,IRBESARTAN|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|LEVOTHYROXINE|AMLODIPINE|SIMVASTATIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|LIRAGLUTIDE|ATEZOLIZUMAB|LINEZOLID|SENNOSIDES|SENNA LEAF|SENNA|INSULIN GLARGINE|BEVACIZUMAB,16,HYPERTENSION|CONSTIPATION|HYPOTHYROIDISM|HYPERTENSION|PAIN|HYPERCHOLESTEROLAEMIA|TYPE 2 DIABETES MELLITUS|TYPE 2 DIABETES MELLITUS|RENAL CELL CARCINOMA|RASH|SEPSIS|BLISTER|CONSTIPATION|TYPE 2 DIABETES MELLITUS|RENAL CELL CARCINOMA,Toxic epidermal necrolysis,1,1
12519854,20160701,Atezolizumab,63,801,63.0,2,42.7,1,0,1,0,0,0,1,Atezolizumab,LANSOPRAZOLE|ATEZOLIZUMAB|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PEMETREXED|PEMETREXED DISODIUM|FAMOTIDINE,25,PROPHYLAXIS|CONSTIPATION|NON-SMALL CELL LUNG CANCER|DEHYDRATION|PYREXIA|INFECTION|PYREXIA|DECREASED APPETITE|HYPONATRAEMIA|CONSTIPATION|HYPOKALAEMIA|PYREXIA|DEHYDRATION|DIARRHOEA,Cardiac failure congestive|Meningitis|Alanine aminotransferase increased|Aspartate aminotransferase increased|Pleural effusion,5,1
12520746,20160701,Atezolizumab,62,801,62.0,2,85,1,0,1,1,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,NON-SMALL CELL LUNG CANCER,Aspartate aminotransferase increased|Rhabdomyolysis,2,1
12520766,20160701,Atezolizumab,83,801,83.0,2,61,1,0,1,0,0,0,0,Atezolizumab,"LATANOPROST|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ATEZOLIZUMAB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",11,GLAUCOMA|OSTEOPOROSIS|RASH|GASTROOESOPHAGEAL REFLUX DISEASE|DIARRHOEA|DECREASED APPETITE|PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NAUSEA|HYPERTENSION,Myopathy|Deep vein thrombosis,2,5
12521495,20160701,Atezolizumab,58,801,58.0,1,100,1,0,1,0,0,0,0,Atezolizumab,ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|AMLODIPINE|RAMIPRIL|RAMIPRIL|TRANEXAMIC ACID|DESLORATADINE|ATEZOLIZUMAB|CHLORPHENIRAMINE MALEATE|AMLODIPINE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|FUROSEMIDE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|TIZANIDINE HYDROCHLORIDE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|HYDROCHLOROTHIAZIDE|LEVOTHYROXINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,30,PAIN|HYPERTENSION|HYPERTENSION|DERMATITIS ACNEIFORM|DERMATITIS BULLOUS|NON-SMALL CELL LUNG CANCER|OSTEOARTHRITIS|PREMEDICATION|HOT FLUSH|DERMATITIS BULLOUS|HYPERTENSION|OSTEOARTHRITIS|PRURITUS|STOMATITIS|OSTEOARTHRITIS|DERMATITIS BULLOUS|DERMATITIS BULLOUS|HYPERTENSION|HYPOTHYROIDISM|DERMATITIS BULLOUS,Dermatitis bullous|Rash maculo-papular,2,1
12521617,20160701,Atezolizumab,87,801,87.0,1,,1,0,1,0,0,0,0,Atezolizumab,"POLYETHYLENE GLYCOL 3350|OXYCODONE|ATEZOLIZUMAB|AMLODIPINE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|SENNOSIDES|SENNA LEAF|SENNA|MORPHINE SULFATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ERGOCALCIFEROL",12,BLADDER TRANSITIONAL CELL CARCINOMA,Musculoskeletal pain,1,1
12524052,20160704,Atezolizumab,69,801,69.0,1,123.8,1,0,1,0,0,0,0,Atezolizumab,MELATONIN|BEVACIZUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|PANTOPRAZOLE|CALCIUM GLUCONATE|FLUTICASONE FUROATE|FOSINOPRIL SODIUM|FOSINOPIRL SODIUM|FOSINOPRIL|SIMVASTATIN|DIPHENHYDRAMINE HYDROCHLORIDE|ATEZOLIZUMAB|LEVOTHYROXINE SODIUM|SENNOSIDES|SENNA LEAF|SENNA|LORAZEPAM,16,PROPHYLAXIS|PROPHYLAXIS|RENAL CELL CARCINOMA|CONSTIPATION PROPHYLAXIS|PROPHYLAXIS|HYPERKALAEMIA|DIABETES MELLITUS|PROPHYLAXIS|HYPERSENSITIVITY|HYPERTENSION|HYPERLIPIDAEMIA|RASH|RENAL CELL CARCINOMA|HYPOTHYROIDISM|CONSTIPATION PROPHYLAXIS|ANXIETY,Myocarditis|Myositis|Fatigue|Muscular weakness,4,1
12524068,20160704,Atezolizumab,72,801,72.0,2,61.9,1,0,1,0,0,0,0,Atezolizumab,OXYCODONE|STANDARDIZED SENNA CONCENTRATE|FAMOTIDINE|AMLODIPINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DIPHENHYDRAMINE HYDROCHLORIDE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|ATEZOLIZUMAB|MAGNESIUM HYDROXIDE|BEVACIZUMAB|PACLITAXEL|METOPROLOL TARTRATE|METOPROLOL|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|ALPRAZOLAM|ALBUTEROL SULFATE|ALBUTEROL|CARBOPLATIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|IBUPROFEN|IBUPROFEN AND DIPHENHYDRAMINE CITRATE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|ALBUTEROL SULFATE,26,PAIN|RHINITIS ALLERGIC|CONSTIPATION|CHEMOTHERAPY|HYPERTENSION|PAIN|CHEMOTHERAPY|RHINITIS ALLERGIC|CHEMOTHERAPY|CHEMOTHERAPY|NON-SMALL CELL LUNG CANCER|CONSTIPATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|DYSPNOEA|ANXIETY|CHEMOTHERAPY|CONSTIPATION|DYSPNOEA|NON-SMALL CELL LUNG CANCER|GASTROOESOPHAGEAL REFLUX DISEASE|CONSTIPATION|DYSPNOEA,Hypophysitis,1,1
12524278,20160704,Atezolizumab,76,801,76.0,2,84.5,1,0,1,0,0,0,0,Atezolizumab,"POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ATEZOLIZUMAB|LORAZEPAM|PROCHLORPERAZINE|TEMAZEPAM|SAXAGLIPTIN|LINACLOTIDE|PROMETHAZINE HYDROCHLORIDE|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|CITALOPRAM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|STANDARDIZED SENNA CONCENTRATE|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|POLYETHYLENE GLYCOL 3350|ESCITALOPRAM|TEMAZEPAM|SIMVASTATIN|STANDARDIZED SENNA CONCENTRATE|STANDARDIZED SENNA CONCENTRATE",35,NAUSEA|BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC|ANXIETY|NAUSEA|INSOMNIA|INSOMNIA|HYPERGLYCAEMIA|CONSTIPATION|NAUSEA|THROMBOSIS PROPHYLAXIS|DYSPEPSIA|BACK PAIN|DEPRESSION|ABDOMINAL PAIN|HYPERTENSION|HYPOKALAEMIA|HYPERTENSION|CONSTIPATION|MUSCULOSKELETAL PAIN|CONSTIPATION|ARTHRALGIA|HYPERGLYCAEMIA|CONSTIPATION|DEPRESSION|ANXIETY|HYPERLIPIDAEMIA,Colitis ischaemic|Colitis|Diverticulitis,3,1
12525086,20160704,Atezolizumab,61,801,61.0,1,72.5,1,1,1,0,0,0,0,Atezolizumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FLUCONAZOLE|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PROPOFOL|PROPOFOL|FUROSEMIDE|ATEZOLIZUMAB|MEROPENEM|PROPOFOL|ACETAZOLAMIDE SODIUM|ACETAZOLAMIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CARBOPLATIN|PACLITAXEL|RANITIDINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREGABALIN,35,HYPERTENSION|PAIN|ANTIFUNGAL PROPHYLAXIS|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|DIABETES MELLITUS|ANTIFUNGAL PROPHYLAXIS|SEDATION|DYSLIPIDAEMIA|HYPOTENSION|PREMEDICATION|VOMITING|INFECTION PROPHYLAXIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|PREMEDICATION|INFECTION PROPHYLAXIS|INFECTION PROPHYLAXIS|PAIN|DIABETES MELLITUS|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|PREMEDICATION|VOMITING|NEURALGIA|DIABETES MELLITUS|PROPHYLAXIS,Febrile neutropenia|Guillain-Barre syndrome,2,1
12527379,20160705,Atezolizumab,68,801,68.0,2,,1,0,0,0,0,0,1,Atezolizumab,PACLITAXEL|ATEZOLIZUMAB|CARBOPLATIN,3,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Erythema multiforme,1,1
12527589,20160705,Atezolizumab,73,801,73.0,1,87.9,1,0,1,0,0,0,0,Atezolizumab,FINASTERIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|AMLODIPINE|ATEZOLIZUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ALLOPURINOL|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)|ENALAPRIL|CEPHALEXIN,11,ADRENAL INSUFFICIENCY|BENIGN PROSTATIC HYPERPLASIA|TYPE 2 DIABETES MELLITUS|HYPERTENSION|RENAL CELL CARCINOMA|ADRENAL INSUFFICIENCY|PROPHYLAXIS|URINARY TRACT INFECTION|RASH|URINARY TRACT INFECTION,Lower respiratory tract infection|Haematuria|Acute kidney injury,3,1
12528941,20160705,Atezolizumab,,,,1,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,International normalised ratio increased,1,3
12528964,20160705,Atezolizumab,69,801,69.0,1,84.77,1,0,0,0,0,0,1,Atezolizumab,"LORAZEPAM|AMLODIPINE|LISINOPRIL|HYDRALAZINE HYDROCHLORIDE|METOPROLOL TARTRATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CLONIDINE|ATENOLOL|INSULIN GLARGINE|BEVACIZUMAB|ATEZOLIZUMAB",15,ANXIETY|HYPERTENSION|HYPERTENSION|HYPERTENSION|HYPERTENSION|HYPERLIPIDAEMIA|BENIGN PROSTATIC HYPERPLASIA|ARTHRALGIA|HYPERTENSION|RHINITIS|HYPERTENSION|DIABETES MELLITUS|RENAL CELL CARCINOMA|DIABETES MELLITUS|RENAL CELL CARCINOMA,Rash erythematous,1,1
12530803,20160706,Atezolizumab,66,801,66.0,2,,1,0,1,0,0,0,0,Atezolizumab,FENTANYL|CITALOPRAM|CITALOPRAM HYDROBROMIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PACLITAXEL|ATEZOLIZUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|VALSARTAN|VALSARTAN ORAL,17,PAIN|PROPHYLAXIS|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HYPOTHYROIDISM|ANTIBIOTIC THERAPY|NAUSEA|HYPERTENSION|BREAST CANCER|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|HYPERTENSION|HYPERTENSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PRODUCT USED FOR UNKNOWN INDICATION|HYPERTENSION,Hypokalaemia,1,3
12534974,20160707,Atezolizumab,58,801,58.0,2,51,1,0,1,0,0,0,0,Atezolizumab,PREGABALIN|ATEZOLIZUMAB,5,ARTHRALGIA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PARAESTHESIA|NON-SMALL CELL LUNG CANCER|CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Parotitis,1,1
12536371,20160707,Atezolizumab,61,801,61.0,1,74,1,0,1,0,0,0,0,Atezolizumab,"CARBOPLATIN|GRANISETRON|GRANISETRON HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ATEZOLIZUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|MORPHINE",8,NON-SMALL CELL LUNG CANCER|PREMEDICATION|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|MUSCULOSKELETAL CHEST PAIN|NON-SMALL CELL LUNG CANCER|MUSCULOSKELETAL CHEST PAIN|MUSCULOSKELETAL CHEST PAIN,Renal failure,1,1
12538555,20160708,Atezolizumab,77,801,77.0,1,74.8,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|TOBRAMYCIN AND DEXAMETHASONE|ENALAPRIL|LORAZEPAM,10,NON-SMALL CELL LUNG CANCER|THROMBOSIS PROPHYLAXIS|LACRIMATION INCREASED|HYPERTENSION|PROPHYLAXIS|PAIN PROPHYLAXIS|INSOMNIA|ARTHRALGIA|COUGH|ARTHRALGIA,Respiratory tract infection|Upper respiratory tract infection bacterial|Pulmonary sepsis,3,1
12539215,20160708,Atezolizumab,62,801,62.0,1,90.2,1,0,1,1,0,0,0,Atezolizumab,ATEZOLIZUMAB|OLANZAPINE|PANTOPRAZOLE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|BEVACIZUMAB|PANTOPRAZOLE|MIRTAZAPINE,11,INSOMNIA|RASH|RENAL CELL CARCINOMA|RASH|PROPHYLAXIS OF NAUSEA AND VOMITING|RENAL CELL CARCINOMA|HYPERTENSION|PROPHYLAXIS|INSOMNIA,Pancreatitis|Pneumonitis,2,1
12543888,20160711,Atezolizumab,49,801,49.0,1,60,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|ATEZOLIZUMAB,7,NON-SMALL CELL LUNG CANCER|PERICARDIAL EFFUSION|PERICARDIAL EFFUSION|ANAEMIA|PAIN,Infusion related reaction|Anaemia|Cardiac tamponade|Superior vena cava syndrome,4,1
12547626,20160712,Atezolizumab,75,801,75.0,2,55.1,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA,Thrombocytopenia|Acute kidney injury|Anaemia,3,1
12550995,20160713,Atezolizumab,72,801,72.0,1,75,1,0,1,0,0,0,0,Atezolizumab,LOSARTAN|ENALAPRIL|ATEZOLIZUMAB|LORAZEPAM,6,HYPERTENSION|HYPERTENSION|GLAUCOMA|NON-SMALL CELL LUNG CANCER|INSOMNIA,Pneumothorax,1,1
12553121,20160713,Atezolizumab,68,801,68.0,1,72,1,0,1,0,0,0,0,Atezolizumab,LATANOPROST|WARFARIN|FOLIC ACID|ATEZOLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE HYDROCHLORIDE|MORPHINE|LACTULOSE|MORPHINE,15,GLAUCOMA|DECREASED APPETITE|NAUSEA|NUTRITIONAL SUPPLEMENTATION|NON-SMALL CELL LUNG CANCER|GASTROOESOPHAGEAL REFLUX DISEASE|BACK PAIN|NAUSEA|MUSCULOSKELETAL CHEST PAIN|MUSCULOSKELETAL CHEST PAIN|CONSTIPATION|BACK PAIN,Alanine aminotransferase increased|Aspartate aminotransferase increased|Sepsis,3,1
12553228,20160713,Atezolizumab,60,801,60.0,2,84,1,1,1,0,0,0,0,Atezolizumab,OXYCODONE HYDROCHLORIDE|ATEZOLIZUMAB|CARBOPLATIN|APREPITANT,17,PROPHYLAXIS OF NAUSEA AND VOMITING|NAUSEA|PAIN|HYPERCALCAEMIA|PROPHYLAXIS OF NAUSEA AND VOMITING|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PAIN|PAIN|PROPHYLAXIS OF NAUSEA AND VOMITING|PAIN|NON-SMALL CELL LUNG CANCER|MUSCULOSKELETAL PAIN|HYPERCALCAEMIA|ANAEMIA|PROPHYLAXIS|PROPHYLAXIS,Asthenia,1,1
12555517,20160714,Atezolizumab,77,801,77.0,2,51.6,1,1,1,0,0,0,0,Atezolizumab,"DAPSONE GEL, 5%|DAPSONE|DASPONE|STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|ATEZOLIZUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|DIPHENHYDRAMINE HYDROCHLORIDE",9,CONSTIPATION|PYREXIA|RHINITIS ALLERGIC|BLADDER TRANSITIONAL CELL CARCINOMA|PYREXIA|COUGH|PAIN|RASH,Toxic epidermal necrolysis,1,1
12556278,20160714,Atezolizumab,,,,1,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Cellulitis,1,1
12560700,20160715,Atezolizumab,69,801,69.0,1,104.3,1,1,1,0,0,0,0,Atezolizumab,"AMLODIPINE|OXYGEN|0XYGEN|DEXMEDETOMIDINE|DICLOFENAC SODIUM|METOPROLOL TARTRATE|METOPROLOL|FUROSEMIDE|DIGOXIN|METRONIDAZOLE|ACETYLCYSTEINE|FENTANYL|QUETIAPINE|PACLITAXEL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|PANTOPRAZOLE SODIUM|THIAMINE HYDROCHLORIDE|FOLIC ACID|CARBOPLATIN|LEVETIRACETAM|LEVETIRACETAM|LANSOPRAZOLE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|FUROSEMIDE|FERROUS SULFATE|HYDRALAZINE HYDROCHLORIDE|HYDRALAZINE HYDROCHLORIDE|CARVEDILOL|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|DIGOXIN|DEXMEDETOMIDINE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|ATEZOLIZUMAB|METOPROLOL TARTRATE|METOPROLOL|NICOTINE POLACRILEX|NICOTINE|NICOTINE POLACRILEX MINI|NICOTINE POLARILEX|HYDROMORPHONE HYDROCHLORIDE|DIGOXIN|POTASSIUM SULFATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DEXTROSE MONOHYDRATE|DEXTROSE|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|LORAZEPAM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DEXTROSE MONOHYDRATE|DEXTROSE|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|TIOTROPIUM BROMIDE|OXYCODONE",66,CARDIAC FAILURE|RESPIRATORY THERAPY|SEDATION|NAUSEA|ARTHRALGIA|HYPERTENSION|HYPERTENSION|DIURETIC THERAPY|HYPERTENSION|INFECTION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|DEHYDRATION|DEPRESSION|NON-SMALL CELL LUNG CANCER STAGE IV|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|GASTROOESOPHAGEAL REFLUX DISEASE|NON-SMALL CELL LUNG CANCER STAGE IV|INFECTION|PRODUCT USED FOR UNKNOWN INDICATION|RESPIRATORY THERAPY|GASTROOESOPHAGEAL REFLUX DISEASE|PAIN|FLUID RETENTION|PRURITUS|ANXIETY|HYPERTENSION|CARDIAC FAILURE|PAIN|PAIN|INFLAMMATION|NON-SMALL CELL LUNG CANCER STAGE IV|CARDIAC FAILURE|INFECTION|PAIN|DEHYDRATION|DIARRHOEA|HYPOTENSION|AGITATION|AGITATION|DEHYDRATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN,Sepsis|Febrile neutropenia,2,1
12563139,20160715,Atezolizumab,73,801,73.0,1,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,10,PROPHYLAXIS|PROPHYLAXIS|HYPERTENSION|HYPERTENSION|BLADDER CANCER|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS,Liver disorder,1,1
12563990,20160715,Atezolizumab,68,801,68.0,1,77.11,1,1,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,METASTATIC CARCINOMA OF THE BLADDER,Dehydration|Impaired gastric emptying,2,
12563994,20160718,Atezolizumab,66,801,66.0,1,59.3,1,0,1,0,0,0,0,Atezolizumab,"MAGNESIUM OXIDE|GABAPENTIN|SITAGLIPTIN|RANITIDINE|MIDAZOLAM HYDROCHLORIDE|BUDESONIDE|LANSOPRAZOLE|ETOMIDATE|ETOMIDATE INJECTION|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|FENTANYL|AMOXICILLIN AND CLAVULANATE POTASSIUM|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|FAMOTIDINE|MORPHINE|HALOPERIDOL|HALOPERIDOL LACTATE|LACTULOSE|OXYCODONE HYDROCHLORIDE|OXYCODONE|RANITIDINE|FENTANYL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FENTANYL|ACETYLCYSTEINE|ATEZOLIZUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|RANITIDINE|NALOXONE|SUCCINYLCHOLINE",41,CONSTIPATION|NECK PAIN|DIABETES MELLITUS|STOMATITIS|SEDATION|PNEUMONIA|STOMATITIS|SEDATION|PNEUMONIA|STOMATITIS|NECK PAIN|NECK PAIN|DIABETES MELLITUS|INFECTION|HYPERGLYCAEMIA|STOMATITIS|NECK PAIN|DELIRIUM|CONSTIPATION|THROMBOSIS|NECK PAIN|NECK PAIN|INFECTION|DECREASED APPETITE|NECK PAIN|INFECTION|PNEUMONIA|NECK PAIN|SEDATION|PNEUMONIA|NON-SMALL CELL LUNG CANCER|DECREASED APPETITE|NECK PAIN|SEDATION|INFECTION,Localised oedema,1,1
12564483,20160718,Atezolizumab,50,801,50.0,1,64,1,0,1,0,0,0,0,Atezolizumab,FOSAPREPITANT|FOSAPREPITANT DIMEGLUMINE|FOSAPREPITANT|FOSAPREPITANT DIMEGLUMINE|PACLITAXEL|GRANISETRON|GRANISETRON HYDROCHLORIDE|ATEZOLIZUMAB|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|RAMIPRIL|NITROGLYCERIN|CARBOPLATIN|METOPROLOL TARTRATE|METOPROLOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|GRANISETRON|GRANISETRON HYDROCHLORIDE,21,HYPERTENSION|ADRENAL INSUFFICIENCY|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NON-SMALL CELL LUNG CANCER|C-REACTIVE PROTEIN INCREASED|HYPERTENSION|PROPHYLACTIC CHEMOTHERAPY|HYPERTENSION|NON-SMALL CELL LUNG CANCER|HYPERTENSION|PROPHYLAXIS,Infection,1,1
12564623,20160718,Atezolizumab,67,801,67.0,2,61.2,1,0,1,0,0,0,0,Atezolizumab,FAMOTIDINE|ATEZOLIZUMAB|FENOFIBRATE|ACETAMINOPHEN AND CODEINE|HYDROCHLOROTHIAZIDE,6,INSOMNIA|GASTROOESOPHAGEAL REFLUX DISEASE|NON-SMALL CELL LUNG CANCER|BLOOD CHOLESTEROL|BACK PAIN|HYPERTENSION,Emphysema,1,1
12565039,20160718,Atezolizumab,69,801,69.0,2,54.6,1,0,1,0,0,0,0,Atezolizumab,BEVACIZUMAB|PACLITAXEL|CARBOPLATIN|ATEZOLIZUMAB,29,NON-SMALL CELL LUNG CANCER|DRY EYE|ERYTHEMA|PROPHYLAXIS|ATRIAL TACHYCARDIA|NON-SMALL CELL LUNG CANCER|HYPERTENSION|PYREXIA|CONSTIPATION|DRY EYE|GASTRITIS PROPHYLAXIS|NEUTROPHIL COUNT DECREASED|PYREXIA|ARTHRALGIA|NAUSEA|NON-SMALL CELL LUNG CANCER|VOMITING|ATRIAL TACHYCARDIA|NON-SMALL CELL LUNG CANCER|DECREASED APPETITE,Platelet count decreased,1,1
12568896,20160719,Atezolizumab,24,801,24.0,2,49,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,5,NEOPLASM|NEOPLASM,Left ventricular dysfunction,1,1
12569205,20160719,Atezolizumab,69,801,69.0,2,68.6,1,0,1,0,0,0,0,Atezolizumab,"ENOXAPARIN SODIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|DIPHENHYDRAMINE HYDROCHLORIDE|MELATONIN|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|SULFAMETHOXAZOLE AND TRIMETHOPRIM|AMLODIPINE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|TRIAMTERENE AND HYDROCHLOROTHIAZIDE|FENOFIBRATE|ZOLPIDEM TARTRATE|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE|ATEZOLIZUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|GABAPENTIN|NAPROXEN|NAPROXEN SODIUM|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ATEZOLIZUMAB|SERTRALINE HYDROCHLORIDE",29,URINARY TRACT INFECTION|HYPONATRAEMIA|URINARY TRACT INFECTION|URINARY TRACT INFECTION|NEOPLASM|HYPOKALAEMIA|CARPAL TUNNEL SYNDROME|DEHYDRATION,Hyponatraemia|Adrenal insufficiency,2,1
12569282,20160719,Atezolizumab,54,801,54.0,1,88,1,0,1,0,0,0,0,Atezolizumab,DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|LOSARTAN|FLUCONAZOLE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|RANITIDINE|FILGRASTIM|PACLITAXEL|ATEZOLIZUMAB|CARBOPLATIN|PANTOPRAZOLE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RANITIDINE,15,PREMEDICATION|ESSENTIAL HYPERTENSION|PROPHYLAXIS|PREMEDICATION|PREMEDICATION|NEUTROPENIA|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|ESSENTIAL HYPERTENSION|PROPHYLAXIS|PREMEDICATION|PREMEDICATION|RASH|RASH,Respiratory tract infection,1,1
12569523,20160719,Atezolizumab,66,801,66.0,1,55.5,1,0,1,0,0,0,0,Atezolizumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|CLOPIDOGREL|ATEZOLIZUMAB|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|FAMOTIDINE,29,PROPHYLAXIS|COUGH|GASTRITIS PROPHYLAXIS|INFECTION PROPHYLAXIS|HYPERTENSION|HEADACHE|INFECTION PROPHYLAXIS|GASTRITIS PROPHYLAXIS|COUGH|MYALGIA|DIARRHOEA|GASTRITIS PROPHYLAXIS|NAUSEA|DIABETES MELLITUS|NAUSEA|PROPHYLAXIS|HYPERTENSION|COUGH|BLOOD ALKALINE PHOSPHATASE INCREASED|HEADACHE|INFECTION PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|DIABETES MELLITUS|ASPARTATE AMINOTRANSFERASE INCREASED|INFECTION PROPHYLAXIS|GASTRITIS PROPHYLAXIS,Aspiration,1,1
12569757,20160719,Atezolizumab,79,801,79.0,1,82,1,0,1,0,0,0,0,Atezolizumab,PACLITAXEL|GRANISETRON|GRANISETRON HYDROCHLORIDE|CARBOPLATIN|HYDROCHLOROTHIAZIDE|ATEZOLIZUMAB|BEVACIZUMAB|TELMISARTAN|ALLOPURINOL|FONDAPARINUX SODIUM,26,NON-SMALL CELL LUNG CANCER STAGE IV|BACK PAIN|HYPERTENSION|GASTRITIS|PROPHYLACTIC CHEMOTHERAPY|PROPHYLACTIC CHEMOTHERAPY|HYPERTENSION|BACK PAIN|PROPHYLACTIC CHEMOTHERAPY|PROPHYLACTIC CHEMOTHERAPY|HYPOKALAEMIA|RENAL FAILURE|THROMBOSIS|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|THROMBOSIS PROPHYLAXIS|HYPERTENSION|GOUT,Intestinal haemorrhage|Diarrhoea|Colitis,3,1
12572849,20160720,Atezolizumab,71,801,71.0,1,119.2,1,0,1,0,0,0,0,Atezolizumab,WARFARIN|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ATEZOLIZUMAB|IRBESARTAN|METOPROLOL TARTRATE|METOPROLOL|BEVACIZUMAB|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|PHYTONADIONE|ALBUTEROL SULFATE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|WARFARIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|WARFARIN|HYDROCHLOROTHIAZIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,28,BRONCHITIS|RENAL CELL CARCINOMA|DYSPNOEA|IRON DEFICIENCY|HYPERTENSION|HYPERTENSION|PULMONARY EMBOLISM|BRONCHITIS|BRONCHITIS|RENAL CELL CARCINOMA|DYSPNOEA|INTERNATIONAL NORMALISED RATIO ABNORMAL|DYSPNOEA|INFECTION PROPHYLAXIS|BRONCHITIS|NAUSEA|ORAL CANDIDIASIS|BRONCHITIS|BRONCHITIS|ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED|HYPERTENSION|NAUSEA|CONSTIPATION|MUCOSAL INFLAMMATION,Hyperthyroidism|Pulmonary embolism|Factor VIII inhibition,3,1
12573126,20160720,Atezolizumab,63,801,63.0,1,62,1,1,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB|TIOTROPIUM BROMIDE|ZOLPIDEM TARTRATE|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|ALPRAZOLAM,7,NON-SMALL CELL LUNG CANCER|DYSPNOEA|CHEST PAIN|ANXIETY|DYSPNOEA|CHEST PAIN|ANXIETY,Haemolysis,1,1
12575965,20160720,Atezolizumab,,,,0,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Blindness,1,3
12579111,20160721,Atezolizumab,53,801,53.0,1,99,1,0,1,0,0,0,0,Atezolizumab,HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ENOXAPARIN SODIUM|ATEZOLIZUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ALLOPURINOL|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,28,DIARRHOEA|HYPERTENSION|PULMONARY EMBOLISM|METASTATIC NEOPLASM|PULMONARY EMBOLISM|GASTROINTESTINAL DISORDER|DEPRESSION|PYREXIA|BONE PAIN|PROPHYLAXIS|IRON DEFICIENCY|ANAEMIA|RENAL FAILURE|PULMONARY EMBOLISM|HYPERURICAEMIA|ADRENAL INSUFFICIENCY|HYPERTENSION|PROPHYLAXIS|BONE PAIN|ADRENAL INSUFFICIENCY,Pyrexia,1,1
12579126,20160721,Atezolizumab,61,801,61.0,2,,1,0,1,0,0,0,0,Atezolizumab,PACLITAXEL|ATEZOLIZUMAB,6,THROMBOSIS|BREAST CANCER METASTATIC|PAIN|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea,1,3
12579505,20160721,Atezolizumab,75,801,75.0,2,45.9,1,0,0,0,1,0,0,Atezolizumab,ERGOCALCIFEROL|AMLODIPINE BESYLATE|CITALOPRAM|GARLIC|ATORVASTATIN CALCIUM|NIACIN|ATEZOLIZUMAB,16,HYPERTENSION|NAUSEA|DEPRESSION|CONSTIPATION|NAUSEA|HYPOTHYROIDISM|HYPERLIPIDAEMIA|HYPERLIPIDAEMIA|ARTHRALGIA|NON-SMALL CELL LUNG CANCER,Retinopathy,1,1
12580060,20160721,Atezolizumab,,,,2,,1,1,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Disease progression,1,5
12580165,20160721,Atezolizumab,78,801,78.0,1,80.6,1,0,0,0,1,0,1,Atezolizumab,PREGABALIN|CARBOPLATIN|ATEZOLIZUMAB|CARBOPLATIN,15,NON-SMALL CELL LUNG CANCER STAGE IV|CARDIAC DISORDER|PAIN|BLOOD CHOLESTEROL|BRONCHITIS|BRONCHITIS|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|NAUSEA|NON-SMALL CELL LUNG CANCER STAGE IV|NAUSEA|HYPERTENSION|CARDIAC FAILURE,Diarrhoea|Asthenia|Asthenia,3,1
12582071,20160722,Atezolizumab,61,801,61.0,2,121.4,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|CILOSTAZOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|CARBOPLATIN|CLOPIDOGREL|CLOPIDOGREL BISULFATE|EZETIMIBE|GLIMEPIRIDE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|TIOTROPIUM BROMIDE|LIRAGLUTIDE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|ALBUTEROL SULFATE|ALBUTEROL,25,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|PERIPHERAL VASCULAR DISORDER|PERIPHERAL VASCULAR DISORDER|PRURITUS|SINUSITIS|BLOOD CHOLESTEROL INCREASED|NAUSEA|NON-SMALL CELL LUNG CANCER STAGE IV|PERIPHERAL VASCULAR DISORDER|BLOOD CHOLESTEROL INCREASED|DIABETES MELLITUS|HYPOMAGNESAEMIA|ANAEMIA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|WEIGHT CONTROL|CONSTIPATION|CONSTIPATION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PAIN|HYPERTENSION,Pneumonia|Chronic obstructive pulmonary disease,2,1
12582569,20160722,Atezolizumab,60,801,60.0,2,79.7,1,0,1,0,0,0,0,Atezolizumab,ALBUTEROL SULFATE|PANTOPRAZOLE|INSULIN GLARGINE|INSULIN GLARGINE|ATEZOLIZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DROPERIDOL|PROPRANOLOL HYDROCHLORIDE|THIAMINE HYDROCHLORIDE,29,HYPERGLYCAEMIA|ASTHMA|ASTHMA|GASTROOESOPHAGEAL REFLUX DISEASE|DEEP VEIN THROMBOSIS|ABDOMINAL PAIN|DIABETES MELLITUS|HYPERGLYCAEMIA|BREAST CANCER METASTATIC|ARTHRALGIA|BREAST CANCER METASTATIC|DIABETES MELLITUS|INFECTION PROPHYLAXIS|HYPERTENSION|PAIN IN EXTREMITY|NAUSEA|NAUSEA|VOMITING|PROPHYLAXIS|DIABETES MELLITUS|MIGRAINE|HEADACHE|PREMEDICATION|VOMITING|BACK PAIN|ELECTROLYTE IMBALANCE|BACK PAIN,Hyperthyroidism,1,1
12586438,20160725,Atezolizumab,65,801,65.0,1,104.7,1,0,1,0,0,0,0,Atezolizumab,ACETAMINOPHEN AND CODEINE|MORPHINE|GABAPENTIN|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|ERGOCALCIFEROL|GABAPENTIN|ATEZOLIZUMAB,8,ABDOMINAL PAIN|BACK PAIN|NEOPLASM|INFECTION|BACK PAIN|NEOPLASM,Constipation|Blood bilirubin increased,2,1
12586747,20160725,Atezolizumab,41,801,41.0,1,73.2,1,0,1,0,0,0,0,Atezolizumab,LORAZEPAM|BEVACIZUMAB|MORPHINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATEZOLIZUMAB,9,INSOMNIA|RENAL CELL CARCINOMA|PAIN|PAIN|PROPHYLAXIS|NAUSEA|RENAL CELL CARCINOMA|PROPHYLAXIS,Cytokine release syndrome,1,1
12587804,20160725,Atezolizumab,50,801,50.0,2,66,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|LEVETIRACETAM,2,NON-SMALL CELL LUNG CANCER,Drug-induced liver injury|Hyperthyroidism,2,1
12591027,20160726,Atezolizumab,53,801,53.0,1,85,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,NEOPLASM,Pneumonia,1,1
12596007,20160727,Atezolizumab,45,801,45.0,1,60,1,0,1,0,0,0,0,Atezolizumab,OXYCODONE HYDROCHLORIDE|OXYCODONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PROPRANOLOL HYDROCHLORIDE|CELECOXIB|LACTULOSE|CELECOXIB|OXYCODONE HYDROCHLORIDE|OXYCODONE|ATEZOLIZUMAB,11,CHEST PAIN|NAUSEA|PALPITATIONS|BACK PAIN|COUGH|CONSTIPATION|CHEST PAIN|BACK PAIN|NON-SMALL CELL LUNG CANCER|COUGH,Pleural effusion,1,1
12596579,20160726,Atezolizumab,29,801,29.0,2,57.6,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|BEVACIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXTROSE MONOHYDRATE|DEXTROSE,15,RENAL CELL CARCINOMA|DIARRHOEA|INFLUENZA LIKE ILLNESS|DECREASED APPETITE|RENAL CELL CARCINOMA|INFLUENZA LIKE ILLNESS|INFLUENZA LIKE ILLNESS|NAUSEA|PYREXIA|PROPHYLAXIS|DIARRHOEA|DIARRHOEA,Colitis|Pain in extremity,2,1
12596601,20160727,Atezolizumab,70,801,70.0,1,62,1,0,1,0,0,0,0,Atezolizumab,CARBOPLATIN|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|KETOPROFEN|PACLITAXEL|ATEZOLIZUMAB|BEVACIZUMAB|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE,29,NON-SMALL CELL LUNG CANCER|DIARRHOEA|NAUSEA|CONSTIPATION|MALAISE|HYPERTENSION|PREMEDICATION|MALAISE|NAUSEA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ASTHENOPIA|PREMEDICATION|PREMEDICATION|RASH|MYALGIA|PYREXIA|NAUSEA|DIARRHOEA,Pleurisy|Pneumonia,2,1
12601776,20160728,Atezolizumab,69,801,69.0,1,80,1,0,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|GABAPENTIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|FLUCONAZOLE|DENOSUMAB|GABAPENTIN",20,GOUT|ABDOMINAL PAIN|BLADDER TRANSITIONAL CELL CARCINOMA|ANAEMIA|ABDOMINAL PAIN|URINARY TRACT INFECTION|PAIN IN EXTREMITY|ABDOMINAL PAIN|METASTASES TO BONE|PAIN IN EXTREMITY|TINEA PEDIS|RASH|PROPHYLAXIS|PROPHYLAXIS|METASTASES TO BONE|ABDOMINAL PAIN|ABDOMINAL PAIN|ABDOMINAL PAIN|THROMBOSIS,Haematuria|Acute kidney injury|Postrenal failure|Toxic epidermal necrolysis,4,1
12602931,20160728,Atezolizumab,72,801,72.0,1,82.6,1,0,1,0,0,0,1,Atezolizumab,GRANISETRON|GRANISETRON HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CARBOPLATIN|AMOXICILLIN AND CLAVULANATE POTASSIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ROSUVASTATIN|TIOTROPIUM BROMIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|APREPITANT|GRANISETRON|GRANISETRON HYDROCHLORIDE|FOLIC ACID|ATEZOLIZUMAB|RIVAROXABAN,27,VOMITING|VOMITING|CONJUNCTIVITIS|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS|PHLEBITIS|PHLEBITIS|NON-SMALL CELL LUNG CANCER|INFECTION|NAUSEA|HYPERCHOLESTEROLAEMIA|DIABETES MELLITUS|DIABETES MELLITUS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|VOMITING|PROPHYLAXIS|CHEST PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|THROMBOSIS PROPHYLAXIS|CONSTIPATION|PROPHYLAXIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Left ventricular dysfunction|Atrial fibrillation|Cardiac tamponade,3,1
12603259,20160728,Atezolizumab,60,801,60.0,1,64.8,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|CARBOPLATIN,14,VOMITING|HAEMOPTYSIS|HAEMOPTYSIS|PROPHYLAXIS|TINEA INFECTION|PROPHYLAXIS|CHEILITIS|NAUSEA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HICCUPS|NON-SMALL CELL LUNG CANCER|TINEA INFECTION,Pericardial effusion|Influenza like illness,2,1
12605346,20160729,Atezolizumab,69,801,69.0,1,57.4,1,0,1,0,0,0,0,Atezolizumab,GRANISETRON HYDROCHLORIDE|MAGNESIUM OXIDE|ATEZOLIZUMAB|CARBOPLATIN|CHLORPHENIRAMINE MALEATE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|CHLORPHENIRAMINE MALEATE|CARBOPLATIN|GRANISETRON HYDROCHLORIDE,26,PREMEDICATION|NAUSEA|INFECTION PROPHYLAXIS|PREMEDICATION|PYREXIA|CONSTIPATION|PNEUMONIA BACTERIAL|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|CONSTIPATION|INSOMNIA|RASH|PROPHYLAXIS|COUGH|ABDOMINAL DISCOMFORT|RASH|HYPERSENSITIVITY|PREMEDICATION,Platelet count decreased|Febrile neutropenia|Pneumonia bacterial,3,1
12605662,20160729,Atezolizumab,68,801,68.0,2,51.2,1,0,0,0,0,0,1,Atezolizumab,ZOLPIDEM TARTRATE|CARBOPLATIN|SUVOREXANT|PREGABALIN|RANITIDINE|PACLITAXEL|ATEZOLIZUMAB|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|MAGNESIUM OXIDE|SUVOREXANT|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS,46,PRODUCTIVE COUGH|HYPERTENSION|INSOMNIA|PYREXIA|COUGH|INSOMNIA|STOMATITIS|NON-SMALL CELL LUNG CANCER METASTATIC|GASTRITIS|PYREXIA|PAIN IN EXTREMITY|PYREXIA|FEBRILE NEUTROPENIA|INSOMNIA|HEADACHE|PAIN IN EXTREMITY|GASTRITIS|PAIN IN EXTREMITY|COUGH|HYPOVITAMINOSIS|PRODUCTIVE COUGH|PAIN IN EXTREMITY|NAUSEA|HYPERSENSITIVITY|NON-SMALL CELL LUNG CANCER METASTATIC|MUSCULOSKELETAL PAIN|HYPOVITAMINOSIS|PRODUCTIVE COUGH|HYPOKALAEMIA|NON-SMALL CELL LUNG CANCER METASTATIC|MUSCULOSKELETAL PAIN|HAEMOPTYSIS|HYPERSENSITIVITY|FEBRILE NEUTROPENIA|HYPOKALAEMIA|HYPERTENSION|HEADACHE|NAUSEA|INFECTION|COUGH|CONSTIPATION|HAEMOPTYSIS|DECREASED APPETITE,Erythema multiforme,1,1
12608029,20160729,Atezolizumab,51,801,51.0,2,74.4,1,0,1,0,0,0,0,Atezolizumab,MINOXIDIL|BEVACIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|TIZANIDINE|ENOXAPARIN SODIUM|ATEZOLIZUMAB|OXYCODONE|BIOTIN|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|ENALAPRIL|TIZANIDINE|STANDARDIZED SENNA CONCENTRATE|AMLODIPINE,15,ALOPECIA|CLEAR CELL RENAL CELL CARCINOMA|SUPPLEMENTATION THERAPY|PAIN|MYALGIA|DEEP VEIN THROMBOSIS|CLEAR CELL RENAL CELL CARCINOMA|PAIN|ALOPECIA|CONSTIPATION|HYPERTENSION|PAIN IN EXTREMITY|CONSTIPATION|HYPERTENSION,Haematuria,1,1
12610696,20160801,Atezolizumab,,,,2,,1,1,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA METASTATIC,Death,1,3
12614849,20160802,Atezolizumab,73,801,73.0,1,84.2,1,1,1,0,0,0,0,Atezolizumab,PACLITAXEL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|SOTALOL HYDROCHLORIDE|OXAZEPAM|ATEZOLIZUMAB|BEVACIZUMAB|VALSARTAN|VALSARTAN ORAL|AMLODIPINE|TIOTROPIUM BROMIDE|DICLOFENAC|DICLOFENAC SODIUM|CARBOPLATIN|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,20,NON-SMALL CELL LUNG CANCER STAGE IV|DIABETES MELLITUS|CORONARY ARTERY INSUFFICIENCY|PROPHYLAXIS|CORONARY ARTERY INSUFFICIENCY|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|CORONARY ARTERY INSUFFICIENCY|CORONARY ARTERY INSUFFICIENCY|CORONARY ARTERY INSUFFICIENCY|MUSCULOSKELETAL CHEST PAIN|DYSPNOEA|MUSCULOSKELETAL CHEST PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|CONSTIPATION PROPHYLAXIS|PROPHYLAXIS|CORONARY ARTERY INSUFFICIENCY|CORONARY ARTERY INSUFFICIENCY|MUSCULOSKELETAL CHEST PAIN|NAUSEA,Febrile neutropenia|Nausea|Hypophosphataemia|Febrile neutropenia,4,1
12615167,20160802,Atezolizumab,,,,2,58,1,1,1,0,0,0,0,Atezolizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB|PREGABALIN|ATEZOLIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",11,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Septic shock|Pyrexia|Multiple organ dysfunction syndrome,3,1
12617078,20160803,Atezolizumab,47,801,47.0,1,123.8,1,0,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FENTANYL|MIDAZOLAM HYDROCHLORIDE|LORATADINE|LORATADINE ORAL|TESTOSTERONE|TESTOSTERONE,|RIVAROXABAN|EPINEPHRINE|ADRENALINUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|FENTANYL|CEPHALEXIN|CYANOCOBALAMIN|PANTOPRAZOLE|CEFOXITIN|CEFOXITIN SODIUM|TADALAFIL|LORAZEPAM",19,BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC|PROPHYLAXIS|ANAESTHESIA|HYPERSENSITIVITY|GYNAECOMASTIA|DIARRHOEA|DEEP VEIN THROMBOSIS|PREMEDICATION|BREATH ODOUR|PREMEDICATION|PAIN|PROPHYLAXIS|GASTROOESOPHAGEAL REFLUX DISEASE|INFECTION PROPHYLAXIS|ERECTILE DYSFUNCTION,Device related infection|Device related infection,2,1
12617204,20160803,Atezolizumab,66,801,66.0,1,79.3,1,1,1,1,1,1,1,Atezolizumab,"ATEZOLIZUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|AMLODIPINE|AMLODIPINE|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|CALCITRIOL|CALCITRIOL CAPSULES 0.25 MCG|CALCITRIOL CAPSULES 0.5 MCG|CALCITRIOL|CALCITRIOL CAPSULES 0.25 MCG|CALCITRIOL CAPSULES 0.5 MCG|CETIRIZINE HYDROCHLORIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|OXYCODONE|VALACYCLOVIR HYDROCHLORIDE|LORAZEPAM|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL|LEVOTHYROXINE|AMOXICILLIN AND CLAVULANATE POTASSIUM|CETIRIZINE HCL|CETIRIZINE",26,Bladder transitional cell carcinoma metastatic|Hypertension|Hypercholesterolaemia|Benign prostatic hyperplasia|Hypertension|Blood cholesterol increased|Nutritional supplementation|Hypersensitivity|Pain|Herpes zoster|Insomnia|Hypothyroidism|Ear discomfort|Hypersensitivity|Hypothyroidism|Paronychia|Hypersensitivity,Rhabdomyolysis|Blood creatine phosphokinase increased,2,1
12617372,20160803,Atezolizumab,68,801,68.0,1,62,1,0,1,0,0,0,0,Atezolizumab,CALCIUM GLUCONATE|LEVOTHYROXINE SODIUM|INSULIN HUMAN|ATEZOLIZUMAB|MORPHINE SULFATE,17,HYPERTENSION|GOUT|ANGINA PECTORIS|HYPOCALCAEMIA|HYPONATRAEMIA|GASTRITIS|HYPOTHYROIDISM|HYPOGLYCAEMIA|NAUSEA|GASTRITIS|GASTRITIS|BLADDER TRANSITIONAL CELL CARCINOMA|HYPERTENSION|HYPERTENSION|ANGINA PECTORIS,Pericardial effusion,1,1
12617935,20160803,Atezolizumab,60,801,60.0,1,63.5,1,0,1,0,0,0,0,Atezolizumab,PACLITAXEL|CARBOPLATIN|PACLITAXEL|PALONOSETRON HYDROCHLORIDE|PACLITAXEL|PACLITAXEL|PALONOSETRON HYDROCHLORIDE|CARBOPLATIN|CARBOPLATIN|PACLITAXEL|UREA|PALONOSETRON HYDROCHLORIDE,21,NON-SMALL CELL LUNG CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING|HEPATIC FUNCTION ABNORMAL|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|TINEA INFECTION|PROPHYLAXIS OF NAUSEA AND VOMITING|TINEA INFECTION|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING,Influenza like illness|Influenza like illness|Pericardial effusion|Influenza like illness|Influenza like illness|Influenza like illness,6,3
12618690,20160803,Atezolizumab,70,801,70.0,2,84.5,1,1,1,0,0,0,0,Atezolizumab,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATEZOLIZUMAB|RANITIDINE|OXAZEPAM|APREPITANT|CARBOPLATIN|PROPRANOLOL HYDROCHLORIDE|TIOTROPIUM BROMIDE|LEVOTHYROXINE|BEVACIZUMAB|PACLITAXEL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,18,PREMEDICATION|NON-SMALL CELL LUNG CANCER STAGE IV|PREMEDICATION|DEPRESSION|PREMEDICATION|CONSTIPATION PROPHYLAXIS|PREMEDICATION|NON-SMALL CELL LUNG CANCER STAGE IV|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CHEST PAIN|ABDOMINAL PAIN UPPER|DEPRESSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|HYPOTHYROIDISM|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PROPHYLAXIS OF NAUSEA AND VOMITING,Haemoptysis,1,1
12620122,20160803,Atezolizumab,,,,1,,1,0,1,0,0,0,0,Atezolizumab,METHYLPREDNISOLONE SODIUM SUCCINATE|ATEZOLIZUMAB,3,THROMBOSIS|BLADDER CANCER,Transient ischaemic attack,1,1
12620752,20160804,Atezolizumab,43,801,43.0,2,60.1,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|BEVACIZUMAB,7,HEADACHE|RENAL CELL CARCINOMA|HEADACHE|PROPHYLAXIS|RENAL CELL CARCINOMA|DIARRHOEA|MUSCULOSKELETAL PAIN,Meningitis,1,1
12622389,20160804,Atezolizumab,74,801,74.0,1,95.8,1,0,1,0,0,0,0,Atezolizumab,ALPRAZOLAM|ALPRAZOLAM|ATEZOLIZUMAB|LORAZEPAM|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE,17,BACK PAIN|INSOMNIA|DEPRESSION|BACK PAIN|BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC|INSOMNIA|OEDEMA|BACK PAIN|CONSTIPATION|ARTHRALGIA|ARTHRALGIA|DEPRESSION|PRURITUS|BONE PAIN|BONE PAIN,Urinary tract infection pseudomonal|Urinary tract infection,2,1
12624394,20160805,Atezolizumab,40,801,40.0,2,120.8,1,0,1,0,0,0,0,Atezolizumab,"LEVOTHYROXINE SODIUM|ALPRAZOLAM|PROMETHAZINE HYDROCHLORIDE|LORAZEPAM|OXYCODONE|POLYETHYLENE GLYCOL 3350|ATEZOLIZUMAB|RIZATRIPTAN BENZOATE|OMEPRAZOLE MAGNESIUM|MOMETASONE FUROATE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|GRANISETRON|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",19,HYPOTHYROIDISM|ANXIETY|NAUSEA|ANXIETY|TUMOUR PAIN|WHITE BLOOD CELL COUNT DECREASED|PREMEDICATION|CONSTIPATION|NEOPLASM|MIGRAINE|DYSPEPSIA|SEASONAL ALLERGY|PREMEDICATION|TUMOUR PAIN|DIARRHOEA|NEOPLASM|NAUSEA|PREMEDICATION,Pneumonia,1,1
12624501,20160805,Atezolizumab,78,801,78.0,1,101.7,1,1,1,0,0,0,0,Atezolizumab,"BISOPROLOL FUMARATE|ROSUVASTATIN|METOPROLOL TARTRATE|METOPROLOL|FLUCONAZOLE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|CEFTRIAXONE|CEFTRIAXONE SODIUM|ATEZOLIZUMAB|CARBOPLATIN|INSULIN GLARGINE|TIOTROPIUM BROMIDE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|VALSARTAN|VALSARTAN ORAL|METRONIDAZOLE",25,NON-SMALL CELL LUNG CANCER STAGE IV|CORONARY ARTERY DISEASE|NAUSEA|NAUSEA|DIABETES MELLITUS|DYSLIPIDAEMIA|VOMITING|CORONARY ARTERY DISEASE|DIABETES MELLITUS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|ATRIAL FLUTTER|SYSTEMIC CANDIDA|RENAL INJURY|OROPHARYNGEAL DISCOMFORT|DYSPNOEA|NON-SMALL CELL LUNG CANCER STAGE IV|VOMITING|NON-SMALL CELL LUNG CANCER STAGE IV|DIABETES MELLITUS|DYSPNOEA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|HYPERTENSION|COLITIS,Pneumonia|Pneumonia,2,1
12624621,20160805,Atezolizumab,79,801,79.0,1,82,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|GRANISETRON|GRANISETRON HYDROCHLORIDE|BEVACIZUMAB|HYDROCHLOROTHIAZIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARBOPLATIN|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|TELMISARTAN|ALLOPURINOL|PACLITAXEL|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|RANITIDINE,27,NON-SMALL CELL LUNG CANCER STAGE IV|INTESTINAL HAEMORRHAGE|RENAL FAILURE|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|HYPERTENSION|BACK PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|DIARRHOEA|HYPOKALAEMIA|BACK PAIN|HYPERTENSION|C-REACTIVE PROTEIN INCREASED|HYPERTENSION|GOUT|HYPOTONIA|HYPERTENSION|NON-SMALL CELL LUNG CANCER STAGE IV|DIARRHOEA|GASTRITIS,Syncope,1,1
12624852,20160805,Atezolizumab,63,801,63.0,2,76.6,1,0,1,1,0,0,0,Atezolizumab,"DEXTROMETHORPHAN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ATEZOLIZUMAB|ESCITALOPRAM|ALPRAZOLAM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|METOPROLOL TARTRATE|METOPROLOL|ATEZOLIZUMAB|LEVOTHYROXINE SODIUM",15,UPPER RESPIRATORY TRACT INFECTION|DIARRHOEA|METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA|UPPER RESPIRATORY TRACT INFECTION|COUGH|ANXIETY|ANXIETY|ARTHRALGIA|NAUSEA|HYPERTENSION|HYPOTHYROIDISM|ARTHRALGIA,Hyperglycaemia,1,1
12625185,20160805,Atezolizumab,79,801,79.0,2,62.2,1,1,1,0,0,0,0,Atezolizumab,OXYGEN|0XYGEN|METHYLPREDNISOLONE SODIUM SUCCINATE|ATEZOLIZUMAB|PROPRANOLOL HYDROCHLORIDE|ATEZOLIZUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE,16,DYSPNOEA|PNEUMONIA|TRANSITIONAL CELL CARCINOMA|TUMOUR PAIN|HYPERTHYROIDISM|URINARY TRACT INFECTION|NAUSEA|PULMONARY EMBOLISM|HYPERTHYROIDISM|METASTATIC NEOPLASM|METASTATIC NEOPLASM|DYSPNOEA|DYSPNOEA|TRANSITIONAL CELL CARCINOMA|TUMOUR PAIN,Cardiac failure|Pleural effusion|Malignant neoplasm progression|Pneumonia,4,1
12625432,20160805,Atezolizumab,61,801,61.0,2,53.7,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|ACETYLCYSTEINE,9,DYSPNOEA|LIP INFECTION|DYSPNOEA|THROMBOSIS|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|PAIN,Autoimmune hepatitis,1,1
12635250,20160808,Atezolizumab,48,801,48.0,2,,1,1,1,0,0,0,1,Atezolizumab,FLUOXETINE HYDROCHLORIDE|BEVACIZUMAB|ALPRAZOLAM|ATEZOLIZUMAB|ALBUTEROL SULFATE|ALBUTEROL,5,DEPRESSION|LUNG NEOPLASM MALIGNANT|DEPRESSION|LUNG NEOPLASM MALIGNANT,Pneumonia|Hypertension|Depression|Fear|Respiratory disorder|Death|Anxiety|Fear of death,8,5
12635714,20160809,Atezolizumab,61,801,61.0,1,110.7,1,1,1,1,0,0,0,Atezolizumab,"CETIRIZINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE|ATEZOLIZUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|DIPHENHYDRAMINE HYDROCHLORIDE|ALBUTEROL SULFATE|ALBUTEROL|DIPHENHYDRAMINE HYDROCHLORIDE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|CETIRIZINE HYDROCHLORIDE",18,DIARRHOEA|VOMITING|SEASONAL ALLERGY|SEASONAL ALLERGY|UPPER-AIRWAY COUGH SYNDROME|CONJUNCTIVAL HYPERAEMIA|NEOPLASM MALIGNANT|NAUSEA|ARTHRALGIA|CONJUNCTIVAL HYPERAEMIA|ASTHMA|NAUSEA|VOMITING|UPPER-AIRWAY COUGH SYNDROME|SEASONAL ALLERGY|HAEMORRHOIDS|CONJUNCTIVAL HYPERAEMIA|UPPER-AIRWAY COUGH SYNDROME,Hypotension|Hepatic failure|Renal failure|Syncope|Sinus tachycardia,5,1
12636042,20160809,Atezolizumab,59,801,59.0,1,54.5,1,1,1,0,0,0,0,Atezolizumab,CARBOPLATIN|PACLITAXEL|MORPHINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PROMETHAZINE|SCOPOLAMINE|LORAZEPAM|FOSAPREPITANT|FOSAPREPITANT DIMEGLUMINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PANTOPRAZOLE|FUROSEMIDE|PROMETHAZINE|DIPHENHYDRAMINE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE|PROCHLORPERAZINE|FENTANYL|PROPOFOL|PROPOFOL|ATEZOLIZUMAB|SCOPOLAMINE|VASOPRESSIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,30,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|PAIN|PAIN|VOMITING|VOMITING|PREMEDICATION|HYPOTENSION|VOMITING|ANXIETY|HYPERCALCAEMIA|PREMEDICATION|PREMEDICATION|PREMEDICATION|NAUSEA|PAIN|PREMEDICATION|PAIN|NAUSEA|PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERCALCAEMIA|NAUSEA|NAUSEA,Pneumonia,1,1
12636185,20160809,Atezolizumab,73,801,73.0,1,74.6,1,0,1,0,0,0,0,Atezolizumab,ERGOCALCIFEROL|ERGOCALCIFEROL|AMOXICILLIN|TAMSULOSIN HYDROCHLORIDE|ERGOCALCIFEROL|ATEZOLIZUMAB|CEFTRIAXONE|CEFTRIAXONE SODIUM|ZINC GLUCONATE,15,CONSTIPATION|CYSTITIS|PRODUCTIVE COUGH|CYSTITIS|PRODUCTIVE COUGH|PROPHYLAXIS|CONSTIPATION|VITAMIN D DEFICIENCY|BLADDER TRANSITIONAL CELL CARCINOMA|CYSTITIS|ZINC DEFICIENCY|ABDOMINAL DISTENSION|HYPERCALCAEMIA,Urinary retention,1,1
12636813,20160809,Atezolizumab,58,801,58.0,1,122,1,0,1,0,0,0,0,Atezolizumab,VALSARTAN|MODAFINIL|PREDNISONE|PREDNISONE|ATEZOLIZUMAB|STANDARDIZED SENNA CONCENTRATE,6,HYPERTENSION|FATIGUE|FATIGUE|BLADDER TRANSITIONAL CELL CARCINOMA|CONSTIPATION PROPHYLAXIS,Dehydration,1,1
12636862,20160809,Atezolizumab,58,801,58.0,1,70.1,1,0,1,0,0,0,0,Atezolizumab,FILGRASTIM|ATEZOLIZUMAB|GRANISETRON|FUROSEMIDE|METOCLOPRAMIDE HYDROCHLORIDE|LACTULOSE|FUROSEMIDE|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CARBOPLATIN|PROMETHAZINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE|HYDROMORPHONE HYDROCHLORIDE,22,PROPHYLAXIS OF NAUSEA AND VOMITING|NEUTROPENIA|NEOPLASM|NAUSEA|OEDEMA PERIPHERAL|NEOPLASM|PROPHYLAXIS OF NAUSEA AND VOMITING|METASTASES TO BONE|CONSTIPATION|OEDEMA PERIPHERAL|TUMOUR PAIN|GASTROOESOPHAGEAL REFLUX DISEASE|PROPHYLAXIS OF NAUSEA AND VOMITING|PREMEDICATION|PROPHYLAXIS|NEOPLASM|NEUTROPENIA|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS|INFECTION PROPHYLAXIS|PAIN,Pruritus|Anaphylactic reaction|Urticaria,3,1
12639000,20160809,Atezolizumab,68,801,68.0,1,,1,1,0,0,0,0,0,Atezolizumab,CARBOPLATIN|MORPHINE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LEVOTHYROXINE|PACLITAXEL|CEFEPIME HYDROCHLORIDE|CEFEPIME|PACLITAXEL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,11,NON-SMALL CELL LUNG CANCER|CHEST PAIN|CHEST PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|HYPOTHYROIDISM|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|ABDOMINAL PAIN UPPER,Septic shock,1,3
12639437,20160810,Atezolizumab,69,801,69.0,1,69,1,0,1,0,0,0,0,Atezolizumab,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATEZOLIZUMAB|OXYGEN|0XYGEN|CARBOPLATIN|IPRATROPIUM BROMIDE|ZOLPIDEM TARTRATE,16,PREMEDICATION|CONSTIPATION|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|RESPIRATORY FAILURE|ORAL CANDIDIASIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|BRONCHITIS|PROPHYLAXIS|PROPHYLAXIS|BRONCHITIS|PROPHYLAXIS,Nephritis,1,1
12639778,20160810,Atezolizumab,66,801,66.0,1,95.8,1,0,0,0,0,0,1,Atezolizumab,AMLODIPINE|LEVOTHYROXINE|OXYCODONE HYDROCHLORIDE|OXYCODONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DIPHENHYDRAMINE HYDROCHLORIDE|PROCHLORPERAZINE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|LORAZEPAM|ATEZOLIZUMAB,11,HYPERTENSION|HYPOTHYROIDISM|BACK PAIN|INSOMNIA|CLEAR CELL RENAL CELL CARCINOMA|HYPERTENSION|CLEAR CELL RENAL CELL CARCINOMA,Acute kidney injury,1,1
12640081,20160810,Atezolizumab,72,801,72.0,1,54.4,1,0,1,0,0,0,1,Atezolizumab,"ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|ATEZOLIZUMAB|BEVACIZUMAB|TERBINAFINE HYDROCHLORIDE|TERBINAFINE TABLETS 250 MG|TERBINAFINE HYDROCHLORIDE 1G IN 100G|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|INSULIN ASPART|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|CYANOCOBALAMIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|NIFEDIPINE|FAMOTIDINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",29,HYPERCHOLESTEROLAEMIA|INFECTION|CONSTIPATION|CONSTIPATION|HYPERTENSION|RENAL CELL CARCINOMA|RENAL CELL CARCINOMA|DERMATITIS CONTACT|TINEA PEDIS|HYPONATRAEMIA|PYREXIA|DERMATITIS|HYPERGLYCAEMIA|DIABETES MELLITUS|ASTHENOPIA|OROPHARYNGEAL PAIN|HYPONATRAEMIA|DIABETES MELLITUS|HYPERTENSION|PROPHYLAXIS,Altered state of consciousness|Hepatic function abnormal|Interstitial lung disease,3,1
12642403,20160810,Atezolizumab,67,801,67.0,2,65,1,0,0,0,0,0,1,Atezolizumab,CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|PACLITAXEL|CARBOPLATIN|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|PROMETHAZINE HYDROCHLORIDE|PROMETHAZINE HYDROCHLORIDE|PROMETHAZINE HYDROCHLORIDE|ATEZOLIZUMAB,14,PREMEDICATION|PREMEDICATION|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|NAUSEA|PROPHYLAXIS,Blood thyroid stimulating hormone increased,1,1
12643230,20160811,Atezolizumab,63,801,63.0,1,60,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,NON-SMALL CELL LUNG CANCER,Henoch-Schonlein purpura nephritis,1,1
12643385,20160811,Atezolizumab,53,801,53.0,2,82.7,1,1,1,0,0,0,0,Atezolizumab,"DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|CARBOPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RANITIDINE|ATEZOLIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RANITIDINE|OXYGEN|0XYGEN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RANITIDINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RANITIDINE|PACLITAXEL",23,ANXIETY|PREMEDICATION|NON-SMALL CELL LUNG CANCER STAGE IV|HEADACHE|PAIN|PREMEDICATION|VOMITING|NON-SMALL CELL LUNG CANCER STAGE IV|PREMEDICATION|DYSPEPSIA|CHEST PAIN|PREMEDICATION|CHEST PAIN|VOMITING|PREMEDICATION|VOMITING|PREMEDICATION|NON-SMALL CELL LUNG CANCER STAGE IV,Acute respiratory failure|Pneumonia|Pneumonitis,3,1
12645247,20160811,Atezolizumab,71,801,71.0,1,77.4,1,0,1,0,0,0,0,Atezolizumab,METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|PACLITAXEL|DIPHENHYDRAMINE HYDROCHLORIDE|CARBOPLATIN|MORPHINE SULFATE,13,VOMITING|DEEP VEIN THROMBOSIS|NON-SMALL CELL LUNG CANCER STAGE IV|VOMITING|HYPERTENSION|HYPERTENSION|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|NAUSEA|NEOPLASM MALIGNANT|NAUSEA|NEOPLASM MALIGNANT,Atrial flutter,1,1
12647391,20160812,Atezolizumab,39,801,39.0,2,57,1,0,0,0,0,0,1,Atezolizumab,PACLITAXEL,2,BREAST CANCER|BREAST CANCER,Ectopic pregnancy,1,3
12647807,20160812,Atezolizumab,74,801,74.0,1,60.5,1,0,1,0,0,0,0,Atezolizumab,ENALAPRIL|ATEZOLIZUMAB|ATEZOLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CARBOPLATIN|ATEZOLIZUMAB|PACLITAXEL,10,HYPERTENSION|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|AORTIC ANEURYSM|RESPIRATORY TRACT INFECTION|NON-SMALL CELL LUNG CANCER STAGE IV,Pneumonitis|Respiratory failure,2,1
12649135,20160812,Atezolizumab,57,801,57.0,1,,1,0,1,0,0,0,0,Atezolizumab,POLYETHYLENE GLYCOL 3350|BIOTIN|ATEZOLIZUMAB|PANTOPRAZOLE SODIUM|ZOLPIDEM TARTRATE|MELOXICAM|FISH OIL|ATEZOLIZUMAB|SENNOSIDES|SENNA LEAF|SENNA,11,BLADDER CANCER,Abdominal pain|Intestinal obstruction|Diarrhoea|Vomiting|Intestinal dilatation|Ileus,6,2
12649162,20160812,Atezolizumab,67,801,67.0,1,86,1,0,1,0,0,0,0,Atezolizumab,LATANOPROST|CARBOPLATIN|ATEZOLIZUMAB|PACLITAXEL,6,GLAUCOMA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pulmonary embolism|Pneumonitis,2,1
12650611,20160815,Atezolizumab,71,801,71.0,1,101,1,0,1,0,0,0,0,Atezolizumab,"PROMETHAZINE HYDROCHLORIDE|NOREPINEPHRINE BITARTRATE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|SODIUM CITRATE|MUPIROCIN|MUPIROCIN CALCIUM|DILTIAZEM HYDROCHLORIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|DIPHENHYDRAMINE HYDROCHLORIDE|INSULIN GLARGINE|AMLODIPINE BESYLATE|NAPROXEN|NAPROXEN SODIUM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|METHYLPREDNISOLONE SODIUM SUCCINATE|FENTANYL|FUROSEMIDE|INSULIN LISPRO|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|FENTANYL|FUROSEMIDE|DILTIAZEM HYDROCHLORIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|INSULIN HUMAN|LINEZOLID|LORAZEPAM|ATEZOLIZUMAB|LISINOPRIL|DILTIAZEM HYDROCHLORIDE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|PHENOBARBITAL|PHENOBARBITAL|NOREPINEPHRINE BITARTRATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|METHYLPREDNISOLONE SODIUM SUCCINATE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OMEPRAZOLE MAGNESIUM|DILTIAZEM HYDROCHLORIDE|DILTIAZEM HYDROCHLORIDE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|BLACK COHOSH, BRYONIA ALBA WHOLE, TOXICODENDRON PUBESCENS WHOLE, ARNICA MONTANA, CAUSTICUM, FERROSOFERRIC PHOSPHATE, SODIUM SULFATE ANHYDROUS, STRYCHNOS NUX-VOMICA SEED, RHODODENDRON AUREUM WHOLE, CITRULLUS COLOCYNTHIS WHOLE, SOLANUM DULCAMARA WHOLE, KALMIA LATIFOLIA WHOLE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, ARSENIC TRIOXIDE, AND TRIBASIC CALCIUM PHOSPHATE|BERBERIS VULGARIS ROOT BARK, BRYONIA ALBA ROOT, PHENOL, MILK THISTLE, CHELIDONIUM MAJUS, JUNIPER BERRY, LYCOPODIUM CLAVATUM SPORE, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, SODIUM SULFATE, STRYCHNOS NUX-VOMICA SEED, PHOSPHORUS, LACTIC ACID, L-, TARAXACUM OFFICINALE, VISCUM ALBUM FRUITING TOP, AND YUCCA FILAMENTOSA|ARTEMISIA CINA PRE-FLOWERING TOP, TANACETUM VULGARE WHOLE, ARTEMISIA VULGARIS WHOLE, DRYOPTERIS FILIX-MAS ROOT, MERCURIC CHLORIDE, AND GRAPHITE|AMBROSIA ARTEMISIAEFOLIA, ARALIA RACEMOSA, ARNICA MONTANA, CALENDULA OFFICINALIS, CHROMICUM ACIDUM, ECHINACEA PURPUREA, EUCALYPTOL, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC VACCINUM, MERCURIUS IODATUS FLAVUS, MERCURIUS SULPHURATUS RUBER, NATRUM ARSENICICUM, ROSA DAMASCENA, SABADILLA, SANGUINARINUM NITRICUM, SYMPHYTUM OFFICINALE|NAJA NAJA WHOLE, SCROPHULARIA NODOSA, LACTIC ACID, DL-, AND RADIUM BROMIDE|APIS MELLIFERA, ASPARAGUS, BERBERIS VULGARIS ROOT BARK, LYTTA VESICATORIA, CHELIDONIUM MAJUS, JUNIPER BERRY, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, POPULUS TREMULOIDES BARK, RHUS AROMATICA ROOT BARK, RUBIA TINCTORUM ROOT, SAW PALMETTO, SOLIDAGO VIRGAUREA FLOWERING TOP, TARAXACUM OFFICINALE, AND ARCTOSTAPHYLOS UVA-URSI LEAF|AVENA SATIVA WHOLE, VALERIANA OFFICINALIS WHOLE, HUMULUS LUPULUS WHOLE, ARABICA COFFEE BEAN, STRYCHNOS IGNATII WHOLE, ZINC VALERATE DIHYDRATE, AMMONIUM BROMIDE, CHAMOMILE, ESCHSCHOLZIA CALIFORNICA, AND PASSIFLORA INCARNATA WHOLE|APIS MELLIFICA, ARGENTUM NITRICUM, BADIAGA, BELLADONNA, CANTHARIS, CAUSTICUM, CHIMAPHILA UMBELLATA, COLOCYNTHIS, CUBEBA OFFICINALIS, CUCURBITA CITRULLUS, CUCURBITA PEPO FLOWER, ECHINACEA ANGUSTIFOLIA, EQUISETUM HYEMALE, ERYNGIUM AQUATICUM, FERRUM PHOSPHORICUM, MITCHELLA REPENS, OLEUM SANTALI, PETROSELINUM SATIVUM, PIPER METHYSTICUM, POPULUS TREMULOIDES BARK, SARSAPARILLA, TEREBINTHINA, UVA URSI|ACHILLEA MILLEFOLIUM, ARNICA MONTANA, HYPERICUM PERFORATUM, HORSE CHESTNUT, AND VISCUM ALBUM WHOLE|ACONITUM NAPELLUS, AMERICAN GINSENG, ARSENICUM IODATUM, BLATTA ORIENTALIS, CALCAREA SULPHURICA, CARPINUS BETULUS FLOWER, CUPRUM METALLICUM, GRINDELIA, HEPAR SULPHURIS CALCAREUM, IPECACUANHA, JUSTICIA ADHATODA, KALI IODATUM, LOBELIA INFLATA, NAPHTHALINUM, NARCISSUS PSEUDONARCISSUS, PINE TAR, POPULUS CANDICANS, TABACUM, THUJA OCCIDENTALIS, THYMUS SERPYLLUM|PASSIFLORA INCARNATA WHOLE, SMILAX ORNATA WHOLE, PHYTOLACCA AMERICANA ROOT, STILLINGIA SYLVATICA ROOT, TRIFOLIUM PRATENSE WHOLE, ARCTIUM LAPPA WHOLE, PRUNUS DULCIS WHOLE, FRANGULA PURSHIANA BARK, BERBERIS VULGARIS WHOLE, GLYCYRRHIZA GLABRA WHOLE, AND LARREA DIVARICATA WHOLE|ALOE, ACTIVATED CHARCOAL, COLCHICUM AUTUMNALE BULB, COLLINSONIA CANADENSIS ROOT, CUCURBITA PEPO FLOWER, DRYOPTERIS FILIX-MAS ROOT, INDOLE, SKIM MILK, LYCOPODIUM CLAVATUM SPORE, ACHILLEA MILLEFOLIUM, SODIUM SULFATE, FRANGULA PURSHIANA BARK, SCROPHULARIA NODOSA, SKATOLE, TARAXACUM OFFICINALE, TARTARIC ACID|ARANEUS DIADEMATUS, ARISAEMA TRIPHYLLUM ROOT, ASTERIAS RUBENS, BAPTISIA TINCTORIA, BARIUM IODIDE, ECHINACEA ANGUSTIFOLIA, FERROUS IODIDE, GOLDENSEAL, LACHESIS MUTA VENOM, PHYTOLACCA AMERICANA ROOT, PINUS SYLVESTRIS FLOWERING TOP, SCROPHULARIA NODOSA, SPONGIA OFFICINALIS SKELETON, ROASTED, AND TEUCRIUM SCORODONIA FLOWERING TOP|ALFALFA, ALLIUM SATIVUM, ASPARAGUS OFFICINALIS, AVENA SATIVA, BELLADONNA, BERBERIS VULGARIS, CHELIDONIUM MAJUS, GLYCYRRHIZA GLABRA, HYDRASTIS CANADENSIS, JUNIPERUS VIRGINIANA, NICCOLUM METALLICUM, PASSIFLORA INCARNATA, SARCOLACTICUM ACIDUM, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE|ALNUS GLUTINOSA, APIS MELLIFICA, BERBERIS VULGARIS, CALCIUM SULFIDE, CROTON TIGLIUM, ECHINACEA ANGUSTIFOLIA, GRAPHITE, GRINDELIA HIRSUTULA, HYDROFLUORIC ACID, JUGLANS REGIA, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, MYRISTICA SEBIFERA, NITRICUM ACIDUM, PHOSPHORUS, RHUS TOXICODENDRON, SCROPHULARIA NODOSA, SOLIDAGO VIRGAUREA, SULPHUR, VINCA MINOR|POLYETHYLENE GLYCOL 3350|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MAGNESIUM OXIDE|DIPHENHYDRAMINE HYDROCHLORIDE|ERYTHROPOIETIN|CEFEPIME HYDROCHLORIDE|CEFEPIME",76,PROPHYLAXIS|PROPHYLAXIS|CONSTIPATION|PROPHYLAXIS|ACUTE KIDNEY INJURY|DYSPNOEA|HYPOKALAEMIA|PROPHYLAXIS|DYSPNOEA|CONSTIPATION|PROPHYLAXIS|HYPERTENSION|PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING|HYPOALBUMINAEMIA|FEBRILE NEUTROPENIA|FEBRILE NEUTROPENIA|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|DIABETES MELLITUS|ANAEMIA|URINARY TRACT INFECTION|DYSLIPIDAEMIA|PROPHYLAXIS|HYPERTENSION|PROPHYLAXIS|PROPHYLAXIS|INFECTION PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|FLUSHING|ENDOTRACHEAL INTUBATION|NON-SMALL CELL LUNG CANCER|HYPERTENSION|PROPHYLAXIS|TREMOR|HYPOKALAEMIA|INFECTION PROPHYLAXIS|HYPOMAGNESAEMIA|PROPHYLAXIS|DIABETES MELLITUS|GASTROOESOPHAGEAL REFLUX DISEASE|ATRIAL FIBRILLATION|HYPOGLYCAEMIA|PROPHYLAXIS|HYPOMAGNESAEMIA|PROPHYLAXIS|ANAEMIA|PROPHYLAXIS,Acute kidney injury,1,1
12650709,20160815,Atezolizumab,36,801,36.0,1,95.7,1,0,1,0,0,0,0,Atezolizumab,"ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ATEZOLIZUMAB|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PROCHLORPERAZINE|ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE|ATEZOLIZUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",14,BACK PAIN|COLON CANCER METASTATIC|ADENOCARCINOMA|HYPERSENSITIVITY|DYSPNOEA|BACK PAIN|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS|PYREXIA|BRONCHITIS|COLON CANCER METASTATIC|PYREXIA|ASTHMA|ADENOCARCINOMA,Retinal vasculitis|Sepsis syndrome,2,1
12651706,20160815,Atezolizumab,77,801,77.0,1,92,1,0,1,1,0,0,1,Atezolizumab,CARBOPLATIN|MAGNESIUM|PACLITAXEL|SIMVASTATIN|FENTANYL|IPRATROPIUM BROMIDE|CARBOPLATIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|PACLITAXEL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,34,NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|MUSCULOSKELETAL CHEST PAIN|LEUKOPENIA|METASTASES TO BONE|NON-SMALL CELL LUNG CANCER|MUSCULOSKELETAL CHEST PAIN|DIABETES MELLITUS|HYPOMAGNESAEMIA|PROPHYLAXIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|HYPERTENSION|DIABETES MELLITUS|MUSCULOSKELETAL CHEST PAIN|PROPHYLAXIS|DIABETES MELLITUS|NAUSEA|HYPERTENSIVE HEART DISEASE|PRODUCT USED FOR UNKNOWN INDICATION|LEUKOPENIA|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|METASTASES TO BONE|METASTASES TO BONE|PROPHYLAXIS|PROPHYLAXIS|NAUSEA,General physical health deterioration|Cholestasis|Respiratory tract infection|Tumour pain,4,3
12651882,20160815,Atezolizumab,55,801,55.0,2,44.05,1,0,1,0,0,0,0,Atezolizumab,"DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|RABEPRAZOLE SODIUM|RABEPRAZOLE|APREPITANT|AMOXICILLIN|HYDROXYZINE HYDROCHLORIDE|HYDROXYZINE|HYDROXYZINE HYDROCHLORIDE ORAL|DOCETAXEL|DOCETAXEL ANHYDROUS|CELECOXIB|CLOBETASOL PROPIONATE|CLOBETASOL PROPIONATE OINTMENT USP, 0.05%|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|DEXAMETHASONE SODIUM PHOSPHATE|PALONOSETRON HYDROCHLORIDE|PACLITAXEL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|HYDROCORTISONE BUTYRATE|DEXAMETHASONE SODIUM PHOSPHATE|PALONOSETRON HYDROCHLORIDE|PALONOSETRON HYDROCHLORIDE|DEXAMETHASONE SODIUM PHOSPHATE|PALONOSETRON HYDROCHLORIDE|APREPITANT|APREPITANT|CARBOPLATIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|OLOPATADINE HYDROCHLORIDE|OLOPATADINE HYDROCHLORIDE OPHTHALMIC|DEXAMETHASONE SODIUM PHOSPHATE|ATEZOLIZUMAB|DIFLUPREDNATE OPHTHALMIC|DIFLUPREDNATE|METOCLOPRAMIDE HYDROCHLORIDE|LORAZEPAM|FAMOTIDINE|MAGNESIUM OXIDE|RAMUCIRUMAB",57,PREMEDICATION|RASH MACULO-PAPULAR|PREMEDICATION|PROPHYLAXIS|PROPHYLAXIS|SEDATION|DISEASE PROGRESSION|CANCER PAIN|RASH MACULO-PAPULAR|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PREMEDICATION|NON-SMALL CELL LUNG CANCER STAGE IV|CONSTIPATION|PYREXIA|RASH MACULO-PAPULAR|PREMEDICATION|CANCER PAIN|PROPHYLAXIS|PREMEDICATION|PYREXIA|NON-SMALL CELL LUNG CANCER STAGE IV|RASH MACULO-PAPULAR|PROPHYLAXIS|RASH MACULO-PAPULAR|PREMEDICATION|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|OESOPHAGITIS|RASH MACULO-PAPULAR|PREMEDICATION|PRESYNCOPE|ANXIETY|PROPHYLAXIS|CONSTIPATION|DISEASE PROGRESSION,Paraesthesia,1,1
12651918,20160815,Atezolizumab,70,801,70.0,2,,1,0,1,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,URETHRAL CANCER,Speech disorder|Mastication disorder|Gait disturbance|Fatigue,4,1
12652038,20160815,Atezolizumab,46,801,46.0,1,130.9,1,0,1,0,0,0,0,Atezolizumab,"LANSOPRAZOLE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|DIPHENHYDRAMINE HYDROCHLORIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|NASAL|SALINE|(SALINE)|BEVACIZUMAB|BISMUTH SUBSALICYLATE|POLYETHYLENE GLYCOL 3350|GUAIFENESIN|PANTOPRAZOLE|ATEZOLIZUMAB|LOSARTAN POTASSIUM|NIFEDIPINE|DICYCLOMINE HYDROCHLORIDE|TRIAMTERENE CAPSULES|TRIAMTERENE|OXYCODONE|DIPHENHYDRAMINE HYDROCHLORIDE",21,DYSPEPSIA|NASAL ABSCESS|PRURITUS|PRURITUS|ARTHRALGIA|CONSTIPATION|NASAL CONGESTION|RENAL CELL CARCINOMA|ABDOMINAL PAIN|CONSTIPATION|NASAL CONGESTION|DYSPEPSIA|RENAL CELL CARCINOMA|HYPERTENSION|HYPERTENSION|ABDOMINAL PAIN|HYPERTENSION|BACK PAIN|PRURITUS|NASAL CONGESTION|NASAL ABSCESS,Angina pectoris,1,1
12652296,20160815,Atezolizumab,68,801,68.0,1,55.4,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|MAGNESIUM OXIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE,11,CHEST PAIN|PROPHYLAXIS|CONSTIPATION|NON-SMALL CELL LUNG CANCER|DECREASED APPETITE|PROPHYLAXIS|CHEST PAIN|PROPHYLAXIS|PROPHYLAXIS,Hepatitis,1,1
12653167,20160815,Atezolizumab,69,801,69.0,1,123.8,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|FLUTICASONE FUROATE|BEVACIZUMAB|SIMVASTATIN|LEVOTHYROXINE SODIUM|PREDNISONE|METOPROLOL TARTRATE|METOPROLOL|SENNOSIDES|SENNA LEAF|SENNA|FUROSEMIDE|FOSINOPRIL SODIUM|FOSINOPIRL SODIUM|FOSINOPRIL|PANTOPRAZOLE|CLOPIDOGREL|PREDNISONE|FUROSEMIDE|METOPROLOL TARTRATE|METOPROLOL|MELATONIN|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PREDNISONE|FUROSEMIDE|METOPROLOL TARTRATE|METOPROLOL,24,RENAL CELL CARCINOMA|HYPERSENSITIVITY|RENAL CELL CARCINOMA|HYPERLIPIDAEMIA|HYPOTHYROIDISM|MUSCULAR WEAKNESS|MUSCULAR WEAKNESS|CONSTIPATION PROPHYLAXIS|MUSCULAR WEAKNESS|PROPHYLAXIS|HYPERTENSION|PROPHYLAXIS|PROPHYLAXIS|MYOCARDITIS|MYOSITIS|FATIGUE|DIABETES MELLITUS|FATIGUE|PROPHYLAXIS|CONSTIPATION PROPHYLAXIS|MYOCARDITIS|FATIGUE|MYOSITIS|MYOSITIS,Hyperkalaemia|Asthenia|Dyspnoea,3,1
12655360,20160816,Atezolizumab,79,801,79.0,2,,1,0,1,0,0,0,0,Atezolizumab,"PACLITAXEL|ATEZOLIZUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",9,Breast cancer|Breast cancer|Prophylaxis|Product used for unknown indication|Constipation|Nausea|Arthralgia|Malnutrition|Dysphagia,Dysphagia,1,3
12658320,20160817,Atezolizumab,53,801,53.0,1,85.3,1,0,1,0,0,0,0,Atezolizumab,BEVACIZUMAB|LORAZEPAM|ATENOLOL|METHYLPREDNISOLONE|ATEZOLIZUMAB|ENALAPRIL,9,DEPRESSION|RENAL CELL CARCINOMA|DEPRESSION|HYPERTENSION|RENAL CELL CARCINOMA|PROPHYLAXIS|HYPERTENSION|PROPHYLAXIS,Acute kidney injury,1,1
12658359,20160817,Atezolizumab,50,801,50.0,1,77.5,1,0,1,0,0,0,0,Atezolizumab,ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE|ATEZOLIZUMAB|LISINOPRIL|DEXLANSOPRAZOLE,6,METASTATIC CARCINOMA OF THE BLADDER|METASTATIC CARCINOMA OF THE BLADDER,Pneumonitis|Rash|Rash|Colitis|Headache,5,1
12662618,20160818,Atezolizumab,53,801,53.0,1,93.2,1,0,1,0,0,0,0,Atezolizumab,OXYCODONE|OXYCODONE|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|NICOTINE POLACRILEX|IPILIMUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|ATEZOLIZUMAB|ZOLPIDEM TARTRATE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|CLONAZEPAM,13,ABDOMINAL PAIN|MUSCULOSKELETAL CHEST PAIN|DEPRESSION|TOBACCO USER|NEOPLASM|HYPOTHYROIDISM|ABDOMINAL PAIN|MUSCULOSKELETAL CHEST PAIN|NEOPLASM|BENIGN PROSTATIC HYPERPLASIA|DEPRESSION|CONSTIPATION|ANXIETY,Diarrhoea,1,1
12662735,20160818,Atezolizumab,41,801,41.0,1,,1,1,1,0,0,0,0,Atezolizumab,IPILIMUMAB|FENTANYL|MAGNESIUM HYDROXIDE|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|ATEZOLIZUMAB|TEMAZEPAM|CALCIUM CARBONATE|ANTACID|FENTANYL|DICLOFENAC|DICLOFENAC SODIUM,14,PAIN PROPHYLAXIS|INFECTION|PAIN|NON-SMALL CELL LUNG CANCER|PAIN|PROPHYLAXIS|INFECTION|NON-SMALL CELL LUNG CANCER|COUGH|PAIN|METASTASES TO BONE|PAIN|CONSTIPATION,Haemoptysis|Dyspnoea,2,1
12664420,20160818,Atezolizumab,64,801,64.0,1,64.5,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,2,NON-SMALL CELL LUNG CANCER|DIARRHOEA,Optic neuritis|Hypophysitis,2,1
12664606,20160818,Atezolizumab,,,,1,,1,0,1,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA,Chest pain|Angioedema|Renal failure|Dyspnoea,4,1
12668299,20160819,Atezolizumab,40,801,40.0,1,,1,0,1,0,0,0,1,Atezolizumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|LACTULOSE|INSULIN LISPRO|ATEZOLIZUMAB|MORPHINE SULFATE|INSULIN GLARGINE|OXYCODONE|OXYCODONE",12,NIGHT SWEATS|CONSTIPATION|DIABETES MELLITUS|METASTATIC RENAL CELL CARCINOMA|PAIN|PAIN|DIABETES MELLITUS|METASTATIC RENAL CELL CARCINOMA|BACK PAIN|CONSTIPATION|ARTHRALGIA,Acute kidney injury,1,5
12669187,20160819,Atezolizumab,32,801,32.0,2,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Muscle spasms|Pain,2,1
12669693,20160819,Atezolizumab,,,,2,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Cellulitis,1,1
12670668,20160822,Atezolizumab,60,801,60.0,1,108.96,1,0,1,0,0,0,0,Atezolizumab,"ESCITALOPRAM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|FOLIC ACID|LORAZEPAM|OMEPRAZOLE MAGNESIUM|ATEZOLIZUMAB",12,PAIN|ANAESTHESIA|LUNG ADENOCARCINOMA|NAUSEA,Pericardial effusion,1,3
12673256,20160822,Atezolizumab,64,801,64.0,1,60,1,0,1,0,0,0,0,Atezolizumab,CARBOPLATIN|ZOLEDRONIC ACID|ZOLEDRONIC ACID|GRANISETRON|GRANISETRON HYDROCHLORIDE|OXYCODONE|INSULIN LISPRO|LANSOPRAZOLE|GRANISETRON|GRANISETRON HYDROCHLORIDE|ATEZOLIZUMAB|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|ZOLEDRONIC ACID|INSULIN GLARGINE|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE,20,NON-SMALL CELL LUNG CANCER STAGE IV|CONSTIPATION|METASTASES TO BONE|TUMOUR PAIN|TYPE 2 DIABETES MELLITUS|PROPHYLAXIS|TUMOUR PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|TUMOUR PAIN|TYPE 2 DIABETES MELLITUS|TYPE 2 DIABETES MELLITUS|TYPE 2 DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER STAGE IV|CONSTIPATION|PREMEDICATION,Pneumonitis|Febrile neutropenia,2,1
12675515,20160823,Atezolizumab,68,801,68.0,1,113.4,1,0,1,0,0,0,1,Atezolizumab,ATENOLOL|ATEZOLIZUMAB|TEMAZEPAM|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|ATENOLOL|FOSINOPRIL,21,NEOPLASM|PAIN|NEOPLASM|INSOMNIA|DYSPEPSIA|CONSTIPATION|BACK PAIN|HYPERCHOLESTEROLAEMIA|HYPERTENSION|TYPE 2 DIABETES MELLITUS|HYPERTENSION|DYSPEPSIA|ARTHRALGIA|BACK PAIN|BACK PAIN|DYSPEPSIA,Anaemia|Gastric cancer,2,1
12677453,20160823,Atezolizumab,,,,2,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Encephalopathy,1,2
12677960,20160823,Atezolizumab,75,801,75.0,2,,1,0,0,1,0,0,0,Atezolizumab,"CARBOPLATIN|ALBUTEROL SULFATE|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CYCLOBENZAPRINE|PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE|PRAMOXINE HYDROCHLORIDE|ERGOCALCIFEROL|PACLITAXEL|FORMOTEROL FUMARATE|FORMOTEROL FUMARATE DIHYDRATE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|FUROSEMIDE|CEFDINIR|ZOLEDRONIC ACID|PACLITAXEL|PACLITAXEL|CARBOPLATIN|TIOTROPIUM BROMIDE|DOXYCYCLINE HYCLATE|DOXYCYCLINE|DOXYCLYCLINE HYCLATE|DOXYCYCLINE HYCLATE|DOXYCYCLINE|DOXYCLYCLINE HYCLATE|CARBOPLATIN|DICLOFENAC|DICLOFENAC SODIUM|PALONOSETRON|PALONOSETRON HYDROCHLORIDE",35,NON-SMALL CELL LUNG CANCER STAGE IV|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NAUSEA|HYPERLIPIDAEMIA|NAUSEA|ARTHRITIS|VOMITING|HAEMORRHOIDS|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NAUSEA|VOMITING|VOMITING|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NEOPLASM MALIGNANT|NAUSEA|DEPRESSION|OEDEMA|INFECTION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|ARTHRITIS|COUGH|PRODUCT USED FOR UNKNOWN INDICATION|HYPERTENSION|ARTHRITIS|VOMITING|NAUSEA,Neutropenia|Thrombocytopenia|Neutropenia,3,1
12680044,20160824,Atezolizumab,47,801,47.0,2,68.7,1,0,1,0,0,0,0,Atezolizumab,"RABEPRAZOLE|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ALBUTEROL SULFATE|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|MELATONIN|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|MOMETASONE FUROATE|ALBUTEROL SULFATE|FENTANYL|ATEZOLIZUMAB|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|LORAZEPAM",32,NECK PAIN|DERMATITIS ACNEIFORM|DYSPEPSIA|NECK PAIN|NECK PAIN|ALLERGY TO ANIMAL|DERMATITIS ACNEIFORM|ASTHMA|NAUSEA|BRONCHOSCOPY|ANAEMIA PROPHYLAXIS|AXILLARY PAIN|PYREXIA|AXILLARY PAIN|ALLERGY TO ANIMAL|BREAST CANCER METASTATIC|SEASONAL ALLERGY|INSOMNIA|DYSPEPSIA|BRONCHOSCOPY|ASTHMA|SEASONAL ALLERGY|DYSPNOEA|BRONCHOSCOPY|BREAST CANCER METASTATIC|URINARY TRACT INFECTION|THROMBOSIS PROPHYLAXIS|INSOMNIA|DERMATITIS ACNEIFORM,Systemic immune activation,1,1
12680109,20160824,Atezolizumab,39,801,39.0,2,58,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,3,BREAST CANCER METASTATIC|COUGH|BREAST CANCER METASTATIC,Pneumothorax,1,1
12682475,20160825,Atezolizumab,61,801,61.0,2,56.5,1,0,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DIPHENHYDRAMINE HYDROCHLORIDE|AMLODIPINE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PANTOPRAZOLE SODIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|CARBOPLATIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DIPHENHYDRAMINE HYDROCHLORIDE|OXYCODONE|ERYTHROPOIETIN|MAGNESIUM OXIDE|FUROSEMIDE|HYDROMORPHONE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE|AMLODIPINE|HYDROMORPHONE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SIMVASTATIN|ERYTHROPOIETIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|FUROSEMIDE|ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE|AMLODIPINE|FOLIC ACID|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PROMETHAZINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",47,NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|NAUSEA|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS|BRONCHOSCOPY|PROPHYLAXIS OF NAUSEA AND VOMITING|PREMEDICATION|PREMEDICATION|GASTROOESOPHAGEAL REFLUX DISEASE|PROPHYLAXIS AGAINST DEHYDRATION|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|PREMEDICATION|CHEST PAIN|ANAEMIA|CHEST PAIN|HYPERTENSION|CONSTIPATION PROPHYLAXIS|HYPERLIPIDAEMIA|PREMEDICATION|ANAEMIA|PREMEDICATION|NAUSEA|INSOMNIA|PREMEDICATION|NAUSEA|PAIN,Lung infection,1,1
12682671,20160825,Atezolizumab,80,801,80.0,1,95.7,1,0,1,0,0,0,0,Atezolizumab,TIOTROPIUM BROMIDE|ATEZOLIZUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CARBOPLATIN|ALLOPURINOL|LISINOPRIL,17,NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|PRURITUS GENERALISED|CARDIAC FAILURE|HYPERTENSION|PRURITUS GENERALISED|PRURITUS GENERALISED|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NON-SMALL CELL LUNG CANCER STAGE IV|TYPE 2 DIABETES MELLITUS|HYPERCHOLESTEROLAEMIA|PRURITUS GENERALISED|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERURICAEMIA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|HYPERTENSIVE HEART DISEASE|CARDIAC FAILURE,Hyperkalaemia,1,1
12683533,20160825,Atezolizumab,38,801,38.0,2,,1,0,0,1,1,0,0,Atezolizumab,"ESCITALOPRAM|POLYETHYLENE GLYCOL 3350|VENLAFAXINE HYDROCHLORIDE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|ENOXAPARIN SODIUM|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ZOLPIDEM TARTRATE|DIPHENHYDRAMINE HYDROCHLORIDE|MORPHINE|ATEZOLIZUMAB",14,HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC,Hypercalcaemia,1,1
12687373,20160826,Atezolizumab,48,801,48.0,1,122,1,0,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|SENNOSIDES|SENNA LEAF|SENNA|PANTOPRAZOLE SODIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CYCLOBENZAPRINE|ZOLPIDEM TARTRATE|PROCHLORPERAZINE|FENTANYL|PREDNISONE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|MORPHINE|COBIMETINIB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE",16,COLORECTAL ADENOCARCINOMA|CONSTIPATION|DIARRHOEA|NAUSEA|MUSCLE SPASMS|INSOMNIA|PAIN|NAUSEA|PAIN|DIARRHOEA|DIARRHOEA|NAUSEA|PAIN|COLORECTAL ADENOCARCINOMA|PAIN|PROCTITIS,Delirium,1,1
12690194,20160826,Atezolizumab,71,801,71.0,2,57,1,0,0,0,0,0,1,Atezolizumab,BEVACIZUMAB|HYDROCORTISONE SODIUM SUCCINATE|ALBUTEROL SULFATE|ALBUTEROL|METHIMAZOLE|CARBOPLATIN|RANITIDINE|FOSAPREPITANT|FOSAPREPITANT DIMEGLUMINE|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|ERGOCALCIFEROL|PROCHLORPERAZINE|CALCIUM CARBONATE|ANTACID|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ATEZOLIZUMAB|PACLITAXEL|VITAMIN E|PEGFILGRASTIM|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|LORATADINE|LORATADINE ORAL|ROSUVASTATIN|EPINEPHRINE|ADRENALINUM,25,NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTHYROIDISM|NON-SMALL CELL LUNG CANCER STAGE IV|CEREBROVASCULAR ACCIDENT PROPHYLAXIS|BACK PAIN|PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|HYPERLIPIDAEMIA,Hepatic enzyme increased,1,1
12691152,20160826,Atezolizumab,57,801,57.0,2,42.9,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|ATEZOLIZUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PACLITAXEL|PACLITAXEL|FLUOXETINE HYDROCHLORIDE|FLUOXETINE,13,TRIPLE NEGATIVE BREAST CANCER|PREMEDICATION|NAUSEA|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PAIN|GASTROOESOPHAGEAL REFLUX DISEASE|CONSTIPATION|TRIPLE NEGATIVE BREAST CANCER|PAIN,Constipation|Colitis,2,3
12694396,20160829,Atezolizumab,,,,2,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Blood urine present,1,1
12700588,20160830,Atezolizumab,61,801,61.0,1,83.54,1,0,1,1,0,0,0,Atezolizumab,ATEZOLIZUMAB|ENOXAPARIN SODIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ENOXAPARIN SODIUM,4,BLADDER CANCER|PULMONARY EMBOLISM|PROPHYLAXIS|DEEP VEIN THROMBOSIS,Haematuria|Haematuria|Dysuria,3,3
12700589,20160830,Atezolizumab,39,801,39.0,1,,1,1,1,0,0,0,0,Atezolizumab,LOSARTAN|ATEZOLIZUMAB,4,TRANSITIONAL CELL CARCINOMA,Dyspnoea|Hepatic enzyme increased,2,1
12701179,20160831,Atezolizumab,32,801,32.0,1,107,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LISINOPRIL|BEVACIZUMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|AMOXICILLIN|AMOXICILLIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|AMLODIPINE,14,RENAL CELL CARCINOMA|VOMITING|HYPERTENSION|RENAL CELL CARCINOMA|RHINITIS|RHINITIS|ANAL INFECTION|PAIN|ANAL INFECTION|PAIN|PROPHYLAXIS OF NAUSEA AND VOMITING|DIARRHOEA|HYPERTENSION,Diabetes mellitus,1,1
12702368,20160831,Atezolizumab,72,801,72.0,1,66.5,1,1,1,0,0,0,0,Atezolizumab,OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|INSULIN ASPART|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|INSULIN ASPART|FENTANYL|ATEZOLIZUMAB,9,BACK PAIN|PROPHYLAXIS OF NAUSEA AND VOMITING|DIABETES MELLITUS|DEHYDRATION|DECREASED APPETITE|BACK PAIN|NON-SMALL CELL LUNG CANCER,Pneumonitis|Muscular weakness,2,1
12704263,20160831,Atezolizumab,72,801,72.0,1,55.3,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|AMLODIPINE|SUVOREXANT|ZOLPIDEM TARTRATE,12,NON-SMALL CELL LUNG CANCER|METASTASES TO BONE|DIARRHOEA|GASTRITIS|ANXIETY|HYPERTENSION|GASTRITIS|INSOMNIA|INSOMNIA,Enterocolitis infectious,1,1
12705030,20160831,Atezolizumab,61,801,61.0,2,54.6,1,1,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|GABAPENTIN|LEVOTHYROXINE SODIUM|DEXTROSE MONOHYDRATE|DEXTROSE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXALIPLATIN",31,GASTRIC CANCER|SPINAL OPERATION|GASTRIC CANCER|GASTRIC CANCER|INFECTION PROPHYLAXIS|SPINAL OPERATION|CHEMOTHERAPY SIDE EFFECT PROPHYLAXIS|HYPOTHYROIDISM|HYPOKALAEMIA|CHEMOTHERAPY SIDE EFFECT PROPHYLAXIS|INSOMNIA|NAUSEA|HYPOKALAEMIA|NEUTROPHIL COUNT DECREASED|DYSPEPSIA|SPINAL OPERATION|SPINAL OPERATION|INFECTION PROPHYLAXIS|INFECTION PROPHYLAXIS|DYSPEPSIA|CHEMOTHERAPY SIDE EFFECT PROPHYLAXIS|NAUSEA|GASTRIC CANCER|GASTRIC CANCER,Neutrophil count decreased,1,1
12705709,20160901,Atezolizumab,62,801,62.0,2,74.84,1,0,0,0,1,0,0,Atezolizumab,"BIOTIN|SUCRALFATE|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)|ERGOCALCIFEROL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|GABAPENTIN|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ATORVASTATIN CALCIUM|OXYCODONE|LIDOCAINE PATCH 5%|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|TOPIRAMATE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|ATEZOLIZUMAB|ALBUTEROL SULFATE|CYCLOSPORINE|LORAZEPAM|HEPARIN SODIUM",33,DRY MOUTH|ORAL CANDIDIASIS|NASAL CONGESTION|URINARY TRACT INFECTION|VITAMIN D DECREASED|MUCOSAL INFLAMMATION|PREMEDICATION|INFECTION|SEASONAL ALLERGY|HYPOTHYROIDISM|PAIN|NASAL CONGESTION|BLOOD CHOLESTEROL INCREASED|PAIN|PAIN|MUCOSAL INFLAMMATION|MUCOSAL INFLAMMATION|MUCOSAL INFLAMMATION|MUCOSAL INFLAMMATION|WEIGHT DECREASED|WEIGHT DECREASED|ACNE|BREAST CANCER METASTATIC|ASTHMA|PREMEDICATION|DRY EYE|NAUSEA|BREAST CANCER METASTATIC|NAUSEA,Keratitis,1,1
12706283,20160901,Atezolizumab,68,801,68.0,1,26.49,1,0,1,0,0,0,0,Atezolizumab,"ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SUVOREXANT|MONTELUKAST SODIUM|ESCITALOPRAM|PHYTONADIONE|LORAZEPAM|PROMETHAZINE|ATEZOLIZUMAB|FISH OIL|ESZOPICLONE|BEVACIZUMAB|LEVOTHYROXINE|BUPROPION|PANTOPRAZOLE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|MONTELUKAST SODIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|HYDRALAZINE HYDROCHLORIDE|MELATONIN|ERGOCALCIFEROL|LOSARTAN POTASSIUM|LOSARTAN|ATEZOLIZUMAB|BENZONATATE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|OXYMETAZOLINE HYDROCHLORIDE|LEVOTHYROXINE|ESZOPICLONE|FUROSEMIDE|FUROSEMIDE|PROCHLORPERAZINE|ZOLPIDEM TARTRATE|NIFEDIPINE|AMLODIPINE BESYLATE|AMLODIPINE|LISINOPRIL|SIMVASTATIN",44,RHINITIS ALLERGIC|INSOMNIA|RHINITIS ALLERGIC|DEPRESSION|NAUSEA|COUGH|RENAL CELL CARCINOMA|DEPRESSION|NAUSEA|NAUSEA|COUGH|CARDIOMYOPATHY|HYPERCHOLESTEROLAEMIA|HYPERTENSION|INSOMNIA|HYPERTENSION|RENAL CELL CARCINOMA|COUGH|HYPERTENSION|EPISTAXIS|HYPOTHYROIDISM|INSOMNIA|CARDIAC FAILURE CONGESTIVE|OEDEMA PERIPHERAL|NAUSEA|INSOMNIA|BLOOD PRESSURE MEASUREMENT|HYPERTENSION|HYPERTENSION|HYPERTENSION|BLOOD CHOLESTEROL INCREASED|EPISTAXIS,Cardiomyopathy|Cardiomyopathy|Adrenal insufficiency,3,1
12713556,20160903,Atezolizumab,75,801,75.0,1,91.44,1,1,1,0,0,0,0,Atezolizumab,"PANTOPRAZOLE SODIUM|WARFARIN SODIUM|WARFARIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ACETAMINOPHEN|FOSAPREPITANT DIMEGLUMINE|ACETAMINOPHEN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FUROSEMIDE|CARBOPLATIN|FOLIC ACID|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|MAGNESIUM HYDROXIDE|MAGNESIUM HYDROXIDE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|ATEZOLIZUMAB|DEXAMETHASONE SODIUM PHOSPHATE",30,BACK PAIN|NAUSEA|PROPHYLAXIS|PAIN|THROMBOSIS PROPHYLAXIS|PAIN|PAIN|PAIN|BACK PAIN|PREMEDICATION|BACK PAIN|NEOPLASM|CHEST PAIN|PREMEDICATION|OEDEMA PERIPHERAL|NAUSEA|PAIN|PREMEDICATION|NEOPLASM|PAIN|HYPERCHOLESTEROLAEMIA|DECREASED APPETITE|PREMEDICATION|BACK PAIN|CONSTIPATION|CONSTIPATION|NEOPLASM|PREMEDICATION,Mental status changes|Hyperglycaemia|Asthenia|Autoimmune hepatitis,4,1
12716598,20160906,Atezolizumab,57,801,57.0,1,62,1,0,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|DEXTROSE ANHYDROUS|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|ZOLEDRONIC ACID|HEPARIN SODIUM|MANNITOL|LANSOPRAZOLE",17,CONSTIPATION|CONSTIPATION|CONSTIPATION|NON-SMALL CELL LUNG CANCER METASTATIC|PRODUCTIVE COUGH|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|BRAIN OEDEMA|PYREXIA|METASTASES TO BONE|DEHYDRATION,Epilepsy,1,1
12719976,20160907,Atezolizumab,65,801,65.0,1,67,1,0,1,0,0,0,0,Atezolizumab,"FILGRASTIM|FILGRASTIM|CEFTRIAXONE|CEFTRIAXONE SODIUM|ATEZOLIZUMAB|HYDROCHLOROTHIAZIDE|ESOMEPRAZOLE SODIUM|LANSOPRAZOLE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PSEUDOEPHEDRINE HYDROCHLORIDE|PSEUDOEPHEDRINE HCL|TRIAMTERENE CAPSULES|TRIAMTERENE|CHLORHEXIDINE GLUCONATE|ANTISEPTIC SKIN CLEANSER",33,LYMPHOCYTE COUNT DECREASED|ALANINE AMINOTRANSFERASE INCREASED|NEUTROPHIL COUNT DECREASED|ASPARTATE AMINOTRANSFERASE INCREASED|DECREASED APPETITE|ASPARTATE AMINOTRANSFERASE INCREASED|PAIN|COUGH|NON-SMALL CELL LUNG CANCER|DECREASED APPETITE|NAUSEA|HYPERTENSION|COUGH|TONSILLITIS|DECREASED APPETITE|DECREASED APPETITE|HYPERTENSION|BLOOD SODIUM DECREASED|BLOOD POTASSIUM DECREASED|PLATELET COUNT DECREASED|VOMITING|NASOPHARYNGITIS|PLATELET COUNT DECREASED|PLATELET COUNT DECREASED|ALANINE AMINOTRANSFERASE INCREASED|COUGH|HYPERTENSION|HYPERTENSION,Febrile neutropenia|Diarrhoea,2,1
12720436,20160907,Atezolizumab,69,801,69.0,1,88,1,0,1,0,0,0,0,Atezolizumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ATEZOLIZUMAB|PACLITAXEL|LEVOTHYROXINE|GLIPIZIDE|CARBOPLATIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CHLORPROMAZINE|METHYLPHENIDATE HYDROCHLORIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|FENOFIBRATE|SIMVASTATIN|LOSARTAN|MODAFINIL|ACETYLCYSTEINE,21,PAIN IN EXTREMITY|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|THYROID DISORDER|DIABETES MELLITUS|PRODUCTIVE COUGH|NON-SMALL CELL LUNG CANCER|DIABETES MELLITUS|OROPHARYNGEAL PAIN|ABDOMINAL DISTENSION|NARCOLEPSY|PYREXIA|OROPHARYNGEAL PAIN|HYPERLIPIDAEMIA|HYPERLIPIDAEMIA|HYPERTENSION|NARCOLEPSY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCTIVE COUGH,Mental status changes|Fall,2,3
12722266,20160907,Atezolizumab,70,801,70.0,1,57.3,1,0,1,0,0,0,1,Atezolizumab,SODIUM HYALURONATE|OLOPATADINE HYDROCHLORIDE|OLOPATADINE HYDROCHLORIDE OPHTHALMIC|ATEZOLIZUMAB|ALLOPURINOL|OLOPATADINE HYDROCHLORIDE|OLOPATADINE HYDROCHLORIDE OPHTHALMIC|CROTAMITON|MOXIFLOXACIN HYDROCHLORIDE|NIFEDIPINE|CELECOXIB|PALONOSETRON HYDROCHLORIDE|CARBOPLATIN|PEMETREXED|PEMETREXED DISODIUM|MAGNESIUM OXIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PALONOSETRON HYDROCHLORIDE|CARBOPLATIN|CANDESARTAN CILEXETIL|CANDESARTAN CILEXETIL|RABEPRAZOLE SODIUM|RABEPRAZOLE|FOLIC ACID|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|RABEPRAZOLE SODIUM|RABEPRAZOLE|PALONOSETRON HYDROCHLORIDE,41,DRY EYE|RASH|HYPOCALCAEMIA|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERURICAEMIA|RASH MACULO-PAPULAR|PRURITUS|PNEUMONIA|DECREASED APPETITE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|ANAEMIA|HAEMOGLOBIN DECREASED|HYPERTENSION|PROPHYLAXIS|HYPOPHOSPHATAEMIA|DEHYDRATION|ARTHRALGIA|PROPHYLAXIS OF NAUSEA AND VOMITING|NON-SMALL CELL LUNG CANCER STAGE IV|CONSTIPATION|BLOOD CREATININE INCREASED|RASH MACULO-PAPULAR|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|GASTRITIS PROPHYLAXIS|VITAMIN SUPPLEMENTATION|PROPHYLAXIS|DEHYDRATION|DYSPNOEA EXERTIONAL|BLOOD CREATININE INCREASED|RASH MACULO-PAPULAR,Leukopenia|Thrombocytopenia,2,1
12725123,20160908,Atezolizumab,54,801,54.0,2,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Pulmonary embolism|Pneumonia,2,3
12727104,20160909,Atezolizumab,71,801,71.0,1,86.1,1,1,1,0,0,0,0,Atezolizumab,BEVACIZUMAB|CARBOPLATIN|ATEZOLIZUMAB|PACLITAXEL|ENALAPRIL,12,DYSLIPIDAEMIA|PREMEDICATION|HYPERTENSION|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|ERYTHEMA|PREMEDICATION|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION,Intestinal obstruction,1,1
12733799,20160912,Atezolizumab,51,801,51.0,2,44.9,1,0,1,1,0,0,0,Atezolizumab,"FILGRASTIM|HYDROMORPHONE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|BEVACIZUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|VORICONAZOLE|HYDROMORPHONE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE|SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE|SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE|SODIUM CHLORIDE, SOLDIUM LACTATE, POTASSIUM CHLORIDE AND CALCIUM CHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|VORICONAZOLE|FUROSEMIDE|HYDROMORPHONE HYDROCHLORIDE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|ATEZOLIZUMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|HYDROMORPHONE HYDROCHLORIDE|DEXTROSE MONOHYDRATE|DEXTROSE|SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE|SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE|SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE|SODIUM CHLORIDE, SOLDIUM LACTATE, POTASSIUM CHLORIDE AND CALCIUM CHLORIDE|FENTANYL|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|FILGRASTIM|INSULIN ASPART",43,PAIN|CONSTIPATION|FEBRILE NEUTROPENIA|BLOOD ELECTROLYTES DECREASED|NAUSEA|NAUSEA|VOMITING|VOMITING|OVARIAN CANCER|INSOMNIA|PAIN|ABDOMINAL PAIN|THROMBOSIS PROPHYLAXIS|BLOOD ELECTROLYTES DECREASED|FUNGAL INFECTION|FLUID RETENTION|PAIN|PAIN|OVARIAN CANCER|CONSTIPATION|THROMBOSIS PROPHYLAXIS|ANTIALLERGIC THERAPY|BLOOD ELECTROLYTES DECREASED|BLOOD ELECTROLYTES DECREASED|PAIN|BLOOD ELECTROLYTES DECREASED|THROMBOSIS PROPHYLAXIS|BLOOD GLUCOSE DECREASED|PAIN,Pneumonitis|Pancytopenia,2,1
12733811,20160912,Atezolizumab,58,801,58.0,2,59.6,1,0,1,0,0,0,0,Atezolizumab,"ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|APREPITANT|APREPITANT|DIMENHYDRINATE|DICLOFENAC SODIUM|ATEZOLIZUMAB|CARBOPLATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE",15,NON-SMALL CELL LUNG CANCER|NAUSEA|NAUSEA|CHEST DISCOMFORT|NAUSEA|NAUSEA|NECK PAIN|ASTHMA|ANAEMIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NAUSEA|NAUSEA,Gastrooesophageal reflux disease,1,1
12735523,20160912,Atezolizumab,51,801,51.0,2,,1,0,0,0,0,0,1,Atezolizumab,"CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|OXYGEN|0XYGEN|PEGFILGRASTIM|PEGFILGRASTIM|METOPROLOL TARTRATE|METOPROLOL|ERGOCALCIFEROL|CLOTRIMAZOLE|DRS. CLOTRIMAZOLE|FAMILY WELLNESS CLOTRIMAZOLE|CLOTRIMAZOLE TOPICAL|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|DEXTROMETHORPHAN HYDROBROMIDE,GUAIFENESIN|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PACLITAXEL|HYDROMORPHONE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|GUAIFENESIN|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|MULTIVITAMIN|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|CARISOPRODOL|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|MAGNESIUM OXIDE|HYDROMORPHONE HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|BENZONATATE|ALBUTEROL SULFATE|ALBUTEROL|PROCHLORPERAZINE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|MAGNESIUM OXIDE|SODIUM PHOSPHATE|MAGNESIUM HYDROXIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|GABAPENTIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|GUAIFENESIN|DIAZEPAM|DRONABINOL",56,HYPERSENSITIVITY|SINUS CONGESTION|EPIGLOTTITIS|PROCTITIS|SUPRAVENTRICULAR TACHYCARDIA|INFECTION PROPHYLAXIS|OROPHARYNGEAL PAIN|PRODUCT USED FOR UNKNOWN INDICATION|SUPRAVENTRICULAR TACHYCARDIA|NUTRITIONAL SUPPLEMENTATION|ORAL CANDIDIASIS|SINUS CONGESTION|COUGH|DYSPHAGIA|URINARY TRACT INFECTION|PYREXIA|BREAST CANCER METASTATIC|BACK PAIN|DYSPHONIA|NAUSEA|SINUS CONGESTION|INFECTION PROPHYLAXIS|HYPOKALAEMIA|VOMITING|INFECTION|PRODUCT USED FOR UNKNOWN INDICATION|BACK PAIN|NUTRITIONAL SUPPLEMENTATION|EPISTAXIS|BREAST CANCER METASTATIC|OROPHARYNGEAL PAIN|HYPOMAGNESAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PROCTITIS|BACK PAIN|DYSPHONIA|BACK PAIN|OROPHARYNGEAL PAIN|PRODUCT USED FOR UNKNOWN INDICATION|HYPOMAGNESAEMIA|COUGH|DYSPNOEA|CONSTIPATION|NAUSEA|OROPHARYNGEAL PAIN|HYPOPHOSPHATAEMIA|CONSTIPATION|GASTROOESOPHAGEAL REFLUX DISEASE|PERIPHERAL SENSORY NEUROPATHY|PROPHYLAXIS OF NAUSEA AND VOMITING|COUGH|ANXIETY|NAUSEA,Febrile neutropenia,1,3
12737083,20160913,Atezolizumab,60,801,60.0,2,,1,1,1,0,0,0,0,Atezolizumab,PACLITAXEL|ATEZOLIZUMAB|CARBOPLATIN|OXYCODONE HYDROCHLORIDE|APREPITANT,17,NON-SMALL CELL LUNG CANCER|MUSCULOSKELETAL PAIN|HYPERCALCAEMIA|NON-SMALL CELL LUNG CANCER|PAIN|NON-SMALL CELL LUNG CANCER|MUSCULOSKELETAL PAIN|HYPERCALCAEMIA|PAIN|PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING|PAIN|ANAEMIA,Asthenia,1,1
12740003,20160913,Atezolizumab,,,,1,,1,1,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|PEMETREXED DISODIUM,2,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
12740289,20160913,Atezolizumab,56,801,56.0,1,83.01,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA,Myasthenia gravis|Dysphagia|Eyelid ptosis,3,1
12740959,20160914,Atezolizumab,73,801,73.0,1,58.8,1,0,1,0,0,0,0,Atezolizumab,LORAZEPAM|CARBOPLATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|PACLITAXEL|ATEZOLIZUMAB|DESLORATADINE|BEVACIZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,22,INSOMNIA|NON-SMALL CELL LUNG CANCER STAGE IV|RASH MACULO-PAPULAR|PREMEDICATION|PREMEDICATION|OSTEOARTHRITIS|NAUSEA|TOOTHACHE|URINARY RETENTION|NON-SMALL CELL LUNG CANCER STAGE IV|RASH MACULO-PAPULAR|DYSPEPSIA|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|NAUSEA|RASH MACULO-PAPULAR|NON-SMALL CELL LUNG CANCER STAGE IV|OSTEOARTHRITIS|PREMEDICATION,Pneumonitis|Hypoxia,2,1
12741758,20160914,Atezolizumab,73,801,73.0,2,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA,Dehydration|Infection|Female genital tract fistula|Abdominal pain,4,1
12742237,20160914,Atezolizumab,,,,1,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC,Speech disorder|Immobile|Gastroenteritis|Pyrexia,4,1
12744165,20160914,Atezolizumab,,,,0,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Intercepted medication error|No adverse event,2,2
12744167,20160914,Atezolizumab,,,,1,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Haematuria,1,5
12744168,20160914,Atezolizumab,,,,0,,1,0,0,0,0,0,0,Atezolizumab,PERTUZUMAB|ATEZOLIZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,No adverse event|Incorrect product storage|Intercepted medication error,3,2
12744169,20160914,Atezolizumab,,,,2,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Pyrexia|Chills,2,3
12744170,20160914,Atezolizumab,,,,2,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea,1,1
12744171,20160914,Atezolizumab,,,,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|DENOSUMAB,2,TRANSITIONAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION,Muscular weakness,1,3
12744172,20160914,Atezolizumab,,,,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Device occlusion,1,2
12744173,20160914,Atezolizumab,,,,0,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA,Diarrhoea,1,3
12744174,20160914,Atezolizumab,,,,0,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia,1,1
12744175,20160914,Atezolizumab,,,,2,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Candida infection|Fatigue,2,3
12744176,20160914,Atezolizumab,,,,2,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Fatigue|Headache,2,2
12744177,20160914,Atezolizumab,,,,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,RENAL CELL CARCINOMA,Influenza like illness,1,5
12744178,20160914,Atezolizumab,75,801,75.0,2,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA,Nausea|Decreased appetite,2,3
12744180,20160914,Atezolizumab,,,,0,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA,Sepsis|Thrombocytopenia,2,3
12744182,20160914,Atezolizumab,77,801,77.0,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Musculoskeletal pain,1,5
12744183,20160914,Atezolizumab,56,801,56.0,1,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA,Urinary tract infection,1,3
12744184,20160914,Atezolizumab,,,,2,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA,Pyrexia|Fatigue,2,1
12744186,20160914,Atezolizumab,,,,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Purpura,1,3
12744188,20160914,Atezolizumab,,,,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Diarrhoea|Gynaecomastia,2,5
12744189,20160914,Atezolizumab,,,,0,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Circumstance or information capable of leading to medication error|No adverse event,2,5
12744192,20160914,Atezolizumab,74,801,74.0,1,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB|AMLODIPINE|LORAZEPAM|ATORVASTATIN CALCIUM,7,TRANSITIONAL CELL CARCINOMA METASTATIC|HYPERTENSION|PAIN|BLOOD CHOLESTEROL INCREASED,Tremor|Anxiety|Nausea|Fatigue|Headache|Feeling cold|Abdominal distension|Asthenia|Influenza like illness|Pyrexia|Gait disturbance|Urinary tract infection|Pain,13,5
12744200,20160914,Atezolizumab,,,,0,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,No adverse event|Circumstance or information capable of leading to medication error,2,3
12744206,20160914,Atezolizumab,,,,2,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Dehydration|Fatigue|Nausea,3,1
12744207,20160914,Atezolizumab,,,,2,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Rheumatoid arthritis,1,2
12744213,20160914,Atezolizumab,,,,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Overdose|Medication error|No adverse event,3,2
12744214,20160914,Atezolizumab,,,,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Tremor|Chills,2,1
12744215,20160914,Atezolizumab,,,,0,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Circumstance or information capable of leading to medication error|No adverse event|Incorrect product storage,3,2
12744216,20160914,Atezolizumab,,,,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Vision blurred,1,1
12744217,20160914,Atezolizumab,,,,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA,Haematuria|Pyrexia|Arthralgia,3,3
12744221,20160914,Atezolizumab,,,,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Purpura,1,3
12744222,20160914,Atezolizumab,37,801,37.0,2,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|COBIMETINIB,2,COLON CANCER|COLON CANCER,Off label use|No adverse event,2,1
12744223,20160914,Atezolizumab,,,,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Diarrhoea,1,3
12744233,20160914,Atezolizumab,,,,2,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Tremor,1,2
12744234,20160914,Atezolizumab,75,801,75.0,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA METASTATIC,Haematuria,1,1
12744235,20160914,Atezolizumab,,,,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Muscle spasms,2,3
12744238,20160914,Atezolizumab,,,,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Rash,1,3
12744239,20160914,Atezolizumab,,,,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA,Pyrexia,1,3
12744240,20160914,Atezolizumab,72,801,72.0,1,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Infusion related reaction,1,1
12744720,20160915,Atezolizumab,63,801,63.0,1,68,1,1,0,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|ZOLEDRONIC ACID|FENTANYL|TIOTROPIUM BROMIDE|LANSOPRAZOLE",10,NON-SMALL CELL LUNG CANCER|BONE PAIN|BONE PAIN|BONE PAIN|BONE PAIN|BONE PAIN,Dyspnoea,1,1
12744931,20160915,Atezolizumab,80,801,80.0,1,98.518,1,1,1,1,1,1,1,Atezolizumab,ATEZOLIZUMAB,1,Lung adenocarcinoma,Pneumonia|Sepsis|Asthenia|Pyrexia|Vomiting|Infection|Systemic inflammatory response syndrome,7,1
12746107,20160915,Atezolizumab,,,,0,,1,1,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Death,1,1
12746409,20160915,Atezolizumab,70,801,70.0,1,,1,0,1,0,0,0,0,Atezolizumab,"NITROGLYCERIN|MAGNESIUM OXIDE|PANTOPRAZOLE|COLCHICINE|ISOSORBIDE MONONITRATE|CARBOPLATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DOCUSATE SODIUM,SENNOSIDES|ROSUVASTATIN|PACLITAXEL|ENALAPRIL|ATENOLOL",18,CHEST PAIN|BLOOD MAGNESIUM DECREASED|NON-SMALL CELL LUNG CANCER|GASTROOESOPHAGEAL REFLUX DISEASE|INFECTION|GOUT|ARRHYTHMIA|PAIN|ANGINA PECTORIS|HAEMOGLOBIN DECREASED|NON-SMALL CELL LUNG CANCER|NAUSEA|VOMITING|CONSTIPATION|BLOOD CHOLESTEROL INCREASED|NON-SMALL CELL LUNG CANCER|HYPERTENSION|HYPERTENSION,Angina unstable,1,3
12747455,20160915,Atezolizumab,70,801,70.0,1,,1,0,0,0,0,0,1,Atezolizumab,"CARBOPLATIN|ZOLEDRONIC ACID|ESOMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FUROSEMIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|FUROSEMIDE|ATEZOLIZUMAB",28,NON-SMALL CELL LUNG CANCER STAGE IV|NAUSEA|MUCOSAL INFECTION|VOMITING|METASTASES TO BONE|PYREXIA|PYREXIA|INSOMNIA|PULMONARY HAEMORRHAGE|GASTRITIS|CONSTIPATION|NON-SMALL CELL LUNG CANCER STAGE IV|VOMITING|PROPHYLACTIC CHEMOTHERAPY|STOMATITIS|PNEUMOCYSTIS JIROVECII PNEUMONIA|HYPERKALAEMIA|CANCER PAIN|NAUSEA|PYREXIA|PYREXIA|PNEUMOCYSTIS JIROVECII PNEUMONIA|DIAGNOSTIC PROCEDURE|NAUSEA|PREMEDICATION|NON-SMALL CELL LUNG CANCER STAGE IV|PULMONARY HAEMORRHAGE,Histiocytosis haematophagic,1,1
12752571,20160916,Atezolizumab,75,801,75.0,1,88.1,1,0,1,0,0,0,0,Atezolizumab,FUROSEMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ATEZOLIZUMAB|ALLOPURINOL,9,HYPERLIPIDAEMIA|MUSCLE SPASMS|MUSCLE SPASMS|OEDEMA PERIPHERAL|DEPRESSION|CAROTID ARTERY STENOSIS|BLADDER CANCER|HYPERURICAEMIA|MUSCLE SPASMS,Hypercalcaemia,1,1
12754336,20160916,Atezolizumab,72,801,72.0,1,81.37,1,0,1,0,0,0,0,Atezolizumab,FAMOTIDINE|INSULIN LISPRO|BEVACIZUMAB|ROSUVASTATIN|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|INSULIN GLARGINE|ATORVASTATIN CALCIUM|FUROSEMIDE|INSULIN GLARGINE|METHYLPREDNISOLONE SODIUM SUCCINATE|ATEZOLIZUMAB|FUROSEMIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|INSULIN GLARGINE|NEBIVOLOL HYDROCHLORIDE|FUROSEMIDE|FUROSEMIDE,28,PROPHYLAXIS|HYPERGLYCAEMIA|METASTATIC RENAL CELL CARCINOMA|HYPERLIPIDAEMIA|HYPERTENSION|ASPARTATE AMINOTRANSFERASE INCREASED|ALANINE AMINOTRANSFERASE INCREASED|HYPERGLYCAEMIA|HEPATIC ENZYME INCREASED|OEDEMA|HYPERGLYCAEMIA|METASTATIC RENAL CELL CARCINOMA|OEDEMA|HYPERLIPIDAEMIA|DECREASED APPETITE|HYPERGLYCAEMIA|CARDIOVASCULAR EVENT PROPHYLAXIS|BLOOD BILIRUBIN INCREASED,Crepitations|Atelectasis|Hyperglycaemia|Muscular weakness|Malignant neoplasm progression|Hyperlipidaemia|Oedema|Hepatotoxicity,8,1
12755629,20160916,Atezolizumab,61,801,61.0,1,72,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Acute kidney injury,1,1
12756049,20160916,Atezolizumab,,,,2,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA,Hepatitis|Organ failure|Sepsis|Hepatic enzyme increased,4,3
12756523,20160917,Atezolizumab,49,801,49.0,2,75,1,0,1,0,0,0,0,Atezolizumab,METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PANTOPRAZOLE|DEXTROMETHORPHAN|LOSARTAN|PEMETREXED|PEMETREXED DISODIUM|CARBOPLATIN|FLUCONAZOLE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ATEZOLIZUMAB,12,PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS|COUGH|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ANTIFUNGAL PROPHYLAXIS|PAIN MANAGEMENT|PAIN MANAGEMENT|ANTIFUNGAL PROPHYLAXIS|ANTIFUNGAL PROPHYLAXIS|NON-SMALL CELL LUNG CANCER,Febrile neutropenia,1,1
12757738,20160919,Atezolizumab,65,801,65.0,1,92.2,1,0,1,0,1,0,0,Atezolizumab,TAMSULOSIN HYDROCHLORIDE|CARBOPLATIN|DUTASTERIDE|ATEZOLIZUMAB|BEVACIZUMAB|PACLITAXEL,8,DYSPEPSIA|BENIGN PROSTATIC HYPERPLASIA|NON-SMALL CELL LUNG CANCER STAGE IV|BENIGN PROSTATIC HYPERPLASIA|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|CONSTIPATION,Optic neuropathy,1,1
12762122,20160920,Atezolizumab,68,801,68.0,1,86.86,1,0,1,0,0,0,1,Atezolizumab,HYDROCHLOROTHIAZIDE|LISINOPRIL|ERGOCALCIFEROL|ATEZOLIZUMAB|POLYETHYLENE GLYCOL 3350|ATEZOLIZUMAB,7,CONSTIPATION|NON-SMALL CELL LUNG CANCER METASTATIC,Dehydration|Choroidal detachment,2,1
12763034,20160920,Atezolizumab,,,,0,,1,1,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Death|Nephritis,2,3
12764742,20160921,Atezolizumab,70,801,70.0,2,66.5,1,0,1,0,0,0,0,Atezolizumab,SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RANITIDINE|ATEZOLIZUMAB,4,HYPONATRAEMIA|BLADDER TRANSITIONAL CELL CARCINOMA,Syncope|Pyrexia,2,1
12764811,20160921,Atezolizumab,58,801,58.0,2,49.4,1,0,1,0,0,0,0,Atezolizumab,"LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|MOMETASONE FUROATE|POVIDONE-IODINE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ATEZOLIZUMAB",27,DIARRHOEA|LIMB INJURY|FACE OEDEMA|SINUSITIS|HYPERTENSION|FACE OEDEMA|CONSTIPATION|HYPERCALCAEMIA|HYPERSENSITIVITY|RHINITIS|HYPOKALAEMIA|LIMB INJURY|LIMB INJURY|FACE OEDEMA|HYPERSENSITIVITY|HYPERSENSITIVITY|HYPERTENSION|FACE OEDEMA|GASTROOESOPHAGEAL REFLUX DISEASE|BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC|HYPERTENSION|FACE OEDEMA|MUCOSAL INFLAMMATION|LIMB INJURY,Peripheral arthritis,1,1
12767140,20160921,Atezolizumab,,,,0,,1,1,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Myocardial infarction,1,3
12767811,20160921,Atezolizumab,58,801,58.0,2,59.6,1,0,1,0,0,0,0,Atezolizumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CARBOPLATIN|APREPITANT|DICLOFENAC SODIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DIMENHYDRINATE|PACLITAXEL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|APREPITANT|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",14,ASTHMA|CHEST DISCOMFORT|NON-SMALL CELL LUNG CANCER|NAUSEA|NAUSEA|NECK PAIN|NAUSEA|NON-SMALL CELL LUNG CANCER|ANAEMIA|NAUSEA|NON-SMALL CELL LUNG CANCER|NAUSEA,Gastrooesophageal reflux disease,1,1
12772342,20160922,Atezolizumab,69,801,69.0,1,104.42,1,1,1,0,0,0,0,Atezolizumab,"PACLITAXEL|LORAZEPAM|POTASSIUM SULFATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|CARBOPLATIN|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|LEVETIRACETAM|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|FERROUS SULFATE|MELOXICAM|PACLITAXEL|METOPROLOL TARTRATE|METOPROLOL|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|NICOTINE POLACRILEX|NICOTINE|NICOTINE POLACRILEX MINI|NICOTINE POLARILEX|DEXMEDETOMIDINE|DEXTROSE MONOHYDRATE|DEXTROSE|THIAMINE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|HYDRALAZINE HYDROCHLORIDE|LEVETIRACETAM|LANSOPRAZOLE|QUETIAPINE|TIOTROPIUM BROMIDE|PANTOPRAZOLE SODIUM|THIAMINE HYDROCHLORIDE|HYDRALAZINE HYDROCHLORIDE|MELOXICAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CARBOPLATIN|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|AMLODIPINE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|QUETIAPINE|FOLIC ACID|DICLOFENAC SODIUM|HYDROMORPHONE HYDROCHLORIDE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|ACETYLCYSTEINE|PANTOPRAZOLE SODIUM|OXYCODONE|MIDAZOLAM HYDROCHLORIDE|DIGOXIN|FUROSEMIDE|FUROSEMIDE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|DEXMEDETOMIDINE HYDROCHLORIDE|CARVEDILOL|PACLITAXEL|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|OXYGEN|0XYGEN|FENTANYL|DEXTROSE MONOHYDRATE|DEXTROSE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE",73,NON-SMALL CELL LUNG CANCER STAGE IV|INFECTION|AGITATION|SEDATION|PAIN|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SEDATION|DEHYDRATION|PAIN|ANXIETY|HYPERTENSION|INFECTION|GASTROOESOPHAGEAL REFLUX DISEASE|PRODUCT USED FOR UNKNOWN INDICATION|DEPRESSION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRURITUS|INFLAMMATION|NAUSEA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER STAGE IV|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|DEHYDRATION|PRODUCT USED FOR UNKNOWN INDICATION|DEHYDRATION|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|ARTHRALGIA|PAIN|RESPIRATORY THERAPY|INFECTION|PRODUCT USED FOR UNKNOWN INDICATION|GASTROOESOPHAGEAL REFLUX DISEASE|PAIN|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|DIURETIC THERAPY|FLUID RETENTION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HYPERTENSION|HYPOTENSION|AGITATION|RESPIRATORY THERAPY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|DIARRHOEA,Sepsis|Febrile neutropenia,2,1
12773548,20160923,Atezolizumab,72,801,72.0,1,82.1,1,0,1,0,0,0,0,Atezolizumab,FLUCONAZOLE|ATEZOLIZUMAB|CLARITHROMYCIN,7,HEADACHE|INSOMNIA|CONSTIPATION|ORAL CANDIDIASIS|NON-SMALL CELL LUNG CANCER|LOWER RESPIRATORY TRACT INFECTION|LOWER RESPIRATORY TRACT INFECTION,Hypercalcaemia|Hypercalcaemia,2,1
12773636,20160923,Atezolizumab,66,801,66.0,2,73.9,1,0,1,0,0,0,0,Atezolizumab,"FUROSEMIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ZOLPIDEM TARTRATE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|HYDROCODONE BITARTRATE AND ACETAMINOPHEN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ZOLPIDEM TARTRATE|ATEZOLIZUMAB|OXYCODONE HYDROCHLORIDE|SENNOSIDES|SENNA LEAF|SENNA|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|TRANYLCYPROMINE|DIPHENHYDRAMINE HYDROCHLORIDE",15,OEDEMA PERIPHERAL|PAIN|INSOMNIA|PAIN|PAIN|PAIN|SLEEP DISORDER|PAIN|NON-SMALL CELL LUNG CANCER|PAIN|CONSTIPATION|DEPRESSION|DRUG HYPERSENSITIVITY,Febrile neutropenia,1,1
12774035,20160923,Atezolizumab,64,801,64.0,2,82.7,1,0,1,0,0,0,0,Atezolizumab,TIOTROPIUM BROMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|AMOXICILLIN|OMEPRAZOLE MAGNESIUM|FLUCONAZOLE|ALBUTEROL SULFATE|ALBUTEROL|ASCORBIC ACID|NASAL|SALINE|(SALINE)|ATEZOLIZUMAB|NASAL|SALINE|(SALINE)|CARBOPLATIN|LOSARTAN|NITROGLYCERIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LORAZEPAM,27,OBSTRUCTIVE AIRWAYS DISORDER|NEUTROPENIA|PROPHYLAXIS|ANXIETY|PHARYNGITIS STREPTOCOCCAL|DYSPEPSIA|ANTIFUNGAL PROPHYLAXIS|WHEEZING|SUPPLEMENTATION THERAPY|ARTHRALGIA|DEHYDRATION|HYPERTENSION|NAUSEA|OTITIS MEDIA|HYPOMAGNESAEMIA|NON-SMALL CELL LUNG CANCER STAGE IV|NASOPHARYNGITIS|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|PROPHYLAXIS|PROPHYLAXIS|ANAEMIA|HYPERCHOLESTEROLAEMIA|NON-SMALL CELL LUNG CANCER STAGE IV|MYRINGITIS|ANXIETY,Dyspnoea|Neutropenia|Nausea|Diarrhoea|Non-cardiac chest pain|Pneumonia,6,1
12775756,20160923,Atezolizumab,73,801,73.0,1,71.51,1,1,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|ZOLPIDEM TARTRATE|LEVOTHYROXINE|MORPHINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|GABAPENTIN|SITAGLIPTIN|PROCHLORPERAZINE MALEATE,14,BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC|BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC,Disease progression,1,1
12775765,20160923,Atezolizumab,71,801,71.0,1,60.3,1,0,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|ENALAPRIL MALEATE|ENALAPRIL|CEFTRIAXONE SODIUM|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|ALLOPURINOL|LANSOPRAZOLE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|BEVACIZUMAB|SPIRONOLACTONE|NAPROXEN SODIUM|NAPROXEN SODIUM 220MG|NAPROXEN SODIUM, COATED TABLETS|NAPROXEN SODIUM TABLET, COATED|MAGNESIUM OXIDE",21,RENAL CELL CARCINOMA|HYPERTENSION|PREMEDICATION|PYREXIA|PREMEDICATION|DRY SKIN|PYREXIA|HYPERURICAEMIA|PREMEDICATION|PYREXIA|RENAL CELL CARCINOMA|HYPERTENSION|PYREXIA|HYPERTENSION|CONSTIPATION|CONSTIPATION,Hyperthyroidism|Diarrhoea|Diabetes mellitus inadequate control,3,1
12778496,20160926,Atezolizumab,68,801,68.0,1,70.6,1,0,0,0,1,0,0,Atezolizumab,"ATEZOLIZUMAB|FENOFIBRATE|SIMVASTATIN|CETIRIZINE HYDROCHLORIDE|LORAZEPAM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CARBOPLATIN|SERTRALINE|OXYCODONE HYDROCHLORIDE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|POLYETHYLENE GLYCOL 3350|DIPHENHYDRAMINE HYDROCHLORIDE",22,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|BLOOD CHOLESTEROL|BLOOD CHOLESTEROL|BONE PAIN|RESPIRATORY DISORDER|RESPIRATORY DISORDER|NAUSEA|PREMEDICATION|PREMEDICATION|ANAEMIA|CARDIOVASCULAR EVENT PROPHYLAXIS|INSOMNIA|NON-SMALL CELL LUNG CANCER STAGE IV|DEPRESSION|VOMITING|ANAEMIA|PAIN|NAUSEA|PREMEDICATION|CONSTIPATION|ANAEMIA,Bone pain|Myalgia,2,1
12781972,20160927,Atezolizumab,63,801,63.0,2,49.35,1,0,0,0,0,0,1,Atezolizumab,CARBOPLATIN|ATEZOLIZUMAB|MISOPROSTOL|PACLITAXEL|AMLODIPINE|ATEZOLIZUMAB|RANITIDINE|MAGNESIUM OXIDE|MAGNESIUM OXIDE,28,NON-SMALL CELL LUNG CANCER STAGE IV|ARTHRALGIA|GASTRITIS|FEBRILE NEUTROPENIA|WHITE BLOOD CELL COUNT DECREASED|NON-SMALL CELL LUNG CANCER STAGE IV|GASTRITIS|GASTRITIS|NON-SMALL CELL LUNG CANCER STAGE IV|CONSTIPATION|WHITE BLOOD CELL COUNT DECREASED|HYPERTENSION|NAUSEA|FEBRILE NEUTROPENIA|FEBRILE NEUTROPENIA|FEBRILE NEUTROPENIA|WHITE BLOOD CELL COUNT DECREASED|NON-SMALL CELL LUNG CANCER STAGE IV|PROCEDURAL PAIN|WHITE BLOOD CELL COUNT DECREASED|HYPERSENSITIVITY|HYPERSENSITIVITY|CONSTIPATION|CONSTIPATION,Erythema multiforme,1,1
12782569,20160927,Atezolizumab,66,801,66.0,2,62.5,1,0,1,0,0,0,1,Atezolizumab,ATEZOLIZUMAB|BUPROPION|LEVOTHYROXINE|LISINOPRIL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|POLYETHYLENE GLYCOL|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|HYDROCHLOROTHIAZIDE|PREDNISONE,13,NON-SMALL CELL LUNG CANCER|HYPERLIPIDAEMIA|ANXIETY|HYPOTHYROIDISM|HYPERSENSITIVITY|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION,Transaminases increased|Type 2 diabetes mellitus|Pancreatitis|Alanine aminotransferase increased|Haematochezia|Hyperglycaemia|Aspartate aminotransferase increased,7,1
12784413,20160927,Atezolizumab,72,801,72.0,1,75.4,1,1,1,0,0,0,0,Atezolizumab,"CARBOPLATIN|LORAZEPAM|ATEZOLIZUMAB|ENOXAPARIN SODIUM|FUROSEMIDE|LORAZEPAM|MORPHINE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|FUROSEMIDE",22,NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS OF NAUSEA AND VOMITING|NON-SMALL CELL LUNG CANCER STAGE IV|INSOMNIA|PYREXIA|HYPERGLYCAEMIA|NON-SMALL CELL LUNG CANCER STAGE IV|VITAMIN SUPPLEMENTATION|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS|HYPOKALAEMIA|HYPERKALAEMIA|VITAMIN SUPPLEMENTATION|ANXIETY|INFECTION PROPHYLAXIS|PAIN|PYREXIA|PLEURAL EFFUSION|DECREASED APPETITE,Pneumonitis,1,1
12786849,20160927,Atezolizumab,56,801,56.0,1,85,1,0,1,1,0,0,0,Atezolizumab,BEVACIZUMAB|ATEZOLIZUMAB,4,TACHYCARDIA|RENAL CELL CARCINOMA|RENAL CELL CARCINOMA,Haemorrhagic stroke,1,1
12787680,20160928,Atezolizumab,63,801,63.0,1,55.8,1,0,1,0,0,0,0,Atezolizumab,KETOCONAZOLE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LORAZEPAM|AMLODIPINE BESYLATE|BEVACIZUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|KETOCONAZOLE|GADOBUTROL|PREDNISONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|BIMATOPROST|ATEZOLIZUMAB|IOHEXOL,27,NAUSEA|INSOMNIA|GENITAL RASH|HYPERTENSION|NEOPLASM|COUGH|VOMITING|GENITAL RASH|COUGH|HYPERTENSION|HYPERNATRAEMIA|HYPONATRAEMIA|GENITAL RASH|GLAUCOMA|NEOPLASM|PROPHYLAXIS,Respiratory failure|Cardiac failure congestive,2,1
12788445,20160927,Atezolizumab,82,801,82.0,1,68.4,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,PROSTATE CANCER,Feeding disorder|Facial paralysis,2,2
12789763,20160928,Atezolizumab,,,,1,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Herpes zoster,1,1
12790742,20160929,Atezolizumab,58,801,58.0,1,77.5,1,0,1,0,0,0,0,Atezolizumab,MORPHINE SULFATE|PANTOPRAZOLE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CARBOPLATIN|ZOLPIDEM TARTRATE|ATEZOLIZUMAB|GRANISETRON|GRANISETRON HYDROCHLORIDE,28,BONE PAIN|BONE PAIN|METASTASES TO BONE|HYPERTENSION|PYREXIA|PROPHYLAXIS|BONE PAIN|NAUSEA|ANXIETY|BONE PAIN|ANXIETY|C-REACTIVE PROTEIN INCREASED|NON-SMALL CELL LUNG CANCER STAGE IV|ANTIPLATELET THERAPY|PYREXIA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|BONE PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|ANXIETY|VOMITING|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NON-SMALL CELL LUNG CANCER STAGE IV|PYREXIA|NAUSEA|NAUSEA|COUGH|THROMBOSIS PROPHYLAXIS|CONSTIPATION,Performance status decreased|Myositis|Blood creatine phosphokinase increased,3,1
12792446,20160927,Atezolizumab,80,801,80.0,1,117.03,1,0,0,0,0,0,1,Atezolizumab,"METOPROLOL TARTRATE|METOPROLOL|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|ATEZOLIZUMAB|ATEZOLIZUMAB|ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",8,BLADDER CANCER|LUNG NEOPLASM MALIGNANT,Musculoskeletal stiffness|Muscular weakness|Dyspnoea|Decreased appetite|Loss of control of legs|Rash|Pain|Fatigue|Constipation|Gait disturbance|Renal disorder|Pollakiuria,12,
12795721,20160929,Atezolizumab,49,801,49.0,1,58,1,0,1,0,0,0,0,Atezolizumab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|AMOXICILLIN AND CLAVULANATE POTASSIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LEVOCETIRIZINE DIHYDROCHLORIDE|ATEZOLIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MAGNESIUM OXIDE|MAGNESIUM OXIDE|BEVACIZUMAB|AMOXICILLIN AND CLAVULANATE POTASSIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|ESOMEPRAZOLE MAGNESIUM|OXALIPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BEVACIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LEVOCETIRIZINE DIHYDROCHLORIDE",92,DIARRHOEA|PREMEDICATION|NAUSEA|RHINORRHOEA|INSOMNIA|TOOTHACHE|TOOTHACHE|TOOTHACHE|URTICARIA|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|PROPHYLAXIS|TOOTHACHE|TOOTHACHE|LATENT TUBERCULOSIS|STOMATITIS|PRURITUS|PROPHYLAXIS|TOOTHACHE|LATENT TUBERCULOSIS|PROPHYLAXIS|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|URTICARIA|PREMEDICATION|DYSPEPSIA|TOOTHACHE|COLORECTAL CANCER METASTATIC|PROPHYLAXIS|PREMEDICATION,Hepatotoxicity,1,1
12796072,20160929,Atezolizumab,69,801,69.0,2,,1,0,1,0,0,0,0,Atezolizumab,PACLITAXEL|PACLITAXEL|ATEZOLIZUMAB|ATEZOLIZUMAB|MIRTAZAPINE|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|FERROUS SULFATE|AMLODIPINE|SIMVASTATIN|ALPRAZOLAM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL,20,Triple negative breast cancer|Triple negative breast cancer|Anxiety|Anxiety|Depression|Anxiety|Depression|Prophylaxis|Prophylaxis|Back pain|Hypertension|Prophylaxis|Hyperlipidaemia|Anxiety|Neck pain|Nausea|Dehydration|Diarrhoea,Alanine aminotransferase increased|Aspartate aminotransferase increased,2,1
12799295,20160930,Atezolizumab,78,801,78.0,1,,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER TRANSITIONAL CELL CARCINOMA,Blood creatinine increased,1,1
12801487,20161003,Atezolizumab,79,801,79.0,1,72,1,0,1,0,0,0,0,Atezolizumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|BEVACIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ATEZOLIZUMAB,16,HYPERTENSION|DIARRHOEA|DYSPEPSIA|HYPERTENSION|DIARRHOEA|RENAL CELL CARCINOMA|CONSTIPATION|CONSTIPATION|GASTROOESOPHAGEAL REFLUX DISEASE|VITAMIN D DEFICIENCY|HYPERCHOLESTEROLAEMIA|RENAL CELL CARCINOMA|HYPERTENSION|DIARRHOEA|HYPERTENSION|DIARRHOEA,Dizziness,1,1
12803703,20161003,Atezolizumab,65,801,65.0,1,,1,0,1,0,0,0,0,Atezolizumab,BISOPROLOL FUMARATE|PACLITAXEL|BISOPROLOL FUMARATE|ATEZOLIZUMAB|CEFUROXIME|RAMIPRIL|RAMIPRIL|EPLERENONE|CARBOPLATIN|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|CEFUROXIME|EPLERENONE,26,PROPHYLAXIS|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER STAGE IV|C-REACTIVE PROTEIN INCREASED|C-REACTIVE PROTEIN INCREASED|HYPERTENSION|C-REACTIVE PROTEIN INCREASED|CORONARY ARTERY DISEASE|NON-SMALL CELL LUNG CANCER STAGE IV|C-REACTIVE PROTEIN INCREASED|HYPERTENSION|C-REACTIVE PROTEIN INCREASED|C-REACTIVE PROTEIN INCREASED|C-REACTIVE PROTEIN INCREASED|PROPHYLAXIS|C-REACTIVE PROTEIN INCREASED|C-REACTIVE PROTEIN INCREASED|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|C-REACTIVE PROTEIN INCREASED|C-REACTIVE PROTEIN INCREASED|PROPHYLAXIS|CORONARY ARTERY DISEASE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Radiation oesophagitis,1,3
12804122,20161003,Atezolizumab,68,801,68.0,1,68.1,1,1,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,BLADDER TRANSITIONAL CELL CARCINOMA,Malaise|Bladder cancer,2,3
12805126,20161004,Atezolizumab,67,801,67.0,2,82.4,1,1,1,0,0,0,0,Atezolizumab,CALCIUM CARBONATE|ANTACID|PACLITAXEL|ATEZOLIZUMAB|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|CARBOPLATIN,9,NAUSEA|OSTEOPENIA|HYPERTENSION|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|NON-SMALL CELL LUNG CANCER STAGE IV|PERIPHERAL VENOUS DISEASE|GASTROINTESTINAL INFECTION|NON-SMALL CELL LUNG CANCER STAGE IV,Neutropenia|Enterocolitis,2,1
12808567,20161004,Atezolizumab,,,,1,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB|PEMBROLIZUMAB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Cerebral haemorrhage,1,5
12808627,20161004,Atezolizumab,67,801,67.0,1,,1,0,0,0,0,0,1,Atezolizumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|IPILIMUMAB|ATENOLOL|ATEZOLIZUMAB|PEMBROLIZUMAB|ATEZOLIZUMAB|RITUXIMAB,10,MALIGNANT MELANOMA|NEOPLASM MALIGNANT|MALIGNANT MELANOMA|NEOPLASM MALIGNANT,Autoimmune haemolytic anaemia,1,1
12808861,20161004,Atezolizumab,,,,0,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Ocular toxicity,1,1
12809045,20161004,Atezolizumab,74,801,74.0,1,,1,0,1,0,0,0,0,Atezolizumab,PACLITAXEL|CARBOPLATIN,3,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Device occlusion,1,1
12809501,20161005,Atezolizumab,40,801,40.0,1,59.5,1,0,1,0,0,0,0,Atezolizumab,"IPRATROPIUM BROMIDE|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|ATEZOLIZUMAB|NEOSTIGMINE METHYLSULFATE|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|OXYCODONE HYDROCHLORIDE|ZOLEDRONIC ACID|BUDESONIDE|CALCIUM CARBONATE|ANTACID|ERGOCALCIFEROL",16,NON-SMALL CELL LUNG CANCER|MINERAL SUPPLEMENTATION|MINERAL SUPPLEMENTATION,Cholecystitis acute,1,1
12810758,20161005,Atezolizumab,62,801,62.0,1,61.5,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|CEFIXIME|MEGESTROL ACETATE|MIRTAZAPINE|TRAMADOL HYDROCHLORIDE|GLUTATHIONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,9,NON-SMALL CELL LUNG CANCER|INFECTION PROPHYLAXIS|DECREASED APPETITE|HEPATIC PAIN|HEPATIC PAIN|HEPATIC FUNCTION ABNORMAL|THROMBOSIS PROPHYLAXIS,Hepatic haematoma,1,1
12811901,20161005,Atezolizumab,69,801,69.0,1,157.6,1,0,1,1,0,0,0,Atezolizumab,RIVAROXABAN|METOCLOPRAMIDE HYDROCHLORIDE|METOPROLOL TARTRATE|METOPROLOL|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FENTANYL|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|PREGABALIN|ATEZOLIZUMAB|LORAZEPAM|FUROSEMIDE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|METOPROLOL TARTRATE|METOPROLOL|SPIRONOLACTONE|SPIRONOLACTONE|CARBOPLATIN|PANTOPRAZOLE,26,ATRIAL FIBRILLATION|UPPER RESPIRATORY TRACT INFECTION|PREMEDICATION|ATRIAL FIBRILLATION|NON-SMALL CELL LUNG CANCER|PREMEDICATION|NAUSEA|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|PAIN|PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER STAGE IV|PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER STAGE IV|MITRAL VALVE INCOMPETENCE|PAIN|PAIN|ATRIAL FIBRILLATION|MITRAL VALVE INCOMPETENCE|CARDIAC FAILURE|NON-SMALL CELL LUNG CANCER STAGE IV|CONSTIPATION,Cardiac failure|Diarrhoea,2,1
12817079,20161006,Atezolizumab,75,801,75.0,1,75.6,1,1,0,0,0,0,0,Atezolizumab,RAMIPRIL|CELECOXIB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ATEZOLIZUMAB|ATORVASTATIN CALCIUM|BEVACIZUMAB|FENTANYL,8,DIABETES MELLITUS|HYPERTENSION|OSTEOARTHRITIS|DIABETES MELLITUS|RENAL CELL CARCINOMA|BLOOD CHOLESTEROL INCREASED|RENAL CELL CARCINOMA|BACK PAIN,Myocardial infarction,1,1
12818648,20161006,Atezolizumab,60,801,60.0,1,72.1,1,0,0,0,0,0,1,Atezolizumab,"AMLODIPINE|FILGRASTIM|CARVEDILOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ATEZOLIZUMAB|PROCHLORPERAZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LORATADINE|LORATADINE ORAL|TBO-FILGRASTIM|CEFTRIAXONE|CEFTRIAXONE SODIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MELATONIN|BEVACIZUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LORAZEPAM|PACLITAXEL|CARBOPLATIN|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|MELATONIN|PEGFILGRASTIM",27,HYPERTENSION|FEBRILE NEUTROPENIA|HYPERTENSION|HEADACHE|INFECTION PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS OF NAUSEA AND VOMITING|PAIN|PROPHYLAXIS|FEBRILE NEUTROPENIA|INFECTION PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING|ANXIETY|NON-SMALL CELL LUNG CANCER STAGE IV|CANCER PAIN|ANXIETY|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|CATHETER SITE PAIN|PYREXIA|GASTROOESOPHAGEAL REFLUX DISEASE|DIARRHOEA|INFECTION PROPHYLAXIS|PROPHYLAXIS,Aspartate aminotransferase increased|Alanine aminotransferase increased,2,1
12818954,20161006,Atezolizumab,58,801,58.0,2,,1,0,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|PACLITAXEL|RANITIDINE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|LOSARTAN|MONTELUKAST|MONTELUKAST|DOXAZOSIN|DOXAZOSIN MESYLATE|SIMVASTATIN|GABAPENTIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",23,BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|THROMBOSIS|PRODUCT USED FOR UNKNOWN INDICATION|ASTHMA|PAIN|HYPERTENSION|HYPERSENSITIVITY|OSTEOPENIA|HYPERSENSITIVITY|ASTHMA|HYPERTENSION|HYPERCHOLESTEROLAEMIA|PAIN|URINARY TRACT INFECTION|ASTHMA|PAIN|CONSTIPATION,Palpitations,1,3
12822403,20161007,Atezolizumab,66,801,66.0,2,47.4,1,0,0,0,0,0,1,Atezolizumab,BEVACIZUMAB|OXYCODONE HYDROCHLORIDE|CARBOPLATIN|PACLITAXEL|BISOPROLOL FUMARATE|LORAZEPAM|ASCORBIC ACID|ATEZOLIZUMAB,25,NON-SMALL CELL LUNG CANCER STAGE IV|CANCER PAIN|PROPHYLAXIS|HYPERLIPIDAEMIA|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|COUGH|CONSTIPATION|CANCER PAIN|HYPERTENSION|HYPERTENSION|INSOMNIA|DECREASED APPETITE|CANCER PAIN|INSOMNIA|HYPERLIPIDAEMIA|CONJUNCTIVITIS ALLERGIC|CANCER PAIN|PROPHYLAXIS|PROPHYLAXIS|NEUTROPHIL COUNT DECREASED|DECREASED APPETITE|NON-SMALL CELL LUNG CANCER STAGE IV,Depressed level of consciousness,1,1
12831651,20161010,Atezolizumab,66,801,66.0,1,89.9,1,0,1,0,0,0,0,Atezolizumab,WARFARIN|LOSARTAN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|AMLODIPINE|BEVACIZUMAB|MICONAZOLE|MICONAZOLE NITRATE|ATEZOLIZUMAB|DOXAZOSIN|DOXAZOSIN MESYLATE,13,TYPE 2 DIABETES MELLITUS|PARATHYROIDECTOMY|HYPERTENSION|PARATHYROIDECTOMY|HYPERTENSION|RENAL CELL CARCINOMA|PRURITUS|PENILE INFECTION|PRURITUS|RENAL CELL CARCINOMA|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION,Cellulitis,1,1
12831983,20161010,Atezolizumab,79,801,79.0,1,72,1,0,1,0,0,0,0,Atezolizumab,BEVACIZUMAB|IRBESARTAN|IRBESARTAN|ATEZOLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,18,RENAL CELL CARCINOMA|DIARRHOEA|HYPERTENSION|DIARRHOEA|DIARRHOEA|HYPERTENSION|HYPERTENSION|RENAL CELL CARCINOMA|CONSTIPATION|HYPERCHOLESTEROLAEMIA|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION|CONSTIPATION|DIARRHOEA|DYSPEPSIA|VITAMIN D DEFICIENCY,Sinus bradycardia,1,1
12835170,20161011,Atezolizumab,57,801,57.0,2,70,1,0,1,0,0,0,0,Atezolizumab,"CITALOPRAM|CITALOPRAM HYDROBROMIDE|ZOLPIDEM TARTRATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OFLOXACIN|OFLOXACIN OTIC|OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3%|OFLOXACIN OTIC SOLUTION|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|ATEZOLIZUMAB",18,DEPRESSION|INSOMNIA|BONE PAIN|CHEMOTHERAPY|BONE PAIN|NAUSEA|UPPER RESPIRATORY TRACT INFECTION|DEPRESSION|BREAST CANCER METASTATIC|RESTLESSNESS|DRY EYE|PROPHYLAXIS|BACK PAIN|BREAST CANCER METASTATIC|BACK PAIN|LEUKOCYTOSIS,Blood creatinine increased,1,1
12835561,20161011,Atezolizumab,67,801,67.0,1,89.1,1,0,1,0,0,0,0,Atezolizumab,"CARBOPLATIN|LORAZEPAM|FUROSEMIDE|ATEZOLIZUMAB|PACLITAXEL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|RIVAROXABAN",11,NON-SMALL CELL LUNG CANCER|INSOMNIA|HYPERTENSION|NON-SMALL CELL LUNG CANCER|COUGH|NON-SMALL CELL LUNG CANCER|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION|PROPHYLAXIS|INSOMNIA|DEHYDRATION,Gastroenteritis,1,1
12835720,20161011,Atezolizumab,55,801,55.0,0,88.08,1,1,0,0,0,0,0,Atezolizumab,PREDNISONE|ATEZOLIZUMAB|MILK THISTLE,4,BLADDER CANCER,Sudden death|Abdominal pain|Arthralgia|Transaminases increased|Pyrexia,5,1
12836019,20161011,Atezolizumab,58,801,58.0,2,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Myositis|Myalgia,2,3
12836625,20161011,Atezolizumab,77,801,77.0,1,,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|ATEZOLIZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION,Asthenia|Acute respiratory failure,2,5
12837763,20161012,Atezolizumab,60,801,60.0,1,49.1,1,0,1,0,0,0,0,Atezolizumab,LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|BEVACIZUMAB|LACTULOSE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ATEZOLIZUMAB,10,CONVULSION PROPHYLAXIS|PROPHYLAXIS|PAIN|CONSTIPATION PROPHYLAXIS|INFECTION PROPHYLAXIS|RENAL CELL CARCINOMA|CONSTIPATION PROPHYLAXIS|RENAL CELL CARCINOMA,Systemic immune activation,1,1
12837789,20161012,Atezolizumab,70,801,70.0,2,82.5,1,0,1,1,0,0,1,Atezolizumab,"ATEZOLIZUMAB|ALPRAZOLAM|ATENOLOL|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|SITAGLIPTIN|LOSARTAN POTASSIUM|LOSARTAN|ERGOCALCIFEROL|OXYCODONE HYDROCHLORIDE|OXYCODONE|BEVACIZUMAB|KETOCONAZOLE|KETOCONAZOLE FOAM|KETOCONAZOLE CREAM, 2%|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALBUTEROL SULFATE|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CALCIUM CARBONATE|ANTACID|SIMVASTATIN|ALBUTEROL SULFATE|ALPRAZOLAM|ATENOLOL|CLOBETASOL PROPIONATE|CLOBETASOL PROPIONATE OINTMENT USP, 0.05%|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|CONJUGATED ESTROGENS|ESTROGENS, CONJUGATED|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|FERROUS SULFATE|INSULIN ASPART|PROCHLORPERAZINE|INSULIN GLARGINE|ALUMINIUM HYDROXIDE|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|CHOLESTYRAMINE|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS",44,RENAL CELL CARCINOMA|HYPERTENSION|TYPE 2 DIABETES MELLITUS|SEASONAL ALLERGY|PSORIASIS|TYPE 2 DIABETES MELLITUS|HYPERTENSION|NUTRITIONAL SUPPLEMENTATION|RENAL CELL CARCINOMA|PSORIASIS|GASTROOESOPHAGEAL REFLUX DISEASE|COUGH|NUTRITIONAL SUPPLEMENTATION|TYPE 2 DIABETES MELLITUS|NUTRITIONAL SUPPLEMENTATION|HYPERCHOLESTEROLAEMIA|DYSPNOEA|COUGH|ANXIETY|PSORIASIS|HYPOTHYROIDISM|OESTROGEN REPLACEMENT THERAPY|NAUSEA|TYPE 2 DIABETES MELLITUS|DEPRESSION|NAUSEA,Systemic inflammatory response syndrome|Acute respiratory failure|Acute kidney injury|Hyponatraemia,4,1
12838603,20161012,Atezolizumab,68,801,68.0,1,68.4,1,1,1,1,0,0,0,Atezolizumab,ATEZOLIZUMAB|LACTULOSE|BISOPROLOL FUMARATE|TIOTROPIUM BROMIDE|OXAZEPAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CARBOPLATIN|RAMIPRIL|OXYGEN|0XYGEN|FENTANYL|MIRTAZAPINE|FENTANYL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,45,NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|NAUSEA|RASH|PROPHYLAXIS|HYPERTENSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|SLEEP DISORDER|PROPHYLAXIS|HYPOCALCAEMIA|PROPHYLAXIS|PROPHYLAXIS|HYPOKALAEMIA|NON-SMALL CELL LUNG CANCER STAGE IV|MUCOSAL INFLAMMATION|HYPERTENSION|METASTASES TO BONE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|LEUKOPENIA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CHEST PAIN|CHEST PAIN|HYPERLIPIDAEMIA|ARTHRALGIA|CHEST PAIN|SLEEP DISORDER|ARTHRALGIA|PROPHYLAXIS|PROPHYLAXIS|ANAEMIA|ARTHRALGIA|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|PROPHYLAXIS,Diarrhoea|Chronic obstructive pulmonary disease|Pneumonia|Mucosal inflammation|Staphylococcal sepsis|General physical health deterioration,6,1
12838909,20161010,Atezolizumab,82,801,82.0,1,68.4,1,0,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|ATEZOLIZUMAB,2,BLADDER CANCER|PROSTATE CANCER,Facial paralysis,1,2
12842289,20161013,Atezolizumab,75,801,75.0,1,73,1,1,1,0,0,0,0,Atezolizumab,"PROPRANOLOL HYDROCHLORIDE|LEVOTHYROXINE SODIUM|NIFEDIPINE|DOXAZOSIN MESYLATE|ATEZOLIZUMAB|LISINOPRIL|LOVASTATIN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ZOLPIDEM TARTRATE|DIPHENHYDRAMINE HYDROCHLORIDE|DOXAZOSIN MESYLATE|BEVACIZUMAB|DOXAZOSIN MESYLATE",15,HYPERTENSION|HYPERTHYROIDISM|HYPERTENSION|RENAL CELL CARCINOMA|HYPERTENSION|HYPERLIPIDAEMIA|BACK PAIN|BACK PAIN|INSOMNIA|PAIN|SEASONAL ALLERGY|RENAL CELL CARCINOMA|HYPERTENSION,Acute respiratory failure|Mental status changes,2,1
12842559,20161013,Atezolizumab,76,801,76.0,1,92.1,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|OMEPRAZOLE MAGNESIUM|LORAZEPAM|SIMVASTATIN|OXYCODONE|BEVACIZUMAB|GABAPENTIN|SOLIFENACIN SUCCINATE|ESCITALOPRAM,12,NEOPLASM|ABDOMINAL PAIN LOWER|ANXIETY|HYPERCHOLESTEROLAEMIA|BACK PAIN|NEOPLASM|NEUROPATHY PERIPHERAL|DIABETES MELLITUS|URINARY TRACT OBSTRUCTION|URINARY TRACT OBSTRUCTION|DEPRESSION,Myocardial infarction,1,1
12842951,20161013,Atezolizumab,,,,1,79,1,0,1,0,0,0,0,Atezolizumab,PREGABALIN|DIAZEPAM|LACTULOSE|OXYCODONE HYDROCHLORIDE|ATEZOLIZUMAB|DULOXETINE HYDROCHLORIDE|ATEZOLIZUMAB,15,NEOPLASM|NEOPLASM,Asthenia,1,1
12847466,20161014,Atezolizumab,75,801,75.0,1,82.6,1,0,1,0,0,0,0,Atezolizumab,CALCIUM GLUCONATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ATENOLOL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATEZOLIZUMAB|CARBOPLATIN|LOSARTAN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PHYTONADIONE|IPRATROPIUM BROMIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FLUCONAZOLE|FLUCONAZOLE,36,NON-SMALL CELL LUNG CANCER STAGE IV|DYSLIPIDAEMIA|HYPOCALCAEMIA|PROPHYLAXIS|HYPERTENSION|ANAEMIA|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|PREMEDICATION|INTERNATIONAL NORMALISED RATIO INCREASED|COUGH|DYSPNOEA|PREMEDICATION|PREMEDICATION|PREMEDICATION|NAUSEA|MYOCARDIAL ISCHAEMIA|PREMEDICATION|DYSPNOEA|CANDIDA INFECTION|HYPOMAGNESAEMIA|PREMEDICATION|CANDIDA INFECTION|COUGH,Febrile neutropenia,1,1
12849052,20161014,Atezolizumab,66,801,66.0,2,,1,0,1,0,0,0,0,Atezolizumab,MORPHINE|ATEZOLIZUMAB,2,ARTHRALGIA|TRANSITIONAL CELL CARCINOMA,General physical health deterioration,1,1
12850463,20161014,Atezolizumab,53,801,53.0,1,78.5,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,NON-SMALL CELL LUNG CANCER,Radiation pneumonitis,1,1
12851053,20161015,Atezolizumab,64,801,64.0,2,62,1,0,1,0,0,0,0,Atezolizumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ATEZOLIZUMAB|DOXEPIN|DOXEPIN HYDROCHLORIDE|FILGRASTIM,11,HYPERTENSION|BREAST CANCER METASTATIC|HAEMODILUTION|HYPERCHOLESTEROLAEMIA|PROPHYLAXIS|PROPHYLAXIS|BREAST CANCER METASTATIC|THYROID FUNCTION TEST ABNORMAL|PROPHYLAXIS|ANXIETY DISORDER|NEUTROPENIA,Erysipelas,1,1
12851102,20161015,Atezolizumab,72,801,72.0,1,51.7,1,0,1,0,0,0,0,Atezolizumab,PROCHLORPERAZINE MALEATE|PEMETREXED|PEMETREXED DISODIUM|DEXTROSE ANHYDROUS|CARBOPLATIN|PRAVASTATIN SODIUM|GRANISETRON HYDROCHLORIDE|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|MAGNESIUM OXIDE|ATEZOLIZUMAB|ESOMEPRAZOLE MAGNESIUM,33,DIABETES MELLITUS|CANCER PAIN|PROPHYLAXIS|PROPHYLAXIS AGAINST DEHYDRATION|NAUSEA|NON-SMALL CELL LUNG CANCER STAGE IV|THROMBOSIS PROPHYLAXIS|CANCER PAIN|CONSTIPATION|CONSTIPATION|DIABETES MELLITUS|HEPATIC FUNCTION ABNORMAL|NAUSEA|NON-SMALL CELL LUNG CANCER STAGE IV|DYSLIPIDAEMIA|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|DIABETES MELLITUS|CATARACT|NAUSEA|PENILE ERYTHEMA|DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER STAGE IV|CONSTIPATION PROPHYLAXIS|PROPHYLAXIS AGAINST DEHYDRATION|NAUSEA|PROPHYLAXIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|INFECTION PROPHYLAXIS|STOMATITIS|CANCER PAIN|GASTRITIS PROPHYLAXIS,Bone marrow failure|Pneumonia aspiration,2,1
12854028,20161017,Atezolizumab,70,801,70.0,1,61.4,1,0,0,0,0,0,1,Atezolizumab,"ZOLEDRONIC ACID|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|CEFEPIME HYDROCHLORIDE|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FUROSEMIDE|CARBOPLATIN|DEXAMETHASONE SODIUM PHOSPHATE|MICONAZOLE|MICONAZOLE NITRATE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|MAGNESIUM OXIDE|PACLITAXEL|PALONOSETRON HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL",32,METASTASES TO BONE|PYREXIA|GASTRITIS|PYREXIA|PYREXIA|PYREXIA|STOMATITIS|HYPERKALAEMIA|NON-SMALL CELL LUNG CANCER STAGE IV|NAUSEA|PROPHYLACTIC CHEMOTHERAPY|MUCOSAL INFECTION|NAUSEA|PYREXIA|VOMITING|PULMONARY HAEMORRHAGE|PRODUCT USED FOR UNKNOWN INDICATION|PNEUMOCYSTIS JIROVECII PNEUMONIA|CONSTIPATION|NON-SMALL CELL LUNG CANCER STAGE IV|PREMEDICATION|CANCER PAIN|PULMONARY HAEMORRHAGE|VOMITING|INSOMNIA|INFECTION PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|NAUSEA|DIAGNOSTIC PROCEDURE,Pulmonary haemorrhage|Haemophagocytic lymphohistiocytosis,2,1
12856504,20161018,Atezolizumab,69,801,69.0,1,80.1,1,0,1,0,0,0,0,Atezolizumab,GARLIC|ATEZOLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PACLITAXEL|CARBOPLATIN|CANDESARTAN CILEXETIL,17,HYPOKALAEMIA|NUTRITIONAL SUPPLEMENTATION|HYPERCHOLESTEROLAEMIA|NON-SMALL CELL LUNG CANCER|MUSCULOSKELETAL PAIN|HYPOKALAEMIA|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ANAEMIA|HYPERTENSION|PROPHYLAXIS|DYSPNOEA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION,Blood creatinine increased|Infection|Acute kidney injury|Stomatitis,4,3
12857226,20161018,Atezolizumab,,,,1,,1,0,1,0,0,0,0,Atezolizumab,COBIMETINIB|COBIMETINIB|COBIMETINIB|ATEZOLIZUMAB,4,COLON CANCER|COLON CANCER,Off label use|Rash|Fatigue|Skin irritation|Mental disorder|Nausea,6,5
12857680,20161018,Atezolizumab,65,801,65.0,2,52.2,1,0,1,0,0,0,0,Atezolizumab,"HYDROCHLOROTHIAZIDE|BEVACIZUMAB|CLOTRIMAZOLE|DRS. CLOTRIMAZOLE|FAMILY WELLNESS CLOTRIMAZOLE|CLOTRIMAZOLE TOPICAL|CLOTRIMAZOLE|DRS. CLOTRIMAZOLE|FAMILY WELLNESS CLOTRIMAZOLE|CLOTRIMAZOLE TOPICAL|ALPRAZOLAM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|ATEZOLIZUMAB|HYDROCORTISONE|CONJUGATED ESTROGENS|ESTROGENS, CONJUGATED|AMLODIPINE BESYLATE|ERGOCALCIFEROL",16,METASTATIC RENAL CELL CARCINOMA|VITAMIN SUPPLEMENTATION|INFECTION|PROBIOTIC THERAPY|METASTATIC RENAL CELL CARCINOMA|VITAMIN SUPPLEMENTATION|URTICARIA|RASH|HYPERTENSION|ANXIETY|CONSTIPATION|METASTATIC RENAL CELL CARCINOMA|PRURITUS|VULVOVAGINAL DRYNESS|HYPERTENSION|VITAMIN SUPPLEMENTATION,Pneumonia|Hyponatraemia|Hyponatraemia,3,1
12858469,20161018,Atezolizumab,55,801,55.0,2,46.1,1,0,1,0,0,0,0,Atezolizumab,"ATEZOLIZUMAB|PALONOSETRON HYDROCHLORIDE|CELECOXIB|PALONOSETRON HYDROCHLORIDE|FAMOTIDINE|CARBOPLATIN|MAGNESIUM OXIDE|DEXAMETHASONE SODIUM PHOSPHATE|RABEPRAZOLE SODIUM|RABEPRAZOLE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|PACLITAXEL|RAMUCIRUMAB|APREPITANT|DEXAMETHASONE SODIUM PHOSPHATE",26,NON-SMALL CELL LUNG CANCER STAGE IV|PREMEDICATION|CANCER PAIN|CANCER PAIN|CONSTIPATION|PROPHYLAXIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|CONSTIPATION|PREMEDICATION|PREMEDICATION|PROPHYLAXIS|PROPHYLAXIS|PREMEDICATION|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|PROPHYLAXIS|PREMEDICATION|PREMEDICATION,Back pain,1,1
12858564,20161018,Atezolizumab,49,801,49.0,1,75,1,1,1,1,0,0,0,Atezolizumab,ATEZOLIZUMAB|BEVACIZUMAB,6,PAIN|RENAL CELL CARCINOMA|RENAL CELL CARCINOMA|PLEURAL EFFUSION|PLEURAL EFFUSION|PAIN,Multiple organ dysfunction syndrome|Peritonitis|Large intestine perforation,3,1
12860502,20161019,Atezolizumab,79,801,79.0,2,64.3,1,0,1,0,0,0,0,Atezolizumab,ALPRAZOLAM|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|ATEZOLIZUMAB|ACETYLCYSTEINE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ATORVASTATIN CALCIUM|ALPRAZOLAM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|MORPHINE,20,THROMBOSIS PROPHYLAXIS|ANXIETY|PROPHYLAXIS|URINARY TRACT INFECTION|NON-SMALL CELL LUNG CANCER|NEUROPATHY PERIPHERAL|HYPERTENSION|LUNG INFILTRATION|PROPHYLAXIS URINARY TRACT INFECTION|HYPERTENSION|HYPERTENSION|HYPERCHOLESTEROLAEMIA|EMBOLISM|VOMITING|HYPONATRAEMIA|PROPHYLAXIS|BACK PAIN,Alanine aminotransferase increased|Aspartate aminotransferase increased|Guillain-Barre syndrome|Hyperthyroidism,4,1
12860801,20161019,Atezolizumab,76,801,76.0,2,70.5,1,0,1,0,0,0,0,Atezolizumab,OBINUTUZUMAB|ALLOPURINOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LORATADINE|LORATADINE ORAL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ATEZOLIZUMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METOPROLOL TARTRATE|METOPROLOL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|GABAPENTIN,13,DIFFUSE LARGE B-CELL LYMPHOMA|TUMOUR LYSIS SYNDROME|PREMEDICATION|HYPERSENSITIVITY|DIFFUSE LARGE B-CELL LYMPHOMA|PREMEDICATION|GASTROOESOPHAGEAL REFLUX DISEASE|ATRIAL FIBRILLATION|VOMITING|NEUROPATHY PERIPHERAL,Pneumonia,1,1
12861160,20161019,Atezolizumab,53,801,53.0,2,82,1,0,0,0,0,0,1,Atezolizumab,"ATEZOLIZUMAB|PIROXICAM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|GABAPENTIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LEVOTHYROXINE",8,BREAST CANCER|SEASONAL ALLERGY|OSTEOARTHRITIS|BREAST CANCER|URINARY TRACT INFECTION|NEUROPATHY PERIPHERAL|ARTHRALGIA|HYPOTHYROIDISM,Cholecystitis acute,1,1
12862011,20161019,Atezolizumab,51,801,51.0,1,,1,0,1,0,0,0,0,Atezolizumab,SIMVASTATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATEZOLIZUMAB|FUROSEMIDE|METOPROLOL TARTRATE|METOPROLOL|RAMIPRIL|APREPITANT|FOSAPREPITANT DIMEGLUMINE|PACLITAXEL|CARBOPLATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|APREPITANT|FOSAPREPITANT DIMEGLUMINE,15,HYPERLIPIDAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|CORONARY ARTERY DISEASE|HYPERTENSION|HYPERTENSION|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|CORONARY ARTERY DISEASE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING|DIARRHOEA,Seizure,1,1
12864322,20161020,Atezolizumab,59,801,59.0,2,77.8,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|OBINUTUZUMAB|SIMETHICONE|ACETAMINOPHEN|LORAZEPAM|PROCHLORPERAZINE|ACETAMINOPHEN|OSELTAMIVIR|OSELTAMIVIR PHOSPHATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FAMOTIDINE|LORAZEPAM|ENOXAPARIN SODIUM|ACETAMINOPHEN|POLYETHYLENE GLYCOL 3350|ALLOPURINOL|ACETAMINOPHEN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|FAMOTIDINE|LORAZEPAM|PROCHLORPERAZINE,22,B-CELL LYMPHOMA RECURRENT|B-CELL LYMPHOMA RECURRENT|ABDOMINAL DISCOMFORT|ARTHRITIS|ALLERGY PROPHYLAXIS|NAUSEA|HEADACHE|OROPHARYNGEAL PAIN|PREMEDICATION|ANXIETY|THROMBOSIS PROPHYLAXIS|PAIN|CONSTIPATION|PROPHYLAXIS|PYREXIA|CONSTIPATION|PREMEDICATION|PREMEDICATION|VOMITING,Ileus,1,1
12864799,20161020,Atezolizumab,58,801,58.0,1,74,1,0,1,1,0,0,0,Atezolizumab,PANTOPRAZOLE|ZOLEDRONIC ACID|LACTULOSE|FENTANYL|ATEZOLIZUMAB|ESTAZOLAM|FENTANYL|FENTANYL|BUPRENORPHINE,17,NAUSEA|METASTASES TO BONE|CONSTIPATION|PAIN|BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC|SLEEP DISORDER|URINARY TRACT INFECTION|PAIN|PAIN|PAIN|PAIN|PAIN|PROPHYLAXIS,Renal failure|Hydronephrosis|Pneumonia|Hepatotoxicity,4,1
12868354,20161020,Atezolizumab,,,,0,,1,0,0,0,0,0,0,Atezolizumab,BEVACIZUMAB|PERTUZUMAB|ALTEPLASE|ATEZOLIZUMAB|TRASTUZUMAB,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,No adverse event|Circumstance or information capable of leading to medication error,2,2
12869215,20161021,Atezolizumab,53,801,53.0,2,,1,0,0,0,0,0,1,Atezolizumab,"PACLITAXEL|PIROXICAM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|GABAPENTIN|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|ERGOCALCIFEROL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PACLITAXEL|LEVOTHYROXINE",11,OSTEOARTHRITIS|URINARY TRACT INFECTION|NEUROPATHY PERIPHERAL|TRIPLE NEGATIVE BREAST CANCER|SEASONAL ALLERGY|PRODUCT USED FOR UNKNOWN INDICATION|ARTHRALGIA|TRIPLE NEGATIVE BREAST CANCER|HYPOTHYROIDISM,Cholecystitis acute,1,1
12869485,20161021,Atezolizumab,76,801,76.0,1,,1,0,1,0,0,0,1,Atezolizumab,DOXAZOSIN|DOXAZOSIN MESYLATE|ATEZOLIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,3,BLADDER CANCER,Fatigue|Decreased appetite|Nausea|Urinary tract infection|Pyrexia|Malaise|Asthenia|Fall|Platelet count decreased,9,5
12871282,20161021,Atezolizumab,,,,0,,1,0,0,0,0,0,0,Atezolizumab,,2,,Product label confusion|International normalised ratio increased,2,
12871585,20161021,Atezolizumab,70,801,70.0,1,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,2,THROMBOSIS PROPHYLAXIS|BLADDER CANCER,International normalised ratio increased|Haematuria,2,1
12873035,20161021,Atezolizumab,35,801,35.0,2,48,1,0,1,0,0,0,0,Atezolizumab,"SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|SULFAMETHOXAZOLE AND TRIMETHOPRIM|METHYLPREDNISOLONE SODIUM SUCCINATE|OBINUTUZUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|OBINUTUZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|PANTOPRAZOLE|METHYLPREDNISOLONE SODIUM SUCCINATE",34,ORAL INFECTION|INFECTION|PREMEDICATION|PRURITUS|PREMEDICATION|DIFFUSE LARGE B-CELL LYMPHOMA|PREMEDICATION|HERPES ZOSTER|INFECTION PROPHYLAXIS|PREMEDICATION|DIFFUSE LARGE B-CELL LYMPHOMA|CANCER PAIN|GASTROOESOPHAGEAL REFLUX DISEASE,Pericardial effusion,1,1
12873457,20161021,Atezolizumab,62,801,62.0,2,,1,0,1,0,0,0,0,Atezolizumab,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PACLITAXEL|ATEZOLIZUMAB|FONDAPARINUX SODIUM|GRANISETRON|GRANISETRON HYDROCHLORIDE",10,PAIN|BREAST CANCER|INFUSION RELATED REACTION|DEEP VEIN THROMBOSIS|BREAST CANCER|DEEP VEIN THROMBOSIS|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|INFUSION RELATED REACTION,Generalised oedema,1,3
12875464,20161024,Atezolizumab,59,801,59.0,2,70.2,1,0,1,0,0,0,0,Atezolizumab,"ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RANITIDINE|IOPAMIDOL|FENTANYL|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|MELOXICAM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|OXYCODONE|OXYCODONE|OXYCODONE|ROSUVASTATIN|ALPRAZOLAM|HYDROMORPHONE HYDROCHLORIDE|HYDROMORPHONE HYDROCHLORIDE|HYDROMORPHONE HYDROCHLORIDE|OXYCODONE|MELOXICAM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|NICOTINE|ALPRAZOLAM|OXYCODONE HYDROCHLORIDE|OXYCODONE|FENTANYL|HYDROMORPHONE HYDROCHLORIDE|LORAZEPAM|FAMOTIDINE|MAGNESIUM HYDROXIDE|CETIRIZINE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|CARBOPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OXYCODONE HYDROCHLORIDE|OXYCODONE|STANDARDIZED SENNA CONCENTRATE|HYDROMORPHONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|GABAPENTIN|CITALOPRAM|CITALOPRAM HYDROBROMIDE|GABAPENTIN|AMOXICILLIN|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|OXYCODONE|GABAPENTIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|GABAPENTIN|PROCHLORPERAZINE|POLYETHYLENE GLYCOL 3350|AMOXICILLIN|ERTAPENEM|ERTAPENEM SODIUM|DIPHENHYDRAMINE HYDROCHLORIDE|PROMETHAZINE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|OXYCODONE|ENOXAPARIN SODIUM|ATEZOLIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ENOXAPARIN SODIUM|ALBUTEROL SULFATE|DIPHENHYDRAMINE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|DRONABINOL|NITROGLYCERIN",81,ARTHRALGIA|IRRITABLE BOWEL SYNDROME|PEPTIC ULCER|CONSTIPATION|PYREXIA|COUGH|ARTHRALGIA|BACK PAIN|ORAL PAIN|BACK PAIN|ARTHRALGIA|NON-CARDIAC CHEST PAIN|BLOOD CHOLESTEROL INCREASED|ABDOMINAL PAIN|HEADACHE|ARTHRALGIA|ARTHRALGIA|BACK PAIN|TOBACCO USER|ANXIETY|NON-CARDIAC CHEST PAIN|PREMEDICATION|PROCEDURAL PAIN|ANXIETY|PEPTIC ULCER|PROPHYLAXIS|NASAL CONGESTION|BACK PAIN|DYSPEPSIA|NON-SMALL CELL LUNG CANCER STAGE IV|ARTHRALGIA|NON-CARDIAC CHEST PAIN|HEADACHE|HEADACHE|NAUSEA|VOMITING|CONSTIPATION|PROCEDURAL PAIN|ABDOMINAL PAIN|PARAESTHESIA|NON-SMALL CELL LUNG CANCER STAGE IV|INSOMNIA|PERSISTENT DEPRESSIVE DISORDER|BACK PAIN|ORAL PAIN|ARTHRALGIA|NON-CARDIAC CHEST PAIN|HEADACHE|BACK PAIN|PYREXIA|DYSPNOEA|PARAESTHESIA|NAUSEA|CONSTIPATION|PREMEDICATION|LYMPHADENOPATHY|INFECTION|PRURITUS|PROCEDURAL NAUSEA|ARTHRITIS|ARTHRITIS|PULMONARY EMBOLISM|NON-SMALL CELL LUNG CANCER STAGE IV|ARTHRITIS|SEIZURE|BLOOD CHOLESTEROL INCREASED|LYMPHADENOPATHY|DEEP VEIN THROMBOSIS|WHEEZING|PRURITUS|HEADACHE|HEADACHE|DECREASED APPETITE|ANGINA PECTORIS,Cholecystitis acute|Immune-mediated hepatitis,2,1
12877198,20161024,Atezolizumab,49,801,49.0,2,,1,1,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|COBIMETINIB,2,COLON CANCER STAGE IV|COLON CANCER STAGE IV,Off label use|Cerebrovascular accident,2,2
12878398,20161024,Atezolizumab,,,,1,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Metastases to liver|Hyponatraemia|Fatigue,3,1
12879522,20161025,Atezolizumab,54,801,54.0,2,86,1,0,1,0,0,0,0,Atezolizumab,ENOXAPARIN SODIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PROCHLORPERAZINE|OXYCODONE|ATEZOLIZUMAB|PREGABALIN|DIPHENHYDRAMINE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|COBIMETINIB|COBIMETINIB,17,PULMONARY EMBOLISM|NAUSEA|DIARRHOEA|NAUSEA|PAIN|PAIN PROPHYLAXIS|DRY SKIN|COLORECTAL ADENOCARCINOMA|PERIPHERAL SENSORY NEUROPATHY|PROPHYLAXIS|VOMITING|PROPHYLAXIS|RASH|BLOOD MAGNESIUM DECREASED|COLORECTAL ADENOCARCINOMA|NUTRITIONAL SUPPLEMENTATION,Syncope|Diarrhoea,2,1
12883222,20161025,Atezolizumab,47,801,47.0,2,135.8,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|CEFEPIME HYDROCHLORIDE|CEFEPIME|SERTRALINE HYDROCHLORIDE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|CARBOPLATIN|PACLITAXEL|CEFEPIME HYDROCHLORIDE|CEFEPIME,7,NON-SMALL CELL LUNG CANCER STAGE IV|DEPRESSION|URINARY TRACT INFECTION|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|URINARY TRACT INFECTION,Drug hypersensitivity,1,1
12883242,20161025,Atezolizumab,61,801,61.0,1,,1,1,1,1,0,0,0,Atezolizumab,DABIGATRAN ETEXILATE|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|PEMETREXED|PEMETREXED DISODIUM|LEVOTHYROXINE|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|PACLITAXEL|EZETIMIBE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|CARBOPLATIN|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|PACLITAXEL|PEMETREXED|PEMETREXED DISODIUM,17,DIARRHOEA|EMPHYSEMA|ATRIAL FIBRILLATION|ATRIAL FIBRILLATION|DEPRESSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPOTHYROIDISM|DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER|HYPERLIPIDAEMIA|DIARRHOEA|NON-SMALL CELL LUNG CANCER|HYPERLIPIDAEMIA|HYPERTENSION,White blood cell count decreased|Respiratory distress|Hyperkalaemia|Neutrophil count decreased|Renal failure|Cardiac arrest,6,1
12883388,20161025,Atezolizumab,66,801,66.0,2,,1,1,1,1,0,0,0,Atezolizumab,"SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|OXYCODONE HYDROCHLORIDE|OXYCODONE|PALONOSETRON HYDROCHLORIDE|CEFAZOLIN SODIUM|CEFAZOLIN|PROPOFOL|PANTOPRAZOLE SODIUM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|FENTANYL|CALCIUM GLUCONATE|ERGOCALCIFEROL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METOCLOPRAMIDE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FENTANYL|HEPARIN SODIUM|PACLITAXEL|SENNOSIDES|SENNA LEAF|SENNA|CHLORHEXIDINE GLUCONATE|CARBOPLATIN|OXYCODONE HYDROCHLORIDE|OXYCODONE|METOCLOPRAMIDE HYDROCHLORIDE|PEGFILGRASTIM|CALCIUM CARBONATE|ANTACID|MORPHINE",42,OSTEOARTHRITIS|ACIDOSIS|HYPERTENSION|HYPERGLYCAEMIA|ARTHRALGIA|NAUSEA|CENTRAL VENOUS CATHETERISATION|ENDOTRACHEAL INTUBATION|ENDOTRACHEAL INTUBATION|OSTEOARTHRITIS|CONSTIPATION|HYPOTHYROIDISM|ARTHRALGIA|PLATELET COUNT DECREASED|CENTRAL VENOUS CATHETERISATION|PAIN|ANTIVIRAL PROPHYLAXIS|HYPOCALCAEMIA|ENDOTRACHEAL INTUBATION|PRODUCT USED FOR UNKNOWN INDICATION|DEHYDRATION|DECREASED APPETITE|PROPHYLAXIS OF NAUSEA AND VOMITING|CENTRAL VENOUS CATHETERISATION|MUSCULOSKELETAL PAIN|ANAEMIA|THROMBOSIS PROPHYLAXIS|ENDOTRACHEAL INTUBATION|NON-SMALL CELL LUNG CANCER|CONSTIPATION|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|MUSCULOSKELETAL PAIN|NAUSEA|PROPHYLAXIS|HYPOCALCAEMIA|DRY EYE|PALLIATIVE CARE,Cardiac failure|Multiple organ dysfunction syndrome|Arthralgia|Respiratory failure|Acute kidney injury,5,1
12883415,20161025,Atezolizumab,74,801,74.0,1,70.58,1,1,0,0,0,0,0,Atezolizumab,PACLITAXEL|PACLITAXEL|CARBOPLATIN,6,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER|NUTRITIONAL SUPPLEMENTATION,Death,1,3
12884233,20161026,Atezolizumab,77,801,77.0,2,63.3,1,0,0,0,0,0,1,Atezolizumab,APREPITANT|FOSAPREPITANT DIMEGLUMINE|SELENIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATEZOLIZUMAB|FOLIC ACID|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|NETUPITANT AND PALONOSETRON|FOSNETUPITANT AND PALONOSETRON|APREPITANT|FOSAPREPITANT DIMEGLUMINE|CARBOPLATIN,14,CONSTIPATION|PREMEDICATION|HYPOTHYROIDISM|PREMEDICATION|SCIATICA|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|PREMEDICATION|NON-SMALL CELL LUNG CANCER STAGE IV|INFECTION PROPHYLAXIS,Leukopenia|Neutropenia,2,1
12884399,20161026,Atezolizumab,65,801,65.0,1,77.4,1,0,1,0,0,0,1,Atezolizumab,"CARBOPLATIN|OXYCODONE|ADENOSINE|ATEZOLIZUMAB|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|ERGOCALCIFEROL|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ROSUVASTATIN|DRONABINOL|POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS|METOPROLOL TARTRATE|METOPROLOL|ACYCLOVIR|MORPHINE|DIPHENHYDRAMINE HYDROCHLORIDE|SERTRALINE HYDROCHLORIDE|AMLODIPINE BESYLATE",22,NEOPLASM|MUSCULOSKELETAL CHEST PAIN|NAUSEA|ARRHYTHMIA|PREMEDICATION|NEOPLASM|HYPERTENSION|NUTRITIONAL SUPPLEMENTATION|NEOPLASM|NAUSEA|HYPERLIPIDAEMIA|METASTASES TO BONE|WEIGHT DECREASED|HYPOPHOSPHATAEMIA|ARRHYTHMIA|GENITAL HERPES|DYSPNOEA|DEPRESSION|HYPERTENSION,Anaemia|Thrombocytopenia|Embolism|Thrombocytopenia,4,1
12884426,20161026,Atezolizumab,58,801,58.0,2,100.2,1,0,0,0,0,0,1,Atezolizumab,"VEMURAFENIB|LOSARTAN POTASSIUM|NASAL|SALINE|(SALINE)|COBIMETINIB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CALCIUM CARBONATE|ANTACID|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATORVASTATIN CALCIUM|LEVOTHYROXINE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|GUAIFENESIN|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|CALCIUM CARBONATE|ANTACID|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|LEVOTHYROXINE|METOPROLOL TARTRATE|METOPROLOL|FUROSEMIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LISINOPRIL|ROSUVASTATIN|AMOXICILLIN|FUROSEMIDE|OXYCODONE|GUAIFENESIN|VEMURAFENIB|VEMURAFENIB|COBIMETINIB|METRONIDAZOLE|METRONIDAZOLE TOPICAL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LEVOTHYROXINE|FAMOTIDINE|ATEZOLIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LEVOTHYROXINE|LEVOTHYROXINE|FAMOTIDINE",46,METASTATIC MALIGNANT MELANOMA|HYPERTENSION|URTICARIA|LOCAL ANAESTHESIA|VIRAL UPPER RESPIRATORY TRACT INFECTION|METASTATIC MALIGNANT MELANOMA|LYMPHOEDEMA|DYSPEPSIA|DERMATITIS ACNEIFORM|NAUSEA|DYSLIPIDAEMIA|DIARRHOEA|DIABETES MELLITUS|RASH MACULO-PAPULAR|INFUSION RELATED REACTION|VIRAL UPPER RESPIRATORY TRACT INFECTION|GASTROOESOPHAGEAL REFLUX DISEASE|GLUCOSE TOLERANCE IMPAIRED|HYPERTENSION|LYMPHOEDEMA|PAIN IN EXTREMITY|HYPERTENSION|HYPERLIPIDAEMIA|VIRAL UPPER RESPIRATORY TRACT INFECTION|LYMPHOEDEMA|PAIN|DEHYDRATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|ULCER|VIRAL UPPER RESPIRATORY TRACT INFECTION|HYPONATRAEMIA|INFUSION RELATED REACTION|METASTATIC MALIGNANT MELANOMA|ARTHRALGIA|HYPOTHYROIDISM|LOCAL ANAESTHESIA|PRURITUS,Electrocardiogram T wave inversion|Electrocardiogram QT prolonged,2,1
12885970,20161026,Atezolizumab,,,,2,,1,0,1,0,0,0,1,Atezolizumab,ATEZOLIZUMAB|CAPECITABINE|MORPHINE,4,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Fall|Fatigue|Spinal cord compression|Urinary tract infection,4,5
12886872,20161026,Atezolizumab,,,,2,,1,1,0,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA,Death,1,1
12887944,20161027,Atezolizumab,63,801,63.0,1,93,1,0,1,0,0,0,0,Atezolizumab,"ARSENICUM ALBUM|ARSENIC TRIOXIDE|OXYCODONE HYDROCHLORIDE|ZINC|ZINCUM METALLICUM|ZINC|ZINCUM METALLICUM|CARBOPLATIN|CALCAREA CARBONICA|OYSTER SHELL CALCIUM CARBONATE, CRUDE|CALCAREA CARBONICA|OYSTER SHELL CALCIUM CARBONATE, CRUDE|SELENIUM|ATEZOLIZUMAB|ACONITUM NAPELLUS|ACONITE|SELENIUM",19,ANXIETY|NON-SMALL CELL LUNG CANCER STAGE IV|PAIN|PARAESTHESIA|INFECTION|NAUSEA|PARAESTHESIA|HYPOAESTHESIA|INFECTION|HYPOAESTHESIA|NON-SMALL CELL LUNG CANCER STAGE IV|PARAESTHESIA|HYPOAESTHESIA|PARAESTHESIA|NON-SMALL CELL LUNG CANCER STAGE IV|PAIN|ANXIETY|HYPOAESTHESIA|INFECTION,General physical health deterioration,1,1
12888023,20161027,Atezolizumab,39,801,39.0,2,91,1,0,1,0,0,0,0,Atezolizumab,PALONOSETRON|PALONOSETRON HYDROCHLORIDE|ATEZOLIZUMAB|OXYCODONE|LORATADINE|LORATADINE ORAL|OXYCODONE|TELMISARTAN|PACLITAXEL|CARBOPLATIN|RANITIDINE,13,BACK PAIN|PROPHYLAXIS|MUSCULOSKELETAL PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|MUSCULOSKELETAL PAIN|BACK PAIN|HYPERTENSION|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Upper respiratory tract infection,1,1
12889759,20161027,Atezolizumab,80,801,80.0,2,48,1,0,0,0,0,0,0,Atezolizumab,CARBOPLATIN|APREPITANT|ATEZOLIZUMAB|PACLITAXEL|APREPITANT|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE,18,NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLACTIC CHEMOTHERAPY|PROPHYLAXIS|COUGH|GASTRITIS|VERTIGO|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLACTIC CHEMOTHERAPY|PROPHYLACTIC CHEMOTHERAPY|PAIN|PROPHYLACTIC CHEMOTHERAPY|VITAMIN B12 DEFICIENCY,Infusion related reaction,1,1
12891677,20161028,Atezolizumab,59,801,59.0,1,97,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB|CALCIUM GLUCONATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CAPECITABINE|AMLODIPINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|GRANISETRON|GRANISETRON HYDROCHLORIDE|CALCIUM GLUCONATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|LANSOPRAZOLE|CALCIUM GLUCONATE|CALCIUM GLUCONATE|GRANISETRON|GRANISETRON HYDROCHLORIDE|CALCIUM GLUCONATE|CALCIUM GLUCONATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|GRANISETRON|GRANISETRON HYDROCHLORIDE|BEVACIZUMAB|CALCIUM GLUCONATE|CALCIUM GLUCONATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|GRANISETRON|GRANISETRON HYDROCHLORIDE,82,COLORECTAL CANCER METASTATIC|PREMEDICATION|COLORECTAL CANCER METASTATIC|HYPERTENSION|VISION BLURRED|CHEST PAIN|VISION BLURRED|NAUSEA|CONJUNCTIVITIS|PREMEDICATION|DIARRHOEA|OROPHARYNGEAL PAIN|MUCOSAL INFLAMMATION|OROPHARYNGEAL PAIN|COLORECTAL CANCER METASTATIC|PREMEDICATION|PREMEDICATION|VISION BLURRED|PREMEDICATION,Blood triglycerides increased|Blood lactate dehydrogenase increased,2,1
12893674,20161028,Atezolizumab,50,801,50.0,1,65,1,1,0,0,0,0,0,Atezolizumab,DEXTROSE ANHYDROUS|DEXTROSE ANHYDROUS|ETOPOSIDE|CARBOPLATIN|ATEZOLIZUMAB,9,PROPHYLAXIS OF NAUSEA AND VOMITING|DEHYDRATION|VOMITING|DEHYDRATION|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|VOMITING,Death,1,1
12894496,20161028,Atezolizumab,67,801,67.0,1,66.8,1,0,1,0,0,0,0,Atezolizumab,LOSARTAN POTASSIUM|ESOMEPRAZOLE MAGNESIUM|ATORVASTATIN CALCIUM|ATEZOLIZUMAB|DULOXETINE HYDROCHLORIDE|FLUCONAZOLE|FLUCONAZOLE|FLUCONAZOLE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|DULOXETINE HYDROCHLORIDE|ESOMEPRAZOLE MAGNESIUM,38,HYPERTENSION|UPPER RESPIRATORY TRACT INFECTION|HYPERTENSION|HICCUPS|PANCREATIC CARCINOMA|NEUROPATHY PERIPHERAL|DECREASED APPETITE|OESOPHAGEAL CANDIDIASIS|HICCUPS|OESOPHAGEAL CANDIDIASIS|PROPHYLAXIS|VOMITING|PANCREATIC CARCINOMA|PANCREATIC CARCINOMA|DIABETES MELLITUS|PROPHYLAXIS|UPPER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|UPPER RESPIRATORY TRACT INFECTION|DIABETES MELLITUS|PROPHYLAXIS|PROPHYLAXIS|UPPER RESPIRATORY TRACT INFECTION|UPPER RESPIRATORY TRACT INFECTION,Dysphagia,1,1
12897473,20161031,Atezolizumab,,,,1,,1,1,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB,1,TRANSITIONAL CELL CARCINOMA,Abdominal pain|Death,2,1
12898048,20161031,Atezolizumab,,,,2,,1,0,0,0,0,0,1,Atezolizumab,ATEZOLIZUMAB,1,BLADDER CANCER,Peripheral swelling,1,1
12898310,20161031,Atezolizumab,61,801,61.0,2,59,1,1,0,0,0,0,0,Atezolizumab,NAPROXEN|NAPROXEN SODIUM|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|ENALAPRIL|PEMETREXED|PEMETREXED DISODIUM|FOLIC ACID|CISPLATIN|GRANISETRON|GRANISETRON HYDROCHLORIDE|ATEZOLIZUMAB|APREPITANT,14,PYREXIA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|HYPERTENSION|NON-SMALL CELL LUNG CANCER STAGE IV|PYREXIA|PROPHYLAXIS|PROPHYLAXIS|DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLACTIC CHEMOTHERAPY|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|PROPHYLACTIC CHEMOTHERAPY|PYREXIA,Death,1,1
12898738,20161101,Atezolizumab,70,801,70.0,2,69.3,1,0,1,0,0,0,0,Atezolizumab,ATEZOLIZUMAB|PACLITAXEL|CARBOPLATIN,4,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|ANAEMIA,Haematochezia|Lethargy,2,1
12898996,20161101,Atezolizumab,64,801,64.0,1,82.8,1,0,1,0,0,0,0,Atezolizumab,"AMLODIPINE|ATEZOLIZUMAB|ROSUVASTATIN|LABETALOL|BEVACIZUMAB|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ERGOCALCIFEROL|CLONIDINE|PREDNISONE|PREDNISONE|LEVOTHYROXINE SODIUM|CALCITRIOL|CALCITRIOL CAPSULES 0.25 MCG|CALCITRIOL CAPSULES 0.5 MCG",21,HYPERLIPIDAEMIA|NASAL POLYPS|BLOOD POTASSIUM INCREASED|HYPERTENSION|SKIN INFECTION|CLEAR CELL RENAL CELL CARCINOMA|BLOOD CHOLESTEROL|HYPERTENSION|CLEAR CELL RENAL CELL CARCINOMA|CHRONIC KIDNEY DISEASE|GASTROOESOPHAGEAL REFLUX DISEASE|PAIN|RAYNAUD^S PHENOMENON|SUPPLEMENTATION THERAPY|HYPERTENSION|NEPHRITIS|ACUTE KIDNEY INJURY|NASAL POLYPS|HYPOTHYROIDISM|SUPPLEMENTATION THERAPY,Oedema|Fatigue,2,1
10300092,20140711,Durvalumab,76,801,76.0,1,73.9,1,0,1,0,0,0,0,Durvalumab,"PROCHLORPERAZINE MALEATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LISINOPRIL|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|PROCHLORPERAZINE MALEATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|TRAMETINIB|MINOCYCLINE|SIMVASTATIN|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN PHOSPHATE GEL USP, 1%|CLINDAMYCIN PHOSPHATE TOPICAL",12,VOMITING|RASH|METASTATIC MALIGNANT MELANOMA|HYPERTENSION|DIARRHOEA|NAUSEA|GASTROOESOPHAGEAL REFLUX DISEASE|RASH|METASTATIC MALIGNANT MELANOMA|RASH|BLOOD CHOLESTEROL|RASH,Chills|Malaise|Diarrhoea|Fatigue|Haemoglobin decreased|Haematocrit decreased|Pyrexia|Atelectasis|Blood sodium decreased|Blood calcium decreased|Blood magnesium decreased,11,1
10465009,20140919,Durvalumab,57,801,57.0,1,102,1,0,1,0,0,0,1,Durvalumab,DABRAFENIB|TRAMETINIB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Electrocardiogram repolarisation abnormality,1,1
10496130,20141003,Durvalumab,,,,0,,1,0,1,0,0,0,1,Durvalumab,TRAMETINIB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Transaminases increased|Pneumonia,2,1
10516673,20141014,Durvalumab,,,,0,,1,0,0,0,0,0,1,Durvalumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ALBUTEROL SULFATE|ALBUTEROL|TRAMETINIB|TIOTROPIUM BROMIDE|RAMIPRIL,7,HYPERCHOLESTEROLAEMIA|PROPHYLAXIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|MALIGNANT MELANOMA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|MALIGNANT MELANOMA|HYPERTENSION,Ejection fraction decreased,1,1
10516779,20141014,Durvalumab,32,801,32.0,1,,1,0,1,0,0,0,1,Durvalumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|TRAMETINIB|DABRAFENIB",6,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Multi-organ failure,1,1
10520352,20141015,Durvalumab,77,801,77.0,1,152,1,0,1,0,0,0,0,Durvalumab,TRAMETINIB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pyrexia,1,1
10565742,20141105,Durvalumab,56,801,56.0,1,100,1,0,1,1,0,0,1,Durvalumab,DABRAFENIB|TRAMETINIB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Hypotension|Pyrexia|Acute kidney injury|Transaminases increased|Disseminated intravascular coagulation,5,1
10570667,20141104,Durvalumab,56,801,56.0,1,99.79,1,0,1,1,0,0,0,Durvalumab,DABRAFENIB|TRAMETINIB,3,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Hypotension|Blast cells absent|Multi-organ failure|Red blood cell schistocytes present|Shift to the left|Thrombocytopenia|Pyrexia|Disseminated intravascular coagulation|Normochromic normocytic anaemia|Neutrophilia|Sepsis,11,3
10591742,20141118,Durvalumab,76,801,76.0,1,67,1,0,1,0,0,0,0,Durvalumab,LISINOPRIL|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,5,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Alanine aminotransferase increased|Aspartate aminotransferase increased|Pyrexia,3,1
10617335,20141201,Durvalumab,46,801,46.0,1,92.2,1,0,1,0,0,0,0,Durvalumab,TRAMETINIB|BIOTIN|CALCIUM CARBONATE|ANTACID|DABRAFENIB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,12,METASTATIC MALIGNANT MELANOMA|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|METASTATIC MALIGNANT MELANOMA|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|PYREXIA|METASTATIC MALIGNANT MELANOMA|SUPPLEMENTATION THERAPY,Febrile neutropenia,1,1
10636088,20141205,Durvalumab,57,801,57.0,1,95,1,0,1,0,0,0,0,Durvalumab,DABRAFENIB|TRAMETINIB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Abdominal pain,1,1
10707512,20150113,Durvalumab,58,801,58.0,1,,1,0,1,0,0,0,1,Durvalumab,DABRAFENIB|TRAMETINIB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Oedema|Renal failure|Dyspnoea,3,1
11010560,20150410,Durvalumab,68,801,68.0,1,74,1,0,1,0,0,0,0,Durvalumab,"LATANOPROST|PREDNISONE|BACLOFEN|SIMVASTATIN|METOPROLOL TARTRATE|METOPROLOL|METRONIDAZOLE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ALBUTEROL SULFATE|ALBUTEROL|CEFEPIME HYDROCHLORIDE|CEFEPIME|TREMELIMUMAB|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|PANTOPRAZOLE|LOSARTAN|CLOPIDOGREL|GABAPENTIN",20,NON-SMALL CELL LUNG CANCER|DYSPNOEA|NON-SMALL CELL LUNG CANCER,Hyponatraemia|Hypotension,2,1
11082805,20150501,Durvalumab,83,801,83.0,2,,1,0,1,0,0,0,0,Durvalumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|ERGOCALCIFEROL|ROSUVASTATIN|VALSARTAN|ESCITALOPRAM|ESOMEPRAZOLE MAGNESIUM|IBRUTINIB|FENOFIBRATE|IBRUTINIB|VALACYCLOVIR HYDROCHLORIDE,13,PROPHYLAXIS|HYPERTENSION|VITAMIN SUPPLEMENTATION|HYPERCHOLESTEROLAEMIA|HYPERTENSION|DEPRESSION|GASTROOESOPHAGEAL REFLUX DISEASE|LUNG ADENOCARCINOMA|HYPERCHOLESTEROLAEMIA|LUNG ADENOCARCINOMA|STOMATITIS,Rhabdomyolysis|Rash maculo-papular|Pulmonary embolism|Pyrexia|Pyelonephritis,5,1
11083823,20150501,Durvalumab,66,801,66.0,2,,1,0,1,0,0,0,0,Durvalumab,"TRAMETINIB|LORAZEPAM|LORAZEPAM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ROSUVASTATIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DABRAFENIB|LORAZEPAM|LEVOTHYROXINE",13,MALIGNANT MELANOMA|VOMITING|DRY EYE|ANXIETY|HEADACHE|MALIGNANT MELANOMA|BLOOD CHOLESTEROL INCREASED|GASTROOESOPHAGEAL REFLUX DISEASE|MALIGNANT MELANOMA|NAUSEA|HYPOTHYROIDISM,Dizziness|Nausea|Vomiting,3,1
11151335,20150601,Durvalumab,64,801,64.0,1,,1,0,1,0,0,0,0,Durvalumab,"CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|ERYTHROMYCIN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|CALCITRIOL|CALCITRIOL CAPSULES 0.25 MCG|CALCITRIOL CAPSULES 0.5 MCG|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|RIVAROXABAN|IBRUTINIB|IBRUTINIB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ERYTHROMYCIN|TESTOSTERONE|TESTOSTERONE,|CLOTRIMAZOLE|DRS. CLOTRIMAZOLE|FAMILY WELLNESS CLOTRIMAZOLE|CLOTRIMAZOLE TOPICAL|PANCRELIPASE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|HYDROXYCHLOROQUINE|DICYCLOMINE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PACLITAXEL|RIVAROXABAN|FENOFIBRATE|LOPERAMIDE HYDROCHLORIDE",29,NEOPLASM|NEOPLASM|DEEP VEIN THROMBOSIS,Gastrointestinal haemorrhage,1,1
11151795,20150601,Durvalumab,28,801,28.0,2,,1,1,1,0,0,0,1,Durvalumab,DABRAFENIB|TRAMETINIB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Malignant neoplasm progression|Eye oedema,2,1
11238190,20150703,Durvalumab,64,801,64.0,2,91.4,1,0,0,0,0,0,1,Durvalumab,"TRAMETINIB|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|DESONIDE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MINOCYCLINE|METRONIDAZOLE|METRONIDAZOLE TOPICAL",9,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Atrial fibrillation|Ejection fraction decreased,2,1
11420717,20150826,Durvalumab,50,801,50.0,1,80,1,0,1,0,0,0,1,Durvalumab,"MORPHINE SULFATE|DABRAFENIB|FAMOTIDINE|LEVETIRACETAM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|MORPHINE SULFATE|TRAMETINIB",11,PREMEDICATION|TUMOUR PAIN|METASTATIC MALIGNANT MELANOMA|PREMEDICATION|PROPHYLAXIS|METASTATIC MALIGNANT MELANOMA|HEADACHE|TUMOUR PAIN|PREMEDICATION|NEUROPATHY PERIPHERAL|METASTATIC MALIGNANT MELANOMA,Haemorrhage intracranial,1,1
11432406,20150828,Durvalumab,76,801,76.0,2,57.14,1,1,1,0,0,0,0,Durvalumab,"IBRUTINIB|LEVOTHYROXINE SODIUM|METRONIDAZOLE|METRONIDAZOLE TOPICAL|PREDNISONE|PROCHLORPERAZINE|IBRUTINIB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|BUPROPION HYDROCHLORIDE|OMEPRAZOLE MAGNESIUM|PANCRELIPASE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LOSARTAN POTASSIUM|RIVAROXABAN|MINOCYCLINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METHYLPHENIDATE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CAPECITABINE|GABAPENTIN",26,PANCREATIC CARCINOMA METASTATIC|PAIN|HYPOTHYROIDISM|PANCREATIC CARCINOMA METASTATIC|NAUSEA|DEPRESSION|NAUSEA|SLEEP DISORDER|DEEP VEIN THROMBOSIS|ASTHENIA|VOMITING,Urinary tract obstruction|Pancreatic carcinoma|Haematuria|Abdominal pain,4,1
11572863,20150929,Durvalumab,66,801,66.0,1,55.19,1,0,1,0,0,0,0,Durvalumab,SIMVASTATIN|LISINOPRIL|ALLOPURINOL|LORAZEPAM|METOPROLOL TARTRATE|METOPROLOL|IBRUTINIB|IBRUTINIB,11,NEOPLASM|NEOPLASM,Muscular weakness|Diarrhoea|Dehydration,3,1
11662189,20151026,Durvalumab,,,,0,,1,0,1,0,0,0,0,Durvalumab,TRAMETINIB|DABRAFENIB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Dyspnoea|Renal failure|Blood glucose increased|Oedema,4,1
11687109,20151030,Durvalumab,48,801,48.0,2,138.4,1,0,1,0,0,0,0,Durvalumab,"THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|BIOTIN|ERGOCALCIFEROL|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|IBRUTINIB|IBRUTINIB|CALCIUM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|IBRUTINIB|IBRUTINIB|LORAZEPAM",13,NEOPLASM|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|CYSTITIS|NEOPLASM|NEOPLASM|SUPPLEMENTATION THERAPY|ARTHRALGIA|NEOPLASM|NEOPLASM|ANXIETY|NEOPLASM,Hypotension|Rash maculo-papular,2,1
11687770,20151030,Durvalumab,31,801,31.0,2,62.3,1,0,1,0,0,0,0,Durvalumab,"CLONAZEPAM|LIDOCAINE PATCH 5%|DULOXETINE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL|XYLOMETAZOLINE HYDROCHLORIDE|IBRUTINIB|GABAPENTIN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|IBRUTINIB|CLONAZEPAM|CYCLOBENZAPRINE|ESCITALOPRAM|NAPROXEN|NAPROXEN SODIUM|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|CLONAZEPAM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FAMOTIDINE|LEVOTHYROXINE SODIUM",25,NEOPLASM|INSOMNIA|PAIN|DIARRHOEA|GASTROOESOPHAGEAL REFLUX DISEASE|NASAL CONGESTION|NEOPLASM|NEUROPATHY PERIPHERAL|PAIN|SINUS DISORDER|PAIN|PROPHYLAXIS OF NAUSEA AND VOMITING|NEOPLASM|ANXIETY|MUSCLE SPASMS|PAIN|PAIN|PAIN|SLEEP DISORDER|PYREXIA|GASTROOESOPHAGEAL REFLUX DISEASE|THYROID DISORDER,Pyrexia|Asthenia|Hypotension|Myalgia,4,1
11753288,20151119,Durvalumab,58,801,58.0,1,95,1,0,1,0,0,0,0,Durvalumab,DABRAFENIB|TRAMETINIB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Abdominal pain,1,1
11784397,20151129,Durvalumab,50,801,50.0,1,80,1,1,1,0,0,0,1,Durvalumab,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|MORPHINE SULFATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FAMOTIDINE|DIPHENHYDRAMINE HYDROCHLORIDE|LEVETIRACETAM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|MORPHINE SULFATE|DABRAFENIB",11,METASTATIC MALIGNANT MELANOMA|HEADACHE|NEUROPATHY PERIPHERAL|TUMOUR PAIN|PREMEDICATION|PREMEDICATION|METASTATIC MALIGNANT MELANOMA|PROPHYLAXIS|PREMEDICATION|TUMOUR PAIN|METASTATIC MALIGNANT MELANOMA,Haemorrhage intracranial,1,5
11806044,20151207,Durvalumab,56,801,56.0,2,57.3,1,0,1,0,0,0,0,Durvalumab,DABRAFENIB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|TRAMETINIB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,6,METASTATIC MALIGNANT MELANOMA|PROPHYLAXIS|METASTATIC MALIGNANT MELANOMA|PROPHYLAXIS|METASTATIC MALIGNANT MELANOMA|PROPHYLAXIS,Diarrhoea,1,5
11809186,20151207,Durvalumab,63,801,63.0,1,,1,0,1,0,0,0,0,Durvalumab,METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|TRAMETINIB|DABRAFENIB,5,TYPE 2 DIABETES MELLITUS|MALIGNANT MELANOMA|MALIGNANT MELANOMA|TYPE 2 DIABETES MELLITUS|MALIGNANT MELANOMA,Tubulointerstitial nephritis,1,5
11810328,20151208,Durvalumab,57,801,57.0,1,102,1,0,1,0,0,0,1,Durvalumab,TRAMETINIB|DABRAFENIB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Electrocardiogram repolarisation abnormality,1,5
11811273,20151208,Durvalumab,76,801,76.0,1,67,1,0,1,0,0,0,0,Durvalumab,PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LISINOPRIL,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA,Aspartate aminotransferase increased|Alanine aminotransferase increased|Pyrexia,3,5
11813451,20151209,Durvalumab,28,801,28.0,2,,1,1,1,0,0,0,0,Durvalumab,DABRAFENIB|TRAMETINIB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Eye oedema|Metastases to meninges,2,1
11827545,20151211,Durvalumab,59,801,59.0,1,,1,0,0,0,0,0,1,Durvalumab,TRAMETINIB|DABRAFENIB,3,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Interstitial lung disease,1,5
11829348,20151211,Durvalumab,73,801,73.0,1,88,1,0,1,0,0,0,0,Durvalumab,,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Asthenia|Syncope,2,5
11871653,20151228,Durvalumab,32,801,32.0,1,,1,0,1,0,0,0,1,Durvalumab,"DABRAFENIB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|IBUPROFEN|TRAMETINIB",6,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA,Granulomatous liver disease,1,5
11924028,20160118,Durvalumab,50,801,50.0,2,63.87,1,0,0,0,0,0,1,Durvalumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|IBRUTINIB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LEVOTHYROXINE|ESTROGENS, CONJUGATED|IBRUTINIB",7,PAIN|LYMPHOMA|PROPHYLAXIS OF NAUSEA AND VOMITING|LYMPHOMA,Alanine aminotransferase increased,1,1
11924036,20160118,Durvalumab,70,801,70.0,1,,1,0,1,0,0,0,0,Durvalumab,IBRUTINIB|EZETIMIBE AND SIMVASTATIN|HYDROCHLOROTHIAZIDE|ASCORBIC ACID|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE|IBRUTINIB,10,SUPPLEMENTATION THERAPY|HYPERCHOLESTEROLAEMIA|SUPPLEMENTATION THERAPY|HYPERTENSION|LYMPHOMA|SUPPLEMENTATION THERAPY|DIABETES MELLITUS|HYPERTENSION|LYMPHOMA,Oesophagitis,1,1
11945226,20160125,Durvalumab,71,801,71.0,1,,1,0,1,0,0,0,0,Durvalumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LORAZEPAM|IBRUTINIB|PANTOPRAZOLE|LORAZEPAM|ZOLPIDEM TARTRATE|IBRUTINIB|ACETAMINOPHEN AND CODEINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ALLOPURINOL,12,LYMPHOMA|ANXIETY|LYMPHOMA,Syncope|Oedema peripheral,2,1
11972144,20160128,Durvalumab,56,801,56.0,1,99.8,1,0,1,1,0,0,1,Durvalumab,DABRAFENIB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Transaminases increased|Disseminated intravascular coagulation|Pyrexia|Hypotension|Acute kidney injury,5,5
11977516,20160129,Durvalumab,,,,0,,1,0,0,0,0,0,0,Durvalumab,"CISPLATIN|ALPRAZOLAM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|LEVOTHYROXINE SODIUM|LORAZEPAM|DIPHENHYDRAMINE HYDROCHLORIDE|MECLIZINE HCL|MECLIZINE HCL 25MG CHEWABLE TABLETS|MECLIZINE HYDROCHLORIDE|MECLIZINE HYDROCHLORIDE CHEWABLE|FLUCONAZOLE|CARISOPRODOL|LEVALBUTEROL TARTRATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARBOPLATIN|HYDROMORPHONE HYDROCHLORIDE|SCOPOLAMINE|OXYCODONE HYDROCHLORIDE|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL|LIDOCAINE PATCH 5%|MECLIZINE HCL|MECLIZINE HCL 25MG CHEWABLE TABLETS|MECLIZINE HYDROCHLORIDE|MECLIZINE HYDROCHLORIDE CHEWABLE",29,ANAL CANCER STAGE IV|ANAL CANCER STAGE IV|NAUSEA|ANXIETY|HYPOTHYROIDISM|ANAL CANCER STAGE IV|NAUSEA|DIZZINESS|CANDIDA INFECTION|WHEEZING|ANAL CANCER STAGE IV|ANAL CANCER STAGE IV|OROPHARYNGEAL PAIN|INFECTION|ANAL CANCER STAGE IV|NAUSEA|NAUSEA,Nausea|Pain of skin|Menorrhagia|Fatigue|Somnolence|Dizziness|Constipation|Vertigo|Anxiety,9,5
12091523,20160218,Durvalumab,23517,804,64.43,2,71.2,1,1,1,0,0,0,0,Durvalumab,"GEFITINIB|ALPRAZOLAM|NAPROXEN|NAPROXEN SODIUM|GEFITINIB|GEFITINIB|ALBUTEROL SULFATE|ALBUTEROL|METHYLPREDNISOLONE|AMLODIPINE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|GEFITINIB|ALPRAZOLAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|HYDROCHLOROTHIAZIDE|CYANOCOBALAMIN",29,NON-SMALL CELL LUNG CANCER|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ANXIETY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPOKALAEMIA|NON-SMALL CELL LUNG CANCER|ANXIETY|NON-SMALL CELL LUNG CANCER|GALLBLADDER DISORDER|INCREASED APPETITE,Hypoxia|Dyspnoea,2,1
12155727,20160307,Durvalumab,74,801,74.0,1,68,1,1,1,0,0,0,1,Durvalumab,"NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|GUAIFENESIN|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|OXYCODONE|GABAPENTIN|VENLAFAXINE HYDROCHLORIDE|CEFPROZIL|MAGNESIUM|ALPRAZOLAM|ERGOCALCIFEROL|TREMELIMUMAB|RIVAROXABAN|OXYCODONE|CARVEDILOL|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",24,CHEMOTHERAPY|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|CHEMOTHERAPY|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|CHEMOTHERAPY,Confusional state|Hypotension|Pneumonia,3,1
12183763,20160316,Durvalumab,69,801,69.0,1,65.7,1,1,0,0,0,0,0,Durvalumab,FINASTERIDE|GLIPIZIDE|ZOLPIDEM TARTRATE|TREMELIMUMAB,8,BENIGN PROSTATIC HYPERPLASIA|MUSCULOSKELETAL CHEST PAIN|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|DIABETES MELLITUS|INSOMNIA|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|BENIGN PROSTATIC HYPERPLASIA|BACK PAIN,Dyspnoea,1,1
12223364,20160330,Durvalumab,,,,0,,1,0,1,0,0,0,1,Durvalumab,,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Transaminases increased|Pneumonia,2,5
12226770,20160331,Durvalumab,73,801,73.0,2,41,1,1,0,0,0,0,0,Durvalumab,IBRUTINIB|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|MORPHINE|IBRUTINIB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|LORAZEPAM,14,LYMPHOMA|PAIN|LYMPHOMA|NAUSEA|HYPERSENSITIVITY|VOMITING,Tumour rupture,1,1
12249280,20160408,Durvalumab,51,801,51.0,1,41.14,1,0,1,0,0,0,0,Durvalumab,"LORAZEPAM|MORPHINE SULFATE|IBRUTINIB|IBRUTINIB|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|BUPROPION HYDROCHLORIDE|LEVOTHYROXINE SODIUM|OXYGEN|0XYGEN|LEVOTHYROXINE SODIUM",15,PAIN|PNEUMONIA|NEOPLASM|ANXIETY|NAUSEA|PAIN|NEOPLASM|ORAL PAIN|SMOKING CESSATION THERAPY|HYPOTHYROIDISM|DYSPNOEA|VOMITING|HYPOTHYROIDISM|NEOPLASM,Diverticulitis,1,1
12249419,20160408,Durvalumab,67,801,67.0,2,,1,0,1,0,0,0,0,Durvalumab,TRAMETINIB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Pyrexia,1,5
12318298,20160429,Durvalumab,69,801,69.0,1,,1,1,1,0,0,0,0,Durvalumab,"METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|IBRUTINIB|CITALOPRAM|CITALOPRAM HYDROBROMIDE|HYDROCODONE BITARTRATE AND ACETAMINOPHEN|MAGNESIUM OXIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PROCHLORPERAZINE|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|PANTOPRAZOLE|IBRUTINIB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE",16,SUPPLEMENTATION THERAPY|DIABETES MELLITUS|NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|NEOPLASM|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|DIABETES MELLITUS|PRODUCT USED FOR UNKNOWN INDICATION|DIARRHOEA|PRODUCT USED FOR UNKNOWN INDICATION|DIARRHOEA,Constipation|Intestinal perforation,2,1
12342757,20160506,Durvalumab,61,801,61.0,2,61.22,1,0,1,0,0,0,0,Durvalumab,"SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE|FENTANYL|PREDNISONE|IBRUTINIB|ACYCLOVIR|MOMETASONE FUROATE|MOMETASONE|GABAPENTIN|IBRUTINIB|CETIRIZINE HYDROCHLORIDE|DENOSUMAB|LEVOTHYROXINE SODIUM|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|LORATADINE|LORATADINE TABLET|PROCHLORPERAZINE|ONABOTULINUMTOXINA|DIPHENHYDRAMINE HYDROCHLORIDE|LORAZEPAM|PROCHLORPERAZINE|AZELASTINE|LORAZEPAM|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ESCITALOPRAM|TRIAMCINOLONE ACETONIDE|TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%",35,PAIN|HYPOPHOSPHATAEMIA|BACK PAIN|NEOPLASM|NEOPLASM|SEASONAL ALLERGY|METASTASIS|HYPOMAGNESAEMIA|SEASONAL ALLERGY|DEPRESSION|NAUSEA|BLEPHAROSPASM|RASH MACULO-PAPULAR|BACK PAIN|VOMITING|SEASONAL ALLERGY|ANXIETY|DIARRHOEA|CONSTIPATION|RASH MACULO-PAPULAR,Metastases to meninges|Metastases to meninges,2,1
12401985,20160525,Durvalumab,60,801,60.0,2,105.9,1,0,0,0,0,0,0,Durvalumab,CLONAZEPAM|DILTIAZEM HYDROCHLORIDE|DIGOXIN|CLONAZEPAM|MELOXICAM|AMLODIPINE|ESCITALOPRAM|LISINOPRIL|TREMELIMUMAB,13,SLEEP DISORDER|HYPERCHOLESTEROLAEMIA|ATRIAL FIBRILLATION|ANXIETY|ARTHRALGIA|HYPERTENSION|DEPRESSION|HYPERTENSION|HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|ARTHRALGIA,Drug ineffective,1,1
12405276,20160525,Durvalumab,606,802,50.5,2,,1,0,0,0,0,0,1,Durvalumab,DICLOFENAC|DICLOFENAC SODIUM|TEMAZEPAM,6,RHEUMATOID ARTHRITIS|DUCTAL ADENOCARCINOMA OF PANCREAS|INSOMNIA|GASTRIC DISORDER|ABDOMINAL PAIN|CANCER PAIN,Acute kidney injury,1,1
12455086,20160610,Durvalumab,73,801,73.0,1,,1,1,1,0,0,0,0,Durvalumab,IBRUTINIB|IBRUTINIB,3,NEOPLASM|NEOPLASM,Pneumonia bacterial,1,1
12476687,20160617,Durvalumab,63,801,63.0,1,93.8,1,0,1,1,0,0,0,Durvalumab,CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|TREMELIMUMAB|TREMELIMUMAB|GABAPENTIN|OXYGEN|0XYGEN|PROCHLORPERAZINE|SERTRALINE|CEFTRIAXONE|CEFTRIAXONE SODIUM|TREMELIMUMAB|FENTANYL|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|TREMELIMUMAB|OMEPRAZOLE MAGNESIUM|OXYCODONE|LORAZEPAM|TREMELIMUMAB|FLUTICASONE PROPIONATE|FLUTICASONE PROPIONATE NASAL|LANOLIN|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|AMOXICILLIN AND CLAVULANATE POTASSIUM|MORPHINE SULFATE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|TREMELIMUMAB|OXYCODONE,39,BACK PAIN|DYSPNOEA|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|OROPHARYNGEAL PAIN|PROPHYLAXIS|OROPHARYNGEAL PAIN|REFLUX GASTRITIS|PROPHYLAXIS|OROPHARYNGEAL PAIN|PROPHYLAXIS|SEASONAL ALLERGY|PROPHYLAXIS|PROPHYLAXIS|ACNE|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|ERECTILE DYSFUNCTION,Mastoiditis|Haemoptysis,2,1
12487187,20160622,Durvalumab,24351,804,66.72,2,65.2,1,1,0,0,0,0,1,Durvalumab,GABAPENTIN|FAMOTIDINE|POLYETHYLENE GLYCOL 3350|PANTOPRAZOLE SODIUM|OLAPARIB|PAROXETINE HYDROCHLORIDE|METOPROLOL TARTRATE|METOPROLOL|TIZANIDINE HYDROCHLORIDE,14,OVARIAN CANCER|OVARIAN CANCER,Myelodysplastic syndrome|Disease progression,2,1
12504473,20160628,Durvalumab,61,801,61.0,2,,1,0,1,0,0,0,0,Durvalumab,SERTRALINE|CHOLESTYRAMINE|CARVEDILOL|PROCHLORPERAZINE|IBRUTINIB|LORAZEPAM|LIDOCAINE AND PRILOCAINE|MELATONIN|SERTRALINE|OXYCODONE|CARVEDILOL|OXYCODONE|DENOSUMAB|IBRUTINIB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,19,DEPRESSION|COLITIS MICROSCOPIC|BREAST PAIN|ATRIAL FIBRILLATION|PROPHYLAXIS|ANXIETY|DIARRHOEA|PROPHYLAXIS|INSOMNIA|ANXIETY|BREAST PAIN|PALPITATIONS|BREAST PAIN|METASTASIS|NEOPLASM|NEOPLASM|PROPHYLAXIS|BREAST PAIN,Hypoxia|Dyspnoea,2,1
12510588,20160629,Durvalumab,55,801,55.0,1,,1,0,1,0,0,0,0,Durvalumab,PROCHLORPERAZINE|LACTULOSE|HYDROMORPHONE HYDROCHLORIDE|CELECOXIB|FENTANYL|PREGABALIN|HYDROMORPHONE HYDROCHLORIDE|TREMELIMUMAB,11,CONSTIPATION|NAUSEA|CONSTIPATION|BONE PAIN|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PAIN|INSOMNIA|BONE PAIN|ANXIETY|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Somnolence,1,1
12528831,20160705,Durvalumab,65,801,65.0,2,,1,1,1,1,0,0,1,Durvalumab,IBRUTINIB|FUROSEMIDE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|POTASSIUM CHLORIDE AND SODIUM CHLORIDE|LISINOPRIL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|BIOTIN|IBRUTINIB,11,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|SUPPLEMENTATION THERAPY|CARDIAC FAILURE CONGESTIVE|HYPERTENSION|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|HYPERTENSION|PROPHYLAXIS|SUPPLEMENTATION THERAPY,Mental status changes|Purpura|Atrial fibrillation|Multiple organ dysfunction syndrome|Pneumonia,5,1
12542064,20160708,Durvalumab,47,801,47.0,1,,1,0,1,0,0,0,0,Durvalumab,MORPHINE SULFATE|RANITIDINE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ZOLEDRONIC ACID|LACTULOSE|MORPHINE SULFATE|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|TREMELIMUMAB|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|ZOLEDRONIC ACID|MAGNESIUM OXIDE,18,ABDOMINAL PAIN UPPER|NAUSEA|TUMOUR PAIN|CONSTIPATION|DECREASED APPETITE|CONSTIPATION|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|TUMOUR PAIN|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|CONSTIPATION|HYPERTENSION|HYPERCALCAEMIA|CONSTIPATION,Hyponatraemia|Tumour pain|Infection,3,1
12565700,20160718,Durvalumab,65,801,65.0,2,,1,0,1,0,0,0,0,Durvalumab,CISPLATIN|GEMCITABINE HYDROCHLORIDE|TREMELIMUMAB,4,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Embolism,1,1
12570560,20160719,Durvalumab,53,801,53.0,1,104,1,0,1,0,0,0,0,Durvalumab,GEMCITABINE HYDROCHLORIDE|TREMELIMUMAB|METOPROLOL TARTRATE|METOPROLOL|CISPLATIN|TREMELIMUMAB|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE,12,HYPERTENSION|ANTICOAGULANT THERAPY|DISEASE PROGRESSION|NON-SMALL CELL LUNG CANCER|ATRIAL FLUTTER|NON-SMALL CELL LUNG CANCER|DISEASE PROGRESSION|BRONCHITIS,Bronchitis,1,1
12583004,20160722,Durvalumab,68,801,68.0,2,52,1,0,0,0,0,0,1,Durvalumab,IBRUTINIB|LORAZEPAM|ERGOCALCIFEROL|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|ACYCLOVIR|ASCORBIC ACID|ACYCLOVIR|IBRUTINIB,11,NEOPLASM|ANXIETY|SUPPLEMENTATION THERAPY|CONSTIPATION|PROPHYLAXIS|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|VIRAL INFECTION|DEPRESSION|NEOPLASM|NEOPLASM,Pneumonitis,1,1
12587462,20160725,Durvalumab,73,801,73.0,2,,1,0,1,0,0,0,0,Durvalumab,GEMCITABINE HYDROCHLORIDE|TREMELIMUMAB|CISPLATIN,4,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Enterocolitis infectious|Urinary tract infection,2,1
12598499,20160727,Durvalumab,80,801,80.0,1,89,1,0,1,0,0,0,1,Durvalumab,LISINOPRIL|SITAGLIPTIN|INSULIN ASPART|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LISINOPRIL|METOPROLOL TARTRATE|METOPROLOL|SITAGLIPTIN|INSULIN ASPART|SITAGLIPTIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|AZACITIDINE|AZACITIDINE FOR|BISOPROLOL FUMARATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|AZACITIDINE|AZACITIDINE FOR|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|METOPROLOL TARTRATE|METOPROLOL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RIVAROXABAN|RIVAROXABAN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LACTULOSE|LACTULOSE,54,PROPHYLAXIS|TYPE 2 DIABETES MELLITUS|PROPHYLAXIS|PHLEBITIS|MYELODYSPLASTIC SYNDROME|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|TYPE 2 DIABETES MELLITUS|PROPHYLAXIS OF NAUSEA AND VOMITING|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HYPERTENSION|DIARRHOEA|PRODUCT USED FOR UNKNOWN INDICATION|MYELODYSPLASTIC SYNDROME|BACK PAIN|SUPPORTIVE CARE|INFECTION PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|INFECTION PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ATRIAL FIBRILLATION|PROPHYLAXIS AGAINST DIARRHOEA|DIARRHOEA|CONSTIPATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonia|Pulmonary oedema|Dyspnoea|Neutropenia|Urinary retention|Fluid retention,6,1
12617099,20160803,Durvalumab,65,801,65.0,2,72.19,1,0,1,0,0,0,0,Durvalumab,DURVALUMAB|POMALIDOMIDE|CALCIUM|ZOLPIDEM TARTRATE|ROSUVASTATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|VALACYCLOVIR HYDROCHLORIDE,9,PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Bone pain|Platelet count decreased|Epistaxis,3,3
12627494,20160805,Durvalumab,56,801,56.0,1,,1,0,1,0,0,0,0,Durvalumab,"TREMELIMUMAB|TREMELIMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|CEFPODOXIME PROXETIL|TREMELIMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|DEXLANSOPRAZOLE|APREPITANT|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|APREPITANT|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|MEGESTROL ACETATE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",56,OESOPHAGEAL ADENOCARCINOMA|INFECTION PROPHYLAXIS|DIARRHOEA|OESOPHAGEAL ADENOCARCINOMA|ABDOMINAL PAIN UPPER|ABDOMINAL PAIN UPPER|PREMEDICATION|ABDOMINAL PAIN UPPER|DIARRHOEA|DIARRHOEA|OESOPHAGEAL ADENOCARCINOMA|ABDOMINAL PAIN UPPER|NASOPHARYNGITIS|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|PREMEDICATION|PYREXIA|PREMEDICATION|PREMEDICATION|DECREASED APPETITE|PREMEDICATION|INFECTION PROPHYLAXIS,Pyrexia|Colitis,2,1
12649898,20160812,Durvalumab,21821,804,59.78,1,49.2,1,0,1,0,0,0,1,Durvalumab,OLAPARIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pneumonitis,1,1
12680945,20160824,Durvalumab,74,801,74.0,1,77,1,0,1,0,0,0,0,Durvalumab,"PREGABALIN|MIRTAZAPINE|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|MORPHINE|MORPHINE|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|MORPHINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIAZEPAM|PANTOPRAZOLE|CEFTRIAXONE|CEFTRIAXONE SODIUM|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|ACETYLCYSTEINE|LACTULOSE|MIRTAZAPINE",33,BACK PAIN|BACK PAIN|THROMBOSIS PROPHYLAXIS|INSOMNIA|DEPRESSION|INSOMNIA|PROPHYLAXIS|PNEUMONIA|PAIN|BACK PAIN|BACK PAIN|CONSTIPATION PROPHYLAXIS|DELIRIUM|PNEUMONIA|BACK PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|BACK PAIN|ANXIETY|GASTRITIS PROPHYLAXIS|PNEUMONIA|SECRETION DISCHARGE|PLASMA CELL MYELOMA|BACK PAIN|CONSTIPATION PROPHYLAXIS|INSOMNIA,Tumour lysis syndrome|Back pain,2,1
12696692,20160830,Durvalumab,77,801,77.0,1,,1,0,1,0,0,0,0,Durvalumab,PREDNISONE|DURVALUMAB,3,ASPARTATE AMINOTRANSFERASE INCREASED|TRANSITIONAL CELL CARCINOMA|TRANSITIONAL CELL CARCINOMA,Blood creatinine increased|Fatigue|Acute kidney injury|Hypoalbuminaemia|Dyspnoea|Oedema peripheral,6,1
12715835,20160906,Durvalumab,24925,804,68.29,1,118.5,1,0,1,0,0,0,0,Durvalumab,"OLAPARIB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DENOSUMAB|FERROUS SULFATE|GABAPENTIN|FISH OIL|CYANOCOBALAMIN|GLIPIZIDE|SERTRALINE|ZOLPIDEM TARTRATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG",18,PROSTATE CANCER|PROSTATE CANCER,Pneumonia aspiration|Vomiting|Nausea,3,1
12717792,20160906,Durvalumab,38,801,38.0,1,60.1,1,0,1,0,0,0,0,Durvalumab,PACLITAXEL|RAMUCIRUMAB|TREMELIMUMAB,10,CONSTIPATION|OESOPHAGEAL ADENOCARCINOMA|BACK PAIN|GASTRIC STENOSIS|GASTRIC ULCER|ANAEMIA|OESOPHAGEAL ADENOCARCINOMA|CONSTIPATION,Gastric perforation,1,1
12717819,20160906,Durvalumab,65,801,65.0,2,,1,0,1,0,0,0,0,Durvalumab,"TREMELIMUMAB|CARBOPLATIN|CISPLATIN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|GEMCITABINE HYDROCHLORIDE|CLONAZEPAM|PANTOPRAZOLE|PAROXETINE HYDROCHLORIDE|OLANZAPINE|MORPHINE",14,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Colitis,1,1
12718102,20160906,Durvalumab,76,801,76.0,1,80,1,1,0,0,0,0,1,Durvalumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DOXAZOSIN MESYLATE|DOXAZOSIN|THALIDOMIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LENALIDOMIDE|DOXAZOSIN|DOXAZOSIN MESYLATE|FOLIC ACID|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SPIRONOLACTONE|DUTASTERIDE|FUROSEMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TRANEXAMIC ACID|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TRIMETHOPRIM|FENTANYL|ELOTUZUMAB|PANTOPRAZOLE|PANTOPRAZOLE|FLUCONAZOLE,52,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|HYPERURICAEMIA|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|INFECTION PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|HYPERTENSION|VITAMIN SUPPLEMENTATION|AORTIC ANEURYSM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BENIGN PROSTATIC HYPERPLASIA|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ANAEMIA|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|GASTROENTERITIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BACK PAIN|PLASMA CELL MYELOMA|GASTRITIS PROPHYLAXIS|AORTIC ANEURYSM|INFECTION PROPHYLAXIS,Acute myeloid leukaemia|Plasma cell myeloma,2,3
12746331,20160915,Durvalumab,74,801,74.0,2,,1,0,1,1,0,0,0,Durvalumab,CARBOPLATIN|PROPRANOLOL HYDROCHLORIDE|DURVALUMAB|TREMELIMUMAB|ETOPOSIDE,5,SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER,Cardiac failure|Myocarditis|Diarrhoea|Nausea|Hyperthyroidism|Febrile neutropenia|Vomiting,7,1
12756427,20160916,Durvalumab,29010,804,79.48,1,73.1,1,0,1,0,0,0,0,Durvalumab,LEVOTHYROXINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALLOPURINOL|POLYETHYLENE GLYCOL 3350|METOPROLOL TARTRATE|METOPROLOL|OLAPARIB,10,PROSTATE CANCER|PROSTATE CANCER,Febrile neutropenia|Hypotension,2,1
12766688,20160921,Durvalumab,70,801,70.0,1,,1,0,1,0,0,0,0,Durvalumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|GEMCITABINE HYDROCHLORIDE|LEVOTHYROXINE SODIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CARBOPLATIN|NAPROXEN|NAPROXEN SODIUM|TREMELIMUMAB",12,BLADDER CANCER|BLADDER CANCER|BLADDER CANCER|BLADDER CANCER,Hypersensitivity|Febrile neutropenia,2,1
12775409,20160923,Durvalumab,74,801,74.0,2,,1,1,0,0,0,0,0,Durvalumab,TREMELIMUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|CARBOPLATIN|ETOPOSIDE,6,SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER,Myocarditis,1,1
12784271,20160927,Durvalumab,69,801,69.0,1,,1,0,0,1,0,0,0,Durvalumab,METOCLOPRAMIDE HYDROCHLORIDE|IBRUTINIB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|MAGNESIUM OXIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CITALOPRAM|PROCHLORPERAZINE EDISYLATE|ERGOCALCIFEROL|INSULIN GLARGINE|IBRUTINIB|PANTOPRAZOLE SODIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS,18,NEOPLASM|DIARRHOEA|NAUSEA|NEOPLASM,Supraventricular tachycardia,1,1
12786703,20160927,Durvalumab,46,801,46.0,2,56.7,1,1,0,0,0,0,0,Durvalumab,DURVALUMAB|TREMELIMUMAB|MEMANTINE HYDROCHLORIDE|MEMANTINE|MEMANTINE HYDROCHLORIDE ORAL,3,,Metastatic neoplasm,1,1
12797216,20160929,Durvalumab,46,801,46.0,2,56.7,1,1,0,0,0,0,0,Durvalumab,MEMANTINE HYDROCHLORIDE|MEMANTINE|MEMANTINE HYDROCHLORIDE ORAL|TREMELIMUMAB|DURVALUMAB,3,,Malignant neoplasm progression,1,1
12805580,20161004,Durvalumab,73,801,73.0,1,65.4,1,0,1,0,0,0,1,Durvalumab,DURVALUMAB|DURVALUMAB,5,CEREBROVASCULAR ACCIDENT PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NEOPLASM|NEOPLASM|NON-SMALL CELL LUNG CANCER,Packed red blood cell transfusion|Anaemia|Occult blood positive,3,3
12819135,20161006,Durvalumab,65,801,65.0,1,,1,1,1,0,0,0,0,Durvalumab,METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ETOPOSIDE|TREMELIMUMAB|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|AMOXICILLIN|CITALOPRAM|CITALOPRAM HYDROBROMIDE|CARBOPLATIN|RAMIPRIL|ERGOCALCIFEROL,14,SMALL CELL LUNG CANCER METASTATIC|SMALL CELL LUNG CANCER METASTATIC|SMALL CELL LUNG CANCER METASTATIC|SMALL CELL LUNG CANCER METASTATIC,Confusional state|Limbic encephalitis,2,1
12839878,20161012,Durvalumab,61,801,61.0,2,,1,1,0,0,0,0,0,Durvalumab,TREMELIMUMAB|LEVOTHYROXINE SODIUM|STANDARDIZED SENNA CONCENTRATE|NAPROXEN|NAPROXEN SODIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|GEMCITABINE HYDROCHLORIDE|CARBOPLATIN,8,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT,Sepsis,1,1
12839887,20161012,Durvalumab,81,801,81.0,1,,1,1,0,0,0,0,1,Durvalumab,"CARBOPLATIN|ETOPOSIDE|ETOPOSIDE|CARBOPLATIN|LOPERAMIDE HCL|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL|TREMELIMUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FENTANYL|AMLODIPINE BESYLATE|MAGNESIUM OXIDE|CARBOPLATIN|ETOPOSIDE|ETOPOSIDE|LACTULOSE|MEGESTROL ACETATE|ZOLPIDEM TARTRATE|CARBOPLATIN|TREMELIMUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|TREMELIMUMAB|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE|ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES",34,CHEST PAIN|CONSTIPATION|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|COUGH|DIARRHOEA|DYSPEPSIA|SMALL CELL LUNG CANCER|PROPHYLAXIS|CHEST PAIN|CHEST PAIN|COUGH|HYPERTENSION|CONSTIPATION|SMALL CELL LUNG CANCER|PROPHYLAXIS|CONSTIPATION|DECREASED APPETITE|DIARRHOEA|INSOMNIA|DIARRHOEA|CHEST PAIN|DYSPEPSIA,Neutrophil count decreased|Pneumonia,2,1
12841361,20161012,Durvalumab,60,801,60.0,1,157.5,1,0,1,0,0,0,1,Durvalumab,"DARATUMUMAB|OXYCODONE|POLYETHYLENE GLYCOL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|VALSARTAN|VALSARTAN ORAL|ALBUTEROL SULFATE|ALBUTEROL|ALLOPURINOL|MULTIVITAMIN|PROCHLORPERAZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FENTANYL|MONTELUKAST|SCOPOLAMINE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ENOXAPARIN SODIUM|HYDROCHLOROTHIAZIDE|MORPHINE|LORAZEPAM|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|FUROSEMIDE|DARATUMUMAB|SENNOSIDES|SENNA LEAF|SENNA|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",36,BONE PAIN|CONSTIPATION|CELLULITIS|DYSPEPSIA|HYPERTENSION|DYSPNOEA|PROPHYLAXIS|VOMITING|ROUTINE HEALTH MAINTENANCE|PROPHYLAXIS|NAUSEA|PROPHYLAXIS|DYSPEPSIA|PAIN MANAGEMENT|PROPHYLAXIS|PLASMA CELL MYELOMA|NAUSEA|PAIN MANAGEMENT|PAIN|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|HYPERTENSION|PAIN MANAGEMENT|ANXIETY|NAUSEA|FLUID RETENTION|PLASMA CELL MYELOMA|HYPERCALCAEMIA|INSOMNIA|HYPOKALAEMIA,Muscle twitching|Hallucination|Tumour lysis syndrome|Memory impairment,4,3
12852450,20161017,Durvalumab,60,801,60.0,1,,1,0,1,0,0,0,0,Durvalumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CALCIUM GLUCONATE|DARATUMUMAB|POMALIDOMIDE|OXYCODONE|MORPHINE|DURVALUMAB|VALSARTAN|VALSARTAN ORAL|VALSARTAN|VALSARTAN ORAL|CALCIUM ACETATE|CALCIUM ACETATE CAPSULES 667 MG|ENOXAPARIN SODIUM|LORAZEPAM|MONTELUKAST|HYDROCHLOROTHIAZIDE|ACYCLOVIR|VALSARTAN|VALSARTAN ORAL|VALSARTAN|VALSARTAN ORAL|SENNOSIDES|SENNA LEAF|SENNA|ALBUTEROL SULFATE|ALBUTEROL|ALBUTEROL SULFATE|ALBUTEROL|ALLOPURINOL|DARATUMUMAB|LORAZEPAM|DURVALUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACYCLOVIR,33,PROPHYLAXIS|HYPERKALAEMIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|HYPERCALCAEMIA|BONE PAIN|PAIN MANAGEMENT|PLASMA CELL MYELOMA|PROPHYLAXIS|HYPERTENSION|BLOOD PHOSPHORUS INCREASED|PROPHYLAXIS|NAUSEA|PROPHYLAXIS|HYPERTENSION|PROPHYLAXIS|NAUSEA|PROPHYLAXIS|PROPHYLAXIS|HYPERTENSION|ROUTINE HEALTH MAINTENANCE|INSOMNIA|ANAPHYLACTIC REACTION|DYSPNOEA|PROPHYLAXIS|DYSPEPSIA|PLASMA CELL MYELOMA|ANXIETY|NAUSEA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS,Cellulitis streptococcal|Oedema peripheral,2,3
12853262,20161017,Durvalumab,39,801,39.0,2,65.9,1,1,1,0,0,0,0,Durvalumab,"ALPRAZOLAM|HYDROMORPHONE HYDROCHLORIDE|MORPHINE|IBRUTINIB|MORPHINE|POLYETHYLENE GLYCOL 3350|ALBUTEROL SULFATE|ALBUTEROL|HYDROMORPHONE HYDROCHLORIDE|METOCLOPRAMIDE HYDROCHLORIDE|LORAZEPAM|ALPRAZOLAM|DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE|DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE|IBRUTINIB",24,INSOMNIA|NON-CARDIAC CHEST PAIN|MUSCULOSKELETAL PAIN|NEOPLASM|NON-CARDIAC CHEST PAIN|CONSTIPATION|NEOPLASM|BLOOD CREATININE INCREASED|DYSPNOEA|SUPPLEMENTATION THERAPY|MUSCULOSKELETAL PAIN|ABDOMINAL PAIN|ANXIETY|ANXIETY|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|CONSTIPATION|ATTENTION DEFICIT HYPERACTIVITY DISORDER|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|URINARY TRACT INFECTION|NEOPLASM|NON-CARDIAC CHEST PAIN,Neoplasm,1,1
12858273,20161018,Durvalumab,60,801,60.0,1,,1,0,1,0,0,0,1,Durvalumab,"SENNOSIDES|SENNA LEAF|SENNA|ENOXAPARIN SODIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|DARATUMUMAB|DARATUMUMAB|HYDROCHLOROTHIAZIDE|MORPHINE|ALBUTEROL SULFATE|ALBUTEROL|LORAZEPAM|MEPERIDINE HYDROCHLORIDE|MONTELUKAST|DURVALUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXYCODONE|FENTANYL|POMALIDOMIDE|POMALIDOMIDE|VALSARTAN|VALSARTAN ORAL|ALLOPURINOL",25,INSOMNIA|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PAIN MANAGEMENT|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|HYPERTENSION|PAIN MANAGEMENT|DYSPNOEA|ANXIETY|HYPERCALCAEMIA|PAIN|PROPHYLAXIS|NAUSEA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|BONE PAIN|PAIN MANAGEMENT|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|HYPERTENSION|NAUSEA|PROPHYLAXIS,Tumour lysis syndrome|Muscle twitching|Memory impairment|Hallucination,4,3
12860660,20161019,Durvalumab,67,801,67.0,1,,1,0,1,0,0,0,1,Durvalumab,"TREMELIMUMAB|LISINOPRIL|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|OMEPRAZOLE MAGNESIUM|FISH OIL|TREMELIMUMAB|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE",12,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|HYPERLIPIDAEMIA|PAIN|GASTROOESOPHAGEAL REFLUX DISEASE|NUTRITIONAL SUPPLEMENTATION|PROPHYLAXIS|SEASONAL ALLERGY,Acute kidney injury,1,1
12862550,20161019,Durvalumab,62,801,62.0,2,,1,0,1,0,0,0,0,Durvalumab,"TREMELIMUMAB|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|STANDARDIZED SENNA CONCENTRATE|LACTULOSE|ALBUTEROL SULFATE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|ETOPOSIDE|TOBRAMYCIN|TOBRAMYCIN SULFATE|TOBRAMYCIN SOLUTION|CARBOPLATIN|DALTEPARIN SODIUM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",15,SMALL CELL LUNG CANCER METASTATIC|SMALL CELL LUNG CANCER METASTATIC|SMALL CELL LUNG CANCER METASTATIC|SMALL CELL LUNG CANCER METASTATIC,Pneumonia|Dyspnoea,2,1
12873531,20161021,Durvalumab,59,801,59.0,2,,1,1,1,0,0,0,0,Durvalumab,FILGRASTIM|OLAPARIB|OLAPARIB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|TOPOTECAN,16,ABDOMINAL PAIN|SMALL CELL LUNG CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING|DIARRHOEA|PROPHYLAXIS|IRRITABLE BOWEL SYNDROME|ABDOMINAL PAIN|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|ANXIETY|DIARRHOEA|ABDOMINAL PAIN|ABDOMINAL PAIN|DISEASE PROGRESSION|SMALL CELL LUNG CANCER|IRRITABLE BOWEL SYNDROME,Pancytopenia,1,1
12880548,20161025,Durvalumab,63,801,63.0,2,50.3,1,0,1,0,0,0,0,Durvalumab,"SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PANTOPRAZOLE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|TREMELIMUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MORPHINE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|DEXTROSE MONOHYDRATE|DEXTROSE|ERLOTINIB HYDROCHLORIDE|FAMOTIDINE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|GUAIFENESIN|PREDNISONE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ENOXAPARIN SODIUM|GLUCAGON|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR",22,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|SINUSITIS|BIOPSY|SINUSITIS,Pancreatitis|Colitis,2,1
12880557,20161025,Durvalumab,65,801,65.0,1,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|GLYBURIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CARBOPLATIN|ETOPOSIDE|FOLIC ACID,10,SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER,Myocardial infarction,1,1
12912685,20161104,Durvalumab,56,801,56.0,2,,1,0,1,0,0,0,0,Durvalumab,GLYCERIN|GLYCERIN SUPPOSITORIES|TREMELIMUMAB|MAGNESIUM OXIDE|MIRTAZAPINE|KETOPROFEN|AMPHOTERICIN B|TREMELIMUMAB|TREMELIMUMAB|MORPHINE SULFATE|WHITE PETROLATUM|PETROLATUM|SKIN PROTECTANT|AMPHOTERICIN B|FUROSEMIDE|MEROPENEM|MEROPENEM|LANSOPRAZOLE|TREMELIMUMAB|PREGABALIN|FAMOTIDINE,63,OSTEOPOROSIS PROPHYLAXIS|INFECTION PROPHYLAXIS|DIARRHOEA|PREMEDICATION|PROCTALGIA|CONSTIPATION|INSOMNIA|CANCER PAIN|HYPOTHYROIDISM|VOMITING|DIARRHOEA|VOMITING|NON-SMALL CELL LUNG CANCER|PNEUMOCYSTIS JIROVECII PNEUMONIA|DRY SKIN|PYREXIA|PREMEDICATION|DIARRHOEA|OROPHARYNGEAL PAIN|STOMATITIS|HYPOTHYROIDISM|NON-SMALL CELL LUNG CANCER|OEDEMA|NON-SMALL CELL LUNG CANCER|INSOMNIA|NON-SMALL CELL LUNG CANCER|OROPHARYNGEAL PAIN|ENTEROCOLITIS|DRY SKIN|ORAL CANDIDIASIS|OEDEMA|NEURALGIA|INFECTION PROPHYLAXIS|OEDEMA|GASTROOESOPHAGEAL REFLUX DISEASE|DIARRHOEA|DIARRHOEA|ENTEROCOLITIS|NEUTROPENIA|NEURALGIA|NEURALGIA|DIARRHOEA|PREMEDICATION|GASTROOESOPHAGEAL REFLUX DISEASE,Oedema peripheral|Enterocolitis|Neutropenia,3,1
12912828,20161104,Durvalumab,78,801,78.0,1,113.6,1,0,1,0,0,0,0,Durvalumab,ACYCLOVIR|CARFILZOMIB|FUROSEMIDE|FUROSEMIDE|POMALIDOMIDE|WARFARIN,13,PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Respiratory failure|Atrial fibrillation,2,3
12933181,20161111,Durvalumab,70,801,70.0,1,,1,0,1,1,1,0,1,Durvalumab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|PEMETREXED|PEMETREXED DISODIUM|CARBOPLATIN|PACLITAXEL|CISPLATIN|TREMELIMUMAB,7,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Ischaemic stroke,1,1
12980768,20161128,Durvalumab,64,801,64.0,1,65,1,0,1,0,0,0,0,Durvalumab,AMLODIPINE|TREMELIMUMAB,5,LUNG INFECTION|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NON-SMALL CELL LUNG CANCER,Drug ineffective,1,1
12997087,20161205,Durvalumab,63,802,5.25,1,,1,0,1,0,0,0,1,Durvalumab,CARBOPLATIN|TREMELIMUMAB|ETOPOSIDE|ETOPOSIDE|ETOPOSIDE|ETOPOSIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ETOPOSIDE|CARBOPLATIN|ETOPOSIDE|TREMELIMUMAB|ETOPOSIDE|ETOPOSIDE|FAMOTIDINE|CARBOPLATIN|TREMELIMUMAB|ETOPOSIDE|CARBOPLATIN|TREMELIMUMAB|ETOPOSIDE|ETOPOSIDE|ETOPOSIDE|CLOPIDOGREL,34,SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|PREMEDICATION|PREMEDICATION|PREMEDICATION|ACUTE MYOCARDIAL INFARCTION|DECREASED APPETITE|PREMEDICATION|PREMEDICATION|SMALL CELL LUNG CANCER|ACUTE MYOCARDIAL INFARCTION|ACUTE MYOCARDIAL INFARCTION|DYSLIPIDAEMIA,Autoimmune hepatitis,1,1
13001796,20161206,Durvalumab,76,801,76.0,1,,1,0,1,0,0,0,0,Durvalumab,CISPLATIN|CLOTRIMAZOLE|DRS. CLOTRIMAZOLE|FAMILY WELLNESS CLOTRIMAZOLE|CLOTRIMAZOLE TOPICAL|GEMCITABINE HYDROCHLORIDE|MOMETASONE|CARBOPLATIN|IRBESARTAN|ERGOCALCIFEROL|FUROSEMIDE|TREMELIMUMAB|PANTOPRAZOLE,12,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Dyspnoea,1,1
13024249,20161213,Durvalumab,,,,0,,1,0,0,0,0,0,1,Durvalumab,PACLITAXEL|CARBOPLATIN,3,NEOPLASM|NEOPLASM|NEOPLASM,Hepatitis,1,1
13037233,20161216,Durvalumab,72,801,72.0,1,66,1,1,1,0,0,0,0,Durvalumab,PACLITAXEL,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Performance status decreased,1,3
13040325,20161219,Durvalumab,70,801,70.0,1,,1,0,0,0,0,0,1,Durvalumab,PROCHLORPERAZINE|GEMCITABINE HYDROCHLORIDE|OXYCODONE|CISPLATIN|TREMELIMUMAB,9,BLADDER CANCER|BLADDER CANCER|BLADDER CANCER|BLADDER CANCER,Hypothyroidism|Hypophysitis|Adrenal insufficiency,3,1
13046878,20161220,Durvalumab,75,801,75.0,2,67.6,1,1,1,0,0,0,0,Durvalumab,MAGNESIUM HYDROXIDE|AMLODIPINE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PEGFILGRASTIM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|LORAZEPAM,29,PROPHYLAXIS|HYPERTENSION|PROPHYLAXIS|PROPHYLAXIS|INFECTION PROPHYLAXIS|BONE DISORDER|GASTROENTERITIS|THROMBOSIS PROPHYLAXIS|PAIN|BACK PAIN|PROPHYLAXIS OF NAUSEA AND VOMITING|THROMBOSIS PROPHYLAXIS|PLASMA CELL MYELOMA|UROSEPSIS|UROSEPSIS|PLASMA CELL MYELOMA|HYPOKALAEMIA|PLASMA CELL MYELOMA|ANXIETY,Urinary tract infection|Delirium|Respiratory tract infection|Gastroenteritis,4,3
13048508,20161221,Durvalumab,71,801,71.0,1,,1,0,1,1,0,0,0,Durvalumab,,2,ACUTE MYELOID LEUKAEMIA|ACUTE MYELOID LEUKAEMIA,Pneumonitis,1,3
13059681,20161223,Durvalumab,73,801,73.0,1,66.2,1,1,1,0,0,0,0,Durvalumab,METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|BISOPROLOL FUMARATE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|RAMIPRIL,8,DIABETES MELLITUS|MYELODYSPLASTIC SYNDROME|HYPERTENSION|ISCHAEMIC CARDIOMYOPATHY|INFECTION PROPHYLAXIS|MYELODYSPLASTIC SYNDROME|HYPERTENSION|HYPERTENSION,Septic shock,1,3
13076548,20161230,Durvalumab,58,801,58.0,1,,1,0,1,0,0,0,0,Durvalumab,"OXYCODONE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|IBRUTINIB|MOMETASONE FUROATE|MOMETASONE|NAPROXEN|NAPROXEN SODIUM|IBRUTINIB|LORAZEPAM|LOPERAMIDE HCL|NAPROXEN|NAPROXEN SODIUM|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OXYCODONE|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|PSYLLIUM HUSK|NAPROXEN|NAPROXEN SODIUM|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|TRIAMCINOLONE ACETONIDE|TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%|ZOLPIDEM TARTRATE|LORAZEPAM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED",42,CHEST DISCOMFORT|ANXIETY|CHEST DISCOMFORT|EAR PAIN|BACK PAIN|HYPOKALAEMIA|NEOPLASM|NEOPLASM|METASTASES TO BONE|SEASONAL ALLERGY|INSOMNIA|CHEST PAIN|CHEST PAIN|NEOPLASM|ANXIETY|DIARRHOEA|CHEST PAIN|CHEST PAIN|HEADACHE|HEADACHE|SEASONAL ALLERGY|HYPOKALAEMIA|BACK PAIN|CHEST PAIN|GLOSSODYNIA|SUPPLEMENTATION THERAPY|DIARRHOEA|DIARRHOEA|NEOPLASM|CHEST DISCOMFORT|DIARRHOEA|ANXIETY|CHEST DISCOMFORT|CHEST DISCOMFORT|GLOSSODYNIA|GASTROOESOPHAGEAL REFLUX DISEASE|INSOMNIA|INSOMNIA|HEADACHE|CHEST PAIN|COUGH|BACK PAIN,Hypokalaemia|Urinary retention,2,1
13090214,20170105,Durvalumab,48,801,48.0,2,82.5,1,1,0,0,0,0,0,Durvalumab,PACLITAXEL|PACLITAXEL,5,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS,Pulmonary haemorrhage,1,3
13105640,20170111,Durvalumab,76,801,76.0,1,87,1,0,1,0,0,0,0,Durvalumab,AZACITIDINE|AZACITIDINE FOR|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|CANDESARTAN|METOPROLOL TARTRATE|METOPROLOL|AMOXICILLIN AND CLAVULANATE POTASSIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|GRANISETRON|GRANISETRON HYDROCHLORIDE|EZETIMIBE|DEXTROSE ANHYDROUS|AZACITIDINE|AZACITIDINE FOR|MEROPENEM|AMIKACIN,30,INFECTION PROPHYLAXIS|GLAUCOMA|HYPERTENSION|PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING|HYPERTENSION|VITAMIN D DEFICIENCY|INFECTION PROPHYLAXIS|PREMEDICATION|HYPERTENSION|NASOPHARYNGITIS|THROMBOPHLEBITIS|PAIN|PROPHYLAXIS OF NAUSEA AND VOMITING|HYPERCHOLESTEROLAEMIA|THROMBOPHLEBITIS|PROPHYLAXIS AGAINST DEHYDRATION|ACUTE MYELOID LEUKAEMIA|HYPERCHOLESTEROLAEMIA|ANTIFUNGAL PROPHYLAXIS|PREMEDICATION|GASTRITIS PROPHYLAXIS|PREMEDICATION|ACUTE MYELOID LEUKAEMIA|PYREXIA|INFECTION PROPHYLAXIS|INFECTION PROPHYLAXIS|PROPHYLAXIS AGAINST DEHYDRATION,Lung infiltration,1,3
13114502,20170113,Durvalumab,30,801,30.0,2,73,1,0,0,0,1,0,1,Durvalumab,PACLITAXEL|PACLITAXEL,3,BREAST CANCER|BREAST CANCER,Transaminases increased|Hypothyroidism|Neuropathy peripheral,3,3
13125158,20170118,Durvalumab,36,801,36.0,1,,1,0,1,0,0,0,0,Durvalumab,PREGABALIN|PROCHLORPERAZINE|GEMCITABINE HYDROCHLORIDE|CISPLATIN|TREMELIMUMAB|FUROSEMIDE|HYDROMORPHONE HYDROCHLORIDE,13,BLADDER CANCER|BLADDER CANCER|BLADDER CANCER|BLADDER CANCER,Colitis|Nausea|Vomiting,3,1
13134992,20170120,Durvalumab,52,801,52.0,1,83,1,0,1,1,0,0,0,Durvalumab,,6,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Bronchospasm|Respiratory tract infection viral,2,3
13149889,20170125,Durvalumab,36,801,36.0,2,67,1,0,1,0,0,0,1,Durvalumab,PACLITAXEL|PACLITAXEL|PACLITAXEL|PACLITAXEL|PANTOPRAZOLE|PACLITAXEL,14,HYPERTHYROIDISM|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|BREAST CANCER|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Hyperthyroidism|Musculoskeletal chest pain|Hypothyroidism|Thrombocytopenia|Thrombocytopenia,5,3
13161485,20170130,Durvalumab,31,801,31.0,2,62,1,0,0,0,0,0,1,Durvalumab,PACLITAXEL,2,BREAST CANCER|BREAST CANCER,Infusion related reaction,1,3
13167862,20170131,Durvalumab,,,,0,,1,0,0,0,0,0,1,Durvalumab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PACLITAXEL",4,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Nausea|Fatigue|Alopecia|Thrombocytopenia|Anaemia|Hypothyroidism|Leukopenia|Neuropathy peripheral|Adverse event|Hyperthyroidism|Infusion related reaction|Neutropenia|Peripheral sensory neuropathy,13,3
13169197,20170201,Durvalumab,66,801,66.0,1,82,1,0,1,0,0,0,0,Durvalumab,OLAPARIB|FOLIC ACID|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|CALCIUM CARBONATE|ANTACID|ERGOCALCIFEROL|MELATONIN|GOSERELIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,10,PROSTATE CANCER|PROSTATE CANCER,Syncope,1,1
13176236,20170201,Durvalumab,22305,804,61.11,1,,1,0,1,0,0,0,0,Durvalumab,ZOLEDRONIC ACID|OLAPARIB|MAGNESIUM,12,SMALL CELL LUNG CANCER|METASTASES TO BONE|PAIN|PAIN|ANTICOAGULANT THERAPY|SMALL CELL LUNG CANCER|PEPTIC ULCER|HYPERTENSION|NUTRITIONAL SUPPLEMENTATION|NAUSEA|PAIN|DYSPNOEA,Pneumonia,1,1
13193856,20170207,Durvalumab,51,801,51.0,2,97,1,0,0,0,0,0,1,Durvalumab,PACLITAXEL,3,BREAST CANCER|HYPOTHYROIDISM|BREAST CANCER,Asthenia|Hypothyroidism,2,3
13196480,20170208,Durvalumab,,,,0,,1,0,1,0,0,0,1,Durvalumab,LENALIDOMIDE|DURVALUMAB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB|ALLOPURINOL|RITUXIMAB|ROSUVASTATIN,9,B-CELL LYMPHOMA|B-CELL LYMPHOMA|LOWER RESPIRATORY TRACT INFECTION|ASTHMA|PYREXIA|B-CELL LYMPHOMA|GOUT|PRODUCT USED FOR UNKNOWN INDICATION|BLOOD CHOLESTEROL INCREASED,Hepatitis,1,3
13226730,20170213,Durvalumab,65,801,65.0,2,101.4,1,0,1,0,0,0,1,Durvalumab,"DARATUMUMAB|AMOXICILLIN AND CLAVULANATE POTASSIUM|GABAPENTIN|DURVALUMAB|DURVALUMAB|FENTANYL|DARATUMUMAB|DURVALUMAB|DURVALUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DARATUMUMAB|DARATUMUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|DAPSONE GEL, 5%|DAPSONE|DASPONE|FLUCONAZOLE|DARATUMUMAB|DURVALUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DALTEPARIN SODIUM|LANSOPRAZOLE|DARATUMUMAB",29,PLASMA CELL MYELOMA|URINARY TRACT INFECTION|PAIN MANAGEMENT|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PAIN MANAGEMENT|DIARRHOEA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|NAUSEA|NAUSEA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|BACK PAIN|DIABETES MELLITUS|INFECTION PROPHYLAXIS|ANTIFUNGAL TREATMENT|PROPHYLAXIS|INFECTION PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|NAUSEA|PULMONARY EMBOLISM|INFECTION PROPHYLAXIS|DIARRHOEA|GASTRITIS PROPHYLAXIS|PLASMA CELL MYELOMA,Dyspnoea|Pulmonary embolism|Pneumonia,3,3
13233584,20170215,Durvalumab,75,801,75.0,1,81.5,1,0,1,0,0,0,1,Durvalumab,PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ROSUVASTATIN|LENALIDOMIDE|ALLOPURINOL|DURVALUMAB|RITUXIMAB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|RITUXIMAB|RITUXIMAB|RITUXIMAB,12,ASTHMA|BLOOD CHOLESTEROL INCREASED|PYREXIA|B-CELL LYMPHOMA|GOUT|B-CELL LYMPHOMA|B-CELL LYMPHOMA|LOWER RESPIRATORY TRACT INFECTION|B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hepatitis,1,3
13236744,20170215,Durvalumab,54,801,54.0,1,76,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|DALTEPARIN SODIUM,3,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|PULMONARY EMBOLISM,Haemorrhagic arteriovenous malformation,1,1
13241369,20170216,Durvalumab,55,801,55.0,2,51,1,1,1,0,0,0,0,Durvalumab,MULTIVITAMIN|AMLODIPINE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|OLAPARIB|AMLODIPINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LISINOPRIL|ENOXAPARIN SODIUM,11,OVARIAN CANCER|OVARIAN CANCER|OVARIAN CANCER|OVARIAN CANCER|HYPONATRAEMIA,Dyspepsia|Acute kidney injury|Decreased appetite|Haemoglobin decreased|Malignant neoplasm progression|Hyponatraemia|Upper gastrointestinal haemorrhage|Syncope|Gastrooesophageal reflux disease|Diarrhoea,10,1
13259217,20170222,Durvalumab,22324,804,61.16,1,,1,1,1,0,0,0,0,Durvalumab,OXYCODONE|OLAPARIB|FORMOTEROL FUMARATE DIHYDRATE|ZOLEDRONIC ACID|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ESOMEPRAZOLE MAGNESIUM|MAGNESIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,21,BACK PAIN|PAIN|SMALL CELL LUNG CANCER|HYPERTENSION|PNEUMONIA|COUGH|SMALL CELL LUNG CANCER|COUGH|NECK PAIN|SMALL CELL LUNG CANCER|NAUSEA|PROPHYLAXIS|METASTASES TO BONE|BACK PAIN|ISCHAEMIC HEART DISEASE PROPHYLAXIS|GASTROOESOPHAGEAL REFLUX DISEASE|HYPOMAGNESAEMIA|DYSPNOEA|PNEUMONIA|HYPONATRAEMIA|CEREBROVASCULAR ACCIDENT PROPHYLAXIS,Hepatic enzyme increased,1,1
13260716,20170222,Durvalumab,76,801,76.0,1,,1,0,0,0,0,0,1,Durvalumab,CLOTRIMAZOLE|DRS. CLOTRIMAZOLE|FAMILY WELLNESS CLOTRIMAZOLE|CLOTRIMAZOLE TOPICAL|GRANISETRON|GRANISETRON HYDROCHLORIDE|CISPLATIN|CARBOPLATIN|FUROSEMIDE|MOMETASONE|ALBUTEROL SULFATE|TREMELIMUMAB|GEMCITABINE HYDROCHLORIDE|IRBESARTAN|ERGOCALCIFEROL|FLUTICASONE PROPIONATE AND SALMETEROL|PANTOPRAZOLE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,17,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Pyrexia|Seizure|Blood bilirubin increased,3,1
13263998,20170223,Durvalumab,63,801,63.0,2,86.8,1,0,1,0,0,0,0,Durvalumab,OLAPARIB|OLAPARIB|OLAPARIB|OLAPARIB|OLAPARIB|OLAPARIB|OLAPARIB|OLAPARIB|OLAPARIB,36,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|VITAMIN D DEFICIENCY|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|VITAMIN B12 DEFICIENCY|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT,Device related infection,1,1
13273661,20170227,Durvalumab,58,801,58.0,1,,1,0,1,0,0,0,0,Durvalumab,OLAPARIB|OLAPARIB|OLAPARIB,10,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PHLEBITIS,Myocardial infarction,1,1
13278454,20170228,Durvalumab,60,801,60.0,1,,1,0,1,0,0,0,0,Durvalumab,BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|TREMELIMUMAB|NEOMYCIN SULFATE|LACTULOSE|PROCHLORPERAZINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TREMELIMUMAB|GEMCITABINE HYDROCHLORIDE|CISPLATIN|FLURBIPROFEN,18,CONSTIPATION|INFECTION|INFECTION|INFECTION|CONSTIPATION|CONSTIPATION|PAIN|VOMITING|STOMATITIS|BLADDER TRANSITIONAL CELL CARCINOMA|DISEASE PROGRESSION|DECREASED APPETITE|DISEASE PROGRESSION|BLADDER TRANSITIONAL CELL CARCINOMA|PAIN,Small intestinal obstruction,1,1
13280437,20170301,Durvalumab,76,801,76.0,1,81.5,1,0,1,0,0,0,1,Durvalumab,PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DOXYCYCLINE|DOXYCYCLINE HYCLATE|ROSUVASTATIN|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|DURVALUMAB|ALLOPURINOL,9,ASTHMA|LOWER RESPIRATORY TRACT INFECTION|BLOOD CHOLESTEROL INCREASED|PYREXIA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|GOUT,Hepatitis,1,3
13350003,20170320,Durvalumab,70,801,70.0,2,,1,0,1,0,0,0,0,Durvalumab,FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|LORAZEPAM|PSYLLIUM HUSK|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|TREMELIMUMAB|HYDROCORTISONE CREAM|HYDROCORTISONE|CARBOPLATIN|ACETAMINOPHEN|STANDARDIZED SENNA CONCENTRATE|LACTULOSE|HYDROCHLOROTHIAZIDE|DIPHENHYDRAMINE HYDROCHLORIDE|PEMETREXED|PEMETREXED DISODIUM|ALBUTEROL SULFATE|FOLIC ACID,21,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Syncope|Fatigue,2,1
13406557,20170405,Durvalumab,61,801,61.0,1,,1,0,1,0,0,0,0,Durvalumab,GABAPENTIN|DURVALUMAB,2,SEIZURE,Mental status changes,1,3
13423459,20170410,Durvalumab,49,801,49.0,1,,1,0,1,1,0,0,0,Durvalumab,DIPHENHYDRAMINE HYDROCHLORIDE|IBRUTINIB|ALLOPURINOL|GABAPENTIN|ACYCLOVIR|ENTECAVIR|ENTECAVIR ANHYDROUS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SULFAMETHOXAZOLE AND TRIMETHOPRIM|IBRUTINIB|ENTECAVIR|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG,18,HYPERSENSITIVITY|PAIN|LYMPHOMA|LYMPHOMA|CONSTIPATION|DRY EYE,Febrile neutropenia|Neutropenia|Febrile neutropenia|Neutropenia,4,1
13424960,20170410,Durvalumab,56,801,56.0,2,,1,0,1,0,0,0,0,Durvalumab,"OLAPARIB|MOMETASONE FUROATE|OLAPARIB|OLAPARIB|OLAPARIB|OLAPARIB|OLAPARIB|OLAPARIB|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,",21,SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|ARRHYTHMIA|PROPHYLAXIS|COUGH|MUCOSAL INFLAMMATION|SMALL CELL LUNG CANCER|PROPHYLAXIS|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|ARTHRALGIA|ARTHRALGIA|COUGH|PROPHYLAXIS|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|COUGH|MUCOSAL INFLAMMATION,General physical health deterioration,1,1
13445183,20170414,Durvalumab,76,801,76.0,1,80.6,1,1,1,0,0,0,0,Durvalumab,PACLITAXEL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|BISOPROLOL FUMARATE|PACLITAXEL|DOXYCYCLINE|DOXYCYCLINE HYCLATE|BISOPROLOL FUMARATE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|SIMVASTATIN|DOXYCYCLINE|DOXYCYCLINE HYCLATE|GABAPENTIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,26,NON-SMALL CELL LUNG CANCER|TYPE 2 DIABETES MELLITUS|ATRIAL FIBRILLATION|TYPE 2 DIABETES MELLITUS|ATRIAL FIBRILLATION|HYPERKALAEMIA|CONSTIPATION|LOWER RESPIRATORY TRACT INFECTION|HYPOMAGNESAEMIA|HYPERTENSION|DEEP VEIN THROMBOSIS|BACK PAIN|HYPERCHOLESTEROLAEMIA|DIABETES MELLITUS|BACK PAIN|CHEST PAIN|NON-SMALL CELL LUNG CANCER|BACK PAIN|PROPHYLAXIS OF NAUSEA AND VOMITING,Pneumocystis jirovecii pneumonia,1,1
13449598,20170417,Durvalumab,71,801,71.0,1,,1,1,0,0,0,0,0,Durvalumab,VINORELBINE|TREMELIMUMAB|GEMCITABINE HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,5,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Death,1,1
13451205,20170418,Durvalumab,53,801,53.0,1,,1,0,1,0,0,0,0,Durvalumab,DURVALUMAB|DURVALUMAB|ACYCLOVIR|DARATUMUMAB|DARATUMUMAB|LEVOTHYROXINE|PANTOPRAZOLE|ALLOPURINOL,11,PLASMA CELL MYELOMA|BONE PAIN|PLASMA CELL MYELOMA|BONE PAIN|PLASMA CELL MYELOMA|ANTIVIRAL PROPHYLAXIS|PLASMA CELL MYELOMA|HYPOTHYROIDISM|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|HYPERURICAEMIA,Acute kidney injury|Hepatitis,2,3
13452042,20170418,Durvalumab,,,,2,67,1,0,0,0,0,0,0,Durvalumab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PACLITAXEL",4,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Infusion related reaction,1,1
13454621,20170418,Durvalumab,74,801,74.0,2,53.94,1,0,1,0,0,0,0,Durvalumab,LORAZEPAM|PACLITAXEL|PROMETHAZINE|PACLITAXEL|OMEPRAZOLE MAGNESIUM|ALPRAZOLAM,9,MUSCLE SPASMS|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING|GASTROOESOPHAGEAL REFLUX DISEASE|NON-SMALL CELL LUNG CANCER|ANXIETY,Muscular weakness,1,1
13454955,20170418,Durvalumab,83,801,83.0,2,,1,0,1,0,0,0,1,Durvalumab,CELECOXIB|TREMELIMUMAB|TREMELIMUMAB|CISPLATIN|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|PREDNISONE|ROSUVASTATIN CALCIUM|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|DIFLUPREDNATE OPHTHALMIC|DIFLUPREDNATE,30,DERMATITIS CONTACT|BACK PAIN|CONSTIPATION|COLITIS ISCHAEMIC|PRURITUS|VITAMIN SUPPLEMENTATION|HYPERTENSION|DIARRHOEA|DIARRHOEA|COLITIS|BACK PAIN|HYPERLIPIDAEMIA|CONSTIPATION|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|FLUID REPLACEMENT|BACK PAIN|DERMATITIS CONTACT|FLUID REPLACEMENT,Pancytopenia,1,1
13487015,20170426,Durvalumab,,,,0,,1,0,0,0,0,0,1,Durvalumab,GEMCITABINE HYDROCHLORIDE|TREMELIMUMAB|DURVALUMAB,3,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT,Hepatitis,1,5
13506906,20170502,Durvalumab,,,,0,,1,0,0,0,0,0,0,Durvalumab,DURVALUMAB,1,BLADDER CANCER,Myasthenia gravis,1,1
13507065,20170503,Durvalumab,77,801,77.0,1,72,1,0,1,0,0,0,0,Durvalumab,,5,INSOMNIA|HYPERTENSION|NEOPLASM MALIGNANT|RASH|INSOMNIA,Polymyalgia rheumatica,1,1
13507774,20170503,Durvalumab,19024,804,52.12,1,,1,0,1,0,0,0,0,Durvalumab,OLAPARIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|GABAPENTIN|GABAPENTIN|GABAPENTIN|OLAPARIB|GABAPENTIN|OLAPARIB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,21,NEOPLASM|ABDOMINAL PAIN|ABDOMINAL PAIN|PROPHYLAXIS|ABDOMINAL PAIN|NEOPLASM|CONSTIPATION PROPHYLAXIS|BACK PAIN|BACK PAIN|NAUSEA|BACK PAIN|VOMITING|ABDOMINAL PAIN|NEOPLASM|NEOPLASM|BACK PAIN|NEOPLASM|ABDOMINAL PAIN|BACK PAIN|NAUSEA|NAUSEA,Dysphagia,1,1
13508559,20170503,Durvalumab,771,802,64.25,1,,1,0,1,0,0,0,1,Durvalumab,TREMELIMUMAB,2,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Autoimmune myositis|Rhabdomyolysis,2,1
13510159,20170503,Durvalumab,66,801,66.0,1,58,1,1,1,0,0,0,1,Durvalumab,LACTULOSE|TREMELIMUMAB|MAGNESIUM,11,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Inflammation|Tumour haemorrhage,2,1
13510249,20170503,Durvalumab,26160,804,71.67,1,95,1,0,1,0,0,0,0,Durvalumab,ALLOPURINOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SOLIFENACIN SUCCINATE|ENOXAPARIN SODIUM,9,PROPHYLAXIS|INFECTION PROPHYLAXIS|PROPHYLAXIS|B-CELL LYMPHOMA|INFECTION PROPHYLAXIS|PROPHYLAXIS|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Pleural infection bacterial,1,1
13510391,20170503,Durvalumab,18341,804,50.25,1,,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|TREMELIMUMAB|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,19,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|ANALGESIC THERAPY|CONSTIPATION|ANALGESIC THERAPY|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|RASH|ANALGESIC THERAPY|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|DEPRESSION|DYSPEPSIA|NAUSEA|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|RASH|NAUSEA|RASH|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Oesophageal candidiasis|Psoriasis|Lethargy,3,1
13510415,20170503,Durvalumab,63,801,63.0,1,66,1,0,1,0,0,0,0,Durvalumab,OLAPARIB|OLAPARIB,11,NEOPLASM MALIGNANT|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|ANAEMIA|NEOPLASM MALIGNANT|CARDIOMYOPATHY|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|BLOOD PRESSURE INCREASED|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT,Streptococcal infection|Febrile bone marrow aplasia,2,1
13510574,20170503,Durvalumab,70,801,70.0,1,93.7,1,0,0,0,0,0,1,Durvalumab,ISOSORBIDE DINITRATE|SIMVASTATIN|LOSARTAN|BISOPROLOL FUMARATE,18,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|ANGINA PECTORIS|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|ARTHRITIS|NEOPLASM MALIGNANT|PROPHYLAXIS|HYPERTENSION|NEOPLASM MALIGNANT|THROMBOSIS PROPHYLAXIS|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|HYPERTENSION|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT,Infusion related reaction,1,1
13514474,20170504,Durvalumab,63,801,63.0,1,81.5,1,0,1,0,0,0,0,Durvalumab,SIMVASTATIN|PENTAMIDINE ISETHIONATE,9,PLASMA CELL MYELOMA|HYPERLIPIDAEMIA|PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|THROMBOSIS PROPHYLAXIS|PREMEDICATION|MINERAL SUPPLEMENTATION,Febrile neutropenia|Upper respiratory tract infection,2,1
13514801,20170504,Durvalumab,41,801,41.0,1,,1,0,0,0,0,0,1,Durvalumab,,1,NON-SMALL CELL LUNG CANCER,Embolism,1,1
13515197,20170504,Durvalumab,68,801,68.0,2,,1,0,1,0,0,0,0,Durvalumab,CALCIUM|ERGOCALCIFEROL|MAGNESIUM|DURVALUMAB|TREMELIMUMAB,10,NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|HYPOMAGNESAEMIA|INFLUENZA LIKE ILLNESS|NUTRITIONAL SUPPLEMENTATION|DYSPEPSIA|ABDOMINAL PAIN|COLORECTAL CANCER|COLORECTAL CANCER|NAUSEA,Small intestinal obstruction,1,1
13515211,20170504,Durvalumab,25621,804,70.19,1,,1,1,1,1,1,0,1,Durvalumab,METOPROLOL TARTRATE|METOPROLOL|SIMVASTATIN|PROPRANOLOL HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LISINOPRIL|FINASTERIDE|ALBUTEROL SULFATE|ALBUTEROL|ALPRAZOLAM|OXAZEPAM|DOXAZOSIN|DOXAZOSIN MESYLATE|PYRIDOSTIGMINE BROMIDE|MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE,21,ATRIAL FIBRILLATION|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|HYPERTENSION|MYASTHENIA GRAVIS|LIPIDS INCREASED|HYPERTENSION|PROPHYLAXIS OF NAUSEA AND VOMITING|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|HYPERTENSION|BENIGN PROSTATIC HYPERPLASIA|BENIGN PROSTATIC HYPERPLASIA|ASTHMA|BLADDER TRANSITIONAL CELL CARCINOMA|ANXIETY|ANXIETY|PROSTATOMEGALY|ANXIETY|ASTHMA,Myasthenia gravis|Myocardial infarction|Respiratory failure|Psychotic disorder,4,1
13515281,20170504,Durvalumab,28331,804,77.62,1,,1,0,1,0,0,0,1,Durvalumab,PANTOPRAZOLE|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB,9,GASTROOESOPHAGEAL REFLUX DISEASE|ABSCESS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|ABSCESS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Pneumonia,1,1
13515374,20170504,Durvalumab,23765,804,65.11,2,,1,0,1,0,0,0,1,Durvalumab,"HYDROCHLOROTHIAZIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|TREMELIMUMAB|ATORVASTATIN CALCIUM|ESOMEPRAZOLE MAGNESIUM|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|CLONAZEPAM|POLYETHYLENE GLYCOL|METOPROLOL TARTRATE|METOPROLOL|OXYCODONE HYDROCHLORIDE|OXYCODONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ESCITALOPRAM|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE",32,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|PAIN|CONSTIPATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERCHOLESTEROLAEMIA|GASTROOESOPHAGEAL REFLUX DISEASE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|IRRITABLE BOWEL SYNDROME|ANXIETY|CONSTIPATION|NON-SMALL CELL LUNG CANCER|HYPERTENSION|PAIN|RASH MACULO-PAPULAR|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DEPRESSION|RASH MACULO-PAPULAR,Pemphigoid|Skin infection,2,1
13515396,20170504,Durvalumab,53,801,53.0,1,85,1,0,1,0,0,0,0,Durvalumab,DARATUMUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|NAPROXEN|NAPROXEN SODIUM|POMALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|GABAPENTIN|FLUCONAZOLE|CLARITHROMYCIN,16,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|INFECTION PROPHYLAXIS|RENAL IMPAIRMENT|SOMNOLENCE|ANTIVIRAL PROPHYLAXIS|PLASMA CELL MYELOMA|PROPHYLAXIS|PERIPHERAL SENSORY NEUROPATHY|INFECTION PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION,Febrile neutropenia|Skin infection,2,3
13516460,20170505,Durvalumab,70,801,70.0,2,,1,0,0,0,0,0,1,Durvalumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|LORAZEPAM|HYDROCHLOROTHIAZIDE|PREDNISONE|PEMETREXED|PEMETREXED DISODIUM|DURVALUMAB|FOLIC ACID|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|STANDARDIZED SENNA CONCENTRATE|CARBOPLATIN|HYDROCORTISONE CREAM|HYDROCORTISONE|TREMELIMUMAB|ALBUTEROL SULFATE|PSYLLIUM HUSK|LACTULOSE|DIPHENHYDRAMINE HYDROCHLORIDE",25,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Pruritus,1,1
13516681,20170505,Durvalumab,61,801,61.0,1,73,1,0,1,0,0,0,1,Durvalumab,RANITIDINE,8,PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Syncope,1,1
13518362,20170505,Durvalumab,26396,804,72.32,1,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|ESOMEPRAZOLE MAGNESIUM|PREGABALIN,19,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|LUMBAR SPINAL STENOSIS|TYPE 2 DIABETES MELLITUS|LUMBAR SPINAL STENOSIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|GASTRIC ULCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|BENIGN PROSTATIC HYPERPLASIA|INSOMNIA|DERMATITIS ACNEIFORM|NON-SMALL CELL LUNG CANCER|CONSTIPATION|BENIGN PROSTATIC HYPERPLASIA|BENIGN PROSTATIC HYPERPLASIA|LUMBAR SPINAL STENOSIS,Hypopituitarism,1,1
13518383,20170505,Durvalumab,46,801,46.0,2,,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB,21,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Amylase increased,1,1
13518902,20170505,Durvalumab,66,801,66.0,1,99.3,1,1,0,0,0,0,1,Durvalumab,"STANDARDIZED SENNA CONCENTRATE|ERGOCALCIFEROL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE|LEVOTHYROXINE|SILDENAFIL CITRATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ZOLPIDEM TARTRATE|CINNAMON",13,NUTRITIONAL SUPPLEMENTATION|CONSTIPATION|NUTRITIONAL SUPPLEMENTATION|ARTHRALGIA|GASTROOESOPHAGEAL REFLUX DISEASE|NUTRITIONAL SUPPLEMENTATION|HYPOTHYROIDISM|HYPERTENSION|NEOPLASM MALIGNANT|ERECTILE DYSFUNCTION|TYPE 2 DIABETES MELLITUS|INSOMNIA|NUTRITIONAL SUPPLEMENTATION,Cerebrovascular accident|Myositis,2,1
13518916,20170505,Durvalumab,12009,804,32.9,2,,1,0,1,1,0,0,1,Durvalumab,,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Hepatitis acute,1,1
13519096,20170505,Durvalumab,54,801,54.0,1,,1,0,1,0,0,0,0,Durvalumab,PREGABALIN|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL,6,PAIN|CONSTIPATION|PAIN|MALAISE|BLADDER CANCER|CONSTIPATION,Diabetic ketoacidosis,1,1
13519111,20170505,Durvalumab,27019,804,74.02,1,,1,0,1,0,0,0,1,Durvalumab,ACARBOSE|TELMISARTAN|TREMELIMUMAB|PREGABALIN|AMOXICILLIN AND CLAVULANATE POTASSIUM|TREMELIMUMAB|FUROSEMIDE|ALLOPURINOL,17,DIABETES MELLITUS|DYSPNOEA|DYSPNOEA|HYPERTENSION|THROMBOSIS PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|DYSPNOEA|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|PARAESTHESIA|PYREXIA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|HYPERTENSION|HYPERURICAEMIA,Autoimmune hepatitis,1,1
13519134,20170505,Durvalumab,25135,804,68.86,2,,1,1,1,1,0,0,1,Durvalumab,TREMELIMUMAB,6,MUSCULOSKELETAL CHEST PAIN|LUNG NEOPLASM MALIGNANT|NON-SMALL CELL LUNG CANCER|HYPOTHYROIDISM|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pancreatitis|Anaphylactic shock,2,1
13519160,20170505,Durvalumab,26892,804,73.68,2,,1,1,1,0,0,0,0,Durvalumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LORATADINE|LORATADINE ORAL|ATENOLOL|AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE|CANDESARTAN|PEMETREXED|PEMETREXED DISODIUM|ROSUVASTATIN|MIRTAZAPINE|OLANZAPINE|CISPLATIN|FOLIC ACID,14,MESOTHELIOMA|MESOTHELIOMA|MESOTHELIOMA,Embolism,1,1
13521867,20170508,Durvalumab,57,801,57.0,1,75.3,1,0,1,0,0,0,1,Durvalumab,"HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|OXYCODONE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|MORPHINE|NAPROXEN|NAPROXEN SODIUM|MULTIVITAMIN|LISINOPRIL",16,NON-SMALL CELL LUNG CANCER|COLORECTAL CANCER|COLORECTAL CANCER|ADENOCARCINOMA PANCREAS|NON-SMALL CELL LUNG CANCER|ADENOCARCINOMA PANCREAS,Tumour pain|Hepatic function abnormal,2,1
13523030,20170508,Durvalumab,17045,804,46.7,2,,1,1,1,1,1,0,0,Durvalumab,TREMELIMUMAB,2,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT,Pneumonitis,1,1
13523308,20170508,Durvalumab,56,801,56.0,1,53.5,1,0,1,0,0,0,0,Durvalumab,"MORPHINE|TREMELIMUMAB|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|DENOSUMAB|ESOMEPRAZOLE MAGNESIUM",8,PROPHYLAXIS|METASTASES TO BONE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|METASTASES TO BONE|METASTASES TO BONE|METASTASES TO BONE|PROPHYLAXIS,Drug reaction with eosinophilia and systemic symptoms,1,1
13523331,20170508,Durvalumab,921,802,76.75,2,,1,0,1,1,0,0,0,Durvalumab,TREMELIMUMAB|VALSARTAN|VALSARTAN ORAL|VALSARTAN|VALSARTAN ORAL|VALSARTAN|VALSARTAN ORAL|DICLOFENAC|DICLOFENAC SODIUM|TREMELIMUMAB|VALSARTAN|VALSARTAN ORAL|ALLOPURINOL|TREMELIMUMAB|TREMELIMUMAB|NIFEDIPINE,36,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|COAGULOPATHY|OEDEMA PERIPHERAL|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|OEDEMA PERIPHERAL|BREAST PAIN|SPINAL FRACTURE|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|HYPERTENSION|HYPERTENSION|GOUT|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|SPINAL FRACTURE,Hyponatraemia,1,1
13524024,20170508,Durvalumab,57,801,57.0,1,123.2,1,1,1,0,0,0,0,Durvalumab,SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LEVETIRACETAM|TREMELIMUMAB|CALCIUM CARBONATE|ANTACID,5,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DYSPEPSIA,Hypoxia|Pneumonitis|Splenic haemorrhage|Haemoptysis,4,1
13526099,20170509,Durvalumab,23870,804,65.4,1,,1,0,1,0,0,0,0,Durvalumab,"TREMELIMUMAB|TOLTERODINE TARTRATE|LATANOPROST|BRIMONIDINE|BRIMONIDINE TARTRATE|TREMELIMUMAB|ATORVASTATIN CALCIUM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|TREMELIMUMAB|ERGOCALCIFEROL|OXAZEPAM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|BRIMONIDINE TARTRATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DIMENHYDRINATE|DORZOLAMIDE|OXAZEPAM|DIMENHYDRINATE",29,BLADDER TRANSITIONAL CELL CARCINOMA|SCIATICA|BLADDER TRANSITIONAL CELL CARCINOMA|HYPERTONIC BLADDER|GLAUCOMA|CORONARY ARTERY DISEASE|PAIN|PAIN|GLAUCOMA|BLADDER TRANSITIONAL CELL CARCINOMA|DYSLIPIDAEMIA|SCIATICA|PAIN|BLADDER TRANSITIONAL CELL CARCINOMA|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|INSOMNIA|NAUSEA|VOMITING|PAIN|SCIATICA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|GLAUCOMA|SCIATICA|VOMITING|GLAUCOMA|ANXIETY|NAUSEA,Gastritis erosive,1,1
13528438,20170509,Durvalumab,71,801,71.0,1,,1,0,1,0,0,0,0,Durvalumab,ROSUVASTATIN|LEVOTHYROXINE SODIUM|DURVALUMAB|DURVALUMAB|TREMELIMUMAB|METOPROLOL TARTRATE|METOPROLOL|TREMELIMUMAB|IRBESARTAN,11,HORMONE-REFRACTORY PROSTATE CANCER|MALIGNANT GENITOURINARY TRACT NEOPLASM|HORMONE-REFRACTORY PROSTATE CANCER|MALIGNANT GENITOURINARY TRACT NEOPLASM,Hypocalcaemia,1,1
13532462,20170510,Durvalumab,82,801,82.0,1,,1,1,1,0,0,0,0,Durvalumab,ETOPOSIDE|ETOPOSIDE|ETOPOSIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|CARBOPLATIN|TREMELIMUMAB,11,SMALL CELL LUNG CANCER|DECREASED APPETITE|PRODUCTIVE COUGH|SMALL CELL LUNG CANCER|DECREASED APPETITE|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|PRODUCTIVE COUGH|DECREASED APPETITE,Febrile neutropenia|Muscular weakness,2,1
13532913,20170510,Durvalumab,19383,804,53.1,2,64.5,1,1,1,0,0,0,0,Durvalumab,"FUROSEMIDE|CEFOTAXIME|CEFOTAXIME INJECTION|TEMAZEPAM|PANTOPRAZOLE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FUROSEMIDE|CEFOTAXIME|CEFOTAXIME INJECTION|ACETYLCYSTEINE|DROPERIDOL|MORPHINE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|IPRATROPIUM BROMIDE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|VORICONAZOLE|PROPOFOL|PREDNISONE|ALLOPURINOL|CEFOTAXIME|CEFOTAXIME INJECTION|IPRATROPIUM BROMIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FLUCONAZOLE|ERYTHROMYCIN|MIRTAZAPINE|PANTOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ADENOSINE|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|VORICONAZOLE|OXAZEPAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FUROSEMIDE|DEXTROSE ANHYDROUS|ROCURONIUM|ROCURONIUM BROMIDE|LORAZEPAM|PROPOFOL|BENDAMUSTINE HCL|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FLUCONAZOLE|FUROSEMIDE|MORPHINE",64,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|B-CELL LYMPHOMA|B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Electrocardiogram QT prolonged|Sepsis|Adrenal insufficiency|Pyrexia|Aptyalism,5,1
13533074,20170510,Durvalumab,26976,804,73.91,1,,1,0,1,0,0,0,0,Durvalumab,SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|GEFITINIB|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|ENALAPRIL|SIMVASTATIN|FUROSEMIDE,33,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PREMEDICATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERSENSITIVITY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|HYPOTHYROIDISM|NON-SMALL CELL LUNG CANCER|HYPERTENSION|RASH|HYPERTENSION|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|WEIGHT INCREASED|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NUTRITIONAL SUPPLEMENTATION|EYE IRRITATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|PREMEDICATION,Clostridium difficile colitis,1,1
13533156,20170510,Durvalumab,21961,804,60.17,1,,1,0,1,0,0,0,0,Durvalumab,DIFLUPREDNATE OPHTHALMIC|DIFLUPREDNATE|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|DIFLUPREDNATE OPHTHALMIC|DIFLUPREDNATE,52,RASH|PROPHYLAXIS|PROPHYLAXIS|THYROIDITIS|THYROIDITIS|GLAUCOMA|THYROIDITIS|THYROIDITIS|THYROIDITIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|THYROIDITIS|PROPHYLAXIS|PROPHYLAXIS|THYROIDITIS|PROPHYLAXIS|THYROIDITIS|BLADDER TRANSITIONAL CELL CARCINOMA|INTERVERTEBRAL DISC PROTRUSION|TINEA PEDIS|THYROIDITIS|PROPHYLAXIS|BLADDER TRANSITIONAL CELL CARCINOMA|INTERVERTEBRAL DISC PROTRUSION|THYROIDITIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|THYROIDITIS|THYROIDITIS|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|INTERVERTEBRAL DISC PROTRUSION|INTERVERTEBRAL DISC PROTRUSION|INTERVERTEBRAL DISC PROTRUSION|RASH|THYROIDITIS|THYROIDITIS|PROPHYLAXIS|BLADDER TRANSITIONAL CELL CARCINOMA|GLAUCOMA|DRY SKIN|PROPHYLAXIS|THYROIDITIS|PROPHYLAXIS|PROPHYLAXIS|THYROIDITIS|PROPHYLAXIS|THYROIDITIS,Liver function test increased,1,1
13537024,20170511,Durvalumab,28276,804,77.47,2,,1,1,1,1,1,0,1,Durvalumab,IPRATROPIUM BROMIDE|LOSARTAN|TREMELIMUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALPRAZOLAM,10,NON-SMALL CELL LUNG CANCER|DYSPNOEA|HYPERTENSION|NON-SMALL CELL LUNG CANCER|PREMEDICATION|PREMEDICATION|GASTROOESOPHAGEAL REFLUX DISEASE|PALLIATIVE CARE|HYPERTENSION|INSOMNIA,Renal failure|Pneumonia|Multiple organ dysfunction syndrome,3,1
13537083,20170511,Durvalumab,20716,804,56.76,1,,1,1,1,1,1,0,1,Durvalumab,TREMELIMUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pneumonitis,1,1
13539764,20170512,Durvalumab,82,801,82.0,1,59,1,0,1,0,0,0,0,Durvalumab,RAMUCIRUMAB|ATENOLOL,4,GASTROINTESTINAL NEOPLASM|GASTROINTESTINAL NEOPLASM,Gastrointestinal haemorrhage|Lipase increased|Subileus,3,1
13540939,20170512,Durvalumab,66,801,66.0,1,97.9,1,0,1,0,0,0,0,Durvalumab,GABAPENTIN|HYOSCYAMINE SULFATE|TREMELIMUMAB|FLUTICASONE PROPIONATE|FLUTICASONE PROPIONATE NASAL|LORAZEPAM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ATENOLOL|ZOLPIDEM TARTRATE|OXYCODONE|BENZONATATE|BUPROPION|MORPHINE SULFATE,15,BACK PAIN|COUGH|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|ANXIETY|GASTROOESOPHAGEAL REFLUX DISEASE|COUGH|HYPERTENSION|SLEEP DISORDER|NON-SMALL CELL LUNG CANCER|BACK PAIN|CORONARY ARTERY DISEASE|COUGH|DEPRESSION|BACK PAIN,Pneumonia,1,1
13540947,20170512,Durvalumab,48,801,48.0,1,89,1,0,1,0,0,0,0,Durvalumab,BACLOFEN|TREMELIMUMAB|FLUOXETINE HYDROCHLORIDE|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|LEVETIRACETAM,13,DEPRESSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DEPRESSION|PRODUCTIVE COUGH|DEPRESSION|DEPRESSION|NEUROPATHY PERIPHERAL|CONSTIPATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|SEIZURE PROPHYLAXIS,Pericarditis,1,1
13540958,20170512,Durvalumab,26762,804,73.32,1,,1,1,0,0,0,0,0,Durvalumab,TREMELIMUMAB|ESCITALOPRAM OXALATE|ESCITALOPRAM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CANDESARTAN|TREMELIMUMAB|TREMELIMUMAB,11,HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ANXIETY DISORDER|DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER|DIABETES MELLITUS|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Cardiac arrest,1,1
13540971,20170512,Durvalumab,20292,804,55.59,1,85.2,1,0,1,0,0,0,0,Durvalumab,,4,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Transient ischaemic attack,1,1
13541171,20170512,Durvalumab,23843,804,65.32,1,,1,1,1,0,0,0,0,Durvalumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|GABAPENTIN|TREMELIMUMAB|TREMELIMUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|TREMELIMUMAB|NIFEDIPINE|MORPHINE|PREDNISONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CLOPIDOGREL|OLANZAPINE|TREMELIMUMAB,41,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CONSTIPATION|MYOCARDIAL INFARCTION|DEPRESSION|PAIN|MYOCARDIAL ISCHAEMIA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|MYOCARDIAL INFARCTION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|BLOOD PRESSURE MEASUREMENT|PAIN|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NON-SMALL CELL LUNG CANCER|NAUSEA|PAIN|PAIN|PAIN|HYPERTENSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|BENIGN PROSTATIC HYPERPLASIA|DEPRESSION|PROPHYLAXIS|MYOCARDIAL INFARCTION|ANXIETY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Chronic obstructive pulmonary disease,1,1
13541212,20170512,Durvalumab,62,801,62.0,1,76,1,0,1,1,0,0,0,Durvalumab,FENTANYL|PREGABALIN|DEXTROSE ANHYDROUS|DOXEPIN|DOXEPIN HYDROCHLORIDE,9,HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC,Loss of consciousness,1,1
13541433,20170512,Durvalumab,21007,804,57.55,1,64,1,1,0,0,0,0,1,Durvalumab,TREMELIMUMAB|KETOPROFEN|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|OXYCODONE HYDROCHLORIDE|KETOPROFEN,18,GASTROOESOPHAGEAL REFLUX DISEASE|VOMITING|NON-SMALL CELL LUNG CANCER|CHEST PAIN|CONSTIPATION|NAUSEA|CHEST PAIN|CHEST PAIN|PROPHYLAXIS|NAUSEA|GASTROOESOPHAGEAL REFLUX DISEASE|GASTROOESOPHAGEAL REFLUX DISEASE|NON-SMALL CELL LUNG CANCER|CHEST PAIN|CHEST PAIN|CONSTIPATION|CHEST PAIN|VOMITING,Interstitial lung disease,1,1
13545128,20170515,Durvalumab,49,801,49.0,1,68,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pericardial effusion,1,1
13546482,20170515,Durvalumab,56,801,56.0,1,,1,0,1,0,0,0,0,Durvalumab,"RITUXIMAB|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE",6,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Febrile neutropenia,1,1
13546499,20170515,Durvalumab,76,801,76.0,1,,1,1,1,0,1,0,1,Durvalumab,METHYLPREDNISOLONE|AMLODIPINE BESYLATE|EPOETIN ALFA,9,ARTHRITIS|BLADDER TRANSITIONAL CELL CARCINOMA|HYPERTENSION|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|PROPHYLAXIS|BLADDER TRANSITIONAL CELL CARCINOMA|ANAEMIA|URINARY TRACT INFECTION,Autoimmune arthritis,1,1
13546601,20170515,Durvalumab,858,802,71.5,2,,1,1,1,0,0,0,0,Durvalumab,"TREMELIMUMAB|GABAPENTIN|TREMELIMUMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|TREMELIMUMAB|SPIRONOLACTONE|FUROSEMIDE|TREMELIMUMAB|ATORVASTATIN CALCIUM|MAGNESIUM OXIDE|MISOPROSTOL|TREMELIMUMAB",35,ADENOCARCINOMA|DIABETES MELLITUS|PROPHYLAXIS|DIARRHOEA|ADENOCARCINOMA|ADENOCARCINOMA|MYOSITIS|ADENOCARCINOMA|PROPHYLAXIS|PROPHYLAXIS|DECREASED APPETITE|LOCALISED OEDEMA|PROPHYLAXIS|PROPHYLAXIS|ADENOCARCINOMA|ADENOCARCINOMA|LOCALISED OEDEMA|ADENOCARCINOMA|HYPERCHOLESTEROLAEMIA|PROPHYLAXIS|PROPHYLAXIS|ADENOCARCINOMA|PROPHYLAXIS|CONSTIPATION|ADENOCARCINOMA|DECREASED APPETITE|PROPHYLAXIS|HYPERALBUMINAEMIA|ADENOCARCINOMA|PROPHYLAXIS|DIABETES MELLITUS|PROPHYLAXIS|PROPHYLAXIS|DIARRHOEA|HYPERALBUMINAEMIA,Gastrointestinal haemorrhage|Myositis,2,1
13546617,20170515,Durvalumab,18827,804,51.58,1,,1,0,1,0,0,0,1,Durvalumab,RANITIDINE|LACTULOSE|TREMELIMUMAB|TREMELIMUMAB|FUROSEMIDE|TREMELIMUMAB|TREMELIMUMAB,15,ESSENTIAL HYPERTENSION|CONSTIPATION|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SPINAL PAIN|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|ESSENTIAL HYPERTENSION|PREMEDICATION|SMALL CELL LUNG CANCER EXTENSIVE STAGE|FATIGUE|PREMEDICATION|SMALL CELL LUNG CANCER EXTENSIVE STAGE,Peripheral sensory neuropathy,1,1
13546665,20170515,Durvalumab,21756,804,59.61,1,,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|TREMELIMUMAB|TREMELIMUMAB,24,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PAIN|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|RASH PAPULAR|RASH PAPULAR|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|INSOMNIA|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|RASH PAPULAR,Pemphigoid,1,1
13546699,20170515,Durvalumab,775,802,64.58,1,,1,0,1,0,0,0,0,Durvalumab,CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|OXYCODONE|DICLOFENAC|DICLOFENAC SODIUM|LORAZEPAM,10,TUMOUR PAIN|BLADDER TRANSITIONAL CELL CARCINOMA|PNEUMONIA LEGIONELLA|BLADDER TRANSITIONAL CELL CARCINOMA|CONSTIPATION|TUMOUR PAIN|TUMOUR PAIN|GASTRIC DISORDER|TUMOUR PAIN|PROPHYLAXIS,Lung infection,1,1
13546736,20170515,Durvalumab,64,801,64.0,1,,1,0,1,0,0,0,0,Durvalumab,"TREMELIMUMAB|PANTOPRAZOLE|MIRTAZAPINE|TREMELIMUMAB|TREMELIMUMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|QUETIAPINE FUMARATE|QUETIAPINE|SILDENAFIL CITRATE|SILDENAFIL|SILDENAFIL POWDER,|PREDNISONE|ENTECAVIR|ENTECAVIR ANHYDROUS",17,HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|DYSPEPSIA|DEPRESSION|HYPERTENSION|HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|PROPHYLAXIS|DEPRESSION|HEPATOCELLULAR CARCINOMA|PROPHYLAXIS|HEPATOCELLULAR CARCINOMA|HEPATIC ENZYME INCREASED|HEPATITIS B DNA ASSAY POSITIVE,Pancreatitis,1,1
13546762,20170515,Durvalumab,16719,804,45.81,1,,1,1,1,1,0,0,1,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,11,DIABETES MELLITUS|PREMEDICATION|NON-SMALL CELL LUNG CANCER|PREMEDICATION|LABORATORY TEST ABNORMAL|NON-SMALL CELL LUNG CANCER|LABORATORY TEST ABNORMAL|PREMEDICATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PREMEDICATION,Alanine aminotransferase increased|Multiple organ dysfunction syndrome|Aspartate aminotransferase increased,3,1
13546767,20170515,Durvalumab,62,801,62.0,1,76,1,0,1,1,0,0,0,Durvalumab,DOXEPIN|DOXEPIN HYDROCHLORIDE|PREGABALIN,7,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Loss of consciousness,1,1
13549273,20170516,Durvalumab,64,801,64.0,1,69,1,1,1,0,0,0,0,Durvalumab,NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|AMOXICILLIN|NAPROXEN|NAPROXEN SODIUM|FENTANYL|TREMELIMUMAB|TREMELIMUMAB|FENTANYL|TREMELIMUMAB,17,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|PHARYNGITIS|PHARYNGITIS|PHARYNGITIS|PHARYNGITIS|CHEST PAIN|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|CHEST PAIN|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Anaemia,1,1
13549345,20170516,Durvalumab,30541,804,83.67,1,,1,0,1,0,0,0,1,Durvalumab,PREDNISONE|PREDNISONE|TREMELIMUMAB|PREDNISONE|TREMELIMUMAB|PREDNISONE|TREMELIMUMAB|TREMELIMUMAB,14,NON-SMALL CELL LUNG CANCER|GASTRITIS PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|PNEUMONITIS|NON-SMALL CELL LUNG CANCER|PNEUMONITIS|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|PNEUMONITIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PNEUMONITIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Acute kidney injury,1,1
13550923,20170516,Durvalumab,67,801,67.0,1,,1,0,1,0,0,0,0,Durvalumab,IRBESARTAN|PANTOPRAZOLE|LORAZEPAM|PANTOPRAZOLE|TREMELIMUMAB|PANCRELIPASE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|DURVALUMAB|OXAZEPAM|PANCRELIPASE|PACLITAXEL|PANTOPRAZOLE,13,HYPERTENSION|GASTROOESOPHAGEAL REFLUX DISEASE|ANXIETY|DYSPEPSIA|PANCREATIC CARCINOMA|PANCREATIC ENZYMES DECREASED|PANCREATIC CARCINOMA|PANCREATIC CARCINOMA|INSOMNIA|RASH|PANCREATIC CARCINOMA|GASTROOESOPHAGEAL REFLUX DISEASE,Colitis,1,1
13551272,20170516,Durvalumab,18939,804,51.89,1,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|ZOLPIDEM TARTRATE|TREMELIMUMAB|ALPRAZOLAM|PANTOPRAZOLE|TREMELIMUMAB,12,BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|INSOMNIA|ANXIETY|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|ANXIETY|GASTRIC DISORDER|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA,Gastroenteritis,1,1
13551371,20170516,Durvalumab,19249,804,52.74,1,,1,0,1,0,0,0,1,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|RIVAROXABAN,13,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PAIN|PAIN|THROMBOPHLEBITIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|THROMBOPHLEBITIS,Ischaemic stroke,1,1
13552184,20170516,Durvalumab,62,801,62.0,1,,1,0,1,0,0,0,0,Durvalumab,STANDARDIZED SENNA CONCENTRATE|DURVALUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PANTOPRAZOLE,8,PULMONARY EMBOLISM|GENITOURINARY TRACT NEOPLASM,Haemorrhage intracranial,1,1
13552420,20170517,Durvalumab,25054,804,68.64,1,,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|MUPIROCIN|MUPIROCIN CALCIUM|ENOXAPARIN SODIUM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|TREMELIMUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FERROUS SULFATE|TREMELIMUMAB,16,NON-SMALL CELL LUNG CANCER|RASH|THROMBOSIS PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ANTIVIRAL PROPHYLAXIS|MUCOSAL INFLAMMATION|MUCOSAL INFLAMMATION|NON-SMALL CELL LUNG CANCER|NAUSEA|ANAEMIA|NON-SMALL CELL LUNG CANCER|RESPIRATORY DISORDER|RASH,Pemphigoid,1,1
13552666,20170517,Durvalumab,19398,804,53.15,1,,1,0,1,0,0,0,1,Durvalumab,TREMELIMUMAB|TREMELIMUMAB,7,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION,Hepatitis acute,1,1
13552757,20170517,Durvalumab,68,801,68.0,1,,1,1,0,0,0,0,0,Durvalumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,3,NON-SMALL CELL LUNG CANCER|PYREXIA,Polymyositis|Myocarditis,2,1
13555044,20170517,Durvalumab,70,801,70.0,1,61,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|GABAPENTIN|TREMELIMUMAB|TREMELIMUMAB|CLONAZEPAM|TREMELIMUMAB,28,HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|DECREASED APPETITE|HEAD AND NECK CANCER METASTATIC|PROPHYLAXIS|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|CONSTIPATION|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|VITAMIN D DEFICIENCY|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC,Pneumonia,1,1
13555073,20170517,Durvalumab,28855,804,79.05,1,,1,1,1,0,0,0,0,Durvalumab,METOPROLOL TARTRATE|METOPROLOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|POLYETHYLENE GLYCOL 3350|UREA|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|OXYCODONE,27,HYPERTENSION|GASTROOESOPHAGEAL REFLUX DISEASE|HYPOKALAEMIA|CONSTIPATION PROPHYLAXIS|OEDEMA PERIPHERAL|VOMITING|BACK PAIN|PULMONARY EMBOLISM|BACK PAIN|NAUSEA|NON-SMALL CELL LUNG CANCER|BACK PAIN|PAIN|CONSTIPATION PROPHYLAXIS|RASH MACULO-PAPULAR|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|MUSCULOSKELETAL CHEST PAIN|RASH MACULO-PAPULAR|NON-SMALL CELL LUNG CANCER|BACK PAIN|HYPERTENSION|HYPOMAGNESAEMIA|PROPHYLAXIS,Polyarthritis,1,1
13555092,20170517,Durvalumab,27738,804,75.99,1,80.6,1,0,1,0,0,0,0,Durvalumab,,2,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Pneumonia,1,1
13557680,20170518,Durvalumab,74,801,74.0,2,,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|GEMCITABINE HYDROCHLORIDE|TREMELIMUMAB|CARBOPLATIN,13,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Gastroenteritis,1,1
13558852,20170518,Durvalumab,28907,804,79.2,1,,1,0,1,1,0,0,0,Durvalumab,"TREMELIMUMAB|MEROPENEM|FUROSEMIDE|FUROSEMIDE|MEROPENEM|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|DEXTROSE ANHYDROUS|FUROSEMIDE|TREMELIMUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|MEROPENEM|DEXTROSE ANHYDROUS|TREMELIMUMAB|MEROPENEM|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|MEROPENEM",78,BLADDER TRANSITIONAL CELL CARCINOMA|HYPOPHYSITIS|HYPOPHYSITIS|HYPOPHYSITIS|HYPOPHYSITIS|HYPOPHYSITIS|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|INSOMNIA|CONSTIPATION|PNEUMONIA|ILEUS|ILEUS|CARDIAC FAILURE|CARDIAC FAILURE|ILEUS|HYPOPHYSITIS|HYPOPHYSITIS|PNEUMONIA|CARDIAC FAILURE|RASH|BLADDER TRANSITIONAL CELL CARCINOMA|HYPOPHYSITIS|HYPOPHYSITIS|ATRIAL FIBRILLATION|HYPOPHYSITIS|INSOMNIA|PHANTOM LIMB SYNDROME|ILEUS|HYPOPHYSITIS|HYPOPHYSITIS|HYPOPHYSITIS|HYPOGLYCAEMIA|CARDIAC FAILURE|CARDIAC FAILURE|ATRIAL FIBRILLATION|CONSTIPATION|HYPOPHYSITIS|HYPOPHYSITIS|HYPOPHYSITIS|BLADDER TRANSITIONAL CELL CARCINOMA|RASH|ILEUS|HYPOPHYSITIS|HYPOPHYSITIS|HYPOPHYSITIS|PNEUMONIA|ILEUS|HYPOGLYCAEMIA|CARDIAC FAILURE|HYPOPHYSITIS|HYPOPHYSITIS|HYPOPHYSITIS|BLADDER TRANSITIONAL CELL CARCINOMA|RASH|HYPERURICAEMIA|HYPOPHYSITIS|HYPOPHYSITIS|HYPOPHYSITIS|HYPOPHYSITIS|PNEUMONIA|ATRIAL FIBRILLATION|ATRIAL FIBRILLATION|HYPOPHYSITIS|HYPOPHYSITIS|RASH|ILEUS|ILEUS|HYPOPHYSITIS|HYPOPHYSITIS|HYPOPHYSITIS|HYPOPHYSITIS|HYPOPHYSITIS|HYPOPHYSITIS|PNEUMONIA|RESTLESSNESS|CARDIAC FAILURE|CARDIAC FAILURE,Ileus|Acute kidney injury|Septic shock,3,1
13558869,20170518,Durvalumab,25526,804,69.93,2,,1,1,1,0,0,0,1,Durvalumab,"TREMELIMUMAB|OXYCODONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OXYCODONE|METOCLOPRAMIDE HYDROCHLORIDE|PROCHLORPERAZINE|TREMELIMUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PANTOPRAZOLE SODIUM|OXYCODONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|OXYCODONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LISINOPRIL|AMLODIPINE|METHYLPREDNISOLONE|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL|BUPROPION HYDROCHLORIDE|MORPHINE|RANITIDINE|OXYCODONE",29,NON-SMALL CELL LUNG CANCER|PAIN|NAUSEA|NON-SMALL CELL LUNG CANCER|PAIN|ABDOMINAL PAIN|NAUSEA|NAUSEA|DIARRHOEA|NON-SMALL CELL LUNG CANCER|PAIN|PROPHYLAXIS|PAIN|NON-SMALL CELL LUNG CANCER|SEASONAL ALLERGY|PAIN|NAUSEA|PAIN|PAIN|BLOOD CREATININE INCREASED|HYPERTENSION|HYPERTENSION|COLITIS|PAIN|DEPRESSION|SUPPLEMENTATION THERAPY|ABDOMINAL PAIN|GASTROOESOPHAGEAL REFLUX DISEASE|PAIN,Small intestinal obstruction,1,1
13559448,20170518,Durvalumab,49,801,49.0,1,,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|AMLODIPINE|TREMELIMUMAB|TREMELIMUMAB|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS,10,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|URINARY TRACT INFECTION,Acute respiratory failure,1,1
13559856,20170518,Durvalumab,15856,804,43.44,1,,1,1,1,1,0,0,0,Durvalumab,OXYCODONE HYDROCHLORIDE|TRAMADOL HYDROCHLORIDE|TREMELIMUMAB|LACTULOSE|TREMELIMUMAB,7,MALIGNANT NEOPLASM OF AMPULLA OF VATER|PAIN|PAIN|MALIGNANT NEOPLASM OF AMPULLA OF VATER|FAECES HARD|MALIGNANT NEOPLASM OF AMPULLA OF VATER|MALIGNANT NEOPLASM OF AMPULLA OF VATER,Platelet count decreased,1,1
13560098,20170518,Durvalumab,958,802,79.83,2,,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|FENTANYL|TREMELIMUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|OXYCODONE|TREMELIMUMAB|TREMELIMUMAB|OXYCODONE,17,BLADDER TRANSITIONAL CELL CARCINOMA|PAIN|BLADDER TRANSITIONAL CELL CARCINOMA|CONSTIPATION|PAIN|BLADDER TRANSITIONAL CELL CARCINOMA|URINARY TRACT INFECTION|NAUSEA|BACK PAIN|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|PROPHYLAXIS|BLADDER TRANSITIONAL CELL CARCINOMA|PYREXIA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|VULVOVAGINAL PAIN,Acute kidney injury,1,1
13560199,20170518,Durvalumab,816,802,68.0,1,,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|DIPYRIDAMOLE,9,AORTIC ANEURYSM|NON-SMALL CELL LUNG CANCER|AORTIC ANEURYSM|NON-SMALL CELL LUNG CANCER|AORTIC ANEURYSM|URINARY RETENTION|BACK PAIN|CONSTIPATION PROPHYLAXIS|NON-SMALL CELL LUNG CANCER,Pericarditis|Pneumonia,2,1
13560429,20170518,Durvalumab,49,801,49.0,1,74,1,1,1,0,0,0,0,Durvalumab,RANITIDINE|RANITIDINE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METRONIDAZOLE|METRONIDAZOLE TOPICAL|FENTANYL|SUFENTANIL|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|RANITIDINE|RANITIDINE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|FENTANYL|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|RANITIDINE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|METRONIDAZOLE|METRONIDAZOLE TOPICAL|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|FENTANYL|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|OXYCODONE|PROPOFOL|FENTANYL|FENTANYL|CEFAZOLIN SODIUM|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|FENTANYL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|FENTANYL|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|RANITIDINE|RANITIDINE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|FENTANYL,78,PROPHYLAXIS|PROPHYLAXIS|DYSPHAGIA|DYSPHAGIA|DYSPHAGIA|PNEUMONIA ASPIRATION|DYSPNOEA|PROPHYLAXIS|DYSPHAGIA|DYSPHAGIA|PNEUMONIA ASPIRATION|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|DYSPHAGIA|DYSPHAGIA|PNEUMONIA ASPIRATION|DYSPHAGIA|PNEUMONIA ASPIRATION|PROPHYLAXIS|PROPHYLAXIS|DYSPHAGIA|DYSPHAGIA|DYSPHAGIA|DYSPHAGIA|PROPHYLAXIS|DYSPHAGIA|PNEUMONIA ASPIRATION|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|GLOSSODYNIA|DYSPHAGIA|DYSPHAGIA|DYSPHAGIA|DYSPHAGIA|PNEUMONIA ASPIRATION|DYSPNOEA|PROPHYLAXIS|PNEUMONIA ASPIRATION|DYSPHAGIA|PROPHYLAXIS|PNEUMONIA ASPIRATION|DYSPNOEA|PROPHYLAXIS|DYSPHAGIA|DYSPHAGIA|PNEUMONIA ASPIRATION|DYSPHAGIA|PNEUMONIA ASPIRATION|DYSPHAGIA|DYSPHAGIA|DYSPHAGIA|PNEUMONIA ASPIRATION|DYSPNOEA|DYSPNOEA|PROPHYLAXIS|PROPHYLAXIS|DYSPHAGIA|PNEUMONIA ASPIRATION|DYSPHAGIA|DYSPHAGIA|PNEUMONIA ASPIRATION|DYSPHAGIA|DYSPHAGIA|PROPHYLAXIS|PROPHYLAXIS|DYSPHAGIA|DYSPHAGIA|DYSPHAGIA|DYSPHAGIA|PROPHYLAXIS|DYSPHAGIA|PNEUMONIA ASPIRATION|DYSPNOEA|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS,Tumour necrosis,1,1
13561178,20170518,Durvalumab,26523,804,72.67,2,,1,1,1,0,0,0,1,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|LEVOTHYROXINE SODIUM,10,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CHEST PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPOTHYROIDISM|NON-SMALL CELL LUNG CANCER,Drug-induced liver injury,1,1
13561195,20170518,Durvalumab,51,801,51.0,1,,1,0,0,0,0,0,1,Durvalumab,ESZOPICLONE|SENNOSIDES|SENNA LEAF|SENNA|LEVETIRACETAM|MIRTAZAPINE|PSYLLIUM HUSK|TOPIRAMATE|TOPIRAMATE SPINKLE|OXYCODONE|LEVETIRACETAM,12,CONSTIPATION|ANTICONVULSANT DRUG LEVEL|INSOMNIA|DYSPEPSIA|SUPPLEMENTATION THERAPY|HEADACHE|PAIN|NAUSEA|GLIOBLASTOMA|GLIOBLASTOMA|ANTICONVULSANT DRUG LEVEL,Drug-induced liver injury,1,1
13561300,20170518,Durvalumab,22492,804,61.62,1,73.5,1,0,1,0,0,0,0,Durvalumab,,2,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Gastrointestinal haemorrhage,1,1
13561895,20170518,Durvalumab,19859,804,54.41,1,79.5,1,0,1,0,0,0,0,Durvalumab,IPRATROPIUM BROMIDE|LORAZEPAM|TIOTROPIUM BROMIDE|ESOMEPRAZOLE MAGNESIUM,8,CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|GASTRIC DISORDER|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Enterocolitis haemorrhagic,1,1
13562250,20170519,Durvalumab,26111,804,71.54,1,,1,1,1,0,0,0,0,Durvalumab,ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|TREMELIMUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|AMLODIPINE|RABEPRAZOLE SODIUM|RABEPRAZOLE|TREMELIMUMAB|TREMELIMUMAB,18,BLADDER TRANSITIONAL CELL CARCINOMA|PROPHYLAXIS|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|CHRONIC GASTRITIS|TYPE 2 DIABETES MELLITUS|DYSLIPIDAEMIA|DECREASED APPETITE|BLADDER TRANSITIONAL CELL CARCINOMA|HYPERTENSION|BLADDER TRANSITIONAL CELL CARCINOMA|TYPE 2 DIABETES MELLITUS|BLADDER TRANSITIONAL CELL CARCINOMA|GASTROOESOPHAGEAL REFLUX DISEASE|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|ABDOMINAL PAIN,Interstitial lung disease,1,1
13564149,20170519,Durvalumab,78,801,78.0,1,57,1,0,1,0,0,0,0,Durvalumab,RANITIDINE|RANITIDINE|TRANEXAMIC ACID|TRANEXAMIC ACID|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|AZACITIDINE|AZACITIDINE FOR|RANITIDINE|RANITIDINE|TRANEXAMIC ACID|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|RANITIDINE|PREDNISONE|AZACITIDINE|AZACITIDINE FOR|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|PREDNISONE|RANITIDINE|TRANEXAMIC ACID,23,ACUTE MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING|PRODUCT USED FOR UNKNOWN INDICATION|HAEMORRHAGE PROPHYLAXIS|ANTIBIOTIC THERAPY|ANTIVIRAL TREATMENT|ACUTE MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS OF NAUSEA AND VOMITING|HAEMORRHAGE PROPHYLAXIS|ANTIBIOTIC THERAPY|ACUTE MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|RASH|ACUTE MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RASH|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia|Interstitial lung disease|Febrile neutropenia|Pneumonia,4,1
13564646,20170519,Durvalumab,28532,804,78.17,2,,1,1,1,0,0,0,0,Durvalumab,FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|VALSARTAN|VALSARTAN ORAL|BETAMETHASONE VALERATE|BETAMETHASONE VALERATE FOAM|TREMELIMUMAB|DIFLUPREDNATE OPHTHALMIC|DIFLUPREDNATE|CELECOXIB|TREMELIMUMAB|TREMELIMUMAB,15,PRURITUS|GASTRITIS PROPHYLAXIS|PRURITUS|HYPERTENSION|PRURITUS|BLADDER TRANSITIONAL CELL CARCINOMA|ECZEMA|HYPERTENSION|BLADDER TRANSITIONAL CELL CARCINOMA|BACK PAIN|BLADDER TRANSITIONAL CELL CARCINOMA|OSTEOPOROSIS|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA,Hypopituitarism,1,1
13564801,20170519,Durvalumab,69,801,69.0,2,66.3,1,0,1,0,0,0,0,Durvalumab,METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PANTOPRAZOLE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MICONAZOLE|MICONAZOLE NITRATE|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|CALCIUM CARBONATE|ANTACID|ERGOCALCIFEROL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FLUCONAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,26,FEBRILE NEUTROPENIA|URINARY TRACT INFECTION|ANTIEMETIC SUPPORTIVE CARE|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|GASTRITIS PROPHYLAXIS|LAXATIVE SUPPORTIVE CARE|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|VAGINAL INFECTION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|HYPOKALAEMIA|OSTEOPOROSIS PROPHYLAXIS|OSTEOPOROSIS PROPHYLAXIS|INFECTION PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|INFECTION PROPHYLAXIS|THROMBOSIS PROPHYLAXIS|FEBRILE NEUTROPENIA,Pyrexia|Febrile neutropenia,2,1
13569351,20170522,Durvalumab,17377,804,47.61,2,,1,0,0,0,0,0,1,Durvalumab,TREMELIMUMAB|FOLIC ACID,3,NON-SMALL CELL LUNG CANCER|PREMEDICATION|NON-SMALL CELL LUNG CANCER,Drug-induced liver injury,1,1
13570980,20170523,Durvalumab,71,801,71.0,2,,1,1,0,0,0,0,0,Durvalumab,STANDARDIZED SENNA CONCENTRATE|POLYETHYLENE GLYCOL|FUROSEMIDE|DURVALUMAB|ALBUTEROL SULFATE|ACETAMINOPHEN|TREMELIMUMAB,11,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Respiratory failure,1,1
13570981,20170523,Durvalumab,64,801,64.0,1,107.6,1,0,0,0,0,0,1,Durvalumab,TREMELIMUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Amylase increased,1,1
13572076,20170523,Durvalumab,49,801,49.0,2,139,1,0,1,0,0,0,0,Durvalumab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PACLITAXEL",8,TRIPLE NEGATIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|TRIPLE NEGATIVE BREAST CANCER|TRIPLE NEGATIVE BREAST CANCER|TRIPLE NEGATIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Syncope,1,3
13572101,20170523,Durvalumab,74,801,74.0,2,,1,0,1,0,0,0,0,Durvalumab,CARBOPLATIN|DOCETAXEL|DOCETAXEL ANHYDROUS|LEVOTHYROXINE SODIUM|CISPLATIN,8,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Nausea|Adrenal insufficiency,2,1
13572842,20170523,Durvalumab,27624,804,75.68,1,,1,0,1,0,0,0,0,Durvalumab,FEXOFENADINE HCL,7,SEASONAL ALLERGY|SEASONAL ALLERGY|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SEASONAL ALLERGY|SEASONAL ALLERGY|SEASONAL ALLERGY|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Arthralgia,1,1
13573399,20170523,Durvalumab,56,801,56.0,2,,1,0,1,0,0,0,0,Durvalumab,GEMCITABINE HYDROCHLORIDE|TREMELIMUMAB,4,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA|PANCREATIC CARCINOMA|PANCREATIC CARCINOMA,Skin infection,1,1
13573547,20170523,Durvalumab,58,801,58.0,2,82,1,0,0,0,0,0,1,Durvalumab,PACLITAXEL|PACLITAXEL,3,BREAST CANCER|BREAST CANCER,Chills,1,3
13574134,20170523,Durvalumab,24080,804,65.97,2,,1,0,0,0,0,0,1,Durvalumab,TREMELIMUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Drug-induced liver injury,1,1
13574208,20170523,Durvalumab,15617,804,42.79,2,73.3,1,0,1,0,0,0,0,Durvalumab,DURVALUMAB,1,TARGETED CANCER THERAPY,Hypotension|Headache|Fatigue|Diarrhoea,4,1
13574886,20170523,Durvalumab,68,801,68.0,1,64.9,1,0,1,0,0,0,0,Durvalumab,CLOPIDOGREL|TREMELIMUMAB|TREMELIMUMAB|ROSUVASTATIN|TREMELIMUMAB,15,CEREBRAL INFARCTION|BLADDER CANCER|HYPERTENSION|BLADDER CANCER|PROPHYLAXIS|BLADDER CANCER|HYPERCHOLESTEROLAEMIA|BLADDER CANCER|BLADDER CANCER|HYPERTENSION|BLADDER CANCER|BLADDER CANCER|BLADDER CANCER|BLADDER CANCER|BLADDER CANCER,Pericarditis,1,1
13576887,20170524,Durvalumab,27036,804,74.07,1,76,1,1,1,1,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|SPIRONOLACTONE|TREMELIMUMAB|AMOXICILLIN AND CLAVULANATE POTASSIUM,20,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|MYOCARDIAL INFARCTION|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PERIPHERAL ARTERIAL OCCLUSIVE DISEASE|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|MYOCARDIAL INFARCTION|MYOCARDIAL INFARCTION|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|MYOCARDIAL INFARCTION|MYOCARDIAL INFARCTION|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Lung disorder,1,1
13577365,20170524,Durvalumab,20946,804,57.39,1,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|URSODIOL|URSOSIOL|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB,11,NON-SMALL CELL LUNG CANCER|HYPOTHYROIDISM|ASPARTATE AMINOTRANSFERASE INCREASED|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Interstitial lung disease|Blood creatine phosphokinase increased,2,1
13577366,20170524,Durvalumab,25011,804,68.52,1,,1,0,1,0,0,0,0,Durvalumab,ERYTHROMYCIN|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|OXYGEN|0XYGEN|TIOTROPIUM BROMIDE,39,NON-SMALL CELL LUNG CANCER|IMPAIRED GASTRIC EMPTYING|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|GASTROOESOPHAGEAL REFLUX PROPHYLAXIS|HYPERTENSION|ISCHAEMIC CARDIOMYOPATHY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ISCHAEMIC CARDIOMYOPATHY|PROPHYLAXIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|ABDOMINAL PAIN|DYSPNOEA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CHEST PAIN|PROPHYLAXIS AGAINST DIARRHOEA|SMALL INTESTINAL OBSTRUCTION|PAIN PROPHYLAXIS|PAIN PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PAIN PROPHYLAXIS|DYSPNOEA|DYSPNOEA|PAIN PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|GASTROOESOPHAGEAL REFLUX PROPHYLAXIS|DYSPNOEA|PAIN PROPHYLAXIS,Vocal cord paralysis,1,1
13577842,20170524,Durvalumab,27286,804,74.76,1,82,1,0,1,0,0,0,0,Durvalumab,,3,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Peripheral artery occlusion,1,1
13577885,20170524,Durvalumab,59,801,59.0,2,58.5,1,0,1,0,0,0,0,Durvalumab,"LEVOTHYROXINE SODIUM|ATORVASTATIN CALCIUM|LORAZEPAM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|AZITHROMYCIN DIHYDRATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|OMEPRAZOLE MAGNESIUM|LOSARTAN POTASSIUM|OXYCODONE|ALBUTEROL SULFATE|ALBUTEROL|TREMELIMUMAB|CARVEDILOL|CLOPIDOGREL",19,NON-SMALL CELL LUNG CANCER|PAIN|NON-SMALL CELL LUNG CANCER,Pneumonitis,1,1
13577991,20170524,Durvalumab,48,801,48.0,1,89,1,0,1,0,0,0,0,Durvalumab,LEVETIRACETAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|TREMELIMUMAB|FLUOXETINE HYDROCHLORIDE|BACLOFEN,12,DEPRESSION|NEUROPATHY PERIPHERAL|CONSTIPATION|EAR PAIN|SEIZURE PROPHYLAXIS|PRODUCTIVE COUGH|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|DEPRESSION|NON-SMALL CELL LUNG CANCER|DEPRESSION|DEPRESSION,Pericarditis,1,1
13578004,20170524,Durvalumab,51,801,51.0,2,75.3,1,0,0,0,0,0,1,Durvalumab,MINOCYCLINE|NEBIVOLOL HYDROCHLORIDE|DULOXETINE HYDROCHLORIDE|TRAMETINIB,7,DERMATITIS ACNEIFORM|METASTATIC MALIGNANT MELANOMA|DERMATITIS ACNEIFORM|HYPERTENSION|DEPRESSION|LACRIMATION INCREASED|METASTATIC MALIGNANT MELANOMA,Choroidal effusion,1,1
13579828,20170525,Durvalumab,24803,804,67.95,1,,1,1,1,1,0,0,0,Durvalumab,,1,NEOPLASM MALIGNANT,Polymyositis,1,1
13579865,20170525,Durvalumab,22471,804,61.56,1,73.5,1,0,1,0,0,0,0,Durvalumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,5,TUMOUR PAIN|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|TUMOUR PAIN|GASTRIC DISORDER,Colitis ulcerative,1,1
13582149,20170525,Durvalumab,25862,804,70.85,2,,1,0,1,0,0,0,1,Durvalumab,"SIMVASTATIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|TREMELIMUMAB|TREMELIMUMAB",8,BLADDER TRANSITIONAL CELL CARCINOMA|THYROIDECTOMY|HYPERCHOLESTEROLAEMIA|MUSCULOSKELETAL CHEST PAIN|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|DIABETES MELLITUS|BLADDER TRANSITIONAL CELL CARCINOMA,Acute kidney injury,1,1
13582220,20170525,Durvalumab,27408,804,75.09,1,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB,17,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|BENIGN PROSTATIC HYPERPLASIA|NON-SMALL CELL LUNG CANCER|CEREBROVASCULAR ACCIDENT|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|BENIGN PROSTATIC HYPERPLASIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Toxic skin eruption,1,1
13582424,20170525,Durvalumab,26378,804,72.27,1,,1,1,1,0,0,0,1,Durvalumab,TREMELIMUMAB|OLMESARTAN MEDOXOMIL|TREMELIMUMAB|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|TREMELIMUMAB|TREMELIMUMAB|NIFEDIPINE|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|ALLOPURINOL,17,BLADDER TRANSITIONAL CELL CARCINOMA|HYPERTENSION|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|ILEUS|PRURITUS|DRY SKIN|BLADDER TRANSITIONAL CELL CARCINOMA|PRURITUS|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|HYPERTENSION|PRURITUS|PRURITUS|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|HYPERURICAEMIA,Pneumonia|Hypopituitarism,2,1
13582448,20170525,Durvalumab,70,801,70.0,1,85.3,1,0,0,0,0,0,1,Durvalumab,"METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|MULTIVITAMIN|DENOSUMAB|OLAPARIB|MELOXICAM|ROSUVASTATIN|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|ERGOCALCIFEROL|OLAPARIB|FISH OIL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",14,PROSTATE CANCER|PROSTATE CANCER|PROSTATE CANCER,Arthritis,1,1
13582525,20170525,Durvalumab,46,801,46.0,1,58,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|DRONABINOL|ALPRAZOLAM|GABAPENTIN|TREMELIMUMAB,10,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|DECREASED APPETITE|ANXIETY|NEUROPATHY PERIPHERAL|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|DIABETES MELLITUS|NAUSEA|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Abdominal pain|Duodenitis|Diarrhoea|Coeliac disease,4,1
13585152,20170526,Durvalumab,69,801,69.0,1,96,1,0,1,0,0,0,0,Durvalumab,PREGABALIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|MAGNESIUM|PREGABALIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|POMALIDOMIDE|POMALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,23,NEUROPATHY PERIPHERAL|INFECTION PROPHYLAXIS|PLASMA CELL MYELOMA|THROMBOSIS PROPHYLAXIS|MUSCLE SPASMS|PAIN|BONE PAIN|PLASMA CELL MYELOMA|METABOLIC ACIDOSIS|RHINOVIRUS INFECTION|RHINOVIRUS INFECTION|HYPERKALAEMIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|VITAMIN D|INFECTION PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|INFECTION PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Pneumonia|Acute kidney injury,2,1
13586241,20170526,Durvalumab,51,801,51.0,2,75.24,1,0,0,0,0,0,1,Durvalumab,NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|CLINDAMYCIN PHOSPHATE|DULOXETINE HYDROCHLORIDE|MINOCYCLINE,7,HYPERTENSION|DERMATITIS ACNEIFORM|DEPRESSION|METASTATIC MALIGNANT MELANOMA|LACRIMATION INCREASED|METASTATIC MALIGNANT MELANOMA|DERMATITIS ACNEIFORM,Choroidal effusion,1,5
13586265,20170526,Durvalumab,26647,804,73.01,2,61.5,1,0,1,0,0,0,0,Durvalumab,"OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FUROSEMIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|FILGRASTIM|LORAZEPAM|AZACITIDINE|AZACITIDINE FOR|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|SIMVASTATIN|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PANTOPRAZOLE|ALLOPURINOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PANTOPRAZOLE",38,DENTAL DISORDER PROPHYLAXIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|INFECTION PROPHYLAXIS|PAIN|GASTRITIS PROPHYLAXIS|PAIN|POLYURIA|PROPHYLAXIS OF NAUSEA AND VOMITING|DENTAL DISORDER PROPHYLAXIS|NEUTROPENIA|PROPHYLAXIS|MYELODYSPLASTIC SYNDROME|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS|PAIN|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|INFECTION PROPHYLAXIS|FLUID REPLACEMENT|PROPHYLAXIS|PROPHYLAXIS|HYPERCHOLESTEROLAEMIA|ANTIFUNGAL PROPHYLAXIS|FLUID REPLACEMENT|PROPHYLAXIS|GASTRITIS PROPHYLAXIS|PAIN|HYPERURICAEMIA|SEASONAL ALLERGY|MYELODYSPLASTIC SYNDROME|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|GASTRITIS PROPHYLAXIS|PAIN|FLUID REPLACEMENT|THROMBOSIS PROPHYLAXIS,Pneumonia,1,1
13586382,20170526,Durvalumab,24077,804,65.96,2,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB,6,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER,Autoimmune pancreatitis,1,1
13586424,20170526,Durvalumab,21056,804,57.69,2,,1,1,1,1,0,0,1,Durvalumab,METHYLPREDNISOLONE|TREMELIMUMAB|METHYLPREDNISOLONE|ASCORBIC ACID|ASCORBIC ACID|TREMELIMUMAB,16,METABOLIC CARDIOMYOPATHY|DIARRHOEA|PROPHYLAXIS|SMALL CELL LUNG CANCER EXTENSIVE STAGE|DIARRHOEA|PROPHYLAXIS|FATIGUE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|METABOLIC CARDIOMYOPATHY|PROPHYLAXIS|FATIGUE|PROPHYLAXIS|FATIGUE|FATIGUE|SMALL CELL LUNG CANCER EXTENSIVE STAGE,Enterocolitis haemorrhagic|Diarrhoea,2,1
13586437,20170526,Durvalumab,23811,804,65.24,2,,1,1,1,1,0,0,0,Durvalumab,"PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|GABAPENTIN|MORPHINE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|BISOPROLOL FUMARATE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",20,BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|DEEP VEIN THROMBOSIS|BLADDER TRANSITIONAL CELL CARCINOMA|PROPHYLAXIS|CANCER PAIN|DEEP VEIN THROMBOSIS|DEEP VEIN THROMBOSIS|INFECTION|PROPHYLAXIS|INFECTION|HYPERTENSION|ULCER|CANCER PAIN|CANCER PAIN|HYPERTENSION|COCCYDYNIA|ULCER|CANCER PAIN|CANCER PAIN,Renal failure|Confusional state|Osteomyelitis|Liver function test increased,4,1
13586457,20170526,Durvalumab,18262,804,50.03,2,,1,0,1,1,0,0,1,Durvalumab,"LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|TREMELIMUMAB|PREGABALIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREGABALIN|LORAZEPAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|NAPROXEN|NAPROXEN SODIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|LACTULOSE|OXYCODONE",19,CANCER PAIN|CANCER PAIN|LOWER RESPIRATORY TRACT INFECTION|NON-SMALL CELL LUNG CANCER|CANCER PAIN|CANCER PAIN|CANCER PAIN|CANCER PAIN|CANCER PAIN|INSOMNIA|EPIGASTRIC DISCOMFORT|CANCER PAIN|CONSTIPATION|NON-SMALL CELL LUNG CANCER|CANCER PAIN|CONSTIPATION|CONSTIPATION|CANCER PAIN|SUPPLEMENTATION THERAPY,Constipation|Autoimmune hepatitis,2,1
13586525,20170526,Durvalumab,24890,804,68.19,2,73,1,0,1,0,0,0,0,Durvalumab,AZACITIDINE|AZACITIDINE FOR,2,ACUTE MYELOID LEUKAEMIA|ACUTE MYELOID LEUKAEMIA,Thrombocytopenia,1,1
13586709,20170526,Durvalumab,23252,804,63.7,1,,1,1,1,1,1,0,1,Durvalumab,TREMELIMUMAB|HYDROCHLOROTHIAZIDE|DICLOFENAC|DICLOFENAC SODIUM|VALSARTAN|VALSARTAN ORAL|TREMELIMUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,16,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CANCER PAIN|HYPERTENSION|PAIN|HYPERTENSION|NON-SMALL CELL LUNG CANCER|ULCER|CANCER PAIN|PROPHYLAXIS|DIABETES MELLITUS|PNEUMONIA|AUTOIMMUNE THYROIDITIS|DIABETES MELLITUS|DIABETES MELLITUS,Neutropenia|Hepatitis,2,1
13591068,20170529,Durvalumab,26774,804,73.35,1,68,1,1,1,0,0,0,0,Durvalumab,IBRUTINIB|PREDNISONE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE,4,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA,Compression fracture|Dyspnoea|Ascites|Sepsis,4,1
13591171,20170529,Durvalumab,27627,804,75.69,2,,1,1,1,1,0,0,1,Durvalumab,SERTRALINE|TREMELIMUMAB,8,NON-SMALL CELL LUNG CANCER|ANTIDEPRESSANT THERAPY|PROPHYLAXIS|HYPOTHYROIDISM|PAIN|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|DYSLIPIDAEMIA,Embolism,1,1
13592130,20170529,Durvalumab,55,801,55.0,2,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|DURVALUMAB,2,COLORECTAL CANCER|COLORECTAL CANCER,Immune-mediated hepatitis,1,1
13593730,20170530,Durvalumab,842,802,70.17,1,,1,0,1,0,0,0,0,Durvalumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|SIMVASTATIN|RAMIPRIL|TREMELIMUMAB|RAMIPRIL,26,NON-SMALL CELL LUNG CANCER|TRANSIENT ISCHAEMIC ATTACK|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERCHOLESTEROLAEMIA|NON-SMALL CELL LUNG CANCER|HYPERTENSION|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|TRANSIENT ISCHAEMIC ATTACK|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|TRANSIENT ISCHAEMIC ATTACK,Secondary adrenocortical insufficiency,1,1
13594803,20170530,Durvalumab,49,801,49.0,1,74,1,1,1,0,0,0,0,Durvalumab,OXYCODONE,3,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Pneumonia aspiration|Pneumonitis,2,1
13595006,20170531,Durvalumab,29069,804,79.64,2,,1,0,0,0,0,0,1,Durvalumab,TREMELIMUMAB|KETOTIFEN FUMARATE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|TREMELIMUMAB|MAGNESIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ATENOLOL|METRONIDAZOLE|METRONIDAZOLE TOPICAL|TREMELIMUMAB|TREMELIMUMAB|OMEPRAZOLE MAGNESIUM|SIMVASTATIN|LISINOPRIL,28,NON-SMALL CELL LUNG CANCER|SEASONAL ALLERGY|DRY MOUTH|PELVIC INFECTION|NON-SMALL CELL LUNG CANCER|NUTRITIONAL SUPPLEMENTATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|PAIN MANAGEMENT|COUGH|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NUTRITIONAL SUPPLEMENTATION|NON-SMALL CELL LUNG CANCER|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|PELVIC INFECTION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ULCER|HYPERLIPIDAEMIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PAIN MANAGEMENT|HYPERTENSION|HYPERLIPIDAEMIA,Nephritis,1,1
13595169,20170531,Durvalumab,24046,804,65.88,1,,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TIOTROPIUM BROMIDE|RAMELTEON|CETIRIZINE HCL|CETIRIZINE,25,DRUG ERUPTION|BRAIN OEDEMA|CONSTIPATION|DRUG ERUPTION|CANCER PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|BRAIN OEDEMA|RASH|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|BRAIN OEDEMA|CONSTIPATION|DRUG ERUPTION|BRAIN OEDEMA|BRAIN OEDEMA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|INSOMNIA|SEASONAL ALLERGY|DRUG ERUPTION|BRAIN OEDEMA|BRAIN OEDEMA|SEASONAL ALLERGY,Herpes zoster,1,1
13597130,20170531,Durvalumab,51,801,51.0,1,72.5,1,1,1,1,0,0,0,Durvalumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALLOPURINOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM,5,GASTRITIS PROPHYLAXIS|BLOOD URIC ACID|ANTIVIRAL PROPHYLAXIS|LYMPHOMA|PNEUMOCYSTIS JIROVECII PNEUMONIA,Gastrointestinal perforation|Cytopenia|Streptococcal infection,3,1
13597800,20170531,Durvalumab,32600,804,89.32,1,73,1,0,1,0,0,0,0,Durvalumab,RANITIDINE|WARFARIN,5,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|GASTROOESOPHAGEAL REFLUX DISEASE|ATRIAL FIBRILLATION,Lower gastrointestinal haemorrhage,1,1
13598140,20170531,Durvalumab,76,801,76.0,1,73,1,0,1,0,0,0,1,Durvalumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CARVEDILOL|FUROSEMIDE|DIAZEPAM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,10,HEPATOCELLULAR CARCINOMA|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION|OEDEMA|HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|ANXIETY|NUTRITIONAL SUPPLEMENTATION|CARDIOVASCULAR EVENT PROPHYLAXIS|NUTRITIONAL SUPPLEMENTATION,Diabetic ketoacidosis,1,1
13598742,20170531,Durvalumab,924,802,77.0,2,,1,0,1,0,0,0,1,Durvalumab,NIFEDIPINE|ALLOPURINOL|TREMELIMUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DICLOFENAC|DICLOFENAC SODIUM|TREMELIMUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|VALSARTAN|VALSARTAN ORAL|TREMELIMUMAB|TREMELIMUMAB|VALSARTAN|VALSARTAN ORAL,38,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|GOUT|NON-SMALL CELL LUNG CANCER|NAUSEA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|SPINAL FRACTURE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NAUSEA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|PROPHYLAXIS|BREAST PAIN|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|COAGULOPATHY|HYPERTENSION|CONSTIPATION|PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Secondary adrenocortical insufficiency,1,1
13598852,20170531,Durvalumab,782,802,65.17,1,,1,1,0,0,0,0,1,Durvalumab,FOLIC ACID,10,NON-SMALL CELL LUNG CANCER|CONSTIPATION|METASTASES TO BONE|PREMEDICATION|METASTASES TO BONE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|METASTASES TO BONE|PREMEDICATION|PROPHYLAXIS,Hypersensitivity,1,1
13598865,20170531,Durvalumab,73,801,73.0,1,,1,1,1,0,0,0,0,Durvalumab,IBRUTINIB|IBRUTINIB|PREDNISONE,5,PANCREATIC CARCINOMA|AUTOIMMUNE HEPATITIS|PANCREATIC CARCINOMA|AUTOIMMUNE HEPATITIS,Compression fracture|Sepsis|Dyspnoea|Ascites,4,1
13598929,20170531,Durvalumab,69,801,69.0,2,107.8,1,0,1,0,0,0,0,Durvalumab,"ERGOCALCIFEROL|GLIMEPIRIDE|LEVOTHYROXINE SODIUM|MAGNESIUM OXIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|HYDRALAZINE HYDROCHLORIDE|INSULIN ASPART|MULTIVITAMIN|CABOZANTINIB|CYANOCOBALAMIN|HYDROCHLOROTHIAZIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SPIRONOLACTONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FENTANYL|LOSARTAN|CELECOXIB|INSULIN GLARGINE-YFGN|INSULIN GLARGINE",28,NAUSEA|METASTATIC RENAL CELL CARCINOMA|RENAL CANCER|METASTATIC RENAL CELL CARCINOMA|PAIN|METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA,Myalgia|Arthralgia,2,1
13598966,20170531,Durvalumab,18645,804,51.08,1,,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|HUMAN INSULIN,3,SMALL CELL LUNG CANCER|TYPE 2 DIABETES MELLITUS|SMALL CELL LUNG CANCER,Hepatic function abnormal,1,1
13598995,20170531,Durvalumab,24722,804,67.73,1,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|DOXAZOSIN|DOXAZOSIN MESYLATE|TREMELIMUMAB|TREMELIMUMAB|CLOPIDOGREL,22,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NON-SMALL CELL LUNG CANCER|HYPERTENSION|RASH|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CONSTIPATION|CEREBRAL INFARCTION,Fulminant type 1 diabetes mellitus,1,1
13599849,20170601,Durvalumab,9836,804,26.95,2,,1,0,1,0,0,0,0,Durvalumab,SENNOSIDES|SENNA LEAF|SENNA,5,METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA,Pleural effusion,1,1
13600048,20170601,Durvalumab,25784,804,70.64,1,,1,1,1,0,0,0,1,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB,8,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Fatigue,1,1
13600479,20170601,Durvalumab,20407,804,55.91,1,69,1,1,1,0,0,0,0,Durvalumab,"OLAPARIB|ESCITALOPRAM OXALATE|ESCITALOPRAM|PROCHLORPERAZINE MALEATE|MIRTAZAPINE|PSEUDOEPHEDRINE HYDROCHLORIDE|PSEUDOEPHEDRINE HCL|OLAPARIB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ESCITALOPRAM OXALATE|ESCITALOPRAM|TIOTROPIUM BROMIDE INHALATION SPRAY|CLOPIDOGREL BISULFATE|MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE",19,SQUAMOUS CELL CARCINOMA OF LUNG|DEPRESSION|NAUSEA|DECREASED APPETITE|DEPRESSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|UPPER-AIRWAY COUGH SYNDROME|SQUAMOUS CELL CARCINOMA OF LUNG|SQUAMOUS CELL CARCINOMA OF LUNG|FLANK PAIN|BACK PAIN|PROPHYLAXIS|ANXIETY|DECREASED APPETITE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CORONARY ARTERY DISEASE|PROPHYLAXIS|PROPHYLAXIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Pneumonia,1,1
13600553,20170601,Durvalumab,27965,804,76.62,1,,1,0,0,0,0,0,1,Durvalumab,ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CITALOPRAM|CITALOPRAM HYDROBROMIDE|MORPHINE SULFATE|PREGABALIN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FLUCONAZOLE|LACTULOSE|POLYMYXIN B SULFATE|POLYMYXIN B|SENNOSIDES|SENNA LEAF|SENNA|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|FERROUS SULFATE|AMOXICILLIN|ACYCLOVIR,64,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DYSPEPSIA|CATARACT OPERATION|CONSTIPATION|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DYSPEPSIA|DEPRESSION|RESPIRATORY TRACT INFECTION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CONSTIPATION|BACK PAIN|PAIN|BACK PAIN|BRONCHIECTASIS|ADRENAL INSUFFICIENCY|THROMBOCYTOPENIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING|PAIN|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|BACK PAIN|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CATARACT OPERATION|CONSTIPATION|ADRENAL INSUFFICIENCY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|BENIGN PROSTATIC HYPERPLASIA|IRON DEFICIENCY|PAIN|LOWER RESPIRATORY TRACT INFECTION|PROPHYLAXIS,Colitis|Thrombocytopenia,2,1
13600760,20170601,Durvalumab,53,801,53.0,2,68,1,0,1,0,0,0,0,Durvalumab,PANTOPRAZOLE,36,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CANCER PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|EAR DISORDER|EAR DISORDER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPOTHYROIDISM|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|GASTRIC ULCER|CANCER PAIN|NON-SMALL CELL LUNG CANCER,Contrast media allergy|Coronary artery disease|Tachycardia|Atrioventricular block complete|Arteriospasm coronary|Troponin increased|Atrial fibrillation,7,1
13602310,20170601,Durvalumab,24792,804,67.92,1,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB,2,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Parotitis,1,1
13602446,20170601,Durvalumab,23750,804,65.07,1,68.9,1,0,1,0,0,0,0,Durvalumab,AMLODIPINE,9,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|DIABETES MELLITUS|PROPHYLAXIS|HYPERTENSION|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|HYPERTENSION|PAIN|DYSLIPIDAEMIA|OSTEOARTHRITIS,Haemorrhage,1,1
13602592,20170601,Durvalumab,21401,804,58.63,1,97,1,0,1,0,0,0,1,Durvalumab,TREMELIMUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|TREMELIMUMAB|SIMVASTATIN|TADALAFIL|TREMELIMUMAB|TREMELIMUMAB|GLIMEPIRIDE,20,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HAEMATURIA|NON-SMALL CELL LUNG CANCER|PAIN|NON-SMALL CELL LUNG CANCER|HYPERCHOLESTEROLAEMIA|ERECTILE DYSFUNCTION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|BLOOD CREATININE INCREASED|NON-SMALL CELL LUNG CANCER|TYPE 2 DIABETES MELLITUS|DEHYDRATION|PROTEINURIA|NON-SMALL CELL LUNG CANCER|TYPE 2 DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS,Pyrexia,1,1
13602692,20170601,Durvalumab,64,801,64.0,1,61,1,0,1,0,0,0,0,Durvalumab,"MORPHINE SULFATE|CAMPHOR AND MENTHOL|PRAMOXINE HYDROCHLORIDE|COLLOIDAL OATMEAL|PRAMOXINE HYDROCHLORIDE, MENTHOL|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE|PANTOPRAZOLE|TREMELIMUMAB|PREDNISONE|PREDNISONE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|INSULIN LISPRO|METHYLPREDNISOLONE|SPIRONOLACTONE|LISINOPRIL|SENNOSIDES|SENNA LEAF|SENNA|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXYCODONE|HYDROCHLOROTHIAZIDE|INSULIN HUMAN|GABAPENTIN",22,HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA,Hyperglycaemia|Hypophosphataemia|Skin disorder|Oedema|Pruritus|Lichenoid keratosis|Dermatitis bullous,7,1
13602743,20170601,Durvalumab,15018,804,41.15,1,76,1,0,1,1,1,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|METHYLPREDNISOLONE|TREMELIMUMAB,24,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPOTHYROIDISM|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPOTHYROIDISM|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTHYROIDISM|HYPERTHYROIDISM|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Acute psychosis,1,1
13602814,20170601,Durvalumab,922,802,76.83,2,,1,0,1,0,0,0,0,Durvalumab,SIMVASTATIN|PREDNISONE|CLOPIDOGREL|CLOPIDOGREL BISULFATE|LOSARTAN,17,BLADDER TRANSITIONAL CELL CARCINOMA|HYPERCHOLESTEROLAEMIA|CHEST PAIN|BLADDER TRANSITIONAL CELL CARCINOMA|GASTROOESOPHAGEAL REFLUX DISEASE|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|PRURITUS|PRURITUS|EMBOLISM|HYPERTENSION|GASTROOESOPHAGEAL REFLUX DISEASE|GASTROOESOPHAGEAL REFLUX DISEASE|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|HEPATITIS|HYPERTENSION,Acute myocardial infarction,1,1
13608479,20170602,Durvalumab,24002,804,65.76,1,,1,1,1,1,0,0,0,Durvalumab,EZETIMIBE AND SIMVASTATIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ERGOCALCIFEROL|LORATADINE|LORATADINE TABLET|OXYGEN|0XYGEN|TIOTROPIUM BROMIDE|GEMFIBROZIL,17,NON-SMALL CELL LUNG CANCER|HYPERLIPIDAEMIA|CORONARY ARTERY DISEASE|NON-SMALL CELL LUNG CANCER|VITAMIN D DEFICIENCY|ANAESTHESIA|SEASONAL ALLERGY|DYSPNOEA|ASTHMA|MEDICAL DIET|NON-SMALL CELL LUNG CANCER|ASTHMA|PROPHYLAXIS|HYPERLIPIDAEMIA|NON-SMALL CELL LUNG CANCER|VITAMIN B12 DEFICIENCY|DYSPNOEA,Respiratory failure|Pneumonitis,2,1
13608901,20170602,Durvalumab,17678,804,48.43,2,,1,0,1,0,0,0,0,Durvalumab,SENNOSIDES|SENNA LEAF|SENNA,20,HEADACHE|HEADACHE|NEOPLASM|NEOPLASM|PAIN|PAIN|CONSTIPATION|NEOPLASM|CONSTIPATION|NEOPLASM|PAIN|PAIN|INSOMNIA|NEOPLASM|NEOPLASM|NEOPLASM|NEOPLASM|NEOPLASM|NEOPLASM|NEOPLASM,Dyspnoea,1,1
13612396,20170605,Durvalumab,27320,804,74.85,1,,1,0,1,0,0,0,0,Durvalumab,"TREMELIMUMAB|OXYCODONE HYDROCHLORIDE|OXYCODONE|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE|ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES|MEGESTROL ACETATE|TREMELIMUMAB|TREMELIMUMAB|MAGNESIUM OXIDE|ATENOLOL",14,NON-SMALL CELL LUNG CANCER|CHEST PAIN|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DECREASED APPETITE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRODUCTIVE COUGH|ANGINA PECTORIS|PRODUCTIVE COUGH|CHEST PAIN|HYPERTENSION,Lipase increased|Diarrhoea,2,1
13612434,20170605,Durvalumab,73,801,73.0,1,84,1,0,1,0,0,0,0,Durvalumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|POMALIDOMIDE,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Pneumonia,1,1
13613557,20170605,Durvalumab,20602,804,56.44,2,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB,6,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Oral candidiasis,1,1
13614618,20170606,Durvalumab,72,801,72.0,1,,1,0,1,0,0,0,1,Durvalumab,"STANDARDIZED SENNA CONCENTRATE|LACTULOSE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|RABEPRAZOLE|GRANISETRON|GRANISETRON HYDROCHLORIDE|PEMETREXED|PEMETREXED DISODIUM|MEROPENEM|GABAPENTIN|DUTASTERIDE|CARBOPLATIN|TREMELIMUMAB|DURVALUMAB|RABEPRAZOLE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|FOLIC ACID|AMOXICILLIN|ALBUTEROL SULFATE|PREDNISONE",34,BONE PAIN|CONSTIPATION|CONSTIPATION|NAUSEA|UPPER RESPIRATORY TRACT INFECTION|INFECTION PROPHYLAXIS|INFECTION PROPHYLAXIS|DYSPEPSIA|NAUSEA|PROPHYLAXIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|BONE PAIN|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|INFECTION PROPHYLAXIS|EMBOLISM|PAIN IN EXTREMITY|BENIGN PROSTATIC HYPERPLASIA|INFECTION PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|GASTROOESOPHAGEAL REFLUX DISEASE|NAUSEA|VOMITING|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CONSTIPATION|PROPHYLAXIS|PROPHYLAXIS|INFECTION PROPHYLAXIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|THROMBOSIS,Anaemia|Pulmonary haemorrhage|Platelet count decreased|Pneumonitis,4,1
13615651,20170606,Durvalumab,30515,804,83.6,1,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB,10,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|IMAGING PROCEDURE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|IMAGING PROCEDURE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Drug-induced liver injury,1,1
13616018,20170606,Durvalumab,,,,2,,1,0,1,0,0,0,0,Durvalumab,"MORPHINE|MAGNESIUM|AMOXICILLIN AND CLAVULANATE POTASSIUM|TREMELIMUMAB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ATENOLOL|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN",12,PAIN|PAIN|SARCOMA|SARCOMA|BLOOD PRESSURE MEASUREMENT,Headache,1,1
13616040,20170606,Durvalumab,840,802,70.0,1,63,1,0,1,0,0,0,1,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|LORATADINE|LORATADINE ORAL|UREA|TREMELIMUMAB|BISOPROLOL FUMARATE|TREMELIMUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METHYLPREDNISOLONE,21,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|RASH|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RASH|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|MITRAL VALVE INCOMPETENCE|HYPERCHOLESTEROLAEMIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|DIPLOPIA|NON-SMALL CELL LUNG CANCER,Hepatotoxicity|Neurotoxicity,2,1
13619617,20170606,Durvalumab,25426,804,69.66,2,52,1,0,1,0,0,0,0,Durvalumab,ROSUVASTATIN CALCIUM,35,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRURITUS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|INFUSION RELATED REACTION|NON-SMALL CELL LUNG CANCER|PRURITUS|INFUSION RELATED REACTION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|THYROID MASS|INFUSION RELATED REACTION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRURITUS|COUGH|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERLIPIDAEMIA,Secondary adrenocortical insufficiency,1,1
13619927,20170607,Durvalumab,20960,804,57.42,1,,1,0,1,0,0,0,0,Durvalumab,FAMOTIDINE,29,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|GASTRITIS PROPHYLAXIS|DYSGEUSIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|GASTRITIS PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CANCER PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CANCER PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ANAEMIA,Myocardial necrosis marker increased,1,1
13620375,20170607,Durvalumab,843,802,70.25,1,72.6,1,0,1,0,0,0,0,Durvalumab,ERGOCALCIFEROL|FUROSEMIDE|TREMELIMUMAB|PREDNISONE|LOSARTAN|GABAPENTIN,7,HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|PERIPHERAL SWELLING|HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|BLOOD PRESSURE ABNORMAL|NEUROPATHY PERIPHERAL,Neuropathy peripheral|Illness|Weight increased|Drug ineffective|Depressed level of consciousness|Weight fluctuation|Hypotension|Intra-abdominal fluid collection|Gait disturbance,9,
13620485,20170607,Durvalumab,56,801,56.0,2,69,1,0,0,0,0,0,1,Durvalumab,TREMELIMUMAB,5,HYPERTENSION|NEOPLASM|NEOPLASM|DIARRHOEA|PROPHYLAXIS,Epistaxis,1,1
13620500,20170607,Durvalumab,19774,804,54.18,1,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB,14,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|INSOMNIA|HYPERTENSION|HIATUS HERNIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRURITUS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CHEST PAIN|PRURITUS,Cholangitis,1,1
13622993,20170607,Durvalumab,20935,804,57.36,2,,1,1,0,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|PREDNISONE|TREMELIMUMAB|TREMELIMUMAB|FAMOTIDINE|TREMELIMUMAB|TREMELIMUMAB,18,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PNEUMONITIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Sudden death,1,1
13624301,20170608,Durvalumab,22070,804,60.47,1,,1,0,1,0,0,0,1,Durvalumab,"INSULIN LISPRO|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|BETAMETHASONE VALERATE|BETAMETHASONE VALERATE FOAM|ALPRAZOLAM|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|TREMELIMUMAB|TREMELIMUMAB|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|BETAMETHASONE VALERATE|BETAMETHASONE VALERATE FOAM",20,BLADDER TRANSITIONAL CELL CARCINOMA|DIABETES MELLITUS|DIABETES MELLITUS|URTICARIA|HYPERTENSION|ANXIETY DISORDER|ARTHRALGIA|PYREXIA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|URTICARIA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|METABOLIC ACIDOSIS|ARTHRALGIA|URTICARIA|INSOMNIA|ARTHRALGIA|BLADDER TRANSITIONAL CELL CARCINOMA,Hepatic function abnormal,1,1
13628067,20170607,Durvalumab,75,801,75.0,1,68.9,1,1,0,0,0,0,0,Durvalumab,LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE,3,INFECTION|GASTRIC ULCER|MYELODYSPLASTIC SYNDROME,Pneumonitis,1,1
13628454,20170608,Durvalumab,75,801,75.0,2,67.6,1,1,1,0,0,0,0,Durvalumab,POMALIDOMIDE|MAGNESIUM HYDROXIDE|AMLODIPINE|OXYCODONE HYDROCHLORIDE|OXYCODONE|PEGFILGRASTIM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LORAZEPAM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|POMALIDOMIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|POMALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,29,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|UROSEPSIS|HYPERTENSION|PAIN|PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|THROMBOSIS PROPHYLAXIS|ANXIETY|PROPHYLAXIS OF NAUSEA AND VOMITING|PLASMA CELL MYELOMA|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING|HYPOKALAEMIA|THROMBOSIS PROPHYLAXIS|UROSEPSIS|BACK PAIN|PROPHYLAXIS|INFECTION PROPHYLAXIS|BONE DISORDER|UROSEPSIS|GASTROENTERITIS|HYPOKALAEMIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Gastroenteritis|Respiratory tract infection|Delirium|Urinary tract infection,4,1
13628597,20170607,Durvalumab,804,802,67.0,2,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|TREMELIMUMAB,18,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pneumonia streptococcal,1,1
13629580,20170608,Durvalumab,53,801,53.0,1,99.3,1,0,1,0,0,0,1,Durvalumab,OLAPARIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|GOSERELIN,5,PROSTATE CANCER|PROSTATE CANCER,Colitis|Hyperglycaemia,2,1
13630020,20170608,Durvalumab,604,802,50.33,2,,1,0,0,0,0,0,1,Durvalumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,4,CANCER PAIN|ABDOMINAL PAIN|DUCTAL ADENOCARCINOMA OF PANCREAS|ABDOMINAL PAIN UPPER,Rheumatoid arthritis,1,1
13634460,20170609,Durvalumab,67,801,67.0,1,53.1,1,0,0,0,0,0,1,Durvalumab,"ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SIMVASTATIN|PROMETHAZINE|MAGNESIUM CHLORIDE|TREMELIMUMAB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",8,NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|PERIPHERAL VASCULAR DISORDER|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|HYPOKALAEMIA,Hyperuricaemia,1,1
13636355,20170609,Durvalumab,56,801,56.0,2,,1,0,1,0,0,0,0,Durvalumab,"GEMCITABINE HYDROCHLORIDE|TREMELIMUMAB|AMOXICILLIN AND CLAVULANATE POTASSIUM|STANDARDIZED SENNA CONCENTRATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DURVALUMAB",7,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA|INFECTION|CONSTIPATION|ABDOMINAL PAIN|PANCREATIC CARCINOMA|PANCREATIC CARCINOMA,Device related infection,1,1
13638054,20170609,Durvalumab,29108,804,79.75,1,,1,1,1,0,0,0,0,Durvalumab,"TREMELIMUMAB|CROTAMITON|TREMELIMUMAB|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE|ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|MIRABEGRON|TREMELIMUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|CROTAMITON|TREMELIMUMAB",27,NON-SMALL CELL LUNG CANCER|RASH MACULO-PAPULAR|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DRY SKIN|GASTRITIS PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|DYSPEPSIA|CEREBRAL INFARCTION|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|DYSPEPSIA|INSOMNIA|ADRENAL INSUFFICIENCY|MICTURITION URGENCY|RASH MACULO-PAPULAR|NON-SMALL CELL LUNG CANCER|ADRENAL INSUFFICIENCY|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ADRENAL INSUFFICIENCY|ADRENAL INSUFFICIENCY|ADRENAL INSUFFICIENCY|RASH MACULO-PAPULAR|NON-SMALL CELL LUNG CANCER|OROPHARYNGEAL PAIN,Interstitial lung disease,1,1
13638058,20170609,Durvalumab,30570,804,83.75,2,67.4,1,0,1,0,0,0,0,Durvalumab,FUROSEMIDE|METHYLPREDNISOLONE|PANTOPRAZOLE|CEFTAZIDIME|METOPROLOL TARTRATE|METOPROLOL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ASCORBIC ACID|AMIKACIN|POTASSIUM CARBONATE|IPRATROPIUM BROMIDE|FUROSEMIDE|CALCIUM CARBONATE|ANTACID|MAGNESIUM|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE,45,ACUTE MYELOID LEUKAEMIA|ACUTE MYELOID LEUKAEMIA|PNEUMONIA|ARRHYTHMIA PROPHYLAXIS|PROPHYLAXIS|GASTRITIS PROPHYLAXIS|PNEUMONIA|PAIN PROPHYLAXIS|FEBRILE NEUTROPENIA|HIATUS HERNIA|PNEUMONIA|ATRIAL FIBRILLATION|PROPHYLAXIS OF NAUSEA AND VOMITING|VITAMIN SUPPLEMENTATION|PAIN PROPHYLAXIS|CHOLESTEROSIS|PNEUMONIA|PROPHYLAXIS|ACUTE MYELOID LEUKAEMIA|SEASONAL ALLERGY|PROPHYLAXIS|ANTICOAGULANT THERAPY|ANXIETY|VITAMIN SUPPLEMENTATION|FEBRILE NEUTROPENIA|PNEUMONIA|PROPHYLAXIS|GASTRITIS PROPHYLAXIS|ACUTE MYELOID LEUKAEMIA|ARRHYTHMIA PROPHYLAXIS|CHOLESTEROSIS|POLYARTHRITIS|ARRHYTHMIA PROPHYLAXIS|PROPHYLAXIS|ACUTE MYELOID LEUKAEMIA|ACUTE MYELOID LEUKAEMIA|FEBRILE NEUTROPENIA|PAIN PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PAIN PROPHYLAXIS|OSTEOARTHRITIS|ANTACID THERAPY|PROPHYLAXIS,Febrile neutropenia|Pneumonia|Urinary tract infection,3,1
13638151,20170609,Durvalumab,20792,804,56.96,2,74,1,0,1,0,0,0,0,Durvalumab,ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|PEMETREXED|PEMETREXED DISODIUM|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|FOLIC ACID|CISPLATIN,8,HORMONE REPLACEMENT THERAPY|PAIN|MESOTHELIOMA|MESOTHELIOMA|PROPHYLAXIS|MESOTHELIOMA,Gastritis,1,1
13638293,20170609,Durvalumab,69,801,69.0,1,,1,0,1,0,0,0,0,Durvalumab,,2,NON-SMALL CELL LUNG CANCER,Myocarditis,1,1
13638346,20170609,Durvalumab,50,801,50.0,2,63,1,0,1,1,0,0,1,Durvalumab,AMOXICILLIN AND CLAVULANATE POTASSIUM,8,VTH NERVE INJURY|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|PAIN|HYPOTHYROIDISM|NEOPLASM MALIGNANT|PAIN|PAIN,Trigeminal neuritis|Alveolitis|Autoimmune myocarditis,3,1
13638540,20170609,Durvalumab,74,801,74.0,1,90,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB,2,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT,Liver injury,1,1
13639007,20170609,Durvalumab,57,801,57.0,1,93.7,1,0,0,0,0,0,1,Durvalumab,LORAZEPAM|HYDROCORTISONE SODIUM SUCCINATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|FILGRASTIM|PREGABALIN|POMALIDOMIDE|POMALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|FILGRASTIM|FILGRASTIM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|FILGRASTIM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|FILGRASTIM|MIRTAZAPINE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|PREGABALIN,45,INSOMNIA|PREMEDICATION|PREMEDICATION|ANTIVIRAL PROPHYLAXIS|PREMEDICATION|RASH ERYTHEMATOUS|NEUTROPENIA|PARAESTHESIA|PLASMA CELL MYELOMA|INFECTION PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|THROMBOSIS PROPHYLAXIS|INFECTION PROPHYLAXIS|DEPRESSION|ROUTINE HEALTH MAINTENANCE|PAIN IN EXTREMITY,Cerebral ischaemia,1,1
13641919,20170612,Durvalumab,24783,804,67.9,2,,1,0,0,0,0,0,1,Durvalumab,"OLMESARTAN MEDOXOMIL|LORAZEPAM|RIVAROXABAN|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CETIRIZINE HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE|FUROSEMIDE|POLYMYXIN B SULFATE|BACLOFEN",16,OVARIAN CANCER|OVARIAN CANCER|HYPERTENSION|ANTICOAGULANT THERAPY|MULTIPLE ALLERGIES|PAIN|NAUSEA|MULTIPLE ALLERGIES|BLOOD POTASSIUM DECREASED|OEDEMA PERIPHERAL|EYE IRRITATION|MUSCLE SPASMS|SUPPLEMENTATION THERAPY|PROPHYLAXIS,Drug-induced liver injury,1,1
13642064,20170612,Durvalumab,62,801,62.0,2,80,1,0,1,1,0,0,1,Durvalumab,AMOXICILLIN AND CLAVULANATE POTASSIUM|AMOXICILLIN AND CLAVULANATE POTASSIUM|FUROSEMIDE|AMOXICILLIN AND CLAVULANATE POTASSIUM|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|FUROSEMIDE|TIGECYCLINE|PANTOPRAZOLE|PANTOPRAZOLE|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG,36,HYPERTENSION|PYREXIA|EAR PAIN|EAR PAIN|HYPERTENSION|THROMBOSIS PROPHYLAXIS|COUGH|PLASMA CELL MYELOMA|ANAEMIA PROPHYLAXIS|PYREXIA|PROPHYLAXIS|COUGH|INFECTION PROPHYLAXIS|PLASMA CELL MYELOMA|PROPHYLAXIS|COUGH|COUGH|PNEUMONIA|INFECTION PROPHYLAXIS|ANAEMIA PROPHYLAXIS|INFECTION PROPHYLAXIS|VITAMIN SUPPLEMENTATION|DIABETES MELLITUS|PROPHYLAXIS|PLASMA CELL MYELOMA|GASTRITIS PROPHYLAXIS|PROPHYLAXIS,Acute kidney injury|Atrial fibrillation|Respiratory failure|Sepsis|Pneumonia,5,3
13642456,20170612,Durvalumab,62,801,62.0,2,80,1,0,1,1,0,0,1,Durvalumab,MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|DARBEPOETIN ALFA|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|FUROSEMIDE|EPOETIN ALFA|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|POMALIDOMIDE|POMALIDOMIDE|POMALIDOMIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PANTOPRAZOLE|AMOXICILLIN AND CLAVULANATE POTASSIUM|TIGECYCLINE|EPOETIN ALFA|AMOXICILLIN AND CLAVULANATE POTASSIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FUROSEMIDE|AMOXICILLIN AND CLAVULANATE POTASSIUM,36,VITAMIN SUPPLEMENTATION|COUGH|COUGH|ANAEMIA PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|HYPERTENSION|PROPHYLAXIS|PROPHYLAXIS|ANAEMIA PROPHYLAXIS|EAR PAIN|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|HYPERTENSION|DIABETES MELLITUS|PROPHYLAXIS|INFECTION PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|GASTRITIS PROPHYLAXIS|COUGH|PNEUMONIA|INFECTION PROPHYLAXIS|INFECTION PROPHYLAXIS|PLASMA CELL MYELOMA|COUGH|ANAEMIA PROPHYLAXIS|EAR PAIN|PLASMA CELL MYELOMA|PROPHYLAXIS|THROMBOSIS PROPHYLAXIS|PYREXIA,Acute kidney injury|Respiratory failure|Sepsis|Pneumonia|Atrial fibrillation,5,1
13642911,20170612,Durvalumab,26038,804,71.34,2,49.8,1,1,1,0,0,0,0,Durvalumab,"ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FUROSEMIDE|MORPHINE|ESCITALOPRAM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|METHYLPREDNISOLONE|METHYLPREDNISOLONE|BENZONATATE|FUROSEMIDE|INSULIN LISPRO|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|FUROSEMIDE|FUROSEMIDE|ALLOPURINOL|ACYCLOVIR|CEFEPIME HYDROCHLORIDE|CEFEPIME|BENZONATATE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METHYLPREDNISOLONE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|RITUXIMAB|FLUCONAZOLE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|FUROSEMIDE|FUROSEMIDE|PROMETHAZINE|PANTOPRAZOLE|IBRUTINIB|IBRUTINIB|METHYLPREDNISOLONE|METHYLPREDNISOLONE|FLUCONAZOLE|MAGNESIUM HYDROXIDE",44,NAUSEA|GASTROOESOPHAGEAL REFLUX DISEASE|INFECTION|FLUID RETENTION|PAIN|ANXIETY|PAIN|INFECTION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|DYSPNOEA|FLUID RETENTION|CONSTIPATION|PROPHYLAXIS|NON-HODGKIN^S LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|OBSTRUCTIVE AIRWAYS DISORDER|PROPHYLAXIS|HYPOKALAEMIA|FLUID RETENTION|FLUID RETENTION|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|DYSPNOEA|HYPOKALAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|HYPOKALAEMIA|MASS|NON-HODGKIN^S LYMPHOMA|INFECTION|SUPPLEMENTATION THERAPY|FLUID RETENTION|FLUID RETENTION|NAUSEA|GASTROOESOPHAGEAL REFLUX DISEASE|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|INFECTION|CONSTIPATION|CONSTIPATION,Pneumonitis,1,1
13643331,20170612,Durvalumab,23347,804,63.96,2,82.4,1,1,1,1,0,0,1,Durvalumab,LEVOTHYROXINE SODIUM|SIMVASTATIN|BISOPROLOL FUMARATE,9,PROPHYLAXIS|HYPERCHOLESTEROLAEMIA|NON-SMALL CELL LUNG CANCER|TUMOUR PAIN|THYROIDECTOMY|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NAUSEA|HYPERTENSION,Rhabdomyolysis|Hepatitis,2,1
13643433,20170612,Durvalumab,15353,804,42.06,1,,1,1,1,0,0,0,0,Durvalumab,"TREMELIMUMAB|TREMELIMUMAB|FUROSEMIDE|GABAPENTIN|MORPHINE|ESCITALOPRAM|ALPRAZOLAM|MORPHINE|GABAPENTIN|FUROSEMIDE|MORPHINE|ESCITALOPRAM|VENLAFAXINE HYDROCHLORIDE|LORAZEPAM|TREMELIMUMAB|MORPHINE|MIRTAZAPINE|VENLAFAXINE HYDROCHLORIDE|LORAZEPAM|MORPHINE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|MORPHINE",52,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PLEURAL EFFUSION|PAIN PROPHYLAXIS|PAIN|PAIN|PAIN|PAIN|INSOMNIA|NUTRITIONAL SUPPLEMENTATION|MUSCULOSKELETAL CHEST PAIN|ANXIETY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PAIN|PAIN|ANXIETY|ANXIETY|PLEURAL EFFUSION|INSOMNIA|MUSCULOSKELETAL CHEST PAIN|PAIN|PAIN|MUSCULOSKELETAL CHEST PAIN|PLEURAL EFFUSION|PAIN|PAIN|MUSCULOSKELETAL CHEST PAIN|ANXIETY|ANXIETY|ANXIETY|NON-SMALL CELL LUNG CANCER|PAIN|PAIN|PAIN|MUSCULOSKELETAL CHEST PAIN|ANXIETY|PAIN PROPHYLAXIS|PROPHYLAXIS|ANXIETY|INSOMNIA|ANXIETY|NON-SMALL CELL LUNG CANCER|PAIN|PAIN|PAIN|PAIN|PAIN|PLEURAL EFFUSION|PAIN|PAIN|PAIN,Pneumonia|Interstitial lung disease,2,1
13643532,20170612,Durvalumab,25074,804,68.7,1,,1,0,1,0,0,0,0,Durvalumab,NITROGLYCERIN|NIACIN|GLIMEPIRIDE|TREMELIMUMAB|FINASTERIDE|ATORVASTATIN CALCIUM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|TREMELIMUMAB|TREMELIMUMAB|OLANZAPINE,15,CORONARY ARTERY DISEASE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CORONARY ARTERY DISEASE|CORONARY ARTERY DISEASE|TYPE 2 DIABETES MELLITUS|ERECTILE DYSFUNCTION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|BENIGN PROSTATIC HYPERPLASIA|CORONARY ARTERY DISEASE|TYPE 2 DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NAUSEA,Dyspnoea|Myalgia,2,1
13645370,20170612,Durvalumab,733,802,61.08,2,63.6,1,0,1,0,0,0,0,Durvalumab,"DURVALUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PREGABALIN|BEVACIZUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",9,BREAST CANCER|PAIN PROPHYLAXIS|PROPHYLAXIS AGAINST BRONCHOSPASM|POLYNEUROPATHY|BREAST CANCER|DIABETES MELLITUS|PAIN PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS AGAINST BRONCHOSPASM,Respiratory tract infection,1,1
13645977,20170613,Durvalumab,23764,804,65.11,1,68.9,1,0,1,0,0,0,0,Durvalumab,AMLODIPINE,9,DIABETES MELLITUS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|HYPERTENSION|OSTEOARTHRITIS|DYSLIPIDAEMIA|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|HYPERTENSION|HEADACHE,Tumour haemorrhage,1,1
13646007,20170613,Durvalumab,731,802,60.92,2,68.2,1,0,1,0,0,0,0,Durvalumab,"DURVALUMAB|PREGABALIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|BEVACIZUMAB|ENALAPRIL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",7,BREAST CANCER|POLYNEUROPATHY|DIABETES MELLITUS|PAIN PROPHYLAXIS|BREAST CANCER|HYPERTENSION|PAIN PROPHYLAXIS,Bronchospasm,1,1
13647547,20170613,Durvalumab,,,,2,,1,0,1,0,0,0,0,Durvalumab,"MORPHINE SULFATE|ATENOLOL|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|TREMELIMUMAB|MAGNESIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|AMOXICILLIN AND CLAVULANATE POTASSIUM",12,PAIN|BLOOD PRESSURE MEASUREMENT|SARCOMA|SARCOMA|PAIN,Headache,1,1
13648549,20170613,Durvalumab,53,801,53.0,1,92,1,1,1,1,0,0,1,Durvalumab,GRANISETRON|GRANISETRON HYDROCHLORIDE|DICLOFENAC|DICLOFENAC SODIUM|ZOLPIDEM TARTRATE|ALPRAZOLAM|RANITIDINE|TREMELIMUMAB|TREMELIMUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|GLIMEPIRIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|SERTRALINE,16,PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|CANCER PAIN|ANXIETY|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|PROPHYLAXIS|DIABETES MELLITUS|PROPHYLAXIS,Dizziness|Hypercalcaemia,2,1
13652367,20170614,Durvalumab,28231,804,77.35,1,,1,1,1,1,0,0,1,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|ALLOPURINOL|SIMVASTATIN|TREMELIMUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,14,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|BLOOD URIC ACID INCREASED|DYSLIPIDAEMIA|PAIN|NON-SMALL CELL LUNG CANCER|DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER|HYPERTENSION|ASTHMA,Large intestine perforation,1,1
13653223,20170614,Durvalumab,26670,804,73.07,2,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB,6,BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA,Decreased appetite,1,1
13653508,20170614,Durvalumab,62,801,62.0,2,,1,0,1,0,0,0,0,Durvalumab,DURVALUMAB|RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Ascites,1,1
13656211,20170615,Durvalumab,22974,804,62.94,2,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE,13,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ATRIAL FIBRILLATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ATRIAL FIBRILLATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pneumonitis,1,1
13656239,20170615,Durvalumab,73,801,73.0,1,84,1,1,1,0,0,0,0,Durvalumab,LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|PSYLLIUM HUSK|DABIGATRAN ETEXILATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PEGFILGRASTIM,14,PLASMA CELL MYELOMA|INFECTION PROPHYLAXIS|RASH|PROPHYLAXIS|PLASMA CELL MYELOMA|CONSTIPATION|PARAPLEGIA|THROMBOSIS PROPHYLAXIS|ATRIAL FIBRILLATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PARAPLEGIA|NEUTROPENIA,Pneumonia,1,3
13656348,20170615,Durvalumab,70,801,70.0,1,83.7,1,0,1,0,0,0,0,Durvalumab,HYDROMORPHONE HYDROCHLORIDE|OLAPARIB|PREDNISONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|MORPHINE SULFATE|LISINOPRIL|DULOXETINE HYDROCHLORIDE,10,PROSTATE CANCER|PROSTATE CANCER,Muscular weakness,1,1
13656852,20170615,Durvalumab,25035,804,68.59,1,,1,1,0,0,0,0,1,Durvalumab,BUDESONIDE|TREMELIMUMAB|LINEZOLID|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|TREMELIMUMAB|TREMELIMUMAB|IPRATROPIUM BROMIDE|TREMELIMUMAB|MEROPENEM|CEFTRIAXONE|CEFTRIAXONE SODIUM,23,PROPHYLAXIS|TYPE 2 DIABETES MELLITUS|BLADDER TRANSITIONAL CELL CARCINOMA|ALANINE AMINOTRANSFERASE INCREASED|ALANINE AMINOTRANSFERASE INCREASED|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|ALANINE AMINOTRANSFERASE INCREASED|ALANINE AMINOTRANSFERASE INCREASED|ALANINE AMINOTRANSFERASE INCREASED|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|ALANINE AMINOTRANSFERASE INCREASED|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|ALANINE AMINOTRANSFERASE INCREASED|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|ALANINE AMINOTRANSFERASE INCREASED|BLADDER TRANSITIONAL CELL CARCINOMA|ALANINE AMINOTRANSFERASE INCREASED,Facial paralysis,1,1
13656873,20170615,Durvalumab,70,801,70.0,1,,1,0,0,0,0,0,1,Durvalumab,"POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|LOSARTAN|FUROSEMIDE",6,HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA,Hepatic function abnormal,1,1
13656926,20170615,Durvalumab,27811,804,76.19,1,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|FUROSEMIDE|TREMELIMUMAB|TREMELIMUMAB,13,BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|OEDEMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|ANAEMIA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|CONSTIPATION|PAIN MANAGEMENT|BLADDER TRANSITIONAL CELL CARCINOMA,Hypopituitarism,1,1
13656935,20170615,Durvalumab,26882,804,73.65,1,,1,0,1,0,0,0,0,Durvalumab,OLAPARIB|FOLIC ACID|LANSOPRAZOLE|OLAPARIB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|OLAPARIB,15,NEOPLASM|PAIN|CONSTIPATION|DYSPEPSIA|NEOPLASM|ANAEMIA|PRURITUS|NEOPLASM|DYSPEPSIA|NEOPLASM|ARTERIAL THROMBOSIS|PAIN|PROPHYLAXIS OF NAUSEA AND VOMITING|NEOPLASM|DYSPEPSIA,Vomiting,1,1
13657213,20170615,Durvalumab,19441,804,53.26,1,,1,0,0,0,0,0,1,Durvalumab,TREMELIMUMAB|FENOFIBRATE|TREMELIMUMAB,8,DYSLIPIDAEMIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DYSLIPIDAEMIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLACTIC CHEMOTHERAPY|CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Hepatitis,1,1
13657284,20170615,Durvalumab,21420,804,58.68,2,54,1,0,1,0,0,0,0,Durvalumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DURVALUMAB|TREMELIMUMAB,5,PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|PAIN|GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE|GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE|PAIN,Cholestasis,1,1
13657373,20170615,Durvalumab,61,801,61.0,1,,1,1,1,1,1,0,1,Durvalumab,TREMELIMUMAB|ALLOPURINOL|ARNICA MONTANA|ARNICA|TREMELIMUMAB|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM,11,HYPNOTHERAPY|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|HYPERURICAEMIA|ANAEMIA|SUPPORTIVE CARE|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PAIN|ULCER|SALIVARY HYPERSECRETION,Pharyngeal oedema,1,1
13657388,20170615,Durvalumab,65,801,65.0,2,56.6,1,1,1,0,0,0,0,Durvalumab,LEVOTHYROXINE SODIUM|OLAPARIB,4,HYPOTHYROIDISM|ASTHMA|OVARIAN CANCER|OVARIAN CANCER,Malaise|Fatigue|Nausea|Vomiting|Dehydration|Hyponatraemia|Constipation|Decreased appetite|Disease progression,9,1
13658232,20170616,Durvalumab,68,801,68.0,1,52.7,1,1,1,0,0,0,1,Durvalumab,TREMELIMUMAB|SITAGLIPTIN|OXYCODONE HYDROCHLORIDE|BIMATOPROST|DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE|BRIMONIDINE TARTRATE,18,RETINAL DETACHMENT|PRURITUS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|RETINAL DETACHMENT|RETINAL DETACHMENT|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|RETINAL DETACHMENT|RETINAL DETACHMENT|PRURITUS,Streptococcal sepsis|Pulmonary embolism|Abscess neck,3,1
13658666,20170616,Durvalumab,51,801,51.0,1,54,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB,8,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Urticaria,1,1
13660456,20170616,Durvalumab,74,801,74.0,1,95.6,1,1,1,0,0,0,0,Durvalumab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|SODIUM PHOSPHATE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|LORAZEPAM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|RANITIDINE|KETOCONAZOLE|KETOCONAZOLE FOAM|KETOCONAZOLE CREAM, 2%|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|HYDROCORTISONE BUTYRATE",52,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|CONSTIPATION PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING|HYPONATRAEMIA|HYPONATRAEMIA|HYPONATRAEMIA|HYPOTENSION|CONSTIPATION|PLASMA CELL MYELOMA|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS|DRY SKIN|NAUSEA|PLASMA CELL MYELOMA|POLYNEUROPATHY|PROPHYLAXIS|THROMBOSIS PROPHYLAXIS|HYPERKALAEMIA|HYPERKALAEMIA|PLASMA CELL MYELOMA|PROPHYLAXIS OF NAUSEA AND VOMITING|INFECTION PROPHYLAXIS|HYPONATRAEMIA|HYPERKALAEMIA|INFECTION PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS OF NAUSEA AND VOMITING|THROMBOSIS PROPHYLAXIS|DRY SKIN|CONSTIPATION PROPHYLAXIS|PAIN|HYPERKALAEMIA|HYPONATRAEMIA|HYPONATRAEMIA|PROPHYLAXIS|DRY SKIN|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PAIN|HYPONATRAEMIA|INFECTION PROPHYLAXIS|INFECTION PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING|THROMBOSIS PROPHYLAXIS|PAIN|DRY SKIN|POLYNEUROPATHY|DRY SKIN,Pathological fracture|Pyrexia,2,1
13660556,20170616,Durvalumab,71,801,71.0,2,60.3,1,0,1,0,0,0,0,Durvalumab,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISONE|CALCIUM|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|TIOTROPIUM BROMIDE|PANTOPRAZOLE",19,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|OVARIAN CANCER|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS|DIFFUSE LARGE B-CELL LYMPHOMA|OVARIAN CANCER|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|GASTRITIS PROPHYLAXIS,Histiocytosis haematophagic,1,1
13661662,20170616,Durvalumab,19198,804,52.6,1,,1,1,1,0,0,0,0,Durvalumab,"LANSOPRAZOLE|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|METOCLOPRAMIDE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|CARBAMAZEPINE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|TREMELIMUMAB|TREMELIMUMAB|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|CARBAMAZEPINE|TREMELIMUMAB|OXYCODONE HYDROCHLORIDE|OXYCODONE|OXYCODONE HYDROCHLORIDE|OXYCODONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METOCLOPRAMIDE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE|OSELTAMIVIR PHOSPHATE|OSELTAMIVIR ACID|OSELTAMIVIR",43,PROPHYLAXIS|PYREXIA|NAUSEA|MALNUTRITION|CANCER PAIN|CANCER PAIN|CANCER PAIN|WOUND COMPLICATION|NAUSEA|MALNUTRITION|CANCER PAIN|MALNUTRITION|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|CANCER PAIN|NAUSEA|NAUSEA|MALNUTRITION|CONSTIPATION PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|CANCER PAIN|PYREXIA|CANCER PAIN|NAUSEA|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|CANCER PAIN|DECREASED APPETITE|RENAL IMPAIRMENT|ORAL PAIN|MALNUTRITION|CANCER PAIN|CANCER PAIN|NAUSEA|MALNUTRITION|RENAL IMPAIRMENT|COLITIS|CANCER PAIN|MALNUTRITION|RENAL IMPAIRMENT|RENAL IMPAIRMENT|ANTIVIRAL PROPHYLAXIS,Hepatitis,1,1
13665638,20170619,Durvalumab,23397,804,64.1,2,,1,0,0,0,0,0,0,Durvalumab,OLAPARIB|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FOLIC ACID|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|SENNOSIDES|SENNA LEAF|SENNA,17,NEOPLASM MALIGNANT|RASH|NEOPLASM MALIGNANT|PROPHYLAXIS|RASH|NEOPLASM MALIGNANT|OSTEOARTHRITIS|DIARRHOEA|NAUSEA|NEOPLASM MALIGNANT|FOLATE DEFICIENCY|DECREASED APPETITE|CONSTIPATION PROPHYLAXIS|WEIGHT DECREASED|NAUSEA|DECREASED APPETITE|CONSTIPATION PROPHYLAXIS,Weight decreased|Constipation|Decreased appetite,3,1
13665648,20170619,Durvalumab,21497,804,58.9,1,,1,0,1,0,0,0,1,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|BENZONATATE|TREMELIMUMAB,9,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DEPRESSION|COUGH|NON-SMALL CELL LUNG CANCER|COUGH|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Diarrhoea|Lipase increased,2,1
13667370,20170620,Durvalumab,29,801,29.0,2,,1,0,1,0,0,0,0,Durvalumab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ARIPIPRAZOLE ORALLY DISINTEGRATING|ARIPIPRAZOLE|ARIPIPRAZOLE ORAL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|SENNOSIDES|SENNA LEAF|SENNA|DURVALUMAB|PACLITAXEL|TREMELIMUMAB,11,PANCREATIC CARCINOMA|PROPHYLAXIS OF NAUSEA AND VOMITING|ANXIETY|DYSPNOEA|VITAMIN SUPPLEMENTATION|NAUSEA|CONSTIPATION|PANCREATIC CARCINOMA|PANCREATIC CARCINOMA|GASTROINTESTINAL PAIN|PANCREATIC CARCINOMA,Vomiting|Biliary tract infection|Pyrexia,3,1
13667712,20170620,Durvalumab,60,801,60.0,1,100.9,1,0,0,0,0,0,1,Durvalumab,SERTRALINE HYDROCHLORIDE|TREMELIMUMAB|FAMOTIDINE|DIVALPROEX SODIUM|OXYCODONE|LEVOTHYROXINE SODIUM|SULFAMETHOXAZOLE AND TRIMETHOPRIM,9,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PAIN,Lipase increased|Amylase increased,2,1
13667859,20170620,Durvalumab,739,802,61.58,1,,1,1,1,0,0,0,1,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|FLUCONAZOLE|TREMELIMUMAB|QUETIAPINE|RANITIDINE|CALCIUM|TREMELIMUMAB,28,BLADDER TRANSITIONAL CELL CARCINOMA|DEPRESSION|BLADDER TRANSITIONAL CELL CARCINOMA|DEPRESSION|MUCOSAL INFLAMMATION|NAUSEA|MUCOSAL INFLAMMATION|BLADDER TRANSITIONAL CELL CARCINOMA|MUSCULOSKELETAL CHEST PAIN|THROMBOSIS|BLADDER TRANSITIONAL CELL CARCINOMA|DEPRESSION|DEPRESSION|NAUSEA|SKIN INJURY|NAUSEA|PRURITUS|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|MUSCULOSKELETAL CHEST PAIN|NAUSEA|HYPOCALCAEMIA|SKIN INJURY|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|NAUSEA|MUCOSAL INFLAMMATION|HYPERURICAEMIA,Intestinal obstruction,1,1
13668107,20170620,Durvalumab,27867,804,76.35,1,,1,0,0,0,0,0,1,Durvalumab,METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PREGABALIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|SENNOSIDES|SENNA LEAF|SENNA|AMOXICILLIN|AMOXICILLIN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|AMOXICILLIN|POLYMYXIN B SULFATE|POLYMYXIN B|AMOXICILLIN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|FERROUS SULFATE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LACTULOSE|AMOXICILLIN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,73,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CATARACT OPERATION|PROPHYLAXIS OF NAUSEA AND VOMITING|BACK PAIN|BACK PAIN|LOWER RESPIRATORY TRACT INFECTION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DYSPEPSIA|CONSTIPATION|BACK PAIN|ADRENAL INSUFFICIENCY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CONSTIPATION|LOWER RESPIRATORY TRACT INFECTION|LOWER RESPIRATORY TRACT INFECTION|ADRENAL INSUFFICIENCY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|BENIGN PROSTATIC HYPERPLASIA|DYSPEPSIA|DEPRESSION|LOWER RESPIRATORY TRACT INFECTION|LOWER RESPIRATORY TRACT INFECTION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CATARACT OPERATION|PAIN|LOWER RESPIRATORY TRACT INFECTION|ADRENAL INSUFFICIENCY|ADRENAL INSUFFICIENCY|ADRENAL INSUFFICIENCY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|IRON DEFICIENCY|CONSTIPATION|PAIN|ADRENAL INSUFFICIENCY|ADRENAL INSUFFICIENCY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PAIN|PROPHYLAXIS|LOWER RESPIRATORY TRACT INFECTION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ANAL INCONTINENCE|BRONCHIECTASIS|BRONCHIECTASIS|ADRENAL INSUFFICIENCY|ADRENAL INSUFFICIENCY,Thrombocytopenia,1,1
13671867,20170620,Durvalumab,25277,804,69.25,1,,1,0,1,0,0,0,0,Durvalumab,"AMIODARONE HYDROCHLORIDE|PREDNISONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ERGOCALCIFEROL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|DIPHENHYDRAMINE HYDROCHLORIDE|TREMELIMUMAB|PREDNISONE|TREMELIMUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|FOLIC ACID|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|LORATADINE|LORATADINE ORAL",16,PROPHYLACTIC CHEMOTHERAPY|RASH|NON-SMALL CELL LUNG CANCER|PROPHYLACTIC CHEMOTHERAPY|PROPHYLAXIS|NUTRITIONAL SUPPLEMENTATION|PROPHYLACTIC CHEMOTHERAPY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|RASH|NON-SMALL CELL LUNG CANCER|PROCEDURAL PAIN|PROPHYLACTIC CHEMOTHERAPY|PROPHYLAXIS|RASH,Pneumonitis,1,1
13672590,20170621,Durvalumab,17964,804,49.22,1,,1,0,1,0,0,0,0,Durvalumab,,2,METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA,Cellulitis,1,1
13673244,20170621,Durvalumab,67,801,67.0,1,77.9,1,0,0,0,0,0,1,Durvalumab,BUPROPION HYDROCHLORIDE|RANITIDINE|OLAPARIB|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|DENOSUMAB|FISH OIL|CALCIUM|GOSERELIN|ERGOCALCIFEROL,15,PROSTATE CANCER|PROSTATE CANCER,Deafness,1,1
13674111,20170621,Durvalumab,65,801,65.0,1,108.1,1,0,1,0,0,0,0,Durvalumab,VITAMIN E|MODAFINIL|ERGOCALCIFEROL|DULOXETINE HYDROCHLORIDE|DULOXETINE|CALCIUM|OLAPARIB|OXYCODONE|ZINC|ZINC GLUCONATE|ZINC CHLORIDE,12,PROSTATE CANCER|PROSTATE CANCER,Optic nerve disorder,1,1
13674444,20170621,Durvalumab,24886,804,68.18,1,,1,0,1,0,0,0,0,Durvalumab,MELATONIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|LORAZEPAM,7,GLIOBLASTOMA|GLIOBLASTOMA,Tumour pseudoprogression,1,1
13674701,20170621,Durvalumab,72,801,72.0,1,93.6,1,0,1,0,0,0,1,Durvalumab,PANTOPRAZOLE|POMALIDOMIDE|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|POMALIDOMIDE,9,PLASMA CELL MYELOMA|INFECTION PROPHYLAXIS|GASTRITIS PROPHYLAXIS|ANTIVIRAL PROPHYLAXIS|PLASMA CELL MYELOMA|HYPERURICAEMIA|PAIN PROPHYLAXIS|THROMBOSIS PROPHYLAXIS|PLASMA CELL MYELOMA,Pneumonia|Thrombocytopenia|Febrile neutropenia,3,1
13676435,20170622,Durvalumab,23724,804,65.0,1,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|MAGNESIUM OXIDE|OXYCODONE|CELECOXIB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|TREMELIMUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,10,BLADDER TRANSITIONAL CELL CARCINOMA|TUMOUR PAIN|BLADDER TRANSITIONAL CELL CARCINOMA|CONSTIPATION|TUMOUR PAIN|TUMOUR PAIN|PYREXIA|BLADDER TRANSITIONAL CELL CARCINOMA|NAUSEA|BLADDER TRANSITIONAL CELL CARCINOMA,Pancreatitis,1,1
13676468,20170622,Durvalumab,16116,804,44.15,1,,1,1,1,0,0,0,0,Durvalumab,DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,12,NON-SMALL CELL LUNG CANCER|PROPHYLAXIS AGAINST DIARRHOEA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|COUGH|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PAIN|PYREXIA|COUGH|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING,Dyspnoea,1,1
13677714,20170622,Durvalumab,21218,804,58.13,2,,1,0,1,0,0,0,0,Durvalumab,"PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LANSOPRAZOLE|FOLIC ACID|TREMELIMUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE",16,NON-SMALL CELL LUNG CANCER|HYPOPHYSITIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PAIN|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|PAIN|PREMEDICATION|NON-SMALL CELL LUNG CANCER|PAIN|CONSTIPATION|NAUSEA,Headache,1,1
13679395,20170622,Durvalumab,24050,804,65.89,1,53.6,1,0,1,0,0,0,0,Durvalumab,,2,OROPHARYNGEAL SQUAMOUS CELL CARCINOMA|OROPHARYNGEAL SQUAMOUS CELL CARCINOMA,Mouth haemorrhage,1,1
13680005,20170622,Durvalumab,60,801,60.0,1,,1,0,0,1,0,0,0,Durvalumab,PACLITAXEL|DURVALUMAB|GEMCITABINE HYDROCHLORIDE|TREMELIMUMAB,4,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA|PANCREATIC CARCINOMA|PANCREATIC CARCINOMA,Febrile neutropenia,1,1
13680846,20170623,Durvalumab,24901,804,68.22,2,,1,1,1,0,0,0,0,Durvalumab,SIMVASTATIN|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|KETOPROFEN|ENOXAPARIN SODIUM|AMLODIPINE|BISOPROLOL FUMARATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|KETOPROFEN|AMLODIPINE|BISOPROLOL FUMARATE|BISOPROLOL FUMARATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ENOXAPARIN SODIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|MAGNESIUM|BISOPROLOL FUMARATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ERGOCALCIFEROL|BISOPROLOL FUMARATE|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|ENOXAPARIN SODIUM|CANDESARTAN CILEXETIL|CANDESARTAN CILEXETIL|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL,49,NON-SMALL CELL LUNG CANCER|NUTRITIONAL SUPPLEMENTATION|HYPERLIPIDAEMIA|COLITIS|PAIN PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|ATRIAL FIBRILLATION|HYPERTENSION|HYPERTENSION|DEHYDRATION|PAIN PROPHYLAXIS|PROPHYLAXIS AGAINST DEHYDRATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|HYPERTENSION|HYPERTENSION|DEHYDRATION|DEHYDRATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ATRIAL FIBRILLATION|DEHYDRATION|BLOOD MAGNESIUM DECREASED|MYALGIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|COLITIS|DEHYDRATION|ANTIBIOTIC THERAPY|PROPHYLAXIS|COLITIS|DEHYDRATION|NON-SMALL CELL LUNG CANCER|VITAMIN SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|HYPERTENSION|MYALGIA|UPPER RESPIRATORY TRACT INFECTION|PROPHYLAXIS AGAINST DEHYDRATION|ATRIAL FIBRILLATION|HYPERTENSION|HYPERTENSION|MYALGIA|UPPER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|COLITIS,Glucocorticoid deficiency,1,1
13681513,20170623,Durvalumab,19082,804,52.28,1,,1,0,1,1,0,0,0,Durvalumab,TREMELIMUMAB|METHADONE|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|TREMELIMUMAB|TREMELIMUMAB|FOLIC ACID|TREMELIMUMAB|MIRTAZAPINE,12,NON-SMALL CELL LUNG CANCER|DRUG ABUSE|ANTIDEPRESSANT DRUG LEVEL|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ANTIDEPRESSANT DRUG LEVEL,Pulmonary embolism|Pericardial effusion|Atrial flutter,3,1
13685627,20170623,Durvalumab,864,802,72.0,1,,1,0,1,1,0,0,0,Durvalumab,LEVOTHYROXINE|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB,12,NON-SMALL CELL LUNG CANCER|AUTOIMMUNE THYROIDITIS|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Diabetic ketoacidosis,1,1
13686812,20170623,Durvalumab,48,801,48.0,2,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|DURVALUMAB|CARBOPLATIN|CISPLATIN|NABILONE|PREGABALIN|OLANZAPINE|PEMETREXED|PEMETREXED DISODIUM|PREDNISONE|BACLOFEN|FOLIC ACID|PREDNISONE,18,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Diarrhoea|Platelet count decreased|Febrile neutropenia|Colitis,4,1
13690293,20170626,Durvalumab,68,801,68.0,1,,1,0,1,0,0,0,0,Durvalumab,"PEMETREXED|PEMETREXED DISODIUM|TREMELIMUMAB|FOLIC ACID|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CARBOPLATIN|DURVALUMAB|ACETAMINOPHEN",18,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|NUTRITIONAL SUPPLEMENTATION|MUCOSAL INFLAMMATION|NUTRITIONAL SUPPLEMENTATION|ARTHRALGIA|HYPERCALCAEMIA OF MALIGNANCY|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NEPHROLITHIASIS|NON-SMALL CELL LUNG CANCER|ARTHRALGIA|RADIOTHERAPY|HYPERCHOLESTEROLAEMIA|PROPHYLAXIS|PROPHYLAXIS|NUTRITIONAL SUPPLEMENTATION,Hypothyroidism|Platelet count decreased|Diarrhoea|Hypotension|Hypokalaemia|Hypopituitarism|Hypophosphataemia|Hypocalcaemia|Anaemia|White blood cell count decreased,10,1
13692334,20170627,Durvalumab,24170,804,66.22,1,,1,1,1,1,1,0,1,Durvalumab,TREMELIMUMAB|BUPROPION HYDROCHLORIDE|TREMELIMUMAB|TREMELIMUMAB|CITALOPRAM|CITALOPRAM HYDROBROMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|TREMELIMUMAB|TREMELIMUMAB|BUPROPION HYDROCHLORIDE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM,17,BLADDER TRANSITIONAL CELL CARCINOMA|TOBACCO ABUSE|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|ASTHENIA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|VOMITING|ABDOMINAL PAIN|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|DEPENDENCE|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA,Pneumonia|Septic shock|Blood creatine phosphokinase increased|General physical health deterioration,4,1
13692981,20170627,Durvalumab,52,801,52.0,1,,1,0,0,0,0,0,1,Durvalumab,ALBUTEROL SULFATE|FOLIC ACID|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|LEVOTHYROXINE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM,8,NON-SMALL CELL LUNG CANCER,Granuloma,1,1
13693477,20170627,Durvalumab,71,801,71.0,2,57,1,0,0,0,0,0,1,Durvalumab,VENLAFAXINE HYDROCHLORIDE|TREMELIMUMAB|ESOMEPRAZOLE MAGNESIUM,12,DEPRESSION|DEPRESSION|DYSLIPIDAEMIA|STOMATITIS|PULMONARY EMBOLISM|ABDOMINAL PAIN|NON-SMALL CELL LUNG CANCER|HEADACHE|ABDOMINAL PAIN|GLAUCOMA|NON-SMALL CELL LUNG CANCER|HYPOTHYROIDISM,Autoimmune hepatitis,1,1
13694769,20170627,Durvalumab,25438,804,69.69,1,,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|HYDROCORTISONE BUTYRATE|ROSUVASTATIN CALCIUM|MONTELUKAST SODIUM|MONTELUKAST|RABEPRAZOLE SODIUM|RABEPRAZOLE|GLIMEPIRIDE|GLIMEPIRIDE|TREMELIMUMAB|TREMELIMUMAB|FLUTICASONE PROPIONATE|FLUTICASONE PROPIONATE NASAL|GLIMEPIRIDE|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|THEOPHYLLINE,22,BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|RASH|DYSLIPIDAEMIA|ASTHMA|ASTHMA|ASTHMA|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|DIABETES MELLITUS|DIABETES MELLITUS|INTERVERTEBRAL DISC PROTRUSION|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|ASTHMA|BLADDER TRANSITIONAL CELL CARCINOMA|DIABETES MELLITUS|RASH|ASTHMA|BLADDER TRANSITIONAL CELL CARCINOMA|CONSTIPATION PROPHYLAXIS|RASH|RASH,Thyroiditis,1,1
13696297,20170628,Durvalumab,25858,804,70.84,2,,1,1,1,0,0,0,0,Durvalumab,"DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|AMLODIPINE|CALCIUM|ESTRADIOL|ESTRADIOL GEL 0.1%|ESTRADIOL TRANSDERMAL|ESTRADIOL,|HYDROMORPHONE HYDROCHLORIDE|PREGABALIN|BUPROPION|STANDARDIZED SENNA CONCENTRATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|FUROSEMIDE|ERGOCALCIFEROL|EZETIMIBE|PROCHLORPERAZINE|CLONAZEPAM|LEVOTHYROXINE SODIUM|DEXLANSOPRAZOLE|DULOXETINE HYDROCHLORIDE|CYCLOBENZAPRINE",25,BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0|CONSTIPATION|HYPERTENSION|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|PAIN|PAIN|DEPRESSION|CONSTIPATION|PAIN|OEDEMA PERIPHERAL|BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0|MINERAL SUPPLEMENTATION|HYPERCHOLESTEROLAEMIA|ANXIETY|ANXIETY|BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0|HYPOTHYROIDISM|CONSTIPATION|CONSTIPATION|BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0|GASTROOESOPHAGEAL REFLUX DISEASE|ANXIETY|PAIN|PAIN,Gastroenteritis viral,1,1
13696363,20170628,Durvalumab,20335,804,55.71,1,,1,0,1,0,0,0,0,Durvalumab,IBRUTINIB|IBRUTINIB,5,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Lung infection,1,1
13696763,20170628,Durvalumab,22748,804,62.32,1,,1,1,0,0,0,0,0,Durvalumab,CLONAZEPAM|LOSARTAN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,8,PAIN|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PAIN|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|HYPERTENSION|PROPHYLAXIS|GASTRITIS,Sudden death,1,1
13697431,20170628,Durvalumab,24344,804,66.7,1,45,1,1,1,1,0,0,0,Durvalumab,CELECOXIB|CEFDINIR|TREMELIMUMAB,8,PAIN|INFECTION PROPHYLAXIS|THROMBOSIS PROPHYLAXIS|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|PROPHYLAXIS|PROPHYLAXIS|PYREXIA,Immune-mediated hepatitis|Cardiomyopathy|Interstitial lung disease,3,1
13699109,20170628,Durvalumab,26369,804,72.24,1,,1,1,1,0,0,0,1,Durvalumab,TREMELIMUMAB|OXYCODONE|TREMELIMUMAB|OXYCODONE|BISOPROLOL FUMARATE|APIXABAN|KETOPROFEN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREGABALIN|OXYCODONE,15,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|TUMOUR PAIN|NON-SMALL CELL LUNG CANCER|TUMOUR PAIN|NON-SMALL CELL LUNG CANCER|TUMOUR PAIN|PAIN PROPHYLAXIS|HYPERTENSION|DEPRESSION|THROMBOSIS PROPHYLAXIS|CANCER PAIN|CANCER PAIN|CANCER PAIN|TUMOUR PAIN,Respiratory failure,1,1
13701816,20170629,Durvalumab,48,801,48.0,2,,1,0,1,0,0,0,0,Durvalumab,PEMETREXED|PEMETREXED DISODIUM|OLANZAPINE|PREDNISONE|BACLOFEN|FOLIC ACID|TREMELIMUMAB|CISPLATIN|PREDNISONE|DURVALUMAB|CARBOPLATIN|PREGABALIN|NABILONE,18,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Diarrhoea|Febrile neutropenia|Platelet count decreased|Colitis,4,1
13703028,20170629,Durvalumab,19012,804,52.09,1,,1,1,1,0,0,0,0,Durvalumab,SENNOSIDES|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|TREMELIMUMAB|METHYLPREDNISOLONE|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|MEGESTROL ACETATE|TREMELIMUMAB|DICLOFENAC|DICLOFENAC SODIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|AMPICILLIN SODIUM AND SULBACTAM SODIUM|MORPHINE SULFATE|CHLORZOXAZONE|LACTULOSE,28,CONSTIPATION|PAIN MANAGEMENT|ASTHENIA|ACUTE KIDNEY INJURY|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|ASTHENIA|CONSTIPATION|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PAIN MANAGEMENT|PYREXIA|DYSPNOEA|CHEST DISCOMFORT|BACK PAIN|ELECTROLYTE IMBALANCE|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|HYPERURICAEMIA|BACK PAIN|CONSTIPATION|APPETITE DISORDER|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|INFLAMMATION|DYSPNOEA|PAIN MANAGEMENT|PAIN MANAGEMENT|PYREXIA|BACK PAIN|TUMOUR PAIN|CONSTIPATION,Interstitial lung disease,1,1
13704587,20170630,Durvalumab,22024,804,60.34,1,,1,0,1,1,1,0,1,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB,11,BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA,Deep vein thrombosis,1,1
13707707,20170630,Durvalumab,919,802,76.58,1,,1,0,0,0,0,0,1,Durvalumab,,6,BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA,Pancreatitis,1,1
13711519,20170703,Durvalumab,70,801,70.0,1,,1,0,0,0,1,0,0,Durvalumab,PREGABALIN,3,DYSLIPIDAEMIA|TRANSITIONAL CELL CARCINOMA|ASTHENIA,Arthralgia,1,1
13711631,20170703,Durvalumab,57,801,57.0,1,58.2,1,1,1,0,0,0,0,Durvalumab,SPIRONOLACTONE|ENTECAVIR|ENTECAVIR ANHYDROUS|ENTECAVIR|TENOFOVIR DISOPROXIL FUMARATE|RAMUCIRUMAB,12,HEPATOCELLULAR CARCINOMA|HYPERTENSION|HYPERTENSION|DIARRHOEA|HEPATOCELLULAR CARCINOMA|HYPERTENSION,Hepatitis acute,1,1
13711638,20170703,Durvalumab,71,801,71.0,2,63,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|VENLAFAXINE HYDROCHLORIDE,10,PULMONARY EMBOLISM|HEADACHE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPOTHYROIDISM|GLAUCOMA|CHOLANGITIS|DEPRESSION|DEPRESSION|DYSLIPIDAEMIA,Cholestasis,1,1
13711660,20170703,Durvalumab,73,801,73.0,1,,1,0,1,0,0,0,0,Durvalumab,LANSOPRAZOLE|NAPROXEN|NAPROXEN SODIUM|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|OLAPARIB|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS),12,GASTROOESOPHAGEAL REFLUX DISEASE|DYSLIPIDAEMIA|MUSCULOSKELETAL PAIN|MUSCULOSKELETAL PAIN|MUSCULOSKELETAL PAIN|TRANSITIONAL CELL CARCINOMA|GLAUCOMA|RASH|NAUSEA|TRANSITIONAL CELL CARCINOMA|EMBOLISM|URINARY TRACT INFECTION,Intracardiac thrombus,1,1
13711670,20170703,Durvalumab,87,801,87.0,1,56,1,1,1,0,0,0,0,Durvalumab,"ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE|ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES|RAMUCIRUMAB",8,BACK PAIN|ABDOMINAL PAIN|GASTROOESOPHAGEAL REFLUX DISEASE|HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|CONSTIPATION|HEPATOCELLULAR CARCINOMA,Hepatic haemorrhage|Acute respiratory distress syndrome|Hypotension,3,1
13711692,20170703,Durvalumab,26883,804,73.65,1,62,1,1,1,0,0,0,0,Durvalumab,METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|OLAPARIB|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|AMOXICILLIN|LANSOPRAZOLE|OLAPARIB|OLAPARIB|FOLIC ACID,24,DECREASED APPETITE|GASTRIC CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING|GASTRIC CANCER|PRURITUS|GASTRIC CANCER|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING|LOWER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|GASTRIC CANCER|ARTERIAL THROMBOSIS|PROPHYLAXIS|HYPOMAGNESAEMIA|WEIGHT DECREASED|GASTRIC CANCER|ABDOMINAL PAIN UPPER|ABDOMINAL PAIN UPPER|CONSTIPATION PROPHYLAXIS|PRURITUS|WEIGHT DECREASED|ARTERIAL THROMBOSIS|ANAEMIA,Blood testosterone decreased|Fatigue,2,1
13711732,20170703,Durvalumab,78,801,78.0,1,64.4,1,0,0,0,0,0,1,Durvalumab,"OLAPARIB|POLYETHYLENE GLYCOL 3350|DUTASTERIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|TADALAFIL|ERGOCALCIFEROL|BENZONATATE|TRIPTORELIN PAMOATE|ZOLPIDEM TARTRATE",11,PROSTATE CANCER|PAIN|PROSTATE CANCER,Pneumonitis,1,1
13712690,20170703,Durvalumab,,,,0,,1,0,1,0,0,0,0,Durvalumab,"TREMELIMUMAB|CLONAZEPAM|MORPHINE|PANTOPRAZOLE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CARBOPLATIN|CISPLATIN|OLANZAPINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|PAROXETINE HYDROCHLORIDE",14,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,5
13712875,20170703,Durvalumab,56,801,56.0,2,,1,0,1,0,0,0,1,Durvalumab,BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|ALPRAZOLAM|ZOLPIDEM TARTRATE|LEVOTHYROXINE|POLYETHYLENE GLYCOL,8,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT,Encephalitis autoimmune,1,1
13714061,20170704,Durvalumab,70,801,70.0,1,,1,0,1,0,0,0,0,Durvalumab,DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|LEVOTHYROXINE|OXYCODONE|TREMELIMUMAB|MULTIVITAMIN|TREMELIMUMAB|TREMELIMUMAB|MAGNESIUM OXIDE|SPIRONOLACTONE|METOPROLOL TARTRATE|METOPROLOL,15,CONSTIPATION|HYPOTHYROIDISM|FLANK PAIN|HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|ROUTINE HEALTH MAINTENANCE|HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|HYPERTENSION|HYPERTENSION,Hepatic encephalopathy,1,1
13714550,20170704,Durvalumab,58,801,58.0,2,49.5,1,0,1,0,0,0,0,Durvalumab,FISH OIL|SPIRONOLACTONE|OLAPARIB|ERGOCALCIFEROL|MAGNESIUM|HYOSCYAMINE SULFATE|PHYTONADIONE,9,OVARIAN CANCER|HYPERSENSITIVITY|OVARIAN CANCER|ABDOMINAL PAIN,Urinary tract infection|Hypotension|Sepsis|Tachycardia|Pyrexia,5,1
13714590,20170704,Durvalumab,22987,804,62.98,1,,1,0,1,0,0,0,0,Durvalumab,"TRANEXAMIC ACID|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",34,BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|HYPERCHOLESTEROLAEMIA|THROMBOSIS|PAIN IN EXTREMITY|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|PAIN IN EXTREMITY|CARDIOVASCULAR EVENT PROPHYLAXIS|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|CONSTIPATION|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|CONSTIPATION,Diverticulitis,1,1
13717181,20170705,Durvalumab,45,801,45.0,2,73,1,0,1,0,1,0,0,Durvalumab,PACLITAXEL|L-TRYPTOPHAN,5,TRIPLE NEGATIVE BREAST CANCER|TRIPLE NEGATIVE BREAST CANCER|TRIPLE NEGATIVE BREAST CANCER|TRIPLE NEGATIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Polyneuropathy|Guillain-Barre syndrome,2,3
13717839,20170705,Durvalumab,46,801,46.0,1,63.6,1,0,1,0,0,0,0,Durvalumab,"OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LORATADINE|LORATADINE TABLET|GABAPENTIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|MULTIVITAMIN|ALBUTEROL SULFATE|ALBUTEROL|OXYCODONE|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE",10,COLON CANCER|COLON CANCER,Lower gastrointestinal haemorrhage|Colitis|Anaemia|Hypotension,4,1
13721128,20170706,Durvalumab,26627,804,72.95,2,43,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|DENOSUMAB|MAGNESIUM OXIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|OLANZAPINE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|LANSOPRAZOLE,21,NON-SMALL CELL LUNG CANCER|COUGH|NAUSEA|METASTASES TO BONE|CONSTIPATION|CONSTIPATION|BACK PAIN|PRURITUS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING|BRAIN OEDEMA|PRODUCTIVE COUGH|METASTASES TO BONE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NAUSEA|GASTRITIS PROPHYLAXIS,Gait disturbance,1,1
13724525,20170706,Durvalumab,,,,0,,1,0,1,0,0,0,1,Durvalumab,CISPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|TREMELIMUMAB,4,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Urinary tract infection|Enterocolitis infectious,2,5
13730058,20170707,Durvalumab,,,,0,,1,0,1,0,0,0,1,Durvalumab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|TREMELIMUMAB|CISPLATIN,4,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Embolism,1,5
13731632,20170707,Durvalumab,27880,804,76.38,2,,1,0,1,1,0,0,1,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|OXYCODONE HYDROCHLORIDE|TREMELIMUMAB|AMLODIPINE|AMLODIPINE|OXYCODONE HYDROCHLORIDE|DENOSUMAB,19,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|BACK PAIN|PROPHYLAXIS|PAIN|PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|HYPERTENSION|DYSPNOEA|DYSPEPSIA|BACK PAIN|PAIN|METASTASES TO BONE,Nausea|Large intestine perforation|Aspartate aminotransferase increased|Colitis,4,1
13731668,20170707,Durvalumab,25707,804,70.43,1,,1,0,1,1,0,0,1,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB,19,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pericardial effusion,1,1
13731765,20170707,Durvalumab,21252,804,58.22,1,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB,6,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Upper respiratory tract infection,1,1
13737182,20170710,Durvalumab,28808,804,78.93,1,79,1,1,1,1,0,0,0,Durvalumab,AMIKACIN|AMLODIPINE|AZACITIDINE|AZACITIDINE FOR|AMIKACIN|AZACITIDINE|AZACITIDINE FOR|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RAMIPRIL|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|NAPROXEN|NAPROXEN SODIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|AMIKACIN|AMIKACIN|CARBAMAZEPINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,25,PRODUCT USED FOR UNKNOWN INDICATION|HYPERTENSION|MYELODYSPLASTIC SYNDROME|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HYPERTENSION|MYELODYSPLASTIC SYNDROME|MYELODYSPLASTIC SYNDROME|NAUSEA|MYELODYSPLASTIC SYNDROME|HYPERTENSION|PROSTATISM|RASH|TRIGEMINAL NEURALGIA|CEREBROVASCULAR ACCIDENT PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CEREBROVASCULAR ACCIDENT PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|TRIGEMINAL NEURALGIA|PROPHYLAXIS OF NAUSEA AND VOMITING,Pneumonia|Multiple organ dysfunction syndrome,2,1
13742833,20170711,Durvalumab,26786,804,73.39,1,,1,1,1,0,0,0,0,Durvalumab,"DEXAMETHASONE SODIUM PHOSPHATE|FUROSEMIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|FENTANYL CITRATE|DIFLORASONE DIACETATE|ASCORBIC ACID|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|TREMELIMUMAB|CISPLATIN|PEMETREXED|PEMETREXED DISODIUM|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE|ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES|OLOPATADINE HYDROCHLORIDE|OLOPATADINE HYDROCHLORIDE OPHTHALMIC|MAGNESIUM OXIDE|FENTANYL CITRATE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|NAPROXEN|NAPROXEN SODIUM|FUROSEMIDE|TREMELIMUMAB|FAMOTIDINE|HYDROCORTISONE BUTYRATE|PALONOSETRON HYDROCHLORIDE|DEXAMETHASONE SODIUM PHOSPHATE",44,NEUTROPHIL COUNT DECREASED|ANAEMIA|CHEMOTHERAPY|MICTURITION DISORDER|CHEMOTHERAPY|ANAEMIA|STOMATITIS|CHEMOTHERAPY|NON-SMALL CELL LUNG CANCER|URTICARIA|DECREASED APPETITE|DECREASED APPETITE|ANAEMIA|CHEMOTHERAPY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|GASTRIC ULCER|DIABETES MELLITUS|URTICARIA|PROPHYLAXIS|CONSTIPATION|NON-SMALL CELL LUNG CANCER|DECREASED APPETITE|STOMATITIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PYREXIA|DIABETES MELLITUS|PROPHYLAXIS|MICTURITION DISORDER|STOMATITIS|NON-SMALL CELL LUNG CANCER|DIABETES MELLITUS|PROPHYLAXIS|PROPHYLAXIS|DECREASED APPETITE|ANAEMIA|URTICARIA|PLATELET COUNT DECREASED|ANAEMIA|CHEMOTHERAPY|CHEMOTHERAPY|CHEMOTHERAPY,Urticaria|Platelet count decreased|Anaemia|Febrile neutropenia,4,1
13742896,20170711,Durvalumab,27942,804,76.55,1,,1,1,1,1,0,0,0,Durvalumab,"FOLIC ACID|GLYBURIDE|MAGNESIUM HYDROXIDE|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|METHYLPREDNISOLONE|IPRATROPIUM BROMIDE|IPRATROPIUM BROMIDE|INSULIN HUMAN|MELATONIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|GENTAMICIN|GENTAMICIN SULFATE|ALBUTEROL SULFATE|ALBUTEROL|OXYCODONE|IPRATROPIUM BROMIDE|HYDROCHLOROTHIAZIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|ALBUTEROL SULFATE|ALBUTEROL|POLYETHYLENE GLYCOL 3350|OXYCODONE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|LORAZEPAM|GLYBURIDE|ENOXAPARIN SODIUM|SELENIUM|FISH OIL|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|ZINC|ZINC GLUCONATE|ZINC CHLORIDE|METHYLPREDNISOLONE|CEFTRIAXONE|CEFTRIAXONE SODIUM|CEFTRIAXONE|CEFTRIAXONE SODIUM|IPRATROPIUM BROMIDE|IPRATROPIUM BROMIDE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|INSULIN HUMAN|ENOXAPARIN SODIUM|SIMVASTATIN|GENTAMICIN|GENTAMICIN SULFATE|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|CEFTRIAXONE|CEFTRIAXONE SODIUM|TIOTROPIUM BROMIDE|ALBUTEROL SULFATE|ALBUTEROL|CEFTRIAXONE|CEFTRIAXONE SODIUM|LIDOCAINE PATCH 5%|SENNOSIDES|SENNA LEAF|SENNA|GLYBURIDE|HYDROCHLOROTHIAZIDE|TIOTROPIUM BROMIDE|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|ERGOCALCIFEROL|METHYLPREDNISOLONE|IPRATROPIUM BROMIDE",71,NUTRITIONAL SUPPLEMENTATION|TYPE 2 DIABETES MELLITUS|CONSTIPATION|DYSPNOEA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PNEUMONIA|DYSPNOEA|DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER|DEPRESSION|GASTROOESOPHAGEAL REFLUX DISEASE|SEPSIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|BACK PAIN|DYSPNOEA|DEEP VEIN THROMBOSIS|ARTHRITIS|HYPERTENSION|DIABETES MELLITUS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PNEUMONIA|PNEUMONIA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CONSTIPATION|BACK PAIN|ASPIRATION PLEURAL CAVITY|AGITATION|TYPE 2 DIABETES MELLITUS|DEEP VEIN THROMBOSIS|NUTRITIONAL SUPPLEMENTATION|HYPERLIPIDAEMIA|HYPERLIPIDAEMIA|CONSTIPATION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|PNEUMONIA|SEPSIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PNEUMONIA|SEPSIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PNEUMONIA|PNEUMONIA|DIABETES MELLITUS|PULMONARY EMBOLISM|BLOOD CHOLESTEROL INCREASED|PNEUMONIA|SEPSIS|PNEUMONIA|NON-SMALL CELL LUNG CANCER|NUTRITIONAL SUPPLEMENTATION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NUTRITIONAL SUPPLEMENTATION|PNEUMONIA|SEPSIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|SEPSIS|CONSTIPATION|DEEP VEIN THROMBOSIS|TYPE 2 DIABETES MELLITUS|OEDEMA|DYSPNOEA|DYSPNOEA|VITAMIN D DEFICIENCY|SEPSIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CONSTIPATION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Overdose|Pneumonia|Pulmonary sepsis|Hypotension|Respiratory failure,5,1
13745705,20170712,Durvalumab,40,801,40.0,1,62,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|FLUCONAZOLE|PHENOL|TREMELIMUMAB,9,HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|HEAD AND NECK CANCER METASTATIC|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|HEAD AND NECK CANCER METASTATIC,Abscess neck,1,1
13747095,20170712,Durvalumab,24160,804,66.19,2,,1,1,1,0,0,0,1,Durvalumab,METOCLOPRAMIDE HYDROCHLORIDE|ATENOLOL|TREMELIMUMAB,11,NAUSEA|HYPERTENSION|NAUSEA|NAUSEA|NAUSEA|HYPERTENSION|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|CANCER PAIN|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|CANCER PAIN|NAUSEA,Fungal infection|Laryngeal oedema|Tongue oedema,3,1
13747283,20170712,Durvalumab,21385,804,58.59,1,,1,1,1,0,0,0,0,Durvalumab,FUROSEMIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|OXYCODONE|MAGNESIUM OXIDE|MAGNESIUM OXIDE|MAGNESIUM OXIDE|OXYCODONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|OXYCODONE|TREMELIMUMAB,38,OSTEOPOROSIS|CANCER PAIN|BRAIN OEDEMA|PLEURAL EFFUSION|SEBORRHOEIC DERMATITIS|PROPHYLAXIS|DENTAL DISORDER PROPHYLAXIS|PNEUMOCYSTIS JIROVECII PNEUMONIA|PNEUMONITIS|CANCER PAIN|NAUSEA|CONSTIPATION|CANCER PAIN|NAUSEA|NUTRITIONAL SUPPLEMENTATION|NON-SMALL CELL LUNG CANCER|CONSTIPATION|LOCAL ANAESTHESIA|PNEUMONIA|CONSTIPATION|CANCER PAIN|BRAIN OEDEMA|NUTRITIONAL SUPPLEMENTATION|PROPHYLAXIS|PNEUMONITIS|PNEUMONITIS|PREMEDICATION|CANCER PAIN|NUTRITIONAL SUPPLEMENTATION|NON-SMALL CELL LUNG CANCER|CANCER PAIN|VITAMIN SUPPLEMENTATION|GASTRIC ULCER|DRY SKIN PROPHYLAXIS|PNEUMOCYSTIS JIROVECII PNEUMONIA|CONSTIPATION|CONSTIPATION|CONSTIPATION,Pneumonitis|Blood calcium increased,2,1
13753133,20170714,Durvalumab,22268,804,61.01,2,67.4,1,0,1,0,0,0,0,Durvalumab,ZIPRASIDONE|ZIPRASIDONE MESYLATE|ZIPRASIDONE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|LEVOTHYROXINE SODIUM|ZIPRASIDONE|ZIPRASIDONE MESYLATE|ZIPRASIDONE HYDROCHLORIDE,26,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|AFFECTIVE DISORDER|DIARRHOEA|NEOPLASM MALIGNANT|HYPOTHYROIDISM|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|SUPPLEMENTATION THERAPY|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|SCHIZOPHRENIA|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|SUPPLEMENTATION THERAPY,Bacteraemia,1,1
13755615,20170714,Durvalumab,46,801,46.0,1,63.6,1,0,1,0,0,0,0,Durvalumab,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ALBUTEROL SULFATE|ALBUTEROL|GABAPENTIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OXYCODONE|MULTIVITAMIN|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|LORATADINE|LORATADINE TABLET",10,COLON CANCER|COLON CANCER,Vomiting|Embolism,2,1
13756162,20170714,Durvalumab,24278,804,66.52,1,62.6,1,0,1,1,0,0,0,Durvalumab,"NAPROXEN SODIUM|NAPROXEN SODIUM 220MG|NAPROXEN SODIUM, COATED TABLETS|NAPROXEN SODIUM TABLET, COATED|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PEMETREXED|PEMETREXED DISODIUM|OXYCODONE HYDROCHLORIDE|PROCHLORPERAZINE|OXYCODONE|CISPLATIN",9,NAUSEA|MESOTHELIOMA|CANCER PAIN|NAUSEA|MESOTHELIOMA|MESOTHELIOMA,Hypoxia|Hyponatraemia,2,1
13756176,20170714,Durvalumab,37,801,37.0,2,,1,1,1,1,0,0,0,Durvalumab,METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DURVALUMAB|MORPHINE SULFATE|TREMELIMUMAB,6,MALIGNANT ASCITES|MALIGNANT ASCITES,Small intestinal obstruction|Hypokalaemia|Aspiration,3,1
13756236,20170714,Durvalumab,22997,804,63.01,1,,1,0,1,0,0,0,0,Durvalumab,"TRANEXAMIC ACID|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL",22,BLADDER TRANSITIONAL CELL CARCINOMA|THROMBOSIS|DIVERTICULITIS|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|HYPERCHOLESTEROLAEMIA|PAIN IN EXTREMITY|BLADDER TRANSITIONAL CELL CARCINOMA|PAIN IN EXTREMITY|DIVERTICULITIS|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|CONSTIPATION|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|DIVERTICULITIS,Intestinal obstruction,1,1
13756420,20170714,Durvalumab,57,801,57.0,1,49.2,1,0,1,0,0,0,0,Durvalumab,"RITUXIMAB|DOXORUBICIN|PREDNISONE|PREDNISONE|AMLODIPINE|FILGRASTIM|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|NAPROXEN|NAPROXEN SODIUM|GOSERELIN|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|CYTARABINE|RAMIPRIL|RITUXIMAB|DOXORUBICIN|ENOXAPARIN SODIUM|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISONE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|RITUXIMAB|FILGRASTIM|MORPHINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|FILGRASTIM|PREDNISONE|ENOXAPARIN SODIUM|ENOXAPARIN SODIUM|FILGRASTIM|APREPITANT|FOSAPREPITANT DIMEGLUMINE",65,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|MUSCULOSKELETAL PAIN|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|HYPERTENSION|PROPHYLAXIS|NEUTROPENIA|FEBRILE NEUTROPENIA|INFECTION PROPHYLAXIS|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|MUSCULOSKELETAL PAIN|INSOMNIA|PROPHYLAXIS|PROPHYLAXIS|CONSTIPATION|PROPHYLAXIS|PROPHYLAXIS|NUTRITIONAL SUPPLEMENTATION|HYPERTENSION|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|VITAMIN D|THROMBOSIS PROPHYLAXIS|INFECTION PROPHYLAXIS|PROPHYLAXIS|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|ABDOMINAL DISCOMFORT|PROPHYLAXIS|NUTRITIONAL SUPPLEMENTATION|PROPHYLAXIS|FLUID REPLACEMENT|DIFFUSE LARGE B-CELL LYMPHOMA|MUSCULOSKELETAL PAIN|PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING|NEUTROPENIA|MUSCULOSKELETAL PAIN|PROPHYLAXIS|DIFFUSE LARGE B-CELL LYMPHOMA|MUSCULOSKELETAL PAIN|NEUTROPENIA|DIFFUSE LARGE B-CELL LYMPHOMA|MUSCULOSKELETAL PAIN|VITAMIN D|THROMBOSIS PROPHYLAXIS|THROMBOSIS PROPHYLAXIS|NEUTROPENIA|NUTRITIONAL SUPPLEMENTATION|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS,Device related infection,1,
13759081,20170717,Durvalumab,29,801,29.0,2,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|ARIPIPRAZOLE ORALLY DISINTEGRATING|ARIPIPRAZOLE|ARIPIPRAZOLE ORAL|SENNOSIDES|SENNA LEAF|SENNA|GEMCITABINE HYDROCHLORIDE|DURVALUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PACLITAXEL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,11,PANCREATIC CARCINOMA|GASTROINTESTINAL PAIN|ANXIETY|CONSTIPATION|HYPOVITAMINOSIS|PANCREATIC CARCINOMA|PANCREATIC CARCINOMA|NAUSEA|DYSPNOEA|PANCREATIC CARCINOMA|PROPHYLAXIS OF NAUSEA AND VOMITING,Pyrexia|Biliary tract infection|Vomiting,3,1
13759121,20170717,Durvalumab,26077,804,71.44,1,72,1,0,1,0,0,0,0,Durvalumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FORMOTEROL FUMARATE DIHYDRATE|PACLITAXEL|IRON|PACLITAXEL|TIOTROPIUM BROMIDE|FENTANYL|DOXAZOSIN|DOXAZOSIN MESYLATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FENTANYL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CLONAZEPAM|ERYTHROPOIETIN|TELMISARTAN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,24,PREMEDICATION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NON-SMALL CELL LUNG CANCER|ANAEMIA PROPHYLAXIS|CONSTIPATION|ANAEMIA PROPHYLAXIS|THROMBOSIS PROPHYLAXIS|BENIGN PROSTATIC HYPERPLASIA|NON-SMALL CELL LUNG CANCER|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CANCER PAIN|BENIGN PROSTATIC HYPERPLASIA|RESPIRATORY TRACT INFECTION|CANCER PAIN|NON-SMALL CELL LUNG CANCER|RESPIRATORY TRACT INFECTION|CANCER PAIN|NON-SMALL CELL LUNG CANCER|THROMBOSIS PROPHYLAXIS|HYPERTENSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PROPHYLAXIS|PREMEDICATION|PREMEDICATION,Lower respiratory tract infection,1,1
13759992,20170717,Durvalumab,24445,804,66.97,1,106.8,1,0,1,0,0,0,0,Durvalumab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|PREDNISONE|RITUXIMAB|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|DOXORUBICIN",13,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Febrile neutropenia,1,1
13760178,20170717,Durvalumab,24961,804,68.39,1,68.3,1,0,1,0,0,0,0,Durvalumab,"OXYCODONE|ACYCLOVIR|METOPROLOL TARTRATE|METOPROLOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|BUPROPION|ALLOPURINOL|GABAPENTIN|LOSARTAN|CEFUROXIME|RIVAROXABAN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|BENDAMUSTINE HCL|RITUXIMAB|RITUXIMAB|BENDAMUSTINE HCL|MORPHINE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LORAZEPAM|TURMERIC",24,NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|DECREASED APPETITE|PAIN|PROPHYLAXIS|HYPERTENSION|HYPOKALAEMIA|DEEP VEIN THROMBOSIS|DEPRESSION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HYPERTENSION|PROPHYLAXIS|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|PAIN|PROPHYLAXIS|ANXIETY|PROPHYLAXIS,Cellulitis,1,1
13760245,20170717,Durvalumab,20620,804,56.49,2,,1,0,1,1,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,16,NON-SMALL CELL LUNG CANCER|ASTHMA|DIARRHOEA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DECREASED APPETITE|ASTHMA|PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NAUSEA|NAUSEA,Lipase increased|Pyrexia,2,1
13760347,20170717,Durvalumab,70,801,70.0,1,61,1,1,1,0,0,0,0,Durvalumab,"TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|GABAPENTIN|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|TREMELIMUMAB|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|CLONAZEPAM",33,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|DECREASED APPETITE|FATIGUE|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|VITAMIN D DEFICIENCY|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|GASTROOESOPHAGEAL REFLUX DISEASE|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|CONSTIPATION|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|MEMORY IMPAIRMENT|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|DYSPNOEA|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Femur fracture|Radius fracture,2,1
13760352,20170717,Durvalumab,77,801,77.0,1,79,1,0,1,0,0,0,0,Durvalumab,AZACITIDINE|AZACITIDINE FOR|AZACITIDINE|AZACITIDINE FOR|CANDESARTAN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|AZACITIDINE|AZACITIDINE FOR|EZETIMIBE|METOPROLOL TARTRATE|METOPROLOL|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION,16,ACUTE MYELOID LEUKAEMIA|PROPHYLAXIS OF NAUSEA AND VOMITING|ACUTE MYELOID LEUKAEMIA|ACUTE MYELOID LEUKAEMIA|ACUTE MYELOID LEUKAEMIA|HYPERTENSION|HYPOKALAEMIA|HYPERTENSION|HYPOKALAEMIA|ACUTE MYELOID LEUKAEMIA|HYPERCHOLESTEROLAEMIA|ACUTE MYELOID LEUKAEMIA|HYPERTENSION|VITAMIN D ABNORMAL|GLAUCOMA|GASTRITIS PROPHYLAXIS,Pneumonia fungal,1,1
13765253,20170718,Durvalumab,26206,804,71.8,1,41.4,1,0,1,0,0,0,0,Durvalumab,"FINASTERIDE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS|SENNOSIDES|SENNA LEAF|SENNA|PROCHLORPERAZINE|CALCIUM CARBONATE|ANTACID",14,HYPERPLASIA|HYPERPLASIA|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|CONSTIPATION|VOMITING|PAIN|PAIN|BLOOD PHOSPHORUS DECREASED|CONSTIPATION|COUGH|VOMITING|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PAIN|NUTRITIONAL SUPPLEMENTATION,Pneumonia|Deep vein thrombosis,2,1
13765519,20170718,Durvalumab,31,801,31.0,2,90,1,0,1,0,0,0,0,Durvalumab,PACLITAXEL,2,TRIPLE NEGATIVE BREAST CANCER|TRIPLE NEGATIVE BREAST CANCER,Otitis media,1,1
13765555,20170718,Durvalumab,23714,804,64.97,1,74.8,1,0,1,0,0,0,0,Durvalumab,MORPHINE|TRANEXAMIC ACID|METHYLPREDNISOLONE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|AZACITIDINE|AZACITIDINE FOR|TELMISARTAN,9,ABDOMINAL PAIN|PROPHYLAXIS|PROPHYLAXIS|ACUTE MYELOID LEUKAEMIA|ORAL DISORDER|CONSTIPATION PROPHYLAXIS|ACUTE MYELOID LEUKAEMIA|PROPHYLAXIS|PROPHYLAXIS,Enteritis|Small intestinal obstruction|Febrile neutropenia,3,1
13765632,20170718,Durvalumab,19400,804,53.15,1,,1,0,0,0,1,0,1,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|TREMELIMUMAB,7,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PREMEDICATION|NON-SMALL CELL LUNG CANCER,Optic neuropathy,1,1
13766173,20170719,Durvalumab,,,,2,,1,0,1,0,0,0,0,Durvalumab,"NIFEDIPINE|TREMELIMUMAB|LEVOTHYROXINE|ATENOLOL AND CHLORTHALIDONE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PREDNISONE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|MAGNESIUM",12,BLOOD PRESSURE MEASUREMENT|SARCOMA|SARCOMA|PNEUMONIA|DIABETES MELLITUS|SUPPLEMENTATION THERAPY|PAIN|MINERAL SUPPLEMENTATION|INFLAMMATION|PROPHYLAXIS|MINERAL SUPPLEMENTATION,Pneumonia,1,1
13767167,20170719,Durvalumab,57,801,57.0,2,,1,0,0,0,0,0,1,Durvalumab,"DURVALUMAB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|LORAZEPAM|CALCIUM CARBONATE|AMLODIPINE|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|CALCIUM CARBONATE|TREMELIMUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CALCIUM CARBONATE|PACLITAXEL|CALCIUM CARBONATE|DIMENHYDRINATE",18,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA|ANXIETY|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION|ANXIETY|DYSPEPSIA|PANCREATIC CARCINOMA|ABDOMINAL PAIN|ABDOMINAL PAIN|PROPHYLAXIS OF NAUSEA AND VOMITING|ABDOMINAL PAIN|CONSTIPATION|GASTROOESOPHAGEAL REFLUX DISEASE|PANCREATIC CARCINOMA|PORTAL VEIN THROMBOSIS|GASTROOESOPHAGEAL REFLUX DISEASE|NAUSEA,Embolism,1,1
13769438,20170719,Durvalumab,72,801,72.0,1,77,1,1,1,1,1,0,0,Durvalumab,TRANEXAMIC ACID|TRANEXAMIC ACID|AZACITIDINE|AZACITIDINE FOR|AMLODIPINE|RAMIPRIL|AZACITIDINE|AZACITIDINE FOR|AZACITIDINE|AZACITIDINE FOR|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS,23,MYELODYSPLASTIC SYNDROME|HYPERTENSION|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING|HAEMORRHAGE PROPHYLAXIS|HAEMORRHAGE PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING|MICTURITION DISORDER|MYELODYSPLASTIC SYNDROME|PYREXIA|HYPERTENSION|HYPERTENSION|MYELODYSPLASTIC SYNDROME|INJECTION SITE ERYTHEMA|PRODUCT USED FOR UNKNOWN INDICATION|MYELODYSPLASTIC SYNDROME|MYELODYSPLASTIC SYNDROME|PYREXIA|GASTRITIS PROPHYLAXIS|MICTURITION DISORDER|MYELODYSPLASTIC SYNDROME|PYREXIA|PRODUCT USED FOR UNKNOWN INDICATION,Febrile infection|Febrile neutropenia|Neutropenic infection|General physical health deterioration,4,1
13769768,20170719,Durvalumab,64,801,64.0,2,70,1,0,1,0,0,0,0,Durvalumab,RAMUCIRUMAB,6,ADENOCARCINOMA GASTRIC|ADENOCARCINOMA GASTRIC,Psoriasis,1,1
13775238,20170720,Durvalumab,27038,804,74.08,1,94,1,0,1,0,0,0,0,Durvalumab,AZACITIDINE|AZACITIDINE FOR|AZACITIDINE|AZACITIDINE FOR|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|BISOPROLOL FUMARATE,7,ACUTE MYELOID LEUKAEMIA|ACUTE MYELOID LEUKAEMIA|BENIGN PROSTATIC HYPERPLASIA|ACUTE MYELOID LEUKAEMIA|ACUTE MYELOID LEUKAEMIA|PROPHYLAXIS|PERIPHERAL VENOUS DISEASE,Febrile neutropenia,1,1
13775276,20170721,Durvalumab,59,801,59.0,2,,1,1,0,0,0,0,0,Durvalumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PANTOPRAZOLE|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE,28,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ADJUSTMENT DISORDER WITH DEPRESSED MOOD|NON-SMALL CELL LUNG CANCER|THROMBOCYTOSIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|COUGH|PNEUMONIA|ADJUSTMENT DISORDER WITH DEPRESSED MOOD|NON-SMALL CELL LUNG CANCER|CANCER PAIN|IRON DEFICIENCY ANAEMIA|NON-SMALL CELL LUNG CANCER|CONSTIPATION|NON-SMALL CELL LUNG CANCER|IRON DEFICIENCY ANAEMIA|GASTRITIS EROSIVE|BRONCHOSPASM|PNEUMONIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Cardiac arrest,1,1
13775933,20170721,Durvalumab,73,801,73.0,1,,1,0,1,1,0,0,1,Durvalumab,"ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|STANDARDIZED SENNA CONCENTRATE|PREDNISONE|OXYBUTYNIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LEVOTHYROXINE|BUPROPION|PANTOPRAZOLE|HYDROCORTISONE CREAM|HYDROCORTISONE|ADENOSINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISONE|GLYCOPYRROLATE|TREMELIMUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|DURVALUMAB|DURVALUMAB|TREMELIMUMAB|BIMATOPROST|METHYLPREDNISOLONE",31,HORMONE-REFRACTORY PROSTATE CANCER|HORMONE-REFRACTORY PROSTATE CANCER|GENITOURINARY TRACT NEOPLASM|GENITOURINARY TRACT NEOPLASM,Aspartate aminotransferase increased|Alanine aminotransferase increased|Supraventricular tachycardia|Myositis,4,1
13776650,20170721,Durvalumab,20605,804,56.45,2,,1,1,1,0,0,0,1,Durvalumab,"TREMELIMUMAB|MORPHINE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,",6,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SCAR|CANCER PAIN,Pneumonitis,1,1
13776839,20170721,Durvalumab,23567,804,64.57,1,,1,0,1,0,0,0,0,Durvalumab,IBRUTINIB|IBRUTINIB|AMOXICILLIN AND CLAVULANATE POTASSIUM,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|VIRAL INFECTION,Syncope|Viral infection,2,1
13778276,20170721,Durvalumab,71,801,71.0,1,,1,1,0,0,0,0,0,Durvalumab,PREGABALIN|METRONIDAZOLE|ACETAMINOPHEN|ATORVASTATIN CALCIUM|PREDNISONE|LORAZEPAM|CEFTRIAXONE|CEFTRIAXONE SODIUM|DURVALUMAB|TREMELIMUMAB|HYDROMORPHONE HYDROCHLORIDE,23,ATRIAL FIBRILLATION|NEURALGIA|COUGH|INFECTION|INFECTION|EROSIVE OESOPHAGITIS|PAIN IN EXTREMITY|HYPERCHOLESTEROLAEMIA|INSOMNIA|HYPOKALAEMIA|COUGH|ATRIAL FIBRILLATION|INSOMNIA|BLOOD BILIRUBIN INCREASED|INSOMNIA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|INFECTION|COLORECTAL CANCER|COLORECTAL CANCER|ABDOMINAL PAIN|PROPHYLAXIS AGAINST DEHYDRATION|FUNGAL INFECTION,Sepsis,1,1
13778617,20170721,Durvalumab,18232,804,49.95,2,35,1,1,1,1,1,0,1,Durvalumab,CEFTRIAXONE|CEFTRIAXONE SODIUM|FENTANYL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|NAPROXEN|NAPROXEN SODIUM|FENTANYL|CEFTRIAXONE|CEFTRIAXONE SODIUM|PHYTONADIONE|TREMELIMUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PHYTONADIONE|PHYTONADIONE,16,INFECTION PROPHYLAXIS|PAIN MANAGEMENT|STOMATITIS|INFECTION|PAIN MANAGEMENT|DECREASED APPETITE|INFECTION PROPHYLAXIS|HEPATITIS ACUTE|BLADDER TRANSITIONAL CELL CARCINOMA|TUMOUR PAIN|INCREASED APPETITE|HEPATITIS ACUTE|BLADDER TRANSITIONAL CELL CARCINOMA|INFECTION|CONSTIPATION|HEPATITIS ACUTE,Deep vein thrombosis|Drug-induced liver injury,2,1
13781155,20170724,Durvalumab,64,801,64.0,1,56.7,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB,2,OESOPHAGEAL SQUAMOUS CELL CARCINOMA|OESOPHAGEAL SQUAMOUS CELL CARCINOMA,Guillain-Barre syndrome,1,1
13783367,20170724,Durvalumab,20104,804,55.08,2,88,1,0,0,1,0,0,1,Durvalumab,SERTRALINE|FLUOCINOLONE ACETONIDE|METHIMAZOLE|TREMELIMUMAB|ALPRAZOLAM|ZOLPIDEM TARTRATE,12,RASH|CONSTIPATION|BREAST CANCER FEMALE|NAUSEA|BREAST CANCER FEMALE|BREAST CANCER FEMALE,Pulmonary embolism,1,1
13783395,20170724,Durvalumab,57,801,57.0,2,,1,0,0,0,0,0,1,Durvalumab,"QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|CALCIUM CARBONATE|GEMCITABINE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|TREMELIMUMAB|LORAZEPAM|CALCIUM CARBONATE|DIMENHYDRINATE|PACLITAXEL|DURVALUMAB|AMLODIPINE|CALCIUM CARBONATE|CALCIUM CARBONATE",19,PULMONARY EMBOLISM|CONSTIPATION|PORTAL VEIN THROMBOSIS|ANXIETY|DYSPEPSIA|PROPHYLAXIS OF NAUSEA AND VOMITING|PANCREATIC CARCINOMA|ABDOMINAL PAIN|ABDOMINAL PAIN|PANCREATIC CARCINOMA|ANXIETY|NAUSEA|PANCREATIC CARCINOMA|PANCREATIC CARCINOMA|HYPERTENSION|ABDOMINAL PAIN|GASTROOESOPHAGEAL REFLUX DISEASE|GASTROOESOPHAGEAL REFLUX DISEASE,Embolism,1,1
13783493,20170724,Durvalumab,65,801,65.0,1,,1,0,0,0,0,0,1,Durvalumab,METOPROLOL TARTRATE|METOPROLOL|DURVALUMAB|TREMELIMUMAB|FUROSEMIDE|ATORVASTATIN CALCIUM,8,HYPERTENSION|INSOMNIA|COLORECTAL CANCER|COLORECTAL CANCER|ATRIAL FIBRILLATION|HYPERTENSION|HYPERTENSION|HYPERCHOLESTEROLAEMIA,Haemorrhage intracranial,1,1
13783557,20170724,Durvalumab,76,801,76.0,2,,1,0,1,0,0,0,0,Durvalumab,DIPHENHYDRAMINE HYDROCHLORIDE|TREMELIMUMAB|DURVALUMAB,4,COUGH|COUGH|COLORECTAL CANCER|COLORECTAL CANCER,Rhabdomyolysis|Troponin T increased,2,1
13783580,20170724,Durvalumab,72,801,72.0,2,,1,0,1,0,0,0,0,Durvalumab,MULTIVITAMIN|PEMETREXED|PEMETREXED DISODIUM|MORPHINE SULFATE|DURVALUMAB|UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE|FOLIC ACID|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|TREMELIMUMAB|ROSUVASTATIN|CISPLATIN|APREPITANT|FOSAPREPITANT DIMEGLUMINE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,16,NUTRITIONAL SUPPLEMENTATION|NON-SMALL CELL LUNG CANCER|BACK PAIN|NON-SMALL CELL LUNG CANCER|OSTEOPOROSIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PROPHYLAXIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|DYSLIPIDAEMIA|NON-SMALL CELL LUNG CANCER|INSOMNIA|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|NAUSEA,Colitis,1,1
13784711,20170725,Durvalumab,24630,804,67.48,1,,1,0,1,0,0,0,1,Durvalumab,TREMELIMUMAB|OXYCODONE AND ACETAMINOPHEN|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|OXYCODONE AND ACETAMINOPHEN TABLETS|OXYCODONE AND ACETAMINOPHEN|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|OXYCODONE AND ACETAMINOPHEN TABLETS|OXYCODONE AND ACETAMINOPHEN|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|OXYCODONE AND ACETAMINOPHEN TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OXYCODONE AND ACETAMINOPHEN|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|OXYCODONE AND ACETAMINOPHEN TABLETS,7,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-CARDIAC CHEST PAIN|BACK PAIN|NON-CARDIAC CHEST PAIN|GASTROOESOPHAGEAL REFLUX DISEASE|BACK PAIN,Autoimmune pancreatitis,1,1
13785954,20170725,Durvalumab,46,801,46.0,2,56.7,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|MEMANTINE HYDROCHLORIDE|MEMANTINE|MEMANTINE HYDROCHLORIDE ORAL|DURVALUMAB,3,,Metastases to pelvis|Metastases to abdominal cavity|Cerebral infarction|Malignant neoplasm progression|Central nervous system lesion|Metastases to central nervous system|Metastatic neoplasm,7,1
13786443,20170725,Durvalumab,58,801,58.0,2,49,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|TREMELIMUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,16,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|PROPHYLAXIS,Pneumonia,1,1
13791072,20170725,Durvalumab,67,801,67.0,1,,1,0,1,0,0,0,0,Durvalumab,DURVALUMAB|PROCHLORPERAZINE|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PANCRELIPASE|PREDNISONE|TREMELIMUMAB|CEPHALEXIN|PREDNISONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE,23,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE|MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,Lower gastrointestinal haemorrhage,1,1
13791289,20170725,Durvalumab,76,801,76.0,1,60,1,1,1,1,0,0,0,Durvalumab,DESLORATADINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LEVOTHYROXINE SODIUM|SODIUM THIOSULFATE|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|METHYLPREDNISOLONE|LORATADINE|LORATADINE TABLET|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|TREMELIMUMAB|CALCIUM GLUCONATE,11,PRURIGO|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PRURIGO|PROPHYLAXIS|PRURIGO|PRURIGO|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PRURIGO,Thrombocytopenia|Sudden cardiac death,2,1
13791480,20170725,Durvalumab,25607,804,70.16,1,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|UREA|DESLORATADINE|CHLORZOXAZONE|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|VALSARTAN|VALSARTAN ORAL|FAMOTIDINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,21,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|RASH|RASH|MYALGIA|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|HYPOTHYROIDISM|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|HYPERTENSION|PROPHYLAXIS|HYPERTENSION|MYALGIA|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Pneumonia,1,1
13791485,20170725,Durvalumab,29607,804,81.12,1,58,1,1,1,0,0,0,0,Durvalumab,"CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|AMLODIPINE BESYLATE AND VALSARTAN|TREMELIMUMAB|PEMETREXED DISODIUM|PEMETREXED|TREMELIMUMAB|TREMELIMUMAB|FOLIC ACID|QUETIAPINE|TREMELIMUMAB|FOLIC ACID",33,NON-SMALL CELL LUNG CANCER|STOMATITIS|ISCHAEMIC ENTERITIS|NON-SMALL CELL LUNG CANCER|ISCHAEMIC ENTERITIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|STOMATITIS|ISCHAEMIC ENTERITIS|NON-SMALL CELL LUNG CANCER|ABDOMINAL PAIN|HYPERTENSION|ISCHAEMIC ENTERITIS|CONSTIPATION PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|CHEMOTHERAPY SINGLE AGENT SYSTEMIC|ISCHAEMIC ENTERITIS|ABDOMINAL PAIN UPPER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PREMEDICATION|PROPHYLAXIS OF NAUSEA AND VOMITING|NON-SMALL CELL LUNG CANCER|ABDOMINAL PAIN|DELIRIUM|ISCHAEMIC ENTERITIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PREMEDICATION|PROPHYLAXIS OF NAUSEA AND VOMITING|ABDOMINAL PAIN|ISCHAEMIC ENTERITIS|ABDOMINAL PAIN UPPER,Colitis ischaemic,1,1
13793443,20170726,Durvalumab,50,801,50.0,1,55,1,0,1,0,0,0,0,Durvalumab,LACTULOSE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|TREMELIMUMAB|TRANEXAMIC ACID,6,OESOPHAGEAL CARCINOMA|CONSTIPATION|TUMOUR HAEMORRHAGE|OESOPHAGEAL CARCINOMA|TUMOUR HAEMORRHAGE|TUMOUR HAEMORRHAGE,Pericardial effusion,1,1
13801105,20170727,Durvalumab,19838,804,54.35,1,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|TREMELIMUMAB|AMLODIPINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|RABEPRAZOLE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|TREMELIMUMAB|METHYLPREDNISOLONE|TREMELIMUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|AMLODIPINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,29,NON-SMALL CELL LUNG CANCER|RASH|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|RASH|RASH|ANTIEMETIC SUPPORTIVE CARE|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|SKIN REACTION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|RASH|RASH|RASH|RASH|HYPERTENSION|SKIN REACTION|RASH|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|SKIN REACTION|RASH|RASH|RASH|RASH,Atrial fibrillation,1,1
13801346,20170727,Durvalumab,19842,804,54.36,1,,1,0,1,1,0,0,1,Durvalumab,HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|TREMELIMUMAB|AMLODIPINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RABEPRAZOLE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|METHYLPREDNISOLONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RABEPRAZOLE|TREMELIMUMAB|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|RABEPRAZOLE|TREMELIMUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RABEPRAZOLE|TREMELIMUMAB|AMLODIPINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,37,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|RASH|SKIN REACTION|RASH|RASH|RASH|NON-SMALL CELL LUNG CANCER|HYPERTENSION|SKIN REACTION|RASH|SKIN REACTION|SKIN REACTION|RASH|PROPHYLAXIS|RASH|SKIN REACTION|NON-SMALL CELL LUNG CANCER|SKIN REACTION|SKIN REACTION|RASH|RASH|VOMITING|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|RASH|RASH|VOMITING|NON-SMALL CELL LUNG CANCER|HYPERTENSION|RASH|RASH,Sepsis,1,1
13801491,20170727,Durvalumab,24534,804,67.22,2,,1,0,1,0,0,0,0,Durvalumab,DURVALUMAB|TREMELIMUMAB,2,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT,Chest pain,1,1
13801622,20170727,Durvalumab,,,,2,,1,0,0,0,0,0,0,Durvalumab,DURVALUMAB,1,,Lung disorder,1,5
13803653,20170728,Durvalumab,58,801,58.0,2,,1,1,0,0,0,0,0,Durvalumab,DURVALUMAB|TREMELIMUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Sudden death,1,1
13803976,20170728,Durvalumab,25731,804,70.5,2,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|REPAGLINIDE|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|AMLODIPINE|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS,18,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DYSPEPSIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPOTENSION|DIABETES MELLITUS,Blood corticotrophin decreased,1,1
13804564,20170728,Durvalumab,,,,1,,1,0,1,0,0,0,0,Durvalumab,DURVALUMAB,1,TRANSITIONAL CELL CANCER OF THE RENAL PELVIS AND URETER,Pneumonitis,1,
13807411,20170728,Durvalumab,70,801,70.0,1,,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|MAGNESIUM OXIDE|MAGNESIUM|PREDNISONE|PREDNISONE|MULTIVITAMIN|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|SPIRONOLACTONE|TREMELIMUMAB|METOPROLOL TARTRATE|METOPROLOL|TREMELIMUMAB|OXYCODONE|LEVOTHYROXINE SODIUM,18,HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|AUTOIMMUNE ENDOCRINE DISORDER|HEPATOCELLULAR CARCINOMA|AUTOIMMUNE ENDOCRINE DISORDER|ROUTINE HEALTH MAINTENANCE|CONSTIPATION|HYPERTENSION|CYSTITIS|HEPATOCELLULAR CARCINOMA|HYPERTENSION|HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|FLANK PAIN|HYPOTHYROIDISM,Acute kidney injury,1,1
13807886,20170728,Durvalumab,24982,804,68.44,1,,1,1,1,1,0,0,0,Durvalumab,INDAPAMIDE|PROMETHAZINE HYDROCHLORIDE|PROMETHAZINE|DURVALUMAB|CARBOPLATIN|METOCLOPRAMIDE HYDROCHLORIDE|DURVALUMAB|DURVALUMAB|PEMETREXED|PEMETREXED DISODIUM|DURVALUMAB|METOCLOPRAMIDE HYDROCHLORIDE,23,HYPERTENSION|DECREASED APPETITE|VOMITING|VOMITING|COUGH|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|PROPHYLAXIS|VOMITING|PROPHYLAXIS|VOMITING|VOMITING|PROPHYLAXIS|DECREASED APPETITE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|COUGH|PROPHYLAXIS|VOMITING|PROPHYLAXIS,Cerebral infarction|Thrombocytopenia|Vomiting,3,1
13812744,20170730,Durvalumab,,,,1,,1,1,0,0,0,0,0,Durvalumab,DURVALUMAB,1,,Death,1,1
13813659,20170731,Durvalumab,23318,804,63.88,1,75,1,1,0,0,0,0,0,Durvalumab,TREMELIMUMAB|OCTREOTIDE ACETATE|OCTREOTIDE,5,NEUROENDOCRINE TUMOUR|NEUROENDOCRINE TUMOUR|CARCINOID SYNDROME|NEUROENDOCRINE TUMOUR|DIABETES MELLITUS,Diarrhoea|Acute kidney injury|Encephalitis,3,1
13814522,20170731,Durvalumab,30431,804,83.37,1,83.3,1,0,1,0,0,0,0,Durvalumab,AZACITIDINE|AZACITIDINE FOR|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|AMOXICILLIN AND CLAVULANATE POTASSIUM|AZACITIDINE|AZACITIDINE FOR|AMOXICILLIN AND CLAVULANATE POTASSIUM|NASAL|SALINE|(SALINE)|AZACITIDINE|AZACITIDINE FOR,19,ACUTE MYELOID LEUKAEMIA|PYREXIA|PYREXIA|ACUTE MYELOID LEUKAEMIA|ACUTE MYELOID LEUKAEMIA|PROPHYLAXIS OF NAUSEA AND VOMITING|ASTHENIA|INFECTION PROPHYLAXIS|BENIGN PROSTATIC HYPERPLASIA|ACUTE MYELOID LEUKAEMIA|HYPERTENSION|PROPHYLAXIS AGAINST DEHYDRATION|INFECTION PROPHYLAXIS|BENIGN PROSTATIC HYPERPLASIA|PROPHYLAXIS AGAINST DEHYDRATION|ASTHENIA|ACUTE MYELOID LEUKAEMIA|PYREXIA|PROPHYLAXIS AGAINST DEHYDRATION,Thrombocytopenia,1,1
13815403,20170731,Durvalumab,62,801,62.0,1,,1,0,1,0,0,0,0,Durvalumab,AMLODIPINE BESYLATE|PEMETREXED|PEMETREXED DISODIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARBOPLATIN|TREMELIMUMAB|TREMELIMUMAB|CARBOPLATIN|PEMETREXED|PEMETREXED DISODIUM|OXYCODONE HYDROCHLORIDE|FOLIC ACID|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,19,PAIN PROPHYLAXIS|PREMEDICATION|PREMEDICATION|NON-SMALL CELL LUNG CANCER|SUPPORTIVE CARE|NON-SMALL CELL LUNG CANCER|PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PAIN|CONSTIPATION|PREMEDICATION|PREMEDICATION|SUPPORTIVE CARE|PAIN,Enterocolitis,1,1
13821152,20170801,Durvalumab,,,,0,,1,1,0,0,0,0,0,Durvalumab,DURVALUMAB,1,,Disease progression,1,1
13822257,20170801,Durvalumab,56,801,56.0,2,69,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|CARBOXYMETHYLCELLULOSE SODIUM,14,NEOPLASM MALIGNANT|DIARRHOEA|HYPERTENSION|DIARRHOEA|HYPERTENSION|HYPERTENSION|HYPERTENSION|HYPERTENSION|NEOPLASM MALIGNANT|VENOUS THROMBOSIS|HYPERTENSION|HYPOTHYROIDISM|HYPERTENSION|HYPERTENSION,Vomiting,1,1
13822414,20170801,Durvalumab,61,801,61.0,1,49.3,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|FAMOTIDINE,10,OESOPHAGEAL CARCINOMA|CHRONIC GASTRITIS|RASH|RASH|RASH|DIARRHOEA|SPINAL CORD INFARCTION|DIARRHOEA|OESOPHAGEAL CARCINOMA|RASH,Thyroiditis,1,1
13825350,20170802,Durvalumab,45,801,45.0,1,,1,0,1,0,0,0,1,Durvalumab,TENOFOVIR DISOPROXIL FUMARATE|TREMELIMUMAB,3,HEPATITIS B|HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA,Tumour rupture,1,1
13825660,20170802,Durvalumab,84,801,84.0,1,104,1,0,1,0,0,0,0,Durvalumab,IBRUTINIB|IBRUTINIB|DURVALUMAB|DURVALUMAB|APIXABAN|FINASTERIDE,8,PRODUCT USED FOR UNKNOWN INDICATION|ANALGESIC THERAPY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ANALGESIC THERAPY|PRODUCT USED FOR UNKNOWN INDICATION|ATRIAL FIBRILLATION|BENIGN PROSTATIC HYPERPLASIA,Pulmonary oedema,1,3
13828084,20170803,Durvalumab,,,,2,,1,1,0,0,0,0,0,Durvalumab,DURVALUMAB,1,BLADDER CANCER,Death,1,1
13828189,20170803,Durvalumab,22128,804,60.62,1,,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|TREMELIMUMAB|TREMELIMUMAB,16,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HEPATITIS|PREMEDICATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HEPATITIS|HEPATITIS|HEPATITIS|NON-SMALL CELL LUNG CANCER|HEPATITIS|NON-SMALL CELL LUNG CANCER,Immune-mediated hepatitis,1,1
13828792,20170803,Durvalumab,66,801,66.0,1,78,1,0,1,0,0,0,0,Durvalumab,PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|TREMELIMUMAB|TREMELIMUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|TREMELIMUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,14,DIARRHOEA|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|DIARRHOEA|RASH|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|RASH|DIARRHOEA|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|DIARRHOEA|ENTEROCOLITIS|PROPHYLAXIS,Pneumonia,1,1
13829025,20170803,Durvalumab,,,,0,,1,0,0,0,0,0,1,Durvalumab,DURVALUMAB|TREMELIMUMAB|PEMBROLIZUMAB|NIVOLUMAB|ATEZOLIZUMAB,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression,1,5
13829031,20170803,Durvalumab,,,,0,,1,0,0,0,0,0,1,Durvalumab,NIVOLUMAB|PEMBROLIZUMAB|DURVALUMAB|TREMELIMUMAB|ATEZOLIZUMAB,5,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression,1,5
13829596,20170803,Durvalumab,60,801,60.0,1,72,1,1,1,0,0,0,1,Durvalumab,DENOSUMAB|OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|TREMELIMUMAB,11,UPPER LIMB FRACTURE|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|UPPER LIMB FRACTURE|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Anaemia,1,1
13831273,20170803,Durvalumab,20613,804,56.47,1,,1,1,1,1,1,1,1,Durvalumab,DURVALUMAB|DURVALUMAB|DURVALUMAB|DURVALUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|ETOPOSIDE|ETOPOSIDE|ETOPOSIDE|ETOPOSIDE|ETOPOSIDE|ETOPOSIDE|ETOPOSIDE|ETOPOSIDE|ETOPOSIDE|ETOPOSIDE|ETOPOSIDE|ETOPOSIDE|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|ACETYLCYSTEINE,25,Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Small cell lung cancer|Productive cough,Alveolitis,1,1
13831283,20170803,Durvalumab,83,801,83.0,2,22.6,1,0,1,0,0,0,0,Durvalumab,"CALCIUM CARBONATE|ANTACID|DULOXETINE HYDROCHLORIDE|DULOXETINE|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|RANITIDINE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|MUPIROCIN|MUPIROCIN CALCIUM|FAMOTIDINE|AMLODIPINE BESYLATE|LATANOPROST|LAMOTRIGINE|LAMOTRIGINE EXTENDED-RELEASE|LAMOTRIGINE CHEWABLE DISPERSIBLE|LAMOTIRIGINE|LISINOPRIL|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|AZACITIDINE|AZACITIDINE FOR|FAMOTIDINE|AMLODIPINE|DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG|DOCUSATE SODIUM, SENNOSIDES|DOCUSATE SODIUM, 50 MG SENNOSIDES, 8.6 MG|ERGOCALCIFEROL",26,OSTEOPOROSIS|DEPRESSION|INFECTION PROPHYLAXIS|EYE LUBRICATION THERAPY|OSTEOARTHRITIS|INFECTION PROPHYLAXIS|DYSPEPSIA|HYPOKALAEMIA|NAUSEA|ASTHENIA|SKIN INFECTION|EYE LUBRICATION THERAPY|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|EYE LUBRICATION THERAPY|BIPOLAR DISORDER|HYPERTENSION|DECREASED APPETITE|INFECTION PROPHYLAXIS|ACUTE MYELOID LEUKAEMIA|ACUTE MYELOID LEUKAEMIA|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION|ANTIBIOTIC PROPHYLAXIS|CONSTIPATION PROPHYLAXIS|OSTEOPOROSIS,Fall,1,1
13831336,20170803,Durvalumab,61,801,61.0,1,62,1,0,1,0,0,0,0,Durvalumab,PANCRELIPASE|RABEPRAZOLE SODIUM|RABEPRAZOLE|MAGNESIUM OXIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|TREMELIMUMAB|KETOPROFEN,11,SUPPLEMENTATION THERAPY|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|CONSTIPATION|DIABETES MELLITUS|HYPERLIPIDAEMIA|PRURITUS|DIARRHOEA|PYREXIA|BILE DUCT CANCER|MYALGIA|BILE DUCT CANCER,Polymyositis,1,1
13833670,20170804,Durvalumab,67,801,67.0,1,,1,1,1,0,0,0,0,Durvalumab,"TREMELIMUMAB|CISPLATIN|MAGNESIUM OXIDE|SILODOSIN|DIMETHICONE 1%|DIMETHICONE 1.5%|LINAGLIPTIN|NITROGLYCERIN|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|MEGESTROL ACETATE|FAMOTIDINE|TREMELIMUMAB|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|TREMELIMUMAB|PACLITAXEL|VALSARTAN|VALSARTAN ORAL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED",30,PYREXIA|PREMEDICATION|BLADDER TRANSITIONAL CELL CARCINOMA|TUMOUR PAIN|ABDOMINAL DISTENSION|PYREXIA|BENIGN PROSTATIC HYPERPLASIA|ABDOMINAL DISTENSION|TYPE 2 DIABETES MELLITUS|CORONARY ARTERY DISEASE|PROPHYLAXIS AGAINST DIARRHOEA|TUMOUR PAIN|PREMEDICATION|DIARRHOEA|PROPHYLAXIS|PREMEDICATION|PREMEDICATION|ABDOMINAL DISTENSION|ABDOMINAL DISTENSION|PROPHYLAXIS OF NAUSEA AND VOMITING|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|HYPERTENSION|CORONARY ARTERY DISEASE,Acute kidney injury,1,1
13835468,20170804,Durvalumab,78,801,78.0,1,79,1,1,1,1,0,0,0,Durvalumab,AMPHOTERICIN B|RAMIPRIL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|AMIKACIN|AMIKACIN|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|NAPROXEN|NAPROXEN SODIUM|CARBAMAZEPINE|AMIKACIN|AMPHOTERICIN B|AMLODIPINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|MEROPENEM|AMIKACIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,28,PNEUMONIA|HYPERTENSION|PROSTATISM|NAUSEA|RASH|TRIGEMINAL NEURALGIA|MYELODYSPLASTIC SYNDROME|TRIGEMINAL NEURALGIA|HYPERTENSION|PNEUMONIA|HYPERTENSION|CEREBROVASCULAR ACCIDENT PROPHYLAXIS|MYELODYSPLASTIC SYNDROME|PNEUMONIA|PROPHYLAXIS OF NAUSEA AND VOMITING|PNEUMONIA|PNEUMONIA|CEREBROVASCULAR ACCIDENT PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING,Pneumonia|Multiple organ dysfunction syndrome,2,3
13835581,20170804,Durvalumab,74,801,74.0,2,,1,0,1,1,0,0,0,Durvalumab,CARBOPLATIN|DURVALUMAB|TREMELIMUMAB|ETOPOSIDE|PROPRANOLOL HYDROCHLORIDE,5,SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER,Hyperthyroidism|Diarrhoea|Nephritis|Cardiac failure|Myocarditis|Nausea|Vomiting|Febrile neutropenia,8,1
13835757,20170804,Durvalumab,21799,804,59.72,1,78.4,1,0,1,0,0,0,1,Durvalumab,LEVOTHYROXINE SODIUM|LENALIDOMIDE|ALLOPURINOL,5,HYPOTHYROIDISM|PLASMA CELL MYELOMA|GOUT|EMBOLISM VENOUS|PLASMA CELL MYELOMA,Febrile neutropenia|Clostridium difficile infection,2,1
13835871,20170804,Durvalumab,51,801,51.0,1,59,1,0,1,1,0,0,1,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|OXYCODONE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|ALBUTEROL SULFATE|ALBUTEROL|TREMELIMUMAB|FENTANYL|TREMELIMUMAB|FENTANYL|LEVOTHYROXINE SODIUM|LORAZEPAM|LORAZEPAM,20,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SEASONAL ALLERGY,Embolic stroke|Pharyngeal haemorrhage|Cardiac arrest,3,1
13835948,20170804,Durvalumab,82,801,82.0,1,81.6,1,0,1,0,0,0,0,Durvalumab,TREMELIMUMAB,2,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT,Hyponatraemia,1,1
13838166,20170807,Durvalumab,22732,804,62.28,2,,1,0,1,0,0,0,1,Durvalumab,TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB|TREMELIMUMAB,9,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Diarrhoea|Amylase increased|Lipase increased,3,1
13839220,20170807,Durvalumab,83,801,83.0,2,22.62,1,0,1,0,0,0,0,Durvalumab,"FAMOTIDINE|LATANOPROST|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|ERGOCALCIFEROL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CALCIUM CARBONATE|ANTACID|FAMOTIDINE|ISAVUCONAZONIUM SULFATE|ACYCLOVIR|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|DULOXETINE HYDROCHLORIDE|DULOXETINE|LAMOTRIGINE|LAMOTRIGINE EXTENDED-RELEASE|LAMOTRIGINE CHEWABLE DISPERSIBLE|LAMOTIRIGINE|LAMOTRIGINE|LAMOTRIGINE EXTENDED-RELEASE|LAMOTRIGINE CHEWABLE DISPERSIBLE|LAMOTIRIGINE|DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG|DOCUSATE SODIUM, SENNOSIDES|DOCUSATE SODIUM, 50 MG SENNOSIDES, 8.6 MG|LISINOPRIL|MUPIROCIN|MUPIROCIN CALCIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|AMLODIPINE|RANITIDINE|AMLODIPINE BESYLATE",28,GASTROOESOPHAGEAL REFLUX DISEASE|PAIN|EYE LUBRICATION THERAPY|INFECTION PROPHYLAXIS|ACUTE MYELOID LEUKAEMIA|OSTEOPOROSIS|ACUTE MYELOID LEUKAEMIA|DECREASED APPETITE|OSTEOARTHRITIS|OSTEOPOROSIS|EYE LUBRICATION THERAPY|ANTIBIOTIC PROPHYLAXIS|ANTIFUNGAL PROPHYLAXIS|INFECTION PROPHYLAXIS|INFECTION PROPHYLAXIS|NAUSEA|DEPRESSION|BIPOLAR DISORDER|CONSTIPATION PROPHYLAXIS|HYPERTENSION|SKIN INFECTION|HYPOKALAEMIA|EYE LUBRICATION THERAPY|ASTHENIA|HYPERTENSION|DYSPEPSIA|PRODUCT USED FOR UNKNOWN INDICATION,Fall,1,1
13840329,20170807,Durvalumab,29776,804,81.58,2,,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|CEFTRIAXONE SODIUM|TREMELIMUMAB|TREMELIMUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|NAPROXEN|NAPROXEN SODIUM,14,BLADDER TRANSITIONAL CELL CARCINOMA|CONSTIPATION|HYPERTENSION|CANCER PAIN|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|TUMOUR ASSOCIATED FEVER|BLADDER TRANSITIONAL CELL CARCINOMA|BLADDER TRANSITIONAL CELL CARCINOMA|NEUROPATHY PERIPHERAL|BLADDER TRANSITIONAL CELL CARCINOMA|ATAXIA|CANCER PAIN|CANCER PAIN,Myoclonus,1,1
13840624,20170807,Durvalumab,53,801,53.0,1,,1,0,1,0,0,0,0,Durvalumab,DURVALUMAB|TREMELIMUMAB,2,ANAPLASTIC THYROID CANCER|ANAPLASTIC THYROID CANCER,Platelet count decreased|Non-cardiac chest pain|Anaemia,3,1
13841340,20170807,Durvalumab,76,801,76.0,2,,1,0,1,0,0,0,0,Durvalumab,STANDARDIZED SENNA CONCENTRATE|ERGOCALCIFEROL|PEMETREXED|PEMETREXED DISODIUM|VITAMIN E|CISPLATIN|DURVALUMAB|TREMELIMUMAB|FOLIC ACID,13,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Constipation|Enterocolitis,2,1
13842406,20170808,Durvalumab,19766,804,54.15,1,,1,1,1,0,0,0,0,Durvalumab,DEXTROSE ANHYDROUS|DEXTROSE ANHYDROUS,10,FATIGUE|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|FATIGUE|PAIN|PROPHYLAXIS|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|INFLAMMATION|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|FATIGUE|INFLAMMATION,Pneumonia,1,1
13843863,20170808,Durvalumab,62,801,62.0,1,,1,0,1,1,0,0,0,Durvalumab,CARBOPLATIN|CARBOPLATIN|TREMELIMUMAB|PEMETREXED|PEMETREXED DISODIUM|OXYCODONE HYDROCHLORIDE|FOLIC ACID|TREMELIMUMAB|PEMETREXED|PEMETREXED DISODIUM,14,PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PAIN|PAIN|CONSTIPATION|PREMEDICATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Diarrhoea,1,1
13844085,20170808,Durvalumab,20027,804,54.87,1,68,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|TREMELIMUMAB,4,GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE|GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE|GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE|GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE,Febrile neutropenia,1,1
13848929,20170809,Durvalumab,,,,0,,1,1,0,0,0,0,1,Durvalumab,DURVALUMAB,1,BLADDER CANCER,Death|Disease progression,2,1
13849097,20170809,Durvalumab,24076,804,65.96,2,,1,0,0,0,0,0,1,Durvalumab,TREMELIMUMAB|FOLIC ACID|TREMELIMUMAB|SIMVASTATIN|TREMELIMUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|TREMELIMUMAB,19,COUGH|NON-SMALL CELL LUNG CANCER|PREMEDICATION|RASH|COUGH|DRY SKIN|DECREASED APPETITE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|BLOOD CHOLESTEROL INCREASED|NON-SMALL CELL LUNG CANCER|HYPERTENSION|COUGH|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|TYPE 2 DIABETES MELLITUS|CHEST PAIN|NON-SMALL CELL LUNG CANCER,Rash maculo-papular,1,1
13849183,20170809,Durvalumab,62,801,62.0,2,77.5,1,0,1,0,0,0,0,Durvalumab,POMALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Syncope,1,1
13849187,20170809,Durvalumab,76,801,76.0,1,92.1,1,0,1,1,0,0,0,Durvalumab,ERGOCALCIFEROL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|INDOMETHACIN|AZACITIDINE|AZACITIDINE FOR|AZACITIDINE|AZACITIDINE FOR|FLUCONAZOLE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|METHYLPREDNISOLONE,19,ACUTE MYELOID LEUKAEMIA|ROUTINE HEALTH MAINTENANCE|FEBRILE NEUTROPENIA|RASH|ALLERGY PROPHYLAXIS|FEBRILE NEUTROPENIA|PROPHYLAXIS|PROPHYLAXIS|GOUT|INFECTION PROPHYLAXIS|ACUTE MYELOID LEUKAEMIA|ACUTE MYELOID LEUKAEMIA|INFECTION PROPHYLAXIS|PAIN MANAGEMENT|ACUTE MYELOID LEUKAEMIA|FEBRILE NEUTROPENIA|HYPOKALAEMIA|INFECTION PROPHYLAXIS|ARTHRALGIA,Hypotension|Atrial fibrillation,2,1
13851492,20170809,Durvalumab,36,801,36.0,1,,1,0,1,0,0,0,0,Durvalumab,"TREMELIMUMAB|TENOFOVIR DISOPROXIL FUMARATE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|TREMELIMUMAB",6,HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|HEPATITIS VIRAL|HEPATOCELLULAR CARCINOMA|PROPHYLAXIS|HEPATOCELLULAR CARCINOMA,Pulmonary haemorrhage,1,1
13852008,20170809,Durvalumab,65,801,65.0,2,70,1,0,1,0,0,0,1,Durvalumab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PACLITAXEL|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",6,TRIPLE NEGATIVE BREAST CANCER|TRIPLE NEGATIVE BREAST CANCER|TRIPLE NEGATIVE BREAST CANCER|TRIPLE NEGATIVE BREAST CANCER|TRIPLE NEGATIVE BREAST CANCER|TRIPLE NEGATIVE BREAST CANCER,Infection|Hepatic enzyme increased,2,1
13854142,20170810,Durvalumab,,,,1,,1,1,0,0,0,0,0,Durvalumab,DURVALUMAB,1,BLADDER CANCER,Death,1,1
13854267,20170809,Durvalumab,25390,804,69.56,1,,1,0,1,0,0,0,1,Durvalumab,TREMELIMUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|TREMELIMUMAB|HYDROXYZINE|SIMVASTATIN|FENOFIBRATE|TREMELIMUMAB|AMLODIPINE|ALPRAZOLAM|LISINOPRIL AND HYDROCHLOROTHIAZIDE|LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS,16,NON-SMALL CELL LUNG CANCER|GASTROOESOPHAGEAL REFLUX PROPHYLAXIS|RASH|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ANAEMIA|RASH|DYSLIPIDAEMIA|HYPERTENSION|BACK PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|ANXIETY|HYPERTENSION|NON-SMALL CELL LUNG CANCER,Renal failure,1,1
13855508,20170810,Durvalumab,23338,804,63.94,2,,1,0,1,0,0,0,1,Durvalumab,"LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|TREMELIMUMAB|PREGABALIN|TREMELIMUMAB|TREMELIMUMAB|MORPHINE|MORPHINE|TREMELIMUMAB|TREMELIMUMAB|ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|AMLODIPINE|TREMELIMUMAB",32,BRONCHITIS|DYSPNOEA|BRONCHITIS|DYSPNOEA|NON-SMALL CELL LUNG CANCER|HYPOMAGNESAEMIA|PAIN|HYPOCALCAEMIA|DIZZINESS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DECREASED APPETITE|DECREASED APPETITE|PAIN|PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PAIN|HYPERCHLORHYDRIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|HYPOMAGNESAEMIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HEPATIC ENZYME INCREASED|HYPOMAGNESAEMIA|PAIN,Musculoskeletal chest pain|Autoimmune hepatitis,2,1
13856031,20170810,Durvalumab,897,802,74.75,1,81.9,1,0,1,0,0,0,1,Durvalumab,TREMELIMUMAB|PREGABALIN|BISOPROLOL FUMARATE|FUROSEMIDE|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|CLOPIDOGREL,10,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|NECK PAIN|CARDIOVASCULAR DISORDER|HYPERTENSION|OEDEMA PERIPHERAL|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|CONSTIPATION|CARDIOVASCULAR DISORDER|HYPERCHOLESTEROLAEMIA|CARDIOVASCULAR DISORDER,Atrial flutter,1,1
13856096,20170810,Durvalumab,24246,804,66.43,1,,1,1,1,1,0,0,0,Durvalumab,ETOPOSIDE|DURVALUMAB|ETOPOSIDE|CARBOPLATIN|ETOPOSIDE,6,SMALL CELL LUNG CANCER|DYSLIPIDAEMIA|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER,Pancytopenia|Septic shock,2,1
13856102,20170810,Durvalumab,64,801,64.0,2,,1,1,1,0,0,0,0,Durvalumab,TREMELIMUMAB|LEVOTHYROXINE|RABEPRAZOLE|PREDNISONE|DURVALUMAB|MULTIVITAMIN|METHYLPREDNISOLONE|PREDNISONE|METHYLPREDNISOLONE,11,ANAL SQUAMOUS CELL CARCINOMA|ANAL SQUAMOUS CELL CARCINOMA,Anaemia|Aspartate aminotransferase increased|Alanine aminotransferase increased|Malignant neoplasm progression|Blood bilirubin increased,5,1
10007927,20140313,Ipilimumab,56,801,56.0,1,,1,0,1,0,0,0,0,Ipilimumab,LEVOTHYROXINE SODIUM|IPILIMUMAB|PREDNISONE|ROSUVASTATIN|LANSOPRAZOLE|LEVETIRACETAM|MONTELUKAST,9,METASTATIC MALIGNANT MELANOMA,Metastases to central nervous system,1,1
10010534,20140314,Ipilimumab,75,801,75.0,2,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,2,,Death,1,5
10011758,20140314,Ipilimumab,65,801,65.0,1,,1,0,1,0,0,0,1,Ipilimumab,CARBOPLATIN|GABAPENTIN|PACLITAXEL|IPILIMUMAB,5,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Febrile neutropenia,1,5
10014635,20140317,Ipilimumab,57,801,57.0,1,56.69,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|INDOMETHACIN,2,MALIGNANT MELANOMA|SPONDYLITIS,Loss of consciousness|Diarrhoea|Vomiting|Chills|Abdominal pain upper|Muscle spasms,6,5
10016675,20140317,Ipilimumab,53,801,53.0,1,,1,0,1,0,0,0,0,Ipilimumab,OXYCODONE HCL|CARBOPLATIN|ETOPOSIDE|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|IPILIMUMAB,12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,VIIth nerve paralysis,1,5
10017133,20140318,Ipilimumab,,,,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10017135,20140318,Ipilimumab,65,801,65.0,1,,1,1,0,0,0,0,1,Ipilimumab,AMLODIPINE|HYDROCHLOROTHIAZIDE|TELMISARTAN|IPILIMUMAB|GLYBURIDE|RANITIDINE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,10,MALIGNANT MELANOMA,Malignant neoplasm progression,1,5
10017877,20140318,Ipilimumab,56,801,56.0,1,104,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Hypertension,1,5
10019434,20140318,Ipilimumab,76,801,76.0,1,,1,0,1,0,0,0,0,Ipilimumab,ETOPOSIDE|CARBOPLATIN|BUDESONIDE|IPILIMUMAB|FUROSEMIDE|IPRATROPIUM BROMIDE|SIMVASTATIN|BISOPROLOL FUMARATE,9,PRODUCT USED FOR UNKNOWN INDICATION|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis,1,5
10020934,20140319,Ipilimumab,64,801,64.0,1,85,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB|IPILIMUMAB,4,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Dehydration|Nausea|Tumour pain|Fatigue|Retching,5,5
10021855,20140319,Ipilimumab,,,,0,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Non-Hodgkin^s lymphoma,1,1
10022267,20140319,Ipilimumab,64,801,64.0,1,107.3,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Lipase increased,1,5
10023090,20140319,Ipilimumab,57,801,57.0,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death|Hypotension|Skin disorder,3,5
10023404,20140320,Ipilimumab,47,801,47.0,2,54,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Colitis|Pyrexia|Haemorrhoids|Pericarditis,4,1
10025566,20140320,Ipilimumab,48,801,48.0,1,89,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|BLEOMYCIN|BLEOMYCIN SULFATE,2,MALIGNANT MELANOMA,Respiratory tract inflammation,1,1
10025792,20140320,Ipilimumab,68,801,68.0,1,,1,1,1,0,0,0,0,Ipilimumab,"IPILIMUMAB|MORPHINE|MULTIVITAMIN|ALPRAZOLAM|POLYETHYLENE GLYCOL 3350|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|SERTRALINE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",16,MALIGNANT MELANOMA|PRURITUS|DRY SKIN|ANXIETY|VOMITING|CONSTIPATION|DIARRHOEA,Malignant neoplasm progression|Pyrexia|Fatigue,3,5
10028474,20140321,Ipilimumab,79,801,79.0,1,,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB|LACTULOSE,6,MALIGNANT MELANOMA,Pneumonia aspiration,1,1
10028475,20140321,Ipilimumab,70,801,70.0,1,93.4,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Alanine aminotransferase increased|Aspartate aminotransferase increased|Lipase increased,3,5
10029146,20140321,Ipilimumab,65,801,65.0,1,,1,1,1,1,0,0,1,Ipilimumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG,9,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Endocrine disorder|Metastatic neoplasm|Platelet count decreased|Dermatitis|Pneumonia|Sepsis,6,5
10030953,20140323,Ipilimumab,70,801,70.0,1,91.9,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB|FINASTERIDE|LEVOTHYROXINE SODIUM,3,MYELODYSPLASTIC SYNDROME|HYPOTHYROIDISM,Febrile neutropenia|Pneumonitis,2,5
10031285,20140324,Ipilimumab,61,801,61.0,1,104,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE,2,MALIGNANT MELANOMA,Colitis|Hypertension,2,5
10031290,20140324,Ipilimumab,,,,0,,1,1,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Death|Malignant neoplasm progression,2,5
10032675,20140324,Ipilimumab,43,801,43.0,1,80.03,1,0,1,0,0,0,0,Ipilimumab,SARGRAMOSTIM|IPILIMUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,5,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Hepatic haematoma|Transaminases increased,2,3
10032762,20140324,Ipilimumab,58,801,58.0,1,113,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Interstitial lung disease|Respiratory failure|Dehydration|Renal failure acute|Autoimmune hepatitis|Blood bilirubin increased,6,5
10033909,20140325,Ipilimumab,,,,1,,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death|Abdominal pain upper|Muscle spasms,3,3
10033914,20140325,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Enterocolitis|Amnesia,2,3
10034314,20140324,Ipilimumab,46,801,46.0,1,98,1,0,1,1,0,0,0,Ipilimumab,"IPILIMUMAB|CALCIUM|FISH OIL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LEVOTHYROXINE|LORAZEPAM|MULTIVITAMIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SAW PALMETTO",11,MALIGNANT MELANOMA,Meningitis aseptic|Rash pruritic|Diarrhoea,3,2
10035923,20140325,Ipilimumab,50,801,50.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Nausea|Vomiting,2,1
10037064,20140326,Ipilimumab,,,,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Visual impairment|Dizziness|Nystagmus|Loss of consciousness,4,1
10039012,20140326,Ipilimumab,6,800,60.0,1,,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB|DACARBAZINE,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Malignant neoplasm progression|Cardiac failure,2,1
10039024,20140326,Ipilimumab,77,801,77.0,2,,1,0,1,0,0,0,0,Ipilimumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SIMVASTATIN|IPILIMUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,6,METASTATIC MALIGNANT MELANOMA,Vomiting|Diarrhoea,2,3
10039038,20140326,Ipilimumab,65,801,65.0,2,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Colitis|VIIth nerve paralysis|Deafness unilateral,3,1
10039521,20140326,Ipilimumab,,,,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10039953,20140326,Ipilimumab,58,801,58.0,2,,1,0,1,0,0,0,1,Ipilimumab,ETOPOSIDE|CARBOPLATIN|IPILIMUMAB,3,SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER,Acute kidney injury,1,5
10040523,20140327,Ipilimumab,76,801,76.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Thyroid disorder|Hypothalamo-pituitary disorder,2,1
10040526,20140327,Ipilimumab,49,801,49.0,2,60.6,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Diarrhoea|Vomiting,2,5
10040627,20140327,Ipilimumab,52,801,52.0,1,107.3,1,1,1,0,0,0,0,Ipilimumab,ZOLEDRONIC ACID|HYDROMORPHONE HYDROCHLORIDE|TRAMETINIB|DABRAFENIB|IPILIMUMAB|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|ATENOLOL,7,METASTASES TO BONE|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|MALIGNANT MELANOMA|PAIN|HYPERTENSION,Hydronephrosis|Dehydration|Oedema peripheral|Feeling of despair|Disorientation|Peripheral swelling|Ill-defined disorder|Hypophagia|Infection|Confusional state|Tremor|Venous thrombosis|Pain|Splenomegaly|Sepsis|Immune system disorder|Delusion|Hospice care|Chills|Dyspnoea|Fungal skin infection|Adverse drug reaction|Gene mutation identification test positive|Oxygen supplementation|Death|Septic shock|Pyrexia|Pancytopenia|Metastatic neoplasm|Hyponatraemia,30,3
10042001,20140327,Ipilimumab,61,801,61.0,2,58,1,0,1,0,0,0,0,Ipilimumab,"COPPER|CUPRIC CHLORIDE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|MAGNESIUM|MANGANESE|MANGANESE CHLORIDE|MONTELUKAST SODIUM|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|IPILIMUMAB|NIACIN|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|ERGOCALCIFEROL|CALCIUM|FISH OIL|ZINC|ZINC GLUCONATE|ZINC CHLORIDE",18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|OVARIAN CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypophysitis,1,3
10042010,20140327,Ipilimumab,63,801,63.0,1,73.7,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Multi-organ failure,1,1
10043164,20140328,Ipilimumab,64,801,64.0,2,,1,0,1,0,0,0,0,Ipilimumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ETOPOSIDE|CARBOPLATIN,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER,Neutropenia,1,5
10043167,20140328,Ipilimumab,38,801,38.0,1,,1,1,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10045223,20140328,Ipilimumab,37,801,37.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Vomiting|Liver disorder|Gallbladder disorder,3,5
10045413,20140328,Ipilimumab,70,801,70.0,2,59.9,1,0,1,0,0,0,0,Ipilimumab,"ESTRADIOL|ESTRADIOL GEL 0.1%|ESTRADIOL TRANSDERMAL|ESTRADIOL,|HYDROXYZINE|METOPROLOL TARTRATE|METOPROLOL|MAGNESIUM HYDROXIDE|POLYETHYLENE GLYCOL 3350|FENTANYL|VEMURAFENIB|LEVOTHYROXINE SODIUM|MULTIVITAMIN|POLYETHYLENE GLYCOL 3350|IPILIMUMAB|FERROUS SULFATE|LISINOPRIL|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|FAMOTIDINE|LEVOTHYROXINE|CAMPHOR AND MENTHOL|PRAMOXINE HYDROCHLORIDE|COLLOIDAL OATMEAL|PRAMOXINE HYDROCHLORIDE, MENTHOL|DOCUSATE SODIUM AND SENNOSIDES|SENNOSIDES AND DOCUSATE SODIUM|SENNA-S|SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG|DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG|SENNA AND DOCUSATE SODIUM TABLETS, 8.6 MG AND 50 MG|SENNOSIDES|DOCUSATE SODIUM, SENNOSIDES|SENNOSIDES 8.6 MG AND DOCUSATE SODIUM 50 MG|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CHLOROTHIAZIDE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|MAGNESIUM CITRATE|MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON|BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY|CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY|FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE|MAGNESIUM CITRATE ORAL SOLUTION|CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE|BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE|CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON|FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON|LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY|LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON|BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON|FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY|LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE|HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FISH OIL|FUROSEMIDE|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|PREDNISONE",36,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Blood creatine increased,1,3
10045634,20140328,Ipilimumab,74,801,74.0,1,,1,0,1,1,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Colitis|Intestinal perforation|Diarrhoea|Rectal haemorrhage,4,5
10045642,20140328,Ipilimumab,,,,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,2,,Haematochezia|International normalised ratio increased,2,1
10046531,20140331,Ipilimumab,64,801,64.0,1,58.4,1,1,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MYELODYSPLASTIC SYNDROME,Pyrexia|Hyponatraemia|Platelet count decreased|Malignant neoplasm progression,4,5
10048487,20140331,Ipilimumab,,,,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Diarrhoea|Dehydration|Diverticulitis|Loss of consciousness,4,1
10048509,20140331,Ipilimumab,61,801,61.0,1,101,1,0,1,0,0,0,0,Ipilimumab,"AMLODIPINE BESYLATE|IPILIMUMAB|CARVEDILOL|WARFARIN|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|AMOXICILLIN AND CLAVULANATE POTASSIUM|METHYLPREDNISOLONE SODIUM SUCCINATE|DIGOXIN|GLYBURIDE|PREDNISONE|PREDNISONE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|AZILSARTAN KAMEDOXOMIL|FUROSEMIDE",18,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis|Dyspnoea,2,3
10048511,20140331,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,General physical health deterioration|Diarrhoea haemorrhagic|Weight decreased|Staphylococcal bacteraemia,4,5
10048676,20140331,Ipilimumab,75,801,75.0,2,,1,0,1,0,0,0,0,Ipilimumab,ETOPOSIDE|IPILIMUMAB|CARBOPLATIN,3,SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|SMALL CELL LUNG CANCER,Metabolic disorder|Diarrhoea|Nausea|Pancytopenia,4,5
10050366,20140401,Ipilimumab,62,801,62.0,1,98,1,1,1,1,1,1,1,Ipilimumab,IPILIMUMAB|PREDNISONE,2,Malignant melanoma|Product used for unknown indication,Ventricular tachycardia|Torsade de pointes|Electrocardiogram QT prolonged|Atrial fibrillation|Colitis|Anaemia|Pneumonia|Deep vein thrombosis|Cognitive disorder|Muscular weakness|Hypokalaemia|Dyspnoea|Hypoxia|Schizophrenia,14,3
10050388,20140401,Ipilimumab,64,801,64.0,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10051026,20140401,Ipilimumab,7,800,70.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Vertigo,1,1
10051209,20140401,Ipilimumab,,,,0,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Death,1,1
10051580,20140401,Ipilimumab,77,801,77.0,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10052922,20140402,Ipilimumab,71,801,71.0,1,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Pneumonia,1,5
10052925,20140402,Ipilimumab,49,801,49.0,2,,1,0,1,0,0,0,0,Ipilimumab,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LANSOPRAZOLE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|IPILIMUMAB,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA,Hypothyroidism|Hypopituitarism|Visual impairment|Hypophysitis|Gastroenteritis viral,5,5
10052940,20140402,Ipilimumab,41,801,41.0,2,,1,0,1,0,0,0,0,Ipilimumab,PANTOPRAZOLE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|IPILIMUMAB|LEVOTHYROXINE SODIUM,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Gastritis|Gastrointestinal infection|Hypophysitis,3,3
10055527,20140403,Ipilimumab,72,801,72.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|DICLOFENAC|DICLOFENAC SODIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,5,MALIGNANT MELANOMA,Inappropriate antidiuretic hormone secretion,1,1
10055528,20140403,Ipilimumab,54,801,54.0,1,106.5,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB|GABAPENTIN,3,MALIGNANT MELANOMA,Peripheral sensory neuropathy|Vomiting|Pulmonary mass|Peripheral motor neuropathy|Dehydration,5,5
10056660,20140403,Ipilimumab,,,,0,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Death,1,1
10057299,20140403,Ipilimumab,81,801,81.0,1,83.6,1,1,1,0,0,0,0,Ipilimumab,SARGRAMOSTIM|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|IPILIMUMAB|SENNOSIDES|SENNA LEAF|SENNA|PANTOPRAZOLE SODIUM|SARGRAMOSTIM|SARGRAMOSTIM|ENOXAPARIN SODIUM|IPILIMUMAB|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SARGRAMOSTIM|ENOXAPARIN SODIUM|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|OXYCODONE|POLYETHYLENE GLYCOL|SARGRAMOSTIM,19,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|CONSTIPATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|DEEP VEIN THROMBOSIS|METASTATIC MALIGNANT MELANOMA|DEEP VEIN THROMBOSIS|METASTATIC MALIGNANT MELANOMA|PULMONARY EMBOLISM|PULMONARY EMBOLISM|PAIN|CONSTIPATION|METASTATIC MALIGNANT MELANOMA,Neoplasm progression|Adrenal insufficiency|Upper gastrointestinal haemorrhage|Small intestinal obstruction|Anaemia,5,1
10059096,20140404,Ipilimumab,61,801,61.0,1,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Adverse event|Respiratory disorder|Metastases to liver,3,5
10059110,20140404,Ipilimumab,77,801,77.0,2,69.4,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|CLORAZEPATE DIPOTASSIUM|FUROSEMIDE|OXYCODONE|ACETAMINOPHEN|ERGOCALCIFEROL|EZETIMIBE,13,MALIGNANT MELANOMA|NAUSEA|PAIN|NAUSEA,Urinary tract infection|White blood cell count increased|Pyrexia|Constipation|Groin pain|Nausea,6,5
10059117,20140404,Ipilimumab,73,801,73.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Sepsis|Leukocytosis,2,5
10059145,20140404,Ipilimumab,,,,0,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Death,1,1
10060409,20140404,Ipilimumab,71,801,71.0,1,91.7,1,0,1,0,0,0,0,Ipilimumab,"SARGRAMOSTIM|SARGRAMOSTIM|IPILIMUMAB|IPILIMUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|LORAZEPAM|LORAZEPAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OXYCODONE|ZOLPIDEM TARTRATE|PREDNISONE|GENTAMICIN SULFATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OXYCODONE HYDROCHLORIDE|OXYCODONE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|ENOXAPARIN SODIUM|FAMOTIDINE|LORAZEPAM|NAPHAZOLINE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ZOLPIDEM TARTRATE",25,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA|CONSTIPATION|ANXIETY|INSOMNIA|PAIN|SLEEP DISORDER,Pruritus|Fatigue|Dyspnoea|Blood pressure increased|Nausea|Rash maculo-papular|Decreased appetite,7,5
10062450,20140407,Ipilimumab,,,,1,104.8,1,0,1,0,0,0,1,Ipilimumab,"IPILIMUMAB|ENOXAPARIN SODIUM|FAMOTIDINE|GENTAMICIN SULFATE|LORAZEPAM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SARGRAMOSTIM|PREDNISONE|IPILIMUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SARGRAMOSTIM|SARGRAMOSTIM|SARGRAMOSTIM|IPILIMUMAB|IPILIMUMAB|ZOLPIDEM TARTRATE|FAMOTIDINE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SARGRAMOSTIM|LORAZEPAM|OXYCODONE HYDROCHLORIDE|OXYCODONE|OXYCODONE HYDROCHLORIDE|OXYCODONE|PREDNISONE|IPILIMUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|FAMOTIDINE|IPILIMUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|ONDANSETRON HYDROCHLORIDE|FAMOTIDINE",36,MALIGNANT MELANOMA|ANXIETY|MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA|INSOMNIA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Myocardial infarction|Aspartate aminotransferase increased|Alanine aminotransferase increased|Rhinorrhoea|Cough|Vomiting|Abdominal pain|Pneumonia|Abdominal pain|Anxiety|Blood alkaline phosphatase increased|Abdominal pain|Transaminases increased|Alanine aminotransferase increased|Dyspnoea|Sinus congestion|Malaise|Headache|Blood bilirubin increased|Abdominal pain|Hepatic steatosis|Abdominal pain|Aspartate aminotransferase increased|Nausea|Dizziness|Alanine aminotransferase increased|Syncope|Hypotension|Metastatic malignant melanoma|Enterocolitis|Aspartate aminotransferase increased|Abdominal pain|Lung disorder|Adrenal insufficiency|Sinus tachycardia|Pulmonary oedema|Angina unstable|Cholecystitis|Fatigue,39,5
10062995,20140407,Ipilimumab,50,801,50.0,2,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LEVETIRACETAM|MECLIZINE HCL 12.5 MG|MECLIZINE|MECLIZINE HYDROCHLORIDE|MECLIZINE HCL 25MG|MECLIZINE HCL 12.5MG|MULTIVITAMIN|PANTOPRAZOLE|POLYETHYLENE GLYCOL|PROMETHAZINE,10,MALIGNANT MELANOMA|NAUSEA,Haemolytic uraemic syndrome,1,5
10063010,20140407,Ipilimumab,57,801,57.0,1,161.3,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FISH OIL|LISINOPRIL|METOPROLOL TARTRATE|METOPROLOL|MULTIVITAMIN|NITROGLYCERIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,12,MALIGNANT MELANOMA,Dyspnoea|Supraventricular tachycardia,2,5
10063019,20140407,Ipilimumab,78,801,78.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,4,METASTATIC MALIGNANT MELANOMA,Exfoliative rash|Dyspnoea,2,5
10064531,20140408,Ipilimumab,71,801,71.0,1,105.2,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Diarrhoea|Pulmonary embolism,2,5
10065425,20140408,Ipilimumab,66,801,66.0,2,72.2,1,0,1,0,0,0,0,Ipilimumab,DABRAFENIB|TRAMETINIB|IPILIMUMAB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Colitis,1,1
10065426,20140408,Ipilimumab,45,801,45.0,2,68.7,1,0,1,0,0,0,0,Ipilimumab,DABRAFENIB|TRAMETINIB|IPILIMUMAB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Colitis|Intestinal perforation,2,1
10068550,20140409,Ipilimumab,60,801,60.0,1,,1,0,1,0,0,0,1,Ipilimumab,NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|HYDROCHLOROTHIAZIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|IPILIMUMAB|TESTOSTERONE|ROSUVASTATIN|FENOFIBRATE|ETOPOSIDE|CARBOPLATIN|NEBIVOLOL HYDROCHLORIDE|ALBUTEROL SULFATE|ALBUTEROL|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|FUROSEMIDE|PANTOPRAZOLE|CISPLATIN|ALBUTEROL SULFATE,18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Peritoneal haemorrhage|Abdominal pain,2,5
10068757,20140409,Ipilimumab,53,801,53.0,1,102.6,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Marrow hyperplasia,1,5
10070052,20140409,Ipilimumab,63,801,63.0,1,85.73,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Erythema|Oedema|Unresponsive to stimuli|Pyrexia|Heart rate increased,5,3
10070132,20140409,Ipilimumab,58,801,58.0,2,83.3,1,0,1,1,0,0,0,Ipilimumab,IPILIMUMAB|FISH OIL,8,MALIGNANT MELANOMA,Pyrexia|Abdominal pain|Abdominal distension|Early satiety|Haematochezia|Proctalgia|Colitis|Intestinal perforation,8,3
10070429,20140409,Ipilimumab,43,801,43.0,1,98.7,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Autoimmune disorder|Pyrexia|Nausea|Fatigue|Hyperthyroidism|Vomiting|Diarrhoea|Thyroiditis|Adrenal insufficiency,9,
10070587,20140410,Ipilimumab,,,,0,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Headache|Pyrexia|Viral infection,3,1
10071026,20140410,Ipilimumab,51,801,51.0,2,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Colitis|Haemorrhage|Diarrhoea|Vomiting,4,5
10071136,20140410,Ipilimumab,70,801,70.0,2,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,NODULAR MELANOMA,Acute febrile neutrophilic dermatosis,1,3
10071961,20140411,Ipilimumab,28,801,28.0,1,80,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Diarrhoea|Haematochezia|Rash,3,3
10071965,20140411,Ipilimumab,74,801,74.0,1,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Small intestinal obstruction,1,1
10072212,20140410,Ipilimumab,65,801,65.0,1,90,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|METHYLPREDNISOLONE,3,MALIGNANT MELANOMA,Diarrhoea|Intestinal perforation|No therapeutic response,3,3
10072321,20140411,Ipilimumab,65,801,65.0,1,105,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Lupus-like syndrome|Hypophysitis|Malignant neoplasm progression,3,1
10072341,20140411,Ipilimumab,41,801,41.0,2,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10072359,20140411,Ipilimumab,75,801,75.0,2,40,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB|FLUCONAZOLE,2,METASTATIC MALIGNANT MELANOMA|ORAL CANDIDIASIS,Diarrhoea|Oral candidiasis,2,1
10072506,20140410,Ipilimumab,43,801,43.0,1,98.7,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,2,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Diarrhoea,1,5
10072514,20140411,Ipilimumab,,,,2,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Hypertension|Palpitations|Dizziness,3,1
10072914,20140411,Ipilimumab,,,,0,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,3
10076765,20140414,Ipilimumab,68,801,68.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Malignant neoplasm progression,1,5
10076792,20140414,Ipilimumab,58,801,58.0,1,133.78,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|SIMVASTATIN|INSULIN ASPART|INSULIN GLARGINE|LOSARTAN,6,METASTATIC MALIGNANT MELANOMA,Hypopituitarism,1,1
10076809,20140414,Ipilimumab,48,801,48.0,1,126.55,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Colitis|Abdominal pain|Diarrhoea,3,5
10076811,20140414,Ipilimumab,57,801,57.0,1,90,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,2,DERMATITIS ALLERGIC|METASTATIC MALIGNANT MELANOMA,Hyperglycaemia|Dermatitis,2,5
10077873,20140414,Ipilimumab,62,801,62.0,2,111.2,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Sepsis|Renal failure acute|Acute respiratory failure|Acute myocardial infarction,4,5
10079436,20140415,Ipilimumab,,,,0,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Colitis ulcerative|Malignant neoplasm progression,2,5
10079861,20140415,Ipilimumab,75,801,75.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|PYRIDOSTIGMINE BROMIDE,3,METASTATIC MALIGNANT MELANOMA,Metastases to central nervous system,1,5
10080037,20140415,Ipilimumab,53,801,53.0,1,,1,0,1,0,0,0,0,Ipilimumab,"IPILIMUMAB|PACLITAXEL|CARBOPLATIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Vomiting|Diarrhoea,2,5
10080531,20140416,Ipilimumab,74,801,74.0,2,,1,1,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Death|Affective disorder|Speech disorder|Confusional state,4,5
10080535,20140416,Ipilimumab,,,,0,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Peritoneal dialysis,1,2
10082279,20140416,Ipilimumab,62,801,62.0,2,73,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|TRAMETINIB|AMLODIPINE BESYLATE|HYDROCHLOROTHIAZIDE,7,MALIGNANT MELANOMA,Hypoglycaemia|Adrenal insufficiency,2,3
10082284,20140416,Ipilimumab,,,,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Listless|Depression|Hypophysitis|Metastases to central nervous system|Blood thyroid stimulating hormone decreased|Hyponatraemia,6,1
10083904,20140417,Ipilimumab,,,,0,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,2
10084593,20140417,Ipilimumab,54,801,54.0,1,,1,1,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10084611,20140417,Ipilimumab,60,801,60.0,2,,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB|LEVETIRACETAM|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|PREDNISONE|LEVOTHYROXINE SODIUM|PANTOPRAZOLE SODIUM,7,MALIGNANT MELANOMA,Malignant neoplasm progression|Haemorrhoids,2,1
10084612,20140417,Ipilimumab,68,801,68.0,2,58,1,0,1,0,0,0,1,Ipilimumab,"IPILIMUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|ZOLPIDEM TARTRATE|GABAPENTIN|OXYCODONE|LEVOTHYROXINE SODIUM",7,SQUAMOUS CELL CARCINOMA OF THE CERVIX,Diarrhoea|Dehydration|Rectal haemorrhage|Colitis|Deep vein thrombosis,5,5
10085593,20140418,Ipilimumab,62,801,62.0,1,,1,1,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Death,1,2
10086714,20140418,Ipilimumab,67,801,67.0,2,,1,1,0,0,0,0,0,Ipilimumab,PREDNISONE|HYDROXYZINE PAMOATE|NAPROXEN|NAPROXEN SODIUM|NICOTINE POLACRILEX|NICOTINE|NICOTINE POLACRILEX MINI|NICOTINE POLARILEX|APREPITANT|FOSAPREPITANT DIMEGLUMINE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ACYCLOVIR|PANTOPRAZOLE SODIUM|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN,22,SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE,Malignant neoplasm progression,1,5
10086717,20140418,Ipilimumab,72,801,72.0,1,,1,0,1,0,0,0,0,Ipilimumab,PACLITAXEL|DIGOXIN|CARBOPLATIN|MINOCYCLINE|TIOTROPIUM BROMIDE|MIRTAZAPINE|IPILIMUMAB|PANTOPRAZOLE|DICLOFENAC|DICLOFENAC SODIUM|METRONIDAZOLE|METRONIDAZOLE TOPICAL|METOPROLOL TARTRATE|METOPROLOL,16,NON-SMALL CELL LUNG CANCER RECURRENT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER RECURRENT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER RECURRENT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea,1,5
10086718,20140418,Ipilimumab,74,801,74.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Anaphylactic shock,1,1
10086722,20140418,Ipilimumab,71,801,71.0,1,,1,1,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Malignant neoplasm progression,1,5
10086723,20140418,Ipilimumab,66,801,66.0,2,68,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Anaemia,1,1
10086724,20140418,Ipilimumab,,,,1,96,1,1,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Malignant neoplasm progression,1,2
10086729,20140418,Ipilimumab,67,801,67.0,1,,1,1,0,1,0,0,0,Ipilimumab,,8,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Tuberculosis|Blood creatinine increased,2,5
10086734,20140418,Ipilimumab,61,801,61.0,1,70,1,1,1,0,0,0,1,Ipilimumab,IPILIMUMAB,5,MALIGNANT MELANOMA,Normochromic normocytic anaemia|Asthenia|Death|Dyspnoea,4,1
10086735,20140418,Ipilimumab,62,801,62.0,2,68,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,2,,Vitiligo|Anaemia,2,1
10086875,20140418,Ipilimumab,30,801,30.0,1,98,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Abdominal pain|Diarrhoea|Nausea|Headache|Pyrexia|Sinusitis,6,5
10087101,20140418,Ipilimumab,48,801,48.0,1,95,1,0,0,0,0,0,1,Ipilimumab,LISINOPRIL|IPILIMUMAB,4,METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA,Lipase increased,1,3
10088294,20140421,Ipilimumab,44,801,44.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Demyelinating polyneuropathy,1,3
10088302,20140421,Ipilimumab,62,801,62.0,1,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Myelitis transverse|Renal failure acute|Colitis|Uveitis|Dermatitis|Urogenital disorder|Asthenia,7,3
10088304,20140421,Ipilimumab,77,801,77.0,1,69,1,1,1,0,0,0,1,Ipilimumab,IPILIMUMAB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Malignant neoplasm progression|Dyspnoea|Chills|Atrial fibrillation,4,5
10088796,20140421,Ipilimumab,3,800,30.0,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Malignant neoplasm progression,1,1
10090263,20140421,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Ischaemic stroke,1,1
10090266,20140421,Ipilimumab,62,801,62.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Colitis|Blood lactate dehydrogenase increased,2,1
10090268,20140421,Ipilimumab,63,801,63.0,2,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Headache|Pyrexia|Hepatocellular injury,3,1
10090489,20140421,Ipilimumab,52,801,52.0,1,111.56,1,1,1,0,0,0,0,Ipilimumab,TRAMETINIB|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|IPILIMUMAB|ZOLEDRONIC ACID|DABRAFENIB|ATENOLOL|HYDROMORPHONE HYDROCHLORIDE|DABRAFENIB,8,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Death|Disorientation|Hyponatraemia|Hydronephrosis|Septic shock|Pancytopenia|Venous thrombosis|Pyrexia|Tremor|Malignant neoplasm progression|Illusion|Fungal skin infection|Dehydration|Infusion related reaction|Chills,15,5
10093982,20140421,Ipilimumab,71,801,71.0,1,74,1,0,1,0,0,0,0,Ipilimumab,"INSULIN HUMAN|INSULIN LISPRO|INSULIN GLULISINE|AMLODIPINE BESYLATE|IPILIMUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DEXTROSE ANHYDROUS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|NATEGLINIDE",15,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diabetes mellitus,1,5
10094135,20140422,Ipilimumab,87,801,87.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Adrenocortical insufficiency acute|Fungal test positive|Blood culture positive,3,5
10094139,20140422,Ipilimumab,82,801,82.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTASES TO CENTRAL NERVOUS SYSTEM,Colitis|Sepsis|Pyelonephritis,3,3
10094145,20140422,Ipilimumab,,,,0,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,3
10094146,20140422,Ipilimumab,54,801,54.0,1,83.5,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Syncope,1,5
10096562,20140422,Ipilimumab,,,,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10096641,20140422,Ipilimumab,64,801,64.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Nausea|Vomiting|Pain,3,5
10097969,20140423,Ipilimumab,88,801,88.0,2,,1,0,1,0,0,0,1,Ipilimumab,"POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|FUROSEMIDE|BISOPROLOL FUMARATE|IPILIMUMAB",5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Arthralgia|Hypophysitis|Blood cortisol decreased|Adrenocorticotropic hormone deficiency|Blood luteinising hormone decreased|Blood thyroid stimulating hormone decreased|Blood follicle stimulating hormone decreased,7,5
10097975,20140423,Ipilimumab,81,801,81.0,1,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,3,,Pyrexia|General physical health deterioration|Muscular weakness|Dehydration|Hormone level abnormal,5,2
10097976,20140423,Ipilimumab,58,801,58.0,2,99.4,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Enterocolitis|Large intestinal ulcer|Gastritis,3,5
10097978,20140423,Ipilimumab,15,801,15.0,1,67.1,1,0,1,0,0,0,0,Ipilimumab,"IPILIMUMAB|CEFTRIAXONE|CEFTRIAXONE SODIUM|PREDNISONE|MORPHINE|LORAZEPAM|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|METHYLPREDNISOLONE",10,MALIGNANT MELANOMA,Pleural effusion,1,3
10098184,20140423,Ipilimumab,67,801,67.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|ROSUVASTATIN,2,MALIGNANT MELANOMA,Adrenal disorder|Colitis,2,5
10098185,20140423,Ipilimumab,68,801,68.0,2,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Fatigue|Nausea,2,5
10098186,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Rash pruritic|Malignant neoplasm progression,2,1
10098187,20140423,Ipilimumab,61,801,61.0,1,97.5,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB|SIMVASTATIN|ALPRAZOLAM,3,METASTATIC MALIGNANT MELANOMA,Rash,1,5
10098188,20140423,Ipilimumab,65,801,65.0,2,,1,0,0,1,0,0,0,Ipilimumab,IPILIMUMAB|TEMOZOLOMIDE,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Malignant neoplasm progression,1,3
10098189,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Pyrexia,1,5
10098190,20140423,Ipilimumab,76,801,76.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Colitis,1,3
10098191,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Pituitary enlargement,1,2
10098192,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Nausea,1,1
10098193,20140423,Ipilimumab,,,,1,83.9,1,0,0,0,0,0,0,Ipilimumab,ROSUVASTATIN|IPILIMUMAB|OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Rash|Fatigue|Constipation,3,5
10098194,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Anorectal discomfort,1,2
10098195,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Nausea,1,1
10098196,20140423,Ipilimumab,78,801,78.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Intestinal perforation|Enterocolitis,2,3
10098197,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Malignant neoplasm progression,1,3
10098198,20140423,Ipilimumab,,,,2,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Colitis|Diarrhoea,2,1
10098199,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Infusion related reaction,1,1
10098200,20140423,Ipilimumab,66,801,66.0,1,100.68,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB|PREDNISONE|PROCHLORPERAZINE MALEATE|ALPRAZOLAM|ZOLPIDEM TARTRATE|FLUOXETINE HCL|HYDROCHLOROTHIAZIDE|LISINOPRIL,9,MALIGNANT MELANOMA,Nervous system disorder|Diarrhoea,2,3
10098201,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Rash|Pruritus,2,5
10098202,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Hepatitis,1,1
10098203,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Malignant neoplasm progression,1,5
10098204,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Myasthenia gravis|Malignant neoplasm progression,2,1
10098205,20140423,Ipilimumab,,,,2,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Stillbirth|Maternal exposure during pregnancy,2,3
10098206,20140423,Ipilimumab,42,801,42.0,2,75.73,1,0,0,0,0,0,0,Ipilimumab,"IPILIMUMAB|HYDROXYCHLOROQUINE|BUPROPION HYDROCHLORIDE|ALPRAZOLAM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|DIPHENHYDRAMINE HYDROCHLORIDE|LORATADINE|LORATADINE TABLET",8,MALIGNANT MELANOMA STAGE IV,Rash|Pruritus|Headache|Fatigue|Nausea|Dry skin,6,5
10098207,20140423,Ipilimumab,72,801,72.0,2,62.13,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|LEVOTHYROXINE SODIUM,3,BLOOD PRESSURE,Neuropathy peripheral|Nasopharyngitis,2,5
10098208,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Malignant neoplasm progression,1,2
10098209,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB|DIPHENHYDRAMINE HYDROCHLORIDE,2,PREMEDICATION,Infusion related reaction|Back pain|Rash,3,1
10098210,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Drug dose omission,1,3
10098211,20140423,Ipilimumab,4,800,40.0,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Nausea|Drug dose omission,2,1
10098212,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Malignant neoplasm progression,1,5
10098213,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,NEOPLASM MALIGNANT,Malignant neoplasm progression,1,5
10098214,20140423,Ipilimumab,71,801,71.0,1,83.9,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,2,MALIGNANT MELANOMA,Pruritus|Headache|Gout,3,5
10098215,20140423,Ipilimumab,76,801,76.0,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Chills,1,3
10098216,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Confusional state,1,1
10098217,20140423,Ipilimumab,81,801,81.0,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Rash pruritic|Abdominal pain upper,2,5
10098218,20140423,Ipilimumab,55,801,55.0,2,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB|INFLIXIMAB,2,,Colitis|Diarrhoea,2,1
10098219,20140423,Ipilimumab,67,801,67.0,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Fatigue|Somnolence,2,5
10098220,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Malignant neoplasm progression,1,1
10098221,20140423,Ipilimumab,,,,2,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Fatigue,1,3
10098222,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Asthenia|Fall|Diarrhoea,3,2
10098223,20140423,Ipilimumab,66,801,66.0,2,,1,0,0,0,0,0,1,Ipilimumab,"IPILIMUMAB|GABAPENTIN|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|FAMOTIDINE|HEPARIN SODIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|CLONAZEPAM|TERIPARATIDE|HYDROXYZINE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ZOLPIDEM TARTRATE|ERGOCALCIFEROL",15,MALIGNANT MELANOMA|RHEUMATOID ARTHRITIS|PAIN,Hepatitis,1,2
10098225,20140423,Ipilimumab,8,800,80.0,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Blood pressure diastolic increased|Chills,2,1
10098226,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Catheter site infection,1,3
10098227,20140423,Ipilimumab,63,801,63.0,2,61.9,1,0,0,0,0,0,0,Ipilimumab,"IPILIMUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALPRAZOLAM|DOCUSATE SODIUM AND SENNOSIDES|SENNOSIDES AND DOCUSATE SODIUM|SENNA-S|SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG|DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG|SENNA AND DOCUSATE SODIUM TABLETS, 8.6 MG AND 50 MG|SENNOSIDES|DOCUSATE SODIUM, SENNOSIDES|SENNOSIDES 8.6 MG AND DOCUSATE SODIUM 50 MG|MAGNESIUM OXIDE|ERGOCALCIFEROL",7,METASTATIC MALIGNANT MELANOMA,Pyrexia,1,1
10098228,20140423,Ipilimumab,68,801,68.0,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Diarrhoea|Headache|Vomiting,3,5
10098229,20140423,Ipilimumab,47,801,47.0,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Vomiting,1,5
10098230,20140423,Ipilimumab,5,800,50.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|IPILIMUMAB,2,METASTATIC MALIGNANT MELANOMA|METASTASES TO CENTRAL NERVOUS SYSTEM,Diarrhoea|Rash,2,1
10098232,20140423,Ipilimumab,,,,2,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Adverse event,1,5
10098235,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Malignant neoplasm progression,1,1
10098236,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Diarrhoea,1,1
10098237,20140423,Ipilimumab,70,801,70.0,1,99.77,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|AMLODIPINE BESYLATE AND VALSARTAN,3,METASTATIC MALIGNANT MELANOMA,Malignant neoplasm progression,1,5
10098238,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Drug intolerance,1,3
10098239,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Enterocolitis,1,1
10098240,20140423,Ipilimumab,73,801,73.0,2,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Asthenia|Chromaturia|Cough,3,3
10098241,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Malignant neoplasm progression,1,5
10098242,20140423,Ipilimumab,52,801,52.0,1,93.42,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|LEVOTHYROXINE SODIUM|ALPRAZOLAM|PREDNISONE,5,MALIGNANT MELANOMA|METASTASES TO CENTRAL NERVOUS SYSTEM,Malignant neoplasm progression,1,1
10098243,20140423,Ipilimumab,45,801,45.0,1,92.3,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Endocrine disorder,1,2
10098244,20140423,Ipilimumab,6,800,60.0,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB|PREDNISONE|METHOTREXATE|METHOTREXATE SODIUM,3,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Arthralgia,1,3
10098245,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Chills,1,2
10098246,20140423,Ipilimumab,65,801,65.0,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Chills|Pyrexia|Tremor,3,2
10098248,20140423,Ipilimumab,81,801,81.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Malignant neoplasm progression,1,5
10098249,20140423,Ipilimumab,,,,2,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Adrenal suppression|Hypopituitarism,2,5
10098251,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Blood bilirubin increased,1,1
10098254,20140423,Ipilimumab,88,801,88.0,2,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Malignant neoplasm progression|Rash,2,1
10098255,20140423,Ipilimumab,62,801,62.0,1,100,1,0,1,0,0,0,0,Ipilimumab,INSULIN GLARGINE|TEMOZOLOMIDE|DILTIAZEM HYDROCHLORIDE|ALPRAZOLAM|ESCITALOPRAM|IPILIMUMAB|BENAZEPRIL HYDROCHLORIDE|SOTALOL HYDROCHLORIDE|INSULIN GLULISINE|RIVAROXABAN,11,METASTATIC MALIGNANT MELANOMA,Diarrhoea|Acute kidney injury,2,1
10098256,20140423,Ipilimumab,67,801,67.0,2,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Pruritus|Lip oedema|Peripheral swelling|Rash,4,5
10098257,20140423,Ipilimumab,46,801,46.0,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Fatigue|Memory impairment,2,5
10098258,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Diarrhoea,1,3
10098259,20140423,Ipilimumab,58,801,58.0,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Blood thyroid stimulating hormone increased,1,3
10098260,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Malignant neoplasm progression,1,5
10098261,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Fatigue,1,5
10098262,20140423,Ipilimumab,80,801,80.0,1,,1,0,1,1,1,0,0,Ipilimumab,IPILIMUMAB,3,MALIGNANT MELANOMA,Diarrhoea|Pruritus,2,1
10098263,20140423,Ipilimumab,,,,1,,1,1,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Failure to thrive|Intestinal perforation,2,1
10098264,20140423,Ipilimumab,58,801,58.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE,4,METASTATIC MALIGNANT MELANOMA|BLOOD CHOLESTEROL INCREASED|DIABETES MELLITUS|PAIN,Diarrhoea|Dehydration|Dysuria|Haematuria|Haematochezia|Conjunctivitis|Malignant neoplasm progression,7,3
10098265,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Diarrhoea,1,3
10098266,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Diarrhoea,1,3
10098267,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Liver function test abnormal,1,3
10098268,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Rash,1,3
10098269,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Stevens-Johnson syndrome,1,3
10098270,20140423,Ipilimumab,,,,0,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,2,,Neuropathy peripheral,1,3
10098271,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Rash|Pruritus,2,5
10098272,20140423,Ipilimumab,,,,2,,1,0,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Hypersensitivity,1,5
10098820,20140423,Ipilimumab,,,,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Leukaemia,1,1
10098824,20140423,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Brain operation|Speech disorder,2,5
10098833,20140423,Ipilimumab,,,,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10098834,20140423,Ipilimumab,58,801,58.0,1,,1,1,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Malignant neoplasm progression|Pleural effusion|Pyrexia|Oedema peripheral|Staphylococcal infection,5,5
10099981,20140423,Ipilimumab,51,801,51.0,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10100575,20140423,Ipilimumab,55,801,55.0,2,79.2,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|DABRAFENIB,4,SKIN PAPILLOMA|MALIGNANT MELANOMA|PAIN|MALIGNANT MELANOMA,Alanine aminotransferase increased|Aspartate aminotransferase increased,2,1
10100928,20140423,Ipilimumab,66,801,66.0,1,,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTASES TO CENTRAL NERVOUS SYSTEM,Malignant neoplasm progression,1,1
10101715,20140423,Ipilimumab,45,801,45.0,2,76.2,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Blood pressure systolic increased,1,1
10101797,20140423,Ipilimumab,77,801,77.0,1,77.2,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Chest pain,1,
10103524,20140424,Ipilimumab,57,801,57.0,1,76.2,1,0,1,0,0,0,0,Ipilimumab,SARGRAMOSTIM|SARGRAMOSTIM|IPILIMUMAB|IPILIMUMAB|DUTASTERIDE|ERGOCALCIFEROL|ROSUVASTATIN|FERROUS SULFATE|RAMELTEON,10,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Petit mal epilepsy,1,3
10108552,20140425,Ipilimumab,56,801,56.0,2,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10112286,20140425,Ipilimumab,35,801,35.0,1,53.1,1,1,1,0,0,0,1,Ipilimumab,"DEXTROSE ANHYDROUS|FUROSEMIDE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|ALLOPURINOL|INSULIN HUMAN|CALCIUM GLUCONATE|RABEPRAZOLE SODIUM|RABEPRAZOLE|IPILIMUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|MEROPENEM",19,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Tumour lysis syndrome|Multi-organ failure,3,3
10120759,20140425,Ipilimumab,56,801,56.0,2,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,2
10120785,20140425,Ipilimumab,40,801,40.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Abdominal pain,1,3
10120790,20140425,Ipilimumab,24,801,24.0,1,90.4,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Soft tissue infection|Pain of skin,2,5
10120810,20140425,Ipilimumab,87,801,87.0,2,,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death|Dehydration|Blood sodium decreased|Syncope,4,5
10120844,20140425,Ipilimumab,23,801,23.0,2,60,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,SQUAMOUS CELL CARCINOMA OF THE CERVIX,Arthralgia,1,5
10126347,20140427,Ipilimumab,44,801,44.0,2,,1,0,1,1,1,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Haemorrhage intracranial|Unresponsive to stimuli|Metastases to central nervous system,3,5
10128424,20140428,Ipilimumab,22,801,22.0,1,64.9,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,HODGKIN^S DISEASE,Hypothermia|Pneumonia staphylococcal|Endocrine disorder|Anaemia,4,5
10129600,20140425,Ipilimumab,66,801,66.0,2,66.1,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|VALSARTAN|VALSARTAN ORAL|LEVOTHYROXINE|ZOLPIDEM TARTRATE|ZOLPIDEM TARTRATE|ALPRAZOLAM|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE,8,,Nausea|Vomiting|Cholecystitis,3,3
10133456,20140428,Ipilimumab,64,801,64.0,1,84,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Hearing impaired,1,3
10133528,20140428,Ipilimumab,66,801,66.0,2,70,1,0,1,0,0,0,1,Ipilimumab,ENOXAPARIN SODIUM|METHYLPREDNISOLONE|DABRAFENIB|TRAMETINIB|IPILIMUMAB,5,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Large intestine perforation|Lower gastrointestinal haemorrhage|Pulmonary embolism|Colitis,4,5
10133546,20140428,Ipilimumab,55,801,55.0,1,73.6,1,0,1,0,0,0,1,Ipilimumab,"IPILIMUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",2,MALIGNANT MELANOMA,Enterocolitis|Lipase increased|Pancreatitis|Diarrhoea|Vomiting|Nausea,6,5
10133673,20140428,Ipilimumab,63,801,63.0,1,61.22,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Diarrhoea|Nausea|Fall|Femur fracture|Fatigue|Dehydration|Dyspnoea|Proctalgia,8,5
10136192,20140429,Ipilimumab,74,801,74.0,1,80,1,1,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,General physical health deterioration,1,1
10136687,20140429,Ipilimumab,76,801,76.0,1,,1,0,1,0,0,0,1,Ipilimumab,"IPILIMUMAB|SIMVASTATIN|RANITIDINE|QUININE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|POTASSIUM BICARBONATE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM BICARBONATE",17,COLITIS|COLITIS|METASTATIC MALIGNANT MELANOMA,Immune thrombocytopenic purpura|Colitis|Clostridium difficile colitis|Rectal haemorrhage,4,1
10141742,20140429,Ipilimumab,69,801,69.0,1,89,1,1,1,1,0,0,0,Ipilimumab,SIMVASTATIN|LORATADINE|LORATADINE ORAL|PREDNISONE|IPILIMUMAB|ENALAPRIL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,11,PROSTATE CANCER,Oesophageal perforation|Pulmonary embolism|Sepsis,3,3
10141749,20140429,Ipilimumab,63,801,63.0,2,37.5,1,0,1,0,0,0,1,Ipilimumab,CALCIUM|IPILIMUMAB|TURMERIC|ERGOCALCIFEROL|FISH OIL|GINKGO BILOBA|PREDNISONE,11,OVARIAN CANCER,Colitis|Small intestinal obstruction,2,5
10142538,20140430,Ipilimumab,,,,2,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Neoplasm|Intestinal perforation|Peritonitis|Weight decreased|General physical health deterioration,5,1
10142539,20140430,Ipilimumab,48,801,48.0,2,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10142552,20140430,Ipilimumab,60,801,60.0,2,56,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|PREDNISONE|MONTELUKAST SODIUM|FISH OIL,4,OVARIAN CANCER,Pituitary tumour|Hyponatraemia|Thyroid disorder|Off label use,4,1
10142554,20140430,Ipilimumab,,,,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Pyrexia|Diarrhoea|Weight decreased,3,2
10143996,20140430,Ipilimumab,68,801,68.0,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10143998,20140430,Ipilimumab,,,,0,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,3
10143999,20140430,Ipilimumab,65,801,65.0,2,59,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|ESCITALOPRAM,2,OVARIAN CANCER,Pituitary tumour|Off label use,2,1
10148984,20140502,Ipilimumab,66,801,66.0,2,,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death|Diarrhoea|Dehydration,3,5
10148987,20140502,Ipilimumab,57,801,57.0,1,77,1,0,1,0,0,0,0,Ipilimumab,NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|PROMETHAZINE|VEMURAFENIB|IPILIMUMAB,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA,Vomiting,1,3
10148988,20140502,Ipilimumab,57,801,57.0,1,76.7,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|PROMETHAZINE,5,MALIGNANT MELANOMA,Malignant neoplasm progression|Nausea,2,3
10150110,20140502,Ipilimumab,59,801,59.0,1,94.7,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Gastrointestinal perforation|Peritonitis|Peritoneal necrosis|Sepsis|Renal failure acute|Abdominal distension|Atrial fibrillation,7,5
10150679,20140502,Ipilimumab,63,801,63.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Rash|Axillary mass,2,3
10150705,20140502,Ipilimumab,,,,2,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Paralysis|Hypoaesthesia|Gastrointestinal motility disorder|Dysuria,4,5
10151809,20140505,Ipilimumab,56,801,56.0,2,54.87,1,0,1,0,0,0,0,Ipilimumab,"IPILIMUMAB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|CLONAZEPAM|GABAPENTIN|MORPHINE|LORAZEPAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|POLYETHYLENE GLYCOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PROCHLORPERAZINE|SERTRALINE",14,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA,Syncope|Hypokalaemia|Ascites|Diarrhoea|Abdominal pain,5,3
10152196,20140505,Ipilimumab,31,801,31.0,2,,1,0,1,0,0,0,0,Ipilimumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|IPILIMUMAB,2,HYPOPHYSITIS|MALIGNANT MELANOMA,Agitation|Anxiety,2,1
10152769,20140505,Ipilimumab,25,801,25.0,2,,1,1,1,0,0,0,1,Ipilimumab,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|IPILIMUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|GABAPENTIN|PANTOPRAZOLE|LOPERAMIDE HCL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|NAPROXEN|NAPROXEN SODIUM,11,,Concomitant disease progression|Renal failure|Neoplasm malignant|Malignant melanoma|Neoplasm progression,5,3
10153091,20140505,Ipilimumab,42,801,42.0,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10153646,20140505,Ipilimumab,,,,0,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Uveitis|Retinitis|Pyrexia,3,1
10153650,20140505,Ipilimumab,75,801,75.0,2,70.3,1,0,1,0,0,0,1,Ipilimumab,PHYTONADIONE|LORATADINE|LORATADINE TABLET|METOPROLOL TARTRATE|METOPROLOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|IPILIMUMAB|METRONIDAZOLE|LORAZEPAM|RANITIDINE,13,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Clostridium difficile infection|Gastrointestinal haemorrhage|Muscular weakness,3,3
10153859,20140506,Ipilimumab,69,801,69.0,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10153863,20140506,Ipilimumab,71,801,71.0,2,83.1,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|DABRAFENIB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Haemorrhage intracranial|Confusional state|Dehydration,3,5
10156364,20140507,Ipilimumab,39,801,39.0,2,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB|IPILIMUMAB,2,MALIGNANT MELANOMA|METASTASES TO LIVER,Hepatic function abnormal|Dermatomyositis|Polyneuropathy|Therapeutic response decreased,4,5
10156372,20140507,Ipilimumab,66,801,66.0,1,,1,0,1,0,0,0,0,Ipilimumab,"IPILIMUMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|FLUDARABINE PHOSPHATE|INTERLEUKIN-11|INTERLEUKIN-5|INTERLEUKIN-3|INTERLEUKIN-10",4,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Cystitis,1,3
10156391,20140507,Ipilimumab,25,801,25.0,2,,1,1,1,0,0,0,1,Ipilimumab,DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PANTOPRAZOLE|GABAPENTIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|NAPROXEN|NAPROXEN SODIUM,11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant melanoma|Concomitant disease progression|Death|Neoplasm malignant|Renal failure|Neoplasm progression,6,3
10160355,20140508,Ipilimumab,29,801,29.0,2,49,1,0,1,0,0,0,0,Ipilimumab,TRAMETINIB|DABRAFENIB|IPILIMUMAB,4,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|METASTASES TO BONE,Musculoskeletal pain|Thoracic vertebral fracture,2,1
10161289,20140508,Ipilimumab,71,801,71.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Muscular weakness,1,5
10161640,20140509,Ipilimumab,57,801,57.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Gastric perforation,1,1
10162220,20140508,Ipilimumab,77,801,77.0,1,74.5,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CLOPIDOGREL|CLOPIDOGREL BISULFATE,3,,Haematochezia|Diarrhoea,2,3
10163320,20140509,Ipilimumab,,,,2,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Gastrointestinal disorder,1,1
10163337,20140509,Ipilimumab,50,801,50.0,1,,1,0,1,0,0,0,0,Ipilimumab,"OXYCODONE HYDROCHLORIDE|MULTIVITAMIN|METOCLOPRAMIDE HYDROCHLORIDE|POLYETHYLENE GLYCOL 3350|GABAPENTIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|IPILIMUMAB|DIAZEPAM|GABAPENTIN|MICONAZOLE|MICONAZOLE NITRATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|OXYCODONE|VEMURAFENIB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|FENTANYL|AMOXICILLIN AND CLAVULANATE POTASSIUM|MINOCYCLINE|ENOXAPARIN SODIUM|NICOTINE POLACRILEX|NICOTINE|NICOTINE POLACRILEX MINI|NICOTINE POLARILEX|LACTULOSE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",26,VOMITING|MALIGNANT MELANOMA|NAUSEA|MALIGNANT MELANOMA,Blood creatinine increased|Haematuria,2,3
10166281,20140512,Ipilimumab,54,801,54.0,1,75.2,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Hypercalcaemia|Sarcoidosis,2,5
10168634,20140513,Ipilimumab,33,801,33.0,2,63.3,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Dehydration|Dysphagia|Oral pain|Stomatitis,4,3
10168642,20140513,Ipilimumab,73,801,73.0,1,159.8,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Abdominal pain|Muscle spasms|Diarrhoea,3,3
10169963,20140513,Ipilimumab,74,801,74.0,1,,1,1,1,0,0,0,0,Ipilimumab,NIACIN|IPILIMUMAB|DUTASTERIDE|GABAPENTIN|AMLODIPINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|QUINAPRIL|QUINAPRIL HYDROCHLORIDE|TESTOSTERONE CYPIONATE|LABETALOL,12,MALIGNANT MELANOMA,Malignant neoplasm progression|Aphagia,2,2
10172682,20140515,Ipilimumab,56,801,56.0,1,80,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Diarrhoea|Vomiting,2,5
10173108,20140425,Ipilimumab,,,,2,,1,0,1,0,0,0,0,Ipilimumab,VEMURAFENIB,3,METASTASES TO CENTRAL NERVOUS SYSTEM,Alopecia|Nausea|Dysgeusia|Flatulence|Abdominal distension|Diarrhoea|Abdominal pain upper|Acrochordon|Skin papilloma|Eye pain|Depression|Vision blurred|Dry eye|Ocular hyperaemia|Rash pruritic|Rash generalised|Chills|Pyrexia|Vomiting|Fatigue|Weight decreased|Heart rate increased|Arthralgia|Pain in extremity|Pain in extremity|Headache|Hyperkeratosis|Decreased appetite,28,5
10174114,20140515,Ipilimumab,79,801,79.0,1,104,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|ALLOPURINOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ATORVASTATIN CALCIUM|CARVEDILOL|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|MELATONIN|MORPHINE|PANTOPRAZOLE SODIUM|STANDARDIZED SENNA CONCENTRATE|SERTRALINE HYDROCHLORIDE,15,MALIGNANT MELANOMA,Stress cardiomyopathy,1,1
10174115,20140515,Ipilimumab,,,,0,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Neurotoxicity|Meningitis,2,1
10174733,20140515,Ipilimumab,51,801,51.0,2,85,1,0,1,0,0,0,1,Ipilimumab,METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE HYDROCHLORIDE|IPILIMUMAB,3,DECREASED APPETITE|NAUSEA|MALIGNANT MELANOMA,Lymphocyte count decreased|Tremor|Neutrophil count decreased|Nausea|White blood cell count decreased,5,5
10174894,20140515,Ipilimumab,63,801,63.0,2,,1,0,1,0,0,0,0,Ipilimumab,IOHEXOL|IPILIMUMAB,9,HYPERTENSION|METASTATIC PAIN|HYPERTENSION|MALIGNANT MELANOMA|DIABETES MELLITUS,Renal failure acute,1,5
10175731,20140516,Ipilimumab,35,801,35.0,2,,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Rash|Headache|Fatigue|Death|Convulsion|Memory impairment,6,3
10175741,20140516,Ipilimumab,56,801,56.0,2,52.61,1,0,1,0,0,0,1,Ipilimumab,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|GEMCITABINE HYDROCHLORIDE|LIDOCAINE PATCH 5%|GABAPENTIN|TRAZODONE HYDROCHLORIDE|IPILIMUMAB|CLONAZEPAM|STANDARDIZED SENNA CONCENTRATE|SERTRALINE|LORAZEPAM|FENTANYL",15,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PANCREATIC CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PANCREATIC CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypokalaemia|Diarrhoea|Portal hypertension|Abdominal pain|Ascites|Vomiting,6,3
10177551,20140516,Ipilimumab,63,801,63.0,2,,1,0,1,0,0,0,0,Ipilimumab,IOHEXOL|OXYCODONE HYDROCHLORIDE|IPILIMUMAB,12,HYPERTENSION|WHOLE BODY SCAN|MALIGNANT MELANOMA|DIABETES MELLITUS|PAIN|HYPERTENSION,Renal failure acute,1,5
10178091,20140518,Ipilimumab,66,801,66.0,1,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Diarrhoea|Pyrexia|Metastases to lung,3,5
10178516,20140516,Ipilimumab,70,801,70.0,1,86,1,0,1,0,0,0,0,Ipilimumab,"IPILIMUMAB|FLUCONAZOLE|ERGOCALCIFEROL|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|IPILIMUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LOSARTAN|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",18,MALIGNANT MELANOMA,Fatigue|Feeling abnormal|Activities of daily living impaired|Fall|Productive cough|Abasia|Asthenia|Decreased appetite|Visual impairment|Diarrhoea|Abdominal distension|Dizziness|Dehydration|Hypophagia|Malignant neoplasm progression|Hypophysitis,16,3
10181433,20140519,Ipilimumab,,,,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Death,1,5
10181686,20140519,Ipilimumab,,,,0,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Cerebrovascular accident,1,5
10182447,20140520,Ipilimumab,57,801,57.0,1,,1,0,1,0,0,0,0,Ipilimumab,ENZALUTAMIDE|SIPULEUCEL-T|SIPULEUCEL-T|SIPULEUCEL-T|IPILIMUMAB|IPILIMUMAB|TADALAFIL,9,PRODUCT USED FOR UNKNOWN INDICATION|PROSTATE CANCER METASTATIC|PROSTATE CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTASES TO BONE,Acute myocardial infarction|Cerebrovascular accident,2,5
10183817,20140520,Ipilimumab,68,801,68.0,2,,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Strangulated hernia|Peritonitis,2,1
10184586,20140521,Ipilimumab,,,,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Diarrhoea|Intestinal perforation,2,1
10184591,20140521,Ipilimumab,65,801,65.0,1,78.6,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Diarrhoea|Vomiting,2,5
10184593,20140521,Ipilimumab,61,801,61.0,2,,1,1,0,0,1,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Malignant neoplasm progression|Colitis ulcerative,2,5
10186000,20140521,Ipilimumab,,,,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death|Diarrhoea,2,5
10186007,20140521,Ipilimumab,62,801,62.0,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10186009,20140521,Ipilimumab,45,801,45.0,1,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Eye pain|Sarcoidosis|Rash|Fatigue|Dehydration|Uveitis|Diarrhoea|Headache|Dry skin|Drug administration error,10,5
10186065,20140521,Ipilimumab,63,801,63.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|IOHEXOL|IOHEXOL,11,HYPERTENSION|PAIN|DIABETES MELLITUS|MALIGNANT MELANOMA|HYPERTENSION|DIAGNOSTIC PROCEDURE|METASTASIS,Renal failure acute,1,3
10186220,20140521,Ipilimumab,58,801,58.0,2,68.7,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Anaemia|Atrial fibrillation|Enterocolitis,3,5
10186520,20140521,Ipilimumab,70,801,70.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|IPILIMUMAB,6,CONSTIPATION|MALIGNANT MELANOMA|MALIGNANT MELANOMA,Diarrhoea|Colitis,2,1
10186800,20140521,Ipilimumab,66,801,66.0,1,83.6,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Acute kidney injury|Muscular weakness|Dehydration|Hypotension|Syncope,5,5
10186801,20140521,Ipilimumab,77,801,77.0,1,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Nausea|Hypopituitarism|Metastases to central nervous system,3,1
10187070,20140522,Ipilimumab,72,801,72.0,1,90.7,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Constipation|Food poisoning|Diarrhoea|Fatigue|Vision blurred|Rash|Pruritus,7,1
10189385,20140522,Ipilimumab,35,801,35.0,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10189394,20140522,Ipilimumab,71,801,71.0,2,,1,1,1,0,0,0,1,Ipilimumab,DACARBAZINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|HYDROXYZINE|IPILIMUMAB|SIMVASTATIN|RAMIPRIL,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Pulmonary embolism|Fatigue|Hypothyroidism|Neurological examination abnormal|Malignant neoplasm progression|Muscular weakness|Rectal haemorrhage|Hypopituitarism|Urosepsis,10,5
10189400,20140522,Ipilimumab,7,800,70.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Nausea,1,3
10189587,20140522,Ipilimumab,45,801,45.0,2,98,1,0,1,0,0,0,0,Ipilimumab,ETOPOSIDE|CARBOPLATIN|IPILIMUMAB,3,SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE,VIIth nerve paralysis,1,3
10189597,20140522,Ipilimumab,70,801,70.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Hyponatraemia|Inappropriate antidiuretic hormone secretion,2,3
10190272,20140522,Ipilimumab,84,801,84.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|FLUOROURACIL|DESONIDE|VITAMIN|NEPAFENAC|LANSOPRAZOLE,6,METASTATIC MALIGNANT MELANOMA,Macular oedema,1,3
10190455,20140522,Ipilimumab,35,801,35.0,2,,1,0,1,1,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Headache|Ataxia|Subarachnoid haemorrhage|Hydrocephalus|Malignant neoplasm progression,5,5
10190457,20140522,Ipilimumab,68,801,68.0,1,130,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Mesenteric panniculitis|Abdominal pain|Back pain,3,5
10190511,20140522,Ipilimumab,,,,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Functional gastrointestinal disorder,1,5
10190833,20140523,Ipilimumab,74,801,74.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Malignant neoplasm progression,1,5
10192429,20140523,Ipilimumab,64,801,64.0,1,,1,1,1,0,0,0,0,Ipilimumab,OXYCODONE HYDROCHLORIDE|PREGABALIN|IPILIMUMAB,5,METASTATIC MALIGNANT MELANOMA,Diarrhoea|Gastrointestinal infection|Malignant neoplasm progression|Fatigue|Headache|Constipation,6,1
10192456,20140523,Ipilimumab,,,,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10192721,20140523,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Rheumatoid arthritis,1,1
10192727,20140523,Ipilimumab,34,801,34.0,0,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|VEMURAFENIB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Convulsion,1,3
10194250,20140525,Ipilimumab,,,,2,95,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Vogt-Koyanagi-Harada syndrome,1,1
10194747,20140526,Ipilimumab,71,801,71.0,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death|Rash|Visual acuity reduced|Decreased appetite|Weight decreased|Mobility decreased|Fatigue,7,3
10195196,20140526,Ipilimumab,57,801,57.0,1,73.47,1,0,1,0,0,0,1,Ipilimumab,TADALAFIL|SIPULEUCEL-T|SIPULEUCEL-T|SIPULEUCEL-T|IPILIMUMAB|IPILIMUMAB|DENOSUMAB|FINASTERIDE|EPLERENONE,12,GENITAL ATROPHY|PROSTATE CANCER METASTATIC|PROSTATE CANCER METASTATIC,Cerebrovascular accident|Acute myocardial infarction|Anaemia,3,3
10195513,20140526,Ipilimumab,67,801,67.0,2,72,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,4,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Diarrhoea|Hypokalaemia,2,5
10195516,20140526,Ipilimumab,23,801,23.0,2,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,SKIN CANCER,Death,1,5
10195730,20140527,Ipilimumab,82,801,82.0,1,,1,1,0,0,0,0,0,Ipilimumab,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MULTIVITAMIN|IPILIMUMAB|PANTOPRAZOLE|THIAMINE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,12,METASTATIC MALIGNANT MELANOMA,Peritonitis|Abdominal sepsis|Colitis|Intestinal perforation,4,5
10195734,20140527,Ipilimumab,70,801,70.0,1,86,1,1,1,0,0,0,1,Ipilimumab,"CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|IPILIMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CLOPIDOGREL|LOSARTAN|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|FLUCONAZOLE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ERGOCALCIFEROL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",15,MALIGNANT MELANOMA|HYPERTENSION,Malignant neoplasm progression|Muscular weakness|Fatigue|Renal failure acute,4,3
10195738,20140527,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Nervous system disorder|Dysarthria,2,5
10195740,20140527,Ipilimumab,71,801,71.0,2,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Anaemia|Hypotension,2,5
10196787,20140523,Ipilimumab,50,801,50.0,1,109,1,1,0,0,0,0,0,Ipilimumab,PACLITAXEL|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|IPILIMUMAB,3,NEOPLASM MALIGNANT,Malaise|Respiratory distress|Paraesthesia|Cardio-respiratory arrest|Hypoxia|Pulseless electrical activity,6,3
10196925,20140527,Ipilimumab,77,801,77.0,2,74.5,1,0,1,0,0,0,0,Ipilimumab,CLOPIDOGREL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|IPILIMUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Haematochezia,1,1
10197276,20140527,Ipilimumab,69,801,69.0,1,76,1,0,1,0,0,0,0,Ipilimumab,TRAMETINIB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SIMVASTATIN|IPILIMUMAB|DABRAFENIB,6,METASTATIC MALIGNANT MELANOMA|DIABETES MELLITUS|METASTATIC MALIGNANT MELANOMA,Clostridium difficile colitis,1,1
10202014,20140528,Ipilimumab,51,801,51.0,2,,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Acute hepatic failure|Malaise|Localised oedema|Oedema peripheral|Hepatic lesion,5,5
10203018,20140528,Ipilimumab,67,801,67.0,1,85.8,1,0,1,0,0,0,0,Ipilimumab,ALENDRONATE SODIUM|ALENDRONATE SODIUM TABLET|IPILIMUMAB|PREDNISONE,5,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Fibromyalgia,1,3
10203019,20140528,Ipilimumab,71,801,71.0,2,82.8,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB|RITUXIMAB|ALBUTEROL SULFATE|ALBUTEROL|LEVOTHYROXINE|ATOVAQUONE|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|ERGOCALCIFEROL,9,LYMPHOMA|LYMPHOMA,Dysarthria|VIIth nerve paralysis|Hypertension,3,5
10205090,20140527,Ipilimumab,68,801,68.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|DRONABINOL|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|PROCHLORPERAZINE,8,NEOPLASM MALIGNANT,Haemorrhoids|Pain|Chest pain|Pruritus|Rash macular|Rash|Rash|Lymphadenopathy|Febrile neutropenia|Pancytopenia,10,2
10205948,20140530,Ipilimumab,,,,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,1
10208365,20140530,Ipilimumab,39,801,39.0,2,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Skin reaction|Abdominal pain|Urine output decreased|Weight decreased|Headache|Night sweats|Neoplasm|Vomiting|Chromaturia|Abscess|Nausea|Back pain|Fatigue|Decreased appetite|Myalgia,15,1
10208414,20140530,Ipilimumab,88,801,88.0,1,75,1,1,1,0,0,0,1,Ipilimumab,IPILIMUMAB,4,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonia|Colitis,2,5
10209761,20140602,Ipilimumab,30,801,30.0,2,,1,1,1,1,0,0,1,Ipilimumab,IPILIMUMAB,1,,Hepatitis|Death|Adverse event|Abdominal pain,4,1
10209765,20140602,Ipilimumab,,,,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10210938,20140602,Ipilimumab,54,801,54.0,1,,1,1,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Malignant neoplasm progression|Sepsis,2,5
10210972,20140602,Ipilimumab,73,801,73.0,1,104.31,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Gait disturbance|Speech disorder|Confusional state|Fatigue|Somnolence,5,5
10213002,20140602,Ipilimumab,44,801,44.0,1,,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Malignant neoplasm progression|Colitis|Cancer pain,3,3
10213216,20140603,Ipilimumab,54,801,54.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Pancytopenia,1,5
10213231,20140530,Ipilimumab,61,801,61.0,1,102.3,1,0,1,1,0,0,0,Ipilimumab,IPILIMUMAB,1,COLITIS,Diarrhoea|Nausea|Vomiting|Gastric haemorrhage,4,2
10213459,20140530,Ipilimumab,74,801,74.0,1,84.82,1,0,1,0,0,0,0,Ipilimumab,,1,METASTATIC MALIGNANT MELANOMA,Joint swelling|Fall|Cellulitis|Asthenia,4,
10215316,20140603,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Multiple sclerosis|Hypophysitis,2,1
10215317,20140603,Ipilimumab,72,801,72.0,1,83.1,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Peripheral sensory neuropathy|Pain,2,1
10215609,20140604,Ipilimumab,46,801,46.0,1,119.7,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Hypophosphataemia,1,5
10216903,20140604,Ipilimumab,71,801,71.0,2,89.79,1,0,1,0,0,0,0,Ipilimumab,"OXYCODONE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|CELECOXIB|PANTOPRAZOLE|SIMVASTATIN|IPILIMUMAB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ATROPINE SULFATE|ATROPINE|WARFARIN SODIUM|WARFARIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS",13,OVARIAN CANCER,Diarrhoea|Pleural effusion,2,3
10217128,20140604,Ipilimumab,27,801,27.0,2,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|METHOTREXATE|METHOTREXATE SODIUM,2,,Ectopic pregnancy,1,1
10217433,20140604,Ipilimumab,68,801,68.0,1,94.3,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Large intestine perforation|Muscular weakness|Diarrhoea,3,5
10217828,20140604,Ipilimumab,76,801,76.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,4,METASTATIC MALIGNANT MELANOMA,Colitis,1,5
10218253,20140605,Ipilimumab,60,801,60.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Colitis|Sepsis|Adrenalitis|Thyroiditis|Hypophysitis,5,3
10219903,20140605,Ipilimumab,57,801,57.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Pyrexia|Asthenia,2,3
10220199,20140605,Ipilimumab,,,,2,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Hypothermia|Diarrhoea,2,1
10222768,20140606,Ipilimumab,48,801,48.0,2,,1,0,1,0,0,0,1,Ipilimumab,ETOPOSIDE|IPILIMUMAB|FORMOTEROL FUMARATE|FORMOTEROL FUMARATE DIHYDRATE|CARBOPLATIN|AMLODIPINE,8,SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Neutropenia,1,5
10222778,20140606,Ipilimumab,65,801,65.0,1,,1,0,1,1,0,0,0,Ipilimumab,BISOPROLOL FUMARATE|CILOSTAZOL|CYANOCOBALAMINE|DIMETHICONE|BODY SHIELD|BODY CLEANSER|SKIN PROTECTANT|RABEPRAZOLE SODIUM|RABEPRAZOLE,19,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Liver function test abnormal|Febrile neutropenia,2,5
10223229,20140609,Ipilimumab,65,801,65.0,1,,1,0,1,0,0,0,1,Ipilimumab,"IPILIMUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",2,METASTATIC MALIGNANT MELANOMA,Autoimmune colitis,1,5
10225135,20140609,Ipilimumab,,,,2,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Colitis|Hypophysitis|Thyroid disorder|Depression,4,1
10225141,20140609,Ipilimumab,,,,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Asthenia|Pyrexia,2,5
10226689,20140609,Ipilimumab,48,801,48.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Pneumonia|Malignant neoplasm progression,2,1
10226972,20140610,Ipilimumab,,,,2,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,1
10228523,20140610,Ipilimumab,80,801,80.0,1,,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Death|Enterocolitis,2,3
10228805,20140610,Ipilimumab,74,801,74.0,1,84.8,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Muscular weakness|Infection,2,3
10229379,20140611,Ipilimumab,49,801,49.0,2,79.4,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Hypophosphataemia,1,5
10230422,20140611,Ipilimumab,76,801,76.0,1,87.9,1,0,1,0,0,0,1,Ipilimumab,"SARGRAMOSTIM|SARGRAMOSTIM|IPILIMUMAB|IPILIMUMAB|IPILIMUMAB|MELOXICAM|ALLOPURINOL|ALLOPURINOL|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|FISH OIL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ERGOCALCIFEROL",17,MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA|MALIGNANT MELANOMA|BACK PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pulmonary fibrosis|Hyponatraemia|Activated partial thromboplastin time prolonged|Thyroxine free decreased|Pulmonary hypertension|Dyspnoea,6,5
10231054,20140611,Ipilimumab,,,,0,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Colectomy,1,1
10231093,20140611,Ipilimumab,56,801,56.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|CLONAZEPAM|DIAZEPAM|GABAPENTIN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LEVOTHYROXINE SODIUM|TESTOSTERONE ENANTHATE|LANSOPRAZOLE,11,MALIGNANT MELANOMA|NAUSEA,Neutrophil count decreased|Platelet count decreased,2,5
10231105,20140611,Ipilimumab,,,,0,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,3
10231108,20140611,Ipilimumab,76,801,76.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|CITALOPRAM|CITALOPRAM HYDROBROMIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|SIMVASTATIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METOPROLOL TARTRATE|METOPROLOL,6,METASTATIC MALIGNANT MELANOMA,Fatigue|Dizziness postural|Nausea|Gait disturbance|Hemiparesis|Amnesia,6,1
10231110,20140611,Ipilimumab,32,801,32.0,1,90.4,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Hypophosphataemia,1,5
10231135,20140611,Ipilimumab,68,801,68.0,2,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Adverse event|Pyrexia,2,5
10231655,20140611,Ipilimumab,74,801,74.0,1,84.8,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Cellulitis|Diarrhoea|Muscular weakness|Fall,4,3
10231998,20140612,Ipilimumab,66,801,66.0,1,,1,0,1,0,0,0,1,Ipilimumab,PACLITAXEL|CARBOPLATIN|IPILIMUMAB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Rash|Lung infection,2,5
10233563,20140612,Ipilimumab,,,,2,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Colitis|Acute psychosis,2,1
10233577,20140612,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Nodule,1,5
10233699,20140611,Ipilimumab,51,801,51.0,2,106.14,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|IPILIMUMAB|IPILIMUMAB|CRIZOTINIB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISONE,8,LUNG NEOPLASM MALIGNANT|NON-SMALL CELL LUNG CANCER,Pulmonary embolism|Inflammation,2,3
10236448,20140613,Ipilimumab,68,801,68.0,1,90.7,1,0,1,0,0,0,1,Ipilimumab,LISINOPRIL|IPILIMUMAB,5,PROSTATE CANCER,Colitis|Pyrexia|Rash|Autoimmune hepatitis,4,3
10236454,20140613,Ipilimumab,80,801,80.0,1,,1,1,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Malignant neoplasm progression,1,1
10236469,20140613,Ipilimumab,71,801,71.0,1,75,1,0,1,1,0,0,1,Ipilimumab,ALPRAZOLAM|IPILIMUMAB|ATENOLOL,8,MALIGNANT MELANOMA,Colitis|Rectal haemorrhage,2,5
10236478,20140613,Ipilimumab,,,,0,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,3
10236480,20140613,Ipilimumab,72,801,72.0,2,,1,1,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Death|Neurological symptom|Lung disorder|Diarrhoea,4,3
10236483,20140613,Ipilimumab,,,,0,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Fuchs^ syndrome,1,3
10237054,20140613,Ipilimumab,70,801,70.0,1,105,1,1,1,1,0,0,0,Ipilimumab,IPILIMUMAB|RAMIPRIL|METOPROLOL TARTRATE|METOPROLOL|INSULIN GLARGINE,7,MALIGNANT MELANOMA STAGE IV,Diabetes mellitus|Coma|Death|Delirium|Myoglobin blood increased|Pulmonary sepsis|Renal failure acute,7,1
10237493,20140615,Ipilimumab,52,801,52.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Abdominal pain,1,5
10237495,20140615,Ipilimumab,51,801,51.0,2,,1,1,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Death|Metabolic acidosis,2,5
10237738,20140616,Ipilimumab,46,801,46.0,1,,1,1,1,0,0,0,1,Ipilimumab,ETOPOSIDE|CARBOPLATIN|IPILIMUMAB,3,SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER,Drug-induced liver injury|Malignant neoplasm progression,2,5
10237745,20140616,Ipilimumab,55,801,55.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Radiation necrosis,1,3
10239302,20140616,Ipilimumab,67,801,67.0,1,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION,Epstein-Barr virus test|Acute respiratory distress syndrome|Herpes simplex,3,3
10239320,20140616,Ipilimumab,56,801,56.0,2,,1,0,1,0,0,0,0,Ipilimumab,CARBOPLATIN|ETOPOSIDE|IPILIMUMAB,3,SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER,Thrombocytopenia,1,3
10239554,20140616,Ipilimumab,70,801,70.0,1,,1,1,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Death|Intestinal perforation|Gastrointestinal necrosis|Diarrhoea,4,1
10240514,20140617,Ipilimumab,56,801,56.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Multiple sclerosis relapse,1,3
10240518,20140617,Ipilimumab,67,801,67.0,2,79.83,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|LORAZEPAM|AMLODIPINE|CLONIDINE|LISINOPRIL,5,MALIGNANT MELANOMA,Depressed level of consciousness|Diarrhoea|Atrial fibrillation|Palpitations,4,5
10244661,20140618,Ipilimumab,78,801,78.0,1,75,1,1,1,0,0,0,0,Ipilimumab,"RAMIPRIL|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|ALLOPURINOL|QUININE SULFATE|QUININE|METHYLPREDNISOLONE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|IPILIMUMAB|ISOSORBIDE MONONITRATE|BUDESONIDE",23,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Intestinal perforation|Death|Colitis,3,5
10248154,20140619,Ipilimumab,52,801,52.0,1,68,1,1,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Death|Malignant neoplasm progression|Pleural effusion,3,1
10249156,20140618,Ipilimumab,83,801,83.0,1,79,1,0,1,0,1,0,0,Ipilimumab,IPILIMUMAB,2,MELANOMA RECURRENT,Blindness unilateral|Fatigue|Pyrexia,3,2
10250918,20140620,Ipilimumab,69,801,69.0,2,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Diarrhoea|Colitis|Pneumocystis jirovecii pneumonia,3,1
10251853,20140623,Ipilimumab,48,801,48.0,1,131.2,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|DASATINIB,2,GASTROINTESTINAL STROMAL TUMOUR|GASTROINTESTINAL STROMAL TUMOUR,Malaise|Proctalgia|Diarrhoea|Perirectal abscess,4,5
10251859,20140623,Ipilimumab,74,801,74.0,1,,1,0,0,0,1,0,0,Ipilimumab,IPILIMUMAB|MEMANTINE HYDROCHLORIDE,3,MALIGNANT MELANOMA,Diarrhoea|Dehydration|Atrial fibrillation|Weight decreased,4,1
10253206,20140623,Ipilimumab,,,,1,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Colitis ulcerative|Dehydration|Full blood count decreased|Rash,4,5
10255882,20140624,Ipilimumab,70,801,70.0,1,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Pneumonitis|Adenocarcinoma of colon|Rash,3,3
10255883,20140624,Ipilimumab,62,801,62.0,1,90.7,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Calculus ureteric,1,5
10255898,20140624,Ipilimumab,57,801,57.0,2,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Meningitis aseptic|Adrenal insufficiency|Malignant neoplasm progression|Myocardial infarction,4,3
10256237,20140624,Ipilimumab,73,801,73.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Colitis|Diarrhoea|Weight decreased|Faecal incontinence,4,3
10257876,20140625,Ipilimumab,66,801,66.0,1,,1,0,1,1,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Hypotension|Adrenal insufficiency|Hepatotoxicity|Gastrointestinal haemorrhage,4,2
10258289,20140625,Ipilimumab,,,,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Headache|Metastases to central nervous system,2,3
10258623,20140625,Ipilimumab,,,,0,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Malignant neoplasm progression|Renal failure,2,3
10261388,20140626,Ipilimumab,69,801,69.0,1,,1,1,0,0,0,0,1,Ipilimumab,CELECOXIB|ATORVASTATIN CALCIUM|LISINOPRIL|FAMOTIDINE|PREDNISONE|IPILIMUMAB|FINASTERIDE,10,METASTATIC MALIGNANT MELANOMA,Colitis,1,3
10261394,20140626,Ipilimumab,60,801,60.0,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,1
10262165,20140626,Ipilimumab,67,801,67.0,2,,1,0,1,0,0,0,0,Ipilimumab,TRAMETINIB|DABRAFENIB|IPILIMUMAB,3,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Supraventricular tachycardia|Urinary tract disorder|Back pain|Urinary tract infection,4,5
10264518,20140625,Ipilimumab,70,801,70.0,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,2,MALIGNANT MELANOMA,Fatigue|Asthenia|Confusional state|Anaemia|Intraventricular haemorrhage|Appetite disorder|Urine output decreased|Dysuria|Myalgia|Back pain|Gait disturbance|Speech disorder|Contusion|Tachycardia,14,3
10265749,20140627,Ipilimumab,72,801,72.0,2,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Colitis|Thrombosis in device,2,1
10265752,20140627,Ipilimumab,54,801,54.0,1,90.7,1,1,1,1,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Malignant neoplasm progression|Coma|Atrial fibrillation|Jaundice|Pneumothorax|Weight decreased,6,5
10265753,20140627,Ipilimumab,53,801,53.0,1,,1,0,1,0,1,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Malignant neoplasm progression|Pain|Hypophysitis|Pruritus,4,3
10268398,20140630,Ipilimumab,80,801,80.0,1,72.9,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB|IPILIMUMAB,2,MYELODYSPLASTIC SYNDROME|ACUTE MYELOID LEUKAEMIA,Pneumonia|Malignant neoplasm progression,2,5
10269530,20140701,Ipilimumab,44,801,44.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,4,MALIGNANT MELANOMA,Adrenal insufficiency|Hypophysitis|Sarcoidosis|Alanine aminotransferase increased|Aspartate aminotransferase increased,5,5
10269532,20140701,Ipilimumab,65,801,65.0,2,85.28,1,1,1,0,0,0,0,Ipilimumab,"VALSARTAN|TEMOZOLOMIDE|NEBIVOLOL HYDROCHLORIDE|GABAPENTIN|OMEPRAZOLE MAGNESIUM|SIMVASTATIN|LEVOTHYROXINE SODIUM|SPIRONOLACTONE|BRIMONIDINE TARTRATE|ALENDRONATE SODIUM|ALENDRONATE SODIUM|VALSARTAN AND HYDROCHLOROTHIAZIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|IPILIMUMAB|LEVOTHYROXINE SODIUM|ACETAMINOPHEN|GABAPENTIN|ALPRAZOLAM|PIOGLITAZONE|AMLODIPINE BESYLATE",25,MALIGNANT MELANOMA|PAIN,Death|Asthenia,2,5
10269537,20140701,Ipilimumab,41,801,41.0,1,79.2,1,1,1,0,0,0,1,Ipilimumab,LACTULOSE|ESOMEPRAZOLE MAGNESIUM|GABAPENTIN|ACYCLOVIR|BACLOFEN|LISINOPRIL|MAGNESIUM|RITUXIMAB|IPILIMUMAB|SENNOSIDES|SENNA LEAF|SENNA|ESCITALOPRAM,15,LYMPHOMA|LYMPHOMA,Dyspnoea|Neck pain|Malignant neoplasm progression|Tumour lysis syndrome|Agitation|Hyperuricaemia|Back pain|Pleural effusion|Hypophosphataemia,9,5
10269547,20140701,Ipilimumab,3,800,30.0,2,,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Malignant neoplasm progression|Pleural effusion,2,1
10269551,20140701,Ipilimumab,73,801,73.0,1,92.7,1,0,1,0,0,0,0,Ipilimumab,PREDNISONE|ENOXAPARIN SODIUM|IPILIMUMAB,3,MALIGNANT MELANOMA,Septic shock|Colitis|Diarrhoea,3,5
10272269,20140702,Ipilimumab,74,801,74.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Depression|Alcoholism|Wrist fracture,3,3
10272279,20140702,Ipilimumab,,,,1,,1,1,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,,Death|Colitis,2,3
10273123,20140702,Ipilimumab,,,,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,VIIth nerve paralysis,1,1
10273812,20140702,Ipilimumab,71,801,71.0,2,,1,0,1,0,0,0,0,Ipilimumab,DABRAFENIB|IPILIMUMAB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Confusional state|Haemorrhage intracranial|Dehydration,3,3
10275272,20140703,Ipilimumab,50,801,50.0,2,85,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB|RIVAROXABAN,2,MALIGNANT MELANOMA,Enterocolitis|Hyperglycaemia,2,5
10276758,20140701,Ipilimumab,64,801,64.0,1,81.65,1,1,0,0,0,0,0,Ipilimumab,METHOTREXATE|METHOTREXATE SODIUM|IPILIMUMAB|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET,3,MALIGNANT MELANOMA,Immune system disorder|Diarrhoea|Large intestine perforation,3,
10276975,20140703,Ipilimumab,,,,2,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Death,1,5
10276978,20140703,Ipilimumab,69,801,69.0,2,130,1,0,1,0,0,0,0,Ipilimumab,DACARBAZINE|AMOXICILLIN AND CLAVULANATE POTASSIUM|ENOXAPARIN SODIUM|SPIRONOLACTONE|IPILIMUMAB|MORPHINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,18,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Device related sepsis|Erysipelas,2,3
10276999,20140703,Ipilimumab,62,801,62.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Capillary leak syndrome|Arthritis|Oedema|Rash|Pleural effusion,5,1
10278569,20140704,Ipilimumab,67,801,67.0,1,89.1,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Lipase increased,1,5
10278571,20140704,Ipilimumab,60,801,60.0,2,56,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,SQUAMOUS CELL CARCINOMA OF THE CERVIX,Abdominal pain|Vomiting|Hyponatraemia|Nausea|Pneumonitis,5,5
10278579,20140704,Ipilimumab,69,801,69.0,1,,1,1,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Death,1,1
10278581,20140704,Ipilimumab,63,801,63.0,2,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10278582,20140704,Ipilimumab,65,801,65.0,2,57.6,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,PLASMA CELL MYELOMA,Immune thrombocytopenic purpura|Eosinophilic pneumonia,2,5
10278699,20140704,Ipilimumab,39,801,39.0,1,,1,1,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Malignant neoplasm progression|Pain,2,5
10280849,20140707,Ipilimumab,81,801,81.0,1,83.5,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Lipase increased,1,5
10280883,20140707,Ipilimumab,37,801,37.0,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,5
10280896,20140707,Ipilimumab,52,801,52.0,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Peripheral swelling|Headache|Hyponatraemia|Vision blurred|Hallucination|Vomiting|Swelling face|Hypothalamo-pituitary disorder,8,1
10280923,20140707,Ipilimumab,79,801,79.0,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Portal vein thrombosis,1,1
10281054,20140707,Ipilimumab,,,,2,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Stomatitis|Mucosal inflammation,2,1
10281058,20140707,Ipilimumab,65,801,65.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Diarrhoea|Faeces discoloured,2,5
10281145,20140707,Ipilimumab,70,801,70.0,2,44,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB|DIGOXIN,4,MALIGNANT MELANOMA,Pyrexia|Malaise|Anaemia|Clostridium difficile colitis,4,5
10281156,20140707,Ipilimumab,75,801,75.0,1,,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Intestinal perforation|Diarrhoea|Pyrexia,3,1
10281176,20140707,Ipilimumab,54,801,54.0,1,,1,1,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Lung disorder|Death,2,5
10281888,20140707,Ipilimumab,61,801,61.0,1,,1,0,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Colitis|Cytomegalovirus colitis,2,3
10283055,20140708,Ipilimumab,30,801,30.0,1,,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB|LEVOCETIRIZINE DIHYDROCHLORIDE,3,MALIGNANT MELANOMA,Colitis|Hepatitis,2,3
10284848,20140708,Ipilimumab,,,,1,,1,0,0,0,0,0,1,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Tooth abscess|Sialoadenitis,2,1
10286209,20140707,Ipilimumab,53,801,53.0,2,69.3,1,0,1,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Drug-induced liver injury,1,3
10287304,20140709,Ipilimumab,,,,2,,1,1,1,0,0,0,1,Ipilimumab,IPILIMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Anal fistula|Colitis|Diabetes mellitus|Malignant neoplasm progression,4,1
10287305,20140709,Ipilimumab,78,801,78.0,2,90.5,1,0,1,0,0,0,1,Ipilimumab,"METHYLPREDNISOLONE SODIUM SUCCINATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|OXYCODONE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE|METOPROLOL TARTRATE|METOPROLOL|ENOXAPARIN SODIUM|AMLODIPINE|METOPROLOL SUCCINATE|IPILIMUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE",16,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CERVIX CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Lung infection|Hyponatraemia|Anaemia|Retroperitoneal haemorrhage|Sepsis|Diarrhoea|Colitis|Acute kidney injury,8,5
10287310,20140709,Ipilimumab,42,801,42.0,2,,1,1,1,0,0,0,1,Ipilimumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FUROSEMIDE|IPILIMUMAB,5,PAIN IN EXTREMITY|OEDEMA PERIPHERAL|MALIGNANT MELANOMA|NEURALGIA,Pancreatitis acute|Nephrolithiasis|Cholelithiasis|Neurological examination abnormal|Diarrhoea|Nausea,6,1
10287320,20140709,Ipilimumab,54,801,54.0,2,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,,Death,1,1
10289441,20140710,Ipilimumab,,,,0,,1,0,1,0,0,0,1,Ipilimumab,LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|PREDNISONE|IPILIMUMAB|LEVOTHYROXINE,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT MELANOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|VOMITING,Urinary tract infection|Vomiting|Adrenal insufficiency|Headache|Diarrhoea,5,5
10292769,20140710,Ipilimumab,,,,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,MALIGNANT MELANOMA,Death,1,3
10292987,20140710,Ipilimumab,69,801,69.0,1,90,1,0,1,0,1,0,1,Ipilimumab,RAMIPRIL|CARBOPLATIN|IPILIMUMAB|CLARITHROMYCIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ETOPOSIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DOXYCYCLINE|DOXYCYCLINE HYCLATE|RANITIDINE,15,HYPERTENSION|LACRIMATION INCREASED|INFECTION|SMALL CELL LUNG CANCER EXTENSIVE STAGE|SMALL CELL LUNG CANCER EXTENSIVE STAGE|ANGINA PECTORIS|LOWER RESPIRATORY TRACT INFECTION|DIABETES MELLITUS|DIABETES MELLITUS|PSORIASIS|SMALL CELL LUNG CANCER EXTENSIVE STAGE|HYPERTENSION|HYPERCHOLESTEROLAEMIA|LOWER RESPIRATORY TRACT INFECTION|PROPHYLAXIS,Dizziness|Pulmonary embolism|Pulmonary fibrosis|Fatigue|Pyrexia,5,3
10295619,20140711,Ipilimumab,75,801,75.0,1,,1,0,1,0,0,0,1,Ipilimumab,CARBOPLATIN|IPILIMUMAB|ETOPOSIDE,3,SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER,Pneumonia,1,5
10295643,20140711,Ipilimumab,,,,1,,1,1,0,0,0,0,0,Ipilimumab,IPILIMUMAB,1,METASTATIC MALIGNANT MELANOMA,Death,1,1
10003816,20140312,Trastuzumab,39,801,39.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,2,BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Anaemia,1,5
10005370,20140313,Trastuzumab,72,801,72.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB,5,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Cardiac disorder|Angina pectoris,2,1
10005380,20140313,Trastuzumab,56,801,56.0,0,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|FULVESTRANT|FULVESTRANT|DENOSUMAB|DENOSUMAB,6,METASTASES TO CENTRAL NERVOUS SYSTEM|METASTASES TO BONE|METASTASES TO CENTRAL NERVOUS SYSTEM|METASTASES TO BONE|METASTASES TO CENTRAL NERVOUS SYSTEM|METASTASES TO BONE,Fatigue|Dry mouth|Decreased appetite|Cognitive disorder,4,1
10005501,20140313,Trastuzumab,69,801,69.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|DOXORUBICIN HYDROCHLORIDE,8,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Febrile neutropenia,1,1
10005525,20140313,Trastuzumab,,,,2,62,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB|DIGOXIN|BISOPROLOL FUMARATE,4,BREAST CANCER|BREAST CANCER|ATRIAL FIBRILLATION|ATRIAL FIBRILLATION,Paraesthesia|Muscular weakness|Asthenia|Local swelling|Paraesthesia|Hypoaesthesia,6,1
10005779,20140313,Trastuzumab,49,801,49.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PERTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|CAPECITABINE|LAPATINIB,7,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Febrile neutropenia,1,1
10005874,20140312,Trastuzumab,54,801,54.0,2,,1,0,0,0,0,0,1,Trastuzumab,VINORELBINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|PACLITAXEL|PACLITAXEL|DOCETAXEL|DOCETAXEL ANHYDROUS|ZOLEDRONIC ACID|ZOLEDRONIC ACID|LETROZOLE|LETROZOLE TABLETS|LETROZOLE|LETROZOLE TABLETS|CAPECITABINE|CAPECITABINE|LAPATINIB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TAMOXIFEN CITRATE,18,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Disease progression|Metastases to bone|Metastases to liver|Nervous system disorder|Pleural effusion|Lung infiltration|Dyspnoea,7,
10005971,20140313,Trastuzumab,55,801,55.0,2,100,1,0,0,0,0,0,0,Trastuzumab,"TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",3,HER-2 POSITIVE BREAST CANCER|BREAST CANCER,Ventricular hypokinesia|Ejection fraction decreased,2,1
10006022,20140313,Trastuzumab,56,801,56.0,2,52,1,0,1,0,0,0,1,Trastuzumab,,1,HER-2 POSITIVE BREAST CANCER,Acute coronary syndrome|Anaemia,2,1
10006244,20140313,Trastuzumab,52,801,52.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,HER-2 POSITIVE BREAST CANCER,Ventricular extrasystoles,1,1
10007427,20140313,Trastuzumab,41,801,41.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,2,INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA,Neurotoxicity|Visual acuity reduced,2,1
10010266,20140314,Trastuzumab,68,801,68.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|CAPECITABINE|LAPATINIB,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Cardiotoxicity,1,1
10010306,20140314,Trastuzumab,47,801,47.0,2,111.5,1,1,1,1,0,0,1,Trastuzumab,"DOXORUBICIN|LEVOTHYROXINE SODIUM|ADO-TRASTUZUMAB EMTANSINE|TRASTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|ADO-TRASTUZUMAB EMTANSINE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|LEVETIRACETAM|GABAPENTIN|TRASTUZUMAB|TRASTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|ADO-TRASTUZUMAB EMTANSINE|ADO-TRASTUZUMAB EMTANSINE|ADO-TRASTUZUMAB EMTANSINE|ADO-TRASTUZUMAB EMTANSINE",20,BREAST CANCER|BREAST CANCER|BREAST CANCER METASTATIC|HER-2 POSITIVE BREAST CANCER|BREAST CANCER|BREAST CANCER,Malaise|Mental disorder|General physical health deterioration|Anaemia|Delirium|Cerebral haemorrhage|Eastern Cooperative Oncology Group performance status worsened|Infusion related reaction|Hydrocephalus|Pain|Asthenia|Blood phosphorus decreased|Muscular weakness|Arteriovenous malformation|Nasopharyngitis|Cough|Nasal dryness|Left ventricular dysfunction|Radiation necrosis|Cerebral haematoma|Pneumonia|Brain abscess|Hyponatraemia|Hypotension|Gastric infection|Central nervous system infection|Blood potassium abnormal|Platelet count decreased|Performance status decreased|Decreased appetite|Headache|Obesity|Depressed level of consciousness|Fall|Dilatation ventricular|Depressed level of consciousness|Influenza like illness|Ventricular hypokinesia|Weight decreased|Clostridium difficile infection|Cystitis|Brain abscess|Heart rate increased|Influenza|Malignant neoplasm progression|Constipation|Infusion related reaction|Anorectal disorder|Coagulopathy|Klebsiella infection|Seizure|Paraesthesia,52,1
10010326,20140314,Trastuzumab,,,,2,55,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PACLITAXEL|FILGRASTIM,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Drug ineffective|Metastases to central nervous system,2,1
10010333,20140314,Trastuzumab,50,801,50.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PERTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|CAPECITABINE|LAPATINIB,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Febrile neutropenia,1,1
10010347,20140314,Trastuzumab,41,801,41.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|LAPATINIB,2,BREAST CANCER METASTATIC,Diarrhoea|Palmar-plantar erythrodysaesthesia syndrome|Injection site reaction,3,1
10010359,20140314,Trastuzumab,,,,2,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,METASTATIC NEOPLASM,Death,1,1
10010625,20140314,Trastuzumab,,,,0,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,METASTATIC GASTRIC CANCER,Disease progression,1,1
10010634,20140314,Trastuzumab,55,801,55.0,2,96.7,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|CARBOPLATIN,3,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Neoplasm|Pain in extremity|Hypoaesthesia|Carpal tunnel decompression,4,5
10010635,20140314,Trastuzumab,60,801,60.0,2,54,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB,4,BREAST CANCER|BREAST CANCER,Infusion related reaction|Anaphylactic reaction,2,1
10010938,20140314,Trastuzumab,54,801,54.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PERTUZUMAB|ADO-TRASTUZUMAB EMTANSINE,5,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Febrile neutropenia,1,1
10011252,20140314,Trastuzumab,46,801,46.0,2,46,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PACLITAXEL|DOXORUBICIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|ZOLEDRONIC ACID,6,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Disease progression,1,1
10013600,20140315,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,HER-2 POSITIVE BREAST CANCER,Autoimmune disorder,1,1
10013603,20140315,Trastuzumab,44,801,44.0,2,70,1,0,0,0,0,0,1,Trastuzumab,PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB,9,BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION,Chills|Hypotension|Hyperhidrosis|Tachycardia|Rash|Erythema|Rash erythematous|Heart rate increased|Body temperature decreased|Oxygen saturation decreased|Hypersensitivity,11,1
10015006,20140317,Trastuzumab,62,801,62.0,2,,1,1,1,0,0,0,0,Trastuzumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB|ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE,9,BREAST CANCER|BREAST CANCER|BREAST CANCER,Neutropenia,1,1
10015069,20140317,Trastuzumab,47,801,47.0,2,,1,0,1,0,1,0,0,Trastuzumab,"DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|MIRTAZAPINE|ALBUTEROL SULFATE|ALBUTEROL|LORAZEPAM|ESCITALOPRAM|IPRATROPIUM BROMIDE|OXYCODONE|METHADONE|ALPRAZOLAM",18,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|INSOMNIA|ASTHMA|BREAST CANCER|ANXIETY|NAUSEA|DEPRESSION|ASTHMA|PAIN|HYPERTENSION|PAIN|ANXIETY,Arthritis|Pain in extremity|Local swelling|Pain|Oropharyngeal pain,5,1
10016682,20140317,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Vision blurred|Headache,2,3
10016692,20140318,Trastuzumab,69,801,69.0,0,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hyperglycaemia|Fatigue,2,1
10016833,20140318,Trastuzumab,69,801,69.0,0,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DENOSUMAB,6,BREAST CANCER METASTATIC|METASTASES TO BONE|METASTASES TO LIVER|METASTASES TO LUNG,Palmar-plantar erythrodysaesthesia syndrome|Skin ulcer|Skin induration|Therapeutic response decreased,4,1
10017128,20140318,Trastuzumab,8,800,80.0,2,,1,1,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PACLITAXEL,2,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Cardiac arrest|Disease progression|Loss of consciousness,3,1
10017155,20140318,Trastuzumab,73,801,73.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,General physical health deterioration|Disease progression|Dyspnoea,3,1
10017164,20140318,Trastuzumab,45,801,45.0,2,,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|LAPATINIB|PACLITAXEL,4,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Dyspnoea|Transaminases increased,2,1
10017166,20140318,Trastuzumab,55,801,55.0,2,,1,0,0,0,0,0,1,Trastuzumab,"TRASTUZUMAB|TRASTUZUMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Chest discomfort|Hypersensitivity,3,1
10017226,20140318,Trastuzumab,47,801,47.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,HER-2 POSITIVE BREAST CANCER,Metastases to central nervous system,1,1
10017264,20140318,Trastuzumab,59,801,59.0,2,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10017269,20140318,Trastuzumab,44,801,44.0,2,60,1,0,0,1,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB,2,BREAST CANCER,Cardiac failure|Hydrothorax|Cardiomyopathy|Vascular calcification|Cholecystitis chronic|Hyperbilirubinaemia|Essential hypertension|Liver disorder|Muscle spasticity|Lymphadenopathy|Lymphadenopathy mediastinal|Pulmonary fibrosis|Bone loss|Polycythaemia|Haemoglobin increased|Thrombocytosis|Dyspnoea,17,1
10017366,20140318,Trastuzumab,54,801,54.0,2,74,1,0,0,0,1,0,0,Trastuzumab,TRASTUZUMAB,1,HER-2 POSITIVE BREAST CANCER,Chest pain|Dyspnoea|Asthenia|Disorientation|Palpitations,5,5
10017536,20140318,Trastuzumab,43,801,43.0,2,60,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,2,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Chest discomfort|Eyelid oedema|Dizziness|Headache,4,1
10019169,20140314,Trastuzumab,53,801,53.0,2,50.8,1,0,0,0,0,0,1,Trastuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN|TRASTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|LORAZEPAM,6,BREAST CANCER|BREAST CANCER,Dry skin|Phlebitis|Skin hyperpigmentation,3,2
10019238,20140318,Trastuzumab,38,801,38.0,2,73,1,0,1,0,0,0,0,Trastuzumab,CARBOPLATIN|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|TRASTUZUMAB|ATENOLOL|LORAZEPAM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FILGRASTIM|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB,15,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Hypokalaemia|Cellulitis|Hypomagnesaemia,3,1
10019239,20140318,Trastuzumab,38,801,38.0,2,73,1,0,1,0,0,0,0,Trastuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|TRASTUZUMAB|CARBOPLATIN|ATENOLOL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LORAZEPAM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|FILGRASTIM,15,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Hypokalaemia|Hypomagnesaemia|Cellulitis,3,1
10019362,20140318,Trastuzumab,54,801,54.0,2,,1,1,1,1,0,0,0,Trastuzumab,TRASTUZUMAB|ALPRAZOLAM,8,BREAST CANCER,Cardio-respiratory arrest|Malignant neoplasm progression|Septic shock|Renal failure acute|Glomerulonephritis,5,5
10020111,20140319,Trastuzumab,47,801,47.0,2,53,1,0,1,0,1,0,0,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DENOSUMAB|TRASTUZUMAB|TRASTUZUMAB,7,BREAST CANCER METASTATIC|PREMEDICATION|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER,Cardiac failure,1,1
10020119,20140319,Trastuzumab,55,801,55.0,2,55,1,0,1,0,0,0,0,Trastuzumab,,3,BREAST CANCER METASTATIC,Vomiting|Nausea|Anal haemorrhage,3,1
10020595,20140319,Trastuzumab,,,,2,138.47,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,2,BREAST CANCER|DIABETES MELLITUS,Dysphagia|Burning sensation|Choking|Peripheral coldness,4,5
10020756,20140319,Trastuzumab,54,801,54.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,2,BREAST CANCER|BREAST CANCER,Arthralgia|Asthenia|Cystitis,3,1
10020842,20140319,Trastuzumab,50,801,50.0,2,60,1,0,0,0,0,0,1,Trastuzumab,"TRASTUZUMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",5,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Febrile neutropenia|Proteinuria|Vomiting|Disease progression,4,1
10020866,20140318,Trastuzumab,58,801,58.0,2,54.43,1,1,0,0,0,0,0,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,,Hypersensitivity|Cardiac arrest|Oxygen saturation decreased,3,
10020993,20140313,Trastuzumab,48,801,48.0,2,,1,0,0,0,0,0,1,Trastuzumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|TRASTUZUMAB|METHOTREXATE|METHOTREXATE SODIUM|CAPECITABINE",9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hepatic steatosis|Disease progression,2,1
10021068,20140319,Trastuzumab,49,801,49.0,2,,1,1,0,0,0,0,0,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER,Disease progression,1,1
10021238,20140319,Trastuzumab,69,801,69.0,2,57.4,1,0,1,0,0,0,0,Trastuzumab,,2,HER-2 POSITIVE BREAST CANCER,ECG signs of myocardial ischaemia,1,1
10021527,20140313,Trastuzumab,48,801,48.0,2,,1,0,0,0,0,0,1,Trastuzumab,"GEMCITABINE HYDROCHLORIDE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|TRASTUZUMAB|TRASTUZUMAB|METHOTREXATE|METHOTREXATE SODIUM|PACLITAXEL|CAPECITABINE",11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hepatic steatosis|Disease progression|Metastases to skin|Breast cancer|Invasive ductal breast carcinoma,5,3
10022012,20140319,Trastuzumab,34,801,34.0,2,77.23,1,1,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|LAPATINIB|DENOSUMAB|PACLITAXEL|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|PACLITAXEL|OMEPRAZOLE MAGNESIUM,14,BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Breast cancer metastatic|Hepatic enzyme increased|Vertigo|Nausea|Dizziness|Balance disorder|Muscular weakness|Ascites|Deafness unilateral|Hydrocephalus|Hypoaesthesia,11,3
10022799,20140319,Trastuzumab,63,801,63.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PERTUZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Generalised oedema|Swelling,2,5
10023121,20140320,Trastuzumab,68,801,68.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB,2,BREAST CANCER,Discomfort,1,3
10023343,20140320,Trastuzumab,42,801,42.0,2,,1,0,1,0,0,0,0,Trastuzumab,CLARITHROMYCIN,2,BREAST CANCER|PNEUMONIA,Pneumonia|Pyrexia,2,1
10023373,20140320,Trastuzumab,64,801,64.0,1,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|CAPECITABINE,2,GASTRIC CANCER|GASTRIC CANCER,Nausea|Vomiting|Aphagia,3,1
10023386,20140320,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,4,BREAST CANCER METASTATIC,Metastases to central nervous system,1,5
10023402,20140320,Trastuzumab,,,,0,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB,2,BREAST CANCER,Weight decreased,1,3
10023403,20140320,Trastuzumab,,,,2,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB|CARBOPLATIN,4,BREAST CANCER,Death,1,1
10023423,20140320,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Injection site pain,1,3
10023424,20140320,Trastuzumab,45,801,45.0,1,,1,0,1,0,1,0,0,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER METASTATIC,Myelitis,1,1
10023446,20140320,Trastuzumab,,,,2,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB|PERTUZUMAB|CARBOPLATIN|AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM|AMLODIPINE AND ATORVASTATIN|SERTRALINE HYDROCHLORIDE|ETANERCEPT|LEVOTHYROXINE SODIUM,9,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Respiratory failure,1,1
10023457,20140320,Trastuzumab,4,800,40.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Discomfort|Pain,2,5
10023513,20131231,Trastuzumab,,,,2,43,1,0,0,0,0,0,1,Trastuzumab,"DOCETAXEL|DOCETAXEL ANHYDROUS|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|TRASTUZUMAB",4,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Chronic myeloid leukaemia,1,3
10023543,20140320,Trastuzumab,,,,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,5,BREAST CANCER,Diarrhoea|Fatigue|Oesophageal pain|Sensation of foreign body|Malaise|Mastectomy|Breast reconstruction|Alopecia|Abdominal discomfort|Abdominal discomfort,10,5
10023545,20140320,Trastuzumab,,,,0,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|CAPECITABINE|PACLITAXEL|LAPATINIB|VINORELBINE,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression|Off label use,2,1
10023565,20140320,Trastuzumab,53,801,53.0,2,50,1,0,0,0,0,0,1,Trastuzumab,"DOCETAXEL|DOCETAXEL ANHYDROUS|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PERTUZUMAB|TRASTUZUMAB|HYDROCORTISONE|PERTUZUMAB|ANASTROZOLE",16,BREAST CANCER METASTATIC|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC|PAIN|PAIN|BREAST CANCER METASTATIC|OEDEMA|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|PAIN,Cardiac failure|Pulmonary embolism|Sinus tachycardia|Hypersensitivity,4,1
10023694,20140320,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,HER-2 POSITIVE BREAST CANCER,Injection site pain,1,3
10023770,20140320,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER METASTATIC,Pain|Pain in extremity|Application site discomfort,3,5
10026292,20140320,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,PRODUCT USED FOR UNKNOWN INDICATION,Brain oedema,1,1
10026399,20140321,Trastuzumab,44,801,44.0,2,,1,0,0,0,0,0,1,Trastuzumab,"TRASTUZUMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",4,BREAST CANCER,Mixed liver injury,1,1
10026645,20140321,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Injection site pain,1,3
10026676,20140321,Trastuzumab,49,801,49.0,2,84,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|DENOSUMAB|PERTUZUMAB|PERTUZUMAB,8,BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Groin abscess,1,1
10026779,20140321,Trastuzumab,55,801,55.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Recall phenomenon|Pneumonitis,2,1
10026917,20140321,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Large intestine polyp,1,1
10027219,20140321,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Chest discomfort|Dyspnoea,2,3
10027263,20140321,Trastuzumab,61,801,61.0,2,,1,1,0,0,0,0,1,Trastuzumab,PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|CAPECITABINE|CAPECITABINE|DOCETAXEL|DOCETAXEL ANHYDROUS|PREGABALIN|LAPATINIB,21,HER-2 POSITIVE BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Cardiac failure acute|Pneumonia influenzal,2,1
10027264,20140321,Trastuzumab,59,801,59.0,2,64.5,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|LETROZOLE|LETROZOLE TABLETS,2,BREAST CANCER|BREAST CANCER,Joint injury,1,5
10027585,20140321,Trastuzumab,61,801,61.0,0,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|PERTUZUMAB,2,BREAST CANCER|BREAST CANCER,Dysphagia,1,1
10027870,20140321,Trastuzumab,,,,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|CAPECITABINE,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Postoperative wound infection|Nausea|Paraesthesia|Sleep disorder|Balance disorder|Vomiting|Infection|Asthenia|Pelvic pain|Oedema peripheral|Pruritus generalised|Constipation|Back pain|Pruritus|Fatigue|Abdominal pain lower|Diarrhoea|Muscular weakness|Hypoaesthesia|Sensory disturbance,20,3
10028112,20140321,Trastuzumab,41,801,41.0,2,,1,0,1,0,0,0,0,Trastuzumab,PACLITAXEL|TRASTUZUMAB|LEVETIRACETAM|SPIRONOLACTONE|CETIRIZINE HYDROCHLORIDE|DOCETAXEL|DOCETAXEL ANHYDROUS,13,BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Hypersensitivity|Oedema|Rash|Blister|Toxic skin eruption|Photosensitivity reaction|Pruritus,7,3
10028575,20140321,Trastuzumab,72,801,72.0,2,70.5,1,0,0,0,0,0,1,Trastuzumab,LAPATINIB|CARBOPLATIN|TRASTUZUMAB|VALACYCLOVIR HYDROCHLORIDE|PANTOPRAZOLE SODIUM,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Rash|Abdominal discomfort|Frequent bowel movements|Increased tendency to bruise|Asthenia|Dizziness|Decreased appetite|Fatigue|Visual impairment|Dysphagia|Stomatitis|Nausea|Diarrhoea|Feeling abnormal|Mucosal inflammation,15,1
10029364,20140322,Trastuzumab,,,,0,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,HER-2 POSITIVE BREAST CANCER,Breast cancer metastatic,1,1
10029453,20140322,Trastuzumab,53,801,53.0,2,,1,1,1,1,1,1,1,Trastuzumab,LETROZOLE|LETROZOLE TABLETS|LAPATINIB|FULVESTRANT|CAPECITABINE|TRASTUZUMAB|TRASTUZUMAB,8,Breast cancer metastatic|Breast cancer metastatic|Breast cancer metastatic|Breast cancer metastatic|Breast cancer metastatic|Breast cancer metastatic,Breast cancer metastatic|Malignant neoplasm progression|Metastases to liver|Metastases to lymph nodes|Palmar-plantar erythrodysaesthesia syndrome|Asthenia,6,3
10029475,20140322,Trastuzumab,46,801,46.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|CAPECITABINE|PACLITAXEL|GEMCITABINE HYDROCHLORIDE|GEMCITABINE,5,BREAST CANCER,Neoplasm,1,1
10029644,20140320,Trastuzumab,63,801,63.0,2,57.15,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,BREAST CANCER METASTATIC,Dyspnoea,1,1
10029982,20140323,Trastuzumab,51,801,51.0,2,,1,0,0,0,0,0,0,Trastuzumab,TRASTUZUMAB|PERTUZUMAB|LORAZEPAM|ZOLPIDEM TARTRATE,8,GROWTH OF EYELASHES|CHEMOTHERAPY|CHEMOTHERAPY|BREAST CANCER|BREAST CANCER|ANXIETY|SLEEP DISORDER|OCULAR HYPERAEMIA,Inappropriate schedule of drug administration|Wrong technique in drug usage process|Drug administered at inappropriate site|Incorrect dose administered|Madarosis|Madarosis|Trichorrhexis|Hair growth abnormal,8,5
10030963,20140324,Trastuzumab,55,801,55.0,2,,1,0,1,0,0,0,0,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER METASTATIC,Neuralgia,1,2
10030982,20140324,Trastuzumab,58,801,58.0,2,,1,1,1,0,0,0,0,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER METASTATIC,Death|Cardiac arrest|Respiratory arrest|Dyspnoea|Hypersensitivity,5,5
10031294,20140324,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Metastases to bone,1,2
10031313,20140324,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Metastases to bone,1,2
10031339,20140324,Trastuzumab,45,801,45.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Fungal infection,1,5
10031438,20140324,Trastuzumab,20,801,20.0,2,48.6,1,0,1,0,0,0,0,Trastuzumab,BECLOMETHASONE DIPROPIONATE,9,BREAST CANCER METASTATIC|PYREXIA|PARONYCHIA|PARONYCHIA|CONSTIPATION|NEUROPATHY PERIPHERAL|STOMATITIS|CONJUNCTIVITIS ALLERGIC|RHINITIS ALLERGIC,Duodenal ulcer,1,1
10031573,20140324,Trastuzumab,41,801,41.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|PACLITAXEL|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|LEVETIRACETAM|CETIRIZINE HYDROCHLORIDE,20,HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Photosensitivity reaction,1,1
10031778,20140324,Trastuzumab,,,,0,,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER METASTATIC,Cardiotoxicity,1,2
10032882,20140324,Trastuzumab,64,801,64.0,0,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|DENOSUMAB,6,BREAST CANCER,Exposed bone in jaw,1,1
10033296,20140324,Trastuzumab,,,,0,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,3,METASTATIC NEOPLASM|METASTATIC NEOPLASM|METASTATIC NEOPLASM,Disease progression,1,1
10033313,20140325,Trastuzumab,,,,2,,1,0,0,0,0,0,0,Trastuzumab,TRASTUZUMAB|PERTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|PACLITAXEL,4,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Disease progression,1,2
10033382,20140325,Trastuzumab,51,801,51.0,2,47,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB,3,BREAST CANCER|BREAST CANCER,Toxic skin eruption,1,2
10033894,20140325,Trastuzumab,50,801,50.0,2,,1,0,1,0,0,0,0,Trastuzumab,"TRASTUZUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|AMISULPRIDE",8,BREAST CANCER METASTATIC|VENOUS THROMBOSIS|DEPRESSION|DEPRESSION|DEPRESSION,Hypersensitivity vasculitis|Arthralgia|Erythema|Petechiae|Vasculitis|Ecchymosis,6,1
10033908,20140325,Trastuzumab,43,801,43.0,2,73,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|CAPECITABINE,5,BREAST CANCER|BREAST CANCER|LYMPHOEDEMA|LYMPHOEDEMA|LYMPHOEDEMA,Inflammation|Breast ulceration|Metastases to breast|Myalgia|Peripheral swelling|Fall|Mobility decreased|Hypoaesthesia|Asthenia,9,5
10034115,20140321,Trastuzumab,35,801,35.0,2,77.16,1,1,1,0,0,0,0,Trastuzumab,LAPATINIB|DENOSUMAB|PACLITAXEL|TRASTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Breast cancer metastatic|Ascites|Metastases to central nervous system|Disease recurrence|Deafness unilateral|Hydrocephalus|Vertigo|Nausea|Dizziness|Balance disorder|Muscular weakness|Hypoaesthesia|Hepatic enzyme increased,13,3
10034146,20140325,Trastuzumab,,,,2,,1,1,0,0,0,0,0,Trastuzumab,PERTUZUMAB|TRASTUZUMAB|CANDESARTAN CILEXETIL,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|PAIN,Pain|Abnormal behaviour,2,1
10034756,20140325,Trastuzumab,,,,0,,1,0,0,0,0,0,1,Trastuzumab,LEUPROLIDE ACETATE|LETROZOLE|TRASTUZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pulmonary hypertension,1,5
10035699,20140325,Trastuzumab,40,801,40.0,2,60,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB,3,HER-2 POSITIVE BREAST CANCER,Pericardial effusion|Pleural effusion|Metastases to heart,3,1
10036184,20140325,Trastuzumab,44,801,44.0,2,96,1,0,1,0,0,0,1,Trastuzumab,DENOSUMAB,11,BREAST CANCER METASTATIC|METASTASES TO BONE|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BONE PAIN|METASTASES TO BONE|METASTASES TO BONE,Post procedural infection|Osteonecrosis,2,3
10036484,20140326,Trastuzumab,,,,0,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Breast cancer metastatic,1,1
10037057,20140326,Trastuzumab,73,801,73.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER METASTATIC,Disease progression,1,5
10037416,20140326,Trastuzumab,,,,2,83.9,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PERTUZUMAB|LETROZOLE|EXEMESTANE|FULVESTRANT|VENLAFAXINE HYDROCHLORIDE|PREGABALIN,11,PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Neuropathy peripheral|Diastolic dysfunction|Mitral valve incompetence|Aortic valve sclerosis|Pulmonary hypertension|Tricuspid valve incompetence|Disease progression|Hypoaesthesia,8,1
10037570,20140326,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Pain in extremity,1,2
10038493,20140326,Trastuzumab,53,801,53.0,2,63,1,0,0,0,0,0,1,Trastuzumab,CAPECITABINE|LAPATINIB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,4,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Diarrhoea|Nausea|Febrile neutropenia|Vomiting|Palmar-plantar erythrodysaesthesia syndrome|Disease progression,6,1
10039836,20140326,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,DOXORUBICIN|TRASTUZUMAB,2,BREAST CANCER|BREAST CANCER,Ejection fraction decreased|Myocardial strain,2,1
10040205,20140327,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Metastases to breast|Fatigue|Nausea|Diarrhoea,4,3
10040235,20140327,Trastuzumab,,,,0,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,HER-2 POSITIVE BREAST CANCER,Disease progression,1,1
10040472,20140327,Trastuzumab,63,801,63.0,2,,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|METHYLPREDNISOLONE|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|ALPRAZOLAM|AMLODIPINE|OXYCODONE HYDROCHLORIDE,15,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Dermo-hypodermitis,1,1
10040486,20140327,Trastuzumab,74,801,74.0,2,68,1,0,1,0,0,0,0,Trastuzumab,"TRASTUZUMAB|TRASTUZUMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PACLITAXEL|PERTUZUMAB|PERTUZUMAB",7,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Pleural infection,1,1
10040778,20140327,Trastuzumab,,,,0,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION,Pain in extremity,1,2
10041528,20140327,Trastuzumab,54,801,54.0,2,50,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,2,METASTASES TO BONE|BREAST CANCER,Osteonecrosis of jaw|Erythema|Pain,3,1
10042395,20140327,Trastuzumab,46,801,46.0,1,60,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,2,BREAST NEOPLASM|BREAST NEOPLASM,Dermatitis,1,5
10042923,20140328,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,RIBAVIRIN|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,HEPATITIS C|BREAST CANCER|BREAST CANCER,Neutropenia|Hepatotoxicity,2,3
10042935,20140328,Trastuzumab,72,801,72.0,2,,1,0,0,0,0,0,1,Trastuzumab,"CARBOPLATIN|DOCETAXEL|DOCETAXEL ANHYDROUS|LAPATINIB|LAPATINIB|TRASTUZUMAB|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|PRILOCAINE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|VALACYCLOVIR HYDROCHLORIDE|PANTOPRAZOLE SODIUM|PROCHLORPERAZINE",12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Rash|Abdominal discomfort|Frequent bowel movements|Increased tendency to bruise|Asthenia|Dizziness|Decreased appetite|Fatigue|Visual impairment|Dysphagia|Stomatitis|Nausea|Diarrhoea|Feeling abnormal|Mucosal inflammation|Drug intolerance,16,
10042968,20140328,Trastuzumab,81,801,81.0,2,51.7,1,0,0,0,0,0,0,Trastuzumab,DENOSUMAB|DENOSUMAB|DENOSUMAB|BIOTIN|FOLIC ACID|SELENIUM|TRASTUZUMAB,10,PRODUCT USED FOR UNKNOWN INDICATION,Myalgia,1,1
10043201,20140328,Trastuzumab,45,801,45.0,2,54,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER METASTATIC,Corneal exfoliation|Lacrimation decreased|Keratitis,3,1
10043212,20140328,Trastuzumab,55,801,55.0,2,,1,0,0,0,0,0,1,Trastuzumab,LETROZOLE|LETROZOLE TABLETS|TRASTUZUMAB,2,BREAST CANCER FEMALE,Ventricular hypokinesia|Ventricular dyskinesia|Ejection fraction decreased,3,3
10043481,20140328,Trastuzumab,,,,2,,1,1,0,1,0,0,0,Trastuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,2,BREAST CANCER|BREAST CANCER,Disease progression,1,1
10043713,20140328,Trastuzumab,,,,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Colitis,1,3
10044364,20140328,Trastuzumab,56,801,56.0,2,,1,1,0,0,0,0,0,Trastuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN|CARBOPLATIN|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|BEVACIZUMAB|BEVACIZUMAB,9,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Acute lymphocytic leukaemia,1,1
10044454,20140328,Trastuzumab,72,801,72.0,2,60.4,1,0,1,0,0,0,0,Trastuzumab,CAPECITABINE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|TRASTUZUMAB|OXYCODONE HYDROCHLORIDE|CISPLATIN|MANNITOL|TRASTUZUMAB|OXYCODONE HYDROCHLORIDE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|OLANZAPINE|OLANZAPINE PAMOATE|CAPECITABINE|LUBIPROSTONE|CISPLATIN|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|OXYCODONE HYDROCHLORIDE,37,NAUSEA|DIARRHOEA|INFUSION RELATED REACTION|HYPERTENSION|GASTROINTESTINAL INFLAMMATION|HER2 POSITIVE GASTRIC CANCER|DEHYDRATION|GASTROINTESTINAL INFLAMMATION|INFUSION RELATED REACTION|INFUSION RELATED REACTION|STOMATITIS|NAUSEA|NAUSEA|INFECTION|GASTROINTESTINAL INFLAMMATION|ABDOMINAL PAIN|CONSTIPATION|INSOMNIA|GASTROINTESTINAL DISORDER PROPHYLAXIS|NAUSEA|INFUSION RELATED REACTION|NAUSEA|HER2 POSITIVE GASTRIC CANCER|HER2 POSITIVE GASTRIC CANCER|STOMATITIS|NAUSEA|GASTROINTESTINAL INFLAMMATION|CONSTIPATION|CONSTIPATION|HER2 POSITIVE GASTRIC CANCER|GASTROINTESTINAL INFLAMMATION,Gastrointestinal inflammation|Decreased appetite,2,1
10044515,20140328,Trastuzumab,55,801,55.0,2,110,1,1,1,1,1,1,1,Trastuzumab,"PACLITAXEL|PACLITAXEL|DOCETAXEL|DOCETAXEL ANHYDROUS|LETROZOLE|LETROZOLE TABLETS|CAPECITABINE|CAPECITABINE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|LAPATINIB|LAPATINIB|VINORELBINE|VINORELBINE",17,Invasive ductal breast carcinoma|Breast cancer metastatic|Breast cancer metastatic|Invasive ductal breast carcinoma|Breast cancer metastatic|Invasive ductal breast carcinoma|Invasive ductal breast carcinoma|Breast cancer metastatic|Breast cancer metastatic|Invasive ductal breast carcinoma|Breast cancer metastatic|Invasive ductal breast carcinoma|Breast cancer metastatic|Product used for unknown indication,Breast cancer metastatic|Lymphangiosis carcinomatosa|Metastases to central nervous system|Metastases to lung|Malignant neoplasm progression|Osteosclerosis|Bone lesion|Pleural effusion|Dyspnoea|Cough|Diarrhoea|Oedema peripheral|Decreased appetite|Fatigue,14,3
10045882,20140329,Trastuzumab,48,801,48.0,2,60,1,0,0,0,0,0,1,Trastuzumab,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",2,HER-2 POSITIVE BREAST CANCER,Drug-induced liver injury,1,1
10046049,20140331,Trastuzumab,86,801,86.0,2,,1,1,0,0,0,0,1,Trastuzumab,CAPECITABINE|TRASTUZUMAB,2,BREAST CANCER METASTATIC|BREAST CANCER,Disease progression|Dry skin|Skin exfoliation,3,1
10046078,20140331,Trastuzumab,56,801,56.0,2,,1,0,0,0,0,0,1,Trastuzumab,"TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|CISPLATIN|CISPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|LAPATINIB|LAPATINIB|CAPECITABINE|DOXORUBICIN HYDROCHLORIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PACLITAXEL|GEMCITABINE HYDROCHLORIDE|GEMCITABINE",20,BREAST CANCER|BREAST CANCER|BREAST CANCER,Disease progression,1,1
10046224,20140331,Trastuzumab,53,801,53.0,2,,1,1,0,0,0,0,0,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,2,BREAST CANCER,Death,1,5
10046700,20140331,Trastuzumab,,,,0,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PACLITAXEL,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10046734,20140331,Trastuzumab,46,801,46.0,2,113.23,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|CARBOPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Failure to thrive,1,1
10046736,20140331,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Metastases to central nervous system,1,5
10046850,20140331,Trastuzumab,70,801,70.0,2,,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB|TRASTUZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Blood creatinine abnormal,2,1
10048534,20140331,Trastuzumab,78,801,78.0,2,,1,0,0,0,1,0,0,Trastuzumab,TRASTUZUMAB|ANASTROZOLE|ANASTROZOLE TABLETS,5,BREAST CANCER,Trismus|Osteonecrosis of jaw|Pain in jaw,3,3
10049131,20140401,Trastuzumab,63,801,63.0,2,,1,0,0,0,0,0,1,Trastuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|OLMESARTAN MEDOXOMIL,4,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Ventricular hypokinesia|Ejection fraction decreased|Disease progression|Chest discomfort|Dyspnoea|Ejection fraction decreased|Ventricular hypokinesia|Hypokinesia,8,5
10049156,20140401,Trastuzumab,55,801,55.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|EXEMESTANE,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Lymphadenopathy,1,1
10049173,20140401,Trastuzumab,,,,2,77,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|LETROZOLE|ASPIRIN|SPIRONOLACTONE,6,BREAST CANCER,Diarrhoea|Colitis|Dehydration|Atrial fibrillation,4,1
10049354,20140401,Trastuzumab,54,801,54.0,2,45,1,1,0,0,0,0,0,Trastuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB,6,BREAST CANCER|BREAST CANCER|BREAST CANCER,Vomiting|Renal failure acute,2,1
10049412,20140401,Trastuzumab,75,801,75.0,1,,1,0,1,0,0,0,0,Trastuzumab,CAPECITABINE|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|PACLITAXEL|PACLITAXEL|PACLITAXEL,9,GASTRIC CANCER RECURRENT|GASTRIC CANCER RECURRENT|GASTRIC CANCER RECURRENT|GASTRIC CANCER RECURRENT|GASTRIC CANCER RECURRENT|GASTRIC CANCER RECURRENT|GASTRIC CANCER,Liver disorder|Neutrophil count increased|C-reactive protein increased,3,2
10049447,20140401,Trastuzumab,45,801,45.0,2,60,1,1,1,1,0,0,0,Trastuzumab,PREGABALIN|METRONIDAZOLE|METRONIDAZOLE TOPICAL|AMOXICILLIN|TRASTUZUMAB|CALCIUM CARBONATE|ANTACID,9,PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER,Acute hepatic failure|Hepatitis B,2,1
10049467,20140401,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|LAPATINIB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10050311,20140401,Trastuzumab,62,801,62.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PACLITAXEL,12,RASH MACULO-PAPULAR|BONE LESION|CANCER PAIN|OSTEONECROSIS OF JAW|PROPHYLAXIS|OSTEONECROSIS OF JAW|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|CONSTIPATION|PROPHYLAXIS,Alopecia|Osteonecrosis of jaw|Influenza like illness,3,1
10050357,20140401,Trastuzumab,69,801,69.0,2,50,1,0,1,0,0,0,0,Trastuzumab,FULVESTRANT|TRASTUZUMAB|DENOSUMAB|LETROZOLE|DOCETAXEL|DOCETAXEL ANHYDROUS,14,METASTASES TO BONE,Osteomyelitis|Cellulitis|Hypocalcaemia|Hypoproteinaemia|Hypoalbuminaemia,5,1
10051770,20140402,Trastuzumab,,,,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,HER-2 POSITIVE BREAST CANCER,White blood cell count decreased,1,5
10051819,20140402,Trastuzumab,70,801,70.0,2,88.9,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE|TRASTUZUMAB|CAPECITABINE|EXEMESTANE|LETROZOLE|LAPATINIB|RAMIPRIL|BISOPROLOL FUMARATE|DESVENLAFAXINE SUCCINATE|VITAMIN E,17,BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Ejection fraction decreased|Drug ineffective|Disease progression|Lacrimation increased|Rhinorrhoea|Headache|Asthenopia,7,5
10051830,20140402,Trastuzumab,48,801,48.0,2,,1,0,0,0,0,0,1,Trastuzumab,"ADO-TRASTUZUMAB EMTANSINE|ADO-TRASTUZUMAB EMTANSINE|ADO-TRASTUZUMAB EMTANSINE|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|BEVACIZUMAB|CAPECITABINE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|CISPLATIN|METHOTREXATE|METHOTREXATE SODIUM",15,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Disease progression|Metastases to central nervous system|Metastases to skin|Skin disorder|Infection|No therapeutic response|Pneumonia|Thrombocytopenia|Urinary tract infection,9,3
10052025,20140402,Trastuzumab,49,801,49.0,2,54.93,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|LEVOTHYROXINE SODIUM,3,BREAST CANCER|THYROID DISORDER,Gastroenteritis viral|Weight decreased|White blood cell count decreased|Urinary tract infection|Fatigue|Diarrhoea|Dehydration|Gastrointestinal inflammation|Asthenia|Vomiting|Candida infection|Heart rate irregular|Fungal infection,13,5
10052030,20140402,Trastuzumab,42,801,42.0,2,120.8,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER FEMALE,Malaise|Headache|Visual impairment,3,3
10052156,20140402,Trastuzumab,61,801,61.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|CAPECITABINE|PACLITAXEL|VINORELBINE|EXEMESTANE|LAPATINIB,8,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Metastases to liver|Disease progression,2,1
10052159,20140402,Trastuzumab,29,801,29.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|CAPECITABINE|PACLITAXEL|CISPLATIN|LAPATINIB,9,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER|BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Breast cancer recurrent|Metastases to lung|Metastases to breast|Metastases to lymph nodes|Metastases to liver|Disease progression|Left ventricular failure,7,1
10052166,20140402,Trastuzumab,47,801,47.0,1,55,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB|CISPLATIN|CAPECITABINE,3,HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER,Cardiac arrest,1,1
10052477,20140402,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Thrombocytopenia,1,5
10052936,20140331,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,RIBAVIRIN|TRASTUZUMAB,4,ANTIVIRAL TREATMENT|ANTIVIRAL TREATMENT|CHEMOTHERAPY|CHEMOTHERAPY,Neutropenia|Hepatotoxicity,2,
10055184,20140402,Trastuzumab,50,801,50.0,2,49,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Respiratory disorder,1,3
10055260,20140403,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Myocardial infarction|Cardiomyopathy|Brain neoplasm,3,5
10055602,20140403,Trastuzumab,46,801,46.0,2,110,1,0,1,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,4,BREAST CANCER|PREMEDICATION|PREMEDICATION,Dysphagia|Personality change|Headache|Nausea|Medication error|Nervous system disorder,6,3
10055637,20140403,Trastuzumab,52,801,52.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|LEVOTHYROXINE SODIUM|LEVETIRACETAM,3,BREAST CANCER,Metastases to central nervous system,1,5
10055907,20140403,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,"TRASTUZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DOCETAXEL|DOCETAXEL ANHYDROUS|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CARBOPLATIN|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|TRASTUZUMAB|FILGRASTIM|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DIPHENHYDRAMINE HYDROCHLORIDE|CARBOPLATIN|FAMOTIDINE",17,BREAST CANCER FEMALE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Platelet count decreased|Fatigue|Pain,3,1
10056009,20140401,Trastuzumab,41,801,41.0,2,,1,0,1,0,0,0,0,Trastuzumab,"PAROXETINE HYDROCHLORIDE|TRASTUZUMAB|PACLITAXEL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|HYDROXYZINE HYDROCHLORIDE|HYDROXYZINE|HYDROXYZINE HYDROCHLORIDE ORAL|SILVER SULFADIAZINE|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|PREDNISONE|SPIRONOLACTONE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|DOCETAXEL|DOCETAXEL ANHYDROUS",13,PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Photosensitivity reaction|Oedema|Rash|Blister|Blister|Wound secretion|Toxic skin eruption|Ectropion|Eosinophilia,9,5
10057519,20140403,Trastuzumab,45,801,45.0,2,,1,1,0,0,0,0,0,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER METASTATIC,Death,1,1
10057531,20140404,Trastuzumab,52,801,52.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER STAGE IV,Chest discomfort|Dyspnoea|Feeling cold,3,1
10057551,20140404,Trastuzumab,59,801,59.0,2,,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB,14,BREAST CANCER|BREAST CANCER|BREAST CANCER,Interstitial lung disease|Stomatitis|Metastases to lymph nodes|Hypoaesthesia|Rash,5,1
10057596,20140404,Trastuzumab,78,801,78.0,2,,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Oedema peripheral|Pulmonary oedema|Congestive cardiomyopathy|Hypertension|Hypotension|Erysipelas,6,5
10057819,20140404,Trastuzumab,57,801,57.0,2,,1,0,0,1,0,0,0,Trastuzumab,"TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|INSULIN LISPRO|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|OFLOXACIN|OFLOXACIN OTIC|OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3%|OFLOXACIN OTIC SOLUTION|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|INSULIN DETEMIR|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB|INSULIN DETEMIR|FLUCONAZOLE|LORATADINE|LORATADINE ORAL|ENALAPRIL|ROSUVASTATIN|PROMETHAZINE HYDROCHLORIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE",53,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Acute kidney injury,1,1
10057837,20140404,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,HER-2 POSITIVE BREAST CANCER,Breast neoplasm|Hysterectomy,2,5
10057846,20140404,Trastuzumab,,,,2,83.9,1,1,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PACLITAXEL|VITAMIN E|LEVOTHYROXINE SODIUM|VITAMIN A|EXEMESTANE|LETROZOLE|RISEDRONATE SODIUM|TRASTUZUMAB|LAPATINIB|CAPECITABINE|CISPLATIN,14,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Disease progression|Drug ineffective|Drug ineffective|Lung lobectomy|Drug ineffective,5,1
10057902,20140404,Trastuzumab,61,801,61.0,2,56,1,0,1,1,0,0,0,Trastuzumab,PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,8,BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|METASTASES TO BONE|BREAST CANCER RECURRENT|HYPOTHYROIDISM,Shock,1,1
10057905,20140404,Trastuzumab,,,,1,,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE|CAPECITABINE|TRASTUZUMAB|TRASTUZUMAB|LAPATINIB,8,HER-2 POSITIVE BREAST CANCER|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|OSTEOPOROSIS|METASTASES TO BONE,Fatigue|Cardiotoxicity|Drug ineffective,3,1
10058270,20140404,Trastuzumab,71,801,71.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|DOCETAXEL|DOCETAXEL ANHYDROUS|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|TOLTERODINE TARTRATE|CANDESARTAN CILEXETIL,9,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Metastases to liver|Metastases to spine|Anxiety|Infusion related reaction|Epistaxis|Hypoaesthesia|Nasopharyngitis|Constipation|Nausea|Blood pressure increased|Decreased appetite,11,3
10058271,20140404,Trastuzumab,,,,0,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|CISPLATIN,3,HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER,Bone marrow failure,1,1
10058272,20140404,Trastuzumab,63,801,63.0,2,,1,0,1,0,0,0,0,Trastuzumab,ALPRAZOLAM|PERTUZUMAB|METHYLPREDNISOLONE|OXYCODONE HYDROCHLORIDE|TRASTUZUMAB,13,HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Dermo-hypodermitis,1,3
10058350,20140404,Trastuzumab,45,801,45.0,2,81,1,0,0,0,1,0,0,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB,3,BREAST CANCER,Arthralgia|Mass,2,3
10058399,20140404,Trastuzumab,,,,2,64.92,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB,4,BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Rash|White blood cell count increased|Metastases to liver,3,5
10060662,20140404,Trastuzumab,37,801,37.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|GOSERELIN,3,BREAST CANCER|BREAST CANCER,Embolism,1,1
10060985,20140405,Trastuzumab,,,,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Chest discomfort|Pain,3,3
10061006,20140405,Trastuzumab,,,,2,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10061151,20140406,Trastuzumab,,,,0,,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,PRODUCT USED FOR UNKNOWN INDICATION,Cerebral haemorrhage,1,2
10061223,20140407,Trastuzumab,74,801,74.0,2,64,1,0,1,0,0,0,0,Trastuzumab,,2,HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Transient ischaemic attack|Transient ischaemic attack,2,1
10061240,20140407,Trastuzumab,37,801,37.0,2,,1,0,0,0,0,0,1,Trastuzumab,ARIPIPRAZOLE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREGABALIN|TRASTUZUMAB|VENLAFAXINE HYDROCHLORIDE|LEVOTHYROXINE SODIUM|BUPROPION HYDROCHLORIDE|PERTUZUMAB|MORPHINE,12,BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Hypoaesthesia|Diarrhoea|Swelling face|Malignant neoplasm progression|Neutrophil count increased|Blood bilirubin decreased|Fatigue|Lymphocyte count decreased|Toxicity to various agents|White blood cell count increased|Paraesthesia,11,3
10061330,20140407,Trastuzumab,,,,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Major depression|Suicidal ideation,2,1
10061345,20140407,Trastuzumab,53,801,53.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|SIMVASTATIN,7,BREAST CANCER|BREAST CANCER,Neutropenia|Drug interaction,2,2
10061521,20140407,Trastuzumab,,,,2,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Metastases to liver,1,3
10061528,20140407,Trastuzumab,38,801,38.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|LAPATINIB|LAPATINIB|LAPATINIB|PACLITAXEL,5,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Blood bilirubin increased|Alanine aminotransferase increased,2,1
10061546,20140407,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Confusional state|Herpes zoster|Weight decreased|Dizziness,4,3
10061585,20140407,Trastuzumab,,,,2,,1,1,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Death|Infection,2,1
10061616,20140407,Trastuzumab,58,801,58.0,2,,1,0,0,0,0,0,0,Trastuzumab,"TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|CAPECITABINE|LAPATINIB|EXEMESTANE|VINORELBINE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PACLITAXEL",10,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER|BREAST CANCER|BREAST CANCER,Drug resistance|Fatigue,2,3
10061970,20140407,Trastuzumab,68,801,68.0,2,70,1,1,0,0,0,0,0,Trastuzumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FUROSEMIDE,15,HER-2 POSITIVE BREAST CANCER,Multiple organ dysfunction syndrome,1,1
10062147,20140407,Trastuzumab,,,,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Hip arthroplasty,1,3
10063821,20140408,Trastuzumab,,,,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Convulsion,1,3
10063833,20140408,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Breast mass,1,3
10063992,20140408,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|LETROZOLE|LETROZOLE TABLETS|CELECOXIB|LEVOTHYROXINE SODIUM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|VENLAFAXINE HYDROCHLORIDE,9,PRODUCT USED FOR UNKNOWN INDICATION,Hypothyroidism|Lymphadenopathy|Disease progression|Drug ineffective,4,3
10064013,20140408,Trastuzumab,58,801,58.0,2,48,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,2,BREAST CANCER|BREAST CANCER,Cystoid macular oedema|Visual acuity reduced,2,1
10064015,20140408,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Metastases to ovary|Pain,2,3
10064016,20140408,Trastuzumab,,,,2,,1,0,0,1,0,0,0,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Convulsion|Syncope|Suspected counterfeit product,3,3
10064046,20140408,Trastuzumab,38,801,38.0,1,77,1,0,1,0,0,0,0,Trastuzumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,HER-2 POSITIVE GASTRIC CANCER|PREMEDICATION|PREMEDICATION,Upper gastrointestinal haemorrhage,1,1
10064049,20140408,Trastuzumab,55,801,55.0,2,,1,0,0,0,0,0,1,Trastuzumab,FILGRASTIM|TRASTUZUMAB|CARBOPLATIN,4,PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|BREAST CANCER|BREAST CANCER,Bone pain|Myalgia,2,1
10064071,20140408,Trastuzumab,35,801,35.0,2,88,1,0,1,1,0,0,0,Trastuzumab,OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|LEVOTHYROXINE|BEVACIZUMAB|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|TRASTUZUMAB|BEVACIZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN,10,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Febrile neutropenia|Abdominal discomfort|Colitis,3,3
10064173,20140408,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER METASTATIC,Jaundice|Abdominal distension,2,5
10064450,20140408,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Ejection fraction decreased|Cardiovascular insufficiency|Supraventricular tachycardia|Heart valve incompetence|Atrioventricular block|Coronary artery disease|Arrhythmia,7,1
10064520,20140408,Trastuzumab,72,801,72.0,0,,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|PREGABALIN,5,BREAST CANCER|BREAST CANCER,Dyspnoea|Panic attack,2,1
10064629,20140408,Trastuzumab,44,801,44.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|VINORELBINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|CISPLATIN,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Tumour lysis syndrome,1,1
10066276,20140408,Trastuzumab,44,801,44.0,2,,1,1,0,0,0,0,0,Trastuzumab,PACLITAXEL|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,6,INFLAMMATORY CARCINOMA OF BREAST STAGE IV|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BONE PAIN,Inflammatory carcinoma of breast stage IV|Haematotoxicity|Musculoskeletal discomfort|Neuropathy peripheral,4,3
10066886,20140408,Trastuzumab,72,801,72.0,2,,1,1,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|CARBOPLATIN,3,ADJUVANT THERAPY|ADJUVANT THERAPY|ADJUVANT THERAPY,Duodenal ulcer perforation|Pancreatitis,2,1
10066930,20140409,Trastuzumab,47,801,47.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Rectal haemorrhage|Asthenia|Dyspnoea exertional|Dizziness|Epistaxis|Headache|Arthralgia|Fatigue|Asthenia|Back pain,10,3
10066935,20140409,Trastuzumab,47,801,47.0,2,63,1,0,1,0,0,0,0,Trastuzumab,MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|PROPOFOL,9,HER-2 POSITIVE BREAST CANCER|OROPHARYNGEAL PAIN|ENDOSCOPY|ARTHRALGIA|ENDOSCOPY|INSOMNIA|HEADACHE|HER-2 POSITIVE BREAST CANCER|ENDOSCOPY,Gastric ulcer,1,1
10066937,20140409,Trastuzumab,65,801,65.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB,10,BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Sepsis,1,1
10067014,20140409,Trastuzumab,77,801,77.0,1,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB|CAPECITABINE|OXALIPLATIN|CISPLATIN,4,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Influenza|Myalgia,2,1
10067097,20140409,Trastuzumab,39,801,39.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,2,BREAST CANCER|BREAST CANCER,Cerebral infarction|Endocarditis,2,1
10067100,20140409,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Bone marrow failure|Blood disorder|Nausea|Diarrhoea|Asthenia|Decreased appetite,6,1
10067345,20140409,Trastuzumab,58,801,58.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|CAPECITABINE|LAPATINIB|LETROZOLE,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression|Liver disorder,2,1
10067361,20140409,Trastuzumab,69,801,69.0,2,66.6,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|CAPECITABINE|TRASTUZUMAB|TRASTUZUMAB,4,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Diverticulum,1,1
10067404,20140409,Trastuzumab,70,801,70.0,0,,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|SIMVASTATIN,5,BREAST CANCER|BREAST CANCER,Atrial fibrillation,1,1
10067405,20140409,Trastuzumab,64,801,64.0,1,,1,1,1,0,0,0,0,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE|DENOSUMAB,2,BREAST CANCER METASTATIC|METASTASES TO BONE,Metastases to pancreas|Cholestasis,2,1
10067758,20140409,Trastuzumab,48,801,48.0,2,81,1,0,1,0,0,0,0,Trastuzumab,BISOPROLOL FUMARATE|BISOPROLOL FUMARATE|BISOPROLOL FUMARATE,6,HER-2 POSITIVE BREAST CANCER,Renal cell carcinoma|Ovarian cancer,2,1
10067867,20140409,Trastuzumab,37,801,37.0,2,,1,0,1,0,0,0,0,Trastuzumab,CARBOPLATIN|TRASTUZUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|AMOXICILLIN AND CLAVULANATE POTASSIUM|AMOXICILLIN AND CLAVULANATE POTASSIUM,9,BRONCHITIS|BREAST CANCER|BREAST CANCER|BREAST CANCER|PREMEDICATION|URINARY TRACT INFECTION|URINARY TRACT INFECTION|BRONCHITIS|PREMEDICATION,Haemolytic anaemia|Anaemia,2,3
10067885,20140409,Trastuzumab,61,801,61.0,2,62,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,2,HER-2 POSITIVE BREAST CANCER,Arachnoiditis|Confusional state|Haemorrhage intracranial|Hydrocephalus|Headache|Somnolence,6,1
10068633,20140409,Trastuzumab,85,801,85.0,2,57,1,0,0,0,0,0,1,Trastuzumab,LAPATINIB|CAPECITABINE|TRASTUZUMAB,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Atrioventricular block second degree|Peripheral arterial occlusive disease|Palmar-plantar erythrodysaesthesia syndrome,3,2
10068945,20140409,Trastuzumab,43,801,43.0,2,,1,0,1,0,0,0,1,Trastuzumab,METFORMIN HCL|TRASTUZUMAB|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|SIMVASTATIN,5,METASTASES TO MENINGES,Ataxia|Headache|Asthenia|Paraesthesia|Aphasia|Meningitis aseptic|Decreased appetite|Vomiting,8,5
10069360,20140410,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|CAPECITABINE|LEVOTHYROXINE SODIUM|PREGABALIN|CANDESARTAN CILEXETIL|TEMAZEPAM|LAPATINIB,11,BREAST CANCER|BREAST CANCER,Thrombosis|Metastases to lung|Metastases to spine,3,5
10069371,20140410,Trastuzumab,65,801,65.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE,8,BREAST CANCER|BREAST CANCER,Lung disorder,1,1
10069436,20140410,Trastuzumab,75,801,75.0,2,,1,0,1,0,0,0,0,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE|TRASTUZUMAB,2,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Cardiac failure congestive|Drug ineffective|Hypertensive crisis,3,1
10069730,20140410,Trastuzumab,64,801,64.0,2,38,1,0,1,0,0,0,0,Trastuzumab,,2,BREAST CANCER,Dyspnoea|Disease progression|Platelet count decreased|Herpes zoster|Anaemia|Aspartate aminotransferase increased|Blood alkaline phosphatase increased|Alanine aminotransferase increased,8,1
10069734,20140410,Trastuzumab,47,801,47.0,2,73.55,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE|DENOSUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,6,BREAST CANCER METASTATIC|METASTASES TO BONE|OVARIAN FAILURE|NUTRITIONAL SUPPLEMENTATION|NAUSEA,Eye haemorrhage|Corneal disorder|Dry eye|Metastases to bone|Metastases to central nervous system,5,3
10069735,20140410,Trastuzumab,70,801,70.0,2,,1,0,1,0,0,0,0,Trastuzumab,"TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|ACYCLOVIR|AMILORIDE HYDROCHLORIDE|CEFPROZIL|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|ROSUVASTATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MORPHINE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SENNOSIDES|SENNA LEAF|SENNA|SPIRONOLACTONE|CALCIUM CARBONATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",19,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Arthralgia|Bone pain|Neutropenic sepsis|Oral pain,4,1
10069949,20140410,Trastuzumab,40,801,40.0,2,,1,0,1,0,0,0,0,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER METASTATIC,Tachycardia|Body temperature increased|Cough|Feeling cold|Chills,5,3
10069991,20140410,Trastuzumab,69,801,69.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|HYDROXYCHLOROQUINE SULFATE,4,BREAST CANCER|PAIN,Systemic lupus erythematosus,1,1
10069994,20140410,Trastuzumab,59,801,59.0,2,41.2,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB|CAPECITABINE|ESOMEPRAZOLE MAGNESIUM,9,BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER|BREAST CANCER|DECREASED APPETITE|BREAST CANCER METASTATIC|DECREASED APPETITE|HEADACHE,Cystitis haemorrhagic|Cystitis haemorrhagic|Platelet count decreased,3,1
10070433,20140410,Trastuzumab,46,801,46.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN|CIMETIDINE|ALBUTEROL SULFATE|ALBUTEROL|DIVALPROEX SODIUM|SERTRALINE HYDROCHLORIDE|TOPIRAMATE|FOLIC ACID|PREDNISONE,15,BREAST CANCER|BREAST CANCER|BREAST CANCER,Vertigo|Trismus|Device related infection|Neutropenic sepsis,4,3
10070691,20140410,Trastuzumab,29,801,29.0,2,65.35,1,0,1,0,0,0,0,Trastuzumab,ZOLEDRONIC ACID,2,BREAST CANCER METASTATIC|PROPHYLAXIS,Cellulitis,1,1
10071159,20140410,Trastuzumab,57,801,57.0,2,,1,1,0,0,0,0,0,Trastuzumab,FILGRASTIM|TRASTUZUMAB|DENOSUMAB|CARBOPLATIN|DENOSUMAB,12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10071627,20140411,Trastuzumab,63,801,63.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|LEVOTHYROXINE SODIUM|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|ALPRAZOLAM,4,BREAST CANCER|THYROID DISORDER|PAIN,Hip fracture|Osteoporosis,2,5
10071661,20140411,Trastuzumab,53,801,53.0,2,60,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|CAPECITABINE|ADO-TRASTUZUMAB EMTANSINE|LAPATINIB|LETROZOLE|EXEMESTANE|DENOSUMAB,9,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER|METASTASES TO BONE,Disease progression|Spinal pain|Pneumonia|Bronchopneumonia,4,1
10071678,20140411,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,CAPECITABINE|TRASTUZUMAB|TRASTUZUMAB,3,GASTRIC CANCER|DISEASE PROGRESSION|JAUNDICE,Disease progression|Jaundice|Off label use,3,1
10071707,20140411,Trastuzumab,,,,2,48,1,0,1,1,1,0,0,Trastuzumab,TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN,4,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Large intestine perforation|Neutropenic colitis|Febrile neutropenia|Mucosal inflammation,4,1
10071725,20140411,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|CAPECITABINE|GOSERELIN|LETROZOLE|LETROZOLE TABLETS|LAPATINIB,6,INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA,Carcinoembryonic antigen increased|Carbohydrate antigen 15-3 increased|Metastases to central nervous system|Asthenia|Gait disturbance|Coordination abnormal|Ataxia|Metastases to central nervous system|Disease progression,9,1
10072105,20140411,Trastuzumab,48,801,48.0,2,58,1,0,1,0,0,0,0,Trastuzumab,OLOPATADINE HYDROCHLORIDE|OLOPATADINE HYDROCHLORIDE OPHTHALMIC,6,BREAST CANCER METASTATIC|HYPERLIPIDAEMIA|HYPERURICAEMIA|PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME|CANCER PAIN|SEASONAL ALLERGY,Cardiac failure congestive,1,1
10072129,20140411,Trastuzumab,64,801,64.0,2,68.1,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB|ANASTROZOLE|ANASTROZOLE|DALTEPARIN SODIUM|ALPRAZOLAM|CARBOPLATIN|SIMVASTATIN|LORATADINE|LORATADINE ORAL|TRASTUZUMAB|PERTUZUMAB,14,BREAST CANCER|BREAST CANCER|BLOOD CHOLESTEROL|ANTICOAGULANT THERAPY|ANXIETY|BREAST CANCER|BLOOD CHOLESTEROL INCREASED|BREAST CANCER|BREAST CANCER,Pyrexia|Thrombosis|Fatigue|Hepatic enzyme increased|White blood cell count decreased|Alopecia|Feeling abnormal|Laryngitis|Vision blurred|Ill-defined disorder|Drug intolerance|Pulmonary thrombosis|Thoracic operation|Weight decreased|Nausea|Chest pain|Epistaxis,17,5
10074632,20140414,Trastuzumab,,,,1,,1,0,0,0,0,0,1,Trastuzumab,CISPLATIN|TRASTUZUMAB,3,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Cerebral infarction|Coagulopathy,2,1
10074706,20140414,Trastuzumab,41,801,41.0,2,74,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER METASTATIC,Hypermetropia,1,1
10074991,20140414,Trastuzumab,,,,2,106.69,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,2,BREAST CANCER METASTATIC,Thrombosis in device|Contrast media allergy|Nausea|Muscle spasms|Hypersensitivity,5,5
10075359,20140414,Trastuzumab,51,801,51.0,2,82.63,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER|BREAST CANCER,Oesophageal infection|Lung disorder|Full blood count decreased|Bronchitis|Pneumonia|Weight decreased|Syncope|Loss of consciousness|Electrolyte imbalance,9,5
10076198,20140414,Trastuzumab,34,801,34.0,2,69,1,0,0,0,0,0,1,Trastuzumab,"DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|TRASTUZUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PROMETHAZINE|APREPITANT|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|POLYETHYLENE GLYCOL",12,BREAST CANCER|BREAST CANCER|METASTASES TO LUNG,Cardiac failure congestive|Exposure during pregnancy|Drug clearance decreased|Contusion,4,3
10077915,20140415,Trastuzumab,50,801,50.0,2,,1,0,1,0,1,0,0,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER METASTATIC,Paraplegia,1,1
10077936,20140415,Trastuzumab,47,801,47.0,2,49,1,0,0,0,0,0,1,Trastuzumab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|TRASTUZUMAB|METHOTREXATE|METHOTREXATE SODIUM|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,White blood cell count decreased|Headache|Immune system disorder|Oropharyngeal pain|Haematocrit decreased,5,5
10077964,20140415,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,DENOSUMAB|CAPECITABINE|TRASTUZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION,Metastases to spine|Palmar-plantar erythrodysaesthesia syndrome|Muscle spasms|Gait disturbance|Arthralgia,5,5
10078293,20140415,Trastuzumab,52,801,52.0,2,,1,0,0,1,0,0,1,Trastuzumab,"ADO-TRASTUZUMAB EMTANSINE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|FAMOTIDINE|LEVETIRACETAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OXYCODONE|SENNOSIDES|SENNA LEAF|SENNA",11,BREAST CANCER METASTATIC|PAIN|DIARRHOEA|PAIN,Intracranial tumour haemorrhage|Hemiplegia|Cerebral haemorrhage,3,3
10078304,20140415,Trastuzumab,68,801,68.0,1,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|CAPECITABINE|CAPECITABINE|CISPLATIN,7,METASTATIC GASTRIC CANCER|METASTATIC GASTRIC CANCER|METASTATIC GASTRIC CANCER|METASTATIC GASTRIC CANCER|METASTATIC GASTRIC CANCER|METASTATIC GASTRIC CANCER|METASTATIC GASTRIC CANCER,Gastrooesophageal reflux disease|Vomiting|Pneumonia,3,1
10078307,20140415,Trastuzumab,49,801,49.0,2,,1,1,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB,2,BREAST CANCER,Death|Vena cava thrombosis|Hepatic neoplasm|Metastases to central nervous system|Ascites|Pleural effusion|Metastases to liver,7,5
10078441,20140415,Trastuzumab,68,801,68.0,2,,1,0,0,0,0,0,1,Trastuzumab,"TRASTUZUMAB|PERTUZUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PERTUZUMAB|RAMIPRIL|PERTUZUMAB|TRASTUZUMAB",11,BREAST CANCER METASTATIC|TOOTHACHE|HER-2 POSITIVE BREAST CANCER|BREAST CANCER,Tooth infection|Abdominal discomfort|Mean platelet volume decreased|Implant site extravasation|Dyspepsia|Depression|Oxygen saturation decreased|Haemorrhoids|Infusion related reaction|Rash|Rib fracture|Muscle spasms|Muscle spasms|Muscular weakness|Peripheral coldness|Mastectomy|Lacrimation increased|Vomiting|Body temperature fluctuation|Blood pressure increased|Gastrooesophageal reflux disease|Pruritus|Stomatitis|Laryngitis|Palpitations|Migraine with aura|Blood creatinine decreased|Blood pressure diastolic decreased|Cough|Diarrhoea|Dyspnoea exertional|Breast pain|Fatigue|Nausea|Bladder prolapse|Depression|Muscular weakness|Dyspnoea|Rib fracture|Migraine|Tooth extraction|Dysgeusia|Hypoaesthesia|Nasopharyngitis|Emotional disorder|Uterine prolapse|Influenza|Diarrhoea|Hypotension|Toothache|Muscle fatigue|Constipation|Poor peripheral circulation,53,3
10078570,20140415,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER,Intracranial tumour haemorrhage,1,1
10078574,20140415,Trastuzumab,48,801,48.0,2,76,1,0,1,0,0,0,0,Trastuzumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|APREPITANT|FOSAPREPITANT DIMEGLUMINE,9,MUCOSAL INFLAMMATION|PREMEDICATION|PREMEDICATION|PREMEDICATION|PROPHYLAXIS|HER-2 POSITIVE BREAST CANCER|PROPHYLAXIS|HER-2 POSITIVE BREAST CANCER,Cholecystitis,1,1
10078634,20140415,Trastuzumab,62,801,62.0,2,39.95,1,0,0,0,0,0,1,Trastuzumab,"CAPECITABINE|CAPECITABINE|CAPECITABINE|CAPECITABINE|CAPECITABINE|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, X-RAY, URANIUM NITRICUM|CHONDRUS CRISPUS, FUCUS VESICULOSUS, THYROIDINUM (SUIS), CADMIUM IODATUM, IODIUM, STRONTIUM CARBONICUM, X-RAY,|CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY",11,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER|PYREXIA,Bronchitis|Pyrexia|Obstruction|Blood bilirubin increased|Jaundice|Pruritus|Heart rate increased|Glossodynia|Pyrexia|Nail disorder|Peripheral swelling|Oropharyngeal pain|Mucosal inflammation|Rhinorrhoea|Nasopharyngitis|Fatigue|Fatigue,17,5
10079014,20140415,Trastuzumab,62,801,62.0,1,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|CISPLATIN,5,GASTRIC CANCER|GASTRIC CANCER,Peritonitis|Vomiting,2,1
10079216,20140415,Trastuzumab,57,801,57.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,3,BREAST CANCER STAGE II|BREAST CANCER STAGE II|BREAST CANCER STAGE II,Thrombotic microangiopathy,1,3
10079640,20140415,Trastuzumab,76,801,76.0,2,,1,0,1,1,0,0,0,Trastuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|PERTUZUMAB|TRASTUZUMAB|PREDNISONE|OXYCODONE|PERTUZUMAB,13,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|PROPHYLAXIS,Hypokalaemia|Diarrhoea|Dehydration,3,1
10079814,20140415,Trastuzumab,61,801,61.0,2,,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB|ANASTROZOLE,6,INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION,Leukopenia|Erythema|Pruritus|Infusion related reaction,4,5
10080423,20140416,Trastuzumab,66,801,66.0,2,58.4,1,0,0,0,0,0,1,Trastuzumab,"CAPECITABINE|CISPLATIN|PERTUZUMAB|TRASTUZUMAB|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|APREPITANT|FOSAPREPITANT DIMEGLUMINE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",14,HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|VOMITING|HER-2 POSITIVE GASTRIC CANCER|HYPERSENSITIVITY|HER-2 POSITIVE GASTRIC CANCER|HYPERSENSITIVITY|VOMITING|GASTROOESOPHAGEAL REFLUX DISEASE|VOMITING|DIABETES MELLITUS|GASTROOESOPHAGEAL REFLUX DISEASE,Gastric haemorrhage,1,1
10080427,20140416,Trastuzumab,61,801,61.0,1,,1,0,0,0,0,0,0,Trastuzumab,CAPECITABINE|TRASTUZUMAB|CISPLATIN,3,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Oral disorder|Palmar-plantar erythrodysaesthesia syndrome,2,1
10080448,20140416,Trastuzumab,64,801,64.0,2,48,1,1,0,0,0,0,1,Trastuzumab,METHYLPREDNISOLONE|ALPRAZOLAM|ENOXAPARIN SODIUM,10,HER-2 POSITIVE BREAST CANCER|BONE PAIN|PALPITATIONS|HERPES ZOSTER|PROPHYLAXIS|MITRAL VALVE INCOMPETENCE|PROPHYLAXIS|ANXIETY,Spider naevus|Liver injury,2,1
10080480,20140416,Trastuzumab,46,801,46.0,2,41.9,1,0,0,1,0,0,1,Trastuzumab,OXYCODONE HYDROCHLORIDE|ZOLPIDEM TARTRATE,8,BREAST CANCER METASTATIC|GASTRITIS PROPHYLAXIS|DYSPEPSIA|NEUROPATHY PERIPHERAL|CONSTIPATION|CANCER PAIN|INSOMNIA|PROPHYLAXIS,Hepatic function abnormal|Platelet count decreased|Anaemia,3,1
10080542,20140416,Trastuzumab,45,801,45.0,2,55.1,1,0,1,0,0,0,0,Trastuzumab,LANSOPRAZOLE|SULFADIAZINE,11,BREAST CANCER METASTATIC|DIZZINESS|DIZZINESS|GASTRITIS PROPHYLAXIS|RHINITIS ALLERGIC|HEPATIC FUNCTION ABNORMAL|MUSCULOSKELETAL STIFFNESS|NEUROPATHY PERIPHERAL|SKIN ULCER|COUGH|BREAST CANCER METASTATIC,Pyrexia,1,1
10080554,20140416,Trastuzumab,55,801,55.0,2,66,1,0,0,0,0,0,1,Trastuzumab,PACLITAXEL|TRASTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|CHRONIC MYELOID LEUKAEMIA,Pleural effusion|Dyspnoea|Burning sensation|Paraesthesia|Somnolence,5,3
10080637,20140414,Trastuzumab,54,801,54.0,2,,1,0,0,0,0,0,0,Trastuzumab,TRASTUZUMAB|LAPATINIB|CAPECITABINE,10,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Nervous system disorder|Pleural effusion|Lung infiltration|Metastases to bone|Malignant neoplasm progression|Breast cancer,6,
10080665,20140416,Trastuzumab,,,,1,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Skin reaction,1,2
10080844,20140416,Trastuzumab,47,801,47.0,2,76.6,1,0,1,1,0,0,0,Trastuzumab,OXYCODONE HYDROCHLORIDE|FLUOROMETHOLONE,7,BREAST CANCER METASTATIC|CANCER PAIN|CANCER PAIN|INSOMNIA|ASTHENOPIA|SEASONAL ALLERGY|SEASONAL ALLERGY,Ventricular fibrillation,1,1
10082747,20140416,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,DENOSUMAB|TRASTUZUMAB,3,METASTASES TO BONE,Cardiac failure congestive|Metastases to bone|Pain in extremity,3,5
10082856,20140416,Trastuzumab,70,801,70.0,2,62,1,0,1,0,0,0,0,Trastuzumab,EVEROLIMUS,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|HYPERTENSION|HYPERTENSION,Cerebral infarction,1,1
10082933,20140417,Trastuzumab,,,,0,,1,0,0,0,0,0,0,Trastuzumab,DENOSUMAB|TRASTUZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION,Arthralgia|Musculoskeletal stiffness,2,5
10082938,20140417,Trastuzumab,57,801,57.0,2,,1,0,1,1,0,0,0,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|CARBOPLATIN|CARBOPLATIN|PACLITAXEL|PACLITAXEL,7,BREAST CANCER,Thrombocytopenia,1,3
10082984,20140417,Trastuzumab,,,,2,53,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB|TRASTUZUMAB|CLONAZEPAM|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|LETROZOLE|LETROZOLE TABLETS|PROCHLORPERAZINE MALEATE|SERTRALINE HYDROCHLORIDE|CEFTRIAXONE SODIUM|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SERTRALINE HYDROCHLORIDE,14,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|PYREXIA|NAUSEA|NAUSEA|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER,Cardiac failure congestive|Diarrhoea,2,1
10083183,20140417,Trastuzumab,62,801,62.0,2,,1,1,1,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE|TRASTUZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Respiratory distress|Cardiac arrest,3,1
10083207,20140417,Trastuzumab,75,801,75.0,2,68,1,1,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB|PACLITAXEL|LOSARTAN|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|METRONIDAZOLE,9,BREAST CANCER|BREAST CANCER|BREAST CANCER,General physical health deterioration|Cardiac failure congestive,2,1
10083291,20140417,Trastuzumab,55,801,55.0,2,,1,0,1,0,0,0,0,Trastuzumab,BEVACIZUMAB|BEVACIZUMAB|TRASTUZUMAB|TRASTUZUMAB|CARBOPLATIN|CARBOPLATIN|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|IRBESARTAN|DIMENHYDRINATE,14,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Clostridium difficile infection|Dehydration|Diarrhoea|Hypovolaemia|Mucosal inflammation|Palmar-plantar erythrodysaesthesia syndrome|Renal failure acute,7,1
10083304,20140417,Trastuzumab,35,801,35.0,2,80.7,1,0,1,1,1,0,1,Trastuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,7,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|NAUSEA|VOMITING,Febrile neutropenia|Diarrhoea|Pyrexia|Rash|Oropharyngeal pain|Myalgia|Mucosal inflammation|Cough,8,2
10083340,20140417,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE|ADO-TRASTUZUMAB EMTANSINE|TRASTUZUMAB|CAPECITABINE|PACLITAXEL,5,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Cholangitis|Fatigue|Pyrexia|Blood bilirubin increased,4,5
10083516,20140417,Trastuzumab,60,801,60.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|CISPLATIN|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN|CARBOPLATIN,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Acoustic stimulation tests abnormal|Areflexia|Asthenia|Ataxia|Diarrhoea|Febrile neutropenia|Gait disturbance|Headache|Memory impairment|Nausea|Neuromyopathy|Neuropathy peripheral|Speech disorder|Vomiting,14,3
10083782,20140417,Trastuzumab,78,801,78.0,1,64.45,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|CISPLATIN|INSULIN HUMAN|PERTUZUMAB|TRASTUZUMAB|CAPECITABINE|PERTUZUMAB|CAPECITABINE|TRASTUZUMAB|CAPECITABINE|ROSUVASTATIN|CISPLATIN|PERTUZUMAB|CISPLATIN|APREPITANT|FOSAPREPITANT DIMEGLUMINE|INSULIN HUMAN|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|APREPITANT|FOSAPREPITANT DIMEGLUMINE|INSULIN HUMAN|CAPECITABINE|CAPECITABINE|CISPLATIN,40,NAUSEA|HER2 POSITIVE GASTRIC CANCER|HER2 POSITIVE GASTRIC CANCER|CHILLS|HER2 POSITIVE GASTRIC CANCER|NAUSEA|CHILLS|PYREXIA|PYREXIA|IRON DEFICIENCY ANAEMIA|HYPERCHOLESTEROLAEMIA|NAUSEA|PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME|DIABETES MELLITUS|HYPERTENSION|NAUSEA|DIARRHOEA|DIARRHOEA|NAUSEA|TYPE 2 DIABETES MELLITUS|DRY SKIN|HER2 POSITIVE GASTRIC CANCER|DIARRHOEA,Decreased appetite|Dehydration|Creatinine renal clearance decreased,3,1
10084222,20140417,Trastuzumab,38,801,38.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|CARBOPLATIN|METHYLPREDNISOLONE SODIUM SUCCINATE,7,PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|BREAST CANCER|BREAST CANCER,Anaemia|Haemolytic anaemia,2,1
10084418,20140417,Trastuzumab,53,801,53.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,2,BREAST CANCER|BREAST CANCER,Dyspnoea|Chest discomfort|Erythema,3,5
10084501,20140404,Trastuzumab,38,801,38.0,2,,1,0,0,0,0,0,0,Trastuzumab,,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Aphasia|Hypoaesthesia|Asthenia,3,
10084504,20140404,Trastuzumab,,,,2,,1,0,0,0,0,0,0,Trastuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Diarrhoea|Rhinorrhoea,2,
10084505,20140417,Trastuzumab,54,801,54.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|LORAZEPAM,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dehydration|Febrile neutropenia|Mucosal inflammation,3,1
10084516,20140404,Trastuzumab,,,,0,,1,0,0,0,0,0,0,Trastuzumab,,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,
10084528,20140404,Trastuzumab,,,,2,,1,0,0,0,0,0,0,Trastuzumab,PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION,Epistaxis|Hypersensitivity|Fatigue|Cardiac disorder|Extrasystoles|Heart rate increased|Insomnia|Dyspnoea|Sinus congestion|Rash|Pruritus|Sinus disorder,12,
10084537,20140404,Trastuzumab,,,,2,,1,0,0,0,0,0,0,Trastuzumab,,4,PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC,Aspartate aminotransferase increased|Alanine aminotransferase increased,2,
10084550,20140404,Trastuzumab,61,801,61.0,2,,1,0,0,0,0,0,0,Trastuzumab,PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Burning sensation,1,
10084568,20140404,Trastuzumab,,,,2,,1,0,0,0,0,0,0,Trastuzumab,,2,BREAST CANCER METASTATIC,Malaise|Rash|Myalgia,3,1
10084579,20140404,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,PERTUZUMAB|TRASTUZUMAB,3,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Flushing|Dysaesthesia|Palmar-plantar erythrodysaesthesia syndrome,3,
10084583,20140404,Trastuzumab,,,,2,,1,0,0,0,0,0,0,Trastuzumab,PERTUZUMAB,4,BREAST CANCER,Clostridium difficile infection,1,1
10084588,20140404,Trastuzumab,,,,2,,1,0,0,0,0,0,0,Trastuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Uveitis,1,5
10084790,20140404,Trastuzumab,,,,2,,1,0,0,0,0,0,0,Trastuzumab,PERTUZUMAB,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Convulsion,1,
10084798,20140404,Trastuzumab,,,,2,,1,0,0,0,0,0,0,Trastuzumab,PERTUZUMAB,4,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Urticaria|Nausea|Flushing,3,1
10084806,20140404,Trastuzumab,,,,2,,1,0,0,0,0,0,0,Trastuzumab,PERTUZUMAB|TRASTUZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Drug resistance|Metastases to bone|Bone pain,3,
10084812,20140404,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,PERTUZUMAB|ADO-TRASTUZUMAB EMTANSINE,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Disease progression,1,5
10084817,20140404,Trastuzumab,39,801,39.0,2,,1,0,0,0,0,0,1,Trastuzumab,PERTUZUMAB|TRASTUZUMAB,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Chest discomfort|Dyspnoea|Pallor|Oxygen saturation decreased,4,
10084827,20140404,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,PERTUZUMAB|TRASTUZUMAB,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pleural effusion,1,2
10084885,20140404,Trastuzumab,,,,2,,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB|TRASTUZUMAB,2,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Mucosal inflammation|Systemic lupus erythematosus,2,3
10084892,20140404,Trastuzumab,43,801,43.0,2,,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN,4,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Vomiting|Nausea,2,
10084899,20140404,Trastuzumab,50,801,50.0,2,,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB|CARBOPLATIN|MORPHINE,5,BREAST CANCER|BREAST CANCER,Mucosal inflammation|Anxiety,2,1
10084910,20140404,Trastuzumab,,,,2,,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Cardiac failure congestive,1,1
10084914,20140404,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,PERTUZUMAB|CARBOPLATIN,4,BREAST CANCER|BREAST CANCER,Diarrhoea|Pyrexia,2,
10084922,20140404,Trastuzumab,79,801,79.0,2,78.29,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB,4,BREAST CANCER|BREAST CANCER,Diarrhoea,1,3
10084928,20140404,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,PERTUZUMAB,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Anaphylactic reaction|Malaise,2,
10084975,20140417,Trastuzumab,66,801,66.0,1,68,1,0,1,0,0,0,0,Trastuzumab,"PERTUZUMAB|CAPECITABINE|CAPECITABINE|CISPLATIN|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|FUROSEMIDE|TRASTUZUMAB|CISPLATIN|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE",30,STOMATITIS|HYPERTENSION|DRY EYE|NAUSEA|HYPERTENSION|STOMATITIS|HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|NAUSEA|DIARRHOEA|PYREXIA|NAUSEA|PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME|DECREASED APPETITE|HER-2 POSITIVE GASTRIC CANCER|DRY SKIN|CONJUNCTIVITIS|OEDEMA|HER-2 POSITIVE GASTRIC CANCER|GASTROOESOPHAGEAL REFLUX DISEASE|NAUSEA|STOMATITIS|DYSGEUSIA|STOMATITIS,Dehydration,1,1
10085377,20140417,Trastuzumab,43,801,43.0,2,,1,1,0,0,0,0,0,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10085422,20140418,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Amnesia,1,3
10085617,20140418,Trastuzumab,53,801,53.0,2,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10085651,20140418,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Vaginal haemorrhage,1,1
10085951,20140418,Trastuzumab,76,801,76.0,2,69.916,1,1,1,1,1,1,1,Trastuzumab,PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|CARBOPLATIN|CLONIDINE|ALLOPURINOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LISINOPRIL|DICLOFENAC SODIUM|MAGNESIUM OXIDE|OMEPRAZOLE MAGNESIUM|PROMETHAZINE HYDROCHLORIDE|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|CARVEDILOL|BUMETANIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,21,Breast cancer|Breast cancer|Breast cancer|Breast cancer,Cellulitis,1,1
10086904,20140418,Trastuzumab,60,801,60.0,2,,1,0,0,0,0,0,1,Trastuzumab,"METOPROLOL TARTRATE|METOPROLOL|EPIRUBICIN HYDROCHLORIDE|HYDROCHLOROTHIAZIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PERTUZUMAB|TRASTUZUMAB",8,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Cardiomyopathy|Cardiac failure|Fatigue,3,5
10087928,20140419,Trastuzumab,54,801,54.0,2,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10088092,20140421,Trastuzumab,49,801,49.0,2,59,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB|PACLITAXEL,5,BREAST CANCER|BREAST CANCER|BREAST CANCER,Thrombosis,1,1
10088097,20140421,Trastuzumab,51,801,51.0,2,55.2,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB,2,BREAST CANCER,Chest discomfort|Dizziness|Dizziness,3,2
10088125,20140421,Trastuzumab,55,801,55.0,2,,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB|CARBOPLATIN|PACLITAXEL|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB,7,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Cerebrovascular accident,1,1
10088138,20140421,Trastuzumab,,,,0,,1,0,0,0,0,0,1,Trastuzumab,"TRASTUZUMAB|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PACLITAXEL|PACLITAXEL|LAMIVUDINE|LAMIVUDINE ORAL|ATAZANAVIR|RITONAVIR|RITONAVIR 100 MG",8,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Ejection fraction decreased|Haematotoxicity|Infection,3,1
10088146,20140421,Trastuzumab,36,801,36.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION,Musculoskeletal stiffness|Skin disorder,2,1
10088273,20140421,Trastuzumab,68,801,68.0,2,,1,0,1,0,0,0,0,Trastuzumab,"PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CLONAZEPAM|LETROZOLE|LETROZOLE TABLETS|PROCHLORPERAZINE MALEATE|SERTRALINE HYDROCHLORIDE|ATORVASTATIN CALCIUM|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|LEVOTHYROXINE SODIUM|CEFTRIAXONE SODIUM",20,METASTATIC NEOPLASM|METASTATIC NEOPLASM|METASTATIC NEOPLASM|PYREXIA|NAUSEA|NAUSEA|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|NAUSEA,Pleural effusion|Cardiomyopathy|Acute respiratory failure|Atelectasis|Upper respiratory tract infection|Decreased appetite|Dehydration,7,1
10088284,20140421,Trastuzumab,65,801,65.0,2,,1,0,1,0,0,0,0,Trastuzumab,FUROSEMIDE|DICLOFENAC SODIUM|FUROSEMIDE|CITALOPRAM|CITALOPRAM HYDROBROMIDE,12,HYPERCHOLESTEROLAEMIA|OEDEMA PERIPHERAL|THROMBOSIS PROPHYLAXIS|HYPERCHOLESTEROLAEMIA|VITAMIN D DEFICIENCY|NASOPHARYNGITIS|NASOPHARYNGITIS|ARTHRALGIA|OEDEMA|BREAST CANCER|PROPHYLAXIS|ARTHRALGIA,Gastrointestinal haemorrhage,1,1
10089140,20140421,Trastuzumab,37,801,37.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,2,BREAST CANCER|BREAST CANCER,Supraventricular tachycardia,1,1
10089176,20140421,Trastuzumab,38,801,38.0,2,92,1,0,1,0,0,0,0,Trastuzumab,INSULIN GLARGINE|REPAGLINIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,12,HER-2 POSITIVE BREAST CANCER,Lung infection,1,1
10089194,20140421,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Gastrooesophageal reflux disease|Nausea|Vomiting|Dehydration|Peripheral swelling|Rash|Cough|Decreased appetite|Anaemia|Myalgia|Dyspnoea|Headache|Pyrexia|Pruritus|Muscle twitching|Asthenia|Hyperaesthesia|Pain|Pain of skin,19,5
10089273,20140421,Trastuzumab,,,,2,58.11,1,0,0,0,0,0,1,Trastuzumab,"TRASTUZUMAB|LEVOTHYROXINE|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|HYDROCHLOROTHIAZIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CARBOPLATIN",8,BREAST CANCER|BREAST CANCER|BLOOD PRESSURE|BREAST CANCER,Hepatic enzyme increased|Nausea|Red blood cell count decreased|Fatigue,4,5
10089342,20140421,Trastuzumab,62,801,62.0,1,80,1,0,1,0,0,0,0,Trastuzumab,"CISPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|TRASTUZUMAB",3,GASTRIC CANCER|GASTRIC CANCER,Toxicity to various agents|Febrile neutropenia|Stomatitis|Diarrhoea|Asthenia|Off label use,6,
10090020,20140421,Trastuzumab,38,801,38.0,2,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB|CAPECITABINE,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Disease progression,1,5
10090028,20140421,Trastuzumab,55,801,55.0,2,39,1,0,1,0,0,0,0,Trastuzumab,FUROSEMIDE|WHITE PETROLATUM|PETROLATUM|SKIN PROTECTANT|METRONIDAZOLE|MORPHINE SULFATE,15,BREAST CANCER METASTATIC|CANCER PAIN|CANCER PAIN|CANCER PAIN|HEPATIC FUNCTION ABNORMAL|HEPATIC FUNCTION ABNORMAL|PLEURAL EFFUSION|PLEURAL EFFUSION|SKIN DISORDER|SKIN DISORDER|PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME|SEASONAL ALLERGY|PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME|CANCER PAIN|CANCER PAIN,Dehydration|Hyperkalaemia|Renal impairment,3,1
10090169,20140421,Trastuzumab,58,801,58.0,2,85.5,1,0,1,0,0,0,0,Trastuzumab,LAPATINIB|PACLITAXEL|TRASTUZUMAB,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Ventricular tachycardia,1,1
10090170,20140421,Trastuzumab,,,,2,49,1,0,1,0,0,0,0,Trastuzumab,LAPATINIB|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN|TRASTUZUMAB|CEFUROXIME,5,BREAST CANCER|BREAST CANCER|BREAST CANCER,Neutropenia|Leukopenia|International normalised ratio increased|Fatigue|Diarrhoea|Dehydration|Colitis|Ileus,8,1
10090171,20140421,Trastuzumab,66,801,66.0,2,94,1,0,1,0,0,0,1,Trastuzumab,LAPATINIB|TRASTUZUMAB|CARBOPLATIN|DOCETAXEL|DOCETAXEL ANHYDROUS|ZOLPIDEM TARTRATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE,10,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Diarrhoea|Dehydration|Asthenia,3,1
10094115,20140422,Trastuzumab,62,801,62.0,1,80,1,0,1,0,0,0,0,Trastuzumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|CISPLATIN|TRASTUZUMAB",3,GASTRIC CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Febrile neutropenia|Stomatitis|Asthenia|Aphagia|Toxicity to various agents,6,1
10094169,20140422,Trastuzumab,37,801,37.0,2,,1,0,0,0,0,0,1,Trastuzumab,LEVOTHYROXINE|TRASTUZUMAB|ROSUVASTATIN,8,HYPOKALAEMIA|NASOPHARYNGITIS|HYPOTHYROIDISM|BREAST CANCER|BREAST CANCER|OSTEOPOROSIS|PHARYNGITIS|HYPERCHOLESTEROLAEMIA,Supraventricular tachycardia,1,1
10094171,20140422,Trastuzumab,,,,0,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Metastases to central nervous system,1,1
10094230,20140422,Trastuzumab,75,801,75.0,2,50,1,1,1,0,0,0,0,Trastuzumab,VALSARTAN|VALSARTAN ORAL|LORAZEPAM|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE,17,DEPRESSION|DEPRESSION|ABDOMINAL PAIN|NAUSEA|RESPIRATORY TRACT INFECTION|ABDOMINAL PAIN|URINARY TRACT INFECTION|HYPERTENSION|HYPERTENSION|METASTATIC GASTRIC CANCER|DEPRESSION|INSOMNIA|PROPHYLAXIS|PROPHYLAXIS|ANAEMIA|HER-2 POSITIVE GASTRIC CANCER|DEPRESSION,Haematemesis|Upper gastrointestinal haemorrhage|Gastrointestinal haemorrhage|Upper gastrointestinal haemorrhage,4,1
10094447,20140422,Trastuzumab,60,801,60.0,2,83,1,0,0,0,0,0,1,Trastuzumab,RIBAVIRIN|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,5,HEPATITIS C|HEPATITIS C|BREAST CANCER|BREAST CANCER,Neutropenia|Hepatotoxicity,2,3
10094495,20140422,Trastuzumab,55,801,55.0,0,,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB|TRASTUZUMAB|VINORELBINE|ATENOLOL|AMLODIPINE|SIMVASTATIN,9,BREAST CANCER|BREAST CANCER|BREAST CANCER,Presyncope,1,1
10094658,20140422,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PERTUZUMAB|VINORELBINE|DOXORUBICIN HYDROCHLORIDE,6,BREAST CANCER|BREAST CANCER|BREAST CANCER,Pituitary tumour,1,5
10094674,20140422,Trastuzumab,65,801,65.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|PACLITAXEL|PACLITAXEL|CARBOPLATIN,5,BREAST CANCER,Disease progression,1,1
10095529,20140422,Trastuzumab,49,801,49.0,2,74,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION,Neutropenic sepsis,1,5
10095955,20140422,Trastuzumab,,,,2,72.4,1,0,1,0,0,0,0,Trastuzumab,LAPATINIB|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN|TRASTUZUMAB,4,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Febrile neutropenia|Mucosal inflammation,2,1
10095961,20140422,Trastuzumab,69,801,69.0,2,74.7,1,0,1,0,0,0,0,Trastuzumab,LAPATINIB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN,4,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Diarrhoea|Dehydration|Hypokalaemia,3,1
10097262,20140422,Trastuzumab,56,801,56.0,2,83,1,0,0,0,0,0,1,Trastuzumab,DENOSUMAB|TRASTUZUMAB,2,METASTASES TO BONE|BREAST CANCER METASTATIC,Diabetes mellitus,1,5
10098182,20140423,Trastuzumab,69,801,69.0,2,60,1,1,0,1,0,0,0,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB,7,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Death|Interstitial lung disease,2,1
10098636,20140421,Trastuzumab,62,801,62.0,2,,1,0,0,0,0,0,0,Trastuzumab,TRASTUZUMAB,3,BREAST CANCER|BREAST CANCER,Febrile convulsion|Abdominal pain|Abdominal pain upper,3,
10098704,20140423,Trastuzumab,61,801,61.0,1,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|CAPECITABINE|DOCETAXEL|DOCETAXEL ANHYDROUS|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN,10,HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER,Jaundice cholestatic|White blood cell count decreased|Neurotoxicity|Platelet count decreased|Pyrexia|Decreased appetite|Asthenia,7,1
10098717,20140423,Trastuzumab,78,801,78.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,7,BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|PREMEDICATION,Cardiac failure congestive|Ejection fraction decreased,2,3
10100486,20140423,Trastuzumab,47,801,47.0,2,61.7,1,0,1,0,0,0,0,Trastuzumab,LAPATINIB|CARBOPLATIN|TRASTUZUMAB,4,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Abdominal pain|Diarrhoea|Nausea|Vomiting,4,1
10100487,20140423,Trastuzumab,47,801,47.0,2,61.7,1,0,1,0,0,0,0,Trastuzumab,LAPATINIB|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN|TRASTUZUMAB,5,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Abdominal pain|Diarrhoea|Nausea|Vomiting,4,1
10101375,20140422,Trastuzumab,49,801,49.0,2,,1,0,1,0,0,0,0,Trastuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION,Neutropenic sepsis|Urinary tract infection,2,3
10101397,20140424,Trastuzumab,68,801,68.0,2,,1,0,1,0,0,0,0,Trastuzumab,PACLITAXEL|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FUROSEMIDE|HYDROXYZINE HYDROCHLORIDE|HYDROXYZINE|HYDROXYZINE HYDROCHLORIDE ORAL|HYDROXYZINE HYDROCHLORIDE|HYDROXYZINE|HYDROXYZINE HYDROCHLORIDE ORAL|HYDROXYZINE HYDROCHLORIDE|HYDROXYZINE|HYDROXYZINE HYDROCHLORIDE ORAL,15,BREAST CANCER|BREAST CANCER|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|PROPHYLAXIS,Pemphigus,1,1
10101773,20140424,Trastuzumab,68,801,68.0,1,,1,1,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,GASTRIC CANCER,Disease progression|Pneumonia aspiration|Sepsis,3,1
10101801,20140424,Trastuzumab,62,801,62.0,2,65,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN|PACLITAXEL,5,INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA,Lymphadenopathy|White blood cell count decreased,2,5
10101987,20140424,Trastuzumab,27,801,27.0,2,98.7,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE|ADO-TRASTUZUMAB EMTANSINE|ADO-TRASTUZUMAB EMTANSINE|ADO-TRASTUZUMAB EMTANSINE|VINORELBINE|CAPECITABINE|ADO-TRASTUZUMAB EMTANSINE|DALTEPARIN SODIUM|TRASTUZUMAB|PERTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|DOXORUBICIN HYDROCHLORIDE|ESTRADIOL|TRASTUZUMAB,17,HER-2 POSITIVE BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Malignant neoplasm progression|Vessel puncture site bruise|Cough|Glomerular filtration rate decreased|Blood lactate dehydrogenase increased|Aspartate aminotransferase increased|Epidermal growth factor receptor decreased|Hypothalamo-pituitary disorder|Blood uric acid increased|Contusion|Weight increased|Infusion related reaction|Blood glucose decreased|Protein total increased|Pituitary tumour|Carbon dioxide increased|White blood cell count increased|Haematocrit decreased|Red cell distribution width increased|Blood phosphorus increased|Haemoglobin decreased|Thrombosis|Weight decreased|Neutrophil count increased|Nasopharyngitis|Diplopia|Blood creatinine increased,27,1
10102035,20140424,Trastuzumab,66,801,66.0,1,,1,0,0,0,0,0,1,Trastuzumab,IRBESARTAN AND HYDROCHLOROTHIAZIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|TRASTUZUMAB|CAPECITABINE,6,METASTATIC GASTRIC CANCER|METASTATIC GASTRIC CANCER|METASTATIC GASTRIC CANCER,Epistaxis|Sunburn|Pulmonary embolism,3,1
10102142,20140424,Trastuzumab,,,,1,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|CISPLATIN,3,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Paraneoplastic syndrome,1,1
10103058,20140424,Trastuzumab,,,,2,87,1,0,0,0,0,0,1,Trastuzumab,LAPATINIB|PACLITAXEL|TRASTUZUMAB|AMOXICILLIN AND CLAVULANATE POTASSIUM,4,BREAST CANCER|BREAST CANCER|BREAST CANCER|URINARY TRACT INFECTION,Hypokalaemia,1,1
10103059,20140424,Trastuzumab,66,801,66.0,2,77.5,1,0,1,0,0,0,0,Trastuzumab,LAPATINIB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN,4,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Hypokalaemia|Dehydration|Diarrhoea|Alanine aminotransferase increased|Aspartate aminotransferase increased,5,1
10103108,20140424,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,LAPATINIB|CAPECITABINE|TRASTUZUMAB|CARBOPLATIN|VINORELBINE,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Ascites|Rash generalised|Skin exfoliation,3,3
10103777,20140424,Trastuzumab,44,801,44.0,2,55,1,0,0,0,0,0,1,Trastuzumab,"DESFLURANE|DESFLURANE|PROPOFOL|SEVOFLURANE|EPIRUBICIN HYDROCHLORIDE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|DOCETAXEL|DOCETAXEL ANHYDROUS|ETODOLAC|FUROSEMIDE|SPIRONOLACTONE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL",21,MAINTENANCE OF ANAESTHESIA|INDUCTION OF ANAESTHESIA|INDUCTION OF ANAESTHESIA|MAINTENANCE OF ANAESTHESIA|MAINTENANCE OF ANAESTHESIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RHYTHM IDIOVENTRICULAR|RHYTHM IDIOVENTRICULAR|RHYTHM IDIOVENTRICULAR,Accelerated idioventricular rhythm,1,1
10108289,20140425,Trastuzumab,54,801,54.0,2,,1,0,1,0,0,0,0,Trastuzumab,BEVACIZUMAB|CAPECITABINE|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|OXALIPLATIN,5,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Dehydration|Malaise,2,1
10108759,20140425,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,PERTUZUMAB|TRASTUZUMAB|CARBOPLATIN,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Convulsion|Hip fracture,2,1
10108817,20140425,Trastuzumab,,,,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|VINORELBINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LEVOTHYROXINE|LORAZEPAM|LORAZEPAM|MECLIZINE HCL 12.5 MG|MECLIZINE|MECLIZINE HYDROCHLORIDE|MECLIZINE HCL 25MG|MECLIZINE HCL 12.5MG|MORPHINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|ERGOCALCIFEROL|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|POLYETHYLENE GLYCOL 3350|STANDARDIZED SENNA CONCENTRATE|FAMOTIDINE,16,BREAST CANCER|BREAST CANCER|INSOMNIA|ANXIETY|NAUSEA,Chest pain,1,3
10108846,20140425,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,3,PRODUCT USED FOR UNKNOWN INDICATION,Pain in extremity|Paraesthesia|Petit mal epilepsy|Insomnia|Diarrhoea|Tremor|Fatigue,7,3
10108889,20140425,Trastuzumab,64,801,64.0,2,84,1,1,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|LATANOPROST,4,BREAST CANCER|HYPERTENSION|ASTHMA,Cerebrovascular accident,1,1
10109192,20140425,Trastuzumab,50,801,50.0,2,67.1,1,0,1,0,0,0,0,Trastuzumab,DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|OXYCODONE HYDROCHLORIDE|TRIAZOLAM|CHLORHEXIDINE GLUCONATE|ANTISEPTIC SKIN CLEANSER,18,BREAST CANCER METASTATIC|INSOMNIA|CONSTIPATION|BACK PAIN|CONSTIPATION|BREAST CANCER METASTATIC|PROPHYLAXIS|PROPHYLAXIS|BREAST CANCER METASTATIC|INSOMNIA|NEUROPATHY PERIPHERAL|PROPHYLAXIS|BREAST CANCER METASTATIC|BACK PAIN|CONSTIPATION|NEUROPATHY PERIPHERAL|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Hepatic function abnormal,1,1
10109386,20140425,Trastuzumab,69,801,69.0,2,,1,0,1,1,0,0,0,Trastuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|PREMEDICATION,Anaphylactic shock,1,1
10109465,20140425,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Haemoptysis|Onychoclasis|Muscle spasms|Dyspnoea exertional|Dry skin|Lethargy|Fatigue|Sleep disorder|Pruritus|Insomnia|Depressed mood,11,3
10110124,20140425,Trastuzumab,45,801,45.0,2,,1,0,0,0,0,0,1,Trastuzumab,FILGRASTIM|CARBOPLATIN|TRASTUZUMAB,4,PROPHYLAXIS|BREAST CANCER|BREAST CANCER|BREAST CANCER,Malaise|Bone pain,2,1
10114457,20140426,Trastuzumab,54,801,54.0,2,56,1,0,0,0,0,0,1,Trastuzumab,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|SIMVASTATIN|FOLIC ACID|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|MEPERIDINE HYDROCHLORIDE|RANITIDINE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|PROMETHAZINE HYDROCHLORIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG",16,ARTHRALGIA|HYPERCHOLESTEROLAEMIA|NUTRITIONAL SUPPLEMENTATION|DYSPEPSIA|HER-2 POSITIVE BREAST CANCER|HYPOKALAEMIA|HYPERTENSION|CONSTIPATION|ARTHRALGIA|ARTHRALGIA|DIABETES MELLITUS,Myelodysplastic syndrome,1,1
10114467,20140426,Trastuzumab,34,801,34.0,2,47,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB|PACLITAXEL,17,NEOADJUVANT THERAPY|ADJUVANT THERAPY|ADJUVANT THERAPY|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|NEOADJUVANT THERAPY|PROPHYLAXIS|PROPHYLAXIS,Interstitial lung disease|Infusion related reaction|Abdominal pain|Acne,4,1
10121007,20140425,Trastuzumab,52,801,52.0,0,,1,1,1,0,0,0,0,Trastuzumab,LAPATINIB|CAPECITABINE|LETROZOLE|LETROZOLE TABLETS|TRASTUZUMAB|VINORELBINE,5,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Breast cancer|Eczema|Pulmonary embolism|Cor pulmonale|Haematoma|Abscess|Sepsis|Disease progression,8,3
10127654,20140428,Trastuzumab,60,801,60.0,2,74,1,0,1,0,0,0,0,Trastuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|CLOPIDOGREL|CLOPIDOGREL BISULFATE,8,BREAST CANCER|BREAST CANCER|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,General physical health deterioration,1,1
10128072,20140428,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PACLITAXEL|DASATINIB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Diarrhoea|Alanine aminotransferase increased|Aspartate aminotransferase increased|Nausea|Vomiting|Fatigue|Hyponatraemia|Pneumonitis,8,3
10128099,20140428,Trastuzumab,72,801,72.0,2,,1,0,0,0,0,0,1,Trastuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB,4,BREAST CANCER|BREAST CANCER,Anaphylactic reaction,1,1
10128470,20140428,Trastuzumab,67,801,67.0,2,,1,0,0,1,0,0,1,Trastuzumab,TRASTUZUMAB|CAPECITABINE|CAPECITABINE|CARBOPLATIN|LAPATINIB|MONTELUKAST SODIUM|LEVOTHYROXINE SODIUM|RABEPRAZOLE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|INSULIN HUMAN|BISOPROLOL FUMARATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,16,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Rash|Ascites|Neoplasm|Skin exfoliation|Disease progression,5,5
10128533,20140428,Trastuzumab,69,801,69.0,2,,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB|GABAPENTIN,3,BREAST NEOPLASM|INVASIVE DUCTAL BREAST CARCINOMA|NEUROTOXICITY,Acute interstitial pneumonitis|Neurotoxicity|Malaise|Cardiac failure congestive|Mitral valve incompetence|Pyrexia|Cardiotoxicity,7,1
10131982,20140428,Trastuzumab,67,801,67.0,2,,1,0,0,0,0,0,0,Trastuzumab,FULVESTRANT|TRASTUZUMAB,2,BREAST CANCER METASTATIC,Ascites|Blood bilirubin increased,2,1
10135850,20140429,Trastuzumab,64,801,64.0,1,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,NEOPLASM MALIGNANT,Death,1,5
10135855,20140429,Trastuzumab,39,801,39.0,2,84,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Cardiac disorder|Gastric cancer,2,5
10135865,20140429,Trastuzumab,65,801,65.0,2,83.08,1,0,1,0,0,0,1,Trastuzumab,FUROSEMIDE|TRASTUZUMAB|PERTUZUMAB,5,BREAST CANCER METASTATIC|DYSPNOEA|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Dyspnoea|Diarrhoea|Nausea|Blood urea increased|Ejection fraction decreased|Blood creatinine increased|Spinal fracture,7,5
10135948,20140428,Trastuzumab,30,801,30.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|PACLITAXEL|DOCETAXEL|DOCETAXEL ANHYDROUS,5,BREAST CANCER|METASTASES TO BONE|METASTASES TO LIVER|BREAST CANCER|BREAST CANCER,Disease progression,1,1
10135994,20140429,Trastuzumab,43,801,43.0,2,,1,1,0,0,0,0,0,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER METASTATIC,Pneumonia,1,3
10136201,20140429,Trastuzumab,67,801,67.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Pleural effusion|Subcutaneous abscess|No therapeutic response,3,5
10136211,20140429,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,"CAPECITABINE|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PACLITAXEL|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|METHOTREXATE|METHOTREXATE SODIUM|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|LAPATINIB",10,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Neutropenia|Febrile neutropenia|Gastrointestinal infection|Abdominal pain|Respiratory tract infection|Lung infection|Myocardial ischaemia|Left ventricular dysfunction|Peripheral motor neuropathy|Musculoskeletal pain|Fatigue|Endometrial hypertrophy,12,1
10136222,20140429,Trastuzumab,44,801,44.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Malignant neoplasm progression,1,5
10136248,20140429,Trastuzumab,53,801,53.0,2,59.5,1,0,0,1,0,0,1,Trastuzumab,"PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RANITIDINE|RANITIDINE|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",11,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Interstitial lung disease|Neutropenia,2,1
10137336,20140429,Trastuzumab,63,801,63.0,1,,1,0,0,0,0,0,1,Trastuzumab,"TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|CAPECITABINE|CAPECITABINE|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|PACLITAXEL|PACLITAXEL|PACLITAXEL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",15,HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|METASTASES TO CENTRAL NERVOUS SYSTEM,Palmar-plantar erythrodysaesthesia syndrome|Lacunar infarction|Asthenia|Decreased appetite,4,1
10141748,20140429,Trastuzumab,41,801,41.0,2,,1,0,1,0,0,0,0,Trastuzumab,"HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PERTUZUMAB|PERTUZUMAB|SELENIUM|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|TRASTUZUMAB|TRASTUZUMAB",21,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|HYPOCALCAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Anaemia,1,5
10142215,20140430,Trastuzumab,72,801,72.0,2,,1,0,1,1,0,0,1,Trastuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Dehydration|Hyperglycaemia|Nausea|Neutropenia|Deep vein thrombosis,5,1
10142239,20140429,Trastuzumab,69,801,69.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|BEVACIZUMAB|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM,3,BREAST CANCER|BREAST CANCER,Subileus|Abdominal pain,2,1
10142280,20140429,Trastuzumab,,,,2,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10142283,20140430,Trastuzumab,49,801,49.0,2,72,1,0,0,0,0,0,1,Trastuzumab,PERTUZUMAB|OXYCODONE HYDROCHLORIDE|LETROZOLE|TRASTUZUMAB,4,BREAST CANCER METASTATIC|PAIN|BREAST CANCER METASTATIC,Pneumothorax,1,1
10142320,20140429,Trastuzumab,67,801,67.0,2,87,1,0,1,0,0,0,0,Trastuzumab,BEVACIZUMAB|CAPECITABINE|CLONAZEPAM|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|OXALIPLATIN,8,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Toxic encephalopathy,1,1
10142336,20140430,Trastuzumab,49,801,49.0,2,69.92,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB|PERTUZUMAB|MORPHINE|GRANISETRON|ALPRAZOLAM|VALSARTAN|CARBOPLATIN|SIMVASTATIN,12,BREAST CANCER|BREAST CANCER|BREAST CANCER|NAUSEA|ANXIETY|GASTROOESOPHAGEAL REFLUX DISEASE|ABDOMINAL PAIN|BLOOD PRESSURE|BREAST CANCER|BLOOD CHOLESTEROL,Dehydration|Anuria|Hypotension|Renal impairment|Gastrooesophageal reflux disease|Dysphagia|Genital herpes|Erythema|Temperature intolerance|Burning sensation|Stomatitis|Anxiety|Dysgeusia,13,5
10142338,20140430,Trastuzumab,,,,0,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PERTUZUMAB,2,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Metastases to central nervous system,1,1
10142400,20140430,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Pharyngeal oedema,1,3
10142404,20140430,Trastuzumab,,,,2,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10142415,20140430,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|LETROZOLE|LETROZOLE TABLETS,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Bone cancer,1,5
10142494,20140430,Trastuzumab,54,801,54.0,1,61,1,0,1,0,0,0,0,Trastuzumab,BEVACIZUMAB|BEVACIZUMAB|CAPECITABINE|CAPECITABINE|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|OXALIPLATIN|OXALIPLATIN|FENTANYL,11,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Abdominal pain|Mucosal inflammation|Diarrhoea,3,1
10142511,20140430,Trastuzumab,75,801,75.0,2,83,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|FULVESTRANT,9,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Rash maculo-papular|Dermatitis,2,1
10142527,20140430,Trastuzumab,44,801,44.0,2,67.9,1,0,1,0,0,0,0,Trastuzumab,BISOPROLOL FUMARATE|EPINEPHRINE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|VALACYCLOVIR HYDROCHLORIDE|RIZATRIPTAN BENZOATE|ZOLPIDEM TARTRATE,13,HYPERTENSION|ANAPHYLACTIC REACTION|DIARRHOEA|PAIN|ORAL HERPES|HER-2 POSITIVE BREAST CANCER|MIGRAINE|INSOMNIA|PROCEDURAL PAIN,Device related infection,1,1
10142540,20140430,Trastuzumab,,,,2,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10142609,20140430,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,"PERTUZUMAB|CAPECITABINE|PERTUZUMAB|TRASTUZUMAB|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|DIMENHYDRINATE|TRASTUZUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",10,BREAST CANCER METASTATIC|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|BREAST CANCER METASTATIC,Disease progression|Cough|Recurrent cancer|Diarrhoea,4,3
10142756,20140428,Trastuzumab,57,801,57.0,2,83,1,0,0,0,0,0,1,Trastuzumab,PACLITAXEL|TRASTUZUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS,4,BREAST CANCER|BREAST CANCER,Arthritis|Interstitial lung disease|Pyrexia,3,3
10143827,20140430,Trastuzumab,33,801,33.0,2,53,1,0,0,0,0,0,1,Trastuzumab,LETROZOLE|LETROZOLE TABLETS|LAPATINIB|TRASTUZUMAB,10,BREAST CANCER METASTATIC|CARDIAC DISORDER|BREAST CANCER METASTATIC|PROPHYLAXIS|CARDIAC DISORDER|CALCIUM DEFICIENCY|VITAMIN SUPPLEMENTATION|RASH|BREAST CANCER METASTATIC|HYPOVITAMINOSIS,Cardiac disorder,1,1
10145009,20140501,Trastuzumab,72,801,72.0,1,81,1,0,1,0,0,0,0,Trastuzumab,BEVACIZUMAB|CAPECITABINE|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|OXALIPLATIN,5,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Diarrhoea|Gastric perforation,2,1
10145050,20140501,Trastuzumab,,,,2,,1,0,0,1,0,0,0,Trastuzumab,TRASTUZUMAB,1,HER-2 POSITIVE BREAST CANCER,Disease progression,1,1
10145054,20140501,Trastuzumab,68,801,68.0,1,77,1,0,1,0,0,0,0,Trastuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|BEVACIZUMAB|OXALIPLATIN|CAPECITABINE|TRASTUZUMAB,5,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Metastases to central nervous system,1,1
10145169,20140501,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Myocardial infarction|Ejection fraction decreased,2,3
10145615,20140501,Trastuzumab,50,801,50.0,2,69.85,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|EXEMESTANE,4,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pain in extremity|Muscular weakness|Pain|Dyspnoea|Nausea|Bone pain|Bone disorder,7,3
10148785,20140502,Trastuzumab,,,,2,,1,0,1,0,0,0,0,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,PRODUCT USED FOR UNKNOWN INDICATION,Respiratory distress,1,2
10148823,20140502,Trastuzumab,52,801,52.0,1,,1,0,1,0,0,0,0,Trastuzumab,BEVACIZUMAB|CAPECITABINE|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|OXALIPLATIN,5,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Cerebrovascular accident,1,1
10148940,20140502,Trastuzumab,37,801,37.0,2,,1,1,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|ADO-TRASTUZUMAB EMTANSINE,3,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Hepatic function abnormal|Drug ineffective|Death,3,5
10148970,20140502,Trastuzumab,49,801,49.0,2,58,1,0,1,0,0,0,0,Trastuzumab,DULOXETINE HYDROCHLORIDE|PREGABALIN|MAGNESIUM OXIDE,7,BREAST CANCER METASTATIC|CANCER PAIN|HYPOCALCAEMIA|CANCER PAIN|CANCER PAIN|ANAEMIA|CONSTIPATION,Dermatitis infected|Malaise,2,1
10149104,20140502,Trastuzumab,37,801,37.0,2,103.1,1,0,1,0,0,0,0,Trastuzumab,"TRASTUZUMAB|MORPHINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|APREPITANT|FOSAPREPITANT DIMEGLUMINE|CYCLOBENZAPRINE|FILGRASTIM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|TRASTUZUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB",16,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Rash maculo-papular|Lung infection,2,1
10149252,20140502,Trastuzumab,70,801,70.0,1,71,1,0,1,0,0,0,0,Trastuzumab,BEVACIZUMAB|CAPECITABINE|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|OXALIPLATIN,5,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Pulmonary embolism,1,1
10149459,20140502,Trastuzumab,63,801,63.0,2,65,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,2,BREAST CANCER|BREAST CANCER,Epilepsy,1,5
10149559,20140502,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Heart rate decreased,1,5
10149959,20140501,Trastuzumab,40,801,40.0,2,108.1,1,0,1,0,0,0,0,Trastuzumab,,1,HER-2 POSITIVE BREAST CANCER,Epistaxis|Thrombocytopenia|Pyrexia,3,1
10151136,20140504,Trastuzumab,,,,2,,1,0,0,1,0,0,1,Trastuzumab,VINORELBINE|CAPECITABINE|CARBOPLATIN|PACLITAXEL|TRASTUZUMAB|LAPATINIB,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Ascites|Rash generalised|Skin exfoliation,3,5
10151588,20140505,Trastuzumab,69,801,69.0,1,,1,0,1,0,0,0,0,Trastuzumab,BEVACIZUMAB|CAPECITABINE|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|OXALIPLATIN,5,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Diarrhoea|Hyponatraemia|Leukopenia,3,1
10151635,20140505,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,HER-2 POSITIVE BREAST CANCER,Full blood count decreased|Epistaxis|Fatigue,3,1
10151687,20140505,Trastuzumab,,,,2,70.9,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE|ADO-TRASTUZUMAB EMTANSINE|PREGABALIN|PREGABALIN|CITALOPRAM|CITALOPRAM HYDROBROMIDE,5,BREAST CANCER METASTATIC|ANALGESIC THERAPY|MYOSCLEROSIS|DEPRESSION,Chest pain|Dyspnoea|Gait disturbance,3,1
10151789,20140505,Trastuzumab,41,801,41.0,2,74.4,1,1,1,0,0,0,0,Trastuzumab,GABAPENTIN|MORPHINE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,6,HER-2 POSITIVE BREAST CANCER,Death|General physical health deterioration,2,1
10151834,20140505,Trastuzumab,71,801,71.0,1,66.5,1,0,1,0,0,0,0,Trastuzumab,METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|MIRTAZAPINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|AMLODIPINE|FLUCONAZOLE|FUROSEMIDE|DABIGATRAN ETEXILATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ALBUTEROL SULFATE|LORAZEPAM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FLUCONAZOLE|SIMVASTATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXYBUTYNIN|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM,37,NAUSEA|ORAL CANDIDIASIS|DEPRESSION|DEPRESSED MOOD|HYPERTENSION|PAIN|NAUSEA|HER-2 POSITIVE GASTRIC CANCER|ASTHMA|ANXIETY|ABDOMINAL PAIN|ORAL CANDIDIASIS|HYPOMAGNESAEMIA|PYREXIA|BLOOD CHOLESTEROL|HYPOKALAEMIA|DECREASED APPETITE|ANAEMIA|NAUSEA|POLLAKIURIA|POLLAKIURIA|HYPERTENSION,Pneumonia,1,1
10151854,20140505,Trastuzumab,56,801,56.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Arthralgia|Synovitis|Myalgia,3,5
10151944,20140505,Trastuzumab,66,801,66.0,1,63.7,1,0,1,0,0,0,0,Trastuzumab,,6,HER-2 POSITIVE GASTRIC CANCER|DRY SKIN|RASH MACULO-PAPULAR|PERIPHERAL SENSORY NEUROPATHY|PERIPHERAL SENSORY NEUROPATHY,Diabetes mellitus,1,1
10152149,20140505,Trastuzumab,50,801,50.0,2,,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|CAPECITABINE|DOCETAXEL|DOCETAXEL ANHYDROUS|GEMCITABINE HYDROCHLORIDE|GEMCITABINE,5,BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Breast cancer metastatic|Tumour embolism|White blood cell count decreased|Neutrophil count decreased,4,5
10152157,20140505,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER,Brain oedema|Incorrect route of drug administration,2,1
10152353,20140505,Trastuzumab,54,801,54.0,2,78,1,0,0,0,0,0,1,Trastuzumab,"PAMIDRONATE DISODIUM|PERTUZUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB|OXYCODONE",10,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Fall|Hip fracture|Rash macular|Burning sensation|Pruritus,5,3
10152379,20140505,Trastuzumab,71,801,71.0,2,,1,0,1,0,0,0,0,Trastuzumab,VENLAFAXINE HYDROCHLORIDE|VENLAFAXINE|PANTOPRAZOLE|MAGNESIUM|MELOXICAM,10,BREAST CANCER METASTATIC|PULMONARY EMBOLISM,Ischaemic stroke|Memory impairment|Aphasia,3,1
10152870,20140505,Trastuzumab,64,801,64.0,2,52,1,1,1,0,0,0,1,Trastuzumab,PACLITAXEL|FUROSEMIDE|DIGOXIN|SPIRONOLACTONE|LAPATINIB|TRASTUZUMAB,6,BREAST CANCER|CARDIAC FAILURE CONGESTIVE|CARDIAC FAILURE CONGESTIVE|CARDIAC FAILURE CONGESTIVE|BREAST CANCER|BREAST CANCER,Cardiac failure congestive,1,1
10153042,20140505,Trastuzumab,,,,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER|BREAST CANCER|BREAST CANCER METASTATIC,Blood iron decreased|Infection|Pyrexia|Ageusia|Lacrimation increased|Nausea|Decreased appetite|Arthralgia|Oropharyngeal pain,9,5
10153705,20140506,Trastuzumab,52,801,52.0,2,,1,0,0,0,0,0,1,Trastuzumab,PERTUZUMAB|TRASTUZUMAB|LEVOTHYROXINE SODIUM,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Tooth abscess,1,5
10153726,20140506,Trastuzumab,66,801,66.0,2,,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB|LAPATINIB|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN,4,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Hypokalaemia|Dehydration|Diarrhoea|Alanine aminotransferase increased|Aspartate aminotransferase increased,5,1
10153816,20140506,Trastuzumab,37,801,37.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER METASTATIC,Foetal death|Maternal exposure during pregnancy,2,1
10153817,20140506,Trastuzumab,44,801,44.0,0,90.8,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|FULVESTRANT,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Infusion related reaction|Headache|Nausea|Pain in extremity|Muscular weakness|Pain,6,2
10153855,20140506,Trastuzumab,52,801,52.0,2,,1,1,1,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Septic shock|Metastasis,2,5
10154046,20140506,Trastuzumab,70,801,70.0,2,46.5,1,0,1,0,0,0,1,Trastuzumab,LORATADINE|LORATADINE TABLET|MANNITOL|RABEPRAZOLE SODIUM|RABEPRAZOLE|GRANISETRON|GRANISETRON HYDROCHLORIDE|TRASTUZUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|FUROSEMIDE|CISPLATIN|CEFEPIME HYDROCHLORIDE|CEFEPIME|TRASTUZUMAB|APREPITANT|FOSAPREPITANT DIMEGLUMINE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|FUROSEMIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CAPECITABINE|OLANZAPINE|OLANZAPINE PAMOATE,30,RHINITIS ALLERGIC|DECREASED APPETITE|GASTRITIS|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING|NUTRITIONAL SUPPLEMENTATION|HER-2 POSITIVE GASTRIC CANCER|GASTRITIS PROPHYLAXIS|HER-2 POSITIVE GASTRIC CANCER|NUTRITIONAL SUPPLEMENTATION|HER-2 POSITIVE GASTRIC CANCER|INSOMNIA|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING|PALPITATIONS|PROPHYLAXIS OF NAUSEA AND VOMITING|DRY SKIN|GASTRITIS PROPHYLAXIS|HYPERTENSION|GASTRITIS PROPHYLAXIS|HER-2 POSITIVE GASTRIC CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING,Cholecystitis acute,1,1
10154071,20140506,Trastuzumab,,,,0,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION,Foetal death|Foetal malformation|Foetal exposure during pregnancy,3,1
10154594,20140502,Trastuzumab,50,801,50.0,2,,1,1,0,0,0,0,0,Trastuzumab,EPIRUBICIN HYDROCHLORIDE|DOCETAXEL|DOCETAXEL ANHYDROUS|DOXORUBICIN|TRASTUZUMAB,5,BREAST CANCER|BREAST CANCER|NEUTROPENIA,Functional gastrointestinal disorder|Abdominal pain|Neutropenia,3,3
10154637,20140506,Trastuzumab,,,,2,,1,1,0,0,0,0,0,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER METASTATIC,Death,1,1
10154655,20140506,Trastuzumab,54,801,54.0,2,,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER METASTATIC,Hepatic enzyme increased,1,5
10154713,20140506,Trastuzumab,43,801,43.0,2,69,1,0,0,0,0,0,1,Trastuzumab,PERTUZUMAB|TRASTUZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MELATONIN,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Blepharospasm,1,3
10154747,20140506,Trastuzumab,40,801,40.0,2,72,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB|CLONAZEPAM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|PREGABALIN|OXYCODONE|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|CALCIUM|PACLITAXEL,17,BREAST CANCER|BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION,Balance disorder|Hyperhidrosis|Mucosal dryness|Burning sensation|Constipation|Dry skin|Dyspnoea|Epistaxis|Fatigue|Hot flush|Hypersensitivity|Hypoaesthesia|Myalgia|Nausea|Oedema peripheral|Paraesthesia|Peripheral motor neuropathy|Peripheral sensory neuropathy|Pruritus|Rash|Rectal fissure|Respiratory tract infection|Urinary tract infection|Vaginal infection|Weight increased|Respiratory tract irritation|Hyperhidrosis|Myalgia|Rhinorrhoea|Oedema peripheral|Swelling|Weight decreased|Insomnia|Fluid retention|Disease progression,35,3
10155861,20140506,Trastuzumab,58,801,58.0,2,63,1,0,0,0,0,0,1,Trastuzumab,SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|TRASTUZUMAB,6,NEOADJUVANT THERAPY|MEDICATION DILUTION|PREMEDICATION|PREMEDICATION|PREMEDICATION|NEOPLASM,Anxiety|Back pain,2,5
10155875,20140506,Trastuzumab,75,801,75.0,2,73,1,0,0,0,1,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|ANASTROZOLE|ANASTROZOLE TABLETS,5,BREAST CANCER|BREAST CANCER|OSTEOPENIA|PRODUCT USED FOR UNKNOWN INDICATION,Neuropathy peripheral,1,5
10156215,20140507,Trastuzumab,54,801,54.0,2,69,1,0,1,0,0,0,0,Trastuzumab,HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|FLUOXETINE HYDROCHLORIDE|CARBAMAZEPINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,18,HER-2 POSITIVE BREAST CANCER|RENAL FAILURE|RENAL FAILURE|ANXIETY|DELIRIUM|DELIRIUM|DELIRIUM|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|HYPOTHYROIDISM|NUTRITIONAL SUPPLEMENTATION|HYPONATRAEMIA|PAIN IN EXTREMITY|PAIN IN EXTREMITY|LARYNGITIS|PHARYNGITIS|INSOMNIA,Transaminases increased,1,1
10156233,20140507,Trastuzumab,,,,0,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB|FILGRASTIM,2,GLOTTIS CARCINOMA,Death,1,3
10156499,20140507,Trastuzumab,75,801,75.0,2,53,1,1,0,0,0,0,0,Trastuzumab,GLIPIZIDE|ADO-TRASTUZUMAB EMTANSINE|SIMVASTATIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|TELMISARTAN,6,DIABETES MELLITUS|HER-2 POSITIVE BREAST CANCER|HYPERLIPIDAEMIA|HYPOTHYROIDISM|DIABETES MELLITUS|HYPERTENSION,Hyperbilirubinaemia|Transaminases increased,2,1
10156555,20140507,Trastuzumab,55,801,55.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|PERTUZUMAB,2,BREAST CANCER|BREAST CANCER,Leukaemia,1,5
10156566,20140507,Trastuzumab,64,801,64.0,1,99.2,1,1,1,1,0,0,0,Trastuzumab,OXALIPLATIN|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|BEVACIZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CAPECITABINE|TRASTUZUMAB|CAPECITABINE|LOVASTATIN|TADALAFIL,11,OESOPHAGEAL CANCER METASTATIC|OESOPHAGEAL CANCER METASTATIC|OESOPHAGEAL CANCER METASTATIC|OESOPHAGEAL CANCER METASTATIC,Myocardial infarction|Atrial fibrillation|Death|Cerebrovascular accident,4,1
10156596,20140507,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE|TRASTUZUMAB,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Disease progression,1,1
10156655,20140507,Trastuzumab,64,801,64.0,1,55,1,1,1,0,0,0,0,Trastuzumab,TRASTUZUMAB,1,GASTRIC CANCER,Ileus,1,1
10156742,20140507,Trastuzumab,60,801,60.0,2,69.01,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB|CAPECITABINE|LAPATINIB|SIMVASTATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXLANSOPRAZOLE,6,BREAST CANCER|BREAST CANCER|BREAST CANCER|NAUSEA|GASTROOESOPHAGEAL REFLUX DISEASE,Convulsion|Dysgeusia|Asthenia|Hypotension,4,5
10156778,20140507,Trastuzumab,70,801,70.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|PERTUZUMAB,2,BREAST CANCER|BREAST CANCER,Pneumonitis,1,1
10157241,20140507,Trastuzumab,38,801,38.0,2,56,1,0,1,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|CAPECITABINE|PACLITAXEL|TRASTUZUMAB|VINORELBINE|TRASTUZUMAB|CAPECITABINE|VINORELBINE|TRASTUZUMAB|PACLITAXEL,14,METASTASES TO LYMPH NODES|BREAST CANCER|METASTASES TO LYMPH NODES|BREAST CANCER|METASTASES TO LYMPH NODES|BREAST CANCER|METASTASES TO LYMPH NODES|METASTASES TO LYMPH NODES|BREAST CANCER|BREAST CANCER,Metastases to liver|Disease progression|Metastases to lung|Pyrexia|Neutrophil count decreased|Chills|Neurotoxicity|Metastases to bone|Hypoaesthesia|White blood cell count decreased|Gastrointestinal disorder,11,5
10157252,20140507,Trastuzumab,51,801,51.0,2,82.5,1,0,1,0,0,0,1,Trastuzumab,PACLITAXEL|QUETIAPINE|TRASTUZUMAB|TRASTUZUMAB,5,BREAST CANCER|BREAST CANCER|DEPRESSION|HER-2 POSITIVE BREAST CANCER,Cardiac failure|C-reactive protein increased|Depression|Dizziness|Dyspepsia|General physical health deterioration|Dry skin|Tinnitus|Dyspnoea|Injection site erythema|Pyrexia|Rash|General physical health deterioration|Fatigue|Injection site erythema|Injection site pruritus|Cardiovascular disorder|Blood pressure increased|Hypertension,19,1
10157395,20140507,Trastuzumab,72,801,72.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB,5,BREAST CANCER,Syncope|Pyrexia|Hypersensitivity|Obstructive airways disorder|Back pain|Blood glucose increased|Hypotension|Chills,8,3
10158608,20140508,Trastuzumab,58,801,58.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,BREAST CANCER,Hypertensive crisis,1,5
10158616,20140508,Trastuzumab,,,,2,,1,1,0,0,0,0,0,Trastuzumab,TRASTUZUMAB|PERTUZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cerebrovascular accident,1,5
10158618,20140508,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Echocardiogram abnormal,1,3
10158632,20140508,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Nipple exudate bloody|Breast pain|Lethargy,3,5
10158647,20140508,Trastuzumab,38,801,38.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|CARBOPLATIN|METHYLPREDNISOLONE SODIUM SUCCINATE,5,BREAST CANCER|BREAST CANCER|BREAST CANCER,Bone marrow failure|Diarrhoea|Nausea|Mucosal inflammation,4,1
10158649,20140508,Trastuzumab,,,,2,,1,1,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|CAPECITABINE,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Diarrhoea|Toxicity to various agents,2,1
10159087,20140508,Trastuzumab,66,801,66.0,2,90,1,1,1,1,0,0,1,Trastuzumab,PACLITAXEL|TRASTUZUMAB|TRASTUZUMAB,5,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Multi-organ disorder|Epistaxis|General physical health deterioration|Cardiac failure|Atrial fibrillation|Dizziness|Lacrimation increased|Tricuspid valve incompetence|Electrolyte imbalance|Erythema|Tachyarrhythmia|Sepsis|Septic shock|Paraesthesia|Pneumonia|Acute respiratory distress syndrome|Dyspnoea|Acute respiratory failure|Mitral valve incompetence|Aortic valve incompetence,20,1
10159093,20140508,Trastuzumab,49,801,49.0,2,,1,0,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|LAPATINIB|DEXCHLORPHENIRAMINE MALEATE,4,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|PREMEDICATION,Alanine aminotransferase increased,1,1
10159123,20140508,Trastuzumab,61,801,61.0,2,,1,1,0,0,0,0,1,Trastuzumab,TRASTUZUMAB|TRASTUZUMAB|CAPECITABINE|PERTUZUMAB,4,BREAST CANCER FEMALE|HER-2 POSITIVE BREAST CANCER|BREAST CANCER STAGE IV|BREAST CANCER STAGE IV,Spinal fracture|Breast cancer metastatic|Disease progression,3,1
10159184,20140508,Trastuzumab,55,801,55.0,2,,1,0,1,0,0,0,0,Trastuzumab,CAPECITABINE|TRASTUZUMAB|CAPECITABINE|LAPATINIB,7,BREAST CANCER METASTATIC|BREAST CANCER|BRAIN OEDEMA|BREAST CANCER METASTATIC|METASTASES TO CENTRAL NERVOUS SYSTEM|BREAST CANCER,Psychotic disorder|Confusional state|Cognitive disorder|Aggression|Acute psychosis|Amnesia|Paranoia,7,1
10159229,20140508,Trastuzumab,53,801,53.0,2,,1,0,1,0,0,0,0,Trastuzumab,TRASTUZUMAB|PERTUZUMAB|LORAZEPAM|PREGABALIN|LEVOTHYROXINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,8,BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER,Febrile neutropenia|Malignant neoplasm progression|Blood iron decreased|Ageusia,4,2
10159230,20140508,Trastuzumab,,,,2,,1,0,0,0,0,0,1,Trastuzumab,ADO-TRASTUZUMAB EMTANSINE,1,BREAST CANCER STAGE IV,Central nervous system lesion,1,2
10159598,20140508,Trastuzumab,52,801,52.0,2,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|TRASTUZUMAB|LEVOTHYROXINE SODIUM|BUPROPION HYDROCHLORIDE|LOSARTAN POTASSIUM,7,BREAST CANCER,Cheilitis|Lip oedema|Dry skin|Nasopharyngitis|Malaise,5,5
10159600,20140508,Trastuzumab,55,801,55.0,2,,1,0,0,0,0,0,1,Trastuzumab,"CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, X-RAY, URANIUM NITRICUM|CHONDRUS CRISPUS, FUCUS VESICULOSUS, THYROIDINUM (SUIS), CADMIUM IODATUM, IODIUM, STRONTIUM CARBONICUM, X-RAY,|CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY|MILK THISTLE|TRASTUZUMAB|MELATONIN|METOPROLOL TARTRATE|METOPROLOL|ACETAMINOPHEN, ASPIRIN, AND CAFFEINE|DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE|DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE|ERGOCALCIFEROL|COCONUT OIL|MAGNESIUM|LAPATINIB|PREGABALIN|FISH OIL|LIDOCAINE HCL, MENTHOL|LIDOCAINE HCL",33,BREAST CANCER|BREAST CANCER|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER,Dyspnoea|Vomiting|Gait disturbance|Disturbance in attention|Balance disorder|Nerve injury|Myalgia|Adverse event|Tooth extraction|Muscular weakness|Ill-defined disorder|Tension|Visual impairment|Dyspepsia|Feeling hot|Chest discomfort|Fatigue|Device failure|Anxiety|Ejection fraction decreased|Extrasystoles|Thyroid function test abnormal|Renal function test abnormal|Hypoaesthesia|Panic attack|Nasal ulcer|Epistaxis|Insomnia|Nasal congestion|Lymphoedema|Neuropathy peripheral|Heart rate irregular|Abdominal distension|Nausea|Onychalgia|Middle insomnia|Blood lactate dehydrogenase increased|Pain|Paraesthesia|Abasia|Liver function test abnormal|Hallucination|Body temperature decreased|Anaemia|Erythema|Memory impairment|Mental impairment|Chest pain|Diarrhoea|Palmar erythema|Somnolence|Pain in extremity|Dry skin|Rash|Musculoskeletal pain|Arthralgia|Hyperventilation|Cough|Weight increased|Muscle tightness|Cognitive disorder,61,5
10159629,20140508,Trastuzumab,,,,2,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|TRASTUZUMAB,2,BREAST CANCER,Fatigue|Hypersomnia,2,5
10159635,20140508,Trastuzumab,,,,2,86.5,1,0,0,0,0,0,0,Trastuzumab,"SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|TRASTUZUMAB|VALSARTAN|ESOMEPRAZOLE MAGNESIUM|LORATADINE|LORATADINE TABLET|LAPATINIB|LAPATINIB|TEMAZEPAM|CETIRIZINE HYDROCHLORIDE",12,BREAST CANCER,Therapy cessation|Diarrhoea|Surgery,3,5
10159646,20140508,Trastuzumab,51,801,51.0,2,81.8,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|TRASTUZUMAB|ATENOLOL|LOSARTAN POTASSIUM|LOSARTAN|LANSOPRAZOLE|LEVETIRACETAM|HYDROCHLOROTHIAZIDE|SIMVASTATIN|GABAPENTIN|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE,10,BREAST CANCER,Headache|Diarrhoea,2,5
10159675,20140508,Trastuzumab,61,801,61.0,2,60,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|DENOSUMAB|TRASTUZUMAB|PROMETHAZINE|LORAZEPAM,8,PRODUCT USED FOR UNKNOWN INDICATION,Epistaxis|Diarrhoea|Decreased appetite,3,5
10159684,20140508,Trastuzumab,59,801,59.0,2,73.6,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|LETROZOLE|LETROZOLE TABLETS|MAGNESIUM|CALCIUM|TRASTUZUMAB,8,BREAST CANCER METASTATIC,Laceration|Rash erythematous|Rash|Retracted nipple|Dyspnoea exertional|Breast discharge|Pain in jaw|Pain|Neuropathy peripheral,9,5
10159705,20140508,Trastuzumab,,,,2,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|CAPECITABINE|GOSERELIN|MULTIVITAMIN|TRASTUZUMAB,7,BREAST CANCER|BREAST CANCER,Diarrhoea|Pain in extremity,2,5
10159721,20140508,Trastuzumab,57,801,57.0,2,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|MULTIVITAMIN|MELATONIN|TRASTUZUMAB|CARBAMAZEPINE|BUPROPION HYDROCHLORIDE|ERGOCALCIFEROL|PROCHLORPERAZINE|CITALOPRAM|HYDROCHLOROTHIAZIDE|LEVOTHYROXINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SENNOSIDES|SENNA LEAF|SENNA|POLYETHYLENE GLYCOL 3350|OXYCODONE|OXYCODONE HYDROCHLORIDE|LIDOCAINE PATCH 5%|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|HYDROXYZINE,24,BREAST CANCER,Diarrhoea|Nausea|Vomiting|Headache|Fatigue|Rash,6,5
10159755,20140508,Trastuzumab,52,801,52.0,2,90,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|TRASTUZUMAB|OXYCODONE,3,BREAST CANCER,Diarrhoea|Myalgia|Fatigue|Malaise|Activities of daily living impaired,5,5
10159785,20140508,Trastuzumab,56,801,56.0,2,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ATENOLOL|EXEMESTANE|FULVESTRANT|FUROSEMIDE|TRASTUZUMAB|LOTEPREDNOL ETABONATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CLOPIDOGREL|MONTELUKAST SODIUM|SIMVASTATIN,14,BREAST CANCER METASTATIC,Nail disorder|Diarrhoea,2,5
10159794,20140508,Trastuzumab,56,801,56.0,2,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|TRASTUZUMAB|EXEMESTANE|VALSARTAN AND HYDROCHLOROTHIAZIDE,4,BREAST CANCER METASTATIC,Diarrhoea|Headache|Dry skin|Skin exfoliation|Dandruff|Rash generalised|Mouth ulceration|Epistaxis|Gingival bleeding|Skin haemorrhage,10,5
10159823,20140508,Trastuzumab,51,801,51.0,2,50.9,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|CAPECITABINE|ADO-TRASTUZUMAB EMTANSINE|ALPRAZOLAM|OXYCODONE,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Weight decreased|Dry eye|Dry mouth|Dry skin|Nail discolouration,6,5
10159826,20140508,Trastuzumab,63,801,63.0,2,60.9,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|TRASTUZUMAB|LETROZOLE|VITAMIN E|FISH OIL,6,BREAST CANCER,Abdominal pain upper|Diarrhoea|Dyspepsia|Pruritus|Photosensitivity reaction|Neoplasm progression|Surgery,7,5
10159848,20140508,Trastuzumab,36,801,36.0,2,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|TRASTUZUMAB|OMEPRAZOLE MAGNESIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LORAZEPAM|LORAZEPAM,8,BREAST CANCER|SKIN ULCER,Rash|Acne|Stomatitis|Nasal dryness|Epistaxis|Cheilitis|Eating disorder|Oral pain|Drug ineffective|Off label use|Stomatitis|Tongue ulceration|Lip ulceration|Pruritus|Tongue eruption|Rash generalised|Food poisoning|Diarrhoea,18,5
10159876,20140508,Trastuzumab,63,801,63.0,2,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|EXEMESTANE|TRASTUZUMAB|DENOSUMAB|HYDROCHLOROTHIAZIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FUROSEMIDE,8,BREAST CANCER,Fatigue|Diarrhoea|Arthralgia|Acne|Eczema,5,5
10159897,20140508,Trastuzumab,74,801,74.0,2,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ACYCLOVIR|OXYCODONE HYDROCHLORIDE|LISINOPRIL|CARVEDILOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CLOPIDOGREL|PREGABALIN|ATORVASTATIN CALCIUM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|LEVOTHYROXINE SODIUM|TRASTUZUMAB,14,BREAST CANCER,Drug ineffective,1,5
10159914,20140508,Trastuzumab,32,801,32.0,2,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|LORAZEPAM|ZOLPIDEM TARTRATE|TRASTUZUMAB,4,BREAST CANCER,Diarrhoea,1,5
10159929,20140508,Trastuzumab,43,801,43.0,2,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|TRASTUZUMAB,2,BREAST CANCER,Adverse event,1,1
10159931,20140508,Trastuzumab,,,,0,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|TRASTUZUMAB|DIPHENHYDRAMINE HYDROCHLORIDE,8,BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Anxiety|Ejection fraction abnormal|Chest pain|Diarrhoea|Hyperventilation|Blood test abnormal|Ejection fraction decreased|Tooth extraction,9,5
10159968,20140508,Trastuzumab,52,801,52.0,2,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|TRASTUZUMAB|ERGOCALCIFEROL,3,BREAST CANCER,Epistaxis,1,5
10159972,20140508,Trastuzumab,,,,2,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|TRASTUZUMAB|LETROZOLE|LETROZOLE TABLETS|ATENOLOL|AMLODIPINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,7,BREAST CANCER,Diarrhoea,1,5
10159995,20140508,Trastuzumab,46,801,46.0,2,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|MULTIVITAMIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TRASTUZUMAB,5,BREAST CANCER,Vomiting|Diarrhoea|Nausea,3,5
10160013,20140508,Trastuzumab,62,801,62.0,2,,1,0,0,0,0,0,0,Trastuzumab,CAPECITABINE|TRASTUZUMAB|LAPATINIB|LAPATINIB|LETROZOLE|LETROZOLE TABLETS|LAPATINIB,6,BREAST CANCER,Chromaturia|Palmar-plantar erythrodysaesthesia syndrome|Nasopharyngitis|Diarrhoea|Asthenia|Fatigue|Hepatic pain|Feeling abnormal|Rhinorrhoea|Nausea|Insomnia|Adverse drug reaction|Cough,13,5
10160033,20140508,Trastuzumab,67,801,67.0,2,,1,0,0,0,0,0,0,Trastuzumab,LAPATINIB|ERGOCALCIFEROL|TRASTUZUMAB,5,BREAST CANCER,Blood test abnormal,1,5
10160046,20140508,Trastuzumab,66,801,66.0,2,63,1,0,0,0,0,0,0,Trastuzumab,"LAPATINIB|TRASTUZUMAB|ZOLPIDEM TARTRATE|DIPHENHYDRAMINE HYDROCHLORIDE|NEBIVOLOL HYDROCHLORIDE|CALCIUM|ERGOCALCIFEROL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ESOMEPRAZOLE MAGNESIUM|MIRTAZAPINE|LEVOTHYROXINE SODIUM|DENOSUMAB",13,BREAST CANCER FEMALE,Diarrhoea|Nausea,2,5
10004046,20140312,Bevacizumab,,,,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,COLORECTAL CANCER METASTATIC,Death,1,5
10005368,20140313,Bevacizumab,48,801,48.0,2,60,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE,2,OVARIAN CANCER|OVARIAN CANCER,Pain|Vomiting|Nausea|Anaemia|Disease progression,5,1
10005435,20140313,Bevacizumab,41,801,41.0,2,68.8,1,1,1,0,0,0,0,Bevacizumab,"BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|LOMUSTINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CLOBAZAM|LEVETIRACETAM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|STANDARDIZED SENNA CONCENTRATE",12,GLIOBLASTOMA MULTIFORME|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Drug ineffective|Convulsion|Oral candidiasis|Thermal burn|Laceration|Influenza|Abdominal pain|Diarrhoea|Dysgeusia|Headache|Laceration|Stress|Nasopharyngitis|Fatigue|Constipation|Incontinence,17,1
10005439,20140313,Bevacizumab,54,801,54.0,2,61,1,1,0,1,0,0,0,Bevacizumab,BEVACIZUMAB|PACLITAXEL|PACLITAXEL,5,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|HEPATIC FUNCTION ABNORMAL|HEPATIC FUNCTION ABNORMAL,Sepsis|Herpes zoster,2,1
10005516,20140313,Bevacizumab,69,801,69.0,1,,1,0,1,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB,5,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Haemorrhage|Oesophageal rupture|Syncope|Haematemesis,4,3
10005565,20140313,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|OXALIPLATIN,5,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Metastases to lymph nodes,1,5
10005814,20140313,Bevacizumab,49,801,49.0,2,50,1,0,0,0,0,0,1,Bevacizumab,CAPECITABINE|BEVACIZUMAB|OXALIPLATIN,3,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Vomiting|Nausea|Hypertension|Disease progression|Disease progression,5,1
10005846,20140313,Bevacizumab,62,801,62.0,2,,1,0,1,0,0,0,0,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|LEVOTHYROXINE|BEVACIZUMAB|ATENOLOL AND CHLORTHALIDONE",8,RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|PREMEDICATION|PREMEDICATION,Infusion related reaction|Respiratory distress,2,3
10005878,20140313,Bevacizumab,51,801,51.0,1,,1,0,1,0,0,0,0,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|FLUOXETINE HYDROCHLORIDE|BEVACIZUMAB",9,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Ascites|Coronary artery disease|Chest pain,3,3
10005898,20140312,Bevacizumab,69,801,69.0,1,,1,0,1,0,0,0,1,Bevacizumab,"OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB",4,RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER,Angina pectoris,1,3
10005916,20140313,Bevacizumab,73,801,73.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|RAMIPRIL|SIMVASTATIN,6,OVARIAN CANCER,Atrial flutter,1,1
10006379,20140313,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,2,,Necrotising fasciitis|Diarrhoea,2,1
10007255,20140311,Bevacizumab,71,801,71.0,1,,1,0,1,0,0,0,0,Bevacizumab,"OXALIPLATIN|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB",5,COLON CANCER|METASTASES TO LIVER,Hypersensitivity vasculitis|Nephritic syndrome|Haematuria|Renal failure acute|Renal failure chronic|Nephrotic syndrome,6,3
10007377,20140312,Bevacizumab,67,801,67.0,2,40.37,1,0,1,0,0,0,0,Bevacizumab,CARBOPLATIN,3,,Abnormal behaviour,1,
10007386,20140312,Bevacizumab,80,801,80.0,1,57.2,1,0,0,0,0,0,0,Bevacizumab,CARBOPLATIN|FLUTICASONE PROPIONATE AND SALMETEROL|AMLODIPINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METOPROLOL TARTRATE|METOPROLOL|MULTIVITAMIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PRASUGREL|PROCHLORPERAZINE|LATANOPROST,18,,Dyspnoea|Cough|Pleural effusion|Pneumonia|Anaemia,5,
10008457,20140313,Bevacizumab,57,801,57.0,1,113,1,0,1,0,0,0,1,Bevacizumab,CISPLATIN|CAPECITABINE|LANSOPRAZOLE|BEVACIZUMAB|BISOPROLOL FUMARATE,7,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Atrial fibrillation|Dyspnoea|Pyrexia|Chest pain|Sinus tachycardia|Pneumonitis,6,1
10008950,20140313,Bevacizumab,58,801,58.0,2,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|OXALIPLATIN,5,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Coma|Posterior reversible encephalopathy syndrome,2,3
10009647,20140312,Bevacizumab,,,,2,,1,0,0,0,0,0,0,Bevacizumab,RUXOLITINIB|RUXOLITINIB|ATORVASTATIN CALCIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|BEVACIZUMAB|GUANFACINE|GUANFACINE HYDROCHLORIDE|GAUNFACINE|ATENOLOL,7,SPLENOMEGALY|WHITE BLOOD CELL COUNT INCREASED,Splenomegaly|White blood cell count increased|Drug ineffective,3,1
10010254,20140313,Bevacizumab,64,801,64.0,2,70,1,0,0,0,0,0,1,Bevacizumab,CAPECITABINE|BEVACIZUMAB|OXALIPLATIN,4,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Disease progression,1,1
10010260,20140313,Bevacizumab,61,801,61.0,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10010279,20140314,Bevacizumab,57,801,57.0,1,62,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,2,RENAL CANCER|RENAL CANCER,Nausea|Anaemia|Disease progression,3,1
10010293,20140314,Bevacizumab,72,801,72.0,2,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB,3,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Lethargy|Pyrexia,2,1
10010325,20140314,Bevacizumab,45,801,45.0,2,59,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,2,BREAST CANCER|BREAST CANCER,Disease progression|Disease progression,2,1
10010579,20140314,Bevacizumab,,,,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10010708,20140314,Bevacizumab,61,801,61.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|PACLITAXEL|CARBOPLATIN|APREPITANT|FOSAPREPITANT DIMEGLUMINE|FLUVASTATIN|CEVIMELINE HYDROCHLORIDE,17,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Proteinuria|Hypertension|Vitreous haemorrhage,3,1
10010756,20140314,Bevacizumab,52,801,52.0,0,62,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|DOXORUBICIN,2,OVARIAN CANCER|OVARIAN CANCER,Anaemia,1,1
10010820,20140314,Bevacizumab,66,801,66.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,3,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Cholecystitis|Hepatic artery aneurysm,2,1
10010835,20140314,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,2,METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA,Abdominal pain|Nausea|Fatigue|Dental caries|Oedema|Diarrhoea|Cystitis noninfective|Hypertension|Anaemia|Vomiting|Dizziness|Dehydration|Neutropenia,13,3
10010971,20140314,Bevacizumab,55,801,55.0,2,48.58,1,0,0,0,0,0,1,Bevacizumab,FENTANYL|MORPHINE SULFATE|LISINOPRIL|BEVACIZUMAB|CAPECITABINE,6,BREAKTHROUGH PAIN|PAIN|NAUSEA,Renal disorder|Intestinal resection|Colon cancer metastatic|Pain|Hypertension|Malaise,6,5
10011134,20140312,Bevacizumab,70,801,70.0,2,,1,0,1,0,0,0,0,Bevacizumab,CARBOPLATIN|PACLITAXEL|BEVACIZUMAB,3,OVARIAN CANCER|OVARIAN CANCER|OVARIAN CANCER,Colonic abscess|Large intestine perforation,2,3
10011278,20140311,Bevacizumab,56,801,56.0,1,,1,0,1,0,0,0,1,Bevacizumab,LOMUSTINE|LEVETIRACETAM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|BEVACIZUMAB,11,GLIOBLASTOMA|GLIOBLASTOMA,Malignant neoplasm progression|Drug ineffective|Glioblastoma|Oropharyngeal pain|Pyrexia|Convulsion|Body temperature decreased,7,
10011492,20140314,Bevacizumab,56,801,56.0,2,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB,5,RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER,Coma|Posterior reversible encephalopathy syndrome,2,3
10011517,20140314,Bevacizumab,56,801,56.0,1,,1,0,0,0,0,0,1,Bevacizumab,"BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,COLON CANCER|COLON CANCER|COLON CANCER,Proteinuria,1,1
10012185,20140314,Bevacizumab,49,801,49.0,1,,1,0,1,0,0,0,0,Bevacizumab,OXALIPLATIN|OXALIPLATIN|BEVACIZUMAB|BEVACIZUMAB,10,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Rectal obstruction|Colitis|Constipation|Abdominal pain|Febrile neutropenia|White blood cell count decreased|Neutrophil count decreased,7,1
10012229,20140314,Bevacizumab,58,801,58.0,1,78.2,1,0,1,0,0,0,1,Bevacizumab,CISPLATIN|CAPECITABINE|BEVACIZUMAB|CITALOPRAM|CITALOPRAM HYDROBROMIDE|LISINOPRIL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PROCHLORPERAZINE,9,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Haematemesis|Neutrophil count decreased|Vertigo|Infection|Nausea|Vomiting|Diarrhoea|Malaise|Neutropenia|Pancytopenia|Febrile neutropenia|Thrombocytopenia,12,
10012230,20140314,Bevacizumab,70,801,70.0,1,93.9,1,0,1,0,0,0,0,Bevacizumab,CISPLATIN|CAPECITABINE|BEVACIZUMAB,4,GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER,Lower respiratory tract infection|Dyspnoea|Asthenia|Sinusitis|Pulmonary embolism|Nasal septum deviation|Haemostasis,7,
10012244,20140314,Bevacizumab,57,801,57.0,1,113,1,0,1,0,0,0,1,Bevacizumab,CISPLATIN|CAPECITABINE|BEVACIZUMAB|BISOPROLOL FUMARATE|LANSOPRAZOLE,7,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis|Chest pain|Pyrexia|Atrial fibrillation|Sinus tachycardia|Abdominal pain,6,
10012257,20140314,Bevacizumab,71,801,71.0,1,,1,0,1,0,0,0,0,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|OXALIPLATIN|BEVACIZUMAB|BEVACIZUMAB|EZETIMIBE AND SIMVASTATIN|DHEA (DEHYDROEPIANDROSTERONE)|FISH OIL|ERGOCALCIFEROL|ALFUZOSIN HYDROCHLORIDE|ATENOLOL|ATENOLOL|DUTASTERIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|HYDROMORPHONE HYDROCHLORIDE|POLYETHYLENE GLYCOL|FENTANYL CITRATE",30,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|PAIN|NEOPLASM MALIGNANT|SUPPLEMENTATION THERAPY|BLOOD CHOLESTEROL INCREASED|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|BENIGN PROSTATIC HYPERPLASIA|HYPERTENSION|HYPERTENSION|BENIGN PROSTATIC HYPERPLASIA|NARCOLEPSY|GASTROOESOPHAGEAL REFLUX DISEASE,Sepsis|Pneumonia|Dyspnoea|Chest pain|Productive cough|Body temperature increased|Dehydration|Nausea|Vomiting|Diarrhoea,10,1
10013105,20140314,Bevacizumab,14,801,14.0,2,,1,0,0,0,0,0,0,Bevacizumab,TEMOZOLOMIDE|TEMOZOLOMIDE|BEVACIZUMAB|BEVACIZUMAB,4,GLIOBLASTOMA,Nausea,1,1
10013542,20140315,Bevacizumab,,,,0,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,COLORECTAL CANCER,Disease progression,1,3
10013549,20140315,Bevacizumab,,,,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,GLIOBLASTOMA,Death,1,5
10013552,20140315,Bevacizumab,23,801,23.0,1,66.74,1,0,0,0,0,0,1,Bevacizumab,"BEVACIZUMAB|ERGOCALCIFEROL|FISH OIL|MELATONIN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|HYPERICUM PERFORATUM|HYPERICUM|VITAMIN E",10,GLIOBLASTOMA|NAUSEA,Visual impairment|Weight fluctuation|Hypoaesthesia|Dysphonia,4,5
10013563,20140315,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Renal failure|Thrombotic microangiopathy|Proteinuria|Hypertension|Haematuria|Anaemia|Thrombocytopenia|Haptoglobin decreased,8,3
10013583,20140315,Bevacizumab,71,801,71.0,2,58,1,0,0,0,0,0,1,Bevacizumab,CAPECITABINE|BEVACIZUMAB|OXALIPLATIN,3,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Nausea|Palmar-plantar erythrodysaesthesia syndrome|Vomiting,3,1
10013593,20140315,Bevacizumab,,,,2,,1,0,1,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Small intestinal perforation|Peritonitis|Cystitis|Malignant neoplasm progression|Pleural effusion|Ascites|Computerised tomogram abnormal,7,1
10013944,20140316,Bevacizumab,34,801,34.0,1,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,RETINAL VEIN OCCLUSION,Vasculitis,1,1
10013945,20140316,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,GLIOBLASTOMA MULTIFORME,Nuclear magnetic resonance imaging abnormal,1,3
10013946,20140316,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,GLIOBLASTOMA MULTIFORME,Nuclear magnetic resonance imaging abnormal,1,3
10013948,20140316,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,GLIOBLASTOMA MULTIFORME,Nuclear magnetic resonance imaging abnormal,1,3
10014024,20140317,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,GLIOBLASTOMA MULTIFORME,Nuclear magnetic resonance imaging abnormal,1,3
10014025,20140317,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,GLIOBLASTOMA MULTIFORME,Nuclear magnetic resonance imaging abnormal,1,3
10014026,20140317,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,MENINGIOMA MALIGNANT,Nuclear magnetic resonance imaging abnormal,1,3
10014062,20140317,Bevacizumab,50,801,50.0,1,99,1,0,0,0,0,0,1,Bevacizumab,"BEVACIZUMAB|CAPECITABINE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",6,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Disease progression|Nausea|Hypertension|Proteinuria,4,1
10014390,20140317,Bevacizumab,47,801,47.0,2,56,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CAPECITABINE|PACLITAXEL,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Pain|Palmar-plantar erythrodysaesthesia syndrome|Disease progression,3,1
10014397,20140317,Bevacizumab,58,801,58.0,1,74,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,2,RENAL CANCER METASTATIC|RENAL CANCER METASTATIC,Asthenia|Pyrexia|Disease progression|Febrile neutropenia,4,1
10014412,20140317,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|SORAFENIB|AXITINIB|PAZOPANIB|PAZOPANIB HYDROCHLORIDE,6,METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA,Renal failure acute|Mucosal inflammation|Proteinuria|Cardiac failure|Thrombocytopenia|Alveolitis|Angina pectoris|Diarrhoea|Palmar-plantar erythrodysaesthesia syndrome,9,3
10014413,20140317,Bevacizumab,67,801,67.0,2,,1,1,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|PACLITAXEL,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Breast cancer metastatic|Pneumothorax|Metastases to lung|Tumour necrosis|Hypertension,5,1
10014453,20140317,Bevacizumab,54,801,54.0,2,65,1,0,0,0,1,0,0,Bevacizumab,BEVACIZUMAB|RAMIPRIL|DICLOFENAC SODIUM,3,OVARIAN CANCER|HYPERTENSION,Tendon pain|Arthralgia|Tendonitis|Myalgia|Tendon disorder,5,1
10014507,20140317,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,CAPECITABINE|OXALIPLATIN|BEVACIZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cardiac disorder|Dyspnoea,2,5
10014560,20140317,Bevacizumab,69,801,69.0,1,,1,0,1,0,0,0,0,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|OXALIPLATIN|BEVACIZUMAB|BEVACIZUMAB",8,RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER,Angina pectoris|Electrocardiogram ST segment abnormal,2,3
10014568,20140317,Bevacizumab,63,801,63.0,2,,1,0,1,0,0,0,0,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|BEVACIZUMAB",4,RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER,Arrhythmia,1,3
10015853,20140317,Bevacizumab,74,801,74.0,2,,1,1,1,0,0,0,1,Bevacizumab,"CETUXIMAB|OXALIPLATIN|PANITUMUMAB|BEVACIZUMAB|MORPHINE SULFATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PANTOPRAZOLE|SPIRONOLACTONE",16,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|HYPOTHYROIDISM|PAIN|NAUSEA|NAUSEA|PROPHYLAXIS,Hepatic lesion|Coma|Epilepsy|Renal disorder|Urinary tract disorder|Blood creatinine increased|Diarrhoea,7,5
10016677,20140317,Bevacizumab,62,801,62.0,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10016795,20140318,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,CAPECITABINE|OXALIPLATIN|BEVACIZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cardiac disorder|Dyspnoea,2,3
10016832,20140318,Bevacizumab,45,801,45.0,2,49,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|CAPECITABINE,6,COLON CANCER METASTATIC|PERITONEAL CARCINOMA METASTATIC|COLON NEOPLASM|GASTRITIS|HYPERTENSION|DIARRHOEA,Urinary tract obstruction,1,3
10016847,20140318,Bevacizumab,69,801,69.0,1,90,1,0,1,0,0,0,0,Bevacizumab,"BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|ALLOPURINOL|ATENOLOL",10,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Thrombosis in device,1,1
10016850,20140318,Bevacizumab,78,801,78.0,2,,1,0,0,0,0,0,1,Bevacizumab,RANIBIZUMAB|RANIBIZUMAB|RANIBIZUMAB|BEVACIZUMAB,4,CHOROIDAL NEOVASCULARISATION|CHOROIDAL NEOVASCULARISATION,Visual field defect,1,3
10016890,20140318,Bevacizumab,63,801,63.0,1,64,1,1,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|OXALIPLATIN|OXYCODONE HYDROCHLORIDE|IRINOTECAN HYDROCHLORIDE,14,RECTAL CANCER RECURRENT|AUTOIMMUNE HEPATITIS|CORONARY ARTERIAL STENT INSERTION|RECTAL CANCER RECURRENT|RECTAL CANCER RECURRENT|RECTAL CANCER RECURRENT|RECTAL CANCER RECURRENT|RECTAL CANCER RECURRENT|RECTAL CANCER RECURRENT,Rectal cancer|Small intestinal perforation|Impaired healing|Gastrointestinal necrosis|Small intestine ulcer|Condition aggravated,6,1
10017126,20140318,Bevacizumab,61,801,61.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|PACLITAXEL|CARBOPLATIN|INDAPAMIDE|RAMIPRIL,5,OVARIAN CANCER|HYPERTENSION|HYPERTENSION,Arthropathy|Neuropathy peripheral|Fatigue|Nausea|Arthralgia,5,1
10017250,20140318,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|CAPECITABINE|ATORVASTATIN CALCIUM|CLOPIDOGREL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|BEVACIZUMAB,11,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Catheterisation cardiac|Proctalgia|Disease progression|Rectal haemorrhage|Anorectal discomfort|Rectal discharge|Palmar-plantar erythrodysaesthesia syndrome|Adenocarcinoma|Asthenia|Dysplasia,10,1
10017453,20140318,Bevacizumab,62,801,62.0,1,56,1,0,0,0,0,0,1,Bevacizumab,CAPECITABINE|BEVACIZUMAB|OXALIPLATIN,3,COLORECTAL CANCER|COLORECTAL CANCER|COLON CANCER,Vomiting|Nausea|Palmar-plantar erythrodysaesthesia syndrome|Disease progression,4,1
10017700,20140318,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,CETUXIMAB|BEVACIZUMAB,3,,Malignant neoplasm progression,1,5
10017916,20140318,Bevacizumab,66,801,66.0,1,63.94,1,0,1,0,0,0,1,Bevacizumab,CETUXIMAB|CETUXIMAB|BEVACIZUMAB|SOTALOL HYDROCHLORIDE,4,METASTASES TO LIVER|COLORECTAL CANCER,Pyrexia|Diarrhoea|White blood cell count decreased|Decreased appetite|Insomnia|Rash pustular|Nasal dryness,7,5
10018166,20140318,Bevacizumab,56,801,56.0,1,,1,0,1,0,0,0,0,Bevacizumab,CETUXIMAB|BEVACIZUMAB|CAPECITABINE|DIPHENHYDRAMINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ATROPINE SULFATE|ATROPINE,10,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Anaphylactic reaction,1,3
10018401,20140312,Bevacizumab,47,801,47.0,2,,1,0,0,0,0,0,1,Bevacizumab,CISPLATIN|ETOPOSIDE,6,NEUROENDOCRINE CARCINOMA METASTATIC|NEUROENDOCRINE CARCINOMA METASTATIC|NEUROENDOCRINE CARCINOMA METASTATIC|NEUROENDOCRINE CARCINOMA METASTATIC,Neuropathy peripheral|Metastases to liver|Malignant neoplasm progression,3,
10018410,20140318,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,OXALIPLATIN|BEVACIZUMAB|CAPECITABINE,3,,Cardiac disorder|Dyspnoea,2,2
10018594,20140318,Bevacizumab,49,801,49.0,1,,1,1,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,4,RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC,Septic shock|Necrotising fasciitis|Renal failure acute,3,1
10018638,20140318,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,2,,Necrotising fasciitis|Diarrhoea,2,3
10018869,20140318,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,BREAST CANCER,Varices oesophageal,1,1
10018900,20140314,Bevacizumab,55,801,55.0,1,45.9,1,1,1,0,0,0,0,Bevacizumab,LEUCOVORIN CALCIUM|GRANISETRON|GRANISETRON HYDROCHLORIDE|MORPHINE SULFATE|MORPHINE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LACTULOSE|STANDARDIZED SENNA CONCENTRATE,15,,Performance status decreased,1,3
10019199,20140312,Bevacizumab,67,801,67.0,1,,1,0,1,0,0,0,0,Bevacizumab,OXALIPLATIN,6,ADENOCARCINOMA OF COLON,Chest discomfort|Flushing|Normochromic normocytic anaemia|Thrombocytopenia|Leukopenia|Febrile neutropenia|Renal tubular necrosis|Blood urine present|Gastrointestinal haemorrhage|Haemodialysis|Protein urine present,11,
10019353,20140318,Bevacizumab,75,801,75.0,1,62,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|GRANISETRON|GRANISETRON HYDROCHLORIDE|FUROSEMIDE|SPIRONOLACTONE,12,RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER,Hepatic cirrhosis|Neutrophil count decreased,2,1
10019557,20140318,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,SORAFENIB|SORAFENIB|BEVACIZUMAB,3,METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA,Hepatic encephalopathy,1,1
10020086,20140318,Bevacizumab,45,801,45.0,2,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10020101,20140318,Bevacizumab,48,801,48.0,1,60,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CAPECITABINE|OXALIPLATIN,3,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Nausea|Palmar-plantar erythrodysaesthesia syndrome,2,1
10020115,20140319,Bevacizumab,51,801,51.0,1,76,1,0,1,0,0,0,1,Bevacizumab,FISH OIL|BEVACIZUMAB|LOMUSTINE|BEVACIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,6,GLIOBLASTOMA|PRODUCT USED FOR UNKNOWN INDICATION,Dysphagia|Insomnia|Weight decreased|Glioblastoma|Fatigue|Cough|Dysphonia|Vomiting|Protein urine present|Neutrophil count increased|Drug ineffective|Gait disturbance|Nausea|Swelling face|Skin abrasion|Aphonia|Upper respiratory tract infection|White blood cell count increased|Balance disorder|Pneumonia aspiration|Oropharyngeal pain|Bacterial test positive|Neutrophil count increased,23,3
10020117,20140319,Bevacizumab,51,801,51.0,2,75.6,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|OXALIPLATIN|ACYCLOVIR|AMLODIPINE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|ENOXAPARIN SODIUM|LORAZEPAM|POLYETHYLENE GLYCOL 3350|OXYCODONE|SENNOSIDES|SENNA LEAF|SENNA,16,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Pyrexia|Tachycardia,2,1
10020137,20140319,Bevacizumab,7,800,70.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|IRINOTECAN HYDROCHLORIDE,10,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Angina unstable|Metastases to lymph nodes,2,1
10020141,20140319,Bevacizumab,62,801,62.0,2,75,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,OVARIAN CANCER,Neuropathy peripheral|Disease progression,2,1
10020149,20140319,Bevacizumab,58,801,58.0,2,54,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|CARBOPLATIN|DOXORUBICIN,3,OVARIAN CANCER|OVARIAN CANCER|OVARIAN CANCER,Renal failure acute,1,1
10020648,20140319,Bevacizumab,86,801,86.0,1,69,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|OXALIPLATIN|GRANISETRON|GRANISETRON HYDROCHLORIDE,9,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING,General physical health deterioration,1,3
10020687,20140319,Bevacizumab,69,801,69.0,1,51,1,1,1,0,0,0,1,Bevacizumab,BEVACIZUMAB,3,MALIGNANT GLIOMA|GLIOBLASTOMA|GLIOBLASTOMA,Neoplasm progression|Wound dehiscence|Cerebrospinal fluid leakage|Extradural abscess,4,1
10020903,20140319,Bevacizumab,71,801,71.0,2,87.8,1,1,0,1,0,0,1,Bevacizumab,BEVACIZUMAB|DENOSUMAB|PACLITAXEL|APREPITANT|FOSAPREPITANT DIMEGLUMINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS,9,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Coma hepatic|Neoplasm malignant|General physical health deterioration|Depressed level of consciousness|Leukopenia|Ascites|Skin necrosis|Dermatitis|Chills|Oedema peripheral|Dysphonia|Pyrexia|Mucosal inflammation|Speech disorder|Dyspnoea|Pruritus,16,1
10021173,20140319,Bevacizumab,66,801,66.0,1,63,1,1,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|CAPECITABINE|OXALIPLATIN,3,COLON CANCER|COLON CANCER|COLON CANCER,Pneumonia|Nausea,2,1
10021249,20140319,Bevacizumab,81,801,81.0,1,67,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CAPECITABINE,2,COLORECTAL CANCER|COLORECTAL CANCER,Palmar-plantar erythrodysaesthesia syndrome|Disease progression,2,1
10022105,20140319,Bevacizumab,73,801,73.0,1,75.6,1,0,1,0,0,0,0,Bevacizumab,PAZOPANIB|PAZOPANIB HYDROCHLORIDE|BEVACIZUMAB|ENOXAPARIN SODIUM|AMLODIPINE|HYDROMORPHONE HYDROCHLORIDE|METHADONE|MAGNESIUM HYDROXIDE|OMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE HYDROCHLORIDE,11,RENAL CELL CARCINOMA|RENAL CELL CARCINOMA,Atrial fibrillation,1,1
10022637,20140319,Bevacizumab,69,801,69.0,1,,1,0,0,1,0,0,0,Bevacizumab,CARBOPLATIN|PACLITAXEL|BEVACIZUMAB,3,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Gastrointestinal perforation|Treatment failure,2,3
10023118,20140320,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,RANIBIZUMAB|BEVACIZUMAB|RANIBIZUMAB|TROPICAMIDE,6,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION|PRODUCT USED FOR UNKNOWN INDICATION|NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,Injection site pain|Localised infection|Visual impairment|Visual acuity reduced|Cataract nuclear|Off label use|Skin cancer|Retinal oedema,8,1
10023137,20140320,Bevacizumab,61,801,61.0,2,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10023462,20140320,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CAPECITABINE,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cardiac disorder|Dyspnoea,2,3
10023514,20140320,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,COLORECTAL CANCER,Abdominal wall neoplasm,1,5
10023663,20140320,Bevacizumab,83,801,83.0,2,,1,0,0,0,0,0,1,Bevacizumab,RANIBIZUMAB|BEVACIZUMAB|ATENOLOL,4,AGE-RELATED MACULAR DEGENERATION|AGE-RELATED MACULAR DEGENERATION|HYPERTENSION|HYPERTENSION,Eye irritation|Headache|Eye pain|Eye haemorrhage|Sinusitis,5,5
10023866,20140320,Bevacizumab,51,801,51.0,1,,1,1,0,0,0,0,0,Bevacizumab,ERLOTINIB HYDROCHLORIDE|BEVACIZUMAB,2,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10023910,20140320,Bevacizumab,,,,1,,1,0,1,1,1,0,0,Bevacizumab,BEVACIZUMAB|CAPECITABINE|OXALIPLATIN,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Intestinal perforation,1,1
10023918,20140320,Bevacizumab,48,801,48.0,1,,1,1,0,0,0,0,0,Bevacizumab,ERLOTINIB HYDROCHLORIDE|BEVACIZUMAB,2,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10024409,20140314,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,,3,SMALL INTESTINE CARCINOMA METASTATIC,Neuropathy peripheral|Fatigue|Pleural effusion|Pain,4,5
10024596,20140320,Bevacizumab,63,801,63.0,2,80,1,0,0,0,0,0,1,Bevacizumab,CAPECITABINE|BEVACIZUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Febrile neutropenia|Anaemia|Off label use,3,1
10024812,20140319,Bevacizumab,68,801,68.0,1,97.3,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,NEOPLASM MALIGNANT,Thrombocytopenia|Transient ischaemic attack|Cerebrovascular accident,3,2
10024968,20140320,Bevacizumab,56,801,56.0,1,,1,1,0,0,0,0,1,Bevacizumab,OXALIPLATIN|DOCETAXEL|DOCETAXEL ANHYDROUS|BEVACIZUMAB,6,GASTRIC CANCER STAGE IV|GASTRIC CANCER STAGE IV|GASTRIC CANCER STAGE IV|CHEMOTHERAPY|CHEMOTHERAPY,Death|Neuropathy peripheral,2,3
10025025,20140320,Bevacizumab,57,801,57.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,2,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Cerebral infarction,1,2
10025027,20140320,Bevacizumab,49,801,49.0,1,,1,0,1,0,0,0,1,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|OXALIPLATIN|BEVACIZUMAB|BEVACIZUMAB",10,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Intestinal obstruction|Colitis|Constipation|Abdominal pain|Febrile neutropenia,5,
10025499,20140319,Bevacizumab,46,801,46.0,2,88.5,1,0,0,0,0,0,1,Bevacizumab,PACLITAXEL|CARBOPLATIN|BEVACIZUMAB|DOXORUBICIN HYDROCHLORIDE,5,BREAST CANCER,Transitional cell carcinoma|Micturition urgency|Incontinence|Pollakiuria|Urinary bladder polyp,5,3
10025507,20140320,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|CARBOPLATIN,3,OVARIAN CANCER|OVARIAN CANCER|OVARIAN CANCER,Glomerulonephritis,1,1
10026022,20140320,Bevacizumab,70,801,70.0,2,,1,0,1,0,0,0,0,Bevacizumab,CARBOPLATIN|BEVACIZUMAB|PACLITAXEL,3,OVARIAN CANCER|OVARIAN CANCER|OVARIAN CANCER,Intestinal perforation|Colonic abscess,2,3
10026077,20140320,Bevacizumab,56,801,56.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,6,COLON CANCER|COLON CANCER|COLON CANCER,Proteinuria,1,3
10026312,20140321,Bevacizumab,58,801,58.0,1,,1,0,0,0,0,0,1,Bevacizumab,"CAPECITABINE|CAPECITABINE|BEVACIZUMAB|BEVACIZUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",7,COLORECTAL CANCER RECURRENT|METASTASES TO LIVER|COLORECTAL CANCER RECURRENT|METASTASES TO LIVER,Disease progression,1,1
10026403,20140321,Bevacizumab,69,801,69.0,1,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|CAPECITABINE|OXALIPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,6,COLON CANCER|COLON CANCER|VOMITING|COLON CANCER|COLON CANCER|COLON CANCER,Renal failure acute|Diarrhoea|Hypomagnesaemia|Hypokalaemia,4,1
10026763,20140318,Bevacizumab,57,801,57.0,1,113,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|CAPECITABINE|CISPLATIN|BISOPROLOL FUMARATE|EPIRUBICIN HYDROCHLORIDE|LANSOPRAZOLE,7,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GASTRIC CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Chest pain|Chest pain|Pyrexia|Pyrexia,5,3
10026784,20140321,Bevacizumab,,,,2,50,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,BREAST CANCER,Seizure|Hypertensive crisis,2,5
10026808,20140321,Bevacizumab,,,,0,,1,1,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|OXALIPLATIN|CAPECITABINE,6,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Gastrointestinal perforation|Impaired healing|Haemorrhage|Hypertension|Embolism venous|Fistula|Embolism arterial|Cardiac failure congestive|Pulmonary embolism|Proteinuria,10,3
10026922,20140319,Bevacizumab,74,801,74.0,1,,1,0,1,0,0,0,0,Bevacizumab,,13,RECTAL CANCER METASTATIC|METASTASES TO LIVER|METASTASES TO LUNG|RECTAL CANCER METASTATIC|METASTASES TO LIVER|METASTASES TO LUNG|RECTAL CANCER METASTATIC|METASTASES TO LIVER|METASTASES TO LUNG|RECTAL CANCER METASTATIC|METASTASES TO LIVER|METASTASES TO LUNG,Hepatitis B|Metastases to liver|Metastases to lung|Malignant neoplasm progression|Rectal cancer|Stomatitis|Recurrent cancer|Drug ineffective|Hepatic failure,9,
10027023,20140321,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Renal failure|Off label use,2,1
10027194,20140321,Bevacizumab,58,801,58.0,1,60,1,0,0,0,0,0,1,Bevacizumab,"BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|RABEPRAZOLE SODIUM|RABEPRAZOLE",17,COLON CANCER RECURRENT|COLON CANCER RECURRENT|COLON CANCER RECURRENT|METASTASES TO BONE|COLON CANCER RECURRENT|COLON CANCER RECURRENT|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING,Osteomyelitis,1,1
10027391,20140321,Bevacizumab,81,801,81.0,2,,1,0,0,0,0,0,1,Bevacizumab,RANIBIZUMAB|BEVACIZUMAB,2,METAMORPHOPSIA|METAMORPHOPSIA,Retinal pigment epithelial tear|Off label use,2,1
10027425,20140321,Bevacizumab,,,,1,115,1,1,1,0,0,0,0,Bevacizumab,CARBOPLATIN|BEVACIZUMAB,3,METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA,Gastric perforation,1,5
10027932,20140319,Bevacizumab,51,801,51.0,1,60.33,1,1,0,0,0,0,0,Bevacizumab,CARBOPLATIN|PEMETREXED DISODIUM|BEVACIZUMAB|ERLOTINIB HYDROCHLORIDE,4,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Hypermetabolism|Non-small cell lung cancer|Malignant neoplasm progression,3,1
10028041,20140318,Bevacizumab,58,801,58.0,1,78.2,1,0,1,0,0,0,0,Bevacizumab,CITALOPRAM|CITALOPRAM HYDROBROMIDE|EPIRUBICIN HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PROCHLORPERAZINE|BEVACIZUMAB|CISPLATIN|CAPECITABINE|LISINOPRIL,10,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Infection|Febrile neutropenia|Haematemesis|Nausea|Diarrhoea|Mobility decreased|Vertigo|Back pain|Vomiting|Neutrophil count decreased|Malaise|Pancytopenia,12,1
10028097,20140321,Bevacizumab,65,801,65.0,2,,1,0,1,0,0,0,1,Bevacizumab,METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|CARBOPLATIN|APREPITANT|FOSAPREPITANT DIMEGLUMINE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB,20,PREMEDICATION|PREMEDICATION|OVARIAN CANCER|OVARIAN CANCER|PREMEDICATION|OVARIAN CANCER,Dermatomyositis|Myalgia|Dysphagia|Blood creatine phosphokinase increased|Lymphopenia|Aspartate aminotransferase increased,6,3
10028242,20140321,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,OXALIPLATIN|CAPECITABINE|BEVACIZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cardiac disorder|Dyspnoea,2,
10028648,20140321,Bevacizumab,55,801,55.0,2,69.8,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|BEVACIZUMAB|SIMVASTATIN|CITALOPRAM|CITALOPRAM HYDROBROMIDE,8,OVARIAN CANCER,Abdominal distension|Proteinuria|Joint stiffness|Abdominal discomfort,4,1
10028827,20140321,Bevacizumab,6,801,6.0,2,,1,0,0,0,0,0,1,Bevacizumab,"BLEOMYCIN|BLEOMYCIN SULFATE|CARBOPLATIN|CISPLATIN|DOXORUBICIN|ETOPOSIDE|ETOPOSIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|MELPHALAN HYDROCHLORIDE|MELPHALAN|BEVACIZUMAB",10,SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA,Bone marrow failure|Venoocclusive liver disease|Abdominal compartment syndrome|Febrile neutropenia|Decreased appetite|Diarrhoea,6,1
10029209,20140321,Bevacizumab,6,801,6.0,2,,1,0,0,0,0,0,1,Bevacizumab,"BLEOMYCIN|BLEOMYCIN SULFATE|CISPLATIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|ETOPOSIDE|CARBOPLATIN|MELPHALAN HYDROCHLORIDE|MELPHALAN|BEVACIZUMAB",9,,Bone marrow failure|Neutropenia|Decreased appetite|Venoocclusive liver disease|Ascites|Abdominal compartment syndrome|Renal failure|Respiratory failure,8,3
10029446,20140322,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Renal failure|Off label use,2,1
10029485,20140322,Bevacizumab,,,,2,54.48,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|METOPROLOL TARTRATE,2,OVARIAN CANCER,Cell marker increased|Hypertension|Epistaxis,3,5
10029492,20140322,Bevacizumab,59,801,59.0,2,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10029494,20140322,Bevacizumab,64,801,64.0,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|CARBOPLATIN|PACLITAXEL,3,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pulmonary cavitation|Haemorrhage,2,1
10029507,20140322,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,NON-SMALL CELL LUNG CANCER,Retinal detachment|Visual acuity reduced,2,1
10029588,20140320,Bevacizumab,48,801,48.0,1,68,1,0,1,1,0,0,0,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|ACETAZOLAMIDE SODIUM|ACETAZOLAMIDE|AMLODIPINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FAMOTIDINE|INSULIN GLARGINE|INSULIN LISPRO|LEVETIRACETAM|OXYCODONE,11,GLIOBLASTOMA MULTIFORME|REFRACTORY CANCER,Intracranial tumour haemorrhage,1,3
10029654,20140322,Bevacizumab,,,,2,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,LUNG NEOPLASM MALIGNANT,Intracranial pressure increased,1,1
10030980,20140324,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,CALCITRIOL|CALCITRIOL CAPSULES 0.25 MCG|CALCITRIOL CAPSULES 0.5 MCG|TROPICAMIDE|RANIBIZUMAB|RANIBIZUMAB|BEVACIZUMAB|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE|CLOPIDOGREL|SIMVASTATIN|FEBUXOSTAT|ERGOCALCIFEROL|GLIMEPIRIDE|RANIBIZUMAB|BEVACIZUMAB|TELMISARTAN AND HYDROCHLOROTHIAZIDE,16,DIABETIC EYE DISEASE|DIABETIC RETINOPATHY|DIABETIC RETINAL OEDEMA|DIABETIC RETINAL OEDEMA|DIABETIC RETINOPATHY,Vitreous floaters|Eye disorder|Ocular hyperaemia|Eye pruritus,4,1
10031029,20140324,Bevacizumab,,,,2,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,6,BILE DUCT CANCER|METASTASES TO GASTROINTESTINAL TRACT|MALIGNANT SPLENIC NEOPLASM|BILE DUCT CANCER|PANCREATIC CARCINOMA,Death|Off label use,2,1
10031037,20140324,Bevacizumab,17,801,17.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,ASTROCYTOMA,Amenorrhoea,1,1
10031235,20140324,Bevacizumab,,,,2,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|CAPECITABINE|TEMOZOLOMIDE,3,NEUROENDOCRINE CARCINOMA|NEUROENDOCRINE CARCINOMA,Hyponatraemia|Speech disorder|Nausea|Weight decreased|Vomiting|Malaise|Thrombocytopenia|Neutropenia|Blood chromogranin A increased|Convulsion|Mental status changes,11,3
10031381,20140324,Bevacizumab,49,801,49.0,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|CAPECITABINE,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10031405,20140324,Bevacizumab,41,801,41.0,2,,1,0,1,0,0,0,0,Bevacizumab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|CISPLATIN|BEVACIZUMAB,3,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Posterior reversible encephalopathy syndrome,1,3
10031450,20140324,Bevacizumab,52,801,52.0,1,,1,0,0,0,0,0,1,Bevacizumab,"CAPECITABINE|BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|CETUXIMAB",8,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Skin toxicity|Nerve injury|Thrombosis in device|Proteinuria|Diarrhoea,5,1
10031466,20140324,Bevacizumab,51,801,51.0,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,2,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10031821,20140324,Bevacizumab,52,801,52.0,2,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,6,RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING,Acute tonsillitis|Autoimmune thyroiditis|Adrenal insufficiency,3,1
10032128,20140324,Bevacizumab,64,801,64.0,1,74,1,1,0,0,0,0,1,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|GRANISETRON|GRANISETRON HYDROCHLORIDE|TAMSULOSIN HYDROCHLORIDE|MINOCYCLINE HYDROCHLORIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|CEFTAZIDIME|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|CLARITHROMYCIN",52,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Respiratory failure|Interstitial lung disease|Peripheral sensory neuropathy|Neuropathy peripheral|Malaise|Decreased appetite|Stomatitis,7,5
10032159,20140324,Bevacizumab,47,801,47.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CAPECITABINE,3,COLON CANCER|COLON CANCER|COLON CANCER,Tooth loss|Stomatitis,2,2
10032319,20140324,Bevacizumab,63,801,63.0,1,,1,0,0,0,0,0,1,Bevacizumab,"BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",5,COLON CANCER METASTATIC|COLON CANCER METASTATIC,Infected skin ulcer|Skin discolouration,2,1
10032393,20140320,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Necrotising fasciitis|Diarrhoea,2,
10032403,20140320,Bevacizumab,67,801,67.0,1,,1,0,1,0,0,0,0,Bevacizumab,,6,RECTAL ADENOCARCINOMA,Hyperhidrosis|Hyperpyrexia|Chills|Pyrexia|Blood pressure increased,5,3
10033295,20140324,Bevacizumab,,,,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10033323,20140325,Bevacizumab,69,801,69.0,2,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|CAPECITABINE|OXALIPLATIN|TELMISARTAN|SIMVASTATIN,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Gastroenteritis,1,3
10033438,20140325,Bevacizumab,,,,2,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,OVARIAN CANCER,Death,1,2
10033724,20140325,Bevacizumab,85,801,85.0,1,56,1,1,0,1,1,0,1,Bevacizumab,GRANISETRON|GRANISETRON HYDROCHLORIDE|AMLODIPINE|BEVACIZUMAB|PEMETREXED DISODIUM|MAGNESIUM OXIDE|ESOMEPRAZOLE MAGNESIUM|BEVACIZUMAB|FUROSEMIDE|PREGABALIN|TIZANIDINE|CARBOPLATIN,19,CONSTIPATION|NON-SMALL CELL LUNG CANCER|LUNG NEOPLASM MALIGNANT|CONSTIPATION|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Pneumonia|Disease progression|Diverticulitis|Sepsis|Intestinal perforation|Neutropenia|Colitis|Febrile neutropenia|Disseminated intravascular coagulation|C-reactive protein increased|Hypoalbuminaemia,11,1
10033871,20140325,Bevacizumab,55,801,55.0,2,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10034047,20140320,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,OXALIPLATIN|BEVACIZUMAB|CAPECITABINE,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cardiac disorder|Dyspnoea,2,
10034112,20140325,Bevacizumab,64,801,64.0,2,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,3,OVARIAN CANCER|OVARIAN CANCER|OVARIAN CANCER,Malignant neoplasm progression,1,1
10034282,20140325,Bevacizumab,57,801,57.0,1,,1,0,0,0,0,0,1,Bevacizumab,"BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,COLON CANCER|COLON CANCER|COLON CANCER,Proteinuria,1,1
10034364,20140325,Bevacizumab,61,801,61.0,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10034392,20140325,Bevacizumab,69,801,69.0,1,55,1,0,0,0,0,0,1,Bevacizumab,CAPECITABINE|BEVACIZUMAB,3,RECTAL CANCER RECURRENT|RECTAL CANCER RECURRENT|RECTAL CANCER RECURRENT,Small intestinal obstruction|Influenza|Anastomotic complication,3,1
10034552,20140325,Bevacizumab,6,801,6.0,2,,1,0,0,0,0,0,1,Bevacizumab,"CARBOPLATIN|CISPLATIN|ETOPOSIDE|BLEOMYCIN|BLEOMYCIN SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|ETOPOSIDE|MELPHALAN HYDROCHLORIDE|MELPHALAN|BEVACIZUMAB",10,SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA,Decreased appetite|Diarrhoea|Bone marrow failure|Febrile neutropenia|Venoocclusive liver disease|Abdominal compartment syndrome,6,1
10034553,20140325,Bevacizumab,6,801,6.0,2,,1,0,0,0,0,0,1,Bevacizumab,"CISPLATIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|BLEOMYCIN|BLEOMYCIN SULFATE|DOXORUBICIN|ETOPOSIDE|ETOPOSIDE|CARBOPLATIN|MELPHALAN HYDROCHLORIDE|MELPHALAN|BEVACIZUMAB",10,SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA|SMALL CELL CARCINOMA,Bone marrow failure|Febrile neutropenia|Decreased appetite|Venoocclusive liver disease|Abdominal compartment syndrome|Diarrhoea,6,1
10034556,20140325,Bevacizumab,69,801,69.0,1,,1,0,1,0,0,0,0,Bevacizumab,CARBOPLATIN|PACLITAXEL|BEVACIZUMAB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Gastric perforation,1,1
10034563,20140325,Bevacizumab,69,801,69.0,1,,1,0,0,0,0,0,1,Bevacizumab,CARBOPLATIN|PACLITAXEL|BEVACIZUMAB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Neutropenia|Proteinuria,2,1
10034565,20140325,Bevacizumab,49,801,49.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CARBOPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|CRIZOTINIB|CRIZOTINIB|PEMETREXED|PEMETREXED DISODIUM,6,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Haemolytic anaemia|Neuropathy peripheral|Fatigue|Metastases to liver|Central nervous system lesion|Hepatic function abnormal|Chromaturia|Faeces pale|Disease progression|Liver function test abnormal,10,5
10034853,20140325,Bevacizumab,64,801,64.0,2,86,1,1,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|PACLITAXEL|BEVACIZUMAB,4,FALLOPIAN TUBE CANCER|FALLOPIAN TUBE CANCER|FALLOPIAN TUBE CANCER,Pleural effusion|Palmar-plantar erythrodysaesthesia syndrome|Fatigue|Disease progression|Abdominal pain lower|Ascites,6,1
10035335,20140325,Bevacizumab,53,801,53.0,1,80,1,1,1,0,0,0,1,Bevacizumab,BEVACIZUMAB|TEMOZOLOMIDE|CEFTRIAXONE|CEFTRIAXONE SODIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,26,BRAIN NEOPLASM MALIGNANT|BRAIN NEOPLASM MALIGNANT|BRAIN NEOPLASM MALIGNANT,Multi-organ failure|Muscle spasms|Hemiparesis|Myoclonus|Deep vein thrombosis|Convulsion|Epistaxis,7,1
10036069,20140325,Bevacizumab,86,801,86.0,2,29,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,2,MALIGNANT GLIOMA,Cerebral haemorrhage|Tumour haemorrhage|Hemiplegia|Hemiplegia,4,1
10036370,20140325,Bevacizumab,68,801,68.0,2,,1,0,1,0,0,0,0,Bevacizumab,PACLITAXEL|BEVACIZUMAB|DENOSUMAB,5,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pulmonary hypertension,1,1
10036450,20140326,Bevacizumab,48,801,48.0,2,77,1,0,0,0,0,0,1,Bevacizumab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE|BEVACIZUMAB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|CARBOPLATIN|ESTRADIOL|ESTRADIOL GEL 0.1%|ESTRADIOL TRANSDERMAL|ESTRADIOL,",5,OVARIAN CANCER|OVARIAN CANCER|OVARIAN CANCER|PAIN,Liver function test abnormal,1,1
10036472,20140326,Bevacizumab,60,801,60.0,1,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,GLIOBLASTOMA,Cerebral haematoma,1,1
10036502,20140326,Bevacizumab,7,800,70.0,1,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|CARBOPLATIN,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Interstitial lung disease|Alveolitis allergic,2,1
10036712,20140326,Bevacizumab,73,801,73.0,2,46,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|CILOSTAZOL|WARFARIN,9,GLIOBLASTOMA|GLIOBLASTOMA|CONVULSION|HYPERTENSION|PLATELET AGGREGATION INHIBITION|BRAIN OEDEMA|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|ASTHMA|THROMBOSIS PROPHYLAXIS,Interstitial lung disease|Pulmonary fibrosis,2,1
10037046,20140326,Bevacizumab,55,801,55.0,2,,1,1,0,0,0,0,1,Bevacizumab,CAPECITABINE|BEVACIZUMAB|IRINOTECAN HYDROCHLORIDE,7,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Neoplasm progression|Venoocclusive liver disease|Splenomegaly|Ascites|Platelet count decreased|Abdominal distension|Hypophagia,7,1
10037157,20140326,Bevacizumab,79,801,79.0,1,66,1,0,1,0,0,0,0,Bevacizumab,OXALIPLATIN|BEVACIZUMAB,5,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Disorientation|Abdominal pain,2,1
10037274,20140326,Bevacizumab,41,801,41.0,2,,1,0,1,0,0,0,0,Bevacizumab,LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|CISPLATIN|BEVACIZUMAB,4,LUNG ADENOCARCINOMA|CONVULSION|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Posterior reversible encephalopathy syndrome|Drug ineffective,2,3
10037307,20140326,Bevacizumab,67,801,67.0,1,85,1,0,0,1,0,0,0,Bevacizumab,BEVACIZUMAB|CAPECITABINE,6,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|PROPHYLAXIS|GASTRITIS|ARTERIAL OCCLUSIVE DISEASE,Acute myeloid leukaemia,1,1
10037469,20140324,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,IRINOTECAN HYDROCHLORIDE|BEVACIZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Necrotising fasciitis,2,3
10037477,20140324,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,OXALIPLATIN|BEVACIZUMAB|CAPECITABINE,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cardiac disorder|Dyspnoea,2,3
10037529,20140326,Bevacizumab,,,,2,,1,1,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|BEVACIZUMAB|BEVACIZUMAB,6,PRODUCT USED FOR UNKNOWN INDICATION|BILE DUCT CANCER|BILE DUCT CANCER|PANCREATIC CARCINOMA|METASTASES TO GASTROINTESTINAL TRACT|MALIGNANT SPLENIC NEOPLASM,Off label use|Metastases to liver|Death,3,5
10037694,20140326,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CAPECITABINE|OXALIPLATIN,3,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Thrombosis|Metastasis|Lymphadenopathy,3,5
10037912,20140326,Bevacizumab,56,801,56.0,1,,1,0,0,0,0,0,1,Bevacizumab,"BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,COLON CANCER|COLON CANCER|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Proteinuria,1,1
10037920,20140326,Bevacizumab,48,801,48.0,1,92,1,0,1,1,0,0,1,Bevacizumab,"BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|RAMIPRIL",7,GLIOBLASTOMA|BLOOD PRESSURE INCREASED,Cerebral haemorrhage|Blood pressure increased|Toxicity to various agents|Rash|Rash|Weight increased|Headache,7,3
10038034,20140326,Bevacizumab,65,801,65.0,2,,1,0,1,0,0,0,1,Bevacizumab,APREPITANT|FOSAPREPITANT DIMEGLUMINE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|CARBOPLATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHYLPREDNISOLONE SODIUM SUCCINATE,9,,Dermatomyositis|Blood creatine phosphokinase increased|Lymphopenia|Dysphagia|Aspartate aminotransferase increased|Myalgia,6,3
10039433,20140326,Bevacizumab,64,801,64.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB,10,INVASIVE DUCTAL BREAST CARCINOMA|METASTASES TO BONE|METASTASES TO LIVER|INVASIVE DUCTAL BREAST CARCINOMA|METASTASES TO BONE|METASTASES TO LIVER|INVASIVE DUCTAL BREAST CARCINOMA|METASTASES TO BONE|METASTASES TO LIVER|INVASIVE DUCTAL BREAST CARCINOMA,Osteonecrosis of jaw,1,3
10039451,20140326,Bevacizumab,82,801,82.0,1,70,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB,6,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Pulmonary embolism|Supraventricular extrasystoles|Hypertension|Exercise tolerance decreased,4,1
10040134,20140326,Bevacizumab,,,,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10040165,20140326,Bevacizumab,61,801,61.0,2,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10040191,20140327,Bevacizumab,61,801,61.0,2,,1,0,0,0,1,0,1,Bevacizumab,BEVACIZUMAB,1,OVARIAN CANCER RECURRENT,Blindness unilateral|Optic ischaemic neuropathy,2,1
10040210,20140327,Bevacizumab,50,801,50.0,2,55,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,COLON CANCER METASTATIC,Pyrexia|Asthenia|Lung infection,3,5
10040286,20140327,Bevacizumab,65,801,65.0,2,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|CARBOPLATIN|APREPITANT|FOSAPREPITANT DIMEGLUMINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHYLPREDNISOLONE SODIUM SUCCINATE,6,OVARIAN CANCER|OVARIAN CANCER|OVARIAN CANCER|OVARIAN CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dermatomyositis|Myalgia|Dysphagia|Blood creatine phosphokinase increased|Lymphopenia|Aspartate aminotransferase increased,6,1
10040287,20140327,Bevacizumab,14,801,14.0,1,41.7,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BEVACIZUMAB|TEMOZOLOMIDE|TEMOZOLOMIDE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|BEVACIZUMAB|TEMOZOLOMIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TEMOZOLOMIDE|BEVACIZUMAB|MORPHINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,28,PRODUCT USED FOR UNKNOWN INDICATION|BRAIN NEOPLASM MALIGNANT|BRAIN NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Headache|Rash,2,1
10040299,20140327,Bevacizumab,,,,2,,1,0,1,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|SUNITINIB MALATE|SUNITINIB MALATE,5,RENAL CANCER METASTATIC|RENAL CANCER METASTATIC|RENAL CANCER METASTATIC|RENAL CANCER METASTATIC,Pneumatosis|Spinal cord compression|Confusional state|Pelvic fracture|Nephritic syndrome|Disease progression,6,1
10040630,20140327,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,COLORECTAL CANCER,Hepatic cirrhosis,1,1
10040670,20140327,Bevacizumab,66,801,66.0,2,,1,1,0,0,0,0,1,Bevacizumab,MORPHINE|FILGRASTIM|BEVACIZUMAB|CAPECITABINE|BEVACIZUMAB|OXALIPLATIN|CEFUROXIME|CEFUROXIME,9,NEUTROPENIA|COLORECTAL CANCER METASTATIC|METASTASIS|COLORECTAL CANCER METASTATIC|PYREXIA|NEUTROPENIA,Colitis ischaemic|Migraine|Diarrhoea,3,1
10040801,20140327,Bevacizumab,83,801,83.0,2,49.94,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,3,LUNG NEOPLASM MALIGNANT|GASTROOESOPHAGEAL REFLUX DISEASE,Device related infection|Heart rate irregular|Decreased appetite|Weight decreased|Pain|Epistaxis,6,5
10040961,20140326,Bevacizumab,73,801,73.0,2,51.9,1,1,1,0,0,0,0,Bevacizumab,CARBOPLATIN,3,,Hypophagia|Asthenia|Fatigue|Dysuria|Tachycardia|Blood urea increased|Blood creatinine increased|Hypovolaemia|Atrial fibrillation|Neutropenia|Urinary tract infection fungal|Hypotension|Sepsis|Respiratory disorder,14,1
10041062,20140327,Bevacizumab,71,801,71.0,1,51,1,1,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|TIOTROPIUM BROMIDE,4,LUNG ADENOCARCINOMA METASTATIC|HYPERTENSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PROPHYLAXIS,Lymphangiosis carcinomatosa|Gastrointestinal perforation|Hypertension|Cachexia|Cancer pain,5,1
10041238,20140327,Bevacizumab,,,,2,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10041331,20140327,Bevacizumab,48,801,48.0,1,92,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|EXTENDED PHENYTOIN SODIUM|EXTENDED PHENYTOIN SODIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CLONAZEPAM,7,ANAPLASTIC ASTROCYTOMA,Confusional state|Disease progression|Abdominal pain|Nasopharyngitis|White blood cell count decreased|Platelet count decreased|Monocyte count increased|Neutrophil count decreased|Eosinophil count increased|Cough|Rhinorrhoea|Off label use,12,1
10041371,20140327,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,COLORECTAL CANCER METASTATIC,Ulcer|Gastritis,2,1
10041486,20140327,Bevacizumab,70,801,70.0,2,62,1,1,0,0,0,0,0,Bevacizumab,DENOSUMAB|PEMETREXED|PEMETREXED DISODIUM|CARBOPLATIN|PACLITAXEL|GEFITINIB|AFATINIB|BEVACIZUMAB|ERLOTINIB HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|ATORVASTATIN CALCIUM|LUBIPROSTONE,21,METASTASES TO BONE,Drowning|Liver disorder|Blood creatinine increased,3,1
10041497,20140327,Bevacizumab,41,801,41.0,2,,1,0,1,0,0,0,0,Bevacizumab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|CISPLATIN|BEVACIZUMAB,3,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Posterior reversible encephalopathy syndrome,1,3
10041785,20140325,Bevacizumab,66,801,66.0,2,,1,0,1,0,0,0,0,Bevacizumab,,5,RECTAL ADENOCARCINOMA,Cardiomyopathy|Cardiogenic shock|Cerebellar infarction|Dehydration|Fatigue|Decreased appetite|Nausea|Vomiting|Sinus tachycardia|Hypomagnesaemia|Electrolyte imbalance|Vertigo,12,3
10042609,20140327,Bevacizumab,,,,1,74.46,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LEVETIRACETAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|BUPROPION HYDROCHLORIDE|ARIPIPRAZOLE|ALPRAZOLAM|ZOLPIDEM TARTRATE,8,GLIOBLASTOMA|BRAIN OEDEMA|CONVULSION|GASTROOESOPHAGEAL REFLUX DISEASE|DEPRESSION|ANXIETY,Brain oedema|Amnesia|Fatigue,3,5
10042719,20140327,Bevacizumab,73,801,73.0,2,,1,1,0,0,0,0,1,Bevacizumab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|BEVACIZUMAB|CAPECITABINE,3,CHOLANGIOCARCINOMA|CHOLANGIOCARCINOMA|CHOLANGIOCARCINOMA,Haemolytic uraemic syndrome|Death,2,1
10042926,20140328,Bevacizumab,,,,2,51,1,0,0,0,1,0,0,Bevacizumab,BEVACIZUMAB,3,OVARIAN CANCER|OVARIAN CANCER|OVARIAN CANCER,Scleroderma|Arthralgia|Antinuclear antibody increased,3,1
10042929,20140328,Bevacizumab,62,801,62.0,1,112.6,1,1,0,0,0,0,0,Bevacizumab,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|BEVACIZUMAB|ALPRAZOLAM|SORAFENIB|CARVEDILOL|IPRATROPIUM BROMIDE|OMEPRAZOLE MAGNESIUM|VITAMIN E,13,HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA,Cardiac arrest,1,1
10042932,20140328,Bevacizumab,63,801,63.0,1,98,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|IRINOTECAN HYDROCHLORIDE|IRINOTECAN HYDROCHLORIDE,8,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|CHEMOTHERAPY,Infected skin ulcer|Skin discolouration,2,1
10042933,20140328,Bevacizumab,66,801,66.0,2,57,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|ENALAPRIL,2,LUNG NEOPLASM MALIGNANT|HYPERTENSION,Pulmonary cavitation,1,1
10042944,20140328,Bevacizumab,44,801,44.0,2,49,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,4,COLON CANCER|COLON CANCER|COLON CANCER,Chest pain|Pericardial effusion,2,3
10042973,20140328,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CAPECITABINE,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Nephrotic syndrome|Proteinuria|Ascites,3,1
10042992,20140328,Bevacizumab,68,801,68.0,2,54,1,0,0,0,1,0,0,Bevacizumab,"PACLITAXEL|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|LETROZOLE|AMLODIPINE BESYLATE|EPIRUBICIN HYDROCHLORIDE|BEVACIZUMAB",8,BREAST CANCER|METASTASES TO BONE|BREAST CANCER|BREAST CANCER|HYPERTENSION|BREAST CANCER|BREAST CANCER|BREAST CANCER,Osteomyelitis,1,1
10043139,20140328,Bevacizumab,57,801,57.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,COLON CANCER,Drug ineffective|Disease progression|Metastases to liver|Metastases to heart,4,5
10043147,20140328,Bevacizumab,58,801,58.0,2,54,1,0,1,0,0,0,0,Bevacizumab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|BEVACIZUMAB|PACLITAXEL|FAMOTIDINE",7,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|ALLERGY PROPHYLAXIS|PROPHYLAXIS|ALLERGY PROPHYLAXIS,Interstitial lung disease,1,1
10043179,20140328,Bevacizumab,78,801,78.0,1,,1,1,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|SITAGLIPTIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DIGOXIN|GLIMEPIRIDE|FUROSEMIDE|INSULIN GLARGINE|RAMIPRIL,9,HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA,Acute respiratory distress syndrome|Pneumonia,2,1
10043205,20140328,Bevacizumab,67,801,67.0,2,53,1,1,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|PEMETREXED DISODIUM|CISPLATIN,5,LUNG ADENOCARCINOMA METASTATIC|LUNG ADENOCARCINOMA METASTATIC|LUNG ADENOCARCINOMA METASTATIC|LUNG ADENOCARCINOMA METASTATIC|LUNG ADENOCARCINOMA METASTATIC,Disease progression|Pancreatic enzymes increased,2,1
10043263,20140328,Bevacizumab,73,801,73.0,1,90,1,0,1,0,0,0,0,Bevacizumab,CAPECITABINE|OXALIPLATIN|ZOLPIDEM TARTRATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|BEVACIZUMAB,6,RECTAL CANCER|RECTAL CANCER|RECTAL CANCER,Malaise|Vocal cord paresis|Cranial nerve disorder,3,1
10043283,20140328,Bevacizumab,79,801,79.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,RETINAL ARTERY OCCLUSION,Eyelid oedema|Off label use,2,1
10043292,20140328,Bevacizumab,76,801,76.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,RETINAL ARTERY OCCLUSION,Punctate keratitis|Off label use,2,1
10043483,20140328,Bevacizumab,50,801,50.0,2,87,1,1,1,1,0,0,0,Bevacizumab,"BEVACIZUMAB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|DULOXETINE HYDROCHLORIDE|GABAPENTIN|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|FUROSEMIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",12,OVARIAN CANCER|OVARIAN CANCER|PAIN|SLEEP DISORDER|THROMBOSIS PROPHYLAXIS|PAIN,Renal failure acute|Urosepsis|Cardiopulmonary failure|Congestive cardiomyopathy|Ejection fraction decreased|Dyspnoea|Respiratory failure|General physical condition abnormal|Infection,9,1
10043550,20140328,Bevacizumab,67,801,67.0,1,82,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB,84,COLON CANCER|COLORECTAL CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Pyrexia|Hydronephrosis,2,1
10043723,20140327,Bevacizumab,76,801,76.0,2,66.4,1,0,0,0,0,0,1,Bevacizumab,CARBOPLATIN,3,,Electrolyte imbalance|Mental status changes|Thoracic vertebral fracture|Asthenia|Urosepsis,5,
10044162,20140328,Bevacizumab,61,801,61.0,1,57,1,0,1,0,0,0,0,Bevacizumab,PEMETREXED DISODIUM|OLANZAPINE|OLANZAPINE PAMOATE|BEVACIZUMAB|BEVACIZUMAB,9,METASTASES TO CENTRAL NERVOUS SYSTEM|CONVULSION|METASTASES TO CENTRAL NERVOUS SYSTEM|LIVER DISORDER|CONVULSION|CONVULSION,Interstitial lung disease|Off label use,2,5
10044347,20140328,Bevacizumab,59,801,59.0,1,,1,0,1,0,0,0,0,Bevacizumab,"BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB|CAPECITABINE",8,COLORECTAL CANCER|CACHEXIA|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Wound abscess|Device related infection,2,1
10044374,20140328,Bevacizumab,69,801,69.0,1,,1,0,1,0,0,0,0,Bevacizumab,CARBOPLATIN|PACLITAXEL|BEVACIZUMAB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Gastric perforation,1,1
10044386,20140328,Bevacizumab,,,,2,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,COLORECTAL CANCER,Death,1,1
10044810,20140328,Bevacizumab,64,801,64.0,1,,1,0,0,0,0,0,1,Bevacizumab,OXALIPLATIN|BEVACIZUMAB|BEVACIZUMAB,4,METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LIVER,Hepatic steatosis,1,3
10045120,20140328,Bevacizumab,72,801,72.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|MAGNESIUM|CALCIUM|ERGOCALCIFEROL|STANDARDIZED SENNA CONCENTRATE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES,8,OVARIAN CANCER|OVARIAN CANCER STAGE III,Ascites|Platelet count decreased|Local swelling|Fatigue,4,5
10045400,20140328,Bevacizumab,49,801,49.0,1,96.1,1,0,0,0,0,0,1,Bevacizumab,"CETUXIMAB|PANITUMUMAB|OXALIPLATIN|CAPECITABINE|BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",7,COLORECTAL CANCER METASTATIC,Rash|Urticaria|Pain in extremity|Chills|Nasal oedema|Erythema|Pain of skin|Neuropathy peripheral|Activities of daily living impaired,9,5
10045847,20140329,Bevacizumab,51,801,51.0,2,48,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|OXALIPLATIN,2,COLON CANCER METASTATIC|COLON CANCER METASTATIC,Loss of consciousness,1,1
10045902,20140329,Bevacizumab,,,,1,77.18,1,0,0,0,0,0,1,Bevacizumab,TEMOZOLOMIDE|SERTRALINE|METHYLPHENIDATE HYDROCHLORIDE|BEVACIZUMAB|BEVACIZUMAB,6,GLIOBLASTOMA MULTIFORME|GLIOBLASTOMA MULTIFORME|DEPRESSION|FATIGUE|GLIOBLASTOMA MULTIFORME,Deafness bilateral|Hypertension|Back pain|Protein urine present,4,5
10046001,20140330,Bevacizumab,72,801,72.0,2,,1,0,1,0,0,0,0,Bevacizumab,"PEGFILGRASTIM|BEVACIZUMAB|BEVACIZUMAB|PACLITAXEL|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",8,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Fatigue|Headache|Muscular weakness|Neutrophil count decreased|Decreased appetite|Abdominal pain,6,3
10046228,20140326,Bevacizumab,63,801,63.0,2,,1,0,1,0,0,0,0,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|BEVACIZUMAB",4,RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER,Arrhythmia,1,
10046237,20140326,Bevacizumab,17,801,17.0,2,,1,0,1,0,0,0,0,Bevacizumab,VINCRISTINE SULFATE|IRINOTECAN HYDROCHLORIDE|BEVACIZUMAB|TEMOZOLOMIDE,4,RENAL CANCER STAGE IV|RENAL CANCER STAGE IV|RENAL CANCER STAGE IV|RENAL CANCER STAGE IV,Diarrhoea|Weight decreased|Neuropathy peripheral|Febrile neutropenia|Pulmonary mass|Lymphadenopathy,6,1
10046661,20140331,Bevacizumab,62,801,62.0,1,60,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|CAPECITABINE|OXALIPLATIN,6,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Hypoglycaemia,1,1
10046693,20140331,Bevacizumab,55,801,55.0,2,60.2,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|PACLITAXEL|PACLITAXEL|PACLITAXEL,5,BREAST CANCER|BREAST CANCER,Fat necrosis,1,1
10046731,20140331,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,COLORECTAL CANCER METASTATIC,Disease progression,1,2
10046733,20140331,Bevacizumab,51,801,51.0,2,63.5,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|CAPECITABINE|CAPECITABINE|CAPECITABINE|BEVACIZUMAB|CAPECITABINE|CAPECITABINE|CAPECITABINE,9,BREAST CANCER|BREAST CANCER,Pleural effusion,1,1
10046747,20140331,Bevacizumab,,,,2,75,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB,2,BREAST CANCER,Pain|Pelvic fluid collection,2,1
10047089,20140328,Bevacizumab,80,801,80.0,1,57.2,1,0,1,0,0,0,0,Bevacizumab,CARBOPLATIN|FLUTICASONE PROPIONATE AND SALMETEROL|AMLODIPINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FERROUS SULFATE|GUAIFENESIN|METOPROLOL TARTRATE|METOPROLOL|MULTIVITAMIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PRASUGREL|PROCHLORPERAZINE|LATANOPROST,18,,Dyspnoea|Orthopnoea|Cough|Pleural effusion|Disease progression|Pneumonia|Haemoptysis,7,3
10047214,20140331,Bevacizumab,68,801,68.0,2,69,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|CARBOPLATIN|PACLITAXEL|AMOXICILLIN AND CLAVULANATE POTASSIUM|AMOXICILLIN AND CLAVULANATE POTASSIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RANITIDINE|POLYETHYLENE GLYCOL,18,OVARIAN CANCER|OVARIAN CANCER|OVARIAN CANCER,Skin ulcer|Catheter site inflammation|Catheter site abscess,3,1
10047436,20140331,Bevacizumab,76,801,76.0,1,,1,0,1,0,0,0,0,Bevacizumab,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|BEVACIZUMAB,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Haemoptysis,1,5
10047563,20140331,Bevacizumab,66,801,66.0,2,,1,1,0,0,0,0,0,Bevacizumab,HALOPERIDOL|HALOPERIDOL LACTATE|MORPHINE|CEFUROXIME|CAPECITABINE|FILGRASTIM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|CEFUROXIME|OXALIPLATIN|BEVACIZUMAB,10,PYREXIA|COLORECTAL CANCER METASTATIC|NEUTROPENIA|PYREXIA|NEUTROPENIA|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Migraine|Colitis ischaemic|Colitis|Diarrhoea,4,1
10048832,20140331,Bevacizumab,63,801,63.0,1,98,1,0,0,0,0,0,1,Bevacizumab,"BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",5,COLON CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER METASTATIC|COLON CANCER METASTATIC|CHEMOTHERAPY,Infected skin ulcer|Skin discolouration,2,1
10048836,20140331,Bevacizumab,48,801,48.0,2,,1,0,1,0,0,0,0,Bevacizumab,"BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|OXALIPLATIN|OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LABETALOL HYDROCHLORIDE|PROCHLORPERAZINE MALEATE|LIDOCAINE AND PRILOCAINE|AMLODIPINE BESYLATE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES",21,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLON CANCER,Device related infection|Discomfort|Pain|Body temperature increased|Erythema,5,1
10048845,20140331,Bevacizumab,63,801,63.0,1,,1,0,0,0,0,0,1,Bevacizumab,"BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",5,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION,Proteinuria,1,1
10049059,20140331,Bevacizumab,46,801,46.0,2,93.6,1,0,0,0,0,0,1,Bevacizumab,PACLITAXEL|DOXORUBICIN HYDROCHLORIDE|BEVACIZUMAB|CARBOPLATIN|BEVACIZUMAB,6,BREAST CANCER|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|BREAST CANCER,Bladder cancer,1,1
10049072,20140331,Bevacizumab,66,801,66.0,2,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10049088,20140331,Bevacizumab,62,801,62.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|IRINOTECAN HYDROCHLORIDE,10,RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC,Interstitial lung disease,1,1
10049095,20140331,Bevacizumab,6,800,60.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|PACLITAXEL,2,PRODUCT USED FOR UNKNOWN INDICATION,Ventricular fibrillation,1,1
10049103,20140401,Bevacizumab,,,,2,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,OVARIAN CANCER,Arrhythmia,1,1
10049117,20140401,Bevacizumab,,,,2,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,OVARIAN CANCER,Intestinal obstruction|Ascites,2,1
10049126,20140401,Bevacizumab,65,801,65.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,DIABETIC RETINAL OEDEMA,Endophthalmitis|Suspected transmission of an infectious agent via product|Product quality issue,3,3
10049133,20140401,Bevacizumab,75,801,75.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,CHOROIDAL NEOVASCULARISATION,Endophthalmitis|Suspected transmission of an infectious agent via product|Product quality issue,3,3
10049182,20140401,Bevacizumab,67,801,67.0,2,49.94,1,0,1,0,0,0,1,Bevacizumab,BEVACIZUMAB|LEFLUNOMIDE|FOLIC ACID|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISONE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ZOLPIDEM TARTRATE|BIMATOPROST|ASPIRIN,12,NON-SMALL CELL LUNG CANCER|CHEMOTHERAPY,Brain neoplasm|Protein urine present|Fatigue,3,5
10049374,20140401,Bevacizumab,77,801,77.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,DIABETIC RETINAL OEDEMA,Endophthalmitis|Suspected transmission of an infectious agent via product|Product quality issue,3,3
10049444,20140401,Bevacizumab,57,801,57.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,RETINAL VEIN OCCLUSION,Endophthalmitis|Suspected transmission of an infectious agent via product|Product quality issue,3,3
10049559,20140401,Bevacizumab,,,,2,63,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,OVARIAN CANCER,Neoplasm progression,1,1
10049566,20140331,Bevacizumab,77,801,77.0,1,85,1,0,1,0,0,0,0,Bevacizumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|BEVACIZUMAB|PROMETHAZINE HYDROCHLORIDE|WARFARIN,8,COLON CANCER,Melaena|Gastrointestinal haemorrhage,2,2
10049613,20140401,Bevacizumab,49,801,49.0,2,,1,1,1,0,0,0,0,Bevacizumab,BEVACIZUMAB,2,BREAST CANCER METASTATIC,Death,1,1
10049674,20140401,Bevacizumab,49,801,49.0,2,,1,0,1,1,0,0,0,Bevacizumab,"BEVACIZUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Haemolytic anaemia|Renal failure acute|Leukocytosis|Coagulation factor decreased|Coombs test positive|Thrombocytopenia|Myalgia|Pyrexia|Nausea|Hypertension,10,1
10049789,20140401,Bevacizumab,65,801,65.0,1,68.2,1,0,1,0,0,0,0,Bevacizumab,"BEVACIZUMAB|PREGABALIN|DOCETAXEL|DOCETAXEL ANHYDROUS|ESTAZOLAM|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED",10,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Prerenal failure,1,1
10049857,20140401,Bevacizumab,69,801,69.0,2,60.84,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB,2,COLORECTAL CANCER,Skin discolouration|Decreased appetite|Malaise|Epistaxis|Headache|Nausea|Abdominal pain upper|Weight decreased|Vomiting|Neuropathy peripheral|Asthenia,11,5
10050083,20140331,Bevacizumab,71,801,71.0,1,99.79,1,0,1,1,1,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB,2,OFF LABEL USE|AGE-RELATED MACULAR DEGENERATION,Age-related macular degeneration|Nervous system disorder|Product quality issue|Retinal degeneration|Lacrimal structure injury,5,
10050309,20140401,Bevacizumab,66,801,66.0,2,,1,1,0,0,0,0,1,Bevacizumab,OXALIPLATIN|CAPECITABINE|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|CEFUROXIME|CEFUROXIME|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|HALOPERIDOL|HALOPERIDOL LACTATE|MORPHINE|FILGRASTIM,12,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|METASTASES TO LIVER|METASTASES TO LUNG|COLORECTAL CANCER METASTATIC|PYREXIA|NEUTROPENIA|NEUTROPENIA,Colitis ischaemic|Diarrhoea|Migraine,3,2
10051762,20140402,Bevacizumab,62,801,62.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CAPECITABINE|OXALIPLATIN,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Gastrointestinal perforation|Acute abdomen,2,1
10051781,20140402,Bevacizumab,35,801,35.0,1,45,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|CAPECITABINE|OXALIPLATIN,3,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Disease progression,1,1
10051784,20140402,Bevacizumab,65,801,65.0,1,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|METHYLPREDNISOLONE|LEVETIRACETAM,6,GLIOBLASTOMA|GLIOBLASTOMA|HYPERTENSION|HYPERTENSION,Pancreatitis acute,1,1
10051810,20140402,Bevacizumab,68,801,68.0,2,58,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CAPECITABINE,4,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Spinal epidural haemorrhage,1,1
10051821,20140402,Bevacizumab,74,801,74.0,2,55,1,1,1,0,0,0,1,Bevacizumab,OXALIPLATIN|BEVACIZUMAB,2,COLON CANCER|COLON CANCER,Hepatic neoplasm|Pyrexia|Transaminases increased|Limb injury|Abdominal discomfort|Pleural effusion|Protein urine present|Condition aggravated|Syncope|Chest discomfort|Fall|Hepatic function abnormal|Decreased appetite|Ascites|Skin discolouration|Gastrointestinal wall thickening,16,1
10051827,20140402,Bevacizumab,78,801,78.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,DIABETIC RETINAL OEDEMA,Endophthalmitis|Headache|Eye pain|Product quality issue|Blindness|Ocular hyperaemia|Suspected transmission of an infectious agent via product|Off label use,8,1
10051847,20140402,Bevacizumab,50,801,50.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,CHOROIDAL NEOVASCULARISATION,Endophthalmitis|Suspected transmission of an infectious agent via product|Product quality issue,3,3
10051876,20140402,Bevacizumab,,,,2,59.7,1,0,0,0,0,0,1,Bevacizumab,"BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|LACTULOSE|OXALIPLATIN",10,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Blood test abnormal|Hypertension|White blood cell count decreased|Drug administration error|Drug ineffective|Disease progression,6,2
10052067,20140402,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB,2,COLON CANCER METASTATIC|COLON CANCER,Colon cancer metastatic|Proteinuria,2,5
10052080,20140402,Bevacizumab,,,,2,63,1,0,1,0,0,0,1,Bevacizumab,PACLITAXEL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|CARBOPLATIN|CARBOPLATIN|PACLITAXEL|BEVACIZUMAB|BEVACIZUMAB|PANTOPRAZOLE|BEVACIZUMAB|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|CARBOPLATIN,19,DEPRESSION|HYPOTHYROIDISM|COUGH|OVARIAN CANCER|NAUSEA|OVARIAN CANCER,Impaired healing|Ureteric stenosis|Lymphocele|General physical health deterioration|Seroma|Urinary tract obstruction|Hydronephrosis|Pyrexia|Anastomotic complication|Lymphocele,10,1
10052095,20140401,Bevacizumab,58,801,58.0,1,79.07,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|ZOLPIDEM TARTRATE|LORATADINE|LORATADINE TABLET|HYDROCHLOROTHIAZIDE|MELATONIN|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|SIMVASTATIN|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE,9,GLIOBLASTOMA|GLIOBLASTOMA,Cerebral infarction|Transient ischaemic attack|Speech disorder,3,3
10052102,20140402,Bevacizumab,70,801,70.0,2,56,1,0,1,0,0,0,0,Bevacizumab,PACLITAXEL|HYDROCHLOROTHIAZIDE|BEVACIZUMAB|PACLITAXEL|BEVACIZUMAB|PACLITAXEL|BEVACIZUMAB|BEVACIZUMAB|PACLITAXEL|RAMIPRIL|METOPROLOL TARTRATE|METOPROLOL|BEVACIZUMAB|BEVACIZUMAB|PACLITAXEL,18,HYPERTENSION|METASTASES TO BONE|BREAST CANCER METASTATIC|HYPERTENSIVE CRISIS|BREAST CANCER METASTATIC|HYPERTENSION|HYPERTENSIVE CRISIS|PREMEDICATION,Anaemia,1,1
10052337,20140402,Bevacizumab,54,801,54.0,1,80,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,COLON CANCER,Hepatic cyst,1,5
10052439,20140402,Bevacizumab,62,801,62.0,1,,1,1,0,0,0,0,1,Bevacizumab,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|BEVACIZUMAB|ALPRAZOLAM|SORAFENIB|CARVEDILOL|IPRATROPIUM BROMIDE,13,HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cardiac arrest,1,1
10052501,20140402,Bevacizumab,,,,1,97.61,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,COLORECTAL CANCER METASTATIC,Nervous system disorder|Malaise|Amnesia|Epistaxis,4,5
10052506,20140402,Bevacizumab,77,801,77.0,2,63.56,1,0,0,0,0,0,1,Bevacizumab,ATORVASTATIN CALCIUM|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|BEVACIZUMAB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|DOXAZOSIN|DOXAZOSIN MESYLATE|LOSARTAN POTASSIUM|LOSARTAN|ERLOTINIB HYDROCHLORIDE|ATENOLOL|FUROSEMIDE|ZOLPIDEM TARTRATE|BEVACIZUMAB|DIGOXIN|ERYTHROPOIETIN|ERLOTINIB HYDROCHLORIDE,17,BLOOD CHOLESTEROL|CARDIAC DISORDER|ANTICOAGULANT THERAPY|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|CARDIAC DISORDER|THYROID DISORDER|CARDIAC DISORDER|CARDIAC FIBRILLATION|LUNG NEOPLASM MALIGNANT,Gait disturbance|Oedema|Pruritus|Erythema|Renal failure|Rash|Rash|Alopecia|Haemorrhage|Eye discharge|Dyspnoea|Decreased appetite,12,5
10052849,20140331,Bevacizumab,63,801,63.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,7,NEUROENDOCRINE CARCINOMA|NEUROENDOCRINE CARCINOMA,Neurotoxicity|Malignant neoplasm progression|Metastases to bone|Neuroendocrine carcinoma,4,3
10052950,20140331,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,COLORECTAL CANCER RECURRENT|COLORECTAL CANCER RECURRENT|COLORECTAL CANCER RECURRENT|COLORECTAL CANCER RECURRENT,Breast abscess,1,
10052992,20140331,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB",4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Depressed level of consciousness,1,
10053121,20140402,Bevacizumab,59,801,59.0,2,,1,1,1,0,0,0,1,Bevacizumab,EVEROLIMUS|EVEROLIMUS TABLETS|EVEROLIMUS|EVEROLIMUS TABLETS|BEVACIZUMAB|LORAZEPAM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|HYDROCHLOROTHIAZIDE|ONDANSETRON HYDROCHLORIDE|OXYCODONE|OXYCODONE HYDROCHLORIDE|PROCHLORPERAZINE MALEATE|ESCITALOPRAM OXALATE|ESCITALOPRAM,11,PERIPHERAL NERVE SHEATH TUMOUR MALIGNANT|OFF LABEL USE|PERIPHERAL NERVE SHEATH TUMOUR MALIGNANT,Motor dysfunction|Peripheral nerve sheath tumour malignant|Spinal cord compression|Wound decomposition|Erythema|Secretion discharge|Neurological decompensation|Asthenia|Gait disturbance|Hypoaesthesia|Pollakiuria|Spinal cord oedema,12,1
10053507,20140402,Bevacizumab,70,801,70.0,0,,1,0,0,0,0,0,1,Bevacizumab,OXALIPLATIN|CAPECITABINE|BEVACIZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Myocardial infarction,1,1
10055209,20140403,Bevacizumab,72,801,72.0,2,,1,0,0,1,0,0,0,Bevacizumab,BEVACIZUMAB|PEMETREXED|PEMETREXED DISODIUM,2,BRONCHIAL CARCINOMA|BRONCHIAL CARCINOMA,Jejunal perforation|Metastases to abdominal cavity,2,5
10055220,20140403,Bevacizumab,49,801,49.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,DIABETIC RETINAL OEDEMA,Endophthalmitis|Suspected transmission of an infectious agent via product|Product quality issue,3,3
10055224,20140403,Bevacizumab,54,801,54.0,2,98.97,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|LISINOPRIL,2,COLORECTAL CANCER|HYPERTENSION,Muscle spasms|White blood cell count decreased,2,5
10055240,20140403,Bevacizumab,66,801,66.0,2,,1,0,0,0,0,0,1,Bevacizumab,RANIBIZUMAB|RANIBIZUMAB|BEVACIZUMAB,3,AGE-RELATED MACULAR DEGENERATION|AGE-RELATED MACULAR DEGENERATION|AGE-RELATED MACULAR DEGENERATION,Conjunctivitis|Visual acuity reduced|Vision blurred|Ocular discomfort|Visual field defect|Metamorphopsia|Ocular discomfort|Colour blindness|Headache|Drug ineffective,10,5
10055248,20140403,Bevacizumab,40,801,40.0,2,,1,1,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|PACLITAXEL,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Death|Hepatic function abnormal|Ultrasound scan abnormal|Epistaxis|Neuropathy peripheral,5,1
10055259,20140403,Bevacizumab,75,801,75.0,2,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|LOSARTAN|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|ALLOPURINOL,8,MACULAR DEGENERATION,Death,1,1
10055278,20140403,Bevacizumab,74,801,74.0,2,67,1,0,1,0,0,0,0,Bevacizumab,"OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",5,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Diarrhoea|Mucosal inflammation|Decreased appetite,3,1
10055282,20140403,Bevacizumab,69,801,69.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CAPECITABINE|IRINOTECAN HYDROCHLORIDE|PREGABALIN,5,COLON CANCER|COLON CANCER|COLON CANCER,Lip disorder|Upper limb fracture|Finger amputation|Neutrophil count decreased|Dizziness|Somnolence,6,2
10055293,20140403,Bevacizumab,74,801,74.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB,2,RETINAL TELANGIECTASIA|CHOROIDAL NEOVASCULARISATION,Endophthalmitis|Suspected transmission of an infectious agent via product|Product quality issue,3,3
10055458,20140403,Bevacizumab,65,801,65.0,2,62.6,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,OVARIAN CANCER,Rash,1,1
10055486,20140403,Bevacizumab,69,801,69.0,1,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE,19,RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC,Rectal haemorrhage|Disease progression,2,1
10056158,20140401,Bevacizumab,56,801,56.0,1,,1,0,0,0,0,0,1,Bevacizumab,,5,METASTATIC GASTRIC CANCER|METASTATIC GASTRIC CANCER|METASTATIC GASTRIC CANCER,Pneumonia|Neuropathy peripheral|Nausea|Vomiting|Small intestinal obstruction,5,
10056313,20140403,Bevacizumab,53,801,53.0,2,55,1,0,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|OXALIPLATIN,5,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Paraneoplastic dermatomyositis,1,1
10056505,20140403,Bevacizumab,69,801,69.0,1,,1,0,1,0,0,0,0,Bevacizumab,"METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|BEVACIZUMAB|BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",9,PROPHYLAXIS OF NAUSEA AND VOMITING|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|PROPHYLAXIS|COLORECTAL CANCER METASTATIC|PREMEDICATION,Chills|Epistaxis|Thrombocytopenic purpura|Thrombocytopenia|Hypotension|Pyrexia|Asthenia,7,3
10057020,20140403,Bevacizumab,66,801,66.0,2,,1,1,0,0,0,0,1,Bevacizumab,CEFUROXIME|CAPECITABINE|OXALIPLATIN|BEVACIZUMAB|BEVACIZUMAB|CEFUROXIME|BEVACIZUMAB|FILGRASTIM|HALOPERIDOL|HALOPERIDOL LACTATE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|MORPHINE,12,NEUTROPENIA|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|METASTASES TO LUNG|PYREXIA|METASTASES TO LIVER|NEUTROPENIA,Colitis ischaemic|Migraine|Diarrhoea,3,1
10057022,20140403,Bevacizumab,66,801,66.0,2,,1,1,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CAPECITABINE|CEFUROXIME|FILGRASTIM|CEFUROXIME|MORPHINE|HALOPERIDOL|HALOPERIDOL LACTATE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS,10,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|PYREXIA|NEUTROPENIA|PRODUCT USED FOR UNKNOWN INDICATION|NEUTROPENIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Colitis ischaemic|Migraine,3,3
10057023,20140403,Bevacizumab,67,801,67.0,1,,1,1,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB,8,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Post procedural haemorrhage|Gastrointestinal anastomotic leak,2,5
10057435,20140403,Bevacizumab,35,801,35.0,2,,1,0,0,0,0,0,1,Bevacizumab,EVEROLIMUS|EVEROLIMUS TABLETS|PACLITAXEL|BEVACIZUMAB,4,BREAST CANCER,Cough|Metastases to heart|Pericardial effusion,3,3
10057709,20140404,Bevacizumab,71,801,71.0,2,,1,0,1,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|CAPECITABINE|PACLITAXEL|PACLITAXEL|PACLITAXEL|PACLITAXEL|BEVACIZUMAB|EVEROLIMUS,13,HYPERTENSION|BREAST CANCER|BREAST CANCER|BREAST CANCER,Ureteral disorder|Pelvic abscess|Diabetes mellitus inadequate control|Cerebral infarction|General physical health deterioration|Malignant neoplasm progression|Cystitis|Haematuria|Bladder cancer,9,1
10057783,20140404,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXALIPLATIN|FLOXURIDINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FLOXURIDINE|BEVACIZUMAB,11,COLORECTAL CANCER|METASTASES TO LIVER|METASTASES TO LIVER|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|METASTASES TO LIVER,Abdominal pain|Diarrhoea|Aspartate aminotransferase|White blood cell disorder|Haemoglobin abnormal|Toxicity to various agents|Neurotoxicity|Vomiting|Blood alkaline phosphatase abnormal|Nausea|Mucosal inflammation|Blood bilirubin abnormal,12,1
10058004,20140403,Bevacizumab,65,801,65.0,1,88.41,1,0,0,0,0,0,1,Bevacizumab,,1,,Abdominal pain|Proteinuria,2,
10058112,20140402,Bevacizumab,,,,0,,1,0,1,0,0,0,0,Bevacizumab,,5,NEOPLASM|NEOPLASM|NEOPLASM|NEOPLASM|NEOPLASM,Hyperglycaemia,1,3
10058137,20140402,Bevacizumab,,,,0,,1,0,1,0,0,0,0,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|BEVACIZUMAB",4,NEOPLASM|NEOPLASM|NEOPLASM|NEOPLASM,Hyperglycaemia|Glucose tolerance impaired,2,3
10058286,20140403,Bevacizumab,76,801,76.0,1,90.18,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|PROCHLORPERAZINE|LORAZEPAM|IRBESARTAN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|AMLODIPINE|CARVEDILOL|PROMETHAZINE|MAGNESIUM HYDROXIDE|SIMETHICONE|DIMETHICONE|NITROGLYCERIN|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|TEMAZEPAM|CEFEPIME HYDROCHLORIDE|CEFEPIME|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PROMETHAZINE|OXYGEN|0XYGEN|SIMETHICONE|DIMETHICONE|NITROGLYCERIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALPRAZOLAM|AMLODIPINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CARVEDILOL|FAMOTIDINE|FILGRASTIM,43,,Diarrhoea|Syncope|Fatigue|Dehydration|Leukopenia|Neutropenia|Dizziness,7,1
10058374,20140403,Bevacizumab,76,801,76.0,1,85.82,1,0,1,0,0,0,0,Bevacizumab,LEUCOVORIN CALCIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PROCHLORPERAZINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|AMLODIPINE|CARVEDILOL|PROMETHAZINE|MAGNESIUM HYDROXIDE|SIMETHICONE|DIMETHICONE|NITROGLYCERIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXTROSE MONOHYDRATE|DEXTROSE|ZOLPIDEM TARTRATE|BENZOCAINE AND MENTHOL|CETYLPYRIDINIUM CHLORIDE|BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM,35,,Oesophageal infection|Diarrhoea|Dehydration|Fatigue|Vomiting|Nausea|Decreased appetite,7,1
10058382,20140404,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CARBOPLATIN|PACLITAXEL,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Febrile neutropenia|Neutropenia|Proteinuria|Hypertension|Neuropathy peripheral|Deep vein thrombosis,6,3
10058386,20140404,Bevacizumab,45,801,45.0,2,49,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,4,COLON CANCER|COLON CANCER|COLON CANCER,Chest pain|Pericardial effusion,2,2
10058555,20140404,Bevacizumab,78,801,78.0,1,,1,1,1,0,0,0,0,Bevacizumab,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|BEVACIZUMAB|BEVACIZUMAB|SITAGLIPTIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DIGOXIN|GLIMEPIRIDE|INSULIN GLARGINE|RAMIPRIL|METOPROLOL TARTRATE|METOPROLOL,12,HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonia|Acute respiratory distress syndrome,2,5
10058611,20140402,Bevacizumab,41,801,41.0,2,,1,0,1,0,0,0,0,Bevacizumab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|CISPLATIN|BEVACIZUMAB,3,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Posterior reversible encephalopathy syndrome|Drug ineffective,2,
10058675,20140404,Bevacizumab,57,801,57.0,2,,1,0,0,0,0,0,1,Bevacizumab,SULFAMETHOXAZOLE AND TRIMETHOPRIM|LEVETIRACETAM|AMLODIPINE|ALPRAZOLAM,12,GLIOBLASTOMA|FEBRILE NEUTROPENIA|GLIOBLASTOMA,Toxic skin eruption,1,3
10058708,20140402,Bevacizumab,69,801,69.0,1,,1,0,1,0,0,0,0,Bevacizumab,,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Gastrointestinal perforation,1,
10059765,20140402,Bevacizumab,10,801,10.0,1,,1,0,0,0,0,0,1,Bevacizumab,,2,PRODUCT USED FOR UNKNOWN INDICATION,Rash|Lip swelling,2,1
10060374,20140404,Bevacizumab,48,801,48.0,0,,1,1,0,0,0,0,0,Bevacizumab,"OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB",4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10060962,20140405,Bevacizumab,58,801,58.0,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10060965,20140405,Bevacizumab,,,,0,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10060973,20140405,Bevacizumab,57,801,57.0,1,83.99,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CISPLATIN|PEMETREXED DISODIUM,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Renal disorder|Haemoptysis|Breath odour|Skin odour abnormal|Infection|Asthenia|Weight increased,7,1
10060986,20140405,Bevacizumab,63,801,63.0,1,,1,1,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|CAPECITABINE|OXALIPLATIN,3,RECTAL CANCER|RECTAL CANCER|RECTAL CANCER,Gastrointestinal perforation|Acute respiratory failure|Sepsis|Pulmonary embolism|Multi-organ failure|Diarrhoea|Pyrexia,7,1
10061005,20140405,Bevacizumab,69,801,69.0,1,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|APREPITANT|FOSAPREPITANT DIMEGLUMINE,28,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|PROPHYLAXIS|VOMITING|PROPHYLAXIS|COLORECTAL CANCER METASTATIC|PREMEDICATION,Chills|Epistaxis|Thrombocytopenic purpura|Thrombocytopenia,4,1
10061010,20140405,Bevacizumab,22,801,22.0,2,,1,1,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|MITOMYCIN|CISPLATIN,3,COLON CANCER|COLON CANCER|COLON CANCER,Disease progression|Renal failure chronic,2,1
10061011,20140405,Bevacizumab,69,801,69.0,1,,1,0,1,0,0,0,0,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB",3,RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC,Proctitis|Condition aggravated|Rectal haemorrhage,3,3
10061182,20140407,Bevacizumab,71,801,71.0,1,80,1,0,0,0,1,0,0,Bevacizumab,BEVACIZUMAB|DENOSUMAB|PACLITAXEL,4,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Osteonecrosis of jaw|Gingival inflammation|Weight decreased,3,2
10061252,20140407,Bevacizumab,69,801,69.0,1,80,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|OXALIPLATIN|CAPECITABINE,3,COLORECTAL CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia|Pyrexia,2,1
10061284,20140407,Bevacizumab,,,,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,BRAIN NEOPLASM MALIGNANT,Death,1,5
10061309,20140407,Bevacizumab,71,801,71.0,2,46,1,1,0,0,0,0,0,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB",11,VOMITING|VOMITING|VOMITING|COLON CANCER|COLON CANCER|HYPERTENSION|PAIN|COLON CANCER|COLON CANCER|VOMITING,Cardiac arrest,1,1
10061323,20140407,Bevacizumab,77,801,77.0,1,78,1,0,1,1,0,0,0,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|OXALIPLATIN,7,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Stomatitis|Nausea|Infection|General physical health deterioration|Fatigue,5,1
10061324,20140407,Bevacizumab,59,801,59.0,1,113.5,1,1,0,0,0,0,0,Bevacizumab,"BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN",4,COLORECTAL CANCER|COLON CANCER|COLON CANCER,Death|Paraesthesia|Neuropathy peripheral|Constipation|Neoplasm|White blood cell count decreased|Fluid retention,7,5
10061385,20140407,Bevacizumab,63,801,63.0,2,50,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|RAMIPRIL|BISOPROLOL FUMARATE|INDAPAMIDE,9,OVARIAN CANCER STAGE III|OVARIAN CANCER STAGE III|BREAST CANCER|HYPERTENSION|HYPERTENSION|HYPERTENSION|HYPERCHOLESTEROLAEMIA|ANXIETY|PROPHYLAXIS,Blood pressure increased|Cough|Back pain|Photopsia|Erythema|Throat tightness|Visual impairment,7,2
10061525,20140407,Bevacizumab,,,,0,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Disease progression,1,1
10061633,20140403,Bevacizumab,52,801,52.0,1,,1,0,0,0,0,0,1,Bevacizumab,,3,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Pulmonary embolism,1,3
10062033,20140407,Bevacizumab,61,801,61.0,1,60,1,0,1,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB,2,COLON CANCER,Platelet count decreased|White blood cell count decreased|General physical health deterioration|Intestinal obstruction,4,5
10062192,20140407,Bevacizumab,51,801,51.0,2,55,1,0,0,0,0,0,1,Bevacizumab,RIVAROXABAN|RIVAROXABAN|BEVACIZUMAB|DICLOFENAC SODIUM,6,JUGULAR VEIN THROMBOSIS|JUGULAR VEIN THROMBOSIS,Subclavian vein thrombosis|Drug ineffective,2,1
10063733,20140407,Bevacizumab,70,801,70.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|PACLITAXEL,2,BREAST CANCER|BREAST CANCER,Pneumothorax,1,1
10063786,20140408,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,LUNG NEOPLASM MALIGNANT,Brain neoplasm malignant|Bone cancer,2,5
10063832,20140408,Bevacizumab,69,801,69.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,COLON CANCER METASTATIC,Skin necrosis,1,1
10064000,20140408,Bevacizumab,61,801,61.0,2,82,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|CISPLATIN|PEMETREXED|PEMETREXED DISODIUM,6,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Herpes zoster|Superinfection bacterial,2,3
10064021,20140408,Bevacizumab,,,,1,65,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB,2,NEUROFIBROMATOSIS,Meningioma surgery|Disease progression|Off label use,3,1
10064036,20140408,Bevacizumab,74,801,74.0,2,,1,0,0,1,0,0,0,Bevacizumab,CAPECITABINE|BEVACIZUMAB|OXALIPLATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PROPRANOLOL HYDROCHLORIDE|BUMETANIDE,9,COLON CANCER|COLON CANCER|COLON CANCER,Large intestine perforation,1,1
10064131,20140408,Bevacizumab,62,801,62.0,1,56.3,1,1,1,0,0,0,1,Bevacizumab,BEVACIZUMAB|HYDROMORPHONE HYDROCHLORIDE,2,COLORECTAL CANCER METASTATIC,Exploratory operation|Small intestine polyp|Weight decreased|Peritonitis,4,5
10064265,20140408,Bevacizumab,69,801,69.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CARBOPLATIN,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Treatment failure|Intestinal perforation,2,1
10064271,20140408,Bevacizumab,69,801,69.0,1,,1,0,0,0,0,0,1,Bevacizumab,CARBOPLATIN|BEVACIZUMAB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Protein urine present|Treatment failure|Disease progression|Neutropenia,4,1
10064280,20140408,Bevacizumab,71,801,71.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CARBOPLATIN,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Haemoglobin decreased|Platelet count decreased|Infection|Treatment failure|Disease progression|Neutropenia,6,1
10064340,20140408,Bevacizumab,70,801,70.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CARBOPLATIN,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Hypertension|Neutropenia|Haemoglobin decreased|Treatment failure|Disease progression,5,1
10064436,20140404,Bevacizumab,69,801,69.0,1,58,1,0,1,0,0,0,0,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|GRANISETRON|GRANISETRON HYDROCHLORIDE|CEFTAZIDIME|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",20,COLORECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER,Malaise|Neuropathy peripheral|Haemoptysis|Interstitial lung disease,4,3
10064453,20140408,Bevacizumab,56,801,56.0,2,47,1,0,1,0,0,0,0,Bevacizumab,"BEVACIZUMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CAPECITABINE|KETOPROFEN|LANSOPRAZOLE",8,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Pyrexia|Enteritis,2,1
10064517,20140408,Bevacizumab,76,801,76.0,1,,1,0,1,0,0,0,0,Bevacizumab,"LORATADINE|LORATADINE ORAL|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|INTERLEUKIN-11|INTERLEUKIN-5|INTERLEUKIN-3|INTERLEUKIN-10|FILGRASTIM|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|FAMOTIDINE|FAMOTIDINE|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE|ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE|ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE|ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE|ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES|FUROSEMIDE|FUROSEMIDE|BEVACIZUMAB|CARBOPLATIN|PACLITAXEL|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|DEXTROMETHORPHAN HYDROBROMIDE|DEXTROMETHORPHAN HYDROBROMIDE|ESOMEPRAZOLE SODIUM|ESOMEPRAZOLE SODIUM|ACETYLCYSTEINE|MOXIFLOXACIN HYDROCHLORIDE|MEGESTROL ACETATE|MEGESTROL ACETATE|MEGESTROL ACETATE|GLUTATHIONE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|RANITIDINE HYDROCHLORIDE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE",304,RHINITIS ALLERGIC|DYSPEPSIA|THROMBOCYTOPENIA|NEUTROPENIA|PEPTIC ULCER|RHINITIS ALLERGIC|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|UPPER RESPIRATORY TRACT INFECTION|COUGH|UPPER RESPIRATORY TRACT INFECTION|COUGH|POSTOPERATIVE WOUND INFECTION|HYPOVITAMINOSIS|HYPOVITAMINOSIS,Proteinuria,1,1
10066370,20140408,Bevacizumab,50,801,50.0,2,51,1,0,0,0,0,0,1,Bevacizumab,REGORAFENIB|REGORAFENIB|BEVACIZUMAB|CAPECITABINE|OXALIPLATIN,5,COLORECTAL CANCER|COLORECTAL CANCER,Blood creatine phosphokinase increased|Malaise|Platelet count decreased|Myalgia|Headache|Hypertension|Pyrexia|White blood cell count decreased|Aspartate aminotransferase increased|Blood lactate dehydrogenase increased,10,1
10066575,20140408,Bevacizumab,57,801,57.0,1,113,1,0,1,0,0,0,0,Bevacizumab,CISPLATIN|CISPLATIN|CAPECITABINE|CAPECITABINE|BEVACIZUMAB|BISOPROLOL FUMARATE|LANSOPRAZOLE,10,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Chest pain|Pyrexia,2,3
10066655,20140408,Bevacizumab,73,801,73.0,2,42,1,0,1,0,0,0,1,Bevacizumab,BEVACIZUMAB|DENOSUMAB|BEVACIZUMAB|METHYLPREDNISOLONE|ESOMEPRAZOLE MAGNESIUM|SITAGLIPTIN|HUMAN INSULIN,24,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTASES TO BONE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hepatic enzyme abnormal|White blood cell count decreased|Hypophosphataemia|Back pain|Subileus|Blood potassium decreased,6,1
10066761,20140408,Bevacizumab,58,801,58.0,1,,1,0,1,0,0,0,0,Bevacizumab,OXALIPLATIN|OXALIPLATIN|BEVACIZUMAB|BEVACIZUMAB,9,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Deep vein thrombosis|Oedema peripheral|Pain in extremity|Erythema|Limb discomfort,5,5
10066883,20140408,Bevacizumab,82,801,82.0,1,,1,0,1,0,0,0,0,Bevacizumab,CAPECITABINE|BEVACIZUMAB,2,COLON CANCER|COLON CANCER,Pneumonia,1,2
10066891,20140408,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|RAMIPRIL,3,BRONCHIAL CARCINOMA|HYPERTENSION|DYSLIPIDAEMIA,Myocardial infarction|Thrombosis|Ventricular fibrillation,3,1
10066919,20140409,Bevacizumab,57,801,57.0,1,,1,0,0,0,0,0,1,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|BEVACIZUMAB|BEVACIZUMAB",6,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|HYPERCHOLESTEROLAEMIA,Deep vein thrombosis|Pain in extremity|Oedema peripheral|Collateral circulation|Tachycardia,5,
10067073,20140409,Bevacizumab,,,,2,64,1,0,1,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|LISINOPRIL|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|PACLITAXEL|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|CARBOPLATIN,25,OVARIAN EPITHELIAL CANCER|PRODUCT USED FOR UNKNOWN INDICATION|OVARIAN EPITHELIAL CANCER|OVARIAN EPITHELIAL CANCER|OVARIAN EPITHELIAL CANCER,White blood cell count decreased|Neutrophil count decreased|Hyponatraemia|Platelet count decreased,4,1
10067149,20140409,Bevacizumab,57,801,57.0,2,,1,0,0,0,0,0,1,Bevacizumab,LEVETIRACETAM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|AMLODIPINE|BEVACIZUMAB|ALPRAZOLAM,12,FEBRILE NEUTROPENIA|GLIOBLASTOMA|GLIOBLASTOMA,Toxic skin eruption,1,3
10067469,20140409,Bevacizumab,56,801,56.0,2,98,1,0,1,0,0,0,1,Bevacizumab,BEVACIZUMAB,3,COLON CANCER,Loss of consciousness|Hypersensitivity|Hyperhidrosis|Nausea|Chest pain|Product substitution issue,6,2
10067777,20140409,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,RITUXIMAB|BEVACIZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10067779,20140409,Bevacizumab,65,801,65.0,0,,1,0,0,0,0,0,1,Bevacizumab,RITUXIMAB|BEVACIZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10067789,20140409,Bevacizumab,48,801,48.0,0,,1,0,0,0,0,0,1,Bevacizumab,"FLUDARABINE PHOSPHATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|RITUXIMAB|BEVACIZUMAB",5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10067814,20140409,Bevacizumab,76,801,76.0,0,,1,0,0,0,0,0,1,Bevacizumab,"FLUDARABINE PHOSPHATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|BEVACIZUMAB",4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression|Bone marrow failure,2,1
10068547,20140409,Bevacizumab,57,801,57.0,1,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB,12,RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC,Agranulocytosis|Thrombocytopenia,2,3
10068810,20140409,Bevacizumab,71,801,71.0,1,,1,0,1,0,0,0,1,Bevacizumab,OXALIPLATIN|LEUCOVORIN CALCIUM|BEVACIZUMAB,5,COLON CANCER METASTATIC|COLON CANCER METASTATIC|ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON,Gastrointestinal obstruction|Adenocarcinoma|Head and neck cancer metastatic|Metastases to lymph nodes|Metastases to central nervous system|Metastases to lung|Oesophagitis|Stomatitis|Mucosal inflammation|Nausea|Weight decreased,11,3
10068837,20140409,Bevacizumab,55,801,55.0,1,,1,0,1,0,0,0,1,Bevacizumab,"CAPECITABINE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|BEVACIZUMAB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|OXALIPLATIN",18,COLON CANCER|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|COLON CANCER,Sinus tachycardia|Nausea|Tachycardia|Central nervous system lesion|Malignant neoplasm progression|Blood creatinine increased|Blood albumin decreased|Diarrhoea|Dehydration|Acquired diaphragmatic eventration|Vomiting|General physical health deterioration|Pleural effusion|Blood potassium decreased|Bundle branch block left,15,5
10069354,20140410,Bevacizumab,,,,0,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10069365,20140410,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,GLIOBLASTOMA MULTIFORME,Activities of daily living impaired|Aphasia,2,5
10069367,20140410,Bevacizumab,11,801,11.0,2,,1,0,0,0,0,0,1,Bevacizumab,TEMOZOLOMIDE|VINCRISTINE SULFATE|IRINOTECAN HYDROCHLORIDE|BEVACIZUMAB,4,NEPHROBLASTOMA|NEPHROBLASTOMA|NEPHROBLASTOMA|NEPHROBLASTOMA,Packed red blood cell transfusion|Nausea|Vomiting|Weight decreased|Diarrhoea,5,1
10069370,20140410,Bevacizumab,7,801,7.0,1,,1,0,0,0,0,0,1,Bevacizumab,TEMOZOLOMIDE|VINCRISTINE SULFATE|IRINOTECAN HYDROCHLORIDE|BEVACIZUMAB,4,NEPHROBLASTOMA|NEPHROBLASTOMA|NEPHROBLASTOMA|NEPHROBLASTOMA,Packed red blood cell transfusion|Diarrhoea|Epistaxis|Nausea|Vomiting|Therapy responder,6,5
10069372,20140410,Bevacizumab,17,801,17.0,2,,1,0,1,0,0,0,1,Bevacizumab,TEMOZOLOMIDE|VINCRISTINE SULFATE|IRINOTECAN HYDROCHLORIDE|BEVACIZUMAB,4,NEPHROBLASTOMA|NEPHROBLASTOMA|NEPHROBLASTOMA|NEPHROBLASTOMA,Platelet transfusion|Packed red blood cell transfusion|Febrile neutropenia|Diarrhoea|Weight decreased|Neuropathy peripheral,6,1
10069377,20140410,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|SORAFENIB,2,METASTATIC RENAL CELL CARCINOMA|METASTATIC RENAL CELL CARCINOMA,Palmar-plantar erythrodysaesthesia syndrome|Diarrhoea,2,3
10069379,20140410,Bevacizumab,8,801,8.0,1,,1,0,0,0,0,0,1,Bevacizumab,TEMOZOLOMIDE|VINCRISTINE SULFATE|IRINOTECAN HYDROCHLORIDE|BEVACIZUMAB,4,NEPHROBLASTOMA|NEPHROBLASTOMA|NEPHROBLASTOMA|NEPHROBLASTOMA,Platelet transfusion|Packed red blood cell transfusion|Hypertension|Diarrhoea,4,1
10069573,20140410,Bevacizumab,44,801,44.0,2,59,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|CANDESARTAN|BEVACIZUMAB,4,BREAST CANCER|BREAST CANCER,Anxiety|Palpitations,2,1
10069683,20140410,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Lower limb fracture,1,1
10069710,20140410,Bevacizumab,71,801,71.0,1,52,1,0,1,0,0,0,0,Bevacizumab,CAPECITABINE|CAPECITABINE|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|CETUXIMAB|DULOXETINE HYDROCHLORIDE,20,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Febrile neutropenia|Pneumonitis|Pneumonia bacterial|Neuropathy peripheral,4,1
10069727,20140410,Bevacizumab,37,801,37.0,1,,1,1,0,0,0,0,0,Bevacizumab,PACLITAXEL|BEVACIZUMAB|CAPECITABINE|BEVACIZUMAB,4,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Death|Breast cancer metastatic|Diarrhoea infectious,3,1
10070136,20140409,Bevacizumab,56,801,56.0,1,77.57,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,COLON CANCER,Erythema|Flushing|Chest discomfort,3,2
10070988,20140410,Bevacizumab,55,801,55.0,2,,1,1,1,0,0,0,0,Bevacizumab,FONDAPARINUX SODIUM|LEVETIRACETAM,9,PRODUCT USED FOR UNKNOWN INDICATION|GLIOBLASTOMA,Cerebral haemorrhage|Altered state of consciousness|Incorrect drug administration duration,3,1
10071414,20140410,Bevacizumab,45,801,45.0,2,,1,0,1,0,0,0,1,Bevacizumab,BEVACIZUMAB,2,ASTROCYTOMA|ASTROCYTOMA,Intracranial aneurysm|Subarachnoid haemorrhage|Hydrocephalus,3,3
10071610,20140410,Bevacizumab,57,801,57.0,1,105,1,0,0,0,0,0,1,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB|OXALIPLATIN|CAPECITABINE|BEVACIZUMAB|CAPECITABINE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB|CAPECITABINE",12,RECTAL CANCER|RECTAL CANCER|METASTASES TO LIVER|RECTAL CANCER|METASTASES TO LIVER|METASTASES TO LIVER|RECTAL CANCER|RECTAL CANCER,Disease progression,1,1
10071660,20140411,Bevacizumab,67,801,67.0,2,61.5,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|PACLITAXEL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Cardiac arrest,1,1
10071729,20140411,Bevacizumab,49,801,49.0,2,38,1,0,0,1,0,0,1,Bevacizumab,BEVACIZUMAB|PACLITAXEL|PACLITAXEL|CARBOPLATIN|CARBOPLATIN|PACLITAXEL|PACLITAXEL|CARBOPLATIN|CARBOPLATIN,10,OVARIAN CANCER METASTATIC|OVARIAN CANCER METASTATIC|OVARIAN CANCER METASTATIC|OVARIAN CANCER METASTATIC|OVARIAN CANCER METASTATIC|OVARIAN CANCER METASTATIC|PROPHYLAXIS|OVARIAN CANCER METASTATIC|OVARIAN CANCER METASTATIC|OVARIAN CANCER METASTATIC,Loss of consciousness|Seizure|Epilepsy|Febrile neutropenia,4,1
10071743,20140411,Bevacizumab,75,801,75.0,1,75.5,1,0,1,0,0,0,1,Bevacizumab,BISOPROLOL FUMARATE|BEVACIZUMAB|BEVACIZUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,13,COLORECTAL CANCER METASTATIC|HYPERTENSION|HYPERTENSION|STOMATITIS|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|DIABETES MELLITUS|COLORECTAL CANCER METASTATIC|STOMATITIS,Stoma site abscess|Cerebral ischaemia|Cerebral ischaemia|Diarrhoea|Metastases to lymph nodes|Acute kidney injury|Hemiplegia|Prerenal failure|Proteinuria|Dehydration|Metabolic acidosis|Infection,12,1
10071895,20140411,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,BREAST CANCER METASTATIC,Sepsis|Gastrointestinal perforation|Cardiac failure congestive|Myocardial infarction|Renal failure acute|Hypertension|Embolism|Haemorrhage|Proteinuria,9,3
10071942,20140411,Bevacizumab,,,,2,,1,1,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB,2,COLORECTAL CANCER,Death|Metastases to liver|Metastases to lung|Influenza,4,3
10071946,20140411,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,GLIOBLASTOMA MULTIFORME,Disease progression,1,2
10071951,20140411,Bevacizumab,31,801,31.0,1,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|CAPECITABINE|IRINOTECAN HYDROCHLORIDE,3,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Malnutrition|Vomiting|Dehydration,3,1
10071986,20140314,Bevacizumab,66,801,66.0,2,,1,1,0,0,0,0,1,Bevacizumab,CARBOPLATIN|SORAFENIB|PACLITAXEL|BEVACIZUMAB,4,LUNG ADENOCARCINOMA STAGE IV|LUNG ADENOCARCINOMA STAGE IV|LUNG ADENOCARCINOMA STAGE IV|LUNG ADENOCARCINOMA STAGE IV,Lung adenocarcinoma recurrent|Fatigue|Oxygen consumption increased|Skin discolouration|Inflammation|Pneumonia,6,
10072087,20140411,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Suspected transmission of an infectious agent via product|Blindness|Eye infection staphylococcal|Product quality issue,4,5
10072092,20140411,Bevacizumab,,,,2,,1,0,1,0,0,0,1,Bevacizumab,EVEROLIMUS|EVEROLIMUS TABLETS|EVEROLIMUS|EVEROLIMUS TABLETS|BEVACIZUMAB,5,PERIPHERAL NERVE SHEATH TUMOUR MALIGNANT|OFF LABEL USE|PERIPHERAL NERVE SHEATH TUMOUR MALIGNANT,Flank pain|Back pain|Urinary tract infection|Cholelithiasis|Nausea|Vomiting|Aphagia,7,1
10072244,20140411,Bevacizumab,63,801,63.0,1,91,1,1,1,0,0,0,0,Bevacizumab,AMLODIPINE BESYLATE|BEVACIZUMAB|BEVACIZUMAB|ALLOPURINOL|OXALIPLATIN,12,COLORECTAL CANCER|HYPERTENSION|RECTAL CANCER|HYPERTENSION|RECTAL CANCER|COLORECTAL CANCER|RECTAL CANCER,Pulmonary haemorrhage|Oesophagobronchial fistula|Haematemesis|Atelectasis|Necrotising colitis|Colorectal cancer,6,3
10072788,20140411,Bevacizumab,57,801,57.0,2,50,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,6,COLON CANCER|COLON CANCER|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Anaemia|Paraesthesia|Neutropenia,3,5
10073665,20140411,Bevacizumab,49,801,49.0,1,91,1,0,0,1,0,0,0,Bevacizumab,OXALIPLATIN|BEVACIZUMAB,3,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Cerebrovascular accident,1,3
10074597,20140413,Bevacizumab,,,,2,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,OVARIAN CANCER,Intestinal obstruction|Fistula,2,5
10074624,20140414,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,RANIBIZUMAB|AFLIBERCEPT|BEVACIZUMAB,3,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION|NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,Blindness|Cerebrovascular accident|Off label use|Dry eye|Drug ineffective,5,1
10074652,20140414,Bevacizumab,44,801,44.0,1,,1,1,1,0,0,0,1,Bevacizumab,BEVACIZUMAB|ETOPOSIDE|OXALIPLATIN|CISPLATIN,6,PANCREATIC CARCINOMA METASTATIC,Death|Myocardial infarction|Coronary artery disease,3,1
10074669,20140414,Bevacizumab,73,801,73.0,2,,1,0,0,0,1,0,0,Bevacizumab,BEVACIZUMAB,4,AGE-RELATED MACULAR DEGENERATION|PRODUCT USED FOR UNKNOWN INDICATION|HYPERTONIA|HYPERTENSION,Retinal haemorrhage|Visual acuity reduced|Off label use|Off label use,4,1
10075404,20140411,Bevacizumab,41,801,41.0,2,76.3,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|CAPECITABINE|OXALIPLATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PROMETHAZINE,7,COLON CANCER METASTATIC,Cerebrovascular accident,1,2
10075431,20140414,Bevacizumab,,,,2,76.27,1,0,1,0,0,0,0,Bevacizumab,"BEVACIZUMAB|PREDNISONE|LEVOTHYROXINE|LISINOPRIL|SOLIFENACIN SUCCINATE|TIZANIDINE HYDROCHLORIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ZOLPIDEM TARTRATE",8,GLIOBLASTOMA MULTIFORME|ANKYLOSING SPONDYLITIS|HYPOTHYROIDISM|HYPERTENSION|ANKYLOSING SPONDYLITIS|PAIN,Ulcer haemorrhage|Costochondritis|Nausea|Aphasia|Ear pain|Hearing impaired|Somnolence|Alopecia|Abdominal pain upper|Drug ineffective,10,5
10075519,20140414,Bevacizumab,51,801,51.0,2,72,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB,2,COLON CANCER METASTATIC,Intestinal obstruction|Pelvic neoplasm|Retroperitoneal neoplasm|Pain|Hernia,5,1
10075731,20140414,Bevacizumab,92,801,92.0,2,,1,0,1,1,0,0,1,Bevacizumab,PIOGLITAZONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|BEVACIZUMAB|IRBESARTAN|AMLODIPINE BESYLATE|VALSARTAN|BEVACIZUMAB|RANIBIZUMAB|DILTIAZEM HYDROCHLORIDE,11,BLOOD PRESSURE MEASUREMENT|DIABETES MELLITUS|ULCER|BLOOD PRESSURE MEASUREMENT|BLOOD PRESSURE MEASUREMENT|HYPERTENSION|NEOVASCULAR AGE-RELATED MACULAR DEGENERATION|NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,Myocardial infarction|Cerebrovascular accident|Abdominal pain upper|Malaise|Abdominal distension|Muscle spasms|Hypertension|Cardiac failure congestive|Retching|Swelling|Blindness|Visual acuity reduced|Peripheral swelling|Atrial fibrillation|Vomiting|Loss of consciousness|Blood pressure abnormal|Asthenia|Dyspnoea,19,1
10075873,20140414,Bevacizumab,,,,2,56.75,1,0,0,0,0,0,1,Bevacizumab,RANIBIZUMAB|BEVACIZUMAB|LOSARTAN|LEVOTHYROXINE|ALPRAZOLAM|ALPRAZOLAM,7,RETINAL VEIN OCCLUSION|RETINAL VEIN OCCLUSION|BLOOD PRESSURE|BLOOD PRESSURE|STRESS|PANIC ATTACK,Ocular hyperaemia|Eye swelling|Eye discharge|Drug ineffective|Pain|Foreign body sensation in eyes,6,5
10075929,20140414,Bevacizumab,62,801,62.0,1,,1,0,0,0,0,0,1,Bevacizumab,FLUDARABINE PHOSPHATE|RITUXIMAB|BEVACIZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression|Bone marrow failure,2,1
10075934,20140414,Bevacizumab,68,801,68.0,1,,1,0,0,0,0,0,1,Bevacizumab,"FLUDARABINE PHOSPHATE|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|BEVACIZUMAB",4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Autoimmune haemolytic anaemia,1,1
10077124,20140410,Bevacizumab,58,801,58.0,2,,1,0,0,0,0,0,1,Bevacizumab,PACLITAXEL|BEVACIZUMAB|METOPROLOL TARTRATE|METOPROLOL,4,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Hypothyroidism|Hypertension|Rash papulosquamous|Pruritus|Dermatitis|Blood alkaline phosphatase increased,6,3
10077899,20140415,Bevacizumab,77,801,77.0,2,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,LUNG NEOPLASM MALIGNANT,Disease progression,1,3
10077976,20140415,Bevacizumab,70,801,70.0,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,CLEAR CELL RENAL CELL CARCINOMA,Pyrexia|Chills|Headache|Asthenia,4,1
10078297,20140415,Bevacizumab,55,801,55.0,2,52,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,10,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|PROPHYLAXIS OF NAUSEA AND VOMITING|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Interstitial lung disease|Breast cancer metastatic,2,1
10078593,20140415,Bevacizumab,73,801,73.0,1,,1,1,1,0,0,0,0,Bevacizumab,CARBOPLATIN|CARBOPLATIN|PEMETREXED|PEMETREXED DISODIUM|BEVACIZUMAB|PEMETREXED|PEMETREXED DISODIUM,7,PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS,Pulmonary haemorrhage|Pneumonia,2,5
10078603,20140415,Bevacizumab,49,801,49.0,1,91,1,0,0,1,0,0,0,Bevacizumab,BEVACIZUMAB,3,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Cerebrovascular accident,1,3
10078814,20140415,Bevacizumab,,,,0,,1,1,0,0,0,0,0,Bevacizumab,CARBOPLATIN|DOCETAXEL|DOCETAXEL ANHYDROUS|BEVACIZUMAB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Death,1,3
10079061,20140415,Bevacizumab,55,801,55.0,1,,1,0,0,0,0,0,1,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|LOSARTAN POTASSIUM|OXALIPLATIN|BEVACIZUMAB|BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",10,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Hypertension,1,
10079128,20140415,Bevacizumab,68,801,68.0,0,,1,1,0,0,0,0,0,Bevacizumab,"OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB",4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Disease progression,2,5
10079150,20140415,Bevacizumab,75,801,75.0,0,,1,1,0,0,0,0,1,Bevacizumab,OXALIPLATIN|BEVACIZUMAB|BEVACIZUMAB,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression|Death,2,1
10080240,20140415,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|PREDNISONE,6,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Haemorrhage,1,1
10080244,20140415,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|PREDNISONE,6,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Proteinuria,1,1
10080247,20140415,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|PREDNISONE,6,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Peritoneal mesothelioma malignant,1,1
10080255,20140415,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|PREDNISONE,6,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Prostate cancer,1,1
10080269,20140415,Bevacizumab,74,801,74.0,1,,1,0,0,0,0,0,1,Bevacizumab,OXALIPLATIN|CAPECITABINE|BEVACIZUMAB,4,CHEMOTHERAPY|CHEMOTHERAPY|CHEMOTHERAPY,Neuropathy peripheral|Metastases to lung|Metastases to lymph nodes|Malignant neoplasm progression|Metastases to liver|Aspartate aminotransferase increased|Alanine aminotransferase increased|Drug effect incomplete,8,3
10080367,20140415,Bevacizumab,52,801,52.0,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10080375,20140415,Bevacizumab,78,801,78.0,1,,1,1,0,0,0,0,0,Bevacizumab,CAPECITABINE|BEVACIZUMAB,3,COLON CANCER|COLON CANCER|COLON CANCER,Hepatic function abnormal|Disease progression|Mental disorder,3,1
10080408,20140416,Bevacizumab,,,,2,56.75,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|RANIBIZUMAB|LEVOTHYROXINE|ALPRAZOLAM|ALPRAZOLAM,6,RETINAL VEIN OCCLUSION|RETINAL VEIN OCCLUSION|BLOOD PRESSURE|HYPOTHYROIDISM|STRESS|PANIC ATTACK,Ocular hyperaemia|Eye discharge|Eye pain|Eye swelling|Drug ineffective|Sensation of foreign body,6,5
10080456,20140416,Bevacizumab,58,801,58.0,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|ROSUVASTATIN|DUTASTERIDE|LEVETIRACETAM|PANTOPRAZOLE,11,GLIOBLASTOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ANXIETY,Dyspnoea|Asthenia|Abdominal pain|Dizziness|Faeces soft|Accidental overdose|Malignant neoplasm progression,7,3
10080481,20140416,Bevacizumab,58,801,58.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|RABEPRAZOLE|LEVETIRACETAM|EXTENDED PHENYTOIN SODIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,5,GLIOBLASTOMA,Hypertension|Deep vein thrombosis|Muscular weakness|Confusional state|Nasopharyngitis|Localised infection|Sinus headache|Cough|Neoplasm|Tumour haemorrhage|Disease progression,11,1
10080506,20140416,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,RANIBIZUMAB|BEVACIZUMAB|AFLIBERCEPT,3,RETINAL VEIN OCCLUSION|RETINAL VEIN OCCLUSION,Eye inflammation|Drug ineffective,2,5
10080544,20140416,Bevacizumab,62,801,62.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB,2,MACULAR OEDEMA,Uveitis|Off label use,2,3
10080606,20140416,Bevacizumab,63,801,63.0,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|TEMOZOLOMIDE,2,PRODUCT USED FOR UNKNOWN INDICATION,Metastases to central nervous system,1,1
10080672,20140416,Bevacizumab,80,801,80.0,2,94.89,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB,2,GLIOBLASTOMA,Fall|Peripheral swelling|Haemorrhage,3,5
10080728,20140416,Bevacizumab,85,801,85.0,1,90,1,0,0,1,0,0,0,Bevacizumab,BEVACIZUMAB|LISINOPRIL,3,AGE-RELATED MACULAR DEGENERATION|HYPERTENSION|HYPERTENSION,Myelodysplastic syndrome|Off label use,2,2
10081083,20140416,Bevacizumab,68,801,68.0,1,,1,0,0,0,0,0,1,Bevacizumab,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|BEVACIZUMAB|BEVACIZUMAB|CARBOPLATIN|PACLITAXEL|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS,8,LUNG ADENOCARCINOMA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Dermatitis|Neutropenia|Malignant neoplasm progression,3,1
10081440,20140416,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,"FLUDARABINE PHOSPHATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|BENDAMUSTINE HCL|BEVACIZUMAB",5,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Mantle cell lymphoma,1,5
10081647,20140416,Bevacizumab,49,801,49.0,1,91,1,0,0,1,0,0,0,Bevacizumab,OXALIPLATIN|BEVACIZUMAB,3,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Cerebrovascular accident,1,3
10081969,20140414,Bevacizumab,37,801,37.0,2,,1,1,0,0,0,0,1,Bevacizumab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|AMLODIPINE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LACOSAMIDE|LEVETIRACETAM|LISINOPRIL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RIZATRIPTAN BENZOATE|TOPIRAMATE|BEVACIZUMAB",12,GLIOBLASTOMA|GLIOBLASTOMA,Glioblastoma|Neoplasm progression|Off label use,3,1
10082359,20140416,Bevacizumab,69,801,69.0,1,,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB,12,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION|COLORECTAL CANCER METASTATIC,Thrombocytopenic purpura|Thrombocytopenia|Epistaxis|Chills|Pyrexia,5,3
10082454,20140416,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,"RITUXIMAB|BENDAMUSTINE HYDROCHLORIDE|FLUDARABINE PHOSPHATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|BEVACIZUMAB",5,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Mantle cell lymphoma recurrent|Off label use,2,5
10082455,20140416,Bevacizumab,49,801,49.0,1,91,1,0,0,1,0,0,0,Bevacizumab,OXALIPLATIN|BEVACIZUMAB,3,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Cerebrovascular accident,1,3
10082510,20140407,Bevacizumab,66,801,66.0,2,,1,1,0,0,0,0,1,Bevacizumab,OXALIPLATIN|CEFUROXIME|MORPHINE|CAPECITABINE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|BEVACIZUMAB|FILGRASTIM|HALOPERIDOL|HALOPERIDOL LACTATE,9,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Migraine|Colitis ischaemic|Colitis|Diarrhoea,4,3
10082703,20140416,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|RITUXIMAB|RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN HYDROCHLORIDE|PREDNISONE|PREDNISONE,11,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Left ventricular dysfunction|Therapeutic response decreased,2,1
10082907,20140417,Bevacizumab,,,,2,56.75,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,COLORECTAL CANCER,Hypersensitivity|Muscle spasms,2,5
10082936,20140417,Bevacizumab,,,,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CARBOPLATIN|AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE|AMLODIPINE BESYLATE AND VALSARTAN,4,OVARIAN CANCER|OVARIAN CANCER|HYPERTONIA,Renal failure|Thrombotic microangiopathy,2,1
10082939,20140417,Bevacizumab,43,801,43.0,2,61.5,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|CARBOPLATIN|PACLITAXEL,5,OVARIAN CANCER|OVARIAN CANCER|OVARIAN CANCER|PROPHYLAXIS|THROMBOSIS,Diaphragmatic hernia,1,1
10082942,20140417,Bevacizumab,66,801,66.0,2,55.39,1,0,1,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,GLIOBLASTOMA,Herpes zoster|Visual impairment|Peripheral swelling|Fatigue,4,5
10082952,20140417,Bevacizumab,59,801,59.0,1,78.5,1,0,1,0,0,0,0,Bevacizumab,"BEVACIZUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|FILGRASTIM|FILGRASTIM",9,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|HYPERTENSION|LEUKOPENIA,Diarrhoea,1,1
10082961,20140417,Bevacizumab,70,801,70.0,2,70,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,RECTAL CANCER METASTATIC,Metastatic neoplasm|Drug ineffective,2,5
10082978,20140417,Bevacizumab,81,801,81.0,1,,1,0,1,1,0,0,1,Bevacizumab,"TRAMADOL HYDROCHLORIDE|NIFEDIPINE|BEVACIZUMAB|BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|AMLODIPINE",9,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Neutrophil count decreased|Haemorrhage|Fatigue|Pulmonary embolism|Pyrexia|Haemoglobin decreased|Metastases to liver,7,1
10082980,20140417,Bevacizumab,70,801,70.0,1,94,1,0,1,0,0,0,0,Bevacizumab,ALLOPURINOL|BEVACIZUMAB|PEMETREXED|PEMETREXED DISODIUM|BEVACIZUMAB|ZOLPIDEM TARTRATE|BEVACIZUMAB|RAMIPRIL|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PEMETREXED|PEMETREXED DISODIUM|PEMETREXED|PEMETREXED DISODIUM,18,HYPERURICAEMIA|LUNG NEOPLASM MALIGNANT|GASTRITIS|HYPERTENSION|PAIN|LUNG NEOPLASM MALIGNANT|PAIN|GASTRITIS|LUNG NEOPLASM MALIGNANT,Fluid intake reduced|Erosive duodenitis|Dysphagia|Mucosal inflammation|Odynophagia|Hypophagia|Pancytopenia|Erosive oesophagitis,8,1
10083198,20140417,Bevacizumab,67,801,67.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,COLORECTAL CANCER,Pancreatitis acute,1,1
10083199,20140417,Bevacizumab,777,802,64.75,2,80.3,1,0,0,0,0,0,1,Bevacizumab,"BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FOLIC ACID|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|CALCIUM|PEMETREXED DISODIUM|BEVACIZUMAB|CARBOPLATIN",10,ASTHMA|CHEMOTHERAPY|OSTEOPENIA,Neoplasm malignant|Memory impairment|Lip injury|Intentional product misuse|Circumstance or information capable of leading to medication error,5,
10083231,20140417,Bevacizumab,,,,1,,1,1,1,1,0,0,1,Bevacizumab,CAPECITABINE|BEVACIZUMAB|BEVACIZUMAB,3,COLON CANCER|COLON CANCER|COLORECTAL CANCER METASTATIC,Osteonecrosis of jaw|Gastrointestinal infection|Fistula|Asthenia|Oedema peripheral|Abscess|Malaise|Catheter site discharge|Abscess intestinal|Skin fragility|Duodenal perforation|Weight decreased|Ascites|Malnutrition|Duodenal fistula,15,5
10083252,20140416,Bevacizumab,50,801,50.0,2,58,1,0,1,0,0,0,0,Bevacizumab,CARBOPLATIN,3,,Malignant neoplasm progression,1,1
10083387,20140417,Bevacizumab,78,801,78.0,1,69,1,0,1,0,0,0,0,Bevacizumab,CAPECITABINE|BEVACIZUMAB|CAPECITABINE|BEVACIZUMAB,4,COLON CANCER METASTATIC|COLON CANCER STAGE IV|COLON CANCER STAGE IV|COLON CANCER METASTATIC,Stomatitis|Asthenia|Vomiting|Mucosal inflammation|Hypokalaemia|Wernicke-Korsakoff syndrome|Diarrhoea,7,1
10083391,20140417,Bevacizumab,34,801,34.0,2,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,3,CHRONIC HEPATITIS C|PRODUCT USED FOR UNKNOWN INDICATION,Retinopathy|Retinal haemorrhage|Retinal neovascularisation|Retinal exudates|Hypoperfusion|Retinal ischaemia|Macular oedema|Visual acuity reduced|Off label use,9,1
10083510,20140417,Bevacizumab,,,,2,65,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,RECTAL CANCER,Drug ineffective|Disease recurrence,2,5
10083545,20140415,Bevacizumab,52,801,52.0,2,,1,0,0,0,0,0,1,Bevacizumab,GRANISETRON|CISPLATIN,4,PROPHYLAXIS OF NAUSEA AND VOMITING,Hypertension|Headache,2,
10083785,20140417,Bevacizumab,,,,2,99.88,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|RANITIDINE|LEVOTHYROXINE SODIUM|CITALOPRAM|CITALOPRAM HYDROBROMIDE,4,COLORECTAL CANCER METASTATIC,Rectal haemorrhage|Micturition frequency decreased|Abdominal pain,3,5
10083918,20140417,Bevacizumab,65,801,65.0,2,50,1,1,0,0,0,0,0,Bevacizumab,CARBOPLATIN|CARBOPLATIN|PACLITAXEL|BEVACIZUMAB|PACLITAXEL,13,OVARIAN CANCER RECURRENT|OVARIAN CANCER METASTATIC|OVARIAN CANCER METASTATIC|OVARIAN CANCER METASTATIC|OVARIAN CANCER RECURRENT,Pyrexia|Death|Shock|Gastrointestinal perforation|Vomiting|Diarrhoea|Pulmonary embolism,7,1
10084138,20140415,Bevacizumab,74,801,74.0,0,,1,1,0,0,0,0,1,Bevacizumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB",4,RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER,Hepatitis B|Hepatic failure,2,3
10084151,20140415,Bevacizumab,71,801,71.0,1,,1,1,1,1,0,0,0,Bevacizumab,,5,COLORECTAL CANCER STAGE IV,Anaphylactic reaction|Loss of consciousness|Dizziness|Shock|Respiratory distress|Cold sweat|Angioedema|Dysarthria|Nausea|Vomiting,10,
10084576,20140417,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,BREAST CANCER METASTATIC,Hiatus hernia,1,1
10084614,20140417,Bevacizumab,54,801,54.0,2,75,1,0,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|PACLITAXEL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,5,OVARIAN CANCER RECURRENT|OVARIAN CANCER RECURRENT|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA,Lethargy|Speech disorder|White blood cell count decreased|Haemoglobin decreased|Blood potassium decreased|Hepatic pain|Febrile neutropenia|Rash|Pyrexia|Off label use|Disease progression,11,1
10085414,20140418,Bevacizumab,62,801,62.0,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|ROSUVASTATIN|TESTOSTERONE,7,BRAIN NEOPLASM MALIGNANT|GLIOBLASTOMA MULTIFORME,Malignant neoplasm progression|Drug ineffective|Muscle twitching|Dizziness,4,1
10085477,20140418,Bevacizumab,,,,2,56,1,1,0,0,0,0,0,Bevacizumab,"BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|IRINOTECAN HYDROCHLORIDE|CALCIUM CARBONATE|ANTACID",5,COLON CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|OSTEOPENIA,Disease progression|Vocal cord paralysis|Fingerprint loss|Dysphonia,4,1
10085565,20140418,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,COLON NEOPLASM,Cartilage injury,1,3
10085616,20140418,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|GLIPIZIDE|GLIPIZIDE|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS,5,DIABETIC RETINOPATHY|MACULAR OEDEMA|DIABETES MELLITUS|DIABETES MELLITUS,Keratorhexis|Essential tremor|Prostatic disorder|Dysuria|Proteinuria|Bacterial infection|Urinary tract infection|Cystitis|Blood glucose fluctuation,9,5
10085621,20140418,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|TEMSIROLIMUS|TEMSIROLIMUS INJECTION,2,CENTRAL NERVOUS SYSTEM NEOPLASM|CENTRAL NERVOUS SYSTEM NEOPLASM,Thrombocytopenia|Alanine aminotransferase increased,2,1
10085659,20140418,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,"BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|IRINOTECAN HYDROCHLORIDE",5,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Neutropenia|Anaemia|Thrombocytopenia|Febrile neutropenia|Fatigue|Decreased appetite|Nausea|Vomiting|Stomatitis|Diarrhoea|Abdominal pain upper|Neuropathy peripheral|Hypersensitivity|Stoma site haemorrhage|Melaena|Rectal haemorrhage|Hypertension|Proteinuria|Impaired healing|Epistaxis|Gingival bleeding,21,3
10085876,20140418,Bevacizumab,54,801,54.0,2,56.07,1,0,0,0,0,0,1,Bevacizumab,ERLOTINIB HYDROCHLORIDE|BEVACIZUMAB|FOLIC ACID|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LEVETIRACETAM|ERYTHROPOIETIN|PANTOPRAZOLE|PEMETREXED DISODIUM|CARBOPLATIN,14,NON-SMALL CELL LUNG CANCER|LUNG NEOPLASM MALIGNANT|PAIN|NAUSEA|CONVULSION|GASTROOESOPHAGEAL REFLUX DISEASE,Eye pruritus|Rash|Growth of eyelashes|Hair texture abnormal|Wound|Blister|Facial pain|Dry skin|Lacrimation increased|Surgical failure|Weight fluctuation,11,5
10085963,20140418,Bevacizumab,82,801,82.0,2,56.3,1,1,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Death|Coma|Hypophagia|Weight decreased|Asthenia|Dizziness|Hypertension|Epistaxis|Bladder disorder|Abdominal pain|Hernia|Body temperature increased|Nausea|Vomiting|Impaired healing|Chest pain|Protein urine absent|Confusional state|Diarrhoea|Constipation|Vision blurred|Fluid retention,22,5
10086164,20140417,Bevacizumab,,,,2,58,1,1,1,0,0,0,0,Bevacizumab,CARBOPLATIN,3,,Malignant neoplasm progression|General physical health deterioration,2,3
10086902,20140418,Bevacizumab,65,801,65.0,1,,1,0,0,0,0,0,1,Bevacizumab,OXALIPLATIN|OXALIPLATIN|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|METOPROLOL TARTRATE|METOPROLOL,13,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Diarrhoea,1,5
10087926,20140419,Bevacizumab,,,,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|METOPROLOL SUCCINATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SIMVASTATIN|ESCITALOPRAM|LEVETIRACETAM,7,NEOPLASM MALIGNANT|PROPHYLAXIS|SEIZURE,Glioblastoma,1,1
10087927,20140419,Bevacizumab,54,801,54.0,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10087931,20140419,Bevacizumab,,,,0,,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB,1,HEPATIC CANCER,Biliary tract disorder,1,3
10088042,20140420,Bevacizumab,,,,1,,1,0,0,0,0,0,1,Bevacizumab,CAPECITABINE|BEVACIZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Gastrointestinal perforation,1,5
10088147,20140421,Bevacizumab,72,801,72.0,1,,1,1,1,0,0,0,0,Bevacizumab,BEVACIZUMAB|SITAGLIPTIN|BEVACIZUMAB|CARBOPLATIN,6,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|LUNG NEOPLASM MALIGNANT|NON-SMALL CELL LUNG CANCER,Lung infection|Pulmonary haemorrhage|Pneumonia,3,1
10088231,20140421,Bevacizumab,56,801,56.0,2,60,1,0,1,0,0,0,1,Bevacizumab,CARBOPLATIN|AMOXICILLIN|PACLITAXEL|BEVACIZUMAB,5,NON-SMALL CELL LUNG CANCER|MUCOSAL INFLAMMATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|MUCOSAL INFLAMMATION,Infection|Mucosal inflammation|Pancytopenia,3,1
10088265,20140421,Bevacizumab,71,801,71.0,2,,1,0,1,0,0,0,0,Bevacizumab,"BEVACIZUMAB|REGORAFENIB|CAPECITABINE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|CETUXIMAB",9,COLORECTAL ADENOCARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION,Aortic dissection,1,1
10088423,20140421,Bevacizumab,41,801,41.0,2,57.83,1,0,0,0,0,0,1,Bevacizumab,BEVACIZUMAB|CARBOPLATIN|PACLITAXEL|PACLITAXEL,5,OVARIAN EPITHELIAL CANCER|OVARIAN EPITHELIAL CANCER|OVARIAN EPITHELIAL CANCER,Blood creatine phosphokinase increased,1,1
10088460,20140421,Bevacizumab,,,,2,,1,0,1,0,0,0,1,Bevacizumab,"BEVACIZUMAB|LEVOTHYROXINE SODIUM|HYDROMORPHONE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",6,HAEMANGIOPERICYTOMA|PRODUCT USED FOR UNKNOWN INDICATION,Neck mass|Weight decreased|Bronchial haemorrhage|Disease progression|Off label use|Nausea,6,1
10089232,20140421,Bevacizumab,,,,0,,1,1,0,0,0,0,0,Bevacizumab,"DOXORUBICIN|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|PREDNISONE|BEVACIZUMAB|BEVACIZUMAB",10,NATURAL KILLER-CELL LYMPHOBLASTIC LYMPHOMA|PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED|NATURAL KILLER-CELL LYMPHOBLASTIC LYMPHOMA|PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED|NATURAL KILLER-CELL LYMPHOBLASTIC LYMPHOMA|PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED|NATURAL KILLER-CELL LYMPHOBLASTIC LYMPHOMA|PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED|NATURAL KILLER-CELL LYMPHOBLASTIC LYMPHOMA|PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,Sudden cardiac death,1,1
10089253,20140421,Bevacizumab,,,,0,,1,1,0,0,0,0,0,Bevacizumab,PEMETREXED|PEMETREXED DISODIUM|PACLITAXEL|BEVACIZUMAB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Respiratory failure,1,3
10089265,20140421,Bevacizumab,,,,0,,1,1,0,0,0,0,0,Bevacizumab,PEMETREXED|PEMETREXED DISODIUM|PACLITAXEL|BEVACIZUMAB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Respiratory failure,1,3
10089326,20140418,Bevacizumab,50,801,50.0,2,58,1,1,0,0,0,0,0,Bevacizumab,CARBOPLATIN,3,,Disease progression|General physical health deterioration,2,1
10089466,20140417,Bevacizumab,49,801,49.0,1,91,1,0,0,1,0,0,0,Bevacizumab,OXALIPLATIN|BEVACIZUMAB,3,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Cerebrovascular accident,1,
10089556,20140418,Bevacizumab,71,801,71.0,2,90.5,1,0,1,0,0,0,0,Bevacizumab,CARBOPLATIN,3,,Hyponatraemia|Dehydration,2,5
10093974,20140421,Bevacizumab,67,801,67.0,2,,1,0,0,0,0,0,1,Bevacizumab,"BEVACIZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|IRINOTECAN HYDROCHLORIDE",4,RECTAL CANCER,Condition aggravated|Restless legs syndrome|Transient ischaemic attack,3,3
10093984,20140421,Bevacizumab,75,801,75.0,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10093985,20140421,Bevacizumab,89,801,89.0,1,,1,1,0,0,0,0,0,Bevacizumab,BEVACIZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10093988,20140421,Bevacizumab,65,801,65.0,1,61,1,0,0,0,0,0,0,Bevacizumab,BEVACIZUMAB|BEVACIZUMAB|CAPECITABINE|CAPECITABINE|CAPECITABINE|CAPECITABINE|CAPECITABINE,14,RECTOSIGMOID CANCER|RECTOSIGMOID CANCER|RECTOSIGMOID CANCER|RECTOSIGMOID CANCER|RECTOSIGMOID CANCER|ADJUVANT THERAPY|RECTOSIGMOID CANCER|RECTOSIGMOID CANCER|RECTOSIGMOID CANCER|ADJUVANT THERAPY|ADJUVANT THERAPY|RECTOSIGMOID CANCER|RECTOSIGMOID CANCER|RECTOSIGMOID CANCER,Device related infection|Palmar-plantar erythrodysaesthesia syndrome|Hypersensitivity,3,1
10004195,20140312,Cetuximab,63,801,63.0,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,2,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Abdominal pain upper|Diarrhoea|Vomiting,3,5
10004513,20140312,Cetuximab,59,801,59.0,1,,1,1,0,0,0,0,0,Cetuximab,METHYLPREDNISOLONE SODIUM SUCCINATE|CETUXIMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,5,PREMEDICATION|COLON CANCER METASTATIC|COLON CANCER METASTATIC|PREMEDICATION|PREMEDICATION,Cardiac arrest,1,3
10004592,20140312,Cetuximab,75,801,75.0,1,,1,0,0,0,0,0,1,Cetuximab,CISPLATIN|CETUXIMAB,3,ADENOCARCINOMA|ADENOCARCINOMA|ADENOCARCINOMA,Electrolyte imbalance|Neutropenia|Dermatitis acneiform|Decreased appetite,4,3
10007399,20140312,Cetuximab,51,801,51.0,1,137,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Dizziness|Syncope|Asthenia|Electrolyte imbalance|Heart rate increased|Pulse abnormal|Dyspnoea|Abasia|Blood pressure decreased,9,
10010337,20140314,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,"CISPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|CETUXIMAB",3,SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY|SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY|SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,Haematotoxicity|Nephropathy toxic,2,3
10010910,20140311,Cetuximab,56,801,56.0,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|CAPECITABINE,3,COLON CANCER|COLON CANCER|COLON CANCER,Skin toxicity,1,3
10014641,20140317,Cetuximab,64,801,64.0,1,66,1,1,1,0,0,0,1,Cetuximab,CETUXIMAB|CISPLATIN,4,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|PREMEDICATION|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Respiratory failure|Suture related complication|Hypoalbuminaemia|Malignant neoplasm progression|Peritonitis|Septic shock|Large intestine perforation|Hypomagnesaemia|Megacolon|Multiple organ dysfunction syndrome,10,3
10016084,20140317,Cetuximab,80,801,80.0,2,,1,0,0,0,0,0,1,Cetuximab,"CETUXIMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|DIGOXIN|INSULIN DETEMIR",9,COLON CANCER|COLON CANCER|COLON CANCER,Herpes zoster,1,1
10017556,20140318,Cetuximab,68,801,68.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10017557,20140318,Cetuximab,45,801,45.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10017558,20140318,Cetuximab,80,801,80.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Eyelid exfoliation|Skin disorder|Pain|Rash|Pruritus,5,5
10017559,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Feeling abnormal,1,5
10017560,20140318,Cetuximab,33,801,33.0,2,54.42,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|CAPECITABINE,2,COLON CANCER,Rash|Pain|Pruritus,3,5
10017562,20140318,Cetuximab,59,801,59.0,1,58.7,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Death,1,5
10017563,20140318,Cetuximab,58,801,58.0,2,70.75,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|NIACIN,6,COLON CANCER METASTATIC,Malaise|Rash pruritic|Purpura|Constipation,4,1
10017564,20140318,Cetuximab,84,801,84.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Dry skin|Pruritus|Rash|Erythema|Ingrowing nail,5,5
10017565,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Oropharyngeal pain,1,5
10017566,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Platelet count decreased|White blood cell count decreased|Drug dose omission,3,5
10017567,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,White blood cell count decreased|Drug dose omission|Nail discolouration,3,5
10017568,20140318,Cetuximab,91,801,91.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Erythema|Pain in extremity|Skin disorder,3,5
10017569,20140318,Cetuximab,66,801,66.0,1,70.75,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,THROAT CANCER,Rash,1,5
10017570,20140318,Cetuximab,40,801,40.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017571,20140318,Cetuximab,87,801,87.0,1,59.86,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE|FERROUS SULFATE|AMLODIPINE|FAMOTIDINE|GLIPIZIDE|HYDROCHLOROTHIAZIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,9,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION,Fatigue|Anxiety,2,3
10017572,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,THROAT CANCER,Speech disorder,1,5
10017574,20140318,Cetuximab,71,801,71.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017575,20140318,Cetuximab,,,,1,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Death,1,5
10017576,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Tooth extraction,1,5
10017577,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Dermatitis acneiform,1,5
10017578,20140318,Cetuximab,,,,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017579,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Skin exfoliation,1,5
10017580,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017581,20140318,Cetuximab,42,801,42.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX,Tooth extraction|Fatigue|Malaise|Weight decreased,4,3
10017582,20140318,Cetuximab,74,801,74.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,SQUAMOUS CELL CARCINOMA,Malaise|Weight decreased,2,5
10017583,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017584,20140318,Cetuximab,72,801,72.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,3,COLORECTAL CANCER,Burning sensation|Back pain|Constipation|Rash,4,3
10017585,20140318,Cetuximab,82,801,82.0,1,62.58,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|CISPLATIN|MANNITOL|DIPHENHYDRAMINE HYDROCHLORIDE|FAMOTIDINE,7,LIP SQUAMOUS CELL CARCINOMA|PREMEDICATION|PREMEDICATION|PREMEDICATION,Rash|Chills,2,3
10017586,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash|Skin haemorrhage|Dry skin,3,5
10017587,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10017589,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017590,20140318,Cetuximab,76,801,76.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Skin exfoliation|Nail disorder|Pain in extremity,3,5
10017591,20140318,Cetuximab,54,801,54.0,2,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,COLON CANCER,Hypersensitivity|Diarrhoea,2,3
10017595,20140318,Cetuximab,88,801,88.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Hypoacusis,1,5
10017597,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10017598,20140318,Cetuximab,33,801,33.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,5
10017599,20140318,Cetuximab,57,801,57.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE|FAMOTIDINE|DIAZEPAM|FUROSEMIDE|IRON|MULTIVITAMIN|SENNOSIDES|SENNA LEAF|SENNA,11,COLORECTAL CANCER|PREMEDICATION,Infusion related reaction,1,5
10017600,20140318,Cetuximab,48,801,48.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017601,20140318,Cetuximab,52,801,52.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017602,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Oropharyngeal pain|Nasopharyngitis,2,5
10017603,20140318,Cetuximab,68,801,68.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|LOSARTAN POTASSIUM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|MORPHINE,5,SQUAMOUS CELL CARCINOMA OF THE TONGUE,Skin exfoliation|Erythema,2,5
10017604,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Swelling face|Blister|Skin haemorrhage|Rash,4,5
10017605,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017606,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise|Speech disorder,2,5
10017607,20140318,Cetuximab,64,801,64.0,1,77.1,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,BLADDER CANCER,Rash,1,5
10017608,20140318,Cetuximab,36,801,36.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|CISPLATIN|MORPHINE SULFATE|OXYCODONE,5,PENILE CANCER,Dry skin|Off label use,2,5
10017609,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Mood altered,1,5
10017610,20140318,Cetuximab,66,801,66.0,1,87.53,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,4,RECTAL CANCER,Skin fissures|Onychoclasis|Dry skin|Rash|Alopecia,5,5
10017611,20140318,Cetuximab,5,800,50.0,1,,1,0,0,1,0,0,0,Cetuximab,CETUXIMAB|ALBUTEROL SULFATE|ALBUTEROL|FAMOTIDINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,5,HEAD AND NECK CANCER|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION,Blood pressure immeasurable|Respiratory failure|Pulse absent|Loss of consciousness|Erythema,5,5
10017612,20140318,Cetuximab,58,801,58.0,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|LISINOPRIL|HYDROCHLOROTHIAZIDE|GLYBURIDE|METFORMIN HCL,7,COLON CANCER METASTATIC|PAIN,Rash pruritic|Constipation|Dry skin,3,5
10017614,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017615,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Fatigue,1,5
10017616,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Pruritus,1,5
10017617,20140318,Cetuximab,57,801,57.0,1,80.27,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Rash pruritic|Acne,2,5
10017618,20140318,Cetuximab,69,801,69.0,1,61.22,1,0,1,1,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Infusion related reaction,1,5
10017619,20140318,Cetuximab,73,801,73.0,1,82.99,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,2,,Rash|Pruritus,2,5
10017621,20140318,Cetuximab,,,,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Hypersensitivity,1,5
10017622,20140318,Cetuximab,,,,2,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER,Hypersensitivity,1,5
10017623,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE,2,PREMEDICATION,Infusion related reaction,1,5
10017624,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE,2,PREMEDICATION,Infusion related reaction,1,5
10017626,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE,2,PREMEDICATION,Infusion related reaction,1,5
10017627,20140318,Cetuximab,,,,2,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Death,1,5
10017629,20140318,Cetuximab,60,801,60.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER,Oral pain|Skin exfoliation,2,5
10017630,20140318,Cetuximab,61,801,61.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,THROAT CANCER,Chapped lips|Rash pustular|Fatigue|Speech disorder|Pruritus generalised|Pruritus,6,5
10017632,20140318,Cetuximab,63,801,63.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Hypomagnesaemia,1,5
10017633,20140318,Cetuximab,,,,2,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER,Hypersensitivity,1,5
10017634,20140318,Cetuximab,74,801,74.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,SALIVARY GLAND NEOPLASM,Skin disorder|Rash macular|Weight decreased,3,5
10017635,20140318,Cetuximab,73,801,73.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,5
10017636,20140318,Cetuximab,69,801,69.0,2,101.58,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|LEVOTHYROXINE|METFORMIN HCL|FERROUS SULFATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,7,LUNG NEOPLASM,White blood cell count decreased|Oral fungal infection|Hypoacusis,3,5
10017637,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Hearing impaired,1,5
10017638,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Hearing impaired,1,5
10017639,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017640,20140318,Cetuximab,7,800,70.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Hypersensitivity,1,5
10017641,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Hypersensitivity,1,5
10017642,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Hypersensitivity,1,5
10017644,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017645,20140318,Cetuximab,54,801,54.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,3,COLON CANCER,Rash,1,5
10017646,20140318,Cetuximab,79,801,79.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Diarrhoea|Lip dry|Fatigue,3,5
10017647,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Hearing impaired,1,5
10017648,20140318,Cetuximab,66,801,66.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10017649,20140318,Cetuximab,65,801,65.0,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,RECTAL CANCER METASTATIC,Anaphylactoid reaction,1,1
10017650,20140318,Cetuximab,70,801,70.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Skin disorder|Hair disorder|Nail disorder|Onychalgia,4,5
10017651,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,White blood cell count decreased,1,5
10017691,20140318,Cetuximab,81,801,81.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017693,20140318,Cetuximab,48,801,48.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|HYDROMORPHONE HYDROCHLORIDE|MORPHINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CALCIUM|DRONABINOL|MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|AMLODIPINE|ZOLPIDEM TARTRATE|GABAPENTIN,14,,Rash pruritic|Haematochezia|Fatigue,3,5
10017694,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10017695,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Drug dose omission|Influenza,2,5
10017696,20140318,Cetuximab,45,801,45.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,THROAT CANCER,Dry skin|Acne,2,5
10017698,20140318,Cetuximab,89,801,89.0,1,76.19,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|DIPHENHYDRAMINE HYDROCHLORIDE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|LACTULOSE|LEVOTHYROXINE|POLYETHYLENE GLYCOL 3350|OXYCODONE,10,HEAD AND NECK CANCER,Loss of consciousness|Hypotension|Dyspnoea,3,5
10017699,20140318,Cetuximab,,,,1,95.24,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER METASTATIC,Chest discomfort|Abdominal pain|Anxiety|Flushing|Skin lesion,5,5
10017701,20140318,Cetuximab,5,800,50.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Dizziness|Loss of consciousness,2,5
10017702,20140318,Cetuximab,60,801,60.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE|LORAZEPAM|LACTULOSE|LISINOPRIL|METOCLOPRAMIDE HYDROCHLORIDE,9,SQUAMOUS CELL CARCINOMA,Hypersensitivity,1,1
10017703,20140318,Cetuximab,55,801,55.0,1,81.63,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,2,NEOPLASM MALIGNANT|DIABETES MELLITUS,Rash,1,5
10017704,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,2,,Penile erythema,1,5
10017705,20140318,Cetuximab,,,,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Pneumonia,1,5
10017706,20140318,Cetuximab,50,801,50.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|LORAZEPAM,3,GASTRIC CANCER,Decreased appetite|Dysgeusia|Rash|Hair texture abnormal|Weight decreased|Nausea,6,5
10017707,20140318,Cetuximab,51,801,51.0,1,83.44,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,3,COLON CANCER STAGE IV,Rash|Epistaxis,2,5
10017709,20140318,Cetuximab,64,801,64.0,2,61.22,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,LYMPHOMA,Rash pustular|Dry skin|Hair growth abnormal|Erythema,4,5
10017710,20140318,Cetuximab,62,801,62.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,TONSIL CANCER,Speech disorder|Mucosal inflammation,2,3
10017711,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Drug administration error|Blood pressure decreased,2,5
10017712,20140318,Cetuximab,49,801,49.0,1,90.25,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|GABAPENTIN|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN,6,COLON CANCER|COLON CANCER,Dermatitis acneiform,1,5
10017713,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|FOLIC ACID,4,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Skin fissures|Onychoclasis,2,5
10017714,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017715,20140318,Cetuximab,48,801,48.0,1,109.97,1,0,0,0,0,0,1,Cetuximab,"CETUXIMAB|BENAZEPRIL HYDROCHLORIDE|HYDROCHLOROTHIAZIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LORAZEPAM|MIRTAZAPINE|PANTOPRAZOLE SODIUM|SUCRALFATE",16,HEAD AND NECK CANCER,Rash,1,1
10017716,20140318,Cetuximab,6,800,60.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,Infusion related reaction,1,5
10017717,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Mucosal inflammation,1,5
10017718,20140318,Cetuximab,,,,2,,1,0,0,1,0,0,0,Cetuximab,CETUXIMAB,1,,Apparent death,1,5
10017719,20140318,Cetuximab,70,801,70.0,2,66.66,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER,Nail bed inflammation,1,5
10017720,20140318,Cetuximab,71,801,71.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Rash,1,5
10017721,20140318,Cetuximab,57,801,57.0,1,,1,0,1,1,0,0,0,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE,2,HEAD AND NECK CANCER|PREMEDICATION,Infusion related reaction,1,5
10017722,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Infusion related reaction,1,5
10017723,20140318,Cetuximab,44,801,44.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Hypersensitivity,1,5
10017724,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Malignant neoplasm progression,1,5
10017725,20140318,Cetuximab,63,801,63.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Pruritus|Dry skin,2,5
10017726,20140318,Cetuximab,59,801,59.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|PACLITAXEL,3,RECTAL CANCER|RECTAL CANCER,Medication error,1,5
10017727,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Pyrexia,1,5
10017728,20140318,Cetuximab,74,801,74.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017729,20140318,Cetuximab,83,801,83.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Lip haemorrhage|Dry skin|Erythema,3,5
10017730,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Infusion related reaction,1,5
10017731,20140318,Cetuximab,58,801,58.0,1,,1,1,1,1,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Death|Cardio-respiratory arrest,2,5
10017732,20140318,Cetuximab,68,801,68.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE,2,RECTAL CANCER,Chills,1,5
10017733,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Stomatitis,1,5
10017734,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Eye pain|Ocular hyperaemia|Vision blurred|Eyelid margin crusting,4,5
10017736,20140318,Cetuximab,63,801,63.0,1,69.76,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|MAGNESIUM,3,ADENOCARCINOMA OF COLON,Hypomagnesaemia|Diarrhoea,2,5
10017737,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise|Speech disorder,2,5
10017738,20140318,Cetuximab,,,,1,,1,0,0,1,0,0,0,Cetuximab,CETUXIMAB,1,,Infusion related reaction,1,5
10017739,20140318,Cetuximab,67,801,67.0,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Dyspnoea|Blood pressure decreased|Nasopharyngitis|Hyperhidrosis|Pallor,5,5
10017740,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Blood magnesium decreased,1,5
10017741,20140318,Cetuximab,77,801,77.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Speech disorder,1,5
10017742,20140318,Cetuximab,78,801,78.0,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER METASTATIC,Chest pain|Respiratory distress,2,5
10017744,20140318,Cetuximab,67,801,67.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER METASTATIC,Rash|Diarrhoea|Hypomagnesaemia,3,5
10017745,20140318,Cetuximab,69,801,69.0,1,97.5,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|POLYETHYLENE GLYCOL 3350|CLOPIDOGREL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|AMLODIPINE BESYLATE|METOPROLOL TARTRATE|METOPROLOL|SIMVASTATIN|TERAZOSIN|TERAZOSIN HYDROCHLORIDE|VALSARTAN|GABAPENTIN|HYDROCHLOROTHIAZIDE|LUBIPROSTONE|OMEPRAZOLE AND SODIUM BICARBONATE,15,LUNG NEOPLASM MALIGNANT|BLOOD PRESSURE|BLOOD PRESSURE|BLOOD PRESSURE|GASTRIC DISORDER,Rash,1,5
10017746,20140318,Cetuximab,56,801,56.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,NEOPLASM MALIGNANT,Hypomagnesaemia,1,5
10017747,20140318,Cetuximab,75,801,75.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Rash,1,5
10017748,20140318,Cetuximab,70,801,70.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|FAMOTIDINE,4,HEAD AND NECK CANCER|PREMEDICATION|PREMEDICATION|PREMEDICATION,Pruritus|Blood pressure decreased|Dyspnoea|Anxiety,4,5
10017749,20140318,Cetuximab,6,800,60.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Infusion related reaction,1,5
10017750,20140318,Cetuximab,67,801,67.0,1,,1,0,0,1,0,0,0,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE,2,HEAD AND NECK CANCER|PREMEDICATION,Infusion related reaction,1,5
10017751,20140318,Cetuximab,44,801,44.0,1,,1,1,1,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER,Death|Adverse event,2,5
10017754,20140318,Cetuximab,62,801,62.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash|Erythema,2,5
10017755,20140318,Cetuximab,60,801,60.0,2,,1,0,0,0,0,0,1,Cetuximab,"CETUXIMAB|CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CIMETIDINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",9,HEAD AND NECK CANCER|LARYNGEAL CANCER|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION,Anaphylactic reaction,1,5
10017757,20140318,Cetuximab,75,801,75.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,TONSIL CANCER,Pyrexia|Hyperhidrosis,2,5
10017758,20140318,Cetuximab,48,801,48.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Conjunctivitis,1,5
10017759,20140318,Cetuximab,76,801,76.0,1,113.83,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|IRINOTECAN HYDROCHLORIDE,3,COLON CANCER|CHEMOTHERAPY|CHEMOTHERAPY,Rash,1,5
10017760,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,5
10017761,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Infusion related reaction,1,5
10017762,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017763,20140318,Cetuximab,77,801,77.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,SQUAMOUS CELL CARCINOMA OF SKIN,Rash,1,5
10017764,20140318,Cetuximab,68,801,68.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,RECTAL CANCER METASTATIC,Rash,1,5
10017765,20140318,Cetuximab,52,801,52.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER,Rash,1,5
10017766,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,4,COLORECTAL CANCER METASTATIC,Rash,1,1
10017767,20140318,Cetuximab,45,801,45.0,2,71.65,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Tachycardia,1,5
10017768,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash|Pruritus,2,5
10017769,20140318,Cetuximab,68,801,68.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE,3,HEAD AND NECK CANCER|PREMEDICATION|PREMEDICATION,Speech disorder|Eating disorder|Dysphagia,3,5
10017771,20140318,Cetuximab,73,801,73.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER METASTATIC,Reading disorder,1,5
10017772,20140318,Cetuximab,84,801,84.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,White blood cell count decreased|Acne,2,5
10017773,20140318,Cetuximab,70,801,70.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|MORPHINE,3,PAIN,Pruritus generalised|Skin disorder|Dry skin,3,5
10017774,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Fatigue,1,5
10017776,20140318,Cetuximab,49,801,49.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017777,20140318,Cetuximab,,,,2,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,5
10017778,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Facial pain|Dysphagia,2,5
10017779,20140318,Cetuximab,53,801,53.0,2,79.36,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|ROSUVASTATIN|MAGNESIUM|BAYER ASPIRIN EXTRA STRENGTH|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES,6,COLON CANCER,Skin disorder|Cough|Throat irritation|Paraesthesia|Dry skin|Acne,6,5
10017780,20140318,Cetuximab,58,801,58.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Decreased appetite|Stomatitis|Weight decreased,3,5
10017781,20140318,Cetuximab,61,801,61.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Onychoclasis,1,5
10017782,20140318,Cetuximab,79,801,79.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Drug hypersensitivity,1,5
10017783,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Fatigue|Dry skin|Nail disorder|Alopecia|Eye disorder,5,5
10017784,20140318,Cetuximab,58,801,58.0,1,92.51,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Skin disorder,1,5
10017786,20140318,Cetuximab,62,801,62.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash pruritic|Paraesthesia,2,5
10017787,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Pyrexia|Skin disorder,2,5
10017788,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Skin disorder,1,5
10017789,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017790,20140318,Cetuximab,76,801,76.0,1,104.31,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|CETUXIMAB|BIOTIN,4,COLON CANCER|HEPATIC CANCER METASTATIC,Rash|Functional gastrointestinal disorder,2,5
10017791,20140318,Cetuximab,62,801,62.0,2,51.25,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER,Fatigue,1,5
10017793,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017795,20140318,Cetuximab,75,801,75.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER METASTATIC,Rash,1,5
10017798,20140318,Cetuximab,64,801,64.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017799,20140318,Cetuximab,69,801,69.0,1,74.83,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEPATIC CANCER,Rash erythematous,1,5
10017800,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Radiation skin injury,1,5
10017801,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Nasopharyngitis,1,5
10017856,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Nausea|Pain of skin,2,5
10017857,20140318,Cetuximab,,,,1,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Death,1,5
10017858,20140318,Cetuximab,67,801,67.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017859,20140318,Cetuximab,67,801,67.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER STAGE IV,Skin disorder|Acne|Haemoptysis|Dry eye|Dry skin|Macule,6,5
10017860,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Dry skin,1,5
10017861,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017862,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10017863,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10017864,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Dry skin|Skin exfoliation,2,5
10017865,20140318,Cetuximab,73,801,73.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017866,20140318,Cetuximab,,,,1,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Death,1,5
10017867,20140318,Cetuximab,57,801,57.0,1,49.43,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|FOLIC ACID,5,THROAT CANCER|PAIN,Skin disorder|Weight decreased,2,5
10017868,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Cough|Dysphonia,2,5
10017869,20140318,Cetuximab,57,801,57.0,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,5
10017870,20140318,Cetuximab,43,801,43.0,1,74.83,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Acne|Oral fungal infection|Blister|Nail disorder|Malaise|Drug dose omission,6,5
10017871,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Oropharyngeal pain|Speech disorder,2,5
10017872,20140318,Cetuximab,66,801,66.0,1,101.13,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|DIVALPROEX SODIUM|ATENOLOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,4,THROAT CANCER,Asthenia|Diarrhoea|Nail disorder|Rash,4,5
10017874,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Hypoacusis,1,5
10017875,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Skin disorder,1,5
10017878,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10017879,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017880,20140318,Cetuximab,66,801,66.0,2,58.96,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|FUROSEMIDE|ATENOLOL,4,HEPATIC CANCER,Onychoclasis|Dry skin,2,5
10017881,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017882,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Skin disorder,1,5
10017883,20140318,Cetuximab,,,,1,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Death,1,5
10017884,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Metastases to liver,1,5
10017885,20140318,Cetuximab,51,801,51.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017886,20140318,Cetuximab,,,,0,,1,1,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malignant neoplasm progression,1,5
10017887,20140318,Cetuximab,85,801,85.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Acne,1,5
10017888,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017889,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017890,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Hypomagnesaemia,1,5
10017891,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017892,20140318,Cetuximab,,,,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,5
10017893,20140318,Cetuximab,45,801,45.0,2,63.04,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER,Dermatitis acneiform|Dry skin|Skin fissures,3,5
10017894,20140318,Cetuximab,59,801,59.0,1,55.33,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|LISINOPRIL|CARVEDILOL|CARVEDILOL|SIMVASTATIN|SIMVASTATIN,6,THROAT CANCER|BLOOD PRESSURE|BLOOD CHOLESTEROL|BLOOD PRESSURE|BLOOD CHOLESTEROL,Rash,1,5
10017895,20140318,Cetuximab,78,801,78.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Hypersensitivity,1,5
10017897,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Nail disorder,1,5
10017898,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017899,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10017900,20140318,Cetuximab,35,801,35.0,2,,1,0,1,0,0,0,1,Cetuximab,CETUXIMAB|CETUXIMAB,2,COLON CANCER STAGE IV|BREAST CANCER STAGE III,Skin infection|Dermatitis allergic,2,5
10017901,20140318,Cetuximab,58,801,58.0,2,105.67,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,LUNG NEOPLASM MALIGNANT,Acne|Skin disorder,2,5
10017902,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|OXALIPLATIN,2,,Rash|Pruritus|Urticaria,3,5
10017903,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash|Speech disorder,2,5
10017904,20140318,Cetuximab,66,801,66.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Herpes zoster|Dry skin|Memory impairment,3,5
10017905,20140318,Cetuximab,39,801,39.0,2,,1,0,0,0,0,0,0,Cetuximab,"CETUXIMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FUROSEMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LEVOTHYROXINE SODIUM|SPIRONOLACTONE|VITAMIN E|MAGNESIUM HYDROXIDE|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 3350|MAGNESIUM HYDROXIDE|ACETAMINOPHEN",18,COLON CANCER|DEEP VEIN THROMBOSIS|COLON CANCER|COLON CANCER|COLON CANCER|NAUSEA|DERMATITIS ACNEIFORM,Skin fissures|Skin exfoliation|Constipation|Blister|Gastric disorder|Nausea|Pain in extremity|Drug dose omission|Skin ulcer|Contusion|Dry skin,11,1
10017908,20140318,Cetuximab,76,801,76.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Hypotension|Malaise,2,5
10017909,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder|Dysphonia,2,5
10017910,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse drug reaction,1,5
10017911,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10017913,20140318,Cetuximab,60,801,60.0,1,134.69,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|IRINOTECAN HYDROCHLORIDE,3,COLORECTAL CANCER METASTATIC,Rash,1,5
10017914,20140318,Cetuximab,61,801,61.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Malignant neoplasm progression,1,5
10017917,20140318,Cetuximab,71,801,71.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Thrombosis|Dry skin|Flushing|Epistaxis,4,5
10017919,20140318,Cetuximab,64,801,64.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,THROAT CANCER,Catheter site rash,1,5
10017920,20140318,Cetuximab,54,801,54.0,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,5
10017921,20140318,Cetuximab,,,,1,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Death,1,5
10017922,20140318,Cetuximab,63,801,63.0,2,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB|IRINOTECAN HYDROCHLORIDE,2,COLON CANCER|COLON CANCER,Malignant neoplasm progression,1,5
10017923,20140318,Cetuximab,,,,2,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017924,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Hypoacusis,1,5
10017925,20140318,Cetuximab,74,801,74.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEPATIC CANCER,Diarrhoea|Muscular weakness,2,5
10017926,20140318,Cetuximab,57,801,57.0,1,149.66,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,3,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Rash|Pruritus|Diarrhoea,3,5
10017927,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash|Pain,2,5
10017928,20140318,Cetuximab,72,801,72.0,2,39,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|IRINOTECAN HYDROCHLORIDE|LEVOTHYROXINE|BIOTIN,5,COLON CANCER,Malignant neoplasm progression|Alopecia|Diarrhoea|Dandruff|Fatigue|Weight increased|Acne|Cough|Pruritus,9,1
10017931,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Back pain,1,5
10017932,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10017933,20140318,Cetuximab,82,801,82.0,2,72.11,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,MASS,Feeling abnormal|Decreased appetite|Vomiting,3,5
10017934,20140318,Cetuximab,,,,1,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Death,1,5
10017935,20140318,Cetuximab,64,801,64.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Throat irritation|Dysphagia,2,5
10017936,20140318,Cetuximab,58,801,58.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10017938,20140318,Cetuximab,,,,1,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Hypersensitivity,1,5
10017939,20140318,Cetuximab,71,801,71.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER,Malaise|Hypoacusis,2,5
10017940,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Anaphylactic shock,1,5
10017941,20140318,Cetuximab,55,801,55.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,2,COLORECTAL CANCER,Rash,1,5
10017942,20140318,Cetuximab,78,801,78.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,LIP AND/OR ORAL CAVITY CANCER,Skin disorder|Stomatitis,2,5
10017943,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,NEOPLASM MALIGNANT,Speech disorder,1,5
10017945,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10017946,20140318,Cetuximab,70,801,70.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|METOPROLOL TARTRATE|METOPROLOL|LORAZEPAM|SERTRALINE|GABAPENTIN,6,,Urticaria,1,5
10017947,20140318,Cetuximab,58,801,58.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Nail disorder,1,5
10017948,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017949,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Hearing impaired,1,5
10017951,20140318,Cetuximab,,,,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,5
10017952,20140318,Cetuximab,93,801,93.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Hearing impaired,1,5
10017953,20140318,Cetuximab,,,,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,5
10017954,20140318,Cetuximab,79,801,79.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Laceration,1,5
10017955,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Dry skin|Malaise,2,5
10017956,20140318,Cetuximab,,,,1,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Death,1,5
10017957,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10017958,20140318,Cetuximab,88,801,88.0,2,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Asthenia,1,5
10017961,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise|Skin disorder,2,5
10017963,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Pruritus|Speech disorder,2,5
10017964,20140318,Cetuximab,,,,1,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Death,1,5
10017965,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,5
10017966,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Vomiting|Headache,2,5
10017967,20140318,Cetuximab,75,801,75.0,1,58.5,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|VALSARTAN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALLOPURINOL|LEVOTHYROXINE,5,THROAT CANCER,Rash|Skin fissures|Weight decreased,3,5
10018029,20140318,Cetuximab,,,,1,,1,0,0,1,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,5
10018031,20140318,Cetuximab,47,801,47.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,5
10018032,20140318,Cetuximab,63,801,63.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash pustular|Skin discolouration,2,5
10018033,20140318,Cetuximab,76,801,76.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Dry skin|Nausea|Malaise|Chills,4,5
10018034,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,2,,Speech disorder,1,5
10018035,20140318,Cetuximab,73,801,73.0,1,,1,0,0,0,0,0,0,Cetuximab,"CETUXIMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",2,,Rash,1,5
10018036,20140318,Cetuximab,41,801,41.0,1,129.25,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|CAPECITABINE|OXALIPLATIN|APREPITANT|FOSAPREPITANT DIMEGLUMINE,4,COLON CANCER|NAUSEA,Rash pustular,1,5
10018037,20140318,Cetuximab,87,801,87.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Hypersensitivity,1,5
10018038,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Fatigue|Nausea|Constipation|Diarrhoea,4,5
10018039,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Hypoacusis,1,5
10018040,20140318,Cetuximab,63,801,63.0,1,72.56,1,0,0,0,0,0,0,Cetuximab,"CETUXIMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,COLON CANCER METASTATIC,Skin toxicity|Weight increased|Hypomagnesaemia,3,1
10018041,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash|Wound,2,5
10018042,20140318,Cetuximab,67,801,67.0,2,69.39,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER,Dry skin|Weight decreased,2,5
10018043,20140318,Cetuximab,71,801,71.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Rash|Alopecia|Dyspnoea|Hair growth abnormal,4,5
10018044,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Drug dose omission,1,5
10018045,20140318,Cetuximab,62,801,62.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10018046,20140318,Cetuximab,70,801,70.0,2,52.15,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,2,SQUAMOUS CELL CARCINOMA|PAIN,Dry skin|Rash pustular,2,5
10018047,20140318,Cetuximab,,,,2,,1,1,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Death|Metastases to central nervous system|Acne|Nail disorder,4,5
10018048,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Rash generalised,1,5
10018049,20140318,Cetuximab,62,801,62.0,1,94.33,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|ZOLPIDEM TARTRATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|MULTIVITAMIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|GLIPIZIDE|MAGNESIUM OXIDE|FUROSEMIDE,16,SQUAMOUS CELL CARCINOMA|CANCER PAIN|HEADACHE,Erythema|Pruritus|Weight decreased,3,5
10018050,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Somnolence,1,5
10018054,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Dry skin,1,5
10018055,20140318,Cetuximab,66,801,66.0,1,,1,0,0,1,0,0,0,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE,4,HEAD AND NECK CANCER,Anaphylactic reaction,1,5
10018057,20140318,Cetuximab,63,801,63.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,NEOPLASM MALIGNANT,Rash,1,5
10018058,20140318,Cetuximab,43,801,43.0,1,58.96,1,0,1,0,0,0,0,Cetuximab,"CETUXIMAB|METHADONE|MORPHINE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL",5,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,Staphylococcal skin infection|Dermatitis acneiform,2,5
10018060,20140318,Cetuximab,65,801,65.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Skin fissures|Stomatitis|Haemorrhage|Eating disorder|Nausea,5,5
10018061,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10018062,20140318,Cetuximab,57,801,57.0,1,71.65,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|OXYCODONE,2,PAIN,Rash papular|Asthenia|Pruritus generalised,3,5
10018063,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10018064,20140318,Cetuximab,56,801,56.0,1,121.08,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER,Rash,1,5
10018065,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10018066,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10018067,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Insomnia,1,5
10018068,20140318,Cetuximab,45,801,45.0,1,61.68,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Vomiting|Dysphonia,2,3
10018069,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,LUNG NEOPLASM MALIGNANT,Exfoliative rash,1,5
10018070,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10018071,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Chapped lips|Lip haemorrhage,2,3
10018072,20140318,Cetuximab,77,801,77.0,1,94.33,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|LISINOPRIL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|LEVOTHYROXINE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|OMEPRAZOLE MAGNESIUM,8,LYMPHOMA,Pyrexia|Headache|Abdominal pain upper|Stress|Weight decreased|Acne,6,5
10018073,20140318,Cetuximab,54,801,54.0,1,163.26,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|IRINOTECAN HYDROCHLORIDE,2,COLON CANCER,Rash pustular,1,1
10018074,20140318,Cetuximab,77,801,77.0,1,,1,0,1,0,0,0,0,Cetuximab,"CETUXIMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DIPHENHYDRAMINE HYDROCHLORIDE|ATROPINE SULFATE|ATROPINE",6,,Anaphylactic reaction,1,5
10018075,20140318,Cetuximab,87,801,87.0,1,63.49,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|LEVOTHYROXINE SODIUM,2,SQUAMOUS CELL CARCINOMA,Rash,1,5
10018076,20140318,Cetuximab,82,801,82.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,SQUAMOUS CELL CARCINOMA,Rash pustular,1,5
10018077,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10018078,20140318,Cetuximab,73,801,73.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,METASTATIC SQUAMOUS CELL CARCINOMA,Rash,1,5
10018079,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash|Diarrhoea,2,5
10018081,20140318,Cetuximab,,,,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Blood pressure decreased|Flushing|Pruritus|Burning sensation,4,5
10018082,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|CISPLATIN,3,SQUAMOUS CELL CARCINOMA|SQUAMOUS CELL CARCINOMA|SQUAMOUS CELL CARCINOMA,Hypomagnesaemia,1,5
10018083,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Hypoaesthesia,1,5
10018084,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10018085,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Hypomagnesaemia,1,5
10018086,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Exfoliative rash,1,5
10018087,20140318,Cetuximab,90,801,90.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise|Weight decreased,2,5
10018088,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,THROAT CANCER,Sepsis|Rash|Aphasia|Cachexia,4,5
10018089,20140318,Cetuximab,,,,1,,1,1,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Death|Confusional state,2,5
10018090,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder|Malaise,2,5
10018092,20140318,Cetuximab,52,801,52.0,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB|IRINOTECAN HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE|ATROPINE SULFATE|ATROPINE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|PROCHLORPERAZINE MALEATE|METOCLOPRAMIDE HYDROCHLORIDE|ZOLPIDEM TARTRATE|TELMISARTAN,13,COLORECTAL CANCER|COLORECTAL CANCER|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION,Chest pain|Lacrimation increased|Erythema|Hyperhidrosis|Dyspnoea|Anxiety|Heart rate increased|Blood pressure increased,8,3
10018096,20140318,Cetuximab,56,801,56.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE,4,PHARYNGEAL CANCER,Dyspnoea|Chest pain|Hypotension|Hyperhidrosis|Pallor,5,3
10018097,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10018098,20140318,Cetuximab,73,801,73.0,1,97.96,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|IRINOTECAN HYDROCHLORIDE|AMLODIPINE BESYLATE|BENAZEPRIL HYDROCHLORIDE|FUROSEMIDE|PANTOPRAZOLE SODIUM|SOLIFENACIN SUCCINATE|BAYER ASPIRIN EXTRA STRENGTH|ROSUVASTATIN|METOPROLOL SUCCINATE|DIPHENHYDRAMINE HYDROCHLORIDE|DIAZEPAM|NITROGLYCERIN|OXYCODONE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|TEMAZEPAM|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|CALCIUM CARBONATE,24,COLORECTAL CANCER|SLEEP DISORDER|ANGINA PECTORIS|VOMITING|NAUSEA,Rash|Diarrhoea|Alopecia|Cystitis|Constipation|Weight decreased,6,5
10018099,20140318,Cetuximab,64,801,64.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10018100,20140318,Cetuximab,89,801,89.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Skin fissures,1,5
10018101,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10018102,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10018105,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Accidental exposure to product,1,3
10018106,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash pruritic,1,5
10018107,20140318,Cetuximab,56,801,56.0,2,97.96,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER METASTATIC,Acne|Somnolence,2,5
10018108,20140318,Cetuximab,84,801,84.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Speech disorder|Oral pain|Dysphagia,3,3
10018109,20140318,Cetuximab,45,801,45.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,2,,Pruritus,1,5
10018110,20140318,Cetuximab,70,801,70.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Rash,1,5
10018111,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malaise,1,5
10018112,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,3
10018113,20140318,Cetuximab,52,801,52.0,2,100.13,1,1,1,0,0,0,0,Cetuximab,"CETUXIMAB|OXYCODONE|FENTANYL|LISINOPRIL|LORAZEPAM|LORAZEPAM|MULTIVITAMIN|CALCIUM CARBONATE, SIMETHICONE|SELENIUM|TAURINE|ERGOCALCIFEROL|SERTRALINE HYDROCHLORIDE|TURMERIC|CALCIUM|POLYETHYLENE GLYCOL 3350",23,COLORECTAL CANCER METASTATIC|PAIN|PAIN|HYPERTENSION|SUPPLEMENTATION THERAPY|ANXIETY|NAUSEA|SUPPLEMENTATION THERAPY|NAUSEA|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|NAUSEA|DEPRESSION|PHYTOTHERAPY|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|CONSTIPATION|SUPPLEMENTATION THERAPY,Malignant neoplasm progression|Metastatic neoplasm,2,5
10018114,20140318,Cetuximab,57,801,57.0,1,,1,1,1,1,0,0,0,Cetuximab,CETUXIMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CARVEDILOL|DICLOFENAC|DICLOFENAC SODIUM|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|ZOLPIDEM TARTRATE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,12,TONSIL CANCER|PREMEDICATION,Infusion related reaction,1,3
10018117,20140318,Cetuximab,68,801,68.0,1,126.98,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,4,COLON CANCER,Device related infection|Bacteraemia,2,1
10018118,20140318,Cetuximab,56,801,56.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,THROAT CANCER,Rash generalised|Skin exfoliation,2,5
10018120,20140318,Cetuximab,5,800,50.0,1,,1,0,1,1,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Tachycardia|Hypotension|Depressed level of consciousness,3,1
10018121,20140318,Cetuximab,,,,0,95.24,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Swelling face|Rash,2,3
10018122,20140318,Cetuximab,63,801,63.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER,Adverse event,1,2
10018123,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Drug administration error,1,2
10018124,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Cardiac arrest,1,3
10018125,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Infusion related reaction,1,1
10018126,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Infusion related reaction,1,1
10018127,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Chills|Back pain,2,3
10018128,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10018129,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Infusion related reaction,1,1
10018130,20140318,Cetuximab,60,801,60.0,2,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malignant neoplasm progression,1,5
10018131,20140318,Cetuximab,79,801,79.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Therapeutic response unexpected,1,5
10018132,20140318,Cetuximab,,,,2,,1,0,1,1,1,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER METASTATIC,Malignant neoplasm progression,1,3
10018133,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Hypersensitivity,1,1
10018134,20140318,Cetuximab,,,,1,,1,0,0,1,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER METASTATIC,Oxygen saturation decreased|Blood pressure decreased|Obstructive airways disorder|Cardiac arrest,4,3
10018135,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER METASTATIC,Oxygen saturation decreased|Blood pressure decreased,2,3
10018137,20140318,Cetuximab,8,800,80.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Rash,1,3
10018138,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10018139,20140318,Cetuximab,57,801,57.0,1,,1,0,0,1,0,0,0,Cetuximab,"CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",3,COLORECTAL CANCER METASTATIC,Infusion related reaction,1,3
10018140,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Infusion related reaction,1,2
10018153,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Infusion related reaction,1,2
10018154,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Rash|Chest pain,2,3
10018155,20140318,Cetuximab,65,801,65.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|LISINOPRIL,2,,Anaphylactic reaction,1,5
10018160,20140318,Cetuximab,50,801,50.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,LARYNGEAL CANCER,Extravasation,1,2
10018162,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Oedema,1,3
10018163,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Drug administration error,1,2
10018164,20140318,Cetuximab,55,801,55.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Medication error,1,5
10018165,20140318,Cetuximab,52,801,52.0,2,82,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,2,COLON CANCER,Alopecia|Dysphonia|Dry skin,3,5
10018167,20140318,Cetuximab,61,801,61.0,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ATROPINE SULFATE|ATROPINE|DOCETAXEL|DOCETAXEL ANHYDROUS|CISPLATIN|CARBOPLATIN,9,HEAD AND NECK CANCER,Anaphylactic reaction,1,3
10018168,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Hypomagnesaemia,1,1
10018169,20140318,Cetuximab,50,801,50.0,1,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER METASTATIC,Consciousness fluctuating|Heart rate decreased|Blood pressure decreased,3,3
10018171,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Bronchospasm|Hypertension|Flushing|Rash|Urticaria,5,1
10018172,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Blood bilirubin increased,1,2
10018173,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Infusion related reaction,1,3
10018174,20140318,Cetuximab,89,801,89.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,METASTATIC NEOPLASM,Blood magnesium decreased|Blood potassium decreased,2,2
10018175,20140318,Cetuximab,,,,2,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Infusion related reaction|Cough,2,3
10018176,20140318,Cetuximab,73,801,73.0,1,64.03,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB|FLUTICASONE PROPIONATE AND SALMETEROL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|CITALOPRAM|ITRACONAZOLE|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|MINOCYCLINE|PREDNISONE|PANTOPRAZOLE SODIUM|SIROLIMUS|SIMVASTATIN,19,METASTATIC SQUAMOUS CELL CARCINOMA,Infusion related reaction,1,3
10018177,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Blood magnesium decreased,1,3
10018178,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Hypomagnesaemia,1,3
10018179,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|CALCIUM,2,,Blood magnesium decreased,1,3
10018180,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Pyrexia,1,5
10018181,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|CARBOPLATIN|CALCIUM,3,HEAD AND NECK CANCER|HEAD AND NECK CANCER,Hypomagnesaemia,1,3
10018182,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Malignant neoplasm progression,1,1
10018183,20140318,Cetuximab,57,801,57.0,1,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Malignant neoplasm progression,1,1
10018184,20140318,Cetuximab,73,801,73.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Product quality issue|Drug administration error,2,2
10018185,20140318,Cetuximab,60,801,60.0,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Dyspnoea|Heart rate decreased,2,3
10018186,20140318,Cetuximab,60,801,60.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Loss of consciousness,1,5
10018187,20140318,Cetuximab,59,801,59.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Oxygen saturation decreased|Tachycardia|Flushing,3,1
10018188,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Pruritus,1,5
10018189,20140318,Cetuximab,64,801,64.0,2,40.7,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|DIPHENHYDRAMINE HYDROCHLORIDE|MAGNESIUM|MULTIVITAMIN|NICOTINE POLACRILEX|NICOTINE|NICOTINE POLACRILEX MINI|NICOTINE POLARILEX|MIRTAZAPINE,13,,Flushing|Dyspnoea,2,2
10018190,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10018191,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Conjunctivitis,1,1
10018192,20140318,Cetuximab,59,801,59.0,1,68.03,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER METASTATIC,Malignant neoplasm progression,1,5
10018193,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Adverse event,1,2
10018194,20140318,Cetuximab,52,801,52.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|CAPECITABINE|LORAZEPAM,6,COLORECTAL CANCER METASTATIC,Rash,1,5
10018195,20140318,Cetuximab,88,801,88.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Rash|Pruritus|Nail discolouration|Weight increased,4,3
10018196,20140318,Cetuximab,6,800,60.0,0,,1,0,0,0,0,0,0,Cetuximab,FOLIC ACID|CETUXIMAB,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Stomatitis|Aphagia,2,3
10018197,20140318,Cetuximab,75,801,75.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Rash,1,2
10018198,20140318,Cetuximab,,,,2,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Hypersensitivity,1,1
10018199,20140318,Cetuximab,66,801,66.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|INSULIN GLARGINE|INSULIN ASPART|DIPHENHYDRAMINE HYDROCHLORIDE|FAMOTIDINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|MAGNESIUM,7,COLORECTAL CANCER METASTATIC,Infusion related reaction,1,1
10018200,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Infusion related reaction,1,1
10018201,20140318,Cetuximab,33,801,33.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Accidental exposure to product|Burning sensation,2,2
10018202,20140318,Cetuximab,,,,1,,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,3
10018203,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Rash|Pruritus|Skin lesion,3,5
10018206,20140318,Cetuximab,75,801,75.0,1,102,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|CARBOPLATIN|PACLITAXEL|METHYLPREDNISOLONE|DIPHENHYDRAMINE HYDROCHLORIDE|APREPITANT|FOSAPREPITANT DIMEGLUMINE,8,SQUAMOUS CELL CARCINOMA OF LUNG,Hypersensitivity|Off label use,2,2
10018207,20140318,Cetuximab,50,801,50.0,2,,1,0,1,1,0,0,1,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Bronchospasm|Hypotension,2,3
10018208,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,3
10018209,20140318,Cetuximab,66,801,66.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Dyspnoea|Flushing,2,2
10018210,20140318,Cetuximab,59,801,59.0,1,69.39,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DOXYCYCLINE|DOXYCYCLINE HYCLATE,4,SQUAMOUS CELL CARCINOMA|PAIN,Chest discomfort|Rash,2,3
10018211,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Anaphylactic reaction,1,1
10018212,20140318,Cetuximab,55,801,55.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Thyroid function test abnormal|Acne,2,5
10018213,20140318,Cetuximab,61,801,61.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET,2,COLON CANCER STAGE III,Acne|Rash|Alopecia|Skin disorder|Pruritus generalised|Dysphonia|Onychalgia,7,5
10018214,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Anaphylactoid reaction,1,3
10018215,20140318,Cetuximab,,,,1,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Death,1,1
10018216,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Infusion related reaction,1,1
10018217,20140318,Cetuximab,60,801,60.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Infusion related reaction,1,3
10018218,20140318,Cetuximab,58,801,58.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|PACLITAXEL|CARBOPLATIN,4,,Malignant neoplasm progression,1,2
10018219,20140318,Cetuximab,63,801,63.0,1,66.85,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,LUNG NEOPLASM MALIGNANT,Malignant neoplasm progression|Off label use,2,3
10018220,20140318,Cetuximab,60,801,60.0,2,102.04,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,RECTAL CANCER,Hypoaesthesia|Anxiety|Blood pressure decreased|Feeling abnormal,4,2
10018221,20140318,Cetuximab,45,801,45.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10018222,20140318,Cetuximab,69,801,69.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE|APREPITANT|FOSAPREPITANT DIMEGLUMINE,7,COLORECTAL CANCER METASTATIC|COLON CANCER|COLON CANCER|COLON CANCER|PREMEDICATION|PREMEDICATION|PREMEDICATION,Infusion related reaction,1,3
10018223,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Infusion related reaction,1,3
10018224,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,3
10018225,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Drug hypersensitivity,1,1
10018226,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|TURMERIC,2,,Drug interaction,1,3
10018228,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Loss of consciousness|Hypotension,2,1
10018229,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Conjunctivitis,1,1
10018230,20140318,Cetuximab,69,801,69.0,1,143,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,3,RECTAL CANCER,Diarrhoea,1,2
10018232,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Fatigue|Malaise,2,5
10018233,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE|LORAZEPAM,3,COLORECTAL CANCER METASTATIC|PREMEDICATION|PREMEDICATION,Rash|Pruritus|Hypoaesthesia|Blood pressure decreased,4,5
10018234,20140318,Cetuximab,53,801,53.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Rash|Acne,2,5
10018235,20140318,Cetuximab,58,801,58.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Infusion related reaction,1,3
10018236,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Infusion related reaction,1,3
10018237,20140318,Cetuximab,73,801,73.0,1,116.1,1,0,0,0,0,0,1,Cetuximab,"CETUXIMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|FERROUS SULFATE|ERGOCALCIFEROL|LISINOPRIL|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|ALLOPURINOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",10,SQUAMOUS CELL CARCINOMA,Infusion related reaction,1,5
10018238,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,3
10018239,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Speech disorder,1,5
10018240,20140318,Cetuximab,53,801,53.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER,Drug dose omission,1,2
10018241,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Hypomagnesaemia,1,1
10018243,20140318,Cetuximab,55,801,55.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,5
10018244,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Conjunctivitis,1,1
10018245,20140318,Cetuximab,60,801,60.0,1,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,4,ADENOCARCINOMA OF COLON,Malignant neoplasm progression,1,5
10018247,20140318,Cetuximab,48,801,48.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|IRINOTECAN HYDROCHLORIDE,4,COLORECTAL CANCER,Pruritus,1,5
10018248,20140318,Cetuximab,76,801,76.0,1,,1,0,0,1,0,0,0,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE,4,COLORECTAL CANCER METASTATIC,Loss of consciousness|Hyperhidrosis|Eye movement disorder|Gait disturbance|Blood pressure abnormal|Heart rate abnormal|Urticaria,7,3
10018249,20140318,Cetuximab,65,801,65.0,1,102.04,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|DIPHENHYDRAMINE HYDROCHLORIDE|LISINOPRIL,4,SQUAMOUS CELL CARCINOMA,Headache|Neck pain,2,5
10018250,20140318,Cetuximab,81,801,81.0,1,76.19,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,BONE CANCER,Rash|Weight decreased,2,5
10018251,20140318,Cetuximab,73,801,73.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLON CANCER METASTATIC,Dry skin,1,3
10018252,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Circumstance or information capable of leading to medication error,1,5
10018253,20140318,Cetuximab,83,801,83.0,1,113.38,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|EZETIMIBE|DUTASTERIDE|SITAGLIPTIN|TERAZOSIN|TERAZOSIN HYDROCHLORIDE|GLIMEPIRIDE|PREDNISONE|LOSARTAN,8,,Rash|Ageusia|Stomatitis|Dysphagia,4,5
10018254,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,4,,Infusion related reaction,1,1
10018255,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,3
10018257,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,"CETUXIMAB|APREPITANT|FOSAPREPITANT DIMEGLUMINE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CISPLATIN|DIPHENHYDRAMINE HYDROCHLORIDE",8,,Infusion related reaction,1,3
10018258,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Flatulence|Diarrhoea,2,5
10018259,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Blood bilirubin increased,1,1
10018266,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Drug dose omission,1,3
10018267,20140318,Cetuximab,72,801,72.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Circumstance or information capable of leading to medication error|Product quality control issue,2,2
10018268,20140318,Cetuximab,,,,0,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Death,1,3
10018269,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Rash,1,3
10018270,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Cardiac arrest,1,1
10018271,20140318,Cetuximab,52,801,52.0,2,,1,0,0,1,0,0,1,Cetuximab,CETUXIMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|CANDESARTAN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,4,,Vital functions abnormal,1,1
10018272,20140318,Cetuximab,42,801,42.0,2,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,ANAL CANCER,Hypotrichosis|Dry skin|Dry eye,3,5
10018273,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE,3,COLORECTAL CANCER,Infusion related reaction,1,5
10018274,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Blood magnesium decreased,1,5
10018275,20140318,Cetuximab,64,801,64.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Drug administration error,1,5
10018276,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Hypomagnesaemia,1,3
10018278,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Infusion related reaction,1,3
10018279,20140318,Cetuximab,66,801,66.0,2,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,COLON CANCER,Dyspnoea|Hyperhidrosis|Hypotension,3,1
10018280,20140318,Cetuximab,5,800,50.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,OROPHARYNGEAL CANCER,Stridor|Dyspnoea|Anxiety,3,1
10018281,20140318,Cetuximab,46,801,46.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Hypotension|Aphonia,2,5
10018282,20140318,Cetuximab,,,,2,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Hypomagnesaemia,1,3
10018283,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Anaphylactic reaction,1,1
10018284,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB|CETUXIMAB|CISPLATIN|CISPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FAMOTIDINE|DIPHENHYDRAMINE HYDROCHLORIDE|ALBUTEROL SULFATE|ALBUTEROL,10,HEAD AND NECK CANCER|OROPHARYNGEAL CANCER|HEAD AND NECK CANCER|OROPHARYNGEAL CANCER|HEAD AND NECK CANCER|OROPHARYNGEAL CANCER,Anaphylactic reaction,1,1
10018285,20140318,Cetuximab,,,,0,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,HEAD AND NECK CANCER,Hypomagnesaemia,1,3
10018286,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Rash pruritic,1,1
10018287,20140318,Cetuximab,5,800,50.0,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,RENAL CANCER,Flushing|Erythema|Dyspnoea|Chest pain|Blood pressure decreased,5,3
10018288,20140318,Cetuximab,58,801,58.0,1,104,1,0,1,0,0,0,0,Cetuximab,CETUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE|LORAZEPAM|PREDNISONE|ATORVASTATIN CALCIUM|NEBIVOLOL HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DULOXETINE HYDROCHLORIDE|INSULIN LISPRO|FOLIC ACID|MULTIVITAMIN|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|RAMIPRIL|METFORMIN HCL|PSYLLIUM HUSK,25,RECTAL CANCER,Anaphylactic reaction,1,3
10018289,20140318,Cetuximab,68,801,68.0,1,94,1,0,1,1,0,0,0,Cetuximab,CETUXIMAB|ESOMEPRAZOLE MAGNESIUM|MULTIVITAMIN,3,TONSIL CANCER,Anaphylactic reaction,1,3
10018290,20140318,Cetuximab,57,801,57.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|CETUXIMAB,2,HEAD AND NECK CANCER|LUNG NEOPLASM MALIGNANT,Injection site extravasation,1,3
10018291,20140318,Cetuximab,,,,1,,1,1,0,0,0,0,0,Cetuximab,CETUXIMAB,1,COLORECTAL CANCER,Death,1,1
10018292,20140318,Cetuximab,51,801,51.0,2,88.9,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB|OXALIPLATIN|LAMOTRIGINE|CLONAZEPAM|AMLODIPINE|BUPROPION|WARFARIN|ERGOCALCIFEROL|DOXEPIN|DOXEPIN HYDROCHLORIDE|SPIRONOLACTONE|ENOXAPARIN SODIUM,14,COLON CANCER RECURRENT|COLON CANCER RECURRENT|COLON CANCER RECURRENT|COLON CANCER RECURRENT,Neutropenia,1,3
10018294,20140318,Cetuximab,,,,1,,1,0,0,0,0,0,1,Cetuximab,CETUXIMAB,1,,Renal failure chronic,1,2
10018295,20140318,Cetuximab,54,801,54.0,1,,1,0,0,0,0,0,0,Cetuximab,CETUXIMAB,1,,Adverse event,1,5
10003730,20140312,Rituximab,65,801,65.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|ETOPOSIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,6,CENTRAL NERVOUS SYSTEM LYMPHOMA|CYSTITIS HAEMORRHAGIC|CENTRAL NERVOUS SYSTEM LYMPHOMA|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10003734,20140312,Rituximab,53,801,53.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|ETOPOSIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,6,CENTRAL NERVOUS SYSTEM LYMPHOMA|CYSTITIS HAEMORRHAGIC|CENTRAL NERVOUS SYSTEM LYMPHOMA|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10003760,20140312,Rituximab,64,801,64.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|ETOPOSIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,6,CENTRAL NERVOUS SYSTEM LYMPHOMA|CYSTITIS HAEMORRHAGIC|CENTRAL NERVOUS SYSTEM LYMPHOMA|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10003767,20140312,Rituximab,48,801,48.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|ETOPOSIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,6,CENTRAL NERVOUS SYSTEM LYMPHOMA|CYSTITIS HAEMORRHAGIC|CENTRAL NERVOUS SYSTEM LYMPHOMA|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10003772,20140312,Rituximab,66,801,66.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|ETOPOSIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,6,CENTRAL NERVOUS SYSTEM LYMPHOMA|CYSTITIS HAEMORRHAGIC|CENTRAL NERVOUS SYSTEM LYMPHOMA|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10003776,20140312,Rituximab,51,801,51.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|ETOPOSIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,6,CENTRAL NERVOUS SYSTEM LYMPHOMA|CYSTITIS HAEMORRHAGIC|CENTRAL NERVOUS SYSTEM LYMPHOMA|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10003782,20140312,Rituximab,66,801,66.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|ETOPOSIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,6,CENTRAL NERVOUS SYSTEM LYMPHOMA|CYSTITIS HAEMORRHAGIC|CENTRAL NERVOUS SYSTEM LYMPHOMA|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10003786,20140312,Rituximab,50,801,50.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|ETOPOSIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,6,CENTRAL NERVOUS SYSTEM LYMPHOMA|CYSTITIS HAEMORRHAGIC|CENTRAL NERVOUS SYSTEM LYMPHOMA|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10003787,20140312,Rituximab,56,801,56.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|ETOPOSIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,6,CENTRAL NERVOUS SYSTEM LYMPHOMA|CYSTITIS HAEMORRHAGIC|CENTRAL NERVOUS SYSTEM LYMPHOMA|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10003789,20140312,Rituximab,54,801,54.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|ETOPOSIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,6,CENTRAL NERVOUS SYSTEM LYMPHOMA|CYSTITIS HAEMORRHAGIC|CENTRAL NERVOUS SYSTEM LYMPHOMA|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10003794,20140312,Rituximab,62,801,62.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|ETOPOSIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,6,CENTRAL NERVOUS SYSTEM LYMPHOMA|CYSTITIS HAEMORRHAGIC|CENTRAL NERVOUS SYSTEM LYMPHOMA|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10003796,20140312,Rituximab,71,801,71.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|ETOPOSIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,6,CENTRAL NERVOUS SYSTEM LYMPHOMA|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CENTRAL NERVOUS SYSTEM LYMPHOMA|CYSTITIS HAEMORRHAGIC,Disease progression,1,1
10003799,20140312,Rituximab,68,801,68.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|ETOPOSIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,6,CENTRAL NERVOUS SYSTEM LYMPHOMA|CYSTITIS HAEMORRHAGIC|CENTRAL NERVOUS SYSTEM LYMPHOMA|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Neurological decompensation|Disease progression,2,1
10004203,20140312,Rituximab,60,801,60.0,1,,1,0,0,0,0,0,1,Rituximab,"BENDAMUSTINE HCL|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN",7,B-CELL LYMPHOMA STAGE IV|B-CELL LYMPHOMA STAGE IV|B-CELL LYMPHOMA STAGE IV|B-CELL LYMPHOMA STAGE IV,Malignant neoplasm progression|Pancytopenia,2,1
10004981,20140312,Rituximab,62,801,62.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|ETOPOSIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,6,CENTRAL NERVOUS SYSTEM LYMPHOMA|CYSTITIS HAEMORRHAGIC|CENTRAL NERVOUS SYSTEM LYMPHOMA|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Neurological decompensation|Disease progression,2,1
10005073,20140312,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|ETOPOSIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,6,CENTRAL NERVOUS SYSTEM LYMPHOMA|CYSTITIS HAEMORRHAGIC|CENTRAL NERVOUS SYSTEM LYMPHOMA|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Bronchopulmonary aspergillosis,1,1
10005183,20140312,Rituximab,76,801,76.0,1,,1,0,1,0,0,0,0,Rituximab,"BENDAMUSTINE HCL|PANTOPRAZOLE|FINASTERIDE|DAPSONE GEL, 5%|DAPSONE|DASPONE|FUROSEMIDE|AMLODIPINE BESYLATE",17,NON-HODGKIN^S LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|NON-HODGKIN^S LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-HODGKIN^S LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION,Skin lesion|Pyrexia|Melaena|Pancytopenia,4,1
10005282,20140312,Rituximab,85,801,85.0,2,,1,0,1,0,0,0,0,Rituximab,LISINOPRIL|BENDAMUSTINE HYDROCHLORIDE|RITUXIMAB,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Circulatory collapse,1,1
10005323,20140313,Rituximab,54,801,54.0,1,,1,0,1,0,0,0,0,Rituximab,CERTOLIZUMAB PEGOL|ETANERCEPT|TOCILIZUMAB|METHOTREXATE|METHOTREXATE SODIUM|RITUXIMAB|RITUXIMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|ABATACEPT,10,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Lung disorder|Cholelithiasis|Cholecystitis|Hypertension|Bronchitis|Asthenia|Pterygium|Gastroenteritis,8,1
10005378,20140313,Rituximab,20,801,20.0,2,,1,0,1,0,0,0,0,Rituximab,MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|HYDROXYCHLOROQUINE|LOSARTAN|FUROSEMIDE|ENALAPRIL|HYDRALAZINE HYDROCHLORIDE|FUROSEMIDE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|AZATHIOPRINE|HYDROXYCHLOROQUINE|HYDRALAZINE HYDROCHLORIDE|PINDOLOL|AZATHIOPRINE|AZATHIOPRINE|PINDOLOL|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|METHYLDOPA,34,HYPERTENSION|NAUSEA|HYPERTENSION|HYPERTENSION|SLE ARTHRITIS|SYSTEMIC LUPUS ERYTHEMATOSUS|PAIN|HYPERSENSITIVITY|PAIN|HYPERTENSION|SLE ARTHRITIS|SLE ARTHRITIS|IMMUNOSUPPRESSION,Proteinuria|Abortion spontaneous|Hypertension|Maternal exposure during pregnancy,4,2
10005479,20140313,Rituximab,,,,2,,1,0,1,0,0,0,1,Rituximab,TOCILIZUMAB,2,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Larynx irritation|Chest pain|Urticaria,3,1
10005527,20140313,Rituximab,,,,2,,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB,3,RHEUMATOID ARTHRITIS,Vasculitis|Pancytopenia|Thrombocytopenia,3,1
10005539,20140313,Rituximab,63,801,63.0,2,,1,1,1,0,0,0,0,Rituximab,RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|RITUXIMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|RITUXIMAB|RITUXIMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM,18,RHEUMATOID ARTHRITIS,Femoral neck fracture|Localised infection|Bronchopneumonia|Pharyngitis|Erysipelas|Cardiac failure|Fall|Respiratory distress,8,1
10005585,20140313,Rituximab,42,801,42.0,2,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,1,NEUROMYELITIS OPTICA,Central nervous system lesion,1,3
10005839,20140313,Rituximab,69,801,69.0,2,,1,1,0,0,0,0,1,Rituximab,"BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB|SIMVASTATIN",19,NEUTROPENIC SEPSIS|PROPHYLAXIS|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Leukoencephalopathy|Peroneal nerve palsy|Mobility decreased|Sensory loss|Grand mal convulsion|Muscular weakness,6,3
10007611,20140311,Rituximab,65,801,65.0,1,,1,1,0,0,0,0,0,Rituximab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN",8,CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE,Disease progression|Off label use|Castleman^s disease|Drug ineffective,4,3
10008490,20140313,Rituximab,64,801,64.0,1,99.7,1,0,1,0,0,0,1,Rituximab,BENDAMUSTINE HYDROCHLORIDE|RITUXIMAB|ACYCLOVIR|AMOXICILLIN|SULFAMETHOXAZOLE AND TRIMETHOPRIM|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|FLUCONAZOLE|LORAZEPAM|LORAZEPAM|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS,15,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Neutropenia|Anaemia|Pancytopenia|Thrombocytopenia,4,3
10008500,20140313,Rituximab,81,801,81.0,1,,1,1,1,1,0,0,0,Rituximab,BENDAMUSTINE HCL|RITUXIMAB|LENALIDOMIDE,3,NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA,Pulmonary embolism|Neoplasm progression|Abdominal pain,3,1
10009595,20140313,Rituximab,51,801,51.0,2,71,1,0,1,0,0,0,0,Rituximab,AMOXICILLIN AND CLAVULANATE POTASSIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FILGRASTIM|BENDAMUSTINE HCL|ACYCLOVIR|RITUXIMAB,16,INFECTION|HYPERTENSION|GASTRIC ULCER|NEUTROPENIA|PYREXIA|LYMPHOMA|INFECTION|GASTRIC ULCER|NAUSEA|INFECTION|INFECTION|HYPERTENSION|HYPERTENSION|LYMPHOMA,Vaginal ulceration,1,1
10009972,20140312,Rituximab,62,801,62.0,1,,1,0,0,0,0,0,0,Rituximab,RUXOLITINIB|RUXOLITINIB|RITUXIMAB|BENDAMUSTINE HCL,4,POLYCYTHAEMIA VERA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Memory impairment|Photophobia|Fatigue|Dysstasia|Mental disorder|White blood cell count increased|Oropharyngeal pain|Cough|Pyrexia|Rhinorrhoea|Apathy|Hypersomnia|Insomnia|Dizziness|Headache|Drug effect decreased,16,5
10010310,20140314,Rituximab,79,801,79.0,1,,1,1,0,0,0,0,0,Rituximab,"DOXORUBICIN|METHYLPREDNISOLONE SODIUM SUCCINATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|RITUXIMAB",5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,
10010344,20140314,Rituximab,25,801,25.0,2,85,1,0,1,0,0,0,0,Rituximab,"RITUXIMAB|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|BLEOMYCIN|BLEOMYCIN SULFATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",9,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Gastric ulcer,1,1
10010513,20140314,Rituximab,,,,1,,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM,22,RHEUMATOID ARTHRITIS,Renal colic|Renal failure acute|Urinary tract infection|Bacterial test positive|Bronchitis|Rhinorrhoea,6,1
10010528,20140314,Rituximab,,,,1,,1,0,1,0,0,0,0,Rituximab,"PEGFILGRASTIM|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE",7,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Back pain,1,3
10010535,20140314,Rituximab,,,,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM,31,RHEUMATOID ARTHRITIS,Foot deformity|Infusion related reaction|Headache|Interstitial lung disease|Gastroenteritis|Drug dependence|Eczema|Dry skin,8,1
10010668,20140314,Rituximab,81,801,81.0,1,,1,1,1,0,0,0,0,Rituximab,RITUXIMAB|BENDAMUSTINE HYDROCHLORIDE|LENALIDOMIDE,3,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Abdominal pain|Pulmonary embolism,2,1
10010843,20140314,Rituximab,69,801,69.0,2,46.72,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|PREDNISONE|FLUOROMETHOLONE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ACYCLOVIR|GABAPENTIN|LEVOTHYROXINE SODIUM,12,SCLERODERMA,Scleroderma|Fasciitis|Dyspnoea|Infusion related reaction|Pneumonia fungal,5,1
10010851,20140314,Rituximab,69,801,69.0,1,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB,1,RHEUMATOID ARTHRITIS,Adenocarcinoma,1,1
10010922,20140314,Rituximab,70,801,70.0,2,77.18,1,0,0,0,0,0,0,Rituximab,RITUXIMAB|FISH OIL,4,HYPERSENSITIVITY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Somnolence|Vision blurred,2,5
10011290,20140312,Rituximab,65,801,65.0,1,,1,1,0,0,0,0,0,Rituximab,"CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|VINCRISTINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CISPLATIN|RITUXIMAB|PREDNISONE",8,CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE,Disease progression|Castleman^s disease|Off label use,3,3
10011391,20140314,Rituximab,66,801,66.0,2,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,7,RHEUMATIC DISORDER|MEDICATION DILUTION|RHEUMATIC DISORDER|PREMEDICATION|PREMEDICATION|PREMEDICATION,Throat irritation|Paraesthesia|Throat irritation|Oral discomfort|Malaise,5,3
10011400,20140314,Rituximab,49,801,49.0,2,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,10,RHEUMATIC DISORDER|MEDICATION DILUTION|RHEUMATIC DISORDER|ADVERSE DRUG REACTION|PREMEDICATION|PREMEDICATION|ADVERSE REACTION|PREMEDICATION|ADVERSE REACTION,Throat irritation|Headache|Chest discomfort,3,3
10011443,20140314,Rituximab,69,801,69.0,1,68,1,0,1,1,0,0,0,Rituximab,"DOXORUBICIN|DOXORUBICIN|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB|RITUXIMAB|RITUXIMAB|BORTEZOMIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",23,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Neutropenic sepsis|Anaemia|Infection|Hypophosphataemia|Pyrexia|Malaise,6,1
10011456,20140314,Rituximab,61,801,61.0,1,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10011494,20140314,Rituximab,61,801,61.0,1,,1,0,0,0,0,0,1,Rituximab,FLUDARABINE PHOSPHATE|RITUXIMAB,2,LEUKAEMIA|LEUKAEMIA,Drug-induced liver injury|Hepatic necrosis,2,3
10011810,20140314,Rituximab,10,801,10.0,1,,1,0,0,0,0,0,1,Rituximab,"PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|MERCAPTOPURINE|DAPSONE GEL, 5%|DAPSONE|DASPONE|DANAZOL|CYTARABINE|METHYLPREDNISOLONE",12,EVANS SYNDROME|EVANS SYNDROME|EVANS SYNDROME|EVANS SYNDROME|EVANS SYNDROME|EVANS SYNDROME|EVANS SYNDROME|EVANS SYNDROME|EVANS SYNDROME|EVANS SYNDROME|EVANS SYNDROME,Cushingoid|Body height below normal|Acne|Skin papilloma|Spinal compression fracture|Headache|Headache|Musculoskeletal stiffness|Insomnia|Lymphopenia|Osteoporosis,11,3
10012111,20140313,Rituximab,68,801,68.0,2,53.7,1,0,0,0,0,0,1,Rituximab,,2,,Hyponatraemia,1,
10012258,20140314,Rituximab,61,801,61.0,2,,1,0,1,0,0,0,1,Rituximab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MESNA|MESNA INJECTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB",5,ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA,Abdominal pain,1,3
10012695,20140314,Rituximab,83,801,83.0,1,,1,1,0,0,0,0,1,Rituximab,"LENALIDOMIDE|RITUXIMAB|RITUXIMAB|BENDAMUSTINE HCL|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",17,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|B-CELL LYMPHOMA,Refractory cytopenia with multilineage dysplasia,1,1
10012751,20140314,Rituximab,63,801,63.0,2,,1,1,0,0,0,0,1,Rituximab,RITUXIMAB|LENALIDOMIDE|RITUXIMAB,3,B-CELL LYMPHOMA|B-CELL LYMPHOMA,Hodgkin^s disease,1,3
10012812,20140314,Rituximab,80,801,80.0,0,,1,1,0,0,0,0,1,Rituximab,BENDAMUSTINE HYDROCHLORIDE|RITUXIMAB,2,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Death|Pleural effusion,2,1
10012813,20140314,Rituximab,64,801,64.0,2,,1,0,0,0,0,0,1,Rituximab,BENDAMUSTINE HYDROCHLORIDE|RITUXIMAB,2,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Blindness unilateral|Optic neuritis|Visual impairment,3,1
10012830,20140314,Rituximab,73,801,73.0,1,45.9,1,0,1,1,0,0,0,Rituximab,IBRUTINIB|IBRUTINIB|BENDAMUSTINE HCL|RITUXIMAB,4,CHRONIC LYMPHOCYTIC LEUKAEMIA|LYMPHOCYTIC LYMPHOMA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Cytomegalovirus infection,1,1
10013243,20140314,Rituximab,,,,0,,1,1,1,0,0,0,1,Rituximab,ECULIZUMAB|RITUXIMAB,2,HAEMOLYTIC URAEMIC SYNDROME|PRODUCT USED FOR UNKNOWN INDICATION,Blood lactate dehydrogenase increased|Nephrolithiasis|Pneumonia|Tremor|Pyrexia|Dysgeusia|Confusional state|Weight decreased|Blood pressure increased|Microangiopathic haemolytic anaemia|Haemoglobin decreased|Death|Blood creatinine increased|Urinary tract infection|Asthenia|Decreased appetite|Oedema|Flank pain|Staphylococcal infection,19,5
10013387,20140314,Rituximab,63,801,63.0,1,,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB,2,LYMPHOMA,"Bladder cancer stage I, with cancer in situ",1,3
10013579,20140315,Rituximab,,,,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM,10,RHEUMATOID ARTHRITIS,Tendon rupture|Joint arthroplasty|Trapezectomy|Ligament operation,4,1
10013594,20140315,Rituximab,43,801,43.0,2,,1,1,1,0,0,0,1,Rituximab,"RITUXIMAB|RITUXIMAB|PREDNISONE|RITUXIMAB|VINCRISTINE SULFATE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|DALTEPARIN SODIUM|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",14,DIFFUSE LARGE B-CELL LYMPHOMA,Vena cava thrombosis|Pelvic neoplasm|Lymphoma|Hypersensitivity|Blood bilirubin increased|Malaise|Full blood count decreased|Stem cell transplant|Lymphoma|Disease progression,10,2
10014012,20140317,Rituximab,,,,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|TOCILIZUMAB|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|ABATACEPT|BELIMUMAB,8,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Prurigo|Synovial rupture|Pemphigoid|Abscess|Furuncle|Keratitis|Skin lesion,7,1
10014257,20140317,Rituximab,,,,1,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB,1,NON-HODGKIN^S LYMPHOMA,Stomatitis|Diarrhoea,2,5
10014983,20140317,Rituximab,69,801,69.0,1,68.5,1,0,1,0,0,0,0,Rituximab,BENDAMUSTINE HCL|BENDAMUSTINE HCL|RITUXIMAB|RITUXIMAB,6,LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|LYMPHOCYTIC LEUKAEMIA,Pain,1,1
10015502,20140317,Rituximab,,,,0,,1,1,0,0,0,0,1,Rituximab,CLADRIBINE|RITUXIMAB|VORINOSTAT,3,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Death|Mantle cell lymphoma recurrent|Neutropenia|Thrombocytopenia|Fatigue|Decreased appetite|Dehydration|Off label use|Therapeutic response unexpected,9,1
10015559,20140317,Rituximab,81,801,81.0,2,,1,0,1,0,0,0,0,Rituximab,DULOXETINE HYDROCHLORIDE|DULOXETIN HYDROCHLORIDE|DULOXETINE|DULOXETINE HYDROCHLORIDE|DULOXETIN HYDROCHLORIDE|DULOXETINE|RITUXIMAB,10,NEURALGIA|NEUROPATHY PERIPHERAL,General physical health deterioration|Weight decreased|Off label use|Colitis microscopic,4,5
10015962,20140317,Rituximab,67,801,67.0,1,,1,1,0,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB,4,PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME,Disease progression|Pulmonary alveolar haemorrhage,2,1
10015973,20140317,Rituximab,44,801,44.0,2,,1,0,0,0,0,0,1,Rituximab,MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|HYDROXYCHLOROQUINE|HYDROXYCHLOROQUINE|RITUXIMAB|RITUXIMAB|AZATHIOPRINE|AZATHIOPRINE,12,PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE,Disease progression|Disease complication,2,1
10015979,20140317,Rituximab,35,801,35.0,1,,1,1,0,0,0,0,1,Rituximab,MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|RITUXIMAB|RITUXIMAB|AZATHIOPRINE|AZATHIOPRINE,10,PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME,Disease progression|Septic shock,2,1
10016041,20140317,Rituximab,46,801,46.0,2,,1,0,0,0,0,0,1,Rituximab,AZATHIOPRINE|AZATHIOPRINE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|RITUXIMAB|RITUXIMAB,8,PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME,Disease progression|Condition aggravated|Pulmonary alveolar haemorrhage,3,1
10016326,20140317,Rituximab,35,801,35.0,1,68,1,1,0,1,0,0,0,Rituximab,ETOPOSIDE|CYTARABINE|METHOTREXATE|METHOTREXATE SODIUM|RITUXIMAB|SOFOSBUVIR|EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE|RALTEGRAVIR|FLUCONAZOLE|FILGRASTIM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,23,HEPATITIS C|HEPATITIS C|BURKITT^S LYMPHOMA|BURKITT^S LYMPHOMA|BURKITT^S LYMPHOMA|BURKITT^S LYMPHOMA|BURKITT^S LYMPHOMA|CHRONIC HEPATITIS C,Bacterial sepsis,1,3
10016372,20140317,Rituximab,32,801,32.0,2,,1,1,0,0,0,0,1,Rituximab,MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|RITUXIMAB|RITUXIMAB|BORTEZOMIB FOR INJECTION|BORTEZOMIB|BORTEZOMIB FOR INJECTION|BORTEZOMIB|ALEMTUZUMAB|ALEMTUZUMAB,12,PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME|PULMONARY ALVEOLAR HAEMORRHAGE|ANTIPHOSPHOLIPID SYNDROME,Disease progression|Pulmonary alveolar haemorrhage|Cerebrovascular accident,3,1
10016395,20140317,Rituximab,73,801,73.0,1,73.8,1,0,1,0,0,0,0,Rituximab,"LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|RITUXIMAB|RITUXIMAB|MORPHINE SULFATE|DALTEPARIN SODIUM|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL",22,LYMPHOMA|LYMPHOMA|LYMPHOMA|ARTHRITIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|ALLERGY PROPHYLAXIS|ALLERGY PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Chondrocalcinosis pyrophosphate|Pyrexia|Ventricular tachycardia,3,1
10016840,20140318,Rituximab,30,801,30.0,2,52,1,1,0,0,0,0,1,Rituximab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,4,SYSTEMIC SCLERODERMA|PULMONARY FIBROSIS|GASTRIC DISORDER|RHEUMATOID ARTHRITIS,Pyrexia|Depression|Blood pressure increased|Somnolence|Respiratory failure|Off label use,6,1
10016854,20140318,Rituximab,58,801,58.0,1,64,1,0,0,0,0,0,1,Rituximab,ALLOPURINOL|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION,8,B-CELL LYMPHOMA|HYPERURICAEMIA|B-CELL LYMPHOMA|COLITIS ULCERATIVE|B-CELL LYMPHOMA|B-CELL LYMPHOMA|LYMPHOMA|B-CELL LYMPHOMA,Ophthalmic herpes simplex,1,1
10016912,20140318,Rituximab,45,801,45.0,2,,1,0,1,0,0,0,1,Rituximab,ETANERCEPT|ETANERCEPT|RITUXIMAB|ETANERCEPT|METHOTREXATE|METHOTREXATE SODIUM|FENTANYL|HYDROMORPHONE HYDROCHLORIDE|PROMETHAZINE HYDROCHLORIDE|PREDNISONE|RITUXIMAB|ETANERCEPT,12,RHEUMATOID ARTHRITIS|PRODUCT USED FOR UNKNOWN INDICATION,Foot deformity|Injection site mass|Injection site pustule|Insomnia|Oral mucosal blistering|Amnesia|Chills|Tooth infection|Joint swelling|Injection site extravasation|Aphthous ulcer|Pain|Sleep disorder|Fatigue|Meniscus injury|Vomiting|Nodule|Peripheral swelling|Injection site infection|Fall|Arthralgia|Injection site haemorrhage|Infection|Joint effusion|Swelling|Bone pain|Mobility decreased|Dental caries|Injection site pain|Influenza like illness|Mouth ulceration|Fractured coccyx|Oral pain|Dysstasia|Pain in extremity|Vein discolouration|Dyspnoea|Burning sensation|Weight decreased|Rheumatoid arthritis|Activities of daily living impaired|Tooth disorder|Memory impairment|Hyperhidrosis|Vascular pain|Treatment failure|Scar|Muscle spasms|Pain in jaw|Back pain,50,1
10017114,20140318,Rituximab,76,801,76.0,2,42,1,1,1,0,0,0,1,Rituximab,"HYDROXYCHLOROQUINE SULFATE|ALBUTEROL SULFATE|RISEDRONATE SODIUM|TOCILIZUMAB|PREGABALIN|TOBRAMYCIN|TOBRAMYCIN SULFATE|TOBRAMYCIN SOLUTION|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PREGABALIN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|FOLIC ACID|DIPHENHYDRAMINE HYDROCHLORIDE|METHOTREXATE|METHOTREXATE SODIUM|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|TOCILIZUMAB|RITUXIMAB|CELECOXIB",17,RHEUMATOID ARTHRITIS|PREMEDICATION|PREMEDICATION|RHEUMATOID ARTHRITIS,Abdominal pain|Poor peripheral circulation|Bronchitis|Weight decreased|Nausea|Frequent bowel movements|Laryngitis|Post-traumatic pain|Gastritis|Dyspepsia|Arthralgia|Musculoskeletal stiffness|Burning sensation|Pain in extremity|Dizziness|Pain|Arthralgia|Rheumatoid arthritis|Erythema|Back pain|Death|Sinusitis|Movement disorder|Haemorrhage|Arthralgia|Oxygen saturation decreased|Limb injury|Infusion related reaction|Oxygen saturation decreased|Blood pressure systolic increased|Blood pressure increased|Headache,32,3
10017355,20140318,Rituximab,,,,1,,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|METHYLPREDNISOLONE|HYDROXYCHLOROQUINE,28,RHEUMATOID ARTHRITIS,Atrial fibrillation|Hepatocellular injury|Infusion related reaction|Chills|Urine analysis abnormal|Dyspepsia|Oedema peripheral|Larynx irritation|Bronchial obstruction|Epistaxis|Bronchopneumonia|Diarrhoea|Upper respiratory tract infection|Bronchopneumonia|Bronchitis,15,1
10017473,20140318,Rituximab,63,801,63.0,1,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB,2,RHEUMATOID ARTHRITIS,Back pain|Intervertebral discitis|Osteochondrosis,3,1
10017475,20140318,Rituximab,65,801,65.0,1,,1,1,1,0,0,0,0,Rituximab,"RITUXIMAB|TOCILIZUMAB|ATORVASTATIN CALCIUM|ALBUTEROL SULFATE|TIOTROPIUM BROMIDE|NITROGLYCERIN|FUROSEMIDE|SALMETEROL XINAFOATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|HUMAN INSULIN|LANSOPRAZOLE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|PREDNISONE|SITAGLIPTIN|SPIRONOLACTONE|OXAZEPAM|PREGABALIN",27,RHEUMATOID ARTHRITIS|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION,Arthralgia|Death|Rheumatoid arthritis|Haemorrhage,4,3
10017494,20140318,Rituximab,,,,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB,9,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Rash|Gastric polyps|Bronchitis|Asthenia|Anaemia|Fall|Rotator cuff syndrome|Iron deficiency anaemia|Abdominal pain|Dyspepsia|Faeces discoloured|Tendon rupture,12,1
10017682,20140318,Rituximab,,,,0,,1,0,0,0,0,0,0,Rituximab,ECULIZUMAB|PREDNISONE|RITUXIMAB,4,HAEMOLYTIC URAEMIC SYNDROME|STEROID THERAPY|PRODUCT USED FOR UNKNOWN INDICATION|HYPERTENSION,Influenza|Sinusitis,2,5
10017804,20140318,Rituximab,,,,2,,1,0,0,0,0,0,0,Rituximab,LABETALOL|BUPROPION HYDROCHLORIDE|RITUXIMAB|AMLODIPINE BESYLATE|ECULIZUMAB,6,PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|HAEMOLYTIC URAEMIC SYNDROME,Nausea|Hair texture abnormal|Fatigue|Alopecia,4,5
10017981,20140318,Rituximab,55,801,55.0,2,,1,0,0,0,1,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|PREDNISONE|PREDNISONE|PREDNISONE,15,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Palmar-plantar erythrodysaesthesia syndrome|Paraesthesia|Erythema|Pain in extremity|Gait disturbance|Oedema,6,3
10018026,20140318,Rituximab,42,801,42.0,2,,1,1,1,0,0,0,0,Rituximab,RITUXIMAB|PREDNISONE|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM,8,DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV,Myocarditis|Cardiac failure|Pulmonary oedema|Pericardial effusion|Convulsion|Cerebrovascular accident,6,3
10018538,20140314,Rituximab,47,801,47.0,2,86.18,1,0,1,1,1,0,0,Rituximab,RITUXIMAB,1,RHEUMATOID ARTHRITIS,Pneumonia|Malaise|Hepatitis|Encephalitis|Cytomegalovirus infection|Asthenia|Balance disorder|Confusional state|Viral infection|Bacterial infection|Mental status changes|Immune system disorder,12,
10018631,20140312,Rituximab,43,801,43.0,1,,1,0,0,0,0,0,1,Rituximab,"DOXORUBICIN|CISPLATIN|CYTARABINE|ETOPOSIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|MELPHALAN HYDROCHLORIDE|MELPHALAN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE",11,NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA,Hepatitis B,1,
10019158,20140318,Rituximab,65,801,65.0,1,,1,1,0,0,0,0,0,Rituximab,"CISPLATIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISONE|RITUXIMAB",8,CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE|CASTLEMAN^S DISEASE,Castleman^s disease|Off label use,2,1
10019420,20140318,Rituximab,51,801,51.0,1,76,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|CLADRIBINE|ALLOPURINOL,6,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Weight decreased|Lung disorder,2,1
10019533,20140318,Rituximab,81,801,81.0,1,,1,1,1,1,0,0,0,Rituximab,LENALIDOMIDE|RITUXIMAB|BENDAMUSTINE HCL,4,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION,B-cell lymphoma|Pulmonary embolism|Abdominal pain|Abdominal pain,4,1
10019656,20140318,Rituximab,50,801,50.0,2,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,3,TRANSPLANT REJECTION|OFF LABEL USE|TRANSPLANT REJECTION,Duodenal ulcer haemorrhage,1,3
10019871,20140318,Rituximab,64,801,64.0,1,92,1,0,0,0,0,0,0,Rituximab,CLOPIDOGREL|ATORVASTATIN CALCIUM|METOPROLOL TARTRATE|RITUXIMAB|BOSUTINIB|BOSUTINIB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,7,LYMPHOMA|CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Diarrhoea|Headache|Abdominal pain upper,3,5
10019971,20140318,Rituximab,48,801,48.0,1,,1,0,0,0,0,0,1,Rituximab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|ETOPOSIDE|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",5,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Chest discomfort|Prinzmetal angina|Chest pain,3,2
10020064,20140318,Rituximab,76,801,76.0,2,72,1,0,1,0,0,0,0,Rituximab,"PREDNISONE|RITUXIMAB|NIFEDIPINE|LOSARTAN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CLOPIDOGREL|CLOPIDOGREL BISULFATE",12,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|TRANSIENT ISCHAEMIC ATTACK|HYPERTENSION|HYPERLIPIDAEMIA|INFECTION|HYPERTENSION|INSOMNIA|DIFFUSE LARGE B-CELL LYMPHOMA,Drug hypersensitivity|Pulmonary embolism,2,1
10020123,20140319,Rituximab,34,801,34.0,1,,1,0,0,0,0,0,1,Rituximab,MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|RITUXIMAB|METHYLPREDNISOLONE|SIROLIMUS,6,PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION,Cytomegalovirus infection|Cryptococcosis,2,3
10020317,20140319,Rituximab,56,801,56.0,1,76,1,0,1,1,0,0,0,Rituximab,"VORINOSTAT|VORINOSTAT|VORINOSTAT|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|RITUXIMAB|DOXORUBICIN|DOXORUBICIN|PREDNISONE|PREDNISONE|CALCIUM CARBONATE|ANTACID|PREDNISONE|LORAZEPAM|POLYETHYLENE GLYCOL 3350|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL",20,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Platelet count decreased|White blood cell count decreased|Anaemia|Febrile neutropenia|Non-cardiac chest pain,5,5
10020327,20140319,Rituximab,68,801,68.0,2,,1,0,1,0,0,0,0,Rituximab,INFLIXIMAB|METHOTREXATE|METHOTREXATE SODIUM|HYDROXYCHLOROQUINE|TOCILIZUMAB|LEFLUNOMIDE|RITUXIMAB,7,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Urinary tract infection|Pyelonephritis|Bronchopneumonia|Pneumonia|Renal colic|Wound infection|Pulmonary embolism|Hypogammaglobulinaemia|Influenza|Escherichia urinary tract infection|Hyperthermia|Abscess limb,12,1
10020558,20140319,Rituximab,,,,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB,13,RHEUMATOID ARTHRITIS,Venous insufficiency|Occipital neuralgia|Spinal disorder|Headache|Granuloma|Pyrexia|Inflammation|Cystitis escherichia|Blood pressure increased|Vertigo|Asthenia|Ear disorder|Influenza|Hypertension|Dyspepsia|Renal cyst|Sinusitis|Humerus fracture|Nausea|Oedema peripheral|Dyspnoea|Urinary tract infection|Cervicitis|Vaginal infection|Influenza like illness|Upper limb fracture|Oedema peripheral,27,1
10020578,20140319,Rituximab,60,801,60.0,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB,1,B-CELL LYMPHOMA,Hepatotoxicity,1,3
10020622,20140319,Rituximab,75,801,75.0,2,66,1,1,0,0,0,0,0,Rituximab,,1,RHEUMATOID ARTHRITIS,Acute abdomen,1,1
10020822,20140319,Rituximab,,,,2,,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM,6,RHEUMATOID ARTHRITIS,Basal cell carcinoma|Large intestine polyp|Subcutaneous abscess|Hot flush|Lung disorder|Bronchitis|Gastroenteritis,7,1
10021939,20140319,Rituximab,,,,2,,1,0,0,1,0,0,0,Rituximab,RITUXIMAB|CLONAZEPAM|BENDAMUSTINE HCL,3,B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION,Loss of consciousness|Pulse absent|Blood pressure immeasurable|Nausea|Feeling hot|Hypotension|Pulse abnormal,7,5
10022110,20140318,Rituximab,77,801,77.0,2,49.9,1,0,0,0,0,0,0,Rituximab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|FLUDARABINE PHOSPHATE|RITUXIMAB",3,,Myelodysplastic syndrome,1,
10022311,20140319,Rituximab,66,801,66.0,1,,1,0,1,0,0,0,0,Rituximab,BENDAMUSTINE HCL|BENDAMUSTINE HCL|RITUXIMAB,3,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Pancreatitis acute|Leukopenia,2,1
10022396,20140319,Rituximab,,,,2,50,1,0,0,0,0,0,1,Rituximab,TOCILIZUMAB|TOCILIZUMAB|PREDNISONE|FOLIC ACID|TOCILIZUMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE,9,RHEUMATOID ARTHRITIS|PRODUCT USED FOR UNKNOWN INDICATION,Blood cholesterol increased|Arthropathy,2,3
10022528,20140319,Rituximab,70,801,70.0,2,,1,1,0,0,0,0,0,Rituximab,ADALIMUMAB|RITUXIMAB|LEFLUNOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB,6,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Lung adenocarcinoma,1,3
10022554,20140318,Rituximab,43,801,43.0,1,72.12,1,0,1,0,0,0,0,Rituximab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PREDNISONE|RITUXIMAB|VINCRISTINE SULFATE",6,,Platelet count decreased,1,1
10022937,20140319,Rituximab,54,801,54.0,1,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PEGFILGRASTIM|CEFEPIME HYDROCHLORIDE|CEFEPIME|METRONIDAZOLE|METRONIDAZOLE TOPICAL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|MICAFUNGIN|MICAFUNGIN SODIUM,10,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|FEBRILE NEUTROPENIA|CLOSTRIDIUM DIFFICILE COLITIS|CLOSTRIDIUM DIFFICILE COLITIS|ANTIFUNGAL TREATMENT,Febrile neutropenia|Neutropenic colitis|Clostridium difficile colitis,3,1
10023369,20140320,Rituximab,58,801,58.0,1,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10023372,20140320,Rituximab,,,,1,99,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|FLUDARABINE PHOSPHATE|FLUDARABINE PHOSPHATE,7,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Acute graft versus host disease in intestine|Escherichia urinary tract infection|Renal failure acute|Graft versus host disease|Acute graft versus host disease in skin|Dehydration,6,1
10023376,20140320,Rituximab,,,,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|ETANERCEPT|ETANERCEPT,4,RHEUMATOID ARTHRITIS,Sciatica|Restless legs syndrome|Bronchitis|Cystitis|Upper respiratory tract infection,5,1
10023393,20140320,Rituximab,,,,2,54.4,1,0,0,0,0,0,1,Rituximab,"TOCILIZUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CALCITRIOL|CALCITRIOL CAPSULES 0.25 MCG|CALCITRIOL CAPSULES 0.5 MCG|RITUXIMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",10,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Skin discolouration|Oropharyngeal pain|Arthralgia|Hypoaesthesia|Hypersensitivity|Localised infection|Arthritis|Sepsis|Hiatus hernia|Hypertension|Osteomyelitis|Hyperparathyroidism|Blood potassium increased|Joint swelling|Urinary tract infection,15,3
10023445,20140320,Rituximab,77,801,77.0,1,74,1,1,1,0,0,0,0,Rituximab,RITUXIMAB,4,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Respiratory failure|Pneumonia,2,1
10023580,20140320,Rituximab,,,,0,,1,1,0,0,0,0,1,Rituximab,"DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|RITUXIMAB|ETOPOSIDE|CYTARABINE|BLEOMYCIN|BLEOMYCIN SULFATE|METHOTREXATE|METHOTREXATE SODIUM",10,NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA,Death|Peripheral sensory neuropathy|Adverse event|Constipation|Fatigue|Headache|Chills|Nausea|Vomiting,9,3
10023722,20140320,Rituximab,75,801,75.0,2,60.3,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE,5,RHEUMATOID ARTHRITIS|PREMEDICATION|PREMEDICATION|PREMEDICATION,Colon cancer stage II|Thermal burn|Hypertension,3,1
10023952,20140320,Rituximab,59,801,59.0,1,,1,0,0,0,0,0,1,Rituximab,TACROLIMUS|FLUDARABINE PHOSPHATE|MELPHALAN HYDROCHLORIDE|MELPHALAN|BUSULFAN|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|METHYLPREDNISOLONE|RITUXIMAB,7,PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PREMEDICATION|PREMEDICATION|PREMEDICATION|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|ACUTE GRAFT VERSUS HOST DISEASE|POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,Drug ineffective|Acute graft versus host disease|Chronic graft versus host disease,3,1
10024074,20140320,Rituximab,53,801,53.0,2,45,1,0,0,0,0,0,1,Rituximab,GLIMEPIRIDE|SITAGLIPTIN|TOCILIZUMAB|DEFLAZACORT|LEFLUNOMIDE|PREDNISOLONE ACETATE|DEFLAZACORT|MELOXICAM,15,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Weight increased|Drug ineffective|Rash macular|Retinal detachment|Nasopharyngitis|Erythema|Rhinitis allergic|Weight decreased|Nausea,9,5
10024268,20140320,Rituximab,60,801,60.0,2,,1,0,0,0,0,0,1,Rituximab,"RITUXIMAB|DOXORUBICIN|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Gastric haemorrhage,1,1
10024374,20140320,Rituximab,57,801,57.0,1,120.2,1,0,0,0,0,0,1,Rituximab,DEXLANSOPRAZOLE|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|METHYLPREDNISOLONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|TOCILIZUMAB|RITUXIMAB,9,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Drug ineffective|Infusion related reaction|Hepatic enzyme increased|Rectal haemorrhage|Bone pain|Blood glucose increased|Rash|Influenza,8,5
10024903,20140320,Rituximab,64,801,64.0,2,92,1,0,0,0,0,0,1,Rituximab,"FLUDARABINE PHOSPHATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|RITUXIMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|DIPHENHYDRAMINE HYDROCHLORIDE|DOXORUBICIN|FLUCONAZOLE|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",14,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Acquired gene mutation|Arthralgia|Heart rate increased|Myalgia,4,3
10024969,20140320,Rituximab,65,801,65.0,2,70,1,0,1,0,0,0,1,Rituximab,"PREDNISONE|PROCHLORPERAZINE|FLUDARABINE PHOSPHATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|RITUXIMAB|RITUXIMAB|FILGRASTIM|RITUXIMAB|DOXORUBICIN|ERGOCALCIFEROL",19,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Blood test abnormal|Hypotension|Infection|Arthralgia|Febrile neutropenia|Malaise|Lymphadenitis|Fatigue|Disease progression|Thrombosis|Weight decreased|Heart rate abnormal|Lymphadenopathy|White blood cell count decreased|Clostridium difficile infection|Platelet count decreased|Pyrexia|Muscle twitching|Nausea|Productive cough|Asthenia|Blood magnesium decreased|Lymph node pain,23,1
10025002,20140320,Rituximab,69,801,69.0,1,99.79,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,3,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Prostate cancer,1,5
10025004,20140320,Rituximab,59,801,59.0,1,87.3,1,0,0,0,0,0,1,Rituximab,BELIMUMAB|RITUXIMAB,3,PRODUCT USED FOR UNKNOWN INDICATION,Stent placement|Pain in jaw|Nausea|Chest pain|Hyperhidrosis,5,5
10025022,20140320,Rituximab,68,801,68.0,1,68.6,1,0,1,1,0,0,0,Rituximab,"ARIPIPRAZOLE ORALLY DISINTEGRATING|ARIPIPRAZOLE|ARIPIPRAZOLE ORAL|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|FLUDARABINE PHOSPHATE",4,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Myocardial infarction,1,1
10025024,20140320,Rituximab,67,801,67.0,1,,1,0,1,0,0,0,0,Rituximab,"ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|VITAMIN E|RITUXIMAB|FLUDARABINE PHOSPHATE|ARIPIPRAZOLE ORALLY DISINTEGRATING|ARIPIPRAZOLE|ARIPIPRAZOLE ORAL|SIMVASTATIN|BUDESONIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|LACTULOSE",11,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Depression,1,1
10025143,20140320,Rituximab,65,801,65.0,2,68.88,1,0,1,0,0,0,1,Rituximab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISONE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|FILGRASTIM|DIPHENHYDRAMINE HYDROCHLORIDE|PROCHLORPERAZINE|ERGOCALCIFEROL",16,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Lymphadenitis|Hypotension|Blood magnesium decreased|Heart rate abnormal|Thrombosis|Pyrexia|Productive cough|Platelet count decreased|Nausea|Clostridium difficile infection|Fatigue|White blood cell count decreased|Febrile neutropenia|Infection|Arthralgia|Blood test abnormal|Lymph node pain|Lymphadenopathy|Muscle twitching|Weight decreased|Malaise|Asthenia|Disease progression,23,1
10025159,20140320,Rituximab,57,801,57.0,2,66.4,1,0,1,0,0,0,1,Rituximab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB|ACYCLOVIR|ALENDRONATE SODIUM|AMOXICILLIN|LORAZEPAM|ROSUVASTATIN|ESCITALOPRAM OXALATE|ESCITALOPRAM|PREGABALIN|MEROPENEM|MORPHINE|CONJUGATED ESTROGENS|ESTROGENS, CONJUGATED|BUPROPION HYDROCHLORIDE|CALCIUM|ERGOCALCIFEROL|HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|MEROPENEM",26,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|INFECTION PROPHYLAXIS|INFECTION PROPHYLAXIS|INFECTION PROPHYLAXIS,Bone marrow transplant|Cataract|Full blood count decreased|Necrosis|No therapeutic response|Wound|Graft versus host disease,7,5
10025435,20140320,Rituximab,58,801,58.0,2,,1,0,0,0,0,0,1,Rituximab,"RITUXIMAB|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|PREDNISONE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|CEFTAZIDIME|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|METHYLPREDNISOLONE",11,IMMUNE TOLERANCE INDUCTION|IMMUNE TOLERANCE INDUCTION|IMMUNE TOLERANCE INDUCTION|IMMUNE TOLERANCE INDUCTION|IMMUNE TOLERANCE INDUCTION|ANTIVIRAL PROPHYLAXIS|URINARY TRACT INFECTION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION,Transplant rejection|Urosepsis|Diabetes mellitus|Serratia infection,4,3
10025901,20140320,Rituximab,62,801,62.0,1,106.4,1,0,1,1,0,0,0,Rituximab,BORTEZOMIB|METHOTREXATE|METHOTREXATE SODIUM|CYTARABINE|RITUXIMAB,4,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Febrile neutropenia|Cough,2,1
10026321,20140321,Rituximab,38,801,38.0,2,,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB,3,THROMBOTIC THROMBOCYTOPENIC PURPURA,Thrombotic thrombocytopenic purpura|Neutrophil count increased|Helicobacter infection|Upper respiratory tract infection|Drug hypersensitivity|Off label use|White blood cell count increased|Blood urea increased|Mean cell volume increased|Lymphocyte count decreased|Red blood cell count decreased|Haematocrit decreased|Blood albumin decreased|Blood calcium decreased|Anion gap increased|Red cell distribution width increased|Blood potassium decreased|Blood bicarbonate increased|Haemoglobin decreased|Blood chloride decreased,20,1
10026391,20140321,Rituximab,58,801,58.0,1,64,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|ALLOPURINOL,8,B-CELL LYMPHOMA|LYMPHOMA|HYPERURICAEMIA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|COLITIS ULCERATIVE,Eye irritation|Ophthalmic herpes simplex,2,3
10026411,20140321,Rituximab,,,,2,,1,0,1,1,0,0,1,Rituximab,RITUXIMAB,1,RHEUMATOID ARTHRITIS,Coronary artery bypass|Dyspepsia|Blood glucose increased,3,3
10026423,20140321,Rituximab,,,,0,,1,1,0,0,0,0,1,Rituximab,RITUXIMAB|METHYLPREDNISOLONE,2,PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION,Hepatocellular carcinoma|Post transplant lymphoproliferative disorder|Bile duct stenosis|Diabetes mellitus|Portal vein occlusion|Intestinal haemorrhage|Hepatitis B,7,3
10026443,20140321,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB,2,THROMBOTIC THROMBOCYTOPENIC PURPURA|THROMBOTIC THROMBOCYTOPENIC PURPURA,Myocardial infarction,1,1
10026447,20140321,Rituximab,70,801,70.0,2,,1,1,1,1,1,1,1,Rituximab,RITUXIMAB|METHYLPREDNISOLONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LEVOTHYROXINE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,7,Rheumatoid arthritis|Premedication|Rheumatoid arthritis|Premedication|Premedication,Cardiac arrest|Myocardial infarction,2,3
10026728,20140321,Rituximab,74,801,74.0,1,95,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|METHYLPREDNISOLONE,4,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHEMOTHERAPY|CHEMOTHERAPY|CHEMOTHERAPY,Ascites|Pleural effusion,2,1
10026754,20140321,Rituximab,65,801,65.0,1,,1,1,0,0,0,0,1,Rituximab,RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|FLUDARABINE PHOSPHATE|MELPHALAN HYDROCHLORIDE|MELPHALAN|GANCICLOVIR SODIUM|GANCICLOVIR|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES,6,ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CYTOMEGALOVIRUS VIRAEMIA|INFECTION,Progressive multifocal leukoencephalopathy|Enterococcal infection|Graft versus host disease|Graft versus host disease in skin|Cytomegalovirus viraemia,5,1
10026857,20140321,Rituximab,52,801,52.0,2,100,1,0,1,0,0,0,1,Rituximab,LENALIDOMIDE|RITUXIMAB|BENDAMUSTINE HCL|ACYCLOVIR|LORAZEPAM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ERGOCALCIFEROL|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|DALTEPARIN SODIUM,15,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|NAUSEA|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PNEUMONIA|PRODUCT USED FOR UNKNOWN INDICATION|DEEP VEIN THROMBOSIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Haemangioma of skin|Thrombocytopenia|Pseudomonal bacteraemia|Atrial fibrillation|Neutropenia|Anxiety,6,3
10027197,20140321,Rituximab,,,,0,,1,1,0,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ETANERCEPT|ETANERCEPT|ETANERCEPT|ETANERCEPT|ETANERCEPT|ETANERCEPT|ETANERCEPT|ETANERCEPT,15,RHEUMATOID ARTHRITIS|SYSTEMIC LUPUS ERYTHEMATOSUS|LUPUS NEPHRITIS|LUPUS PNEUMONITIS|STIFF PERSON SYNDROME|NEUROPSYCHIATRIC LUPUS|SYSTEMIC LUPUS ERYTHEMATOSUS|SPONDYLOARTHROPATHY|JUVENILE IDIOPATHIC ARTHRITIS|SICKLE CELL ANAEMIA|UVEITIS|PSORIATIC ARTHROPATHY|OPTIC NEURITIS|BACK PAIN|RADICULOPATHY,Death|Progressive multifocal leukoencephalopathy|Myocardial infarction|Pyrexia|Pruritus generalised|Pruritus|Hypotension|Pneumonia|Urinary tract infection,9,3
10027267,20140321,Rituximab,73,801,73.0,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|LEFLUNOMIDE,2,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Parkinson^s disease,1,1
10027286,20140321,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,"RITUXIMAB|RITUXIMAB|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|FLUDARABINE PHOSPHATE|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|SIROLIMUS|METHOTREXATE|METHOTREXATE SODIUM",9,B-CELL LYMPHOMA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|B-CELL LYMPHOMA|B-CELL LYMPHOMA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE,Febrile neutropenia|Cytomegalovirus infection,2,3
10027436,20140321,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,"RITUXIMAB|RITUXIMAB|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|FLUDARABINE PHOSPHATE|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|SIROLIMUS|METHOTREXATE|METHOTREXATE SODIUM",9,B-CELL LYMPHOMA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|B-CELL LYMPHOMA|B-CELL LYMPHOMA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE,Febrile neutropenia,1,3
10027834,20140321,Rituximab,60,801,60.0,1,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|SIMVASTATIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREGABALIN|OXYCODONE HYDROCHLORIDE|TADALAFIL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|CYTARABINE|CISPLATIN|CARMUSTINE|ETOPOSIDE|MELPHALAN HYDROCHLORIDE|MELPHALAN,21,PRODUCT USED FOR UNKNOWN INDICATION|MANTLE CELL LYMPHOMA,Neutropenia|Post procedural sepsis|Incision site cellulitis|Renal failure|Disseminated intravascular coagulation,5,1
10027953,20140321,Rituximab,,,,1,,1,0,0,0,0,0,1,Rituximab,"DOXORUBICIN|PREDNISONE|ETOPOSIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB",8,,Neutropenia|Thrombocytopenia|Cough|Pyrexia,4,3
10028016,20140321,Rituximab,58,801,58.0,1,,1,0,0,0,0,0,1,Rituximab,METHOTREXATE|METHOTREXATE SODIUM|AZATHIOPRINE|RITUXIMAB,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,General physical health deterioration|Dysphagia|Muscle injury|Muscle enzyme increased|Hypophagia,5,3
10028435,20140307,Rituximab,52,801,52.0,2,58.2,1,0,1,0,0,0,0,Rituximab,"RITUXIMAB|AMLODIPINE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|BRENTUXIMAB VEDOTIN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DOXORUBICIN",15,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Atelectasis|Bronchopneumonia|Lung infection|Bronchiolitis|Respiratory tract infection,5,1
10028500,20140321,Rituximab,65,801,65.0,1,36,1,1,1,1,0,0,0,Rituximab,BENDAMUSTINE HCL|BENDAMUSTINE HCL|RITUXIMAB,3,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 4,Eastern Cooperative Oncology Group performance status|Malaise|Somnolence|Decreased appetite|Somnolence,5,1
10028582,20140321,Rituximab,73,801,73.0,1,45.9,1,0,1,1,0,0,0,Rituximab,BENDAMUSTINE HCL|BENDAMUSTINE HCL|RITUXIMAB|RITUXIMAB|IBRUTINIB,5,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Cytomegalovirus infection,1,1
10028651,20140321,Rituximab,72,801,72.0,1,71.5,1,0,1,0,0,0,0,Rituximab,BENDAMUSTINE HCL|BENDAMUSTINE HCL|RITUXIMAB|RITUXIMAB,6,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Respiratory failure,1,1
10029476,20140322,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,"RITUXIMAB|RITUXIMAB|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|FLUDARABINE PHOSPHATE|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|SIROLIMUS|METHOTREXATE|METHOTREXATE SODIUM",9,B-CELL LYMPHOMA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|B-CELL LYMPHOMA|B-CELL LYMPHOMA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE,Febrile neutropenia,1,3
10029605,20140322,Rituximab,31,801,31.0,2,,1,0,0,0,0,0,1,Rituximab,TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|MYCOPHENOLIC ACID|MYCOPHENILIC ACID|RITUXIMAB,6,IMMUNOSUPPRESSION|IMMUNOSUPPRESSION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|IMMUNOSUPPRESSION|PRODUCT USED FOR UNKNOWN INDICATION,Pyelonephritis|Neutropenia,2,3
10029628,20140322,Rituximab,42,801,42.0,2,70,1,0,1,0,0,0,0,Rituximab,"VORINOSTAT|VORINOSTAT|FLUDARABINE PHOSPHATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|HYDROXYCHLOROQUINE SULFATE|WARFARIN SODIUM|WARFARIN|ACYCLOVIR|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|LORAZEPAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OXYCODONE|TRAMADOL HYDROCHLORIDE|PROCHLORPERAZINE|VENLAFAXINE HYDROCHLORIDE",20,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Back pain|Pyrexia,2,5
10029795,20140319,Rituximab,54,801,54.0,1,,1,0,1,1,0,0,1,Rituximab,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PEGFILGRASTIM",6,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Colitis|Neutropenic colitis|Clostridium difficile colitis|Stomatitis|Febrile neutropenia,5,
10029873,20140319,Rituximab,,,,1,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,3,FACTOR IX DEFICIENCY,Anaphylactic reaction,1,
10029925,20140323,Rituximab,58,801,58.0,1,,1,0,1,0,0,0,1,Rituximab,"DOXORUBICIN|ETOPOSIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|RITUXIMAB",8,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Cough|Pyrexia|Neutropenia|Thrombocytopenia,4,3
10030924,20140323,Rituximab,85,801,85.0,2,,1,0,1,0,0,0,0,Rituximab,BENDAMUSTINE HCL|RITUXIMAB|RITUXIMAB|BENDAMUSTINE HCL,4,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Atrial fibrillation,1,1
10030981,20140324,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB,1,THROMBOTIC THROMBOCYTOPENIC PURPURA,Thrombotic thrombocytopenic purpura,1,1
10030984,20140324,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB,1,THROMBOTIC THROMBOCYTOPENIC PURPURA,Nervous system disorder,1,1
10031006,20140324,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,"RITUXIMAB|RITUXIMAB|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|FLUDARABINE PHOSPHATE|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|SIROLIMUS|METHOTREXATE|METHOTREXATE SODIUM",9,B-CELL LYMPHOMA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|B-CELL LYMPHOMA|B-CELL LYMPHOMA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE,Febrile neutropenia,1,3
10031019,20140324,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,"RITUXIMAB|RITUXIMAB|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|FLUDARABINE PHOSPHATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|SIROLIMUS|METHOTREXATE|METHOTREXATE SODIUM",9,B-CELL LYMPHOMA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|B-CELL LYMPHOMA|B-CELL LYMPHOMA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE,Febrile neutropenia|Abscess|Bacteraemia,3,3
10031283,20140324,Rituximab,,,,0,,1,1,0,0,0,0,1,Rituximab,"RITUXIMAB|RITUXIMAB|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|FLUDARABINE PHOSPHATE|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|SIROLIMUS|METHOTREXATE|METHOTREXATE SODIUM",9,B-CELL LYMPHOMA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|B-CELL LYMPHOMA|B-CELL LYMPHOMA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE,Stevens-Johnson syndrome|Hyperglycaemia|Alanine aminotransferase increased|Neutropenia|Thrombocytopenia|Thrombotic thrombocytopenic purpura|Infection|Cytomegalovirus infection,8,3
10031305,20140324,Rituximab,60,801,60.0,2,70,1,0,1,0,0,0,1,Rituximab,GLIMEPIRIDE,2,DIABETES MELLITUS|RHEUMATOID ARTHRITIS,Myocardial infarction|Hypertension,2,5
10031367,20140324,Rituximab,57,801,57.0,1,85.5,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|BENDAMUSTINE HCL|ACYCLOVIR|IDELALISIB|IDELALISIB,6,NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA,Alanine aminotransferase increased,1,1
10031387,20140324,Rituximab,76,801,76.0,1,76,1,1,0,1,0,0,0,Rituximab,RITUXIMAB|BORTEZOMIB FOR INJECTION|BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB FOR INJECTION|BORTEZOMIB|RITUXIMAB|RITUXIMAB,12,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MANTLE CELL LYMPHOMA,Mantle cell lymphoma|Myelodysplastic syndrome,2,1
10031441,20140324,Rituximab,,,,2,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|TOCILIZUMAB|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM,22,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Malaise|Loss of consciousness|Ligament rupture|Occipital neuralgia|Thyroid neoplasm|Fall|Thyroid neoplasm|Vertigo|Vomiting|Diarrhoea|Nausea|Herpes zoster|Bronchitis|Gastroenteritis viral,14,1
10031447,20140324,Rituximab,71,801,71.0,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|TOCILIZUMAB|RITUXIMAB,7,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Haemorrhoids|Nausea|Sleep apnoea syndrome|Bladder prolapse|Gastrointestinal infection|Escherichia urinary tract infection|Dyspepsia|Diverticulitis|Depression suicidal|Asthenia|Depression|Cough,12,1
10031782,20140324,Rituximab,83,801,83.0,2,54.4,1,0,1,0,0,0,0,Rituximab,"DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|PREDNISONE|STANDARDIZED SENNA CONCENTRATE|ACYCLOVIR|RITUXIMAB|DOXORUBICIN|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RANITIDINE",18,PREMEDICATION|PREMEDICATION|CONSTIPATION|ANAEMIA|DIFFUSE LARGE B-CELL LYMPHOMA|CONSTIPATION|ORAL HERPES|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIARRHOEA|URINARY TRACT INFECTION|HYPOKALAEMIA|DIFFUSE LARGE B-CELL LYMPHOMA|PREMEDICATION|PREMEDICATION|DIFFUSE LARGE B-CELL LYMPHOMA|PREMEDICATION,Failure to thrive|Febrile neutropenia|Fatigue|Dehydration,4,1
10031823,20140324,Rituximab,,,,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|LEFLUNOMIDE|RITUXIMAB|LEFLUNOMIDE|TOCILIZUMAB|RITUXIMAB|RITUXIMAB|LEFLUNOMIDE,11,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Arthritis bacterial|Back pain|Sciatica|Device related infection|Septic arthritis staphylococcal|Device related infection|Herpes virus infection|Venous thrombosis limb|Asthenia,9,1
10032411,20140320,Rituximab,72,801,72.0,2,63,1,0,0,0,0,0,1,Rituximab,,12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Blood pressure increased|Oedema peripheral|Drug ineffective|Huerthle cell carcinoma|Hypotension,5,3
10032732,20140324,Rituximab,54,801,54.0,1,,1,0,0,1,0,0,0,Rituximab,BENDAMUSTINE HYDROCHLORIDE|RITUXIMAB,2,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Intestinal haemorrhage,1,1
10032895,20140324,Rituximab,,,,1,,1,1,0,0,0,0,1,Rituximab,BENDAMUSTINE HCL|RITUXIMAB,2,,Death|Monocytosis,2,1
10033302,20140324,Rituximab,51,801,51.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Diffuse large B-cell lymphoma,1,1
10033345,20140325,Rituximab,22,801,22.0,2,,1,0,1,0,0,0,1,Rituximab,MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|RITUXIMAB|BELIMUMAB|HYDROXYCHLOROQUINE,5,LUPUS NEPHRITIS|PERITONITIS LUPUS|PERITONITIS LUPUS|SYSTEMIC LUPUS ERYTHEMATOSUS|SYSTEMIC LUPUS ERYTHEMATOSUS,Pleuropericarditis|Oesophagitis|Ascites|Off label use|Peritonitis|Chest pain|Proteinuria|Influenza|Lupus nephritis,9,1
10033347,20140325,Rituximab,74,801,74.0,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|SERTRALINE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|ESOMEPRAZOLE MAGNESIUM|PREDNISONE,5,RHEUMATOID ARTHRITIS|PAIN|RHEUMATOID ARTHRITIS,Lung neoplasm malignant|Pneumonectomy|Fall|Sternal fracture|Dyspnoea,5,5
10033403,20140325,Rituximab,69,801,69.0,1,68,1,0,1,1,0,0,0,Rituximab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|DOXORUBICIN|DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BORTEZOMIB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",23,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Anaemia|Malaise|Pyrexia|Hypophosphataemia|Infection|Neutropenic sepsis,6,1
10033896,20140325,Rituximab,66,801,66.0,2,,1,0,0,0,0,0,0,Rituximab,RITUXIMAB|TOCILIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|METHYLPREDNISOLONE|AMLODIPINE|DOXAZOSIN|DOXAZOSIN MESYLATE|HYDROXYCHLOROQUINE SULFATE|PREDNISONE|HYDROCHLOROTHIAZIDE|PANTOPRAZOLE|SPIRONOLACTONE,15,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|PREMEDICATION|PREMEDICATION|PREMEDICATION,Hypertension|Vision blurred,2,3
10033942,20140324,Rituximab,78,801,78.0,2,86.64,1,0,0,0,0,0,0,Rituximab,RITUXIMAB,1,WALDENSTROM^S MACROGLOBULINAEMIA,Tremor|Chills,2,3
10033981,20140325,Rituximab,61,801,61.0,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB,2,,Salivary gland enlargement|Local swelling|Eye swelling|Pyrexia|Malaise|Central venous catheterisation,6,5
10034052,20140325,Rituximab,69,801,69.0,1,,1,0,0,0,0,0,1,Rituximab,PEGFILGRASTIM|RITUXIMAB|INOTUZUMAB OZOGAMICIN|METHOTREXATE SODIUM|METHOTREXATE SODIUM|CYTARABINE,6,ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA,Sepsis,1,1
10034056,20140325,Rituximab,49,801,49.0,1,,1,0,0,0,0,0,1,Rituximab,INOTUZUMAB OZOGAMICIN|METHOTREXATE SODIUM|METHOTREXATE SODIUM|PEGFILGRASTIM|RITUXIMAB,6,ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|GRANULOCYTE COUNT DECREASED|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA,Bacteraemia,1,1
10034070,20140324,Rituximab,44,801,44.0,1,85,1,0,1,0,0,0,0,Rituximab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|ETOPOSIDE|PREDNISONE|RITUXIMAB|VINCRISTINE SULFATE",6,,Haematemesis|Haemoglobin decreased|Gastric haemorrhage|Gastric ulcer,4,1
10034078,20140324,Rituximab,40,801,40.0,1,108.8,1,0,1,0,0,0,0,Rituximab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PREDNISONE|VINCRISTINE SULFATE",6,,Rectal haemorrhage|Abdominal pain lower|Dizziness|Dizziness postural|Haemoglobin decreased|Haematochezia|Lower gastrointestinal haemorrhage|Diverticulum|Haemorrhoids|Anaemia,10,
10034088,20140325,Rituximab,,,,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|RITUXIMAB,4,RHEUMATOID ARTHRITIS,Cataract|Diabetic retinopathy|Perforated ulcer|Osteitis|Asphyxia|Acute pulmonary oedema,6,1
10034100,20140325,Rituximab,50,801,50.0,2,101,1,0,1,0,0,0,0,Rituximab,"VORINOSTAT|VORINOSTAT|RITUXIMAB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|DOXORUBICIN|PREDNISONE|PREDNISONE",12,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Left ventricular dysfunction,1,5
10034191,20140325,Rituximab,,,,1,63.5,1,0,1,0,0,0,0,Rituximab,BENDAMUSTINE HCL|BENDAMUSTINE HCL|RITUXIMAB|RITUXIMAB,5,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Pulmonary embolism,1,1
10034266,20140325,Rituximab,51,801,51.0,1,,1,0,0,1,0,0,0,Rituximab,RITUXIMAB,4,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Acute leukaemia,1,1
10034596,20140325,Rituximab,69,801,69.0,2,53,1,0,0,0,0,0,1,Rituximab,SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SENNOSIDES|SENNA LEAF|SENNA|CLARITHROMYCIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SENNOSIDES|SENNA LEAF|SENNA|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|RITUXIMAB|BENDAMUSTINE HCL|MEROPENEM|PHENOL|RITUXIMAB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|RITUXIMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FLUCONAZOLE,29,PYREXIA|CONSTIPATION|ORAL PAIN|NECK PAIN|LOWER RESPIRATORY TRACT INFECTION|PYREXIA|PAIN IN EXTREMITY|C-REACTIVE PROTEIN INCREASED|BACK PAIN|OROPHARYNGEAL PAIN|ORAL PAIN|NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT|NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT|LOWER RESPIRATORY TRACT INFECTION|OROPHARYNGEAL PAIN|OROPHARYNGEAL PAIN|NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT|NAUSEA|PAIN IN EXTREMITY|ORAL CANDIDIASIS,Injection site erythema,1,1
10034620,20140325,Rituximab,,,,2,,1,1,0,0,0,0,1,Rituximab,RITUXIMAB,1,RHEUMATOID ARTHRITIS,Sepsis|Gangrene|Peripheral vascular disorder|Parkinson^s disease,4,1
10034735,20140325,Rituximab,43,801,43.0,1,75,1,0,1,0,0,0,1,Rituximab,AGALSIDASE BETA|RITUXIMAB|AGALSIDASE BETA,3,FABRY^S DISEASE|FABRY^S DISEASE,End stage renal disease|Surgery|Hospitalisation,3,3
10035252,20140325,Rituximab,54,801,54.0,1,,1,0,0,0,0,0,1,Rituximab,"FLUDARABINE PHOSPHATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|LENALIDOMIDE",4,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Demyelination|Lhermitte^s sign|Erectile dysfunction|Sensory loss,4,3
10035302,20140321,Rituximab,65,,,1,,1,1,0,0,0,0,0,Rituximab,,5,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Hepatic failure|Hepatitis B,2,
10035319,20140321,Rituximab,44,801,44.0,2,,1,0,0,0,0,0,1,Rituximab,,5,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Hepatic failure|Hepatitis B,2,
10035680,20140325,Rituximab,54,801,54.0,1,,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|PEGFILGRASTIM,6,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION,Neutropenic colitis|Clostridium difficile colitis|Febrile neutropenia|Stomatitis,4,1
10035829,20140306,Rituximab,68,801,68.0,1,,1,0,1,0,1,0,0,Rituximab,LENALIDOMIDE,14,CHRONIC LYMPHOCYTIC LEUKAEMIA,Rash pruritic|Pyrexia,2,1
10035872,20140325,Rituximab,49,801,49.0,2,,1,0,0,0,0,0,1,Rituximab,HYDROCORTISONE SODIUM SUCCINATE|RITUXIMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS,7,PREMEDICATION|RHEUMATIC DISORDER|RHEUMATIC DISORDER|MEDICATION DILUTION|PREMEDICATION|ADVERSE REACTION|PREMEDICATION,Headache|Throat irritation|Chest discomfort,3,3
10036445,20140326,Rituximab,78,801,78.0,2,,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM,15,RHEUMATOID ARTHRITIS,Genitourinary tract infection|Spinal fracture|Joint arthroplasty|Hypertension|Osteoarthritis|Escherichia urinary tract infection|Portal hypertensive gastropathy|Depression|Wound necrosis|Urinary tract infection|Seborrhoeic keratosis|Infusion related reaction|Urinary tract infection|Leukocytosis,14,1
10036479,20140326,Rituximab,52,801,52.0,2,,1,0,1,0,0,0,1,Rituximab,"RITUXIMAB|PREDNISONE|CONJUGATED ESTROGENS|ESTROGENS, CONJUGATED",4,IMMUNE THROMBOCYTOPENIC PURPURA|PLATELET COUNT DECREASED,Platelet count decreased|Basedow^s disease|Weight increased|Off label use,4,5
10036480,20140326,Rituximab,46,801,46.0,1,,1,0,0,0,0,0,1,Rituximab,"FOLIC ACID|METHYLPREDNISOLONE|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|HYDROCORTISONE",8,PREMEDICATION|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|PREMEDICATION|PREMEDICATION,Pain|Rheumatoid arthritis|Oedema peripheral|Abdominal discomfort|Haematochezia|Fatigue|Nasopharyngitis,7,3
10036532,20140326,Rituximab,78,801,78.0,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB,10,RHEUMATOID ARTHRITIS,Fall|C-reactive protein abnormal|Atrial fibrillation|Acute kidney injury|Meningitis bacterial|Aphasia|Inflammation|Gastroenteritis|Joint dislocation|Vitritis|Tendon rupture|Confusional state|Cerebral infarction|Infusion related reaction|Hyperthermia,15,1
10036536,20140326,Rituximab,47,801,47.0,2,52.3,1,0,0,0,0,0,0,Rituximab,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PROCHLORPERAZINE MALEATE|CLOBETASOL PROPIONATE|CLOBETASOL PROPIONATE OINTMENT USP, 0.05%|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|MICONAZOLE|MICONAZOLE NITRATE",14,NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT|NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT|NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT|NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT|NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT|DISCOMFORT|RASH MACULO-PAPULAR|MUCOSAL INFLAMMATION|VAGINAL INFLAMMATION|NEUTROPENIA,Muscular weakness,1,1
10036538,20140326,Rituximab,51,801,51.0,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|LEFLUNOMIDE|LEFLUNOMIDE|LEFLUNOMIDE|LEFLUNOMIDE|ADALIMUMAB|CERTOLIZUMAB PEGOL|METHYLPREDNISOLONE|GOLIMUMAB,23,RHEUMATOID ARTHRITIS,Bronchitis|Pyrexia|Mental disorder|Sinusitis|Arthritis|Open angle glaucoma|Oral fungal infection|Psoriasis|Dysuria|Bronchitis|Infusion related reaction,11,1
10037095,20140115,Rituximab,68,801,68.0,1,,1,0,0,0,0,0,1,Rituximab,"FLUDARABINE PHOSPHATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB",3,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Septic shock|Renal failure|Dialysis|Hypogammaglobulinaemia|Night sweats|Weight decreased|Fatigue,7,1
10037113,20140326,Rituximab,,,,2,,1,0,0,0,0,0,1,Rituximab,"MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|TOCILIZUMAB|TOCILIZUMAB|TOCILIZUMAB|TOCILIZUMAB|TOCILIZUMAB|RITUXIMAB|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METHYLPREDNISOLONE SODIUM SUCCINATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",12,PRODUCT USED FOR UNKNOWN INDICATION|RHEUMATOID ARTHRITIS|PRODUCT USED FOR UNKNOWN INDICATION,Anaphylactic reaction|Hypoaesthesia|Scleroderma|Skin hyperpigmentation|Skin hypopigmentation|Atrophy|Red cell distribution width increased|Blood glucose increased|Basophil count decreased,9,1
10037122,20140326,Rituximab,71,801,71.0,2,,1,1,1,0,0,0,0,Rituximab,TOCILIZUMAB|RITUXIMAB,4,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Death|General physical health deterioration|Gastrointestinal disorder|Vertigo,4,1
10037299,20140326,Rituximab,57,801,57.0,1,76,1,0,1,1,0,0,0,Rituximab,"VORINOSTAT|VORINOSTAT|VORINOSTAT|RITUXIMAB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|DOXORUBICIN|PREDNISONE|PREDNISONE|CALCIUM CARBONATE|ANTACID|POLYETHYLENE GLYCOL 3350|PANTOPRAZOLE|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL",18,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Febrile neutropenia|Sepsis|Platelet count decreased|White blood cell count decreased|Anaemia|Hypotension|Lung infection,7,5
10037432,20140326,Rituximab,,,,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|TOCILIZUMAB|ABATACEPT|METHOTREXATE|METHOTREXATE SODIUM|METHYLPREDNISOLONE,11,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Asthma|Arthritis|Infusion related reaction|Diarrhoea|Abscess limb,5,1
10037517,20140326,Rituximab,,,,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Progressive multifocal leukoencephalopathy,1,1
10037955,20140326,Rituximab,60,801,60.0,2,,1,0,0,0,0,0,1,Rituximab,ANTI-THYMOCYTE GLOBULIN (RABBIT)|CYCLOSPORINE|CYCLOSPORINE|RITUXIMAB,4,IMMUNOSUPPRESSANT DRUG THERAPY|IMMUNOSUPPRESSANT DRUG THERAPY|IMMUNOSUPPRESSANT DRUG THERAPY,Liver disorder|Post transplant lymphoproliferative disorder|Pyrexia,3,3
10037957,20140326,Rituximab,47,801,47.0,2,49.9,1,0,1,0,0,0,0,Rituximab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE HYDROCHLORIDE|NAPROXEN|NAPROXEN SODIUM|METHYLPREDNISOLONE|FOLIC ACID|RITUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE|METHOTREXATE|METHOTREXATE SODIUM,8,PREMEDICATION|PREMEDICATION|PREMEDICATION|RHEUMATOID ARTHRITIS,Vasodilatation|Red blood cell count abnormal|Pruritus|Infusion related reaction|Cough|Peripheral swelling|Inflammation,7,5
10037974,20140325,Rituximab,50,801,50.0,1,66.68,1,0,0,0,0,0,1,Rituximab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|VINCRISTINE SULFATE",6,,Nausea|Candida infection|Constipation,3,
10038030,20140321,Rituximab,54,801,54.0,1,,1,0,1,1,0,0,0,Rituximab,GEMCITABINE HYDROCHLORIDE|IFOSFAMIDE|VINORELBINE|RITUXIMAB|ALLOPURINOL,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypophosphataemia|Neutropenic sepsis|Platelet count abnormal|White blood cell count abnormal|Haemoglobin abnormal,5,3
10038148,20140326,Rituximab,,,,2,,1,0,0,0,0,0,1,Rituximab,AZATHIOPRINE|INTERFERON BETA-1A|RITUXIMAB|MITOXANTRONE HYDROCHLORIDE|MITOXANTRONE,5,MULTIPLE SCLEROSIS|MULTIPLE SCLEROSIS|MULTIPLE SCLEROSIS|MULTIPLE SCLEROSIS|MULTIPLE SCLEROSIS,Neuromyelitis optica|Drug ineffective,2,3
10038194,20140306,Rituximab,65,801,65.0,1,118.6,1,0,0,0,0,0,1,Rituximab,LENALIDOMIDE,3,MYELODYSPLASTIC SYNDROME,Pancytopenia,1,1
10038882,20140326,Rituximab,75,801,75.0,1,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|CYTARABINE|PREGABALIN|METHOTREXATE|METHOTREXATE SODIUM|FILGRASTIM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Renal failure acute|Malaise,2,1
10039083,20140326,Rituximab,19,802,1.58,1,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|BORTEZOMIB FOR INJECTION|BORTEZOMIB|METHOTREXATE|METHOTREXATE SODIUM,5,GLYCOGEN STORAGE DISEASE TYPE II|OFF LABEL USE|GLYCOGEN STORAGE DISEASE TYPE II|GLYCOGEN STORAGE DISEASE TYPE II|GLYCOGEN STORAGE DISEASE TYPE II,Death,1,3
10039365,20140326,Rituximab,,,,0,,1,0,1,0,0,0,1,Rituximab,ECULIZUMAB|CYANOCOBALAMIN|PREDNISONE|LABETALOL|ATORVASTATIN CALCIUM|SUMATRIPTAN|AMLODIPINE BESYLATE|FUROSEMIDE|CITALOPRAM|ECULIZUMAB|POTASSIUM CHLORIDE|TOPIRAMATE|RITUXIMAB|LEVOTHYROXINE SODIUM,17,HAEMOLYTIC URAEMIC SYNDROME|PRODUCT USED FOR UNKNOWN INDICATION|DEPRESSION|VITAMIN B12 DEFICIENCY|THROMBOTIC THROMBOCYTOPENIC PURPURA|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|MIGRAINE|BENIGN INTRACRANIAL HYPERTENSION|HYPERTENSION|BENIGN INTRACRANIAL HYPERTENSION|DEPRESSION|BENIGN INTRACRANIAL HYPERTENSION|BENIGN INTRACRANIAL HYPERTENSION|THROMBOTIC THROMBOCYTOPENIC PURPURA|HYPOTHYROIDISM,Pulmonary embolism,1,1
10039409,20140326,Rituximab,,,,2,,1,0,0,0,0,0,1,Rituximab,AZATHIOPRINE|GLATIRAMER ACETATE|GLATIRAMER|RITUXIMAB|MITOXANTRONE HYDROCHLORIDE|MITOXANTRONE,7,MULTIPLE SCLEROSIS|MULTIPLE SCLEROSIS|MULTIPLE SCLEROSIS|MULTIPLE SCLEROSIS|MULTIPLE SCLEROSIS|MULTIPLE SCLEROSIS,Neuromyelitis optica|Drug ineffective,2,3
10039527,20140326,Rituximab,71,801,71.0,1,79,1,0,1,0,0,0,0,Rituximab,BENDAMUSTINE HCL|BENDAMUSTINE HCL|RITUXIMAB|RITUXIMAB|ERGOCALCIFEROL|SENNOSIDES|SENNA LEAF|SENNA|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,19,CHRONIC LYMPHOCYTIC LEUKAEMIA|NON-HODGKIN^S LYMPHOMA|CHRONIC LYMPHOCYTIC LEUKAEMIA|NON-HODGKIN^S LYMPHOMA|CHRONIC LYMPHOCYTIC LEUKAEMIA|NON-HODGKIN^S LYMPHOMA,Hepatic enzyme increased|Pneumonitis|Oropharyngeal pain,3,5
10039643,20140326,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|PREDNISONE|RITUXIMAB|RITUXIMAB",7,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,"Neutropenia|Vomiting|Diarrhoea|Leukopenia|Febrile neutropenia|Pneumonia|Sepsis|Vertigo|Follicle centre lymphoma, follicular grade I, II, III refractory|Hepatic enzyme abnormal|Tumour lysis syndrome|Urine output decreased|Injection site reaction|Pruritus|Chills|Asthenia|Nausea|Constipation|Abdominal pain|Dyspepsia|Pyrexia|Mucosal inflammation|Injection site erythema|Anaemia|Paraesthesia|Headache|Neuropathy peripheral|Alopecia|Erythema|Rash|Myalgia|Cough|Dyspnoea|Insomnia|Dry mouth",35,1
10040030,20140326,Rituximab,58,801,58.0,1,,1,0,0,0,1,0,0,Rituximab,GADODIAMIDE|GADODIAMIDE|GADODIAMIDE|GADODIAMIDE|GADODIAMIDE|GADODIAMIDE|GADODIAMIDE|GADODIAMIDE|GADODIAMIDE|METHOTREXATE|METHOTREXATE SODIUM|RITUXIMAB|TEMOZOLOMIDE,15,BRAIN NEOPLASM|NEOPLASM|RENAL FAILURE CHRONIC,Nephrogenic systemic fibrosis,1,4
10040036,20140326,Rituximab,61,801,61.0,2,52.4,1,1,1,0,0,0,1,Rituximab,IBRUTINIB|ACYCLOVIR|RITUXIMAB|FILGRASTIM|OXYCODONE|IBRUTINIB|METHYLPREDNISOLONE,8,DAIRY INTOLERANCE|B-CELL LYMPHOMA|ANTIVIRAL PROPHYLAXIS|PAIN,Intraventricular haemorrhage|Febrile neutropenia|Platelet count decreased,3,1
10040119,20140326,Rituximab,67,801,67.0,1,70.8,1,0,0,0,0,0,1,Rituximab,"LENALIDOMIDE|LENALIDOMIDE|FLUDARABINE PHOSPHATE|FLUDARABINE PHOSPHATE|FLUDARABINE PHOSPHATE|FLUDARABINE PHOSPHATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ATORVASTATIN CALCIUM",14,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|PNEUMONIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Lung adenocarcinoma,1,1
10040221,20140327,Rituximab,94,801,94.0,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB,1,LYMPHOMA,Respiratory failure,1,1
10040236,20140327,Rituximab,65,801,65.0,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB,1,CHRONIC LYMPHOCYTIC LEUKAEMIA,Meningitis aseptic,1,1
10040256,20140327,Rituximab,80,801,80.0,2,40,1,1,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|CEFTRIAXONE|CEFTRIAXONE SODIUM|PREDNISONE|SULFAMETHOXAZOLE AND TRIMETHOPRIM,5,ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS|LUNG DISORDER|VASCULITIS|PROPHYLAXIS,Pneumonia|Septic shock|Sinusitis|Secondary immunodeficiency|Generalised oedema|Clostridium difficile colitis|Malnutrition,7,1
10040469,20140327,Rituximab,,,,2,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,1,VASCULITIS,Breast cancer,1,1
10040533,20140327,Rituximab,,,,2,,1,0,0,0,0,0,1,Rituximab,ECULIZUMAB|WARFARIN|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|ECULIZUMAB|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|RITUXIMAB|METHYLPREDNISOLONE|BORTEZOMIB FOR INJECTION|BORTEZOMIB|PREDNISONE|ARGATROBAN|ARGATROBAN|ALEMTUZUMAB|WARFARIN,16,HAEMOLYTIC URAEMIC SYNDROME|IMMUNOSUPPRESSION|JUGULAR VEIN THROMBOSIS|SUBCLAVIAN ARTERY THROMBOSIS|IMMUNOSUPPRESSION|IMMUNOSUPPRESSION|TRANSPLANT REJECTION|TRANSPLANT REJECTION|TRANSPLANT REJECTION|TRANSPLANT REJECTION|JUGULAR VEIN THROMBOSIS|JUGULAR VEIN THROMBOSIS|SUBCLAVIAN ARTERY THROMBOSIS|TRANSPLANT REJECTION|SUBCLAVIAN ARTERY THROMBOSIS,Kidney transplant rejection,1,3
10040579,20140327,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|TOCILIZUMAB|METHOTREXATE|METHOTREXATE SODIUM|CYCLOSPORINE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,5,JUVENILE IDIOPATHIC ARTHRITIS|JUVENILE IDIOPATHIC ARTHRITIS|JUVENILE IDIOPATHIC ARTHRITIS|JUVENILE IDIOPATHIC ARTHRITIS|JUVENILE IDIOPATHIC ARTHRITIS,Neutropenia|Blood alkaline phosphatase increased|Cellulitis|Bronchiolitis|Alanine aminotransferase increased|Aspartate aminotransferase increased|Infusion related reaction|Adenoiditis|Sinusitis|Otitis media|Upper respiratory tract infection|Pyoderma streptococcal|Herpes virus infection|Gastroenteritis|Drug resistance,15,1
10040719,20140327,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,1,PROPHYLAXIS AGAINST TRANSPLANT REJECTION,Polyomavirus-associated nephropathy|Transplant failure,2,3
10040831,20140327,Rituximab,,,,0,,1,1,0,0,0,0,1,Rituximab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|RITUXIMAB|ETOPOSIDE",7,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|CARDIOTOXICITY,Sepsis|Disease progression|Infection|Pneumonia bacterial|Hepatorenal syndrome|Hepatic cirrhosis|Hepatic encephalopathy|Subdural haematoma|Pulmonary haemorrhage|Pneumonia|Drug effect decreased|Lung disorder|Neuropathy peripheral|Encephalopathy|Drug tolerance decreased,15,3
10040920,20140327,Rituximab,,,,0,,1,0,1,0,0,0,0,Rituximab,"BORTEZOMIB|RITUXIMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ALLOPURINOL",10,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|ATRIAL FIBRILLATION|PRODUCT USED FOR UNKNOWN INDICATION,Chest pain,1,1
10041154,20140327,Rituximab,,,,2,,1,0,1,0,0,0,1,Rituximab,"DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",6,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|NEUTROPENIA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Sepsis|Neutrophil count abnormal|Drug ineffective,3,3
10041214,20140327,Rituximab,22,801,22.0,2,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB,1,FOCAL SEGMENTAL GLOMERULOSCLEROSIS,Pneumocystis jirovecii pneumonia|Sepsis|Off label use,3,3
10041322,20140326,Rituximab,40,801,40.0,1,108.8,1,0,0,0,0,0,1,Rituximab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PREDNISONE|VINCRISTINE SULFATE",6,,Rectal haemorrhage|Haemoglobin decreased|Diverticulum|Melaena|Hypotension,5,
10041360,20140327,Rituximab,,,,1,75,1,0,1,0,0,0,0,Rituximab,"ALEMTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|SULFAMETHOXAZOLE AND TRIMETHOPRIM",17,CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT|CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT|CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT|CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT|CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT|PROPHYLAXIS,Disease progression|Hypoxia|Basal cell carcinoma|Pancytopenia|Pancytopenia|Pyrexia|Haemoglobin decreased|Thrombocytopenia|Interstitial lung disease|Blood fibrinogen increased|C-reactive protein increased|Procalcitonin increased|Haptoglobin increased|Brain natriuretic peptide increased|Pleural effusion|Staphylococcal sepsis,16,1
10041877,20140327,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,DOXORUBICIN|PREDNISONE|RITUXIMAB,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,1
10041883,20140327,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,DOXORUBICIN|PREDNISONE|RITUXIMAB,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Metastases to lymph nodes,1,1
10041884,20140327,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,DOXORUBICIN|PREDNISONE|RITUXIMAB,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,1
10041907,20140327,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,DOXORUBICIN|PREDNISONE|RITUXIMAB,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Metastases to lymph nodes|Disease progression,2,1
10041909,20140327,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,DOXORUBICIN|PREDNISONE|RITUXIMAB,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,B-cell lymphoma recurrent,1,1
10041917,20140327,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,DOXORUBICIN|PREDNISONE|RITUXIMAB,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,B-cell lymphoma recurrent,1,1
10042089,20140327,Rituximab,69,801,69.0,1,68,1,0,1,1,0,0,0,Rituximab,"PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB|RITUXIMAB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|BORTEZOMIB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",23,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Neutropenic sepsis|Anaemia|Infection|Hypophosphataemia|Pyrexia|Malaise,6,1
10042125,20140327,Rituximab,10,801,10.0,2,,1,0,0,0,0,0,1,Rituximab,METHYLPREDNISOLONE|METHYLPREDNISOLONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE,9,ALLERGIC GRANULOMATOUS ANGIITIS|ALLERGIC GRANULOMATOUS ANGIITIS|OFF LABEL USE|ALLERGIC GRANULOMATOUS ANGIITIS|ALLERGIC GRANULOMATOUS ANGIITIS|ALLERGIC GRANULOMATOUS ANGIITIS|ALLERGIC GRANULOMATOUS ANGIITIS,Allergic granulomatous angiitis|Drug ineffective|Disease recurrence,3,3
10042160,20140327,Rituximab,67,801,67.0,1,63,1,0,0,0,0,0,1,Rituximab,IBRUTINIB|IBRUTINIB|BENDAMUSTINE HCL|RITUXIMAB,4,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Squamous cell carcinoma,1,1
10042750,20140327,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,DOXORUBICIN|PREDNISONE|RITUXIMAB,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,1
10042760,20140327,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,DOXORUBICIN|PREDNISONE|RITUXIMAB,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,1
10042762,20140327,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,DOXORUBICIN|PREDNISONE|RITUXIMAB,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,B-cell lymphoma recurrent,1,1
10042765,20140327,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,DOXORUBICIN|PREDNISONE|RITUXIMAB,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,1
10042766,20140327,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,DOXORUBICIN|PREDNISONE|RITUXIMAB,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,1
10042767,20140327,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,DOXORUBICIN|PREDNISONE|RITUXIMAB,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,B-cell lymphoma recurrent,1,1
10042769,20140327,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,DOXORUBICIN|PREDNISONE|RITUXIMAB,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,1
10042941,20140328,Rituximab,,,,1,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,1,VASCULITIS,Prostate cancer,1,1
10042956,20140328,Rituximab,69,801,69.0,1,,1,0,1,1,0,0,0,Rituximab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|IPRATROPIUM BROMIDE|AMLODIPINE|TIOTROPIUM BROMIDE",12,MALIGNANT LYMPHOID NEOPLASM|LYMPHOMA|LYMPHOMA|LYMPHOMA,Lung neoplasm malignant|Chronic obstructive pulmonary disease,2,1
10042960,20140328,Rituximab,77,801,77.0,1,98.4,1,0,1,0,1,0,0,Rituximab,"FUROSEMIDE|CLOPIDOGREL|CLOPIDOGREL BISULFATE|GABAPENTIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BISOPROLOL FUMARATE|RITUXIMAB|SIMVASTATIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LINAGLIPTIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|MEROPENEM|RAMIPRIL",18,HYPERTENSION|B-CELL LYMPHOMA|CARDIAC DISORDER|CARDIAC DISORDER|HYPERTENSION|ANALGESIC THERAPY|B-CELL LYMPHOMA|HYPERTENSION|B-CELL LYMPHOMA|HYPERCHOLESTEROLAEMIA|PROPHYLAXIS|CARDIAC DISORDER|TYPE 2 DIABETES MELLITUS|B-CELL LYMPHOMA|CARDIAC DISORDER,Sepsis|Renal failure,2,1
10042964,20140328,Rituximab,,,,2,,1,1,1,0,0,0,1,Rituximab,VORICONAZOLE|LEFLUNOMIDE|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|LEFLUNOMIDE|RITUXIMAB,9,ASPERGILLUS INFECTION|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Bronchopneumonia|Aspergillus infection|Respiratory failure|Infusion related reaction|Hypertension|Lung abscess|Sciatica|Cholestasis|Infection|Liver function test abnormal|Lung abscess|Nasopharyngitis,12,1
10042967,20140328,Rituximab,,,,0,,1,1,0,0,0,0,1,Rituximab,RITUXIMAB|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|BASILIXIMAB|CYCLOSPORINE,6,PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION,Transplant failure,1,3
10042976,20140328,Rituximab,62,801,62.0,1,91.5,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|BENDAMUSTINE HCL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,7,NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT|NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT|NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT,Dermatitis exfoliative|Pyrexia,2,1
10042981,20140328,Rituximab,,,,0,,1,1,1,1,1,1,1,Rituximab,RITUXIMAB|LENALIDOMIDE,2,Non-Hodgkin^s lymphoma unspecified histology indolent|Non-Hodgkin^s lymphoma unspecified histology indolent,Malignant neoplasm progression|Neutropenia|Fatigue|Thrombocytopenia|Cough|Dyspnoea|Oedema|Tumour lysis syndrome|Lymphopenia|Hyponatraemia|Myalgia|Neuropathy peripheral|Infection|Infusion related reaction|Thrombosis|Respiratory failure|Arterial thrombosis|Dizziness|Pyrexia|Memory impairment|Pain|Upper respiratory tract infection|Leukopenia|Sepsis|Pneumonia|Pancreatic carcinoma,26,1
10043137,20140328,Rituximab,58,801,58.0,2,73,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,1,MALIGNANT LYMPHOID NEOPLASM,Polyneuropathy,1,1
10043200,20140328,Rituximab,52,801,52.0,1,,1,0,1,0,0,0,0,Rituximab,SULFAMETHOXAZOLE AND TRIMETHOPRIM,5,LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA,Acute polyneuropathy,1,1
10043783,20140328,Rituximab,66,801,66.0,2,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|TOCILIZUMAB|METHOTREXATE|METHOTREXATE SODIUM,3,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Lung neoplasm malignant,1,1
10043784,20140328,Rituximab,,,,0,,1,0,1,0,0,0,0,Rituximab,"BORTEZOMIB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",6,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Fall,1,1
10044226,20140327,Rituximab,42,801,42.0,1,118.2,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,1,MYOSITIS,Urticaria|Pruritus|Bronchospasm,3,3
10044260,20140328,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|FLUDARABINE PHOSPHATE|RITUXIMAB",4,STEM CELL TRANSPLANT|STEM CELL TRANSPLANT|STEM CELL TRANSPLANT,Stevens-Johnson syndrome,1,3
10044518,20140328,Rituximab,,,,1,,1,1,0,0,0,0,0,Rituximab,LENALIDOMIDE|RITUXIMAB,2,CHRONIC LYMPHOCYTIC LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION,Chronic lymphocytic leukaemia,1,1
10044688,20140328,Rituximab,59,801,59.0,1,,1,0,1,0,0,0,0,Rituximab,PEGFILGRASTIM|CARBOPLATIN|RITUXIMAB|OXYCODONE HYDROCHLORIDE,7,NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA,Febrile neutropenia,1,1
10044710,20140328,Rituximab,34,801,34.0,2,,1,0,1,0,0,0,0,Rituximab,PEGFILGRASTIM|RITUXIMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,6,HODGKIN^S DISEASE|HODGKIN^S DISEASE|HODGKIN^S DISEASE|HODGKIN^S DISEASE,Nausea|Vomiting|Posture abnormal,3,1
10045182,20140328,Rituximab,50,801,50.0,1,,1,1,0,0,0,0,1,Rituximab,CISPLATIN|METHYLPREDNISOLONE|RITUXIMAB|ETOPOSIDE|CYTARABINE|VINCRISTINE SULFATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,9,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Pneumonia adenoviral|Cystitis haemorrhagic,2,1
10045336,20140328,Rituximab,34,801,34.0,2,99.8,1,0,1,0,0,0,1,Rituximab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TRANEXAMIC ACID|RITUXIMAB|ROMIPLOSTIM|LANSOPRAZOLE,9,IMMUNE THROMBOCYTOPENIC PURPURA|ANTIEMETIC SUPPORTIVE CARE|IMMUNE THROMBOCYTOPENIC PURPURA|IMMUNE THROMBOCYTOPENIC PURPURA|IMMUNE THROMBOCYTOPENIC PURPURA|IMMUNE THROMBOCYTOPENIC PURPURA|GASTROOESOPHAGEAL REFLUX PROPHYLAXIS,Purpura|Rash erythematous|Melaena|Haemorrhage|Vaginal haemorrhage|Rectal haemorrhage|Haemoglobin decreased|Rash maculo-papular|Arthralgia|Off label use|Incorrect dose administered,11,1
10045360,20140328,Rituximab,76,801,76.0,1,68,1,1,1,1,0,0,0,Rituximab,BENDAMUSTINE HYDROCHLORIDE|IBRUTINIB|IBRUTINIB|RITUXIMAB,4,LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA,Multiple organ dysfunction syndrome|Septic shock|Diarrhoea|Renal impairment,4,1
10045391,20140328,Rituximab,50,801,50.0,1,,1,0,1,0,0,0,0,Rituximab,BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,13,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|NEUTROPENIA,Sepsis|Cytomegalovirus enterocolitis|Neutropenia|Liver disorder,4,1
10045518,20140328,Rituximab,72,801,72.0,2,,1,0,0,0,0,0,1,Rituximab,BENDAMUSTINE HCL|BENDAMUSTINE HCL|RITUXIMAB|BENDAMUSTINE HCL|BENDAMUSTINE HCL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,8,WALDENSTROM^S MACROGLOBULINAEMIA|PRODUCT USED FOR UNKNOWN INDICATION,Neutrophil count decreased|Polyarthritis|Off label use,3,3
10045866,20140329,Rituximab,69,801,69.0,1,68,1,0,1,1,0,0,0,Rituximab,"DOXORUBICIN|DOXORUBICIN|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB|RITUXIMAB|RITUXIMAB|BORTEZOMIB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",23,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Hypophosphataemia|Neutropenic sepsis|Infection|Anaemia|Pyrexia|Malaise,6,
10045892,20140329,Rituximab,78,801,78.0,2,68,1,0,1,0,0,0,0,Rituximab,"RITUXIMAB|PREDNISONE|ZOLPIDEM TARTRATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN",16,HYPERTENSION|B-CELL LYMPHOMA|HYPERTENSION|B-CELL LYMPHOMA|PROPHYLAXIS|HYPOKALAEMIA|PROPHYLAXIS OF NAUSEA AND VOMITING|B-CELL LYMPHOMA|PROPHYLAXIS OF NAUSEA AND VOMITING|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|INSOMNIA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Deep vein thrombosis,1,1
10046043,20140331,Rituximab,66,801,66.0,2,,1,0,0,0,0,0,1,Rituximab,ERYTHROPOIETIN|SULFAMETHOXAZOLE AND TRIMETHOPRIM|RITUXIMAB,3,ANAEMIA,Drug ineffective|Aplasia pure red cell|Haemoglobin abnormal|Therapeutic response decreased,4,3
10046288,20140331,Rituximab,,,,1,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|HYDROXYCHLOROQUINE,21,RHEUMATOID ARTHRITIS|PREMEDICATION,Emphysema|Infusion related reaction|Dyspepsia|Pruritus|Hypertension|Crepitations|Skin lesion,7,1
10046651,20140331,Rituximab,31,801,31.0,2,58.4,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE HYDROCHLORIDE|DIMENHYDRINATE|RITUXIMAB|LANSOPRAZOLE|LANSOPRAZOLE|MEPERIDINE HYDROCHLORIDE,10,THROMBOTIC THROMBOCYTOPENIC PURPURA,Off label use|Migraine|Blood lactate dehydrogenase increased|Ill-defined disorder|Pneumonia|Thrombotic thrombocytopenic purpura|ADAMTS13 activity decreased|Weight increased|Infusion related reaction|Unevaluable event,10,1
10046750,20140331,Rituximab,50,801,50.0,1,,1,1,0,0,0,0,1,Rituximab,"CISPLATIN|ETOPOSIDE|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METHYLPREDNISOLONE|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",9,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Pneumonia adenoviral|Respiratory failure|Cystitis haemorrhagic,3,1
10046803,20140331,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|AZACITIDINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISONE|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB FOR INJECTION|BORTEZOMIB|RITUXIMAB,23,PLASMA CELL MYELOMA|CHRONIC LYMPHOCYTIC LEUKAEMIA|ACUTE MYELOID LEUKAEMIA|MYELODYSPLASTIC SYNDROME|CHRONIC MYELOMONOCYTIC LEUKAEMIA|T-CELL LYMPHOMA|PANCREATIC CARCINOMA|PLASMA CELL LEUKAEMIA|MANTLE CELL LYMPHOMA|WALDENSTROM^S MACROGLOBULINAEMIA|NON-HODGKIN^S LYMPHOMA|NEUROBLASTOMA|BONE MARROW POLYMORPHONUCLEAR LEUKOCYTE COUNT INCREASED|RENAL CELL CARCINOMA|MALIGNANT MELANOMA|PROSTATE CANCER|HEPATOCELLULAR CARCINOMA|ACUTE MYELOID LEUKAEMIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Graft versus host disease|Bone marrow failure|Embolism|Tumour flare|Neutropenia|Thrombocytopenia|Leukopenia|Anaemia|Infection|Fatigue|Nausea|Diarrhoea|Headache|Rash,14,1
10047005,20140331,Rituximab,12,801,12.0,1,,1,0,0,0,0,0,1,Rituximab,METHYLPREDNISOLONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB,4,NEPHROTIC SYNDROME|NEPHROTIC SYNDROME|NEPHROTIC SYNDROME|NEPHROTIC SYNDROME,Aspergillus infection,1,2
10047455,20140331,Rituximab,23,801,23.0,2,,1,1,0,0,0,0,0,Rituximab,AMPHOTERICIN B|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|AMIKACIN|RITUXIMAB|IFOSFAMIDE|CARBOPLATIN|ETOPOSIDE,8,PYREXIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Shock|Multi-organ failure,2,1
10047712,20140331,Rituximab,40,801,40.0,2,48.6,1,0,1,0,0,0,0,Rituximab,"EVEROLIMUS|EVEROLIMUS TABLETS|BASILIXIMAB|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|RITUXIMAB|METHYLPREDNISOLONE SODIUM SUCCINATE",14,IMMUNOSUPPRESSION|IMMUNOSUPPRESSION|ANTIFUNGAL PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|IMMUNOSUPPRESSION|ANTIVIRAL PROPHYLAXIS|KIDNEY TRANSPLANT REJECTION|IMMUNOSUPPRESSION|IMMUNOSUPPRESSION|PROPHYLAXIS,Sepsis,1,1
10047732,20140331,Rituximab,,,,0,,1,1,0,0,0,0,1,Rituximab,"RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE",5,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Infection in an immunocompromised host|Febrile neutropenia|Cardiac failure|Thrombosis|Neuropathy peripheral|Intestinal perforation,6,1
10047736,20140331,Rituximab,64,801,64.0,1,85,1,0,1,1,0,0,0,Rituximab,FOLIC ACID|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|HYDROCHLOROTHIAZIDE,12,INFECTION PROPHYLAXIS|LYMPHOMA|LYMPHOMA|INFECTION PROPHYLAXIS|THROMBOSIS PROPHYLAXIS|HYPERTENSION|INFECTION PROPHYLAXIS|HYPERTENSION|HYPERTENSION,Septic shock,1,3
10048700,20140331,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,3,CHRONIC ALLOGRAFT NEPHROPATHY|OFF LABEL USE|CHRONIC ALLOGRAFT NEPHROPATHY,Neoplasm,1,3
10048701,20140331,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB,3,CHRONIC ALLOGRAFT NEPHROPATHY|OFF LABEL USE|CHRONIC ALLOGRAFT NEPHROPATHY,Death,1,3
10048825,20140331,Rituximab,31,801,31.0,2,,1,0,0,0,0,0,1,Rituximab,"PREDNISONE|METHOTREXATE|METHOTREXATE SODIUM|AZATHIOPRINE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|MITOMYCIN",7,,Drug resistance|Granulomatosis with polyangiitis|Disease recurrence,3,3
10049114,20140401,Rituximab,59,801,59.0,2,,1,0,1,0,0,0,0,Rituximab,METHOTREXATE|METHOTREXATE SODIUM|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB,14,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Ankle arthroplasty|Fall|Cystitis|Melanoderma|Sleep disorder|Hyperkeratosis,6,1
10049128,20140401,Rituximab,,,,1,,1,0,1,1,0,0,0,Rituximab,METHOTREXATE|METHOTREXATE SODIUM|RITUXIMAB|LEFLUNOMIDE,5,PRODUCT USED FOR UNKNOWN INDICATION|RHEUMATOID ARTHRITIS,Dyspnoea exertional|Weight decreased|Asthenia|Urinary tract disorder|Diarrhoea|Productive cough|Suicide attempt|Suicide attempt|Dysuria|Sciatica,10,1
10049145,20140401,Rituximab,,,,2,62.6,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|INFLIXIMAB|METHOTREXATE|METHOTREXATE SODIUM|PREDNISONE,4,RHEUMATOID ARTHRITIS|PRODUCT USED FOR UNKNOWN INDICATION,Immunosuppression|Platelet count decreased|Drug ineffective,3,5
10049174,20140401,Rituximab,,,,2,,1,0,0,0,1,0,0,Rituximab,RITUXIMAB|LEFLUNOMIDE|LEFLUNOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB,13,RHEUMATOID ARTHRITIS,Sciatica|Neuropathy peripheral,2,1
10049323,20140401,Rituximab,,,,1,84,1,0,1,0,0,0,0,Rituximab,"RITUXIMAB|RITUXIMAB|CLONAZEPAM|THIOTEPA|THIOTEPA|BUSULFAN|BUSULFAN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",11,MALIGNANT LYMPHOID NEOPLASM|CENTRAL NERVOUS SYSTEM LYMPHOMA|CONVULSION|MALIGNANT LYMPHOID NEOPLASM|CENTRAL NERVOUS SYSTEM LYMPHOMA|MALIGNANT LYMPHOID NEOPLASM|CENTRAL NERVOUS SYSTEM LYMPHOMA|MALIGNANT LYMPHOID NEOPLASM|CENTRAL NERVOUS SYSTEM LYMPHOMA|MALIGNANT LYMPHOID NEOPLASM|CENTRAL NERVOUS SYSTEM LYMPHOMA,Systemic candida|Sepsis|Febrile bone marrow aplasia,3,1
10049539,20140401,Rituximab,69,801,69.0,1,68,1,0,1,1,0,0,0,Rituximab,"PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|BORTEZOMIB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",13,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypophosphataemia|Anaemia|Malaise|Pyrexia|Infection|Neutropenic sepsis,6,3
10049715,20140401,Rituximab,22,801,22.0,2,,1,1,1,0,0,0,0,Rituximab,"RITUXIMAB|INSULIN DETEMIR|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|AZATHIOPRINE|URSODIOL|URSOSIOL|CHOLESTYRAMINE|PREDNISONE|LORAZEPAM|MORPHINE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",12,GRAFT VERSUS HOST DISEASE|PREMEDICATION|PREMEDICATION,Blood bilirubin increased|Blood count abnormal|Off label use|Hepatic failure,4,1
10049765,20140401,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,1,VASCULITIS,Progressive multifocal leukoencephalopathy|Vasculitis,2,3
10049769,20140401,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,1,VASCULITIS,Progressive multifocal leukoencephalopathy,1,1
10050131,20140331,Rituximab,83,801,83.0,1,70.9,1,0,1,0,0,0,0,Rituximab,BENDAMUSTINE HYDROCHLORIDE|RITUXIMAB|IPRATROPIUM BROMIDE|CARVEDILOL|GABAPENTIN|GLIPIZIDE|ATORVASTATIN CALCIUM|LISINOPRIL|ESOMEPRAZOLE MAGNESIUM,12,,Squamous cell carcinoma of skin,1,1
10050289,20140401,Rituximab,56,801,56.0,2,76.2,1,0,0,0,0,0,1,Rituximab,BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|RITUXIMAB|PREDNISONE|CALCIUM|FOLIC ACID,8,B-CELL LYMPHOMA|B-CELL LYMPHOMA,Autoimmune haemolytic anaemia|Neutrophil count abnormal|White blood cell count abnormal|Off label use,4,3
10051036,20140401,Rituximab,53,801,53.0,1,70.8,1,0,1,1,0,0,0,Rituximab,"ETOPOSIDE|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|VORINOSTAT|DOXORUBICIN",7,NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA,Platelet count decreased|Febrile neutropenia|White blood cell count decreased,3,3
10051219,20140401,Rituximab,78,801,78.0,1,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|METHYLPREDNISOLONE|MOMETASONE FUROATE|MOMETASONE|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|RITUXIMAB|PEGFILGRASTIM|BENDAMUSTINE HCL|RITUXIMAB|RITUXIMAB|PEGFILGRASTIM|FOLIC ACID|BENDAMUSTINE HCL|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CEFPODOXIME PROXETIL|BENDAMUSTINE HCL|RITUXIMAB|RITUXIMAB|METHYLPREDNISOLONE|PEGFILGRASTIM|PEGFILGRASTIM|TELMISARTAN|BENDAMUSTINE HCL|RITUXIMAB|RITUXIMAB|RITUXIMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ALPRAZOLAM|AMOXICILLIN AND CLAVULANATE POTASSIUM|RITUXIMAB|RITUXIMAB|RITUXIMAB,65,RHINITIS ALLERGIC|B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NEUTROPHIL COUNT DECREASED|NEUTROPHIL COUNT DECREASED|PRODUCT USED FOR UNKNOWN INDICATION|B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|B-CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RHINITIS ALLERGIC|PRODUCT USED FOR UNKNOWN INDICATION,Squamous cell carcinoma,1,1
10051835,20140402,Rituximab,50,801,50.0,2,59,1,1,1,1,1,1,1,Rituximab,"TOCILIZUMAB|TOCILIZUMAB|TOCILIZUMAB|TOCILIZUMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|FOLIC ACID|FISH OIL|PREDNISONE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|CALCIUM",13,Rheumatoid arthritis|Rheumatoid arthritis|Rheumatoid arthritis,Cataract|Arthralgia|Rheumatoid arthritis|Drug ineffective|Blood pressure increased|Heart rate decreased|Pain|Musculoskeletal discomfort|Blood pressure fluctuation|Infusion related reaction|Weight increased|Blood pressure systolic abnormal|Blood pressure systolic increased|Oxygen saturation decreased|Weight decreased,15,3
10052024,20140402,Rituximab,69,801,69.0,2,,1,0,1,0,0,0,0,Rituximab,METHOTREXATE|METHOTREXATE SODIUM|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM,10,RHEUMATOID ARTHRITIS,Partial seizures|Chest pain|Device dislocation|Neutropenia|Cholecystectomy|Pancreatitis|Herpes zoster|Pain in extremity|Encephalitis|Synovial rupture,10,1
10052029,20140402,Rituximab,44,801,44.0,2,54.48,1,0,0,0,0,0,1,Rituximab,TOCILIZUMAB|RITUXIMAB|RITUXIMAB|NAPROXEN|NAPROXEN SODIUM|RISEDRONATE SODIUM|DOXYCYCLINE|DOXYCYCLINE HYCLATE|RABEPRAZOLE|PREDNISONE|METHOTREXATE|METHOTREXATE SODIUM,10,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Anaphylactic reaction|Breast cancer|Hypertension|Osteoporosis,4,1
10052041,20140402,Rituximab,,,,2,,1,0,1,0,0,0,0,Rituximab,"PEGFILGRASTIM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|SULFAMETHOXAZOLE AND TRIMETHOPRIM|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|ATENOLOL|VALSARTAN|VALSARTAN ORAL",10,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|INFECTION PROPHYLAXIS|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|HYPERTENSION|HYPERTENSION,Embolism,1,1
10052113,20140402,Rituximab,,,,2,,1,0,1,0,0,0,0,Rituximab,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISONE|VALSARTAN|VALSARTAN ORAL|HYDROCHLOROTHIAZIDE|ALLOPURINOL|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|AMPHOTERICIN B|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",18,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|PROPHYLAXIS|PROPHYLAXIS|OSTEOPOROSIS|GASTROOESOPHAGEAL REFLUX DISEASE|PROPHYLAXIS|VITAMIN SUPPLEMENTATION|INFECTION PROPHYLAXIS|BLOOD POTASSIUM DECREASED|PAIN|INFECTION PROPHYLAXIS|INFECTION PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING,Hypertensive crisis|Hyponatraemia|Vomiting|Nausea,4,1
10052241,20140402,Rituximab,14,802,1.17,1,9.6,1,0,1,0,0,0,0,Rituximab,METHOTREXATE|METHOTREXATE SODIUM|BORTEZOMIB FOR INJECTION|BORTEZOMIB|RITUXIMAB|RANITIDINE|SOTALOL HYDROCHLORIDE|POLYETHYLENE GLYCOL 3350,8,GLYCOGEN STORAGE DISEASE TYPE II|IMMUNE TOLERANCE INDUCTION|IMMUNE TOLERANCE INDUCTION|IMMUNE TOLERANCE INDUCTION|GASTROOESOPHAGEAL REFLUX DISEASE|CONSTIPATION,Respiratory failure|Oxygen saturation decreased|Rhinovirus infection|Increased upper airway secretion,4,1
10052320,20140402,Rituximab,,,,0,,1,0,1,0,0,0,0,Rituximab,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Cholelithiasis,1,1
10052543,20140331,Rituximab,66,801,66.0,1,105.6,1,0,0,0,0,0,1,Rituximab,"BRENTUXIMAB VEDOTIN|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PROCHLORPERAZINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ALLOPURINOL|ALBUTEROL SULFATE|ALBUTEROL",30,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Second primary malignancy|Myelodysplastic syndrome|Febrile neutropenia|Diarrhoea|Thrombocytopenia,5,1
10052692,20140331,Rituximab,69,801,69.0,1,68,1,0,1,1,0,0,0,Rituximab,"VINCRISTINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB|BORTEZOMIB FOR INJECTION|BORTEZOMIB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",13,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Hypophosphataemia|Anaemia|Neutropenic sepsis|Infection|Malaise|Febrile neutropenia|Hypotension|Toxicity to various agents,8,3
10052698,20140402,Rituximab,52,801,52.0,1,,1,0,1,0,0,0,0,Rituximab,SULFAMETHOXAZOLE AND TRIMETHOPRIM,17,LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA,Acute polyneuropathy,1,3
10053007,20140402,Rituximab,52,801,52.0,2,,1,0,1,0,0,0,0,Rituximab,TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|RIVAROXABAN|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|DRONEDARONE|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|RITUXIMAB|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|DRONEDARONE,13,ANTICOAGULANT THERAPY|THROMBOSIS PROPHYLAXIS|RENAL TRANSPLANT|IMMUNE TOLERANCE INDUCTION|ARRHYTHMIA PROPHYLAXIS,Renal impairment|Drug level above therapeutic|Drug interaction|Blood creatinine increased|Fluid overload|Fatigue|Oedema,7,3
10053274,20140402,Rituximab,49,801,49.0,2,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,5,RHEUMATIC DISORDER|MEDICATION DILUTION|PREMEDICATION|PREMEDICATION|PREMEDICATION,Headache|Throat irritation|Chest discomfort,3,5
10053323,20140402,Rituximab,67,801,67.0,1,63,1,0,0,0,0,0,1,Rituximab,BENDAMUSTINE HCL|RITUXIMAB|IBRUTINIB,3,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Squamous cell carcinoma,1,1
10053399,20140402,Rituximab,65,801,65.0,1,,1,1,1,1,1,0,0,Rituximab,RITUXIMAB|GANCICLOVIR SODIUM|GANCICLOVIR|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,10,EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE)|CYTOMEGALOVIRUS INFECTION|INTERSTITIAL LUNG DISEASE|EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE)|INTERSTITIAL LUNG DISEASE|EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE)|INTERSTITIAL LUNG DISEASE|INTERSTITIAL LUNG DISEASE,Pneumonia adenoviral|Lung abscess|Cytomegalovirus infection|Interstitial lung disease|Pneumonia pneumococcal,5,1
10053674,20140402,Rituximab,19,801,19.0,1,,1,1,0,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|PREDNISONE|CYTARABINE|MELPHALAN HYDROCHLORIDE|MELPHALAN,12,NEUROMYELITIS OPTICA|NEUROMYELITIS OPTICA|OFF LABEL USE|NEUROMYELITIS OPTICA|IMMUNOSUPPRESSANT DRUG THERAPY|IMMUNOSUPPRESSANT DRUG THERAPY|IMMUNOSUPPRESSANT DRUG THERAPY|IMMUNOSUPPRESSANT DRUG THERAPY|IMMUNOSUPPRESSANT DRUG THERAPY|IMMUNOSUPPRESSANT DRUG THERAPY|IMMUNOSUPPRESSANT DRUG THERAPY|PROPHYLAXIS,Brain stem syndrome|Pulmonary alveolar haemorrhage|Condition aggravated|Immunoglobulins abnormal,4,3
10053687,20140402,Rituximab,64,801,64.0,1,112.04,1,0,1,0,0,0,0,Rituximab,BENDAMUSTINE HYDROCHLORIDE|IBRUTINIB|ACYCLOVIR|PROCHLORPERAZINE|RITUXIMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|IBRUTINIB|ZOLPIDEM TARTRATE|ALLOPURINOL|LORAZEPAM,12,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Pleural effusion,1,3
10055210,20140403,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,"PREDNISONE|DOXORUBICIN|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",5,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Non-small cell lung cancer|Febrile neutropenia|Anaemia|Hyperuricaemia|Stomatitis|Malignant neoplasm of ampulla of Vater|Peripheral sensory neuropathy|Diarrhoea|Neutropenia|Metabolic disorder|Hyperglycaemia|Lymphopenia|Skin cancer|Infection|Hypoglycaemia|Hyponatraemia|Hypoxia|Syncope|Fatigue|Hypocalcaemia|Dyspnoea|Bladder cancer,22,1
10055284,20140403,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|MITOXANTRONE HYDROCHLORIDE|MITOXANTRONE",6,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10055292,20140403,Rituximab,,,,1,,1,0,1,0,0,0,1,Rituximab,"RITUXIMAB|RITUXIMAB|FLUDARABINE PHOSPHATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",6,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Adenocarcinoma of colon,1,1
10055551,20140403,Rituximab,,,,2,,1,0,1,0,0,0,1,Rituximab,RITUXIMAB,1,RHEUMATOID ARTHRITIS,Hepatocellular injury|Neutropenia|Nasopharyngitis|Sinusitis|Duodenal ulcer|Hiatus hernia|Pyrexia|Hyperthermia|Chills|Cough|Rib fracture|Fall|Hepatic steatosis|Cholestasis|Chest pain|Rales,16,1
10055728,20140403,Rituximab,75,801,75.0,1,,1,0,1,0,0,0,0,Rituximab,CISPLATIN|METHOTREXATE|METHOTREXATE SODIUM|RITUXIMAB|CYTARABINE|PREGABALIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,13,NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|PROPHYLAXIS|NON-HODGKIN^S LYMPHOMA,Renal failure acute|Malaise|Loss of consciousness|Polyuria|Renal tubular necrosis,5,3
10055931,20140403,Rituximab,71,801,71.0,1,,1,0,0,0,0,0,1,Rituximab,PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB|DOXORUBICIN,5,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Granuloma|Herpes virus infection,2,3
10056142,20140401,Rituximab,,,,2,,1,0,1,0,0,0,0,Rituximab,,6,DERMATOMYOSITIS,Sepsis,1,1
10056278,20140403,Rituximab,82,801,82.0,1,139.38,1,0,0,0,0,0,0,Rituximab,"BENDAMUSTINE HYDROCHLORIDE|RITUXIMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DIPHENHYDRAMINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",6,NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION,Extravasation|Peripheral swelling,2,3
10056331,20140403,Rituximab,58,801,58.0,2,73,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,1,MALIGNANT LYMPHOID NEOPLASM,Polyneuropathy,1,1
10057049,20140403,Rituximab,60,801,60.0,1,,1,0,1,0,0,0,0,Rituximab,BENDAMUSTINE HCL|BENDAMUSTINE HCL|RITUXIMAB|RITUXIMAB,4,B-CELL LYMPHOMA|B-CELL LYMPHOMA,Lymphocyte count decreased,1,1
10057123,20140403,Rituximab,66,801,66.0,1,,1,0,1,0,0,0,0,Rituximab,BENDAMUSTINE HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|RITUXIMAB|ALLOPURINOL,6,MANTLE CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MANTLE CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION,Balanoposthitis|Platelet count decreased,2,1
10057305,20140403,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB,3,WALDENSTROM^S MACROGLOBULINAEMIA|WALDENSTROM^S MACROGLOBULINAEMIA,Necrotising fasciitis|Off label use,2,1
10057481,20140403,Rituximab,51,801,51.0,2,,1,0,0,0,0,0,0,Rituximab,AMBRISENTAN|AMBRISENTAN|RITUXIMAB,3,PULMONARY HYPERTENSION|CONNECTIVE TISSUE DISORDER,Hepatic enzyme increased,1,1
10057543,20140404,Rituximab,56,801,56.0,1,,1,0,1,0,0,0,0,Rituximab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|FLUDARABINE PHOSPHATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",6,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|DEPRESSION,Cardiac failure|Myocardial ischaemia,2,1
10057577,20140404,Rituximab,,,,1,86.26,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|LENALIDOMIDE,2,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Platelet count abnormal|Lymphadenopathy|Gastric dilatation|Somnolence|Pyrexia|Decreased appetite|Abdominal pain upper|Malaise|Contusion,9,5
10057786,20140404,Rituximab,61,801,61.0,2,,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|METHYLPREDNISOLONE,19,RHEUMATOID ARTHRITIS|PREMEDICATION,Swelling|Infusion related reaction|Bronchitis|Cholelithiasis|Asthenia|Gastrointestinal disorder|Asthenia|Weight increased|Colonic abscess,9,1
10057795,20140404,Rituximab,,,,2,,1,0,1,0,0,0,0,Rituximab,"RITUXIMAB|PEGFILGRASTIM|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISONE|ALLOPURINOL|VALSARTAN|VALSARTAN ORAL|HYDROCHLOROTHIAZIDE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|AMPHOTERICIN B|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",18,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|HYPERTENSION|GASTROOESOPHAGEAL REFLUX DISEASE|VITAMIN SUPPLEMENTATION|PAIN|NAUSEA|BLOOD POTASSIUM DECREASED,Hypertension|Hyponatraemia|Vomiting|Nausea,4,1
10057984,20140404,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|ETOPOSIDE|TREOSULFAN|FILGRASTIM,9,NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA,Hypokalaemia|Renal failure|Infection,3,3
10058223,20140404,Rituximab,,,,2,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM,4,RHEUMATOID ARTHRITIS,Temporal arteritis,1,1
10058311,20140404,Rituximab,50,801,50.0,1,94.8,1,0,0,0,0,0,1,Rituximab,PHYTONADIONE|CELECOXIB|TOCILIZUMAB|VITAMIN E|ERGOCALCIFEROL|TOCILIZUMAB|TOCILIZUMAB|TOCILIZUMAB|PREDNISONE|FOLIC ACID|TOCILIZUMAB|OXYCODONE HYDROCHLORIDE|MANGANESE|MANGANESE CHLORIDE|PREGABALIN|TOCILIZUMAB|RITUXIMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,26,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|DIABETES MELLITUS,Negative thoughts|Weight decreased|Rheumatoid arthritis|Therapeutic response decreased|Drug ineffective|Joint swelling|Drug ineffective|Arthralgia|Drug effect decreased|Diabetes mellitus|Arthropathy|Pain,12,1
10058614,20140404,Rituximab,,,,0,,1,1,0,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|TREOSULFAN|TREOSULFAN|ETOPOSIDE|FILGRASTIM,10,NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA,Death|Infection|Leukopenia|Thrombocytopenia|Blood bilirubin abnormal|Transaminases abnormal|Blood alkaline phosphatase abnormal|Nausea|Vomiting|Diarrhoea|Stomatitis|Gastrointestinal disorder|Blood creatinine abnormal|Renal disorder|Bladder disorder|Lung disorder|Pyrexia|Hypersensitivity|Septic shock|Renal failure,20,3
10059464,20140404,Rituximab,75,801,75.0,1,,1,0,1,0,0,0,1,Rituximab,PREGABALIN|CISPLATIN|CYTARABINE|METHOTREXATE SODIUM|METFORMIN HCL|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,12,,Renal failure acute|Renal tubular necrosis,2,3
10060261,20140404,Rituximab,48,801,48.0,2,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|TERIFLUNOMIDE,2,MULTIPLE SCLEROSIS,Diarrhoea|Drug ineffective|Multiple sclerosis|Influenza like illness|Abdominal discomfort|Alopecia|Kidney infection,7,5
10060794,20140404,Rituximab,49,801,49.0,2,,1,0,0,0,0,0,1,Rituximab,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|METHYLPREDNISOLONE|METHYLPREDNISOLONE",6,NEUROMYELITIS OPTICA|OFF LABEL USE|IMMUNOSUPPRESSANT DRUG THERAPY|IMMUNOSUPPRESSANT DRUG THERAPY|NEUROMYELITIS OPTICA,No therapeutic response,1,3
10060983,20140405,Rituximab,49,801,49.0,2,,1,0,1,0,0,0,1,Rituximab,METHYLPREDNISOLONE|CYCLOSPORINE|RITUXIMAB|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|PREDNISONE|RITUXIMAB|RITUXIMAB|METHYLPREDNISOLONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,10,PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|POLYMYOSITIS|PREMEDICATION|PREMEDICATION,Fatigue|Myositis|Labyrinthitis|Headache|Nasopharyngitis|Intentional product use issue|Eye irritation|Infusion related reaction|Alopecia|White blood cell count decreased|Viral infection|Off label use|Respiratory disorder,13,1
10061000,20140405,Rituximab,79,801,79.0,2,68.71,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|BENDAMUSTINE HCL|BENDAMUSTINE HCL|ACYCLOVIR|FUROSEMIDE|LISINOPRIL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SIMVASTATIN,15,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Bile duct obstruction,1,1
10061009,20140405,Rituximab,,,,2,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|METHYLPREDNISOLONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,23,RHEUMATOID ARTHRITIS,Asthenia|Dysphonia|Bone fissure|Hypogammaglobulinaemia|Herpes zoster|Tooth abscess|Diarrhoea|Hordeolum|Femoral neck fracture|Fall|Laryngitis|Productive cough|Influenza like illness|Headache|Dysglobulinaemia,15,1
10061154,20140407,Rituximab,75,801,75.0,1,,1,0,1,0,0,0,1,Rituximab,CISPLATIN|CYTARABINE|METHOTREXATE|METHOTREXATE SODIUM|ALLOPURINOL|PREGABALIN|TRIMETHOPRIM|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE SODIUM PHOSPHATE|NEOMYCIN SULFATE,14,NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA,Renal failure acute|Malaise,2,
10061243,20140407,Rituximab,47,801,47.0,1,83,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|METHYLPREDNISOLONE|BASILIXIMAB|AMLODIPINE|TELMISARTAN,9,PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION|HYPERTENSION|HYPERTENSION,Febrile neutropenia,1,1
10061254,20140407,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|BENDAMUSTINE HCL,2,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10061397,20140407,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Pulmonary hypertension|Scleroderma|Connective tissue disorder,3,1
10061420,20140407,Rituximab,,,,2,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10061508,20140407,Rituximab,54,801,54.0,0,,1,1,1,0,0,0,0,Rituximab,"DOXORUBICIN|RITUXIMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",6,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|PROPHYLAXIS,Febrile neutropenia,1,3
10061510,20140407,Rituximab,,,,0,,1,1,1,0,0,0,1,Rituximab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|RITUXIMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",7,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|PROPHYLAXIS,Death|Febrile neutropenia|Neutropenia,3,3
10061511,20140407,Rituximab,76,801,76.0,0,,1,1,1,0,0,0,0,Rituximab,"DOXORUBICIN|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",6,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|PROPHYLAXIS,Febrile neutropenia,1,3
10061608,20140403,Rituximab,54,801,54.0,1,,1,0,1,0,0,0,0,Rituximab,,4,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Lhermitte^s sign|Demyelination|Erectile dysfunction|Urinary hesitation|Sensory loss|CSF protein increased|Visual evoked potentials abnormal|Brain stem auditory evoked response abnormal,8,3
10061670,20140403,Rituximab,44,801,44.0,1,,1,0,1,0,0,0,0,Rituximab,"VINCRISTINE SULFATE|METHOTREXATE|METHOTREXATE SODIUM|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYTARABINE|METHYLPREDNISOLONE|RITUXIMAB|AMLODIPINE|ENOXAPARIN SODIUM",14,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hepatocellular injury,1,3
10061942,20140407,Rituximab,31,801,31.0,2,,1,0,0,0,0,0,1,Rituximab,"MYCOPHENOLIC ACID|MYCOPHENILIC ACID|PREDNISONE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|RITUXIMAB",8,RENAL TRANSPLANT|RENAL TRANSPLANT|RENAL TRANSPLANT,Autoimmune neutropenia|Transplant rejection,2,1
10062213,20140407,Rituximab,,,,2,,1,0,0,0,0,0,1,Rituximab,"TOCILIZUMAB|RITUXIMAB|HYDROXYCHLOROQUINE SULFATE|CYCLOBENZAPRINE|ERGOCALCIFEROL|FOLIC ACID|GARLIC|METHOTREXATE|METHOTREXATE SODIUM|NAPROXEN|NAPROXEN SODIUM|SULFASALAZINE|LEVOTHYROXINE SODIUM|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE",13,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cataract,1,5
10062250,20140407,Rituximab,,,,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|TOCILIZUMAB|ABATACEPT|DIAZEPAM|CLOPIDOGREL|RITUXIMAB,11,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Abdominal pain upper|Bronchitis|Diarrhoea|Chest pain|Abdominal pain|Cough|Flushing|Eosinophilia|Acute coronary syndrome,9,1
10062560,20140407,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,ANTI-THYMOCYTE GLOBULIN (RABBIT)|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|GANCICLOVIR SODIUM|GANCICLOVIR|RITUXIMAB,12,BONE MARROW CONDITIONING REGIMEN|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|ANTIVIRAL PROPHYLAXIS|PROPHYLAXIS,Post transplant lymphoproliferative disorder,1,3
10063046,20140407,Rituximab,9,801,9.0,1,,1,0,0,0,0,0,1,Rituximab,METHOTREXATE|METHOTREXATE SODIUM|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|RITUXIMAB|INFLIXIMAB|TOCILIZUMAB,7,DERMATOMYOSITIS|OFF LABEL USE|DERMATOMYOSITIS|DERMATOMYOSITIS|DERMATOMYOSITIS|DERMATOMYOSITIS|DERMATOMYOSITIS,Dermatitis|Myositis|Calcinosis,3,3
10063292,20140407,Rituximab,69,801,69.0,2,52,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METHYLPREDNISOLONE|RANITIDINE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|PEGFILGRASTIM|PREDNISONE|GRANISETRON|GRANISETRON HYDROCHLORIDE,12,NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT STAGE IV|NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT STAGE IV|NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT STAGE IV,Enteritis|Nausea|Hypoalbuminaemia|Oedema|Diarrhoea|Pyrexia,6,1
10063387,20140407,Rituximab,76,801,76.0,1,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,5,PEMPHIGUS|PEMPHIGUS|PEMPHIGUS,Pneumonia|Bacteraemia|Cytomegalovirus infection|Herpes simplex,4,3
10063761,20140408,Rituximab,,,,1,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,1,AUTOIMMUNE RETINOPATHY,Visual acuity reduced,1,1
10063762,20140408,Rituximab,51,801,51.0,1,,1,0,0,0,0,0,1,Rituximab,MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|METHYLPREDNISOLONE|RITUXIMAB,3,PRODUCT USED FOR UNKNOWN INDICATION,Pulmonary embolism,1,1
10063787,20140408,Rituximab,25,801,25.0,2,,1,0,0,0,0,0,1,Rituximab,METHYLPREDNISOLONE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|BASILIXIMAB|RITUXIMAB,5,RENAL TRANSPLANT,Glomerulonephritis,1,1
10063795,20140408,Rituximab,27,801,27.0,1,,1,0,0,0,0,0,1,Rituximab,MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|RITUXIMAB,3,PRODUCT USED FOR UNKNOWN INDICATION,Polyomavirus-associated nephropathy|Focal segmental glomerulosclerosis,2,1
10063798,20140408,Rituximab,57,801,57.0,2,,1,0,0,0,0,0,1,Rituximab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|METHYLPREDNISOLONE SODIUM SUCCINATE|RITUXIMAB|DIPHENHYDRAMINE HYDROCHLORIDE|METHOTREXATE|METHOTREXATE SODIUM|CONJUGATED ESTROGENS|ESTROGENS, CONJUGATED|HYDROXYCHLOROQUINE SULFATE|FOLIC ACID",9,PREMEDICATION|PREMEDICATION|RHEUMATOID ARTHRITIS|PREMEDICATION,Urticaria|Hypotension|Blood pressure fluctuation|Infusion related reaction|Burning sensation|Abdominal hernia|Rhinorrhoea|Oxygen saturation decreased|Blood pressure increased|Tremor|Nasopharyngitis|Blood pressure systolic increased|Gastroenteritis|Blood pressure diastolic abnormal|Paraesthesia,15,3
10063982,20140408,Rituximab,73,801,73.0,2,,1,1,1,0,0,0,1,Rituximab,LEFLUNOMIDE|RITUXIMAB|HYDROXYCHLOROQUINE|METHOTREXATE|METHOTREXATE SODIUM|CYCLOSPORINE|METHYLPREDNISOLONE,9,PREMEDICATION|RHEUMATOID ARTHRITIS|PREMEDICATION,Cardiopulmonary failure|Fall|Constipation|Loss of personal independence in daily activities|Pneumonia|Purpura|Urinary tract infection|Abdominal pain|Bronchiectasis|Infusion related reaction|Haematoma|Pelvic fracture|Back pain|Superinfection,14,1
10064175,20140408,Rituximab,47,801,47.0,1,104.3,1,0,0,0,0,0,1,Rituximab,OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|RITUXIMAB|CELECOXIB|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RITUXIMAB|METHYLPREDNISOLONE,7,PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PREMEDICATION|RHEUMATOID ARTHRITIS|PREMEDICATION,Rheumatoid arthritis|Nasopharyngitis|Oxygen saturation decreased|Urticaria|Nausea|Infusion related reaction|Rash|Blood pressure increased|Blood pressure fluctuation|Haematochezia|Vessel puncture site bruise|Malaise,12,3
10064307,20140408,Rituximab,36,801,36.0,1,,1,0,0,0,0,0,1,Rituximab,MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|RITUXIMAB|BASILIXIMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Lymphocele,1,1
10064522,20140408,Rituximab,,,,1,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|CARMUSTINE|ETOPOSIDE PHOSPHATE|MELPHALAN HYDROCHLORIDE|MELPHALAN|CISPLATIN|CISPLATIN,13,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Small cell lung cancer,1,1
10064535,20140408,Rituximab,21,801,21.0,2,42,1,0,1,0,0,0,0,Rituximab,ANTI-THYMOCYTE GLOBULIN (RABBIT)|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|METHYLPREDNISOLONE|CYCLOSPORINE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|RITUXIMAB|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|FLUCONAZOLE,12,IMMUNOSUPPRESSANT DRUG THERAPY|IMMUNOSUPPRESSANT DRUG THERAPY|IMMUNOSUPPRESSANT DRUG THERAPY|INFECTION PROPHYLAXIS|IMMUNOSUPPRESSANT DRUG THERAPY|PROPHYLAXIS|PROPHYLAXIS|IMMUNOSUPPRESSANT DRUG THERAPY|IMMUNOSUPPRESSANT DRUG THERAPY|INFECTION PROPHYLAXIS|INFECTION PROPHYLAXIS|INFECTION PROPHYLAXIS,Cystitis haemorrhagic|Haematuria|Cystitis|Cytomegalovirus infection|White blood cell count decreased|Hepatic function abnormal|Hyponatraemia,7,1
10064671,20140408,Rituximab,58,801,58.0,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB,2,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Febrile neutropenia,1,3
10065005,20140407,Rituximab,79,801,79.0,1,,1,0,0,0,0,0,0,Rituximab,RITUXIMAB,1,CHRONIC LYMPHOCYTIC LEUKAEMIA,Chills|Blood pressure increased|Infusion related reaction,3,2
10065255,20140404,Rituximab,58,801,58.0,1,87.1,1,0,0,0,0,0,1,Rituximab,"RITUXIMAB|PREDNISONE|DOXORUBICIN|BRENTUXIMAB VEDOTIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",10,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Cataract|Optic nerve disorder|Vitreous degeneration|Optic nerve injury|Visual acuity reduced|Refraction disorder,6,1
10065558,20140408,Rituximab,,,,0,,1,0,1,0,0,0,0,Rituximab,"BORTEZOMIB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METHOTREXATE|METHOTREXATE SODIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",9,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Neutropenia,1,1
10066705,20140408,Rituximab,44,801,44.0,2,,1,0,0,0,0,0,1,Rituximab,METHYLPREDNISOLONE|RITUXIMAB|IRON SUCROSE,5,ANAEMIA|ANAEMIA|ANAEMIA|ANAEMIA|ANAEMIA,No therapeutic response,1,3
10066934,20140409,Rituximab,80,801,80.0,1,81.72,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|ERYTHROPOIETIN|LISINOPRIL|FUROSEMIDE|BRINZOLAMIDE|TIMOLOL|LATANOPROST|ACYCLOVIR,12,NON-HODGKIN^S LYMPHOMA|HAEMOGLOBIN|BLOOD PRESSURE|GLAUCOMA|GLAUCOMA|GLAUCOMA,Chest discomfort|Tremor|Pyrexia|Blood pressure increased|Chills|Visual impairment|Muscle tightness,7,5
10066949,20140409,Rituximab,52,801,52.0,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM,9,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Uterine leiomyoma|Influenza|Purpura,3,1
10067211,20140409,Rituximab,6,801,6.0,1,,1,0,1,1,0,0,0,Rituximab,CYTARABINE|RITUXIMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|RITUXIMAB|CYTARABINE|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM,9,B-CELL LYMPHOMA|INFECTION PROPHYLAXIS|B-CELL LYMPHOMA|BURKITT^S LEUKAEMIA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Chorioretinitis|Meningitis|Encephalitis|Sepsis,4,1
10067534,20140409,Rituximab,60,801,60.0,2,76,1,0,0,0,0,0,1,Rituximab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CLONAZEPAM|AZATHIOPRINE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,7,PRODUCT USED FOR UNKNOWN INDICATION|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|DIABETES MELLITUS|HYPERTENSION,Pruritus|Drug ineffective|Dengue fever|Throat tightness,4,1
10067552,20140409,Rituximab,67,801,67.0,1,,1,0,0,1,0,0,1,Rituximab,RITUXIMAB|RITUXIMAB|RISPERIDONE|RALTEGRAVIR|RITUXIMAB|ABACAVIR SULFATE AND LAMIVUDINE,14,URINARY RETENTION|HERPES VIRUS INFECTION|HIV INFECTION|HIV TEST POSITIVE|DEPRESSION|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|PREMEDICATION|HIV INFECTION|CASTLEMAN^S DISEASE|HIV INFECTION|DEPRESSION,Sepsis|Product use issue|Kaposi^s sarcoma|Off label use,4,1
10067676,20140409,Rituximab,,,,2,56,1,1,1,0,0,0,1,Rituximab,HYDROCHLOROTHIAZIDE|DEFLAZACORT|CAPTOPRIL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|TOCILIZUMAB|RITUXIMAB,7,PRODUCT USED FOR UNKNOWN INDICATION|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Blood glucose increased|Death|Cataract|Musculoskeletal disorder|Nasopharyngitis|Pain in extremity|Arthropathy|Glaucoma|Arthralgia|Musculoskeletal pain,10,5
10067713,20140408,Rituximab,71,801,71.0,2,81,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,1,,Chest pain|Dyspnoea|Hypotension|Infusion related reaction,4,1
10067773,20140409,Rituximab,42,801,42.0,2,100,1,0,0,1,1,0,1,Rituximab,SULFASALAZINE|ADALIMUMAB|ADALIMUMAB-FKJP|ADALIMUMAB-AATY|ADALIMUMAB-ADAZ|PREDNISONE|INFLIXIMAB|PREDNISONE|DICLOFENAC|DICLOFENAC SODIUM|DEFLAZACORT|LEFLUNOMIDE|PREDNISONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SULFASALAZINE,17,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|PAIN|RHEUMATOID ARTHRITIS|PRODUCT USED FOR UNKNOWN INDICATION,Cushing^s syndrome|Dysphagia|Arthritis|Back pain|Dyspnoea|Dizziness|Colitis|Dizziness|Arthralgia|Pain|Oesophageal disorder|Headache|Somnolence|Vision blurred|Oropharyngeal pain|Cough|Muscle rigidity|Gastrooesophageal reflux disease|Decreased appetite|Arthropathy|Mood altered|Asthenia|Swelling|Headache|Muscle rigidity|Tachycardia|Drug ineffective|Upper respiratory tract infection|Mobility decreased|Feeling of despair|Infection|Weight increased|Throat tightness|Kidney infection|Pharyngitis|Superficial vein prominence|Ear pruritus|Ear pain|Malaise|Ear pruritus|Tendonitis|Emotional disorder|Gait disturbance|Weight increased|Dysstasia|Vaginal infection|Ear discomfort|Infusion site haematoma|Medication error|Infection,50,3
10068025,20140409,Rituximab,67,801,67.0,1,,1,0,1,0,1,0,1,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB,20,MANTLE CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MANTLE CELL LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION,Septic embolus|Thrombocytopenia|Neutropenia|Pleural effusion|Infection|Pneumonia|Neutropenia|Staphylococcal bacteraemia,8,1
10068569,20140409,Rituximab,64,801,64.0,1,112.2,1,0,1,0,0,0,0,Rituximab,BENDAMUSTINE HCL|RITUXIMAB|IBRUTINIB|IBRUTINIB|ZOLPIDEM TARTRATE|ALLOPURINOL|LORAZEPAM|PROCHLORPERAZINE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,12,MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA|MANTLE CELL LYMPHOMA,Pleural effusion,1,1
10068647,20140409,Rituximab,28,801,28.0,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB,4,PRODUCT USED FOR UNKNOWN INDICATION,Cerebrovascular accident,1,3
10069056,20140409,Rituximab,38,801,38.0,2,,1,0,0,0,0,0,1,Rituximab,"VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|BASILIXIMAB|RITUXIMAB|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE",9,ANTIFUNGAL PROPHYLAXIS|RENAL TRANSPLANT|ANTIVIRAL PROPHYLAXIS|RENAL TRANSPLANT|KIDNEY TRANSPLANT REJECTION|RENAL TRANSPLANT|RENAL TRANSPLANT|RENAL TRANSPLANT|RENAL TRANSPLANT,Thrombotic microangiopathy|Haemolytic anaemia|Platelet count decreased|Oropharyngeal pain|Bacterial infection|Drug ineffective|Hyperthermia|Haematuria|Haptoglobin decreased|Diarrhoea|Transplant rejection,11,3
10069079,20140409,Rituximab,12,801,12.0,1,,1,0,1,0,0,0,0,Rituximab,PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METHYLPREDNISOLONE|RITUXIMAB,4,NEPHROTIC SYNDROME|NEPHROTIC SYNDROME|NEPHROTIC SYNDROME,Aspergillus infection|Cough|Dyspnoea|Blood beta-D-glucan increased|Lung disorder|Hypertensive encephalopathy|Drug ineffective,7,3
10069375,20140410,Rituximab,,,,1,,1,0,0,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|BENDAMUSTINE HCL|HYDROCHLOROTHIAZIDE|TRAVOPROST|TRAVOPROST (ISOMER FREE),6,WALDENSTROM^S MACROGLOBULINAEMIA|WALDENSTROM^S MACROGLOBULINAEMIA,Heart sounds abnormal|Burning sensation|Off label use,3,5
10069388,20140410,Rituximab,69,801,69.0,2,62.6,1,0,1,0,0,0,1,Rituximab,RITUXIMAB|LEVOTHYROXINE SODIUM|PREGABALIN|CELECOXIB|NAPROXEN|NAPROXEN SODIUM|ESOMEPRAZOLE MAGNESIUM|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|MIRTAZAPINE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|METHYLPREDNISOLONE|PANTOPRAZOLE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALENDRONATE SODIUM|ALENDRONATE SODIUM TABLET|TIOTROPIUM BROMIDE|MORPHINE,24,RHEUMATOID ARTHRITIS|PREMEDICATION|PREMEDICATION|PREMEDICATION,Pain in extremity|Bronchitis|Back pain|Musculoskeletal pain|Lung neoplasm malignant|Arthralgia|Drug ineffective|Weight increased|Arthralgia|Pneumonia|Joint swelling|Laryngitis,12,3
10069422,20140410,Rituximab,69,801,69.0,2,,1,0,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM,16,RHEUMATOID ARTHRITIS|PRODUCT USED FOR UNKNOWN INDICATION,Vasculitis|Cough|Bronchitis|Drug intolerance|Sleep disorder|Irritability|Nausea|Purpura,8,1
10069435,20140410,Rituximab,57,801,57.0,1,,1,0,0,0,0,0,1,Rituximab,"RITUXIMAB|FLUDARABINE PHOSPHATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",3,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Disease progression|White blood cell count abnormal|Lymphocyte count abnormal|Abdominal lymphadenopathy|Chronic hepatitis C|Weight decreased|Fatigue,7,1
10069663,20140410,Rituximab,59,801,59.0,1,62.6,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|PREDNISONE|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|NAPROXEN|NAPROXEN SODIUM,6,RHEUMATOID ARTHRITIS,Blood pressure increased|Lung disorder|Pain|Hypotension|Hypotension|Blood pressure systolic increased|Blood pressure fluctuation|Heart rate decreased,8,3
10069912,20140410,Rituximab,60,801,60.0,1,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|OXYGEN|0XYGEN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LEFLUNOMIDE|OXYCODONE HYDROCHLORIDE|BACLOFEN,6,RHEUMATOID ARTHRITIS|LUNG DISORDER|RHEUMATOID ARTHRITIS|SPINAL COLUMN STENOSIS|BACK PAIN,Death|Malaise|Chronic obstructive pulmonary disease,3,3
10070074,20140408,Rituximab,58,801,58.0,1,,1,0,1,0,0,0,1,Rituximab,DOXORUBICIN,7,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Hepatic cirrhosis|Oesophageal varices haemorrhage|Neutropenia|Thrombocytopenia|Cough|Pyrexia,6,
10070078,20140410,Rituximab,38,801,38.0,1,,1,0,0,0,0,0,1,Rituximab,FLUDARABINE PHOSPHATE|RITUXIMAB|OBINUTUZUMAB,6,PROPHYLAXIS|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA|LYMPHOCYTIC LYMPHOMA,Dyspnoea|Fungal infection|Lymphocytic infiltration|Lower respiratory tract infection bacterial|Chronic hepatitis B|Pyrexia|Bone marrow failure,7,1
10070283,20140410,Rituximab,62,801,62.0,0,,1,0,0,0,0,0,1,Rituximab,"FLUDARABINE PHOSPHATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB",3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10070363,20140409,Rituximab,67,801,67.0,2,58.6,1,0,1,0,0,0,0,Rituximab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|ETOPOSIDE|METHOTREXATE|METHOTREXATE SODIUM|PREDNISONE|VINCRISTINE SULFATE",7,,Pyrexia|Fatigue|Neutrophil count decreased|Clostridium test positive|Haemoglobin decreased,5,1
10070369,20140410,Rituximab,49,801,49.0,1,,1,0,0,1,0,0,0,Rituximab,"FILGRASTIM|CETIRIZINE HYDROCHLORIDE|RANITIDINE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUDARABINE PHOSPHATE|RITUXIMAB|DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",16,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA|NON-HODGKIN^S LYMPHOMA,Burkitt^s leukaemia,1,3
10070529,20140410,Rituximab,70,801,70.0,2,,1,1,1,1,0,0,1,Rituximab,CHLORAMBUCIL,21,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|SECONDARY IMMUNODEFICIENCY|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|SECONDARY IMMUNODEFICIENCY|SECONDARY IMMUNODEFICIENCY,Creutzfeldt-Jakob disease|Hearing impaired|Dementia|Anterograde amnesia|Blindness cortical|Visual impairment|Ataxia|Visual impairment|Cerebellar syndrome|Dementia Alzheimer^s type|Osmotic demyelination syndrome,11,5
10070530,20140410,Rituximab,70,801,70.0,2,,1,1,1,1,0,0,1,Rituximab,CHLORAMBUCIL,29,CHRONIC LYMPHOCYTIC LEUKAEMIA|SECONDARY IMMUNODEFICIENCY|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|SECONDARY IMMUNODEFICIENCY|SECONDARY IMMUNODEFICIENCY|CHRONIC LYMPHOCYTIC LEUKAEMIA,Osmotic demyelination syndrome|Visual impairment|Dementia|Anterograde amnesia|Ataxia|Dementia Alzheimer^s type|Blindness cortical|Visual impairment|Creutzfeldt-Jakob disease|Cerebellar syndrome|Hearing impaired,11,5
10070765,20140410,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10070766,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Febrile neutropenia,1,3
10070770,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10070783,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10071037,20140410,Rituximab,,,,1,,1,0,0,0,0,0,1,Rituximab,CELECOXIB|RITUXIMAB,2,RHEUMATOID ARTHRITIS,Haematochezia|Rheumatoid arthritis|Nausea,3,5
10071434,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071436,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071437,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10071438,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071439,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10071440,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071441,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071442,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071443,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071444,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071445,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071446,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071447,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071448,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071449,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071451,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071452,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071453,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10071454,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10071455,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10071456,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071458,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071460,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Febrile neutropenia,1,3
10071462,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071463,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Febrile neutropenia,1,3
10071464,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071465,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071467,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071468,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071473,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Febrile neutropenia,1,3
10071474,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071476,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071479,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071483,20140410,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10071908,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,INFLIXIMAB|RITUXIMAB,2,RHEUMATOID ARTHRITIS,Lupus-like syndrome|Interstitial lung disease,2,5
10072104,20140411,Rituximab,68,801,68.0,1,,1,0,1,0,0,0,1,Rituximab,"SULFAMETHOXAZOLE AND TRIMETHOPRIM|DOXORUBICIN|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|CEFEPIME HYDROCHLORIDE|CEFEPIME|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PROCHLORPERAZINE",10,ANTIFUNGAL PROPHYLAXIS|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|ANTI-INFECTIVE THERAPY|ANTI-INFECTIVE THERAPY|NAUSEA|NAUSEA,Febrile neutropenia|Escherichia bacteraemia|Pneumocystis jirovecii pneumonia|Hepatosplenic candidiasis,4,1
10072401,20140410,Rituximab,73,801,73.0,1,82.3,1,1,0,0,0,0,0,Rituximab,RITUXIMAB,1,,Pruritus|Infusion related reaction|Blood pressure systolic increased|No therapeutic response|Diarrhoea|Hypothermia|Skin discolouration|Platelet count decreased|Shift to the left|Blood sodium decreased|Blood calcium decreased|Pneumothorax|Spinal osteoarthritis|Septic shock|Multi-organ failure|Intestinal ischaemia|Dehydration|Colitis|Renal failure|Hypogammaglobulinaemia|Acute myocardial infarction|Gastrooesophageal reflux disease|Systemic inflammatory response syndrome|Hepatic failure|Circulatory collapse|Respiratory failure|Disseminated intravascular coagulation|Lactic acidosis|Metabolic acidosis|Bronchiectasis|Erythema|Rash|Rash|Throat tightness|Dysphonia|Nasal congestion|Troponin increased,37,2
10072563,20140411,Rituximab,66,801,66.0,1,88,1,0,1,1,0,0,1,Rituximab,TIOTROPIUM BROMIDE|TOCILIZUMAB|RITUXIMAB|TOCILIZUMAB|DIMENHYDRINATE|METHYLPREDNISOLONE|DICLOFENAC SODIUM AND MISOPROSTOL|HYDROXYCHLOROQUINE|CEPHALEXIN|TOCILIZUMAB|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|TOCILIZUMAB|MORPHINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|HYDROXYCHLOROQUINE SULFATE|ALBUTEROL SULFATE|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE,19,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Peripheral swelling|Malaise|Swelling|Weight increased|Infection|Osteomyelitis|Abscess|Drug effect decreased|Blood pressure increased|Arthropathy|Staphylococcal osteomyelitis|Clostridium difficile infection|Cardiac failure congestive|Arthritis bacterial|Pain,15,1
10072608,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,"FLUDARABINE PHOSPHATE|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,1
10072615,20140411,Rituximab,11,802,0.92,1,8,1,1,1,0,0,0,0,Rituximab,DEFEROXAMINE MESYLATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CEFOTAXIME|CEFOTAXIME INJECTION|RITUXIMAB,14,SERUM FERRITIN INCREASED|LIVER FUNCTION TEST ABNORMAL|IMMUNOSUPPRESSION|IMMUNOSUPPRESSION,Death|Hypoxic-ischaemic encephalopathy|General physical health deterioration|Depressed level of consciousness|Convulsion|Brain oedema|Mydriasis|Pupillary reflex impaired|Hernia|Hypotension|Haematemesis|Haemoglobin decreased,12,3
10072636,20140411,Rituximab,,,,2,,1,0,0,0,0,0,0,Rituximab,PROMETHAZINE HYDROCHLORIDE|CEFTRIAXONE|CEFTRIAXONE SODIUM|RITUXIMAB|MORPHINE SULFATE|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)|ZOLPIDEM TARTRATE,10,,Drug hypersensitivity,1,1
10072791,20140411,Rituximab,,,,0,,1,0,0,0,0,0,0,Rituximab,BENDAMUSTINE HYDROCHLORIDE|RITUXIMAB,3,,Rash|Rash,2,5
10072838,20140411,Rituximab,53,801,53.0,2,71,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|LENALIDOMIDE,2,LYMPHOMA|LYMPHOMA,Breast cancer,1,3
10072968,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10072972,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10072976,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10072977,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10072978,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10072982,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10072984,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10072985,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10072987,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10072988,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10072991,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10072992,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10072995,20140411,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10072997,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10072999,20140411,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10073000,20140411,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10073001,20140411,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10073002,20140411,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10073003,20140411,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10073005,20140411,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10073007,20140411,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10073010,20140411,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10073011,20140411,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,PREDNISONE|RITUXIMAB|DOXORUBICIN,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10073012,20140411,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10073015,20140411,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10073017,20140411,Rituximab,,,,0,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Death,1,3
10073027,20140411,Rituximab,,,,0,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|DOXORUBICIN|PREDNISONE,5,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Disease progression,1,3
10073125,20140411,Rituximab,70,801,70.0,1,,1,0,1,0,0,0,1,Rituximab,CHLORAMBUCIL|RITUXIMAB|OFATUMUMAB|PREGABALIN|SIMVASTATIN|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|RAMIPRIL,10,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA|HAEMOLYSIS,Basal cell carcinoma,1,1
10074682,20140414,Rituximab,,,,2,,1,1,1,0,0,0,0,Rituximab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB,6,RHEUMATOID ARTHRITIS,Hepatocellular carcinoma|Hepatic cancer recurrent|Abdominal pain|Dry eye|Conjunctivitis bacterial|Pruritus generalised|Nausea|Gamma-glutamyltransferase increased|Infection|Fall|Humerus fracture|Liver function test abnormal|Diarrhoea|Balance disorder|Dry skin|Tinnitus|Lung infection,17,1
10074692,20140414,Rituximab,,,,2,,1,1,1,0,0,0,0,Rituximab,METHOTREXATE|METHOTREXATE SODIUM|RITUXIMAB|LEFLUNOMIDE,4,RHEUMATOID ARTHRITIS,Fall|Lymphoproliferative disorder|Pulmonary embolism|Fall|Cholestasis|Foot deformity|Pelvic fracture|Femur fracture|Iron deficiency anaemia|Urinary tract infection,10,1
10074929,20140414,Rituximab,45,801,45.0,1,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB|PREDNISONE|ALENDRONATE SODIUM|ALENDRONATE SODIUM TABLET|AZATHIOPRINE,6,GRANULOMATOSIS WITH POLYANGIITIS,Infusion related reaction|Aggression|Tremor|Back pain|Acne|Arthralgia,6,3
10074939,20140414,Rituximab,76,801,76.0,2,,1,1,1,0,0,0,0,Rituximab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CARBOPLATIN|RITUXIMAB|RITUXIMAB|ETOPOSIDE|CYTARABINE|CLADRIBINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|IFOSFAMIDE|IBRITUMOMAB TIUXETAN|IBRITUMOMAB TIUXETAN|DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",14,B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA|B-CELL LYMPHOMA,Leukaemia|Myelodysplastic syndrome,2,1
10074951,20140414,Rituximab,,,,2,,1,0,0,0,0,0,0,Rituximab,DIMETHYL FUMARATE|DIMETHYL FUMARATE|DIMETHYL FUMARATE|DIMETHYL FUMARATE|DIMETHYL FUMARATE|RITUXIMAB,6,RELAPSING-REMITTING MULTIPLE SCLEROSIS|RELAPSING-REMITTING MULTIPLE SCLEROSIS|RELAPSING-REMITTING MULTIPLE SCLEROSIS|RELAPSING-REMITTING MULTIPLE SCLEROSIS|RELAPSING-REMITTING MULTIPLE SCLEROSIS,Multiple sclerosis|Secondary progressive multiple sclerosis|General symptom|Central nervous system lesion|Asthenia|Fatigue|Musculoskeletal stiffness|Mobility decreased|Gastrointestinal motility disorder|Chest discomfort|Band sensation|Neurological decompensation|Drug ineffective|Irritable bowel syndrome|Respiratory disorder|Muscular weakness|Limb discomfort|Poor peripheral circulation|Oedema peripheral|Cardiovascular disorder|Nausea|Flushing|Gastrointestinal disorder|Multiple sclerosis relapse,24,5
10075361,20140414,Rituximab,71,801,71.0,2,70,1,1,0,0,0,0,0,Rituximab,METHOTREXATE|METHOTREXATE SODIUM|AMLODIPINE BESYLATE|AMLODIPINE BESYLATE,12,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|VERTIGO|MYOCARDIAL ISCHAEMIA|HYPERTENSION|MYOCARDIAL ISCHAEMIA|HYPERTENSION|HYPERTENSION|OSTEOPOROSIS|HYPERTENSION|MYOCARDIAL ISCHAEMIA|MYOCARDIAL ISCHAEMIA,Sudden death,1,1
10075861,20140414,Rituximab,66,801,66.0,1,,1,0,0,0,0,0,1,Rituximab,CYCLOSPORINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB,5,BURKITT^S LYMPHOMA|BURKITT^S LYMPHOMA|BURKITT^S LYMPHOMA|BURKITT^S LYMPHOMA|BURKITT^S LYMPHOMA,Second primary malignancy|Epstein-Barr virus associated lymphoma|Immunosuppression,3,1
10075940,20140414,Rituximab,72,801,72.0,1,78.01,1,0,1,0,0,0,0,Rituximab,"RITUXIMAB|CHLORAMBUCIL|CHLORAMBUCIL|ACETYLCYSTEINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL|GRANISETRON|GRANISETRON HYDROCHLORIDE|PREDNISONE|PREDNISONE|CLOPIDOGREL BISULFATE|EZETIMIBE AND SIMVASTATIN|FAMOTIDINE|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|HYDROCORTISONE SODIUM SUCCINATE|PROMETHAZINE HYDROCHLORIDE|PROMETHAZINE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE|CLOPIDOGREL|FERROUS SULFATE|VALSARTAN|SIMVASTATIN",33,CHRONIC LYMPHOCYTIC LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Pneumonia cryptococcal|Hyperhidrosis|Cough|Dyspnoea exertional|Respiratory failure|Rales,6,3
10076847,20140414,Rituximab,,,,0,,1,1,1,0,0,0,1,Rituximab,ECULIZUMAB|ECULIZUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB,6,HAEMOLYTIC URAEMIC SYNDROME|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Oropharyngeal pain|Blood creatine increased|Pain|Vomiting|Death|Decreased appetite|Renal failure|Red blood cell count decreased|Pneumonia|Unevaluable event|Platelet count decreased|Renal disorder|Nausea,14,3
10077677,20140414,Rituximab,24,802,2.0,1,,1,0,0,0,0,0,1,Rituximab,"RITUXIMAB|CYCLOSPORINE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",10,AUTOIMMUNE HAEMOLYTIC ANAEMIA|OFF LABEL USE|AUTOIMMUNE HAEMOLYTIC ANAEMIA|AUTOIMMUNE HAEMOLYTIC ANAEMIA|AUTOIMMUNE HAEMOLYTIC ANAEMIA|PROPHYLAXIS AGAINST TRANSPLANT REJECTION|AUTOIMMUNE HAEMOLYTIC ANAEMIA|PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION|PROPHYLAXIS AGAINST TRANSPLANT REJECTION,Drug ineffective|Neutropenia,2,3
10077869,20140414,Rituximab,69,801,69.0,2,,1,1,1,0,0,0,0,Rituximab,"PEGFILGRASTIM|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|METHOTREXATE|METHOTREXATE SODIUM|RITUXIMAB|RITUXIMAB|RITUXIMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM",10,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|NON-HODGKIN^S LYMPHOMA,Non-Hodgkin^s lymphoma,1,1
10077953,20140415,Rituximab,48,801,48.0,2,,1,1,0,0,0,0,0,Rituximab,RITUXIMAB,1,SYSTEMIC LUPUS ERYTHEMATOSUS,Zygomycosis,1,3
10077966,20140415,Rituximab,,,,2,,1,0,1,0,0,0,1,Rituximab,RITUXIMAB,2,GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE,Dehydration|Renal failure|Blood pressure abnormal|Weight decreased,4,5
10078221,20140415,Rituximab,59,801,59.0,2,65.8,1,0,1,0,0,0,1,Rituximab,TOCILIZUMAB|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|METHYLPREDNISOLONE|ACETAMINOPHEN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|TOCILIZUMAB|CELECOXIB|FOLIC ACID|RITUXIMAB,11,PREMEDICATION|ARTHRITIS|RHEUMATOID ARTHRITIS|ULCER|RHEUMATOID ARTHRITIS,Treatment failure|Ulcer|Weight decreased|Infection|Dizziness|Blood creatinine decreased|Pneumonia|Infection|Nausea|Weight increased|Infusion related reaction|Injection site discomfort|Ill-defined disorder,13,3
10078229,20140415,Rituximab,,,,2,,1,0,0,0,0,0,1,Rituximab,TOCILIZUMAB|ETANERCEPT|RITUXIMAB|TOCILIZUMAB|RITUXIMAB|RITUXIMAB|METHOTREXATE|METHOTREXATE SODIUM,10,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS,Lupus-like syndrome|Cough|Pancytopenia|Abortion spontaneous,4,1
10078230,20140415,Rituximab,,,,2,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,1,NON-HODGKIN^S LYMPHOMA,Pyoderma gangrenosum,1,3
10078242,20140415,Rituximab,,,,2,,1,0,0,0,0,0,1,Rituximab,RITUXIMAB,1,NON-HODGKIN^S LYMPHOMA,Pyoderma gangrenosum,1,3
10078425,20140415,Rituximab,53,801,53.0,1,83.6,1,0,1,0,0,0,0,Rituximab,"ALTEPLASE|MICAFUNGIN SODIUM|INSULIN LISPRO|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CYCLOSPORINE|FENTANYL CITRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|CEFEPIME HYDROCHLORIDE|CEFEPIME|RITUXIMAB|OXYCODONE HYDROCHLORIDE|CYCLOSPORINE|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|PALIVIZUMAB|FUROSEMIDE|ATENOLOL|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CLONAZEPAM|BENZOCAINE|TOPICAL ANESTHETIC|BENZOCAINE|TOPICAL ANESTHETIC|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|RITUXIMAB|ATENOLOL|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|POSACONAZOLE|TACROLIMUS|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|ZOLPIDEM TARTRATE|PALIVIZUMAB|RITUXIMAB|DEMECLOCYCLINE|FUROSEMIDE|OXYCODONE HYDROCHLORIDE|LORATADINE|LORATADINE ORAL|AZTREONAM|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|CLONAZEPAM|OXYCODONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|INSULIN GLARGINE|TACROLIMUS|METRONIDAZOLE|METRONIDAZOLE TOPICAL|FUROSEMIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|INSULIN LISPRO|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|TACROLIMUS|TACROLIMUS|MORPHINE|PANTOPRAZOLE|RITUXIMAB|OXYCODONE|ATENOLOL|ENOXAPARIN SODIUM|MAGNESIUM OXIDE|SPIRONOLACTONE|PANTOPRAZOLE|PANTOPRAZOLE|LEVALBUTEROL|LEVALBUTEROL HYDROCHLORIDE",73,CHRONIC GRAFT VERSUS HOST DISEASE,Pneumonia|Hepatic function abnormal|Chest pain|Pneumonia|Pneumonia respiratory syncytial viral,5,1
10078434,20140415,Rituximab,60,801,60.0,1,,1,0,0,0,0,0,1,Rituximab,"DOXORUBICIN|BENDAMUSTINE HYDROCHLORIDE|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|IBRUTINIB",7,B-CELL LYMPHOMA STAGE IV|B-CELL LYMPHOMA STAGE IV|B-CELL LYMPHOMA STAGE IV|B-CELL LYMPHOMA STAGE IV|B-CELL LYMPHOMA STAGE IV|B-CELL LYMPHOMA STAGE IV,Pancytopenia|Disease progression,2,1
10078513,20140415,Rituximab,70,801,70.0,1,67,1,1,1,0,0,0,0,Rituximab,INFLIXIMAB|INFLIXIMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ISONIAZID|RITUXIMAB|EPIRUBICIN HYDROCHLORIDE,19,RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|GASTRIC ULCER|RHEUMATOID ARTHRITIS|HYPERTENSION|HYPERLIPIDAEMIA|DIABETES MELLITUS|ANAEMIA|LIVER DISORDER|HYPERTENSION,Pneumocystis jirovecii pneumonia,1,1
10078550,20140415,Rituximab,74,801,74.0,2,,1,0,1,0,0,0,1,Rituximab,,3,MICROSCOPIC POLYANGIITIS,Diabetes mellitus|Off label use|Clostridium difficile infection|Renal impairment,4,3
18987168,20210309,Epcoritamab,75,801,75.0,2,59,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|ALENDRONATE SODIUM|DAPTOMYCIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|FLUCONAZOLE|FOSCARNET SODIUM|FUROSEMIDE|GABAPENTIN|GANCICLOVIR SODIUM|GANCICLOVIR|GENTAMICIN|GENTAMICIN SULFATE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|LAMOTRIGINE|LAMOTRIGINE EXTENDED-RELEASE|LAMOTRIGINE CHEWABLE DISPERSIBLE|LAMOTIRIGINE|LINEZOLID|MAGNESIUM|MIRTAZAPINE|OXYCODONE HYDROCHLORIDE|OXYCODONE|PANTOPRAZOLE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACYCLOVIR|FILGRASTIM|METRONIDAZOLE|METRONIDAZOLE TOPICAL|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|ALLOPURINOL|PEGFILGRASTIM",39,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Immune effector cell-associated neurotoxicity syndrome|Pyrexia|Off label use|Bronchopulmonary aspergillosis,4,3
19014024,20210316,Epcoritamab,75,801,75.0,2,59,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|PANTOPRAZOLE|FUROSEMIDE|ALENDRONATE SODIUM|FOSCARNET SODIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|DAPTOMYCIN|OXYCODONE HYDROCHLORIDE|OXYCODONE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|GABAPENTIN|GANCICLOVIR SODIUM|GANCICLOVIR|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MIRTAZAPINE|LAMOTRIGINE|LAMOTRIGINE EXTENDED-RELEASE|LAMOTRIGINE CHEWABLE DISPERSIBLE|LAMOTIRIGINE|LINEZOLID|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|MAGNESIUM|GENTAMICIN|GENTAMICIN SULFATE|GENTAMICIN|GENTAMICIN SULFATE|FLUCONAZOLE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE ACETATE|ALLOPURINOL|PEGFILGRASTIM|FILGRASTIM|ACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|METRONIDAZOLE|METRONIDAZOLE TOPICAL",57,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Bronchopulmonary aspergillosis|Immune effector cell-associated neurotoxicity syndrome|Pyrexia|Off label use,4,5
19030763,20210319,Epcoritamab,74,801,74.0,2,59,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|ALENDRONATE SODIUM|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|GABAPENTIN|LAMOTRIGINE|LAMOTRIGINE EXTENDED-RELEASE|LAMOTRIGINE CHEWABLE DISPERSIBLE|LAMOTIRIGINE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|MIRTAZAPINE|PANTOPRAZOLE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALLOPURINOL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OXYCODONE HYDROCHLORIDE|OXYCODONE|FLUCONAZOLE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|MEROPENEM|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|TOCILIZUMAB|FUROSEMIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|MAGNESIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FOSCARNET SODIUM|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|FUROSEMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN",47,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Urosepsis|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Bronchopulmonary aspergillosis|Urosepsis|Urinary tract infection|Off label use,4,3
19134472,20210414,Epcoritamab,79,801,79.0,2,87.9,1,0,1,0,0,0,0,Epcoritamab,ALLOPURINOL|RITUXIMAB|BENDAMUSTINE HCL|BENDAMUSTINE HCL|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS,28,PROPHYLAXIS|B-CELL LYMPHOMA STAGE IV|B-CELL LYMPHOMA STAGE IV|B-CELL LYMPHOMA STAGE IV,Cytokine release syndrome,1,1
19228757,20210507,Epcoritamab,65,801,65.0,2,80,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|PACLITAXEL|PACLITAXEL|CARBOPLATIN|ALBUTEROL SULFATE|ALBUTEROL|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FLUTICASONE FUROATE|FLUTICASONE FUROATE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CALCIUM|ACYCLOVIR|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CLEMASTINE FUMARATE|LANSOPRAZOLE|MORPHINE SULFATE|DAPSONE GEL, 5%|DAPSONE|DASPONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PRAMIPEXOLE|CEFUROXIME|CEFUROXIME|CEFUROXIME|CEFUROXIME|CEFUROXIME|CEFUROXIME|CEFUROXIME|CEFUROXIME|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|PRAMIPEXOLE|MORPHINE SULFATE",93,Follicular lymphoma|Non-small cell lung cancer|Transitional cell carcinoma|Non-small cell lung cancer|Follicular lymphoma|Visual impairment|Transitional cell carcinoma|Follicular lymphoma|Transitional cell carcinoma|Product used for unknown indication|Headache|Product used for unknown indication|Product used for unknown indication|Hiatus hernia|Product used for unknown indication|Product used for unknown indication|Hiatus hernia|Product used for unknown indication|Mucosal inflammation|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Pain|Product used for unknown indication|Product used for unknown indication,Abdominal pain|Abdominal pain|Constipation,3,1
19250748,20210513,Epcoritamab,67,801,67.0,2,62.7,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ZOLEDRONIC ACID|FUROSEMIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|MORPHINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREGABALIN|ALLOPURINOL|FLUCONAZOLE|DALTEPARIN SODIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|POTASSIUM PHOSPHATE, DIBASIC|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|MAGNESIUM|METHYLPREDNISOLONE|SODIUM PHOSPHATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|IOMEPROL INJECTION|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|PEGFILGRASTIM-BMEZ|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CIPROFLOXACIN HYDROCHLORIDE|CYCLOPENTOLATE HYDROCHLORIDE|DEXAMETHASONE SODIUM PHOSPHATE|FENTANYL|GENTAMICIN|GENTAMICIN SULFATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|INSULIN HUMAN|DEXAMETHASONE|PHENYLEPHRINE HYDROCHLORIDE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|OXYCODONE HYDROCHLORIDE|OXYCODONE|CLEMASTINE FUMARATE|HYDROCORTISONE SODIUM SUCCINATE|TOCILIZUMAB|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|DICLOFENAC SODIUM|DICLOFENAC SODIUM|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|IOHEXOL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|AMOXICILLIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PEGFILGRASTIM-BMEZ|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|IOMEPROL INJECTION|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN",87,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Prophylaxis|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Cytokine release syndrome|Fatigue|Diarrhoea|Anaemia|Off label use|Dyspnoea|Vomiting|Infusion related reaction,8,3
19308930,20210526,Epcoritamab,67,801,67.0,2,62.7,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|HYDROCORTISONE SODIUM SUCCINATE|PREGABALIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CEFUROXIME|FLUCONAZOLE|ALLOPURINOL|DALTEPARIN SODIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|POTASSIUM PHOSPHATE, DIBASIC|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ISOSORBIDE MONONITRATE|METHYLPREDNISOLONE|ZOLEDRONIC ACID|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|MAGNESIUM|AMOXICILLIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|SODIUM PHOSPHATE|PEGFILGRASTIM|CALCIUM CARBONATE|ANTACID|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS",47,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Dyspnoea|Anaemia|Diarrhoea|Infusion related reaction|Vomiting|Fatigue|Diarrhoea|Off label use,9,3
19319224,20210527,Epcoritamab,74,801,74.0,1,100,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|VINCRISTINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DESLORATADINE|ALLOPURINOL|ENTECAVIR|ENTECAVIR ANHYDROUS|FELODIPINE|FELODIPINE EXTENDED-RELEASE TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SIMVASTATIN|TIOTROPIUM BROMIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PROPRANOLOL HYDROCHLORIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|FILGRASTIM|ZOLPIDEM TARTRATE",27,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Prophylaxis,Cytokine release syndrome,1,3
19323889,20210528,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CARBOPLATIN|SODIUM PHOSPHATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DICLOFENAC|DICLOFENAC SODIUM|FLUCONAZOLE|FLUCONAZOLE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ENOXAPARIN SODIUM|VITAMIN A PALMITATE|ALLOPURINOL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACYCLOVIR|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|HYALURONIC ACID|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|FLUTICASONE FUROATE|VITAMIN A PALMITATE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|FILGRASTIM|TRAMADOL HYDROCHLORIDE|ACYCLOVIR|LIDOCAINE HYDROCHLORIDE|LIDOCAINE HYDROCHLORIDE ANHYDROUS|CETIRIZINE HYDROCHLORIDE|MORPHINE",83,B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Lymphoma|Premedication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Thrombocytopenia|Neutropenia,2,3
19359540,20210602,Epcoritamab,65,801,65.0,2,,1,0,1,0,0,0,0,Epcoritamab,OXALIPLATIN,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cytokine release syndrome,1,3
19359584,20210602,Epcoritamab,55,801,55.0,1,93,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|SULFAMETHOXAZOLE AND TRIMETHOPRIM|AMOXICILLIN AND CLAVULANATE POTASSIUM|IRBESARTAN AND HYDROCHLOROTHIAZIDE|PREGABALIN|TADALAFIL|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|FESOTERODINE FUMARATE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ERTAPENEM|ERTAPENEM SODIUM|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|ALLOPURINOL|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE,38,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Sepsis,1,3
19375238,20210604,Epcoritamab,74,801,74.0,2,59,1,1,1,1,1,1,1,Epcoritamab,"PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|OXYCODONE HYDROCHLORIDE|OXYCODONE|MAGNESIUM|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|FUROSEMIDE|FUROSEMIDE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|LAMOTRIGINE|LAMOTRIGINE EXTENDED-RELEASE|LAMOTRIGINE CHEWABLE DISPERSIBLE|LAMOTIRIGINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FLUCONAZOLE|ALENDRONATE SODIUM|TRIMETHOPRIM|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|MIRTAZAPINE|FOSCARNET SODIUM|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|MEROPENEM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|PANTOPRAZOLE|TOCILIZUMAB|ALLOPURINOL|GABAPENTIN|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM",51,Urosepsis|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Urosepsis,Bronchopulmonary aspergillosis|Urinary tract infection|Urosepsis|Off label use,4,3
19386218,20210607,Epcoritamab,67,801,67.0,2,62.7,1,0,1,0,0,0,0,Epcoritamab,ALLOPURINOL|DALTEPARIN SODIUM|ZOLEDRONIC ACID|PREGABALIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|OXALIPLATIN|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,24,DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|PREMEDICATION|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|PREMEDICATION,Cytokine release syndrome,1,3
19430078,20210617,Epcoritamab,55,801,55.0,1,93,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|SULFAMETHOXAZOLE AND TRIMETHOPRIM|METHYLPREDNISOLONE|TADALAFIL|PREGABALIN|ERTAPENEM|ERTAPENEM SODIUM|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|FESOTERODINE FUMARATE|ALLOPURINOL|AMOXICILLIN AND CLAVULANATE POTASSIUM|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR,43,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Malignant neoplasm progression|Sepsis|Cytokine release syndrome|Off label use,4,5
19443182,20210621,Epcoritamab,55,801,55.0,1,93,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|METHYLPREDNISOLONE|TADALAFIL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|PREGABALIN|PREGABALIN|ALLOPURINOL|AMOXICILLIN AND CLAVULANATE POTASSIUM|ERTAPENEM|ERTAPENEM SODIUM|FESOTERODINE FUMARATE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR,39,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Premedication|Premedication|Premedication,Sepsis|Platelet count decreased|Procalcitonin increased|White blood cell count decreased|Blood creatine increased|Haemoglobin decreased|C-reactive protein increased|Neutrophil count decreased|Off label use,9,3
19577382,20210719,Epcoritamab,79,801,79.0,1,,1,0,1,0,0,0,0,Epcoritamab,RITUXIMAB|LENALIDOMIDE,4,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Cytokine release syndrome|Cytokine release syndrome|Febrile neutropenia,3,3
19595699,20210722,Epcoritamab,68,801,68.0,2,75.1,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ALLOPURINOL|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PEGFILGRASTIM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACYCLOVIR|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PANTOPRAZOLE|METHYLPREDNISOLONE SODIUM SUCCINATE|ATENOLOL|DIGOXIN|FILGRASTIM|FUROSEMIDE|TOCILIZUMAB|POTASSIUM PHOSPHATE, DIBASIC|LACTULOSE|MEROPENEM|FOSCARNET SODIUM|GANCICLOVIR SODIUM|GANCICLOVIR|OXALIPLATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN",58,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Off label use|Hepatitis acute|Myelodysplastic syndrome|Multiple organ dysfunction syndrome|Capillary leak syndrome|Pleural effusion|Cytokine release syndrome,7,3
19641596,20210730,Epcoritamab,79,801,79.0,1,,1,0,1,0,0,0,1,Epcoritamab,RITUXIMAB|LENALIDOMIDE,4,DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA,Febrile neutropenia|Cytokine release syndrome,2,3
19651466,20210803,Epcoritamab,72,801,72.0,1,73,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|TOCILIZUMAB|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|PREDNISONE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|PREDNISONE|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|ACYCLOVIR|ALLOPURINOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|TOCILIZUMAB,20,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Prophylaxis|Premedication|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Small intestinal perforation,1,3
19656605,20210804,Epcoritamab,61,801,61.0,1,65,1,0,1,0,0,0,0,Epcoritamab,"LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|DEXCHLORPHENIRAMINE MALEATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|SULFAMETHOXAZOLE AND TRIMETHOPRIM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|LEUCOVORIN CALCIUM",30,Follicular lymphoma stage II|Follicular lymphoma stage II|Follicular lymphoma stage II|Product used for unknown indication|Prophylaxis|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Cytokine release syndrome|Cytokine release syndrome,3,3
19656785,20210804,Epcoritamab,68,801,68.0,2,75.1,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|PANTOPRAZOLE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACYCLOVIR|ALLOPURINOL|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CALCIUM CARBONATE|ANTACID|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PEGFILGRASTIM|PEGFILGRASTIM|ATENOLOL|DIGOXIN|TOCILIZUMAB|POTASSIUM PHOSPHATE, DIBASIC|MAGNESIUM HYDROXIDE|FILGRASTIM|FUROSEMIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE",51,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Hepatitis acute|Multiple organ dysfunction syndrome|Ascites|Cytokine release syndrome|Capillary leak syndrome|Pleural effusion|Myelodysplastic syndrome|Off label use,8,3
19682821,20210810,Epcoritamab,72,801,72.0,1,73,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|METHYLPREDNISOLONE SODIUM SUCCINATE|PANTOPRAZOLE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACYCLOVIR|ACYCLOVIR|CALCIUM CARBONATE|ANTACID|ALLOPURINOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATENOLOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PEGFILGRASTIM|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|SPIRONOLACTONE|FUROSEMIDE|TOCILIZUMAB|TOCILIZUMAB|DIGOXIN|DEXAMETHASONE SODIUM PHOSPHATE|FILGRASTIM|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|PREDNISONE|PREDNISONE|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE",58,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Multiple organ dysfunction syndrome|Ascites|Small intestinal perforation|Cytokine release syndrome|Off label use,5,5
19700696,20210813,Epcoritamab,68,801,68.0,2,90,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|METHYLPREDNISOLONE|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PROMETHAZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CITALOPRAM|CITALOPRAM HYDROBROMIDE|ALENDRONATE SODIUM|MIRTAZAPINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|TRAMADOL HYDROCHLORIDE|URSODIOL|URSOSIOL|ACYCLOVIR|ALLOPURINOL|CIPROFLOXACIN HYDROCHLORIDE",27,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Escherichia urinary tract infection,1,3
19701295,20210814,Epcoritamab,52,801,52.0,2,101,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN|DOXORUBICIN|RITUXIMAB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|PREDNISONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RASBURICASE|FILGRASTIM|FILGRASTIM|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|FLUCONAZOLE|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|SENNOSIDES|SENNA LEAF|SENNA",33,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Febrile neutropenia,1,3
19702647,20210815,Epcoritamab,52,801,52.0,2,101,1,1,1,1,1,1,1,Epcoritamab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|DOXORUBICIN|RITUXIMAB|RITUXIMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RASBURICASE|FILGRASTIM|ACYCLOVIR|FLUCONAZOLE|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|SENNOSIDES|SENNA LEAF|SENNA",31,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication,Febrile neutropenia|Febrile neutropenia,2,3
19731093,20210821,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ACYCLOVIR|ACYCLOVIR|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|AMOXICILLIN AND CLAVULANATE POTASSIUM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BUMETANIDE|ENOXAPARIN SODIUM|COLCHICINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FLUCONAZOLE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FUROSEMIDE|METHYLPREDNISOLONE|DEXAMETHASONE SODIUM PHOSPHATE|LATANOPROST|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|AMITRIPTYLINE HYDROCHLORIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|LORAZEPAM|FILGRASTIM|TRAMADOL HYDROCHLORIDE|TRAMADOL HYDROCHLORIDE|TRAMADOL HYDROCHLORIDE|VITAMIN A PALMITATE|LATANOPROST|ALPRAZOLAM",92,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Cholecystitis|Cholecystitis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Acute kidney injury|Tumour lysis syndrome|Periodontitis|Cardiac failure|Condition aggravated|Coronary artery disease|Off label use,7,3
19733943,20210824,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|CLEMASTINE FUMARATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACYCLOVIR|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|AMOXICILLIN AND CLAVULANATE POTASSIUM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BUMETANIDE|ENOXAPARIN SODIUM|COLCHICINE|DEXAMETHASONE SODIUM PHOSPHATE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FLUCONAZOLE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FUROSEMIDE|LATANOPROST|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|AMITRIPTYLINE HYDROCHLORIDE|LORAZEPAM|FILGRASTIM|TRAMADOL HYDROCHLORIDE|VITAMIN A PALMITATE|LATANOPROST|ALPRAZOLAM",42,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Premedication|Prophylaxis|Cholecystitis,Acute kidney injury|Off label use,2,3
19742058,20210824,Epcoritamab,72,801,72.0,2,70.9,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CYTARABINE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|RITUXIMAB|PROMETHAZINE|PROMETHAZINE|PROMETHAZINE|PROMETHAZINE|PROMETHAZINE|PROMETHAZINE|PROMETHAZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LORATADINE|LORATADINE ORAL|PROMETHAZINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|MIRTAZAPINE|METOCLOPRAMIDE HYDROCHLORIDE|ROSUVASTATIN|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|FLUCONAZOLE|FUROSEMIDE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS",44,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Premedication|Premedication|Prophylaxis|Premedication,Streptococcal endocarditis|Cytokine release syndrome|Cytokine release syndrome,3,3
19744251,20210825,Epcoritamab,75,801,75.0,2,59,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|PANTOPRAZOLE|FUROSEMIDE|ALENDRONATE SODIUM|FOSCARNET SODIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|DAPTOMYCIN|OXYCODONE HYDROCHLORIDE|OXYCODONE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|GABAPENTIN|GANCICLOVIR SODIUM|GANCICLOVIR|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MIRTAZAPINE|LAMOTRIGINE|LAMOTRIGINE EXTENDED-RELEASE|LAMOTRIGINE CHEWABLE DISPERSIBLE|LAMOTIRIGINE|LINEZOLID|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|MAGNESIUM|GENTAMICIN|GENTAMICIN SULFATE|GENTAMICIN|GENTAMICIN SULFATE|GENTAMICIN|GENTAMICIN SULFATE|FLUCONAZOLE|FILGRASTIM|METRONIDAZOLE|METRONIDAZOLE TOPICAL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALLOPURINOL|PEGFILGRASTIM",59,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Bronchopulmonary aspergillosis|Immune effector cell-associated neurotoxicity syndrome|Pyrexia|Off label use,4,3
19749782,20210826,Epcoritamab,72,801,72.0,2,70.9,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|PROMETHAZINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|MIRTAZAPINE|ROSUVASTATIN|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|LORATADINE|LORATADINE ORAL|FLUCONAZOLE|FUROSEMIDE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PROMETHAZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PROMETHAZINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PROMETHAZINE HYDROCHLORIDE|PROMETHAZINE HYDROCHLORIDE|PROMETHAZINE HYDROCHLORIDE|PROMETHAZINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PROMETHAZINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PROMETHAZINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE",53,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Prophylaxis|Prophylaxis|Prophylaxis|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Prophylaxis|Diffuse large B-cell lymphoma stage IV|Prophylaxis|Diffuse large B-cell lymphoma stage IV,Cytokine release syndrome|Streptococcal endocarditis|Streptococcal sepsis,3,3
19750689,20210826,Epcoritamab,68,801,68.0,2,90,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|RITUXIMAB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|VINCRISTINE SULFATE|VINCRISTINE SULFATE|PREDNISONE|PREDNISONE|PREDNISONE|METHYLPREDNISOLONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PROMETHAZINE|PROMETHAZINE|ACYCLOVIR|ALLOPURINOL|MIRTAZAPINE|TRAMADOL HYDROCHLORIDE|ALENDRONATE SODIUM|URSODIOL|URSOSIOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CARVEDILOL|CITALOPRAM|CITALOPRAM HYDROBROMIDE",38,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Escherichia urinary tract infection|Febrile neutropenia,2,3
19756803,20210828,Epcoritamab,72,801,72.0,1,71.9,1,1,1,1,1,1,1,Epcoritamab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|RITUXIMAB|VINCRISTINE SULFATE|PREDNISONE|PREDNISONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ENOXAPARIN SODIUM|ROSUVASTATIN|FENOFIBRATE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|FENOFIBRATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PALONOSETRON|PALONOSETRON HYDROCHLORIDE",40,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Febrile neutropenia,2,3
19764531,20210830,Epcoritamab,74,801,74.0,2,59,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FUROSEMIDE|FUROSEMIDE|FLUCONAZOLE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|TOCILIZUMAB|ALLOPURINOL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LAMOTRIGINE|LAMOTRIGINE EXTENDED-RELEASE|LAMOTRIGINE CHEWABLE DISPERSIBLE|LAMOTIRIGINE|OXYCODONE HYDROCHLORIDE|OXYCODONE|PANTOPRAZOLE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|ALENDRONATE SODIUM|GABAPENTIN|MEROPENEM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|MIRTAZAPINE|MAGNESIUM|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|FOSCARNET SODIUM|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE",51,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Urosepsis,Bronchopulmonary aspergillosis|Urosepsis|Urinary tract infection|Off label use,4,3
19765445,20210830,Epcoritamab,72,801,72.0,1,71.9,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE SODIUM SUCCINATE|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|FENOFIBRATE|ESOMEPRAZOLE SODIUM|ROSUVASTATIN|ENOXAPARIN SODIUM|ACYCLOVIR|ONDANSETRON HYDROCHLORIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",31,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Cytokine release syndrome|Febrile neutropenia,2,3
19771466,20210831,Epcoritamab,52,801,52.0,2,101,1,1,1,1,1,1,1,Epcoritamab,"VINCRISTINE SULFATE|VINCRISTINE SULFATE|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RASBURICASE|FILGRASTIM|ACYCLOVIR|FLUCONAZOLE|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|SENNOSIDES|SENNA LEAF|SENNA",26,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication,Febrile neutropenia|Febrile neutropenia,2,1
19773391,20210901,Epcoritamab,64,801,64.0,2,60,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|FLUCONAZOLE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM,14,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III|Prophylaxis|Premedication|Premedication,C-reactive protein increased|Mania|Cytokine release syndrome,3,3
19776614,20210901,Epcoritamab,72,801,72.0,1,71.9,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|PREDNISONE|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|ENOXAPARIN SODIUM|ROSUVASTATIN|FENOFIBRATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|ACYCLOVIR|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FENOFIBRATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PALONOSETRON|PALONOSETRON HYDROCHLORIDE",38,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Cytokine release syndrome|Febrile neutropenia,2,3
19787218,20210903,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CYTARABINE|CYTARABINE|CARBOPLATIN|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|COLCHICINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LATANOPROST|AMITRIPTYLINE HYDROCHLORIDE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|BUMETANIDE|FLUCONAZOLE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ENOXAPARIN SODIUM|ACYCLOVIR|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|TRAMADOL HYDROCHLORIDE|FUROSEMIDE|CLEMASTINE FUMARATE|FILGRASTIM|AMOXICILLIN AND CLAVULANATE POTASSIUM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LATANOPROST|VITAMIN A PALMITATE|ALPRAZOLAM|LORAZEPAM",44,,Acute kidney injury|Condition aggravated|Tumour lysis syndrome,3,3
19787220,20210903,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CYTARABINE|CARBOPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|OXALIPLATIN|VITAMIN A PALMITATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FILGRASTIM|AMOXICILLIN AND CLAVULANATE POTASSIUM|FUROSEMIDE|ENOXAPARIN SODIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|AMITRIPTYLINE HYDROCHLORIDE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FLUCONAZOLE|ALPRAZOLAM|LATANOPROST|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CLEMASTINE FUMARATE|ACYCLOVIR|LORAZEPAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LATANOPROST|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BUMETANIDE|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|COLCHICINE",43,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Tumour lysis syndrome|Acute kidney injury|Off label use,3,3
19788543,20210903,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|CARBOPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|CYTARABINE|OXALIPLATIN|LORAZEPAM|ALPRAZOLAM|AMITRIPTYLINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ENOXAPARIN SODIUM|LATANOPROST|FLUCONAZOLE|FILGRASTIM|LATANOPROST|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|BUMETANIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ACYCLOVIR|COLCHICINE|DEXAMETHASONE SODIUM PHOSPHATE|FUROSEMIDE|VITAMIN A PALMITATE|TRAMADOL HYDROCHLORIDE|AMOXICILLIN AND CLAVULANATE POTASSIUM|CLEMASTINE FUMARATE",44,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Condition aggravated|Acute kidney injury|Tumour lysis syndrome,3,3
19795289,20210906,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CYTARABINE|CARBOPLATIN|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CLEMASTINE FUMARATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACYCLOVIR|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|AMOXICILLIN AND CLAVULANATE POTASSIUM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BUMETANIDE|ENOXAPARIN SODIUM|COLCHICINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FLUCONAZOLE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FUROSEMIDE|LATANOPROST|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|AMITRIPTYLINE HYDROCHLORIDE|LORAZEPAM|FILGRASTIM|VITAMIN A PALMITATE|LATANOPROST|ALPRAZOLAM",42,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Premedication|Prophylaxis|Cholecystitis,Acute kidney injury,1,3
19803676,20210908,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|OXALIPLATIN|CYTARABINE|CYTARABINE|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|COLCHICINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LATANOPROST|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|AMITRIPTYLINE HYDROCHLORIDE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|BUMETANIDE|FLUCONAZOLE|ENOXAPARIN SODIUM|ACYCLOVIR|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TRAMADOL HYDROCHLORIDE|RASBURICASE|RASBURICASE|ONDANSETRON HYDROCHLORIDE|CLEMASTINE FUMARATE|FILGRASTIM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LATANOPROST|VITAMIN A PALMITATE|ALPRAZOLAM|LORAZEPAM",45,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Acute kidney injury|Condition aggravated|Tumour lysis syndrome,3,3
19808553,20210908,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CYTARABINE|CARBOPLATIN|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACYCLOVIR|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BUMETANIDE|ENOXAPARIN SODIUM|COLCHICINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FLUCONAZOLE|FUROSEMIDE|METHYLPREDNISOLONE|LATANOPROST|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|AMITRIPTYLINE HYDROCHLORIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|CLEMASTINE FUMARATE|LORAZEPAM|FILGRASTIM|TRAMADOL HYDROCHLORIDE|VITAMIN A PALMITATE|LATANOPROST",46,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Prophylaxis|Cholecystitis,Coronary artery disease,1,3
19810557,20210909,Epcoritamab,67,801,67.0,1,98.10,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RASBURICASE|CEFTAZIDIME|DEXTROSE MONOHYDRATE|DEXTROSE|GRANISETRON|GRANISETRON HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METOPROLOL TARTRATE|METOPROLOL|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|ROSUVASTATIN|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CYTARABINE",31,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Premedication|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Respiratory failure|Guillain-Barre syndrome,2,3
19812350,20210909,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|CLEMASTINE FUMARATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|ACYCLOVIR|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BUMETANIDE|ENOXAPARIN SODIUM|COLCHICINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE SODIUM PHOSPHATE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FLUCONAZOLE|FUROSEMIDE|LATANOPROST|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|AMITRIPTYLINE HYDROCHLORIDE|LORAZEPAM|FILGRASTIM|TRAMADOL HYDROCHLORIDE|VITAMIN A PALMITATE|LATANOPROST",44,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Cholecystitis|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Off label use|Coronary artery disease|Periodontitis|Acute kidney injury,4,3
19821487,20210913,Epcoritamab,58,801,58.0,2,82,1,1,1,1,1,1,1,Epcoritamab,"VINCRISTINE SULFATE|RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|APREPITANT|RASBURICASE|ACYCLOVIR|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|ALLOPURINOL|CALCIUM ACETATE|CALCIUM ACETATE CAPSULES 667 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|PEGFILGRASTIM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE",24,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Tumour lysis syndrome,1,3
19828420,20210914,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|CYTARABINE|CARBOPLATIN|RITUXIMAB|COLCHICINE|LORAZEPAM|ALPRAZOLAM|AMITRIPTYLINE HYDROCHLORIDE|AMITRIPTYLINE HYDROCHLORIDE|FUROSEMIDE|LATANOPROST|BUMETANIDE|VITAMIN A PALMITATE|LATANOPROST|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FILGRASTIM|DEXAMETHASONE SODIUM PHOSPHATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ENOXAPARIN SODIUM|FLUCONAZOLE|ACYCLOVIR|CLEMASTINE FUMARATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",44,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Premedication|Product used for unknown indication|Prophylaxis,Acute kidney injury,1,3
19828819,20210915,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|LENALIDOMIDE,3,B-cell lymphoma|B-cell lymphoma|Diffuse large B-cell lymphoma stage III,Cytokine release syndrome|Febrile neutropenia,2,1
19829023,20210914,Epcoritamab,67,801,67.0,1,98.1,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CYTARABINE|CYTARABINE|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RASBURICASE|CEFTAZIDIME|DEXTROSE MONOHYDRATE|DEXTROSE|GRANISETRON|GRANISETRON HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METOPROLOL TARTRATE|METOPROLOL|PANTOPRAZOLE|ROSUVASTATIN|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE",27,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Premedication,Guillain-Barre syndrome,1,1
19835902,20210914,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE SODIUM PHOSPHATE|CYTARABINE|CYTARABINE|CARBOPLATIN|RITUXIMAB|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FUROSEMIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALPRAZOLAM|BUMETANIDE|FLUCONAZOLE|ENOXAPARIN SODIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SULFAMETHOXAZOLE AND TRIMETHOPRIM|LATANOPROST|FILGRASTIM|LATANOPROST|LORAZEPAM|LORAZEPAM|AMITRIPTYLINE HYDROCHLORIDE|DEXAMETHASONE SODIUM PHOSPHATE|VITAMIN A PALMITATE|COLCHICINE",40,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage II|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Acute kidney injury,1,3
19837272,20210915,Epcoritamab,72,801,72.0,1,71.9,1,0,1,1,0,0,1,Epcoritamab,METHYLPREDNISOLONE|PREDNISONE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ROSUVASTATIN|RITUXIMAB|VINCRISTINE SULFATE|FENOFIBRATE,19,PREMEDICATION|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|PREMEDICATION|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV|DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV,Febrile neutropenia|Pyrexia|Cytokine release syndrome|Hypotension|Pyrexia|Bradycardia|Hypoxia,7,3
19850522,20210917,Epcoritamab,58,801,58.0,2,82,1,0,1,0,0,0,0,Epcoritamab,"PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RASBURICASE|APREPITANT",24,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Tumour lysis syndrome,1,3
19854569,20210920,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|BENDAMUSTINE HCL|BENDAMUSTINE HCL|ACYCLOVIR|CEFUROXIME|CLEMASTINE FUMARATE|DAPSONE GEL, 5%|DAPSONE|DASPONE|FLUTICASONE FUROATE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PRAMIPEXOLE|ALBUTEROL SULFATE|ALBUTEROL",31,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,Blood creatinine increased|Hydronephrosis|Abdominal pain|Constipation|Sepsis,5,1
19861172,20210921,Epcoritamab,65,801,65.0,1,80,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FUROSEMIDE|FOLIC ACID|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION,9,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Pneumothorax|Off label use,2,1
19862931,20210921,Epcoritamab,67,801,67.0,1,98.1,1,1,1,1,1,1,1,Epcoritamab,CARBOPLATIN|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|CYTARABINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|RASBURICASE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,21,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Quadriparesis|Guillain-Barre syndrome|Respiratory failure,3,3
19865367,20210921,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|OXALIPLATIN|CYTARABINE|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|CLEMASTINE FUMARATE|METHYLPREDNISOLONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|RASBURICASE|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|AMITRIPTYLINE HYDROCHLORIDE|BUMETANIDE|LATANOPROST|FLUCONAZOLE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ENOXAPARIN SODIUM|FILGRASTIM|INSULIN HUMAN|FUROSEMIDE|VITAMIN A PALMITATE|ISOSORBIDE MONONITRATE|ACYCLOVIR|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|COLCHICINE|TRAMADOL HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",47,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Periodontitis|Cardiac failure|Cardiac failure|Acute kidney injury,4,3
19866098,20210922,Epcoritamab,72,801,72.0,1,71.9,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PREDNISONE|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|FENOFIBRATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METHYLPREDNISOLONE SODIUM SUCCINATE|ACYCLOVIR|METHYLPREDNISOLONE|METHYLPREDNISOLONE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ENOXAPARIN SODIUM|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|ROSUVASTATIN|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",32,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Cytokine release syndrome|Febrile neutropenia,2,3
19873201,20210922,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|CYTARABINE|CARBOPLATIN|OXALIPLATIN|RITUXIMAB|CLEMASTINE FUMARATE|METHYLPREDNISOLONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE SODIUM SUCCINATE|ACYCLOVIR|FUROSEMIDE|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|TRAMADOL HYDROCHLORIDE|VITAMIN A PALMITATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|BUMETANIDE|LATANOPROST|FLUCONAZOLE|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|FILGRASTIM|DEXAMETHASONE SODIUM PHOSPHATE|AMITRIPTYLINE HYDROCHLORIDE|CLEMASTINE FUMARATE|ENOXAPARIN SODIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|COLCHICINE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM",49,Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Acute kidney injury|Coronary artery disease|Periodontitis|Off label use,4,3
19873655,20210922,Epcoritamab,67,801,67.0,1,98.1,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARBOPLATIN|RITUXIMAB|CYTARABINE|CYTARABINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RASBURICASE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CEFTAZIDIME|PANTOPRAZOLE|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|METOPROLOL TARTRATE|METOPROLOL|ROSUVASTATIN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|DEXTROSE MONOHYDRATE|DEXTROSE",33,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Guillain-Barre syndrome|Quadriparesis|Respiratory failure,3,3
19875031,20210923,Epcoritamab,67,801,67.0,1,98.1,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARBOPLATIN|CYTARABINE|CYTARABINE|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|PROPOFOL|ROSUVASTATIN|CEFTAZIDIME|PANTOPRAZOLE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXTROSE MONOHYDRATE|DEXTROSE|GRANISETRON|GRANISETRON HYDROCHLORIDE|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|RASBURICASE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METOPROLOL TARTRATE|METOPROLOL",33,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Premedication,Respiratory failure|Guillain-Barre syndrome|Quadriparesis,3,3
19876675,20210924,Epcoritamab,67,801,67.0,1,98.1,1,0,1,1,1,0,0,Epcoritamab,CYTARABINE|CYTARABINE|CARBOPLATIN|DEXAMETHASONE SODIUM PHOSPHATE|RITUXIMAB|RASBURICASE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,17,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Guillain-Barre syndrome,1,1
19877281,20210923,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,CYTARABINE|CYTARABINE|CARBOPLATIN|RITUXIMAB|DEXAMETHASONE SODIUM PHOSPHATE|OXALIPLATIN|CLEMASTINE FUMARATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE,12,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Cardiac failure,1,1
19877429,20210923,Epcoritamab,67,801,67.0,1,98.1,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CYTARABINE|CYTARABINE|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RASBURICASE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DEXTROSE MONOHYDRATE|DEXTROSE|ROSUVASTATIN|PANTOPRAZOLE|METOPROLOL TARTRATE|METOPROLOL|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|CEFTAZIDIME|GRANISETRON|GRANISETRON HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",31,,Quadriparesis|Guillain-Barre syndrome|Respiratory failure,3,3
19880960,20210924,Epcoritamab,72,801,72.0,1,71.9,1,0,1,1,0,0,0,Epcoritamab,"PREDNISONE|PREDNISONE|RITUXIMAB|METHYLPREDNISOLONE|FENOFIBRATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|ROSUVASTATIN|SULFAMETHOXAZOLE AND TRIMETHOPRIM|METHYLPREDNISOLONE",20,,Cytokine release syndrome|Febrile neutropenia,2,3
19885060,20210927,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PROPOFOL|CYTARABINE|CYTARABINE|RITUXIMAB|CARBOPLATIN|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RASBURICASE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ROSUVASTATIN|CEFTAZIDIME|PANTOPRAZOLE|DEXTROSE MONOHYDRATE|DEXTROSE|GRANISETRON|GRANISETRON HYDROCHLORIDE|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METOPROLOL TARTRATE|METOPROLOL",44,Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Quadriparesis|Guillain-Barre syndrome|Respiratory failure,3,3
19885115,20210927,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|CARBOPLATIN|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|OXALIPLATIN|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|METHYLPREDNISOLONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|TRAMADOL HYDROCHLORIDE|FLUCONAZOLE|FLUCONAZOLE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LORAZEPAM|AMITRIPTYLINE HYDROCHLORIDE|ENOXAPARIN SODIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FILGRASTIM|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BUMETANIDE|FUROSEMIDE|LATANOPROST|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|VITAMIN A PALMITATE|COLCHICINE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|LATANOPROST|ACYCLOVIR|DEXAMETHASONE SODIUM PHOSPHATE",61,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Cholecystitis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Off label use|Periodontitis|Acute kidney injury|Coronary artery disease|Cardiac failure,5,3
19885676,20210927,Epcoritamab,67,801,67.0,2,62.7,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|ZOLEDRONIC ACID|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|MORPHINE|FUROSEMIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ALLOPURINOL|ISOSORBIDE MONONITRATE|DALTEPARIN SODIUM|FLUCONAZOLE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PREGABALIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|HYDROCORTISONE SODIUM SUCCINATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METHYLPREDNISOLONE|METHYLPREDNISOLONE|MAGNESIUM|AMOXICILLIN|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|SODIUM PHOSPHATE|POTASSIUM PHOSPHATE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|CALCIUM|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|IOMEPROL INJECTION|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PEGFILGRASTIM|PEGFILGRASTIM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|FENTANYL|DICLOFENAC SODIUM|INSULIN HUMAN|METRONIDAZOLE|METRONIDAZOLE TOPICAL|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|DEXAMETHASONE|DICLOFENAC SODIUM|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|PHENYLEPHRINE HYDROCHLORIDE|CLEMASTINE FUMARATE|CYCLOPENTOLATE HYDROCHLORIDE|POTASSIUM PHOSPHATE, DIBASIC|TOCILIZUMAB|CIPROFLOXACIN HYDROCHLORIDE|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE|DEXAMETHASONE SODIUM PHOSPHATE|GENTAMICIN|GENTAMICIN SULFATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|IOHEXOL",98,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Premedication|Premedication|Prophylaxis,Cytokine release syndrome|Anaemia|Diarrhoea|Infusion related reaction|Vomiting|Dyspnoea|Fatigue|Off label use,8,3
19885686,20210927,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|CYTARABINE|CYTARABINE|CARBOPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXALIPLATIN|ACYCLOVIR|FUROSEMIDE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|METHYLPREDNISOLONE|LATANOPROST|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|TRAMADOL HYDROCHLORIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ENOXAPARIN SODIUM|METHYLPREDNISOLONE SODIUM SUCCINATE|AMITRIPTYLINE HYDROCHLORIDE|FLUCONAZOLE|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|VITAMIN A PALMITATE|LORAZEPAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|METHYLPREDNISOLONE|CLEMASTINE FUMARATE|LATANOPROST|FILGRASTIM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BUMETANIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|COLCHICINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",51,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Diffuse large B-cell lymphoma stage III,Periodontitis|Cardiac failure|Acute kidney injury,3,3
19889784,20210927,Epcoritamab,67,801,67.0,1,98.1,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|RITUXIMAB|CARBOPLATIN|CYTARABINE|CYTARABINE|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|PROPOFOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RASBURICASE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METOPROLOL TARTRATE|METOPROLOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|DEXTROSE MONOHYDRATE|DEXTROSE|PANTOPRAZOLE|CEFTAZIDIME",35,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Guillain-Barre syndrome,1,1
19890986,20210928,Epcoritamab,45,801,45.0,1,98.7,1,1,1,1,1,1,1,Epcoritamab,CARBOPLATIN|CYTARABINE|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACYCLOVIR|FILGRASTIM|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|FOLIC ACID|LANSOPRAZOLE|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|CARBOPLATIN|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CYTARABINE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|CHLORPHENIRAMINE MALEATE|CYTARABINE|RITUXIMAB|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB,66,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Prophylaxis|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Product used for unknown indication|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Premedication|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Product used for unknown indication|Diffuse large B-cell lymphoma stage II|Product used for unknown indication|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Product use issue|Thrombocytopenia|Cellulitis|Febrile neutropenia|Neutropenic infection|Disease progression,6,3
19892567,20210928,Epcoritamab,68,801,68.0,2,90,1,1,1,1,1,1,1,Epcoritamab,"METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|VINCRISTINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|PROMETHAZINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|ALENDRONATE SODIUM|MIRTAZAPINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|TRAMADOL HYDROCHLORIDE|URSODIOL|URSOSIOL|ACYCLOVIR|ALLOPURINOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CLOPIDOGREL|CLOPIDOGREL BISULFATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",33,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Premedication|Prophylaxis,Gastrointestinal infection,1,1
19892948,20210929,Epcoritamab,65,801,65.0,1,80,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|FUROSEMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FOLIC ACID|PANTOPRAZOLE,11,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Subarachnoid haemorrhage|Pneumothorax|Off label use,3,1
19894501,20210928,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|RITUXIMAB|FUROSEMIDE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METHYLPREDNISOLONE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PRAMIPEXOLE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|DAPSONE GEL, 5%|DAPSONE|DASPONE|ALBUTEROL SULFATE|ALBUTEROL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|AMOXICILLIN",39,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Prophylaxis|Prophylaxis|Prophylaxis,Cytomegalovirus infection|Cytomegalovirus test positive,2,1
19900191,20210930,Epcoritamab,69,801,69.0,1,91,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|CYTARABINE|DEXAMETHASONE SODIUM PHOSPHATE|RITUXIMAB|DEXCHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|HYDROCHLOROTHIAZIDE|LOSARTAN|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|AMIKACIN|CEFTRIAXONE|CEFTRIAXONE SODIUM|PREGABALIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,22,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Prophylaxis,Immune effector cell-associated neurotoxicity syndrome,1,3
19904505,20211001,Epcoritamab,42,801,42.0,1,80,1,0,1,1,0,0,0,Epcoritamab,RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|ALMOTRIPTAN|ALMOTRIPTAN MALATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PANTOPRAZOLE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|RIZATRIPTAN BENZOATE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR,22,Follicular lymphoma|Follicular lymphoma stage IV|Follicular lymphoma|Follicular lymphoma stage IV|Follicular lymphoma|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Dizziness,1,1
19904807,20210930,Epcoritamab,70,801,70.0,1,83,1,1,1,1,1,1,1,Epcoritamab,METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|SULFAMETHOXAZOLE AND TRIMETHOPRIM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|PREGABALIN|GABAPENTIN|ALLOPURINOL|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|SITAGLIPTIN,20,Premedication|Follicular lymphoma stage IV,Diabetes mellitus|Cytokine release syndrome,2,1
19905153,20211001,Epcoritamab,45,801,45.0,1,98.7,1,1,1,1,1,1,1,Epcoritamab,CARBOPLATIN|RITUXIMAB|CYTARABINE|DALTEPARIN SODIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACYCLOVIR|FILGRASTIM|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|FOLIC ACID|LANSOPRAZOLE|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE,22,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Prophylaxis|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Thrombocytopenia|Cellulitis,2,1
19910649,20211004,Epcoritamab,65,801,65.0,1,80,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN|FUROSEMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PANTOPRAZOLE|FOLIC ACID,13,Product used for unknown indication|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Subarachnoid haemorrhage|Pneumothorax|Cytokine release syndrome|Off label use,4,1
19910946,20211004,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARBOPLATIN|CYTARABINE|CYTARABINE|RITUXIMAB|ALPRAZOLAM|AMOXICILLIN AND CLAVULANATE POTASSIUM|FILGRASTIM|VITAMIN A PALMITATE|ACYCLOVIR|COLCHICINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ENOXAPARIN SODIUM|FUROSEMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LATANOPROST|CLEMASTINE FUMARATE|AMITRIPTYLINE HYDROCHLORIDE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|BUMETANIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LATANOPROST|LORAZEPAM|FLUCONAZOLE",43,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Acute kidney injury,1,3
19913509,20211004,Epcoritamab,45,801,45.0,1,98.70,1,1,1,1,1,1,1,Epcoritamab,CARBOPLATIN|OXALIPLATIN|CYTARABINE|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DALTEPARIN SODIUM|CHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACYCLOVIR|FILGRASTIM|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|FOLIC ACID|LANSOPRAZOLE|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARBOPLATIN|CYTARABINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CYTARABINE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE,34,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Prophylaxis|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II,Thrombocytopenia|Cellulitis|Neutropenic infection|Product use issue,4,3
19920285,20211005,Epcoritamab,55,801,55.0,1,93,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|METHYLPREDNISOLONE|TADALAFIL|PREGABALIN|ERTAPENEM|ERTAPENEM SODIUM|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|FESOTERODINE FUMARATE|ALLOPURINOL|AMOXICILLIN AND CLAVULANATE POTASSIUM|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR,45,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Premedication,Sepsis|Cytokine release syndrome|Off label use,3,3
19920523,20211005,Epcoritamab,63,801,63.0,1,79,1,0,1,1,0,0,0,Epcoritamab,"RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARBOPLATIN|CYTARABINE|CYTARABINE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|AMITRIPTYLINE HYDROCHLORIDE|AMOXICILLIN AND CLAVULANATE POTASSIUM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|ALPRAZOLAM|ENOXAPARIN SODIUM|CLEMASTINE FUMARATE|VITAMIN A PALMITATE|LATANOPROST|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FUROSEMIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACYCLOVIR|LORAZEPAM|FLUCONAZOLE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|BUMETANIDE|FILGRASTIM|LATANOPROST|COLCHICINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",43,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Premedication|Prophylaxis|Diffuse large B-cell lymphoma stage III,Acute kidney injury,1,3
19922860,20211005,Epcoritamab,78,801,78.0,1,58.1,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|VINCRISTINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ALLOPURINOL|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PEGFILGRASTIM-BMEZ|CYANOCOBALAMIN|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|FERROUS SULFATE|FLUCONAZOLE|FUROSEMIDE|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE",33,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Prophylaxis,Diarrhoea,1,1
19924059,20211006,Epcoritamab,65,801,65.0,1,80,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|DEXCHLORPHENIRAMINE MALEATE|FUROSEMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PANTOPRAZOLE|FOLIC ACID,11,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Subarachnoid haemorrhage|Pneumothorax|Cytokine release syndrome|Off label use,4,3
19924790,20211006,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE SODIUM PHOSPHATE|CARBOPLATIN|CARBOPLATIN|OXALIPLATIN|CYTARABINE|CYTARABINE|RITUXIMAB|METHYLPREDNISOLONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CLEMASTINE FUMARATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|BUMETANIDE|FILGRASTIM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LATANOPROST|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FLUCONAZOLE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|VITAMIN A PALMITATE|LATANOPROST|ENOXAPARIN SODIUM|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|ACYCLOVIR|FUROSEMIDE|AMITRIPTYLINE HYDROCHLORIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|LORAZEPAM|TRAMADOL HYDROCHLORIDE|COLCHICINE|CLEMASTINE FUMARATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",50,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cardiac failure,1,1
19926038,20211006,Epcoritamab,65,801,65.0,1,80,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|FOLIC ACID|FUROSEMIDE|PANTOPRAZOLE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,11,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Subarachnoid haemorrhage|Pneumothorax|Off label use,3,1
19930154,20211007,Epcoritamab,52,801,52.0,2,101,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|ACYCLOVIR|CHLORPHENIRAMINE MALEATE|FLUCONAZOLE|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FILGRASTIM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RASBURICASE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RITUXIMAB|RITUXIMAB|VINCRISTINE SULFATE|VINCRISTINE SULFATE|SENNOSIDES|SENNA LEAF|SENNA",26,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Febrile neutropenia|Febrile neutropenia,2,1
19931005,20211007,Epcoritamab,69,801,69.0,1,55,1,1,1,1,1,1,1,Epcoritamab,CYTARABINE|CYTARABINE|OXALIPLATIN|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,19,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Prophylaxis,Cytokine release syndrome,1,3
19948830,20211013,Epcoritamab,69,801,69.0,1,91,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|OXALIPLATIN|CYTARABINE|CYTARABINE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|RITUXIMAB|RITUXIMAB|AMIKACIN|AMIKACIN|ADENOSINE|CEFTRIAXONE|CEFTRIAXONE SODIUM|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|HYDROCHLOROTHIAZIDE|LOSARTAN|MEROPENEM|METHYLPREDNISOLONE|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|PREGABALIN|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|RASBURICASE|FUROSEMIDE|MORPHINE",54,Diffuse large B-cell lymphoma stage IV|B-cell lymphoma|B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Prophylaxis|B-cell lymphoma|B-cell lymphoma|Diffuse large B-cell lymphoma|B-cell lymphoma|Diffuse large B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Immune effector cell-associated neurotoxicity syndrome|Off label use,2,1
19952339,20211014,Epcoritamab,45,801,45.0,1,98.7,1,0,1,0,0,0,0,Epcoritamab,CARBOPLATIN|OXALIPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|CYTARABINE|DALTEPARIN SODIUM|RITUXIMAB|CHLORPHENIRAMINE MALEATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,15,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Prophylaxis|Diffuse large B-cell lymphoma,Thrombocytopenia|Neutropenic infection,2,1
19952901,20211014,Epcoritamab,45,801,45.0,1,98.7,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|CARBOPLATIN|CARBOPLATIN|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DALTEPARIN SODIUM|DALTEPARIN SODIUM|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|FILGRASTIM|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|FOLIC ACID|LANSOPRAZOLE|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|CHLORPHENIRAMINE MALEATE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,41,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Prophylaxis|Diffuse large B-cell lymphoma stage II|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Thrombocytopenia|Neutropenic infection|Product use issue|Febrile neutropenia|Cellulitis|Disease progression,6,3
19954801,20211014,Epcoritamab,79,801,79.0,1,77.5,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|FILGRASTIM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FLUCONAZOLE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN,24,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Cytokine release syndrome,1,3
19957715,20211015,Epcoritamab,78,801,78.0,1,58.1,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FERROUS SULFATE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|ALLOPURINOL|PEGFILGRASTIM-BMEZ|ACYCLOVIR|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|MAGNESIUM|FLUCONAZOLE|TRIMETHOPRIM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALENDRONATE SODIUM|ALENDRONATE SODIUM TABLET|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",32,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Hypokalaemia|Diarrhoea,2,3
19959438,20211015,Epcoritamab,63,801,63.0,2,62,1,1,1,1,1,1,1,Epcoritamab,METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|CLEMASTINE FUMARATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|ENOXAPARIN SODIUM|ONDANSETRON HYDROCHLORIDE|ALLOPURINOL|PANTOPRAZOLE,16,Diffuse large B-cell lymphoma stage IV|Steroid therapy|Diffuse large B-cell lymphoma stage IV,Gastric haemorrhage,1,1
19959439,20211015,Epcoritamab,68,801,68.0,2,90,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|PROMETHAZINE HYDROCHLORIDE|PROMETHAZINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CEFTAZIDIME|CITALOPRAM|CITALOPRAM HYDROBROMIDE|CLOPIDOGREL|CLOPIDOGREL BISULFATE|ALENDRONATE SODIUM|MIRTAZAPINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|TRAMADOL HYDROCHLORIDE|URSODIOL|URSOSIOL|ACYCLOVIR|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|FOLIC ACID|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|FOSFOMYCIN TROMETHAMINE|GRANULES FOR ORAL SOLUTION|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",48,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Neutrophil count decreased,1,3
19959442,20211015,Epcoritamab,62,801,62.0,2,68.9,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|CLEMASTINE FUMARATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METHYLPREDNISOLONE SODIUM SUCCINATE|ACYCLOVIR|ALLOPURINOL|CALCIUM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|DALTEPARIN SODIUM|FUROSEMIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|MORPHINE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|TOCILIZUMAB|PEGFILGRASTIM-BMEZ",31,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis,Constipation|Sepsis,2,1
19959446,20211015,Epcoritamab,77,801,77.0,2,77.4,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|ALLOPURINOL|AMLODIPINE|ESTRADIOL|ESTRADIOL GEL 0.1%|ESTRADIOL TRANSDERMAL|ESTRADIOL,|FILGRASTIM|DALTEPARIN SODIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METOPROLOL TARTRATE|METOPROLOL|MIRTAZAPINE|MORPHINE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OXAZEPAM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM",41,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Constipation,1,1
19959448,20211015,Epcoritamab,69,801,69.0,2,51.9,1,1,1,1,1,1,1,Epcoritamab,"VINCRISTINE SULFATE|RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|PREDNISONE|PEGFILGRASTIM|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|ALLOPURINOL|CEFTRIAXONE|CEFTRIAXONE SODIUM|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FAMOTIDINE|FENTANYL|IOHEXOL|LACTULOSE|MAGNESIUM OXIDE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|MORPHINE SULFATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MINERAL OIL|PANTOPRAZOLE|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM PHOSPHATE, DIBASIC|PROCHLORPERAZINE|SENNOSIDES A AND B|SODIUM PHOSPHATE",40,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Premedication,Constipation,1,3
19961087,20211016,Epcoritamab,52,801,52.0,2,101,1,0,1,0,0,0,0,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|ACYCLOVIR|CHLORPHENIRAMINE MALEATE|FLUCONAZOLE|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FILGRASTIM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RASBURICASE|SENNOSIDES|SENNA LEAF|SENNA|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",22,,Febrile neutropenia,1,3
19961089,20211016,Epcoritamab,45,801,45.0,1,98.7,1,0,1,1,0,0,1,Epcoritamab,CARBOPLATIN|OXALIPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|CYTARABINE|DALTEPARIN SODIUM|RITUXIMAB|CHLORPHENIRAMINE MALEATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,15,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Prophylaxis|Diffuse large B-cell lymphoma stage II,Thrombocytopenia|Neutropenic infection,2,3
19965131,20211018,Epcoritamab,79,801,79.0,2,87.9,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|BENDAMUSTINE HCL|PRAMIPEXOLE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CLEMASTINE FUMARATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|CEFUROXIME|ALBUTEROL SULFATE,20,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,Abdominal pain|Constipation,2,1
19965234,20211018,Epcoritamab,69,801,69.0,1,91,1,1,1,1,1,1,1,Epcoritamab,"CYTARABINE|OXALIPLATIN|RITUXIMAB|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|HYDROCHLOROTHIAZIDE|LOSARTAN|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|AMIKACIN|CEFTRIAXONE|CEFTRIAXONE SODIUM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PREGABALIN",35,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Prophylaxis|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication,Immune effector cell-associated neurotoxicity syndrome,1,1
19965922,20211018,Epcoritamab,45,801,45.0,1,99,1,1,1,1,1,1,1,Epcoritamab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|DALTEPARIN SODIUM|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|DALTEPARIN SODIUM|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|FILGRASTIM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|FOLIC ACID|LANSOPRAZOLE|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN,55,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Prophylaxis|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Prophylaxis|Premedication|Premedication|Premedication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Prophylaxis|Prophylaxis|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II,Thrombocytopenia|Neutropenic infection|Disease progression|Product use issue|Cellulitis|Febrile neutropenia|Neutropenia,7,3
19967476,20211019,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|CYTARABINE|CYTARABINE|CARBOPLATIN|DEXAMETHASONE SODIUM PHOSPHATE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FUROSEMIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALPRAZOLAM|BUMETANIDE|FLUCONAZOLE|ENOXAPARIN SODIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SULFAMETHOXAZOLE AND TRIMETHOPRIM|LATANOPROST|FILGRASTIM|LATANOPROST|LORAZEPAM|AMITRIPTYLINE HYDROCHLORIDE|VITAMIN A PALMITATE|VITAMIN A PALMITATE|COLCHICINE",39,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Acute kidney injury,1,3
19972039,20211020,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"PREDNISONE|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",6,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Hyponatraemia,1,1
19976020,20211021,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|DOXORUBICIN|RITUXIMAB|RITUXIMAB|ACYCLOVIR|CHLORPHENIRAMINE MALEATE|FLUCONAZOLE|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FILGRASTIM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RASBURICASE|SENNOSIDES|SENNA LEAF|SENNA",29,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Febrile neutropenia|Febrile neutropenia,2,3
19977321,20211020,Epcoritamab,,,,2,101,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|VINCRISTINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|ACYCLOVIR|CHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FLUCONAZOLE|LANSOPRAZOLE|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FILGRASTIM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RASBURICASE|SENNA LEAF",23,,Febrile neutropenia,1,3
19993190,20211026,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|PROPOFOL|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|CARBOPLATIN|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|CYTARABINE|CYTARABINE|ROSUVASTATIN|CEFTAZIDIME|PANTOPRAZOLE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXTROSE MONOHYDRATE|DEXTROSE|GRANISETRON|GRANISETRON HYDROCHLORIDE|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RASBURICASE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METOPROLOL TARTRATE|METOPROLOL",34,Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Diffuse large B-cell lymphoma stage III|Premedication|Premedication,Guillain-Barre syndrome,1,1
20000458,20211026,Epcoritamab,62,801,62.0,2,68.9,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|RITUXIMAB|RITUXIMAB|PREDNISONE|PREDNISONE|LENALIDOMIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|TOCILIZUMAB|FUROSEMIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ALLOPURINOL|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|CALCIUM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|RITUXIMAB|RITUXIMAB|MORPHINE|MORPHINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CLEMASTINE FUMARATE|ACYCLOVIR|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DALTEPARIN SODIUM|PEGFILGRASTIM-BMEZ|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS",42,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Premedication|Premedication|Prophylaxis|Prophylaxis,Cytokine release syndrome|Hydronephrosis|Blood creatinine increased|Sepsis|Constipation,5,1
20002986,20211027,Epcoritamab,78,801,78.0,1,76.9,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|RITUXIMAB|PROMETHAZINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|ACYCLOVIR|ALLOPURINOL|AMLODIPINE|FLUCONAZOLE|FOLIC ACID|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXPANTHENOL|RAMIPRIL|TRAMADOL HYDROCHLORIDE|RASBURICASE",37,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Prophylaxis|Prophylaxis,Hyponatraemia,1,1
20012428,20211029,Epcoritamab,72,801,72.0,1,62.5,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|FUROSEMIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SCOPOLAMINE|ENTECAVIR|ENTECAVIR ANHYDROUS|PANTOPRAZOLE|TAMSULOSIN HYDROCHLORIDE|AZITHROMYCIN DIHYDRATE|ALLOPURINOL,20,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication,Lung disorder|Septic shock|Sepsis|Off label use,4,3
20013033,20211029,Epcoritamab,79,801,79.0,1,87.9,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|BENDAMUSTINE HCL|PRAMIPEXOLE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CLEMASTINE FUMARATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|CEFUROXIME|ALBUTEROL SULFATE,20,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,Abdominal pain|Constipation,2,1
20013560,20211029,Epcoritamab,68,801,68.0,2,75.1,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|PANTOPRAZOLE|PANTOPRAZOLE|PANTOPRAZOLE|PANTOPRAZOLE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CALCIUM CARBONATE|ANTACID|CALCIUM CARBONATE|ANTACID|CALCIUM CARBONATE|ANTACID|CALCIUM CARBONATE|ANTACID|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PEGFILGRASTIM|PEGFILGRASTIM|PEGFILGRASTIM|PEGFILGRASTIM|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|DIGOXIN|DIGOXIN|DIGOXIN|DIGOXIN|DIGOXIN|DIGOXIN|DIGOXIN|DIGOXIN|TOCILIZUMAB|TOCILIZUMAB|TOCILIZUMAB|TOCILIZUMAB|FILGRASTIM|FILGRASTIM|FILGRASTIM|FILGRASTIM|ATENOLOL|ATENOLOL|ATENOLOL|ATENOLOL|ATENOLOL|ATENOLOL|ATENOLOL|ATENOLOL|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|POTASSIUM PHOSPHATE, DIBASIC|POTASSIUM PHOSPHATE, DIBASIC|POTASSIUM PHOSPHATE, DIBASIC|POTASSIUM PHOSPHATE, DIBASIC|MEROPENEM|MEROPENEM|MEROPENEM|MEROPENEM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|LACTULOSE|LACTULOSE|LACTULOSE|LACTULOSE|FOSCARNET SODIUM|FOSCARNET SODIUM|FOSCARNET SODIUM|FOSCARNET SODIUM|GANCICLOVIR SODIUM|GANCICLOVIR|GANCICLOVIR SODIUM|GANCICLOVIR|GANCICLOVIR SODIUM|GANCICLOVIR|GANCICLOVIR SODIUM|GANCICLOVIR",260,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Multiple organ dysfunction syndrome|Myelodysplastic syndrome|Ascites|Cytokine release syndrome|Pleural effusion|Capillary leak syndrome|Hepatitis acute|Off label use,8,3
20019303,20211101,Epcoritamab,68,801,68.0,2,90,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|METHYLPREDNISOLONE SODIUM SUCCINATE|PROMETHAZINE HYDROCHLORIDE|CARVEDILOL|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",18,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Neutrophil count decreased,1,1
20022122,20211102,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|CARBOPLATIN|CARBOPLATIN|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE SODIUM PHOSPHATE|OXALIPLATIN|ACYCLOVIR|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BUMETANIDE|ENOXAPARIN SODIUM|COLCHICINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FLUCONAZOLE|FLUCONAZOLE|INSULIN HUMAN|FUROSEMIDE|FUROSEMIDE|METHYLPREDNISOLONE|LATANOPROST|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|AMITRIPTYLINE HYDROCHLORIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|LORAZEPAM|FILGRASTIM|TRAMADOL HYDROCHLORIDE|TRAMADOL HYDROCHLORIDE|VITAMIN A PALMITATE|VITAMIN A PALMITATE|LATANOPROST|LORAZEPAM",72,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Prophylaxis|Cholecystitis,Heart failure with reduced ejection fraction|Acute kidney injury|Cardiac failure|Coronary artery disease|Periodontitis|Off label use,6,3
20026855,20211103,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|VINCRISTINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|PEGFILGRASTIM-BMEZ|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ALLOPURINOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|FLUCONAZOLE|FERROUS SULFATE|FUROSEMIDE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE",29,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Prophylaxis,Hypokalaemia,1,1
20027809,20211103,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DALTEPARIN SODIUM|DALTEPARIN SODIUM|DALTEPARIN SODIUM|DALTEPARIN SODIUM|DALTEPARIN SODIUM|DALTEPARIN SODIUM|DALTEPARIN SODIUM|DALTEPARIN SODIUM|DALTEPARIN SODIUM|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|DALTEPARIN SODIUM|ACYCLOVIR|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|FILGRASTIM|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|FOLIC ACID|LANSOPRAZOLE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,345,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Prophylaxis|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Prophylaxis|Prophylaxis|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Prophylaxis|Premedication|Premedication|Premedication|Prophylaxis|Prophylaxis,Disease progression|Neutropenic infection|Febrile neutropenia|Febrile neutropenia|Neutropenia|Thrombocytopenia|Cellulitis|Product use issue|Neutropenic infection,9,3
20037545,20211105,Epcoritamab,72,801,72.0,1,73,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|METHYLPREDNISOLONE SODIUM SUCCINATE|PANTOPRAZOLE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|CALCIUM CARBONATE|ANTACID|ALLOPURINOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATENOLOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PEGFILGRASTIM|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|SPIRONOLACTONE|FUROSEMIDE|TOCILIZUMAB|TOCILIZUMAB|DIGOXIN|DEXAMETHASONE SODIUM PHOSPHATE|FILGRASTIM|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|PREDNISONE|PREDNISONE|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE",63,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication,Ascites|Multiple organ dysfunction syndrome|Small intestinal perforation|Cytokine release syndrome|Off label use,5,3
20048774,20211109,Epcoritamab,45,801,45.0,1,98.7,1,1,1,1,1,1,1,Epcoritamab,CARBOPLATIN|CYTARABINE|CYTARABINE|RITUXIMAB|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACYCLOVIR|FILGRASTIM|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|FOLIC ACID|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CHLORPHENIRAMINE MALEATE,24,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II,Febrile neutropenia,1,1
20048840,20211109,Epcoritamab,87,801,87.0,2,66.8,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|VALSARTAN|VALSARTAN ORAL|METHIMAZOLE|HYDROCHLOROTHIAZIDE|ACYCLOVIR|ALLOPURINOL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METHIMAZOLE|TORSEMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FUROSEMIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|BISOPROLOL FUMARATE|ASCORBIC ACID|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|VALSARTAN|VALSARTAN ORAL|HYDROCHLOROTHIAZIDE",35,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Premedication|Premedication|Prophylaxis|Prophylaxis|Prophylaxis|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Prophylaxis|Prophylaxis,Cytokine release syndrome|Hypokalaemia|Off label use|Enterocolitis,4,1
20050880,20211110,Epcoritamab,,,,0,,1,0,1,1,0,0,0,Epcoritamab,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PREDNISOLONE ACETATE",6,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Hyponatraemia,1,1
20052925,20211110,Epcoritamab,87,801,87.0,1,68.20,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ALLOPURINOL|CARVEDILOL|ENTECAVIR|ENTECAVIR ANHYDROUS|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|TRIMETHOPRIM|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE,15,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Premedication|Premedication|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Sepsis,1,1
20074750,20211116,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|CYTARABINE|CARBOPLATIN|RITUXIMAB|CLEMASTINE FUMARATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|AMOXICILLIN AND CLAVULANATE POTASSIUM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BUMETANIDE|ENOXAPARIN SODIUM|COLCHICINE|DEXAMETHASONE SODIUM PHOSPHATE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FLUCONAZOLE|INSULIN HUMAN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FUROSEMIDE|LATANOPROST|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|AMITRIPTYLINE HYDROCHLORIDE|LORAZEPAM|FILGRASTIM|TRAMADOL HYDROCHLORIDE|VITAMIN A PALMITATE|LATANOPROST|ALPRAZOLAM",44,Product used for unknown indication|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Premedication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Cholecystitis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Tumour lysis syndrome|Acute kidney injury|Off label use,3,3
20078013,20211117,Epcoritamab,87,801,87.0,2,66.8,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ASCORBIC ACID|BISOPROLOL FUMARATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FUROSEMIDE|FUROSEMIDE|HYDROCHLOROTHIAZIDE|HYDROCHLOROTHIAZIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACYCLOVIR|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM BICARBONATE|POTASSIUM BICARBONATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METHIMAZOLE|METHIMAZOLE|TORSEMIDE|VALSARTAN|VALSARTAN ORAL|ALLOPURINOL|PREDNISONE|PREDNISONE",45,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Enterocolitis|Hypokalaemia|Cytokine release syndrome|Off label use,4,3
20079960,20211117,Epcoritamab,77,801,77.0,2,77.4,1,1,1,1,1,1,1,Epcoritamab,"PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|ALLOPURINOL|ACYCLOVIR|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|FILGRASTIM|DALTEPARIN SODIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|MIRTAZAPINE|AMLODIPINE|METOPROLOL TARTRATE|METOPROLOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ESTRADIOL|ESTRADIOL GEL 0.1%|ESTRADIOL TRANSDERMAL|ESTRADIOL,|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|MAGNESIUM HYDROXIDE|MORPHINE|SODIUM CITRATE",35,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Constipation,1,3
20085928,20211118,Epcoritamab,87,801,87.0,1,68.2,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ENTECAVIR|ENTECAVIR ANHYDROUS|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE|ALLOPURINOL|CARVEDILOL|TRIMETHOPRIM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM,15,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytomegalovirus infection reactivation|Sepsis,2,5
20087580,20211118,Epcoritamab,87,801,87.0,2,66.8,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|OXALIPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METHIMAZOLE|VALSARTAN|VALSARTAN ORAL|VALSARTAN|VALSARTAN ORAL|FUROSEMIDE|BISOPROLOL FUMARATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ALLOPURINOL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|TORSEMIDE|METHIMAZOLE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|HYDROCHLOROTHIAZIDE|ACYCLOVIR|ASCORBIC ACID|POTASSIUM BICARBONATE|POTASSIUM CITRATE|HYDROCHLOROTHIAZIDE",45,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Premedication|Premedication|Prophylaxis|Prophylaxis|Prophylaxis,Enterocolitis|Hypokalaemia|Cytokine release syndrome|Off label use,4,3
20088209,20211118,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|CARVEDILOL|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PROMETHAZINE HYDROCHLORIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",17,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Neutrophil count decreased,1,1
20092292,20211119,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXALIPLATIN|RITUXIMAB|CLEMASTINE FUMARATE|METHYLPREDNISOLONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|OXALIPLATIN|VITAMIN A PALMITATE|AMITRIPTYLINE HYDROCHLORIDE|FUROSEMIDE|LORAZEPAM|ENOXAPARIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|BUMETANIDE|FLUCONAZOLE|FILGRASTIM|COLCHICINE|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SULFAMETHOXAZOLE AND TRIMETHOPRIM|LATANOPROST|ACYCLOVIR|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|TRAMADOL HYDROCHLORIDE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|LATANOPROST|METHYLPREDNISOLONE SODIUM SUCCINATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE",55,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Prophylaxis|Diffuse large B-cell lymphoma stage III|Prophylaxis|Diffuse large B-cell lymphoma stage III,Acute kidney injury|Periodontitis|Cardiac failure,3,3
20092862,20211120,Epcoritamab,87,801,87.0,2,66.8,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|POTASSIUM BICARBONATE|POTASSIUM BICARBONATE|PREDNISONE|PREDNISONE|BISOPROLOL FUMARATE|ASCORBIC ACID|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FUROSEMIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|VALSARTAN|VALSARTAN ORAL|VALSARTAN|VALSARTAN ORAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|HYDROCHLOROTHIAZIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ALLOPURINOL|METHIMAZOLE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METHIMAZOLE|ACYCLOVIR|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TORSEMIDE|HYDROCHLOROTHIAZIDE",43,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Premedication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis,Enterocolitis|Hypokalaemia|Cytokine release syndrome|Off label use,4,1
20096113,20211122,Epcoritamab,87,801,87.0,1,68.2,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ALLOPURINOL|CARVEDILOL|ENTECAVIR|ENTECAVIR ANHYDROUS|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|TRIMETHOPRIM|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE,15,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytomegalovirus infection reactivation|Sepsis,2,1
20100261,20211123,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|VINCRISTINE SULFATE|VINCRISTINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PROMETHAZINE HYDROCHLORIDE|PROMETHAZINE HYDROCHLORIDE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|CARVEDILOL|ALENDRONATE SODIUM|ALLOPURINOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|MIRTAZAPINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|METHYLPREDNISOLONE SODIUM SUCCINATE|TRAMADOL HYDROCHLORIDE|ACYCLOVIR|CLOPIDOGREL|CLOPIDOGREL BISULFATE|CLOPIDOGREL|CLOPIDOGREL BISULFATE|CEFTAZIDIME|URSODIOL|URSOSIOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METHYLPREDNISOLONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",62,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Neutrophil count decreased,1,3
20100288,20211123,Epcoritamab,87,801,87.0,1,68.2,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ENTECAVIR|ENTECAVIR ANHYDROUS|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE|ALLOPURINOL|CARVEDILOL|TRIMETHOPRIM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM,15,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytomegalovirus infection reactivation|Sepsis,2,1
20101193,20211123,Epcoritamab,87,801,87.0,2,66.8,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|OXALIPLATIN|ALLOPURINOL|ACYCLOVIR|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|VALSARTAN|VALSARTAN ORAL|VALSARTAN|VALSARTAN ORAL|POTASSIUM BICARBONATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FUROSEMIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|HYDROCHLOROTHIAZIDE|METHIMAZOLE|TORSEMIDE|BISOPROLOL FUMARATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PREDNISONE|PREDNISONE|ASCORBIC ACID|METHIMAZOLE|POTASSIUM CITRATE|HYDROCHLOROTHIAZIDE",44,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Premedication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Enterocolitis|Hypokalaemia|Cytokine release syndrome|Hypokalaemia|Off label use,5,5
20109041,20211124,Epcoritamab,76,801,76.0,2,51.3,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|FLUCONAZOLE|DEXCHLORPHENIRAMINE MALEATE|AMLODIPINE BESYLATE|ALLOPURINOL|METHYLPREDNISOLONE|FUROSEMIDE|LORAZEPAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MAGNESIUM,20,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Product used for unknown indication,Febrile neutropenia|Cytokine release syndrome|Off label use,3,3
20109405,20211124,Epcoritamab,87,801,87.0,2,66.8,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|POTASSIUM BICARBONATE|POTASSIUM BICARBONATE|PREDNISONE|PREDNISONE|PREDNISONE|BISOPROLOL FUMARATE|ASCORBIC ACID|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE HYDROCHLORIDE|FUROSEMIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|VALSARTAN|VALSARTAN ORAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|HYDROCHLOROTHIAZIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ALLOPURINOL|METHIMAZOLE|METHIMAZOLE|ACYCLOVIR|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TORSEMIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",41,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Enterocolitis|Cytokine release syndrome|Hypokalaemia|Hypokalaemia|Off label use,5,3
20118712,20211126,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN|DOXORUBICIN|DOXORUBICIN|DOXORUBICIN|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|VINCRISTINE SULFATE|VINCRISTINE SULFATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACYCLOVIR|ACYCLOVIR|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|FLUCONAZOLE|FLUCONAZOLE|LANSOPRAZOLE|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FILGRASTIM|FILGRASTIM|FILGRASTIM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RASBURICASE|RASBURICASE|SENNOSIDES|SENNA LEAF|SENNA",81,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Immune disorder prophylaxis|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma,Disease recurrence|Febrile neutropenia|Febrile neutropenia,3,1
20120308,20211126,Epcoritamab,87,801,87.0,1,68.2,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TRIMETHOPRIM|ALLOPURINOL|CARVEDILOL|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE|ENTECAVIR|ENTECAVIR ANHYDROUS,15,,Sepsis,1,1
20124600,20211129,Epcoritamab,87,801,87.0,1,68.2,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,8,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytomegalovirus infection reactivation,1,3
20128196,20211129,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|LENALIDOMIDE|LENALIDOMIDE|PREDNISONE|PREDNISONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE ACETATE|PREDNISOLONE ACETATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|ALLOPURINOL|FILGRASTIM|ACYCLOVIR|CALCIUM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|DALTEPARIN SODIUM|FUROSEMIDE|FUROSEMIDE|GENTAMICIN|GENTAMICIN SULFATE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|METRONIDAZOLE|METRONIDAZOLE TOPICAL|METRONIDAZOLE|METRONIDAZOLE TOPICAL|MORPHINE|MORPHINE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PREDNISOLONE ACETATE|PREDNISOLONE ACETATE|PREDNISOLONE ACETATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|CLEMASTINE FUMARATE|TOCILIZUMAB|PEGFILGRASTIM-BMEZ",80,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Sepsis|Blood creatinine increased|Hyperkalaemia|Constipation|Cytokine release syndrome|Hydronephrosis|Off label use,7,1
20138034,20211202,Epcoritamab,45,801,45.0,1,98.7,1,1,1,1,1,1,1,Epcoritamab,CARBOPLATIN|CYTARABINE|CYTARABINE|ACYCLOVIR|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|FILGRASTIM|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|FOLIC ACID|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|RITUXIMAB,23,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Diffuse large B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Diffuse large B-cell lymphoma,Febrile neutropenia|Thrombocytopenia|Neutropenic infection|Cytokine release syndrome,4,1
20144492,20211203,Epcoritamab,45,801,45.0,1,98.7,1,0,1,0,0,0,0,Epcoritamab,CARBOPLATIN|CYTARABINE|CYTARABINE|ACYCLOVIR|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|FILGRASTIM|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|FOLIC ACID|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|RITUXIMAB,23,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Febrile neutropenia,1,1
20150567,20211206,Epcoritamab,73,801,73.0,2,65,1,0,1,0,0,0,0,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|CARVEDILOL|DULOXETINE HYDROCHLORIDE|DULOXETINE|FERROUS SULFATE|GLIPIZIDE|LISINOPRIL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,24,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Pneumonia,1,5
20152609,20211206,Epcoritamab,44,801,44.0,2,59,1,0,1,0,0,0,0,Epcoritamab,BENDAMUSTINE HYDROCHLORIDE|RITUXIMAB|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|ALBUTEROL SULFATE|ALBUTEROL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACYCLOVIR|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|FLUCONAZOLE,32,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cholecystitis infective|Cytokine release syndrome|Cytokine release syndrome,3,1
20160007,20211208,Epcoritamab,72,801,72.0,1,62.5,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ALLOPURINOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ENTECAVIR|ENTECAVIR ANHYDROUS|FUROSEMIDE|PANTOPRAZOLE|SCOPOLAMINE|FLUCONAZOLE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|AZITHROMYCIN DIHYDRATE|TAMSULOSIN HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE,22,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Premedication|Prophylaxis|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Septic shock|Off label use|Lung disorder,3,3
20163586,20211209,Epcoritamab,79,801,79.0,1,74,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN|ALBUMIN HUMAN|ALBUMIN HUMAN|PANTOPRAZOLE|OCTREOTIDE ACETATE|OCTREOTIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|IRBESARTAN|ALLOPURINOL|LINEZOLID,25,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Ascites|Generalised oedema|Off label use,3,3
20169862,20211210,Epcoritamab,62,801,62.0,2,68.9,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|LENALIDOMIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METHYLPREDNISOLONE SODIUM SUCCINATE|FUROSEMIDE|GENTAMICIN|GENTAMICIN SULFATE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|METRONIDAZOLE|METRONIDAZOLE TOPICAL|MORPHINE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",23,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV,Hyperkalaemia,1,1
20171309,20211210,Epcoritamab,62,801,62.0,2,68.9,1,0,1,0,0,0,0,Epcoritamab,"LENALIDOMIDE|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PREDNISONE|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|TOCILIZUMAB|FUROSEMIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ALLOPURINOL|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|CALCIUM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|MORPHINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CLEMASTINE FUMARATE|ACYCLOVIR|METHYLPREDNISOLONE SODIUM SUCCINATE|DALTEPARIN SODIUM|PEGFILGRASTIM|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",35,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Premedication|Product used for unknown indication|Prophylaxis|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis,Cytokine release syndrome|Blood creatinine increased|Constipation|Sepsis,4,1
20172646,20211211,Epcoritamab,62,801,62.0,2,68.9,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN|PEGFILGRASTIM-BMEZ|PREDNISONE|LENALIDOMIDE|CALCIUM|ALLOPURINOL|METHYLPREDNISOLONE SODIUM SUCCINATE|DALTEPARIN SODIUM|ACYCLOVIR|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|FUROSEMIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|RITUXIMAB|RITUXIMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|TOCILIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CLEMASTINE FUMARATE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|MORPHINE|MORPHINE",39,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma stage IV|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Prophylaxis|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Hydronephrosis|Blood creatinine increased|Constipation|Cytokine release syndrome|Sepsis,5,1
20175907,20211213,Epcoritamab,78,801,78.0,1,76.9,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|ALLOPURINOL|AMLODIPINE|BISOPROLOL FUMARATE|FOLIC ACID|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|RAMIPRIL|ALPRAZOLAM|FLUCONAZOLE|FLUCONAZOLE|HALOPERIDOL|HALOPERIDOL LACTATE|FUROSEMIDE|DICLOFENAC|DICLOFENAC SODIUM",44,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Pneumonia,1,3
20175908,20211213,Epcoritamab,62,801,62.0,2,68.9,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISOLONE ACETATE|PREDNISONE|METHYLPREDNISOLONE SODIUM SUCCINATE|FILGRASTIM|ACYCLOVIR|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|FUROSEMIDE|GENTAMICIN|GENTAMICIN SULFATE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|METRONIDAZOLE|METRONIDAZOLE TOPICAL|MORPHINE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",27,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV,Hyperkalaemia,1,1
20180069,20211214,Epcoritamab,53,801,53.0,1,82.1,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|BUPROPION|GABAPENTIN|DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE|DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE|DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE|DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CETIRIZINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE|DULOXETINE HYDROCHLORIDE|GABAPENTIN|MEPERIDINE HYDROCHLORIDE|NALOXONE HYDROCHLORIDE NASAL|NALOXONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|POLYETHYLENE GLYCOL 3350|QUETIAPINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LIDOCAINE PATCH 5%|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FAMOTIDINE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACYCLOVIR",35,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Fatigue|Depression,2,1
20182698,20211214,Epcoritamab,68,801,68.0,1,72,1,0,1,0,0,0,0,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|HYDROCORTISONE SODIUM SUCCINATE|HYDROCORTISONE SODIUM SUCCINATE|ALLOPURINOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|VALACYCLOVIR HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,18,Follicular lymphoma|B-cell lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Atrial flutter,2,1
20183112,20211214,Epcoritamab,79,801,79.0,1,74,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|ALBUMIN HUMAN|ALBUMIN HUMAN|PANTOPRAZOLE|OCTREOTIDE ACETATE|OCTREOTIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|IRBESARTAN|ALLOPURINOL|LINEZOLID,24,,Ascites|Off label use,2,3
20188177,20211215,Epcoritamab,72,801,72.0,1,62.5,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|FLUCONAZOLE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ENTECAVIR|ENTECAVIR ANHYDROUS|PANTOPRAZOLE|TAMSULOSIN HYDROCHLORIDE|AZITHROMYCIN DIHYDRATE|ALLOPURINOL,22,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Lung disorder|Septic shock|Sepsis|Off label use,4,5
20188876,20211215,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|PREDNISOLONE ACETATE",6,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Hyponatraemia,1,1
20202456,20211217,Epcoritamab,72,801,72.0,1,62.5,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|FLUCONAZOLE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|FUROSEMIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SCOPOLAMINE|ENTECAVIR|ENTECAVIR ANHYDROUS|PANTOPRAZOLE|TAMSULOSIN HYDROCHLORIDE|AZITHROMYCIN DIHYDRATE|ALLOPURINOL|BECLOMETHASONE DIPROPIONATE,21,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Premedication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Lung disorder|Sepsis|Septic shock|Off label use,4,3
20208833,20211220,Epcoritamab,53,801,53.0,1,82,1,0,1,0,0,0,0,Epcoritamab,"BENDAMUSTINE HYDROCHLORIDE|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|BUPROPION|RITUXIMAB|CETIRIZINE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE|DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE|DIPHENHYDRAMINE HYDROCHLORIDE|DULOXETINE HYDROCHLORIDE|GABAPENTIN|MEPERIDINE HYDROCHLORIDE|NALOXONE HYDROCHLORIDE NASAL|NALOXONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|POLYETHYLENE GLYCOL 3350|QUETIAPINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",22,Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Fatigue|Depression,2,3
20213572,20211221,Epcoritamab,72,801,72.0,1,62.5,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXCHLORPHENIRAMINE MALEATE|FLUCONAZOLE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|FUROSEMIDE|ENTECAVIR|ENTECAVIR ANHYDROUS|PANTOPRAZOLE|TAMSULOSIN HYDROCHLORIDE|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|ALLOPURINOL|BECLOMETHASONE DIPROPIONATE,21,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Off label use|Septic shock|Sepsis,3,3
20215777,20211222,Epcoritamab,62,801,62.0,2,68.9,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|PREDNISONE|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|LENALIDOMIDE|DOXORUBICIN|DOXORUBICIN|FUROSEMIDE|ALLOPURINOL|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|TOCILIZUMAB|TOCILIZUMAB|PEGFILGRASTIM-BMEZ|DALTEPARIN SODIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|CALCIUM|METHYLPREDNISOLONE SODIUM SUCCINATE|ACYCLOVIR|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|MORPHINE|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CLEMASTINE FUMARATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|RITUXIMAB|RITUXIMAB|RITUXIMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",41,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma stage IV|Follicular lymphoma stage IV,Constipation|Sepsis,2,3
20224028,20211223,Epcoritamab,62,801,62.0,2,68.9,1,0,1,1,0,0,0,Epcoritamab,"RITUXIMAB|LENALIDOMIDE|PREDNISOLONE ACETATE|VINCRISTINE SULFATE|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|MORPHINE|RITUXIMAB|RITUXIMAB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|FILGRASTIM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METRONIDAZOLE|METRONIDAZOLE TOPICAL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FUROSEMIDE|GENTAMICIN|GENTAMICIN SULFATE|METHYLPREDNISOLONE SODIUM SUCCINATE|ACYCLOVIR",28,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV,Hyperkalaemia,1,1
20226115,20211224,Epcoritamab,45,801,45.0,1,98.7,1,1,1,1,1,1,1,Epcoritamab,CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|DALTEPARIN SODIUM|DALTEPARIN SODIUM|DALTEPARIN SODIUM|OXALIPLATIN|OXALIPLATIN|ACYCLOVIR|ATOVAQUONE|ATOVAQUONE ORAL SUSPENSION|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE SODIUM PHOSPHATE|FILGRASTIM|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|FOLIC ACID|LANSOPRAZOLE|MEROPENEM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB,66,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Prophylaxis|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Diffuse large B-cell lymphoma stage II|Prophylaxis|Diffuse large B-cell lymphoma|Product used for unknown indication|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II,Cytokine release syndrome|Disease progression|Cellulitis|Thrombocytopenia|Neutropenic infection|Pyrexia|Neutropenia|Febrile neutropenia|Pneumonia|Lower respiratory tract infection,10,3
20226428,20211224,Epcoritamab,72,801,72.0,1,62.5,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|FLUCONAZOLE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|FUROSEMIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|PANTOPRAZOLE|AZITHROMYCIN DIHYDRATE|ALLOPURINOL,17,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Premedication,Pneumonia|Septic shock|Off label use,3,3
20232857,20211227,Epcoritamab,73,801,73.0,2,65,1,0,1,0,0,0,0,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|PREDNISONE|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|CARVEDILOL|DULOXETINE HYDROCHLORIDE|DULOXETINE|FERROUS SULFATE|GLIPIZIDE|LISINOPRIL|LORAZEPAM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,20,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Pneumonia,1,5
20237332,20211228,Epcoritamab,79,801,79.0,2,87.9,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|BENDAMUSTINE HCL|BENDAMUSTINE HCL|PRAMIPEXOLE|ACYCLOVIR|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALBUTEROL SULFATE|ALBUTEROL|CEFUROXIME|DAPSONE GEL, 5%|DAPSONE|DASPONE|CLEMASTINE FUMARATE",22,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,Constipation|Abdominal pain|Sepsis|Blood creatinine increased|Hydronephrosis,5,1
20247051,20211229,Epcoritamab,79,801,79.0,1,74,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|ALBUMIN HUMAN|ALBUMIN HUMAN|PANTOPRAZOLE|OCTREOTIDE ACETATE|OCTREOTIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|IRBESARTAN|ALLOPURINOL|LINEZOLID,23,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Generalised oedema|Ascites|Off label use,3,3
20249020,20211229,Epcoritamab,66,801,66.0,2,66.8,1,0,1,0,0,0,0,Epcoritamab,LENALIDOMIDE|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|METHYLPREDNISOLONE|ALLOPURINOL|EZETIMIBE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREDNISONE,19,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,1
20255231,20211230,Epcoritamab,74,801,74.0,1,100,1,1,1,1,1,1,1,Epcoritamab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|RITUXIMAB|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DESLORATADINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALLOPURINOL|ENTECAVIR|ENTECAVIR ANHYDROUS|FELODIPINE|FELODIPINE EXTENDED-RELEASE TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SIMVASTATIN|TIOTROPIUM BROMIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|PROPRANOLOL HYDROCHLORIDE|PREDNISONE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FILGRASTIM|ZOLPIDEM TARTRATE",28,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Prophylaxis,Cytokine release syndrome|Hypoxia|Hypotension,3,1
20257476,20211230,Epcoritamab,69,801,69.0,2,51.9,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|VINCRISTINE SULFATE|PREDNISONE",6,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Constipation|Constipation,2,1
20267048,20211231,Epcoritamab,78,801,78.0,1,76.9,1,1,1,1,1,1,1,Epcoritamab,"METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|RITUXIMAB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|BISOPROLOL FUMARATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RAMIPRIL|ACYCLOVIR|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|ALLOPURINOL|AMLODIPINE|FOLIC ACID",49,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Neutropenic infection|Pneumonia,2,1
20291419,20220104,Epcoritamab,69,801,69.0,2,51.9,1,0,1,0,0,0,0,Epcoritamab,"PREDNISONE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PEGFILGRASTIM",10,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Constipation,1,1
20304377,20220106,Epcoritamab,79,801,79.0,1,74,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ALBUMIN HUMAN|IRBESARTAN|ALLOPURINOL|OCTREOTIDE ACETATE|OCTREOTIDE|PANTOPRAZOLE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|HUMAN IMMUNOGLOBULIN G,15,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II,Ascites|Off label use,2,3
20323986,20220111,Epcoritamab,43,801,43.0,2,,1,0,1,0,0,0,0,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB,6,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III,Cytokine release syndrome,1,1
20328246,20220112,Epcoritamab,66,801,66.0,2,66.8,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|EZETIMIBE|EZETIMIBE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALLOPURINOL|CALCIUM CARBONATE|ANTACID|CALCIUM CARBONATE|ANTACID|PREDNISONE|PREDNISONE,28,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Pyrexia,2,1
20333785,20220113,Epcoritamab,79,801,79.0,1,74,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|OXALIPLATIN|ALBUMIN HUMAN|ALBUMIN HUMAN|PANTOPRAZOLE|OCTREOTIDE ACETATE|OCTREOTIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|IRBESARTAN|ALLOPURINOL|LINEZOLID|SULFAMETHOXAZOLE AND TRIMETHOPRIM,24,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Ascites,1,5
20335984,20220114,Epcoritamab,67,801,67.0,1,98.1,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|CYTARABINE|RITUXIMAB|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|RASBURICASE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CEFTAZIDIME|PANTOPRAZOLE|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|METOPROLOL TARTRATE|METOPROLOL|ROSUVASTATIN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|GRANISETRON|GRANISETRON HYDROCHLORIDE|DEXTROSE MONOHYDRATE|DEXTROSE",32,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Guillain-Barre syndrome|Respiratory failure,2,3
20341002,20220117,Epcoritamab,79,801,79.0,1,74,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN|ALBUMIN HUMAN|ALBUMIN HUMAN|PANTOPRAZOLE|OCTREOTIDE ACETATE|OCTREOTIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|IRBESARTAN|ALLOPURINOL|APIXABAN|LINEZOLID,23,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Ascites|Off label use,2,3
20348143,20220119,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|CARBOPLATIN|CYTARABINE|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|RASBURICASE,18,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Guillain-Barre syndrome|Quadriparesis|Respiratory failure,3,3
20360102,20220121,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|BENDAMUSTINE HCL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|CLEMASTINE FUMARATE|ALBUTEROL SULFATE|ALBUTEROL|DAPSONE GEL, 5%|DAPSONE|DASPONE|CEFUROXIME|PRAMIPEXOLE",20,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,Blood creatinine increased|Hydronephrosis|Abdominal pain|Constipation|Sepsis,5,1
20379274,20220126,Epcoritamab,53,801,53.0,1,82.1,1,1,1,1,1,1,1,Epcoritamab,BENDAMUSTINE HYDROCHLORIDE|RITUXIMAB,7,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Premedication|Premedication,Fatigue|Somnolence,2,3
20392492,20220128,Epcoritamab,79,801,79.0,1,76.9,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|BISOPROLOL FUMARATE|FOLIC ACID|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|RAMIPRIL|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|FLUCONAZOLE|DICLOFENAC|DICLOFENAC SODIUM",45,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis,Enterocolitis infectious,1,3
20439141,20220207,Epcoritamab,62,801,62.0,1,125.7,1,0,1,0,0,0,0,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|ACYCLOVIR|ENALAPRIL|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|SIMVASTATIN|SITAGLIPTIN|TOCILIZUMAB,19,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Pneumocystis jirovecii infection|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pyrexia,Cytokine release syndrome|Pneumocystis jirovecii infection|Diarrhoea|Dehydration,4,3
20449400,20220209,Epcoritamab,66,801,66.0,2,72,1,0,1,0,0,0,0,Epcoritamab,"LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACYCLOVIR",18,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Device occlusion,1,1
20451209,20220209,Epcoritamab,72,801,72.0,1,50,1,0,1,0,0,0,0,Epcoritamab,LENALIDOMIDE|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|ALLOPURINOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREDNISONE|FERROUS SULFATE,14,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication,Cytokine release syndrome,1,1
20454770,20220210,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|RITUXIMAB|ALLOPURINOL|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LENALIDOMIDE|ACYCLOVIR,12,Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|Product used for unknown indication,Cytokine release syndrome,1,1
20459534,20220211,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"AMOXICILLIN|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACYCLOVIR|ACYCLOVIR|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FERROUS SULFATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE",66,Product used for unknown indication|B-cell lymphoma|Follicular lymphoma stage III|Follicular lymphoma|Pain|Prophylaxis|Prophylaxis|Pyrexia|Product used for unknown indication|Prophylaxis|Follicular lymphoma|B-cell lymphoma|Follicular lymphoma|Product used for unknown indication|B-cell lymphoma|Follicular lymphoma stage III|Follicular lymphoma|Product used for unknown indication|Prophylaxis|Follicular lymphoma stage III|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Pyrexia|Hypotension|Fibrin D dimer increased|Haemoglobin decreased|C-reactive protein increased,6,1
20471660,20220214,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"ACYCLOVIR|ACYCLOVIR|LENALIDOMIDE|LENALIDOMIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|AMOXICILLIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|FERROUS SULFATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",53,Prophylaxis|B-cell lymphoma|Follicular lymphoma|Prophylaxis|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|Follicular lymphoma|Product used for unknown indication|Prophylaxis|Follicular lymphoma|Pain|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Hypotension|Pyrexia|Pyrexia|Haemoglobin decreased|Fibrin D dimer increased|C-reactive protein increased,7,1
20478919,20220216,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|CETIRIZINE HYDROCHLORIDE|METHYLPREDNISOLONE|FUROSEMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MAGNESIUM|FILGRASTIM|ACYCLOVIR|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|ALLOPURINOL|DARBEPOETIN ALFA|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BISOPROLOL FUMARATE|BUMETANIDE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|ENOXAPARIN SODIUM|DEXAMETHASONE SODIUM PHOSPHATE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FLUCONAZOLE|FOLIC ACID|ATORVASTATIN CALCIUM|LISINOPRIL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|TRAMADOL HYDROCHLORIDE|LATANOPROST|CARBOPLATIN|CARBOPLATIN",41,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Blood creatinine increased|Off label use,2,3
20483281,20220217,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,ACYCLOVIR|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|ALLOPURINOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|RITUXIMAB|LENALIDOMIDE,12,Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|B-cell lymphoma,Cytokine release syndrome,1,1
20483995,20220217,Epcoritamab,66,801,66.0,2,72,1,0,1,0,0,0,0,Epcoritamab,"LENALIDOMIDE|RITUXIMAB|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACYCLOVIR",8,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Vascular stent thrombosis,1,1
20484621,20220217,Epcoritamab,44,801,44.0,2,58.6,1,0,1,1,0,0,0,Epcoritamab,RITUXIMAB|BENDAMUSTINE HCL|FLUCONAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|CALCIUM CARBONATE|ANTACID|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|ACYCLOVIR|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ALBUTEROL SULFATE|ALBUTEROL,32,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cholecystitis infective|Cytokine release syndrome,2,3
20490098,20220218,Epcoritamab,69,801,69.0,1,91,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE SODIUM PHOSPHATE|CYTARABINE|OXALIPLATIN|RITUXIMAB|DEXCHLORPHENIRAMINE MALEATE|LOSARTAN|HYDROCHLOROTHIAZIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|MEROPENEM|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|CEFTRIAXONE|CEFTRIAXONE SODIUM|PREGABALIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|AMIKACIN|RASBURICASE|ADENOSINE|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE",29,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Immune effector cell-associated neurotoxicity syndrome|Off label use,2,3
20491049,20220218,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALLOPURINOL|ACYCLOVIR|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|RITUXIMAB|LENALIDOMIDE,12,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|B-cell lymphoma,Cytokine release syndrome,1,1
20492717,20220219,Epcoritamab,76,801,76.0,2,51.3,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|DEXCHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|ALLOPURINOL|FLUCONAZOLE|FUROSEMIDE|LORAZEPAM|MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREDNISONE|AMLODIPINE|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|FILGRASTIM|FUROSEMIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|LOSARTAN|CALCIUM CARBONATE|ANTACID|POTASSIUM PHOSPHATE, MONOBASIC|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|RASBURICASE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|TRIMETHOPRIM|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN",44,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Prophylaxis|Prophylaxis|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Prophylaxis|Prophylaxis|Prophylaxis|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Febrile neutropenia|Off label use|Cytokine release syndrome,3,3
20494557,20220221,Epcoritamab,67,801,67.0,2,76.2,1,0,1,0,0,0,0,Epcoritamab,LENALIDOMIDE|RITUXIMAB|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ALLOPURINOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|AMLODIPINE BESYLATE AND VALSARTAN|DALTEPARIN SODIUM|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ATORVASTATIN CALCIUM|MAGNESIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|VALACYCLOVIR HYDROCHLORIDE|LACTULOSE,20,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,5
20495726,20220221,Epcoritamab,62,801,62.0,1,125.7,1,0,1,0,0,0,0,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|OXYGEN|0XYGEN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|SITAGLIPTIN",16,Follicular lymphoma|Follicular lymphoma|Pneumocystis jirovecii infection|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Dehydration|Pneumocystis jirovecii infection|Diarrhoea,4,1
20497315,20220221,Epcoritamab,62,801,62.0,1,125.7,1,1,1,1,1,1,1,Epcoritamab,ENALAPRIL|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|SIMVASTATIN|LENALIDOMIDE|RITUXIMAB|SITAGLIPTIN,8,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication,Disease progression|Pneumocystis jirovecii infection|Cytokine release syndrome|Diarrhoea|Colitis|Dehydration|Abdominal pain,7,1
20497619,20220221,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|VINCRISTINE SULFATE|DOXORUBICIN|DOXORUBICIN|DOXORUBICIN|DOXORUBICIN|DOXORUBICIN|DOXORUBICIN|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PREDNISOLONE ACETATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RAMIPRIL|AMLODIPINE|AMLODIPINE|ACYCLOVIR|ACYCLOVIR|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|BISOPROLOL FUMARATE|FOLIC ACID|ALLOPURINOL|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|FLUCONAZOLE|PROMETHAZINE HYDROCHLORIDE|PROMETHAZINE HYDROCHLORIDE|PROMETHAZINE HYDROCHLORIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|TRAMADOL HYDROCHLORIDE|RASBURICASE|FLUCONAZOLE|FLUCONAZOLE|DICLOFENAC SODIUM",131,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Product used for unknown indication|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Product used for unknown indication|Prophylaxis|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Hyponatraemia|Neutropenic infection|Pneumonia|Enterocolitis infectious,4,1
20500204,20220222,Epcoritamab,50,801,50.0,1,87.8,1,0,1,0,0,0,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|BENZONATATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|REMDESIVIR|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE",18,B-cell lymphoma|B-cell lymphoma|B-cell lymphoma|COVID-19|Cough|Cough|Pyrexia|COVID-19|Product used for unknown indication|Product used for unknown indication|Prophylaxis,Pneumonia|Pneumonia,2,1
20504670,20220223,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|ACYCLOVIR|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED",18,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Device occlusion,1,1
20507458,20220223,Epcoritamab,62,801,62.0,1,125.7,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|SITAGLIPTIN|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|ENALAPRIL|SIMVASTATIN|ACYCLOVIR,16,Follicular lymphoma|Follicular lymphoma|Pneumocystis jirovecii infection,Pneumocystis jirovecii infection|Cytokine release syndrome|Diarrhoea|Dehydration,4,3
20510243,20220224,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|CYTARABINE|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|FILGRASTIM|ACYCLOVIR|LATANOPROST|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SULFAMETHOXAZOLE AND TRIMETHOPRIM|LISINOPRIL|TRAMADOL HYDROCHLORIDE|METHYLPREDNISOLONE|FUROSEMIDE|CETIRIZINE HYDROCHLORIDE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|ENOXAPARIN SODIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|BUMETANIDE|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|ALLOPURINOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DARBEPOETIN ALFA|FOLIC ACID|DEXAMETHASONE SODIUM PHOSPHATE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|BISOPROLOL FUMARATE|ATORVASTATIN CALCIUM|MAGNESIUM|FLUCONAZOLE",41,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Acute kidney injury|Blood creatinine increased|Off label use,3,3
20510626,20220224,Epcoritamab,67,801,67.0,2,61,1,0,1,1,0,0,0,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|APIXABAN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|MEROPENEM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",24,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Febrile neutropenia|Follicular lymphoma,2,1
20511322,20220224,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"ACYCLOVIR|LENALIDOMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALLOPURINOL|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|AMOXICILLIN",13,Product used for unknown indication|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,1
20511701,20220224,Epcoritamab,66,801,66.0,2,72,1,0,1,1,0,0,0,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|RITUXIMAB|ACYCLOVIR|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED",19,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Device occlusion,1,1
20512398,20220224,Epcoritamab,69,801,69.0,1,91,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|RITUXIMAB|CYTARABINE|LOSARTAN|HYDROCHLOROTHIAZIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MEROPENEM|AMIKACIN|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|RASBURICASE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|ADENOSINE|PREGABALIN|CEFTRIAXONE|CEFTRIAXONE SODIUM|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE BITARTRATE|METHYLPREDNISOLONE",43,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Immune effector cell-associated neurotoxicity syndrome|Off label use,2,3
20512511,20220224,Epcoritamab,66,801,66.0,2,72,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACYCLOVIR|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED",17,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Prophylaxis,Vascular stent occlusion,1,1
20518138,20220225,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACYCLOVIR|LENALIDOMIDE|RITUXIMAB|PREDNISONE|ALLOPURINOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",12,Product used for unknown indication|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,1
20526689,20220228,Epcoritamab,78,801,78.0,1,76.9,1,1,1,1,1,1,1,Epcoritamab,"VINCRISTINE SULFATE|RITUXIMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|BISOPROLOL FUMARATE|FOLIC ACID|AMLODIPINE|ALLOPURINOL|ACYCLOVIR|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|METHYLPREDNISOLONE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|RAMIPRIL",37,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|COVID-19 immunisation,Pneumonia|Neutrophil count decreased,2,3
20530307,20220301,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|APIXABAN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|MEROPENEM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR",24,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Febrile neutropenia|Follicular lymphoma|Disease progression|Off label use,4,1
20531626,20220301,Epcoritamab,62,801,62.0,1,125.7,1,0,1,0,0,0,0,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|ENALAPRIL|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|SIMVASTATIN|SITAGLIPTIN,10,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Pneumocystis jirovecii infection|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Pneumocystis jirovecii infection|Diarrhoea|Dehydration,4,3
20534052,20220301,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CYTARABINE|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LISINOPRIL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FUROSEMIDE|TRAMADOL HYDROCHLORIDE|ACYCLOVIR|METHYLPREDNISOLONE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|BISOPROLOL FUMARATE|ALLOPURINOL|LATANOPROST|DARBEPOETIN ALFA|SULFAMETHOXAZOLE AND TRIMETHOPRIM|FOLIC ACID|ATORVASTATIN CALCIUM|FLUCONAZOLE|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|MAGNESIUM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|BUMETANIDE|DEXAMETHASONE SODIUM PHOSPHATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ENOXAPARIN SODIUM|FILGRASTIM",41,Product used for unknown indication|Product used for unknown indication|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication,Blood creatinine increased|Off label use|Acute kidney injury,3,3
20534211,20220301,Epcoritamab,62,801,62.0,1,125.7,1,0,1,1,0,0,0,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|SIMVASTATIN|SITAGLIPTIN|ACYCLOVIR|TOCILIZUMAB|ENALAPRIL,23,Follicular lymphoma|Pneumocystis jirovecii infection|Product used for unknown indication|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pyrexia|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Dehydration|Pneumocystis jirovecii infection|Diarrhoea,4,3
20542844,20220302,Epcoritamab,62,801,62.0,1,125.7,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|OXYGEN|0XYGEN|TRIMETHOPRIM,15,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pneumocystis jirovecii infection|Pneumocystis jirovecii infection,Dehydration,1,1
20543012,20220302,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CYTARABINE|RITUXIMAB|DEXAMETHASONE SODIUM PHOSPHATE|FILGRASTIM|ACYCLOVIR|LATANOPROST|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SULFAMETHOXAZOLE AND TRIMETHOPRIM|LISINOPRIL|TRAMADOL HYDROCHLORIDE|METHYLPREDNISOLONE|FUROSEMIDE|CETIRIZINE HYDROCHLORIDE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|ENOXAPARIN SODIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|BUMETANIDE|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|ALLOPURINOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DARBEPOETIN ALFA|FOLIC ACID|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|BISOPROLOL FUMARATE|ATORVASTATIN CALCIUM|MAGNESIUM|FLUCONAZOLE|AMOXICILLIN AND CLAVULANATE POTASSIUM",41,Diffuse large B-cell lymphoma stage III,Acute kidney injury|Blood creatinine increased|Off label use,3,3
20543726,20220303,Epcoritamab,76,801,76.0,2,51.3,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|ALLOPURINOL|AMLODIPINE BESYLATE|AMLODIPINE BESYLATE|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|FILGRASTIM|FLUCONAZOLE|FLUCONAZOLE|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|LORAZEPAM|LORAZEPAM|LOSARTAN|MAGNESIUM|MAGNESIUM|MAGNESIUM|CALCIUM CARBONATE|ANTACID|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PANTOPRAZOLE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXCHLORPHENIRAMINE MALEATE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM PHOSPHATE|PREDNISONE|RASBURICASE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|TRIMETHOPRIM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE",57,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Febrile neutropenia|Cytokine release syndrome|Off label use,3,3
20544496,20220303,Epcoritamab,62,801,62.0,1,125.7,1,0,1,1,0,0,0,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|OXYGEN|0XYGEN|TRIMETHOPRIM|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE,15,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Pneumocystis jirovecii infection|Product used for unknown indication|Pneumocystis jirovecii infection,Dehydration,1,1
20544711,20220303,Epcoritamab,76,801,76.0,2,51.3,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN|ALLOPURINOL|AMLODIPINE BESYLATE|FUROSEMIDE|FLUCONAZOLE|LORAZEPAM|MAGNESIUM|METHYLPREDNISOLONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXCHLORPHENIRAMINE MALEATE|ALBUMIN HUMAN|AMLODIPINE|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|FILGRASTIM|FUROSEMIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|LOSARTAN|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|CALCIUM CARBONATE|ANTACID|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM PHOSPHATE|PREDNISONE|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|RASBURICASE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|TRIMETHOPRIM",41,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Febrile neutropenia|Off label use,3,3
20545291,20220303,Epcoritamab,56,801,56.0,2,83.20,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|ATORVASTATIN CALCIUM|BIOTIN|BUPROPION|ERGOCALCIFEROL|GABAPENTIN|LEVOTHYROXINE SODIUM|LIDOCAINE PATCH 5%|LORAZEPAM|LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE|MAGNESIUM|MONTELUKAST SODIUM|OMEPRAZOLE MAGNESIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|GEMCITABINE HYDROCHLORIDE|GEMCITABINE",25,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Pneumonia|Off label use,2,3
20546524,20220303,Epcoritamab,,,,0,,1,0,1,0,0,0,0,Epcoritamab,"ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALLOPURINOL|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|PREDNISONE|AMOXICILLIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LENALIDOMIDE|RITUXIMAB|ACYCLOVIR",14,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|B-cell lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,3
20546816,20220303,Epcoritamab,62,801,62.0,1,125.7,1,0,1,1,0,0,0,Epcoritamab,"RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|SITAGLIPTIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OXYGEN|0XYGEN|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE",16,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Pneumocystis jirovecii infection|Product used for unknown indication|Product used for unknown indication,Dehydration|Cytokine release syndrome|Pneumocystis jirovecii infection|Diarrhoea,4,1
20547415,20220303,Epcoritamab,53,801,53.0,1,82.1,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|GABAPENTIN|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|QUETIAPINE|BUPROPION HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE|DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE|DIPHENHYDRAMINE HYDROCHLORIDE|DULOXETINE HYDROCHLORIDE|MEPERIDINE HYDROCHLORIDE|NALOXONE HYDROCHLORIDE NASAL|NALOXONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|POLYETHYLENE GLYCOL 3350",24,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Premedication|Premedication|Premedication,Fatigue|Depression,2,3
20548169,20220303,Epcoritamab,67,801,67.0,2,76.2,1,0,1,0,0,0,0,Epcoritamab,LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ALLOPURINOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|AMLODIPINE BESYLATE AND VALSARTAN|DALTEPARIN SODIUM|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ATORVASTATIN CALCIUM|MAGNESIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|VALACYCLOVIR HYDROCHLORIDE|FUROSEMIDE|LACTULOSE,31,Follicular lymphoma|B-cell lymphoma|B-cell lymphoma|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Cytokine release syndrome,2,3
20548590,20220303,Epcoritamab,62,801,62.0,1,125.7,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|TRIMETHOPRIM|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|ENALAPRIL|SIMVASTATIN|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS,16,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Diarrhoea|Cytokine release syndrome|Pneumocystis jirovecii infection,3,3
20549789,20220304,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|CYTARABINE|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|FILGRASTIM|ACYCLOVIR|LATANOPROST|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SULFAMETHOXAZOLE AND TRIMETHOPRIM|LISINOPRIL|TRAMADOL HYDROCHLORIDE|METHYLPREDNISOLONE|FUROSEMIDE|CETIRIZINE HYDROCHLORIDE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|ENOXAPARIN SODIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|BUMETANIDE|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|ALLOPURINOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DARBEPOETIN ALFA|FOLIC ACID|DEXAMETHASONE SODIUM PHOSPHATE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|BISOPROLOL FUMARATE|ATORVASTATIN CALCIUM|MAGNESIUM|FLUCONAZOLE",41,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Off label use|Acute kidney injury|Blood creatinine increased,3,3
20553967,20220304,Epcoritamab,44,801,44.0,2,58.6,1,0,1,0,0,0,0,Epcoritamab,BENDAMUSTINE HYDROCHLORIDE|RITUXIMAB|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|ALBUTEROL SULFATE|ALBUTEROL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,28,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cholecystitis infective|Cytokine release syndrome|Cytokine release syndrome,3,1
20556439,20220305,Epcoritamab,62,801,62.0,1,125.7,1,1,1,1,1,1,1,Epcoritamab,METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|ENALAPRIL|LENALIDOMIDE|RITUXIMAB|SIMVASTATIN|SITAGLIPTIN,8,Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma|Product used for unknown indication,Disease progression|Cytokine release syndrome|Pneumocystis jirovecii infection|Dehydration|Colitis|Abdominal pain|Diarrhoea,7,1
20558341,20220307,Epcoritamab,74,801,74.0,2,65,1,0,1,0,0,0,0,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|PREDNISONE|PREDNISONE|PREDNISONE|CARVEDILOL|DULOXETINE HYDROCHLORIDE|DULOXETINE|FERROUS SULFATE|GLIPIZIDE|LISINOPRIL|LORAZEPAM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,30,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Mental status changes,1,1
20558580,20220307,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|OXYGEN|0XYGEN|TRIMETHOPRIM|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE,15,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Pneumocystis jirovecii infection|Product used for unknown indication|Pneumocystis jirovecii infection,Dehydration,1,1
20563673,20220308,Epcoritamab,62,801,62.0,1,125.7,1,1,1,1,1,1,1,Epcoritamab,SIMVASTATIN|ENALAPRIL MALEATE|ENALAPRIL|RITUXIMAB|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|LENALIDOMIDE|SITAGLIPTIN,8,Product used for unknown indication|Product used for unknown indication|Follicular lymphoma|Product used for unknown indication|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma,Cytokine release syndrome|Diarrhoea|Pneumocystis jirovecii infection|Dehydration|Colitis|Abdominal pain|Disease progression,7,1
20563852,20220308,Epcoritamab,51,801,51.0,1,96.1,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|RITUXIMAB|RITUXIMAB|RITUXIMAB|SODIUM PHOSPHATE|CARBOPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CLEMASTINE FUMARATE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|METHYLPREDNISOLONE SODIUM SUCCINATE|FLUTICASONE FUROATE|DICLOFENAC|DICLOFENAC SODIUM|FLUCONAZOLE|LIDOCAINE HYDROCHLORIDE|LIDOCAINE HYDROCHLORIDE ANHYDROUS|CETIRIZINE HYDROCHLORIDE|MORPHINE|VITAMIN A PALMITATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FUROSEMIDE|FUROSEMIDE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|FILGRASTIM|TRAMADOL HYDROCHLORIDE|ACYCLOVIR|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|METHYLPREDNISOLONE",60,B-cell lymphoma|B-cell lymphoma|Diffuse large B-cell lymphoma|Lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Product used for unknown indication|Premedication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Thrombocytopenia|Neutropenia,2,3
20563871,20220308,Epcoritamab,51,801,51.0,1,96.1,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE SODIUM PHOSPHATE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CARBOPLATIN|RITUXIMAB|RITUXIMAB|RITUXIMAB|MORPHINE|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|VITAMIN A PALMITATE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|FUROSEMIDE|FUROSEMIDE|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|TRAMADOL HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|HUMAN IMMUNOGLOBULIN G|LIDOCAINE HYDROCHLORIDE|LIDOCAINE HYDROCHLORIDE ANHYDROUS|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|OXYMETAZOLINE HYDROCHLORIDE|FILGRASTIM|FLUCONAZOLE|AMOXICILLIN AND CLAVULANATE POTASSIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CHLORHEXIDINE GLUCONATE|ANTISEPTIC SKIN CLEANSER|ACYCLOVIR|FLUTICASONE FUROATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHYLPREDNISOLONE",56,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Neutropenia,1,3
20564333,20220308,Epcoritamab,51,801,51.0,1,96.1,1,1,1,1,1,1,1,Epcoritamab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|RITUXIMAB|RITUXIMAB|CARBOPLATIN|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|FLUCONAZOLE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FLUTICASONE FUROATE|VITAMIN A PALMITATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACYCLOVIR|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|FUROSEMIDE|CETIRIZINE HYDROCHLORIDE,29,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Neutropenia,1,1
20566463,20220308,Epcoritamab,76,801,76.0,2,51.3,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXCHLORPHENIRAMINE MALEATE|LORAZEPAM|ALLOPURINOL|MAGNESIUM|FUROSEMIDE|METHYLPREDNISOLONE|AMLODIPINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FLUCONAZOLE,20,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Febrile neutropenia|Off label use,3,3
20566787,20220308,Epcoritamab,56,801,56.0,2,83.2,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ATORVASTATIN CALCIUM|BIOTIN|BUPROPION|ERGOCALCIFEROL|GABAPENTIN|LEVOTHYROXINE SODIUM|LIDOCAINE PATCH 5%|LORAZEPAM|LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE|MAGNESIUM|MONTELUKAST SODIUM|OMEPRAZOLE MAGNESIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS",25,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Pneumonia,1,1
20567154,20220308,Epcoritamab,76,801,76.0,2,51.3,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXCHLORPHENIRAMINE MALEATE|LORAZEPAM|ALLOPURINOL|MAGNESIUM|MAGNESIUM|FUROSEMIDE|FUROSEMIDE|FLUCONAZOLE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|AMLODIPINE BESYLATE|AMLODIPINE BESYLATE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|FILGRASTIM|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|POTASSIUM PHOSPHATES|POTASSIUM PHOSPHATE, MONOBASIC AND POTASSIUM PHOSPHATE, DIBASIC|POTASSIUM PHOSPHATES IN SODIUM CHLORIDE|POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC|POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION,|MONOBASIC POTASSIUM PHOSPHATE AND DIBASIC POTASSIUM PHOSPHATE|POTASSIUM PHOSPHATE|PANTOPRAZOLE|PREDNISONE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|RASBURICASE|ALBUMIN HUMAN|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|TRIMETHOPRIM|ONDANSETRON HYDROCHLORIDE|LOSARTAN|CALCIUM CARBONATE|ANTACID|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE",53,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Premedication|Premedication|Prophylaxis|Prophylaxis,Malignant neoplasm progression|Diffuse large B-cell lymphoma|Febrile neutropenia|Cytokine release syndrome|Off label use,5,3
20568664,20220308,Epcoritamab,62,801,62.0,1,125.7,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|SITAGLIPTIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OXYGEN|0XYGEN|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE",15,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Pneumocystis jirovecii infection,Cytokine release syndrome|Pneumocystis jirovecii infection|Diarrhoea|Dehydration,4,1
20575788,20220310,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|SITAGLIPTIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OXYGEN|0XYGEN|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE",16,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Pneumocystis jirovecii infection|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Dehydration|Cytokine release syndrome|Pneumocystis jirovecii infection|Diarrhoea,4,1
20580641,20220311,Epcoritamab,65,801,65.0,1,80,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|FUROSEMIDE|FOLIC ACID,11,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Pneumothorax|Off label use,2,1
20581229,20220311,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|RITUXIMAB|RITUXIMAB|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CARBOPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MORPHINE|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|VITAMIN A PALMITATE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|FUROSEMIDE|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|TRAMADOL HYDROCHLORIDE|HUMAN IMMUNOGLOBULIN G|LIDOCAINE HYDROCHLORIDE|LIDOCAINE HYDROCHLORIDE ANHYDROUS|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|FILGRASTIM|FLUCONAZOLE|AMOXICILLIN AND CLAVULANATE POTASSIUM|CETIRIZINE HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CHLORHEXIDINE GLUCONATE|ANTISEPTIC SKIN CLEANSER|ACYCLOVIR|FLUTICASONE FUROATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHYLPREDNISOLONE",55,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Neutropenia,1,3
20584660,20220311,Epcoritamab,65,801,65.0,1,80,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|FUROSEMIDE|FOLIC ACID,11,,Pneumothorax|Off label use,2,1
20584666,20220311,Epcoritamab,75,801,75.0,2,89,1,0,1,0,0,0,0,Epcoritamab,"RITUXIMAB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PREDNISONE|PREDNISONE|PREDNISONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MAGNESIUM|BRIMONIDINE|BRIMONIDINE TARTRATE|CICLOPIROX|DABIGATRAN ETEXILATE|DIGOXIN|LEVOTHYROXINE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOPROLOL TARTRATE|METOPROLOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|PEGFILGRASTIM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|GRANISETRON|GRANISETRON HYDROCHLORIDE",43,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV,Pneumonia klebsiella|Urinary tract infection,2,1
20585735,20220312,Epcoritamab,79,801,79.0,2,88,1,0,1,0,0,0,0,Epcoritamab,BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|RITUXIMAB|RITUXIMAB|PRAMIPEXOLE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALBUTEROL SULFATE|ALBUTEROL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CLEMASTINE FUMARATE,28,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication,Hydronephrosis|Constipation|Sepsis|Blood creatinine increased,4,1
20591947,20220314,Epcoritamab,46,801,46.0,1,87.6,1,0,1,0,0,0,0,Epcoritamab,LENALIDOMIDE|RITUXIMAB,3,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,Cytokine release syndrome,1,3
20595031,20220315,Epcoritamab,56,801,56.0,2,83.2,1,1,1,1,1,1,1,Epcoritamab,"PREDNISONE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ATORVASTATIN CALCIUM|BIOTIN|BUPROPION|ERGOCALCIFEROL|GABAPENTIN|LEVOTHYROXINE SODIUM|LIDOCAINE PATCH 5%|LORAZEPAM|LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE|MAGNESIUM|MONTELUKAST SODIUM|OMEPRAZOLE MAGNESIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",25,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Sudden cardiac death|Pneumonia,2,3
20601609,20220316,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|TRAMADOL HYDROCHLORIDE|BUMETANIDE|CLEMASTINE FUMARATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|COLCHICINE|DEXAMETHASONE SODIUM PHOSPHATE|AMITRIPTYLINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|METHYLPREDNISOLONE SODIUM SUCCINATE|LATANOPROST|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|ENOXAPARIN SODIUM|VITAMIN A PALMITATE|ACYCLOVIR|FLUCONAZOLE|FILGRASTIM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|FUROSEMIDE|METHYLPREDNISOLONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",43,,Acute kidney injury|Periodontitis|Cardiac failure,3,3
20605686,20220317,Epcoritamab,67,801,67.0,2,76.2,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ALLOPURINOL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|AMLODIPINE BESYLATE AND VALSARTAN|DALTEPARIN SODIUM|VALACYCLOVIR HYDROCHLORIDE|MAGNESIUM|ATORVASTATIN CALCIUM|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|FUROSEMIDE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|SULFAMETHOXAZOLE AND TRIMETHOPRIM|LACTULOSE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|SITAGLIPTIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS,45,B-cell lymphoma|B-cell lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Off label use|Off label use|Cytokine release syndrome|Pneumocystis jirovecii pneumonia,4,5
20605722,20220317,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|SULFAMETHOXAZOLE AND TRIMETHOPRIM|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ALLOPURINOL|HYDROCORTISONE SODIUM SUCCINATE|HYDROCORTISONE SODIUM SUCCINATE|VALACYCLOVIR HYDROCHLORIDE,18,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Atrial flutter,2,1
20605807,20220317,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ENALAPRIL|SIMVASTATIN|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|SITAGLIPTIN|ACYCLOVIR|TOCILIZUMAB,18,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Pneumocystis jirovecii infection|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pyrexia,Dehydration|Cytokine release syndrome|Pneumocystis jirovecii infection|Diarrhoea,4,3
20606560,20220317,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|AMOXICILLIN|FERROUS SULFATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PREDNISONE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALLOPURINOL|ACYCLOVIR|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",41,B-cell lymphoma|Follicular lymphoma|Follicular lymphoma stage III|B-cell lymphoma|Follicular lymphoma stage III|B-cell lymphoma|Follicular lymphoma|Follicular lymphoma stage III|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Pyrexia,Cytokine release syndrome|Hypotension|Pyrexia|Fibrin D dimer increased|C-reactive protein increased|Haemoglobin decreased,6,1
20633294,20220324,Epcoritamab,75,801,75.0,2,98,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PREDNISONE|DABIGATRAN ETEXILATE|PEGFILGRASTIM|MAGNESIUM|CEFUROXIME|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|GENTAMICIN|GENTAMICIN SULFATE|BRIMONIDINE|BRIMONIDINE TARTRATE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|CICLOPIROX|CALCIUM CARBONATE|ANTACID|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOPROLOL TARTRATE|METOPROLOL|LEVOTHYROXINE|GRANISETRON|GRANISETRON HYDROCHLORIDE|DABIGATRAN ETEXILATE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIGOXIN|DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE|DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE PRESERVATIVE FREE",42,,Pneumonia klebsiella|Off label use,2,3
20633771,20220324,Epcoritamab,57,801,57.0,1,90.2,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|VINCRISTINE SULFATE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",17,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,COVID-19,1,1
20634958,20220325,Epcoritamab,50,801,50.0,1,71.6,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|BENZONATATE|DEXTROMETHORPHAN HYDROBROMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|HOMATROPINE HYDROBROMIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SENNOSIDES|SENNA LEAF|SENNA|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|LORATADINE|LORATADINE ORAL|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PEGFILGRASTIM",45,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma|Neutrophil count decreased,Pneumonia|COVID-19,2,1
20637302,20220325,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|FLUCONAZOLE|TRAMADOL HYDROCHLORIDE|FOLIC ACID|ALLOPURINOL|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|DARBEPOETIN ALFA|LATANOPROST|LISINOPRIL|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|FILGRASTIM|ACYCLOVIR|BUMETANIDE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ENOXAPARIN SODIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BISOPROLOL FUMARATE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|MAGNESIUM|FUROSEMIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHYLPREDNISOLONE",41,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Acute kidney injury,1,3
20643224,20220328,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,ALLOPURINOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACYCLOVIR|LENALIDOMIDE|PREDNISONE|AMOXICILLIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RITUXIMAB,13,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|B-cell lymphoma,Cytokine release syndrome,1,1
20644013,20220328,Epcoritamab,57,801,57.0,1,89,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|RITUXIMAB|RITUXIMAB|DESLORATADINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE,9,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,3
20644722,20220328,Epcoritamab,75,801,75.0,2,89,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|LEVOTHYROXINE|DABIGATRAN ETEXILATE|METOPROLOL TARTRATE|METOPROLOL|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PEGFILGRASTIM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|BRIMONIDINE|BRIMONIDINE TARTRATE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CICLOPIROX|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DIGOXIN|MAGNESIUM|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|GRANISETRON|GRANISETRON HYDROCHLORIDE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR",45,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV,Pneumonia klebsiella|Urinary tract infection|Weight increased|Body temperature increased|Off label use,5,1
20650926,20220329,Epcoritamab,46,801,46.0,1,87.6,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|VINCRISTINE SULFATE|VINCRISTINE SULFATE|ACYCLOVIR|TRIMETHOPRIM|TRIMETHOPRIM|TRIMETHOPRIM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|METHYLPREDNISOLONE|PREDNISONE,21,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,Cytokine release syndrome,1,1
20651077,20220329,Epcoritamab,57,801,57.0,1,90.2,1,1,1,0,0,0,0,Epcoritamab,"PREDNISONE|PREDNISONE|PREDNISONE|DOXORUBICIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",13,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,COVID-19,1,3
20651835,20220330,Epcoritamab,67,801,67.0,2,76.2,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|FUROSEMIDE|FUROSEMIDE|MAGNESIUM|MAGNESIUM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR HYDROCHLORIDE|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|DALTEPARIN SODIUM|DALTEPARIN SODIUM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ALLOPURINOL|ALLOPURINOL|AMLODIPINE BESYLATE AND VALSARTAN|AMLODIPINE BESYLATE AND VALSARTAN|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM|LACTULOSE|LACTULOSE|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SITAGLIPTIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS,63,Follicular lymphoma|B-cell lymphoma|Follicular lymphoma|B-cell lymphoma|B-cell lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Pneumocystis jirovecii pneumonia|Off label use,3,3
20656100,20220330,Epcoritamab,62,801,62.0,1,125.70,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|TRIMETHOPRIM|ENALAPRIL|SIMVASTATIN|SIMVASTATIN|SITAGLIPTIN|SITAGLIPTIN|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|TOCILIZUMAB",23,Follicular lymphoma|Pneumocystis jirovecii infection|Follicular lymphoma|Follicular lymphoma stage III|Pneumocystis jirovecii infection|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Cytokine release syndrome|Pyrexia|Diarrhoea|Diarrhoea,Malignant neoplasm progression|Cytokine release syndrome|Pneumocystis jirovecii infection|Diarrhoea|Dehydration,5,3
20657547,20220331,Epcoritamab,50,801,50.0,1,71.6,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|DEXTROMETHORPHAN HYDROBROMIDE|DEXTROMETHORPHAN HYDROBROMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CALCIUM CARBONATE|ANTACID|LORATADINE|LORATADINE ORAL|PANTOPRAZOLE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MAGNESIUM HYDROXIDE|MAGNESIUM HYDROXIDE|MAGNESIUM HYDROXIDE|MAGNESIUM HYDROXIDE|MAGNESIUM HYDROXIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|BENZONATATE|BENZONATATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PREDNISONE|PREDNISONE|FILGRASTIM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LACTULOSE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|SENNOSIDES A AND B|ENTECAVIR|ENTECAVIR ANHYDROUS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PEGFILGRASTIM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL",70,Follicular lymphoma stage IV|B-cell lymphoma|Follicular lymphoma stage IV|B-cell lymphoma|Follicular lymphoma stage IV|B-cell lymphoma|Cough|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|COVID-19|Cough|Pyrexia|Prophylaxis|Product used for unknown indication|Neutrophil count decreased|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Pneumonia|COVID-19,2,1
20662354,20220401,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|CYTARABINE|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|FILGRASTIM|ACYCLOVIR|LATANOPROST|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SULFAMETHOXAZOLE AND TRIMETHOPRIM|LISINOPRIL|TRAMADOL HYDROCHLORIDE|METHYLPREDNISOLONE|FUROSEMIDE|CETIRIZINE HYDROCHLORIDE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|ENOXAPARIN SODIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|BUMETANIDE|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|ALLOPURINOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DARBEPOETIN ALFA|FOLIC ACID|DEXAMETHASONE SODIUM PHOSPHATE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|BISOPROLOL FUMARATE|ATORVASTATIN CALCIUM|MAGNESIUM|FLUCONAZOLE",41,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Acute kidney injury,1,3
20676502,20220405,Epcoritamab,68,801,68.0,1,72,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|HYDROCORTISONE SODIUM SUCCINATE|HYDROCORTISONE SODIUM SUCCINATE|ALLOPURINOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|VALSARTAN|VALSARTAN ORAL,31,Follicular lymphoma|Follicular lymphoma|B-cell lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,COVID-19|Cytokine release syndrome|Atrial flutter|Off label use|Pneumonia,5,3
20686278,20220407,Epcoritamab,,,,2,67.3,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|ALLOPURINOL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|PANTOPRAZOLE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|CALCIUM CARBONATE|ANTACID|ACYCLOVIR|CLEMASTINE FUMARATE|MAGNESIUM HYDROXIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,35,Follicular lymphoma|Histology|Follicular lymphoma stage IV|Follicular lymphoma|Follicular lymphoma stage IV|Follicular lymphoma|Histology abnormal|Follicular lymphoma stage IV|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Pyrexia|Rash maculo-papular|Cytokine release syndrome,3,3
20691252,20220408,Epcoritamab,65,801,65.0,2,60.30,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|ALLOPURINOL|PANTOPRAZOLE,42,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Toxic skin eruption,1,3
20704419,20220413,Epcoritamab,42,801,42.0,1,138,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|RITUXIMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ROSUVASTATIN|CYANOCOBALAMIN|EZETIMIBE|BISOPROLOL FUMARATE|SILDENAFIL CITRATE|SILDENAFIL|SILDENAFIL POWDER,|NITROGLYCERIN|OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ALLOPURINOL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR",28,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Thrombophlebitis,1,1
20704600,20220413,Epcoritamab,65,801,65.0,2,,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|RITUXIMAB|RITUXIMAB,4,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III,Toxic skin eruption,1,3
20705752,20220413,Epcoritamab,55,801,55.0,2,67.3,1,0,1,0,0,0,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|RITUXIMAB|RITUXIMAB|RITUXIMAB|PANTOPRAZOLE|MAGNESIUM HYDROXIDE|MAGNESIUM HYDROXIDE|MAGNESIUM HYDROXIDE|MAGNESIUM HYDROXIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ACYCLOVIR|ACYCLOVIR|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|CALCIUM CARBONATE|ANTACID,80,Follicular lymphoma stage IV|Histology|Follicular lymphoma|Prophylaxis|Histology abnormal|Follicular lymphoma|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytomegalovirus test positive|Hypersensitivity|Cytokine release syndrome|Pyrexia|Infusion related reaction,5,3
20710064,20220414,Epcoritamab,75,801,75.0,2,98,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN|DOXORUBICIN|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|LEVOTHYROXINE|DIGOXIN|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|BRIMONIDINE|BRIMONIDINE TARTRATE|PREDNISONE|PREDNISONE|CICLOPIROX|MAGNESIUM|PREDNISONE|PEGFILGRASTIM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|GRANISETRON|GRANISETRON HYDROCHLORIDE|METOPROLOL TARTRATE|METOPROLOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|DABIGATRAN ETEXILATE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR",44,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Pneumonia klebsiella|Urinary tract infection,2,1
20712833,20220415,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"ALLOPURINOL|ACYCLOVIR|LENALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RITUXIMAB|AMOXICILLIN|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|PREDNISONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACYCLOVIR|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FERROUS SULFATE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RITUXIMAB|RITUXIMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METHYLPREDNISOLONE|METHYLPREDNISOLONE|PREDNISONE",35,Prophylaxis|Prophylaxis|Follicular lymphoma stage III|Pain|Follicular lymphoma stage III|Follicular lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pyrexia|Follicular lymphoma stage III|Follicular lymphoma stage III|Pain|Pain|Follicular lymphoma stage III|Follicular lymphoma stage III|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,3
20736309,20220421,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|AMOXICILLIN|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|LENALIDOMIDE|LENALIDOMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACYCLOVIR|ACYCLOVIR|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FERROUS SULFATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,",74,Product used for unknown indication|Prophylaxis|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pain|Product used for unknown indication|Pain|Product used for unknown indication|Pain|Product used for unknown indication|Pain|B-cell lymphoma|Follicular lymphoma|B-cell lymphoma|Follicular lymphoma|B-cell lymphoma|Follicular lymphoma|B-cell lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Prophylaxis|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Product used for unknown indication,Hypotension|Cytokine release syndrome|Pyrexia|Fibrin D dimer increased|C-reactive protein increased|Haemoglobin decreased,6,1
20737559,20220422,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACYCLOVIR|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|AMOXICILLIN|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FERROUS SULFATE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE",49,B-cell lymphoma|Follicular lymphoma|Pain|Prophylaxis|Follicular lymphoma|Prophylaxis|Follicular lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Follicular lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication,Pyrexia|Hypotension|Cytokine release syndrome|C-reactive protein increased|Fibrin D dimer increased|Haemoglobin decreased,6,3
20737579,20220422,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|ALLOPURINOL|RITUXIMAB|RITUXIMAB|RITUXIMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACYCLOVIR|FERROUS SULFATE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,",29,Follicular lymphoma stage III|Prophylaxis|Follicular lymphoma stage III|Follicular lymphoma stage III|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pyrexia,Cytokine release syndrome|Pyrexia,2,3
20739170,20220422,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"ACYCLOVIR|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|RITUXIMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALLOPURINOL|LENALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PREDNISONE|FERROUS SULFATE|METHYLPREDNISOLONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,",19,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,3
20743749,20220425,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|RITUXIMAB|ACYCLOVIR|ALLOPURINOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|PREDNISONE|METHYLPREDNISOLONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FERROUS SULFATE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,",21,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III|Prophylaxis|Prophylaxis|Prophylaxis|Pyrexia|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Pain|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Hypotension|Cytokine release syndrome,2,1
20743756,20220425,Epcoritamab,65,801,65.0,2,,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE,4,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage II,Toxic skin eruption,1,3
20746562,20220425,Epcoritamab,42,801,42.0,1,138,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|LENALIDOMIDE|ALLOPURINOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ROSUVASTATIN|BISOPROLOL FUMARATE|OXYCODONE HYDROCHLORIDE|OXYCODONE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|NITROGLYCERIN|EZETIMIBE|CYANOCOBALAMIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|PREDNISONE|OXYCODONE HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|SILDENAFIL CITRATE|SILDENAFIL|SILDENAFIL POWDER,",28,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Thrombophlebitis,1,1
20749789,20220426,Epcoritamab,55,801,55.0,2,67.3,1,1,1,1,1,1,1,Epcoritamab,ALLOPURINOL|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|CALCIUM CARBONATE|ANTACID|CALCIUM CARBONATE|ANTACID|MAGNESIUM HYDROXIDE|MAGNESIUM HYDROXIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,63,Prophylaxis|Follicular lymphoma stage IV|Histology|Follicular lymphoma|Follicular lymphoma stage IV|Follicular lymphoma|Histology abnormal|Follicular lymphoma|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Pyrexia|Rash maculo-papular|Cytomegalovirus test positive|Infusion related reaction|Hypersensitivity,6,3
20752076,20220426,Epcoritamab,72,801,72.0,1,50.0,1,0,1,0,0,0,0,Epcoritamab,"RITUXIMAB|ALLOPURINOL|LENALIDOMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|METHYLPREDNISOLONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FERROUS SULFATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",19,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Pyrexia|Cytokine release syndrome,2,3
20757113,20220427,Epcoritamab,65,801,65.0,2,164,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|PREDNISONE|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|GENTAMICIN|GENTAMICIN SULFATE|FLUCONAZOLE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE",19,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Premedication|Premedication|Premedication|Premedication,Dyspepsia,1,3
20757326,20220427,Epcoritamab,42,801,42.0,1,138,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|LENALIDOMIDE|ALLOPURINOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ROSUVASTATIN|BISOPROLOL FUMARATE|OXYCODONE HYDROCHLORIDE|OXYCODONE|SILDENAFIL CITRATE|SILDENAFIL|SILDENAFIL POWDER,|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|NITROGLYCERIN|EZETIMIBE|CYANOCOBALAMIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|PREDNISONE|OXYCODONE HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",28,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Thrombophlebitis,1,1
20767818,20220429,Epcoritamab,65,801,65.0,2,60.30,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|RITUXIMAB|RITUXIMAB|CLEMASTINE FUMARATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|ALLOPURINOL|PANTOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,13,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Toxic skin eruption,1,3
20767932,20220429,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|DESLORATADINE,9,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,1
20769454,20220429,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ALLOPURINOL|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RITUXIMAB|ACYCLOVIR|LENALIDOMIDE|FERROUS SULFATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|METHYLPREDNISOLONE,20,Prophylaxis|Prophylaxis|Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III|Pain|Follicular lymphoma stage III|Prophylaxis|Follicular lymphoma stage III,Hypotension|Cytokine release syndrome,2,1
20771605,20220430,Epcoritamab,55,801,55.0,2,67.3,1,0,1,0,0,0,1,Epcoritamab,LENALIDOMIDE,2,Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Rash maculo-papular|Pyrexia,3,1
20775878,20220502,Epcoritamab,55,801,55.0,2,67.3,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|PANTOPRAZOLE,12,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Rash maculo-papular|Pyrexia,3,3
20778089,20220503,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"ACYCLOVIR|ACYCLOVIR|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALLOPURINOL|ALLOPURINOL|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|PREDNISONE|PREDNISONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LENALIDOMIDE|LENALIDOMIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|FERROUS SULFATE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",42,Product used for unknown indication|Prophylaxis|Prophylaxis|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma|B-cell lymphoma|Follicular lymphoma|B-cell lymphoma|Pain|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|Follicular lymphoma|Product used for unknown indication|Prophylaxis|Follicular lymphoma|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Pyrexia|Cytokine release syndrome|Hypotension|Haemoglobin decreased|Fibrin D dimer increased|C-reactive protein increased,6,1
20792496,20220506,Epcoritamab,,,,1,138,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ROSUVASTATIN|CYANOCOBALAMIN|EZETIMIBE|BISOPROLOL FUMARATE|SILDENAFIL CITRATE|SILDENAFIL|SILDENAFIL POWDER,|NITROGLYCERIN|OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ALLOPURINOL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR",29,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Thrombophlebitis,1,3
20806602,20220510,Epcoritamab,73,801,73.0,1,82,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|CANDESARTAN|DAPAGLIFLOZIN|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR,27,Follicular lymphoma|Follicular lymphoma stage III|Follicular lymphoma|Follicular lymphoma stage III|Follicular lymphoma|Follicular lymphoma stage III,COVID-19 pneumonia,1,3
20807174,20220510,Epcoritamab,53,801,53.0,1,82.1,1,0,1,0,0,0,0,Epcoritamab,"BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|BUPROPION|GABAPENTIN|RITUXIMAB|CETIRIZINE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE|DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE|DIPHENHYDRAMINE HYDROCHLORIDE|DULOXETINE HYDROCHLORIDE|GABAPENTIN|MEPERIDINE HYDROCHLORIDE|NALOXONE HYDROCHLORIDE NASAL|NALOXONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|POLYETHYLENE GLYCOL 3350|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",27,Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma stage IV|Follicular lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication,Fatigue|Depression,2,1
20814553,20220511,Epcoritamab,67,801,67.0,2,76.2,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|AMLODIPINE BESYLATE AND VALSARTAN|DALTEPARIN SODIUM|FUROSEMIDE|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|LACTULOSE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ATORVASTATIN CALCIUM|MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LENALIDOMIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR HYDROCHLORIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ALLOPURINOL|ALLOPURINOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SITAGLIPTIN,53,Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|B-cell lymphoma|B-cell lymphoma|B-cell lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Pneumocystis jirovecii pneumonia|Cytokine release syndrome|Intentional product use issue|Product use issue|Off label use,5,5
20816553,20220512,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"ALLOPURINOL|LENALIDOMIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|PREDNISONE|PREDNISONE|ACYCLOVIR|RITUXIMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|FERROUS SULFATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",34,Prophylaxis|B-cell lymphoma|Prophylaxis|Pain|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma|Product used for unknown indication|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Pyrexia|Hypotension|Pyrexia|Fibrin D dimer increased|Haemoglobin decreased|C-reactive protein increased,7,1
20822456,20220512,Epcoritamab,73,801,73.0,2,65,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|LISINOPRIL|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|CARVEDILOL|DULOXETINE HYDROCHLORIDE|DULOXETINE|FERROUS SULFATE|GLIPIZIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|LORAZEPAM|CYANOCOBALAMIN|CEFEPIME HYDROCHLORIDE|CEFEPIME|CEFEPIME HYDROCHLORIDE|CEFEPIME|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM,46,Follicular lymphoma|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Pneumonia|Sinus tachycardia|Bundle branch block right|Candida infection,4,3
20825152,20220513,Epcoritamab,69,801,69.0,1,91,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|DEXAMETHASONE SODIUM PHOSPHATE|RITUXIMAB|CYTARABINE|LOSARTAN|DEXCHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|HYDROCHLOROTHIAZIDE|METHYLPREDNISOLONE|MEROPENEM|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|CEFTRIAXONE|CEFTRIAXONE SODIUM|PREGABALIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|AMIKACIN|RASBURICASE|ADENOSINE|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE",26,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Immune effector cell-associated neurotoxicity syndrome|Off label use,2,3
20825367,20220513,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"AMOXICILLIN|RITUXIMAB|RITUXIMAB|RITUXIMAB|FERROUS SULFATE|ALLOPURINOL|ACYCLOVIR|ACYCLOVIR|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|PREDNISONE|PREDNISONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LENALIDOMIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALLOPURINOL|PREDNISONE",40,Product used for unknown indication|B-cell lymphoma|B-cell lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Prophylaxis|Prophylaxis|Pain|Pain|Pain|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Product used for unknown indication|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication,Hypotension|Pyrexia|Cytokine release syndrome|Haemoglobin decreased|Fibrin D dimer increased|Pyrexia|C-reactive protein increased,7,1
20827580,20220513,Epcoritamab,69,801,69.0,1,91,1,1,1,1,1,1,1,Epcoritamab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXALIPLATIN|RITUXIMAB|CYTARABINE|HYDROCHLOROTHIAZIDE|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|RASBURICASE|MEROPENEM|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|AMIKACIN|METHYLPREDNISOLONE|PREGABALIN|ADENOSINE|LOSARTAN|CEFTRIAXONE|CEFTRIAXONE SODIUM|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",31,B-cell lymphoma|B-cell lymphoma|B-cell lymphoma|B-cell lymphoma|B-cell lymphoma,Immune effector cell-associated neurotoxicity syndrome|Off label use,2,3
20830332,20220514,Epcoritamab,69,801,69.0,1,91,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|DEXAMETHASONE SODIUM PHOSPHATE|CYTARABINE|RITUXIMAB|METHYLPREDNISOLONE|MEROPENEM|HYDROCHLOROTHIAZIDE|DEXCHLORPHENIRAMINE MALEATE|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|CEFTRIAXONE|CEFTRIAXONE SODIUM|LOSARTAN|PREGABALIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|AMIKACIN|RASBURICASE|ADENOSINE|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",26,,Immune effector cell-associated neurotoxicity syndrome|Off label use,2,3
20831830,20220516,Epcoritamab,82,801,82.0,1,,1,0,1,1,0,0,1,Epcoritamab,"RITUXIMAB|DOXORUBICIN|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CETIRIZINE HYDROCHLORIDE",9,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Cytokine release syndrome|Diabetic metabolic decompensation,2,3
20832883,20220516,Epcoritamab,73,801,73.0,1,82,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|DAPAGLIFLOZIN|PANTOPRAZOLE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|CANDESARTAN|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS,27,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,COVID-19 pneumonia,1,3
20835235,20220516,Epcoritamab,69,801,69.0,2,72.9,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|TOCILIZUMAB|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|METHYLPREDNISOLONE SODIUM SUCCINATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,14,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV,Interstitial lung disease,1,3
20837946,20220517,Epcoritamab,74,801,74.0,2,65,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|LISINOPRIL|LISINOPRIL|FERROUS SULFATE|FERROUS SULFATE|DULOXETINE HYDROCHLORIDE|DULOXETINE|GLIPIZIDE|GLIPIZIDE|LORAZEPAM|LORAZEPAM|CYANOCOBALAMIN|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|CARVEDILOL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,44,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Mental status changes,1,1
20852059,20220520,Epcoritamab,50,801,50.0,1,70.9,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|CALCIUM CARBONATE|ANTACID|PEGFILGRASTIM|BENZONATATE|DEXTROMETHORPHAN HYDROBROMIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|REMDESIVIR|REMDESIVIR|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|PREDNISONE|FILGRASTIM|LACTULOSE|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350",34,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|COVID-19|Cough|Cough|Pyrexia|COVID-19|Premedication|Premedication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Pneumonia|Pneumonia|COVID-19,3,1
20857563,20220520,Epcoritamab,67,801,67.0,2,56,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|RITUXIMAB|VINCRISTINE SULFATE|VINCRISTINE SULFATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE|PREDNISONE|PREDNISONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|FILGRASTIM|LEVOTHYROXINE SODIUM|GRANISETRON HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ALLOPURINOL|FLUCONAZOLE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OXAZEPAM|METHYLPREDNISOLONE SODIUM SUCCINATE|BISOPROLOL FUMARATE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR",49,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Prophylaxis|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Premedication|Premedication|Premedication|Prophylaxis|Prophylaxis,Cytokine release syndrome|Pyrexia,2,1
20858862,20220522,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE,4,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III,Toxic skin eruption,1,3
20859468,20220523,Epcoritamab,,,,1,72.00,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|HYDROCORTISONE SODIUM SUCCINATE|HYDROCORTISONE SODIUM SUCCINATE|ALLOPURINOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,20,Follicular lymphoma|B-cell lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Atrial flutter|Intentional product use issue,3,1
20859883,20220523,Epcoritamab,65,801,65.0,2,164,1,0,1,1,0,0,0,Epcoritamab,"RITUXIMAB|VINCRISTINE SULFATE|PREDNISONE|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|FLUCONAZOLE|GENTAMICIN|GENTAMICIN SULFATE|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE SODIUM SUCCINATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISONE",21,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Premedication|Premedication|Premedication|Premedication,Dyspepsia,1,3
20866391,20220524,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|LENALIDOMIDE|ALLOPURINOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ROSUVASTATIN|BISOPROLOL FUMARATE|OXYCODONE HYDROCHLORIDE|OXYCODONE|SILDENAFIL CITRATE|SILDENAFIL|SILDENAFIL POWDER,|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|NITROGLYCERIN|EZETIMIBE|CYANOCOBALAMIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|PREDNISONE|OXYCODONE HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",28,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Thrombophlebitis|Off label use,2,1
20866751,20220524,Epcoritamab,82,801,82.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|DOXORUBICIN|PREDNISONE|PREDNISONE|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|CALCIUM CARBONATE|ANTACID|CEFUROXIME SODIUM|FILGRASTIM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|GRANISETRON HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CETIRIZINE HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE",28,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Cytokine release syndrome|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Premedication|Premedication,Cytokine release syndrome|Hypotension|Hypoxia|Pyrexia|Diabetic metabolic decompensation|Urinary tract infection|Breath sounds abnormal|Dyspnoea,8,1
20874234,20220525,Epcoritamab,65,801,65.0,2,164,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|PREDNISONE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|FLUCONAZOLE|GENTAMICIN|GENTAMICIN SULFATE|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED",17,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Dyspepsia,1,3
20889757,20220530,Epcoritamab,72,801,72.0,1,50,1,0,1,0,0,0,0,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|ALLOPURINOL|PREDNISONE|PREDNISONE|PREDNISONE|ACYCLOVIR|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|RITUXIMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|FERROUS SULFATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,",33,B-cell lymphoma|Follicular lymphoma|Prophylaxis|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Pain|Product used for unknown indication|Prophylaxis|Follicular lymphoma|Product used for unknown indication|Follicular lymphoma|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Pyrexia|Hypotension|Pyrexia|C-reactive protein increased|Fibrin D dimer increased|Haemoglobin decreased,7,1
20889760,20220530,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|VINCRISTINE SULFATE|VINCRISTINE SULFATE|VINCRISTINE SULFATE|VINCRISTINE SULFATE|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|GENTAMICIN|GENTAMICIN SULFATE|GENTAMICIN|GENTAMICIN SULFATE|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|FLUCONAZOLE|FLUCONAZOLE|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|PREDNISONE",49,B-cell lymphoma|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma|B-cell lymphoma|Diffuse large B-cell lymphoma stage III|B-cell lymphoma|Diffuse large B-cell lymphoma stage III|B-cell lymphoma|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma|B-cell lymphoma|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Neutropenia|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Cytokine release syndrome|Premedication|Premedication|Premedication|Prophylaxis|Cytokine release syndrome,Dyspepsia,1,3
20891142,20220530,Epcoritamab,74,801,74.0,2,65,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|DULOXETINE HYDROCHLORIDE|DULOXETINE|FERROUS SULFATE|FERROUS SULFATE|GLIPIZIDE|GLIPIZIDE|LISINOPRIL|LISINOPRIL|LORAZEPAM|LORAZEPAM|CYANOCOBALAMIN|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|CARVEDILOL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,50,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Klebsiella sepsis,1,3
20901975,20220601,Epcoritamab,78,801,78.0,2,55,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|VINCRISTINE SULFATE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|PREDNISONE|PREDNISONE|AMLODIPINE BESYLATE|GRANISETRON HYDROCHLORIDE|LANSOPRAZOLE|ALPRAZOLAM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ALLOPURINOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",35,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Prophylaxis,COVID-19 pneumonia|COVID-19 pneumonia,2,3
20906513,20220602,Epcoritamab,46,801,46.0,1,87.6,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|LENALIDOMIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|VINCRISTINE SULFATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ALLOPURINOL|TRIMETHOPRIM",13,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,Cytokine release syndrome,1,1
20906904,20220602,Epcoritamab,69,801,69.0,1,91,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|DEXAMETHASONE SODIUM PHOSPHATE|OXALIPLATIN|CYTARABINE|LOSARTAN|DEXCHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|HYDROCHLOROTHIAZIDE|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|RASBURICASE|MEROPENEM|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|AMIKACIN|METHYLPREDNISOLONE|PREGABALIN|ADENOSINE|CEFTRIAXONE|CEFTRIAXONE SODIUM|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|AMIKACIN",29,B-cell lymphoma|B-cell lymphoma|B-cell lymphoma|B-cell lymphoma|B-cell lymphoma,Immune effector cell-associated neurotoxicity syndrome,1,3
20909326,20220603,Epcoritamab,52,801,52.0,1,,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|SULFAMETHOXAZOLE AND TRIMETHOPRIM,26,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Squamous cell carcinoma,1,1
20911203,20220603,Epcoritamab,74,801,74.0,2,60,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|VINCRISTINE SULFATE|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",10,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication,Cytokine release syndrome,1,3
20913924,20220604,Epcoritamab,67,801,67.0,2,61.5,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|ACYCLOVIR|ALBUTEROL SULFATE|ALBUTEROL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ALPRAZOLAM|DICLOFENAC|DICLOFENAC SODIUM,28,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV,COVID-19,1,1
20913952,20220604,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|AMOXICILLIN|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ALLOPURINOL|ALLOPURINOL|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|FERROUS SULFATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FERROUS SULFATE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",158,B-cell lymphoma|Follicular lymphoma stage III|Product used for unknown indication|Prophylaxis|Prophylaxis|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|Follicular lymphoma stage III|Follicular lymphoma|B-cell lymphoma|Follicular lymphoma stage III|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Pain|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pyrexia|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Hypotension|Pyrexia|Haemoglobin decreased|C-reactive protein increased|Fibrin D dimer increased|Intentional product use issue,7,1
20914055,20220604,Epcoritamab,80,801,80.0,1,75.1,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|LENALIDOMIDE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FLUTICASONE PROPIONATE|FLUTICASONE PROPIONATE NASAL|RIVAROXABAN|SIMVASTATIN|ERGOCALCIFEROL,11,B-cell lymphoma|Follicular lymphoma stage II|Follicular lymphoma,COVID-19 pneumonia,1,1
20923744,20220607,Epcoritamab,76,801,76.0,1,110,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|METOPROLOL TARTRATE|METOPROLOL|MOMETASONE|SILDENAFIL CITRATE|SILDENAFIL|SILDENAFIL POWDER,|SIMVASTATIN",21,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,COVID-19|Sinusitis,2,1
20925181,20220607,Epcoritamab,67,801,67.0,2,56,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|PREDNISONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE|PREDNISONE|FILGRASTIM|LEVOTHYROXINE SODIUM|GRANISETRON HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ALLOPURINOL|FLUCONAZOLE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OXAZEPAM|BISOPROLOL FUMARATE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR",37,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Premedication|Premedication|Prophylaxis|Prophylaxis,Cytokine release syndrome,1,3
20929384,20220608,Epcoritamab,62,801,62.0,1,80.7,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|RITUXIMAB|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PREDNISONE|PREDNISONE|PREDNISONE|DICLOFENAC|DICLOFENAC SODIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ACYCLOVIR|ALLOPURINOL|ALPRAZOLAM|ALPRAZOLAM|DULOXETINE HYDROCHLORIDE|DULOXETINE|DULOXETINE HYDROCHLORIDE|DULOXETINE|ENALAPRIL|INSULIN GLARGINE|LEUCOVORIN CALCIUM|LORAZEPAM|LORAZEPAM|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|ALLOPURINOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ENALAPRIL,42,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Abdominal infection,1,3
20938474,20220609,Epcoritamab,68,801,68.0,2,62.1,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|ACYCLOVIR|ALBUTEROL SULFATE|ALBUTEROL|CITALOPRAM|CITALOPRAM HYDROBROMIDE|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL|GABAPENTIN|LORAZEPAM|MONTELUKAST|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|RIVAROXABAN|FILGRASTIM|PEGFILGRASTIM|SENNOSIDES|SENNA LEAF|SENNA",27,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,Atrial tachycardia,1,1
20939256,20220609,Epcoritamab,67,801,67.0,2,76,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|ALLOPURINOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|AMLODIPINE BESYLATE AND VALSARTAN|AMLODIPINE BESYLATE AND VALSARTAN|DALTEPARIN SODIUM|DALTEPARIN SODIUM|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|ATORVASTATIN CALCIUM|VALACYCLOVIR HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|MAGNESIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|LACTULOSE|FUROSEMIDE,32,Follicular lymphoma|B-cell lymphoma|Follicular lymphoma|B-cell lymphoma|Follicular lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Intentional product use issue|Cytokine release syndrome,2,3
20944819,20220610,Epcoritamab,73,801,73.0,2,70.9,1,1,1,1,1,1,1,Epcoritamab,CARBOPLATIN|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RITUXIMAB|LORATADINE|LORATADINE ORAL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE|FILGRASTIM|FLUCONAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|MIRTAZAPINE|METOCLOPRAMIDE HYDROCHLORIDE|ROSUVASTATIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM,30,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication,Sinusitis,1,3
20945740,20220610,Epcoritamab,67,801,67.0,2,56,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|PREDNISONE|PREDNISONE",8,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Cytokine release syndrome,1,3
20946891,20220610,Epcoritamab,78,801,78.0,2,55,1,1,1,1,0,0,0,Epcoritamab,"RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|GRANISETRON HYDROCHLORIDE|AMLODIPINE BESYLATE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ALLOPURINOL|LANSOPRAZOLE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ALPRAZOLAM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",38,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Prophylaxis|Premedication|Premedication,COVID-19 pneumonia|COVID-19 pneumonia,2,3
20949094,20220613,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|DOXORUBICIN|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CETIRIZINE HYDROCHLORIDE",9,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Diabetic metabolic decompensation|Cytokine release syndrome,2,3
20949583,20220613,Epcoritamab,63,801,63.0,1,79,1,0,1,0,0,0,0,Epcoritamab,"RITUXIMAB|CYTARABINE|CARBOPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXALIPLATIN|VITAMIN A PALMITATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FILGRASTIM|AMOXICILLIN AND CLAVULANATE POTASSIUM|FUROSEMIDE|ENOXAPARIN SODIUM|AMITRIPTYLINE HYDROCHLORIDE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|TRAMADOL HYDROCHLORIDE|FLUCONAZOLE|ALPRAZOLAM|LATANOPROST|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|CLEMASTINE FUMARATE|ACYCLOVIR|LORAZEPAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LATANOPROST|INSULIN HUMAN|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BUMETANIDE|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|DEXAMETHASONE SODIUM PHOSPHATE|COLCHICINE",43,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Cholecystitis|Premedication,Acute kidney injury|Off label use|Tumour lysis syndrome,3,3
20952146,20220613,Epcoritamab,67,801,67.0,2,56,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|VINCRISTINE SULFATE|VINCRISTINE SULFATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|VINCRISTINE SULFATE|DOXORUBICIN|FILGRASTIM|ALLOPURINOL|OXAZEPAM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|BISOPROLOL FUMARATE|PREDNISONE|PREDNISONE|PREDNISONE|GRANISETRON HYDROCHLORIDE|FLUCONAZOLE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|LEVOTHYROXINE SODIUM|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",49,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage III|Premedication|Prophylaxis|Premedication|Premedication,Cytokine release syndrome|Atrial fibrillation|Respiratory tract infection|Pyrexia,4,3
20965708,20220616,Epcoritamab,67,801,67.0,2,61.50,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ALPRAZOLAM|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALBUTEROL SULFATE|ALBUTEROL|ACYCLOVIR|HYDROCORTISONE ACETATE,25,Non-Hodgkin^s lymphoma|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,COVID-19 pneumonia,1,3
20973445,20220617,Epcoritamab,80,801,80.0,1,81.2,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|PREDNISONE|DEXCHLORPHENIRAMINE MALEATE|ACYCLOVIR|ENTECAVIR|ENTECAVIR ANHYDROUS|LEUCOVORIN CALCIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FUROSEMIDE|LOSARTAN|HISTAMINE|HISTAMINUM HYDROCHLORICUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALLOPURINOL,20,Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Pneumonia|Febrile neutropenia|Hypogammaglobulinaemia,3,1
20974718,20220617,Epcoritamab,73,801,73.0,2,70.90,1,1,1,1,1,1,1,Epcoritamab,CARBOPLATIN|CYTARABINE|RITUXIMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LORATADINE|LORATADINE ORAL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE|FILGRASTIM|FLUCONAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|MIRTAZAPINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ROSUVASTATIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM,25,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Sinusitis|Off label use,2,3
20975688,20220617,Epcoritamab,67,801,67.0,2,56,1,1,1,1,1,1,1,Epcoritamab,"PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|ALLOPURINOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE|PREDNISONE|PREDNISONE|GRANISETRON HYDROCHLORIDE|LEVOTHYROXINE SODIUM|FLUCONAZOLE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|FILGRASTIM|BISOPROLOL FUMARATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OXAZEPAM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",41,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Prophylaxis|Prophylaxis|Premedication|Premedication|Premedication,Pyrexia|Cytokine release syndrome|Atrial fibrillation,3,3
20978150,20220618,Epcoritamab,80,801,80.0,1,76.66,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|LORAZEPAM|ENOXAPARIN SODIUM|GABAPENTIN|BUPROPION HYDROCHLORIDE|LEVETIRACETAM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|ROSUVASTATIN|LACTULOSE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|METOPROLOL TARTRATE|CEFEPIME HYDROCHLORIDE|CEFEPIME|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|APIXABAN|INSULIN LISPRO|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|MELATONIN|SENNOSIDES|PREDNISONE|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|PREDNISONE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PREDNISONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,42,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Premedication|Premedication|Premedication|Premedication|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Prophylaxis|Premedication|Premedication|Premedication|Premedication|Premedication|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Oedema peripheral|Constipation|Atrial fibrillation|Haematuria|Urinary retention|Immune effector cell-associated neurotoxicity syndrome|Cytokine release syndrome,7,3
20983618,20220620,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|VINCRISTINE SULFATE|DOXORUBICIN|DOXORUBICIN|PREDNISONE|PREDNISONE|PREDNISONE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CALCIUM CARBONATE|ANTACID|FILGRASTIM|CETIRIZINE HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE HYDROCHLORIDE|CEFUROXIME SODIUM|GRANISETRON HYDROCHLORIDE",33,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Cytokine release syndrome|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication,Diabetic metabolic decompensation|Cytokine release syndrome|Hypotension|Hypoxia|Pyrexia|Urinary tract infection|Breath sounds abnormal|Dyspnoea,8,1
20983642,20220620,Epcoritamab,87,801,87.0,2,66.8,1,1,1,1,0,0,0,Epcoritamab,"OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|FUROSEMIDE|METHIMAZOLE|METHIMAZOLE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|VALSARTAN|VALSARTAN ORAL|VALSARTAN|VALSARTAN ORAL|ACYCLOVIR|ACYCLOVIR|TORSEMIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ASCORBIC ACID|BISOPROLOL FUMARATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHIMAZOLE|METHIMAZOLE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ALLOPURINOL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|HYDROCHLOROTHIAZIDE|HYDROCHLOROTHIAZIDE|POTASSIUM CITRATE|PREDNISONE|PREDNISONE|HYDROCHLOROTHIAZIDE|HYDROCHLOROTHIAZIDE|POTASSIUM BICARBONATE|POTASSIUM BICARBONATE|METOCLOPRAMIDE HYDROCHLORIDE|FUROSEMIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ALLOPURINOL",59,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Product used for unknown indication|Diffuse large B-cell lymphoma|Product used for unknown indication|Prophylaxis|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Enterocolitis|Cytokine release syndrome|Hypokalaemia|Off label use,4,1
20988532,20220621,Epcoritamab,43,801,43.0,2,57.1,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|METHYLPREDNISOLONE|ACYCLOVIR|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ALLOPURINOL|LORAZEPAM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|FAMOTIDINE|NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL, ETHINYL ESTRADIOL AND FERROUS FUMARATE|PANTOPRAZOLE|PANTOPRAZOLE SODIUM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED",25,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,1
20990739,20220622,Epcoritamab,74,801,74.0,2,85.5,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|FAMOTIDINE|GRANISETRON HYDROCHLORIDE|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|TELMISARTAN|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR",30,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Cytokine release syndrome|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Pancreatitis acute,1,3
20993750,20220622,Epcoritamab,76,801,76.0,2,51.3,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MAGNESIUM|FUROSEMIDE|ALLOPURINOL|AMLODIPINE BESYLATE|METHYLPREDNISOLONE|LORAZEPAM|FLUCONAZOLE|DEXCHLORPHENIRAMINE MALEATE|DEXCHLORPHENIRAMINE MALEATE,20,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Febrile neutropenia|Cytokine release syndrome|Off label use,3,3
20994345,20220622,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CARBOPLATIN|OXALIPLATIN|RITUXIMAB|RITUXIMAB|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|VITAMIN A PALMITATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FILGRASTIM|AMOXICILLIN AND CLAVULANATE POTASSIUM|FUROSEMIDE|ENOXAPARIN SODIUM|AMITRIPTYLINE HYDROCHLORIDE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|TRAMADOL HYDROCHLORIDE|FLUCONAZOLE|ALPRAZOLAM|LATANOPROST|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CLEMASTINE FUMARATE|ACYCLOVIR|LORAZEPAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LATANOPROST|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BUMETANIDE|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|DEXAMETHASONE SODIUM PHOSPHATE|COLCHICINE",46,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Acute kidney injury|Tumour lysis syndrome|Off label use,3,3
21003809,20220624,Epcoritamab,79,801,79.0,2,87.9,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|TOCILIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|PRAMIPEXOLE|LOSARTAN POTASSIUM|LOSARTAN|CALCIUM|MOMETASONE FUROATE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|FUROSEMIDE|ALLOPURINOL|TRIMETHOPRIM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ERGOCALCIFEROL",35,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Abdominal pain|Diarrhoea,2,3
21006397,20220624,Epcoritamab,79,801,79.0,2,87.9,1,0,1,0,0,0,1,Epcoritamab,"BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SULFAMETHOXAZOLE AND TRIMETHOPRIM|TOCILIZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|PRAMIPEXOLE|LOSARTAN POTASSIUM|LOSARTAN|MOMETASONE FUROATE|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ALLOPURINOL",31,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Abdominal pain|Diarrhoea,2,3
21008353,20220627,Epcoritamab,73,801,73.0,1,80.1,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|BRIMONIDINE TARTRATE, TIMOLOL MALEATE|DIGOXIN|SACUBITRIL AND VALSARTAN|EPLERENONE|FINASTERIDE|ATORVASTATIN CALCIUM|BIMATOPROST|MIRABEGRON|OXYCODONE|PANTOPRAZOLE|SENNOSIDES A AND B|TRAVOPROST|TRAVOPROST (ISOMER FREE)|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PREDNISONE|ACYCLOVIR|APIXABAN|BRIMONIDINE|BRIMONIDINE TARTRATE|CARVEDILOL|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|PEGFILGRASTIM|VALSARTAN|VALSARTAN ORAL",37,Follicular lymphoma stage II|Follicular lymphoma stage II|Follicular lymphoma stage II,Electrocardiogram T wave inversion,1,1
21009260,20220627,Epcoritamab,66,801,66.0,1,78,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|VALSARTAN|VALSARTAN ORAL|VALACYCLOVIR HYDROCHLORIDE,18,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,COVID-19,1,1
21011163,20220627,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FILGRASTIM|ACYCLOVIR|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ENOXAPARIN SODIUM|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|MAGNESIUM|FLUCONAZOLE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|LISINOPRIL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ATORVASTATIN CALCIUM|METHYLPREDNISOLONE|ALLOPURINOL|LATANOPROST|BISOPROLOL FUMARATE|FOLIC ACID|FUROSEMIDE|BUMETANIDE|TRAMADOL HYDROCHLORIDE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|CETIRIZINE HYDROCHLORIDE|DARBEPOETIN ALFA|DEXAMETHASONE SODIUM PHOSPHATE|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",43,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Acute kidney injury|Off label use,2,3
21011207,20220627,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|OXALIPLATIN|RITUXIMAB|CYTARABINE|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|AMITRIPTYLINE HYDROCHLORIDE|AMITRIPTYLINE HYDROCHLORIDE|ACYCLOVIR|ACYCLOVIR|ENOXAPARIN SODIUM|ENOXAPARIN SODIUM|FLUCONAZOLE|FLUCONAZOLE|FILGRASTIM|FILGRASTIM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|LATANOPROST|LATANOPROST|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DEXAMETHASONE SODIUM PHOSPHATE|BUMETANIDE|BUMETANIDE|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|COLCHICINE|COLCHICINE|VITAMIN A PALMITATE|VITAMIN A PALMITATE|TRAMADOL HYDROCHLORIDE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|METHYLPREDNISOLONE|FUROSEMIDE|CLEMASTINE FUMARATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|RASBURICASE|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|AMITRIPTYLINE HYDROCHLORIDE|BUMETANIDE|LATANOPROST|ENOXAPARIN SODIUM|FILGRASTIM|INSULIN HUMAN|FUROSEMIDE|VITAMIN A PALMITATE|ISOSORBIDE MONONITRATE|TRAMADOL HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",101,Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Cholecystitis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Coronary artery disease|Periodontitis|Cardiac failure|Cardiac failure|Acute kidney injury|Off label use,6,3
21012577,20220627,Epcoritamab,63,801,63.0,1,79,1,0,1,0,0,0,1,Epcoritamab,"CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|DEXAMETHASONE SODIUM PHOSPHATE|RITUXIMAB|CYTARABINE|FUROSEMIDE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FLUCONAZOLE|MAGNESIUM|FOLIC ACID|LATANOPROST|METHYLPREDNISOLONE|ATORVASTATIN CALCIUM|AMOXICILLIN AND CLAVULANATE POTASSIUM|BISOPROLOL FUMARATE|DARBEPOETIN ALFA|FILGRASTIM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|LISINOPRIL|BUMETANIDE|ALLOPURINOL|ACYCLOVIR|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ENOXAPARIN SODIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CETIRIZINE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",41,Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Acute kidney injury|Off label use,2,3
21015395,20220628,Epcoritamab,52,801,52.0,1,,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|ALLOPURINOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,12,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,Cytokine release syndrome|Febrile neutropenia,2,1
21017277,20220628,Epcoritamab,72,801,72.0,1,50,1,0,1,1,0,0,0,Epcoritamab,"RITUXIMAB|LENALIDOMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACYCLOVIR|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|ALLOPURINOL|FERROUS SULFATE",18,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III|Prophylaxis|Prophylaxis|Pain|Pyrexia|Prophylaxis|Prophylaxis,Hypotension|Cytokine release syndrome,2,1
21025046,20220629,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|CYTARABINE|DEXAMETHASONE SODIUM PHOSPHATE|OXALIPLATIN|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|PREGABALIN|HYDROCHLOROTHIAZIDE|RASBURICASE|AMIKACIN|AMIKACIN|LOSARTAN|METHYLPREDNISOLONE|MEROPENEM|CEFTRIAXONE|CEFTRIAXONE SODIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ADENOSINE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE",30,B-cell lymphoma|B-cell lymphoma|B-cell lymphoma|B-cell lymphoma|B-cell lymphoma,Immune effector cell-associated neurotoxicity syndrome|Disease progression,2,3
21025076,20220629,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|VINCRISTINE SULFATE|AMLODIPINE BESYLATE|AMLODIPINE BESYLATE|GRANISETRON HYDROCHLORIDE|GRANISETRON HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|LANSOPRAZOLE|ALLOPURINOL|ALLOPURINOL|ALPRAZOLAM|ALPRAZOLAM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR",63,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Premedication|Premedication|Prophylaxis|Prophylaxis,COVID-19 pneumonia|Multiple organ dysfunction syndrome|COVID-19 pneumonia,3,3
21039258,20220704,Epcoritamab,66,801,66.0,1,78.0,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|VALSARTAN|VALSARTAN ORAL|VALACYCLOVIR HYDROCHLORIDE,22,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,COVID-19,1,3
21041119,20220705,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|LENALIDOMIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ALLOPURINOL|PREDNISONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LEUCOVORIN CALCIUM|FUROSEMIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FILGRASTIM|ACYCLOVIR|LOSARTAN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LORAZEPAM|GABAPENTIN,25,B-cell lymphoma|B-cell lymphoma|B-cell lymphoma,Febrile neutropenia,1,1
21041623,20220705,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|LENALIDOMIDE|METHYLPREDNISOLONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALLOPURINOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,12,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,Cytokine release syndrome|Febrile neutropenia,2,1
21041811,20220705,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|CYTARABINE|CYTARABINE|CYTARABINE|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|DEXAMETHASONE SODIUM PHOSPHATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TRAMADOL HYDROCHLORIDE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|FUROSEMIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALPRAZOLAM|BUMETANIDE|INSULIN HUMAN|FLUCONAZOLE|ENOXAPARIN SODIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SULFAMETHOXAZOLE AND TRIMETHOPRIM|LATANOPROST|FILGRASTIM|LATANOPROST|LORAZEPAM|AMITRIPTYLINE HYDROCHLORIDE|VITAMIN A PALMITATE|VITAMIN A PALMITATE|COLCHICINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CLEMASTINE FUMARATE|ACYCLOVIR|AMOXICILLIN AND CLAVULANATE POTASSIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG",55,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Cholecystitis|Premedication|Premedication|Prophylaxis,Acute kidney injury,1,3
21044646,20220705,Epcoritamab,73,801,73.0,1,80.10,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|PREDNISONE|APIXABAN|BRIMONIDINE|BRIMONIDINE TARTRATE|BRIMONIDINE|BRIMONIDINE TARTRATE|CARVEDILOL|CARVEDILOL|BRIMONIDINE TARTRATE, TIMOLOL MALEATE|BRIMONIDINE TARTRATE, TIMOLOL MALEATE|DIGOXIN|EPLERENONE|EPLERENONE|SACUBITRIL AND VALSARTAN|SACUBITRIL AND VALSARTAN|FINASTERIDE|FINASTERIDE|FINASTERIDE|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM|BIMATOPROST|BIMATOPROST|MIRABEGRON|MIRABEGRON|OXYCODONE|OXYCODONE|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|SENNOSIDES|SENNA LEAF|SENNA|TRAVOPROST|TRAVOPROST (ISOMER FREE)|TRAVOPROST|TRAVOPROST (ISOMER FREE)|TRAVOPROST|TRAVOPROST (ISOMER FREE)|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACYCLOVIR",43,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Electrocardiogram T wave inversion|Electrocardiogram T wave abnormal,2,3
21050311,20220707,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|AMOXICILLIN|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METHYLPREDNISOLONE SODIUM SUCCINATE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|DAPSONE GEL, 5%|DAPSONE|DASPONE|FUROSEMIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PRAMIPEXOLE|ALBUTEROL SULFATE|ALBUTEROL|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,",145,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma stage IV|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis,Cytomegalovirus test positive|Cytomegalovirus infection,2,1
21051203,20220707,Epcoritamab,63,801,63.0,1,79,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|RITUXIMAB|DEXAMETHASONE SODIUM PHOSPHATE|ALLOPURINOL|METHYLPREDNISOLONE|FILGRASTIM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MAGNESIUM|CETIRIZINE HYDROCHLORIDE|ACYCLOVIR|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|DARBEPOETIN ALFA|ATORVASTATIN CALCIUM|ENOXAPARIN SODIUM|BUMETANIDE|LATANOPROST|BISOPROLOL FUMARATE|TRAMADOL HYDROCHLORIDE|FUROSEMIDE|FLUCONAZOLE|FOLIC ACID|LISINOPRIL|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|SULFAMETHOXAZOLE AND TRIMETHOPRIM",41,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Blood creatinine increased|Off label use,2,3
21056220,20220708,Epcoritamab,70,801,70.0,1,76.5,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|LENALIDOMIDE|APIXABAN|BISOPROLOL FUMARATE|FENOFIBRATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|DIGOXIN,17,B-cell lymphoma|Follicular lymphoma|Follicular lymphoma,Atrial fibrillation,1,1
21056697,20220708,Epcoritamab,72,801,72.0,1,,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN,5,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II,Cytokine release syndrome|Off label use,2,3
21063105,20220711,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|ALLOPURINOL|METHYLPREDNISOLONE|FILGRASTIM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MAGNESIUM|CETIRIZINE HYDROCHLORIDE|ACYCLOVIR|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|DARBEPOETIN ALFA|ATORVASTATIN CALCIUM|ENOXAPARIN SODIUM|BUMETANIDE|LATANOPROST|BISOPROLOL FUMARATE|TRAMADOL HYDROCHLORIDE|FUROSEMIDE|FLUCONAZOLE|FOLIC ACID|LISINOPRIL|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|AMOXICILLIN AND CLAVULANATE POTASSIUM|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG|SULFAMETHOXAZOLE AND TRIMETHOPRIM",41,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Blood creatinine increased,1,3
21068795,20220712,Epcoritamab,68,801,68.0,1,72,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|VALACYCLOVIR HYDROCHLORIDE|VALSARTAN|VALSARTAN ORAL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|HYDROCORTISONE SODIUM SUCCINATE|HYDROCORTISONE SODIUM SUCCINATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALLOPURINOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|DALTEPARIN SODIUM,33,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,COVID-19|Atrial flutter|Pneumonia|Cytokine release syndrome|Off label use,5,1
21079009,20220713,Epcoritamab,68,801,68.0,2,87,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|PREDNISOLONE ACETATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|INSULIN HUMAN|LOSARTAN|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|METOCLOPRAMIDE HYDROCHLORIDE|MOMETASONE FUROATE|MOMETASONE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|REMDESIVIR,38,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,COVID-19,1,3
21079757,20220714,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|VINCRISTINE SULFATE|VINCRISTINE SULFATE|PREDNISONE|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|GENTAMICIN|GENTAMICIN SULFATE|METHYLPREDNISOLONE SODIUM SUCCINATE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|FLUCONAZOLE",24,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Dyspepsia,1,3
21088542,20220715,Epcoritamab,91,801,91.0,2,81.6,1,1,1,1,1,1,1,Epcoritamab,"VINCRISTINE SULFATE|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PANTOPRAZOLE|ACYCLOVIR|SIMVASTATIN|LEVOTHYROXINE|ENALAPRIL|PANTOPRAZOLE SODIUM|VALACYCLOVIR HYDROCHLORIDE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",23,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Premedication|Premedication,Cytomegalovirus infection reactivation|Confusional state,2,3
21089704,20220715,Epcoritamab,91,801,91.0,2,81.6,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|PREDNISONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PANTOPRAZOLE|SIMVASTATIN|LEVOTHYROXINE|ACYCLOVIR|ENALAPRIL|CEFTRIAXONE|CEFTRIAXONE SODIUM|PANTOPRAZOLE SODIUM|VALACYCLOVIR HYDROCHLORIDE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM",24,Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Premedication|Premedication|Prophylaxis|Prophylaxis|Cytomegalovirus infection reactivation,Confusional state|Cytomegalovirus infection reactivation,2,1
21099089,20220719,Epcoritamab,72,801,72.0,1,,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN,5,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Off label use,2,3
21108514,20220721,Epcoritamab,72,801,72.0,1,,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN,5,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II,Cytokine release syndrome|Off label use,2,3
21119793,20220722,Epcoritamab,72,801,72.0,1,,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|GEMCITABINE HYDROCHLORIDE,7,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Off label use,2,3
21121498,20220722,Epcoritamab,72,801,72.0,1,,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN,5,Diffuse large B-cell lymphoma|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Off label use,2,5
21125549,20220725,Epcoritamab,72,801,72.0,1,,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|GEMCITABINE HYDROCHLORIDE,5,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II,Cytokine release syndrome|Off label use,2,3
21151551,20220730,Epcoritamab,54,801,54.0,1,82.40,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|CHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALLOPURINOL|CANNABIDIOL|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|FAMOTIDINE|DEXTROSE MONOHYDRATE|DEXTROSE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SENNOSIDES|SENNA LEAF|SENNA|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|FILGRASTIM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|GEMCITABINE HYDROCHLORIDE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE",28,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Premedication|Premedication|Neutrophil count decreased|Discomfort|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Premedication|Premedication|Premedication,Off label use|Cytokine release syndrome,2,3
21166794,20220803,Epcoritamab,54,801,54.0,1,82.4,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ALLOPURINOL|CANNABIDIOL|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|FAMOTIDINE|DEXTROSE MONOHYDRATE|DEXTROSE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|SENNOSIDES|SENNA LEAF|SENNA|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|FILGRASTIM",28,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Premedication|Premedication|Discomfort|Neutrophil count decreased,Cytokine release syndrome,1,3
21173978,20220804,Epcoritamab,76,801,76.0,2,51.3,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FUROSEMIDE|FUROSEMIDE|POTASSIUM PHOSPHATES|POTASSIUM PHOSPHATE, MONOBASIC AND POTASSIUM PHOSPHATE, DIBASIC|POTASSIUM PHOSPHATES IN SODIUM CHLORIDE|POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC|POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION,|MONOBASIC POTASSIUM PHOSPHATE AND DIBASIC POTASSIUM PHOSPHATE|POTASSIUM PHOSPHATE|FLUCONAZOLE|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|FUROSEMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LORAZEPAM|LORAZEPAM|PREDNISONE|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|ALBUMIN HUMAN|AMLODIPINE BESYLATE|CALCIUM CARBONATE|ANTACID|DEXCHLORPHENIRAMINE MALEATE|TRIMETHOPRIM|FILGRASTIM|AMLODIPINE|AMLODIPINE|METHYLPREDNISOLONE|ALLOPURINOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|MAGNESIUM|LOSARTAN|RASBURICASE|METHYLPREDNISOLONE|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|AMLODIPINE|DEXCHLORPHENIRAMINE MALEATE|DEXCHLORPHENIRAMINE MALEATE",56,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Febrile neutropenia|Cytokine release syndrome|Off label use,3,3
21184780,20220808,Epcoritamab,76,801,76.0,2,51.3,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|OXALIPLATIN|DEXCHLORPHENIRAMINE MALEATE|METHYLPREDNISOLONE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|FILGRASTIM|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|FUROSEMIDE|FUROSEMIDE|POTASSIUM PHOSPHATES|POTASSIUM PHOSPHATE, MONOBASIC AND POTASSIUM PHOSPHATE, DIBASIC|POTASSIUM PHOSPHATES IN SODIUM CHLORIDE|POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC|POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION,|MONOBASIC POTASSIUM PHOSPHATE AND DIBASIC POTASSIUM PHOSPHATE|POTASSIUM PHOSPHATE|PANTOPRAZOLE|ALLOPURINOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREDNISONE|LORAZEPAM|LORAZEPAM|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|RASBURICASE|AMLODIPINE|AMLODIPINE|MAGNESIUM|MAGNESIUM|ALBUMIN HUMAN|FLUCONAZOLE|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|TRIMETHOPRIM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LOSARTAN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|AMLODIPINE BESYLATE|CALCIUM CARBONATE|ANTACID",45,Diffuse large B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Febrile neutropenia|Off label use,3,5
21185154,20220808,Epcoritamab,78,801,78.0,2,87,1,0,1,0,0,0,1,Epcoritamab,"ANAKINRA|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|PREDNISONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ATORVASTATIN CALCIUM|BENAZEPRIL HYDROCHLORIDE|CLOPIDOGREL|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|FUROSEMIDE|LANSOPRAZOLE|METOPROLOL TARTRATE|METOPROLOL|EZETIMIBE|ZOLPIDEM TARTRATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MAGNESIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|BENZONATATE|MENTHOL|MENTHOL, UNSPECIFIED FORM|COUGH SUPPRESSANT|MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE|AMISH ORIGINS MEDICATED|MAXIMUM STRENGTH MEDICATED FOOT POWDER|ALBUMIN HUMAN|CEFEPIME HYDROCHLORIDE|CEFEPIME|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ALLOPURINOL|PANTOPRAZOLE|CEFTRIAXONE|CEFTRIAXONE SODIUM|DEXTROSE MONOHYDRATE|DEXTROSE|LEVETIRACETAM",38,Product used for unknown indication|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,3
21186184,20220808,Epcoritamab,83,801,83.0,2,54.4,1,0,1,0,0,0,0,Epcoritamab,"DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|PREDNISONE|RITUXIMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CALCIUM CARBONATE|ANTACID|CYANOCOBALAMIN|FLUCONAZOLE|INSULIN LISPRO|LISINOPRIL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PANTOPRAZOLE|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|RALOXIFENE|SODIUM ZIRCONIUM CYCLOSILICATE",31,Product used for unknown indication|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Pneumonia|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Pneumocystis jirovecii pneumonia|Pneumonia|Pneumocystis jirovecii pneumonia|Pneumonia|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Hyponatraemia,1,1
21194093,20220810,Epcoritamab,79,801,79.0,2,87.9,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|METHYLPREDNISOLONE SODIUM SUCCINATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|CALCIUM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|MICONAZOLE|MICONAZOLE NITRATE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|PRAMIPEXOLE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALBUTEROL SULFATE|ALBUTEROL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DAPSONE GEL, 5%|DAPSONE|DASPONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FUROSEMIDE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,",105,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma stage IV|Product used for unknown indication|Follicular lymphoma|Prophylaxis|Product used for unknown indication|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Product used for unknown indication,Cytomegalovirus infection|Cytomegalovirus test positive,2,1
21198776,20220811,Epcoritamab,62,801,62.0,1,125.7,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|ACYCLOVIR|ENALAPRIL|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|SIMVASTATIN|SITAGLIPTIN|TOCILIZUMAB,18,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Pneumocystis jirovecii infection|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pyrexia,Cytokine release syndrome|Pneumocystis jirovecii infection|Diarrhoea|Dehydration,4,3
21199019,20220811,Epcoritamab,54,801,54.0,1,82.4,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|ALLOPURINOL|CANNABIDIOL|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|FAMOTIDINE|DEXTROSE MONOHYDRATE|DEXTROSE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SENNOSIDES|SENNA LEAF|SENNA|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|FILGRASTIM",24,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Neutrophil count decreased,Cytokine release syndrome|Off label use,2,3
21206702,20220812,Epcoritamab,54,801,54.0,1,82.4,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|ALLOPURINOL|CANNABIDIOL|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CHLORPHENIRAMINE MALEATE|FAMOTIDINE|DEXTROSE MONOHYDRATE|DEXTROSE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SENNOSIDES|SENNA LEAF|SENNA|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM",20,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Off label use,2,3
21212846,20220815,Epcoritamab,78,801,78.0,2,87.10,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ATORVASTATIN CALCIUM|BENAZEPRIL HYDROCHLORIDE|CLOPIDOGREL|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|FUROSEMIDE|LANSOPRAZOLE|METOPROLOL TARTRATE|METOPROLOL|FISH OIL|EZETIMIBE|ZOLPIDEM TARTRATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MAGNESIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|BENZONATATE|MENTHOL|MENTHOL, UNSPECIFIED FORM|COUGH SUPPRESSANT|MAXIMUM STRENGTH MEDICATED FOOT POWDER TALC FREE|AMISH ORIGINS MEDICATED|MAXIMUM STRENGTH MEDICATED FOOT POWDER|ALBUMIN HUMAN|CEFEPIME HYDROCHLORIDE|CEFEPIME|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ALLOPURINOL|PANTOPRAZOLE|CEFTRIAXONE|CEFTRIAXONE SODIUM|DEXTROSE MONOHYDRATE|DEXTROSE|LEVETIRACETAM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|PREDNISONE|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE",48,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Premedication|Prophylaxis|Prophylaxis|Diffuse large B-cell lymphoma stage III|Prophylaxis|Prophylaxis|Prophylaxis|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Prophylaxis|Prophylaxis|Premedication|Premedication|Premedication,Cytokine release syndrome,1,1
21218477,20220816,Epcoritamab,72,801,72.0,1,70.4,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|VINCRISTINE SULFATE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|ALLOPURINOL|APREPITANT|ATOVAQUONE|ATOVAQUONE ORAL SUSPENSION|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|DULAGLUTIDE|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|INSULIN ASPART|LORAZEPAM|LOSARTAN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|MIRABEGRON|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OXYCODONE|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|PEGFILGRASTIM|PROCHLORPERAZINE|SERTRALINE|TADALAFIL|ZOLPIDEM TARTRATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FLUCONAZOLE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|METHOTREXATE|METHOTREXATE SODIUM|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|SENNOSIDES|SENNA LEAF|SENNA|SODIUM HYALURONATE|AMOXICILLIN|MAGNESIUM HYDROXIDE|MAGNESIUM HYDROXIDE|PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE|MORPHINE SULFATE|CEFADROXIL|INSULIN GLARGINE|SERTRALINE HYDROCHLORIDE",70,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Prophylaxis|Stomatitis,Disease progression|Cytokine release syndrome|Blood lactic acid increased|Tachycardia|Pyrexia|Neutrophil count decreased|Stomatitis|Diarrhoea,8,1
21220377,20220817,Epcoritamab,54,801,54.0,1,129.5,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|ACYCLOVIR|FILGRASTIM|MOMETASONE FUROATE|MOMETASONE|PEGFILGRASTIM|ALBUTEROL SULFATE|ALBUTEROL|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|DOXYCYCLINE|DOXYCYCLINE HYCLATE|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN",34,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV,COVID-19|Infection,2,1
21221569,20220817,Epcoritamab,75,801,75.0,2,45,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|LEVOTHYROXINE SODIUM|OXYCODONE|OXYCODONE HYDROCHLORIDE|PANTOPRAZOLE|CLOPIDOGREL|IVABRADINE|TIOTROPIUM BROMIDE|LEVOCETIRIZINE DIHYDROCHLORIDE|FILGRASTIM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|CHLORPROMAZINE|FUROSEMIDE|ZOLEDRONIC ACID|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE,27,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,General physical health deterioration|Thrombotic microangiopathy,2,3
21232712,20220819,Epcoritamab,,,,1,92,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|FUROSEMIDE|EMPAGLIFLOZIN|PIOGLITAZONE|ROSUVASTATIN CALCIUM|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|FILGRASTIM,26,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication,Septic shock,1,3
21233409,20220819,Epcoritamab,65,801,65.0,2,80,1,1,1,1,1,1,1,Epcoritamab,"BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|PACLITAXEL|PACLITAXEL|PACLITAXEL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ACYCLOVIR|CALCIUM|CEFUROXIME|CLEMASTINE FUMARATE|DAPSONE GEL, 5%|DAPSONE|DASPONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FLUTICASONE FUROATE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LANSOPRAZOLE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MORPHINE SULFATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PRAMIPEXOLE|ALBUTEROL SULFATE|ALBUTEROL|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|METHYLPREDNISOLONE SODIUM SUCCINATE|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|MOMETASONE FUROATE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|TOCILIZUMAB|ALBUTEROL SULFATE|MICONAZOLE|MICONAZOLE NITRATE|PRAMIPEXOLE DIHYDROCHLORIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,",95,Transitional cell carcinoma|Non-small cell lung cancer|Transitional cell carcinoma|Non-small cell lung cancer|Transitional cell carcinoma|Transitional cell carcinoma|Transitional cell carcinoma|Visual impairment|Transitional cell carcinoma|Follicular lymphoma|Follicular lymphoma|Visual impairment|Follicular lymphoma|Pain|Product used for unknown indication|Product used for unknown indication|Hiatus hernia|Product used for unknown indication|Product used for unknown indication|Headache|Headache|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pain|Product used for unknown indication|Product used for unknown indication|Hiatus hernia|Product used for unknown indication|Pain|Mucosal inflammation|Pain|Product used for unknown indication|Product used for unknown indication|Pain|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Prophylaxis|Prophylaxis,Hydronephrosis|Cytomegalovirus infection|Off label use|Product use issue|Sepsis|Constipation|Constipation|Constipation|Abdominal pain|Abdominal pain|Abdominal pain|Blood creatinine increased|Constipation|Abdominal pain|Diarrhoea,15,1
21237587,20220822,Epcoritamab,65,801,65.0,2,80,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|PACLITAXEL|ATEZOLIZUMAB|BEVACIZUMAB|BENDAMUSTINE HCL|RITUXIMAB|ACYCLOVIR|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)|MORPHINE SULFATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PRAMIPEXOLE|ALBUTEROL SULFATE|ALBUTEROL|CEFUROXIME|CLEMASTINE FUMARATE|DAPSONE GEL, 5%|DAPSONE|DASPONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|MORPHINE SULFATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PRAMIPEXOLE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|AMOXICILLIN|FUROSEMIDE|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|METHYLPREDNISOLONE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|METHYLPREDNISOLONE SODIUM SUCCINATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|CALCIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|CEFUROXIME|DAPSONE GEL, 5%|DAPSONE|DASPONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ATEZOLIZUMAB|ATEZOLIZUMAB|RITUXIMAB|RITUXIMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|BEVACIZUMAB|CARBOPLATIN|PACLITAXEL|CLEMASTINE FUMARATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ATEZOLIZUMAB|ATEZOLIZUMAB|PACLITAXEL|DAPSONE GEL, 5%|DAPSONE|DASPONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|BENDAMUSTINE HCL|BEVACIZUMAB|RITUXIMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB",99,Transitional cell carcinoma|Transitional cell carcinoma|Visual impairment|Transitional cell carcinoma|Transitional cell carcinoma|Follicular lymphoma|Product used for unknown indication|Follicular lymphoma|Pain|Hiatus hernia|Headache|Pain|Hiatus hernia|Pain|Mucosal inflammation|Pain|Pain|Pain|Pain|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Prophylaxis|Headache|Pain|Product used for unknown indication|Non-small cell lung cancer|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Non-small cell lung cancer|Transitional cell carcinoma|Transitional cell carcinoma|Product used for unknown indication|Transitional cell carcinoma|Product used for unknown indication|Prophylaxis|Pain|Prophylaxis|Non-small cell lung cancer|Transitional cell carcinoma|Product used for unknown indication|Follicular lymphoma|Transitional cell carcinoma|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Abdominal pain|Cytomegalovirus infection|Product use issue|Constipation|Off label use|Hydronephrosis|Sepsis|Blood creatinine increased,8,1
21237923,20220822,Epcoritamab,68,801,68.0,1,106.6,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|CLEMASTINE FUMARATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|ALLOPURINOL|LOSARTAN POTASSIUM|LOSARTAN|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PEGFILGRASTIM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|REMDESIVIR|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHYLPREDNISOLONE SODIUM SUCCINATE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN,28,Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I,Infusion related reaction|Pyrexia,2,3
21242093,20220823,Epcoritamab,72,801,72.0,1,71.80,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|ACYCLOVIR|ALENDRONATE SODIUM|AMLODIPINE|PEGFILGRASTIM,14,Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I,Infusion related reaction|Off label use|Nausea|Vomiting,4,3
21242502,20220823,Epcoritamab,65,801,65.0,2,80,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CARBOPLATIN|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|PACLITAXEL|PACLITAXEL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MORPHINE SULFATE|ALBUTEROL SULFATE|ALBUTEROL|ALBUTEROL SULFATE|ALBUTEROL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)|MORPHINE SULFATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CALCIUM|CALCIUM|CEFUROXIME|CEFUROXIME|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|DAPSONE GEL, 5%|DAPSONE|DASPONE|DAPSONE GEL, 5%|DAPSONE|DASPONE|FLUTICASONE FUROATE|FLUTICASONE FUROATE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PRAMIPEXOLE|PRAMIPEXOLE|ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|ANTACID|CALCIUM CARBONATE|ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE AND SIMETHICONE|ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE|MAGNESIUM OXIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|PRAMIPEXOLE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|FUROSEMIDE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METOCLOPRAMIDE HYDROCHLORIDE|MICONAZOLE|MICONAZOLE NITRATE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|CLEMASTINE FUMARATE|ALBUTEROL SULFATE|ALBUTEROL|ALBUTEROL SULFATE|ALBUTEROL",127,Transitional cell carcinoma|Transitional cell carcinoma|Transitional cell carcinoma|Transitional cell carcinoma|Transitional cell carcinoma|Non-small cell lung cancer|Transitional cell carcinoma|Visual impairment|Transitional cell carcinoma|Transitional cell carcinoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Visual impairment|Visual impairment|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pain|Hiatus hernia|Headache|Product used for unknown indication|Product used for unknown indication|Pain|Hiatus hernia|Pain|Mucosal inflammation|Pain|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Headache|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pain|Product used for unknown indication|Product used for unknown indication|Mucosal inflammation|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Sepsis|Cytokine release syndrome|Lymphadenectomy|White blood cell count abnormal|Hydronephrosis|Oedema peripheral|Diarrhoea|Abdominal pain|Blood creatinine increased|Constipation|Cytomegalovirus infection|Body temperature abnormal,12,1
21263678,20220829,Epcoritamab,75,801,75.0,2,45,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN|CHLORPROMAZINE|LEVOTHYROXINE SODIUM|FUROSEMIDE|PANTOPRAZOLE|OXYCODONE HYDROCHLORIDE|OXYCODONE|CLOPIDOGREL|IVABRADINE|TIOTROPIUM BROMIDE|LEVOCETIRIZINE DIHYDROCHLORIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|FILGRASTIM|ZOLEDRONIC ACID|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN,28,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,General physical health deterioration|Thrombotic microangiopathy|Off label use,3,3
21266529,20220829,Epcoritamab,75,801,75.0,2,45,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|ZOLEDRONIC ACID|OXYCODONE HYDROCHLORIDE|FILGRASTIM|LEVOCETIRIZINE DIHYDROCHLORIDE|IVABRADINE|LEVOTHYROXINE SODIUM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|CLOPIDOGREL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|FUROSEMIDE|TIOTROPIUM BROMIDE|PANTOPRAZOLE|OXYCODONE|CHLORPROMAZINE,29,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,General physical health deterioration|Thrombotic microangiopathy|Off label use,3,3
21269426,20220830,Epcoritamab,68,801,68.0,1,,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACYCLOVIR|ALLOPURINOL|LOSARTAN POTASSIUM|LOSARTAN|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|OXYGEN|0XYGEN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|REMDESIVIR|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,18,Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Prophylaxis|Prophylaxis|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I,COVID-19,1,3
21270293,20220830,Epcoritamab,75,801,75.0,2,45,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|OXALIPLATIN|SULFAMETHOXAZOLE AND TRIMETHOPRIM|FUROSEMIDE|LEVOCETIRIZINE DIHYDROCHLORIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|FILGRASTIM|PANTOPRAZOLE|TIOTROPIUM BROMIDE|IVABRADINE|LEVOTHYROXINE SODIUM|OXYCODONE HYDROCHLORIDE|CLOPIDOGREL|OXYCODONE|ZOLEDRONIC ACID|CHLORPROMAZINE,27,Product used for unknown indication|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,General physical health deterioration|Thrombotic microangiopathy,2,5
21274126,20220831,Epcoritamab,75,801,75.0,2,45,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|OXALIPLATIN|FUROSEMIDE|LEVOCETIRIZINE DIHYDROCHLORIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|FILGRASTIM|PANTOPRAZOLE|TIOTROPIUM BROMIDE|IVABRADINE|LEVOTHYROXINE SODIUM|OXYCODONE HYDROCHLORIDE|CLOPIDOGREL|OXYCODONE|ZOLEDRONIC ACID|CHLORPROMAZINE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN,27,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Thrombotic microangiopathy|General physical health deterioration|Off label use,3,3
21285795,20220902,Epcoritamab,77,801,77.0,2,77.4,1,1,1,1,1,1,1,Epcoritamab,"PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|ALLOPURINOL|ALPRAZOLAM|ARIPIPRAZOLE ORALLY DISINTEGRATING|ARIPIPRAZOLE|ARIPIPRAZOLE ORAL|BUTALBITAL, ACETAMINOPHEN AND CAFFEINE|BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE|BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES|CEFEPIME HYDROCHLORIDE|CEFEPIME|FLUCONAZOLE|FLUTICASONE FUROATE AND VILANTEROL|INSULIN LISPRO|LEVOTHYROXINE|MELATONIN|PANTOPRAZOLE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|UMECLIDINIUM|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE",26,Cytokine release syndrome|Chronic lymphocytic leukaemia|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Dizziness|Anxiety|Headache|Depression,4,1
21289520,20220902,Epcoritamab,78,801,78.0,2,55,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|PREDNISONE|AMLODIPINE BESYLATE|GRANISETRON HYDROCHLORIDE|LANSOPRAZOLE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ALLOPURINOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",32,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,COVID-19 pneumonia|Multiple organ dysfunction syndrome,2,1
21289978,20220902,Epcoritamab,62,801,62.0,1,82.1,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LORAZEPAM|LORAZEPAM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|CYCLOPENTOLATE HYDROCHLORIDE|ENOXAPARIN SODIUM|BISOPROLOL FUMARATE|DEXCHLORPHENIRAMINE MALEATE|MAGNESIUM|METOCLOPRAMIDE HYDROCHLORIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM,24,,Diarrhoea|Vena cava thrombosis|Off label use,3,3
21290104,20220902,Epcoritamab,70,801,70.0,1,68,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIGOXIN|AMINOPHYLLINE|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS",22,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Cytokine release syndrome|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Arthritis bacterial,1,1
21291636,20220903,Epcoritamab,65,801,65.0,2,80,1,1,1,1,1,1,1,Epcoritamab,"BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|PACLITAXEL|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|CARBOPLATIN|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|CLEMASTINE FUMARATE|MORPHINE SULFATE|FLUTICASONE FUROATE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|LANSOPRAZOLE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ALBUTEROL SULFATE|ALBUTEROL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|CEFUROXIME|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DAPSONE GEL, 5%|DAPSONE|DASPONE|DAPSONE GEL, 5%|DAPSONE|DASPONE|PRAMIPEXOLE|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|MORPHINE SULFATE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PRAMIPEXOLE|ANTACID|CALCIUM CARBONATE|ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE AND SIMETHICONE|ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE|MAGNESIUM OXIDE|ALLOPURINOL|LOSARTAN POTASSIUM|LOSARTAN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SULFAMETHOXAZOLE AND TRIMETHOPRIM|METHYLPREDNISOLONE SODIUM SUCCINATE|ACYCLOVIR|TOCILIZUMAB|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|MOMETASONE FUROATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE",111,Transitional cell carcinoma|Non-small cell lung cancer|Non-small cell lung cancer|Transitional cell carcinoma|Transitional cell carcinoma|Follicular lymphoma|Follicular lymphoma stage IV|Transitional cell carcinoma|Visual impairment|Follicular lymphoma|Follicular lymphoma stage IV|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma stage IV|Follicular lymphoma|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pain|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pain|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pain|Product used for unknown indication|Mucosal inflammation|Hiatus hernia|Product used for unknown indication|Headache|Product used for unknown indication|Headache|Pain|Hiatus hernia|Product used for unknown indication|Product used for unknown indication|Pain|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Mucosal inflammation|Product used for unknown indication|Product used for unknown indication,Hydronephrosis|Cytomegalovirus infection|Product use issue|Sepsis|Blood creatinine increased|Abdominal pain|Constipation|Diarrhoea,8,1
21293611,20220905,Epcoritamab,65,801,65.0,1,93,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ACYCLOVIR|FILGRASTIM|LANSOPRAZOLE|ERYTHROMYCIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,21,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Prophylaxis|Prophylaxis|Prophylaxis|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis,Upper gastrointestinal haemorrhage,1,3
21298558,20220906,Epcoritamab,72,801,72.0,1,71.8,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|PEGFILGRASTIM|ALENDRONATE SODIUM|ACYCLOVIR,14,Diffuse large B-cell lymphoma|Product used for unknown indication|Diffuse large B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Infusion related reaction|Vomiting|Nausea|Off label use,4,5
21298565,20220906,Epcoritamab,68,801,68.0,1,106.6,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CLEMASTINE FUMARATE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|LOSARTAN POTASSIUM|LOSARTAN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE SODIUM SUCCINATE|ALLOPURINOL|CEFUROXIME|ACYCLOVIR|PEGFILGRASTIM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|REMDESIVIR|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,28,Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Infusion related reaction|Pyrexia,2,5
21299180,20220906,Epcoritamab,65,801,65.0,2,80,1,1,1,1,1,1,1,Epcoritamab,"CARBOPLATIN|CARBOPLATIN|PACLITAXEL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|MORPHINE SULFATE|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|MORPHINE SULFATE|FLUTICASONE FUROATE|FLUTICASONE FUROATE|FLUTICASONE FUROATE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|LANSOPRAZOLE|LANSOPRAZOLE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ALBUTEROL SULFATE|ALBUTEROL|ALBUTEROL SULFATE|ALBUTEROL|CALCIUM|CALCIUM|CEFUROXIME|CEFUROXIME|CEFUROXIME|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DAPSONE GEL, 5%|DAPSONE|DASPONE|DAPSONE GEL, 5%|DAPSONE|DASPONE|DAPSONE GEL, 5%|DAPSONE|DASPONE|PRAMIPEXOLE|PRAMIPEXOLE|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)|ACYCLOVIR|ACYCLOVIR",89,Transitional cell carcinoma|Transitional cell carcinoma|Follicular lymphoma|Transitional cell carcinoma|Non-small cell lung cancer|Non-small cell lung cancer|Transitional cell carcinoma|Follicular lymphoma|Follicular lymphoma|Visual impairment|Pain|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pain|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Mucosal inflammation|Hiatus hernia|Product used for unknown indication|Headache|Headache|Pain|Product used for unknown indication|Hiatus hernia|Product used for unknown indication,Abdominal pain|Constipation|Constipation|Abdominal pain|Sepsis|Hydronephrosis|Blood creatinine increased,7,1
21301765,20220907,Epcoritamab,70,801,70.0,1,68,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|DOXORUBICIN|PREDNISONE|PREDNISONE|PREDNISONE|DIGOXIN|AMINOPHYLLINE|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",22,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,1
21306687,20220908,Epcoritamab,59,801,59.0,2,52.40,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|CLONAZEPAM|DESIPRAMINE|ERGOCALCIFEROL|FAMOTIDINE|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|ATOVAQUONE|ATOVAQUONE ORAL SUSPENSION|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|APIXABAN",28,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,COVID-19 pneumonia,1,3
21309227,20220908,Epcoritamab,65,801,65.0,1,93,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ACYCLOVIR|FILGRASTIM|LANSOPRAZOLE,9,Follicular lymphoma stage IV|Follicular lymphoma stage IV,Haematemesis|Haematochezia|Diarrhoea|Upper gastrointestinal haemorrhage|Vomiting,5,3
21322548,20220912,Epcoritamab,66,801,66.0,1,78,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|VALSARTAN|VALSARTAN ORAL|VALSARTAN|VALSARTAN ORAL|VALACYCLOVIR HYDROCHLORIDE,19,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,COVID-19,1,3
21328024,20220913,Epcoritamab,78,801,78.0,2,55,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|GRANISETRON HYDROCHLORIDE|LANSOPRAZOLE|AMLODIPINE BESYLATE|PREDNISONE|ALLOPURINOL",32,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,COVID-19 pneumonia|Multiple organ dysfunction syndrome,2,1
21333745,20220914,Epcoritamab,70,801,70.0,1,76.50,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|MAGNESIUM HYDROXIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACYCLOVIR|DOXYCYCLINE|DOXYCYCLINE HYCLATE|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE,33,B-cell lymphoma|Follicular lymphoma|Follicular lymphoma|B-cell lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Premedication|Prophylaxis|Product used for unknown indication,Haemophilus infection,1,1
21341595,20220916,Epcoritamab,65,801,65.0,1,93,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|ACYCLOVIR|FILGRASTIM|LANSOPRAZOLE,10,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Haematemesis|Haematochezia|Diarrhoea|Vomiting|Upper gastrointestinal haemorrhage,5,3
21346259,20220917,Epcoritamab,49,801,49.0,1,105.50,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|ALLOPURINOL|FOLIC ACID|POVIDONE-IODINE|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|TRAMADOL HYDROCHLORIDE|METHYLPREDNISOLONE|BISOPROLOL FUMARATE|FLUCONAZOLE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|LORAZEPAM|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|METHYLPREDNISOLONE",39,Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Diffuse large B-cell lymphoma stage I|Premedication|Premedication|Prophylaxis|Prophylaxis|Prophylaxis|Premedication|Prophylaxis,Febrile neutropenia,1,3
21346370,20220917,Epcoritamab,89,801,89.0,1,87.6,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|ALBUTEROL SULFATE|ALBUTEROL|ALLOPURINOL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|POLYETHYLENE GLYCOL 3350|MORPHINE|PANTOPRAZOLE|PROGESTERONE|SENNOSIDES A AND B|SILVER SULFADIAZINE|PREDNISONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISONE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|PREDNISONE",32,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Prophylaxis|Prophylaxis|Prophylaxis|Premedication|Premedication|Diffuse large B-cell lymphoma stage IV|Prophylaxis|Prophylaxis|Diffuse large B-cell lymphoma stage IV,Febrile neutropenia,1,1
21356865,20220920,Epcoritamab,65,801,65.0,1,93,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|ACYCLOVIR|FILGRASTIM|LANSOPRAZOLE,10,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Haematemesis|Haematochezia|Diarrhoea|Vomiting,4,3
21358885,20220921,Epcoritamab,61,801,61.0,2,45.30,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALBUTEROL SULFATE|ALBUTEROL|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|DOXYCYCLINE|DOXYCYCLINE HYCLATE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LORATADINE|LORATADINE ORAL|LORAZEPAM|MECLIZINE HCL 12.5 MG|MECLIZINE|MECLIZINE HYDROCHLORIDE|MECLIZINE HCL 25MG|MECLIZINE HCL 12.5MG|MUPIROCIN CALCIUM|OLANZAPINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISONE|LORATADINE|LORATADINE ORAL|LORATADINE|LORATADINE ORAL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LORATADINE|LORATADINE ORAL|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN",30,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Premedication|Premedication|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Febrile neutropenia|Sepsis,2,1
21359755,20220921,Epcoritamab,64,801,64.0,1,106,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR,15,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV,Pneumonia|COVID-19,2,1
21359809,20220921,Epcoritamab,73,801,73.0,1,82,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|CANDESARTAN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|DAPAGLIFLOZIN|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|PANTOPRAZOLE,28,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,COVID-19 pneumonia,1,3
21365898,20220922,Epcoritamab,68,801,68.0,2,59.3,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|RITUXIMAB|VINCRISTINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALLOPURINOL|FENTANYL|MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CALCIUM CARBONATE|ANTACID|PREGABALIN",31,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Febrile neutropenia,1,1
21373619,20220925,Epcoritamab,73,801,73.0,1,82,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|CANDESARTAN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|DAPAGLIFLOZIN|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|PANTOPRAZOLE,27,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,COVID-19 pneumonia,1,3
21373661,20220926,Epcoritamab,67,801,67.0,1,98.1,1,1,1,1,1,1,1,Epcoritamab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARBOPLATIN|RITUXIMAB|CYTARABINE|CYTARABINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RASBURICASE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,21,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Quadriparesis|Respiratory failure|Guillain-Barre syndrome,3,3
21377526,20220926,Epcoritamab,72,801,72.0,1,73,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|PREDNISONE|PREDNISONE|TOCILIZUMAB|TOCILIZUMAB|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS,15,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Small intestinal perforation,1,3
21379034,20220927,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|GRANISETRON HYDROCHLORIDE|LANSOPRAZOLE|AMLODIPINE BESYLATE|PREDNISONE|ALLOPURINOL",32,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,COVID-19 pneumonia|Multiple organ dysfunction syndrome,2,1
21380971,20220927,Epcoritamab,75,801,75.0,2,45,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN|FUROSEMIDE|LEVOCETIRIZINE DIHYDROCHLORIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|FILGRASTIM|PANTOPRAZOLE|TIOTROPIUM BROMIDE|IVABRADINE|LEVOTHYROXINE SODIUM|OXYCODONE HYDROCHLORIDE|CLOPIDOGREL|OXYCODONE|ZOLEDRONIC ACID|CHLORPROMAZINE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN,27,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,General physical health deterioration|Thrombotic microangiopathy|Off label use,3,3
21381450,20220927,Epcoritamab,87,801,87.0,1,68.2,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ENTECAVIR|ENTECAVIR ANHYDROUS|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE|ALLOPURINOL|CARVEDILOL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TRIMETHOPRIM|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM,15,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Sepsis,1,1
21382377,20220927,Epcoritamab,54,801,54.0,1,82.6,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LOSARTAN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",26,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III,Pneumonia|Hypoxia|Pyrexia|COVID-19 pneumonia,4,1
21382614,20220927,Epcoritamab,68,801,68.0,1,80,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|RITUXIMAB|VINCRISTINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|ALLOPURINOL|EPOETIN ALFA|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREGABALIN|TRIMETHOPRIM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM",24,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Cardiac failure|Cytopenia,2,3
21383524,20220927,Epcoritamab,54,801,54.0,1,82.60,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LOSARTAN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE",25,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,COVID-19 pneumonia|Hypoxia|Pneumonia|Condition aggravated,4,3
21383670,20220928,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|BENDAMUSTINE HCL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|PREDNISONE|MOMETASONE FUROATE|MOMETASONE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|ALBUTEROL SULFATE|ALBUTEROL|PEGFILGRASTIM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|FILGRASTIM|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|DOXYCYCLINE|DOXYCYCLINE HYCLATE",34,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV,COVID-19|Infection|Overdose,3,1
21385906,20220928,Epcoritamab,77,801,77.0,1,56.5,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|PREDNISONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACYCLOVIR|ATORVASTATIN CALCIUM|DICLOFENAC SODIUM|MAGNESIUM CITRATE|MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON|BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY|CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY|FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE|MAGNESIUM CITRATE ORAL SOLUTION|CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE|BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE|CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON|FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON|LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY|LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON|BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON|FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY|LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE|HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON|CARBOXYMETHYLCELLULOSE SODIUM|FILGRASTIM-SNDZ|LEVOTHYROXINE|PANTOPRAZOLE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|SULFAMETHOXAZOLE AND TRIMETHOPRIM|TOCILIZUMAB,26,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Prophylaxis|Premedication|Premedication|Diffuse large B-cell lymphoma stage II,Cytokine release syndrome|Sepsis,2,1
21386254,20220928,Epcoritamab,69,801,69.0,2,90,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR,24,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,COVID-19 pneumonia,1,1
21386716,20220928,Epcoritamab,68,801,68.0,2,59.3,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|RITUXIMAB|VINCRISTINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALLOPURINOL|AMITRIPTYLINE HYDROCHLORIDE|CALCIUM CARBONATE|ANTACID|FENTANYL|FENTANYL|PREGABALIN|PREGABALIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACYCLOVIR|PREDNISONE|METHYLPREDNISOLONE",40,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication,Febrile neutropenia,1,1
21387781,20220928,Epcoritamab,68,801,68.0,1,80,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|RITUXIMAB|VINCRISTINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|ALLOPURINOL|EPOETIN ALFA|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREGABALIN|TRIMETHOPRIM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM",24,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Cytopenia|Cardiac failure,2,1
21391837,20220929,Epcoritamab,68,801,68.0,2,59.3,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|AMITRIPTYLINE HYDROCHLORIDE|CALCIUM GLUCONATE|CALCIUM CARBONATE|ANTACID|FENTANYL|FENTANYL|FUROSEMIDE|FUROSEMIDE|PREGABALIN|PREGABALIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACYCLOVIR|DEXTROSE AND SODIUM CHLORIDE|DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE|DEXTROSE MONOHYDRATE, SODIUM CHLORIDE|DEXTROSE AND SODIUM CHLORIDE|DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE|DEXTROSE MONOHYDRATE, SODIUM CHLORIDE|MAGNESIUM|MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|PREGABALIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS",79,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Premedication|Prophylaxis|Premedication|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Product used for unknown indication|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Neutropenia|Product used for unknown indication|Prophylaxis|Upper respiratory tract infection|Prophylaxis|Constipation|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Constipation|Cytokine release syndrome|Premedication|Drug therapy|Prophylaxis,Immune effector cell-associated neurotoxicity syndrome|Immune effector cell-associated neurotoxicity syndrome|Somnolence|Paraesthesia|Spinal fracture|Febrile neutropenia|Diarrhoea|Gastroenteritis|Thrombocytopenia|C-reactive protein increased|Haemoglobin decreased,11,1
21394641,20220930,Epcoritamab,78,801,78.0,2,83.6,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|GUAIFENESIN|HYDROCHLOROTHIAZIDE|LEVALBUTEROL|LEVALBUTEROL HYDROCHLORIDE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ALBUTEROL SULFATE|DEXTROMETHORPHAN HYDROBROMIDE|SENNOSIDES A AND B|APIXABAN|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|PREDNISONE|PREDNISONE|PREDNISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,37,Follicular lymphoma stage III|Follicular lymphoma stage III|Follicular lymphoma stage III,Atrial fibrillation,1,3
21395686,20220930,Epcoritamab,66,801,66.0,2,66.8,1,0,1,1,0,0,0,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|EZETIMIBE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALLOPURINOL|METHYLPREDNISOLONE|CALCIUM CARBONATE|ANTACID|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|ERGOCALCIFEROL,19,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,1
21395757,20220930,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE,4,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Prophylaxis,Immune effector cell-associated neurotoxicity syndrome,1,3
21402798,20221003,Epcoritamab,65,801,65.0,2,80,1,1,1,1,1,1,1,Epcoritamab,"BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|BENDAMUSTINE HYDROCHLORIDE|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|PACLITAXEL|PACLITAXEL|PACLITAXEL|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|ATEZOLIZUMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)|MORPHINE SULFATE|MORPHINE SULFATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ACYCLOVIR|ACYCLOVIR|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CALCIUM|CALCIUM|CEFUROXIME|CEFUROXIME|CEFUROXIME|CLEMASTINE FUMARATE|CLEMASTINE FUMARATE|DAPSONE GEL, 5%|DAPSONE|DASPONE|DAPSONE GEL, 5%|DAPSONE|DASPONE|FLUTICASONE FUROATE|FLUTICASONE FUROATE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MICONAZOLE NITRATE|JOCK ITCH SPRAY|ANTIFUNGAL LIQUID CONTINUOUS SPRAY|ATHLETES FOOT LIQUID|ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE|ATHLETES FOOT POWDER SPRAY TALC FREE|MICONAZORB ANTIFUNGAL POWDER TALC FREE|ANTIFUNGAL MICONAZOLE POWDER SPRAY|ANTIFUNGAL|JOCK ITCH SPRAY TALC FREE|ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY|MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY|ATHLETES FOOT SPRAY|ANTIFUNGAL POWDER SPRAY|JOCK ITCH POWDER SPRAY|ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE|MORPHINE SULFATE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PRAMIPEXOLE|PRAMIPEXOLE|ALBUTEROL SULFATE|ALBUTEROL|ALBUTEROL SULFATE|ALBUTEROL|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DAPSONE GEL, 5%|DAPSONE|DASPONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ANTACID|CALCIUM CARBONATE|ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE AND SIMETHICONE|ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE|MAGNESIUM OXIDE",124,Visual impairment|Follicular lymphoma|Transitional cell carcinoma|Visual impairment|Transitional cell carcinoma|Transitional cell carcinoma|Non-small cell lung cancer|Transitional cell carcinoma|Non-small cell lung cancer|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Hiatus hernia|Pain|Hiatus hernia|Product used for unknown indication|Product used for unknown indication|Headache|Pain|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Mucosal inflammation|Mucosal inflammation|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pain|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Mucosal inflammation,Sepsis|Hydronephrosis|Cytomegalovirus infection|Blood creatinine increased|Abdominal pain|Constipation|Off label use|Product use issue,8,1
21410177,20221005,Epcoritamab,79,801,79.0,2,70.8,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|PREDNISONE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|FERRIC CARBOXYMALTOSE|FERRIC CARBOXYMALTOSE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|SENNOSIDES|ACYCLOVIR|CEPHALEXIN|DEXTROSE MONOHYDRATE|DEXTROSE|FOSCARNET SODIUM|FUROSEMIDE|GLIPIZIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|LISINOPRIL|MAGNESIUM OXIDE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|PROPOFOL|SITAGLIPTIN",45,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,Cytomegalovirus colitis,1,1
21416305,20221006,Epcoritamab,72,801,72.0,1,78,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|CHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|PREDNISONE|ACYCLOVIR|ALLOPURINOL|DUTASTERIDE|FILGRASTIM|FOLIC ACID|FUROSEMIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|PANTOPRAZOLE|RABEPRAZOLE|SILODOSIN|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,30,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Prophylaxis|Prophylaxis|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Premedication|Premedication|Premedication|Premedication,Cytokine release syndrome,1,1
21418893,20221006,Epcoritamab,59,801,59.0,2,52.4,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ATOVAQUONE|ATOVAQUONE ORAL SUSPENSION|CLONAZEPAM|DESIPRAMINE|ERGOCALCIFEROL|FAMOTIDINE|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|PREDNISONE|PREDNISONE|APIXABAN|HYDROCORTISONE SODIUM SUCCINATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BENZONATATE|CHLORHEXIDINE GLUCONATE|ANTISEPTIC SKIN CLEANSER|PSYLLIUM HUSK|ROCURONIUM|ROCURONIUM BROMIDE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL",41,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|COVID-19 prophylaxis,COVID-19 pneumonia,1,1
21419300,20221006,Epcoritamab,70,801,70.0,1,68,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|DOXORUBICIN|DOXORUBICIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIGOXIN|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|AMINOPHYLLINE|PREDNISONE",31,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Cytokine release syndrome|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis,Arthritis bacterial,1,3
21420454,20221007,Epcoritamab,68,801,68.0,1,80,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|METHYLPREDNISOLONE|ALLOPURINOL|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|TRIMETHOPRIM|ACYCLOVIR|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|LIDOCAINE HYDROCHLORIDE|LIDOCAINE HYDROCHLORIDE ANHYDROUS",23,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cardiac failure|Cytopenia|Decreased appetite|Asthenia|Diarrhoea,5,3
21421356,20221007,Epcoritamab,66,801,66.0,2,66.8,1,0,1,0,0,0,1,Epcoritamab,LENALIDOMIDE|RITUXIMAB|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ERGOCALCIFEROL|ALLOPURINOL|CALCIUM CARBONATE|ANTACID|EZETIMIBE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREDNISONE,22,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,1
21422582,20221007,Epcoritamab,81,801,81.0,1,69,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE|METHYLPREDNISOLONE|PREDNISONE|FILGRASTIM|GRANISETRON HYDROCHLORIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALLOPURINOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",25,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Cytokine release syndrome,1,1
21424643,20221007,Epcoritamab,67,801,67.0,2,61,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|APIXABAN|MEROPENEM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",30,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Hypotension|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication,Pneumocystis jirovecii infection|Cytokine release syndrome|Febrile neutropenia,3,1
21425676,20221008,Epcoritamab,77,801,77.0,1,85.7,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXCHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACYCLOVIR|AMLODIPINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|INDAPAMIDE|LATANOPROST|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|TRIMETHOPRIM|METHYLPREDNISOLONE|CEFEPIME HYDROCHLORIDE|CEFEPIME|ENOXAPARIN SODIUM|LORAZEPAM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",34,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Premedication|Premedication|Prophylaxis|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Prophylaxis|Premedication,Condition aggravated|Cytokine release syndrome,2,1
21434306,20221010,Epcoritamab,45,801,45.0,1,99,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|CYTARABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DALTEPARIN SODIUM|DALTEPARIN SODIUM|DALTEPARIN SODIUM|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ACYCLOVIR|ACYCLOVIR|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|FILGRASTIM|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|FOLIC ACID|LANSOPRAZOLE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,52,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Prophylaxis|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage II|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Thrombocytopenia|Neutropenic infection|Febrile neutropenia|Cellulitis|Disease progression|Neutropenia|Product use issue,7,1
21434450,20221010,Epcoritamab,68,801,68.0,2,59.3,1,0,1,1,0,0,1,Epcoritamab,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|DOXORUBICIN|VINCRISTINE SULFATE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|AMITRIPTYLINE HYDROCHLORIDE|ALLOPURINOL|FENTANYL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MAGNESIUM|CALCIUM CARBONATE|ANTACID|PREGABALIN|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|ACYCLOVIR|PREDNISONE|PREDNISONE|PREDNISONE",43,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication,Febrile neutropenia|Paraesthesia|Thrombocytopenia|Gastroenteritis|Somnolence|Diarrhoea|Spinal fracture|Immune effector cell-associated neurotoxicity syndrome,8,1
21436932,20221010,Epcoritamab,72,801,72.0,1,70.4,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|VINCRISTINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACYCLOVIR|ALLOPURINOL|APREPITANT|ATOVAQUONE|ATOVAQUONE ORAL SUSPENSION|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|DULAGLUTIDE|FLUCONAZOLE|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|INSULIN ASPART|LORAZEPAM|LOSARTAN|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|MIRABEGRON|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|METHOTREXATE|METHOTREXATE SODIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|OXYCODONE|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|PEGFILGRASTIM|AMOXICILLIN|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|PROCHLORPERAZINE|SERTRALINE|SENNOSIDES A AND B|SODIUM HYALURONATE|TADALAFIL|MAGNESIUM HYDROXIDE|MAGNESIUM HYDROXIDE|PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE|MORPHINE SULFATE|ZOLPIDEM TARTRATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CEFADROXIL|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|SERTRALINE HYDROCHLORIDE",70,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Premedication|Premedication|Stomatitis|Prophylaxis|Prophylaxis,Neutrophil count decreased|Stomatitis|Diarrhoea|Cytokine release syndrome,4,1
21439567,20221011,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"ACYCLOVIR|ACYCLOVIR|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ALLOPURINOL|RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FERROUS SULFATE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",44,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma|Product used for unknown indication|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication,Cytokine release syndrome|Pyrexia|Hypotension|Fibrin D dimer increased|C-reactive protein increased|Haemoglobin decreased,6,1
21449073,20221013,Epcoritamab,60,801,60.0,1,101.1,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ACYCLOVIR|ALLOPURINOL|ALPROSTADIL|FILGRASTIM,23,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,COVID-19|Lower respiratory tract infection,2,3
21450544,20221013,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ALLOPURINOL|RITUXIMAB|RITUXIMAB|RITUXIMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACYCLOVIR|LENALIDOMIDE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|PREDNISONE|PREDNISONE|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACYCLOVIR|ACYCLOVIR|FERROUS SULFATE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",44,Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Prophylaxis|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Hypotension|Pyrexia|Haemoglobin decreased|Fibrin D dimer increased|C-reactive protein increased,6,1
21451580,20221013,Epcoritamab,70,801,70.0,1,71.5,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|LORATADINE|LORATADINE ORAL|PROMETHAZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ALLOPURINOL|APIXABAN|BISOPROLOL FUMARATE|FENOFIBRATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR,30,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Atrial fibrillation,1,3
21452318,20221013,Epcoritamab,70,801,70.0,1,68,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|DOXORUBICIN|PREDNISONE|PREDNISONE|DIGOXIN|AMINOPHYLLINE|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",34,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Prophylaxis,Pneumonia|Cytokine release syndrome|C-reactive protein increased,3,1
21453528,20221013,Epcoritamab,62,801,62.0,1,125.7,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ACYCLOVIR|ENALAPRIL|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|SIMVASTATIN|SITAGLIPTIN|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,19,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Pneumocystis jirovecii infection,Neoplasm progression|Cytokine release syndrome|Diarrhoea|Pneumocystis jirovecii infection|Dehydration,5,1
21453658,20221013,Epcoritamab,68,801,68.0,1,80,1,1,1,1,1,1,1,Epcoritamab,"VINCRISTINE SULFATE|RITUXIMAB|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|TRIMETHOPRIM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ALLOPURINOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREGABALIN|EPOETIN ALFA|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ACYCLOVIR|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|ERYTHROPOIETIN|ERYTHROPOIETIN|LIDOCAINE HYDROCHLORIDE|LIDOCAINE HYDROCHLORIDE ANHYDROUS",33,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Prophylaxis|Product used for unknown indication,Cardiac failure|Cytopenia|Diarrhoea|Asthenia|Decreased appetite,5,3
21459844,20221014,Epcoritamab,67,801,67.0,2,56,1,1,1,1,1,1,1,Epcoritamab,"METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE|PREDNISONE|FILGRASTIM|LEVOTHYROXINE SODIUM|GRANISETRON HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ALLOPURINOL|FLUCONAZOLE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OXAZEPAM|BISOPROLOL FUMARATE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RITUXIMAB|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN",30,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV,Cytokine release syndrome,1,1
21459890,20221014,Epcoritamab,83,801,83.0,2,56,1,1,1,1,1,1,1,Epcoritamab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|PREDNISONE|RITUXIMAB|FENTANYL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|LACTULOSE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METOPROLOL TARTRATE|METOPROLOL",17,B-cell lymphoma|B-cell lymphoma|B-cell lymphoma|B-cell lymphoma|B-cell lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,1
21459980,20221014,Epcoritamab,79,801,79.0,1,77.5,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|FLUCONAZOLE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CETIRIZINE HYDROCHLORIDE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE ALLERGY|CETIRIZINE HYDROCHLORIDE TABLETS|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|FILGRASTIM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|PREDNISONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SULFAMETHOXAZOLE AND TRIMETHOPRIM,24,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,3
21463787,20221017,Epcoritamab,77,801,77.0,1,85.7,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACYCLOVIR|INDAPAMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METHYLPREDNISOLONE|LATANOPROST|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXCHLORPHENIRAMINE MALEATE|AMLODIPINE|TRIMETHOPRIM|ENOXAPARIN SODIUM,30,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Condition aggravated|Pyrexia,3,1
21464644,20221017,Epcoritamab,73,801,73.0,2,58,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|ALPRAZOLAM|AMPHOTERICIN B|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BISOPROLOL FUMARATE|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|OXYCODONE HYDROCHLORIDE|OXYCODONE|PRAMIPEXOLE|SOLIFENACIN SUCCINATE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|PEGFILGRASTIM-BMEZ|TRIMETHOPRIM,24,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II,Thrombotic microangiopathy,1,3
21464970,20221017,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LENALIDOMIDE|ACYCLOVIR|ACYCLOVIR|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RITUXIMAB|RITUXIMAB|RITUXIMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREDNISONE|PREDNISONE|PREDNISONE|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METHYLPREDNISOLONE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|FERROUS SULFATE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",39,Product used for unknown indication|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,C-reactive protein increased|Cytokine release syndrome|Haemoglobin decreased|Fibrin D dimer increased|Hypotension|Pyrexia,6,1
21470737,20221018,Epcoritamab,72,801,72.0,1,78,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|RABEPRAZOLE|DUTASTERIDE|SILODOSIN|METHYLPREDNISOLONE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|FILGRASTIM|FOLIC ACID|PANTOPRAZOLE|FUROSEMIDE|PREDNISONE|ACYCLOVIR|ALLOPURINOL|GRANISETRON|GRANISETRON HYDROCHLORIDE,31,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,1
21472081,20221018,Epcoritamab,72,801,72.0,1,78,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|OXALIPLATIN|RABEPRAZOLE|ALLOPURINOL|DUTASTERIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|PANTOPRAZOLE|FOLIC ACID|FUROSEMIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|SILODOSIN|PREDNISONE|ACYCLOVIR|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE,29,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,5
21472541,20221018,Epcoritamab,77,801,77.0,1,85.7,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|OXALIPLATIN|ACYCLOVIR|AMLODIPINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXCHLORPHENIRAMINE MALEATE|INDAPAMIDE|LATANOPROST|METHYLPREDNISOLONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|TRIMETHOPRIM|ENOXAPARIN SODIUM|CEFEPIME HYDROCHLORIDE|CEFEPIME|LORAZEPAM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",36,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Prophylaxis|Premedication|Premedication|Premedication,Pneumonia|Cytokine release syndrome|General physical health deterioration|Pyrexia|Off label use,5,1
21473849,20221018,Epcoritamab,72,801,72.0,1,78,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RABEPRAZOLE|DUTASTERIDE|SILODOSIN|METHYLPREDNISOLONE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|CHLORPHENIRAMINE MALEATE|FILGRASTIM|FOLIC ACID|PANTOPRAZOLE|FUROSEMIDE|PREDNISONE|ACYCLOVIR|ALLOPURINOL,30,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,1
21479029,20221019,Epcoritamab,79,801,79.0,1,,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|RITUXIMAB,3,B-cell lymphoma|B-cell lymphoma|Diffuse large B-cell lymphoma stage III,Cytokine release syndrome|Febrile neutropenia,2,1
21481710,20221020,Epcoritamab,77,801,77.0,1,85.7,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACYCLOVIR|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|AMLODIPINE|CEFEPIME HYDROCHLORIDE|CEFEPIME|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXCHLORPHENIRAMINE MALEATE|ENOXAPARIN SODIUM|INDAPAMIDE|LATANOPROST|LORAZEPAM|METHYLPREDNISOLONE|METOCLOPRAMIDE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|TRIMETHOPRIM",38,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Premedication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Condition aggravated|Pyrexia,3,1
21484608,20221020,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALLOPURINOL|ALLOPURINOL|PREDNISONE|PREDNISONE|PREDNISONE|ACYCLOVIR|ACYCLOVIR|RITUXIMAB|RITUXIMAB|RITUXIMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|AMOXICILLIN|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|FERROUS SULFATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,",44,B-cell lymphoma|Follicular lymphoma|Pain|Follicular lymphoma|Prophylaxis|Product used for unknown indication|Prophylaxis|Prophylaxis|Follicular lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Follicular lymphoma|Prophylaxis|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Hypotension|Pyrexia|Fibrin D dimer increased|C-reactive protein increased|Haemoglobin decreased,6,1
21488350,20221020,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|VALACYCLOVIR HYDROCHLORIDE|VALSARTAN|VALSARTAN ORAL,18,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,COVID-19,1,1
21488994,20221021,Epcoritamab,78,801,78.0,2,61.2,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FILGRASTIM,21,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma stage IV|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Squamous cell carcinoma|Basal cell carcinoma,2,3
21489951,20221021,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|CANDESARTAN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|DAPAGLIFLOZIN|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|PANTOPRAZOLE,27,Follicular lymphoma stage III|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma stage III|Follicular lymphoma|Follicular lymphoma stage III,COVID-19 pneumonia,1,3
21490403,20221021,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|AMOXICILLIN|ACYCLOVIR|LENALIDOMIDE|LENALIDOMIDE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|ALLOPURINOL|ALLOPURINOL|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RITUXIMAB|RITUXIMAB|RITUXIMAB|FERROUS SULFATE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",41,Product used for unknown indication|Product used for unknown indication|Prophylaxis|B-cell lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Pain|Follicular lymphoma|Follicular lymphoma|B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Pyrexia|Hypotension|Pyrexia|Fibrin D dimer increased|C-reactive protein increased|Haemoglobin decreased,7,1
21493432,20221021,Epcoritamab,62,801,62.0,1,82.1,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE HYDROCHLORIDE|MAGNESIUM|ACYCLOVIR|ENOXAPARIN SODIUM|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|METOCLOPRAMIDE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FILGRASTIM|DEXCHLORPHENIRAMINE MALEATE|DEXCHLORPHENIRAMINE MALEATE|DEXCHLORPHENIRAMINE MALEATE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|BISOPROLOL FUMARATE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CYCLOPENTOLATE HYDROCHLORIDE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CODEINE SULFATE|LORAZEPAM|BUDESONIDE|TRIMETHOPRIM|RITONAVIR|RITONAVIR 100 MG,48,,Anaemia,1,1
21493438,20221021,Epcoritamab,73,801,73.0,2,58,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ALPRAZOLAM|PEGFILGRASTIM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|SULFAMETHOXAZOLE AND TRIMETHOPRIM|AMPHOTERICIN B|BISOPROLOL FUMARATE|SOLIFENACIN SUCCINATE|OXYCODONE HYDROCHLORIDE|OXYCODONE|PRAMIPEXOLE|MAGNESIUM|CALCIUM GLUCONATE|OXYGEN|0XYGEN|TRIMETHOPRIM,28,Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II|Diffuse large B-cell lymphoma stage II,Thrombotic microangiopathy|Seizure|Cardiac arrest|Anaemia,4,3
21499363,20221024,Epcoritamab,73,801,73.0,1,80.10,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|ACYCLOVIR|APIXABAN|BRIMONIDINE|BRIMONIDINE TARTRATE|CARVEDILOL|BRIMONIDINE TARTRATE, TIMOLOL MALEATE|DIGOXIN|SACUBITRIL AND VALSARTAN|EPLERENONE|FINASTERIDE|ATORVASTATIN CALCIUM|BIMATOPROST|OXYBUTYNIN|OXYCODONE|PANTOPRAZOLE|TRAVOPROST|TRAVOPROST (ISOMER FREE)|SENNOSIDES A AND B|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PENICILLIN V POTASSIUM",36,Follicular lymphoma stage II|Follicular lymphoma stage II|Follicular lymphoma stage II|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,COVID-19|Sepsis,2,3
21499729,20221024,Epcoritamab,77,801,77.0,1,,1,1,1,1,1,1,1,Epcoritamab,"OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|ENOXAPARIN SODIUM|ENOXAPARIN SODIUM|DEXCHLORPHENIRAMINE MALEATE|DEXCHLORPHENIRAMINE MALEATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|AMLODIPINE|AMLODIPINE|ACYCLOVIR|ACYCLOVIR|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METHYLPREDNISOLONE|METHYLPREDNISOLONE|LATANOPROST|LATANOPROST|TRIMETHOPRIM|TRIMETHOPRIM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|INDAPAMIDE|INDAPAMIDE|CEFEPIME HYDROCHLORIDE|CEFEPIME|LORAZEPAM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",52,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|General physical health deterioration|Condition aggravated|Pyrexia,4,1
21509324,20221026,Epcoritamab,66,801,66.0,1,78,1,1,1,1,1,1,1,Epcoritamab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|VALACYCLOVIR HYDROCHLORIDE|VALSARTAN|VALSARTAN ORAL,18,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,Ill-defined disorder|COVID-19,2,1
21524518,20221029,Epcoritamab,83,801,83.0,2,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|METHYLPREDNISOLONE SODIUM SUCCINATE|PREDNISONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ALLOPURINOL|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR",18,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Product used for unknown indication|Diffuse large B-cell lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Sepsis,1,1
21526497,20221031,Epcoritamab,73,801,73.0,2,58,1,1,1,1,1,1,1,Epcoritamab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|ALPRAZOLAM|PEGFILGRASTIM|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|SULFAMETHOXAZOLE AND TRIMETHOPRIM|AMPHOTERICIN B|BISOPROLOL FUMARATE|SOLIFENACIN SUCCINATE|OXYCODONE HYDROCHLORIDE|OXYCODONE|PRAMIPEXOLE|MAGNESIUM|CALCIUM GLUCONATE|OXYGEN|0XYGEN,32,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Thrombocytopenia|Anaemia|Thrombotic microangiopathy,3,3
21530899,20221031,Epcoritamab,65,801,65.0,2,70,1,1,1,1,1,1,1,Epcoritamab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PREDNISONE|RITUXIMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|GENTAMICIN|GENTAMICIN SULFATE|FLUCONAZOLE",19,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Dyspepsia,1,1
21537101,20221101,Epcoritamab,67,801,67.0,2,61,1,1,1,1,1,1,1,Epcoritamab,"LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|APIXABAN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR",16,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome,1,3
21540303,20221102,Epcoritamab,73,801,73.0,1,80.1,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|ACYCLOVIR|APIXABAN|BRIMONIDINE|BRIMONIDINE TARTRATE|CARVEDILOL|BRIMONIDINE TARTRATE, TIMOLOL MALEATE|DIGOXIN|TIMOLOL|SACUBITRIL AND VALSARTAN|EPLERENONE|FINASTERIDE|ATORVASTATIN CALCIUM|BIMATOPROST|OXYBUTYNIN|OXYCODONE|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|SENNOSIDES|SENNA LEAF|SENNA|TRAVOPROST|TRAVOPROST (ISOMER FREE)|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PENICILLIN V POTASSIUM|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|PEGFILGRASTIM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL",44,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma,COVID-19|Sepsis,2,1
21541486,20221102,Epcoritamab,73,801,73.0,2,58,1,1,1,1,1,1,1,Epcoritamab,OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|PEGFILGRASTIM|PEGFILGRASTIM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ALPRAZOLAM|ALPRAZOLAM|AMPHOTERICIN B|AMPHOTERICIN B|OXYCODONE HYDROCHLORIDE|OXYCODONE|OXYCODONE HYDROCHLORIDE|OXYCODONE|PRAMIPEXOLE|PRAMIPEXOLE|SOLIFENACIN SUCCINATE|SOLIFENACIN SUCCINATE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|BISOPROLOL FUMARATE|MAGNESIUM|CALCIUM GLUCONATE|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|OXYGEN|0XYGEN|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS,43,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Thrombotic microangiopathy|Thrombocytopenia|Anaemia,3,3
21550256,20221103,Epcoritamab,68,801,68.0,1,80,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|RITUXIMAB|VINCRISTINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|TRIMETHOPRIM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREGABALIN|ALLOPURINOL|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ERYTHROPOIETIN|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|ACYCLOVIR",27,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma,Cardiac failure|Cytopenia,2,1
21554431,20221104,Epcoritamab,77,801,77.0,1,85.70,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXCHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACYCLOVIR|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CEFEPIME HYDROCHLORIDE|CEFEPIME|ENOXAPARIN SODIUM|INDAPAMIDE|LATANOPROST|LORAZEPAM|METHYLPREDNISOLONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PREDNISONE|TRIMETHOPRIM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXCHLORPHENIRAMINE MALEATE|DEXCHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",41,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Premedication|Premedication|Premedication|Prophylaxis|Prophylaxis|Premedication|Premedication|Premedication|Premedication|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Ataxia,1,3
21556069,20221104,Epcoritamab,77,801,77.0,1,85.7,1,1,1,1,1,1,1,Epcoritamab,"GEMCITABINE HYDROCHLORIDE|OXALIPLATIN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|TRIMETHOPRIM|ENOXAPARIN SODIUM|PREDNISONE|LATANOPROST|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHYLPREDNISOLONE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACYCLOVIR|INDAPAMIDE|DEXCHLORPHENIRAMINE MALEATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LORAZEPAM|CEFEPIME HYDROCHLORIDE|CEFEPIME|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE",37,,Malaise|Ataxia,2,3
21556993,20221104,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"ACYCLOVIR|ACYCLOVIR|ACYCLOVIR|LENALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RITUXIMAB|RITUXIMAB|RITUXIMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|ALLOPURINOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|FERROUS SULFATE",38,Product used for unknown indication|Product used for unknown indication|Follicular lymphoma|Product used for unknown indication|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Hypotension|Pyrexia|C-reactive protein increased|Haemoglobin decreased|Fibrin D dimer increased,6,1
21557699,20221106,Epcoritamab,83,801,83.0,2,56,1,0,1,1,0,0,1,Epcoritamab,"DOXORUBICIN|VINCRISTINE SULFATE|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|RITUXIMAB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|METOPROLOL TARTRATE|METOPROLOL|FENTANYL|DENOSUMAB|LACTULOSE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",20,Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma stage IV,Chills|Pyrexia|Cytokine release syndrome,3,3
21563336,20221108,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|DOXORUBICIN|DOXORUBICIN|PREDNISONE|PREDNISONE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|METHYLPREDNISOLONE SODIUM SUCCINATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|DIGOXIN|AMINOPHYLLINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER",28,Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III|Diffuse large B-cell lymphoma stage III,Septic shock|Cytokine release syndrome,2,1
21563780,20221108,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,RITUXIMAB|RITUXIMAB|LENALIDOMIDE|EZETIMIBE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALLOPURINOL|METHYLPREDNISOLONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|CALCIUM CARBONATE|ANTACID|ERGOCALCIFEROL,19,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Cytokine release syndrome|Off label use,2,1
21564286,20221108,Epcoritamab,,,,0,,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|APIXABAN|MEROPENEM",36,Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Follicular lymphoma|Product used for unknown indication|Premedication|Product used for unknown indication|Premedication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Hypotension,Febrile neutropenia|Pneumocystis jirovecii infection|Cytokine release syndrome|Off label use,4,3
21565249,20221108,Epcoritamab,54,801,54.0,2,85.3,1,1,1,1,1,1,1,Epcoritamab,"RITUXIMAB|LENALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|METHYLPREDNISOLONE|ACYCLOVIR|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ALLOPURINOL|AMPHOTERICIN B|ISONIAZID|CITALOPRAM|CITALOPRAM HYDROBROMIDE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|IVERMECTIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|TRIAMCINOLONE ACETONIDE|TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%|FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG",29,Follicular lymphoma stage IV|Follicular lymphoma stage IV|Follicular lymphoma stage IV,Cytokine release syndrome,1,1
21565640,20221108,Epcoritamab,81,801,81.0,2,54.3,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|RITUXIMAB|RITUXIMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PEGFILGRASTIM|CONJUGATED ESTROGENS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|IPRATROPIUM BROMIDE|GUAIFENESIN|ACYCLOVIR|ALBUTEROL SULFATE|ALBUTEROL|APREPITANT|BENZOCAINE|TOPICAL ANESTHETIC|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|LORATADINE|LORATADINE ORAL|OXYCODONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|HUMAN IMMUNOGLOBULIN G|SENNOSIDES|SENNA LEAF|SENNA|PROCHLORPERAZINE|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE",66,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Premedication|Premedication|Pneumonia viral|Rhinorrhoea|Rhinovirus infection|Rhinovirus infection,Febrile neutropenia|Rhinovirus infection|Pneumonia viral|Pneumonia viral|Tachycardia|Pyrexia|Fatigue|Productive cough|Sputum discoloured|Dyspnoea|Decreased appetite|Neutrophil count decreased,12,1
21568357,20221108,Epcoritamab,81,801,81.0,2,54.3,1,1,1,1,1,1,1,Epcoritamab,"DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|RITUXIMAB|VINCRISTINE SULFATE|VINCRISTINE SULFATE|VINCRISTINE SULFATE|VINCRISTINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CONJUGATED ESTROGENS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR|PEGFILGRASTIM|IPRATROPIUM BROMIDE|GUAIFENESIN|ACYCLOVIR|ALBUTEROL SULFATE|ALBUTEROL|APREPITANT|BENZOCAINE|TOPICAL ANESTHETIC|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|OXYCODONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|SENNOSIDES A AND B|LORATADINE|LORATADINE ORAL|PROCHLORPERAZINE|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",57,Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Diffuse large B-cell lymphoma stage IV|Rhinorrhoea|Rhinovirus infection,Decreased appetite|Pneumonia viral|Pneumonia viral|Neutrophil count decreased,4,3
21568463,20221108,Epcoritamab,72,801,72.0,1,50,1,1,1,1,1,1,1,Epcoritamab,"ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|PREDNISONE|LENALIDOMIDE|LENALIDOMIDE|RITUXIMAB|RITUXIMAB|RITUXIMAB|RITUXIMAB|ACYCLOVIR|ACYCLOVIR|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALLOPURINOL|ALLOPURINOL|ALLOPURINOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FERROUS SULFATE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|SODIUM FLUORIDE|SODIUM FLUORIDE F 18|SODIUM FLUORIDE F-18|TOOTHPASTE|SODIUM FLUORIDE F18|CLEAR MINT, GEL TOOTHPASTE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|VALGANCICLOVIR HYDROCHLORIDE|VALGANCICLOVIR|VALGANCICLOVIR HYDROCHLORIDE POWDER,|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG",49,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|B-cell lymphoma|Follicular lymphoma|B-cell lymphoma|Follicular lymphoma|B-cell lymphoma|Follicular lymphoma|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Prophylaxis|Product used for unknown indication|Product used for unknown indication,Pyrexia|Hypotension|Cytokine release syndrome|Fibrin D dimer increased|Haemoglobin decreased|C-reactive protein increased,6,3
10003960,20140312,Pertuzumab,45,801,45.0,2,,1,1,1,1,0,0,0,Pertuzumab,PACLITAXEL|FENTANYL CITRATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|SPIRONOLACTONE,8,OVARIAN EPITHELIAL CANCER|OVARIAN EPITHELIAL CANCER|OVARIAN EPITHELIAL CANCER,Gastrointestinal obstruction|Anaemia|General physical health deterioration,3,5
10031862,20140324,Pertuzumab,,,,2,36.3,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,BREAST CANCER,Peptic ulcer,1,5
10034860,20140325,Pertuzumab,62,801,62.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Gastrointestinal haemorrhage,1,1
10040602,20140327,Pertuzumab,46,801,46.0,2,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,BREAST CANCER METASTATIC,Death,1,1
10040725,20140327,Pertuzumab,63,801,63.0,2,65.38,1,0,0,0,0,0,1,Pertuzumab,AMLODIPINE|CALCITRIOL|CALCITRIOL CAPSULES 0.25 MCG|CALCITRIOL CAPSULES 0.5 MCG|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|PREDNISONE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|PERTUZUMAB|DOCUSATE SODIUM|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|ERGOCALCIFEROL,16,BREAST CANCER METASTATIC|RENAL TRANSPLANT|RENAL TRANSPLANT,Colorectal cancer|Peptic ulcer|Lower limb fracture|Anal squamous cell carcinoma,4,1
10042954,20140328,Pertuzumab,,,,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10049361,20140401,Pertuzumab,,,,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB,2,BREAST CANCER|BREAST CANCER,Clostridium difficile colitis,1,1
10055306,20140403,Pertuzumab,,,,2,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,BREAST CANCER,Breast cancer metastatic,1,1
10069657,20140410,Pertuzumab,67,801,67.0,2,,1,0,0,1,0,0,0,Pertuzumab,PERTUZUMAB,1,BREAST CANCER METASTATIC,Flushing|Skin reaction|Respiratory fatigue,3,1
10070153,20140410,Pertuzumab,65,801,65.0,1,,1,0,0,1,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Hypovolaemia|Loss of consciousness|Hypotension,3,1
10078378,20140415,Pertuzumab,,,,2,,1,0,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,BREAST CANCER METASTATIC,Diarrhoea,1,1
10084461,20140404,Pertuzumab,,,,2,,1,0,0,0,0,0,0,Pertuzumab,,1,BREAST CANCER,Paraesthesia oral|Paraesthesia|Rash|Urticaria,4,
10084511,20140404,Pertuzumab,,,,0,,1,0,0,0,0,0,0,Pertuzumab,,1,PRODUCT USED FOR UNKNOWN INDICATION,Rash,1,
10084517,20140404,Pertuzumab,,,,2,,1,0,0,0,0,0,0,Pertuzumab,,2,NEOADJUVANT THERAPY|BREAST CANCER,Dyspnoea,1,
10084524,20140404,Pertuzumab,,,,2,,1,0,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Pruritus|Dermatitis acneiform,2,5
10084533,20140404,Pertuzumab,,,,2,,1,0,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,BREAST CANCER,Rash|Malaise,2,5
10084561,20140404,Pertuzumab,,,,2,,1,0,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Abdominal pain upper|Vomiting,2,2
10084574,20140404,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,BREAST CANCER METASTATIC,Leukocytosis|Diarrhoea,2,3
10084802,20140404,Pertuzumab,,,,2,,1,0,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,HER-2 POSITIVE BREAST CANCER,Lip swelling|Swelling,2,
10084809,20140404,Pertuzumab,,,,2,,1,0,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Rhinorrhoea|Nasal dryness|Erythema,3,
10084834,20140404,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,BREAST CANCER METASTATIC,Rash|Furuncle,2,1
10094255,20140422,Pertuzumab,65,801,65.0,1,,1,0,0,1,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Hypovolaemia|Loss of consciousness|Hypotension|Anaphylactic shock,4,1
10137700,20140428,Pertuzumab,63,801,63.0,2,77.11,1,0,1,1,0,0,0,Pertuzumab,PERTUZUMAB|PERTUZUMAB,2,HER-2 POSITIVE BREAST CANCER|BREAST CANCER STAGE IV,Anaphylactic reaction|Aspiration,2,
10160090,20140508,Pertuzumab,,,,2,,1,0,0,0,0,0,0,Pertuzumab,LAPATINIB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE SODIUM PHOSPHATE|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|PERTUZUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LORAZEPAM|LEVETIRACETAM|BUPROPION HYDROCHLORIDE,14,PRODUCT USED FOR UNKNOWN INDICATION,Malnutrition|Decreased appetite|Eye operation|Back pain|Asthenia|Sleep disorder,6,5
10161325,20140509,Pertuzumab,64,801,64.0,1,89,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN,4,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Disease progression,1,1
10161387,20140509,Pertuzumab,66,801,66.0,2,53,1,1,0,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|CLOPIDOGREL|VALSARTAN,6,BREAST CANCER METASTATIC|BREAST CANCER|BREAST CANCER METASTATIC|PERIPHERAL ARTERIAL OCCLUSIVE DISEASE|PERIPHERAL ARTERIAL OCCLUSIVE DISEASE|HYPERTENSION,Breast cancer|Respiratory failure|Abdominal pain lower,3,1
10161593,20140509,Pertuzumab,61,801,61.0,2,108.96,1,0,1,1,1,0,1,Pertuzumab,PERTUZUMAB|RITUXIMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|CARBOPLATIN|CARBOPLATIN|ANASTROZOLE|ANASTROZOLE TABLETS|ALPRAZOLAM|LEVOTHYROXINE|NADOLOL|PANTOPRAZOLE|PROCHLORPERAZINE|PROCHLORPERAZINE,22,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|NAUSEA|VOMITING,Diarrhoea|Diarrhoea|Dehydration|Rash,4,1
10161979,20140509,Pertuzumab,59,801,59.0,2,,1,1,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|AMLODIPINE|LACTULOSE|PACLITAXEL|PHYTONADIONE,7,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Hepatic encephalopathy|Febrile neutropenia,2,1
10162402,20140509,Pertuzumab,57,801,57.0,2,,1,1,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|RIBAVIRIN|PEGINTERFERON ALFA-2A,6,CHEMOTHERAPY|CHRONIC HEPATITIS C|CHEMOTHERAPY|CHEMOTHERAPY|CHRONIC HEPATITIS C|CHRONIC HEPATITIS C,Pulmonary sepsis|Dysarthria|Periarthritis,3,3
10163909,20140510,Pertuzumab,51,801,51.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|ALPRAZOLAM|NIFEDIPINE|RANITIDINE|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE,11,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Rectal haemorrhage,1,1
10163919,20140510,Pertuzumab,,,,2,,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Colitis|Diarrhoea,2,3
10166114,20140512,Pertuzumab,38,801,38.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|PACLITAXEL,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Back pain|Muscle tightness|Musculoskeletal pain|Neuropathy peripheral|Pruritus,5,3
10166255,20140512,Pertuzumab,,,,2,,1,0,1,0,0,0,0,Pertuzumab,CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|AMOXICILLIN|PERTUZUMAB|FILGRASTIM|TRASTUZUMAB,7,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Back pain|Diarrhoea|Blood count abnormal|Spinal disorder|Neutrophil count decreased,5,5
10166391,20140512,Pertuzumab,66,801,66.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|SITAGLIPTIN|SPIRONOLACTONE|METHYLPREDNISOLONE|FENOFIBRATE|INSULIN GLARGINE|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,13,HER-2 POSITIVE BREAST CANCER|PROPHYLAXIS|PROPHYLAXIS|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Hyperglycaemia|General physical health deterioration|Febrile neutropenia,3,1
10168377,20140513,Pertuzumab,62,801,62.0,1,55.9,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|REMIFENTANIL HYDROCHLORIDE|PROPOFOL|CISPLATIN|FENTANYL|PERTUZUMAB|CAPECITABINE|MANNITOL|CEFAZOLIN SODIUM|TRASTUZUMAB,46,NAUSEA|PROCEDURAL PAIN|GENERAL ANAESTHESIA|NAUSEA|ELECTROLYTE SUBSTITUTION THERAPY|PROCEDURAL PAIN|PROCEDURAL PAIN|TUMOUR PAIN|SKIN HYPERPIGMENTATION|PROCEDURAL PAIN|GENERAL ANAESTHESIA|GENERAL ANAESTHESIA|HER-2 POSITIVE GASTRIC CANCER|PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME|PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME|ANAESTHESIA|HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|PROCEDURAL PAIN|GENERAL ANAESTHESIA|CONSTIPATION|SKIN HYPERPIGMENTATION|SKIN HYPERPIGMENTATION|PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME|INFECTION|ELECTROLYTE SUBSTITUTION THERAPY|NAUSEA|NAUSEA|PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME|INFECTION|PROCEDURAL PAIN|ELECTROLYTE SUBSTITUTION THERAPY|HER-2 POSITIVE GASTRIC CANCER|PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME|PROCEDURAL PAIN|GENERAL ANAESTHESIA,Tumour haemorrhage,1,1
10168408,20140513,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Interstitial lung disease,1,1
10170843,20140514,Pertuzumab,66,801,66.0,2,69.9,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|ENALAPRIL MALEATE|ENALAPRIL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,5,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|GASTRITIS,Febrile neutropenia|Acute respiratory distress syndrome|Respiratory failure,3,1
10172792,20140515,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Rash|Skin cancer,2,3
10172870,20140515,Pertuzumab,7,800,70.0,2,,1,0,1,0,0,0,0,Pertuzumab,ERIBULIN MESYLATE|PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT,Abscess,1,1
10174447,20140515,Pertuzumab,55,801,55.0,2,,1,0,1,0,0,0,0,Pertuzumab,ATENOLOL|AMLODIPINE BESYLATE|SIMVASTATIN|TRASTUZUMAB|PERTUZUMAB,9,INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA,Presyncope|Paraesthesia,2,2
10174699,20140515,Pertuzumab,68,801,68.0,2,111,1,0,1,0,0,0,0,Pertuzumab,"TRASTUZUMAB|LISINOPRIL AND HYDROCHLOROTHIAZIDE|PERTUZUMAB|ROSUVASTATIN|CELECOXIB|CLONAZEPAM|ERGOCALCIFEROL|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|PERTUZUMAB|TRASTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CHLORAMBUCIL|DENOSUMAB",21,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|HER-2 POSITIVE BREAST CANCER|BREAST CANCER METASTATIC|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Abdominal pain upper|Renal pain|Diarrhoea|Dry mouth|Dry skin|Fatigue|Bone cancer|Femur fracture|Paraesthesia|Abdominal discomfort|Nausea|Haemorrhoidal haemorrhage|Pyrexia|Cough|Hyperhidrosis|Muscle spasms|Vomiting|Eating disorder|Face oedema|Dyspnoea|Headache|Hypoaesthesia|Neuralgia|Weight decreased|Nasopharyngitis|Urinary tract infection|Injection site extravasation|Red blood cell count decreased|Anxiety|Bone pain|Flushing|Haemorrhoids|Kidney infection|Bowel movement irregularity|Dental operation|Upper limb fracture|Swelling face|Constipation|Myalgia|Stomatitis,40,3
10174915,20140515,Pertuzumab,58,801,58.0,2,,1,0,0,0,0,0,1,Pertuzumab,PROCHLORPERAZINE|ERGOCALCIFEROL|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB,8,HER-2 POSITIVE BREAST CANCER|BREAST CANCER|BREAST CANCER,Dry mouth|Dry skin|Peripheral sensorimotor neuropathy|Hypersensitivity|Hyperhidrosis|Hypoacusis|Flushing|Neuralgia|Vomiting|Dyspepsia|Pain in extremity|Dyspnoea|Pollakiuria|Fatigue|Hot flush|Diarrhoea|Epistaxis|Hyperaesthesia|Pulmonary oedema|White blood cell count abnormal|Cough|Hypoaesthesia|Myalgia|Swelling,24,1
10175580,20140516,Pertuzumab,,,,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB,1,BREAST CANCER,Skin toxicity,1,1
10176020,20140516,Pertuzumab,44,801,44.0,2,,1,0,1,0,0,0,0,Pertuzumab,GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|TRASTUZUMAB|TRASTUZUMAB|PACLITAXEL|PERTUZUMAB|PERTUZUMAB,24,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Rectal haemorrhage,1,1
10176492,20140516,Pertuzumab,66,801,66.0,2,,1,1,1,0,0,0,1,Pertuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB,6,CHEMOTHERAPY|CHEMOTHERAPY|CHEMOTHERAPY|CHEMOTHERAPY|CHEMOTHERAPY|CHEMOTHERAPY,Subcutaneous emphysema|Sepsis|Pneumonitis|Febrile neutropenia|Hypotension|Pyrexia|Bacteraemia|Acute respiratory failure|Acute respiratory distress syndrome,9,3
10176639,20140516,Pertuzumab,55,801,55.0,2,,1,0,1,0,0,0,0,Pertuzumab,AMLODIPINE BESYLATE|ATENOLOL|SIMVASTATIN|TRASTUZUMAB|PERTUZUMAB,9,INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA,Presyncope|Paraesthesia,2,2
10178368,20140519,Pertuzumab,7,800,70.0,2,,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB,4,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pneumothorax,1,1
10179320,20140519,Pertuzumab,59,801,59.0,2,85.81,1,0,1,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|CARBOPLATIN,5,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|PROPHYLAXIS,Odynophagia|Oral candidiasis|Mucosal inflammation|Neutropenia|Diarrhoea|Pyrexia|Drug intolerance|Anaemia,8,1
10182279,20140520,Pertuzumab,77,801,77.0,2,60,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|METASTASES TO BONE|BREAST CANCER,Dehydration|Mucosal inflammation,2,3
10184601,20140521,Pertuzumab,55,801,55.0,2,,1,0,1,0,0,0,0,Pertuzumab,PACLITAXEL|CARBOPLATIN|TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|DARBEPOETIN ALFA|PERTUZUMAB,7,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Cardiac failure|Myocardial infarction,2,1
10184660,20140521,Pertuzumab,,,,2,65,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,2,BREAST CANCER|BREAST CANCER,Diarrhoea|Urinary tract infection|Rash|Hypoaesthesia|Dysstasia|Muscular weakness,6,1
10184993,20140521,Pertuzumab,62,801,62.0,2,48,1,0,1,0,0,0,0,Pertuzumab,"CAPECITABINE|PERTUZUMAB|CISPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TRASTUZUMAB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|TRASTUZUMAB|RANITIDINE|PERTUZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",12,HER2 POSITIVE GASTRIC CANCER|HER2 POSITIVE GASTRIC CANCER|HER2 POSITIVE GASTRIC CANCER|ASTHENIA|ACUTE KIDNEY INJURY|HER2 POSITIVE GASTRIC CANCER|HER2 POSITIVE GASTRIC CANCER|HYPERTENSION|NAUSEA,Malnutrition,1,1
10186599,20140521,Pertuzumab,57,801,57.0,2,136.2,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|CARBOPLATIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,5,BREAST CANCER|BREAST CANCER,Red blood cell count decreased|Fatigue|Diarrhoea|Dyspnoea|Dysgeusia|Rash|Blister|Nail infection|Skin exfoliation,9,5
10186816,20140521,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,BREAST CANCER,Interstitial lung disease,1,1
10186880,20140522,Pertuzumab,,,,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|ADO-TRASTUZUMAB EMTANSINE,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pleural effusion|Weight decreased|Aphonia|Vital functions abnormal,4,5
10187193,20140522,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|CARBOPLATIN,4,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Myocardial infarction,1,3
10190171,20140522,Pertuzumab,79,801,79.0,2,,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Cardiac failure,1,5
10190582,20140523,Pertuzumab,51,801,51.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB,8,BREAST CANCER|BREAST CANCER|BREAST CANCER|ARTHRALGIA,Viral rash,1,1
10190913,20140523,Pertuzumab,46,801,46.0,2,105,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|LEVOTHYROXINE SODIUM,4,HER-2 POSITIVE BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER,Neck mass|Influenza like illness,2,5
10194775,20140526,Pertuzumab,50,801,50.0,2,69,1,0,1,0,0,0,1,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB,4,BREAST CANCER METASTATIC,Pneumonia|Diarrhoea|Syncope|Dizziness|Pain in extremity,5,1
10194801,20140526,Pertuzumab,,,,2,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,2,BREAST CANCER|BREAST CANCER,Death,1,5
10195616,20140527,Pertuzumab,59,801,59.0,2,89.44,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|PERTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PALONOSETRON|PALONOSETRON HYDROCHLORIDE,5,BREAST CANCER METASTATIC,Flushing|Dyspnoea|Loss of consciousness|Hypersensitivity|Erythema|Eye movement disorder|Nausea,7,2
10195853,20140527,Pertuzumab,54,801,54.0,2,60,1,0,0,0,0,0,1,Pertuzumab,"TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|ANASTROZOLE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",8,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Head titubation|Febrile neutropenia|Dysphonia,3,1
10196077,20140522,Pertuzumab,55,801,55.0,2,,1,0,1,0,0,0,0,Pertuzumab,ATENOLOL|AMLODIPINE BESYLATE|TRASTUZUMAB,9,INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA|INVASIVE DUCTAL BREAST CARCINOMA,Paraesthesia|Presyncope|Dizziness|Blood pressure systolic increased|Blood pressure orthostatic,5,
10196154,20140527,Pertuzumab,,,,2,70.37,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,5,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER,Metastases to liver|Recurrent cancer|Alopecia|Hair growth abnormal,4,5
10196493,20140527,Pertuzumab,,,,2,,1,0,1,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Malignant neoplasm progression|Cardiomyopathy|Ejection fraction decreased,3,1
10196535,20140527,Pertuzumab,40,801,40.0,2,,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cardiac failure,1,1
10200441,20140528,Pertuzumab,55,801,55.0,2,62,1,1,1,0,0,0,0,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB|PERTUZUMAB|TRASTUZUMAB,5,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Acute myeloid leukaemia,1,1
10203636,20140529,Pertuzumab,74,801,74.0,1,46.2,1,1,0,0,0,0,0,Pertuzumab,"TRASTUZUMAB|TRASTUZUMAB|CAPECITABINE|CISPLATIN|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|APREPITANT|FOSAPREPITANT DIMEGLUMINE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|PERTUZUMAB|PERTUZUMAB",16,HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|ELECTROLYTE IMBALANCE|STOMATITIS|NAUSEA|VOMITING|NAUSEA|VOMITING|NAUSEA|VOMITING|PRODUCTIVE COUGH|COUGH|HER-2 POSITIVE GASTRIC CANCER,Pneumonia,1,1
10206658,20140530,Pertuzumab,58,801,58.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|RANITIDINE|RANITIDINE|RANITIDINE|RANITIDINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PERTUZUMAB|RANITIDINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|RANITIDINE|RANITIDINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TRASTUZUMAB|RANITIDINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PACLITAXEL|RANITIDINE|AMOXICILLIN|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|RANITIDINE|RANITIDINE|PACLITAXEL|RANITIDINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|BISOPROLOL FUMARATE|RANITIDINE|RANITIDINE|RANITIDINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,97,BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|BREAST CANCER,Lower respiratory tract infection,1,1
10208973,20140530,Pertuzumab,42,801,42.0,2,,1,0,1,0,0,0,0,Pertuzumab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TRASTUZUMAB|PERTUZUMAB|CLARITHROMYCIN",7,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|BREAST INFLAMMATION|HER-2 POSITIVE BREAST CANCER,Flushing|Chest discomfort,2,5
10209557,20140602,Pertuzumab,73,801,73.0,2,,1,0,0,1,0,0,0,Pertuzumab,PERTUZUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LANSOPRAZOLE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,9,BREAST CANCER|HYPERTENSION|ANXIETY|HYPERTENSION|MYOCARDIAL INFARCTION|MYOCARDIAL INFARCTION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cardiac arrest,1,1
10209766,20140602,Pertuzumab,81,801,81.0,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|CAPECITABINE,7,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Cardiotoxicity,1,1
10209947,20140602,Pertuzumab,,,,2,92.16,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|CARBOPLATIN|DOCETAXEL|DOCETAXEL ANHYDROUS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE SODIUM PHOSPHATE|PALONOSETRON HYDROCHLORIDE|PEGFILGRASTIM|PROCHLORPERAZINE MALEATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|HYDROCHLOROTHIAZIDE|LOPERAMIDE HCL|LOPERAMIDE HCL|IBUPROFEN|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE,26,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Blood pressure decreased|Dyspnoea|Pharyngeal oedema|Chest discomfort|Nausea|Urticaria|Rash|Tachycardia|Hypertension|Swollen tongue|Vomiting,11,1
10213101,20140603,Pertuzumab,82,801,82.0,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|CAPECITABINE,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Cardiotoxicity,1,1
10213142,20140603,Pertuzumab,,,,2,83,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,7,BREAST CANCER|BREAST CANCER|BREAST CANCER,Febrile neutropenia|Pyoderma|Dysphagia,3,2
10213523,20140603,Pertuzumab,30,801,30.0,2,,1,1,0,0,0,0,1,Pertuzumab,PACLITAXEL|CARBOPLATIN|CARBOPLATIN|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB,11,BREAST CANCER METASTATIC|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Death|Breast cancer metastatic,2,3
10213680,20140603,Pertuzumab,82,801,82.0,2,57,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Haematemesis|Melaena|Gastric ulcer|Nausea,4,1
10215380,20140604,Pertuzumab,39,801,39.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|LINCOMYCIN|LINCOMYCIN HYDROCHLORIDE|TRASTUZUMAB,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Off label use|Wound infection|Lung neoplasm malignant|Anxiety,4,3
10215400,20140604,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Infusion related reaction,1,1
10215427,20140604,Pertuzumab,,,,2,,1,0,1,0,0,0,0,Pertuzumab,ADO-TRASTUZUMAB EMTANSINE|TRASTUZUMAB|PERTUZUMAB,4,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pulmonary toxicity|Acute respiratory distress syndrome|Lung infiltration|Dyspnoea,4,1
10216087,20140604,Pertuzumab,79,801,79.0,2,70.5,1,0,1,0,0,0,0,Pertuzumab,"DICLOFENAC SODIUM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|PACLITAXEL|FUROSEMIDE|RANITIDINE|PERTUZUMAB|TRIAMCINOLONE ACETONIDE|TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%|ZINC OXIDE|PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/LIGHT|ZINC OXIDE OINTMENT|PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/TAN|SKIN PROTECTANT|PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 NATURAL/MEDIUM|PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 COOL/DEEP|MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN|PERTUZUMAB",14,OVARIAN EPITHELIAL CANCER|OVARIAN EPITHELIAL CANCER,Eczema asteatotic|Cardiac failure,2,1
10217776,20140604,Pertuzumab,76,801,76.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|PERTUZUMAB|METHYLPREDNISOLONE|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|PREGABALIN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|AMOXICILLIN AND CLAVULANATE POTASSIUM,19,NEUTROPENIA|BREAST CANCER METASTATIC|NAUSEA|HYPERSENSITIVITY|HYPERSENSITIVITY,Pyrexia,1,1
10217877,20140605,Pertuzumab,58,801,58.0,2,65.83,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|CARBOPLATIN,6,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Anal pruritus|Rectal fissure|Haemorrhoids|Pyrexia|Swelling|Red blood cell count decreased|White blood cell count decreased|Myalgia,8,5
10217891,20140605,Pertuzumab,49,801,49.0,2,78.6,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Blood pressure increased|Cerebrovascular accident,2,2
10217905,20140605,Pertuzumab,66,801,66.0,2,90,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB,5,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Erythema,1,1
10218238,20140605,Pertuzumab,57,801,57.0,0,53.12,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Hypocalcaemia,1,1
10218276,20140605,Pertuzumab,74,801,74.0,2,,1,1,0,0,0,0,0,Pertuzumab,TRASTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FUROSEMIDE|DENOSUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|PERTUZUMAB|INSULIN GLARGINE,12,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Enterocolitis|Septic shock|Renal failure acute|Mucosal inflammation|Dehydration|Haemodynamic instability|Pancytopenia|Diarrhoea,8,3
10218363,20140605,Pertuzumab,70,801,70.0,1,66,1,0,1,0,0,0,0,Pertuzumab,MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|CISPLATIN|APREPITANT|FOSAPREPITANT DIMEGLUMINE|TRASTUZUMAB|CAPECITABINE|CAPECITABINE|TRASTUZUMAB|CISPLATIN|FUROSEMIDE|CAPECITABINE|CISPLATIN|ROSUVASTATIN|ESOMEPRAZOLE MAGNESIUM|OLANZAPINE|OLANZAPINE PAMOATE|PERTUZUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|APREPITANT|FOSAPREPITANT DIMEGLUMINE,31,CONSTIPATION|CONSTIPATION|NAUSEA|NAUSEA|NAUSEA|HER2 POSITIVE GASTRIC CANCER|CONSTIPATION|HICCUPS|HER2 POSITIVE GASTRIC CANCER|OEDEMA PERIPHERAL|HER2 POSITIVE GASTRIC CANCER|BLOOD CHOLESTEROL INCREASED|INSOMNIA|NAUSEA|HYPERTENSION|HER2 POSITIVE GASTRIC CANCER|NAUSEA|NAUSEA|HICCUPS|NAUSEA,Gastrointestinal inflammation|Decreased appetite,2,1
10218428,20140605,Pertuzumab,43,801,43.0,2,71.5,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RANITIDINE|RANITIDINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PERTUZUMAB,8,BREAST CANCER|PREMEDICATION|ANALGESIC THERAPY|BREAST CANCER,Tremor|Chills|Drug interaction,3,2
10220671,20140606,Pertuzumab,69,801,69.0,2,75,1,0,1,0,0,0,0,Pertuzumab,TOPOTECAN|PERTUZUMAB,2,OVARIAN CANCER|OVARIAN CANCER,Sepsis,1,1
10220794,20140606,Pertuzumab,46,801,46.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS,9,HER-2 POSITIVE BREAST CANCER|METASTASES TO BONE|METASTASES TO LIVER|HER-2 POSITIVE BREAST CANCER|METASTASES TO BONE|METASTASES TO LIVER|HER-2 POSITIVE BREAST CANCER|METASTASES TO LIVER|METASTASES TO BONE,Metastases to central nervous system|Convulsion|Disease progression|Diarrhoea,4,3
10223261,20140609,Pertuzumab,44,801,44.0,2,52.66,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pulmonary oedema,1,1
10223394,20140609,Pertuzumab,54,801,54.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB,1,BREAST CANCER,Malaise|Tachycardia|Dyspnoea|Hypotension|Pyrexia|Headache|Tinnitus,7,1
10223631,20140609,Pertuzumab,59,801,59.0,2,91,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|CANDESARTAN CILEXETIL,10,BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Device related infection,1,1
10226758,20140610,Pertuzumab,35,801,35.0,2,,1,1,1,0,0,0,1,Pertuzumab,"DIPHENHYDRAMINE HYDROCHLORIDE|TRASTUZUMAB|TRASTUZUMAB|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|LORAZEPAM|DALTEPARIN SODIUM|VENLAFAXINE HYDROCHLORIDE|DOCETAXEL|DOCETAXEL ANHYDROUS|SULFAMETHOXAZOLE AND TRIMETHOPRIM|PERTUZUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PERTUZUMAB|STANDARDIZED SENNA CONCENTRATE",15,PREMEDICATION|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|HER-2 POSITIVE BREAST CANCER,Fatigue|Haemoglobin decreased|Infusion related reaction|Heart rate increased|Angioedema|Disease progression|Platelet count decreased|Neutrophil count decreased,8,1
10227013,20140610,Pertuzumab,,,,2,,1,0,1,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|AMOXICILLIN AND CLAVULANATE POTASSIUM,4,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Stevens-Johnson syndrome|Blood bilirubin increased|Jaundice|Leukopenia|Malaise,5,1
10227106,20140610,Pertuzumab,68,801,68.0,2,46,1,0,1,0,0,0,0,Pertuzumab,"DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|OXYCODONE HYDROCHLORIDE|TRASTUZUMAB|OXYCODONE HYDROCHLORIDE",11,GASTRITIS PROPHYLAXIS|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER|CONSTIPATION|PROPHYLAXIS|CANCER PAIN|CONSTIPATION|CANCER PAIN|BREAST CANCER RECURRENT|CANCER PAIN,Acute pulmonary oedema,1,1
10229342,20140611,Pertuzumab,57,801,57.0,2,,1,0,1,0,0,0,0,Pertuzumab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TRASTUZUMAB|CETIRIZINE HYDROCHLORIDE|CALCIUM CARBONATE|ANTACID|LORATADINE|LORATADINE ORAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METRONIDAZOLE|ZOLPIDEM TARTRATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|MOMETASONE FUROATE|MOMETASONE FUROATE|LORATADINE|LORATADINE ORAL|DENOSUMAB|ACETYLCYSTEINE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PREGABALIN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PERTUZUMAB|PACLITAXEL|DENOSUMAB|PERTUZUMAB|TRASTUZUMAB|VANCOMYCIN HYDROCHLORIDE|FERRIC CARBOXYMALTOSE INJECTION|FERRIC CARBOXYMALTOSE",56,HER-2 POSITIVE BREAST CANCER|NEURALGIA|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Dyspnoea,1,1
10229378,20140611,Pertuzumab,53,801,53.0,2,,1,0,1,0,1,0,0,Pertuzumab,TRASTUZUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|SITAGLIPTIN|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|EMPAGLIFLOZIN|TEMAZEPAM|TEMAZEPAM|EMPAGLIFLOZIN|PERTUZUMAB|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|FLUCONAZOLE|TRASTUZUMAB|SITAGLIPTIN|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|INSULIN GLARGINE|DOCETAXEL|DOCETAXEL ANHYDROUS|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|ITRACONAZOLE|DENOSUMAB|PERTUZUMAB|GRANISETRON|GRANISETRON HYDROCHLORIDE|LIRAGLUTIDE|LIRAGLUTIDE,45,HER-2 POSITIVE BREAST CANCER|INSOMNIA|HYPOCALCAEMIA|SKIN INFECTION|HER-2 POSITIVE BREAST CANCER|PROPHYLAXIS|HER-2 POSITIVE BREAST CANCER|ANXIETY,Febrile neutropenia|Abdominal pain upper|Bronchitis|Dyspnoea|Diarrhoea,5,1
10233190,20140612,Pertuzumab,40,801,40.0,2,,1,1,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Lung infection|Wound infection|Diarrhoea|Malaise|Central nervous system lesion|Lung neoplasm malignant|Acne|Drug ineffective|Death|Head injury,10,3
10234489,20140613,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PACLITAXEL|PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Macular oedema,1,1
10234862,20140613,Pertuzumab,27,801,27.0,1,62.7,1,0,1,0,0,0,0,Pertuzumab,"TRASTUZUMAB|TRASTUZUMAB|CAPECITABINE|CISPLATIN|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|APREPITANT|FOSAPREPITANT DIMEGLUMINE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|FUROSEMIDE|PERTUZUMAB|PERTUZUMAB",23,HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|STOMATITIS|NAUSEA|VOMITING|ILEUS|NAUSEA|VOMITING|NAUSEA|VOMITING|DIARRHOEA|DIARRHOEA|GASTRITIS|ELECTROLYTE IMBALANCE|HYPERVOLAEMIA|NAUSEA|VOMITING|DECREASED APPETITE|BLOOD CREATININE INCREASED|HER-2 POSITIVE GASTRIC CANCER,Ileus,1,1
10235017,20140613,Pertuzumab,61,801,61.0,2,58,1,0,1,0,0,0,0,Pertuzumab,CAPECITABINE|CAPECITABINE|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|EPIRUBICIN HYDROCHLORIDE,26,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|NEOADJUVANT THERAPY|ADJUVANT THERAPY|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|NEOADJUVANT THERAPY|BREAST CANCER METASTATIC|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|BREAST CANCER METASTATIC|SEASONAL ALLERGY|SEASONAL ALLERGY|SEASONAL ALLERGY|SEASONAL ALLERGY|NEOADJUVANT THERAPY|NEOADJUVANT THERAPY|NEOADJUVANT THERAPY,Skin disorder|Neutrophil count decreased|Rash|Palmar-plantar erythrodysaesthesia syndrome|Skin exfoliation,5,1
10237641,20140616,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,2,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Rash|Acne|Pain,3,1
10237644,20140616,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,2,BREAST CANCER|BREAST CANCER,Disease progression|Echocardiogram abnormal|Blood pressure decreased,3,5
10237795,20140616,Pertuzumab,60,801,60.0,2,59.52,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|PACLITAXEL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN,7,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pyrexia|Pneumonia,2,1
10238511,20140616,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,"TRASTUZUMAB|PERTUZUMAB|CAPECITABINE|BUPROPION HYDROCHLORIDE|ALPRAZOLAM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|TIZANIDINE|ANASTROZOLE|FULVESTRANT|HYOSCYAMINE SULFATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|HYDROMORPHONE HYDROCHLORIDE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FUROSEMIDE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|BACLOFEN|VILAZODONE HYDROCHLORIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|MORPHINE SULFATE|AMOXICILLIN",31,BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Palmar-plantar erythrodysaesthesia syndrome|Gastrointestinal disorder|Neuropathy peripheral|Disease progression|Metastasis|Diarrhoea|Dyspnoea|Fatigue|Pathological fracture|Malaise|Nausea|Neutropenia|Anaemia|Bone pain|Depression|Pneumonitis|Otitis media|Dry mouth|Increased tendency to bruise,19,1
10240182,20140617,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,ADO-TRASTUZUMAB EMTANSINE|TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pulmonary oedema|Fatigue|Sluggishness|Dyspnoea|Haemoglobin decreased|Metastasis,6,5
10240833,20140617,Pertuzumab,62,801,62.0,2,94.89,1,0,0,0,0,0,1,Pertuzumab,ACETAMINOPHEN|TRASTUZUMAB|PERTUZUMAB|CARBOPLATIN|DIPHENHYDRAMINE HYDROCHLORIDE,8,PREMEDICATION|NEOADJUVANT THERAPY|DIARRHOEA|BREAST CANCER|NEOADJUVANT THERAPY|NEOADJUVANT THERAPY|PREMEDICATION,Anaphylactic reaction|Syncope|Nausea|Blood pressure increased|Rash|Eye swelling|Vomiting,7,3
10242845,20140618,Pertuzumab,59,801,59.0,2,,1,0,1,0,0,0,0,Pertuzumab,"GRANISETRON|GRANISETRON HYDROCHLORIDE|PERTUZUMAB|CITALOPRAM|CITALOPRAM HYDROBROMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREGABALIN|LANSOPRAZOLE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|MOMETASONE|FOSAPREPITANT|FOSAPREPITANT DIMEGLUMINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",18,HER-2 POSITIVE BREAST CANCER|NAUSEA|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|ANXIETY|ASTHMA|HYPERTENSION|PROPHYLAXIS OF NAUSEA AND VOMITING|ASTHMA|ASTHMA|NEURALGIA|DYSPEPSIA|HER-2 POSITIVE BREAST CANCER|LICHEN PLANUS|PROPHYLAXIS OF NAUSEA AND VOMITING,Migraine with aura,1,5
10251600,20140623,Pertuzumab,42,801,42.0,2,47,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,11,BREAST ULCERATION|PROPHYLAXIS|HER-2 POSITIVE BREAST CANCER|PAIN|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|PREMEDICATION|GASTRITIS PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING,Peritonitis|Duodenal ulcer perforation,2,1
10252607,20140623,Pertuzumab,69,801,69.0,2,113,1,0,1,0,0,0,1,Pertuzumab,"CELECOXIB|CLONAZEPAM|DENOSUMAB|KETOTIFEN FUMARATE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|TRASTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ERGOCALCIFEROL|IRBESARTAN AND HYDROCHLOROTHIAZIDE|PERTUZUMAB|LISINOPRIL AND HYDROCHLOROTHIAZIDE|LISINOPRIL AND HYDROCHLOROTHIAZIDE|CALCIUM|LISINOPRIL AND HYDROCHLOROTHIAZIDE|PERTUZUMAB|TRASTUZUMAB|PAROXETINE HYDROCHLORIDE|ROSUVASTATIN CALCIUM|VENLAFAXINE HYDROCHLORIDE|ROSUVASTATIN|TRASTUZUMAB|TRASTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|CARVEDILOL|HYDROMORPHONE HYDROCHLORIDE|HYDROCORTISONE SODIUM SUCCINATE|CLONAZEPAM|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PAROXETINE HYDROCHLORIDE|CAPECITABINE|PAROXETINE HYDROCHLORIDE|STANDARDIZED SENNA CONCENTRATE|OXALIPLATIN|CLONAZEPAM",48,CONSTIPATION|BREAST CANCER METASTATIC|HYPERTENSION|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|BREAST CANCER METASTATIC|GASTROOESOPHAGEAL REFLUX DISEASE|MACULAR DEGENERATION|METASTATIC GASTRIC CANCER|METASTATIC GASTRIC CANCER|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|HER-2 POSITIVE BREAST CANCER|HYPERTENSION|MACULAR DEGENERATION|PAIN|GASTROOESOPHAGEAL REFLUX DISEASE|BREAST CANCER METASTATIC|CARDIAC DISORDER|CONSTIPATION,Fracture|Gingival operation|Headache|Hypertension|Dermatitis|Viral upper respiratory tract infection|Epistaxis|Malaise|Alanine aminotransferase increased|Haemoglobin decreased|Needle issue|Pyrexia|Aspartate aminotransferase increased|Mean cell haemoglobin concentration decreased|Monocyte count increased|Red blood cell count decreased|Peripheral swelling|Muscle spasms|Poor venous access|Dry skin|Unevaluable event|Chest pain|Gingivitis|Urinary tract infection|Carbohydrate antigen 125 increased|Hyperlipidaemia|Pleural effusion|Fungal infection|Paraesthesia|Rhinorrhoea|Tooth extraction|Blood test abnormal|Blood bicarbonate decreased|Bone disorder|Carbohydrate antigen 15-3 increased|Haematocrit decreased|Platelet count decreased|Red cell distribution width increased|Tooth fracture|Face oedema|Tumour marker increased|Weight decreased|Hypoaesthesia|Pruritus|Bone pain|Cough|Blood calcium increased|Blood glucose increased|Mean cell volume increased|Fatigue|Pain in extremity|Dysgeusia|Myalgia|Carcinoembryonic antigen increased|Haemolysis|Lymphocyte count decreased|White blood cell count decreased|Dyspnoea|Diarrhoea|Gingival swelling|Dry mouth|Tooth disorder|Blood lactate dehydrogenase increased|Liver disorder|Malaise|Drug ineffective|Rectal haemorrhage|Blood alkaline phosphatase increased|Pain,69,3
10254262,20140624,Pertuzumab,72,801,72.0,2,92.6,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB,4,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Onychomadesis|Wound infection|Weight increased|Oedema|Erythema|Palmar-plantar erythrodysaesthesia syndrome|Fat necrosis|Generalised oedema|Skin disorder,9,1
10255029,20140624,Pertuzumab,65,801,65.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|DENOSUMAB|TRASTUZUMAB,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypotension|Thrombocytopenia|Loss of consciousness|Oxygen saturation decreased,4,3
10257580,20140625,Pertuzumab,66,801,66.0,0,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB,9,METASTASES TO LIVER|METASTASES TO BONE|METASTASES TO LIVER|METASTASES TO BONE|HER-2 POSITIVE BREAST CANCER|METASTASES TO LIVER|HER-2 POSITIVE BREAST CANCER|METASTASES TO BONE|HER-2 POSITIVE BREAST CANCER,Infection|Febrile neutropenia|Fluid imbalance|Diarrhoea,4,3
10257727,20140625,Pertuzumab,49,801,49.0,2,60,1,1,1,0,0,0,1,Pertuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|WARFARIN|FUROSEMIDE,13,INFLAMMATORY CARCINOMA OF THE BREAST|INFLAMMATORY CARCINOMA OF THE BREAST|INFLAMMATORY CARCINOMA OF THE BREAST|JUGULAR VEIN THROMBOSIS,Disease progression|Cardiac failure|Haemoptysis|Pulmonary oedema|Anaemia|Pneumonia|Haematuria,7,1
10260598,20140626,Pertuzumab,,,,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Interstitial lung disease,1,1
10260860,20140626,Pertuzumab,42,801,42.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB,26,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Metastases to central nervous system|Fatigue|Mucous membrane disorder|Nail disorder,4,3
10263821,20140627,Pertuzumab,79,801,79.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,BREAST CANCER METASTATIC,Fatigue|Asthenia|Decreased appetite|Hypersomnia,4,5
10264258,20140627,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,4,METASTASES TO BONE|METASTASES TO BONE|METASTASES TO BONE|METASTASES TO BONE,Disease progression|Neuropathy peripheral,2,1
10264498,20140627,Pertuzumab,56,801,56.0,2,,1,1,0,0,1,0,1,Pertuzumab,TRASTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|PERTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER|BREAST CANCER METASTATIC,Dementia|Disease progression|Fatigue,3,5
10264672,20140627,Pertuzumab,33,801,33.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|MORPHINE|TRASTUZUMAB|DENOSUMAB|HYDROCORTISONE|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB,13,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Rhinorrhoea|Peripheral swelling|Headache|Oropharyngeal pain|Diarrhoea|Rash|Eye infection|Cough|Mucosal inflammation|Breast disorder|Disturbance in attention|Hot flush|Mucous membrane disorder|Nasal obstruction|Neuropathy peripheral|Arthralgia|Flushing|Pruritus|Surgery|Dizziness|Hyperhidrosis|Respiratory tract congestion|Decreased appetite|Myalgia|Abdominal pain upper|Fatigue|Nasopharyngitis|Hypoaesthesia|Nausea|Weight decreased|Nasal congestion|Paraesthesia|Pyrexia,33,3
10267095,20140630,Pertuzumab,57,801,57.0,2,53,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|PACLITAXEL|TRASTUZUMAB|WARFARIN|DOCETAXEL|DOCETAXEL ANHYDROUS|ESTAZOLAM|ESTAZOLAM,13,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|THROMBOSIS|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Cardiac failure congestive|Cardiomyopathy,2,1
10267100,20140630,Pertuzumab,52,801,52.0,2,83,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FAMOTIDINE,6,BREAST CANCER|BREAST CANCER|PREMEDICATION|BREAST CANCER|PREMEDICATION|PREMEDICATION,Tachycardia|Chills|Nausea,3,3
10267935,20140630,Pertuzumab,65,801,65.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|DENOSUMAB,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Oxygen saturation decreased|Loss of consciousness|Nausea|Back pain|Hypotension|Thrombocytopenia,6,3
10269310,20140701,Pertuzumab,67,801,67.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|FAMOTIDINE|DOCETAXEL|DOCETAXEL ANHYDROUS,6,BREAST CANCER|BREAST CANCER|BREAST CANCER,Diarrhoea|Decreased appetite|Dehydration|Salivary gland calculus,4,5
10269553,20140701,Pertuzumab,50,801,50.0,0,,1,1,1,0,0,0,0,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,6,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LIVER,Asthenia|Disease progression|Drug ineffective,3,3
10269869,20140701,Pertuzumab,64,801,64.0,2,40,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|PACLITAXEL|PACLITAXEL,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|HER-2 POSITIVE BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Infusion related reaction,1,1
10269990,20140701,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Chills|Lymphoedema|Skin cancer|Bronchospasm|Breast induration|Headache,6,3
10270072,20140701,Pertuzumab,64,801,64.0,2,,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,6,BREAST CANCER|BREAST CANCER|BREAST CANCER,Agranulocytosis,1,1
10270725,20140701,Pertuzumab,55,801,55.0,2,,1,1,0,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB,5,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Septic shock,1,1
10271967,20140702,Pertuzumab,59,801,59.0,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PACLITAXEL|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB,6,BREAST CANCER|BREAST CANCER|BREAST CANCER,Mucosal inflammation|Asthenia|Febrile neutropenia|Fatigue|Neutropenia|Alopecia,6,1
10275344,20140703,Pertuzumab,,,,2,63,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|DARUNAVIR|TRASTUZUMAB|RITONAVIR|EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE,6,BREAST CANCER METASTATIC|HIV INFECTION|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Colitis|Lung disorder|Vulval ulceration,3,1
10277951,20140704,Pertuzumab,50,801,50.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Asthenia|Bone pain|Spinal fracture,3,1
10279112,20140707,Pertuzumab,49,801,49.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|CLONAZEPAM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TRAMADOL HYDROCHLORIDE|TRASTUZUMAB|GABAPENTIN,11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Folliculitis|Gastrointestinal disorder|Neuropathy peripheral|Ejection fraction abnormal|Gastrooesophageal reflux disease,5,2
10279196,20140707,Pertuzumab,45,801,45.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|FILGRASTIM|TRASTUZUMAB,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Clostridium difficile infection,1,3
10279453,20140707,Pertuzumab,51,801,51.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER,Cystoid macular oedema,1,1
10279477,20140707,Pertuzumab,73,801,73.0,2,,1,0,1,1,0,0,0,Pertuzumab,PACLITAXEL|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB,11,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Colitis,1,1
10280266,20140707,Pertuzumab,56,801,56.0,2,,1,0,1,0,0,0,1,Pertuzumab,PERTUZUMAB|FUROSEMIDE|TRASTUZUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DICLOFENAC SODIUM|DOCETAXEL|DOCETAXEL ANHYDROUS|MORPHINE SULFATE|MORPHINE SULFATE|MORPHINE SULFATE|PREGABALIN,22,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Neutropenia|Drug hypersensitivity|Electrolyte imbalance|Vomiting|Diarrhoea|Pyrexia,6,1
10280619,20140707,Pertuzumab,,,,2,,1,1,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,4,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Platelet count decreased|Fatigue|Disease progression|Angioedema|Heart rate increased|Haemoglobin decreased|Neutrophil count decreased,7,1
10281777,20140707,Pertuzumab,60,801,60.0,2,,1,1,0,1,0,0,0,Pertuzumab,TRASTUZUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DOCETAXEL|DOCETAXEL ANHYDROUS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PERTUZUMAB|RANITIDINE,12,BREAST CANCER|BREAST CANCER|PROPHYLAXIS|PROPHYLAXIS|BREAST CANCER|HYPERTENSION|PROPHYLAXIS|PROPHYLAXIS,Peritonitis|Gastrointestinal perforation|Neutropenia,3,1
10282701,20140708,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,HER-2 POSITIVE BREAST CANCER,Cardiotoxicity,1,1
10283127,20140708,Pertuzumab,43,801,43.0,2,,1,1,0,0,0,0,0,Pertuzumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB,10,NAUSEA|VOMITING|PREMEDICATION|HER-2 POSITIVE BREAST CANCER|PROPHYLAXIS|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Hepatic failure|Cardio-respiratory arrest,2,1
10283132,20140708,Pertuzumab,51,801,51.0,2,,1,0,0,0,0,0,1,Pertuzumab,EXTENDED PHENYTOIN SODIUM|TRASTUZUMAB|PERTUZUMAB|DESLORATADINE,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Nasopharyngitis|Pain|Headache|Influenza like illness|Sinusitis|Disease progression,6,5
10283151,20140708,Pertuzumab,64,801,64.0,2,,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,3,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Tachycardia|Clostridium difficile colitis|Hypotension|Agranulocytosis,4,3
10289017,20140710,Pertuzumab,48,801,48.0,2,,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Abdominal pain|Nausea,2,1
10289059,20140710,Pertuzumab,51,801,51.0,2,,1,0,0,0,0,0,1,Pertuzumab,PACLITAXEL|TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cystoid macular oedema,1,1
10289400,20140710,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,2,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT,Metastases to central nervous system|Metastases to liver,2,5
10298418,20140711,Pertuzumab,51,801,51.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER,Cystoid macular oedema,1,5
10300584,20140714,Pertuzumab,40,801,40.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Interstitial lung disease,1,1
10300653,20140714,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Interstitial lung disease,1,1
10301307,20140714,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Thrombocytopenia|Immune thrombocytopenic purpura|Adverse drug reaction,3,1
10301603,20140714,Pertuzumab,64,801,64.0,2,,1,1,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|LAPATINIB|CAPECITABINE|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|PACLITAXEL,8,BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Pericardial effusion|HER-2 positive breast cancer|Infusion related reaction|Wheezing,4,1
10302339,20140714,Pertuzumab,37,801,37.0,2,39,1,0,0,0,0,0,1,Pertuzumab,DENOSUMAB|TRASTUZUMAB|PERTUZUMAB|ERIBULIN MESYLATE|OXYCODONE HYDROCHLORIDE|ESOMEPRAZOLE MAGNESIUM,22,METASTASES TO BONE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Osteonecrosis of jaw|Vomiting|Stomatitis,3,1
10304377,20140715,Pertuzumab,43,801,43.0,2,,1,0,1,0,0,0,0,Pertuzumab,EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE|PERTUZUMAB|TRASTUZUMAB|RITONAVIR|DARUNAVIR,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Enterocolitis infectious|Pyrexia|Vaginal ulceration|Oral candidiasis,4,1
10304432,20140715,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Lung infiltration,1,1
10307158,20140716,Pertuzumab,49,801,49.0,2,98,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,9,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Dermatitis allergic|Dyspnoea|Pneumonia|General physical health deterioration|Tachycardia,5,1
10309519,20140717,Pertuzumab,65,801,65.0,2,45,1,1,1,1,0,0,0,Pertuzumab,OXYCODONE HYDROCHLORIDE|TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB,11,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|PROPHYLAXIS|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Altered state of consciousness|White blood cell count increased|Blood sodium decreased|Metastases to meninges|Blood pressure increased,5,1
10310588,20140717,Pertuzumab,43,801,43.0,2,,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|DARUNAVIR|DARUNAVIR 600 MG|DARUNAVIR 800 MG|EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE|RITONAVIR,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Oral pain|Pain|Abdominal pain|Decreased appetite|Vaginal ulceration|Pyrexia|Oral candidiasis|Diarrhoea|Enterocolitis infectious,9,3
10310646,20140717,Pertuzumab,43,801,43.0,2,,1,1,0,0,0,0,0,Pertuzumab,TRASTUZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,10,VOMITING|PREMEDICATION|HER-2 POSITIVE BREAST CANCER|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|PROPHYLAXIS|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER,Hepatic failure|Cardio-respiratory arrest,2,1
10312863,20140716,Pertuzumab,51,801,51.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,3,BREAST CANCER,Cystoid macular oedema,1,3
10328440,20140721,Pertuzumab,84,801,84.0,0,62,1,0,1,0,0,0,0,Pertuzumab,"PERTUZUMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|TRASTUZUMAB",3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Bronchospasm,1,1
10328999,20140721,Pertuzumab,60,801,60.0,2,59.9,1,1,1,0,0,0,1,Pertuzumab,CAPECITABINE|PERTUZUMAB|LEVOTHYROXINE SODIUM|TRASTUZUMAB|PERTUZUMAB,6,BREAST CANCER METASTATIC|HER-2 POSITIVE BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Drug effect decreased|Malignant neoplasm progression|Therapeutic product ineffective|Hepatic enzyme increased|Pleural effusion,5,2
10330373,20140722,Pertuzumab,52,801,52.0,2,,1,1,0,0,0,0,0,Pertuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Death,1,2
10331032,20140722,Pertuzumab,51,801,51.0,2,,1,1,0,0,0,0,0,Pertuzumab,CAPECITABINE|PERTUZUMAB|GOSERELIN|TRASTUZUMAB|ANASTROZOLE|EXEMESTANE,7,METAPLASTIC BREAST CARCINOMA|METAPLASTIC BREAST CARCINOMA,Ventricular fibrillation|Ejection fraction decreased|Hypertension|Ventricular hypokinesia,4,1
10331850,20140722,Pertuzumab,36,801,36.0,2,62,1,0,1,0,0,0,0,Pertuzumab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|TRASTUZUMAB|PERTUZUMAB|PACLITAXEL",5,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Circulatory collapse,1,3
10332912,20140722,Pertuzumab,52,801,52.0,2,92,1,0,1,0,0,0,0,Pertuzumab,"PACLITAXEL|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PERTUZUMAB|RAMIPRIL|RAMIPRIL",7,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Gastritis haemorrhagic,1,3
10334978,20140723,Pertuzumab,59,801,59.0,2,,1,0,1,0,0,0,1,Pertuzumab,"LANSOPRAZOLE|FOSAPREPITANT|FOSAPREPITANT DIMEGLUMINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PERTUZUMAB|CITALOPRAM|CITALOPRAM HYDROBROMIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",16,PROPHYLAXIS|PROPHYLAXIS|ASTHMA|PROPHYLAXIS OF NAUSEA AND VOMITING|HER-2 POSITIVE BREAST CANCER|ANXIETY|PROPHYLAXIS|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|ASTHMA|HYPERTENSION,Neutropenia|Cellulitis|Injection site infection|Pain in extremity,4,5
10337500,20140724,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PACLITAXEL|TRASTUZUMAB|PERTUZUMAB,4,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Breast cancer metastatic,1,1
10339465,20140724,Pertuzumab,64,801,64.0,2,49.9,1,0,1,0,0,0,0,Pertuzumab,"PERTUZUMAB|GRANISETRON|GRANISETRON HYDROCHLORIDE|LETROZOLE|LETROZOLE TABLETS|PERTUZUMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|LETROZOLE|APREPITANT|FOSAPREPITANT DIMEGLUMINE",15,HER-2 POSITIVE BREAST CANCER|NAUSEA|DIARRHOEA|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|NAUSEA|HER-2 POSITIVE BREAST CANCER|NAUSEA|NAUSEA|HER-2 POSITIVE BREAST CANCER|NAUSEA,Cardiac failure,1,1
10339537,20140724,Pertuzumab,63,801,63.0,2,,1,0,1,0,0,0,0,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|FAMOTIDINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FUROSEMIDE|PERTUZUMAB|LORATADINE|LORATADINE ORAL|METHYLPREDNISOLONE|TRASTUZUMAB|MEGESTROL ACETATE|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|FERROUS SULFATE|ALPRAZOLAM|FILGRASTIM,23,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HYPERSENSITIVITY|HYPERSENSITIVITY|VOMITING|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|NEUTROPENIA,Hypoalbuminaemia,1,1
10341224,20140725,Pertuzumab,55,801,55.0,2,,1,0,1,0,0,0,0,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|PERTUZUMAB,3,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Febrile neutropenia,1,1
10342200,20140725,Pertuzumab,46,801,46.0,2,67,1,0,1,0,0,0,0,Pertuzumab,CISPLATIN|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|LORAZEPAM|CAPECITABINE|PANTOPRAZOLE,9,HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|ABDOMINAL PAIN|NAUSEA|HER-2 POSITIVE GASTRIC CANCER|ANXIETY|HER-2 POSITIVE GASTRIC CANCER|PROPHYLAXIS,Cerebral ischaemia,1,1
10342296,20140725,Pertuzumab,,,,2,95.34,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB,6,BREAST CANCER|BREAST CANCER|BREAST CANCER,Flushing|Heart rate increased|Paraesthesia oral|Chest discomfort,4,3
10343966,20140728,Pertuzumab,66,801,66.0,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10343978,20140728,Pertuzumab,,,,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10343980,20140728,Pertuzumab,,,,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10344001,20140728,Pertuzumab,77,801,77.0,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10344008,20140728,Pertuzumab,73,801,73.0,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10344034,20140728,Pertuzumab,73,801,73.0,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10344038,20140728,Pertuzumab,69,801,69.0,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10344055,20140728,Pertuzumab,65,801,65.0,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10344092,20140728,Pertuzumab,72,801,72.0,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10344098,20140728,Pertuzumab,60,801,60.0,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10344121,20140728,Pertuzumab,,,,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10344124,20140728,Pertuzumab,52,801,52.0,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10344480,20140728,Pertuzumab,,,,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10344976,20140728,Pertuzumab,73,801,73.0,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Peripheral swelling,1,3
10346815,20140729,Pertuzumab,45,801,45.0,2,,1,0,1,1,1,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|FLUCONAZOLE|PERTUZUMAB|TRASTUZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,10,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|BONE PAIN,Neutropenia|Ejection fraction decreased|Cardiac failure,3,1
10349511,20140730,Pertuzumab,31,801,31.0,2,76,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB|HYDROCORTISONE,10,PREMEDICATION|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|PREMEDICATION,Hypersensitivity|Nausea|Rash|Dyspnoea|Cardiovascular disorder|Chills|Flushing|Abdominal pain,8,1
10349612,20140730,Pertuzumab,59,801,59.0,2,51.76,1,1,1,0,1,0,0,Pertuzumab,PERTUZUMAB|DENOSUMAB|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|BACLOFEN|DOCETAXEL|DOCETAXEL ANHYDROUS|LORAZEPAM|OXYCODONE|LACTULOSE|PROCHLORPERAZINE|STANDARDIZED SENNA CONCENTRATE|CYANOCOBALAMIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXYCODONE HYDROCHLORIDE|OXYCODONE|CAPECITABINE|LAPATINIB|TRASTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|ONDANSETRON HYDROCHLORIDE|HYDROXYCHLOROQUINE,22,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER|BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Metastases to lung|Gait disturbance|Constipation|Asthenia|Oral candidiasis|Oedema peripheral|Speech disorder|Performance status decreased|Decubitus ulcer|Ecchymosis|Disease progression|Dyspnoea|Nausea|Weight decreased|Escherichia urinary tract infection,15,1
10353309,20140731,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pancreatitis,1,1
10358340,20140801,Pertuzumab,30,801,30.0,1,51.4,1,0,1,1,0,0,1,Pertuzumab,CAPECITABINE|PERTUZUMAB|BEVACIZUMAB|CAPECITABINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PERTUZUMAB|DENOSUMAB|ADO-TRASTUZUMAB EMTANSINE|CAPECITABINE|LAPATINIB|CALCIUM CARBONATE|ANTACID|CYANOCOBALAMIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|TRASTUZUMAB|PERTUZUMAB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL,20,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|HER-2 POSITIVE BREAST CANCER|BREAST CANCER METASTATIC|HER-2 POSITIVE BREAST CANCER,Headache|Malignant neoplasm progression|Skin cancer|Muscular weakness|Bacteraemia|Febrile neutropenia|Dizziness,7,1
10358411,20140801,Pertuzumab,72,801,72.0,2,,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|AMOXICILLIN|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|FLUCONAZOLE|RAMIPRIL|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|ZOLPIDEM TARTRATE|PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|AMOXICILLIN|BISOPROLOL FUMARATE|FLUCONAZOLE,46,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Cellulitis,1,1
10359252,20140804,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,BREAST CANCER,Renal impairment|Urine output decreased,2,2
10359515,20140804,Pertuzumab,44,801,44.0,2,,1,0,0,1,0,0,0,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB,3,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Hepatic cirrhosis,1,1
10361706,20140805,Pertuzumab,58,801,58.0,0,,1,0,1,0,0,0,0,Pertuzumab,ALPRAZOLAM|PERTUZUMAB|TRASTUZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SITAGLIPTIN,7,BREAST CANCER|BREAST CANCER|BREAST CANCER,Non-cardiac chest pain|Dyspnoea,2,1
10361709,20140805,Pertuzumab,63,801,63.0,2,79.45,1,0,1,0,0,0,0,Pertuzumab,AMLODIPINE|PERTUZUMAB|PERTUZUMAB,5,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Syncope,1,1
10364104,20140806,Pertuzumab,70,801,70.0,2,,1,0,0,0,0,0,1,Pertuzumab,ENALAPRIL|TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Cerebral ischaemia,1,1
10366453,20140806,Pertuzumab,72,801,72.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|FENTANYL TRANSDERMAL|MIRTAZAPINE|PERTUZUMAB|LOSARTAN|CETRIMIDE|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL|TRASTUZUMAB|TRASTUZUMAB|FENTANYL TRANSDERMAL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PACLITAXEL|MORPHINE|LORATADINE|LORATADINE ORAL|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL,21,HER-2 POSITIVE BREAST CANCER|PROPHYLAXIS|HER-2 POSITIVE BREAST CANCER|NAUSEA|HER-2 POSITIVE BREAST CANCER|DYSPEPSIA,Cystitis haemorrhagic,1,1
10366862,20140807,Pertuzumab,,,,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|TRASTUZUMAB,4,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Infusion related reaction|Rash|Syncope|Burning sensation|Migraine with aura|Skin warm|Blindness|Hypoaesthesia|Malaise|Flushing|Folliculitis|Dyspnoea|Candida infection|Chest pain|White blood cell count decreased,15,5
10367765,20140306,Pertuzumab,,,,1,82.1,1,0,1,0,1,0,0,Pertuzumab,,5,PLASMA CELL MYELOMA,Plasma cell myeloma|Protein total increased|Sinus disorder|Pyrexia,4,1
10369610,20140807,Pertuzumab,29,801,29.0,2,,1,0,0,0,0,0,0,Pertuzumab,TRASTUZUMAB|OMEPRAZOLE MAGNESIUM|FILGRASTIM|TRASTUZUMAB|PERTUZUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|FILGRASTIM|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|FAMOTIDINE|DEXAMETHASONE SODIUM PHOSPHATE|TRASTUZUMAB|IRON SUCROSE|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|CARBOPLATIN,33,PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|VOMITING,Blood pressure diastolic decreased|Gastrooesophageal reflux disease|Heart rate increased|Decreased appetite|Anxiety|Dermatitis acneiform|Nasopharyngitis|Back pain|Nausea|Vomiting|White blood cell count decreased|Flushing|Stomatitis|Rash maculo-papular|Paranasal sinus hypersecretion|Fatigue|Pain|Depression|Alopecia,19,1
10381197,20140813,Pertuzumab,76,801,76.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|ACETAMINOPHEN AND CODEINE|TRASTUZUMAB|PERTUZUMAB|PREDNISONE|TRASTUZUMAB|OXYCODONE,9,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Ejection fraction decreased,1,1
10384003,20140814,Pertuzumab,,,,1,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10384420,20140814,Pertuzumab,45,801,45.0,2,72,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|BISOPROLOL FUMARATE|TRASTUZUMAB|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|BISOPROLOL FUMARATE|TRASTUZUMAB|PERTUZUMAB|TRASTUZUMAB|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|RAMIPRIL,18,HER-2 POSITIVE BREAST CANCER|TACHYCARDIA|DEPRESSION|HYPERTENSION|PROPHYLAXIS|HER-2 POSITIVE BREAST CANCER|VOMITING|VOMITING|DEPRESSION|HER-2 POSITIVE BREAST CANCER|HYPERTENSION|VOMITING,Nausea|Dizziness|Erysipelas|Vomiting,4,1
10384697,20140814,Pertuzumab,60,801,60.0,2,,1,0,1,0,0,0,0,Pertuzumab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE|LACTULOSE|PERTUZUMAB|AMITRIPTYLINE HYDROCHLORIDE|APREPITANT|APREPITANT|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|GRANISETRON|GRANISETRON HYDROCHLORIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|APREPITANT|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|NAPROXEN|NAPROXEN SODIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|APREPITANT|APREPITANT|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",32,HER-2 POSITIVE BREAST CANCER|CONSTIPATION|ASTHMA|MIGRAINE|NAUSEA|HER-2 POSITIVE BREAST CANCER|NAUSEA|NAUSEA|OSTEOARTHRITIS|PROPHYLAXIS|NAUSEA|CONSTIPATION|MOUTH ULCERATION|HER-2 POSITIVE BREAST CANCER,Lower respiratory tract infection|Cough|Back pain|Pyrexia|Neutropenic sepsis|Fatigue|Malaise|Headache|Sputum discoloured,9,5
10385852,20140814,Pertuzumab,69,801,69.0,2,53.7,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB,9,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Loss of consciousness,1,1
10386296,20140815,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,BREAST CANCER,Interstitial lung disease,1,1
10386300,20140815,Pertuzumab,65,801,65.0,2,,1,1,0,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION,Sepsis|Neutropenia,2,1
10386332,20140815,Pertuzumab,64,801,64.0,2,54,1,1,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|TRASTUZUMAB|PERTUZUMAB,8,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER,Interstitial lung disease|Encephalopathy,2,1
10387108,20140815,Pertuzumab,38,801,38.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|PERTUZUMAB|PACLITAXEL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TRASTUZUMAB|TRASTUZUMAB|RANITIDINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PACLITAXEL|LISINOPRIL,13,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Cellulitis|Pneumonia|Cellulitis,3,1
10388140,20140815,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|BREAST CANCER,Dyspnoea|Hypotension|Cough|Anaphylactic reaction,4,5
10389531,20140818,Pertuzumab,45,801,45.0,2,55,1,0,0,0,0,0,0,Pertuzumab,TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB,5,BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER,Tachycardia|Dyspnoea exertional,2,1
10389585,20140818,Pertuzumab,58,801,58.0,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|CARBOPLATIN|PERTUZUMAB,4,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Pancytopenia,1,1
10391174,20140818,Pertuzumab,72,801,72.0,2,,1,0,1,0,0,0,0,Pertuzumab,MORPHINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LOSARTAN POTASSIUM|LOSARTAN|FENTANYL CITRATE|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|MIRTAZAPINE|TRASTUZUMAB|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|CETRIMIDE|FENTANYL CITRATE,16,BREAST CANCER|BREAST CANCER|BREAST CANCER,Cystitis haemorrhagic,1,1
10391179,20140818,Pertuzumab,64,801,64.0,2,39,1,0,0,0,0,0,1,Pertuzumab,GRANISETRON|GRANISETRON HYDROCHLORIDE|TRASTUZUMAB|PERTUZUMAB,8,BREAST CANCER|PROPHYLAXIS|PROPHYLAXIS|BREAST CANCER|BREAST CANCER|PROPHYLAXIS|PROPHYLAXIS,Arrhythmia supraventricular|Oxygen saturation decreased,2,1
10391483,20140818,Pertuzumab,60,801,60.0,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Interstitial lung disease,1,1
10392271,20140819,Pertuzumab,51,801,51.0,2,,1,0,1,0,0,0,1,Pertuzumab,PANTOPRAZOLE|FILGRASTIM|METHYLPREDNISOLONE|PERTUZUMAB|TRASTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PERTUZUMAB|MORPHINE|DOCETAXEL|DOCETAXEL ANHYDROUS,18,BREAST CANCER|BREAST CANCER|CANCER PAIN|BREAST CANCER|BREAST CANCER|BREAST CANCER,Neutropenia|Pain|Vomiting|Vomiting,4,1
10392345,20140819,Pertuzumab,43,801,43.0,2,68,1,0,0,0,1,0,0,Pertuzumab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PACLITAXEL|PERTUZUMAB|TRASTUZUMAB|APREPITANT|FOSAPREPITANT DIMEGLUMINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",10,BREAST CANCER|BREAST CANCER|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Ataxia|Peripheral sensory neuropathy,2,1
10393206,20140819,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Interstitial lung disease|Pyrexia|Infusion related reaction,3,1
10394659,20140820,Pertuzumab,56,801,56.0,2,,1,0,1,0,0,0,0,Pertuzumab,MIRTAZAPINE|TRASTUZUMAB|PERTUZUMAB|TRASTUZUMAB|PANTOPRAZOLE|PACLITAXEL|PERTUZUMAB|CETIRIZINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|AMOXICILLIN,27,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Erysipelas,1,1
10395020,20140820,Pertuzumab,27,801,27.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|PACLITAXEL|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB,6,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Stoma site infection,1,1
10395494,20140820,Pertuzumab,59,801,59.0,2,80.6,1,0,0,0,0,0,1,Pertuzumab,"CAPECITABINE|TRASTUZUMAB|PERTUZUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CAPECITABINE|TRASTUZUMAB|PERTUZUMAB|LAPATINIB|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|ECHINACEA ANGUSTIFOLIA, HAMAMMELIS VIRGINIANA, CALCAREA PHOSPHORICA, HYDRASTIS CANADANESIS, SENEGA OFFICINALIS, SILICEA, CONIUM, AURUM MURIATICUM NATRONATUM, CALCAREA CARBONICA, FUCUS VESICULOSUS, LACHESIS MUTUS|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE",14,BREAST CANCER|BREAST CANCER METASTATIC|HER-2 POSITIVE BREAST CANCER|BREAST CANCER METASTATIC,Headache|Hypersensitivity|Skin fissures|Cardiac arrest|Metastases to lung,5,1
10395579,20140820,Pertuzumab,49,801,49.0,2,66.4,1,0,1,0,0,0,1,Pertuzumab,"TRASTUZUMAB|POLYETHYLENE GLYCOL 3350|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|LORATADINE|LORATADINE TABLET|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PERTUZUMAB|TRASTUZUMAB|OMEPRAZOLE MAGNESIUM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|OXYCODONE|POLYETHYLENE GLYCOL 3350",15,CONSTIPATION|HYPERCHOLESTEROLAEMIA|HEADACHE|RHINITIS ALLERGIC|PAIN|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|GASTROOESOPHAGEAL REFLUX DISEASE|CONSTIPATION|PROPHYLAXIS|PROCEDURAL PAIN|NAUSEA|PROPHYLAXIS,Fatigue|Coronary artery embolism|Dyspnoea|Myocardial infarction|Acute myocardial infarction|Hyperhidrosis|Chest pain|Acute coronary syndrome,8,3
10397607,20140821,Pertuzumab,41,801,41.0,2,81,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|RANITIDINE HYDROCHLORIDE|TRASTUZUMAB|PERTUZUMAB|PACLITAXEL,7,BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT,Headache|Abdominal pain|Hypertension,3,2
10398095,20140821,Pertuzumab,79,801,79.0,2,,1,0,0,0,1,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,4,BREAST CANCER METASTATIC|HYPOPITUITARISM|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Dementia|Depression|Cognitive disorder,3,1
10401056,20140822,Pertuzumab,38,801,38.0,2,52.66,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Onycholysis,1,1
10401362,20140822,Pertuzumab,57,801,57.0,1,61.5,1,0,1,0,0,0,0,Pertuzumab,LANSOPRAZOLE|MEROPENEM|TRASTUZUMAB|APREPITANT|FOSAPREPITANT DIMEGLUMINE|GRANISETRON|GRANISETRON HYDROCHLORIDE|CISPLATIN|APREPITANT|FOSAPREPITANT DIMEGLUMINE|TRASTUZUMAB|MANNITOL|CAPECITABINE|FUROSEMIDE|PERTUZUMAB|CEFTRIAXONE SODIUM,18,PROPHYLAXIS OF NAUSEA AND VOMITING|GASTRITIS PROPHYLAXIS|INFECTION PROPHYLAXIS|HER2 POSITIVE GASTRIC CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING|HER2 POSITIVE GASTRIC CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING|CONSTIPATION|STOMATITIS|GASTRITIS|HER2 POSITIVE GASTRIC CANCER|HER2 POSITIVE GASTRIC CANCER|INFECTION PROPHYLAXIS,Acute kidney injury|Stomatitis|Decreased appetite|Anaemia|Thrombocytopenia|Neutropenia,6,1
10403172,20140822,Pertuzumab,36,801,36.0,2,,1,0,0,0,0,0,1,Pertuzumab,"CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, X-RAY, URANIUM NITRICUM|CHONDRUS CRISPUS, FUCUS VESICULOSUS, THYROIDINUM (SUIS), CADMIUM IODATUM, IODIUM, STRONTIUM CARBONICUM, X-RAY,|CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY|CAPECITABINE|PERTUZUMAB|TRASTUZUMAB|LAPATINIB",6,METASTASES TO CENTRAL NERVOUS SYSTEM|METASTASES TO CENTRAL NERVOUS SYSTEM|BREAST CANCER|METASTASES TO CENTRAL NERVOUS SYSTEM,Malignant neoplasm progression,1,3
10404908,20140825,Pertuzumab,58,801,58.0,2,55.9,1,0,1,0,0,0,0,Pertuzumab,"VALACYCLOVIR HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PACLITAXEL|PROPRANOLOL HYDROCHLORIDE|ACETAMINOPHEN, ASPIRIN, AND CAFFEINE|ACETAMINOPHEN, ASPIRIN, AND CAFFEINE|VALACYCLOVIR HYDROCHLORIDE|PERTUZUMAB|TRASTUZUMAB",13,HYPERSENSITIVITY|MIGRAINE|BREAST CANCER|MIGRAINE|MIGRAINE|HEADACHE|GENITAL HERPES SIMPLEX|BREAST CANCER|BREAST CANCER,Device related infection|Catheter site erythema|Erythema|Cellulitis|Blood culture positive|Catheter site pain,6,3
10408855,20140826,Pertuzumab,48,801,48.0,2,63,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB,4,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pericardial effusion|Pleural effusion,2,1
10408858,20140826,Pertuzumab,47,801,47.0,2,48,1,0,1,0,0,0,0,Pertuzumab,PACLITAXEL|PERTUZUMAB|PERTUZUMAB,5,BREAST CANCER|BREAST CANCER|BREAST CANCER,Hypokalaemia,1,1
10411049,20140826,Pertuzumab,54,801,54.0,2,76,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pleural effusion,1,1
10411811,20140827,Pertuzumab,,,,2,,1,0,1,1,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Septic shock|Febrile neutropenia|Diarrhoea,3,1
10412307,20140827,Pertuzumab,65,801,65.0,2,69.01,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,2,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Pneumonitis,1,1
10414272,20140828,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Granuloma,1,1
10414333,20140828,Pertuzumab,59,801,59.0,2,87.2,1,0,1,0,0,0,0,Pertuzumab,"PREGABALIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LANSOPRAZOLE|AMOXICILLIN|AMOXICILLIN|RANITIDINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LETROZOLE|LETROZOLE TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PERTUZUMAB|FELODIPINE|FELODIPINE EXTENDED-RELEASE TABLETS|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CITALOPRAM|CITALOPRAM HYDROBROMIDE|SENNOSIDES|SENNA LEAF|SENNA|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|PERTUZUMAB|MOMETASONE|FLUCONAZOLE",41,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|NEURALGIA|THROMBOPHLEBITIS|CELLULITIS|ANAPHYLACTIC REACTION|DYSPEPSIA|THROMBOPHLEBITIS|ANAPHYLACTIC REACTION|NEUTROPENIA|EYE PRURITUS|SKIN INFECTION|STOMATITIS|HEADACHE|HYPERSENSITIVITY|PREMEDICATION|NEUTROPENIA|THROMBOPHLEBITIS|HYPERSENSITIVITY|BREAST CANCER|NAUSEA|HER-2 POSITIVE BREAST CANCER|ASTHMA|HYPERTENSION|HER-2 POSITIVE BREAST CANCER|ANXIETY|ASTHMA|CONSTIPATION|THROMBOSIS|HER-2 POSITIVE BREAST CANCER|ASTHMA|LICHEN PLANUS|SKIN INFECTION|DIARRHOEA,Pyrexia,1,1
10414605,20140828,Pertuzumab,58,801,58.0,2,,1,1,0,0,0,0,0,Pertuzumab,LAPATINIB|PERTUZUMAB|TRASTUZUMAB,5,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Death,1,1
10415212,20140828,Pertuzumab,49,801,49.0,2,,1,0,0,0,0,0,1,Pertuzumab,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|MICONAZOLE|MICONAZOLE NITRATE|TRASTUZUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|PERTUZUMAB|TRASTUZUMAB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MICONAZOLE|MICONAZOLE NITRATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISONE,24,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|PREMEDICATION,Hepatocellular injury|Hepatitis C,2,1
10417413,20140829,Pertuzumab,,,,2,,1,0,1,0,1,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|CARBOPLATIN|TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,6,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Deafness|Abdominal discomfort|Nerve injury|Weight decreased|Rhinorrhoea|Diarrhoea|Diarrhoea|Arthralgia,8,1
10421493,20140901,Pertuzumab,86,801,86.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,BREAST CANCER,General physical health deterioration|Pulmonary oedema,2,1
10421855,20140901,Pertuzumab,69,801,69.0,2,,1,1,0,0,0,0,1,Pertuzumab,ADO-TRASTUZUMAB EMTANSINE|CAPECITABINE|LAPATINIB|TRASTUZUMAB|PERTUZUMAB,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Death|Pulmonary toxicity,2,1
10422703,20140902,Pertuzumab,43,801,43.0,2,,1,0,1,0,0,0,0,Pertuzumab,PACLITAXEL|TRASTUZUMAB|PERTUZUMAB|CARBOPLATIN|TRASTUZUMAB|PACLITAXEL|LORAZEPAM|TRASTUZUMAB|AMOXICILLIN AND CLAVULANATE POTASSIUM|PERTUZUMAB|PERTUZUMAB|CARBOPLATIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,16,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Abdominal pain|Pyrexia|Diarrhoea|Vomiting|Constipation,5,1
10422712,20140902,Pertuzumab,65,801,65.0,2,61,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Atrial fibrillation,1,1
10422765,20140902,Pertuzumab,65,801,65.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,NEOPLASM MALIGNANT,Tachycardia|Oxygen saturation decreased|Blood pressure increased|Chills,4,1
10425982,20140903,Pertuzumab,67,801,67.0,2,75.45,1,0,1,0,0,0,0,Pertuzumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|IRBESARTAN|TRASTUZUMAB|CANDESARTAN CILEXETIL|PERTUZUMAB,11,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Gastroenteritis,1,1
10426662,20140903,Pertuzumab,60,801,60.0,2,92.3,1,0,0,0,0,0,1,Pertuzumab,RAMIPRIL|DULOXETINE HYDROCHLORIDE|PERTUZUMAB|PERTUZUMAB,13,HER-2 POSITIVE BREAST CANCER|HYPOTHYROIDISM|PREMEDICATION|PREMEDICATION|DEPRESSION|HYPERTENSION|PAIN|PAIN|DEPRESSION|HER-2 POSITIVE BREAST CANCER|PAIN,Confusional state,1,1
10429241,20140904,Pertuzumab,47,801,47.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|PACLITAXEL,3,BREAST CANCER|BREAST CANCER,Hypokalaemia,1,5
10429804,20140904,Pertuzumab,57,801,57.0,2,,1,0,1,0,0,0,0,Pertuzumab,PACLITAXEL|CARBOPLATIN|TRASTUZUMAB|PERTUZUMAB,9,HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Supraventricular tachycardia,1,1
10430057,20140904,Pertuzumab,51,801,51.0,2,,1,0,1,0,0,0,0,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|FILGRASTIM|FILGRASTIM|FILGRASTIM|FILGRASTIM|TRASTUZUMAB|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|GRANISETRON|GRANISETRON HYDROCHLORIDE|FILGRASTIM|FILGRASTIM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FILGRASTIM|TRASTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LORAZEPAM|LETROZOLE|LETROZOLE TABLETS|FILGRASTIM|PERTUZUMAB|PERTUZUMAB|FILGRASTIM|FILGRASTIM|LETROZOLE|LETROZOLE TABLETS|GRANISETRON|GRANISETRON HYDROCHLORIDE,27,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|ANXIETY|HER-2 POSITIVE BREAST CANCER|NEUTROPENIA,Varicella,1,1
10430779,20140904,Pertuzumab,43,801,43.0,2,,1,0,1,0,0,0,1,Pertuzumab,TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB,12,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Acute cutaneous lupus erythematosus|Systemic lupus erythematosus,2,1
10431529,20140904,Pertuzumab,,,,2,,1,0,0,1,0,0,0,Pertuzumab,PERTUZUMAB,1,BREAST CANCER METASTATIC,Status epilepticus,1,3
10431872,20140905,Pertuzumab,67,801,67.0,2,53.6,1,0,1,0,0,0,0,Pertuzumab,"TRASTUZUMAB|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PERTUZUMAB|CAPECITABINE|CISPLATIN|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|APREPITANT|FOSAPREPITANT DIMEGLUMINE|APREPITANT|FOSAPREPITANT DIMEGLUMINE",15,HER-2 POSITIVE GASTRIC CANCER|GASTRITIS|STOMATITIS|STOMATITIS|NAUSEA|VOMITING|HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|HER-2 POSITIVE GASTRIC CANCER|GASTRITIS|ELECTROLYTE IMBALANCE|VOMITING|VOMITING|NAUSEA|NAUSEA,Enteritis,1,1
10436073,20140908,Pertuzumab,68,801,68.0,2,,1,0,1,0,0,0,0,Pertuzumab,PACLITAXEL|TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Dermatomyositis,1,3
10436918,20140908,Pertuzumab,65,801,65.0,2,61,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Atrial fibrillation,1,3
10442629,20140909,Pertuzumab,,,,0,,1,1,0,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT,Febrile neutropenia|Hepatic failure|Disseminated intravascular coagulation,3,1
10442683,20140909,Pertuzumab,32,801,32.0,2,50,1,0,1,0,0,0,0,Pertuzumab,PREGABALIN|OXYCODONE HYDROCHLORIDE|PERTUZUMAB|PERTUZUMAB,10,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Tumour lysis syndrome|Infusion related reaction,2,1
10443447,20140910,Pertuzumab,48,801,48.0,2,,1,0,1,0,0,0,0,Pertuzumab,"PEGFILGRASTIM|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB|FOLIC ACID|FILGRASTIM|CARBOPLATIN|DIPHENHYDRAMINE HYDROCHLORIDE|FILGRASTIM|AMOXICILLIN|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ZOLPIDEM TARTRATE|FLUCONAZOLE|FILGRASTIM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|FERROUS SULFATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ATENOLOL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DRONABINOL|FLUCONAZOLE",27,PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|PREMEDICATION|PREMEDICATION|PREMEDICATION|PROPHYLAXIS,Abdominal pain,1,1
10445438,20140910,Pertuzumab,62,801,62.0,2,,1,0,1,0,0,0,1,Pertuzumab,TRASTUZUMAB|PREGABALIN|PERTUZUMAB|TRASTUZUMAB|PERTUZUMAB|TRASTUZUMAB|ESTRADIOL,15,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Ejection fraction decreased|Fatigue|Dysstasia|Horner^s syndrome|Cardiac failure|Pain|N-terminal prohormone brain natriuretic peptide increased,7,3
10446528,20140911,Pertuzumab,55,801,55.0,2,57.2,1,0,1,1,0,0,0,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|CARBOPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|TRASTUZUMAB,5,BREAST CANCER|BREAST CANCER|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER,Gastrointestinal stoma complication|Hyperglycaemia|Hyponatraemia|Diarrhoea|Vulvitis,5,1
10448621,20140912,Pertuzumab,64,801,64.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB,4,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Diarrhoea|Neutropenia|Abdominal discomfort|Infection,4,3
10448635,20140912,Pertuzumab,78,801,78.0,2,83,1,1,0,0,0,0,0,Pertuzumab,DOXORUBICIN|PACLITAXEL|PERTUZUMAB|TRASTUZUMAB,4,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Acute respiratory failure,1,1
10448666,20140912,Pertuzumab,59,801,59.0,2,57,1,0,1,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|METOPROLOL TARTRATE|METOPROLOL|PERTUZUMAB|DENOSUMAB|FULVESTRANT|TRASTUZUMAB,14,PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Gastric disorder|Infusion related reaction|Blood pressure systolic increased|Ill-defined disorder|Contusion|Oropharyngeal pain|Insomnia|Pain in extremity|Fatigue|Hypotension|Erythema|Injection site discomfort|Malaise|Paraesthesia|Body temperature decreased|Nasopharyngitis|Cough|Hypertension|Peripheral coldness|Device related infection|Headache|Catheter site erythema|Poor venous access|Blood pressure increased|Gastric infection|Nausea|Body temperature decreased|Weight decreased|Weight increased,29,1
10448724,20140912,Pertuzumab,65,801,65.0,2,60,1,0,1,0,0,0,1,Pertuzumab,LETROZOLE|PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB,13,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Febrile neutropenia|Interstitial lung disease|Pyrexia,3,1
10450027,20140910,Pertuzumab,80,801,80.0,2,,1,0,0,0,1,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,4,BREAST CANCER METASTATIC,Cognitive disorder|Dementia|Depression,3,1
10454633,20140915,Pertuzumab,,,,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Gastroenteritis|Hypovolaemic shock|Renal failure,3,1
10454700,20140915,Pertuzumab,,,,1,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER MALE|BREAST CANCER MALE|BREAST CANCER MALE,Haemolytic anaemia|Peripheral motor neuropathy|Aldolase increased|Asthenia,4,1
10456174,20140916,Pertuzumab,79,801,79.0,2,38,1,1,0,0,0,0,0,Pertuzumab,BEVACIZUMAB|TRASTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|PACLITAXEL|PERTUZUMAB|PERTUZUMAB,6,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Decreased appetite|Cardiac failure acute|Acute myocardial infarction,3,1
10456462,20140916,Pertuzumab,,,,0,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Sepsis,1,1
10457837,20140916,Pertuzumab,33,801,33.0,1,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|LAPATINIB|PERTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Bacteraemia,1,3
10458890,20140917,Pertuzumab,78,801,78.0,2,83,1,1,0,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|PACLITAXEL,4,,Respiratory failure,1,1
10460478,20140918,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,2,BREAST CANCER|BREAST CANCER,Insomnia|Muscle atrophy|Candida infection|Arthralgia,4,5
10460952,20140918,Pertuzumab,65,801,65.0,2,60,1,0,1,0,1,0,1,Pertuzumab,PERTUZUMAB|PERTUZUMAB|LETROZOLE|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB|PERTUZUMAB,15,BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Febrile neutropenia|Pyrexia|Interstitial lung disease|Dyspnoea,4,5
10462431,20140918,Pertuzumab,69,801,69.0,2,61,1,0,1,1,0,0,0,Pertuzumab,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PERTUZUMAB|PACLITAXEL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|APREPITANT|FOSAPREPITANT DIMEGLUMINE|GRANISETRON",8,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Thrombocytopenia|Leukopenia|Infection|Anaemia,4,1
10462988,20140919,Pertuzumab,56,801,56.0,2,,1,1,0,0,0,0,0,Pertuzumab,TRASTUZUMAB|CARBOPLATIN|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB,4,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Staphylococcal sepsis|Cellulitis|Folliculitis|Abscess,4,1
10463672,20140919,Pertuzumab,51,801,51.0,1,83.22,1,0,1,0,0,0,0,Pertuzumab,OCTREOTIDE ACETATE|MORPHINE SULFATE|HUMAN INSULIN|BEVACIZUMAB|PERTUZUMAB|LEVOTHYROXINE SODIUM|AMLODIPINE BESYLATE|OMEPRAZOLE MAGNESIUM,10,NEUROENDOCRINE CARCINOMA|PAIN|DIABETES MELLITUS|NEUROPATHY PERIPHERAL|NEUROENDOCRINE CARCINOMA|NEUROENDOCRINE CARCINOMA|HYPOTHYROIDISM|HYPERTENSION|GASTROOESOPHAGEAL REFLUX DISEASE|PAIN,Gastroenteritis viral,1,1
10464108,20140919,Pertuzumab,64,801,64.0,2,61.1,1,0,1,0,0,0,0,Pertuzumab,RAMIPRIL|PERTUZUMAB|TRASTUZUMAB|CALCIUM CARBONATE|ANTACID|PANTOPRAZOLE|PERTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREGABALIN,11,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Syncope,1,1
10465622,20140919,Pertuzumab,37,801,37.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,5,PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|BREAST CANCER|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Neutropenia|Presyncope|Asthenia|Mucosal inflammation,4,5
10469634,20140923,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,2,BREAST CANCER|BREAST CANCER,Thrombosis|Peripheral swelling|Periarthritis|Oedema|Catheter site vasculitis|Tooth discolouration,6,5
10470909,20140923,Pertuzumab,52,801,52.0,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|CALCIUM CHLORIDE INJECTION|CALCIUM CHLORIDE|NITROFURANTOIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS|NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)|PERTUZUMAB|PERTUZUMAB|CLARITHROMYCIN,13,BREAST CANCER|BREAST CANCER|BREAST CANCER,Ejection fraction decreased,1,3
10470916,20140923,Pertuzumab,38,801,38.0,2,126.58,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|CARBOPLATIN|LOSARTAN|DOXYCYCLINE|DOXYCYCLINE HYCLATE|AMLODIPINE|DOCETAXEL|DOCETAXEL ANHYDROUS|CLONIDINE|TRASTUZUMAB|FUROSEMIDE|OXYCODONE,13,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Hypomagnesaemia,1,1
10470954,20140923,Pertuzumab,68,801,68.0,2,,1,0,1,0,0,0,0,Pertuzumab,"PERTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",13,HER-2 POSITIVE BREAST CANCER|PYREXIA|HER-2 POSITIVE BREAST CANCER|VOMITING|HER-2 POSITIVE BREAST CANCER|VOMITING|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HEADACHE|VOMITING,Neutropenic sepsis|Pyrexia|Febrile neutropenia,3,5
10471654,20140923,Pertuzumab,52,801,52.0,2,75,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB,6,BREAST CANCER METASTATIC|METASTASES TO LUNG|METASTASES TO LUNG|BREAST CANCER METASTATIC|METASTASES TO LUNG|BREAST CANCER METASTATIC,Dyspnoea|Pulmonary hypertension|Malaise,3,2
10477816,20140926,Pertuzumab,,,,2,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB,4,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Febrile neutropenia|Hepatic failure,2,1
10480539,20140929,Pertuzumab,56,801,56.0,2,,1,0,0,0,0,0,1,Pertuzumab,"TRASTUZUMAB|CARBOPLATIN|PERTUZUMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PACLITAXEL",7,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Acute leukaemia,1,1
10482496,20140929,Pertuzumab,38,801,38.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Paraesthesia|Hemiparesis|Diarrhoea,3,1
10483759,20140930,Pertuzumab,68,801,68.0,2,71.7,1,0,1,0,0,0,0,Pertuzumab,PACLITAXEL|PERTUZUMAB|PERTUZUMAB|PANTOPRAZOLE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|PERTUZUMAB|PACLITAXEL|MAGNESIUM|PERTUZUMAB|ENOXAPARIN SODIUM|PACLITAXEL|OXYCODONE HYDROCHLORIDE|OXYCODONE|PACLITAXEL|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|ALLOPURINOL|PERTUZUMAB|PROCHLORPERAZINE,20,BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dermatomyositis|Nausea|Dermatomyositis,3,3
10485085,20140930,Pertuzumab,57,801,57.0,2,98,1,0,0,0,0,0,1,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|GOSERELIN|PERTUZUMAB|PERTUZUMAB|LORAZEPAM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|TRASTUZUMAB|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|CANDESARTAN|TRASTUZUMAB,11,BREAST CANCER|PSORIASIS|HER-2 POSITIVE BREAST CANCER|CARDIAC FAILURE|PSYCHOTIC DISORDER|DIABETES MELLITUS|HER-2 POSITIVE BREAST CANCER|HYPERTENSION|HYPERTENSION,Congestive cardiomyopathy|Congestive cardiomyopathy|Diarrhoea,3,1
10485410,20140930,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|CARBOPLATIN|TRASTUZUMAB,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Renal failure,1,1
10487417,20141001,Pertuzumab,63,801,63.0,2,,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PACLITAXEL|PERTUZUMAB|PERTUZUMAB,5,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC,Cardiomyopathy|Pulmonary embolism,2,3
10488739,20141002,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|CARBOPLATIN,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Dehydration|Renal failure,3,1
10489251,20141002,Pertuzumab,67,801,67.0,2,100.42,1,0,1,0,0,0,0,Pertuzumab,PACLITAXEL|PERTUZUMAB,3,HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER,Dehydration|Dehydration|Diarrhoea|Ascites|Dehydration|Diarrhoea|Bursitis infective,7,1
10490456,20141002,Pertuzumab,47,801,47.0,2,74,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|FILGRASTIM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,9,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Device related infection,1,1
10493993,20141003,Pertuzumab,51,801,51.0,2,,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PACLITAXEL|CARBOPLATIN|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB,6,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Diarrhoea|Infection|Thrombosis,3,1
10495453,20141003,Pertuzumab,,,,2,,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Sepsis,1,1
10495755,20141003,Pertuzumab,56,801,56.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,9,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Metastases to bone|Neoplasm progression|Diarrhoea|Metastases to lung|Metastases to liver,5,3
10496228,20141003,Pertuzumab,51,801,51.0,2,88.2,1,0,1,0,0,0,0,Pertuzumab,"LORAZEPAM|LORATADINE|LORATADINE TABLET|SPIRONOLACTONE|OMEPRAZOLE MAGNESIUM|ALBUTEROL SULFATE|ALBUTEROL|CLONAZEPAM|PERTUZUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MOMETASONE FUROATE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL",14,PROPHYLAXIS|PRE-EXISTING DISEASE|PRE-EXISTING DISEASE|PROPHYLAXIS|PRE-EXISTING DISEASE|PRE-EXISTING DISEASE|HER-2 POSITIVE BREAST CANCER|PRE-EXISTING DISEASE|HER-2 POSITIVE BREAST CANCER|PRE-EXISTING DISEASE|PRE-EXISTING DISEASE|PRE-EXISTING DISEASE|PROPHYLAXIS,Deep vein thrombosis,1,1
10498137,20141006,Pertuzumab,56,801,56.0,2,,1,1,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PERTUZUMAB,7,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER,Metastases to bone|Death,2,1
10498141,20141006,Pertuzumab,63,801,63.0,2,,1,0,1,0,0,0,0,Pertuzumab,DIAZEPAM|TRASTUZUMAB|LACTULOSE|ZOLEDRONIC ACID|PERTUZUMAB|PACLITAXEL|TOPIRAMATE|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|PERTUZUMAB|TRASTUZUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ROSUVASTATIN,26,CONSTIPATION|ANXIETY|PROPHYLAXIS|HER-2 POSITIVE BREAST CANCER|CONSTIPATION|METASTASES TO BONE|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|PAIN|DEPRESSION|NAUSEA|PAIN,Dehydration,1,1
10501515,20141007,Pertuzumab,,,,2,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,BREAST CANCER,Death,1,5
10502473,20141007,Pertuzumab,60,801,60.0,2,,1,0,1,0,0,0,0,Pertuzumab,"PERTUZUMAB|PACLITAXEL|PERTUZUMAB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PANTOPRAZOLE|ENOXAPARIN SODIUM|CEFUROXIME|CALCIUM CARBONATE|ANTACID|QUETIAPINE",17,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Diarrhoea,1,5
10503111,20141007,Pertuzumab,40,801,40.0,2,78.09,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,2,BREAST CANCER|BREAST CANCER,Hypomagnesaemia|Blood magnesium decreased,2,3
10503204,20141008,Pertuzumab,,,,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|PACLITAXEL,3,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Colitis,1,1
10503370,20141008,Pertuzumab,60,801,60.0,2,85,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER METASTATIC,Conjunctival pallor|Loss of consciousness|Pallor|Hypotension,4,1
10505022,20141008,Pertuzumab,42,801,42.0,2,98.7,1,0,1,1,0,0,0,Pertuzumab,PERTUZUMAB|PERTUZUMAB|RIZATRIPTAN|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|TRASTUZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RITUXIMAB|TRASTUZUMAB|LORAZEPAM|PACLITAXEL|RANITIDINE,17,BREAST CANCER|BREAST CANCER|CATHETER SITE PAIN|MIGRAINE|GASTROOESOPHAGEAL REFLUX DISEASE|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|COUGH|PRODUCT USED FOR UNKNOWN INDICATION|GASTROOESOPHAGEAL REFLUX DISEASE|MUSCLE SPASMS,Autoimmune haemolytic anaemia,1,1
10505605,20141008,Pertuzumab,43,801,43.0,2,69,1,0,0,0,1,0,0,Pertuzumab,"PACLITAXEL|PERTUZUMAB|TRASTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|APREPITANT|FOSAPREPITANT DIMEGLUMINE",10,BREAST CANCER|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Polyneuropathy|Ataxia|Peripheral sensory neuropathy,3,1
10505739,20141008,Pertuzumab,36,801,36.0,2,,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|CARBOPLATIN|PERTUZUMAB|PACLITAXEL,4,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Pulmonary embolism,1,1
10509075,20141009,Pertuzumab,66,801,66.0,2,85,1,0,1,0,0,0,1,Pertuzumab,VINORELBINE|TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT,Dyspnoea|Pyrexia|Dyspnoea|Hyperventilation|Blood pressure increased,5,1
10510535,20141010,Pertuzumab,71,801,71.0,2,44,1,0,1,0,0,0,1,Pertuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|BISOPROLOL FUMARATE|DALTEPARIN SODIUM|TRASTUZUMAB|HYDROCHLOROTHIAZIDE|PANTOPRAZOLE|LETROZOLE|RAMIPRIL|AMLODIPINE,16,BREAST CANCER|METASTATIC NEOPLASM|METASTATIC NEOPLASM|METASTATIC NEOPLASM|BREAST CANCER,Deep vein thrombosis|Hypotension|Blood potassium decreased|Thrombosis|Malignant neoplasm progression|Weight decreased|Diarrhoea|Urinary tract infection|Blood pressure increased|Pain|Fall|Uterine disorder|Loss of consciousness|Dyspnoea,14,1
10510976,20141010,Pertuzumab,66,801,66.0,2,,1,0,1,0,0,0,0,Pertuzumab,"PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, X-RAY, URANIUM NITRICUM|CHONDRUS CRISPUS, FUCUS VESICULOSUS, THYROIDINUM (SUIS), CADMIUM IODATUM, IODIUM, STRONTIUM CARBONICUM, X-RAY,|CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB",8,BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Gastroenteritis|Malnutrition,2,1
10512218,20141010,Pertuzumab,35,801,35.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,2,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Hand-foot-and-mouth disease|Pericarditis,2,1
10514181,20141013,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pulmonary fibrosis,1,1
10517364,20141014,Pertuzumab,60,801,60.0,2,50,1,1,1,0,0,0,0,Pertuzumab,"TRASTUZUMAB|TRASTUZUMAB|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|PACLITAXEL|FUROSEMIDE|PERTUZUMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|PERTUZUMAB",11,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Tongue neoplasm malignant stage unspecified,1,1
10518492,20141015,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Blood magnesium decreased|Diarrhoea,2,3
10520117,20141015,Pertuzumab,44,801,44.0,2,49,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB,5,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pneumonia,1,1
10520441,20141015,Pertuzumab,,,,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|PERTUZUMAB,2,BREAST CANCER,Urinary tract infection,1,5
10520473,20141015,Pertuzumab,,,,2,,1,1,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|PACLITAXEL,3,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Cardiac failure,1,1
10520689,20141015,Pertuzumab,82,801,82.0,2,,1,1,1,0,0,0,1,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Somnolence|Metastasis|Disease progression|Cerebral haemorrhage|Death,5,1
10522717,20141016,Pertuzumab,54,801,54.0,2,,1,0,1,0,0,0,0,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|TRASTUZUMAB|TRASTUZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FLUCONAZOLE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PERTUZUMAB|PERTUZUMAB|SIMVASTATIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,33,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|ANTIEMETIC SUPPORTIVE CARE|HER-2 POSITIVE BREAST CANCER|HYPOKALAEMIA|PROPHYLAXIS,Metastases to central nervous system,1,1
10525114,20141017,Pertuzumab,58,801,58.0,2,81,1,1,1,0,0,0,1,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|CLEMASTINE FUMARATE|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,31,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HYPERSENSITIVITY|NEUTROPENIA|HER-2 POSITIVE BREAST CANCER|LEUKOPENIA|PREMEDICATION|HYPOTHYROIDISM|LEUKOPENIA|NEUTROPENIA,Compression fracture|Neutropenia|Weight decreased|Leukopenia|Vomiting|Fatigue|Gait disturbance|Visual impairment|Fall|Dysarthria|Leukopenia|Disorientation|Dysstasia|Diarrhoea|Cerebral disorder|Paraesthesia|Metastases to central nervous system|Visual impairment,18,1
10525121,20141017,Pertuzumab,,,,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10525435,20141017,Pertuzumab,72,801,72.0,2,68,1,0,1,0,0,0,0,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB,12,HER-2 POSITIVE BREAST CANCER|POLYMYALGIA RHEUMATICA|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|POLYMYALGIA RHEUMATICA,Bronchitis chronic|Interstitial lung disease|Pneumonitis|Pneumonia,4,1
10525722,20141017,Pertuzumab,33,801,33.0,2,104.5,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|PERTUZUMAB|VENLAFAXINE HYDROCHLORIDE|TRASTUZUMAB,10,PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Drug dose omission|Cellulitis|Weight decreased|Dry mouth|Paraesthesia|Dental caries|Constipation|Seizure|Heart rate irregular|Malignant neoplasm progression|Heart rate increased|Heart rate increased|Diarrhoea|Infusion related reaction|Blood pressure increased|Dyspepsia|Skin lesion|Rhinorrhoea|Body temperature decreased|Sinusitis,20,3
10526332,20141019,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|VINORELBINE,3,BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT,Hyperventilation|Blood pressure increased|Dyspnoea|Pyrexia,4,3
10526976,20141020,Pertuzumab,49,801,49.0,2,68,1,0,0,0,0,0,1,Pertuzumab,BEVACIZUMAB|PERTUZUMAB|ROSUVASTATIN|TRASTUZUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|PREGABALIN,8,BREAST CANCER|HER-2 POSITIVE BREAST CANCER|BREAST CANCER,Seizure|Cough|Herpes virus infection|Urine analysis abnormal|Clostridium difficile infection|Protein urine|Urinary tract infection|Painful defaecation|Off label use|Blood magnesium decreased|Increased viscosity of bronchial secretion|Infusion related reaction,12,3
10526984,20141020,Pertuzumab,,,,2,,1,0,1,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,2,BREAST CANCER|BREAST CANCER,Appendicitis|Diarrhoea|Intestinal obstruction,3,5
10528975,20141020,Pertuzumab,42,801,42.0,0,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10531205,20141021,Pertuzumab,40,801,40.0,2,,1,0,1,0,0,0,0,Pertuzumab,"SELENIUM|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|DENOSUMAB|PERTUZUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PACLITAXEL|TRASTUZUMAB|ALBUTEROL SULFATE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE",23,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HYPOCALCAEMIA|PRODUCT USED FOR UNKNOWN INDICATION,Anaemia,1,1
10532557,20141021,Pertuzumab,37,801,37.0,2,60,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|DENOSUMAB|PERTUZUMAB|PERTUZUMAB,7,BREAST CANCER METASTATIC|BREAST CANCER|HER-2 POSITIVE BREAST CANCER|BREAST CANCER METASTATIC,Neuropathy peripheral|Viral upper respiratory tract infection|Heart rate increased|Hot flush|Musculoskeletal pain|Pyrexia|Hypotension|Heart rate increased|Thyroxine abnormal|Seasonal allergy|Conjunctival haemorrhage|Oropharyngeal pain|Pyrexia|Body temperature decreased|Thyroid function test abnormal|Back pain|Stomatitis|Epistaxis|Radiation skin injury|Cough|Rhinorrhoea|Myalgia|Hypotension|Weight decreased|Weight increased,25,3
10532847,20141022,Pertuzumab,59,801,59.0,2,33,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|TRASTUZUMAB|CAPECITABINE|TRASTUZUMAB|PERTUZUMAB|LETROZOLE|LETROZOLE TABLETS|PERTUZUMAB,8,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Gastric ulcer haemorrhage|Cardiac failure congestive,2,1
10533949,20141022,Pertuzumab,,,,2,,1,1,0,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|PACLITAXEL|LAPATINIB|CAPECITABINE|TRASTUZUMAB|ADO-TRASTUZUMAB EMTANSINE,8,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Breast cancer|Respiratory failure,2,3
10537729,20141023,Pertuzumab,50,801,50.0,2,51,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB,5,BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT,Interstitial lung disease,1,1
10538187,20141023,Pertuzumab,67,801,67.0,2,,1,0,0,0,0,0,1,Pertuzumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB",5,BREAST CANCER METASTATIC|TOOTHACHE|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Depression|Speech disorder|Blood pressure increased|Vomiting|Malaise|Urogenital prolapse|Lacrimation increased|Diarrhoea|Toothache|Abdominal discomfort|Diarrhoea|Memory impairment|Hypotension|Aura|Thinking abnormal|Tooth infection|Influenza|Oxygen saturation decreased|Laryngitis|Dysgeusia|Migraine|Mean platelet volume decreased|Muscular weakness|Stomatitis|Pruritus|Dyspnoea exertional|Palpitations,27,1
10541588,20141024,Pertuzumab,59,801,59.0,2,,1,0,1,0,0,0,1,Pertuzumab,PACLITAXEL|PERTUZUMAB|FUROSEMIDE|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN|SPIRONOLACTONE|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB,14,HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|HER-2 POSITIVE BREAST CANCER,Cardiac failure|Tongue neoplasm malignant stage unspecified|Invasive ductal breast carcinoma,3,1
10545961,20141027,Pertuzumab,49,801,49.0,2,65.5,1,0,1,0,0,0,0,Pertuzumab,CARVEDILOL|LORATADINE|LORATADINE TABLET|CLONIDINE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|LORATADINE|LORATADINE TABLET|HYDROCHLOROTHIAZIDE|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|HYDROCHLOROTHIAZIDE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE|METHYLPREDNISOLONE,20,FACE OEDEMA|HER-2 POSITIVE BREAST CANCER|OEDEMA PERIPHERAL|OEDEMA PERIPHERAL|OEDEMA PERIPHERAL|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|FACE OEDEMA|FACE OEDEMA|OEDEMA PERIPHERAL|FACE OEDEMA|ATRIAL FIBRILLATION,Ill-defined disorder|Supraventricular extrasystoles,2,1
10548506,20141028,Pertuzumab,47,801,47.0,2,,1,0,0,0,0,0,1,Pertuzumab,PACLITAXEL|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB,5,BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Neuralgia|Diarrhoea|No therapeutic response,3,3
10548549,20141028,Pertuzumab,50,801,50.0,2,,1,0,1,0,0,0,1,Pertuzumab,"PERTUZUMAB|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|BISOPROLOL FUMARATE|TRASTUZUMAB|ADO-TRASTUZUMAB EMTANSINE|ADO-TRASTUZUMAB EMTANSINE|LETROZOLE|LETROZOLE TABLETS|FULVESTRANT|IRON|LEVOTHYROXINE SODIUM",15,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Fatigue|Hepatic pain|Diarrhoea|Metastases to central nervous system|Vomiting|Dehydration|Localised infection|Dysgeusia|Ejection fraction decreased|Disease progression|Nausea,11,3
10548711,20141028,Pertuzumab,46,801,46.0,2,49.9,1,0,1,0,0,0,1,Pertuzumab,"PERTUZUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|EXTENDED PHENYTOIN SODIUM|RANITIDINE|BISOPROLOL FUMARATE|HYDROMORPHONE HYDROCHLORIDE|NABILONE|HALOPERIDOL|HALOPERIDOL LACTATE|PAROXETINE HYDROCHLORIDE|DIGOXIN|TRASTUZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS",16,HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cardiac output decreased|Breast cancer|Weight decreased|Diarrhoea|Lung disorder|Headache|Syncope|Condition aggravated|Nausea,9,5
10548901,20141028,Pertuzumab,5,800,50.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB,1,BREAST CANCER,Diarrhoea|Dehydration,2,1
10548950,20141028,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Lung infiltration|Diarrhoea|Rales,3,1
10550933,20141029,Pertuzumab,49,801,49.0,2,65.5,1,0,1,0,0,0,0,Pertuzumab,PACLITAXEL|PERTUZUMAB|CARVEDILOL|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|PERTUZUMAB|TRASTUZUMAB|CARVEDILOL|LORATADINE|LORATADINE TABLET|TRASTUZUMAB|CLONIDINE,10,BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|CONSTIPATION|BREAST CANCER|ATRIAL FIBRILLATION|OEDEMA PERIPHERAL|BREAST CANCER METASTATIC,Oedema peripheral|Atrial fibrillation|Face oedema|Supraventricular extrasystoles,4,1
10551967,20141029,Pertuzumab,57,801,57.0,2,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB,1,BREAST CANCER METASTATIC,Ventricular fibrillation|Cardiac arrest,2,1
10551970,20141029,Pertuzumab,32,801,32.0,2,62.8,1,0,1,1,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|CARBOPLATIN|PERTUZUMAB,6,INVASIVE BREAST CARCINOMA|INVASIVE BREAST CARCINOMA|INVASIVE BREAST CARCINOMA|INVASIVE BREAST CARCINOMA,Vertigo|Sinus tachycardia|Platelet count decreased,3,1
10552531,20141029,Pertuzumab,65,801,65.0,2,,1,0,0,0,0,0,0,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER|BREAST CANCER|BREAST CANCER,Skin disorder,1,1
10554295,20141030,Pertuzumab,54,801,54.0,2,,1,0,1,0,0,0,0,Pertuzumab,"DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PERTUZUMAB|INDAPAMIDE",8,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HYPOKALAEMIA,Metastases to central nervous system,1,1
10556171,20141031,Pertuzumab,42,801,42.0,2,98.8,1,0,1,0,0,0,1,Pertuzumab,"PEGFILGRASTIM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARBOPLATIN|PERTUZUMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|TRASTUZUMAB|FOSAPREPITANT|FOSAPREPITANT DIMEGLUMINE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PALONOSETRON|PALONOSETRON HYDROCHLORIDE|DOCETAXEL|DOCETAXEL ANHYDROUS|PROCHLORPERAZINE|OXYCODONE AND ACETAMINOPHEN|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|OXYCODONE AND ACETAMINOPHEN TABLETS",15,BONE PAIN,Pain|Rash,2,1
10556770,20141031,Pertuzumab,,,,2,,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|CARBOPLATIN,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Parasitic gastroenteritis|Diarrhoea|Dehydration|Neutropenia,4,1
10558762,20141031,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,FULVESTRANT|PERTUZUMAB|TRASTUZUMAB,3,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Disease progression,1,1
10558815,20141031,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Weight decreased,1,1
10558818,20141031,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,HER-2 POSITIVE BREAST CANCER,Depression|Feeling abnormal|Anxiety|Nausea,4,5
10562907,20141104,Pertuzumab,64,801,64.0,2,,1,0,1,0,0,0,0,Pertuzumab,RANITIDINE|RANITIDINE|TRASTUZUMAB|TRASTUZUMAB|DOXAZOSIN|DOXAZOSIN MESYLATE|LANSOPRAZOLE|MAGNESIUM PHOSPHATE|RANITIDINE|RANITIDINE|RANITIDINE|LISINOPRIL|NITROGLYCERIN|DOXYCYCLINE|DOXYCYCLINE HYCLATE|RANITIDINE|RANITIDINE|RANITIDINE|PERTUZUMAB|ATENOLOL|RANITIDINE|RANITIDINE|PERTUZUMAB|PACLITAXEL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CITALOPRAM|CITALOPRAM HYDROBROMIDE|RANITIDINE|ERYTHROMYCIN|IRBESARTAN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|RANITIDINE|RANITIDINE|RANITIDINE|RANITIDINE|FLUCONAZOLE,72,HER-2 POSITIVE BREAST CANCER|PREMEDICATION|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|PREMEDICATION,Urinary tract infection,1,1
10564231,20141104,Pertuzumab,68,801,68.0,2,,1,0,1,0,0,0,0,Pertuzumab,"FILGRASTIM|FUROSEMIDE|PROCHLORPERAZINE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|PERTUZUMAB|APREPITANT|RABEPRAZOLE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG",23,HER-2 POSITIVE BREAST CANCER|NEUTROPENIA|PROCTALGIA|FLUID RETENTION|NAUSEA|HER-2 POSITIVE BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLACTIC CHEMOTHERAPY|PROPHYLACTIC CHEMOTHERAPY|ARTHRALGIA|PROCTALGIA|CONSTIPATION|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLACTIC CHEMOTHERAPY|CONSTIPATION|GASTROOESOPHAGEAL REFLUX DISEASE|PRODUCT USED FOR UNKNOWN INDICATION|SINUS TACHYCARDIA|ASTHMA|HYPOTHYROIDISM|HER-2 POSITIVE BREAST CANCER|CONSTIPATION|MACULAR DEGENERATION,Febrile neutropenia|Pyrexia,2,5
10566966,20141105,Pertuzumab,,,,2,68,1,0,1,0,1,0,0,Pertuzumab,ADO-TRASTUZUMAB EMTANSINE|CAPECITABINE|TRASTUZUMAB|DENOSUMAB|PERTUZUMAB|TRASTUZUMAB|CAPECITABINE,8,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Neuropathy peripheral|Gastric disorder|Diarrhoea|Dehydration|Asthenia|Abdominal pain upper|Malaise|Headache|Abdominal discomfort|Fatigue|Dizziness|Nausea|Alopecia|Dysgeusia|Somnolence|Fall|Insomnia|Vomiting|Decreased appetite|Vision blurred|Femur fracture|Palmar-plantar erythrodysaesthesia syndrome|Gastritis,23,5
10567265,20141106,Pertuzumab,56,801,56.0,0,,1,0,1,0,0,0,0,Pertuzumab,VINORELBINE|PERTUZUMAB|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB,13,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Pruritus|Depression,2,1
10568026,20141105,Pertuzumab,,,,0,,1,0,1,1,0,0,0,Pertuzumab,TRASTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PERTUZUMAB,4,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Diastolic dysfunction|Respiratory distress,2,2
10569302,20141106,Pertuzumab,31,801,31.0,2,,1,0,1,0,0,0,0,Pertuzumab,"GOSERELIN|ENOXAPARIN SODIUM|DIPHENHYDRAMINE HYDROCHLORIDE|ERGOCALCIFEROL|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|TRASTUZUMAB|ENOXAPARIN SODIUM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|GRANISETRON|GRANISETRON HYDROCHLORIDE|PREDNISONE|ZOLEDRONIC ACID|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PERTUZUMAB|PERTUZUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE",23,BREAST CANCER|HER-2 POSITIVE BREAST CANCER|PROPHYLAXIS|HER-2 POSITIVE BREAST CANCER|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|HER-2 POSITIVE BREAST CANCER|PROPHYLAXIS|NAUSEA,Herpes zoster disseminated|Febrile neutropenia,2,1
10569528,20141106,Pertuzumab,45,801,45.0,2,,1,0,1,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|PREGABALIN|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|PAIN|PAIN|BREAST CANCER METASTATIC,Interstitial lung disease|Vomiting|Hypokalaemia|Pancytopenia|Diarrhoea|Neutropenic sepsis|Pneumonitis,7,1
10569723,20141107,Pertuzumab,52,801,52.0,2,,1,0,1,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|CARBACHOL|TRASTUZUMAB|ANASTROZOLE|DIPHENHYDRAMINE HYDROCHLORIDE|PERTUZUMAB,9,HER-2 POSITIVE BREAST CANCER|BREAST CANCER|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER,Blood creatinine increased|Carbohydrate antigen 15-3 increased|Oral herpes|Haemoglobin decreased|Tachycardia|Influenza|Nervousness|Blood urea increased|Paraesthesia|Pruritus|Drug hypersensitivity|Eye infection|Red cell distribution width increased|Mean platelet volume decreased|Diarrhoea|Breast cancer metastatic|Infusion related reaction|Pain|Peripheral swelling|Hypoaesthesia|Loss of consciousness|Mean cell haemoglobin concentration decreased|Hypotension|Carcinoembryonic antigen increased|Pain in extremity|Nasopharyngitis|Nasal neoplasm|Red blood cell count decreased|Breast pain|Haematocrit decreased|Nasopharyngitis|Hypoaesthesia,32,5
10570891,20141107,Pertuzumab,47,801,47.0,2,,1,0,1,1,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|PERTUZUMAB|TRASTUZUMAB|PACLITAXEL,5,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Intracranial pressure increased,1,1
10571295,20141107,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB,1,BREAST CANCER,Toxicity to various agents,1,1
10571435,20141107,Pertuzumab,39,801,39.0,2,,1,0,1,0,0,0,0,Pertuzumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|TRASTUZUMAB|APREPITANT|FOSAPREPITANT DIMEGLUMINE|PERTUZUMAB|PERTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARBOPLATIN|DOCETAXEL|DOCETAXEL ANHYDROUS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIPHENHYDRAMINE HYDROCHLORIDE|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB",20,NAUSEA|PREMEDICATION|PREMEDICATION|DIARRHOEA|HER-2 POSITIVE BREAST CANCER|BREAST CANCER|BREAST CANCER|PREMEDICATION|PREMEDICATION|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|PREMEDICATION|PREMEDICATION|BREAST CANCER|BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Hypokalaemia|Hypocalcaemia,2,1
10574851,20141110,Pertuzumab,,,,2,,1,1,0,0,0,0,1,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Abdominal pain upper|Sepsis,2,3
10576894,20141111,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Bronchitis,1,1
10578624,20141112,Pertuzumab,,,,2,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB|ADO-TRASTUZUMAB EMTANSINE,2,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Disease progression,1,1
10578634,20141112,Pertuzumab,74,801,74.0,2,68,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|TRASTUZUMAB|GRANISETRON|GRANISETRON HYDROCHLORIDE|EXEMESTANE|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|CANDESARTAN CILEXETIL|PREGABALIN,26,BREAST CANCER|VOMITING|VOMITING|HER-2 POSITIVE BREAST CANCER|LUNG DISORDER|VOMITING|LUNG DISORDER|VOMITING|BREAST CANCER|BREAST CANCER|LUNG DISORDER|HYPERTENSION|STOMATITIS|POLYNEUROPATHY,General physical health deterioration|Disease progression,2,1
10580756,20141113,Pertuzumab,46,801,46.0,2,88.08,1,0,1,0,0,0,0,Pertuzumab,TRASTUZUMAB|TRASTUZUMAB|PERTUZUMAB|CARBOPLATIN,5,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Blood creatine phosphokinase increased|Myalgia|Chromaturia|Rhabdomyolysis,4,1
10580935,20141113,Pertuzumab,71,801,71.0,2,,1,1,1,1,1,0,0,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|CEFTAZIDIME|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PREDNISONE|FILGRASTIM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|AMOXICILLIN|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RANITIDINE|FILGRASTIM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PERTUZUMAB|METRONIDAZOLE|METRONIDAZOLE TOPICAL,33,ABDOMINAL PAIN|DIARRHOEA|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Cholecystitis|Pneumonia,2,1
10582442,20141113,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Myocardial infarction|Hypersensitivity|Dyspnoea,3,1
10585734,20141114,Pertuzumab,60,801,60.0,2,72,1,0,1,0,0,0,1,Pertuzumab,PERTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,8,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Pathological fracture|Osteolysis,2,1
10586695,20141114,Pertuzumab,60,801,60.0,2,52.66,1,0,1,0,0,0,0,Pertuzumab,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|TRASTUZUMAB|PERTUZUMAB|PANTOPRAZOLE|FUROSEMIDE|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|CALCIUM CARBONATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DOCETAXEL|DOCETAXEL ANHYDROUS|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM",16,BREAST CANCER METASTATIC,Skin reaction|Fatigue|Asthenia,3,3
10587302,20141117,Pertuzumab,38,801,38.0,2,75.2,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,5,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|BLOOD GLUCOSE INCREASED|HER-2 POSITIVE BREAST CANCER,Vertigo|Diarrhoea|Upper extremity mass|Weight increased|Headache|Dizziness|Chest discomfort|Head discomfort|Blood glucose increased|Fatigue|Skin exfoliation,11,1
10588489,20141117,Pertuzumab,46,801,46.0,2,68,1,0,1,1,0,0,1,Pertuzumab,APREPITANT|APREPITANT|APREPITANT|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB|APREPITANT|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|APREPITANT|APREPITANT|APREPITANT|APREPITANT|PERTUZUMAB|APREPITANT|APREPITANT|APREPITANT|APREPITANT|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,50,NEUTROPENIA|NAUSEA|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|NAUSEA|NAUSEA|NAUSEA,Dizziness|Brain oedema|Confusional state|General physical health deterioration|Metastases to central nervous system,5,1
10589267,20141118,Pertuzumab,52,801,52.0,2,,1,0,1,0,0,0,1,Pertuzumab,DIPHENHYDRAMINE HYDROCHLORIDE|PERTUZUMAB|TRASTUZUMAB,4,PREMEDICATION|HER-2 POSITIVE BREAST CANCER|PREMEDICATION|BREAST CANCER,Loss of consciousness|Tachycardia|Product use issue,3,3
10589560,20141114,Pertuzumab,,,,2,,1,0,0,0,0,0,0,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,3,BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|BREAST CANCER RECURRENT,Dyspnoea|Blood pressure increased|Pyrexia|Hyperventilation,4,3
10591955,20141119,Pertuzumab,72,801,72.0,1,66,1,0,1,1,1,0,0,Pertuzumab,TRASTUZUMAB|TRASTUZUMAB|PREDNISONE|GABAPENTIN|METHYLPREDNISOLONE SODIUM SUCCINATE|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|PREDNISONE,19,HER-2 POSITIVE BREAST CANCER|NAUSEA|PROPHYLAXIS|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|NAUSEA|HYPERSENSITIVITY|GANGRENE,Gangrene|Osteomyelitis,2,1
10595301,20141120,Pertuzumab,33,801,33.0,2,,1,0,1,1,0,0,0,Pertuzumab,CEFTRIAXONE|CEFTRIAXONE SODIUM|TRASTUZUMAB|PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE,8,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Interstitial lung disease,1,1
10597085,20141121,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression,1,5
10597265,20141121,Pertuzumab,59,801,59.0,2,,1,0,1,0,0,0,0,Pertuzumab,CARBOPLATIN|PERTUZUMAB|PACLITAXEL|TRASTUZUMAB|PERTUZUMAB|TRASTUZUMAB,6,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Hypophosphataemia|Hypomagnesaemia|Hypocalcaemia|Dehydration,4,1
10597291,20141121,Pertuzumab,74,801,74.0,2,79,1,0,1,0,0,0,0,Pertuzumab,LORATADINE|LORATADINE ORAL|OXYCODONE HYDROCHLORIDE|PERTUZUMAB|TRASTUZUMAB|PERTUZUMAB|FUROSEMIDE,17,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Vomiting|Dermatitis bullous,2,1
10597295,20141121,Pertuzumab,,,,1,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hepatic enzyme increased,1,3
10597721,20141121,Pertuzumab,,,,0,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Febrile neutropenia|Cardiotoxicity,2,1
10600151,20141122,Pertuzumab,,,,0,,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Upper gastrointestinal haemorrhage,1,1
10600152,20141122,Pertuzumab,,,,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Loss of consciousness,1,5
10601813,20141124,Pertuzumab,71,801,71.0,2,,1,1,1,1,1,0,0,Pertuzumab,DOCETAXEL|DOCETAXEL ANHYDROUS|TRASTUZUMAB|TRASTUZUMAB|FILGRASTIM|PERTUZUMAB|PERTUZUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|PREDNISONE|PERTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FILGRASTIM|DOCETAXEL|DOCETAXEL ANHYDROUS|RANITIDINE,20,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Cholecystitis|Blood bilirubin increased|Aspartate aminotransferase increased|Pneumonia,4,1
10602411,20141124,Pertuzumab,,,,2,,1,1,0,0,0,0,0,Pertuzumab,PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|PERTUZUMAB,4,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Tachycardia|Rectal haemorrhage|Hypotension,3,1
10607637,20141124,Pertuzumab,62,801,62.0,2,47.6,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|ZOLEDRONIC ACID,4,BREAST CANCER METASTATIC,Palmar-plantar erythrodysaesthesia syndrome,1,2
10608328,20141125,Pertuzumab,44,801,44.0,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|LAPATINIB|MORPHINE|PERTUZUMAB|PREGABALIN,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Hypersensitivity|Pain|Diarrhoea,4,3
10609206,20141126,Pertuzumab,51,801,51.0,2,,1,0,0,1,0,0,0,Pertuzumab,DEXAMETHASONE SODIUM PHOSPHATE|DIPHENHYDRAMINE HCL|DIPHENHYDRAMINE HYDROCHLORIDE|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|PACLITAXEL|CIMETIDINE|PERTUZUMAB|TRASTUZUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,12,BREAST CANCER|BREAST CANCER|BREAST CANCER,Neutrophil count decreased,1,5
10611495,20141126,Pertuzumab,48,801,48.0,2,,1,0,0,0,0,0,1,Pertuzumab,ADO-TRASTUZUMAB EMTANSINE|PERTUZUMAB|TRASTUZUMAB,4,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Cardiotoxicity,1,1
10611539,20141126,Pertuzumab,58,801,58.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|TRASTUZUMAB,3,BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC,Cardiotoxicity,1,1
10612034,20141126,Pertuzumab,48,801,48.0,2,60,1,0,1,0,0,0,0,Pertuzumab,PERTUZUMAB|PERTUZUMAB,5,HER-2 POSITIVE BREAST CANCER|PROPHYLAXIS|HER-2 POSITIVE BREAST CANCER,Anaemia|Endometrial hypertrophy,2,1
10612225,20141127,Pertuzumab,61,801,61.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|CAPECITABINE|FULVESTRANT|TRASTUZUMAB|TRASTUZUMAB,6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Cardiotoxicity,1,1
10612253,20141127,Pertuzumab,57,801,57.0,2,,1,0,0,0,0,0,1,Pertuzumab,CAPECITABINE|ANASTROZOLE|PERTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|TRASTUZUMAB|FULVESTRANT|TRASTUZUMAB,9,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Cardiotoxicity,1,1
10612266,20141127,Pertuzumab,72,801,72.0,2,,1,0,0,0,0,0,1,Pertuzumab,PERTUZUMAB|CAPECITABINE|TRASTUZUMAB|TRASTUZUMAB|FULVESTRANT|TRASTUZUMAB,8,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Cardiotoxicity|Rash,2,1
10613190,20141128,Pertuzumab,65,801,65.0,2,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|TRASTUZUMAB|PERTUZUMAB|PERTUZUMAB|TRASTUZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS,8,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Pneumonia|Rash|Cough,3,2
10613308,20141128,Pertuzumab,,,,0,,1,0,0,0,0,0,1,Pertuzumab,TRASTUZUMAB|PERTUZUMAB|PACLITAXEL,3,HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER|HER-2 POSITIVE BREAST CANCER,Oedema peripheral|Asthenia|Neutropenia|Alopecia|Mucosal inflammation|Febrile neutropenia|Diarrhoea,7,1
10005517,20140313,Panitumumab,77,801,77.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,COLON CANCER|METASTASES TO LIVER,Spinal cord compression|Back pain|Conjunctivitis,3,5
10017097,20140318,Panitumumab,82,801,82.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,NEOPLASM MALIGNANT,Paronychia,1,2
10023349,20140320,Panitumumab,74,801,74.0,1,77,1,0,0,0,0,0,0,Panitumumab,DEXTROSE ANHYDROUS|PANITUMUMAB|PANITUMUMAB|PANITUMUMAB|PANITUMUMAB,17,PROPHYLAXIS|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|PROPHYLAXIS,Pruritus|Rash|Flushing|Stomatitis|Paronychia,5,2
10023362,20140320,Panitumumab,76,801,76.0,2,45,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|PANITUMUMAB|PANITUMUMAB|OXALIPLATIN|GRANISETRON|GRANISETRON HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE,16,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Muscular weakness|Hypoaesthesia,2,2
10023365,20140320,Panitumumab,88,801,88.0,1,,1,1,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Lung neoplasm malignant|Acute respiratory failure,2,3
10026249,20140320,Panitumumab,62,801,62.0,2,39,1,0,1,0,0,0,1,Panitumumab,"PANITUMUMAB|PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",5,RECTOSIGMOID CANCER|RECTOSIGMOID CANCER|RECTOSIGMOID CANCER|RECTOSIGMOID CANCER,Gastrointestinal perforation,1,1
10026278,20140320,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN",4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Skin toxicity|Nail disorder,2,5
10026681,20140321,Panitumumab,82,801,82.0,1,71,1,0,0,1,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB|LORATADINE|LORATADINE TABLET|AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM|AMLODIPINE AND ATORVASTATIN|ESOMEPRAZOLE MAGNESIUM,8,COLORECTAL CANCER RECURRENT|METASTASES TO LIVER,Interstitial lung disease,1,2
10026705,20140321,Panitumumab,88,801,88.0,1,55.5,1,1,0,0,0,0,0,Panitumumab,"OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|SITAGLIPTIN|ENTECAVIR|PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",16,ANGINA PECTORIS|COLON CANCER|HYPERTENSION|OSTEOPOROSIS|COLON CANCER|COLON CANCER|COLON CANCER|TYPE 2 DIABETES MELLITUS|ANGINA PECTORIS|INSOMNIA|CHRONIC HEPATITIS B|METASTASES TO LIVER|TYPE 2 DIABETES MELLITUS|METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LIVER,Sudden death|Palmar-plantar erythrodysaesthesia syndrome,2,2
10031022,20140324,Panitumumab,54,801,54.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,3,COLON CANCER|METASTASES TO LIVER,Hepatic neoplasm|Metastases to stomach|Haematology test abnormal|Rash,4,5
10031417,20140324,Panitumumab,,,,0,,1,1,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Abdominal pain|Rash|Constipation,3,1
10031543,20140324,Panitumumab,,,,0,,1,0,0,1,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Hypokalaemia|Anaemia,2,3
10031558,20140324,Panitumumab,69,801,69.0,1,,1,1,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Condition aggravated|Anaemia,2,1
10032274,20140324,Panitumumab,76,801,76.0,2,84,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,6,OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|HYPOKALAEMIA|RASH,Neutropenia,1,3
10033125,20140324,Panitumumab,,,,0,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Rash|Conjunctivitis,2,3
10033128,20140324,Panitumumab,,,,0,,1,0,0,1,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Rash,1,1
10035952,20140325,Panitumumab,67,801,67.0,2,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB|PANITUMUMAB|CAPECITABINE|CAPECITABINE|CAPECITABINE,7,COLON CANCER METASTATIC|METASTASES TO LIVER|COLON CANCER METASTATIC|METASTASES TO LIVER|METASTASES TO LUNG,Respiratory arrest|Metastases to lung,2,5
10037506,20140326,Panitumumab,,,,0,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Liver disorder,1,1
10038645,20140326,Panitumumab,64,801,64.0,1,120,1,0,1,0,0,0,1,Panitumumab,OXALIPLATIN|PANITUMUMAB|CETUXIMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,10,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Contusion|Petechiae|Epistaxis|Thrombocytopenia,4,5
10040100,20140326,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Stevens-Johnson syndrome|Diabetes mellitus|Psoriasis,3,5
10040177,20140326,Panitumumab,83,801,83.0,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,RECTAL CANCER,Urinary tract infection|General physical health deterioration|Diarrhoea|Vomiting,4,5
10040228,20140327,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Haemodialysis,1,1
10040231,20140327,Panitumumab,41,801,41.0,2,59,1,0,1,0,0,0,1,Panitumumab,PANITUMUMAB|MITOMYCIN|CAPECITABINE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE,5,ANAL CANCER|ANAL CANCER|ANAL CANCER|DERMATITIS|DIARRHOEA,Febrile neutropenia|Diarrhoea,2,3
10040234,20140327,Panitumumab,47,801,47.0,1,62,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|METHOTREXATE|METHOTREXATE SODIUM|DOXORUBICIN|CISPLATIN|CAPSAICIN,9,TRANSITIONAL CELL CARCINOMA|TRANSITIONAL CELL CARCINOMA|TRANSITIONAL CELL CARCINOMA|TRANSITIONAL CELL CARCINOMA|TRANSITIONAL CELL CARCINOMA|PROPHYLAXIS,Vomiting|Decreased appetite,2,1
10040568,20140327,Panitumumab,75,801,75.0,2,75,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Pyrexia|Tremor|Chills|Cough,5,1
10041547,20140325,Panitumumab,,,,0,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB,2,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Sudden death,1,3
10045997,20140330,Panitumumab,,,,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Ulcer haemorrhage|Rash,2,5
10045999,20140330,Panitumumab,43,801,43.0,2,49,1,0,0,1,0,0,0,Panitumumab,"PANITUMUMAB|IRINOTECAN HYDROCHLORIDE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",5,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|METASTASES TO BONE,Interstitial lung disease,1,1
10047485,20140331,Panitumumab,24,801,24.0,0,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|MIRTAZAPINE|MINOCYCLINE,5,COLORECTAL CANCER|COLORECTAL CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Anaemia|Colonic fistula|Small intestinal obstruction,3,1
10048063,20140331,Panitumumab,66,801,66.0,1,40,1,0,1,0,0,0,1,Panitumumab,"PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",16,GASTRIC ULCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|DIARRHOEA|ABDOMINAL PAIN UPPER|DIARRHOEA|DIARRHOEA|WOUND COMPLICATION|INSOMNIA,Neutropenia|Renal failure acute|Diarrhoea,3,2
10051818,20140402,Panitumumab,24,801,24.0,0,98.34,1,0,1,0,0,0,1,Panitumumab,PANITUMUMAB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|MIRTAZAPINE|MINOCYCLINE,5,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Anaemia|Small intestinal obstruction|Colonic fistula,3,3
10052182,20140402,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB|OXALIPLATIN|OXALIPLATIN,8,COLORECTAL CANCER METASTATIC|METASTASES TO LIVER|COLORECTAL CANCER METASTATIC|METASTASES TO LIVER|COLORECTAL CANCER METASTATIC|METASTASES TO LIVER|COLORECTAL CANCER METASTATIC|METASTASES TO LIVER,Rash,1,5
10055222,20140403,Panitumumab,75,801,75.0,2,70,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,OESOPHAGEAL ADENOCARCINOMA,Neutropenia,1,3
10055768,20140403,Panitumumab,66,801,66.0,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|CETUXIMAB,6,ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON,Lip oedema|Hypertension|Tachycardia|Hypersensitivity|Pyrexia|Chills,6,3
10061306,20140407,Panitumumab,60,801,60.0,1,,1,0,1,0,0,0,0,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN",4,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Intestinal obstruction|Mucosal inflammation|Hypomagnesaemia,3,3
10063755,20140408,Panitumumab,64,801,64.0,1,59,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|TRAMETINIB|DABRAFENIB,3,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Pyrexia,1,1
10066200,20140408,Panitumumab,11,801,11.0,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,NEOPLASM,Hypoxia,1,3
10070005,20140409,Panitumumab,60,801,60.0,1,100.7,1,1,0,1,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Dyspnoea|Mental status changes|Aspiration|Infection|Pulmonary embolism,5,2
10071644,20140411,Panitumumab,75,801,75.0,2,86,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",6,OESOPHAGEAL ADENOCARCINOMA METASTATIC|OESOPHAGEAL ADENOCARCINOMA METASTATIC|OESOPHAGEAL ADENOCARCINOMA METASTATIC|OESOPHAGEAL ADENOCARCINOMA METASTATIC|HYPOKALAEMIA|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER,Diarrhoea,1,3
10072789,20140411,Panitumumab,67,801,67.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Upper limb fracture|Neuropathy peripheral|Fall,3,5
10073539,20140411,Panitumumab,71,801,71.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Scab,1,5
10077786,20140414,Panitumumab,66,801,66.0,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Procedural pain,1,3
10077856,20140414,Panitumumab,,,,0,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10077858,20140414,Panitumumab,,,,1,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10077868,20140414,Panitumumab,7,800,70.0,1,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLON CANCER,Infusion related reaction,1,1
10078310,20140415,Panitumumab,87,801,87.0,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Enteritis infectious|Depressed level of consciousness|Vomiting,3,1
10078713,20140415,Panitumumab,51,801,51.0,2,113,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|CARBOPLATIN|RAMIPRIL|AMLODIPINE|OXYCODONE,8,OVARIAN CANCER RECURRENT|OVARIAN CANCER RECURRENT|OVARIAN CANCER RECURRENT|HYPERTENSION|HYPERTENSION|HYPERTENSION|PROPHYLAXIS|PAIN,Thrombocytopenia,1,1
10080601,20140416,Panitumumab,60,801,60.0,2,,1,1,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death|Chest discomfort|Cough|Dysphonia,4,1
10084264,20140417,Panitumumab,43,801,43.0,0,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|SIMVASTATIN|MINOCYCLINE,3,COLON CANCER METASTATIC,Nausea|Haematemesis,2,3
10084779,20140417,Panitumumab,48,801,48.0,1,76,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB|DENOSUMAB|FOLIC ACID,7,COLORECTAL CANCER METASTATIC|METASTASES TO BONE|METASTASES TO BONE|PRODUCT USED FOR UNKNOWN INDICATION|COLORECTAL CANCER METASTATIC|METASTASES TO BONE,Rash maculo-papular|Rash pruritic|Superinfection,3,5
10085469,20140418,Panitumumab,66,801,66.0,1,48.5,1,0,0,1,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB|PANITUMUMAB,12,METASTASES TO LIVER|METASTASES TO LUNG|COLON CANCER|COLON CANCER|METASTASES TO LIVER|METASTASES TO LIVER|COLON CANCER|METASTASES TO LUNG|METASTASES TO LUNG|METASTASES TO LUNG|COLON CANCER|METASTASES TO LIVER,Interstitial lung disease,1,1
10085668,20140418,Panitumumab,55,801,55.0,1,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB|FILGRASTIM|DARBEPOETIN ALFA,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10090285,20140421,Panitumumab,42,801,42.0,1,119.8,1,1,1,0,0,0,1,Panitumumab,PANITUMUMAB|MINOCYCLINE|PREDNISONE,5,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|PAIN,Pneumonia|Malignant neoplasm progression|Renal failure acute|Pulmonary embolism,4,3
10094475,20140422,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Skin toxicity,1,3
10094479,20140422,Panitumumab,70,801,70.0,2,48,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,4,COLON CANCER,Dermatitis|Conjunctivitis|Rash,3,1
10097339,20140423,Panitumumab,72,801,72.0,2,84,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|CARBOPLATIN,3,OVARIAN CANCER RECURRENT|OVARIAN CANCER RECURRENT|OVARIAN CANCER RECURRENT,Anaemia,1,1
10097390,20140423,Panitumumab,63,801,63.0,1,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Dermatitis acneiform,1,1
10097467,20140423,Panitumumab,66,801,66.0,2,84,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|CARBOPLATIN|CALCIUM|METOPROLOL TARTRATE|METOPROLOL|RIVAROXABAN,9,SQUAMOUS CELL CARCINOMA OF LUNG|SQUAMOUS CELL CARCINOMA OF LUNG|SQUAMOUS CELL CARCINOMA OF LUNG,Atrial fibrillation,1,1
10101113,20140424,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Blood magnesium decreased|Blood potassium decreased|Blood calcium decreased,3,2
10101896,20140424,Panitumumab,70,801,70.0,2,56,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|ERYTHROMYCIN,3,COLORECTAL CANCER|COLORECTAL CANCER,Renal failure acute,1,1
10103614,20140424,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Skin toxicity|Rash,2,5
10136223,20140429,Panitumumab,75,801,75.0,1,100,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|CAPECITABINE,3,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Musculoskeletal pain|Upper limb fracture|Pleural effusion|Condition aggravated|Metastases to bone|Metastases to liver|Pain|Metastases to lung|Rash|Medication error,10,5
10141603,20140429,Panitumumab,42,801,42.0,2,38,1,0,1,0,0,0,1,Panitumumab,PANITUMUMAB|DABRAFENIB|DABRAFENIB|DABRAFENIB,4,COLORECTAL CANCER|COLORECTAL CANCER,Diarrhoea haemorrhagic|Pyrexia,2,1
10142250,20140430,Panitumumab,52,801,52.0,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLON CANCER,Pneumothorax,1,2
10144029,20140430,Panitumumab,70,801,70.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|BISOPROLOL FUMARATE,5,COLORECTAL CANCER METASTATIC|DIABETES MELLITUS,Stoma site haemorrhage|Skin fragility|Skin fissures,3,5
10144982,20140501,Panitumumab,42,801,42.0,2,38,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|DABRAFENIB|DABRAFENIB|DABRAFENIB,4,COLORECTAL CANCER|COLORECTAL CANCER,Pyrexia|Diarrhoea haemorrhagic,2,1
10145037,20140501,Panitumumab,39,801,39.0,1,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10151892,20140505,Panitumumab,81,801,81.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Hypomagnesaemia,1,2
10151976,20140505,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Pneumomediastinum,1,3
10154050,20140506,Panitumumab,42,801,42.0,1,119.8,1,0,1,0,0,0,1,Panitumumab,"PANITUMUMAB|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|MINOCYCLINE|PREDNISONE",5,COLORECTAL CANCER METASTATIC|PAIN|COLORECTAL CANCER METASTATIC,Pulmonary embolism|Pneumonia|Acute kidney injury,3,3
10166067,20140512,Panitumumab,63,801,63.0,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Dermatitis acneiform,1,1
10168661,20140513,Panitumumab,,,,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Skin reaction|Abscess|Acne,3,5
10170624,20140514,Panitumumab,52,801,52.0,2,69.8,1,0,1,0,0,0,0,Panitumumab,"PANITUMUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|TEMAZEPAM|EVEROLIMUS|EVEROLIMUS TABLETS|ROSUVASTATIN|LORAZEPAM",10,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|PROPHYLAXIS|HYPERCHOLESTEROLAEMIA|DEPRESSION,Dysarthria,1,1
10173174,20140425,Panitumumab,74,801,74.0,2,60,1,0,0,0,0,0,1,Panitumumab,VEMURAFENIB,2,COLON CANCER,Malaise|Fatigue|Alanine aminotransferase increased|Aspartate aminotransferase increased,4,1
10177211,20140516,Panitumumab,68,801,68.0,1,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Skin exfoliation,1,3
10178296,20140519,Panitumumab,7,800,70.0,1,70,1,1,0,1,0,0,1,Panitumumab,PANITUMUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|OXALIPLATIN,8,COLON CANCER|COLON CANCER|HICCUPS|MALAISE|COLON CANCER|PAIN MANAGEMENT|COLON CANCER,Interstitial lung disease|Colon cancer,2,1
10179131,20140519,Panitumumab,61,801,61.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|CAPECITABINE|PANITUMUMAB|BEVACIZUMAB|CAPECITABINE|BEVACIZUMAB|BEVACIZUMAB,16,METASTASES TO LIVER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LIVER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|METASTASES TO LIVER|METASTASES TO LIVER,Stomatitis|Decreased appetite|Neuropathy peripheral|Muscular weakness|Diarrhoea|Malaise,6,1
10181448,20140519,Panitumumab,71,801,71.0,1,57.2,1,1,1,1,0,0,1,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|FUROSEMIDE|SPIRONOLACTONE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",13,COLON CANCER|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|COLON CANCER|COLON CANCER|COLON CANCER,Interstitial lung disease|Pneumocystis jirovecii pneumonia|Pneumomediastinum,3,1
10182116,20140520,Panitumumab,68,801,68.0,1,66.7,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|PACLITAXEL,2,HEAD AND NECK CANCER|HEAD AND NECK CANCER,Neutropenia|Skin ulcer|Dyspnoea,3,3
10183790,20140520,Panitumumab,66,801,66.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Skin toxicity|Scab|Rash papular,3,5
10184430,20140521,Panitumumab,11,801,11.0,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,NEOPLASM,Pleural effusion|Hypoxia,2,3
10185065,20140521,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,"BEVACIZUMAB|PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",6,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Skin toxicity|Diarrhoea|Mucosal inflammation|Neutropenia|Pulmonary embolism|Hypomagnesaemia|Hypertension|Haemorrhage|Embolism arterial|Embolism venous|Proteinuria|Infusion related reaction,12,3
10185233,20140521,Panitumumab,49,801,49.0,2,60,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",10,PRODUCT USED FOR UNKNOWN INDICATION|OVARIAN CANCER METASTATIC|HEPATIC CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|OVARIAN CANCER METASTATIC|HEPATIC CANCER METASTATIC|OVARIAN CANCER METASTATIC|COLORECTAL CANCER METASTATIC|HEPATIC CANCER METASTATIC,Tongue oedema|Pruritus generalised|Respiratory tract oedema|Dyspnoea|Oral mucosa erosion|Lip oedema|Rash pruritic|Rash papular|Rash,9,3
10189958,20140522,Panitumumab,73,801,73.0,1,44,1,1,0,0,0,0,1,Panitumumab,ESOMEPRAZOLE MAGNESIUM|SENNOSIDES|SENNA LEAF|SENNA|PANITUMUMAB,11,PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Interstitial lung disease,1,1
10190001,20140522,Panitumumab,65,801,65.0,1,69.5,1,1,1,1,0,0,1,Panitumumab,"CETUXIMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|CETUXIMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB",11,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Interstitial lung disease|Pneumocystis jirovecii pneumonia|Paronychia|Skin disorder,4,1
10190614,20140523,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,4,COLORECTAL CANCER METASTATIC|SKIN REACTION|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Abdominal discomfort|Acne|Scar|Malaise|Drug interaction|Skin reaction|Drug dose omission|Skin exfoliation|Rash pustular|Dermatitis acneiform|Carcinoembryonic antigen increased|Face oedema|Skin discolouration|Hepatic neoplasm|Ephelides|Rhinalgia|Pruritus|Bowel movement irregularity|Drug hypersensitivity,19,1
10192151,20140523,Panitumumab,70,801,70.0,1,72,1,0,0,0,0,0,1,Panitumumab,OXALIPLATIN|PANITUMUMAB,5,ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON,Lung disorder|Pleural effusion|Pulmonary embolism,3,1
10194783,20140526,Panitumumab,80,801,80.0,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Vulvovaginal mycotic infection|Abdominal pain upper,2,5
10194937,20140526,Panitumumab,65,801,65.0,1,80,1,0,1,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Hypersensitivity,1,5
10195319,20140526,Panitumumab,66,801,66.0,1,,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Neurotoxicity|Rash|Paronychia,3,1
10195327,20140526,Panitumumab,54,801,54.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|BEVACIZUMAB,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Neoplasm|Metastases to lung|Diarrhoea|Weight decreased|Constipation|Rash pustular|Mobility decreased|Malaise|Vomiting|Dermatitis infected|Skin discolouration|Rash|Acne|Alopecia|Therapeutic response decreased,15,1
10200351,20140528,Panitumumab,73,801,73.0,1,75,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|DOXAZOSIN|DOXAZOSIN MESYLATE|FUROSEMIDE,6,RECTAL CANCER|CONGESTIVE CARDIOMYOPATHY|CONGESTIVE CARDIOMYOPATHY|CONGESTIVE CARDIOMYOPATHY|CONGESTIVE CARDIOMYOPATHY,Biliary dilatation|Aspartate aminotransferase increased|Alanine aminotransferase increased|Gamma-glutamyltransferase increased|Blood bilirubin increased|Blood lactate dehydrogenase increased|Blood alkaline phosphatase|Hepatic enzyme increased|Pulmonary mass|Renal cyst|Paratracheal lymphadenopathy,11,5
10200357,20140528,Panitumumab,72,801,72.0,2,80,1,1,1,0,0,0,0,Panitumumab,DOXYCYCLINE|DOXYCYCLINE HYCLATE|CARBOPLATIN|PANITUMUMAB,4,PROPHYLAXIS|OVARIAN CANCER RECURRENT|OVARIAN CANCER RECURRENT|OVARIAN CANCER RECURRENT,Vomiting,1,1
10200484,20140528,Panitumumab,7,800,70.0,1,,1,1,0,0,0,0,1,Panitumumab,PANITUMUMAB,2,COLON CANCER|COLON CANCER,Interstitial lung disease|Colon cancer,2,1
10200851,20140528,Panitumumab,70,801,70.0,2,65,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER METASTATIC,Herpes virus infection|Stomatitis,2,5
10200852,20140528,Panitumumab,70,801,70.0,2,60,1,0,1,1,0,0,0,Panitumumab,GRANISETRON|GRANISETRON HYDROCHLORIDE|PANITUMUMAB,7,NEURALGIA|COLON CANCER STAGE IV|ARRHYTHMIA|PREMEDICATION|COLON CANCER STAGE IV|CANCER PAIN|PREMEDICATION,Loss of consciousness|Respiratory arrest|Laryngeal discomfort|Anaphylactic reaction|Hypotension|Vomiting|Pruritus,7,3
10205740,20140530,Panitumumab,75,801,75.0,1,,1,0,1,0,0,0,0,Panitumumab,CISPLATIN|PANITUMUMAB|CAPECITABINE,4,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Anastomotic complication,1,1
10205764,20140530,Panitumumab,75,801,75.0,2,55,1,0,1,0,0,0,0,Panitumumab,MAGNESIUM|PANITUMUMAB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|CARBOPLATIN,8,DERMATITIS|HYPOMAGNESAEMIA|DERMATITIS|OVARIAN CANCER|DERMATITIS|ANALGESIC THERAPY|OVARIAN CANCER|OVARIAN CANCER,Superinfection|Dermatitis acneiform,2,1
10209346,20140531,Panitumumab,56,801,56.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE,8,GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|DIARRHOEA|DIARRHOEA|DIARRHOEA,Folliculitis,1,3
10210928,20140602,Panitumumab,36,801,36.0,1,56.6,1,1,1,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Death|Rash|Xerophthalmia|Dyspnoea|Investigation,5,5
10213021,20140603,Panitumumab,74,801,74.0,1,109,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,NEOPLASM MALIGNANT,Infusion related reaction,1,1
10213123,20140603,Panitumumab,67,801,67.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Interstitial lung disease|Diarrhoea,2,3
10213130,20140603,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|IRINOTECAN HYDROCHLORIDE,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Interstitial lung disease,1,1
10214602,20140603,Panitumumab,43,801,43.0,1,,1,0,1,0,0,0,0,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|FOLIC ACID|ALPRAZOLAM|PANITUMUMAB|APREPITANT|FOSAPREPITANT DIMEGLUMINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FOLIC ACID|OXALIPLATIN|CETUXIMAB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE",20,HYPERSENSITIVITY|PREMEDICATION|PREMEDICATION,Jaundice|Serum ferritin increased|Chills|Thrombocytopenia|Leukopenia|Histiocytosis haematophagic|Blood bilirubin increased,7,3
10215574,20140604,Panitumumab,,,,2,,1,1,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Death|Pneumatosis intestinalis,2,1
10218649,20140605,Panitumumab,,,,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Convulsion,1,5
10220188,20140605,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Disease progression,1,1
10220580,20140606,Panitumumab,,,,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Hypersensitivity|Tachycardia|Flushing|Chest pain,4,3
10220583,20140606,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Anaphylactic reaction,1,3
10220786,20140606,Panitumumab,36,801,36.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Skin toxicity|Rash|Back pain|Oropharyngeal pain|Chest pain,5,5
10223312,20140609,Panitumumab,71,801,71.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|CAPECITABINE,4,RECTAL CANCER,Dermatitis acneiform,1,3
10224485,20140609,Panitumumab,54,801,54.0,2,57.1,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|EVEROLIMUS|EVEROLIMUS,9,COLORECTAL CANCER METASTATIC|PROPHYLAXIS|COLORECTAL CANCER METASTATIC|PLEURAL EFFUSION|OEDEMA PERIPHERAL|COLORECTAL CANCER METASTATIC|PAIN,Pleural effusion|Rectal haemorrhage|Pulmonary embolism|Abdominal pain,4,1
10229392,20140611,Panitumumab,,,,2,,1,0,1,0,0,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN",5,COLON CANCER METASTATIC,Abscess limb,1,5
10231086,20140611,Panitumumab,61,801,61.0,1,93.6,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Skin toxicity|Keratitis|Rash pustular|Punctate keratitis|Corneal dystrophy|Blister|Mucosal erosion|Rash|Pain of skin|Conjunctivitis|Pruritus|Visual acuity reduced|Conjunctival hyperaemia,13,5
10231120,20140611,Panitumumab,69,801,69.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Metastases to liver|Blood magnesium decreased,2,5
10231855,20140612,Panitumumab,56,801,56.0,1,65,1,0,1,0,0,0,0,Panitumumab,OXALIPLATIN|PANITUMUMAB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,12,BILE DUCT CANCER|HYPERTENSION|PROPHYLAXIS|PULMONARY EMBOLISM|BILE DUCT CANCER|BILE DUCT CANCER|BILIARY TRACT DISORDER|DEPRESSION|HYPERTENSION|POLIOMYELITIS|PROPHYLAXIS|PROPHYLAXIS,Interstitial lung disease,1,1
10234182,20140612,Panitumumab,54,801,54.0,1,106.8,1,0,1,0,0,0,1,Panitumumab,TRAMETINIB|DABRAFENIB|OLMESARTAN MEDOXOMIL|DABRAFENIB|PANITUMUMAB,5,COLORECTAL CANCER|HYPERTENSION|COLORECTAL CANCER|COLORECTAL CANCER,Acute kidney injury,1,1
10234534,20140613,Panitumumab,70,801,70.0,2,,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN",4,GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER,White blood cell count abnormal,1,3
10234969,20140613,Panitumumab,73,801,73.0,1,57,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,11,PROPHYLAXIS OF NAUSEA AND VOMITING|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|PROPHYLAXIS OF NAUSEA AND VOMITING|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|PROPHYLAXIS OF NAUSEA AND VOMITING,Duodenal ulcer,1,1
10236441,20140613,Panitumumab,43,801,43.0,1,,1,0,1,0,0,0,1,Panitumumab,LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ALPRAZOLAM|CETUXIMAB|PANITUMUMAB|FOLIC ACID|OXALIPLATIN|APREPITANT|FOSAPREPITANT DIMEGLUMINE,18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PREMEDICATION|HYPERSENSITIVITY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Thrombocytopenia|Histiocytosis haematophagic|Serum ferritin increased|Jaundice|Leukopenia|Chills|Blood bilirubin increased,7,5
10237385,20140614,Panitumumab,64,801,64.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,RECTAL CANCER RECURRENT,Hypomagnesaemia,1,2
10237388,20140614,Panitumumab,52,801,52.0,1,,1,0,0,0,0,0,1,Panitumumab,IRINOTECAN HYDROCHLORIDE|PANITUMUMAB,2,ANAL CANCER RECURRENT|ANAL CANCER RECURRENT,Hypomagnesaemia,1,2
10237730,20140616,Panitumumab,62,801,62.0,2,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10240593,20140617,Panitumumab,61,801,61.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Heat stroke|Skin toxicity,2,3
10242838,20140618,Panitumumab,85,801,85.0,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|CAPECITABINE,2,PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Urinary tract infection,2,3
10242850,20140618,Panitumumab,54,801,54.0,1,,1,0,1,0,0,0,0,Panitumumab,METHYLPREDNISOLONE SODIUM SUCCINATE|CALCIUM GLUCONATE|PANITUMUMAB|METRONIDAZOLE|METRONIDAZOLE TOPICAL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN,15,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Cholangitis,1,3
10245534,20140619,Panitumumab,74,801,74.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN|FOLIC ACID,5,GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER,Rash,1,3
10245541,20140619,Panitumumab,73,801,73.0,1,71,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,5,GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER,Stomatitis,1,3
10245555,20140619,Panitumumab,73,801,73.0,1,79,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,5,GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER,Rash,1,3
10245560,20140619,Panitumumab,73,801,73.0,1,61,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,5,GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER,Neutropenia,1,3
10245707,20140619,Panitumumab,73,801,73.0,1,65,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,5,GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER,Rash,1,3
10248107,20140619,Panitumumab,7,800,70.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Nephrotic syndrome,1,1
10250175,20140620,Panitumumab,60,801,60.0,1,111.11,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|FENOFIBRATE|LISINOPRIL|SPIRONOLACTONE|WARFARIN SODIUM|WARFARIN|TRAZODONE HYDROCHLORIDE|LENALIDOMIDE|ACYCLOVIR|METAXALONE|CYCLOBENZAPRINE|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|LOVASTATIN|INSULIN ASPART|INSULIN GLARGINE,19,CEREBROVASCULAR ACCIDENT PROPHYLAXIS,Deep vein thrombosis,1,3
10251440,20140623,Panitumumab,63,801,63.0,1,73,1,0,1,0,0,0,0,Panitumumab,OXALIPLATIN|PANITUMUMAB,12,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|DIARRHOEA|GASTROOESOPHAGEAL REFLUX DISEASE|HYPOKALAEMIA|COLORECTAL CANCER METASTATIC|DIARRHOEA|INFECTION PROPHYLAXIS|INSOMNIA|COLORECTAL CANCER METASTATIC,Febrile neutropenia,1,1
10251923,20140623,Panitumumab,,,,1,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Malaise,1,2
10254685,20140624,Panitumumab,73,801,73.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Skin reaction|Dermatitis acneiform,2,1
10254913,20140624,Panitumumab,30,801,30.0,1,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Stomatitis,1,3
10255174,20140624,Panitumumab,81,801,81.0,2,44.8,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|PANITUMUMAB|PANITUMUMAB,8,PROPHYLAXIS|COLON CANCER|METASTASES TO LIVER|PRURITUS,Drug hypersensitivity|Acne|Alopecia,3,1
10255219,20140624,Panitumumab,58,801,58.0,1,78,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB|AMLODIPINE BESYLATE|ENALAPRIL,10,COLON CANCER|METASTASES TO LIVER|COLON CANCER|METASTASES TO LIVER|COLON CANCER|METASTASES TO LIVER|COLON CANCER|METASTASES TO LIVER|HYPERTENSION|HYPERTENSION,Rash|Bile duct obstruction|Chromaturia,3,5
10256636,20140624,Panitumumab,,,,0,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Dermatitis acneiform,1,3
10257440,20140625,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,BEVACIZUMAB|PANITUMUMAB,6,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Skin toxicity|Neutropenia|Diarrhoea|Mucosal inflammation|Pulmonary embolism|Hypokalaemia|Hypertension|Proteinuria,8,3
10260011,20140625,Panitumumab,58,801,58.0,1,57.8,1,0,1,0,0,0,0,Panitumumab,FILGRASTIM|PANTOPRAZOLE|CISPLATIN|PANITUMUMAB|DOXYCYCLINE|DOXYCYCLINE HYCLATE,8,OESOPHAGEAL SQUAMOUS CELL CARCINOMA|OESOPHAGEAL SQUAMOUS CELL CARCINOMA|OESOPHAGEAL SQUAMOUS CELL CARCINOMA,Hypocalcaemia,1,1
10261927,20140626,Panitumumab,54,801,54.0,1,106.8,1,0,1,0,0,0,1,Panitumumab,"APREPITANT|FOSAPREPITANT DIMEGLUMINE|METHYLPHENIDATE HYDROCHLORIDE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|TRAMETINIB|MINOCYCLINE|NIFEDIPINE|DESONIDE|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|OXYCODONE|TRAMETINIB|PANITUMUMAB|PANITUMUMAB|DABRAFENIB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DABRAFENIB|OLMESARTAN MEDOXOMIL",24,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|HYPERTENSION,Acute kidney injury,1,1
10262266,20140626,Panitumumab,,,,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Hospitalisation,1,3
10264662,20140627,Panitumumab,51,801,51.0,2,,1,0,1,0,0,0,0,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Skin disorder|Tenderness|Rash,3,5
10265837,20140627,Panitumumab,8,800,80.0,1,63.8,1,1,1,0,0,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|OXALIPLATIN|AMLODIPINE|PANITUMUMAB|OXALIPLATIN|ESOMEPRAZOLE MAGNESIUM",17,METASTASES TO LIVER|RECTAL CANCER|METASTASES TO LIVER|RECTAL CANCER|RECTAL CANCER|METASTASES TO LIVER|RECTAL CANCER|METASTASES TO LIVER,Gastric ulcer|Interstitial lung disease,2,1
10268376,20140630,Panitumumab,58,801,58.0,2,57,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN|CETUXIMAB,6,SMALL INTESTINE CARCINOMA|SMALL INTESTINE CARCINOMA|SMALL INTESTINE CARCINOMA|SMALL INTESTINE CARCINOMA|SMALL INTESTINE CARCINOMA|SMALL INTESTINE CARCINOMA,Supraventricular tachycardia|Atrial tachycardia,2,2
10269343,20140701,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Blood bilirubin abnormal,1,2
10269706,20140701,Panitumumab,59,801,59.0,1,64,1,0,0,0,0,0,1,Panitumumab,OXALIPLATIN|PANITUMUMAB|PANITUMUMAB,6,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Skin toxicity,1,1
10270982,20140701,Panitumumab,,,,0,,1,0,1,0,0,0,1,Panitumumab,DABRAFENIB|PANITUMUMAB|TRAMETINIB|DABRAFENIB|TRAMETINIB,7,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|VOMITING,Delirium|Hyponatraemia,2,1
10271794,20140701,Panitumumab,72,801,72.0,2,42.9,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|TRAMETINIB|DABRAFENIB,3,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Dehydration,1,1
10271796,20140701,Panitumumab,53,801,53.0,1,,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB",5,PRODUCT USED FOR UNKNOWN INDICATION,Neuropathy peripheral|Rash|Hepatectomy,3,1
10271799,20140701,Panitumumab,,,,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,2,COLORECTAL CANCER,Rash|Skin toxicity|Sepsis|Eyelid function disorder,4,3
10272060,20140702,Panitumumab,,,,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Constipation|Asthenia|Eastern Cooperative Oncology Group performance status worsened|Vomiting,4,1
10272067,20140702,Panitumumab,59,801,59.0,1,67,1,0,1,0,0,0,0,Panitumumab,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PANITUMUMAB|CISPLATIN|PANTOPRAZOLE|MOXIFLOXACIN HYDROCHLORIDE,10,OESOPHAGEAL SQUAMOUS CELL CARCINOMA|OESOPHAGEAL SQUAMOUS CELL CARCINOMA|OESOPHAGEAL SQUAMOUS CELL CARCINOMA,Anaemia,1,1
10272068,20140702,Panitumumab,70,801,70.0,2,,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER,White blood cell count decreased,1,1
10272354,20140702,Panitumumab,56,801,56.0,1,70,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Malaise|Diarrhoea|Myalgia|Abdominal discomfort|Rash,5,5
10274894,20140702,Panitumumab,68,801,68.0,1,57.7,1,0,1,0,0,0,1,Panitumumab,DABRAFENIB|TRAMETINIB|PANITUMUMAB|TRAMETINIB|DABRAFENIB|PANITUMUMAB,9,VOMITING|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS OF NAUSEA AND VOMITING,Delirium|Hyponatraemia,2,1
10276159,20140703,Panitumumab,52,801,52.0,2,,1,0,1,0,0,0,0,Panitumumab,DOXYCYCLINE|DOXYCYCLINE HYCLATE|PANITUMUMAB|DESONIDE,4,COLORECTAL CANCER STAGE IV,Metastases to liver|Urinary tract infection|Onychoclasis|Disease progression|Constipation|Infrequent bowel movements,6,5
10277594,20140704,Panitumumab,78,801,78.0,1,,1,1,1,1,0,0,0,Panitumumab,FILGRASTIM|PANITUMUMAB|CAPECITABINE,3,NEUTROPENIA|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Mucosal inflammation|Lower gastrointestinal haemorrhage,2,3
10278632,20140704,Panitumumab,68,801,68.0,1,73.9,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,5,COLON CANCER METASTATIC|METASTASES TO LIVER|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Folliculitis|Pruritus|Rash|Carcinoembryonic antigen increased,4,3
10279303,20140707,Panitumumab,51,801,51.0,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB|CETUXIMAB|CAPECITABINE|CETUXIMAB|CETUXIMAB|CAPECITABINE|PANITUMUMAB|CAPECITABINE,18,METASTASES TO LIVER|METASTASES TO LUNG|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|METASTASES TO LUNG|METASTASES TO LIVER|METASTASES TO LUNG|COLORECTAL CANCER|METASTASES TO LIVER|METASTASES TO LIVER|COLORECTAL CANCER|COLORECTAL CANCER|METASTASES TO LIVER|METASTASES TO LUNG|METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LUNG,Rash|Carcinoembryonic antigen increased|Metastases to liver|Disease progression,4,3
10280080,20140707,Panitumumab,53,801,53.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,3,METASTASES TO LIVER|COLORECTAL CANCER METASTATIC,Arthropod bite|Dry skin|Rash|Blister|Hepatic neoplasm|Feeling hot|Skin discolouration|Dermatitis contact|Skin injury|Pruritus,10,5
10281592,20140707,Panitumumab,81,801,81.0,2,,1,0,0,0,1,0,0,Panitumumab,BEVACIZUMAB|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|PANITUMUMAB|CAPECITABINE,7,COLON CANCER|ASTHMA|COLON CANCER|COLON CANCER|COLON CANCER,Hypoacusis,1,3
10283162,20140708,Panitumumab,,,,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Hypocalcaemia|Myalgia|Muscle spasms|Hypomagnesaemia,4,5
10283843,20140708,Panitumumab,56,801,56.0,1,,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Interstitial lung disease|Infusion related reaction,2,2
10286021,20140709,Panitumumab,51,801,51.0,1,,1,0,0,0,0,0,1,Panitumumab,"METHYLPREDNISOLONE SODIUM SUCCINATE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",8,COLON CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Neutropenia|Thrombocytopenia|Leukopenia,3,3
10287759,20140709,Panitumumab,,,,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Muscle spasms|Musculoskeletal stiffness|Hypocalcaemia|Myalgia|Hypomagnesaemia,5,5
10287856,20140709,Panitumumab,40,801,40.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,PRODUCT USED FOR UNKNOWN INDICATION,Drug effect incomplete|Metastases to liver,2,5
10289373,20140710,Panitumumab,63,801,63.0,1,,1,0,1,0,0,0,0,Panitumumab,OXALIPLATIN|PANITUMUMAB,2,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Skin reaction,1,5
10289640,20140710,Panitumumab,67,801,67.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Malaise|Skin reaction,2,2
10289953,20140710,Panitumumab,64,801,64.0,1,,1,0,0,0,0,0,1,Panitumumab,OXALIPLATIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PANITUMUMAB|BEVACIZUMAB|CAPECITABINE,8,PRODUCT USED FOR UNKNOWN INDICATION,Lung disorder|Neutropenia|Drug tolerance decreased|Hepatic lesion|Skin toxicity|Disease progression|Neuropathy peripheral|Drug effect incomplete|Bone lesion|Asthenia,10,5
10289994,20140710,Panitumumab,53,801,53.0,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,2,NEOPLASM|PROPHYLAXIS,Rash|Drug interaction|Diarrhoea,3,1
10293277,20140710,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,OXALIPLATIN|PANITUMUMAB,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Drug intolerance|Neurotoxicity,2,1
10293381,20140710,Panitumumab,68,801,68.0,1,,1,0,0,0,0,0,1,Panitumumab,CAPECITABINE|OXALIPLATIN|PANITUMUMAB,3,HEPATIC CANCER|HEPATIC CANCER|HEPATIC CANCER,Surgery|Neuropathy peripheral|Rash|Palmar-plantar erythrodysaesthesia syndrome|Haematotoxicity,5,1
10296974,20140711,Panitumumab,49,801,49.0,2,94,1,0,1,0,0,0,0,Panitumumab,CARBOPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|PANITUMUMAB,3,OVARIAN CANCER RECURRENT|OVARIAN CANCER RECURRENT|OVARIAN CANCER RECURRENT,Thrombocytopenia,1,1
10297803,20140711,Panitumumab,79,801,79.0,1,,1,0,0,1,0,0,1,Panitumumab,PANITUMUMAB,2,COLON CANCER,Interstitial lung disease,1,1
10297844,20140711,Panitumumab,,,,1,,1,0,1,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN|PANITUMUMAB|PANITUMUMAB|OXALIPLATIN|OXALIPLATIN,15,HYPERTENSION|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|METASTASES TO LUNG|METASTASES TO LUNG|METASTASES TO LIVER|METASTASES TO LUNG|METASTASES TO LIVER|RECTAL CANCER METASTATIC|HYPERTENSION|METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LUNG,Paraneoplastic syndrome|Skin reaction|Skin necrosis,3,5
10300124,20140711,Panitumumab,54,801,54.0,2,89.5,1,0,0,0,1,0,0,Panitumumab,DABRAFENIB|DABRAFENIB|PANITUMUMAB|BEVACIZUMAB|DABRAFENIB,5,COLORECTAL CANCER|CHEMOTHERAPY|CHEMOTHERAPY,Alveolitis allergic,1,1
10304306,20140715,Panitumumab,73,801,73.0,2,42.9,1,0,1,0,0,0,0,Panitumumab,DABRAFENIB|DABRAFENIB|TRAMETINIB|PANITUMUMAB|DABRAFENIB|TRAMETINIB|TRAMETINIB,7,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Decreased appetite,1,1
10304317,20140715,Panitumumab,59,801,59.0,1,47.84,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|EVEROLIMUS|EVEROLIMUS TABLETS,7,COLORECTAL CANCER|COLORECTAL CANCER|BLOOD CHOLESTEROL ABNORMAL|HYPERMAGNESAEMIA|RASH|COLORECTAL CANCER,Pyrexia|Infection|Rash,3,3
10305629,20140715,Panitumumab,34,801,34.0,1,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Disease progression,1,1
10306213,20140715,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Urinary retention|Renal failure|Hyperkalaemia,3,2
10306236,20140715,Panitumumab,40,801,40.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,4,METASTASIS|METASTASIS|METASTASIS|METASTASIS,Skin toxicity,1,1
10308085,20140716,Panitumumab,51,801,51.0,1,,1,0,0,0,0,0,1,Panitumumab,OXALIPLATIN|METHYLPREDNISOLONE SODIUM SUCCINATE|APREPITANT|FOSAPREPITANT DIMEGLUMINE|PANITUMUMAB|AMOXICILLIN|GENTAMICIN|GENTAMICIN SULFATE,11,TUBERCULOSIS|COLON CANCER|COLON CANCER|CHEMOTHERAPY|CHEMOTHERAPY|CHEMOTHERAPY|CHEMOTHERAPY|COLON CANCER,Thrombocytopenia|Neutropenia|Leukopenia|Anaemia,4,3
10308232,20140716,Panitumumab,62,801,62.0,1,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,METASTASES TO THE RESPIRATORY SYSTEM|METASTASES TO GASTROINTESTINAL TRACT,Death,1,5
10312222,20140718,Panitumumab,54,801,54.0,2,51,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|CARBOPLATIN,3,OVARIAN CANCER|OVARIAN CANCER|OVARIAN CANCER,Erysipelas,1,1
10313110,20140718,Panitumumab,71,801,71.0,1,57.2,1,1,1,1,0,0,1,Panitumumab,"FUROSEMIDE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|SPIRONOLACTONE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN",13,COLON CANCER|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|COLON CANCER|COLON CANCER|COLON CANCER,Interstitial lung disease|Pneumomediastinum|Pneumocystis jirovecii pneumonia,3,1
10313148,20140718,Panitumumab,59,801,59.0,1,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,METASTASES TO LIVER|COLON CANCER,Pancreatitis acute,1,1
10314124,20140718,Panitumumab,69,801,69.0,1,47.5,1,1,1,0,0,0,1,Panitumumab,PANITUMUMAB,3,COLON CANCER|PNEUMOCYSTIS JIROVECII PNEUMONIA|COLON CANCER,Interstitial lung disease|Pancytopenia,2,1
10327172,20140720,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Pyrexia|Sepsis,2,1
10330239,20140721,Panitumumab,73,801,73.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB|OXALIPLATIN,4,COLON CANCER|COLON CANCER|COLON CANCER,Ascites,1,1
10330644,20140722,Panitumumab,76,801,76.0,1,,1,1,1,0,0,0,0,Panitumumab,PANITUMUMAB|METHYLPREDNISOLONE|PACLITAXEL|IPRATROPIUM BROMIDE,8,HEAD AND NECK CANCER|HEAD AND NECK CANCER,Aspiration|Mucosal inflammation|Respiratory failure,3,3
10335616,20140723,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,PRODUCT USED FOR UNKNOWN INDICATION,Skin toxicity,1,5
10341374,20140725,Panitumumab,71,801,71.0,1,57.2,1,1,1,1,0,0,0,Panitumumab,"PANITUMUMAB|PANITUMUMAB|PANITUMUMAB|PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|PANITUMUMAB|PANITUMUMAB|OXALIPLATIN|PANITUMUMAB|PANITUMUMAB|PANITUMUMAB|PANITUMUMAB|PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|PANITUMUMAB|SPIRONOLACTONE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|PANITUMUMAB|FUROSEMIDE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|PANITUMUMAB|PANITUMUMAB|PANITUMUMAB|PANITUMUMAB",40,COLON CANCER STAGE IV|COLON CANCER STAGE IV|COLON CANCER STAGE IV|COLON CANCER STAGE IV|COLON CANCER STAGE IV|COLON CANCER STAGE IV|METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LIVER|COLON CANCER STAGE IV|METASTASES TO LIVER|COLON CANCER STAGE IV|COLON CANCER STAGE IV|METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LIVER|COLON CANCER STAGE IV|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER STAGE IV|COLON CANCER STAGE IV|METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LIVER|COLON CANCER STAGE IV|METASTASES TO LIVER|COLON CANCER STAGE IV|METASTASES TO LIVER|COLON CANCER STAGE IV|COLON CANCER STAGE IV|METASTASES TO LIVER|COLON CANCER STAGE IV,Pyrexia|Dyspnoea|Interstitial lung disease|Pneumomediastinum|Cough|Pneumocystis jirovecii pneumonia,6,1
10343166,20140725,Panitumumab,74,801,74.0,1,91.7,1,0,0,0,0,0,1,Panitumumab,ATENOLOL|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|ATORVASTATIN CALCIUM|PANITUMUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|DENOSUMAB|TEMAZEPAM|LEVOTHYROXINE SODIUM,9,HYPERTENSION|AFFECTIVE DISORDER|HYPERCHOLESTEROLAEMIA|COLORECTAL CANCER METASTATIC|TYPE 2 DIABETES MELLITUS|HYPERTENSION|SLEEP DISORDER|HYPOTHYROIDISM,Eye irritation|Conjunctivitis|Rash|Photophobia|Scleral discolouration|Pruritus|Ocular hyperaemia,7,2
10343954,20140727,Panitumumab,44,801,44.0,2,94,1,1,1,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,8,METASTASES TO LIVER|ADENOCARCINOMA OF COLON|METASTASES TO LIVER|METASTASES TO LIVER|ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON|COLON CANCER|METASTASES TO LIVER,Anxiety|Vomiting|Decubitus ulcer|Infected skin ulcer|Rash|Weight increased|Diarrhoea|Disease progression,8,5
10344435,20140728,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia|Hypertensive crisis|Chills|Back pain,4,5
10351375,20140730,Panitumumab,60,801,60.0,1,,1,0,1,0,0,0,0,Panitumumab,CISPLATIN|PANITUMUMAB|CAPECITABINE,4,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Pneumonia|Leukopenia,2,1
10353751,20140731,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Rash pustular|Paronychia|Pruritus|Pain|Skin fissures|Skin toxicity|Xerosis,7,3
10355980,20140801,Panitumumab,67,801,67.0,2,64,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB",12,METASTASES TO LIVER|METASTASES TO LUNG|METASTASES TO LIVER|METASTASES TO LUNG|COLON CANCER STAGE IV|COLON CANCER STAGE IV|METASTASES TO LIVER|COLON CANCER STAGE IV|METASTASES TO LUNG|METASTASES TO LUNG|METASTASES TO LIVER|COLON CANCER STAGE IV,Anaemia,1,5
10358022,20140801,Panitumumab,67,801,67.0,2,46.5,1,1,0,0,0,0,1,Panitumumab,RABEPRAZOLE SODIUM|RABEPRAZOLE|SPIRONOLACTONE|PANITUMUMAB|FUROSEMIDE|OXYCODONE HYDROCHLORIDE|LACTULOSE,10,COLON CANCER|AMMONIA INCREASED,Diarrhoea|Stomatitis|Interstitial lung disease,3,3
10358420,20140801,Panitumumab,70,801,70.0,2,52.5,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|OMEPRAZOLE MAGNESIUM,6,COLORECTAL CANCER|COLORECTAL CANCER,Small intestinal obstruction,1,3
10359150,20140804,Panitumumab,77,801,77.0,1,52,1,1,0,0,0,0,1,Panitumumab,"PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",5,COLON CANCER RECURRENT|COLON CANCER RECURRENT|COLON CANCER RECURRENT|COLON CANCER RECURRENT,Interstitial lung disease,1,1
10363098,20140805,Panitumumab,51,801,51.0,1,,1,0,0,0,0,0,1,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|CETUXIMAB|PANITUMUMAB|CAPECITABINE",6,ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON,Skin toxicity|Disease progression|Rash,3,1
10364040,20140806,Panitumumab,85,801,85.0,2,,1,1,1,0,0,0,0,Panitumumab,PANITUMUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CAPECITABINE|CAPECITABINE,4,PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Urinary tract infection,2,3
10364393,20140806,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Keratitis,1,3
10364395,20140806,Panitumumab,49,801,49.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Skin reaction,1,5
10364413,20140806,Panitumumab,85,801,85.0,1,,1,0,1,0,0,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN",4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Pulmonary embolism,1,5
10366815,20140807,Panitumumab,42,801,42.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PREGABALIN|PANITUMUMAB,15,DISEASE RECURRENCE|PAIN|ADENOCARCINOMA OF COLON,Hepatocellular injury|Epstein-Barr virus test positive|Pain|Transaminases increased,4,1
10368414,20140807,Panitumumab,,,,1,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Sepsis,1,1
10369766,20140808,Panitumumab,60,801,60.0,1,65.4,1,0,1,0,1,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|IRINOTECAN HYDROCHLORIDE",4,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Renal failure acute|Diarrhoea|Febrile neutropenia|Intestinal obstruction,4,1
10371409,20140808,Panitumumab,49,801,49.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,PRODUCT USED FOR UNKNOWN INDICATION,Rash|Disease progression,2,3
10374817,20140811,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Diarrhoea|Duodenal ulcer,2,1
10375288,20140811,Panitumumab,70,801,70.0,2,,1,1,1,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,6,METASTASES TO LIVER|RECTOSIGMOID CANCER STAGE IV|RECTOSIGMOID CANCER STAGE IV|METASTASES TO LIVER|METASTASES TO LIVER|RECTOSIGMOID CANCER STAGE IV,Metabolic acidosis|Atrial fibrillation|Anuria|Drug interaction|Necrotising fasciitis,5,3
10375291,20140811,Panitumumab,59,801,59.0,1,,1,0,1,0,0,0,1,Panitumumab,PANITUMUMAB,2,METASTASES TO LIVER|METASTASES TO LIVER,Necrotising fasciitis|Drug interaction,2,3
10377036,20140812,Panitumumab,75,801,75.0,2,,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",8,COLON CANCER|COLON CANCER|METASTASES TO LIVER|METASTASES TO LIVER|COLON CANCER|COLON CANCER|METASTASES TO LIVER|METASTASES TO LIVER,Venoocclusive liver disease,1,1
10377074,20140812,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Skin toxicity|Stomatitis|Paronychia,3,1
10379916,20140813,Panitumumab,78,801,78.0,1,45,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,6,OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA,Asthenia,1,1
10379930,20140813,Panitumumab,64,801,64.0,2,69,1,0,1,0,0,0,0,Panitumumab,OXALIPLATIN|CAPECITABINE|LEVOTHYROXINE SODIUM|PANITUMUMAB,9,PRODUCT USED FOR UNKNOWN INDICATION,Paraesthesia,1,1
10380162,20140813,Panitumumab,8,800,80.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Condition aggravated|Neutrophil count decreased,2,1
10383212,20140813,Panitumumab,65,801,65.0,2,43,1,0,0,0,0,0,1,Panitumumab,OXALIPLATIN|PANITUMUMAB,5,OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA,Blood alkaline phosphatase increased,1,3
10383228,20140814,Panitumumab,47,801,47.0,1,,1,0,1,0,0,0,0,Panitumumab,PACLITAXEL|PANITUMUMAB,8,HEAD AND NECK CANCER|HEAD AND NECK CANCER,Mucosal inflammation,1,3
10383233,20140814,Panitumumab,65,801,65.0,2,43,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN|METHYLPREDNISOLONE SODIUM SUCCINATE,8,OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA,Aspartate aminotransferase increased,1,3
10386414,20140815,Panitumumab,74,801,74.0,2,58.3,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|CEFTRIAXONE|CEFTRIAXONE SODIUM|CISPLATIN,4,OESOPHAGEAL CARCINOMA|OESOPHAGEAL SQUAMOUS CELL CARCINOMA|OESOPHAGEAL SQUAMOUS CELL CARCINOMA,Mucosal inflammation,1,3
10386450,20140815,Panitumumab,60,801,60.0,1,84,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,5,OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA,Neutropenia,1,3
10386456,20140815,Panitumumab,67,801,67.0,1,89,1,0,1,0,0,0,0,Panitumumab,CISPLATIN|PANITUMUMAB|RIVAROXABAN|ATORVASTATIN CALCIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,7,OESOPHAGEAL SQUAMOUS CELL CARCINOMA|OESOPHAGEAL SQUAMOUS CELL CARCINOMA|OESOPHAGEAL SQUAMOUS CELL CARCINOMA,Dehydration,1,3
10386489,20140815,Panitumumab,73,801,73.0,2,,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|IRINOTECAN HYDROCHLORIDE|IRINOTECAN HYDROCHLORIDE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",8,COLON CANCER|COLON CANCER|METASTASES TO LIVER|COLON CANCER|METASTASES TO LIVER|METASTASES TO LIVER|METASTASES TO LIVER|COLON CANCER,Bone marrow failure,1,1
10386763,20140815,Panitumumab,59,801,59.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Skin toxicity|Disease progression,2,1
10387757,20140815,Panitumumab,71,801,71.0,2,,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN",4,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Anaphylactic reaction,1,1
10389263,20140818,Panitumumab,71,801,71.0,2,49,1,1,0,0,0,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",15,METASTASES TO LIVER|METASTASES TO LIVER|COLON CANCER|COLON CANCER|METASTASES TO LIVER|COLON CANCER|METASTASES TO LIVER|COLON CANCER|COLON CANCER|METASTASES TO LIVER,Neutrophil count decreased|Colon cancer,2,1
10394554,20140820,Panitumumab,57,801,57.0,1,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10394568,20140820,Panitumumab,65,801,65.0,2,,1,1,1,0,0,0,1,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|MAGNESIUM|PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|MAGNESIUM",10,NEOPLASM MALIGNANT|ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON|NEOPLASM MALIGNANT|ADENOCARCINOMA OF COLON|NEOPLASM MALIGNANT|ADENOCARCINOMA OF COLON|NEOPLASM MALIGNANT,Epilepsy|Seizure|Hypomagnesaemia|Surgery|Generalised tonic-clonic seizure,5,1
10395571,20140820,Panitumumab,19,801,19.0,1,57,1,0,0,0,1,0,0,Panitumumab,PANITUMUMAB,2,COLORECTAL CANCER|COLORECTAL CANCER METASTATIC,Skin toxicity,1,1
10397564,20140820,Panitumumab,70,801,70.0,1,62.5,1,1,0,0,0,0,0,Panitumumab,DABRAFENIB|TRAMETINIB|DABRAFENIB|PANITUMUMAB,4,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Death,1,1
10397595,20140821,Panitumumab,75,801,75.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,7,OESOPHAGEAL ADENOCARCINOMA|HYPOKALAEMIA|RASH|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA,Leukopenia,1,3
10397600,20140821,Panitumumab,55,801,55.0,1,,1,0,1,0,0,0,0,Panitumumab,DOXYCYCLINE|DOXYCYCLINE HYCLATE|PANITUMUMAB,5,COLORECTAL CANCER METASTATIC|PROPHYLAXIS|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Dermatitis allergic,1,1
10397688,20140821,Panitumumab,52,801,52.0,2,70,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Rash|Pruritus|Skin exfoliation|Skin lesion,4,5
10398304,20140821,Panitumumab,56,801,56.0,1,78,1,0,0,0,1,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Vomiting|Diarrhoea|Weight decreased|Intestinal obstruction,4,5
10398330,20140821,Panitumumab,54,801,54.0,1,,1,0,0,0,1,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Rash,1,5
10401035,20140822,Panitumumab,35,801,35.0,2,64,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Rash|Oral mucosal blistering,2,5
10401044,20140822,Panitumumab,77,801,77.0,1,60.3,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|OXALIPLATIN|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB",11,METASTASES TO LIVER|PROPHYLAXIS|METASTASES TO LIVER|METASTASES TO LIVER|COLON CANCER|METASTASES TO LIVER|COLON CANCER|COLON CANCER|COLON CANCER|PROPHYLAXIS,Device dislocation,1,1
10403300,20140822,Panitumumab,52,801,52.0,1,65,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Erythema|Rhinalgia|Facial pain|Rash,4,5
10405137,20140825,Panitumumab,71,801,71.0,1,67,1,0,0,0,1,0,0,Panitumumab,OXALIPLATIN|PANITUMUMAB,4,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Blister|Rash,2,5
10405652,20140825,Panitumumab,62,801,62.0,2,,1,0,0,0,0,0,1,Panitumumab,CETUXIMAB|DACARBAZINE|BEVACIZUMAB|PANITUMUMAB|METHOTREXATE|METHOTREXATE SODIUM|STREPTOZOCIN|CAPECITABINE|ZOLEDRONIC ACID|CISPLATIN,11,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Hypertension|Renal injury|Proteinuria|Renal tubular disorder|Renal failure acute|Thrombotic microangiopathy|Anaemia|Thrombocytopenia|Haematuria|Renal ischaemia,10,3
10408084,20140825,Panitumumab,76,801,76.0,2,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10408140,20140826,Panitumumab,67,801,67.0,1,,1,0,1,0,0,0,0,Panitumumab,PACLITAXEL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|SIMVASTATIN|PANITUMUMAB,5,HEAD AND NECK CANCER|HEAD AND NECK CANCER,Colitis ischaemic,1,3
10408805,20140826,Panitumumab,55,801,55.0,2,68,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,RECTAL CANCER,Breast cancer,1,5
10409373,20140826,Panitumumab,63,801,63.0,2,,1,1,1,0,1,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Investigation|Rash|Dry skin|Death|Onychomycosis,5,5
10411331,20140826,Panitumumab,71,801,71.0,1,78,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Dermatitis acneiform,1,3
10411822,20140827,Panitumumab,71,801,71.0,1,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Death,1,1
10412118,20140827,Panitumumab,46,801,46.0,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Rash,1,5
10414719,20140828,Panitumumab,,,,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,PRODUCT USED FOR UNKNOWN INDICATION,Acne|Skin toxicity|Hypertrichosis|Erythema|Skin irritation,5,5
10414742,20140828,Panitumumab,7,800,70.0,1,78,1,1,0,0,0,0,1,Panitumumab,"IRINOTECAN HYDROCHLORIDE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB",4,RECTAL CANCER RECURRENT|RECTAL CANCER RECURRENT|RECTAL CANCER RECURRENT|RECTAL CANCER RECURRENT,Hepatitis fulminant,1,1
10414765,20140828,Panitumumab,61,801,61.0,2,70,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Skin toxicity,1,5
10415080,20140828,Panitumumab,,,,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Rash|Disease progression,2,5
10415474,20140828,Panitumumab,76,801,76.0,1,51,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,4,COLON NEOPLASM|COLON NEOPLASM|COLON NEOPLASM,Stomatitis|Rash pustular,2,1
10415475,20140828,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|IRINOTECAN HYDROCHLORIDE",4,COLORECTAL CANCER RECURRENT|COLORECTAL CANCER RECURRENT|COLORECTAL CANCER RECURRENT|COLORECTAL CANCER RECURRENT,Pneumatosis intestinalis,1,1
10416606,20140828,Panitumumab,59,801,59.0,2,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Genital rash|Rash,2,5
10416609,20140828,Panitumumab,47,801,47.0,1,69.9,1,1,0,1,0,0,1,Panitumumab,"PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,COLORECTAL CANCER RECURRENT|COLORECTAL CANCER RECURRENT|COLORECTAL CANCER RECURRENT|COLORECTAL CANCER RECURRENT,Intra-abdominal haemorrhage|Rash|Device related infection|Alopecia|Hepatic failure,5,1
10416611,20140828,Panitumumab,8,800,80.0,1,,1,0,1,0,0,0,0,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|IRINOTECAN HYDROCHLORIDE",4,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Benign prostatic hyperplasia,1,1
10419263,20140829,Panitumumab,50,801,50.0,2,63,1,0,1,1,0,0,0,Panitumumab,PANITUMUMAB|OXALIPLATIN|PANTOPRAZOLE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|METOPROLOL TARTRATE|METOPROLOL|ALLOPURINOL,9,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|PROPHYLAXIS|COLON CANCER METASTATIC|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS,Cerebral haemorrhage,1,1
10423386,20140902,Panitumumab,70,801,70.0,1,,1,0,1,0,0,0,1,Panitumumab,PANITUMUMAB|BEVACIZUMAB,10,COLON CANCER|COLON CANCER|COLON CANCER,Pneumocystis jirovecii pneumonia,1,1
10425573,20140902,Panitumumab,46,801,46.0,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Rash,1,5
10425663,20140903,Panitumumab,66,801,66.0,1,89,1,0,1,0,0,0,0,Panitumumab,CISPLATIN|PANITUMUMAB|RIVAROXABAN,6,OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC|OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC|OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC,Oesophageal stenosis,1,1
10426140,20140903,Panitumumab,67,801,67.0,1,70,1,1,1,0,0,0,0,Panitumumab,OXALIPLATIN|PANITUMUMAB,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Folliculitis|Pneumomediastinum|General physical health deterioration|Atypical pneumonia|Skin disorder|Sepsis|Pneumopericardium,7,5
10428876,20140904,Panitumumab,61,801,61.0,1,,1,0,1,0,0,0,1,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|PANITUMUMAB",5,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Folliculitis,1,1
10429126,20140904,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Rash,1,5
10431797,20140905,Panitumumab,65,801,65.0,1,62,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB",13,METASTASES TO LIVER|SCAN WITH CONTRAST|COLON CANCER|ANTIALLERGIC THERAPY|PROPHYLAXIS OF NAUSEA AND VOMITING|COLON CANCER|METASTASES TO LIVER|ANTIEMETIC SUPPORTIVE CARE|COLON CANCER|METASTASES TO LIVER|WHITE BLOOD CELL COUNT DECREASED|COLON CANCER|METASTASES TO LIVER,Rash|Arthralgia|Stoma site pain|White blood cell count decreased|Nausea|Loss of consciousness|Joint effusion|Dizziness|Arthralgia|Faeces hard|Subdural hygroma,11,1
10431820,20140905,Panitumumab,55,801,55.0,1,70,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|CISPLATIN,3,OESOPHAGEAL SQUAMOUS CELL CARCINOMA|OESOPHAGEAL SQUAMOUS CELL CARCINOMA|OESOPHAGEAL SQUAMOUS CELL CARCINOMA,Diarrhoea,1,3
10432238,20140905,Panitumumab,72,801,72.0,1,,1,1,0,0,0,0,0,Panitumumab,"CETUXIMAB|PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN",7,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Toxicity to various agents|Disease progression|Rash,3,3
10432448,20140905,Panitumumab,43,801,43.0,2,,1,0,0,0,0,0,0,Panitumumab,GRANISETRON|GRANISETRON HYDROCHLORIDE|PANITUMUMAB,3,COLORECTAL CANCER METASTATIC|NAUSEA|COLORECTAL CANCER,Headache,1,1
10432464,20140905,Panitumumab,,,,1,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLON CANCER,Mucosal inflammation|Sepsis|Diarrhoea|Renal failure,4,5
10433874,20140905,Panitumumab,52,801,52.0,2,,1,0,0,0,0,0,1,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|SENNOSIDES|SENNA LEAF|SENNA|OXALIPLATIN|PANITUMUMAB",8,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Hair growth abnormal|Ingrowing nail|Paronychia|Rash,4,5
10435271,20140908,Panitumumab,51,801,51.0,2,60,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|PANITUMUMAB,5,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Troponin T increased|Blood creatine phosphokinase increased|Troponin T increased|Blood creatine phosphokinase increased,4,3
10438887,20140908,Panitumumab,75,801,75.0,1,,1,0,0,0,0,0,1,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|IRINOTECAN HYDROCHLORIDE",4,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Skin disorder|Neutrophil count decreased,2,1
10440286,20140909,Panitumumab,60,801,60.0,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Rash pustular|Staphylococcal infection,2,1
10440616,20140909,Panitumumab,44,801,44.0,1,,1,0,0,0,0,0,1,Panitumumab,DICLOFENAC SODIUM|PANITUMUMAB,4,PAIN|PAIN|COLON CANCER|PAIN,Neoplasm progression|No therapeutic response,2,2
10440635,20140909,Panitumumab,67,801,67.0,1,80,1,0,1,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB|FUROSEMIDE|PREGABALIN|PITAVASTATIN CALCIUM,18,COLON CANCER|METASTASES TO LIVER|HYPERTENSIVE HEART DISEASE|LIVER DISORDER|PROPHYLAXIS|HYPERTENSIVE HEART DISEASE|NEUROPATHY PERIPHERAL|GASTRITIS|HYPERTENSIVE HEART DISEASE|HYPERLIPIDAEMIA|HYPERTENSIVE HEART DISEASE|DRY SKIN PROPHYLAXIS|HYPERTENSIVE HEART DISEASE,Interstitial lung disease,1,1
10441934,20140909,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Hypomagnesaemia,1,1
10443228,20140910,Panitumumab,62,801,62.0,2,,1,1,1,0,0,0,0,Panitumumab,PANITUMUMAB|CISPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE,3,CHOLANGIOCARCINOMA|CHOLANGIOCARCINOMA|CHOLANGIOCARCINOMA,Hip fracture|Osteonecrosis|Pulmonary embolism,3,3
10443231,20140910,Panitumumab,67,801,67.0,1,55,1,0,1,0,0,0,1,Panitumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PANITUMUMAB,3,PAIN|OEDEMA|SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,Hypokalaemia|Off label use|Spinal fracture,3,1
10446122,20140910,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,"OXALIPLATIN|PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Throat tightness|Swollen tongue,2,5
10446178,20140911,Panitumumab,68,801,68.0,2,47.2,1,0,1,0,0,0,0,Panitumumab,TRAMETINIB|PANITUMUMAB|DABRAFENIB|TRAMETINIB,4,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Peripheral artery thrombosis,1,1
10446198,20140911,Panitumumab,69,801,69.0,2,67,1,0,1,0,0,0,0,Panitumumab,CARBOPLATIN|PANITUMUMAB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE,4,OVARIAN CANCER RECURRENT|OVARIAN CANCER RECURRENT|OVARIAN CANCER RECURRENT|PROPHYLAXIS,Vomiting|Nausea,2,3
10446237,20140911,Panitumumab,,,,0,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Rash|Cough,3,3
10447051,20140911,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Cataract,1,2
10448537,20140911,Panitumumab,58,801,58.0,2,40,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Cheilitis|Dry skin|Rash,3,3
10450199,20140912,Panitumumab,67,801,67.0,0,,1,1,0,0,0,0,0,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB|PANITUMUMAB",5,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Disease progression,1,1
10450770,20140912,Panitumumab,57,801,57.0,2,52,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Facial pain|Rash|Back pain,3,3
10451660,20140915,Panitumumab,73,801,73.0,1,57,1,0,1,0,0,0,1,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR",8,COLON CANCER|COLON CANCER|COLON CANCER|PROPHYLAXIS|COLON CANCER|PROPHYLAXIS,Interstitial lung disease|Dry skin|Hypomagnesaemia|Pigmentation disorder|Stomatitis|Diarrhoea|Dysgeusia|Paronychia|Neuropathy peripheral|Dermatitis acneiform,10,1
10451702,20140915,Panitumumab,,,,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Asthenia|Vomiting|Constipation|Eastern Cooperative Oncology Group performance status worsened,4,1
10451765,20140915,Panitumumab,62,801,62.0,1,78,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Rash,1,3
10453227,20140915,Panitumumab,64,801,64.0,1,64,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Rash,1,3
10453233,20140915,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Skin toxicity|Diarrhoea,2,5
10455143,20140916,Panitumumab,7,800,70.0,1,50.4,1,0,0,0,0,0,1,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|PANITUMUMAB|CAPECITABINE",6,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Dermatitis acneiform|Hyperammonaemia|Decreased appetite|Nausea|Vomiting|Altered state of consciousness,6,1
10457454,20140916,Panitumumab,65,801,65.0,2,,1,0,1,1,0,0,0,Panitumumab,PANITUMUMAB|LINEZOLID,2,RECTAL CANCER,Colitis|Diarrhoea|Mucosal inflammation|Pneumonia,4,1
10458018,20140916,Panitumumab,71,801,71.0,1,81,1,0,1,0,0,0,1,Panitumumab,PANITUMUMAB|OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|PANITUMUMAB,12,PRODUCT USED FOR UNKNOWN INDICATION|GOUT,Leukopenia|Tension|Anxiety|Chest pain|Disinhibition|Affective disorder|Chills|Decreased appetite|Stress cardiomyopathy|Dysphoria,10,1
10459792,20140917,Panitumumab,78,801,78.0,2,69,1,0,1,0,0,0,0,Panitumumab,DABRAFENIB|TRAMETINIB|PANITUMUMAB,3,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Urinary tract infection,1,1
10460588,20140918,Panitumumab,,,,2,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Subdural haematoma,1,5
10462357,20140918,Panitumumab,,,,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Hypersensitivity|Erythema|Skin reaction,3,1
10462983,20140919,Panitumumab,65,801,65.0,1,62,1,0,1,0,0,0,0,Panitumumab,CISPLATIN|PANITUMUMAB,8,OESOPHAGEAL CANCER METASTATIC|OESOPHAGEAL CANCER METASTATIC|OESOPHAGEAL CANCER METASTATIC,Stomatitis,1,1
10464921,20140919,Panitumumab,72,801,72.0,1,70,1,0,1,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Deep vein thrombosis|Pulmonary embolism|Dyspnoea exertional,3,5
10465734,20140920,Panitumumab,82,801,82.0,1,68,1,1,1,0,0,0,0,Panitumumab,PANITUMUMAB,5,OESOPHAGEAL ADENOCARCINOMA METASTATIC|OESOPHAGEAL ADENOCARCINOMA METASTATIC|OESOPHAGEAL ADENOCARCINOMA METASTATIC|OESOPHAGEAL ADENOCARCINOMA METASTATIC,Death,1,3
10465886,20140922,Panitumumab,65,801,65.0,2,36,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,5,OESOPHAGEAL ADENOCARCINOMA METASTATIC|OESOPHAGEAL ADENOCARCINOMA METASTATIC|OESOPHAGEAL ADENOCARCINOMA METASTATIC|OESOPHAGEAL ADENOCARCINOMA METASTATIC,Xerosis,1,3
10466592,20140922,Panitumumab,60,801,60.0,1,45,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB|OXYCODONE HYDROCHLORIDE,5,RECTAL CANCER RECURRENT,Febrile neutropenia|Pneumonia,2,1
10466965,20140922,Panitumumab,78,801,78.0,2,69.3,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|DABRAFENIB|TRAMETINIB,3,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Urinary tract infection,1,1
10466987,20140922,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Skin toxicity,1,5
10469161,20140923,Panitumumab,79,801,79.0,1,,1,1,1,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION,Hypoproteinaemia|Death|Oedema|Vomiting|Asthenia|Abdominal discomfort|Nausea|Pneumonia,8,2
10471764,20140924,Panitumumab,73,801,73.0,2,,1,1,0,0,0,0,0,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",5,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Erythema|Death,2,3
10471782,20140924,Panitumumab,64,801,64.0,1,,1,1,0,0,0,0,1,Panitumumab,"OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB",4,METASTASES TO ADRENALS|METASTASES TO ADRENALS|METASTASES TO ADRENALS|METASTASES TO ADRENALS,Disseminated intravascular coagulation|Intestinal obstruction|Sepsis|Necrotising colitis,4,1
10472170,20140924,Panitumumab,,,,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Skin lesion|Arthropathy|Polyneuropathy,3,5
10474719,20140925,Panitumumab,61,801,61.0,1,73,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|CISPLATIN,4,OESOPHAGEAL CANCER METASTATIC|OESOPHAGEAL CANCER METASTATIC|OESOPHAGEAL CANCER METASTATIC,Diarrhoea,1,1
10474761,20140925,Panitumumab,64,801,64.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,RECTAL ADENOCARCINOMA|COLON CANCER,Skin ulcer|Gamma-glutamyltransferase increased|Rash|Thrombocytopenia,4,3
10474770,20140925,Panitumumab,57,801,57.0,1,,1,0,0,0,0,0,1,Panitumumab,CAPECITABINE|IRINOTECAN HYDROCHLORIDE|BEVACIZUMAB|PANITUMUMAB|IRINOTECAN HYDROCHLORIDE|BEVACIZUMAB|BEVACIZUMAB|IRINOTECAN HYDROCHLORIDE,18,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Portal vein thrombosis|Metastases to liver|Metastases to skin|Thrombosis|Intestinal obstruction,5,1
10475274,20140925,Panitumumab,62,801,62.0,2,,1,0,0,0,0,0,1,Panitumumab,CISPLATIN|METHOTREXATE|METHOTREXATE SODIUM|BEVACIZUMAB|PANITUMUMAB|DACARBAZINE|STREPTOZOCIN|CAPECITABINE,10,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Hypertension|Nephropathy|Haematuria|Anaemia|Thrombocytopenia|Renal impairment|Proteinuria|Renal failure acute|Renal ischaemia,9,3
10476812,20140926,Panitumumab,46,801,46.0,1,62,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|OXALIPLATIN,5,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Urinary tract infection,1,1
10476818,20140926,Panitumumab,36,801,36.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,RECTAL ADENOCARCINOMA,Skin toxicity|Rash papulosquamous|Pruritus generalised,3,3
10479855,20140928,Panitumumab,74,801,74.0,1,57,1,1,1,0,0,0,1,Panitumumab,PANITUMUMAB,1,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Respiratory distress,1,1
10480636,20140929,Panitumumab,51,801,51.0,1,,1,1,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Respiratory distress,1,5
10482933,20140929,Panitumumab,69,801,69.0,1,,1,0,0,0,0,0,1,Panitumumab,"OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB",4,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Neutrophil count decreased,1,1
10483034,20140930,Panitumumab,59,801,59.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Skin toxicity|Rash,2,5
10483778,20140930,Panitumumab,58,801,58.0,1,57.2,1,0,0,1,0,0,0,Panitumumab,IRINOTECAN HYDROCHLORIDE|PANITUMUMAB|IRINOTECAN HYDROCHLORIDE|PANITUMUMAB,12,METASTASES TO LIVER|METASTASES TO LIVER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|METASTASES TO LIVER|METASTASES TO LIVER|RECTAL CANCER,Tumour lysis syndrome,1,1
10485625,20141001,Panitumumab,53,801,53.0,2,65,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|MITOMYCIN|CAPECITABINE,3,ANAL CANCER|ANAL CANCER|ANAL CANCER,Asthenia,1,3
10485653,20141001,Panitumumab,55,801,55.0,1,57,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|OXALIPLATIN,5,GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER,Vomiting,1,3
10488712,20141002,Panitumumab,78,801,78.0,2,86,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Gastrointestinal haemorrhage|Stoma site haemorrhage|Oral disorder,3,1
10488797,20141002,Panitumumab,54,801,54.0,2,,1,1,1,0,0,0,0,Panitumumab,PANITUMUMAB,2,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,General physical health deterioration,1,1
10493806,20141003,Panitumumab,,,,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Skin toxicity,1,5
10494130,20141003,Panitumumab,71,801,71.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Colorectal cancer recurrent|Periorbital oedema|Erythema,3,5
10494478,20141003,Panitumumab,68,801,68.0,1,,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",2,COLON CANCER|COLON CANCER,Q fever|Erythema,2,3
10494717,20141003,Panitumumab,68,801,68.0,1,,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",2,COLON CANCER|COLON CANCER,Erythema|Q fever,2,3
10496450,20141004,Panitumumab,68,801,68.0,1,,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",2,COLON CANCER|COLON CANCER,Erythema|Q fever,2,3
10496637,20141006,Panitumumab,69,801,69.0,0,,1,1,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Dyspnoea|Disease progression,2,1
10498065,20141006,Panitumumab,46,801,46.0,1,70,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Metastases to bladder|Mouth ulceration|Discomfort|Leukoplakia|Tongue ulceration|Constipation|Rash|Dysphagia|Mucosal inflammation,9,3
10500721,20141007,Panitumumab,,,,1,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Rash,1,1
10501110,20141007,Panitumumab,68,801,68.0,1,,1,0,1,0,0,0,0,Panitumumab,IRINOTECAN HYDROCHLORIDE|PANITUMUMAB|DEXCHLORPHENIRAMINE MALEATE,5,COLON CANCER|COLON CANCER|ACNE|COLON CANCER|COLON CANCER,Mental disorder|Acne,2,2
10502537,20141007,Panitumumab,59,801,59.0,1,82,1,0,0,0,0,0,0,Panitumumab,"PANITUMUMAB|LEUCOVORIN CALCIUM|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Conjunctivitis,1,3
10502538,20141007,Panitumumab,71,801,71.0,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION,Rash|Carcinoembryonic antigen increased|Skin ulcer|Rash pustular|Wound secretion,5,3
10502539,20141007,Panitumumab,,,,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB|IRINOTECAN HYDROCHLORIDE,2,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Diarrhoea|Skin toxicity,2,1
10502540,20141007,Panitumumab,,,,0,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Rash,1,5
10502541,20141007,Panitumumab,,,,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Keratitis,1,5
10502544,20141007,Panitumumab,69,801,69.0,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Dry skin|Neuropathy peripheral,2,1
10502545,20141007,Panitumumab,,,,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Paronychia,1,5
10502547,20141007,Panitumumab,68,801,68.0,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Secretion discharge|Rash,2,5
10502548,20141007,Panitumumab,,,,1,,1,0,0,0,0,0,0,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB",4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Hypocalcaemia|Electrolyte imbalance|Hypomagnesaemia|Hypokalaemia,4,5
10502549,20141007,Panitumumab,,,,2,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Rash,1,5
10502550,20141007,Panitumumab,,,,0,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Neutrophil count decreased,1,5
10502551,20141007,Panitumumab,79,801,79.0,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Rash,1,5
10502552,20141007,Panitumumab,,,,0,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Blood magnesium decreased,1,5
10502553,20141007,Panitumumab,,,,0,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Blood magnesium decreased,1,5
10502554,20141007,Panitumumab,,,,0,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Conjunctivitis|Skin reaction,2,3
10502555,20141007,Panitumumab,57,801,57.0,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB|CISPLATIN,3,PRODUCT USED FOR UNKNOWN INDICATION|COLORECTAL CANCER STAGE IV|COLORECTAL CANCER STAGE IV,Disease progression|Toxicity to various agents,2,5
10502556,20141007,Panitumumab,,,,0,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Rash,1,5
10502557,20141007,Panitumumab,,,,0,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Eye inflammation|Ocular toxicity,2,3
10502558,20141007,Panitumumab,,,,2,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Incorrect dose administered,1,2
10502559,20141007,Panitumumab,,,,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Skin reaction,1,3
10502560,20141007,Panitumumab,,,,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Rash|Tumour marker increased|Drug ineffective,3,5
10502561,20141007,Panitumumab,77,801,77.0,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Blood pressure increased|Malaise|Heart rate increased|Tremor,4,3
10502562,20141007,Panitumumab,,,,0,,1,0,0,0,0,0,0,Panitumumab,"PANITUMUMAB|PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN",5,RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER,Wrong technique in drug usage process,1,2
10502563,20141007,Panitumumab,60,801,60.0,2,,1,0,0,0,0,0,0,Panitumumab,IRON DEXTRAN|PANITUMUMAB,2,IRON DEFICIENCY|COLORECTAL CANCER METASTATIC,Extra dose administered,1,3
10502564,20141007,Panitumumab,,,,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Rash|Dermatitis acneiform,2,1
10502565,20141007,Panitumumab,,,,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Restlessness|Anxiety,2,5
10502566,20141007,Panitumumab,43,801,43.0,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Rash papular|Rash pruritic|Rash pustular,3,3
10502567,20141007,Panitumumab,,,,2,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Back pain|Pyrexia|Chills,3,5
10502568,20141007,Panitumumab,82,801,82.0,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Eye irritation|Eye swelling,2,3
10502570,20141007,Panitumumab,,,,2,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Nausea|Rash|Adverse event|Headache,4,5
10502571,20141007,Panitumumab,,,,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Erythema|Infusion related reaction,2,3
10502578,20141007,Panitumumab,64,801,64.0,2,,1,0,0,0,0,0,0,Panitumumab,FILGRASTIM|PANITUMUMAB|FISH OIL|ATORVASTATIN CALCIUM|CALCIUM,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pain|Dermatitis acneiform,2,5
10502581,20141007,Panitumumab,,,,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Rash,1,3
10502582,20141007,Panitumumab,,,,1,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Rash,1,1
10502583,20141007,Panitumumab,,,,2,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Rash,1,2
10502584,20141007,Panitumumab,52,801,52.0,1,104,1,0,0,0,0,0,0,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|PANITUMUMAB|PANITUMUMAB",5,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Hypophagia|Rash|Stomatitis,3,2
10503226,20141008,Panitumumab,,,,1,,1,0,1,0,0,0,1,Panitumumab,DESLORATADINE|ALLOPURINOL|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|PANITUMUMAB|DENOSUMAB|ALPRAZOLAM,10,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|METASTASES TO BONE|COLORECTAL CANCER METASTATIC,Thrombocytopenia|Haematuria,2,1
10506164,20141009,Panitumumab,60,801,60.0,1,75,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB|IRINOTECAN HYDROCHLORIDE|PANITUMUMAB,4,COLON CANCER|COLON CANCER,Hypomagnesaemia,1,2
10506329,20141009,Panitumumab,41,801,41.0,1,111.6,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Acne,1,3
10506341,20141009,Panitumumab,72,801,72.0,1,59,1,1,0,0,0,0,0,Panitumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PANITUMUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ATROPINE SULFATE|ATROPINE,8,PREMEDICATION|COLORECTAL CANCER|COLORECTAL CANCER|PREMEDICATION|COLORECTAL CANCER METASTATIC|PREMEDICATION|COLORECTAL CANCER METASTATIC|PREMEDICATION,Death|Rash,2,1
10509548,20141010,Panitumumab,67,801,67.0,1,86,1,0,1,0,0,0,0,Panitumumab,CISPLATIN|PANITUMUMAB,4,OESOPHAGEAL SQUAMOUS CELL CARCINOMA|OESOPHAGEAL SQUAMOUS CELL CARCINOMA|OESOPHAGEAL SQUAMOUS CELL CARCINOMA,Pulmonary embolism,1,1
10509620,20141010,Panitumumab,,,,2,,1,1,0,0,1,0,1,Panitumumab,PANITUMUMAB,7,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Neuropathy peripheral|Colon cancer,2,1
10510588,20141010,Panitumumab,,,,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,NEOPLASM,Drug ineffective,1,5
10512548,20141011,Panitumumab,75,801,75.0,1,77,1,0,1,0,0,0,0,Panitumumab,CISPLATIN|PANITUMUMAB,7,OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC|OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC|OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC,Vomiting,1,1
10512837,20141013,Panitumumab,,,,0,,1,0,1,0,0,0,0,Panitumumab,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|PANITUMUMAB|PANITUMUMAB|OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN,6,GALLBLADDER CANCER|GALLBLADDER CANCER|BILE DUCT CANCER|BILE DUCT CANCER|BILE DUCT CANCER|GALLBLADDER CANCER,Hospitalisation,1,3
10513369,20141013,Panitumumab,59,801,59.0,1,110,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,2,COLON CANCER|COLON CANCER,Hypomagnesaemia,1,2
10513648,20141013,Panitumumab,,,,1,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|FLOXURIDINE,3,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Diarrhoea,1,3
10515084,20141014,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|OXALIPLATIN|PANITUMUMAB,6,GALLBLADDER CANCER|BILE DUCT CANCER|GALLBLADDER CANCER|GALLBLADDER CANCER|BILE DUCT CANCER|BILE DUCT CANCER,Performance status decreased,1,3
10515151,20141014,Panitumumab,67,801,67.0,2,66,1,0,0,0,1,0,0,Panitumumab,PANITUMUMAB,13,METASTASES TO LUNG|COLON CANCER METASTATIC|COLORECTAL CANCER|COLON CANCER METASTATIC|COLORECTAL CANCER|COLON CANCER METASTATIC|METASTASES TO LIVER|METASTASES TO LIVER|COLORECTAL CANCER|METASTASES TO LIVER|METASTASES TO LUNG|METASTASES TO LUNG|COLORECTAL CANCER,Anaemia,1,5
10518445,20141015,Panitumumab,57,801,57.0,1,70,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Rash,1,3
10519023,20141015,Panitumumab,71,801,71.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Fatigue|Neuropathy peripheral|Thrombocytopenia|Insomnia|Neutropenia|Abdominal pain,6,5
10519853,20141015,Panitumumab,65,801,65.0,1,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10520930,20141016,Panitumumab,70,801,70.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Thrombocytopenia|Diarrhoea|Fatigue|Skin toxicity,4,5
10520933,20141016,Panitumumab,74,801,74.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Skin toxicity|Fatigue,2,5
10521020,20141016,Panitumumab,50,801,50.0,1,43.8,1,0,0,0,0,0,1,Panitumumab,METHOTREXATE|METHOTREXATE SODIUM|FILGRASTIM|PANITUMUMAB,6,TRANSITIONAL CELL CARCINOMA|PROPHYLAXIS|TRANSITIONAL CELL CARCINOMA|TRANSITIONAL CELL CARCINOMA|TRANSITIONAL CELL CARCINOMA|TRANSITIONAL CELL CARCINOMA,Neutropenia,1,3
10521035,20141016,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Skin toxicity,1,5
10521108,20141016,Panitumumab,69,801,69.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Nausea|Vomiting|Depression|Hypertension|Fatigue,5,5
10521205,20141016,Panitumumab,55,801,55.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Neutropenia|Abdominal pain|Hypertension|Fatigue|Rash|Pyrexia,6,5
10521211,20141016,Panitumumab,62,801,62.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Diarrhoea|Skin toxicity,2,5
10521217,20141016,Panitumumab,53,801,53.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Skin toxicity|Nausea|Diarrhoea|Fatigue|Vomiting|Hypomagnesaemia,6,5
10521220,20141016,Panitumumab,64,801,64.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Vomiting|Neutropenia|Pyrexia|Nausea,4,5
10521233,20141016,Panitumumab,62,801,62.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Fatigue|Skin toxicity,2,5
10521234,20141016,Panitumumab,61,801,61.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Thrombocytopenia|Fatigue|Neutropenia,3,5
10521243,20141016,Panitumumab,68,801,68.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,RECTOSIGMOID CANCER|COLON CANCER,Skin toxicity,1,5
10521244,20141016,Panitumumab,70,801,70.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Skin toxicity|Thrombocytopenia|Vomiting|Neutropenia|Fatigue|Nausea,6,5
10521245,20141016,Panitumumab,64,801,64.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Dyspnoea|Neutropenia|Nausea|Vomiting|Cough,5,5
10521251,20141016,Panitumumab,80,801,80.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Skin toxicity,1,5
10521252,20141016,Panitumumab,62,801,62.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,RECTOSIGMOID CANCER|COLON CANCER,Skin toxicity,1,5
10521253,20141016,Panitumumab,59,801,59.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Neuropathy peripheral|Skin toxicity|Diarrhoea|Vomiting|Nausea,5,5
10521254,20141016,Panitumumab,77,801,77.0,1,72,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Pruritus|Rash,2,3
10521262,20141016,Panitumumab,56,801,56.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Hypomagnesaemia|Skin toxicity,2,5
10521265,20141016,Panitumumab,65,801,65.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Skin toxicity|Neuropathy peripheral,2,5
10521281,20141016,Panitumumab,70,801,70.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Vomiting|Neutropenia|Fatigue|Nausea|Headache,5,5
10521283,20141016,Panitumumab,,,,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,COLORECTAL CANCER METASTATIC|RECTOSIGMOID CANCER,Neuropathy peripheral|Pyrexia,2,5
10521284,20141016,Panitumumab,66,801,66.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Nausea|Vomiting|Neutropenia|Skin toxicity|Fatigue,5,5
10521293,20141016,Panitumumab,62,801,62.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,RECTOSIGMOID CANCER|COLON CANCER,Neutropenia|Fatigue|Diarrhoea,3,5
10521304,20141016,Panitumumab,,,,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Fatigue|Nausea|Vomiting|Neuropathy peripheral,4,5
10521336,20141016,Panitumumab,49,801,49.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Skin toxicity|Diarrhoea,2,5
10521344,20141016,Panitumumab,76,801,76.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,RECTOSIGMOID CANCER|COLORECTAL CANCER METASTATIC,Fatigue|Diarrhoea|Skin toxicity|Insomnia,4,5
10521352,20141016,Panitumumab,67,801,67.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,COLORECTAL CANCER METASTATIC|RECTOSIGMOID CANCER,Skin toxicity,1,5
10521363,20141016,Panitumumab,63,801,63.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Fatigue|Neutropenia,2,5
10521611,20141016,Panitumumab,57,801,57.0,1,46,1,1,0,0,0,0,0,Panitumumab,CISPLATIN|PANITUMUMAB,3,OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC|OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC|OESOPHAGEAL SQUAMOUS CELL CARCINOMA METASTATIC,Death,1,3
10521710,20141016,Panitumumab,62,801,62.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Hypomagnesaemia|Nausea|Hypertension|Fatigue|Headache|Neutropenia|Diarrhoea|Vomiting,8,5
10521733,20141016,Panitumumab,66,801,66.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Depression|Diarrhoea,2,5
10521809,20141016,Panitumumab,50,801,50.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Neuropathy peripheral,1,5
10521817,20141016,Panitumumab,57,801,57.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Skin toxicity|Thrombocytopenia|Diarrhoea|Hypomagnesaemia,4,5
10521993,20141016,Panitumumab,67,801,67.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Fatigue|Vomiting|Neutropenia|Skin toxicity|Thrombocytopenia|Nausea,6,5
10523442,20141016,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,COLORECTAL CANCER METASTATIC|RECTOSIGMOID CANCER,Fatigue|Skin toxicity,2,5
10523544,20141017,Panitumumab,57,801,57.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Pyrexia|Vomiting|Neutropenia|Nausea|Fatigue|Abdominal pain,6,5
10523545,20141017,Panitumumab,67,801,67.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLON CANCER,Nausea|Neutropenia|Abdominal pain|Skin toxicity|Pyrexia|Vomiting,6,5
10523546,20141017,Panitumumab,34,801,34.0,1,,1,0,1,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Urethral haemorrhage,1,3
10523552,20141017,Panitumumab,51,801,51.0,2,,1,0,0,0,0,0,0,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,COLORECTAL CANCER METASTATIC|COLORECTAL ADENOCARCINOMA,Rash,1,3
10523599,20141017,Panitumumab,62,801,62.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Skin toxicity|Depression,2,5
10523731,20141017,Panitumumab,73,801,73.0,1,77,1,0,0,0,0,0,1,Panitumumab,PANTOPRAZOLE|PANITUMUMAB,9,OESOPHAGEAL ADENOCARCINOMA METASTATIC|ABDOMINAL PAIN UPPER|OESOPHAGEAL ADENOCARCINOMA METASTATIC|OESOPHAGEAL ADENOCARCINOMA METASTATIC|OESOPHAGEAL ADENOCARCINOMA METASTATIC|ABDOMINAL PAIN UPPER|HYPERTENSION|HYPERTENSION,Decreased appetite,1,3
10523833,20141017,Panitumumab,61,801,61.0,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,COLORECTAL CANCER METASTATIC|RECTOSIGMOID CANCER,Vomiting|Nausea|Skin toxicity|Hypomagnesaemia|Neuropathy peripheral,5,5
10523834,20141017,Panitumumab,70,801,70.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,RECTOSIGMOID CANCER|COLON CANCER,Headache|Nausea|Neutropenia,3,5
10524317,20141017,Panitumumab,36,801,36.0,2,,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",3,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Nocardiosis|Catheter site infection|Pyrexia,3,3
10526473,20141020,Panitumumab,79,801,79.0,2,60,1,0,0,0,0,0,1,Panitumumab,RANITIDINE|PANITUMUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION,Conjunctivitis bacterial,1,1
10526490,20141020,Panitumumab,55,801,55.0,1,95,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|CISPLATIN,3,OESOPHAGEAL SQUAMOUS CELL CARCINOMA|OESOPHAGEAL SQUAMOUS CELL CARCINOMA|OESOPHAGEAL SQUAMOUS CELL CARCINOMA,Renal failure,1,3
10527002,20141020,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,OXALIPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|PANITUMUMAB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|OXALIPLATIN|PANITUMUMAB,6,BILE DUCT CANCER|GALLBLADDER CANCER|GALLBLADDER CANCER|BILE DUCT CANCER|GALLBLADDER CANCER|BILE DUCT CANCER,Anaemia|Hyponatraemia|Hyperbilirubinaemia,3,3
10529317,20141021,Panitumumab,74,801,74.0,1,99.6,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|CAPECITABINE|METOPROLOL TARTRATE|METOPROLOL|BUPROPION HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PANTOPRAZOLE|ENOXAPARIN SODIUM|OXALIPLATIN|CLINDAMYCIN PHOSPHATE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|AMLODIPINE|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|METHYLPHENIDATE HYDROCHLORIDE,19,HYPERTENSION|ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON|HYPERTENSION|DEPRESSION|URTICARIA|GASTROOESOPHAGEAL REFLUX DISEASE|PULMONARY EMBOLISM|ADENOCARCINOMA OF COLON|PROSTATIC DISORDER|RASH|PROPHYLAXIS|NAUSEA|PRURITUS|HYPERTENSION|DEPRESSION|SKIN INFECTION|CROHN^S DISEASE|FATIGUE,Skin infection,1,3
10530025,20141021,Panitumumab,72,801,72.0,1,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|OXALIPLATIN|PANITUMUMAB|OXALIPLATIN,8,METASTASES TO LIVER|COLORECTAL CANCER|METASTASES TO LIVER|COLORECTAL CANCER|METASTASES TO LIVER|COLORECTAL CANCER|COLORECTAL CANCER|METASTASES TO LIVER,Pneumonitis,1,1
10531534,20141021,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,VORINOSTAT|DIPHENHYDRAMINE HYDROCHLORIDE|METHOTREXATE|METHOTREXATE SODIUM|PANITUMUMAB|LEVETIRACETAM|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|RITUXIMAB|HYDROXYUREA,12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CENTRAL NERVOUS SYSTEM LYMPHOMA|PRODUCT USED FOR UNKNOWN INDICATION|LYMPHOEDEMA|PRODUCT USED FOR UNKNOWN INDICATION,Dizziness|Change of bowel habit|Seizure|Feeling cold|Nail bed infection|Nasal obstruction|Alopecia|Chills|Abdominal distension|Irritability|Cluster headache|Asthenia|Fatigue|Poor peripheral circulation|Insomnia|Rash|Malignant neoplasm progression|Decreased activity|Obstructive airways disorder|Rhinorrhoea|Paraesthesia|Sinusitis|Road traffic accident,23,5
10532933,20141022,Panitumumab,55,801,55.0,2,,1,0,1,0,1,0,0,Panitumumab,PANITUMUMAB|OXYCODONE,2,COLORECTAL ADENOCARCINOMA,Dehydration|Vomiting,2,1
10533883,20141022,Panitumumab,62,801,62.0,1,,1,0,1,0,0,0,0,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|OXALIPLATIN|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|PANITUMUMAB",8,METASTASES TO LIVER|METASTASES TO LIVER|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|METASTASES TO LIVER|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|METASTASES TO LIVER,Pneumonitis,1,1
10534760,20141022,Panitumumab,70,801,70.0,1,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10537210,20141023,Panitumumab,,,,2,78,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB|OXALIPLATIN,5,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Tachycardia|Hypotension|Back pain|Spinal pain|Chills,5,1
10537238,20141023,Panitumumab,46,801,46.0,2,55,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,5,OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA,Diarrhoea,1,3
10539693,20141024,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Intestinal perforation,1,1
10540418,20141024,Panitumumab,59,801,59.0,1,,1,0,0,0,0,0,1,Panitumumab,APREPITANT|FOSAPREPITANT DIMEGLUMINE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|PANITUMUMAB,6,COLON CANCER,Iridocyclitis,1,3
10541417,20141024,Panitumumab,45,801,45.0,2,55,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|FOLIC ACID,5,OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA,Rash,1,3
10542507,20141027,Panitumumab,,,,1,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Death,1,2
10542579,20141027,Panitumumab,76,801,76.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Hypomagnesaemia,1,2
10543239,20141027,Panitumumab,74,801,74.0,2,60,1,1,1,0,0,0,1,Panitumumab,"OXALIPLATIN|OXALIPLATIN|CETUXIMAB|BEVACIZUMAB|SPIRONOLACTONE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PANITUMUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|BEVACIZUMAB|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION",25,COLORECTAL CANCER|COLORECTAL CANCER|NAUSEA|COLORECTAL CANCER|NAUSEA|CONSTIPATION|COLORECTAL CANCER|OEDEMA|PAIN|COLORECTAL CANCER|NAUSEA|COLORECTAL CANCER|COLORECTAL CANCER|HYPOTHYROIDISM|PROPHYLAXIS,Urinary tract disorder|Posterior reversible encephalopathy syndrome|Blood alkaline phosphatase increased|Coma|Metastases to liver|Renal disorder|Blood creatinine increased|Epilepsy|Diarrhoea,9,1
10543258,20141027,Panitumumab,63,801,63.0,1,72.5,1,0,0,0,1,0,1,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|MORPHINE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|OXALIPLATIN|ENOXAPARIN SODIUM",19,GASTROOESOPHAGEAL CANCER|BACK PAIN|ABDOMINAL PAIN UPPER|GASTROOESOPHAGEAL CANCER|DIABETES MELLITUS|PROPHYLAXIS,Vomiting|Nausea,2,3
10544618,20141027,Panitumumab,35,801,35.0,1,73.7,1,0,1,0,0,0,0,Panitumumab,VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN,5,COLORECTAL CANCER|COLORECTAL CANCER|RASH|INFECTION|COLORECTAL CANCER,Chills,1,1
10547376,20141028,Panitumumab,55,801,55.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Hypomagnesaemia,1,2
10549144,20141016,Panitumumab,54,801,54.0,1,,1,0,0,0,0,0,0,Panitumumab,CABOZANTINIB,4,COLON CANCER,Off label use|Rash|Acne|Erythema,4,5
10550370,20141029,Panitumumab,,,,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|PANITUMUMAB,2,COLORECTAL CANCER METASTATIC,Disease progression,1,2
10551273,20141029,Panitumumab,52,801,52.0,1,,1,0,1,0,0,0,0,Panitumumab,PACLITAXEL|RANITIDINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PANITUMUMAB,6,HEAD AND NECK CANCER|HEAD AND NECK CANCER,Arthritis bacterial|Skin toxicity,2,3
10553407,20141030,Panitumumab,69,801,69.0,1,60.6,1,0,0,0,0,0,1,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",5,RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER,Neutrophil count decreased,1,1
10553970,20141030,Panitumumab,65,801,65.0,1,,1,0,0,0,0,0,1,Panitumumab,BEVACIZUMAB|PANITUMUMAB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|IRINOTECAN HYDROCHLORIDE|BEVACIZUMAB|IRINOTECAN HYDROCHLORIDE|IRINOTECAN HYDROCHLORIDE,31,RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC,Anal fistula|Perirectal abscess|Skin disorder|Neuropathy peripheral|Diarrhoea|Dermatitis|Anaphylactic reaction|Metastases to lung,8,1
10559217,20141103,Panitumumab,79,801,79.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|PANITUMUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|CALCIUM GLUCONATE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|CALCIUM GLUCONATE|CALCIUM GLUCONATE,21,COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|METASTASES TO LIVER|METASTASES TO LIVER|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|METASTASES TO LIVER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Oedema|Mucosal inflammation|Rash pustular|Erythema,4,3
10560969,20141103,Panitumumab,79,801,79.0,1,,1,0,0,0,0,0,1,Panitumumab,"CALCIUM GLUCONATE|OXALIPLATIN|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|PANITUMUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",8,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Erythema|Acute generalised exanthematous pustulosis|Oedema|Mucosal inflammation,4,1
10561767,20141103,Panitumumab,42,801,42.0,1,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|PANITUMUMAB,8,PRODUCT USED FOR UNKNOWN INDICATION|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC,Thrombocytopenia,1,1
10563494,20141104,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,GASTROINTESTINAL CARCINOMA,Leukaemia,1,2
10569366,20141106,Panitumumab,42,801,42.0,1,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|PANITUMUMAB,8,RECTAL CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|RECTAL CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|RECTAL CANCER METASTATIC|RECTAL CANCER METASTATIC,Thrombocytopenia,1,3
10569524,20141106,Panitumumab,55,801,55.0,2,68.49,1,0,1,0,0,0,1,Panitumumab,DIPHENHYDRAMINE HYDROCHLORIDE|CLONAZEPAM|PANITUMUMAB|ESCITALOPRAM|PIMECROLIMUS|OXALIPLATIN,15,COLON CANCER METASTATIC|COLORECTAL CANCER STAGE IV|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Jaundice|Carcinoembryonic antigen increased|Bile duct obstruction|Skin disorder|Dry skin|Rash|Oedema|Skin tightness|Lacrimation decreased|Erythema|Abdominal discomfort|Vomiting|Eczema|Growth of eyelashes|Waist circumference increased|Pruritus|Hypokalaemia|Skin lesion|Pancreatitis|Ocular hyperaemia|Nausea|Eyelash hyperpigmentation|Blood bilirubin abnormal|Abdominal pain|Skin burning sensation|Eye pruritus|Ascites|Weight increased|Ocular discomfort|Dry eye|Skin exfoliation,31,3
10570689,20141107,Panitumumab,,,,2,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Rash,1,1
10571277,20141107,Panitumumab,,,,1,57,1,1,0,1,0,0,1,Panitumumab,IRINOTECAN HYDROCHLORIDE|IRINOTECAN HYDROCHLORIDE|PANITUMUMAB,10,ANTIEMETIC SUPPORTIVE CARE|CANCER PAIN|COLON CANCER|COLON CANCER|PROPHYLAXIS|GASTRITIS|COLON CANCER|COLON CANCER|ANTIEMETIC SUPPORTIVE CARE|GASTRITIS PROPHYLAXIS,Interstitial lung disease,1,1
10572454,20141110,Panitumumab,74,801,74.0,0,,1,1,0,0,0,0,0,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|BEVACIZUMAB",5,PRODUCT USED FOR UNKNOWN INDICATION|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Death|Malignant neoplasm progression,2,1
10572582,20141110,Panitumumab,70,801,70.0,1,113,1,1,0,0,0,0,0,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|OXALIPLATIN",4,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Pulmonary embolism|Skin toxicity,2,1
10573088,20141110,Panitumumab,79,801,79.0,2,65,1,1,1,0,1,0,1,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER,Malnutrition|Death|Immunodeficiency|Gastrostomy,4,3
10574173,20141110,Panitumumab,56,801,56.0,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,RECTAL CANCER,Vomiting|Diarrhoea,2,1
10574478,20141110,Panitumumab,79,801,79.0,1,,1,0,0,0,0,0,1,Panitumumab,"FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|PANITUMUMAB|PANITUMUMAB|CALCIUM GLUCONATE|METHYLPREDNISOLONE SODIUM SUCCINATE",11,METASTASES TO LIVER|COLON CANCER|COLON CANCER|METASTASES TO LIVER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COLON CANCER|METASTASES TO LIVER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Rash pustular|Mucosal inflammation|Oedema|Erythema,4,1
10575187,20141111,Panitumumab,61,801,61.0,2,47,1,0,0,1,0,0,1,Panitumumab,PANITUMUMAB|BEVACIZUMAB|PANITUMUMAB,7,MALIGNANT ASCITES|MALIGNANT ASCITES|COLON CANCER METASTATIC|MALIGNANT ASCITES|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Intestinal perforation|Malignant ascites,2,1
10578103,20141112,Panitumumab,60,801,60.0,1,,1,0,1,0,1,0,0,Panitumumab,PANITUMUMAB,1,COLORECTAL CANCER METASTATIC,Hospitalisation,1,3
10578130,20141112,Panitumumab,,,,2,83,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB,1,RECTOSIGMOID CANCER,Stoma site haemorrhage,1,1
10580344,20141112,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,EVEROLIMUS|EVEROLIMUS TABLETS|PANITUMUMAB,3,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Rash|Diarrhoea|Palmar-plantar erythrodysaesthesia syndrome|Gastric ulcer|Mouth ulceration|Nausea|Candida infection|Hypomagnesaemia,8,3
10580562,20141113,Panitumumab,,,,2,,1,0,0,0,0,0,1,Panitumumab,"PANITUMUMAB|IRINOTECAN HYDROCHLORIDE|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",4,PRODUCT USED FOR UNKNOWN INDICATION,Pollakiuria|Bile duct adenocarcinoma,2,2
10581744,20141113,Panitumumab,73,801,73.0,1,49,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB|LEVOLEUCOVORIN INJECTION|LEVOLEUCOVORIN CALCIUM|LEVOLEUCOVORIN|WARFARIN|PREGABALIN|LEVOLEUCOVORIN INJECTION|LEVOLEUCOVORIN CALCIUM|LEVOLEUCOVORIN|PANITUMUMAB|LEVOLEUCOVORIN INJECTION|LEVOLEUCOVORIN CALCIUM|LEVOLEUCOVORIN|SENNOSIDES|SENNA LEAF|SENNA|MAGNESIUM OXIDE,36,RECTAL CANCER|NAUSEA|RECTAL CANCER METASTATIC|RECTAL CANCER|RECTAL CANCER METASTATIC,Interstitial lung disease|Toxic epidermal necrolysis|Staphylococcal scalded skin syndrome,3,1
10582875,20141114,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|EVEROLIMUS|EVEROLIMUS TABLETS,3,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Fatigue|Erythema|Dermatitis acneiform|Alopecia|Pyrexia|Discomfort|Diarrhoea|Pneumothorax,8,3
10582876,20141114,Panitumumab,,,,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB|EVEROLIMUS|EVEROLIMUS TABLETS,3,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Febrile neutropenia|Diarrhoea|Hypomagnesaemia|Dermatitis acneiform|Neutropenia,5,3
10586226,20141116,Panitumumab,44,801,44.0,1,78,1,0,0,0,0,0,0,Panitumumab,CAPECITABINE|PANITUMUMAB|DOXYCYCLINE|DOXYCYCLINE HYCLATE,3,COLORECTAL CANCER|COLORECTAL CANCER,Rash,1,3
10586355,20141117,Panitumumab,57,801,57.0,2,70,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|OXALIPLATIN,4,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Subileus,1,1
10586417,20141117,Panitumumab,62,801,62.0,1,80,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|RAMIPRIL|OXALIPLATIN,6,COLORECTAL CANCER METASTATIC|HYPERTENSION|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|HYPERTENSION|COLORECTAL CANCER METASTATIC,General physical health deterioration|Skin irritation,2,1
10589304,20141118,Panitumumab,64,801,64.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION,Folliculitis|Pruritus|Skin toxicity|Xerosis,4,3
10589319,20141118,Panitumumab,30,801,30.0,2,,1,1,0,0,0,0,0,Panitumumab,ROBINUL|SILDENAFIL CITRATE|PANITUMUMAB,18,PRODUCT USED FOR UNKNOWN INDICATION,Arrhythmia,1,1
10589500,20141118,Panitumumab,63,801,63.0,1,69,1,0,1,0,0,0,0,Panitumumab,SERTRALINE|ENOXAPARIN SODIUM|PANITUMUMAB|LISINOPRIL|CETIRIZINE HYDROCHLORIDE|MINOCYCLINE,11,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Fall,1,5
10591946,20141119,Panitumumab,61,801,61.0,1,63,1,0,0,0,0,0,1,Panitumumab,OXALIPLATIN|PANITUMUMAB,5,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Rash erythematous|Skin exfoliation,2,1
10591949,20141119,Panitumumab,47,801,47.0,1,71,1,0,1,0,0,0,0,Panitumumab,CARBOPLATIN|PANITUMUMAB|OXYCODONE|ZOLPIDEM TARTRATE,5,NON-SMALL CELL LUNG CANCER STAGE IIIA|NON-SMALL CELL LUNG CANCER STAGE IIIA|PAIN|NON-SMALL CELL LUNG CANCER STAGE IIIA|INSOMNIA,Nausea|Vomiting,2,3
10592952,20141119,Panitumumab,65,801,65.0,1,,1,0,0,0,0,0,1,Panitumumab,BEVACIZUMAB|OXALIPLATIN|BEVACIZUMAB|PANITUMUMAB,17,RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER|RECTAL CANCER,Anaphylactoid reaction|Neuropathy peripheral,2,1
10595097,20141120,Panitumumab,59,801,59.0,1,,1,0,1,1,0,0,0,Panitumumab,PANITUMUMAB,2,COLON CANCER|COLON CANCER,Necrotising fasciitis,1,3
10597264,20141121,Panitumumab,41,801,41.0,1,,1,1,0,0,0,0,0,Panitumumab,PANITUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10600481,20141124,Panitumumab,53,801,53.0,2,69.8,1,0,1,0,0,0,0,Panitumumab,MINOCYCLINE|PANITUMUMAB|ROSUVASTATIN|EVEROLIMUS|EVEROLIMUS TABLETS,6,RASH|DEPRESSION|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|HYPERCHOLESTEROLAEMIA|COLORECTAL CANCER METASTATIC,Dermatitis infected,1,1
10600490,20141124,Panitumumab,77,801,77.0,1,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,7,COLON CANCER|COLON CANCER|COLON CANCER|COLON CANCER,Blood pressure decreased,1,1
10600917,20141124,Panitumumab,67,801,67.0,1,,1,0,1,1,0,0,0,Panitumumab,PANITUMUMAB,1,COLON CANCER,Henoch-Schonlein purpura,1,1
10601159,20141124,Panitumumab,79,801,79.0,0,,1,0,0,0,0,0,1,Panitumumab,PANITUMUMAB,3,COLON CANCER|COLON CANCER|COLON CANCER,Conjunctivitis,1,1
10603347,20141124,Panitumumab,,,,2,,1,0,1,0,0,0,0,Panitumumab,PANITUMUMAB|PANITUMUMAB|PANITUMUMAB|PANITUMUMAB,8,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Anaemia|Dermatitis|Hypomagnesaemia,3,3
10605709,20141125,Panitumumab,77,801,77.0,2,,1,0,1,0,0,0,0,Panitumumab,"BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|PANITUMUMAB|PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|FELODIPINE|FELODIPINE EXTENDED-RELEASE TABLETS|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CANDESARTAN|TIOTROPIUM BROMIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",16,COLON CANCER|METASTASES TO LIVER,Haemolysis,1,3
10609644,20141126,Panitumumab,79,801,79.0,1,65,1,1,1,0,0,0,0,Panitumumab,"PANITUMUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL",3,ADENOCARCINOMA OF COLON|COLON CANCER|COLON CANCER,Rash|Neoplasm progression|Orchitis|Dermatitis acneiform,4,1
10609723,20141126,Panitumumab,69,801,69.0,2,,1,0,1,0,0,0,0,Panitumumab,"SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|MITOMYCIN|PANITUMUMAB",17,ANAL CANCER|HYPERSENSITIVITY|GASTROINTESTINAL INFLAMMATION|PROPHYLAXIS|DIZZINESS|NAUSEA|PROCTALGIA|DIARRHOEA|DYSPEPSIA|HYPERTENSION|HAEMORRHOIDS|HAEMORRHOIDS|ANAL CANCER|FLATULENCE|ANAL CANCER|NAUSEA|GASTROINTESTINAL INFLAMMATION,Pyrexia|Urinary tract infection,2,1
10149473,20140502,Ramucirumab,60,801,60.0,2,47.8,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|ROSUVASTATIN,8,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|DYSLIPIDAEMIA|TUMOUR PAIN|HEADACHE|CONSTIPATION|GASTRITIS PROPHYLAXIS,Infection,1,1
10149474,20140502,Ramucirumab,62,801,62.0,2,61.6,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,7,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|PROPHYLAXIS OF NAUSEA AND VOMITING|INSOMNIA,Large intestinal haemorrhage,1,1
10160611,20140508,Ramucirumab,52,801,52.0,2,83.91,1,0,0,0,0,0,1,Ramucirumab,CETUXIMAB|RAMUCIRUMAB,3,ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON,Blood pressure increased,1,5
10162428,20140509,Ramucirumab,64,801,64.0,1,50.9,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|EMPHYSEMA,Febrile neutropenia|Decreased appetite,2,1
10173937,20140515,Ramucirumab,65,801,65.0,1,99,1,1,1,1,0,0,0,Ramucirumab,PANTOPRAZOLE|RAMUCIRUMAB,6,PAIN|PAINFUL DEFAECATION|HYPERTENSION|PROPHYLAXIS|HEPATOCELLULAR CARCINOMA|HAEMORRHOIDS,Peritonitis|Large intestine perforation|Sepsis|Anal abscess,4,1
10257647,20140625,Ramucirumab,,,,2,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death|Off label use,2,5
10257649,20140625,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Acute pulmonary oedema|Loss of consciousness|Cough|Heart rate decreased|Off label use,5,5
10268450,20140630,Ramucirumab,,,,2,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Soft tissue disorder,1,5
10276190,20140703,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Death,1,5
10285131,20140708,Ramucirumab,55,801,55.0,1,61.6,1,0,1,1,0,0,0,Ramucirumab,"RAMUCIRUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",5,GASTRIC CANCER|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS,Anaphylactic reaction,1,1
10297160,20140708,Ramucirumab,59,801,59.0,1,65,1,0,0,1,0,0,0,Ramucirumab,RAMUCIRUMAB,1,METASTATIC GASTRIC CANCER,Pulmonary embolism|Tremor|Pneumonia|Transient ischaemic attack|Heart rate irregular|Grip strength decreased|Abasia|Computerised tomogram abnormal|Muscular weakness,9,2
10301104,20140708,Ramucirumab,51,801,51.0,1,128,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL ADENOCARCINOMA,Muscle spasms,1,2
10305160,20140715,Ramucirumab,69,801,69.0,1,84.35,1,1,1,0,0,0,1,Ramucirumab,DRONABINOL|METOPROLOL TARTRATE|METOPROLOL|SIMVASTATIN|ISOSORBIDE MONONITRATE|OMEPRAZOLE MAGNESIUM|ALBUTEROL SULFATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|FUROSEMIDE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|RAMUCIRUMAB,11,OESOPHAGEAL ADENOCARCINOMA,Hepatic infarction,1,5
10305605,20140714,Ramucirumab,72,801,72.0,2,59.3,1,0,1,1,0,0,1,Ramucirumab,METOPROLOL TARTRATE|METOPROLOL|PANTOPRAZOLE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SENNOSIDES|SENNA LEAF|SENNA|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LORAZEPAM|CLONIDINE|LABETALOL|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|POLYETHYLENE GLYCOL|LOSARTAN|MAGNESIUM HYDROXIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|RAMUCIRUMAB,16,GASTRIC CANCER,Aphasia|Headache|Transient ischaemic attack|Hypertensive encephalopathy|Hypoacusis,5,2
10308767,20140716,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL ADENOCARCINOMA,Bile duct obstruction,1,5
10328579,20140721,Ramucirumab,52,801,52.0,1,,1,0,1,0,0,0,0,Ramucirumab,ESCITALOPRAM|CAPECITABINE|WARFARIN|LEVOTHYROXINE SODIUM|ESOMEPRAZOLE MAGNESIUM|LORAZEPAM|RAMUCIRUMAB|WARFARIN,8,DEEP VEIN THROMBOSIS|GASTRIC CANCER,Dizziness|Nausea|Loss of consciousness|Hypotension,4,1
10340442,20140724,Ramucirumab,,,,2,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|HYDROMORPHONE HYDROCHLORIDE|FENTANYL|PACLITAXEL,4,GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER,Productive cough|Pleural effusion|Pneumothorax,3,5
10340445,20140724,Ramucirumab,55,801,55.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Pyrexia,1,5
10340453,20140724,Ramucirumab,72,801,72.0,2,58,1,0,1,0,0,0,1,Ramucirumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|RAMUCIRUMAB,3,GASTRIC CANCER,Transient ischaemic attack|Neurological symptom|Dysarthria|Hypertension,4,5
10347178,20140729,Ramucirumab,72,801,72.0,1,65.31,1,1,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIPHENHYDRAMINE HYDROCHLORIDE,3,GASTRIC CANCER STAGE IV,Malignant neoplasm progression|Pleural effusion,2,1
10348352,20140729,Ramucirumab,77,801,77.0,2,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB|RAMUCIRUMAB,3,OESOPHAGEAL CARCINOMA|GASTRIC CANCER,Death,1,1
10354449,20140731,Ramucirumab,61,801,61.0,1,69.1,1,0,1,0,0,0,0,Ramucirumab,DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB|FUROSEMIDE,14,COUGH|HYPOTHYROIDISM|NON-SMALL CELL LUNG CANCER STAGE IV|CONSTIPATION|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|MYALGIA|MYALGIA|NON-SMALL CELL LUNG CANCER STAGE IV|ANAEMIA|DRY SKIN|OEDEMA|CONJUNCTIVITIS,Hepatic cirrhosis,1,1
10368207,20140807,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|FENTANYL|LISINOPRIL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OMEPRAZOLE MAGNESIUM,6,OESOPHAGEAL CARCINOMA,Death,1,5
10368213,20140807,Ramucirumab,65,801,65.0,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL CARCINOMA,Death,1,5
10376265,20140811,Ramucirumab,76,801,76.0,1,65.2,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|LORATADINE|LORATADINE ORAL|RAMUCIRUMAB|GABAPENTIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|LATANOPROST|FUROSEMIDE,13,BLADDER CANCER|STOMATITIS|BLADDER CANCER|BLADDER CANCER|BLADDER CANCER,Urinary tract infection|Acute kidney injury,2,3
10385729,20140814,Ramucirumab,55,801,55.0,2,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Malignant neoplasm progression,1,5
10401488,20140822,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Urticaria,1,5
10403497,20140822,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Headache,1,5
10407834,20140825,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,OESOPHAGEAL ADENOCARCINOMA|PREMEDICATION,Dyspnoea|Respiratory tract oedema,2,5
10410772,20140826,Ramucirumab,77,801,77.0,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,3,GASTRIC CANCER|GASTRIC CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Cardiac failure congestive|Ejection fraction decreased,2,5
10412926,20140827,Ramucirumab,,,,1,114.69,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB|OMEPRAZOLE MAGNESIUM,2,OESOPHAGEAL CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION,Gastrointestinal haemorrhage|Deep vein thrombosis|Pulmonary embolism,3,5
10413676,20140827,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION,Neuropathy peripheral,1,5
10415083,20140828,Ramucirumab,55,801,55.0,2,72,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,6,COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER|COLORECTAL CANCER,Febrile neutropenia|Deep vein thrombosis,2,1
10416768,20140828,Ramucirumab,57,801,57.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Thrombosis|Haemorrhage|Off label use,3,5
10418031,20140828,Ramucirumab,72,801,72.0,1,105,1,0,1,0,0,0,0,Ramucirumab,LITHIUM|LITHIUM BROMATUM|RAMUCIRUMAB,2,BIPOLAR I DISORDER|OESOPHAGEAL CARCINOMA,Antipsychotic drug level above therapeutic|Sedation|Mental status changes|Hyponatraemia|Confusional state|Toxicity to various agents,6,2
10418688,20140829,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|METOPROLOL TARTRATE,2,GASTRIC CANCER,Proteinuria|Hypertension,2,5
10424879,20140902,Ramucirumab,,,,2,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL CARCINOMA,Haemorrhage,1,5
10424960,20140902,Ramucirumab,48,801,48.0,1,85.71,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL ADENOCARCINOMA,Gastrointestinal haemorrhage,1,3
10426857,20140903,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Fatigue,1,5
10432426,20140905,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,NEOPLASM MALIGNANT,Diarrhoea,1,5
10439056,20140908,Ramucirumab,74,801,74.0,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Malignant neoplasm progression,1,5
10439061,20140908,Ramucirumab,76,801,76.0,1,,1,1,0,0,0,0,0,Ramucirumab,SULFAMETHOXAZOLE AND TRIMETHOPRIM|RAMUCIRUMAB|FLUCONAZOLE|DIPHENHYDRAMINE HYDROCHLORIDE,4,GASTRIC CANCER|PREMEDICATION,Intestinal obstruction,1,3
10444912,20140910,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,4,GASTRIC CANCER,Vomiting,1,5
10458646,20140917,Ramucirumab,68,801,68.0,1,88.35,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|ESOMEPRAZOLE MAGNESIUM,2,OESOPHAGEAL ADENOCARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION,Gastrointestinal haemorrhage|Shock haemorrhagic,2,5
10459276,20140917,Ramucirumab,,,,1,70.75,1,1,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|LABETALOL|SIMVASTATIN|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|METOPROLOL TARTRATE|METOPROLOL|DRONABINOL|FAMOTIDINE,14,OESOPHAGEAL CARCINOMA,Malignant neoplasm progression|Aspiration|Respiratory failure,3,3
10460193,20140917,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|TRASTUZUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION,Neck pain|Fatigue|Ear pain|Headache,4,5
10461729,20140918,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE HYDROCHLORIDE|RAMUCIRUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,4,ADENOCARCINOMA GASTRIC,Skin burning sensation,1,5
10461828,20140918,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea,1,5
10472211,20140924,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Bone pain|Malaise,2,5
10475713,20140925,Ramucirumab,,,,2,82,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,METASTATIC GASTRIC CANCER,Vomiting|Posterior reversible encephalopathy syndrome|Nausea,3,5
10476069,20140925,Ramucirumab,70,801,70.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|HYDRALAZINE HYDROCHLORIDE|PANTOPRAZOLE|RAMUCIRUMAB|LOSARTAN|INSULIN ASPART|AMLODIPINE|CLONIDINE|INSULIN GLARGINE|LISINOPRIL,12,GASTROOESOPHAGEAL CANCER,Blood urine present,1,5
10476543,20140925,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Urticaria,1,5
10477393,20140926,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Drug intolerance,1,5
10479267,20140926,Ramucirumab,67,801,67.0,1,51.5,1,0,1,0,0,0,0,Ramucirumab,SODIUM HYALURONATE|INSULIN ASPART|DOCETAXEL|DOCETAXEL ANHYDROUS|FAMOTIDINE|GLIMEPIRIDE|DOCETAXEL|DOCETAXEL ANHYDROUS|NATEGLINIDE|RAMUCIRUMAB,13,DIABETES MELLITUS|CATARACT|CATARACT|DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER STAGE IV|GASTRIC ULCER|CATARACT|DIABETES MELLITUS|CATARACT|DIABETES MELLITUS|COUGH|NON-SMALL CELL LUNG CANCER STAGE IV,Febrile neutropenia,1,1
10484236,20140930,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Malignant neoplasm progression,1,5
10490373,20141002,Ramucirumab,74,801,74.0,2,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Death,1,5
10497338,20141006,Ramucirumab,,,,1,85.71,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|FAMOTIDINE|ATENOLOL|FUROSEMIDE|ISOSORBIDE MONONITRATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|SAXAGLIPTIN|RAMUCIRUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|MIRTAZAPINE|ATORVASTATIN CALCIUM,13,GASTRIC CANCER|OESOPHAGEAL ADENOCARCINOMA,Nausea|Dizziness|Urticaria,3,5
10501324,20141007,Ramucirumab,58,801,58.0,1,61,1,0,0,0,0,0,1,Ramucirumab,PROMETHAZINE HYDROCHLORIDE|HYDROMORPHONE HYDROCHLORIDE|LISINOPRIL|RAMUCIRUMAB,4,GASTROOESOPHAGEAL CANCER,Blood pressure increased,1,3
10501953,20141007,Ramucirumab,,,,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|LEVOTHYROXINE SODIUM,3,OESOPHAGEAL CARCINOMA,Dyspnoea|Tremor|Fatigue|Malignant neoplasm progression|Vision blurred|Confusional state,6,5
10503698,20141008,Ramucirumab,51,801,51.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Pain,1,5
10505351,20141008,Ramucirumab,55,801,55.0,1,,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,OESOPHAGEAL ADENOCARCINOMA|GASTROOESOPHAGEAL CANCER,Off label use|Malignant neoplasm progression,2,1
10509367,20141009,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Drug ineffective|Ultrasound scan abnormal|Tumour marker increased,3,5
10509368,20141009,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Epistaxis,1,2
10520203,20141015,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION,Haematuria,1,5
10527689,20141020,Ramucirumab,70,801,70.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB|RAMUCIRUMAB,3,OESOPHAGEAL CARCINOMA,Infusion site extravasation,1,2
10528106,20141020,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Catheter site haemorrhage,1,5
10528937,20141020,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,,Colitis,1,5
10532015,20141021,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Malignant neoplasm progression,1,5
10533854,20141022,Ramucirumab,65,801,65.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Petechiae,1,5
10533990,20141022,Ramucirumab,,,,1,87.39,1,0,1,0,0,0,1,Ramucirumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|CARVEDILOL|AMLODIPINE|RAMUCIRUMAB|LISINOPRIL,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|OESOPHAGEAL ADENOCARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION,Sepsis|Back pain|Leukopenia|Bacteraemia|Blood pressure increased|Thrombocytopenia,6,1
10534139,20141022,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Dysphonia|Laryngitis,2,5
10534216,20141022,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL ADENOCARCINOMA,Proteinuria,1,5
10534453,20141022,Ramucirumab,67,801,67.0,2,94.7,1,0,0,0,0,0,0,Ramucirumab,FISH OIL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|RAMUCIRUMAB|MAGNESIUM OXIDE|ERGOCALCIFEROL|MAGNESIUM CITRATE|MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON|BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY|CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY|FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE|MAGNESIUM CITRATE ORAL SOLUTION|CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE|BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE|CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON|FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON|LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY|LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON|BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON|FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY|LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE|HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON|RAMUCIRUMAB|SENNOSIDES|SENNA LEAF|SENNA|LEVOTHYROXINE SODIUM|ATENOLOL,11,OESOPHAGEAL CARCINOMA|CONSTIPATION,Back pain|Muscle twitching|Pain in extremity,3,5
10560092,20141103,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Oesophageal irritation|Haematemesis,2,5
10561500,20141103,Ramucirumab,58,801,58.0,1,61.13,1,1,0,0,0,0,1,Ramucirumab,LISINOPRIL|RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|GASTRIC CANCER STAGE IV,Hypertension|Malignant neoplasm progression|Death,3,1
10561501,20141103,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Haematemesis|Oesophageal rupture|Oesophageal stenosis,3,5
10561502,20141103,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTROOESOPHAGEAL CANCER,Gastrointestinal haemorrhage|Haemoglobin decreased,2,5
10562644,20141104,Ramucirumab,66,801,66.0,1,91.5,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Upper gastrointestinal haemorrhage,1,2
10563573,20141104,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Fatigue|Hepatic cirrhosis|Malignant neoplasm progression,3,5
10565400,20141105,Ramucirumab,59,801,59.0,1,87.7,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,ADENOCARCINOMA GASTRIC,Gastrointestinal haemorrhage,1,2
10566481,20141105,Ramucirumab,,,,1,73.7,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression,1,5
10566487,20141105,Ramucirumab,66,801,66.0,1,,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA,Oesophageal perforation|Death,2,5
10571206,20141107,Ramucirumab,70,801,70.0,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10571236,20141107,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10579035,20141112,Ramucirumab,84,801,84.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Hyponatraemia,1,5
10581918,20141113,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Nausea,1,3
10583682,20141114,Ramucirumab,84,801,84.0,1,67,1,0,1,0,0,0,0,Ramucirumab,FUROSEMIDE|RAMUCIRUMAB,2,GASTROOESOPHAGEAL CANCER,Hyponatraemia,1,1
10586894,20141117,Ramucirumab,,,,0,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,White blood cell count decreased,1,5
10586932,20141117,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,White blood cell count decreased,1,5
10587297,20141117,Ramucirumab,72,801,72.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PANTOPRAZOLE SODIUM,5,GASTRIC CANCER,Hypertension,1,1
10590390,20141118,Ramucirumab,,,,1,66,1,0,1,0,0,0,0,Ramucirumab,METHIMAZOLE|OXYCODONE HCL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FERROUS SULFATE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE|HYDROMORPHONE HYDROCHLORIDE|RAMUCIRUMAB|HYDROMORPHONE HYDROCHLORIDE,11,GASTRIC CANCER,Haematemesis|Malignant neoplasm progression,2,2
10593785,20141119,Ramucirumab,,,,1,,1,1,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,CHEMOTHERAPY|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Pneumonia aspiration|Gastrointestinal haemorrhage,3,1
10597709,20141121,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Hypertension|Nasal disorder|Vision blurred|Headache|Nasopharyngitis,5,5
10597770,20141121,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Abdominal pain upper,1,5
10597886,20141121,Ramucirumab,,,,0,,1,0,0,0,0,0,0,Ramucirumab,PACLITAXEL|FILGRASTIM|RAMUCIRUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pain,1,5
10598021,20141121,Ramucirumab,,,,0,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Myalgia|Off label use|Bone pain,3,5
10598210,20141121,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Gastrointestinal perforation,1,5
10602296,20141124,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Hypertension,1,5
10602367,20141124,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Death,1,5
10602368,20141124,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Death,1,5
10609409,20141126,Ramucirumab,58,801,58.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Malignant neoplasm progression|Headache,2,5
10609414,20141126,Ramucirumab,,,,0,,1,0,0,0,0,0,1,Ramucirumab,CISPLATIN|PEMETREXED|PEMETREXED DISODIUM|CARBOPLATIN|FOLIC ACID|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|RAMUCIRUMAB,7,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Peripheral vascular disorder,1,3
10609707,20141126,Ramucirumab,,,,0,,1,0,0,0,0,0,1,Ramucirumab,CARBOPLATIN|RAMUCIRUMAB|CARBOPLATIN|FOLIC ACID|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|CISPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PEMETREXED|PEMETREXED DISODIUM,9,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Respiratory failure,1,3
10610248,20141126,Ramucirumab,62,801,62.0,1,84,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|ENTECAVIR|ENTECAVIR ANHYDROUS|CIPROFLOXACIN HYDROCHLORIDE|OXALIPLATIN|CIMETIDINE,11,HEPATOCELLULAR CARCINOMA|HEPATOCELLULAR CARCINOMA|CHRONIC HEPATITIS B|INFECTION PROPHYLAXIS|HEPATOCELLULAR CARCINOMA|ABDOMINAL PAIN|ABDOMINAL PAIN|HEPATIC CIRRHOSIS|HEPATOCELLULAR CARCINOMA|CONSTIPATION PROPHYLAXIS,Blood bilirubin increased,1,1
10612085,20141127,Ramucirumab,,,,0,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|CARBOPLATIN|PEMETREXED|PEMETREXED DISODIUM|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|FOLIC ACID|CISPLATIN,7,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Ischaemic cerebral infarction,1,3
10612092,20141127,Ramucirumab,,,,0,,1,0,0,0,0,0,1,Ramucirumab,CARBOPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|CISPLATIN|FOLIC ACID|PEMETREXED|PEMETREXED DISODIUM|RAMUCIRUMAB,7,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Proteinuria,1,3
10612150,20141127,Ramucirumab,,,,0,,1,0,0,0,0,0,1,Ramucirumab,CARBOPLATIN|RAMUCIRUMAB|CISPLATIN|FOLIC ACID|PEMETREXED|PEMETREXED DISODIUM,6,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Gastrointestinal perforation,1,3
10612172,20141127,Ramucirumab,,,,0,,1,1,0,0,0,0,0,Ramucirumab,CARBOPLATIN|CISPLATIN|PEMETREXED|PEMETREXED DISODIUM|RAMUCIRUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FOLIC ACID,7,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Multi-organ failure,1,3
10612178,20141127,Ramucirumab,,,,0,,1,1,0,0,0,0,0,Ramucirumab,CISPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FOLIC ACID|CARBOPLATIN|PEMETREXED|PEMETREXED DISODIUM|RAMUCIRUMAB,7,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Myocardial infarction,1,3
10612181,20141127,Ramucirumab,,,,0,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PEMETREXED|PEMETREXED DISODIUM|CARBOPLATIN|CISPLATIN|FOLIC ACID|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,7,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Sudden death,1,3
10612192,20141127,Ramucirumab,,,,0,,1,0,0,0,0,0,1,Ramucirumab,CISPLATIN|RAMUCIRUMAB|PEMETREXED|PEMETREXED DISODIUM|CARBOPLATIN|FOLIC ACID,6,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Angina pectoris,1,3
10612363,20141127,Ramucirumab,,,,0,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|CISPLATIN|CARBOPLATIN|PEMETREXED|PEMETREXED DISODIUM,4,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Intestinal ischaemia,1,3
10612367,20141127,Ramucirumab,,,,0,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PEMETREXED|PEMETREXED DISODIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CISPLATIN|CARBOPLATIN|FOLIC ACID,7,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Cardiac failure congestive,1,3
10614236,20141128,Ramucirumab,69,801,69.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|OXALIPLATIN|MITOMYCIN,5,GASTRIC CANCER,Pancytopenia|Tumour marker increased,2,5
10614237,20141128,Ramucirumab,61,801,61.0,1,149.1,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB,2,GASTROOESOPHAGEAL CANCER|GASTRIC CANCER,Gastrooesophageal cancer|Dehydration,2,2
10614239,20141128,Ramucirumab,,,,1,75,1,1,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTROOESOPHAGEAL CANCER,Malignant neoplasm progression,1,3
10614240,20141128,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10622709,20141203,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Vomiting|Nausea|Fatigue,3,5
10625938,20141204,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Adverse drug reaction,1,5
10627935,20141205,Ramucirumab,69,801,69.0,1,,1,0,0,0,1,0,0,Ramucirumab,AMLODIPINE BESYLATE|MULTIVITAMIN|RAMUCIRUMAB|GABAPENTIN|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|CETUXIMAB|CETUXIMAB,11,DIARRHOEA|COLORECTAL CANCER|HEPATIC CANCER,Rash,1,5
10631101,20141205,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression,1,5
10638195,20141208,Ramucirumab,,,,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTROOESOPHAGEAL CANCER,Skin lesion,1,5
10646551,20141211,Ramucirumab,65,801,65.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Melaena,1,5
10648116,20141212,Ramucirumab,73,801,73.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Palmar erythema|Pruritus|Rash,3,5
10648687,20141212,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Fatigue,1,5
10654283,20141216,Ramucirumab,54,801,54.0,1,51.1,1,0,1,0,0,0,0,Ramucirumab,ESOMEPRAZOLE MAGNESIUM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|IRBESARTAN|RAMUCIRUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DOCETAXEL|DOCETAXEL ANHYDROUS,8,PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|HYPERTENSION|CANCER PAIN|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|CONSTIPATION PROPHYLAXIS,Condition aggravated|Febrile neutropenia,2,1
10668626,20141222,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|General physical health deterioration,2,5
10672339,20141223,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Feeling abnormal,1,3
10674747,20141224,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,GASTROOESOPHAGEAL CANCER,Gastric haemorrhage|Nausea|Decreased appetite|Fatigue,4,5
10679204,20141229,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,GASTRIC NEOPLASM|GASTRIC NEOPLASM,Malignant neoplasm progression|Haemorrhage,2,5
10680784,20141229,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Rash,1,5
10692410,20150106,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB,2,GASTRIC CANCER|GASTROOESOPHAGEAL CANCER,Proteinuria,1,5
10698896,20150108,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,PRODUCT USED FOR UNKNOWN INDICATION,Rash pruritic,1,5
10706578,20150113,Ramucirumab,60,801,60.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,METASTATIC GASTRIC CANCER,Infusion site extravasation,1,2
10706959,20150113,Ramucirumab,73,801,73.0,2,68.7,1,0,1,1,0,0,0,Ramucirumab,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LORAZEPAM|RAMUCIRUMAB|LORAZEPAM|ABEMACICLIB,7,ANTIEMETIC SUPPORTIVE CARE|ANXIETY|NON-SMALL CELL LUNG CANCER|DIARRHOEA|ANTIEMETIC SUPPORTIVE CARE|NON-SMALL CELL LUNG CANCER,Cardiogenic shock|Small intestinal obstruction|Diarrhoea|Stress cardiomyopathy,4,1
10709865,20150113,Ramucirumab,83,801,83.0,1,64.86,1,0,1,0,0,0,0,Ramucirumab,"HYDROMORPHONE HYDROCHLORIDE|RAMUCIRUMAB|ATORVASTATIN CALCIUM|AMLODIPINE BESYLATE|DENOSUMAB|FAMOTIDINE|METOPROLOL TARTRATE|METOPROLOL|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|LATANOPROST",15,LUNG NEOPLASM MALIGNANT,Myocardial infarction|Transient ischaemic attack,2,3
10711552,20150114,Ramucirumab,,,,2,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Gastrointestinal haemorrhage,1,1
10711561,20150114,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10716848,20150116,Ramucirumab,70,801,70.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL ADENOCARCINOMA,Infusion related reaction,1,5
10717372,20150116,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LEVOTHYROXINE|RAMUCIRUMAB|PANTOPRAZOLE|METOPROLOL SUCCINATE|QUINAPRIL|QUINAPRIL HYDROCHLORIDE|ATORVASTATIN CALCIUM,8,OESOPHAGEAL CARCINOMA,Internal haemorrhage,1,3
10721599,20150119,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Dyspnoea|Flushing|Chills,3,5
10724490,20150120,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Hypercalcaemia,1,5
10724492,20150120,Ramucirumab,63,801,63.0,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Off label use|Jugular vein thrombosis,2,5
10726132,20150121,Ramucirumab,86,801,86.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DIPHENHYDRAMINE HYDROCHLORIDE,2,GASTROOESOPHAGEAL CANCER,Rash|Urticaria,2,5
10729813,20150122,Ramucirumab,63,801,63.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL CANCER METASTATIC,Neutrophil count decreased,1,2
10733208,20150123,Ramucirumab,86,801,86.0,0,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Arthritis,1,5
10733210,20150123,Ramucirumab,83,801,83.0,0,,1,0,0,0,0,0,0,Ramucirumab,SPIRONOLACTONE|PACLITAXEL|RAMUCIRUMAB|LACTULOSE|OMEPRAZOLE MAGNESIUM,5,GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER,Blood pressure increased|Tremor,2,3
10736737,20150126,Ramucirumab,,,,2,,1,0,0,1,1,0,1,Ramucirumab,RAMUCIRUMAB,1,LUNG NEOPLASM MALIGNANT,Hypertension|Posterior reversible encephalopathy syndrome,2,5
10742308,20150127,Ramucirumab,,,,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL ADENOCARCINOMA,Pulmonary embolism|Gastrointestinal haemorrhage|Gastrointestinal perforation|Deep vein thrombosis,4,5
10742570,20150127,Ramucirumab,75,801,75.0,1,89.34,1,1,0,0,0,0,0,Ramucirumab,"DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|RAMUCIRUMAB",6,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV|PREMEDICATION,Cardiac arrest|Coronary artery disease,2,5
10751105,20150128,Ramucirumab,,,,0,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,ADENOCARCINOMA|ADENOCARCINOMA,Malabsorption,1,1
10751247,20150128,Ramucirumab,,,,0,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,ADENOCARCINOMA|ADENOCARCINOMA,Sepsis,1,1
10751373,20150128,Ramucirumab,,,,0,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,ADENOCARCINOMA|ADENOCARCINOMA,Gastrointestinal haemorrhage,1,1
10751386,20150128,Ramucirumab,,,,0,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,ADENOCARCINOMA|ADENOCARCINOMA,Pulmonary embolism,1,1
10751414,20150128,Ramucirumab,,,,0,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,ADENOCARCINOMA|ADENOCARCINOMA,Death,1,1
10753622,20150129,Ramucirumab,,,,0,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,ADENOCARCINOMA|ADENOCARCINOMA,Septic shock,1,1
10755808,20150202,Ramucirumab,,,,0,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Cardiac disorder,1,1
10755825,20150202,Ramucirumab,,,,0,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Haemorrhage,1,1
10755877,20150202,Ramucirumab,,,,0,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pulmonary embolism,1,1
10755883,20150202,Ramucirumab,,,,0,,1,1,0,0,0,0,0,Ramucirumab,DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Respiratory arrest,1,1
10755891,20150202,Ramucirumab,,,,0,,1,1,0,0,0,0,0,Ramucirumab,DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Renal failure,1,1
10757203,20150203,Ramucirumab,,,,2,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Malignant neoplasm progression,1,3
10758500,20150203,Ramucirumab,70,801,70.0,1,,1,0,1,0,0,0,0,Ramucirumab,DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Stomatitis,1,5
10761583,20150204,Ramucirumab,45,801,45.0,2,60,1,1,1,0,0,0,0,Ramucirumab,CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|RAMUCIRUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|SPIRONOLACTONE,10,URINARY RETENTION|HEPATOCELLULAR CARCINOMA|HYPOPROTEINAEMIA|CHOLELITHIASIS|LAXATIVE SUPPORTIVE CARE|GASTRIC PH|BLOOD PRESSURE INCREASED|PYREXIA|PROPHYLAXIS|FLUID RETENTION,Oesophageal varices haemorrhage|Peritonitis bacterial|Ascites|Death,4,1
10766989,20150205,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTROINTESTINAL CARCINOMA,Jaundice|Malignant neoplasm progression,2,5
10781553,20150210,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Pain|Weight decreased|Postoperative adhesion,3,1
10783649,20150210,Ramucirumab,64,801,64.0,2,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB,4,OESOPHAGEAL ADENOCARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10792257,20150213,Ramucirumab,77,801,77.0,1,,1,1,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|RIVAROXABAN,2,GASTRIC CANCER|THROMBOSIS,Haemorrhage|Thrombosis,2,5
10793485,20150213,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTROOESOPHAGEAL CANCER,Malignant neoplasm progression,1,3
10794205,20150213,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Loss of consciousness|Chest discomfort|Circulatory collapse,3,5
10802481,20150217,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Anaphylactic reaction,1,5
10803135,20150217,Ramucirumab,,,,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Fungal infection,1,3
10833766,20150219,Ramucirumab,61,801,61.0,1,77.1,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER,Erythema|Burning sensation,2,3
10846502,20150220,Ramucirumab,66,801,66.0,1,79.37,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|FENTANYL|SIMETHICONE|DIMETHICONE|OMEPRAZOLE MAGNESIUM|LACTULOSE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|LORAZEPAM,10,GASTRIC CANCER STAGE IV,Cerebrovascular accident,1,3
10846853,20150220,Ramucirumab,63,801,63.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|METHYLPREDNISOLONE SODIUM SUCCINATE,4,OESOPHAGEAL CARCINOMA|OESOPHAGEAL CARCINOMA|PREMEDICATION|PREMEDICATION,Infusion related reaction,1,5
10861968,20150224,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Mucosal inflammation,1,5
10865828,20150224,Ramucirumab,,,,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Thrombosis,1,5
10866954,20150225,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Weight decreased,1,5
10873330,20150227,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,OXALIPLATIN|CAPECITABINE|RAMUCIRUMAB,4,OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA,Hernia,1,1
10873879,20150227,Ramucirumab,53,801,53.0,2,66.5,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|GUAIFENESIN|CARVEDILOL|BUPROPION HYDROCHLORIDE|FOLIC ACID|PREDNISONE|ALPRAZOLAM|VITAMIN E,13,LUNG NEOPLASM MALIGNANT|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|HYPERTENSION|ANTIDEPRESSANT THERAPY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Thrombocytopenia|Hypertension|Thrombocytopenia|Renal disorder,4,5
10873880,20150227,Ramucirumab,59,801,59.0,1,88.35,1,1,1,0,0,0,1,Ramucirumab,POTASSIUM CHLORIDE|RAMUCIRUMAB|PANTOPRAZOLE SODIUM,8,OESOPHAGEAL ADENOCARCINOMA,Gastrointestinal haemorrhage|Malignant neoplasm progression|Haemoptysis|Medical device complication,4,5
10877635,20150302,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Epistaxis,1,5
10881723,20150303,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC DISORDER,Erythema|Hypertension|Paraesthesia,3,5
10883223,20150303,Ramucirumab,66,801,66.0,1,102.49,1,0,0,0,0,0,0,Ramucirumab,METOPROLOL TARTRATE|METOPROLOL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|RAMUCIRUMAB|RAMUCIRUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FAMOTIDINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,8,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV|METASTASES TO BONE,Infusion related reaction,1,3
10883291,20150303,Ramucirumab,71,801,71.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|CARBOPLATIN,6,SQUAMOUS CELL CARCINOMA OF LUNG|SQUAMOUS CELL CARCINOMA OF LUNG|PRODUCT USED FOR UNKNOWN INDICATION|SQUAMOUS CELL CARCINOMA OF LUNG|SQUAMOUS CELL CARCINOMA OF LUNG|SQUAMOUS CELL CARCINOMA OF LUNG,Proteinuria,1,5
10884829,20150304,Ramucirumab,,,,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,LUNG NEOPLASM MALIGNANT,Hypertension|Headache|Malignant neoplasm progression,3,5
10891412,20150306,Ramucirumab,73,801,73.0,2,,1,0,1,0,0,0,0,Ramucirumab,DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Febrile neutropenia|Oropharyngeal pain|Candida infection|Herpes simplex|Mucosal inflammation|Rash,6,5
10891975,20150306,Ramucirumab,79,801,79.0,1,,1,1,0,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Febrile neutropenia,1,5
10892014,20150306,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Cellulitis|Oedema peripheral,2,5
10892019,20150306,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Oedema peripheral|Cellulitis,2,5
10892240,20150306,Ramucirumab,,,,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL CARCINOMA,Colitis,1,1
10899264,20150309,Ramucirumab,65,801,65.0,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Neutropenia|Fatigue|Sepsis|Heart rate increased,4,5
10904803,20150311,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Proteinuria,1,5
10907153,20150312,Ramucirumab,60,801,60.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Infusion related reaction,1,5
10907860,20150312,Ramucirumab,55,801,55.0,1,61,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL|ATORVASTATIN CALCIUM,5,GASTRIC CANCER STAGE IV|GASTRIC CANCER STAGE IV,Peripheral ischaemia|Peripheral embolism,2,5
10908894,20150312,Ramucirumab,66,801,66.0,1,67,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Fall|Pulmonary embolism|Rib fracture,3,1
10910878,20150312,Ramucirumab,44,801,44.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Chest discomfort|Pruritus|Rash|Palmar erythema,4,5
10913752,20150313,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Blood urine present|Cystitis noninfective,2,5
10914643,20150313,Ramucirumab,66,801,66.0,1,67,1,1,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Pulmonary embolism|Rib fracture|Fall|Confusional state|Malignant neoplasm progression,5,5
10922841,20150317,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Death,1,5
10928435,20150319,Ramucirumab,,,,2,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Stomatitis,1,5
10929377,20150319,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,2,LUNG NEOPLASM MALIGNANT|PREMEDICATION,Pruritus|Urticaria,2,5
10929799,20150319,Ramucirumab,66,801,66.0,1,,1,1,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB,2,OESOPHAGEAL ADENOCARCINOMA,Pleural effusion|Arteriosclerosis coronary artery|Tumour haemorrhage|Malignant neoplasm progression|Atelectasis|Localised oedema,6,3
10935246,20150320,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB|RAMUCIRUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT,Stomatitis,1,5
10945313,20150323,Ramucirumab,62,801,62.0,2,69,1,0,0,0,1,0,1,Ramucirumab,PACLITAXEL|RAMUCIRUMAB|RANITIDINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PREMEDICATION,Blood alkaline phosphatase increased|Neutrophil count decreased|Haemoglobin decreased|Aspartate aminotransferase increased|Neuropathy peripheral|Platelet count decreased|International normalised ratio abnormal|Blood bilirubin increased|Alanine aminotransferase increased,9,5
10947357,20150323,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Rash,1,5
10949340,20150324,Ramucirumab,,,,0,,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,4,GASTRIC NEOPLASM|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|GASTRIC NEOPLASM,Feeding disorder|Disease progression|Hypotension|General physical health deterioration|Vomiting|Gastric neoplasm,6,1
10952868,20150325,Ramucirumab,66,801,66.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Neutropenia|Stomatitis|Fatigue|Chills,4,5
10953141,20150325,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Blood count abnormal,1,5
10956287,20150326,Ramucirumab,60,801,60.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,4,PRODUCT USED FOR UNKNOWN INDICATION|OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Red blood cell count decreased|Hepatocellular injury|Haematocrit decreased|Haemoglobin decreased|Blood urea increased|Blood creatinine increased|Cholestasis,8,5
10956295,20150326,Ramucirumab,,,,2,64,1,1,0,1,0,0,0,Ramucirumab,RAMUCIRUMAB,1,METASTATIC GASTRIC CANCER,Malignant neoplasm progression|Lung infection|Diverticular perforation,3,1
10956579,20150326,Ramucirumab,,,,1,,1,1,1,0,0,0,0,Ramucirumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RAMUCIRUMAB|AMOXICILLIN AND CLAVULANATE POTASSIUM,7,PAIN|NAUSEA|GASTROOESOPHAGEAL CANCER|PAIN|GASTRIC CANCER,Off label use|Haematocrit decreased|Blood glucose increased|Malignant neoplasm progression|Chills|Stoma site reaction|Red blood cell count decreased|Culture positive|Haemoglobin decreased|Discomfort|Platelet count increased,11,3
10961265,20150327,Ramucirumab,75,801,75.0,1,,1,0,0,0,0,0,0,Ramucirumab,DIPHENHYDRAMINE HYDROCHLORIDE|RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,PREMEDICATION|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Erythema|Flushing,2,5
10962385,20150327,Ramucirumab,,,,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Pulmonary mass|Pneumonitis|Malignant neoplasm progression|Diarrhoea|Toxicity to various agents|Pneumonia|Neutropenia|Fatigue,8,5
10965682,20150330,Ramucirumab,65,801,65.0,1,,1,0,1,0,0,0,0,Ramucirumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ALPRAZOLAM|RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,4,PREMEDICATION|PREMEDICATION|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Myocardial infarction,1,5
10969750,20150331,Ramucirumab,76,801,76.0,1,,1,1,1,0,0,0,0,Ramucirumab,"LATANOPROST|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|DIPHENHYDRAMINE HYDROCHLORIDE|HYDROCODONE BITARTRATE AND ACETAMINOPHEN|CLONIDINE|FERROUS SULFATE|RANITIDINE|GABAPENTIN|HYDRALAZINE HYDROCHLORIDE|METOLAZONE|ERGOCALCIFEROL|FUROSEMIDE|RAMUCIRUMAB|CIMETIDINE|PREDNISONE|NIFEDIPINE",23,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GASTRIC CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GASTRIC CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,White blood cell count decreased|Vomiting|Multi-organ failure|Cerebrovascular accident|Nausea,5,5
10973679,20150401,Ramucirumab,56,801,56.0,1,82.4,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER|GASTRIC CANCER,Hypertension,1,2
10974748,20150401,Ramucirumab,,,,2,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,2,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Embolism arterial,1,5
10974856,20150401,Ramucirumab,64,801,64.0,2,51.7,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER,Lip swelling|Pharyngeal oedema|Aphagia|Dyspnoea|Swollen tongue|Rash|Gingival swelling|Epistaxis|Dysphonia,9,5
10974858,20150401,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10974859,20150401,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,NON-SMALL CELL LUNG CANCER,Hypoxia|Hypotension|Dizziness|Dyspnoea,4,2
10978859,20150402,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|CARBOPLATIN,4,OESOPHAGEAL ADENOCARCINOMA,Orthostatic hypotension,1,5
10983120,20150402,Ramucirumab,51,801,51.0,2,50,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,,Intestinal perforation,1,1
10992148,20150406,Ramucirumab,53,801,53.0,1,,1,0,0,0,0,0,0,Ramucirumab,DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Oral pain,1,1
10994406,20150407,Ramucirumab,52,801,52.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Drug interaction|Mucosal inflammation,2,5
11001900,20150408,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Abdominal pain|Pallor,2,5
11002686,20150408,Ramucirumab,81,801,81.0,2,,1,0,0,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Haemangioma of skin,1,5
11005489,20150409,Ramucirumab,45,801,45.0,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Cerebrovascular accident,1,5
11010242,20150410,Ramucirumab,83,801,83.0,1,64.85,1,0,1,0,0,0,0,Ramucirumab,"AMLODIPINE BESYLATE|DENOSUMAB|OLANZAPINE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|HYDROMORPHONE HYDROCHLORIDE|LATANOPROST|RAMUCIRUMAB|METOPROLOL TARTRATE|METOPROLOL|ATORVASTATIN CALCIUM",15,LUNG NEOPLASM MALIGNANT,Transient ischaemic attack|Myocardial infarction,2,5
11010971,20150410,Ramucirumab,65,801,65.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Gait disturbance|Communication disorder|Cerebrovascular accident|Cognitive disorder,4,5
11025989,20150414,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,NON-SMALL CELL LUNG CANCER,Dry skin,1,5
11038488,20150416,Ramucirumab,82,801,82.0,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB,3,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Epistaxis,1,5
11039274,20150416,Ramucirumab,,,,2,,1,0,1,0,0,0,0,Ramucirumab,DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB|FOLIC ACID,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Urine output decreased|Mucosal inflammation|Eating disorder,3,5
11039277,20150416,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Death,1,5
11043156,20150417,Ramucirumab,60,801,60.0,1,79,1,0,1,0,0,0,0,Ramucirumab,IRON|HYDROMORPHONE HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|CETUXIMAB|RAMUCIRUMAB,10,PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PAIN|GASTROOESOPHAGEAL REFLUX DISEASE|GASTROOESOPHAGEAL REFLUX DISEASE|NAUSEA|NAUSEA|ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON|ADENOCARCINOMA OF COLON,Nausea|Blood bilirubin increased|Acute kidney injury|Hyponatraemia|Dehydration|Vomiting|Ascites,7,3
11049073,20150420,Ramucirumab,,,,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,Deep vein thrombosis,1,5
11049077,20150420,Ramucirumab,,,,1,,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Cardiomegaly|Oxygen saturation decreased,2,5
11049078,20150420,Ramucirumab,45,801,45.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,NON-SMALL CELL LUNG CANCER,Pulmonary embolism,1,5
11052044,20150421,Ramucirumab,,,,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Hepatic haemorrhage,1,5
11056084,20150422,Ramucirumab,50,801,50.0,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,2,NON-SMALL CELL LUNG CANCER,Mucosal inflammation|Decreased appetite|Weight decreased,3,5
11056469,20150422,Ramucirumab,57,801,57.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTROOESOPHAGEAL CANCER,Ascites,1,5
11057471,20150422,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Drug intolerance|Malaise,2,5
11057825,20150423,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Headache,1,5
11057862,20150423,Ramucirumab,72,801,72.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Oedema,1,5
11061112,20150424,Ramucirumab,56,801,56.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Cerebrovascular accident,1,5
11061769,20150423,Ramucirumab,54,801,54.0,1,62.3,1,0,1,1,0,0,0,Ramucirumab,RAMUCIRUMAB,1,COLON CANCER,Seizure|Anaphylactic reaction|Angioedema,3,2
11069392,20150427,Ramucirumab,,,,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Transient ischaemic attack|Dysarthria,2,5
11069393,20150427,Ramucirumab,,,,0,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia,1,5
11069408,20150427,Ramucirumab,49,801,49.0,2,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Lower respiratory tract infection|Pulmonary embolism,2,5
11070130,20150427,Ramucirumab,78,801,78.0,1,,1,0,1,0,0,0,0,Ramucirumab,DIPHENHYDRAMINE HYDROCHLORIDE|RAMUCIRUMAB,2,PREMEDICATION|GASTRIC CANCER,Unresponsive to stimuli,1,5
11111161,20150513,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER,Gastrointestinal perforation,1,5
11116162,20150514,Ramucirumab,79,801,79.0,1,71.9,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,HAEMATOLOGICAL MALIGNANCY,Fall|Urinary retention|Hypophagia|Oliguria,4,2
11116411,20150515,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB,4,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Intestinal perforation,1,5
11118773,20150518,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Gastrointestinal haemorrhage,1,5
11119764,20150518,Ramucirumab,49,801,49.0,2,,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Cerebral ischaemia,1,5
11120103,20150518,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
11125679,20150520,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,LUNG NEOPLASM MALIGNANT,Hypertension|Inappropriate schedule of drug administration,2,5
11128937,20150521,Ramucirumab,65,801,65.0,1,,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Haemoptysis|Malignant neoplasm progression,2,5
11132211,20150522,Ramucirumab,50,801,50.0,2,,1,1,1,0,0,0,1,Ramucirumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SENNOSIDES|SENNA LEAF|SENNA|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|MORPHINE|OXYCODONE HYDROCHLORIDE|RAMUCIRUMAB|LORAZEPAM|OMEPRAZOLE MAGNESIUM|ERYTHROPOIETIN|ERYTHROPOIETIN|DOCUSATE CALCIUM|DOCUSATE SODIUM|MARC GLASSMAN|DOCUSATE SODIUM SENNOSIDES|DOCUSATE SODIUM AND SENNOSIDES|STOOL SOFTENER|DOCUSATE SODIUM 100MG|CLONAZEPAM|MORPHINE|FILGRASTIM|OXYCODONE|PROCHLORPERAZINE MALEATE|LORAZEPAM|CLONAZEPAM|IPRATROPIUM BROMIDE AND ALBUTEROL|DIPHENHYDRAMINE HYDROCHLORIDE|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL,30,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTASES TO LUNG|NAUSEA|VOMITING|PRODUCT USED FOR UNKNOWN INDICATION|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTASES TO LUNG|PRODUCT USED FOR UNKNOWN INDICATION|ANAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|ANXIETY|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Tumour haemorrhage|Fatigue|Malignant neoplasm progression|Dyspnoea|Vitamin D deficiency|Malaise,6,5
11135305,20150525,Ramucirumab,70,801,70.0,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Blood pressure systolic increased,1,5
11135307,20150525,Ramucirumab,,,,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,LUNG NEOPLASM MALIGNANT,Diarrhoea,1,5
11137531,20150526,Ramucirumab,56,801,56.0,2,,1,0,1,0,0,0,0,Ramucirumab,PREDNISONE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|RAMUCIRUMAB|DIAZEPAM,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Pulmonary embolism,1,3
11146485,20150528,Ramucirumab,,,,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Capillary leak syndrome|Oedema|Liver function test abnormal,3,5
11152823,20150601,Ramucirumab,55,801,55.0,1,55.78,1,1,1,0,0,0,0,Ramucirumab,"LEVETIRACETAM|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|RAMUCIRUMAB|PEMETREXED DISODIUM|CARBOPLATIN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|SEIZURE|PRODUCT USED FOR UNKNOWN INDICATION,Death|Colitis|Chest pain|Stomatitis|Off label use|Large intestine perforation,6,3
11156295,20150602,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Malignant neoplasm progression,1,2
11156920,20150602,Ramucirumab,63,801,63.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Decreased appetite|Oral pain|Mucosal inflammation,3,3
11165464,20150604,Ramucirumab,,,,2,,1,0,0,0,0,0,1,Ramucirumab,DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB|RAMIPRIL,3,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Hypertension|Heart rate increased,2,5
11168524,20150605,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Drug dose omission|Blood pressure increased,2,3
11169023,20150605,Ramucirumab,79,801,79.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,NON-SMALL CELL LUNG CANCER,Off label use|Pulmonary embolism,2,5
11174529,20150609,Ramucirumab,68,801,68.0,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Epididymitis,1,5
11174530,20150609,Ramucirumab,,,,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Abdominal abscess,1,5
11179050,20150610,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Lip swelling|Stomatitis,2,5
11179747,20150609,Ramucirumab,62,801,62.0,1,71.65,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,5,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT,Intestinal obstruction,1,3
11181668,20150611,Ramucirumab,25,801,25.0,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Malignant neoplasm progression,1,5
11181673,20150611,Ramucirumab,52,801,52.0,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER|GASTRIC CANCER,Death|Drug intolerance,2,5
11190247,20150615,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,"RAMUCIRUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",2,GASTRIC CANCER|PAIN,Dysuria|Fluid retention|Constipation|Oral disorder|Nausea|Throat tightness|Malignant neoplasm progression|Protein urine present|Pain|Urticaria|Faeces hard,11,5
11193568,20150616,Ramucirumab,34,801,34.0,1,110,1,0,1,1,0,0,1,Ramucirumab,RAMUCIRUMAB|ROMIPLOSTIM,2,GASTRIC CANCER|THROMBOCYTOPENIA,Pulmonary embolism|Thrombosis|Thrombocytopenia|Haemorrhage|Subdural haematoma,5,5
11200776,20150618,Ramucirumab,42,801,42.0,1,85,1,0,1,0,0,0,0,Ramucirumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LANSOPRAZOLE,7,PROPHYLAXIS|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|GASTRIC CANCER STAGE IV|GASTRIC CANCER STAGE IV|PAIN,Haematemesis,1,3
11201159,20150619,Ramucirumab,62,801,62.0,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Hypertension|Cognitive disorder,2,5
11209287,20150622,Ramucirumab,55,801,55.0,1,,1,1,0,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA,Malignant neoplasm progression,1,5
11215547,20150624,Ramucirumab,50,801,50.0,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Rash,1,3
11215548,20150624,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Drug ineffective,1,5
11215549,20150624,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DIPHENHYDRAMINE HYDROCHLORIDE,2,GASTRIC CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Hypertension|Hypersensitivity,2,5
11219411,20150625,Ramucirumab,71,801,71.0,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|TRASTUZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Blood creatine increased,1,5
11219617,20150625,Ramucirumab,49,801,49.0,1,,1,1,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL|METHYLPREDNISOLONE SODIUM SUCCINATE,3,METASTATIC GASTRIC CANCER|METASTATIC GASTRIC CANCER|METASTATIC GASTRIC CANCER,Shock haemorrhagic|Abdominal pain upper|Haemodynamic instability|Anaemia|Haematemesis|Blood alkaline phosphatase increased,6,1
11222747,20150626,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
11226431,20150629,Ramucirumab,65,801,65.0,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,LUNG NEOPLASM MALIGNANT,Haemorrhage,1,5
11227654,20150630,Ramucirumab,,,,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Mucosal inflammation,1,5
11228308,20150630,Ramucirumab,77,801,77.0,1,87.4,1,0,1,0,0,0,0,Ramucirumab,DUTASTERIDE|LEVOTHYROXINE SODIUM|RAMUCIRUMAB|FUROSEMIDE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ATOMOXETINE HYDROCHLORIDE|AMLODIPINE BESYLATE,14,MICTURITION DISORDER|HYPOTHYROIDISM|VOMITING|METASTATIC RENAL CELL CARCINOMA|BACTERIAL INFECTION|OEDEMA|METASTATIC RENAL CELL CARCINOMA|LAXATIVE SUPPORTIVE CARE|GASTROOESOPHAGEAL REFLUX DISEASE|ATTENTION DEFICIT/HYPERACTIVITY DISORDER|NAUSEA|NAUSEA|MICTURITION DISORDER|HYPERTENSION,Abdominal distension|Ascites,2,1
11229047,20150630,Ramucirumab,53,801,53.0,1,,1,1,0,0,0,0,0,Ramucirumab,PACLITAXEL|EPIRUBICIN HYDROCHLORIDE|RAMUCIRUMAB,3,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Disease progression|Gastric cancer,2,5
11229396,20150630,Ramucirumab,,,,1,,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Diarrhoea|Intestinal obstruction,2,5
11231880,20150630,Ramucirumab,70,801,70.0,1,69.85,1,0,0,0,0,0,1,Ramucirumab,,1,OESOPHAGEAL CARCINOMA,Nausea|Rash|Dyspnoea|Urticaria|Vomiting,5,2
11235430,20150702,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|DIPHENHYDRAMINE HYDROCHLORIDE,2,ADENOCARCINOMA GASTRIC|SUPPLEMENTATION THERAPY,Infusion related reaction,1,5
11241462,20150706,Ramucirumab,55,801,55.0,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,LUNG NEOPLASM MALIGNANT,Infusion related reaction,1,5
11248015,20150708,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL CARCINOMA,Malaise,1,5
11249196,20150708,Ramucirumab,,,,2,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Death,1,5
11249207,20150708,Ramucirumab,69,801,69.0,2,64.8,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB|RIVAROXABAN,4,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER,Ejection fraction decreased|Blood sodium decreased|Seizure|Cardiac failure congestive,4,5
11252461,20150708,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Vomiting|Nausea|Headache,3,5
11252462,20150708,Ramucirumab,48,801,48.0,1,,1,0,0,0,0,0,0,Ramucirumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RAMUCIRUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,4,GASTRIC CANCER,Urticaria|Pruritus,2,5
11252470,20150708,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTROOESOPHAGEAL CANCER,Malignant neoplasm progression,1,5
11252471,20150708,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Urticaria,1,5
11252477,20150708,Ramucirumab,85,801,85.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Speech disorder|Disorientation,2,5
11252504,20150708,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL ADENOCARCINOMA,Nausea|Vomiting|Headache,3,5
11252505,20150708,Ramucirumab,,,,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTROOESOPHAGEAL CANCER,Dyspnoea|Hypertension|Hypoxia,3,5
11252509,20150708,Ramucirumab,57,801,57.0,2,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Headache,1,5
11252510,20150708,Ramucirumab,48,801,48.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Malignant neoplasm progression,1,5
11252513,20150708,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTROOESOPHAGEAL CANCER,Malignant neoplasm progression,1,5
11252514,20150708,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTROOESOPHAGEAL CANCER,Malignant neoplasm progression,1,5
11252515,20150708,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|CARBOPLATIN|DIPHENHYDRAMINE HYDROCHLORIDE,4,GASTRIC CANCER|GASTRIC CANCER|PREMEDICATION,Off label use|Hypersensitivity,2,5
11252661,20150708,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DIPHENHYDRAMINE HYDROCHLORIDE|RAMUCIRUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",5,PREMEDICATION|PREMEDICATION|OESOPHAGEAL ADENOCARCINOMA|PREMEDICATION,Erythema|Retching|Blood pressure decreased,3,5
11252673,20150708,Ramucirumab,64,801,64.0,1,,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Gastric haemorrhage,1,5
11252674,20150708,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Haematochezia|Vomiting,2,1
11252680,20150708,Ramucirumab,,,,1,,1,0,1,0,0,0,1,Ramucirumab,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|RAMUCIRUMAB",3,PRODUCT USED FOR UNKNOWN INDICATION,Gastric ulcer perforation,1,5
11252703,20150708,Ramucirumab,65,801,65.0,1,,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Tumour haemorrhage,1,5
11252705,20150708,Ramucirumab,,,,1,,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB,3,GASTROOESOPHAGEAL CANCER|GASTROOESOPHAGEAL CANCER,Gastrointestinal haemorrhage|Haemoglobin decreased,2,5
11252710,20150708,Ramucirumab,37,801,37.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PROMETHAZINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|RAMUCIRUMAB|LORAZEPAM,7,GASTRIC CANCER,Pyrexia,1,2
11252723,20150708,Ramucirumab,45,801,45.0,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Posterior reversible encephalopathy syndrome,1,5
11252726,20150708,Ramucirumab,42,801,42.0,2,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Malignant neoplasm progression,1,5
11252727,20150708,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Malignant neoplasm progression,1,5
11255857,20150709,Ramucirumab,40,801,40.0,1,75.4,1,0,1,0,0,0,0,Ramucirumab,METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|RAMUCIRUMAB,2,OESOPHAGEAL ADENOCARCINOMA,Malignant neoplasm progression,1,5
11261701,20150710,Ramucirumab,65,801,65.0,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER|GASTRIC CANCER,Cardiac failure|Lymphangiosis carcinomatosa,2,5
11266144,20150713,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,International normalised ratio increased,1,3
11270555,20150714,Ramucirumab,67,801,67.0,2,50,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Cerebrovascular accident,1,3
11273328,20150715,Ramucirumab,63,801,63.0,1,82.09,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA,Acute respiratory distress syndrome|Atypical pneumonia,2,5
11273762,20150715,Ramucirumab,65,801,65.0,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Disease progression,1,5
11276617,20150716,Ramucirumab,54,801,54.0,1,55.5,1,1,1,0,1,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,4,GASTRIC CANCER|GASTRIC CANCER,Chest pain|Oesophageal perforation|Pleural effusion,3,2
11277242,20150716,Ramucirumab,,,,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,LUNG NEOPLASM MALIGNANT,Blood pressure increased|Off label use,2,5
11279079,20150717,Ramucirumab,67,801,67.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB,2,GASTRIC CANCER,Stomatitis|Nasopharyngitis,2,1
11284476,20150720,Ramucirumab,65,801,65.0,1,100.95,1,1,0,0,0,0,0,Ramucirumab,"RAMUCIRUMAB|PRASUGREL HYDROCHLORIDE|ALBUTEROL SULFATE|ALPRAZOLAM|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PACLITAXEL|DIGOXIN|FUROSEMIDE|HYOSCYAMINE SULFATE",14,SQUAMOUS CELL CARCINOMA OF LUNG|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SQUAMOUS CELL CARCINOMA OF LUNG|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Paranasal sinus hypersecretion|Productive cough|Arthralgia|Weight decreased|Dyspnoea exertional|Fatigue|Breath sounds abnormal|Headache|Hypoaesthesia|Non-cardiac chest pain|Nausea|Constipation|Muscle spasms|Neuropathy peripheral|Asthenia|Haemoptysis,16,1
11284478,20150720,Ramucirumab,79,801,79.0,1,65,1,0,1,0,0,0,1,Ramucirumab,AMLODIPINE|ALLOPURINOL|RAMUCIRUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OXYCODONE HYDROCHLORIDE|OXYCODONE,8,GASTRIC CANCER,Posterior reversible encephalopathy syndrome,1,1
11284719,20150720,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL ADENOCARCINOMA,Malignant neoplasm progression,1,5
11290208,20150721,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Hypoalbuminaemia|Lymphoedema|Nephrotic syndrome,3,5
11290223,20150721,Ramucirumab,61,801,61.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,OESOPHAGEAL ADENOCARCINOMA STAGE IV|PRODUCT USED FOR UNKNOWN INDICATION,Transient ischaemic attack,1,5
11293381,20150722,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,PACLITAXEL|EPIRUBICIN HYDROCHLORIDE,3,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Malignant neoplasm progression|Adverse event|Product use issue|Drug ineffective,4,5
11306260,20150723,Ramucirumab,52,801,52.0,1,49,1,0,0,0,0,0,0,Ramucirumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|RAMUCIRUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|RAMUCIRUMAB,7,PREMEDICATION|GASTRIC CANCER|PREMEDICATION|GASTRIC CANCER|PREMEDICATION|PREMEDICATION,Nausea|Rash generalised,2,3
11306471,20150723,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Malaise,1,3
11310093,20150724,Ramucirumab,41,801,41.0,2,46,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|ESOMEPRAZOLE MAGNESIUM|PACLITAXEL,4,GASTRIC CANCER|CANCER PAIN|PROPHYLAXIS|GASTRIC CANCER,Gastric perforation|Peritonitis,2,5
11310170,20150724,Ramucirumab,56,801,56.0,1,,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,METASTATIC GASTRIC CANCER|METASTATIC GASTRIC CANCER,Confusional state|Malignant neoplasm progression|Bone marrow failure,3,5
11310174,20150724,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,NEOPLASM MALIGNANT,Death,1,5
11310177,20150724,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Cerebrovascular disorder,1,5
11314599,20150727,Ramucirumab,76,801,76.0,1,,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Pneumonia,1,5
11316310,20150728,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,OXALIPLATIN|RAMUCIRUMAB|PANITUMUMAB,6,COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC|COLON CANCER METASTATIC,Prostate cancer|Anaphylactic reaction|Malignant neoplasm progression,3,1
11317946,20150728,Ramucirumab,75,801,75.0,1,,1,0,0,0,0,0,1,Ramucirumab,FUROSEMIDE|RAMUCIRUMAB|PACLITAXEL,7,GASTRIC CANCER|GASTRIC CANCER,Anaemia,1,1
11317950,20150728,Ramucirumab,65,801,65.0,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER RECURRENT|GASTRIC CANCER RECURRENT,Gastric cancer recurrent,1,5
11317963,20150728,Ramucirumab,86,801,86.0,2,48.5,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,PROPHYLAXIS|GASTRIC CANCER STAGE IV,Acute myocardial infarction|Malignant neoplasm progression|Gastrointestinal haemorrhage,3,1
11324881,20150730,Ramucirumab,44,801,44.0,1,57.4,1,1,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,GASTRIC CANCER|PREMEDICATION,Tumour haemorrhage|Malignant ascites,2,2
11324891,20150730,Ramucirumab,64,801,64.0,1,49.5,1,0,1,0,0,0,0,Ramucirumab,LANSOPRAZOLE|ESOMEPRAZOLE MAGNESIUM|RAMUCIRUMAB|PACLITAXEL,13,PROPHYLAXIS|CONSTIPATION|PROPHYLAXIS|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|ADENOCARCINOMA GASTRIC|ADENOCARCINOMA GASTRIC|IRON DEFICIENCY ANAEMIA|PROPHYLAXIS|PROPHYLAXIS|HYPERURICAEMIA,Interstitial lung disease,1,1
11324892,20150730,Ramucirumab,,,,2,,1,0,0,0,0,0,1,Ramucirumab,DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pericardial effusion|Ascites,2,5
11327040,20150731,Ramucirumab,52,801,52.0,2,51,1,1,1,1,0,0,0,Ramucirumab,PACLITAXEL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METHYLPREDNISOLONE|RANITIDINE|RAMUCIRUMAB|MORPHINE|CLOMIPRAMINE HYDROCHLORIDE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM,13,OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA,Nausea|Peritonitis|Vomiting|Blood pressure systolic increased|Gastrointestinal perforation,5,1
11327631,20150731,Ramucirumab,61,801,61.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Blood creatinine increased|Renal impairment,2,2
11327632,20150731,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Anaphylactic reaction,1,5
11328599,20150731,Ramucirumab,57,801,57.0,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|OCTREOTIDE ACETATE|OCTREOTIDE ACETATE|MORPHINE,5,GASTRIC CANCER|VOMITING|ILEUS PARALYTIC|DYSPNOEA|THROMBOSIS PROPHYLAXIS,Pleural effusion|Ascites|C-reactive protein increased|Respiratory distress|Malignant neoplasm progression,5,5
11331245,20150803,Ramucirumab,38,801,38.0,2,47.4,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,5,GASTRIC CANCER STAGE IV|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|GASTRIC CANCER STAGE IV,Febrile neutropenia,1,5
11331253,20150803,Ramucirumab,55,801,55.0,2,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER RECURRENT|GASTRIC CANCER RECURRENT,Metastases to meninges,1,5
11331256,20150803,Ramucirumab,55,801,55.0,1,,1,0,0,0,0,0,1,Ramucirumab,CAPECITABINE|RAMUCIRUMAB,2,COLON CANCER,Drug hypersensitivity|Fall|Photopsia|Swelling face|Blood pressure systolic decreased|Urticaria|Anaphylactic reaction,7,1
11331257,20150803,Ramucirumab,73,801,73.0,2,39.4,1,0,0,0,0,0,1,Ramucirumab,RALOXIFENE HYDROCHLORIDE|RAMUCIRUMAB|PACLITAXEL|PACLITAXEL|LANSOPRAZOLE,8,GASTRIC CANCER RECURRENT|GASTRIC CANCER RECURRENT,Neuropathy peripheral|Neutrophil count decreased,2,5
11331258,20150803,Ramucirumab,62,801,62.0,2,51.8,1,1,1,0,0,0,0,Ramucirumab,ESOMEPRAZOLE MAGNESIUM|RAMUCIRUMAB,7,GASTROOESOPHAGEAL REFLUX DISEASE|ADENOCARCINOMA GASTRIC|CONSTIPATION|IRON DEFICIENCY ANAEMIA|HYPERTENSION|ADENOCARCINOMA GASTRIC|HYPERTENSION,Pulmonary artery thrombosis,1,1
11342695,20150805,Ramucirumab,69,801,69.0,1,,1,0,1,0,0,0,0,Ramucirumab,SUCRALFATE|SERTRALINE HYDROCHLORIDE|ENOXAPARIN SODIUM|RIVAROXABAN|PACLITAXEL|RAMUCIRUMAB|METOPROLOL TARTRATE,7,OESOPHAGEAL CARCINOMA|OESOPHAGEAL CARCINOMA,Transient ischaemic attack,1,3
11348948,20150807,Ramucirumab,60,801,60.0,1,,1,0,1,0,0,0,1,Ramucirumab,"TRASTUZUMAB|OXALIPLATIN|OXALIPLATIN|TRASTUZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|TRASTUZUMAB|FLUOROURACIL CREAM, 0.5%|FLUOROURACIL|RAMUCIRUMAB",11,OESOPHAGEAL ADENOCARCINOMA METASTATIC|OESOPHAGEAL ADENOCARCINOMA METASTATIC|OESOPHAGEAL ADENOCARCINOMA METASTATIC|OESOPHAGEAL ADENOCARCINOMA METASTATIC,Oesophageal carcinoma recurrent|Anaphylactic shock|Seizure,3,1
11349276,20150807,Ramucirumab,42,801,42.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|CAPECITABINE,3,ADENOCARCINOMA GASTRIC|ADENOCARCINOMA GASTRIC|ADENOCARCINOMA GASTRIC,Abdominal distension|Diarrhoea|Infectious colitis|Gastritis|Abdominal pain upper|Large intestinal stenosis|Colitis|Gilbert^s syndrome|Blood bilirubin increased|Rash papular|Large intestinal obstruction|Skin hyperpigmentation|Pyogenic granuloma|Blood pressure increased|Platelet count decreased|Tongue haemorrhage|Haemangioma,17,5
11350050,20150807,Ramucirumab,65,801,65.0,1,,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Pneumothorax|Malignant neoplasm progression|Neutrophil count decreased,3,2
11361886,20150810,Ramucirumab,76,801,76.0,1,,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER|GASTRIC CANCER,Pneumonia|Respiratory failure,2,5
11369172,20150812,Ramucirumab,62,801,62.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,7,AUTONOMIC NERVOUS SYSTEM IMBALANCE|GASTRIC CANCER STAGE IV,Intestinal obstruction|Douglas^ abscess,2,2
11369175,20150812,Ramucirumab,75,801,75.0,2,,1,1,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Cachexia,1,5
11371311,20150812,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Stomatitis,1,5
11376064,20150813,Ramucirumab,75,801,75.0,2,,1,0,1,0,1,0,1,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,4,GASTRIC CANCER,Vomiting|Haemoglobin decreased|Pulmonary congestion|Peritonitis|Anal haemorrhage|Abscess|Nausea|Asthenia,8,5
11382769,20150814,Ramucirumab,55,801,55.0,1,,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Gastrointestinal perforation,1,5
11387440,20150817,Ramucirumab,57,801,57.0,1,,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL|PROPOFOL,5,ANAESTHESIA PROCEDURE|GASTRIC CANCER RECURRENT|ANAESTHESIA PROCEDURE|GASTRIC CANCER RECURRENT|ANAESTHESIA PROCEDURE,Coma hepatic|Drug-induced liver injury|Hepatic failure|Disseminated intravascular coagulation|Ileus,5,1
11387444,20150817,Ramucirumab,72,801,72.0,1,49,1,1,0,1,0,0,0,Ramucirumab,FUROSEMIDE|SPIRONOLACTONE|FUROSEMIDE|SPIRONOLACTONE|RAMUCIRUMAB,10,PLEURAL EFFUSION|GASTRIC ULCER|MALIGNANT ASCITES|MALIGNANT ASCITES|PRURITUS|PLEURAL EFFUSION|NAUSEA|ADENOCARCINOMA GASTRIC|ADENOCARCINOMA GASTRIC,Pleural effusion|Pneumonia|Neutropenia,3,5
11391682,20150818,Ramucirumab,75,801,75.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER|GASTRIC CANCER,Neutrophil count decreased|White blood cell count decreased,2,5
11391683,20150818,Ramucirumab,71,801,71.0,1,,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Blood alkaline phosphatase increased|Catheter site infection|Blood urea increased,3,5
11391685,20150818,Ramucirumab,41,801,41.0,2,,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Metastases to meninges,1,5
11392317,20150818,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,NEOPLASM MALIGNANT,Death,1,5
11397177,20150819,Ramucirumab,83,801,83.0,2,,1,0,0,0,0,0,1,Ramucirumab,METHYLPREDNISOLONE SODIUM SUCCINATE|RAMUCIRUMAB|METHYLPREDNISOLONE SODIUM SUCCINATE,7,URTICARIA|ADENOCARCINOMA GASTRIC|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION,Urticaria,1,5
11403956,20150821,Ramucirumab,55,801,55.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|FAMOTIDINE|PACLITAXEL,4,GASTRIC CANCER STAGE IV|PROPHYLAXIS|PROPHYLAXIS|GASTRIC CANCER STAGE IV,Infection|Vomiting,2,5
11403958,20150821,Ramucirumab,70,801,70.0,2,,1,0,0,0,0,0,1,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Anaemia|Melaena,2,1
11403964,20150821,Ramucirumab,85,801,85.0,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,GASTRIC CANCER|PREMEDICATION,Pneumonia,1,5
11406037,20150821,Ramucirumab,60,801,60.0,1,,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB|TRASTUZUMAB,2,METASTATIC GASTRIC CANCER,Intestinal ischaemia|Clostridial infection|Intestinal ulcer|Hypokalaemia|Diaphragmatic hernia|Nausea|Enterococcal infection|Haemoptysis|Gastrointestinal necrosis|Hepatic function abnormal|General physical health deterioration|Gastrointestinal haemorrhage|Lung infection|Infection,14,1
11416635,20150825,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Flushing|Lip discolouration|Feeling hot,3,5
11416871,20150825,Ramucirumab,38,801,38.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,COLON CANCER STAGE IV|COLON CANCER STAGE IV,Muscle spasms,1,5
11417385,20150825,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL CARCINOMA,Hearing impaired|Visual impairment,2,3
11420517,20150826,Ramucirumab,83,801,83.0,1,82,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,ADENOCARCINOMA GASTRIC|ADENOCARCINOMA GASTRIC,Prerenal failure|Dehydration|Enteritis|Leukopenia,4,5
11420758,20150826,Ramucirumab,73,801,73.0,1,44,1,1,1,1,0,0,1,Ramucirumab,OCTREOTIDE ACETATE|RAMUCIRUMAB|RIVAROXABAN|RIVAROXABAN,10,CONSTIPATION|NAUSEA|ILEUS|POLLAKIURIA|DECREASED APPETITE|GASTRIC CANCER STAGE IV|THROMBOSIS PROPHYLAXIS|DISSEMINATED INTRAVASCULAR COAGULATION,Platelet count decreased|Cerebral haemorrhage|Sepsis|Disseminated intravascular coagulation|Malignant neoplasm progression,5,5
11422094,20150827,Ramucirumab,84,801,84.0,1,82,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,ADENOCARCINOMA GASTRIC|ADENOCARCINOMA GASTRIC,Off label use|Pyrexia|Leukopenia|Enteritis,4,3
11424523,20150827,Ramucirumab,66,801,66.0,1,61,1,0,1,0,0,0,0,Ramucirumab,FUROSEMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RAMUCIRUMAB|PACLITAXEL|SPIRONOLACTONE|FUROSEMIDE|SPIRONOLACTONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,9,OEDEMA PERIPHERAL|OEDEMA PERIPHERAL|ABDOMINAL PAIN UPPER|GASTRIC CANCER|GASTRIC CANCER|OEDEMA PERIPHERAL|ASCITES|ASCITES|MALAISE,Pneumocystis jirovecii pneumonia,1,5
11428052,20150828,Ramucirumab,71,801,71.0,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Catheter site infection|Blood urea increased|Blood alkaline phosphatase increased,3,5
11428127,20150828,Ramucirumab,71,801,71.0,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Catheter site infection|Blood alkaline phosphatase increased|Blood urea increased,3,5
11429076,20150827,Ramucirumab,84,801,84.0,1,66.23,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB,2,RECTOSIGMOID CANCER METASTATIC|RECTOSIGMOID CANCER METASTATIC,Respiratory rate increased|Rash generalised|Blood pressure systolic increased|Flushing|Blood pressure diastolic decreased|Ear discomfort|Pruritus|Chest pain|Oxygen saturation decreased,9,3
11429089,20150827,Ramucirumab,77,801,77.0,2,78.47,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB,2,RECTAL CANCER|RECTAL CANCER,Rash generalised|Heart rate increased|Respiratory rate increased|Asthenia|Pallor|Pruritus|Dyspnoea|Dizziness,8,3
11431062,20150828,Ramucirumab,71,801,71.0,1,,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Catheter site infection|Blood urea increased|Blood alkaline phosphatase increased,3,3
11431170,20150828,Ramucirumab,58,801,58.0,1,,1,0,0,0,0,0,1,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Leukopenia|Neutropenia,2,5
11431423,20150828,Ramucirumab,71,801,71.0,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Blood urea increased|Catheter site infection|Blood alkaline phosphatase increased,3,3
11434032,20150831,Ramucirumab,65,801,65.0,2,,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Tumour haemorrhage,1,2
11438264,20150901,Ramucirumab,71,801,71.0,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Blood alkaline phosphatase increased|Blood urea increased|Catheter site infection,3,2
11445031,20150902,Ramucirumab,66,801,66.0,1,,1,1,0,0,0,0,1,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Hepatic atrophy|Malignant neoplasm progression|Tumour haemorrhage,3,5
11448673,20150902,Ramucirumab,71,801,71.0,1,,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Catheter site infection|Blood alkaline phosphatase increased|Blood urea increased,3,3
11459997,20150904,Ramucirumab,55,801,55.0,1,69.4,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,5,PROPHYLAXIS|PROPHYLAXIS|GASTRIC CANCER STAGE IV|PROPHYLAXIS|PROPHYLAXIS,Infusion related reaction,1,5
11460002,20150904,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL ADENOCARCINOMA,Bronchial fistula,1,5
11466053,20150907,Ramucirumab,,,,1,,1,1,0,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,3,GASTRIC CANCER|GASTRIC CANCER|GASTRIC CANCER,Malignant neoplasm progression,1,5
11467203,20150908,Ramucirumab,77,801,77.0,2,,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL ADENOCARCINOMA,Cerebrovascular accident,1,3
11467806,20150908,Ramucirumab,74,801,74.0,2,44,1,1,0,0,0,0,0,Ramucirumab,PACLITAXEL|FUROSEMIDE|SPIRONOLACTONE|FENTANYL|RAMUCIRUMAB,8,CONSTIPATION|GASTRIC CANCER STAGE IV|ASCITES|ASCITES|PAIN|MALAISE|PAIN|GASTRIC CANCER STAGE IV,Malignant neoplasm progression|White blood cell count decreased,2,5
11482254,20150909,Ramucirumab,68,801,68.0,1,47,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|DEXAMETHASONE SODIUM PHOSPHATE|FAMOTIDINE|RAMUCIRUMAB,5,GASTRIC CANCER STAGE IV|PROPHYLAXIS|PROPHYLAXIS|GASTRIC CANCER STAGE IV|PROPHYLAXIS,White blood cell count decreased|Pyrexia|Pneumonia|Pyrexia|Dysphonia,5,1
11491822,20150910,Ramucirumab,44,801,44.0,2,,1,1,0,1,1,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,3,GASTRIC CANCER|GASTRIC CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Cerebral haemorrhage,2,5
11496549,20150911,Ramucirumab,74,801,74.0,1,38.6,1,1,0,0,0,0,0,Ramucirumab,ESOMEPRAZOLE MAGNESIUM|RAMUCIRUMAB|FUROSEMIDE,6,HAEMORRHAGE PROPHYLAXIS|HAEMORRHAGE PROPHYLAXIS|INSOMNIA|GASTRIC CANCER STAGE IV|ASCITES|INSOMNIA,Gastrointestinal perforation,1,5
11496558,20150911,Ramucirumab,33,801,33.0,1,53,1,0,1,0,0,0,1,Ramucirumab,GRANISETRON|GRANISETRON HYDROCHLORIDE|FAMOTIDINE|RAMUCIRUMAB|PACLITAXEL,6,PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|GASTRIC CANCER|GASTRIC CANCER|PROPHYLAXIS,Ileus|Ascites,2,5
11496559,20150911,Ramucirumab,66,801,66.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,PRODUCT USED FOR UNKNOWN INDICATION,Anaemia,1,5
11500643,20150914,Ramucirumab,50,801,50.0,2,,1,1,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER|GASTRIC CANCER,Death|Gastrointestinal haemorrhage,2,5
11500647,20150914,Ramucirumab,63,801,63.0,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB|PACLITAXEL|PACLITAXEL,4,GASTRIC CANCER|GASTRIC CANCER,White blood cell count decreased|Neutrophil count decreased,2,5
11500648,20150914,Ramucirumab,59,801,59.0,1,52,1,0,0,1,0,0,0,Ramucirumab,VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|FAMOTIDINE|RAMUCIRUMAB,7,PROPHYLAXIS|PROPHYLAXIS|GASTRIC CANCER RECURRENT|PROPHYLAXIS,Anaphylactic reaction,1,5
11500650,20150914,Ramucirumab,61,801,61.0,2,51,1,1,1,0,0,0,1,Ramucirumab,FUROSEMIDE|RAMUCIRUMAB|PACLITAXEL|SITAGLIPTIN|ESOMEPRAZOLE MAGNESIUM,8,GASTRIC CANCER|GASTRIC CANCER,Anaemia|Disseminated intravascular coagulation|Tumour haemorrhage|Malignant neoplasm progression,4,1
11500653,20150914,Ramucirumab,71,801,71.0,1,53.5,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,8,CANCER PAIN|ADENOCARCINOMA GASTRIC|STOMATITIS|ADENOCARCINOMA GASTRIC|STOMATITIS|CANCER PAIN|CONSTIPATION,Interstitial lung disease|Stomatitis,2,5
11506895,20150915,Ramucirumab,,,,0,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,General physical health deterioration,1,3
11513983,20150916,Ramucirumab,51,801,51.0,1,74.1,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,6,CANCER PAIN|BACK PAIN|PROPHYLAXIS|GASTRIC CANCER STAGE IV|GASTRIC CANCER STAGE IV|CANCER PAIN,Subclavian vein thrombosis,1,5
11518306,20150917,Ramucirumab,60,801,60.0,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,COLORECTAL CANCER,Off label use|Infusion related reaction,2,5
11518768,20150917,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL ADENOCARCINOMA,Rash|Pruritus,2,5
11520886,20150918,Ramucirumab,65,801,65.0,1,102.3,1,0,0,0,0,0,0,Ramucirumab,OXYCODONE|ATENOLOL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|RAMUCIRUMAB|SIMVASTATIN|RAMUCIRUMAB|OXYCODONE HYDROCHLORIDE|SIROLIMUS,12,BRAIN NEOPLASM MALIGNANT|OESOPHAGEAL CARCINOMA,Hypersensitivity,1,3
11529887,20150921,Ramucirumab,,,,1,,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL ADENOCARCINOMA,Chest pain|Haemorrhage,2,5
11529890,20150921,Ramucirumab,69,801,69.0,1,52,1,1,1,1,0,0,0,Ramucirumab,PACLITAXEL|PACLITAXEL|RAMUCIRUMAB,6,STOMATITIS|SEIZURE|GASTRIC CANCER RECURRENT|METASTASES TO CENTRAL NERVOUS SYSTEM|GASTRIC CANCER RECURRENT,Malignant neoplasm progression|Interstitial lung disease|Pyrexia|Stomatitis,4,1
11535124,20150922,Ramucirumab,76,801,76.0,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,COLORECTAL CANCER METASTATIC,Infusion site extravasation|Infusion site swelling,2,1
11537044,20150922,Ramucirumab,78,801,78.0,2,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression|Off label use,2,3
11540863,20150923,Ramucirumab,64,801,64.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB,3,GASTRIC CANCER|GASTRIC CANCER,Oxygen saturation decreased|Chills|Blood pressure increased,3,5
11541045,20150923,Ramucirumab,,,,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,NON-SMALL CELL LUNG CANCER,Hyponatraemia,1,5
11543023,20150923,Ramucirumab,,,,2,,1,0,0,0,0,0,1,Ramucirumab,DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Dacryostenosis acquired,1,5
11553425,20150925,Ramucirumab,75,801,75.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL|PACLITAXEL|RAMUCIRUMAB,5,GASTRIC CANCER|GASTRIC CANCER|PREMEDICATION,Blood pressure increased|White blood cell count decreased|Paraesthesia|Neutrophil count decreased,4,5
11561244,20150928,Ramucirumab,,,,2,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,1,LUNG NEOPLASM MALIGNANT,Pericardial effusion,1,1
11569015,20150929,Ramucirumab,75,801,75.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER|GASTRIC CANCER,Post procedural bile leak|Platelet count decreased,2,5
11569024,20150929,Ramucirumab,65,801,65.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Decreased appetite,1,5
11569026,20150929,Ramucirumab,82,801,82.0,1,48,1,0,1,0,0,0,0,Ramucirumab,FUROSEMIDE|RAMUCIRUMAB,8,PREMEDICATION|OEDEMA|GASTRIC CANCER|HAEMOGLOBIN DECREASED|GASTRIC CANCER|PREMEDICATION|PREMEDICATION,Gastrointestinal haemorrhage|Platelet count decreased,2,2
11569033,20150929,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION,White blood cell count decreased,1,1
11575722,20150930,Ramucirumab,,,,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIPHENHYDRAMINE HYDROCHLORIDE,5,PREMEDICATION|GASTRIC CANCER|PREMEDICATION|PREMEDICATION|PREMEDICATION,Flushing|Heart rate increased|Urticaria|Nausea,4,5
11582840,20151001,Ramucirumab,,,,1,52.7,1,1,1,1,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,8,GASTRIC CANCER RECURRENT|GASTRIC CANCER RECURRENT,Microangiopathic haemolytic anaemia|Malignant neoplasm progression|Altered state of consciousness|Pyrexia|Vena cava thrombosis,5,5
11583720,20150930,Ramucirumab,68,801,68.0,1,,1,0,1,0,0,0,0,Ramucirumab,,1,OESOPHAGEAL CARCINOMA,Gastrointestinal haemorrhage|Anaemia,2,2
11584908,20151001,Ramucirumab,67,801,67.0,1,61.4,1,1,1,1,1,0,1,Ramucirumab,PACLITAXEL|RAMUCIRUMAB|LANSOPRAZOLE,7,PREMEDICATION|PREMEDICATION|HYPERTENSION|PREMEDICATION|GASTRIC CANCER|GASTRIC CANCER|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER,Blood pressure increased|Pulmonary embolism|Deep vein thrombosis|Malignant neoplasm progression|Focal segmental glomerulosclerosis|Renal disorder,6,1
11588444,20151002,Ramucirumab,81,801,81.0,1,51,1,1,0,0,0,0,1,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Hypertension|Decreased appetite|Abdominal pain|Protein urine|Nausea|Loss of consciousness|Facial spasm|Faecal incontinence|Malaise|Malignant neoplasm progression,10,5
11588445,20151002,Ramucirumab,,,,2,,1,1,0,0,0,0,0,Ramucirumab,OXYCODONE HYDROCHLORIDE|RAMUCIRUMAB|RAMUCIRUMAB|PACLITAXEL|FAMOTIDINE|MORPHINE SULFATE,7,PAIN|GASTRIC CANCER|GASTRIC CANCER|PROPHYLAXIS|PROPHYLAXIS|GASTRIC CANCER,Malignant neoplasm progression,1,2
11588946,20151002,Ramucirumab,61,801,61.0,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|LORATADINE|LORATADINE ORAL,2,NON-SMALL CELL LUNG CANCER|PREMEDICATION,Burning sensation|Flushing|Nausea|Vomiting|Paraesthesia,5,5
11598230,20151006,Ramucirumab,61,801,61.0,1,40,1,0,0,0,0,0,0,Ramucirumab,CAPECITABINE|RAMUCIRUMAB|ESOMEPRAZOLE MAGNESIUM|HYDROCORTISONE SODIUM SUCCINATE|TRASTUZUMAB|CISPLATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FAMOTIDINE,13,GASTRIC CANCER|GASTRIC CANCER|PREMEDICATION|GASTRIC CANCER|GASTRIC CANCER|PREMEDICATION|PREMEDICATION|PREMEDICATION,Platelet count decreased|Infusion related reaction,2,5
11608154,20151007,Ramucirumab,65,801,65.0,1,,1,0,0,0,0,0,1,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Jaundice cholestatic,1,5
11612681,20151008,Ramucirumab,31,801,31.0,2,,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER RECURRENT|GASTRIC CANCER RECURRENT,Interstitial lung disease|Abdominal pain|Haemoptysis,3,5
11613777,20151008,Ramucirumab,,,,1,,1,1,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL CARCINOMA,Malignant neoplasm progression,1,5
11615801,20151009,Ramucirumab,65,801,65.0,1,,1,0,0,0,0,0,1,Ramucirumab,INSULIN GLARGINE|PACLITAXEL|RAMUCIRUMAB,6,DIABETES MELLITUS|GASTRIC CANCER|GASTRIC CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Hypoglycaemia,1,2
11615802,20151009,Ramucirumab,71,801,71.0,1,45,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER STAGE IV|GASTRIC CANCER STAGE IV,C-reactive protein increased|Pyrexia|Malaise|Pyrexia,4,5
11615807,20151009,Ramucirumab,69,801,69.0,1,49.2,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,6,GASTRIC CANCER|GASTRIC CANCER|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS,Erythema multiforme,1,5
11615815,20151009,Ramucirumab,58,801,58.0,1,45.2,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PREGABALIN|FENTANYL,5,GASTRIC CANCER,Pyrexia|Hepatic failure|Biliary tract disorder|Hyperbilirubinaemia|Malignant neoplasm progression,5,2
11615818,20151009,Ramucirumab,52,801,52.0,2,,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,GASTRIC CANCER,Epidural haemorrhage|Tumour haemorrhage|Shock haemorrhagic,3,5
11619847,20151012,Ramucirumab,77,801,77.0,2,78.46,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB,2,RECTAL CANCER,Infusion related reaction|Injection site pruritus|Dyspnoea|Rash generalised|Asthenia|Pallor|Dizziness,7,5
11620783,20151012,Ramucirumab,84,801,84.0,1,66.21,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB,2,COLON CANCER,Flushing|Rash|Pruritus|Ear discomfort|Chest pain|Hypertension,6,5
11634355,20151015,Ramucirumab,48,801,48.0,2,54.4,1,1,1,0,0,0,1,Ramucirumab,ESOMEPRAZOLE MAGNESIUM|RAMUCIRUMAB|PACLITAXEL|RAMUCIRUMAB|PACLITAXEL,7,CONSTIPATION|ADENOCARCINOMA GASTRIC|ADENOCARCINOMA GASTRIC,Liver disorder|Pneumonia|White blood cell count decreased,3,5
11637613,20151016,Ramucirumab,65,801,65.0,0,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL|PACLITAXEL|RAMUCIRUMAB,4,GASTRIC CANCER|GASTRIC CANCER,Haematuria|Leukopenia,2,5
11641013,20151019,Ramucirumab,39,801,39.0,2,46.1,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|OCTREOTIDE ACETATE|BEVACIZUMAB|FUROSEMIDE,8,GASTRIC CANCER|GASTRIC CANCER,Peritonitis|Intestinal perforation|Pyrexia|Pneumonia|Thrombosis,5,5
11649673,20151021,Ramucirumab,77,801,77.0,1,61.7,1,0,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,4,ADENOCARCINOMA GASTRIC|ADENOCARCINOMA GASTRIC|PREMEDICATION|PREMEDICATION,Interstitial lung disease|Anaphylactic reaction|Neutrophil count decreased,3,5
11652401,20151022,Ramucirumab,68,801,68.0,1,60,1,0,1,1,0,0,1,Ramucirumab,LANSOPRAZOLE|RAMUCIRUMAB|PACLITAXEL,3,ULCER|GASTRIC CANCER STAGE IV|GASTRIC CANCER STAGE IV,Abdominal pain upper|Pyrexia|Malignant neoplasm progression|Gastric perforation,4,5
11659310,20151026,Ramucirumab,76,801,76.0,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|FOLIC ACID|DOCETAXEL|DOCETAXEL ANHYDROUS,4,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Eye inflammation|Erythema of eyelid|Eye irritation|Lacrimation increased|Ocular hyperaemia,5,5
11660899,20151026,Ramucirumab,73,801,73.0,2,58,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|RIVAROXABAN|RAMUCIRUMAB,8,GASTRIC CANCER STAGE IV|GASTRIC CANCER STAGE IV,Peritonitis|Ileus paralytic,2,5
11660900,20151026,Ramucirumab,75,801,75.0,2,36,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,GASTRIC CANCER,Melaena|Vomiting|Pneumonia,3,5
11660901,20151026,Ramucirumab,64,801,64.0,1,,1,0,1,1,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,6,GASTRIC CANCER|PREMEDICATION|PREMEDICATION|GASTRIC CANCER|PREMEDICATION|PREMEDICATION,Febrile neutropenia|Disseminated intravascular coagulation|Pneumonia,3,5
11660902,20151026,Ramucirumab,56,801,56.0,2,,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER,Small intestinal perforation|Intestinal obstruction|Peritonitis,3,5
11660903,20151026,Ramucirumab,65,801,65.0,2,,1,1,0,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Febrile neutropenia,1,5
11661230,20151026,Ramucirumab,,,,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION,Skin exfoliation,1,5
11668077,20151027,Ramucirumab,65,801,65.0,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER|GASTRIC CANCER,Dehydration,1,5
11668079,20151027,Ramucirumab,67,801,67.0,1,56.2,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER RECURRENT|GASTRIC CANCER RECURRENT,Thrombosis|Protein urine present,2,5
11668165,20151027,Ramucirumab,65,801,65.0,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,GASTRIC CANCER,Haematemesis,1,1
11672589,20151026,Ramucirumab,64,801,64.0,1,74.8,1,0,0,0,0,0,1,Ramucirumab,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DOCETAXEL|DOCETAXEL ANHYDROUS|RAMUCIRUMAB|PREDNISONE|RAMUCIRUMAB|DENOSUMAB|MULTIVITAMIN|LORAZEPAM|DOCETAXEL|DOCETAXEL ANHYDROUS,17,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Asthenia|Stevens-Johnson syndrome|Erythema multiforme|Dyspnoea,4,3
11681962,20151028,Ramucirumab,62,801,62.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|ERGOCALCIFEROL|PACLITAXEL|PACLITAXEL,8,,Haemorrhoids|Heart rate increased|Rectal haemorrhage,3,
11684293,20151029,Ramucirumab,67,801,67.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,2,OESOPHAGEAL CARCINOMA|OESOPHAGEAL CARCINOMA,White blood cell count decreased,1,3
11686532,20151030,Ramucirumab,68,801,68.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER|GASTRIC CANCER,Retinal detachment|Retinal haemorrhage,2,5
11686534,20151030,Ramucirumab,67,801,67.0,1,67,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB|PREGABALIN,10,CANCER PAIN|ADENOCARCINOMA GASTRIC|CANCER PAIN|PRODUCT USED FOR UNKNOWN INDICATION|ADENOCARCINOMA GASTRIC|NEURALGIA|HYPERTENSION|HYPERTENSION|CANCER PAIN|PROPHYLAXIS,Interstitial lung disease|Neutrophil count decreased,2,5
11689899,20151102,Ramucirumab,73,801,73.0,1,57.6,1,1,1,0,1,0,0,Ramucirumab,ESOMEPRAZOLE MAGNESIUM|RAMUCIRUMAB|PACLITAXEL,6,CANCER PAIN|PROPHYLAXIS|NEUROPATHY PERIPHERAL|GASTRIC CANCER|GASTRIC CANCER|PELVIC VENOUS THROMBOSIS,Interstitial lung disease|Pneumothorax,2,5
11689901,20151102,Ramucirumab,67,801,67.0,2,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,PREMEDICATION|GASTRIC CANCER,Small intestinal perforation,1,5
11701118,20151105,Ramucirumab,79,801,79.0,1,59.5,1,1,1,1,0,0,0,Ramucirumab,RAMUCIRUMAB,6,GASTRIC CANCER STAGE IV|GASTRIC CANCER STAGE IV,Tumour haemorrhage|Decreased appetite|Stomatitis|Pyrexia|Neutrophil count decreased,5,5
11704562,20151106,Ramucirumab,69,801,69.0,1,,1,0,1,1,0,0,0,Ramucirumab,FILGRASTIM|RAMUCIRUMAB|GABAPENTIN|LORATADINE|LORATADINE TABLET,6,ADENOCARCINOMA GASTRIC|ADENOCARCINOMA GASTRIC,Intestinal perforation,1,3
11705740,20151106,Ramucirumab,52,801,52.0,1,61.5,1,1,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,ADENOCARCINOMA GASTRIC|ADENOCARCINOMA GASTRIC,Sepsis,1,1
11717099,20151109,Ramucirumab,56,801,56.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB|METHYLPREDNISOLONE|CETIRIZINE HYDROCHLORIDE|RAMUCIRUMAB,9,METASTATIC NEOPLASM|PREMEDICATION|DIARRHOEA|NAUSEA|METASTATIC NEOPLASM,White blood cell count increased|Neutropenia|Uveitis,3,5
11717118,20151109,Ramucirumab,76,801,76.0,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER|GASTRIC CANCER,Cardiac failure,1,5
11717120,20151109,Ramucirumab,65,801,65.0,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER|GASTRIC CANCER,Interstitial lung disease,1,5
11718205,20151110,Ramucirumab,62,801,62.0,1,,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL|RAMUCIRUMAB|PACLITAXEL,8,MALIGNANT ASCITES|IRON DEFICIENCY ANAEMIA|MALIGNANT ASCITES|GASTRIC CANCER|ABDOMINAL PAIN|GASTRIC CANCER|ABDOMINAL PAIN,Malignant neoplasm progression|Disseminated intravascular coagulation|Hypoaesthesia,3,5
11718208,20151110,Ramucirumab,62,801,62.0,1,62.5,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB|PACLITAXEL,6,HYPOPARATHYROIDISM|GASTRIC CANCER STAGE IV|GASTRIC CANCER STAGE IV|POST PROCEDURAL HYPOTHYROIDISM|PROPHYLAXIS OF NAUSEA AND VOMITING,Appendicitis,1,5
11719932,20151110,Ramucirumab,66,801,66.0,1,,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Leukopenia|Pyrexia|Neutropenia,3,1
11723031,20151111,Ramucirumab,,,,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION,Gastrointestinal haemorrhage,1,5
11730330,20151112,Ramucirumab,57,801,57.0,1,54,1,1,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB|PACLITAXEL,3,ADENOCARCINOMA GASTRIC|ADENOCARCINOMA GASTRIC,Nausea|Ileal perforation|Ascites,3,1
11730332,20151112,Ramucirumab,64,801,64.0,2,44,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|AMLODIPINE BESYLATE,4,ADENOCARCINOMA GASTRIC|PAIN|HYPERTENSION|PAIN,Abdominal pain,1,1
11737194,20151113,Ramucirumab,55,801,55.0,1,,1,1,0,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER|GASTRIC CANCER,Febrile neutropenia|Malignant neoplasm progression,2,1
11742877,20151116,Ramucirumab,48,801,48.0,1,,1,0,0,0,0,0,1,Ramucirumab,RANITIDINE|RAMUCIRUMAB,5,PRODUCT USED FOR UNKNOWN INDICATION,Gastric fistula|Malignant neoplasm progression|Gastric perforation,3,5
11743959,20151116,Ramucirumab,60,801,60.0,1,,1,1,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,OESOPHAGEAL ADENOCARCINOMA|OESOPHAGEAL ADENOCARCINOMA,Gastrointestinal haemorrhage|Gastrointestinal perforation|Haemoptysis,3,5
11747540,20151117,Ramucirumab,,,,1,,1,0,1,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL|PACLITAXEL,3,GASTRIC CANCER|GASTRIC CANCER,Abnormal behaviour|Leukoencephalopathy,2,5
11747546,20151117,Ramucirumab,71,801,71.0,2,,1,1,1,0,0,0,1,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER|GASTRIC CANCER,Blood glucose decreased|Diarrhoea|Malignant neoplasm progression,3,1
11747553,20151117,Ramucirumab,76,801,76.0,1,58.5,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|RAMUCIRUMAB|PACLITAXEL|PACLITAXEL|PACLITAXEL|ESOMEPRAZOLE MAGNESIUM,9,GASTRIC CANCER|GASTRIC CANCER,Interstitial lung disease,1,1
11750932,20151117,Ramucirumab,57,801,57.0,1,52.2,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,ADENOCARCINOMA GASTRIC|ADENOCARCINOMA GASTRIC,Abdominal pain,1,1
11751160,20151118,Ramucirumab,74,801,74.0,1,,1,0,1,0,0,0,1,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,ADENOCARCINOMA GASTRIC|ADENOCARCINOMA GASTRIC,Neutrophil count decreased|Pneumonia|Malignant neoplasm progression,3,5
11762011,20151120,Ramucirumab,54,801,54.0,2,41.2,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,ADENOCARCINOMA GASTRIC|ADENOCARCINOMA GASTRIC,Abdominal pain,1,1
11768714,20151123,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,DIPHENHYDRAMINE HYDROCHLORIDE|RAMUCIRUMAB,2,PREMEDICATION|GASTRIC CANCER,Paraesthesia|Oral mucosal erythema,2,5
11769369,20151123,Ramucirumab,,,,2,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Myocardial infarction,1,5
11773201,20151124,Ramucirumab,,,,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB,2,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Diarrhoea haemorrhagic,1,5
11773865,20151124,Ramucirumab,,,,1,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|DIPHENHYDRAMINE HYDROCHLORIDE,2,COLORECTAL CANCER,Swollen tongue|Oral mucosal blistering|Oral mucosal erythema,3,5
11777404,20151125,Ramucirumab,68,801,68.0,2,,1,1,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|PACLITAXEL,2,GASTRIC CANCER|GASTRIC CANCER,Gastrointestinal perforation,1,5
11787303,20151130,Ramucirumab,74,801,74.0,1,,1,0,1,0,0,0,0,Ramucirumab,PACLITAXEL|PACLITAXEL|RAMUCIRUMAB,3,GASTRIC CANCER|GASTRIC CANCER,Febrile neutropenia|Ascites|Pseudomembranous colitis|Proteinuria,4,5
11787304,20151130,Ramucirumab,55,801,55.0,1,54.8,1,0,0,0,0,0,0,Ramucirumab,PACLITAXEL|RAMUCIRUMAB,2,GASTRIC CANCER RECURRENT|GASTRIC CANCER RECURRENT,Sputum retention|Interstitial lung disease,2,1
11788823,20151201,Ramucirumab,51,801,51.0,2,,1,0,0,0,0,0,0,Ramucirumab,RAMUCIRUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,4,PRODUCT USED FOR UNKNOWN INDICATION|COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION,Fatigue|Vomiting|Rectal haemorrhage|Abdominal pain|Rectal haemorrhage|Platelet count decreased,6,5
11792139,20151201,Ramucirumab,55,801,55.0,1,,1,0,0,0,0,0,1,Ramucirumab,RAMUCIRUMAB,1,OESOPHAGEAL NEOPLASM,Lung abscess|Perforation,2,5
11793695,20151201,Ramucirumab,72,801,72.0,1,62,1,0,1,0,0,0,0,Ramucirumab,SIMVASTATIN|RAMUCIRUMAB|PACLITAXEL,5,INVESTIGATION|INVESTIGATION,Pneumonia,1,3
10182595,20140416,Daratumumab,50,801,50.0,2,,1,0,1,0,0,0,0,Daratumumab,POMALIDOMIDE,21,PLASMA CELL MYELOMA,Plasma cell myeloma,1,1
10272990,20140702,Daratumumab,,,,0,,1,1,1,1,0,0,0,Daratumumab,MORPHINE|ALBUTEROL SULFATE|BORTEZOMIB|LACTULOSE|OXYCODONE|DARATUMUMAB|ENALAPRIL|VALACYCLOVIR HYDROCHLORIDE,9,PAIN|PLASMA CELL MYELOMA|PAIN|PLASMA CELL MYELOMA,General physical health deterioration|Delirium,2,1
10365627,20140806,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LENALIDOMIDE|DARATUMUMAB,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Electrocardiogram QT prolonged|Hypokalaemia,2,1
10646863,20141211,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,FILGRASTIM|MAGNESIUM OXIDE|LENALIDOMIDE|LANSOPRAZOLE|ALLOPURINOL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FUROSEMIDE|DARATUMUMAB,10,PROPHYLAXIS|CONSTIPATION|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|PROPHYLAXIS|HYPOKALAEMIA|PLASMA CELL MYELOMA,Sinus bradycardia|Electrocardiogram QT prolonged|Hypokalaemia,3,1
10662524,20141218,Daratumumab,,,,0,,1,0,1,0,0,0,1,Daratumumab,CLARITHROMYCIN|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB|DARATUMUMAB|WARFARIN|BORTEZOMIB|BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,9,UPPER RESPIRATORY TRACT INFECTION|PLASMA CELL MYELOMA|HEART VALVE REPLACEMENT|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Tumour lysis syndrome|Platelet count decreased|Neoplasm|Flank pain,4,1
10662526,20141218,Daratumumab,,,,0,,1,0,1,1,0,0,1,Daratumumab,ALLOPURINOL|SERTRALINE|ACITRETIN|DARATUMUMAB|PANTOPRAZOLE|BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SULFAMETHOXAZOLE AND TRIMETHOPRIM,13,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Pneumonia|Sepsis,2,1
10723596,20150120,Daratumumab,,,,0,,1,0,1,0,0,0,0,Daratumumab,BORTEZOMIB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Incarcerated umbilical hernia,1,1
10727217,20150121,Daratumumab,,,,0,,1,0,1,0,0,0,0,Daratumumab,BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Flank pain,1,1
10741559,20150127,Daratumumab,70,801,70.0,2,80,1,1,1,1,0,0,0,Daratumumab,LENALIDOMIDE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Systemic inflammatory response syndrome|Cardiopulmonary failure,2,3
10855244,20150223,Daratumumab,54,801,54.0,2,,1,0,1,0,0,0,1,Daratumumab,"METOPROLOL SUCCINATE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ZOLPIDEM TARTRATE|DARATUMUMAB|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|FILGRASTIM|LISINOPRIL|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FILGRASTIM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOPROLOL SUCCINATE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|FUROSEMIDE|ACONITUM NAPELLUS, ARSENIC TRIOXIDE, ATROPA BELLADONNA, BRYONIA ALBA ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, FERRUM PHOSPHORICUM, GELSEMIUM SEMPERVIRENS ROOT|DARATUMUMAB|DARATUMUMAB|ACYCLOVIR|LENALIDOMIDE|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOPROLOL SUCCINATE|LISINOPRIL|DARATUMUMAB",35,INSOMNIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|COUGH|PAIN|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|ARTHRALGIA|THROMBOSIS PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MUSCLE SPASMS|HYPERTENSION|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION,Pulmonary embolism|Deep vein thrombosis,2,1
10874467,20150227,Daratumumab,,,,0,,1,1,1,1,1,0,1,Daratumumab,BORTEZOMIB|DARATUMUMAB|DARATUMUMAB|BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,6,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Hydrothorax|Pneumonia|Humerus fracture|Bone pain|Haemoglobin decreased,5,1
11032100,20150415,Daratumumab,74,801,74.0,1,42.1,1,1,1,1,0,0,0,Daratumumab,LENALIDOMIDE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Pneumonia,1,1
11048129,20150420,Daratumumab,70,801,70.0,1,93,1,1,1,1,0,0,0,Daratumumab,LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|INFECTION PROPHYLAXIS,Septic shock,1,3
11109430,20150513,Daratumumab,53,801,53.0,2,117.9,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Mastitis,1,3
11112929,20150514,Daratumumab,,,,0,,1,0,1,0,0,0,0,Daratumumab,BORTEZOMIB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION,Restless legs syndrome,1,5
11145713,20150528,Daratumumab,,,,0,,1,1,1,1,0,0,1,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB|DARATUMUMAB,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Duodenal ulcer|Acute kidney injury,2,1
11184916,20150612,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB FOR INJECTION|BORTEZOMIB|THALIDOMIDE|DARATUMUMAB,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Coombs indirect test positive|Soft tissue infection|Prerenal failure|Pneumonia|Haematotoxicity,5,3
11195147,20150617,Daratumumab,,,,0,,1,1,0,0,0,0,1,Daratumumab,MELPHALAN HYDROCHLORIDE|MELPHALAN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISONE|POMALIDOMIDE|DARATUMUMAB|BORTEZOMIB FOR INJECTION|BORTEZOMIB,7,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Cardiac failure|Hypoxia|Haematotoxicity|Plasma cell myeloma|Pneumonia|Diarrhoea|Soft tissue infection|Mental status changes|Hyperviscosity syndrome|Prerenal failure,10,3
11197418,20150617,Daratumumab,,,,0,,1,1,1,0,0,0,1,Daratumumab,DARATUMUMAB|BISOPROLOL FUMARATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|ALLOPURINOL|PANTOPRAZOLE|BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR,20,PLASMA CELL MYELOMA|ANTIFUNGAL PROPHYLAXIS|PROPHYLAXIS|GAMMA-GLUTAMYLTRANSFERASE INCREASED|HYPERTENSION|MYOCARDIAL ISCHAEMIA|ALANINE AMINOTRANSFERASE INCREASED|MYOCARDIAL ISCHAEMIA|OSTEOPOROSIS PROPHYLAXIS|ANTIVIRAL PROPHYLAXIS|PROPHYLAXIS|GAMMA-GLUTAMYLTRANSFERASE INCREASED|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|HYPERTENSION|DETOXIFICATION|ANTIVIRAL PROPHYLAXIS|ALANINE AMINOTRANSFERASE INCREASED,Organising pneumonia|Pneumonia,2,1
11221173,20150626,Daratumumab,77,801,77.0,1,,1,0,1,0,1,0,0,Daratumumab,DARATUMUMAB|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CLOPIDOGREL,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION,Cerebrovascular accident,1,1
11227948,20150630,Daratumumab,74,801,74.0,2,59,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LENALIDOMIDE,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Proctalgia|Constipation,2,3
11228148,20150630,Daratumumab,61,801,61.0,2,58.9,1,1,0,0,0,0,0,Daratumumab,POMALIDOMIDE|DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Dyspnoea,1,3
11232914,20150701,Daratumumab,51,801,51.0,1,,1,0,0,0,0,0,1,Daratumumab,POMALIDOMIDE|POMALIDOMIDE|DARATUMUMAB,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Laryngeal inflammation,1,1
11258447,20150710,Daratumumab,73,801,73.0,1,78,1,0,1,0,0,0,0,Daratumumab,LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Asthenia|Asthenia|Pulmonary calcification,3,3
11375399,20150813,Daratumumab,69,801,69.0,1,83.8,1,0,0,0,0,0,1,Daratumumab,ACYCLOVIR|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LEVOTHYROXINE|POMALIDOMIDE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|POMALIDOMIDE|POMALIDOMIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM,9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Rash,1,1
11394839,20150819,Daratumumab,67,801,67.0,2,65,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LENALIDOMIDE|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,5,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Bile duct stone,1,5
11401047,20150820,Daratumumab,,,,0,,1,1,1,0,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB|DARATUMUMAB,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Hypercalcaemia|Blood creatinine increased|Pulmonary haemorrhage|Epistaxis,4,1
11441840,20150901,Daratumumab,,,,0,,1,0,1,0,0,0,0,Daratumumab,BORTEZOMIB|FILGRASTIM|BORTEZOMIB|BORTEZOMIB|PREDNISONE|LORAZEPAM|BORTEZOMIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DARATUMUMAB|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|BISOPROLOL FUMARATE|BISOPROLOL FUMARATE,23,NEUTROPENIA|ACUTE MYOCARDIAL INFARCTION|PROPHYLAXIS|MYOCARDIAL ISCHAEMIA|PLASMA CELL MYELOMA|ACUTE MYOCARDIAL INFARCTION|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS|ACUTE MYOCARDIAL INFARCTION|PLASMA CELL MYELOMA|ACUTE MYOCARDIAL INFARCTION|PROPHYLAXIS|MYOCARDIAL ISCHAEMIA|MYOCARDIAL ISCHAEMIA|PLASMA CELL MYELOMA|MYOCARDIAL ISCHAEMIA|ACUTE MYOCARDIAL INFARCTION|MYOCARDIAL ISCHAEMIA,Neurotoxicity,1,1
11441974,20150901,Daratumumab,66,801,66.0,2,56,1,1,1,0,0,0,0,Daratumumab,BORTEZOMIB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LENALIDOMIDE,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Febrile neutropenia,1,1
11490847,20150910,Daratumumab,65,801,65.0,1,65,1,0,0,0,0,0,1,Daratumumab,BORTEZOMIB FOR INJECTION|BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB FOR INJECTION|BORTEZOMIB|LENALIDOMIDE,10,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|ANTIFUNGAL PROPHYLAXIS|PLASMA CELL MYELOMA|ANTIVIRAL PROPHYLAXIS|ANAEMIA|PLASMA CELL MYELOMA,Adenocarcinoma of colon,1,3
11515204,20150916,Daratumumab,,,,0,,1,1,1,0,0,0,0,Daratumumab,"BORTEZOMIB|CEFEPIME HYDROCHLORIDE|CEFEPIME|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|CALCIUM ACETATE|CALCIUM ACETATE CAPSULES 667 MG|ZOLPIDEM TARTRATE|FUROSEMIDE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|PANTOPRAZOLE|PREDNISONE|CEFEPIME HYDROCHLORIDE|CEFEPIME|CEFEPIME HYDROCHLORIDE|CEFEPIME|LACTULOSE|MELOXICAM|FLUCONAZOLE|FILGRASTIM|DARATUMUMAB|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|AMOXICILLIN AND CLAVULANATE POTASSIUM|ALLOPURINOL|FUROSEMIDE|FLUCONAZOLE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|HYDROCORTISONE SODIUM SUCCINATE|CALCIUM ACETATE|CALCIUM ACETATE CAPSULES 667 MG|ZOLPIDEM TARTRATE|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|RANITIDINE|FILGRASTIM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|PANTOPRAZOLE|IPRATROPIUM BROMIDE|BEPOTASTINE BESILATE|FUROSEMIDE|FUROSEMIDE|FILGRASTIM|FILGRASTIM|ZOLPIDEM TARTRATE|FUROSEMIDE|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL|FILGRASTIM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|MELPHALAN HYDROCHLORIDE|MELPHALAN|IPRATROPIUM BROMIDE|ZOLPIDEM TARTRATE|FUROSEMIDE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|FILGRASTIM|BORTEZOMIB|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|FILGRASTIM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",88,INFECTION PROPHYLAXIS|INFECTION PROPHYLAXIS|GASTROINTESTINAL DISORDER THERAPY|RASH|RASH|PLASMA CELL MYELOMA|INFECTION PROPHYLAXIS|RENAL REPLACEMENT THERAPY|CONSTIPATION|PYREXIA|PAIN PROPHYLAXIS|BONE DISORDER|RASH|INFECTION PROPHYLAXIS|PLASMA CELL MYELOMA|NUTRITIONAL SUPPLEMENTATION|INFECTION PROPHYLAXIS|HYPOMAGNESAEMIA|PROPHYLAXIS|INFECTION PROPHYLAXIS|RASH|RASH|RASH|EMPHYSEMA|HYPERPHOSPHATAEMIA|GASTROINTESTINAL DISORDER THERAPY|ELECTROLYTE IMBALANCE|DELIRIUM|DYSPNOEA|RASH|FLUID RETENTION|PROPHYLAXIS|NEUTROPHIL COUNT DECREASED|RASH|INSOMNIA|GASTROINTESTINAL DISORDER THERAPY|PREMEDICATION|BIOPSY BONE MARROW|PLASMA CELL MYELOMA|HYPERTENSION|CONSTIPATION|EMPHYSEMA|INFECTION PROPHYLAXIS|PLASMA CELL MYELOMA|ELECTROLYTE IMBALANCE|HYPOKALAEMIA|INFECTION PROPHYLAXIS|HYPOKALAEMIA,Tumour lysis syndrome,1,1
11525640,20150918,Daratumumab,55,801,55.0,2,84,1,1,1,1,0,0,1,Daratumumab,BORTEZOMIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE,6,PLASMA CELL MYELOMA|GASTROINTESTINAL DISORDER THERAPY|PLASMA CELL MYELOMA|BACK PAIN|PLASMA CELL MYELOMA|ANTIVIRAL PROPHYLAXIS,Pulmonary artery thrombosis|Acute coronary syndrome,2,1
11617200,20151009,Daratumumab,,,,0,,1,0,1,0,0,0,0,Daratumumab,BORTEZOMIB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Faecaloma,1,1
11663157,20151027,Daratumumab,,,,0,,1,0,1,0,0,0,0,Daratumumab,MELPHALAN HYDROCHLORIDE|MELPHALAN|DARATUMUMAB|ALLOPURINOL|PREDNISONE|FLUCONAZOLE|BORTEZOMIB|BORTEZOMIB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BORTEZOMIB|PREDNISONE,13,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Oesophagitis haemorrhagic,1,1
11689384,20151102,Daratumumab,,,,0,,1,0,1,1,0,0,1,Daratumumab,SULFAMETHOXAZOLE AND TRIMETHOPRIM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|DARATUMUMAB|CETIRIZINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE,17,HERPES ZOSTER|PROPHYLAXIS|PROPHYLAXIS|OSTEOPOROSIS|HYPOCALCAEMIA|INFECTION|PLASMA CELL MYELOMA|PROPHYLAXIS|PRURITUS|ANAEMIA|PLASMA CELL MYELOMA|PROPHYLAXIS|PLASMA CELL MYELOMA|GASTROINTESTINAL DISORDER THERAPY|PYREXIA|CONSTIPATION|PROPHYLAXIS,Cardiac failure,1,5
11714065,20151109,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,POMALIDOMIDE|BORTEZOMIB|DARATUMUMAB,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Unevaluable event|Plasma cell myeloma,2,5
11716218,20151109,Daratumumab,77,801,77.0,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|POMALIDOMIDE|POMALIDOMIDE,3,PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA,Plasma cell myeloma,1,1
11717353,20151110,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,LENALIDOMIDE|BORTEZOMIB|DARATUMUMAB,4,PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Monoclonal immunoglobulin present|Unevaluable event,2,5
11719729,20151110,Daratumumab,73,801,73.0,1,72.64,1,0,1,0,0,0,0,Daratumumab,POMALIDOMIDE|POMALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB,5,PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Upper respiratory tract infection|Cytopenia,2,1
11745833,20151117,Daratumumab,68,801,68.0,1,90.4,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Lethargy|Hypercalcaemia|Acute myocardial infarction|Renal failure,4,1
11745931,20151117,Daratumumab,71,801,71.0,2,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA,Pyrexia,1,1
11746529,20151117,Daratumumab,57,801,57.0,2,75,1,0,1,0,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|VALSARTAN|VALSARTAN ORAL|DARATUMUMAB|MELPHALAN HYDROCHLORIDE|MELPHALAN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISONE|PREDNISONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BORTEZOMIB|MORPHINE|ACYCLOVIR,24,PLASMA CELL MYELOMA|DIABETES MELLITUS|HYPERTENSION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PREMEDICATION|BONE LESION|PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|CHRONIC GASTRITIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS,Pneumococcal sepsis,1,1
11746537,20151117,Daratumumab,76,801,76.0,1,93,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB|DARATUMUMAB|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|DARATUMUMAB|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MONTELUKAST SODIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|INSULIN GLARGINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,33,PLASMA CELL MYELOMA|HYPOKALAEMIA|DIARRHOEA|STAPHYLOCOCCAL BACTERAEMIA|TYPE 2 DIABETES MELLITUS|PROPHYLAXIS|PLASMA CELL MYELOMA|HYPERTENSION|HYPERTENSION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|DIARRHOEA|HYPERTHERMIA|HYPERTHERMIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|ASTHMA|PROPHYLAXIS|HYPERTHERMIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|ASTHMA|PROPHYLAXIS|DIARRHOEA|TYPE 2 DIABETES MELLITUS|PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|TYPE 2 DIABETES MELLITUS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Sepsis syndrome,1,1
11755802,20151119,Daratumumab,62,801,62.0,2,92.4,1,0,0,0,0,0,1,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB|PANTOPRAZOLE|DARATUMUMAB|FUROSEMIDE|RAMIPRIL,10,PLASMA CELL MYELOMA|HEADACHE|PLASMA CELL MYELOMA|PROPHYLAXIS|VITAMIN D DEFICIENCY|PROPHYLAXIS|HYPOTHYROIDISM|PLASMA CELL MYELOMA|JOINT SWELLING,Intraductal proliferative breast lesion,1,1
11779121,20151125,Daratumumab,73,801,73.0,1,73,1,0,1,1,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|BORTEZOMIB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISONE|POMALIDOMIDE|MELPHALAN HYDROCHLORIDE|MELPHALAN|THALIDOMIDE,9,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Sepsis,1,1
11779288,20151125,Daratumumab,73,801,73.0,1,58,1,1,0,0,0,0,0,Daratumumab,BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Death,1,5
11780982,20151126,Daratumumab,,,,0,,1,0,1,0,0,0,0,Daratumumab,"PREGABALIN|LUBIPROSTONE|BORTEZOMIB|PREDNISONE|ROSUVASTATIN|DEXTROMETHORPHAN HYDROBROMIDE|LOSARTAN POTASSIUM|LOSARTAN|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ZOLEDRONIC ACID|VALACYCLOVIR HYDROCHLORIDE|MELPHALAN HYDROCHLORIDE|MELPHALAN|DARATUMUMAB|EPINASTINE HYDROCHLORIDE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE",36,PROPHYLAXIS|CONSTIPATION|LUMBAR SPINAL STENOSIS|NAUSEA|RIB FRACTURE|RASH|DRY EYE|CONSTIPATION|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|UNEVALUABLE EVENT|CONSTIPATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|DYSLIPIDAEMIA|VOMITING|RASH|COUGH|HYPERTENSION|ASTHENOPIA|PROPHYLAXIS|CONSTIPATION|RASH|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|COUGH|PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|RHINITIS ALLERGIC|VOMITING|NAUSEA|PROPHYLAXIS|UNEVALUABLE EVENT,Cytomegalovirus infection,1,1
11781469,20151126,Daratumumab,61,801,61.0,1,56.6,1,0,1,0,0,0,0,Daratumumab,BORTEZOMIB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXYCODONE|BORTEZOMIB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACYCLOVIR,12,PLASMA CELL MYELOMA|CONSTIPATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PAIN|PAIN|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PAIN|PLASMA CELL MYELOMA|NAUSEA|ANTIVIRAL PROPHYLAXIS,Pleural effusion,1,1
11781470,20151126,Daratumumab,59,801,59.0,1,54,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA,Asthenia|Malaise,2,1
11787758,20151130,Daratumumab,74,801,74.0,2,50.2,1,0,1,0,0,0,0,Daratumumab,"TRIMETHOPRIM|DARATUMUMAB|ROSUVASTATIN|LOSARTAN POTASSIUM|LOSARTAN|LUBIPROSTONE|DARATUMUMAB|EPINASTINE HYDROCHLORIDE|MELPHALAN HYDROCHLORIDE|MELPHALAN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ZOLEDRONIC ACID|BORTEZOMIB|DEXTROMETHORPHAN HYDROBROMIDE|PREGABALIN|VALACYCLOVIR HYDROCHLORIDE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE",46,PROPHYLAXIS|PROPHYLAXIS|RASH|PROPHYLAXIS|ANTIFUNGAL PROPHYLAXIS|DYSLIPIDAEMIA|HYPERTENSION|RASH|CONSTIPATION|CONSTIPATION|RASH|PROPHYLAXIS|NAUSEA|COUGH|RIB FRACTURE|ANTIFUNGAL PROPHYLAXIS|PLASMA CELL MYELOMA|RHINITIS ALLERGIC|ASTHENOPIA|PROPHYLAXIS|NAUSEA|VOMITING|RASH|RASH|PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|CONSTIPATION|CONSTIPATION|COUGH|PLASMA CELL MYELOMA|DRY EYE|VOMITING|RIB FRACTURE|RASH|COUGH|PROPHYLAXIS|CONSTIPATION|PROPHYLAXIS|PROPHYLAXIS|LUMBAR SPINAL STENOSIS|PROPHYLAXIS|PROPHYLAXIS|UNEVALUABLE EVENT,Cytomegalovirus infection,1,1
11791945,20151201,Daratumumab,,,,0,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB|POMALIDOMIDE|DARATUMUMAB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,5,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Plasma cell myeloma,1,1
11791986,20151201,Daratumumab,69,801,69.0,2,65,1,0,1,0,0,0,1,Daratumumab,DARATUMUMAB|DARATUMUMAB|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,15,THROMBOSIS PROPHYLAXIS|PYREXIA|VENOUS THROMBOSIS|HEADACHE|BRONCHITIS|SLEEP DISORDER THERAPY|COUGH|PLASMA CELL MYELOMA|VENOUS THROMBOSIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|HIATUS HERNIA|HYPERTENSION|HYPERTENSION,Pulmonary embolism|General physical health deterioration,2,1
11792188,20151201,Daratumumab,,,,0,,1,1,0,0,0,0,0,Daratumumab,POMALIDOMIDE|DARATUMUMAB|DARATUMUMAB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,5,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Adverse event,1,1
11792226,20151201,Daratumumab,66,801,66.0,1,,1,0,1,0,0,0,1,Daratumumab,DARATUMUMAB|POMALIDOMIDE|CARFILZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,5,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Rib fracture|Myalgia|Spinal fracture|Diabetes mellitus|Humerus fracture,5,1
11792235,20151201,Daratumumab,,,,0,,1,1,0,0,0,0,0,Daratumumab,POMALIDOMIDE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Adverse event,1,1
11794376,20151202,Daratumumab,,,,0,,1,1,0,0,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|POMALIDOMIDE|DARATUMUMAB|DARATUMUMAB,5,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Adverse event,1,1
11794410,20151202,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB|POMALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,6,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Diarrhoea|Tremor|Constipation|Pruritus|Hypertension|Back pain|Muscle spasms|Anaemia|Leukopenia|Pyrexia|Vomiting|Upper respiratory tract infection|Dizziness|Nasal congestion|Headache|Insomnia|Fatigue|Chills|Anxiety|Nausea|Throat irritation|Arthralgia|Neutropenia|Dyspnoea|Thrombocytopenia|Lymphopenia|Oedema peripheral|Musculoskeletal chest pain|Cough,29,1
11794575,20151202,Daratumumab,,,,0,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB|POMALIDOMIDE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,4,PLASMA CELL MYELOMA RECURRENT|PLASMA CELL MYELOMA RECURRENT|PLASMA CELL MYELOMA RECURRENT,Adverse event,1,1
11795106,20151202,Daratumumab,41,801,41.0,1,61.8,1,0,1,0,0,0,0,Daratumumab,DIPHENHYDRAMINE HYDROCHLORIDE|MEPERIDINE HYDROCHLORIDE|ACYCLOVIR|MOMETASONE FUROATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|OXYCODONE|DARATUMUMAB|FAMOTIDINE|MORPHINE SULFATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DARATUMUMAB|GABAPENTIN,19,INFUSION RELATED REACTION|INFUSION RELATED REACTION|INFUSION RELATED REACTION|PLASMA CELL MYELOMA|COUGH|INFUSION RELATED REACTION,Anaemia|Thrombocytopenia|Chest pain|Diarrhoea|Pancytopenia|Leukopenia|Haematuria,7,1
11796969,20151202,Daratumumab,54,801,54.0,2,,1,0,1,0,0,0,0,Daratumumab,"OXYCODONE HYDROCHLORIDE|OXYCODONE|VORICONAZOLE|SODIUM BICARBONATE|SODIUM BICARBONATE INJECTION,|DARATUMUMAB|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|DENOSUMAB|CEFEPIME HYDROCHLORIDE|CEFEPIME|CALCIUM|CALCITRIOL|CALCITRIOL CAPSULES 0.25 MCG|CALCITRIOL CAPSULES 0.5 MCG|PANTOPRAZOLE|ALLOPURINOL|GANCICLOVIR SODIUM|GANCICLOVIR|FILGRASTIM",13,PLASMA CELL MYELOMA,Asthenia|Myoclonus|Fall|Femur fracture|Aphasia|Confusional state|Mental status changes,7,2
11799824,20151203,Daratumumab,66,801,66.0,1,63,1,0,1,0,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|DARATUMUMAB|LENALIDOMIDE,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Oral fungal infection,1,1
11800335,20151203,Daratumumab,,,,2,63.56,1,0,0,0,0,0,1,Daratumumab,"CALCIUM|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|CARFILZOMIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ERGOCALCIFEROL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|FLUCONAZOLE|POMALIDOMIDE|POMALIDOMIDE|FLUCONAZOLE|PREDNISONE|ESTRADIOL|ACYCLOVIR|SEVELAMER CARBONATE|BORTEZOMIB|DARATUMUMAB|TEMAZEPAM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OMEPRAZOLE MAGNESIUM|MAGNESIUM|LORAZEPAM",28,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pancytopenia|Feeling abnormal|Bone pain|Plasma cell myeloma|Drug ineffective|Fatigue|Rash,7,1
11803883,20151204,Daratumumab,50,801,50.0,2,94,1,0,1,0,0,0,0,Daratumumab,CETIRIZINE HYDROCHLORIDE|BORTEZOMIB|BRINZOLAMIDE|DARATUMUMAB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE,20,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Gamma-glutamyltransferase increased|Alanine aminotransferase increased,2,1
11803902,20151204,Daratumumab,69,801,69.0,1,55.8,1,0,1,0,0,0,1,Daratumumab,DARATUMUMAB|SIMVASTATIN|DARATUMUMAB|MELPHALAN HYDROCHLORIDE|MELPHALAN|AMLODIPINE|AMLODIPINE|AMLODIPINE BESYLATE|BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|AMLODIPINE|SIMVASTATIN|FENOFIBRATE,18,PLASMA CELL MYELOMA|HYPERLIPIDAEMIA|PLASMA CELL MYELOMA|CEREBROVASCULAR ACCIDENT|HYPERTENSION|HYPERTENSION|HYPERTENSION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|HYPERTENSION|CEREBRAL INFARCTION|INFECTION PROPHYLAXIS|HYPERLIPIDAEMIA|CONSTIPATION PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER,Acute myocardial infarction,1,1
11806462,20151207,Daratumumab,65,801,65.0,1,89.5,1,0,1,0,0,0,1,Daratumumab,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FENTANYL|FUROSEMIDE|DARATUMUMAB|LACTULOSE|STANDARDIZED SENNA CONCENTRATE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FINASTERIDE|LENALIDOMIDE|ACYCLOVIR|RAMIPRIL|FLUCONAZOLE|LANSOPRAZOLE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,22,BLOOD CALCIUM|PROPHYLAXIS|PLASMA CELL MYELOMA|CONSTIPATION|CONSTIPATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|ANALGESIC THERAPY|PROPHYLAXIS|MALAISE|MALAISE,Pneumonia|Urinary tract infection,2,1
11807907,20151207,Daratumumab,77,801,77.0,2,65.2,1,0,1,0,0,0,0,Daratumumab,"FERROUS SULFATE|SPIRONOLACTONE|DARATUMUMAB|BORTEZOMIB FOR INJECTION|BORTEZOMIB|LISINOPRIL|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|POLYETHYLENE GLYCOL|BORTEZOMIB FOR INJECTION|BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISONE|MELPHALAN HYDROCHLORIDE|MELPHALAN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CARVEDILOL|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|BORTEZOMIB FOR INJECTION|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|DARATUMUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|SPIRONOLACTONE|ACYCLOVIR|SIMVASTATIN",26,ANAEMIA|OEDEMA PERIPHERAL|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|HYPERTENSION|CONSTIPATION|PROPHYLAXIS|CONSTIPATION|CONSTIPATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|CONSTIPATION|PLASMA CELL MYELOMA|CORONARY ARTERY DISEASE|LEFT VENTRICULAR FAILURE|CONSTIPATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|BONE PAIN|OEDEMA PERIPHERAL|PROPHYLAXIS|HYPERLIPIDAEMIA,Hypertension|Pulmonary oedema|Infusion related reaction|Dyspnoea,4,1
11807908,20151207,Daratumumab,,,,0,,1,0,1,1,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA,Hypoxia|Infusion related reaction|Cardio-respiratory arrest,3,5
11810072,20151207,Daratumumab,63,801,63.0,1,86.6,1,0,0,0,0,0,1,Daratumumab,,1,,Product label confusion,1,2
11810549,20151208,Daratumumab,60,801,60.0,1,79,1,0,1,1,0,0,0,Daratumumab,DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MAGNESIUM CARBONATE|CALCIUM CARBONATE|ANTACID|DARATUMUMAB|CALCIUM CARBONATE|ANTACID|BORTEZOMIB,18,PLASMA CELL MYELOMA|HYPERURICAEMIA|MUSCLE SPASMS|PHARYNGITIS|PROPHYLAXIS|HYPOCALCAEMIA|PROPHYLAXIS|VIRAL INFECTION|PLASMA CELL MYELOMA|SINUSITIS|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|HYPOKALAEMIA|PROPHYLAXIS|HYPERTENSION|PNEUMOCYSTIS JIROVECII INFECTION,Diverticular perforation|Peritonitis,2,1
11811611,20151208,Daratumumab,69,801,69.0,1,80.994,1,0,1,0,0,0,1,Daratumumab,POMALIDOMIDE|POMALIDOMIDE|POMALIDOMIDE|POMALIDOMIDE|POMALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|GABAPENTIN|WARFARIN SODIUM|WARFARIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ENOXAPARIN SODIUM|DARATUMUMAB|RIVAROXABAN,15,Plasma cell myeloma|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Prothrombin time abnormal|International normalised ratio abnormal|Thrombosis|Drug ineffective,4,3
11813971,20151209,Daratumumab,83,801,83.0,2,66.23,1,0,1,1,0,0,0,Daratumumab,DARATUMUMAB|LENALIDOMIDE|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,7,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Cerebrovascular accident,1,1
11828681,20151211,Daratumumab,51,801,51.0,1,75,1,0,1,0,0,0,0,Daratumumab,"OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACYCLOVIR|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|DARATUMUMAB|ACYCLOVIR|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOPROLOL TARTRATE|METOPROLOL|DARATUMUMAB|FENTANYL|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM",15,BREAKTHROUGH PAIN|NAUSEA|PLASMA CELL MYELOMA|ORAL CANDIDIASIS|VOMITING,Pneumonia|Septic shock,2,1
11828796,20151211,Daratumumab,58,801,58.0,2,81.19,1,0,1,0,0,0,0,Daratumumab,"LENALIDOMIDE|LENALIDOMIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|NAPROXEN|NAPROXEN SODIUM|LENALIDOMIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|AMOXICILLIN|DARATUMUMAB|HYDROCHLOROTHIAZIDE|LENALIDOMIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|BACLOFEN|GABAPENTIN",24,MUSCULOSKELETAL PAIN|ANXIETY|PLASMA CELL MYELOMA|HYPOKALAEMIA|NAUSEA|RASH|MUSCULOSKELETAL PAIN|PULMONARY EMBOLISM|THROMBOSIS PROPHYLAXIS|GASTROOESOPHAGEAL REFLUX DISEASE|CELLULITIS|PLASMA CELL MYELOMA|OEDEMA|CONSTIPATION|PROPHYLAXIS|PLASMA CELL MYELOMA|ARTHRALGIA|PROPHYLAXIS|MUSCULOSKELETAL PAIN|NEUROPATHY PERIPHERAL,Pneumonia legionella,1,1
11837063,20151215,Daratumumab,,,,0,,1,0,1,0,0,0,0,Daratumumab,"PROCHLORPERAZINE|AMOXICILLIN AND CLAVULANATE POTASSIUM|ACYCLOVIR|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|ZOLEDRONIC ACID|DARATUMUMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|TRIMETHOPRIM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|HEPARIN SODIUM|ACYCLOVIR|TRAMADOL HYDROCHLORIDE|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM",53,FATIGUE|SPINAL COMPRESSION FRACTURE|NAUSEA|DECREASED APPETITE|LUNG INFECTION|PROPHYLAXIS|MUSCLE SPASMS|ERYTHEMA MULTIFORME|PROPHYLAXIS|PROPHYLAXIS|OSTEOPOROSIS|PROPHYLAXIS|ANGINA PECTORIS|CONSTIPATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|HYPONATRAEMIA|SPINAL COMPRESSION FRACTURE|LUNG INFECTION|PLASMA CELL MYELOMA|CHRONIC GASTRITIS|SPINAL COMPRESSION FRACTURE|ERYTHEMA MULTIFORME|PROPHYLAXIS|PROPHYLAXIS|INSOMNIA|PLASMA CELL MYELOMA|SPINAL COMPRESSION FRACTURE|CHRONIC GASTRITIS|CONSTIPATION|NAUSEA|DIARRHOEA|NAUSEA|OSTEOPOROSIS|HERPES ZOSTER|PROPHYLAXIS|SPINAL COMPRESSION FRACTURE|LUNG INFECTION|LUNG INFECTION,Tuberculous pleurisy,1,1
11837942,20151215,Daratumumab,76,801,76.0,2,86,1,0,1,0,0,0,1,Daratumumab,CALCIUM GLUCONATE|MELPHALAN HYDROCHLORIDE|MELPHALAN|ALLOPURINOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|DARATUMUMAB|IRBESARTAN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|PREDNISONE|FONDAPARINUX SODIUM|BORTEZOMIB|BORTEZOMIB,21,DYSPNOEA|PROPHYLAXIS|PROPHYLAXIS|HYPOCALCAEMIA|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|HYPERTENSION|TREMOR|HYPERTENSION|PLASMA CELL MYELOMA|PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PYREXIA,Atrial fibrillation,1,1
11838017,20151215,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,"MORPHINE SULFATE|PROCHLORPERAZINE MALEATE|ATOVAQUONE|ATOVAQUONE ORAL SUSPENSION|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|FENTANYL|BORTEZOMIB FOR INJECTION|BORTEZOMIB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|MAGNESIUM OXIDE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ZOLPIDEM TARTRATE|MORPHINE|OXYCODONE|PREDNISONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|BORTEZOMIB FOR INJECTION|BORTEZOMIB|LENALIDOMIDE|ERGOCALCIFEROL|POLYETHYLENE GLYCOL|MORPHINE|PREDNISONE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MORPHINE|MORPHINE|SENNOSIDES|ALLOPURINOL|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|DARATUMUMAB|ZOLEDRONIC ACID|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|MORPHINE|NABUMETONE|ASCORBIC ACID|AMLODIPINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FAMOTIDINE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|CARFILZOMIB|ACYCLOVIR|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SIMVASTATIN|ERGOCALCIFEROL|FUROSEMIDE",59,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Plasma cell myeloma|Constipation,2,1
11841692,20151216,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Neurotoxicity,1,1
11841693,20151216,Daratumumab,78,801,78.0,1,76,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|CANDESARTAN|BISOPROLOL FUMARATE|FUROSEMIDE|SPIRONOLACTONE|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|PROMETHAZINE HYDROCHLORIDE|PROMETHAZINE HYDROCHLORIDE|NASAL|SALINE|(SALINE)|DARATUMUMAB|BORTEZOMIB|PROMETHAZINE HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LACTULOSE|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CLOPIDOGREL|CLOPIDOGREL BISULFATE|LATANOPROST|PROMETHAZINE HYDROCHLORIDE,26,HYPERTENSION|RENAL IMPAIRMENT|HYPERLIPIDAEMIA|GASTROOESOPHAGEAL REFLUX DISEASE|DIZZINESS|PRURITUS|DIARRHOEA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|DYSPNOEA|CONSTIPATION|MYOCARDIAL ISCHAEMIA|MYOCARDIAL ISCHAEMIA|CONSTIPATION|HEADACHE|PLASMA CELL MYELOMA|ANGINA PECTORIS|ANGINA PECTORIS|PROPHYLAXIS|MYOCARDIAL ISCHAEMIA|RHINORRHOEA,Diarrhoea|Acute myocardial infarction,2,1
11842824,20151216,Daratumumab,82,801,82.0,1,,1,0,0,0,0,0,1,Daratumumab,LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|LENALIDOMIDE|DIGOXIN|AMLODIPINE BESYLATE|DARATUMUMAB|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DOXAZOSIN MESYLATE|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|PRAVASTATIN SODIUM|LENALIDOMIDE,13,PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Squamous cell carcinoma of skin,1,1
11843054,20151216,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DULOXETINE HYDROCHLORIDE|LENALIDOMIDE|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB|DARATUMUMAB,6,PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Fatigue|Hot flush|Diarrhoea,3,5
11845617,20151217,Daratumumab,,,,0,,1,0,1,0,0,0,0,Daratumumab,"CARFILZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB FOR INJECTION|BORTEZOMIB|LENALIDOMIDE|POMALIDOMIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",8,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Aspergillus infection|Mucosal inflammation|Oesophageal ulcer,3,3
11847510,20151217,Daratumumab,58,801,58.0,1,,1,0,1,0,0,0,0,Daratumumab,BORTEZOMIB FOR INJECTION|BORTEZOMIB|LENALIDOMIDE|POMALIDOMIDE|DARATUMUMAB|MELPHALAN HYDROCHLORIDE|MELPHALAN|CARFILZOMIB,8,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Aspergillus infection,1,3
11849883,20151218,Daratumumab,67,801,67.0,1,,1,1,1,0,0,0,1,Daratumumab,"LISINOPRIL|ACYCLOVIR|CALCIUM|OXYCODONE|OXYCODONE HYDROCHLORIDE|DARATUMUMAB|GABAPENTIN|ESOMEPRAZOLE MAGNESIUM|BISACODYL|SENNOSIDES|DOCUSATE SODIUM AND SENNOSIDES|SENNOSIDES, 25 MG|POLYETHYLENE GLYCOL 3350|BISACODYL 5MG|LAXATIVE",10,PLASMA CELL MYELOMA|NEUROPATHY PERIPHERAL,Urine output decreased|Death,2,5
11849884,20151218,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Tumour lysis syndrome,1,2
11849885,20151218,Daratumumab,53,801,53.0,2,57,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB|LEVOTHYROXINE SODIUM|POMALIDOMIDE,3,PLASMA CELL MYELOMA|HYPOTHYROIDISM|PLASMA CELL MYELOMA,Plasma cell myeloma,1,2
11850205,20151218,Daratumumab,51,801,51.0,2,,1,0,0,0,0,0,0,Daratumumab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DARATUMUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE",6,PREMEDICATION|PREMEDICATION,Product use issue|Off label use,2,3
11863916,20151223,Daratumumab,66,801,66.0,1,74.5,1,0,1,0,0,0,0,Daratumumab,LENALIDOMIDE|CALCIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LENALIDOMIDE|DARATUMUMAB|RAMIPRIL|OXYCODONE,16,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|THROMBOSIS PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Troponin increased,1,1
11871086,20151228,Daratumumab,,,,1,,1,0,1,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Confusional state|Infusion related reaction|Hospitalisation,3,3
11878717,20151230,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Transfusion|Adverse event,2,2
11881961,20151231,Daratumumab,73,801,73.0,1,70,1,0,1,0,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREGABALIN|LENALIDOMIDE|DARATUMUMAB|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE,7,PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Affective disorder|Diarrhoea|Confusional state,3,3
11886633,20160104,Daratumumab,55,801,55.0,2,84,1,1,1,1,0,0,1,Daratumumab,CEFTRIAXONE|CEFTRIAXONE SODIUM|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|CEFTRIAXONE|CEFTRIAXONE SODIUM|CEFTRIAXONE|CEFTRIAXONE SODIUM|HYDROCORTISONE SODIUM SUCCINATE|CEFTRIAXONE|CEFTRIAXONE SODIUM|MORPHINE|ATROPINE SULFATE|ATROPINE|FUROSEMIDE|DARATUMUMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|EPINEPHRINE|ADRENALINUM|MANNITOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DOPAMINE HYDROCHLORIDE|DOPAMINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CEFTRIAXONE|CEFTRIAXONE SODIUM|CEFTRIAXONE|CEFTRIAXONE SODIUM|METHYLPREDNISOLONE SODIUM SUCCINATE|CALCIUM GLUCONATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB,26,SINUS TACHYCARDIA|PULMONARY ARTERY THROMBOSIS|ANTIVIRAL PROPHYLAXIS|BACK PAIN|TACHYPNOEA|ACUTE CORONARY SYNDROME|PULMONARY ARTERY THROMBOSIS|ACUTE CORONARY SYNDROME|ACUTE CORONARY SYNDROME|ACUTE CORONARY SYNDROME|PLASMA CELL MYELOMA|SINUS TACHYCARDIA|ACUTE CORONARY SYNDROME|ACUTE CORONARY SYNDROME|GASTROINTESTINAL DISORDER THERAPY|ACUTE CORONARY SYNDROME|PLASMA CELL MYELOMA|CHEST PAIN|ACUTE CORONARY SYNDROME|ACUTE CORONARY SYNDROME|ACUTE CORONARY SYNDROME|ACUTE CORONARY SYNDROME|PLASMA CELL MYELOMA,Acute coronary syndrome|Pulmonary artery thrombosis,2,1
11887710,20160105,Daratumumab,58,801,58.0,1,,1,0,1,0,0,0,0,Daratumumab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB FOR INJECTION|BORTEZOMIB|DARATUMUMAB|CARFILZOMIB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|POMALIDOMIDE|POSACONAZOLE|POSACONAZOLE DELAYED-RELEASE|LENALIDOMIDE|MICAFUNGIN|MICAFUNGIN SODIUM",11,PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|PROPHYLAXIS,Vomiting|Oesophagitis|Thrombocytopenia|Aspergillus infection|Nausea|Gastrointestinal haemorrhage|Haematemesis|Diarrhoea|Mucosal inflammation|Oesophageal infection|Erosive duodenitis,11,3
11888721,20160105,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,LENALIDOMIDE|DARATUMUMAB|LENALIDOMIDE|LENALIDOMIDE,4,PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA,Laboratory test abnormal,1,2
11890526,20160105,Daratumumab,75,801,75.0,1,,1,0,0,0,0,0,1,Daratumumab,LORATADINE|LORATADINE TABLET|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SIMVASTATIN|DARATUMUMAB|DOXAZOSIN MESYLATE|DOXAZOSIN,5,SEASONAL ALLERGY|NEOPLASM MALIGNANT|BLOOD CHOLESTEROL|PLASMA CELL MYELOMA|BENIGN PROSTATIC HYPERPLASIA,Cough|Lung disorder|Respiratory disorder,3,5
11892705,20160106,Daratumumab,67,801,67.0,2,94,1,0,1,0,0,0,1,Daratumumab,"BORTEZOMIB|BORTEZOMIB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DARATUMUMAB|MELPHALAN HYDROCHLORIDE|MELPHALAN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|LEVOTHYROXINE|LEVOTHYROXINE|AMOXICILLIN AND CLAVULANATE POTASSIUM|FOLIC ACID|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|OSELTAMIVIR|OSELTAMIVIR PHOSPHATE|DEXTROSE ANHYDROUS|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|BORTEZOMIB|BORTEZOMIB|LEVOTHYROXINE|LEVOTHYROXINE|FUROSEMIDE|CLONIDINE|IPRATROPIUM BROMIDE|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|LEVOTHYROXINE|FLUCONAZOLE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|AMIKACIN|FENTANYL|DEXTROSE ANHYDROUS|IPRATROPIUM BROMIDE|BORTEZOMIB|BORTEZOMIB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|FUROSEMIDE|CLONIDINE|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|CLARITHROMYCIN|LOSARTAN|AMLODIPINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|AMOXICILLIN|AMOXICILLIN|BORTEZOMIB|BISOPROLOL FUMARATE|CLARITHROMYCIN|ALLOPURINOL|OXYCODONE HYDROCHLORIDE|CLOPIDOGREL|CLOPIDOGREL BISULFATE|AMOXICILLIN AND CLAVULANATE POTASSIUM|BORTEZOMIB|BORTEZOMIB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FOLIC ACID|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LANSOPRAZOLE|MEROPENEM|POTASSIUM PHOSPHATES|POTASSIUM PHOSPHATE, MONOBASIC AND POTASSIUM PHOSPHATE, DIBASIC|POTASSIUM PHOSPHATES IN SODIUM CHLORIDE|POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC|POTASSIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE, DIBASIC INJECTION,|MONOBASIC POTASSIUM PHOSPHATE AND DIBASIC POTASSIUM PHOSPHATE|POTASSIUM PHOSPHATE|FLUCONAZOLE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CLARITHROMYCIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DOXYCYCLINE|DOXYCYCLINE HYCLATE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|AMOXICILLIN AND CLAVULANATE POTASSIUM|FLUCONAZOLE|CEFTRIAXONE|CEFTRIAXONE SODIUM|MAGNESIUM|SPIRONOLACTONE|FUROSEMIDE",136,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|GASTROOESOPHAGEAL REFLUX DISEASE|PROPHYLAXIS|HYPOTHYROIDISM|LOWER RESPIRATORY TRACT INFECTION|SEPSIS|PROPHYLAXIS|UPPER RESPIRATORY TRACT INFECTION|MACROCYTOSIS|NEUROPATHY PERIPHERAL|SEPSIS|PAIN IN EXTREMITY|PROPHYLAXIS|BLOOD MAGNESIUM DECREASED|HYPERCHOLESTEROLAEMIA|PROPHYLAXIS|ACUTE CORONARY SYNDROME|CONSTIPATION|HYPERTENSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PROPHYLAXIS|NEUTROPENIA|HYPOMAGNESAEMIA|INFECTION PROPHYLAXIS|BACK PAIN|NAUSEA|ACUTE CORONARY SYNDROME|PAIN IN EXTREMITY|SEPSIS|PAIN IN EXTREMITY|TYPE 2 DIABETES MELLITUS|ACUTE CORONARY SYNDROME|BACK PAIN|UPPER RESPIRATORY TRACT INFECTION|PERIPHERAL SWELLING|THROMBOSIS PROPHYLAXIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PROPHYLAXIS|PLASMA CELL MYELOMA|LOWER RESPIRATORY TRACT INFECTION|HYPERTENSION|HYPERTENSION|PROPHYLAXIS|NAUSEA|PROPHYLAXIS|PROPHYLAXIS|NEUROPATHY PERIPHERAL|PLASMA CELL MYELOMA|SEPSIS|HYPOKALAEMIA|UPPER RESPIRATORY TRACT INFECTION|LOWER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|HYPERTENSION|HYPOMAGNESAEMIA|SEPSIS|PROPHYLAXIS|HYPOCALCAEMIA|NEUROPATHY PERIPHERAL|SEPSIS|MACROCYTOSIS|SEPSIS|LOWER RESPIRATORY TRACT INFECTION|LOWER RESPIRATORY TRACT INFECTION|MACROCYTOSIS|TYPE 2 DIABETES MELLITUS|ANTACID THERAPY|BLOOD CHOLESTEROL|PROPHYLAXIS|PROPHYLAXIS|ECZEMA|DYSPEPSIA|SEPSIS|ACUTE CORONARY SYNDROME|DEHYDRATION|SEPSIS|LOWER RESPIRATORY TRACT INFECTION|PAIN|UPPER RESPIRATORY TRACT INFECTION|UPPER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|UPPER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|SEPSIS|BACK PAIN|COUGH|SEPSIS|ACUTE CORONARY SYNDROME|TYPE 2 DIABETES MELLITUS|HYPOMAGNESAEMIA|ACUTE CORONARY SYNDROME|SEPSIS|PERIPHERAL SWELLING,Neutropenia|Neuropathy peripheral|Acute kidney injury|Acute coronary syndrome|Atrial fibrillation|Peripheral swelling|Upper respiratory tract infection|Sepsis|Lower respiratory tract infection|Abdominal pain|Chronic obstructive pulmonary disease|Back pain|Thrombocytopenia|Spinal column stenosis|Constipation,15,1
11895040,20160107,Daratumumab,75,801,75.0,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,White blood cell count decreased|Platelet count decreased,2,5
11895269,20160107,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,White blood cell count decreased|Platelet count decreased,2,5
11895669,20160107,Daratumumab,68,801,68.0,2,79,1,1,1,1,0,0,1,Daratumumab,DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Pneumonia|Respiratory failure|Cardiac failure congestive|Atrial fibrillation,4,3
11896485,20160107,Daratumumab,,,,0,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Hospitalisation|Drug dose omission,2,2
11898519,20160108,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Thrombocytopenia|Ototoxicity,2,2
11900392,20160108,Daratumumab,55,801,55.0,2,84,1,1,1,1,0,0,0,Daratumumab,BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DARATUMUMAB|DARATUMUMAB,7,PLASMA CELL MYELOMA|BACK PAIN|PLASMA CELL MYELOMA|ANTIVIRAL PROPHYLAXIS|GASTROINTESTINAL DISORDER THERAPY|PLASMA CELL MYELOMA,Acute coronary syndrome|Pulmonary artery thrombosis,2,1
11906587,20160111,Daratumumab,67,801,67.0,2,,1,0,1,0,0,0,1,Daratumumab,POMALIDOMIDE|POMALIDOMIDE|POMALIDOMIDE|DARATUMUMAB,4,PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|White blood cell count decreased|Pyrexia|Oropharyngeal pain,4,2
11908165,20160111,Daratumumab,,,,0,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,2
11909702,20160112,Daratumumab,74,801,74.0,2,67.19,1,0,1,1,1,0,0,Daratumumab,"MORPHINE SULFATE|PROCHLORPERAZINE MALEATE|MAGNESIUM OXIDE|ATOVAQUONE|METOCLOPRAMIDE HYDROCHLORIDE|ERGOCALCIFEROL|METOPROLOL TARTRATE|METOPROLOL|METHYLPREDNISOLONE|PREDNISONE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MORPHINE SULFATE|FAMOTIDINE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|MORPHINE SULFATE|SIMVASTATIN|ZOLPIDEM TARTRATE|ZOLEDRONIC ACID|ERGOCALCIFEROL|NABUMETONE|FUROSEMIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|LENALIDOMIDE|MORPHINE SULFATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FAMOTIDINE|PREDNISONE|FUROSEMIDE|ACYCLOVIR|MORPHINE SULFATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARFILZOMIB|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|ERGOCALCIFEROL|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|FENTANYL|PROCHLORPERAZINE MALEATE|ATORVASTATIN CALCIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|AMLODIPINE|BORTEZOMIB FOR INJECTION|BORTEZOMIB|OXYCODONE|ALLOPURINOL|LENALIDOMIDE|MORPHINE SULFATE|MORPHINE SULFATE|MORPHINE SULFATE|MORPHINE SULFATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|ASCORBIC ACID|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE",74,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|VITAMIN SUPPLEMENTATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Urinary tract infection|Acute kidney injury|Plasma cell myeloma,3,1
11909893,20160112,Daratumumab,79,801,79.0,2,76,1,0,1,0,0,0,1,Daratumumab,BORTEZOMIB|BORTEZOMIB|DARATUMUMAB|ALLOPURINOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|AMOXICILLIN AND CLAVULANATE POTASSIUM|BORTEZOMIB|PREDNISONE|PREDNISONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|PREDNISONE|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|DARATUMUMAB|AMLODIPINE|DOXAZOSIN|DOXAZOSIN MESYLATE|LACTULOSE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|CLARITHROMYCIN|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|METOCLOPRAMIDE HYDROCHLORIDE|FUROSEMIDE|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|MELPHALAN HYDROCHLORIDE|MELPHALAN|LANSOPRAZOLE|AMLODIPINE|LACTULOSE|CLARITHROMYCIN|BORTEZOMIB|BORTEZOMIB|DARATUMUMAB|LANSOPRAZOLE,71,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|ARTHRALGIA|ANTIVIRAL PROPHYLAXIS|GOUT|INFECTION PROPHYLAXIS|ARTHRALGIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|INFECTION|INFECTION PROPHYLAXIS|EYE PRURITUS|HYPERTENSION|INFECTION|HYPERTENSION|ARTHRALGIA|PNEUMONIA|SEPSIS|PNEUMONIA|INFECTION PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|ARTHRALGIA|PNEUMONIA|HYPERTENSION|OEDEMA PERIPHERAL|PLASMA CELL MYELOMA|IRON DEFICIENCY|CONSTIPATION PROPHYLAXIS|INFECTION|THROMBOSIS PROPHYLAXIS|PNEUMONIA|PROPHYLAXIS|HYPERTENSION|INFECTION,Acute kidney injury|Infection|Drug dose omission|Pneumonia|Urinary tract infection|Sepsis|Oedema peripheral|Joint swelling|Anaemia|Arthralgia|Eye pruritus,11,3
11909998,20160112,Daratumumab,,,,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Amblyopia|Optic ischaemic neuropathy,2,5
11911307,20160112,Daratumumab,79,801,79.0,1,100,1,0,1,1,0,0,1,Daratumumab,BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|FOLIC ACID|BORTEZOMIB|BORTEZOMIB|PREDNISONE|DARATUMUMAB|IPRATROPIUM BROMIDE|DARATUMUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|MELPHALAN HYDROCHLORIDE|MELPHALAN|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|AMIKACIN|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|ERGOCALCIFEROL|IPRATROPIUM BROMIDE|BORTEZOMIB|BORTEZOMIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|AMOXICILLIN|AMOXICILLIN|OXYGEN|0XYGEN|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|ERGOCALCIFEROL|CALCIUM,72,MALAISE|URINARY TRACT OBSTRUCTION|URINARY TRACT INFECTION|VITAMIN SUPPLEMENTATION|THROMBOSIS PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|DEPRESSION|INFECTION PROPHYLAXIS|SEPSIS|URINARY TRACT INFECTION|VOMITING|NAUSEA|SEPSIS|SEPSIS|PLASMA CELL MYELOMA|PYREXIA|PROPHYLAXIS|VOMITING|DIARRHOEA|BRONCHITIS|SEPSIS|HYPERCALCAEMIA|INFECTION PROPHYLAXIS|SEPSIS|SEPSIS|MUSCULOSKELETAL PAIN|GASTROINTESTINAL DISORDER THERAPY|NAUSEA|BRONCHITIS|HYPERCALCAEMIA|URINARY TRACT INFECTION|SEPSIS|SEPSIS|PLASMA CELL MYELOMA|INFLUENZA LIKE ILLNESS|CHILLS|SEPSIS|HYPERCALCAEMIA|PROPHYLAXIS|HYPERURICAEMIA|URINARY TRACT INFECTION|URINARY TRACT INFECTION,Urinary tract obstruction|Benign prostatic hyperplasia|Septic shock|Hyponatraemia|Acute kidney injury|Pneumonia|Sepsis|Superinfection|Oedema peripheral|Platelet count decreased|Bronchitis|Coagulopathy|Anaemia|Urinary tract infection|Pyrexia|Phlebitis|Sinus disorder,17,1
11911427,20160112,Daratumumab,60,801,60.0,1,111.2,1,0,1,0,0,0,0,Daratumumab,"AMLODIPINE|CALCIUM CARBONATE|ANTACID|FUROSEMIDE|FUROSEMIDE|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|LORAZEPAM|DARATUMUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|TADALAFIL|SPIRONOLACTONE|CLOPIDOGREL|CLOPIDOGREL BISULFATE|BORTEZOMIB|OXYCODONE|ALLOPURINOL|SERTRALINE|SERTRALINE|TERAZOSIN|TERAZOSIN HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ATENOLOL|MORPHINE|LIDOCAINE HYDROCHLORIDE|BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ALBUTEROL SULFATE|ALBUTEROL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|DARATUMUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PANTOPRAZOLE",31,HYPERTENSION|HYPOCALCAEMIA|HYPERTENSION|OEDEMA|HYPERTENSION|ANXIETY|OSTEOARTHRITIS|ORGANIC ERECTILE DYSFUNCTION|HYPERLIPIDAEMIA|HYPERTENSION|PROPHYLAXIS|PLASMA CELL MYELOMA|BACK PAIN|HYPERURICAEMIA|ANXIETY|DEPRESSION|HYPERTENSION|ARTHRALGIA|HYPERTENSION|BACK PAIN|DYSPHAGIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|DYSPNOEA|OSTEOARTHRITIS|HYPOKALAEMIA|PLASMA CELL MYELOMA|ARTHRALGIA|CHRONIC GASTRITIS|GASTROOESOPHAGEAL REFLUX DISEASE,Transient ischaemic attack,1,1
11916600,20160114,Daratumumab,71,801,71.0,2,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|LENALIDOMIDE,2,PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA,Adverse drug reaction,1,1
11919927,20160115,Daratumumab,,,,2,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Product quality issue|Bone marrow failure,2,1
11922419,20160115,Daratumumab,61,801,61.0,2,52,1,0,1,0,0,0,0,Daratumumab,THALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB|DARATUMUMAB,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Femoral neck fracture|Fall,2,1
11923885,20160118,Daratumumab,69,801,69.0,2,65,1,1,1,1,0,0,1,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB|VALACYCLOVIR HYDROCHLORIDE|DARATUMUMAB,9,PLASMA CELL MYELOMA|ISCHAEMIC STROKE|PLASMA CELL MYELOMA|ANTIVIRAL PROPHYLAXIS|ELECTROLYTE SUBSTITUTION THERAPY|PLASMA CELL MYELOMA|INFECTION PROPHYLAXIS|GASTROINTESTINAL DISORDER THERAPY|OSTEOPOROSIS PROPHYLAXIS,Ischaemic stroke,1,1
11925236,20160118,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Transfusion|Adverse event,2,1
11927911,20160119,Daratumumab,60,801,60.0,2,53.52,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|FENTANYL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FENTANYL,8,PLASMA CELL MYELOMA|PAIN IN EXTREMITY|BACK PAIN|BACK PAIN|PAIN IN EXTREMITY|PAIN IN EXTREMITY|BACK PAIN,Neutropenia|Sepsis|Pancytopenia|Platelet count decreased|Organ failure,5,1
11935649,20160121,Daratumumab,,,,0,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Asthenia|Anaemia,2,3
11936160,20160121,Daratumumab,67,801,67.0,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|CARFILZOMIB|CARFILZOMIB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea,1,2
11936843,20160121,Daratumumab,,,,1,,1,0,0,0,0,0,1,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|POMALIDOMIDE|BORTEZOMIB FOR INJECTION|BORTEZOMIB|DARATUMUMAB,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Psychotic disorder|Plasma cell myeloma recurrent,2,1
11936936,20160121,Daratumumab,73,801,73.0,1,70,1,0,1,0,0,0,0,Daratumumab,LENALIDOMIDE|PREGABALIN|ENALAPRIL|DARATUMUMAB|PANTOPRAZOLE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACYCLOVIR,12,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,General physical health deterioration|Diarrhoea|Periorbital cellulitis|Gait disturbance,4,1
11940787,20160122,Daratumumab,53,801,53.0,2,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Malaise|Blood count abnormal|Death,3,3
11944413,20160125,Daratumumab,50,801,50.0,2,63,1,0,1,0,0,0,0,Daratumumab,BORTEZOMIB|THALIDOMIDE|DARATUMUMAB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,5,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Tachycardia,1,1
11948837,20160125,Daratumumab,78,801,78.0,1,64,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BISOPROLOL FUMARATE|DARATUMUMAB|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|DARATUMUMAB|ISOSORBIDE MONONITRATE|CALCIUM CARBONATE|ANTACID|BORTEZOMIB|PANTOPRAZOLE|ALLOPURINOL|BORTEZOMIB|BISOPROLOL FUMARATE|DARATUMUMAB,21,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|HYPERTENSION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|CORONARY ARTERY DISEASE|VITAMIN D DEFICIENCY|PLASMA CELL MYELOMA|CORONARY ARTERY DISEASE|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|CORONARY ARTERY DISEASE|PROPHYLAXIS|INFECTION PROPHYLAXIS|VITAMIN D DEFICIENCY|PLASMA CELL MYELOMA|PROPHYLAXIS,Pulmonary oedema,1,1
11952523,20160126,Daratumumab,67,801,67.0,2,94,1,0,1,0,0,0,1,Daratumumab,"SENNOSIDES|SENNA LEAF|SENNA|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|SPIRONOLACTONE|DARATUMUMAB|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FOLIC ACID|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BORTEZOMIB|BORTEZOMIB|BISOPROLOL FUMARATE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|LEVOTHYROXINE|CEFTRIAXONE|CEFTRIAXONE SODIUM|LANSOPRAZOLE|CLOPIDOGREL|CLOPIDOGREL BISULFATE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|BORTEZOMIB|BORTEZOMIB|AMLODIPINE|LEVOTHYROXINE|AMOXICILLIN AND CLAVULANATE POTASSIUM|CLONIDINE|FUROSEMIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OSELTAMIVIR|OSELTAMIVIR PHOSPHATE|MAGNESIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BISOPROLOL FUMARATE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ALLOPURINOL|FOLIC ACID|FUROSEMIDE|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|AMOXICILLIN AND CLAVULANATE POTASSIUM|POTASSIUM PHOSPHATE|POTASSIUM PHOSPHATE|CLARITHROMYCIN|AMOXICILLIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BORTEZOMIB|LEVOTHYROXINE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|IPRATROPIUM BROMIDE|FENTANYL|FLUCONAZOLE|FLUCONAZOLE|LANSOPRAZOLE|OXYCODONE HYDROCHLORIDE|CLARITHROMYCIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|LOSARTAN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FUROSEMIDE|MEROPENEM|CLARITHROMYCIN|AMOXICILLIN|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|BORTEZOMIB|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|AMIKACIN|DEXTROSE ANHYDROUS|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE",123,CONSTIPATION|SEPSIS|BACK PAIN|PROPHYLAXIS|PLASMA CELL MYELOMA|ACUTE CORONARY SYNDROME|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|ACUTE CORONARY SYNDROME|MACROCYTOSIS|PROPHYLAXIS|NAUSEA|PROPHYLAXIS|NEUROPATHY PERIPHERAL|UPPER RESPIRATORY TRACT INFECTION|HYPERTENSION|UPPER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|ACUTE CORONARY SYNDROME|SEPSIS|TYPE 2 DIABETES MELLITUS|DYSPEPSIA|PROPHYLAXIS|PLASMA CELL MYELOMA|SEPSIS|PAIN|LOWER RESPIRATORY TRACT INFECTION|HYPERTENSION|PROPHYLAXIS|PROPHYLAXIS|HYPERTENSION|THROMBOSIS PROPHYLAXIS|HYPOKALAEMIA|PROPHYLAXIS|SEPSIS|PAIN IN EXTREMITY|HYPOMAGNESAEMIA|HYPOKALAEMIA|UPPER RESPIRATORY TRACT INFECTION|GASTROOESOPHAGEAL REFLUX DISEASE|PROPHYLAXIS|PROPHYLAXIS|PERIPHERAL SWELLING|PAIN IN EXTREMITY|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|MACROCYTOSIS|HYPERCHOLESTEROLAEMIA|HYPOCALCAEMIA|LOWER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|LOWER RESPIRATORY TRACT INFECTION|NAUSEA|PROPHYLAXIS|HYPOMAGNESAEMIA|PROPHYLAXIS|PROPHYLAXIS|DEHYDRATION|LOWER RESPIRATORY TRACT INFECTION|UPPER RESPIRATORY TRACT INFECTION|UPPER RESPIRATORY TRACT INFECTION|HYPOTHYROIDISM|TYPE 2 DIABETES MELLITUS|SEPSIS|ACUTE CORONARY SYNDROME|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|UPPER RESPIRATORY TRACT INFECTION|PAIN IN EXTREMITY|BACK PAIN|SEPSIS|PROPHYLAXIS|ACUTE CORONARY SYNDROME|NEUROPATHY PERIPHERAL|BACK PAIN|UPPER RESPIRATORY TRACT INFECTION|LOWER RESPIRATORY TRACT INFECTION|SEPSIS|PLASMA CELL MYELOMA|PROPHYLAXIS|HYPERTENSION|SEPSIS|COUGH|PROPHYLAXIS|SEPSIS|SEPSIS|LOWER RESPIRATORY TRACT INFECTION|PLASMA CELL MYELOMA|INFECTION PROPHYLAXIS|ANTACID THERAPY|PROPHYLAXIS|PROPHYLAXIS|SEPSIS|PROPHYLAXIS|TYPE 2 DIABETES MELLITUS|ECZEMA|NEUROPATHY PERIPHERAL,Spinal column stenosis|Neutropenia|Acute kidney injury|Thrombocytopenia|Acute coronary syndrome|Abdominal pain|Lower respiratory tract infection|Sepsis|Neuropathy peripheral|Chronic obstructive pulmonary disease|Atrial fibrillation|Upper respiratory tract infection|Constipation|Peripheral swelling|Back pain,15,1
11952540,20160126,Daratumumab,67,801,67.0,1,85,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|SELENIUM|SIMVASTATIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,12,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|THROMBOSIS|NUTRITIONAL SUPPLEMENTATION|THROMBOSIS|THROMBOSIS|HYPERCHOLESTEROLAEMIA|MINERAL SUPPLEMENTATION|THROMBOSIS|PLASMA CELL MYELOMA|THROMBOSIS,Sepsis,1,1
11953565,20160126,Daratumumab,76,801,76.0,1,82,1,0,1,1,0,0,0,Daratumumab,DARATUMUMAB|MELPHALAN HYDROCHLORIDE|MELPHALAN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ROSUVASTATIN|BORTEZOMIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACETYLCYSTEINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|SIMVASTATIN,14,PLASMA CELL MYELOMA|CARBOHYDRATE INTOLERANCE|PLASMA CELL MYELOMA|SPINAL CORD COMPRESSION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|SPINAL CORD COMPRESSION|SPINAL CORD COMPRESSION|SPINAL CORD COMPRESSION,Respiratory failure,1,1
11956050,20160126,Daratumumab,63,801,63.0,1,108.96,1,0,0,0,0,0,0,Daratumumab,OXYCODONE HYDROCHLORIDE|LENALIDOMIDE|ALLOPURINOL|LENALIDOMIDE|COLESEVELAM HYDROCHLORIDE|ACYCLOVIR|LISINOPRIL|DARATUMUMAB|ALLOPURINOL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,13,PAIN|RENAL DISORDER|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HERPES VIRUS INFECTION|HYPERTENSION|PLASMA CELL MYELOMA|PROPHYLAXIS|BONE PAIN|PREMEDICATION,Psoriasis,1,3
11957191,20160126,Daratumumab,,,,1,,1,1,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Dyspnoea|Platelet count decreased|Diarrhoea|Plasma cell myeloma|White blood cell count decreased|Red blood cell count decreased|Pneumonia|Infection|Pyrexia|Fatigue,10,5
11957194,20160126,Daratumumab,53,801,53.0,1,74.2,1,0,1,0,0,0,1,Daratumumab,FLUOXETINE HYDROCHLORIDE|PREDNISONE|DARATUMUMAB|BUPROPION HYDROCHLORIDE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|METHYLPREDNISOLONE|DARATUMUMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|HYDROMORPHONE HYDROCHLORIDE|LORAZEPAM|OMEPRAZOLE MAGNESIUM|TACROLIMUS|TACROLIMUS OINTMENT 0.1%|TACROLIMUS EXTENDED-RELEASE CAPSULES|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|MAGNESIUM OXIDE|PREGABALIN,20,PLASMA CELL MYELOMA|ANTIFUNGAL PROPHYLAXIS|PAIN,Hypotension|Hypoxia|Hypercalcaemia|Pneumonia aspiration|Acute kidney injury,5,1
11967215,20160127,Daratumumab,84,801,84.0,1,71,1,0,1,0,0,0,0,Daratumumab,ACYCLOVIR|AMOXICILLIN AND CLAVULANATE POTASSIUM|PREDNISONE|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|DARATUMUMAB|GABAPENTIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|AMOXICILLIN AND CLAVULANATE POTASSIUM,49,PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|URINARY TRACT INFECTION|NEUROPATHY PERIPHERAL|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|LIVER DISORDER|PROPHYLAXIS|PROPHYLAXIS|NECK PAIN|PROPHYLAXIS|OSTEOARTHRITIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|UPPER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|PROPHYLAXIS|NEUTROPENIA|NECK PAIN|PROPHYLAXIS|NEUROPATHY PERIPHERAL|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|NECK PAIN|PROPHYLAXIS|HYPERTENSION|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS|NEUROPATHY PERIPHERAL|NEUROPATHY PERIPHERAL|PROPHYLAXIS|UPPER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|PROPHYLAXIS|NECK PAIN|PROPHYLAXIS|PROPHYLAXIS|NECK PAIN|GASTROINTESTINAL INFECTION,Urinary tract infection|Peripheral sensory neuropathy|Neutropenia|Gastrointestinal infection|Thrombocytopenia|Petechiae|Upper respiratory tract infection,7,1
11972743,20160128,Daratumumab,89,801,89.0,1,55.2,1,0,1,0,0,0,1,Daratumumab,"BORTEZOMIB|PHYTONADIONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|BORTEZOMIB|CYANOCOBALAMIN|MELPHALAN HYDROCHLORIDE|MELPHALAN|TRAMADOL HYDROCHLORIDE|KETOPROFEN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PYRIDOXINE HYDROCHLORIDE|TRIMETHOPRIM|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|ACYCLOVIR|CHLORHEXIDINE GLUCONATE|ANTISEPTIC SKIN CLEANSER|DARATUMUMAB|MELPHALAN HYDROCHLORIDE|MELPHALAN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|FUROSEMIDE|DARATUMUMAB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE",72,PLASMA CELL MYELOMA|CONSTIPATION|LUMBAR SPINAL STENOSIS|CONSTIPATION|URINARY TRACT INFECTION|DECREASED APPETITE|INFECTION PROPHYLAXIS|PROPHYLAXIS|VIRAL UPPER RESPIRATORY TRACT INFECTION|HYPOKALAEMIA|VIRAL UPPER RESPIRATORY TRACT INFECTION|CENTRAL VENOUS CATHETERISATION|ANTIDIARRHOEAL SUPPORTIVE CARE|PLASMA CELL MYELOMA|LUMBAR SPINAL STENOSIS|DRY SKIN|URINARY TRACT INFECTION|VIRAL UPPER RESPIRATORY TRACT INFECTION|LUMBAR SPINAL STENOSIS|INFECTION PROPHYLAXIS|PROPHYLAXIS|ANTIVIRAL PROPHYLAXIS|PLASMA CELL MYELOMA|ESSENTIAL TREMOR|SPINAL COMPRESSION FRACTURE|DECREASED APPETITE|ESSENTIAL TREMOR|CONSTIPATION|LUMBAR SPINAL STENOSIS|PLASMA CELL MYELOMA|SPINAL COMPRESSION FRACTURE|PYREXIA|LUMBAR SPINAL STENOSIS|PROPHYLAXIS|DECREASED APPETITE|INFECTION PROPHYLAXIS|VIRAL UPPER RESPIRATORY TRACT INFECTION|ANTIDIARRHOEAL SUPPORTIVE CARE|ANTIDIARRHOEAL SUPPORTIVE CARE|ABDOMINAL TENDERNESS|ANTIDIARRHOEAL SUPPORTIVE CARE|SPINAL COMPRESSION FRACTURE|ANTIVIRAL PROPHYLAXIS|DECREASED APPETITE|SKIN ABRASION|DIARRHOEA|PLASMA CELL MYELOMA|OSTEOPOROSIS|SPINAL COMPRESSION FRACTURE|DECREASED APPETITE|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|HYPERURICAEMIA|PROPHYLAXIS|VIRAL UPPER RESPIRATORY TRACT INFECTION|PLEURAL EFFUSION|DIARRHOEA|PLASMA CELL MYELOMA|SPINAL COMPRESSION FRACTURE|URINARY TRACT INFECTION|PYREXIA|PYREXIA|VIRAL UPPER RESPIRATORY TRACT INFECTION|VIRAL UPPER RESPIRATORY TRACT INFECTION|LUMBAR SPINAL STENOSIS|PROPHYLAXIS|DECREASED APPETITE|DECREASED APPETITE|ANTIDIARRHOEAL SUPPORTIVE CARE|HYPONATRAEMIA|URINARY TRACT INFECTION|INSOMNIA,Influenza|Cytomegalovirus infection reactivation,2,1
11973164,20160128,Daratumumab,,,,1,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death|Drug ineffective for unapproved indication,2,5
11980688,20160129,Daratumumab,67,801,67.0,1,85,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SIMVASTATIN|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|SELENIUM,12,PLASMA CELL MYELOMA|THROMBOSIS|HYPERCHOLESTEROLAEMIA|MINERAL SUPPLEMENTATION|PLASMA CELL MYELOMA|THROMBOSIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|NUTRITIONAL SUPPLEMENTATION,Sepsis,1,5
11980835,20160129,Daratumumab,67,801,67.0,1,85,1,0,1,0,0,0,0,Daratumumab,PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SIMVASTATIN|SELENIUM|DARATUMUMAB|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB,12,PLASMA CELL MYELOMA|MINERAL SUPPLEMENTATION|THROMBOSIS|HYPERCHOLESTEROLAEMIA|THROMBOSIS|NUTRITIONAL SUPPLEMENTATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Sepsis,1,3
11980845,20160129,Daratumumab,67,801,67.0,2,94,1,0,1,0,0,0,1,Daratumumab,"CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|LEVOTHYROXINE|FLUCONAZOLE|OXYCODONE HYDROCHLORIDE|SPIRONOLACTONE|BORTEZOMIB|BORTEZOMIB|LOSARTAN|AMIKACIN|CEFTRIAXONE|CEFTRIAXONE SODIUM|CLOPIDOGREL|CLOPIDOGREL BISULFATE|CLARITHROMYCIN|MELPHALAN HYDROCHLORIDE|MELPHALAN|LEVOTHYROXINE|LEVOTHYROXINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CLONIDINE|FLUCONAZOLE|FOLIC ACID|MEROPENEM|POTASSIUM PHOSPHATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|AMLODIPINE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|AMOXICILLIN|SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DARATUMUMAB|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|IPRATROPIUM BROMIDE|DEXTROSE ANHYDROUS|SENNOSIDES|SENNA LEAF|SENNA|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|HYDROXOCOBALAMIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BORTEZOMIB|BORTEZOMIB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ALLOPURINOL|OSELTAMIVIR|OSELTAMIVIR PHOSPHATE|AMOXICILLIN AND CLAVULANATE POTASSIUM|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CLONIDINE|FENTANYL|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|MAGNESIUM|CLARITHROMYCIN|AMOXICILLIN AND CLAVULANATE POTASSIUM|BORTEZOMIB|BORTEZOMIB|BISOPROLOL FUMARATE|LEVOTHYROXINE|LEVOTHYROXINE|LEVOTHYROXINE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|IPRATROPIUM BROMIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LANSOPRAZOLE|MEROPENEM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|HYDROXOCOBALAMIN|FILGRASTIM|DARATUMUMAB|BORTEZOMIB",116,INFECTION PROPHYLAXIS|HYPOCALCAEMIA|COUGH|SEPSIS|PROPHYLAXIS|NEUROPATHY PERIPHERAL|ACUTE CORONARY SYNDROME|HYPERTENSION|SEPSIS|SEPSIS|SEPSIS|PRODUCT USED FOR UNKNOWN INDICATION|SEPSIS|LOWER RESPIRATORY TRACT INFECTION|HYPOTHYROIDISM|PROPHYLAXIS|SEPSIS|BACK PAIN|MACROCYTOSIS|NEUROPATHY PERIPHERAL|PROPHYLAXIS|PLASMA CELL MYELOMA|HYPERTENSION|HYPERCHOLESTEROLAEMIA|UPPER RESPIRATORY TRACT INFECTION|SEPSIS|ACUTE CORONARY SYNDROME|PAIN IN EXTREMITY|NEUROPATHY PERIPHERAL|LOWER RESPIRATORY TRACT INFECTION|SEPSIS|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|UPPER RESPIRATORY TRACT INFECTION|ACUTE CORONARY SYNDROME|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|UPPER RESPIRATORY TRACT INFECTION|TYPE 2 DIABETES MELLITUS|TYPE 2 DIABETES MELLITUS|ACUTE CORONARY SYNDROME|BACK PAIN|CONSTIPATION|PROPHYLAXIS|MACROCYTOSIS|PROPHYLAXIS|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|SEPSIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|LOWER RESPIRATORY TRACT INFECTION|BLOOD MAGNESIUM DECREASED|PLASMA CELL MYELOMA|ANTACID THERAPY|GASTROOESOPHAGEAL REFLUX DISEASE|ACUTE CORONARY SYNDROME|PROPHYLAXIS|HYPERTENSION|NAUSEA|PAIN IN EXTREMITY|THROMBOSIS PROPHYLAXIS|PERIPHERAL SWELLING|HYPOMAGNESAEMIA|PAIN IN EXTREMITY|BACK PAIN|HYPOMAGNESAEMIA|SEPSIS|LOWER RESPIRATORY TRACT INFECTION|HYPERTENSION|DIABETES MELLITUS|LOWER RESPIRATORY TRACT INFECTION|ECZEMA|DYSPEPSIA|SEPSIS|NAUSEA|LOWER RESPIRATORY TRACT INFECTION|PAIN|HYPOKALAEMIA|MACROCYTOSIS|NEUTROPENIA|BLOOD CHOLESTEROL,Acute coronary syndrome|Spinal column stenosis|Back pain|Abdominal pain|Neuropathy peripheral|Chronic obstructive pulmonary disease|Acute kidney injury|Atrial fibrillation|Peripheral swelling|Thrombocytopenia|Lower respiratory tract infection|Constipation|Neutropenia|Upper respiratory tract infection|Sepsis,15,1
11982513,20160129,Daratumumab,73,801,73.0,1,102,1,0,0,0,0,0,1,Daratumumab,,1,PLASMA CELL MYELOMA,Product preparation error|Drug titration error|Drug dispensing error|Infusion related reaction,4,2
11982808,20160201,Daratumumab,67,801,67.0,1,106.9,1,1,1,1,0,0,0,Daratumumab,BORTEZOMIB|DARATUMUMAB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,5,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Acute kidney injury|Duodenal ulcer,2,1
11982809,20160201,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,LENALIDOMIDE|DARATUMUMAB,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Protein total increased|Blood count abnormal|Atrial fibrillation|Pneumonia|Dyspnoea|Decreased appetite|Pyrexia|Vomiting|Pain|Eye disorder|Fatigue|Infusion related reaction|Nausea|Headache|Arthropathy|Constipation|Diarrhoea,17,5
11982810,20160201,Daratumumab,50,801,50.0,2,63,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB|THALIDOMIDE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|THALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB FOR INJECTION|BORTEZOMIB|BORTEZOMIB FOR INJECTION|BORTEZOMIB,9,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Tachycardia,1,1
11983888,20160201,Daratumumab,89,801,89.0,1,53,1,0,1,0,0,0,1,Daratumumab,"LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|DARATUMUMAB|TRIMETHOPRIM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CHLORHEXIDINE GLUCONATE|ANTISEPTIC SKIN CLEANSER|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|FUROSEMIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACYCLOVIR|CHLORHEXIDINE GLUCONATE|ANTISEPTIC SKIN CLEANSER|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|FUROSEMIDE|GANCICLOVIR SODIUM|GANCICLOVIR|BORTEZOMIB|BORTEZOMIB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CYANOCOBALAMIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|KETOPROFEN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|TRAMADOL HYDROCHLORIDE|PYRIDOXINE HYDROCHLORIDE|ACYCLOVIR",93,ESSENTIAL TREMOR|CENTRAL VENOUS CATHETERISATION|PROPHYLAXIS|INFECTION PROPHYLAXIS|CYTOMEGALOVIRUS INFECTION|INCISION SITE PAIN|ANTIFUNGAL PROPHYLAXIS|LOSS OF CONSCIOUSNESS|CYTOMEGALOVIRUS INFECTION|DECREASED APPETITE|PLASMA CELL MYELOMA|OSTEOPOROSIS|DRY SKIN|HYPERURICAEMIA|DIARRHOEA|NAUSEA|DIARRHOEA|ANTIFUNGAL PROPHYLAXIS|THROMBOCYTOPENIA|INFLUENZA|CONSTIPATION|NASOPHARYNGITIS|PROPHYLAXIS OF NAUSEA AND VOMITING|DIARRHOEA|DIARRHOEA|NASOPHARYNGITIS|ABDOMINAL TENDERNESS|DECREASED APPETITE|HYPOKALAEMIA|SKIN ABRASION|NASOPHARYNGITIS|HYPONATRAEMIA|URINARY TRACT INFECTION|NASOPHARYNGITIS|HERPES ZOSTER DISSEMINATED|PLASMA CELL MYELOMA|CONSTIPATION|CONSTIPATION|INFLUENZA|SPINAL COMPRESSION FRACTURE|SPINAL COMPRESSION FRACTURE|PROPHYLAXIS AGAINST DEHYDRATION|PROPHYLAXIS AGAINST DEHYDRATION|DECREASED APPETITE|NASOPHARYNGITIS|CONSTIPATION|ANTIFUNGAL PROPHYLAXIS|LUMBAR SPINAL STENOSIS|SPINAL COMPRESSION FRACTURE|PROPHYLAXIS OF NAUSEA AND VOMITING|NASOPHARYNGITIS|BRONCHITIS|MALNUTRITION|ANTIVIRAL PROPHYLAXIS|SKIN EROSION|LOSS OF CONSCIOUSNESS|PLEURAL EFFUSION|INSOMNIA|CYTOMEGALOVIRUS INFECTION|PYREXIA|DECREASED APPETITE|ORTHOSTATIC INTOLERANCE|ANTIDIARRHOEAL SUPPORTIVE CARE|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|CONSTIPATION|LUMBAR SPINAL STENOSIS|ENTEROCOLITIS|URINARY TRACT INFECTION|DIARRHOEA|LUMBAR SPINAL STENOSIS|NASOPHARYNGITIS|LUMBAR SPINAL STENOSIS|SPINAL COMPRESSION FRACTURE|LUMBAR SPINAL STENOSIS|LUMBAR SPINAL STENOSIS|LUMBAR SPINAL STENOSIS|MALNUTRITION|DECREASED APPETITE|DIARRHOEA|ANTIVIRAL PROPHYLAXIS,Cytomegalovirus infection|Skin abrasion|Decreased appetite|Loss of consciousness|Incision site pain|Thrombocytopenia|Diarrhoea|Pleural effusion|Hyponatraemia|Orthostatic intolerance|Skin erosion|Urinary tract infection|Nausea|Abdominal tenderness|Insomnia|Pyrexia|Hypokalaemia|Herpes zoster|Influenza,19,1
11984640,20160201,Daratumumab,60,801,60.0,2,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Cardiac arrest|Fall,2,3
11984754,20160201,Daratumumab,37,801,37.0,2,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
11988099,20160202,Daratumumab,50,801,50.0,2,63,1,0,1,0,0,0,0,Daratumumab,BORTEZOMIB|THALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|THALIDOMIDE|BORTEZOMIB|DARATUMUMAB,8,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Tachycardia,1,1
11988371,20160202,Daratumumab,,,,1,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA RECURRENT,Adverse event,1,5
11988372,20160202,Daratumumab,77,801,77.0,2,79.83,1,1,1,1,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB|LEVETIRACETAM,3,PLASMA CELL MYELOMA|SEIZURE PROPHYLAXIS,Subdural haematoma,1,5
11990201,20160202,Daratumumab,,,,1,90.8,1,0,0,0,0,0,1,Daratumumab,"MONTELUKAST SODIUM|HYDROCODONE BITARTRATE AND ACETAMINOPHEN|LENALIDOMIDE|ALFUZOSIN HCL|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACYCLOVIR|OXYCODONE HYDROCHLORIDE|OXYCODONE|ESOMEPRAZOLE MAGNESIUM|LENALIDOMIDE|DARATUMUMAB|ERGOCALCIFEROL|PREGABALIN|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|LENALIDOMIDE|LENALIDOMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",20,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Plasma cell myeloma,1,3
11990561,20160202,Daratumumab,71,801,71.0,2,71,1,0,1,0,0,0,1,Daratumumab,DARATUMUMAB|FOLIC ACID|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DULOXETINE HYDROCHLORIDE|DULOXETINE|EPOETIN ALFA|MELPHALAN HYDROCHLORIDE|MELPHALAN|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|PANTOPRAZOLE|EPOETIN ALFA|BUDESONIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|DONEPEZIL HYDROCHLORIDE|NEBIVOLOL|NEBIVOLOL HYDROCHLORIDE|PREGABALIN|ZOLEDRONIC ACID|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREDNISONE|RANITIDINE|FUROSEMIDE|LACTULOSE|BORTEZOMIB|DARATUMUMAB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,28,HAEMOLYSIS|PLASMA CELL MYELOMA|ANXIETY DISORDER|WHEEZING|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|CYSTITIS|GASTRITIS|ANAEMIA|PROPHYLAXIS|PROPHYLAXIS|WHEEZING|ANXIETY DISORDER|ANXIETY DISORDER|BONE PAIN|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|WHEEZING|CONSTIPATION|PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS,Hypokalaemia|Anaemia|Neutropenia|Lower respiratory tract infection|Haemolysis|Wheezing|Cystitis,7,1
11992067,20160203,Daratumumab,69,801,69.0,2,54.89,1,0,0,0,0,0,0,Daratumumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|BISACODYL|SENNOSIDES|DOCUSATE SODIUM AND SENNOSIDES|SENNOSIDES, 25 MG|POLYETHYLENE GLYCOL 3350|BISACODYL 5MG|LAXATIVE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACYCLOVIR|DIPHENHYDRAMINE HYDROCHLORIDE|DARATUMUMAB|MONTELUKAST SODIUM|METHYLPREDNISOLONE|LOPERAMIDE HCL|LOPERAMIDE HYDROCHLORIDE",11,LAXATIVE SUPPORTIVE CARE|PREMEDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PAIN|ANTIDIARRHOEAL SUPPORTIVE CARE,Product use issue|Off label use,2,5
11992221,20160203,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,"DARATUMUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|METHYLPREDNISOLONE SODIUM SUCCINATE|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",5,PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PREMEDICATION|PREMEDICATION,Feeling abnormal|Dysarthria|Off label use|Product use issue,4,5
11992282,20160203,Daratumumab,,,,1,68.04,1,0,0,0,0,0,0,Daratumumab,"GARLIC|LEVOTHYROXINE|DIPHENHYDRAMINE HYDROCHLORIDE|SAW PALMETTO|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DARATUMUMAB|SELENIUM|POTASSIUM CITRATE|MULTIVITAMIN",19,NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|NUTRITIONAL SUPPLEMENTATION|PREMEDICATION|NUTRITIONAL SUPPLEMENTATION|GASTROOESOPHAGEAL REFLUX DISEASE|PREMEDICATION|NUTRITIONAL SUPPLEMENTATION|PLASMA CELL MYELOMA|NUTRITIONAL SUPPLEMENTATION|PROPHYLAXIS|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION,Product use issue|Off label use,2,5
11992355,20160203,Daratumumab,,,,2,58.06,1,0,0,0,0,0,0,Daratumumab,"DIPHENHYDRAMINE HYDROCHLORIDE|AMLODIPINE|DARATUMUMAB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",4,PREMEDICATION|BLOOD PRESSURE MEASUREMENT|PLASMA CELL MYELOMA|PREMEDICATION,Product use issue|Off label use,2,5
11994141,20160203,Daratumumab,43,801,43.0,1,75,1,0,1,1,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB|BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,9,SLEEP DISORDER THERAPY|OSTEOPOROSIS PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|PLASMA CELL MYELOMA|PROPHYLAXIS OF NAUSEA AND VOMITING,Pneumonia pneumococcal|Sepsis,2,1
12000843,20160204,Daratumumab,64,801,64.0,2,,1,0,1,0,0,0,0,Daratumumab,"METHYLPREDNISOLONE|DIPHENHYDRAMINE HYDROCHLORIDE|DARATUMUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",5,PREMEDICATION|PREMEDICATION|PLASMA CELL MYELOMA|PROPHYLAXIS|PREMEDICATION,Neck mass|Respiratory distress,2,3
12000844,20160204,Daratumumab,72,801,72.0,1,100,1,0,1,1,0,0,0,Daratumumab,DARATUMUMAB|BORTEZOMIB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MELPHALAN HYDROCHLORIDE|MELPHALAN|CALCIUM|AMOXICILLIN|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|SALMETEROL XINAFOATE|SALMETEROL XINAFOATE|BUDESONIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISONE|FILGRASTIM|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|FENTANYL|ERGOCALCIFEROL|CEFTRIAXONE|CEFTRIAXONE SODIUM|TIMOLOL|BUDESONIDE|DARATUMUMAB,37,PLASMA CELL MYELOMA|DEPRESSION|VOMITING|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|NOCTURIA|BACK PAIN|BRONCHITIS|VOMITING|COUGH|COUGH|DYSPNOEA|BACK PAIN|DYSPNOEA|NAUSEA|PLASMA CELL MYELOMA|NAUSEA|PROPHYLAXIS|DYSPNOEA|BRONCHITIS|BRONCHITIS|BACK PAIN|PROPHYLAXIS|BRONCHITIS|BACK PAIN|GLAUCOMA|HYPERURICAEMIA|COUGH|BACK PAIN|BACK PAIN|PLASMA CELL MYELOMA|BACK PAIN|MUSCULOSKELETAL PAIN|DIARRHOEA,Sepsis,1,1
12001130,20160204,Daratumumab,73,801,73.0,2,31.8,1,0,1,0,0,0,1,Daratumumab,FAMOTIDINE|ZOLPIDEM TARTRATE|AMLODIPINE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BORTEZOMIB|DARATUMUMAB|TRIMETHOPRIM|MELPHALAN HYDROCHLORIDE|MELPHALAN|ALENDRONATE SODIUM|ALENDRONATE SODIUM TABLET|ACYCLOVIR,31,PROPHYLAXIS|DRY SKIN|INSOMNIA|HYPERTENSION|PLASMA CELL MYELOMA|PROPHYLAXIS|DIARRHOEA|CONSTIPATION|NAUSEA|PLASMA CELL MYELOMA|HYPERCHOLESTEROLAEMIA|PHARYNGITIS|OSTEOPOROSIS|DIARRHOEA|PLASMA CELL MYELOMA|FEBRILE NEUTROPENIA|FEBRILE NEUTROPENIA|PHARYNGITIS|DIARRHOEA|DERMATITIS CONTACT|CONSTIPATION|PROPHYLAXIS|BACK PAIN|PROPHYLAXIS|PLASMA CELL MYELOMA|OSTEOPOROSIS|FEBRILE NEUTROPENIA|PROPHYLAXIS|FEBRILE NEUTROPENIA|PHARYNGITIS|PROPHYLAXIS,Neutropenia|Constipation|Leukopenia|Pharyngitis|Febrile neutropenia|Diarrhoea|Insomnia|Nausea,8,1
12001139,20160204,Daratumumab,74,801,74.0,2,67.19,1,0,1,1,1,0,0,Daratumumab,"ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PROCHLORPERAZINE MALEATE|SIMVASTATIN|ATORVASTATIN CALCIUM|MAGNESIUM OXIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|METOCLOPRAMIDE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METHYLPREDNISOLONE|MORPHINE SULFATE|MORPHINE SULFATE|MORPHINE SULFATE|PROCHLORPERAZINE MALEATE|ZOLEDRONIC ACID|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|ERGOCALCIFEROL|PREDNISONE|ALLOPURINOL|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|MORPHINE SULFATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METOPROLOL TARTRATE|METOPROLOL|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|LENALIDOMIDE|MORPHINE SULFATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|POLYETHYLENE GLYCOL (3350)|POLYETHYLENE GLYCOL 3350|POLYETHYLENE GLYCOL 400|INSTALAX POLYETHYLENE GLYCOL 3350|ASCORBIC ACID|MORPHINE SULFATE|MORPHINE SULFATE|ZOLPIDEM TARTRATE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|FAMOTIDINE|PREDNISONE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ACYCLOVIR|MORPHINE SULFATE|ATOVAQUONE|FAMOTIDINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|OXYCODONE|NABUMETONE|FUROSEMIDE|FUROSEMIDE|LENALIDOMIDE|MORPHINE SULFATE|AMLODIPINE|BORTEZOMIB FOR INJECTION|BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARFILZOMIB|ERGOCALCIFEROL|ERGOCALCIFEROL|FENTANYL|DARATUMUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM",74,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|VITAMIN SUPPLEMENTATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Plasma cell myeloma|Acute kidney injury|Urinary tract infection,3,1
12003857,20160204,Daratumumab,,,,0,,1,0,1,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Unevaluable event|Incorrect drug administration duration,2,5
12010881,20160205,Daratumumab,60,801,60.0,2,90,1,0,1,1,0,0,0,Daratumumab,DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,5,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Paraspinal abscess,1,1
12012167,20160205,Daratumumab,53,801,53.0,1,101.8,1,0,1,0,0,0,0,Daratumumab,BORTEZOMIB|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR HYDROCHLORIDE|LAMIVUDINE|LAMIVUDINE ORAL|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SULFAMETHOXAZOLE AND TRIMETHOPRIM|ALLOPURINOL|RASBURICASE|RASBURICASE|WARFARIN|PANTOPRAZOLE|FILGRASTIM|CLARITHROMYCIN|RASBURICASE|BORTEZOMIB|BORTEZOMIB|VALACYCLOVIR HYDROCHLORIDE|VALACYCLOVIR HYDROCHLORIDE|LAMIVUDINE|LAMIVUDINE ORAL|RASBURICASE|RASBURICASE|RASBURICASE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CEFTRIAXONE|CEFTRIAXONE SODIUM|RASBURICASE|BORTEZOMIB|ALLOPURINOL|DARATUMUMAB|WARFARIN|CLARITHROMYCIN|RASBURICASE,49,PLASMA CELL MYELOMA|VARICELLA ZOSTER VIRUS INFECTION|PROPHYLAXIS|EXPOSURE TO COMMUNICABLE DISEASE|CONSTIPATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS|FLUID RETENTION|HYPERURICAEMIA|PROPHYLAXIS|HEART VALVE REPLACEMENT|GASTROOESOPHAGEAL REFLUX PROPHYLAXIS|NEUTROPHIL COUNT DECREASED|FLANK PAIN|PERTUSSIS|PROPHYLAXIS|EPISTAXIS|PROPHYLAXIS|HYPERURICAEMIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|VARICELLA ZOSTER VIRUS INFECTION|PROPHYLAXIS|EXPOSURE TO COMMUNICABLE DISEASE|FLANK PAIN|PROPHYLAXIS|HYPERCALCAEMIA|HYPERCALCAEMIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|CONSTIPATION|CONSTIPATION|PYREXIA|TUMOUR LYSIS SYNDROME|PLASMA CELL MYELOMA|PROPHYLAXIS|ABDOMINAL PAIN|CHRONIC KIDNEY DISEASE|PLASMA CELL MYELOMA|AORTIC VALVE REPLACEMENT|UPPER RESPIRATORY TRACT INFECTION|FLUID RETENTION|FLUID RETENTION|EPISTAXIS|HYPERPHOSPHATAEMIA|PROPHYLAXIS|TUMOUR LYSIS SYNDROME,Tumour lysis syndrome|Flank pain|Plasmacytoma|Platelet count decreased|Plasmacytoma,5,1
12012176,20160205,Daratumumab,70,801,70.0,1,73,1,0,1,0,0,0,0,Daratumumab,MELPHALAN HYDROCHLORIDE|MELPHALAN|DARATUMUMAB|DARATUMUMAB|ESOMEPRAZOLE MAGNESIUM|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,21,PLASMA CELL MYELOMA|BACK PAIN|BACK PAIN|INFECTION PROPHYLAXIS|BACK PAIN|BACK PAIN|VITAMIN C DEFICIENCY|PLASMA CELL MYELOMA|GASTROINTESTINAL DISORDER THERAPY|GASTROINTESTINAL DISORDER THERAPY|GASTROINTESTINAL DISORDER THERAPY|BACK PAIN|BACK PAIN|GASTROINTESTINAL DISORDER THERAPY|PLASMA CELL MYELOMA|INFECTION PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|GASTROINTESTINAL DISORDER THERAPY,Pulmonary oedema|Stress cardiomyopathy,2,1
12013058,20160205,Daratumumab,78,801,78.0,2,104.33,1,0,1,0,0,0,0,Daratumumab,"DARATUMUMAB|FUROSEMIDE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OXYGEN|0XYGEN|MEPERIDINE HYDROCHLORIDE|ALLOPURINOL|CLONIDINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LISINOPRIL|LENALIDOMIDE|DARATUMUMAB|ATENOLOL|FERROUS SULFATE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",19,PLASMA CELL MYELOMA|HYPERTENSION|CONSTIPATION|PROPHYLAXIS|DYSPNOEA|CHILLS|GOUT|HYPERTENSION|PLASMA CELL MYELOMA|HYPERTENSION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|HYPERTENSION|ANAEMIA|DIABETES MELLITUS|PROPHYLAXIS,Peripheral swelling|Gout|Abdominal pain|Leukopenia|Chronic kidney disease,5,1
12014867,20160205,Daratumumab,72,801,72.0,1,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction|Death|Dyspnoea|Back pain,4,5
12040132,20160208,Daratumumab,68,801,68.0,2,58,1,0,1,0,0,0,1,Daratumumab,AMLODIPINE|CALCIUM|ERGOCALCIFEROL|DARATUMUMAB,6,HYPERTENSION|MINERAL SUPPLEMENTATION|VITAMIN SUPPLEMENTATION|VITAMIN SUPPLEMENTATION|VITAMIN SUPPLEMENTATION|PLASMA CELL MYELOMA,Thrombocytopenia|Neutrophil count decreased|Chills|Nausea|Anaemia|Angina bullosa haemorrhagica|Back pain|Chest discomfort|Laboratory test interference|Infusion related reaction,10,3
12046436,20160209,Daratumumab,65,801,65.0,2,72.19,1,0,0,0,0,0,1,Daratumumab,POMALIDOMIDE|DARATUMUMAB|POMALIDOMIDE|POMALIDOMIDE|POMALIDOMIDE,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA,Neutrophil count decreased|Laboratory test abnormal|Plasma cell myeloma,3,1
12047520,20160208,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Endotracheal intubation|Adverse event|Infusion related reaction,3,1
12055982,20160209,Daratumumab,60,801,60.0,2,90,1,0,1,1,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB|DARATUMUMAB,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Paraspinal abscess,1,1
12060434,20160210,Daratumumab,65,801,65.0,2,54.5,1,0,1,1,0,0,0,Daratumumab,LENALIDOMIDE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Uterine abscess|Thrombocytopenia|Dehydration|Diarrhoea,4,3
12067087,20160210,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION,Adverse event,1,5
12067088,20160210,Daratumumab,51,801,51.0,2,,1,0,1,0,0,0,1,Daratumumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DIPHENHYDRAMINE HYDROCHLORIDE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB",5,PROPHYLAXIS|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION,Bronchospasm|Wheezing|Infusion related reaction|Chills,4,5
12067089,20160210,Daratumumab,75,801,75.0,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction,1,2
12067090,20160210,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DIPHENHYDRAMINE HYDROCHLORIDE,2,PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION,Feeling abnormal|Chills,2,1
12067091,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Incorrect product storage,1,2
12067092,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction|Hypotension,2,5
12067094,20160210,Daratumumab,,,,1,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Thrombocytopenia|Pneumonia,2,2
12067095,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia,1,5
12067096,20160210,Daratumumab,71,801,71.0,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Oxygen saturation decreased|Respiratory distress|Chills,3,2
12067098,20160210,Daratumumab,69,801,69.0,2,54.89,1,0,0,0,0,0,1,Daratumumab,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|DIPHENHYDRAMINE HYDROCHLORIDE|MONTELUKAST SODIUM|METHYLPREDNISOLONE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",8,PROPHYLAXIS|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PAIN,Therapeutic response decreased|Bone pain,2,5
12067099,20160210,Daratumumab,72,801,72.0,2,57.15,1,1,1,0,0,0,1,Daratumumab,DARATUMUMAB|ACYCLOVIR,3,PLASMA CELL MYELOMA|ANAEMIA,Pancytopenia|Myocardial infarction|Fatigue|Acute respiratory failure|Cardiac failure congestive|Plasma cell myeloma|Sepsis,7,3
12067102,20160210,Daratumumab,60,801,60.0,1,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Oxygen saturation decreased|Dyspnoea,2,3
12067104,20160210,Daratumumab,69,801,69.0,1,,1,0,1,1,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Pneumonia,1,5
12067105,20160210,Daratumumab,62,801,62.0,2,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction|Dyspnoea|Oxygen saturation abnormal|Throat tightness|Chest discomfort,5,5
12067107,20160210,Daratumumab,,,,2,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction|Dysphagia|Nasal congestion|Throat tightness,4,3
12067108,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Drug dose omission,1,2
12067110,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Vomiting|Chills,2,5
12067111,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Cough,1,5
12067112,20160210,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Chills|Infusion related reaction|Dyspnoea|Decreased appetite|Inappropriate schedule of drug administration,5,3
12067113,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction,1,5
12067114,20160210,Daratumumab,61,801,61.0,2,66.23,1,0,0,0,0,0,0,Daratumumab,ACYCLOVIR|ALPRAZOLAM|ATENOLOL|DARATUMUMAB|BUPROPION HYDROCHLORIDE,6,ANXIETY|MITRAL VALVE PROLAPSE|PLASMA CELL MYELOMA|NAUSEA|DEPRESSION,Fatigue|Infusion related reaction|Nausea|Cough|Rash|Chills|Pruritus|Headache|Crying,9,5
12067115,20160210,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Blister,1,5
12067116,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Wrong device used|Medication error,2,2
12067117,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Adverse drug reaction,1,3
12067118,20160210,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Back pain,1,5
12067119,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA,Infusion related reaction,1,1
12067120,20160210,Daratumumab,87,801,87.0,2,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction|Respiratory disorder|Wheezing|Dyspnoea|Pallor|Malaise,6,3
12067121,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Incorrect drug administration duration,1,5
12067122,20160210,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,LORAZEPAM|DARATUMUMAB|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|DARATUMUMAB,4,ANXIETY|PLASMA CELL MYELOMA|ASTHMA|PLASMA CELL MYELOMA,Nausea|Sinus congestion,2,2
12067124,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Cough|Infusion related reaction,2,3
12067125,20160210,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,MONTELUKAST SODIUM|DARATUMUMAB,2,PREMEDICATION|PLASMA CELL MYELOMA,Skin discolouration|Medication error,2,3
12067127,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Transfusion,1,3
12067129,20160210,Daratumumab,56,801,56.0,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Chills|Nausea,2,5
12067131,20160210,Daratumumab,64,801,64.0,2,99,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Product preparation error,1,2
12067132,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Infusion related reaction,1,5
12067135,20160210,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction|Dyspnoea,2,5
12067136,20160210,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Inappropriate schedule of drug administration|Infusion related reaction,2,5
12067137,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction,1,5
12067139,20160210,Daratumumab,65,801,65.0,1,55.79,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Laboratory test abnormal,1,3
12067140,20160210,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Underdose,1,5
12067145,20160210,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction,1,2
12067147,20160210,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Dyspnoea|Infusion related reaction,2,5
12067148,20160210,Daratumumab,87,801,87.0,2,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction|Dyspnoea,2,2
12067152,20160210,Daratumumab,7,800,70.0,1,,1,0,1,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Platelet count decreased|Oxygen saturation decreased|Neutropenia|Foaming at mouth|Infusion related reaction|White blood cell count decreased|Chills|Dyspnoea|Bronchospasm|Hypertension|Blood pressure increased,11,5
12067155,20160210,Daratumumab,64,801,64.0,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction,1,3
12067161,20160210,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction|Cough|Throat irritation|Rhinorrhoea,4,2
12067162,20160210,Daratumumab,,,,2,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Wheezing|Hypertension|Infusion related reaction|Heart rate abnormal|Throat tightness|Heart rate decreased,6,3
12067164,20160210,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea,1,3
12067165,20160210,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction|Chest pain|Anxiety,3,5
12067167,20160210,Daratumumab,6,800,60.0,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Respiratory tract congestion|Chest pain|Infusion related reaction,3,5
12067168,20160210,Daratumumab,53,801,53.0,1,,1,0,0,0,0,0,0,Daratumumab,LENALIDOMIDE|DARATUMUMAB|BORTEZOMIB,5,PRODUCT USED FOR UNKNOWN INDICATION,Nasal pruritus|Nausea|Nasal congestion|Rhinorrhoea|Infusion related reaction|Feeling of body temperature change|Vomiting,7,5
12067171,20160210,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction,1,5
12067172,20160210,Daratumumab,82,801,82.0,1,79.38,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Respiratory disorder|Infusion related reaction|Cough,3,5
12067174,20160210,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DIPHENHYDRAMINE HYDROCHLORIDE,2,PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION,Paranasal sinus discomfort|Infusion related reaction|Dizziness,3,3
12067175,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction|Vomiting|Cough|Throat irritation,4,3
12067235,20160210,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Flushing|Arthropathy|Respiratory tract congestion|Poor quality sleep,4,5
12067236,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Platelet count decreased,1,1
12067255,20160210,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Respiratory disorder|Chest pain|Incorrect dose administered|Chest discomfort|Infusion related reaction,5,5
12067256,20160210,Daratumumab,68,801,68.0,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Cough|Vomiting|Infusion related reaction|Underdose|Throat irritation|Wheezing,6,3
12067259,20160210,Daratumumab,49,801,49.0,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction|Drug ineffective for unapproved indication,2,5
12067277,20160210,Daratumumab,8,800,80.0,2,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,2,PLASMA CELL MYELOMA|PREMEDICATION,Infusion related reaction|Pneumonia,2,2
12067284,20160210,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction|Rhinorrhoea|Throat irritation,3,2
12067286,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Cough|Bronchitis,2,5
12067287,20160210,Daratumumab,46,801,46.0,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Drug dose omission|Platelet count decreased,2,5
12067289,20160210,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Bronchospasm|Infusion related reaction|Incorrect drug administration duration,3,5
12067295,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|ALBUTEROL SULFATE|ALBUTEROL|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE,3,PRODUCT USED FOR UNKNOWN INDICATION,Chest discomfort|Infusion related reaction|Nasal congestion|Cough,4,2
12067297,20160210,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction|Flushing|Pruritus,3,5
12067298,20160210,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Headache|Nausea,2,1
12067299,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Vomiting|Underdose,2,5
12067301,20160210,Daratumumab,,,,0,84.1,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction|Wrong technique in product usage process|Chest discomfort|Dyspnoea,4,2
12067302,20160210,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Chills,1,5
12067311,20160210,Daratumumab,62,801,62.0,1,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction,1,2
12067319,20160210,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion site extravasation,1,5
12067320,20160210,Daratumumab,53,801,53.0,1,,1,0,0,0,0,0,1,Daratumumab,LORAZEPAM|ACYCLOVIR|PREDNISONE|DARATUMUMAB,6,PRODUCT USED FOR UNKNOWN INDICATION,Thrombocytopenia,1,1
12067321,20160210,Daratumumab,62,801,62.0,1,82.9,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LEVOTHYROXINE|ESOMEPRAZOLE MAGNESIUM|OXYCODONE,10,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Infusion related reaction|Respiratory distress,2,3
12067323,20160210,Daratumumab,73,801,73.0,1,102,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction|Cough|Dyspnoea|Product packaging issue,4,2
12067324,20160210,Daratumumab,60,801,60.0,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Neutropenia|Thrombocytopenia,2,2
12067325,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Adverse event,1,5
12067331,20160210,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction,1,5
12067333,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction|Nasal congestion,2,2
12067334,20160210,Daratumumab,67,801,67.0,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN,2,PLASMA CELL MYELOMA,Back pain,1,5
12067335,20160210,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Pyrexia,1,1
12067336,20160210,Daratumumab,59,801,59.0,1,73,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Throat irritation|Nasal congestion|Chills|Infusion related reaction,4,2
12067338,20160210,Daratumumab,70,801,70.0,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction|Chest discomfort,2,5
12067339,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DIPHENHYDRAMINE HYDROCHLORIDE,2,PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction|Confusional state|Chills,3,1
12067341,20160210,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction|Nausea|Vomiting|Blood potassium decreased|Chest pain|Diarrhoea,6,5
12067342,20160210,Daratumumab,54,801,54.0,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Chills|Nausea|Infusion related reaction,3,5
12067344,20160210,Daratumumab,4,800,40.0,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction|Chills,2,3
12067348,20160210,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Platelet count decreased,1,5
12067671,20160211,Daratumumab,66,801,66.0,2,81.65,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Asthenia|Fatigue|Dyspnoea exertional,3,3
12067673,20160211,Daratumumab,,,,1,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,5
12070537,20160211,Daratumumab,,,,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Cough|Infusion related reaction|Seizure|Hypertension,4,1
12071092,20160211,Daratumumab,59,801,59.0,1,68,1,0,1,0,0,0,0,Daratumumab,BORTEZOMIB|VALACYCLOVIR HYDROCHLORIDE|DARATUMUMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ALBUTEROL SULFATE|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL,14,PLASMA CELL MYELOMA|ANTIVIRAL PROPHYLAXIS|PLASMA CELL MYELOMA|COUGH|COUGH|COUGH|ANTIBIOTIC PROPHYLAXIS|GASTROINTESTINAL DISORDER THERAPY|PLASMA CELL MYELOMA|PROPHYLAXIS|ASTHMA|ASTHMA|CONSTIPATION|BENIGN PROSTATIC HYPERPLASIA,Pneumonia cytomegaloviral,1,1
12071319,20160211,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FISH OIL|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|CALCIUM|ISOSORBIDE DINITRATE|IXAZOMIB|DARATUMUMAB|LOSARTAN POTASSIUM|LOSARTAN,12,PLASMA CELL MYELOMA,Platelet count decreased|Diarrhoea,2,5
12073426,20160212,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Haemolysis,1,1
12074291,20160212,Daratumumab,71,801,71.0,2,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|LENALIDOMIDE,2,PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA,Adverse drug reaction,1,3
12079384,20160216,Daratumumab,59,801,59.0,2,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Death,1,3
12079385,20160216,Daratumumab,,,,0,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Confusional state|Mental status changes|Hospitalisation|Metabolic disorder,4,1
12079386,20160216,Daratumumab,62,801,62.0,1,79.38,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB|DARATUMUMAB|LEVOTHYROXINE SODIUM,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|THYROID DISORDER,Cough|Bone lesion|Upper limb fracture|Disease progression|Drug dose omission|Productive cough|Infusion related reaction|Wheezing,8,5
12079387,20160216,Daratumumab,,,,2,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Blood uric acid increased|Tumour lysis syndrome|Renal failure,3,1
12080412,20160216,Daratumumab,72,801,72.0,1,,1,1,0,1,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|DARATUMUMAB|LENALIDOMIDE,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Multiple organ dysfunction syndrome,1,1
12083758,20160217,Daratumumab,73,801,73.0,2,76.19,1,0,0,0,0,0,0,Daratumumab,"LORAZEPAM|PREGABALIN|IXAZOMIB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SULFAMETHOXAZOLE AND TRIMETHOPRIM|CALCIUM|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|IXAZOMIB|IXAZOMIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|MAGNESIUM|FOLIC ACID|LEVOTHYROXINE SODIUM|LENALIDOMIDE",19,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Somnambulism|Fall|Product blister packaging issue|Off label use|Skin abrasion|Thrombocytopenia,6,3
12085532,20160217,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Neutropenia|Pancytopenia,2,2
12085557,20160217,Daratumumab,71,801,71.0,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Drug effect incomplete|Condition aggravated|Natural killer cell count decreased|Granulocyte count decreased|Monocyte count decreased,5,3
12089395,20160218,Daratumumab,71,801,71.0,1,90,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|LENALIDOMIDE|ZOLEDRONIC ACID|CLARITHROMYCIN|CLARITHROMYCIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB,11,PLASMA CELL MYELOMA|INFECTION PROPHYLAXIS|PLASMA CELL MYELOMA|PROPHYLAXIS|BLOOD PHOSPHORUS DECREASED|LOWER RESPIRATORY TRACT INFECTION|LOWER RESPIRATORY TRACT INFECTION|LOWER RESPIRATORY TRACT INFECTION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|LOWER RESPIRATORY TRACT INFECTION,Sepsis,1,1
12089396,20160218,Daratumumab,71,801,71.0,1,104,1,0,1,0,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FUROSEMIDE|GABAPENTIN|MORPHINE|ERGOCALCIFEROL|DARATUMUMAB|DOFETILIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|DILTIAZEM HYDROCHLORIDE|POMALIDOMIDE|ALLOPURINOL|CALCIUM CARBONATE|ANTACID|LOVASTATIN|METOPROLOL TARTRATE|METOPROLOL|DARATUMUMAB|FINASTERIDE,24,PLASMA CELL MYELOMA|PAIN|ATRIAL FIBRILLATION|HIGH FREQUENCY ABLATION|DRY EYE|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|DIARRHOEA,Febrile neutropenia|Cardiac failure congestive|Atrial fibrillation|Pneumonitis|Cellulitis,5,1
12089600,20160218,Daratumumab,60,801,60.0,2,58,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB|PREGABALIN,4,ABDOMINAL PAIN LOWER|NON-HODGKIN^S LYMPHOMA|DIFFUSE LARGE B-CELL LYMPHOMA|PERIPHERAL SENSORY NEUROPATHY,Abdominal pain,1,1
12090901,20160218,Daratumumab,55,801,55.0,1,,1,0,1,0,0,0,0,Daratumumab,AMIKACIN|DARATUMUMAB|OXYCODONE HYDROCHLORIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,13,BACTERIAL INFECTION|PLASMA CELL MYELOMA|VIRAL INFECTION|PAIN|PAIN|BACTERIAL INFECTION|GASTROOESOPHAGEAL REFLUX DISEASE|PLASMA CELL MYELOMA,Systemic inflammatory response syndrome,1,1
12090904,20160218,Daratumumab,62,801,62.0,1,67,1,1,1,0,1,0,0,Daratumumab,LACTULOSE|BORTEZOMIB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|METOPROLOL TARTRATE|METOPROLOL|SIMVASTATIN|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION,15,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Pneumonia|Pulmonary sepsis,2,1
12091041,20160218,Daratumumab,68,801,68.0,1,,1,1,0,0,0,0,0,Daratumumab,POMALIDOMIDE|ACYCLOVIR|GABAPENTIN|DARATUMUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|POMALIDOMIDE|WARFARIN|PSYLLIUM HUSK|ERGOCALCIFEROL|GUAIFENESIN|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|FENTANYL,21,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CLOSTRIDIUM DIFFICILE INFECTION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
12094044,20160219,Daratumumab,55,801,55.0,1,86,1,0,1,0,0,0,0,Daratumumab,"ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|MONTELUKAST SODIUM|METHYLPREDNISOLONE|DARATUMUMAB|DARATUMUMAB|METHYLPREDNISOLONE",8,MANTLE CELL LYMPHOMA,Pyrexia|Neutropenia,2,1
12094625,20160219,Daratumumab,59,801,59.0,1,79,1,0,1,0,0,0,0,Daratumumab,BORTEZOMIB|THALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB,5,PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Pneumocystis jirovecii infection,1,1
12099938,20160222,Daratumumab,77,801,77.0,1,87.54,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Pulmonary oedema|Hypertension,2,3
12100475,20160222,Daratumumab,64,801,64.0,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Product preparation error|Infusion related reaction,2,3
12100476,20160222,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Medication error,1,2
12100477,20160222,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction|Wrong technique in product usage process,2,2
12100478,20160222,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction,1,3
12100479,20160222,Daratumumab,71,801,71.0,2,86.18,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Medication error,1,5
12100480,20160222,Daratumumab,64,801,64.0,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Back pain,1,5
12100482,20160222,Daratumumab,77,801,77.0,2,69,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,White blood cell count decreased,1,2
12100483,20160222,Daratumumab,78,801,78.0,1,88,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Drug administration error,1,1
12100484,20160222,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB|POMALIDOMIDE,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Neutropenia,1,5
12100485,20160222,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Underdose,1,3
12100486,20160222,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Inappropriate schedule of drug administration,1,2
12100487,20160222,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Cough|Infusion related reaction,2,1
12100488,20160222,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Fatigue,1,5
12100489,20160222,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Infusion related reaction|Chills,3,3
12100490,20160222,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Mental status changes,1,5
12100491,20160222,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Light chain analysis increased,1,5
12100492,20160222,Daratumumab,62,801,62.0,1,74.84,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB|OXYCODONE|ACYCLOVIR|METHYLPREDNISOLONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DARATUMUMAB|DARATUMUMAB,7,PLASMA CELL MYELOMA|CANCER PAIN|PREMEDICATION|PREMEDICATION|PREMEDICATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Feeling cold|Drug intolerance|Tremor|Pain in extremity|Eye disorder|Infusion related reaction|Bronchospasm|Dyspnoea|Unevaluable event|Paraesthesia|Chest discomfort|Feeling abnormal,12,5
12100493,20160222,Daratumumab,,,,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,2,PLASMA CELL MYELOMA,Dyspnoea|Dyspnoea|Infusion related reaction,3,3
12100494,20160222,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Cough|Hyperhidrosis|Infusion related reaction|Wheezing,4,3
12100495,20160222,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cough|Infusion related reaction|Dyspnoea|Wheezing,4,1
12100496,20160222,Daratumumab,57,801,57.0,1,110,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction|Hypertension,2,5
12100497,20160222,Daratumumab,79,801,79.0,1,68.95,1,0,1,1,0,0,0,Daratumumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DARATUMUMAB|DARATUMUMAB|DUTASTERIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LORAZEPAM,7,HYPERSENSITIVITY|GASTROOESOPHAGEAL REFLUX DISEASE|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|BENIGN PROSTATIC HYPERPLASIA|PLASMA CELL MYELOMA|NAUSEA,Dyspnoea|Wheezing|Infusion related reaction|Hypoxia|Flushing|Hypertension,6,5
12100499,20160222,Daratumumab,,,,2,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Platelet count decreased,1,5
12100500,20160222,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Expired product administered|Unevaluable event,2,2
12100501,20160222,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Vitamin D decreased,1,5
12100765,20160222,Daratumumab,58,801,58.0,2,81.1,1,0,1,0,0,0,0,Daratumumab,"HYDROCHLOROTHIAZIDE|DARATUMUMAB|LENALIDOMIDE|LENALIDOMIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|WARFARIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LENALIDOMIDE|ACYCLOVIR|WARFARIN|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|GABAPENTIN|LENALIDOMIDE|LENALIDOMIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|AMOXICILLIN|BACLOFEN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|NAPROXEN|NAPROXEN SODIUM|LENALIDOMIDE|LENALIDOMIDE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)",28,OEDEMA|PLASMA CELL MYELOMA|GASTROOESOPHAGEAL REFLUX DISEASE|THROMBOSIS PROPHYLAXIS|CONSTIPATION|RASH|PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PULMONARY EMBOLISM|PROPHYLAXIS|NAUSEA|HYPOKALAEMIA|NEUROPATHY PERIPHERAL|MUSCULOSKELETAL PAIN|ARTHRALGIA|CELLULITIS|MUSCULOSKELETAL PAIN|PLASMA CELL MYELOMA|MUSCULOSKELETAL PAIN|ANXIETY,Pneumonia legionella,1,5
12102423,20160222,Daratumumab,69,801,69.0,2,,1,0,0,0,0,0,1,Daratumumab,LENALIDOMIDE|LENALIDOMIDE|DARATUMUMAB|LENALIDOMIDE,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Plasma cell myeloma|Full blood count decreased|Drug ineffective,3,2
12106497,20160223,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,LENALIDOMIDE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Adenocarcinoma gastric,1,3
12106539,20160223,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LENALIDOMIDE,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Febrile neutropenia,1,3
12113010,20160225,Daratumumab,66,801,66.0,1,,1,0,1,0,0,0,1,Daratumumab,ACYCLOVIR|POMALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ALLOPURINOL|CARFILZOMIB|DARATUMUMAB,9,SEPSIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|SEPSIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|SEPSIS,Myalgia|Diabetes mellitus|Pathological fracture|Rib fracture,4,1
12116320,20160225,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Haemolysis|Blood urine present|Renal colic,3,2
12119694,20160226,Daratumumab,,,,2,58,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,4,PRODUCT USED FOR UNKNOWN INDICATION,Acute kidney injury|Haemoglobin decreased|Platelet count decreased|Epistaxis,4,1
12119945,20160226,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,"EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE|NEBIVOLOL HYDROCHLORIDE|FUROSEMIDE|PSYLLIUM HUSK|LENALIDOMIDE|LENALIDOMIDE|PANTOPRAZOLE SODIUM|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|DARATUMUMAB|LORAZEPAM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|NIFEDIPINE|LENALIDOMIDE|ERGOCALCIFEROL",23,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION,Abdominal discomfort|Diarrhoea|Nausea|Constipation|Decreased appetite,5,3
12120342,20160226,Daratumumab,72,801,72.0,1,,1,1,0,1,0,0,0,Daratumumab,DARATUMUMAB|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Multiple organ dysfunction syndrome,1,1
12120496,20160226,Daratumumab,74,801,74.0,2,50.2,1,0,1,0,0,0,0,Daratumumab,"DARATUMUMAB|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|GANCICLOVIR SODIUM|GANCICLOVIR|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|IOHEXOL|IOHEXOL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BORTEZOMIB|BORTEZOMIB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|LUBIPROSTONE|IOHEXOL|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|MELPHALAN HYDROCHLORIDE|MELPHALAN|DEXTROMETHORPHAN HYDROBROMIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ZOLEDRONIC ACID|PREGABALIN|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|LUBIPROSTONE|LUBIPROSTONE|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|TRIMETHOPRIM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREGABALIN|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|MAGNESIUM OXIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ROSUVASTATIN|EPINASTINE HYDROCHLORIDE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|LUBIPROSTONE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|OSELTAMIVIR PHOSPHATE|FUROSEMIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|ZOLEDRONIC ACID|PREGABALIN|PREGABALIN|VALACYCLOVIR HYDROCHLORIDE|TRIMETHOPRIM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",145,PLASMA CELL MYELOMA|VOMITING|INSOMNIA|CYTOMEGALOVIRUS INFECTION|UPPER RESPIRATORY TRACT INFECTION|VOMITING|NAUSEA|PROPHYLAXIS|PLASMA CELL MYELOMA|PYREXIA|PLASMA CELL MYELOMA|HYPERTENSION|CONSTIPATION|NAUSEA|PROPHYLAXIS|RASH GENERALISED|ANTICOAGULANT THERAPY|PYREXIA|LUMBAR SPINAL STENOSIS|LUMBAR SPINAL STENOSIS|ANTIFUNGAL PROPHYLAXIS|PROPHYLAXIS|PYREXIA|PLASMA CELL MYELOMA|RASH|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|CYTOMEGALOVIRUS INFECTION|RASH GENERALISED|RASH|PLASMA CELL MYELOMA|VOMITING|COUGH|BONE LESION|CONSTIPATION|COUGH|LOCAL ANAESTHESIA|CONSTIPATION|CYTOMEGALOVIRUS INFECTION|RASH GENERALISED|PROPHYLAXIS|RASH GENERALISED|RASH|NAUSEA|BONE LESION|THROMBOSIS PROPHYLAXIS|PROPHYLAXIS|TUMOUR LYSIS SYNDROME|LUMBAR SPINAL STENOSIS|CONSTIPATION|DYSLIPIDAEMIA|RHINITIS ALLERGIC|ASTHENOPIA|PROPHYLAXIS|RIB FRACTURE|RASH GENERALISED|TUMOUR LYSIS SYNDROME|PROPHYLAXIS|LUMBAR SPINAL STENOSIS|PROPHYLAXIS|CONSTIPATION|ANTIVIRAL PROPHYLAXIS|OEDEMA PERIPHERAL|DRY SKIN|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|DRY EYE|PROPHYLAXIS|CONSTIPATION|CYTOMEGALOVIRUS INFECTION|RASH GENERALISED|LUMBAR SPINAL STENOSIS|PROPHYLAXIS|CYTOMEGALOVIRUS INFECTION|RHINITIS ALLERGIC|PYREXIA|ANTIFUNGAL PROPHYLAXIS,Constipation|Dry skin|Upper respiratory tract infection|Pyrexia|Rib fracture|Rash|Cytomegalovirus infection|Insomnia|Vomiting|Nausea|Musculoskeletal pain|Oedema peripheral|Diarrhoea,13,1
12121219,20160226,Daratumumab,63,801,63.0,2,90.9,1,1,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Periorbital disorder|Renal failure|Pain|Pancytopenia|Numb chin syndrome|Confusional state|Plasma cell myeloma|Hypercalcaemia of malignancy|Epistaxis,9,3
12123110,20160226,Daratumumab,81,801,81.0,2,57.1,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Dyspnoea|Infusion related reaction|Oxygen saturation decreased|Blood glucose decreased|Hypotension|Unresponsive to stimuli,6,2
12128825,20160229,Daratumumab,,,,1,86.26,1,0,0,0,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|OMEPRAZOLE MAGNESIUM|DIAZEPAM|POMALIDOMIDE|ACYCLOVIR|DOCUSATE SODIUM|CARFILZOMIB|ASPIRIN|ASPIRIN 81 MG DELAYED RELEASE TABLETS|DARATUMUMAB,11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Therapeutic response changed,1,3
12130712,20160301,Daratumumab,54,801,54.0,2,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Adverse drug reaction|Plasma cell myeloma,2,5
12131941,20160301,Daratumumab,79,801,79.0,1,88,1,1,1,1,1,0,1,Daratumumab,MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|PREDNISONE|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|ZOLEDRONIC ACID|DARATUMUMAB,18,PLASMA CELL MYELOMA|PERIPHERAL ARTERY ANEURYSM|PROPHYLAXIS|GASTRITIS PROPHYLAXIS|BACK PAIN|PROPHYLAXIS|ANTIFUNGAL PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|HYPERTENSION|OSTEOPOROSIS PROPHYLAXIS|HYPERTENSION|BACK PAIN|PROPHYLAXIS|PLASMA CELL MYELOMA|AORTIC ANEURYSM|BACK PAIN,Hypovolaemic shock|Acute myocardial infarction,2,1
12136649,20160302,Daratumumab,59,801,59.0,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Administration site mass|Infusion site hypoaesthesia|Neuralgia|Catheter site swelling|Drug dose omission,5,3
12137415,20160302,Daratumumab,,,,1,63.5,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Metastatic neoplasm,1,3
12137516,20160302,Daratumumab,66,801,66.0,2,62,1,0,1,0,0,0,1,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Acute kidney injury|Infusion related reaction,2,1
12137517,20160302,Daratumumab,79,801,79.0,1,78.02,1,0,1,1,0,0,0,Daratumumab,"NOREPINEPHRINE BITARTRATE|DEXTROSE MONOHYDRATE|DEXTROSE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DARATUMUMAB|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE BITARTRATE|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DARATUMUMAB|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|PHOSPHORUS|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",18,PLASMA CELL MYELOMA,Neutropenic sepsis,1,1
12137518,20160302,Daratumumab,70,801,70.0,1,81,1,1,1,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA,Disease progression|Pyrexia,2,1
12137519,20160302,Daratumumab,68,801,68.0,1,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA,Sepsis|Pneumonia,2,1
12137521,20160302,Daratumumab,46,801,46.0,1,61,1,1,1,0,0,0,0,Daratumumab,"VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|OXYCODONE HYDROCHLORIDE|POMALIDOMIDE|DARATUMUMAB|MORPHINE|BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE|DARBEPOETIN ALFA|DIPHENHYDRAMINE HYDROCHLORIDE|DARATUMUMAB|AZITHROMYCIN DIHYDRATE|OXYCODONE HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DIPHENHYDRAMINE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|MORPHINE|OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|AZITHROMYCIN DIHYDRATE|POLYETHYLENE GLYCOL 3350|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",30,INFUSION RELATED REACTION|UPPER RESPIRATORY TRACT INFECTION|BONE PAIN|UPPER RESPIRATORY TRACT INFECTION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|REFLUX LARYNGITIS|UPPER RESPIRATORY TRACT INFECTION|HEADACHE|ANAEMIA|INFUSION RELATED REACTION|UPPER RESPIRATORY TRACT INFECTION|HEADACHE|HEADACHE|CARDIOVASCULAR EVENT PROPHYLAXIS|UPPER RESPIRATORY TRACT INFECTION|REFLUX LARYNGITIS|BACK PAIN|CONSTIPATION PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING|UPPER RESPIRATORY TRACT INFECTION|BACK PAIN|HEADACHE|BONE PAIN|CONSTIPATION PROPHYLAXIS|MUSCLE SPASMS|UPPER RESPIRATORY TRACT INFECTION|CONSTIPATION PROPHYLAXIS|UPPER RESPIRATORY TRACT INFECTION,Anaemia|Pyrexia|Blood calcium increased|Bacteraemia|Renal failure|Hypercalcaemia|Viral infection,7,1
12137522,20160302,Daratumumab,68,801,68.0,2,54,1,0,1,0,0,0,0,Daratumumab,ATENOLOL|PANTOPRAZOLE SODIUM|DARATUMUMAB|ROSUVASTATIN|ACYCLOVIR|LORAZEPAM|COLESEVELAM HYDROCHLORIDE|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|DARATUMUMAB,12,PLASMA CELL MYELOMA,Urinary tract infection,1,1
12138140,20160302,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|LENALIDOMIDE|DARATUMUMAB,5,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Fatigue|Rhinitis allergic|Thrombocytopenia|Muscle spasms|Pyrexia|Plasma cell myeloma|Allergic oedema|Nasal congestion|Hypertension|Adenocarcinoma gastric|Neutropenia|Anaemia|Diarrhoea|Cough|Nausea|Infusion related reaction|Febrile neutropenia|Gastroenteritis|Dyspnoea|Vomiting,20,3
12138182,20160302,Daratumumab,66,801,66.0,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Back pain|Disease progression|Dyspnoea|Infusion related reaction,4,3
12139021,20160302,Daratumumab,62,801,62.0,1,69.92,1,0,0,0,0,0,1,Daratumumab,LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|POMALIDOMIDE|DARATUMUMAB|LENALIDOMIDE|LENALIDOMIDE|POMALIDOMIDE,8,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Diarrhoea|Rash pruritic,2,3
12140346,20160303,Daratumumab,67,801,67.0,2,93,1,0,1,0,0,0,1,Daratumumab,"PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BORTEZOMIB|FUROSEMIDE|OXYCODONE HYDROCHLORIDE|CLONIDINE|DEXTROSE ANHYDROUS|LANSOPRAZOLE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BORTEZOMIB|BORTEZOMIB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|FLUCONAZOLE|IPRATROPIUM BROMIDE|LANSOPRAZOLE|DARATUMUMAB|BORTEZOMIB|BORTEZOMIB|FILGRASTIM|FOLIC ACID|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|FUROSEMIDE|HYDROXOCOBALAMIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|ALLOPURINOL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DEXTROSE ANHYDROUS|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|MELPHALAN HYDROCHLORIDE|MELPHALAN|BISOPROLOL FUMARATE|CLARITHROMYCIN|DOXYCYCLINE|DOXYCYCLINE HYCLATE|FLUCONAZOLE|LOSARTAN|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|IPRATROPIUM BROMIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BORTEZOMIB|AMOXICILLIN|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|FUROSEMIDE|HYDROXOCOBALAMIN|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BORTEZOMIB|BORTEZOMIB|AMLODIPINE|FOLIC ACID|SENNOSIDES|SENNA LEAF|SENNA|CLONIDINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|AMOXICILLIN AND CLAVULANATE POTASSIUM",92,PERIPHERAL SWELLING|NEUROPATHY PERIPHERAL|PROPHYLAXIS|HYPERTENSION|TYPE 2 DIABETES MELLITUS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|DYSPEPSIA|PLASMA CELL MYELOMA|PROPHYLAXIS|HYPERCHOLESTEROLAEMIA|NEUTROPENIA|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|PROPHYLAXIS|BACK PAIN|PROPHYLAXIS|PERIPHERAL SWELLING|PROPHYLAXIS|TYPE 2 DIABETES MELLITUS|GASTROOESOPHAGEAL REFLUX DISEASE|NAUSEA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|ANTACID THERAPY|BACK PAIN|TYPE 2 DIABETES MELLITUS|HYPERTENSION|UPPER RESPIRATORY TRACT INFECTION|UPPER RESPIRATORY TRACT INFECTION|BACK PAIN|HYPERTENSION|BLOOD MAGNESIUM DECREASED|PROPHYLAXIS|NEUROPATHY PERIPHERAL|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PROPHYLAXIS|PAIN PROPHYLAXIS|UPPER RESPIRATORY TRACT INFECTION|UPPER RESPIRATORY TRACT INFECTION|INFECTION PROPHYLAXIS|PERIPHERAL SWELLING|MACROCYTOSIS|HYPOTHYROIDISM|PROPHYLAXIS|PROPHYLAXIS|HYPOCALCAEMIA|HYPERTENSION|UPPER RESPIRATORY TRACT INFECTION|NAUSEA|MACROCYTOSIS|NEUROPATHY PERIPHERAL|CONSTIPATION|PROPHYLAXIS|ECZEMA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PROPHYLAXIS,Sepsis|Acute coronary syndrome|Lower respiratory tract infection|Neutropenia|Atrial fibrillation|Myocarditis|Back pain|Constipation|Peripheral swelling|Neuropathy peripheral,10,1
12140776,20160303,Daratumumab,67,801,67.0,2,93,1,0,1,0,0,0,1,Daratumumab,"PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|MELPHALAN HYDROCHLORIDE|MELPHALAN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DEXTROSE ANHYDROUS|BORTEZOMIB|BORTEZOMIB|AMOXICILLIN|LOSARTAN|CLARITHROMYCIN|DOXYCYCLINE|DOXYCYCLINE HYCLATE|FUROSEMIDE|FUROSEMIDE|DARATUMUMAB|BORTEZOMIB|BORTEZOMIB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|LANSOPRAZOLE|BORTEZOMIB|BORTEZOMIB|FLUCONAZOLE|ALLOPURINOL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FOLIC ACID|FUROSEMIDE|HYDROXOCOBALAMIN|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FILGRASTIM|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|CLONIDINE|BORTEZOMIB|BISOPROLOL FUMARATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|BORTEZOMIB|BORTEZOMIB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|OXYCODONE HYDROCHLORIDE|SENNOSIDES|SENNA LEAF|SENNA|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BORTEZOMIB|BORTEZOMIB|AMLODIPINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|FOLIC ACID|HYDROXOCOBALAMIN|IPRATROPIUM BROMIDE",70,PLASMA CELL MYELOMA|ANTACID THERAPY|HYPOCALCAEMIA|TYPE 2 DIABETES MELLITUS|BLOOD MAGNESIUM DECREASED|TYPE 2 DIABETES MELLITUS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|UPPER RESPIRATORY TRACT INFECTION|HYPERCHOLESTEROLAEMIA|PROPHYLAXIS|HYPERTENSION|UPPER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|PERIPHERAL SWELLING|PLASMA CELL MYELOMA|UPPER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|PROPHYLAXIS|BACK PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|UPPER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|PROPHYLAXIS|HYPOTHYROIDISM|PROPHYLAXIS|PLASMA CELL MYELOMA|TYPE 2 DIABETES MELLITUS|INFECTION PROPHYLAXIS|GASTROOESOPHAGEAL REFLUX DISEASE|PROPHYLAXIS|BACK PAIN|NEUTROPENIA|NEURALGIA|NEUROPATHY PERIPHERAL|HYPERTENSION|HYPERTENSION|NAUSEA|PROPHYLAXIS|PROPHYLAXIS|NEURALGIA|CONSTIPATION|PROPHYLAXIS|UPPER RESPIRATORY TRACT INFECTION|HYPERTENSION|BACK PAIN|NAUSEA|PROPHYLAXIS|MACROCYTOSIS|MACROCYTOSIS|PLASMA CELL MYELOMA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Acute coronary syndrome|Peripheral swelling|Neutropenia|Lower respiratory tract infection|Back pain|Constipation|Neuropathy peripheral|Sepsis|Atrial fibrillation,9,1
12140909,20160302,Daratumumab,65,801,65.0,1,,1,0,0,0,0,0,0,Daratumumab,POMALIDOMIDE|DARATUMUMAB|BORTEZOMIB,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Abdominal hernia|Pneumonia|Chronic obstructive pulmonary disease|Sepsis,4,2
12141076,20160303,Daratumumab,,,,1,,1,1,1,0,0,0,0,Daratumumab,DARATUMUMAB|LENALIDOMIDE,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Sepsis,1,3
12141077,20160303,Daratumumab,,,,0,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Immunodeficiency|Pneumonia,2,3
12142372,20160303,Daratumumab,,,,1,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Death,1,5
12142638,20160303,Daratumumab,69,801,69.0,2,61,1,0,1,0,0,0,0,Daratumumab,BORTEZOMIB|BORTEZOMIB|DARATUMUMAB|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|BORTEZOMIB|PREDNISONE|PREDNISONE|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|DARATUMUMAB|MELPHALAN HYDROCHLORIDE|MELPHALAN|VORICONAZOLE|BORTEZOMIB|BORTEZOMIB|PREDNISONE,30,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|NEUTROPENIA|NEUTROPENIA|HYPOALBUMINAEMIA|PROPHYLAXIS|PROPHYLAXIS|NEUTROPENIA|NEUTROPENIA|PLASMA CELL MYELOMA,Thrombocytopenia|Neutropenia|Pleural effusion|Hypoalbuminaemia|Anaemia,5,1
12147536,20160304,Daratumumab,62,801,62.0,1,73.8,1,0,1,0,0,0,0,Daratumumab,POMALIDOMIDE|DARATUMUMAB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|POMALIDOMIDE|MELPHALAN HYDROCHLORIDE|MELPHALAN,6,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Sepsis,1,1
12149899,20160304,Daratumumab,52,801,52.0,1,85.35,1,0,1,0,0,0,0,Daratumumab,"LENALIDOMIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|MELPHALAN HYDROCHLORIDE|MELPHALAN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|POMALIDOMIDE|ELOTUZUMAB|DARATUMUMAB|LENALIDOMIDE|LENALIDOMIDE|BORTEZOMIB FOR INJECTION|BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LENALIDOMIDE|MELPHALAN HYDROCHLORIDE|MELPHALAN|DARATUMUMAB|BORTEZOMIB FOR INJECTION|BORTEZOMIB|PREDNISONE|CARFILZOMIB",20,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Appendicitis perforated|Pancytopenia,2,3
12151685,20160304,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,ACYCLOVIR|PREDNISONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DIPHENHYDRAMINE HYDROCHLORIDE|CLONAZEPAM|POMALIDOMIDE|GABAPENTIN|DARATUMUMAB|POMALIDOMIDE|ACYCLOVIR|CITALOPRAM|CITALOPRAM HYDROBROMIDE,16,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Scab|Pruritus|Rash|Full blood count decreased,4,3
12154990,20160307,Daratumumab,65,801,65.0,2,71,1,1,1,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA,Tremor|Renal impairment|Diarrhoea|Pyrexia|Neutropenia|Acute kidney injury,6,1
12155998,20160307,Daratumumab,74,801,74.0,1,79.37,1,0,1,1,0,0,0,Daratumumab,DARATUMUMAB|ACYCLOVIR|FENTANYL|LEVOTHYROXINE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|DANAZOL|OXYCODONE|EZETIMIBE AND SIMVASTATIN|PREGABALIN|ACYCLOVIR|DARATUMUMAB|ALPRAZOLAM|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|ALLOPURINOL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS,19,ANTIVIRAL PROPHYLAXIS|PLASMA CELL MYELOMA,Dyspnoea|Sepsis|Thrombocytopenia|Anaemia,4,1
12155999,20160307,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Pneumonia|Pneumonitis,2,2
12158731,20160308,Daratumumab,64,801,64.0,2,,1,0,0,0,0,0,0,Daratumumab,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DARATUMUMAB",3,PREMEDICATION|PLASMA CELL MYELOMA,Off label use|Product use issue,2,3
12161287,20160308,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,POMALIDOMIDE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Feeling abnormal|Insomnia,2,3
12162821,20160308,Daratumumab,65,801,65.0,2,,1,0,0,0,0,0,0,Daratumumab,BORTEZOMIB|CARFILZOMIB|DARATUMUMAB|BORTEZOMIB,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Depressed mood|Crying|Vomiting|Hypophagia,4,1
12162995,20160309,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Hospice care,1,1
12162996,20160309,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Transfusion,1,1
12163110,20160308,Daratumumab,56,801,56.0,2,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Back pain|Infusion related reaction|Chest pain,3,2
12165564,20160309,Daratumumab,67,801,67.0,2,93,1,0,1,0,0,0,0,Daratumumab,"AMLODIPINE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|FLUCONAZOLE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|FILGRASTIM|FOLIC ACID|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|HYDROXOCOBALAMIN|LOSARTAN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|DEXTROSE ANHYDROUS|BORTEZOMIB|BORTEZOMIB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|LANSOPRAZOLE|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|BORTEZOMIB|ALLOPURINOL|AMOXICILLIN|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OXYCODONE HYDROCHLORIDE|IPRATROPIUM BROMIDE|BORTEZOMIB|FOLIC ACID|HYDROXOCOBALAMIN|CLONIDINE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|BISOPROLOL FUMARATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXTROSE ANHYDROUS|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|AMOXICILLIN AND CLAVULANATE POTASSIUM|DARATUMUMAB|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|BORTEZOMIB|CLARITHROMYCIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|IPRATROPIUM BROMIDE|BORTEZOMIB|BORTEZOMIB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|CLONIDINE",84,HYPERTENSION|HYPERCHOLESTEROLAEMIA|INFECTION PROPHYLAXIS|BACK PAIN|BACK PAIN|PROPHYLAXIS|ANTACID THERAPY|PROPHYLAXIS|ECZEMA|NEUTROPENIA|PROPHYLAXIS|PERIPHERAL SWELLING|PROPHYLAXIS|HYPERTENSION|DIABETES MELLITUS|CONSTIPATION|TYPE 2 DIABETES MELLITUS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|UPPER RESPIRATORY TRACT INFECTION|UPPER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|NEUROPATHY PERIPHERAL|PROPHYLAXIS|TYPE 2 DIABETES MELLITUS|DYSPEPSIA|PLASMA CELL MYELOMA|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|UPPER RESPIRATORY TRACT INFECTION|NAUSEA|HYPOTHYROIDISM|NAUSEA|NEUROPATHY PERIPHERAL|NEUROPATHY PERIPHERAL|PLASMA CELL MYELOMA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|UPPER RESPIRATORY TRACT INFECTION|PLASMA CELL MYELOMA|PROPHYLAXIS|MACROCYTOSIS|MACROCYTOSIS|BACK PAIN|PAIN PROPHYLAXIS|HYPERTENSION|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|UPPER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|BLOOD MAGNESIUM DECREASED|GASTROOESOPHAGEAL REFLUX DISEASE|PROPHYLAXIS|HYPOCALCAEMIA|PROPHYLAXIS|PROPHYLAXIS|HYPERTENSION,Neuropathy peripheral|Sepsis|Acute coronary syndrome|Atrial fibrillation|Peripheral swelling|Neutropenia|Back pain|Lower respiratory tract infection|Constipation,9,5
12167714,20160310,Daratumumab,45,801,45.0,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Renal disorder|Plasma cell myeloma,2,1
12171438,20160311,Daratumumab,61,801,61.0,2,,1,1,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Febrile neutropenia|Disease progression,2,3
12174997,20160314,Daratumumab,68,801,68.0,2,93,1,0,1,0,0,0,0,Daratumumab,"DARATUMUMAB|HYDROXOCOBALAMIN|BISOPROLOL FUMARATE|ALLOPURINOL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|MELPHALAN HYDROCHLORIDE|MELPHALAN|LOSARTAN|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|BORTEZOMIB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BISOPROLOL FUMARATE|DARATUMUMAB|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|SENNOSIDES|SENNA LEAF|SENNA|FLUCONAZOLE|MELPHALAN HYDROCHLORIDE|MELPHALAN|FUROSEMIDE|OXYCODONE HYDROCHLORIDE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|BORTEZOMIB|HYDROXOCOBALAMIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|BORTEZOMIB|BORTEZOMIB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|FOLIC ACID|OXYCODONE HYDROCHLORIDE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|LANSOPRAZOLE|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|FUROSEMIDE|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|ALLOPURINOL|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION",59,PLASMA CELL MYELOMA|NEUROPATHY PERIPHERAL|HYPERTENSION|TUMOUR LYSIS SYNDROME|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|NEUROPATHY PERIPHERAL|HYPERTENSION|HYPOTHYROIDISM|BACK PAIN|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|NEUROPATHY PERIPHERAL|BACK PAIN|PLASMA CELL MYELOMA|HYPERTENSION|HYPERCHOLESTEROLAEMIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|BLOOD MAGNESIUM DECREASED|NEURALGIA|PLASMA CELL MYELOMA|TYPE 2 DIABETES MELLITUS|CONSTIPATION|BACK PAIN|PLASMA CELL MYELOMA|PERIPHERAL SWELLING|NEURALGIA|UPPER RESPIRATORY TRACT INFECTION|HYPOTHYROIDISM|PLASMA CELL MYELOMA|MACROCYTOSIS|HYPOCALCAEMIA|PROPHYLAXIS|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERCHOLESTEROLAEMIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|MACROCYTOSIS|NEUROPATHY PERIPHERAL|NEURALGIA|HYPOTHYROIDISM|UPPER RESPIRATORY TRACT INFECTION|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PERIPHERAL SWELLING|NEUROPATHY PERIPHERAL|NEUROPATHY PERIPHERAL|NEURALGIA|INFECTION PROPHYLAXIS|PROPHYLAXIS|UPPER RESPIRATORY TRACT INFECTION|PROPHYLAXIS,Atrial fibrillation|Upper respiratory tract infection|Sepsis,3,1
12174998,20160314,Daratumumab,82,801,82.0,2,55,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|SIMVASTATIN|FAMOTIDINE|LISINOPRIL|DARATUMUMAB|RIVAROXABAN|DULOXETINE HYDROCHLORIDE|DONEPEZIL HYDROCHLORIDE|METHYLPREDNISOLONE|OXYCODONE HYDROCHLORIDE|ACYCLOVIR|HYDROXYCHLOROQUINE SULFATE,13,PLASMA CELL MYELOMA|DEEP VEIN THROMBOSIS,Chest pain,1,1
12174999,20160314,Daratumumab,74,801,74.0,1,78,1,0,1,0,0,0,0,Daratumumab,LENALIDOMIDE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Bronchitis|Sepsis,2,1
12178042,20160314,Daratumumab,70,801,70.0,2,73.7,1,0,0,0,0,0,1,Daratumumab,"METHYLPREDNISOLONE SODIUM SUCCINATE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ACYCLOVIR|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|DIPHENHYDRAMINE HYDROCHLORIDE|DARATUMUMAB|POMALIDOMIDE|POMALIDOMIDE|ZOLPIDEM TARTRATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIPHENHYDRAMINE HYDROCHLORIDE",16,PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL LEUKAEMIA|PLASMA CELL LEUKAEMIA|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|CHILLS|PRODUCT USED FOR UNKNOWN INDICATION,Thrombocytopenia|Haemoglobin decreased|Neutropenia,3,2
12181410,20160315,Daratumumab,69,801,69.0,1,,1,0,0,0,0,0,0,Daratumumab,IXAZOMIB|DARATUMUMAB,2,PLASMA CELL MYELOMA,Diarrhoea|Off label use|Abdominal pain upper|Diarrhoea|Vomiting|Drug ineffective|Abdominal pain upper|Vomiting,8,3
12181757,20160315,Daratumumab,76,801,76.0,1,53.6,1,0,1,0,0,0,1,Daratumumab,BORTEZOMIB|TIZANIDINE|ZOLEDRONIC ACID|ZOLEDRONIC ACID|ZOLEDRONIC ACID|VORICONAZOLE|VORICONAZOLE|MEROPENEM|LANSOPRAZOLE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LOSARTAN POTASSIUM|LOSARTAN|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|OXYCODONE|MELPHALAN HYDROCHLORIDE|MELPHALAN|ZOLEDRONIC ACID|ZOLEDRONIC ACID|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|BORTEZOMIB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PITAVASTATIN CALCIUM|PITAVASTATIN|AMLODIPINE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|OXYCODONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|HYDROCORTISONE SODIUM SUCCINATE|MEROPENEM|OXYCODONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ZOLEDRONIC ACID|MEROPENEM|OXYCODONE|DARATUMUMAB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|MEROPENEM|MEROPENEM|OXYCODONE|OXYCODONE|OXYCODONE|FILGRASTIM,138,PLASMA CELL MYELOMA|SPINAL COMPRESSION FRACTURE|PROPHYLAXIS|THROMBOSIS PROPHYLAXIS|LUNG INFECTION|LUNG INFECTION|SEPSIS|LUNG INFECTION|DIABETES MELLITUS|HYPERURICAEMIA|CHRONIC GASTRITIS|PROPHYLAXIS|PROPHYLAXIS OF NAUSEA AND VOMITING|LUNG INFECTION|SEPSIS|PROPHYLAXIS|BACK PAIN|VOMITING|DECREASED APPETITE|UPPER RESPIRATORY TRACT INFECTION|SEPSIS|ANTIFUNGAL PROPHYLAXIS|HYPERTENSION|LIP DRY|ORAL CANDIDIASIS|CYTOMEGALOVIRUS INFECTION|SEPSIS|BACK PAIN|PLASMA CELL MYELOMA|INFECTION PROPHYLAXIS|VOMITING|PROPHYLAXIS OF NAUSEA AND VOMITING|PLASMA CELL MYELOMA|INSOMNIA|SEPSIS|PROPHYLAXIS|PYREXIA|CONSTIPATION|SEPSIS|CANCER PAIN|HYPERLIPIDAEMIA|HYPERTENSION|PROPHYLAXIS|DRY SKIN|INSOMNIA|CONSTIPATION|CHILLS|CHRONIC GASTRITIS|PROPHYLAXIS|ANTIVIRAL PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|SEPSIS|DRUG ERUPTION|PLASMA CELL MYELOMA|CONSTIPATION|PROPHYLAXIS|BLOOD CREATININE INCREASED|DEHYDRATION|LACRIMATION INCREASED|CATARACT|SEPSIS|SEPSIS|CANCER PAIN|PLASMA CELL MYELOMA|DEHYDRATION|INSOMNIA|BACK PAIN|PROPHYLAXIS OF NAUSEA AND VOMITING|SEPSIS|SEPSIS|DECREASED APPETITE|DEHYDRATION|NEUTROPHIL COUNT DECREASED|LACRIMATION DISORDER,Hypoxia|Depressed level of consciousness|Vomiting|Back pain|Decreased appetite|Cytomegalovirus infection|Gait disturbance|Oral candidiasis|Drug eruption|Insomnia|Neutrophil count decreased|Choking|Lung infection|Sepsis|Infection|Syncope|Dehydration|Peripheral sensory neuropathy,18,1
12181775,20160315,Daratumumab,70,801,70.0,2,78,1,0,1,0,0,0,1,Daratumumab,BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|PREDNISONE|PREDNISONE|METRONIDAZOLE|METRONIDAZOLE TOPICAL|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|AMLODIPINE BESYLATE AND VALSARTAN|LACTULOSE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB|BORTEZOMIB|ALPRAZOLAM|BORTEZOMIB|BORTEZOMIB|PREDNISONE|PREDNISONE|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|PREDNISONE|CLOPIDOGREL|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|PREDNISONE|DARATUMUMAB|MELPHALAN HYDROCHLORIDE|MELPHALAN|LANSOPRAZOLE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ZOLPIDEM TARTRATE|CIPROFLOXACIN|CIPROFLOXACIN HYDROCHLORIDE|CIPROFOLXACIN|CIPROFLOXACIN TABLETS|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|MELPHALAN HYDROCHLORIDE|MELPHALAN|FOLIC ACID|AMOXICILLIN AND CLAVULANATE POTASSIUM|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|BORTEZOMIB|LOSARTAN,76,PROPHYLAXIS|MYOCARDIAL ISCHAEMIA|DUODENAL ULCER|ILEUS PARALYTIC|INFECTIVE MYOSITIS|DIARRHOEA|HYPERTENSION|CONSTIPATION|FEMUR FRACTURE|VOMITING|GOUT|PROPHYLAXIS|ANXIETY|PROPHYLAXIS|DYSLIPIDAEMIA|INFECTIVE MYOSITIS|PLASMA CELL MYELOMA|FEMUR FRACTURE|HYPERTENSION|HYPERTENSION|PATHOLOGICAL FRACTURE|INFECTIVE MYOSITIS|CELLULITIS|ABDOMINAL PAIN UPPER|ANXIETY|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS|ANXIETY|DYSLIPIDAEMIA|ILEUS PARALYTIC|URINARY TRACT INFECTION|VOMITING|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|INFECTIVE MYOSITIS|PLASMA CELL MYELOMA|HYPERTENSION|OBESITY|PRODUCT USED FOR UNKNOWN INDICATION|HYPERTENSION|NEUTROPENIA,Herpes zoster|Vomiting|Infective myositis|Ileus paralytic|Urinary tract infection|Anaemia|Diarrhoea|Neutropenia,8,1
12184009,20160316,Daratumumab,,,,2,,1,0,1,0,0,0,0,Daratumumab,LENALIDOMIDE|LENALIDOMIDE|IXAZOMIB|DARATUMUMAB|LENALIDOMIDE|ACYCLOVIR|LENALIDOMIDE|DEXLANSOPRAZOLE,8,PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonia,1,3
12184169,20160316,Daratumumab,68,801,68.0,1,92,1,1,0,0,0,0,1,Daratumumab,DARATUMUMAB|PREDNISONE|VALACYCLOVIR HYDROCHLORIDE|MELPHALAN HYDROCHLORIDE|MELPHALAN|BORTEZOMIB,14,ANTIEMETIC SUPPORTIVE CARE|IMPLANTABLE DEFIBRILLATOR INSERTION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|ANTIVIRAL PROPHYLAXIS|GOUTY ARTHRITIS|GASTRIC ULCER|PLASMA CELL MYELOMA|IMPLANTABLE DEFIBRILLATOR INSERTION|HYPERTENSION|PAIN MANAGEMENT|PLASMA CELL MYELOMA|PAIN MANAGEMENT|THROMBOSIS PROPHYLAXIS,Cardiac arrest,1,1
12187866,20160317,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Pneumonitis,1,1
12188086,20160317,Daratumumab,81,801,81.0,1,77.18,1,0,1,0,0,0,1,Daratumumab,ASPIRIN|DARATUMUMAB|ZOLPIDEM TARTRATE|PANTOPRAZOLE SODIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LISINOPRIL|POMALIDOMIDE|CEFADROXIL|BENZONATATE|ROSUVASTATIN|LORATADINE|LORATADINE TABLET|CLOPIDOGREL BISULFATE|EZETIMIBE|VENLAFAXINE HYDROCHLORIDE|LEVOTHYROXINE SODIUM,18,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Laboratory test abnormal|Blood pressure abnormal|Bone lesion|Diarrhoea|Weight decreased|Upper respiratory tract infection,6,3
12188417,20160317,Daratumumab,6,800,60.0,1,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Pneumonia|Infusion related reaction|Adverse event,3,3
12190771,20160318,Daratumumab,,,,2,54.43,1,0,1,0,0,0,0,Daratumumab,PREDNISONE|DARATUMUMAB|DARATUMUMAB|METHOTREXATE|METHOTREXATE SODIUM|PREDNISONE|METHOTREXATE|METHOTREXATE SODIUM,10,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Anaemia|Therapeutic response decreased|Adverse event|Ocular neoplasm|Adverse event|Adverse event|Brain neoplasm|Spinal cord neoplasm|Pneumonia|Abasia|Urinary tract infection|Asthenia|Dehydration|Diarrhoea,14,5
12193222,20160319,Daratumumab,,,,1,,1,1,0,0,0,0,1,Daratumumab,DARATUMUMAB|ELOTUZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Acute respiratory failure,2,1
12195260,20160321,Daratumumab,58,801,58.0,2,,1,0,1,0,0,0,0,Daratumumab,BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MONTELUKAST|BORTEZOMIB|OXYCODONE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DARATUMUMAB|OXYCODONE HYDROCHLORIDE|DARATUMUMAB|PREGABALIN,27,PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|HYPOVITAMINOSIS|PREMEDICATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION|PREMEDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ERYSIPELAS|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|CONSTIPATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HYPOVITAMINOSIS,Encephalopathy,1,3
12201829,20160322,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Extravasation,1,2
12202119,20160322,Daratumumab,,,,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Neutrophil count increased|Sepsis|Tachycardia|Pleural effusion|Blood creatinine increased,5,3
12203759,20160322,Daratumumab,74,801,74.0,1,86.18,1,0,0,0,0,0,0,Daratumumab,,1,,Neuropathy peripheral|Condition aggravated,2,
12204029,20160323,Daratumumab,,,,2,55.84,1,0,0,0,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|POMALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|DARATUMUMAB|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|PREDNISONE|POMALIDOMIDE|LORATADINE|LORATADINE TABLET,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION,Musculoskeletal stiffness|Nervousness|Paraesthesia,3,3
12205081,20160323,Daratumumab,51,801,51.0,2,82.17,1,0,1,0,0,0,0,Daratumumab,POMALIDOMIDE|DARATUMUMAB|POMALIDOMIDE,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Hypocalcaemia,1,3
12205162,20160323,Daratumumab,60,801,60.0,1,58,1,0,0,0,0,0,1,Daratumumab,"ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|OLOPATADINE HYDROCHLORIDE|OLOPATADINE HYDROCHLORIDE OPHTHALMIC|OXYCODONE HYDROCHLORIDE|OXYCODONE|PROCHLORPERAZINE|WHITE PETROLATUM|PETROLATUM|SKIN PROTECTANT|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE|DARATUMUMAB|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|LENALIDOMIDE|CHLORPROMAZINE HYDROCHLORIDE|CHLORPROMAZINE|CHLORPROMAZINE HYDROCHLORIDE|CHLORPROMAZINE",28,BACK PAIN|RASH|BACK PAIN|NAUSEA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|BACK PAIN|PROPHYLAXIS|CONSTIPATION|BACK PAIN|BACK PAIN|NUTRITIONAL SUPPLEMENTATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|INSOMNIA|THROMBOSIS PROPHYLAXIS|INFECTION PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|GASTRITIS PROPHYLAXIS|HYPERTENSION|CONSTIPATION|RASH|PLASMA CELL MYELOMA|HICCUPS|HICCUPS,Bacterial infection,1,1
12205517,20160323,Daratumumab,46,801,46.0,1,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Dialysis|Blood creatinine increased|Oxygen saturation decreased|Transfusion|Dyspnoea,5,1
12205670,20160323,Daratumumab,57,801,57.0,1,97.2,1,0,0,0,0,0,0,Daratumumab,"THALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB|THALIDOMIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|THALIDOMIDE|LORAZEPAM|OXYCODONE HYDROCHLORIDE|BORTEZOMIB|ETOPOSIDE|ENOXAPARIN SODIUM|ENOXAPARIN SODIUM|ACYCLOVIR|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CISPLATIN|MELPHALAN HYDROCHLORIDE|MELPHALAN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|STANDARDIZED SENNA CONCENTRATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PENTAMIDINE ISETHIONATE|BORTEZOMIB|DOXORUBICIN HYDROCHLORIDE|DOXORUBICIN HYDROCHLORIDE|POLYETHYLENE GLYCOL 3350|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OMEPRAZOLE MAGNESIUM|THALIDOMIDE|ENOXAPARIN SODIUM|FENTANYL|DARATUMUMAB",37,PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|DEEP VEIN THROMBOSIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Eye swelling|Eye irritation|Feeling abnormal|Hot flush|Dizziness,5,2
12207859,20160324,Daratumumab,75,801,75.0,1,80,1,0,1,0,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LENALIDOMIDE|ATENOLOL|DARATUMUMAB|FERROUS SULFATE|RIVAROXABAN|ATORVASTATIN CALCIUM|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES,10,PLASMA CELL MYELOMA|PROPHYLAXIS|PLASMA CELL MYELOMA|HYPERTENSION|PLASMA CELL MYELOMA|IRON DEFICIENCY ANAEMIA|DEEP VEIN THROMBOSIS|HYPERCHOLESTEROLAEMIA|CHEST PAIN|PROPHYLAXIS,Chest pain|Spinal compression fracture|Back pain|Pulmonary embolism,4,1
12208487,20160324,Daratumumab,51,801,51.0,2,88.6,1,0,1,0,0,0,0,Daratumumab,POMALIDOMIDE|CISPLATIN|DARATUMUMAB|POMALIDOMIDE|ETOPOSIDE|DARATUMUMAB,9,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,VIth nerve paralysis|Arthralgia|Acute kidney injury|Hypercalcaemia,4,3
12210684,20160325,Daratumumab,61,801,61.0,1,58.3,1,0,1,0,0,0,0,Daratumumab,"LENALIDOMIDE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OXYCODONE HYDROCHLORIDE|OXYCODONE|MAGNESIUM OXIDE|DARATUMUMAB|DARATUMUMAB|OXYCODONE HYDROCHLORIDE|OXYCODONE|PROCHLORPERAZINE|OLOPATADINE HYDROCHLORIDE|OLOPATADINE HYDROCHLORIDE OPHTHALMIC|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OLOPATADINE HYDROCHLORIDE|OLOPATADINE HYDROCHLORIDE OPHTHALMIC|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE",27,PLASMA CELL MYELOMA|GASTRITIS PROPHYLAXIS|GASTROINTESTINAL DISORDER THERAPY|BACK PAIN|NUTRITIONAL SUPPLEMENTATION|PROPHYLAXIS|THROMBOSIS PROPHYLAXIS|CONSTIPATION|NUTRITIONAL SUPPLEMENTATION|HYPERTENSION|DRY SKIN|PLASMA CELL MYELOMA|NOCTURIA|BACK PAIN|CONSTIPATION|PLASMA CELL MYELOMA|BACK PAIN|PROPHYLAXIS OF NAUSEA AND VOMITING|RASH|NUTRITIONAL SUPPLEMENTATION|PLASMA CELL MYELOMA|PROPHYLAXIS|INSOMNIA|DRY SKIN|PLASMA CELL MYELOMA|ASPIRATION BONE MARROW,Bronchitis,1,1
12210685,20160325,Daratumumab,72,801,72.0,2,82,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Urinary tract infection|Pyrexia,2,1
12210686,20160325,Daratumumab,60,801,60.0,1,55,1,0,1,0,0,0,0,Daratumumab,MAGNESIUM OXIDE|LENALIDOMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PROCHLORPERAZINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OLOPATADINE HYDROCHLORIDE|OLOPATADINE HYDROCHLORIDE OPHTHALMIC|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|DARATUMUMAB|LENALIDOMIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE|LENALIDOMIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE,25,CONSTIPATION|PLASMA CELL MYELOMA|HYPERTENSION|PROPHYLAXIS|THROMBOSIS PROPHYLAXIS|MINERAL SUPPLEMENTATION|INSOMNIA|PROPHYLAXIS OF NAUSEA AND VOMITING|BACK PAIN|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|GASTROINTESTINAL DISORDER THERAPY|RASH|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|BACK PAIN|CONSTIPATION|NOCTURIA|PLASMA CELL MYELOMA|GASTRITIS PROPHYLAXIS|BACK PAIN|PLASMA CELL MYELOMA,Hypoxia,1,1
12215042,20160328,Daratumumab,51,801,51.0,1,91.71,1,0,0,0,0,0,1,Daratumumab,IBUPROFEN|IBUPROFEN AND DIPHENHYDRAMINE CITRATE|DARATUMUMAB|THALIDOMIDE,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA,Pneumonia necrotising,1,3
12215590,20160328,Daratumumab,64,801,64.0,2,94.5,1,0,1,0,0,0,0,Daratumumab,HYDROMORPHONE HYDROCHLORIDE|FUROSEMIDE|ENOXAPARIN SODIUM|DARATUMUMAB|POMALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ALPRAZOLAM|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|POMALIDOMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,13,THROMBOSIS PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|THROMBOSIS PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|THROMBOSIS PROPHYLAXIS,Pneumonia,1,1
12216395,20160328,Daratumumab,56,801,56.0,1,,1,1,0,0,0,0,0,Daratumumab,BEVACIZUMAB|DARATUMUMAB|BORTEZOMIB,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Death,1,2
12218078,20160329,Daratumumab,85,801,85.0,2,58.57,1,0,1,0,0,0,1,Daratumumab,"ACYCLOVIR|GABAPENTIN|POMALIDOMIDE|CALCIUM|WARFARIN|LORAZEPAM|CEFDINIR|MAGNESIUM|FENTANYL|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CARBIDOPA AND LEVODOPA|CARVEDILOL|ALBUTEROL SULFATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SOLIFENACIN SUCCINATE|PREDNISONE|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|PANTOPRAZOLE|FUROSEMIDE|HYDRALAZINE HYDROCHLORIDE|INSULIN GLARGINE",31,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PARKINSON^S DISEASE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Blood glucose increased|Upper respiratory tract infection|Clostridium difficile colitis|Acute kidney injury,4,1
12219094,20160329,Daratumumab,,,,0,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infection,1,1
12223224,20160330,Daratumumab,,,,0,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
12225562,20160331,Daratumumab,67,801,67.0,2,62,1,0,1,0,0,0,0,Daratumumab,ACYCLOVIR|GABAPENTIN|DARATUMUMAB|DARATUMUMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|GABAPENTIN|PREDNISONE,16,ANTIVIRAL PROPHYLAXIS|NEURALGIA|PLASMA CELL MYELOMA|BACK PAIN|OEDEMA PERIPHERAL|INFECTION PROPHYLAXIS|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|BACK PAIN|NEURALGIA|NEURALGIA|PLASMA CELL MYELOMA|GASTROINTESTINAL DISORDER THERAPY|SLEEP DISORDER THERAPY|NEURALGIA,H1N1 influenza,1,1
12226736,20160331,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,3
12230986,20160401,Daratumumab,61,801,61.0,2,67.19,1,0,0,0,0,0,1,Daratumumab,DULOXETINE HYDROCHLORIDE|DULOXETINE|POMALIDOMIDE|GABAPENTIN|ROSUVASTATIN|ERGOCALCIFEROL|POMALIDOMIDE|DARATUMUMAB,8,PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Urinary tract infection|Anaemia,2,3
12231021,20160401,Daratumumab,76,801,76.0,2,61.5,1,0,1,0,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LENALIDOMIDE|LOSARTAN|DICLOFENAC|DICLOFENAC SODIUM|DARATUMUMAB|DARATUMUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FISH OIL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SIMVASTATIN,16,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|BRONCHITIS|HYPERTENSION|ARTHRALGIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|GASTROOESOPHAGEAL REFLUX DISEASE|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|ROUTINE HEALTH MAINTENANCE|BRONCHITIS|CORONARY ARTERY DISEASE|ROUTINE HEALTH MAINTENANCE|ROUTINE HEALTH MAINTENANCE|HYPERLIPIDAEMIA,Anaemia|Pneumonia|Urosepsis,3,1
12231112,20160401,Daratumumab,,,,2,58.57,1,0,1,0,0,0,0,Daratumumab,"LENALIDOMIDE|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BENDAMUSTINE HCL|METHYLPREDNISOLONE SODIUM SUCCINATE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|BORTEZOMIB|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL|LORATADINE|LORATADINE TABLET|ALBUTEROL SULFATE|ALBUTEROL|CARVEDILOL|ERGOCALCIFEROL|DARATUMUMAB|LOSARTAN|LENALIDOMIDE|LENALIDOMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LENALIDOMIDE|FUROSEMIDE|LORAZEPAM",28,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Memory impairment|Upper limb fracture,2,3
12232255,20160401,Daratumumab,,,,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Anaphylactic reaction|Underdose,2,5
12233025,20160403,Daratumumab,39,801,39.0,1,81.72,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|POMALIDOMIDE|POMALIDOMIDE|ARIPIPRAZOLE,5,PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|DIABETES MELLITUS|PRODUCT USED FOR UNKNOWN INDICATION,Full blood count decreased,1,5
12233904,20160404,Daratumumab,71,801,71.0,1,114,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|POMALIDOMIDE|POMALIDOMIDE|DARATUMUMAB,5,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Febrile neutropenia|Pneumonia respiratory syncytial viral,2,1
12235198,20160404,Daratumumab,76,801,76.0,1,72.58,1,0,0,0,0,0,1,Daratumumab,DIPHENHYDRAMINE HYDROCHLORIDE|FUROSEMIDE|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALLOPURINOL|METOPROLOL TARTRATE|DARATUMUMAB|ACYCLOVIR|METHYLPREDNISOLONE|WARFARIN|CLOTRIMAZOLE|DRS. CLOTRIMAZOLE|FAMILY WELLNESS CLOTRIMAZOLE|CLOTRIMAZOLE TOPICAL|MAGNESIUM|FUROSEMIDE,15,NUTRITIONAL SUPPLEMENTATION|INFUSION RELATED REACTION|PERIPHERAL SWELLING|BACK PAIN|PAIN|GOUT|ATRIAL FIBRILLATION|PLASMA CELL MYELOMA|HERPES ZOSTER|PROPHYLAXIS OF NAUSEA AND VOMITING|NAUSEA|DEEP VEIN THROMBOSIS|CANDIDA INFECTION|DEEP VEIN THROMBOSIS,Diarrhoea|Asthenia|Insomnia|Muscle contracture|Prothrombin time prolonged|Muscle twitching|Dehydration|Cystitis,8,3
12236160,20160404,Daratumumab,,,,1,74.91,1,0,0,0,0,0,1,Daratumumab,"LENALIDOMIDE|OXYCODONE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|RIBAVIRIN|VORICONAZOLE|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|MECLIZINE HCL 12.5 MG|MECLIZINE|MECLIZINE HYDROCHLORIDE|MECLIZINE HCL 25MG|MECLIZINE HCL 12.5MG|POSACONAZOLE|MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|DARATUMUMAB|ACYCLOVIR|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|FUROSEMIDE|AZITHROMYCIN DIHYDRATE",20,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Haemoglobin decreased|Platelet count decreased,2,3
12237714,20160405,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB|MONTELUKAST SODIUM,2,PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION,Adverse event,1,2
12237985,20160405,Daratumumab,67,801,67.0,1,,1,1,0,0,0,0,0,Daratumumab,LENALIDOMIDE|ERGOCALCIFEROL|LORAZEPAM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACYCLOVIR|LENALIDOMIDE|DARATUMUMAB|CALCIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LENALIDOMIDE|MAGNESIUM,12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
12239152,20160405,Daratumumab,,,,2,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Transfusion|Laboratory test interference,2,5
12242251,20160406,Daratumumab,66,801,66.0,2,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|LENALIDOMIDE|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|GABAPENTIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,11,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|GASTROINTESTINAL DISORDER THERAPY|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|GASTROINTESTINAL DISORDER THERAPY|PLASMA CELL MYELOMA|PROPHYLAXIS|THORACIC VERTEBRAL FRACTURE|NEUROPATHY PERIPHERAL|PLASMA CELL MYELOMA,Sepsis,1,1
12242252,20160406,Daratumumab,68,801,68.0,2,52,1,1,1,1,1,1,1,Daratumumab,DARATUMUMAB|LENALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ACYCLOVIR|ESOMEPRAZOLE MAGNESIUM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SENNOSIDES|GANCICLOVIR SODIUM|GANCICLOVIR|MICAFUNGIN SODIUM,18,Plasma cell myeloma|Plasma cell myeloma|Plasma cell myeloma|Eczema|Eczema|Eczema|Eczema|Insomnia|Prophylaxis|Prophylaxis|Prophylaxis|Prophylaxis|Constipation|Cytomegalovirus infection|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Epstein-Barr virus associated lymphoproliferative disorder|Cytomegalovirus infection,2,1
12242253,20160406,Daratumumab,,,,2,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion site reaction|Wrong technique in product usage process|Adverse event|Nausea|Erythema|Contusion|Platelet count decreased,7,2
12242254,20160406,Daratumumab,,,,1,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Atrial fibrillation,1,3
12243707,20160406,Daratumumab,54,801,54.0,2,,1,0,0,0,0,0,0,Daratumumab,"TADALAFIL|AMBRISENTAN|LORAZEPAM|MACITENTAN|ERGOCALCIFEROL|AMBRISENTAN|SILDENAFIL CITRATE|SILDENAFIL|SILDENAFIL POWDER,|MAGNESIUM|OXYCODONE|MACITENTAN|ACYCLOVIR|LOSARTAN POTASSIUM|LOSARTAN|PREGABALIN|FUROSEMIDE|TADALAFIL|LEVOTHYROXINE|PREDNISONE|POTASSIUM CHLORIDE|DARATUMUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OXYCODONE HYDROCHLORIDE",23,PULMONARY ARTERIAL HYPERTENSION|PULMONARY ARTERIAL HYPERTENSION|PULMONARY ARTERIAL HYPERTENSION|PULMONARY ARTERIAL HYPERTENSION,Sinus pain|Vaginal disorder|Headache|Nasal congestion|Sinusitis|Aphonia|Cough|Paranasal sinus hypersecretion|Upper-airway cough syndrome|Hypersensitivity|Dysphonia|Sinus congestion|Sinus disorder|Unevaluable event|Oropharyngeal pain|Vulvovaginal discomfort|Condition aggravated|Nasopharyngitis,18,2
12244022,20160406,Daratumumab,74,801,74.0,2,,1,1,0,0,0,0,0,Daratumumab,"LENALIDOMIDE|MAGNESIUM|PHOSPHORUS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PSYLLIUM HUSK|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|LENALIDOMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LORAZEPAM|MELATONIN|SENNOSIDES|SENNA LEAF|SENNA|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|ETOMIDATE|ETOMIDATE INJECTION|STANDARDIZED SENNA CONCENTRATE|SODIUM PHOSPHATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|VASOPRESSIN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXYCODONE|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PANTOPRAZOLE|SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE|SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE|SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE|SODIUM CHLORIDE, SOLDIUM LACTATE, POTASSIUM CHLORIDE AND CALCIUM CHLORIDE|MORPHINE|FENTANYL|POLYETHYLENE GLYCOL 3350|BORTEZOMIB|DARATUMUMAB",46,PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ANXIETY|INSOMNIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|CONSTIPATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION,Plasma cell myeloma|Full blood count decreased|Bacterial sepsis|Drug intolerance|Febrile neutropenia|Cardiac arrest|Atrial fibrillation,7,1
12246893,20160407,Daratumumab,47,801,47.0,2,59.02,1,0,1,0,0,0,0,Daratumumab,POMALIDOMIDE|BORTEZOMIB|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|CALCIUM CARBONATE|ANTACID|BORTEZOMIB|BORTEZOMIB|DARATUMUMAB|POMALIDOMIDE,13,PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Plasma cell myeloma|Blood calcium increased|Platelet count decreased,3,1
12249200,20160408,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Extravasation,1,2
12249344,20160408,Daratumumab,76,801,76.0,2,86,1,0,1,0,0,0,1,Daratumumab,BORTEZOMIB|DARATUMUMAB|PANTOPRAZOLE|BORTEZOMIB|PREDNISONE|IRBESARTAN|BORTEZOMIB|FONDAPARINUX SODIUM|MELPHALAN HYDROCHLORIDE|MELPHALAN|ALLOPURINOL|SULFAMETHOXAZOLE AND TRIMETHOPRIM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,20,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS|PLASMA CELL MYELOMA|HYPERTENSION|PROPHYLAXIS|PROPHYLAXIS|HYPERTENSION|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|PROPHYLAXIS|PROPHYLAXIS|PLASMA CELL MYELOMA|PROPHYLAXIS,Dyspnoea|Relapsing fever|Hypocalcaemia|Thrombocytopenia|Tremor|Atrial fibrillation,6,1
12249346,20160408,Daratumumab,67,801,67.0,2,54,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|BORTEZOMIB|PREDNISONE|OMEGA-3-ACID ETHYL ESTERS|BEPOTASTINE BESILATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FLUCONAZOLE|DARATUMUMAB|MELPHALAN HYDROCHLORIDE|MELPHALAN|AMLODIPINE BESYLATE|BORTEZOMIB,23,PLASMA CELL MYELOMA|HYPERTENSION|HYPERTENSION|PLASMA CELL MYELOMA|HYPERTENSION|ASTHMA|INFECTION PROPHYLAXIS|INFECTION PROPHYLAXIS|PREMEDICATION|PROPHYLAXIS|PLASMA CELL MYELOMA|HYPERTENSION|PLASMA CELL MYELOMA|OSTEOPOROSIS PROPHYLAXIS|HYPERTENSION|PAIN PROPHYLAXIS|PLASMA CELL MYELOMA|INFECTION PROPHYLAXIS,Cough|Respiratory arrest|Vomiting|Chills|Syncope|Eye movement disorder,6,1
12249806,20160408,Daratumumab,71,801,71.0,2,,1,1,1,0,0,0,0,Daratumumab,DARATUMUMAB|ALPRAZOLAM,6,PLASMABLASTIC LYMPHOMA,Plasmablastic lymphoma|Off label use|Death,3,5
12250219,20160408,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Plasma cell myeloma|Hypoglycaemia,2,1
12250520,20160408,Daratumumab,50,801,50.0,2,,1,0,0,0,0,0,1,Daratumumab,"LENALIDOMIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ERGOCALCIFEROL|CALCIUM|DARATUMUMAB|LENALIDOMIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|LENALIDOMIDE|FILGRASTIM|FISH OIL|ACYCLOVIR",12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Thrombosis|Neutropenia,2,2
12252917,20160408,Daratumumab,65,801,65.0,2,56,1,0,0,0,0,0,1,Daratumumab,DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|GABAPENTIN|DARATUMUMAB|CITALOPRAM|CITALOPRAM HYDROBROMIDE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|WARFARIN,11,PLASMA CELL MYELOMA,Vomiting|Infusion related reaction|Dyspnoea|Diarrhoea|Blood pressure decreased|Erythema,6,2
12253784,20160411,Daratumumab,55,801,55.0,2,88.3,1,0,1,0,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LISINOPRIL AND HYDROCHLOROTHIAZIDE|LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS|LEVOTHYROXINE|DARATUMUMAB|LENALIDOMIDE|SERTRALINE HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB,9,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Diarrhoea|Syncope,2,1
12253785,20160411,Daratumumab,73,801,73.0,1,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Wheezing|Dyspnoea|Product label issue|Respiratory failure|Infusion related reaction|Hypoxia,6,2
12253786,20160411,Daratumumab,,,,1,,1,1,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Malaise|Death,2,3
12253787,20160411,Daratumumab,67,801,67.0,1,80,1,0,1,1,0,0,0,Daratumumab,BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|DARATUMUMAB,4,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Herpes zoster|Acute kidney injury,2,1
12253788,20160411,Daratumumab,7,800,70.0,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Escherichia infection|Infectious colitis|Cardiac failure congestive|Dyspnoea|Pulmonary oedema|Drug dose omission,6,2
12253789,20160411,Daratumumab,57,801,57.0,1,88,1,1,1,1,0,0,0,Daratumumab,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ALPRAZOLAM|INSULIN GLARGINE|LOVASTATIN|DARATUMUMAB|METOPROLOL TARTRATE|METOPROLOL|LEVOTHYROXINE SODIUM,12,PRODUCT USED FOR UNKNOWN INDICATION,Cerebrovascular accident|Ejection fraction decreased,2,1
12254386,20160411,Daratumumab,,,,0,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Vomiting,1,2
12254946,20160411,Daratumumab,63,801,63.0,1,79,1,0,1,0,0,0,0,Daratumumab,THALIDOMIDE|BORTEZOMIB|MORPHINE|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,5,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Overdose,1,1
12255756,20160411,Daratumumab,72,801,72.0,1,104.33,1,0,1,0,0,0,0,Daratumumab,VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|ZOLPIDEM TARTRATE|ERGOCALCIFEROL|DARATUMUMAB|FLUCONAZOLE|FLUOXETINE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|METOPROLOL TARTRATE|BUMETANIDE|MAGNESIUM OXIDE|CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE,18,PLASMA CELL MYELOMA,Sepsis|Hiccups|Aphthous ulcer|Bronchitis|Thrombocytopenia|Respiratory failure|Eructation|Neutropenia|Oedema peripheral|Oropharyngeal pain|Candida infection|Feeding disorder|Pneumonia|Dysphagia|Anaemia|Laboratory test abnormal,16,
12256951,20160412,Daratumumab,,,,2,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
12256952,20160412,Daratumumab,62,801,62.0,2,52,1,0,1,1,1,0,0,Daratumumab,MELPHALAN HYDROCHLORIDE|MELPHALAN|LISINOPRIL|BISOPROLOL FUMARATE|DARATUMUMAB|PREDNISONE|DARATUMUMAB|BORTEZOMIB,14,PLASMA CELL MYELOMA|PROPHYLAXIS|OSTEOCHONDROSIS|HYPERTENSION|PROPHYLAXIS|ANTIVIRAL PROPHYLAXIS|CARDIOVASCULAR DISORDER|HYPERTENSION|HYPOKALAEMIA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|THROMBOSIS PROPHYLAXIS,Pulmonary oedema,1,1
12256953,20160412,Daratumumab,73,801,73.0,2,63,1,0,1,1,0,0,0,Daratumumab,RIVAROXABAN|FUROSEMIDE|DARATUMUMAB|FENTANYL|EPOETIN ALFA-EPBX|DARATUMUMAB,21,PLASMA CELL MYELOMA,Pneumonitis|Therapy non-responder,2,1
12263770,20160413,Daratumumab,7,800,70.0,2,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction|Rhinorrhoea|Swollen tongue|Dyspnoea,4,1
12263771,20160413,Daratumumab,,,,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Thrombocytopenia,1,5
12263772,20160413,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,White blood cell count decreased|Neutrophil count decreased,2,3
12263773,20160413,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Neutropenia,1,5
12263774,20160413,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Upper limb fracture|Fall|Inappropriate schedule of drug administration,3,3
12263775,20160413,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Product preparation error|Drug dose omission,2,3
12263776,20160413,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion site extravasation|Drug dose omission,2,5
12263777,20160413,Daratumumab,58,801,58.0,2,62,1,0,0,0,0,0,0,Daratumumab,ALBUTEROL SULFATE|ALBUTEROL|ACYCLOVIR|METHYLPREDNISOLONE|LEVOTHYROXINE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|PANTOPRAZOLE|DARATUMUMAB|CALCITRIOL|CALCITRIOL CAPSULES 0.25 MCG|CALCITRIOL CAPSULES 0.5 MCG|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|OXYCODONE,13,PROPHYLAXIS|PREMEDICATION|PREMEDICATION|PLASMA CELL MYELOMA,Respiratory rate increased|Heart rate increased|Sinusitis,3,2
12263778,20160413,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Dysgeusia|Ageusia,2,5
12263779,20160413,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Underdose|Infusion related reaction|Expired product administered,3,2
12263780,20160413,Daratumumab,,,,1,73,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Vomiting|Product preparation error|Infusion related reaction,3,3
12263785,20160413,Daratumumab,,,,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Pneumonia,1,5
12263786,20160413,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction|Dysphonia|Restless legs syndrome|Secretion discharge,4,5
12263792,20160413,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Nasopharyngitis|Dysphonia,2,5
12263794,20160413,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Product preparation error,1,3
12263800,20160413,Daratumumab,6,800,60.0,2,,1,0,1,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Wheezing|Infusion related reaction,3,5
12263801,20160413,Daratumumab,,,,2,,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,2,PRODUCT USED FOR UNKNOWN INDICATION|PREMEDICATION,Respiratory disorder|Underdose|Infusion related reaction|Tachycardia,4,2
12263802,20160413,Daratumumab,77,801,77.0,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Blood alkaline phosphatase increased|Alanine aminotransferase increased|Aspartate aminotransferase increased,3,2
12263803,20160413,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Throat tightness|Cough|Sneezing|Sinus congestion|Dysphonia|Infusion related reaction|Lacrimation increased,7,3
12263812,20160413,Daratumumab,62,801,62.0,1,,1,0,0,0,0,0,1,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|POMALIDOMIDE|DARATUMUMAB,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Adverse drug reaction|Drug dose omission|Pneumonia|Cough,4,5
12263813,20160413,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|POMALIDOMIDE,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Pneumonia|Respiratory tract congestion|Limb discomfort,3,5
12263815,20160413,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA,Product preparation error|Blood glucose abnormal|Product container issue|Adverse drug reaction|Adverse event,5,2
12263816,20160413,Daratumumab,71,801,71.0,2,89.6,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB|GLIMEPIRIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|DARATUMUMAB|GABAPENTIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|MONTELUKAST SODIUM|WARFARIN|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|CETIRIZINE HYDROCHLORIDE|LEVOTHYROXINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|MONTELUKAST|ACYCLOVIR|SOTALOL HYDROCHLORIDE|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|DILTIAZEM HYDROCHLORIDE,21,PLASMA CELL MYELOMA|PREMEDICATION|PLASMA CELL MYELOMA|PREMEDICATION|PROPHYLAXIS|PREMEDICATION,Infusion related reaction,1,2
12263817,20160413,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Product preparation error,1,3
12263818,20160413,Daratumumab,83,801,83.0,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Inappropriate schedule of drug administration,1,3
12263819,20160413,Daratumumab,,,,2,70.31,1,0,0,0,0,0,1,Daratumumab,BORTEZOMIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|PREDNISONE|POMALIDOMIDE,8,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PROPHYLAXIS,Back pain|Musculoskeletal chest pain,2,1
12263820,20160413,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Medication error,1,2
12263821,20160413,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion site extravasation,1,2
12263826,20160413,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Drug dose omission|Inappropriate schedule of drug administration,2,5
12263827,20160413,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Inappropriate schedule of drug administration|Product label confusion,2,1
12263904,20160413,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Tachycardia|Nausea|Vomiting,3,3
12263905,20160413,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Underdose,1,5
12263911,20160413,Daratumumab,76,801,76.0,1,83.92,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB|DARATUMUMAB|DARATUMUMAB|DARATUMUMAB,4,PLASMA CELL MYELOMA|PLASMACYTOMA|PLASMACYTOMA|PLASMA CELL MYELOMA,Chest discomfort|Diarrhoea|Pain|Pruritus|Musculoskeletal chest pain|Cough|Fatigue|Insomnia|Myalgia|Nausea|Infusion related reaction|Swelling|Nasal congestion|Chest pain,14,3
12263914,20160413,Daratumumab,,,,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Anaemia|Thrombocytopenia|Drug ineffective,3,1
12263921,20160413,Daratumumab,62,801,62.0,1,109,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB,2,PLASMA CELL MYELOMA,Pneumonia|Blood beta-D-glucan increased,2,2
12263923,20160413,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Anaemia|Thrombocytopenia|Neutropenia,3,2
12263925,20160413,Daratumumab,,,,2,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Neutropenia,1,2
12263926,20160413,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Thrombocytopenia|Neutropenia,2,2
12263927,20160413,Daratumumab,,,,2,,1,0,0,0,0,0,1,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB|POMALIDOMIDE,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Neutropenia,1,2
12263928,20160413,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction|Incorrect dose administered|Product preparation error,3,5
12263934,20160413,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Adverse event|Insomnia,2,5
12263935,20160413,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Inappropriate schedule of drug administration,1,2
12263937,20160413,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Platelet count decreased,1,5
12263938,20160413,Daratumumab,,,,2,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Thrombocytopenia,1,2
12265861,20160413,Daratumumab,67,801,67.0,2,62,1,0,1,0,0,0,0,Daratumumab,PREDNISONE|DARATUMUMAB|OSELTAMIVIR PHOSPHATE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|MELPHALAN HYDROCHLORIDE|MELPHALAN|ACYCLOVIR|BORTEZOMIB|PREDNISONE|MELPHALAN HYDROCHLORIDE|MELPHALAN|ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|GABAPENTIN|BORTEZOMIB|GABAPENTIN|AMOXICILLIN AND CLAVULANATE POTASSIUM|BORTEZOMIB,33,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|NEURALGIA|BACK PAIN|SLEEP DISORDER THERAPY|CONSTIPATION|PYREXIA|INFECTION PROPHYLAXIS|PROPHYLAXIS|OEDEMA PERIPHERAL|DERMO-HYPODERMITIS|PLASMA CELL MYELOMA|BACK PAIN|ANTIVIRAL PROPHYLAXIS|PYREXIA|PLASMA CELL MYELOMA|PYREXIA|BACK PAIN|GASTROINTESTINAL DISORDER THERAPY|NEURALGIA|BACK PAIN|DERMO-HYPODERMITIS|NEURALGIA|THROMBOSIS PROPHYLAXIS,Oedema peripheral|Dermo-hypodermitis|Neuralgia|Constipation|Diarrhoea|H1N1 influenza,6,1
12268894,20160414,Daratumumab,60,801,60.0,1,71,1,0,1,0,0,0,0,Daratumumab,DARATUMUMAB|DALTEPARIN SODIUM|AMOXICILLIN|PANTOPRAZOLE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DALTEPARIN SODIUM|FUROSEMIDE|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|PREDNISONE,15,PLASMA CELL MYELOMA|PULMONARY EMBOLISM|PHARYNGITIS|VIRAL INFECTION|CHRONIC GASTRITIS|PLASMA CELL MYELOMA|PULMONARY EMBOLISM|HYPERCHOLESTEROLAEMIA|SWELLING|FUNGAL INFECTION|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|HYPERTROPHIC CARDIOMYOPATHY|PLASMA CELL MYELOMA,Neutropenia|Pneumonia|Oedema peripheral,3,1
12269351,20160414,Daratumumab,,,,1,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,3
12269456,20160414,Daratumumab,,,,1,,1,0,0,0,0,0,1,Daratumumab,LENALIDOMIDE|LENALIDOMIDE|ACYCLOVIR|LENALIDOMIDE|LENALIDOMIDE|LENALIDOMIDE|DARATUMUMAB|SULFAMETHOXAZOLE AND TRIMETHOPRIM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ERGOCALCIFEROL|OXYCODONE HYDROCHLORIDE|LENALIDOMIDE|LOSARTAN POTASSIUM|LOSARTAN,15,PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Blood test abnormal|Pulmonary mass,2,3
12272368,20160415,Daratumumab,79,801,79.0,2,76,1,0,1,0,0,0,0,Daratumumab,MELPHALAN HYDROCHLORIDE|MELPHALAN|MELPHALAN HYDROCHLORIDE|MELPHALAN|DOXAZOSIN|DOXAZOSIN MESYLATE|DARATUMUMAB|BORTEZOMIB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|LANSOPRAZOLE|FUROSEMIDE|DARATUMUMAB|AMLODIPINE|ALLOPURINOL|BORTEZOMIB|MELPHALAN HYDROCHLORIDE|MELPHALAN|LACTULOSE|CLARITHROMYCIN,23,PLASMA CELL MYELOMA|PNEUMONIA|PLASMA CELL MYELOMA|HYPERTENSION|HYPERTENSION|PLASMA CELL MYELOMA|ARTHRALGIA|PLASMA CELL MYELOMA|ARTHRALGIA|HYPERTENSION|PLASMA CELL MYELOMA|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|OEDEMA PERIPHERAL|PLASMA CELL MYELOMA|PROPHYLAXIS|IRON DEFICIENCY|HYPERTENSION|GOUT|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|CONSTIPATION|PNEUMONIA|PROPHYLAXIS,Sepsis|Arthralgia,2,1
12274456,20160415,Daratumumab,,,,2,,1,1,0,0,0,0,1,Daratumumab,DARATUMUMAB|BORTEZOMIB|CARFILZOMIB,3,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Clostridium difficile infection,1,5
12276315,20160418,Daratumumab,45,801,45.0,1,84,1,0,1,0,0,0,0,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BORTEZOMIB|DARATUMUMAB|THALIDOMIDE|DARATUMUMAB,5,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Drug reaction with eosinophilia and systemic symptoms,1,1
12276317,20160418,Daratumumab,57,801,57.0,1,88,1,1,1,1,0,0,1,Daratumumab,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LOVASTATIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL|DARATUMUMAB|LEVOTHYROXINE SODIUM|INSULIN GLARGINE|OMEPRAZOLE MAGNESIUM|ACYCLOVIR|METOPROLOL TARTRATE|METOPROLOL,12,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Cerebrovascular accident|Ejection fraction decreased,2,1
12278458,20160418,Daratumumab,,,,0,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death|Cardiac disorder,2,1
12278459,20160418,Daratumumab,,,,0,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
12279957,20160418,Daratumumab,45,801,45.0,1,84,1,0,1,0,0,0,0,Daratumumab,BORTEZOMIB|THALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DARATUMUMAB,6,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|DRY EYE|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|THROMBOSIS PROPHYLAXIS,Drug reaction with eosinophilia and systemic symptoms,1,1
12282182,20160419,Daratumumab,94,801,94.0,2,,1,1,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death|Adverse event,2,5
12282862,20160419,Daratumumab,,,,2,77.63,1,0,0,0,0,0,0,Daratumumab,"CARFILZOMIB|DARATUMUMAB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|POMALIDOMIDE|ATOVAQUONE|ATOVAQUONE ORAL SUSPENSION|POMALIDOMIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|POMALIDOMIDE|LORAZEPAM|AMLODIPINE BESYLATE|ACYCLOVIR",16,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Drug ineffective|Laboratory test abnormal,2,3
12284303,20160420,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Headache|Infusion related reaction,2,5
12284304,20160420,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Respiratory tract congestion|Infusion related reaction|Erythema,3,5
12284305,20160420,Daratumumab,56,801,56.0,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|DARATUMUMAB,2,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA,Infusion related reaction|Cough,2,3
12284306,20160420,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia,1,1
12284318,20160420,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction|Muscle twitching|Headache|Pain|Nausea|Chills,6,3
12284319,20160420,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction,1,3
12284328,20160420,Daratumumab,,,,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Flushing|Infusion related reaction,2,3
12284329,20160420,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Sneezing|Infusion related reaction,2,3
12284340,20160420,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Infusion related reaction|Hypersensitivity,2,3
12284341,20160420,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Platelet count decreased,1,1
12284342,20160420,Daratumumab,,,,0,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Hypersensitivity|Infusion related reaction,2,1
12284343,20160420,Daratumumab,,,,1,,1,0,1,1,0,0,1,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction,1,5
12284350,20160420,Daratumumab,62,801,62.0,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB|POMALIDOMIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,PLASMA CELL MYELOMA,Drug dose omission|Influenza,2,5
12284351,20160420,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Cough|Rhinorrhoea|Lacrimation increased|Sneezing|Infusion related reaction,5,5
12284354,20160420,Daratumumab,,,,2,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Infusion related reaction|Nausea|Underdose,3,3
12284355,20160420,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Underdose,1,3
12284356,20160420,Daratumumab,66,801,66.0,1,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PLASMA CELL MYELOMA,Wrong technique in product usage process|Underdose,2,3
12284359,20160420,Daratumumab,45,801,45.0,2,,1,0,0,0,0,0,1,Daratumumab,DARATUMUMAB|FILGRASTIM,2,PLASMA CELL MYELOMA,Neutrophil count decreased,1,2
12284360,20160420,Daratumumab,,,,0,,1,0,0,0,0,0,0,Daratumumab,DARATUMUMAB,1,PRODUCT USED FOR UNKNOWN INDICATION,Urticaria|Hypersensitivity|Infusion related reaction,3,2
10003612,20140312,Imatinib,,,,2,,1,1,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,GASTROINTESTINAL STROMAL TUMOUR,Death|Pleural effusion|Blister|Hypothyroidism|Blood potassium decreased|Anaemia|Nausea|Vomiting|Constipation|Blood pressure increased|Fluid retention|Pollakiuria|Local swelling|Joint swelling|Swelling,15,5
10003910,20140312,Imatinib,89,801,89.0,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10003970,20140312,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB,1,CHRONIC MYELOID LEUKAEMIA,Breast cancer|Second primary malignancy|Metastases to pleura|Metastases to lymph nodes,4,3
10004100,20140312,Imatinib,69,801,69.0,2,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10004141,20140312,Imatinib,,,,1,76,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,GASTRIC CANCER,Hepatic lesion|Malignant neoplasm progression|Gastric cancer|Product use issue,4,3
10004155,20140312,Imatinib,62,801,62.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10004248,20140312,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,,Fear of death|Depression,2,5
10004912,20140312,Imatinib,,,,2,,1,0,0,0,1,0,1,Imatinib,IMATINIB MESYLATE,1,,Movement disorder|Metastasis|Disease progression,3,3
10004956,20140312,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Death,1,3
10005805,20140313,Imatinib,78,801,78.0,2,,1,0,0,0,0,0,1,Imatinib,DASATINIB|IMATINIB MESYLATE,2,ACUTE LYMPHOCYTIC LEUKAEMIA,Yellow skin|Ocular icterus|Fall|Periorbital contusion|Mass|Head injury|CSF test abnormal|Nausea|Fatigue|Bone pain,10,5
10006082,20140313,Imatinib,68,801,68.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,5
10006085,20140313,Imatinib,65,801,65.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10006086,20140313,Imatinib,17,801,17.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10006146,20140313,Imatinib,60,801,60.0,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE|AMLODIPINE BESYLATE|SORAFENIB|CAPECITABINE,8,HEPATIC CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Off label use|Death,2,5
10007919,20140313,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,COLON CANCER|GASTRIC CANCER,Bladder neoplasm|Toxicity to various agents,2,5
10007961,20140313,Imatinib,45,801,45.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Muscular weakness|Malnutrition,2,3
10008063,20140313,Imatinib,88,801,88.0,2,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,GASTROINTESTINAL STROMAL TUMOUR,Fall,1,5
10010080,20140312,Imatinib,,,,1,,1,0,0,0,0,0,0,Imatinib,RUXOLITINIB|IMATINIB MESYLATE,2,,Mouth ulceration,1,1
10011603,20140314,Imatinib,36,801,36.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB|METHOTREXATE|METHOTREXATE SODIUM|BUSULFAN,5,CHRONIC MYELOID LEUKAEMIA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE,Chronic graft versus host disease|Leukaemia recurrent|Chronic myeloid leukaemia|Drug ineffective,4,3
10011606,20140314,Imatinib,50,801,50.0,2,,1,0,0,0,0,0,1,Imatinib,"IMATINIB|METHOTREXATE|METHOTREXATE SODIUM|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",5,CHRONIC MYELOID LEUKAEMIA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE,Leukaemia recurrent|Acute graft versus host disease|Chronic graft versus host disease|Chronic myeloid leukaemia|Drug ineffective,5,3
10011609,20140314,Imatinib,44,801,44.0,2,,1,0,0,0,0,0,1,Imatinib,"IMATINIB|METHOTREXATE|METHOTREXATE SODIUM|BUSULFAN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",5,CHRONIC MYELOID LEUKAEMIA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE,Leukaemia recurrent|Acute graft versus host disease|Chronic graft versus host disease|Chronic myeloid leukaemia|Drug ineffective,5,3
10011657,20140314,Imatinib,59,801,59.0,1,,1,0,0,0,0,0,1,Imatinib,MELPHALAN HYDROCHLORIDE|MELPHALAN|FLUDARABINE PHOSPHATE|DASATINIB|NILOTINIB,6,CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Malignant neoplasm progression|Platelet count decreased|Haemophagocytic lymphohistiocytosis|Blood bilirubin increased|Drug intolerance|Platelet count decreased|Hepatic function abnormal|Blood glucose increased|Lipase increased|Graft versus host disease|Drug resistance|Blood cholesterol increased,12,3
10011694,20140314,Imatinib,,,,1,99.77,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Nephrolithiasis|Ureteric obstruction,2,5
10011932,20140314,Imatinib,55,801,55.0,2,,1,0,0,0,0,0,1,Imatinib,NILOTINIB|NILOTINIB,3,CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Fatigue|Cyst|Ear pain|Pain in extremity|Blood bilirubin increased,5,5
10011947,20140314,Imatinib,61,801,61.0,2,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Malnutrition,1,5
10011952,20140314,Imatinib,,,,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10012340,20140314,Imatinib,39,801,39.0,1,,1,0,0,0,0,0,1,Imatinib,"IMATINIB|METHOTREXATE|METHOTREXATE SODIUM|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",4,CHRONIC MYELOID LEUKAEMIA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE,Leukaemia recurrent|Chronic graft versus host disease|Chronic myeloid leukaemia|Drug ineffective,4,3
10012364,20140314,Imatinib,41,801,41.0,1,,1,0,0,0,0,0,1,Imatinib,"IMATINIB|METHOTREXATE|METHOTREXATE SODIUM|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",5,CHRONIC MYELOID LEUKAEMIA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE,Leukaemia recurrent|Acute graft versus host disease|Chronic graft versus host disease|Chronic myeloid leukaemia|Drug ineffective,5,3
10014837,20140317,Imatinib,37,801,37.0,1,,1,0,0,0,0,0,1,Imatinib,DASATINIB|DASATINIB,7,CHRONIC MYELOID LEUKAEMIA TRANSFORMATION|CHRONIC MYELOID LEUKAEMIA (IN REMISSION)|CHRONIC MYELOID LEUKAEMIA TRANSFORMATION|CHRONIC MYELOID LEUKAEMIA,Intestinal obstruction|Chronic graft versus host disease in skin|Pancytopenia|Drug ineffective|Gastrointestinal haemorrhage|Pancreatitis|Enteritis infectious,7,3
10016354,20140317,Imatinib,57,801,57.0,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB,2,CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Splenomegaly|Blast crisis in myelogenous leukaemia|Chronic myeloid leukaemia transformation|Lymphadenopathy|Lethargy|Abdominal pain,6,3
10016456,20140317,Imatinib,40,801,40.0,2,,1,1,0,0,0,0,1,Imatinib,"IMATINIB|METHOTREXATE|METHOTREXATE SODIUM|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",4,CHRONIC MYELOID LEUKAEMIA|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE,Blast crisis in myelogenous leukaemia|Acute graft versus host disease|Chronic graft versus host disease|Chronic myeloid leukaemia|Leukaemia recurrent,5,3
10016580,20140317,Imatinib,,,,2,153,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE|LEVOTHYROXINE SODIUM|ENALAPRIL|AMLODIPINE|MAGNESIUM|OMEPRAZOLE MAGNESIUM|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|METOPROLOL TARTRATE|METOPROLOL|FERROUS SULFATE,10,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10018352,20140318,Imatinib,65,801,65.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10021539,20140319,Imatinib,,,,1,,1,0,0,0,0,0,0,Imatinib,NILOTINIB|DASATINIB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA,Gene mutation identification test positive|White blood cell count increased|Drug resistance,3,5
10025362,20140320,Imatinib,,,,0,,1,1,0,0,0,0,1,Imatinib,IMATINIB,1,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,Death|Acute lymphocytic leukaemia recurrent,2,3
10025701,20140320,Imatinib,,,,0,,1,1,0,0,0,0,1,Imatinib,IMATINIB,1,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,Death|Acute lymphocytic leukaemia recurrent,2,3
10026717,20140321,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,AMLODIPINE|FUROSEMIDE|RAMIPRIL|LOSARTAN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|IMATINIB|LETROZOLE|LETROZOLE TABLETS,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Thrombocytosis,1,1
10027687,20140321,Imatinib,21,801,21.0,2,,1,0,1,0,1,0,1,Imatinib,MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|CYCLOSPORINE|MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|BUSULFAN|CYCLOSPORINE|METHOTREXATE|METHOTREXATE SODIUM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|FLUDARABINE PHOSPHATE,22,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|CHRONIC MYELOID LEUKAEMIA|BONE MARROW CONDITIONING REGIMEN|PRODUCT USED FOR UNKNOWN INDICATION|BONE MARROW CONDITIONING REGIMEN|STEM CELL TRANSPLANT|PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE|GRAFT VERSUS HOST DISEASE|BONE MARROW CONDITIONING REGIMEN,Posterior reversible encephalopathy syndrome|Sclerema|Status epilepticus|Drug ineffective|Philadelphia chromosome positive|Oedema|Joint contracture,7,
10029250,20140321,Imatinib,60,801,60.0,1,,1,0,1,0,0,0,1,Imatinib,IMATINIB,1,CHRONIC MYELOID LEUKAEMIA,Pneumonia klebsiella|Hydronephrosis|Haemoptysis|Cough|Sepsis|Disseminated intravascular coagulation|Renal failure acute|Bladder transitional cell carcinoma|Concomitant disease progression|Bone marrow disorder|Pancytopenia,11,3
10029277,20140321,Imatinib,79,801,79.0,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,5
10029415,20140322,Imatinib,,,,0,,1,1,0,0,0,0,1,Imatinib,IMATINIB,1,ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT,Death|Acute lymphocytic leukaemia recurrent,2,3
10029424,20140322,Imatinib,52,801,52.0,1,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Aneurysm,1,5
10029436,20140322,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,THALIDOMIDE|IMATINIB,4,IMMUNOSUPPRESSION|PLASMA CELL MYELOMA,Scleroderma|Chronic graft versus host disease|Restrictive pulmonary disease|Joint range of motion decreased,4,3
10031977,20140324,Imatinib,,,,1,,1,0,1,0,0,0,0,Imatinib,RAMIPRIL,2,HYPERTENSION|GASTROINTESTINAL STROMAL TUMOUR,Renal colic|Abdominal pain|Nephrolithiasis,3,1
10032280,20140324,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,,Rib fracture,1,1
10034224,20140324,Imatinib,68,801,68.0,2,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE|SIMVASTATIN|FUROSEMIDE|NIACIN|CALCIUM|VITAMIN|PREDNISONE|CLOPIDOGREL,10,,Cerebrovascular accident,1,
10036465,20140326,Imatinib,59,801,59.0,1,86,1,0,1,0,0,0,0,Imatinib,,14,GASTRIC ULCER|PROPHYLAXIS|DIARRHOEA|VENTRICULAR EXTRASYSTOLES|PRODUCT USED FOR UNKNOWN INDICATION|EYE DISCHARGE|EYELID PTOSIS|THYROID HORMONE REPLACEMENT THERAPY|CHRONIC MYELOID LEUKAEMIA|GASTRIC ULCER|INTERVERTEBRAL DISC PROTRUSION|CONJUNCTIVAL HAEMORRHAGE,Skin erosion|Conjunctival haemorrhage|Conjunctival hyperaemia|Back pain|Dyspepsia|Gastroenteritis|Epigastric discomfort|Eyelid oedema|Eye discharge|Eczema asteatotic|Hypertrophic cardiomyopathy|Diarrhoea|Nasopharyngitis|Gastroenteritis|Renal impairment|Epigastric discomfort|Ventricular extrasystoles|Gastric ulcer|Diarrhoea|Nasopharyngitis|Diarrhoea|Retinal tear|Diarrhoea|Haemorrhoids|External ear inflammation|Seasonal allergy|Diarrhoea|Nasopharyngitis|Nasopharyngitis|Intervertebral disc protrusion|Chronic gastritis|Influenza|Dental caries,33,3
10036466,20140326,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,GABAPENTIN|SIMVASTATIN|IMATINIB MESYLATE,5,,Limb discomfort,1,5
10038689,20140326,Imatinib,57,801,57.0,1,117,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|FISH OIL|FISH OIL|HYDROCHLOROTHIAZIDE|SITAGLIPTIN,7,RECTOSIGMOID CANCER,Death,1,5
10039097,20140326,Imatinib,64,801,64.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB|IMATINIB|IMATINIB|IMATINIB|IMATINIB|IMATINIB,6,GASTROINTESTINAL STROMAL TUMOUR|METASTASES TO LIVER,Gastrointestinal stromal tumour|Neoplasm recurrence|Malignant neoplasm progression|Oedema|Generalised erythema,5,3
10039215,20140326,Imatinib,32,801,32.0,1,,1,0,0,0,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Lower limb fracture|Accident|Cytogenetic analysis abnormal,3,5
10039235,20140326,Imatinib,30,801,30.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10039291,20140326,Imatinib,4,801,4.0,2,,1,0,1,0,0,0,0,Imatinib,IMATINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,5,ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA,Pneumatosis intestinalis|Stomatitis|Diarrhoea|Abdominal pain|Abdominal distension|Neutropenia,6,3
10039377,20140326,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE,4,CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Nausea|Vomiting|Dyspnoea|Spinal column stenosis|Abdominal discomfort|Frequent bowel movements|Increased appetite|Polyp|Disturbance in attention|Stress|Diarrhoea|Fatigue|Headache|Influenza like illness|Influenza|Migraine|Muscle spasms|Cough|Food allergy|Dysgeusia|Decreased appetite|Gastrointestinal disorder,22,5
10040530,20140327,Imatinib,43,801,43.0,1,,1,1,1,0,0,0,0,Imatinib,"BOSENTAN|EPOPROSTENOL|SILDENAFIL CITRATE|SILDENAFIL|SILDENAFIL POWDER,|IMATINIB|IMATINIB",5,PULMONARY ARTERIAL HYPERTENSION|PULMONARY ARTERIAL HYPERTENSION|PULMONARY ARTERIAL HYPERTENSION|PULMONARY ARTERIAL HYPERTENSION,Right ventricular failure|Pulmonary oedema|Oxygen saturation decreased|Dyspnoea|Brain natriuretic peptide increased,5,1
10041147,20140327,Imatinib,57,801,57.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|CLOPIDOGREL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,4,CHRONIC MYELOID LEUKAEMIA,Cerebrovascular accident|Muscular weakness|Asthenia|Alopecia|Myalgia|Arthralgia|Weight decreased|Diarrhoea,8,5
10042448,20140327,Imatinib,64,801,64.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10042507,20140327,Imatinib,12,801,12.0,2,33.4,1,0,1,0,0,0,0,Imatinib,LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|GABAPENTIN|ZONISAMIDE|MULTIVITAMIN|ALBUTEROL SULFATE|ALBUTEROL,9,SEIZURE|NAUSEA|PAIN|DYSPNOEA|SEIZURE|PRODUCT USED FOR UNKNOWN INDICATION|DYSPNOEA|SEIZURE|NEUROFIBROMA,Liver function test abnormal,1,3
10043282,20140328,Imatinib,74,801,74.0,1,,1,0,0,0,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Neoplasm skin|Rectal polyp|Erythema|Blood iron decreased|Second primary malignancy|Serum ferritin decreased|Frequent bowel movements|Colon adenoma|Precancerous cells present|Haematochezia|Colon dysplasia|Polyp|Diverticulum intestinal|Large intestine polyp,14,5
10044695,20140328,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Typhoid fever,1,1
10044951,20140328,Imatinib,46,801,46.0,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB|IMATINIB,4,CHRONIC MYELOID LEUKAEMIA,Haematotoxicity|Anaemia|Thrombocytopenia,3,
10045139,20140328,Imatinib,71,801,71.0,1,,1,0,1,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE|LINAGLIPTIN|IMATINIB MESYLATE|IMATINIB MESYLATE|DASATINIB|IMATINIB MESYLATE|RAMIPRIL|IMATINIB MESYLATE|ATORVASTATIN CALCIUM|IMATINIB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|GLYBURIDE,19,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BLOOD CHOLESTEROL INCREASED|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|DIABETES MELLITUS|PRODUCT USED FOR UNKNOWN INDICATION,Internal haemorrhage|Glaucoma|Gait disturbance|Headache|Hypoaesthesia|Cataract|Haemoglobin decreased|Diabetes mellitus|Gastrointestinal infection|Pain in extremity|Blood glucose increased|Blood iron decreased|Feeling abnormal|Blindness|Nausea|Malaise|Asthenia|Paraesthesia|Diarrhoea|Pain|Anaemia|Gastric antral vascular ectasia|Haematochezia|Dyspnoea|Chest pain|Muscle spasms|Myalgia|Pain|Fall|Chills|Fatigue,31,5
10046809,20140331,Imatinib,63,801,63.0,2,,1,0,1,0,1,0,0,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|METOPROLOL TARTRATE|METOPROLOL|GABAPENTIN|DULOXETINE HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ERGOCALCIFEROL,10,OESOPHAGEAL CARCINOMA|GASTROINTESTINAL STROMAL TUMOUR,Fall|Mobility decreased|Muscular weakness|Back pain|Neck pain,5,5
10047052,20140328,Imatinib,55,801,55.0,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Rash generalised,1,2
10049643,20140401,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,2,CHRONIC MYELOID LEUKAEMIA,Tendonitis,1,1
10049651,20140401,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,LYMPHOMA|CHRONIC MYELOID LEUKAEMIA,Blindness,1,5
10049693,20140401,Imatinib,60,801,60.0,1,65,1,1,1,0,0,0,0,Imatinib,,2,ACUTE LYMPHOCYTIC LEUKAEMIA|CHROMOSOME ANALYSIS ABNORMAL,Pancytopenia|Haemodynamic instability|Pyrexia|Vomiting|Bacterial infection|Septic shock|Abdominal pain,7,5
10049696,20140401,Imatinib,,,,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Death,1,5
10049704,20140401,Imatinib,,,,1,,1,1,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,,Death,1,5
10053347,20140402,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,,1,HYPEREOSINOPHILIC SYNDROME,Macrocytosis|Bone erosion,2,1
10053704,20140402,Imatinib,57,801,57.0,1,,1,1,0,0,0,0,1,Imatinib,IMATINIB,1,GASTROINTESTINAL STROMAL TUMOUR,Death|Metastasis|Metastases to lymph nodes|Drug ineffective,4,3
10054865,20140402,Imatinib,42,801,42.0,0,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Death,1,5
10054930,20140402,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,MALIGNANT MELANOMA,Death,1,5
10054945,20140402,Imatinib,57,801,57.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB,3,CHRONIC MYELOID LEUKAEMIA,Gastric antral vascular ectasia|Gastrointestinal haemorrhage,2,3
10055864,20140403,Imatinib,56,801,56.0,1,,1,0,1,0,0,0,1,Imatinib,GEMFIBROZIL|ENALAPRIL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION,Second primary malignancy|Bladder cancer|Abdominal pain upper|Myalgia|Pyrexia|Haematuria|Drug resistance|Influenza|Drug ineffective|Abdominal pain upper,10,1
10056155,20140403,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,SOFT TISSUE SARCOMA,Second primary malignancy|Paralysis|Pancreatic carcinoma|Cerebrovascular accident,4,5
10056838,20140403,Imatinib,69,801,69.0,2,,1,1,0,0,0,0,0,Imatinib,FILGRASTIM|BOSUTINIB|BOSUTINIB|BOSUTINIB|HYDROCHLOROTHIAZIDE|HYDROXYUREA|IMATINIB|DASATINIB,9,PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Sudden death|Neutropenia|Pleural effusion|Abdominal pain|Pulmonary mass|Thrombocytopenia|Nausea,7,1
10056946,20140403,Imatinib,66,801,66.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10057582,20140404,Imatinib,53,801,53.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10058292,20140402,Imatinib,27,801,27.0,1,,1,0,1,1,0,0,1,Imatinib,MESALAMINE|IMATINIB|HYDROXYUREA,6,COLITIS ULCERATIVE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|EOSINOPHILIA,Hypereosinophilic syndrome|Diarrhoea|Weight decreased|Coagulopathy|Fatigue|Lymphadenopathy|Rash papular|Abdominal distension|Vitamin K deficiency|Exercise tolerance decreased|Mucosal inflammation|Pancytopenia|Eosinophilic myocarditis|Pulmonary hypertension|Pneumonia bacterial|Pulmonary alveolar haemorrhage|Acute respiratory failure|Haemoptysis|Neuropathy peripheral|Respiratory distress,20,1
10058447,20140404,Imatinib,61,801,61.0,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|AMLODIPINE|ATENOLOL|LOSARTAN POTASSIUM|LOSARTAN|METFORMIN HCL|CHLORTHALIDONE|LEVOTHYROXINE|TERBINAFINE HYDROCHLORIDE,10,NEOPLASM MALIGNANT|CAPILLARY LEAK SYNDROME,Drug interaction|Hypotension,2,5
10058449,20140404,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Bladder cancer|Second primary malignancy|Blood urine present|Depression,4,1
10060544,20140404,Imatinib,59,801,59.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10060546,20140404,Imatinib,58,801,58.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10060860,20140404,Imatinib,72,801,72.0,2,,1,0,0,0,0,0,0,Imatinib,ESCITALOPRAM|MACITENTAN|ISOSORBIDE DINITRATE|SPIRONOLACTONE|GEMFIBROZIL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ATORVASTATIN CALCIUM|IMATINIB MESYLATE,12,PULMONARY ARTERIAL HYPERTENSION,Ocular icterus|Nausea|Lethargy|Red blood cell count decreased|Abdominal pain upper|Vomiting|Anaemia,7,5
10063639,20140407,Imatinib,50,801,50.0,1,,1,0,0,0,0,0,1,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,Second primary malignancy|Colon cancer,2,5
10063674,20140407,Imatinib,66,801,66.0,2,,1,0,1,0,0,0,1,Imatinib,CITALOPRAM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OLANZAPINE|DIPHENHYDRAMINE HYDROCHLORIDE,11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Anxiety|Pruritus|Eructation|Eating disorder|Depression|Nasopharyngitis|Depressed mood|Vomiting|Flatulence|Head discomfort|Dry mouth|Feeling abnormal|Skin tightness|Insomnia|Dysgeusia|Fatigue|Malaise|Gait disturbance|Decreased appetite|Dizziness|Oropharyngeal pain|Burning sensation|Weight decreased|Dysphonia|Ear discomfort|Inappropriate schedule of drug administration|Viral infection|Abdominal discomfort|Diarrhoea|Asthenia|Nausea|Skin burning sensation,32,1
10063677,20140407,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,COMPLICATIONS OF BONE MARROW TRANSPLANT|GRAFT VERSUS HOST DISEASE,Mobility decreased|Skin tightness|Product use issue|Scleroderma|Skin fissures,5,1
10063698,20140407,Imatinib,65,801,65.0,2,,1,0,0,0,0,0,0,Imatinib,NILOTINIB,4,CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Dyspnoea|Rash|Electrocardiogram QT prolonged|Oedema|Palpitations|Drug intolerance|Cardiomegaly,7,1
10064635,20140407,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE,3,GASTROINTESTINAL CARCINOMA|MALIGNANT CONNECTIVE TISSUE NEOPLASM|SOFT TISSUE SARCOMA,Hypersensitivity,1,2
10065431,20140408,Imatinib,59,801,59.0,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,ACUTE LYMPHOCYTIC LEUKAEMIA,Death,1,5
10066239,20140408,Imatinib,68,801,68.0,1,,1,1,1,0,0,0,1,Imatinib,FEBUXOSTAT|FEBUXOSTAT TABLETS 40 MG|FEBUXOSTAT TABLETS 80 MG,6,GASTROINTESTINAL STROMAL TUMOUR|DISSEMINATED INTRAVASCULAR COAGULATION|GASTROINTESTINAL STROMAL TUMOUR|TUMOUR LYSIS SYNDROME,Decreased appetite|Cardiac failure|Malaise|Disseminated intravascular coagulation|Metastases to liver|Tumour lysis syndrome|Death|Drug ineffective,8,3
10066269,20140408,Imatinib,27,801,27.0,1,,1,1,0,0,0,0,1,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,Tuberculosis|No therapeutic response|Death,3,5
10066272,20140408,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,IMATINIB,1,,Lung disorder,1,1
10066436,20140408,Imatinib,72,801,72.0,2,,1,0,1,0,0,0,1,Imatinib,"IMATINIB MESYLATE|IMATINIB MESYLATE|ACETAMINOPHEN AND CODEINE|FLUTICASONE PROPIONATE AND SALMETEROL|ALPRAZOLAM|FLUOCINONIDE|FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%|KETOCONAZOLE|KETOCONAZOLE FOAM|KETOCONAZOLE CREAM, 2%|LISINOPRIL|NITROGLYCERIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OXYCODONE AND ACETAMINOPHEN|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|OXYCODONE AND ACETAMINOPHEN TABLETS|PRAVASTATIN SODIUM|PROCHLORPERAZINE MALEATE|SUMATRIPTAN SUCCINATE|ZOLPIDEM TARTRATE",23,GASTROINTESTINAL STROMAL TUMOUR|PAIN|PAIN|DIARRHOEA|PRURITUS|CHEST PAIN|MIGRAINE|INSOMNIA,Bladder cancer|Second primary malignancy|Pallor|Cystitis haemorrhagic|Intra-abdominal pressure increased|Urinary tract infection|Haematuria|Back pain|Micturition urgency|Abdominal pain|Myalgia|Anxiety|Blood pressure increased|Cerebrovascular accident|Rash,15,5
10066466,20140408,Imatinib,92,801,92.0,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10066789,20140408,Imatinib,45,801,45.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10066798,20140408,Imatinib,71,801,71.0,2,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10066804,20140408,Imatinib,39,801,39.0,1,,1,1,0,0,0,0,0,Imatinib,,1,ACUTE LYMPHOCYTIC LEUKAEMIA,Death,1,3
10066944,20140409,Imatinib,71,801,71.0,1,,1,0,1,0,0,0,1,Imatinib,ENTECAVIR,2,CHRONIC MYELOID LEUKAEMIA,Hepatitis B|Hepatitis B antigen positive|Hepatic function abnormal|Intestinal obstruction,4,5
10068673,20140409,Imatinib,58,801,58.0,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,2,NEOPLASM MALIGNANT,Fall|Spinal fracture|Insomnia,3,5
10068835,20140409,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|NILOTINIB|DASATINIB,3,CHRONIC MYELOID LEUKAEMIA,Diffuse large B-cell lymphoma|Second primary malignancy|Therapeutic response decreased,3,5
10069007,20140409,Imatinib,27,801,27.0,1,,1,1,0,0,0,0,1,Imatinib,IMATINIB|DASATINIB,2,CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Sepsis|Blast crisis in myelogenous leukaemia,2,3
10069010,20140409,Imatinib,68,801,68.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10069013,20140409,Imatinib,49,801,49.0,2,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL NEOPLASM,Death,1,3
10069014,20140409,Imatinib,67,801,67.0,1,,1,1,0,0,0,0,0,Imatinib,,2,ACUTE MYELOID LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA,Death,1,5
10069105,20140409,Imatinib,27,801,27.0,1,,1,1,0,0,0,0,1,Imatinib,IMATINIB|METHOTREXATE|METHOTREXATE SODIUM,3,CHRONIC MYELOID LEUKAEMIA,Chronic myeloid leukaemia|Blast crisis in myelogenous leukaemia|Hepatosplenomegaly|Lymphadenopathy|Central nervous system leukaemia,5,3
10070230,20140410,Imatinib,77,801,77.0,2,47,1,0,0,1,0,0,1,Imatinib,,7,NEOPLASM RECURRENCE|GASTROINTESTINAL STROMAL TUMOUR|PRODUCT USED FOR UNKNOWN INDICATION|NEUROPATHY PERIPHERAL,Vitamin K deficiency|Haemorrhagic diathesis|Food interaction|Drug level increased|Haemoglobin decreased|Purpura|Prothrombin time prolonged|Haemorrhage subcutaneous|Melaena|Subcutaneous haematoma|Prothrombin time prolonged|Genital haemorrhage|Haemorrhagic diathesis|Haemoptysis|Faeces discoloured,15,3
10070452,20140410,Imatinib,59,801,59.0,1,72,1,1,0,0,0,0,1,Imatinib,SUNITINIB MALATE,7,ADJUVANT THERAPY|GASTROINTESTINAL STROMAL TUMOUR|ASCITES|GASTROINTESTINAL STROMAL TUMOUR,Metastases to liver|Skin exfoliation|Drug ineffective|Gastrointestinal stromal tumour|Face oedema,5,3
10070853,20140410,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,BONE CANCER,Death,1,5
10070954,20140410,Imatinib,9,801,9.0,1,26.5,1,0,1,0,1,0,0,Imatinib,ETOPOSIDE|METHOTREXATE|METHOTREXATE SODIUM|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA,Renal tubular disorder|Hepatocellular injury|Amyotrophy,3,1
10071163,20140410,Imatinib,83,801,83.0,1,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR|GASTROINTESTINAL NEOPLASM,Death,1,5
10071239,20140410,Imatinib,54,801,54.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,5
10072227,20140411,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE,4,,Lung neoplasm malignant|Malaise|Cough|Swelling|Bone pain|Palpitations|Myalgia|Asthenia|Fluid retention|Rash,10,5
10072243,20140411,Imatinib,,,,1,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,CARCINOID TUMOUR OF THE APPENDIX|CHRONIC MYELOID LEUKAEMIA,Osteomyelitis|Abdominal pain upper|Decreased appetite|Renal impairment|Back pain|Infection|Weight decreased|Nausea|Vomiting,9,1
10072265,20140411,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,,Crohn^s disease|Abdominal discomfort,2,5
10072275,20140411,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Foot fracture,1,1
10073077,20140411,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|GLIPIZIDE|LOSARTAN POTASSIUM|VALSARTAN|VALSARTAN ORAL|AMLODIPINE|GLYBURIDE,9,,Diabetes mellitus|Nausea|Diarrhoea|Headache|Rash|Fatigue|Malaise,7,1
10073627,20140411,Imatinib,28,801,28.0,2,,1,0,0,0,0,0,0,Imatinib,IMATINIB|IMATINIB|IMATINIB|IMATINIB MESYLATE|IMATINIB|AMOXICILLIN|SPIRONOLACTONE|DEXTROMETHORPHAN|SPIRONOLACTONE,25,ASPIRATION BONE MARROW|CHRONIC MYELOID LEUKAEMIA|HEPATIC ENZYME ABNORMAL|COUGH|CHRONIC MYELOID LEUKAEMIA|UPPER RESPIRATORY TRACT INFECTION|NAUSEA|COUGH|UPPER RESPIRATORY TRACT INFECTION|EYELID OEDEMA,Aspartate aminotransferase increased,1,1
10074200,20140412,Imatinib,,,,1,,1,0,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,No adverse event,1,1
10076599,20140414,Imatinib,50,801,50.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10076603,20140414,Imatinib,66,801,66.0,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,LYMPHOCYTIC LEUKAEMIA,Death,1,5
10076613,20140414,Imatinib,,,,1,,1,1,0,0,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Lung infection|Chronic myeloid leukaemia|Cardiac failure,3,3
10076823,20140414,Imatinib,56,801,56.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10077151,20140414,Imatinib,65,801,65.0,2,,1,0,0,0,0,0,1,Imatinib,ALLOPURINOL|CELECOXIB|IMATINIB MESYLATE|IMATINIB MESYLATE,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA,Fatigue|Asthma|Hypophagia|Dysgeusia|Headache|Weight decreased|Visual impairment|Feeling cold|Pruritus|Influenza like illness|Impaired healing|Nausea|Arthritis|Vision blurred|Seasonal allergy|Cough|Dry skin|Lower respiratory tract infection|Arthralgia|Acrochordon,20,5
10079094,20140415,Imatinib,7,801,7.0,1,,1,0,0,0,0,0,1,Imatinib,FLUCONAZOLE|NILOTINIB|DASATINIB,4,PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Blood creatine phosphokinase increased|Joint ankylosis|Drug intolerance|Myalgia|Chest pain,5,3
10079374,20140415,Imatinib,69,801,69.0,1,,1,0,0,0,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Polyp,1,3
10079433,20140415,Imatinib,47,801,47.0,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,UTERINE CANCER,Death,1,5
10079437,20140415,Imatinib,77,801,77.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10079625,20140415,Imatinib,,,,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Neutropenic sepsis,1,5
10080323,20140415,Imatinib,,,,1,,1,1,0,0,0,0,1,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR,Metastases to lymph nodes|Gastrointestinal stromal tumour|Malignant neoplasm progression|Metastases to liver|Cardiac disorder|Pulmonary mass,6,5
10080750,20140416,Imatinib,27,801,27.0,2,50,1,0,1,0,0,0,1,Imatinib,"SILDENAFIL CITRATE|SILDENAFIL|SILDENAFIL POWDER,|SILDENAFIL CITRATE|SILDENAFIL|SILDENAFIL POWDER,|ERGOCALCIFEROL|BOSENTAN|SPIRONOLACTONE",9,PRODUCT USED FOR UNKNOWN INDICATION|SUPPLEMENTATION THERAPY|PRODUCT USED FOR UNKNOWN INDICATION|PULMONARY ARTERIAL HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Right atrial dilatation|Tricuspid valve incompetence|Palpitations|Pericardial effusion|Right ventricular hypertrophy|Presyncope|Pulmonary arterial hypertension|Condition aggravated|Dizziness|Oxygen saturation decreased,11,5
10081165,20140416,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,NEOPLASM MALIGNANT,Death,1,5
10083749,20140417,Imatinib,57,801,57.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB|FLUDARABINE PHOSPHATE|MITOXANTRONE HYDROCHLORIDE|MITOXANTRONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,5,LYMPHOMA|LYMPHOMA,Acute myeloid leukaemia|Second primary malignancy,2,3
10083866,20140417,Imatinib,55,801,55.0,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Death,1,5
10083979,20140417,Imatinib,35,801,35.0,1,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL NEOPLASM|GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10084534,20140417,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB,1,LEUKAEMIA,Tuberculosis|Cough,2,5
10086026,20140418,Imatinib,,,,1,,1,1,1,0,0,0,1,Imatinib,IMATINIB MESYLATE|NILOTINIB,3,CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Myocardial infarction|Septic shock|Infection|Brain injury|Coma|General physical health deterioration|Blast crisis in myelogenous leukaemia|Chronic myeloid leukaemia transformation|Decreased immune responsiveness|Nephrolithiasis|Pancytopenia|Malaise|Drug ineffective|White blood cell count decreased|No therapeutic response,15,5
10086029,20140418,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Death,1,5
10086420,20140417,Imatinib,62,801,62.0,1,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC LYMPHOCYTIC LEUKAEMIA,Investigation,1,3
10088005,20140420,Imatinib,36,801,36.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB|IMATINIB|IMATINIB|IMATINIB,4,GASTROINTESTINAL STROMAL TUMOUR,Musculoskeletal pain|White blood cell count decreased|Flank pain|Bone marrow failure|Intra-abdominal haemorrhage|Oedema,6,3
10088018,20140420,Imatinib,36,801,36.0,1,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR|GASTROINTESTINAL NEOPLASM,Death,1,5
10088899,20140421,Imatinib,62,801,62.0,2,66.12,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,GASTROINTESTINAL STROMAL TUMOUR|SMALL INTESTINE CARCINOMA,Intussusception|Fluid retention|Eye swelling|White blood cell count decreased|Pterygium,5,1
10088976,20140421,Imatinib,64,801,64.0,1,,1,0,1,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,HEPATIC CANCER|OFF LABEL USE,Intestinal mass|Myocardial infarction,2,5
10090258,20140421,Imatinib,68,801,68.0,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|FISH OIL|RABEPRAZOLE SODIUM|HYDROXYUREA|ALLOPURINOL,9,CHRONIC MYELOID LEUKAEMIA,Fracture|Chest pain|Dyspnoea|Hypertension|Oedema peripheral|Rash|Palpitations|White blood cell count decreased|Red blood cell count decreased|Platelet count decreased,10,1
10097212,20140422,Imatinib,42,801,42.0,1,,1,0,1,0,0,0,1,Imatinib,IMATINIB MESYLATE|LACTULOSE|ENOXAPARIN SODIUM|ESCITALOPRAM|OXYCODONE HCL|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|RIFAXIMIN|SPIRONOLACTONE|FENTANYL|ZOLPIDEM TARTRATE|BUDESONIDE|ALBUTEROL SULFATE|ALBUTEROL,18,GASTROINTESTINAL STROMAL TUMOUR|PAIN|PRURITUS,Apparent death|Hepatic encephalopathy|Portal vein thrombosis|Inguinal hernia|Cholestasis|Cholangitis|Non-alcoholic steatohepatitis|Renal failure|Fluid retention|Liver injury|Hepatic failure|Portal hypertensive gastropathy|Hydrothorax|Testicular hypertrophy|Feeling abnormal|Diarrhoea|Pain|Back pain|Blood magnesium decreased|Ascites,20,1
10097222,20140422,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR,Colon cancer|Second primary malignancy,2,2
10097227,20140422,Imatinib,69,801,69.0,2,,1,1,1,1,1,1,1,Imatinib,PACLITAXEL|PACLITAXEL,10,Acute lymphocytic leukaemia|Product used for unknown indication,Gastric cancer|Second primary malignancy|Anaemia|Hepatic function abnormal,4,2
10098317,20140423,Imatinib,71,801,71.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Loss of consciousness|Blood potassium decreased|Paraesthesia|Hyperhidrosis|Syncope,5,5
10098564,20140422,Imatinib,52,801,52.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,,Rash|Drug dose omission|Nasopharyngitis,3,3
10100908,20140423,Imatinib,41,801,41.0,1,,1,1,0,0,0,0,0,Imatinib,,1,ACUTE LYMPHOCYTIC LEUKAEMIA,Death,1,3
10101971,20140424,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,AMLODIPINE|LETROZOLE|LETROZOLE TABLETS|FUROSEMIDE|LOSARTAN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|RAMIPRIL|IMATINIB,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA,Thrombocytosis,1,1
10101986,20140424,Imatinib,72,801,72.0,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,5
10101990,20140424,Imatinib,69,801,69.0,1,,1,1,0,0,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death|Cerebral ischaemia|Hemiplegia,3,5
10102366,20140424,Imatinib,,,,1,120,1,0,1,0,0,0,1,Imatinib,IMATINIB MESYLATE|PREDNISONE|ROSUVASTATIN|FLUTICASONE PROPIONATE AND SALMETEROL|ALBUTEROL SULFATE|ALBUTEROL|METOPROLOL TARTRATE|METOPROLOL|LOSARTAN|OXYCODONE HYDROCHLORIDE|TIOTROPIUM BROMIDE|VARENICLINE TARTRATE,12,CHRONIC MYELOID LEUKAEMIA,Pleural effusion|Dyspnoea|Productive cough|Oedema peripheral|Oedema|Atelectasis|Mitral valve incompetence|Chronic obstructive pulmonary disease|Bronchitis chronic|Acute coronary syndrome|H1N1 influenza|Pneumonia|Cardiac failure congestive|Myocardial infarction|Diastolic dysfunction|Sepsis|Cholelithiasis|Hypoxia|Tachypnoea|Emotional distress|Nasopharyngitis|Anxiety,22,5
10102720,20140424,Imatinib,,,,2,,1,0,1,0,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Gastrooesophageal reflux disease|Abdominal pain upper|Feeling abnormal,3,5
10109938,20140425,Imatinib,,,,2,,1,0,1,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,NEOPLASM MALIGNANT|OFF LABEL USE,Hemiplegia|Spinal cord haemorrhage|Neoplasm recurrence,3,5
10119184,20140425,Imatinib,67,801,67.0,2,57.9,1,1,1,0,0,0,0,Imatinib,SPIRONOLACTONE|BOSENTAN|FUROSEMIDE|SILDENAFIL CITRATE,17,PULMONARY HYPERTENSION|PULMONARY HYPERTENSION|PULMONARY HYPERTENSION|PULMONARY HYPERTENSION|PULMONARY HYPERTENSION|PULMONARY HYPERTENSION|PULMONARY HYPERTENSION|PULMONARY ARTERIAL HYPERTENSION,Subdural haematoma|Loss of consciousness|Fall,3,1
10120026,20140426,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,CLOPIDOGREL|IMATINIB MESYLATE|WARFARIN,3,PRODUCT USED FOR UNKNOWN INDICATION|LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION,Epistaxis|Cerebrovascular accident|Rectal haemorrhage,3,5
10136350,20140429,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,LOSARTAN|AMLODIPINE|FUROSEMIDE|LETROZOLE|LETROZOLE TABLETS|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|RAMIPRIL|IMATINIB,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA,Thrombocytosis,1,1
10138047,20140429,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB,1,CHRONIC GRAFT VERSUS HOST DISEASE,Arteriospasm coronary,1,5
10140054,20140429,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,LETROZOLE|LETROZOLE TABLETS|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|AMLODIPINE|FUROSEMIDE|LOSARTAN|RAMIPRIL|IMATINIB,10,METASTATIC PAIN|CHRONIC MYELOID LEUKAEMIA,Thrombocytosis,1,3
10140185,20140429,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,METFORMIN HCL|RAMIPRIL|LOSARTAN|FUROSEMIDE|LETROZOLE|LETROZOLE TABLETS|IMATINIB,10,METASTATIC PAIN|CHRONIC MYELOID LEUKAEMIA,Thrombocytosis,1,1
10140763,20140429,Imatinib,79,801,79.0,2,,1,1,0,0,0,0,1,Imatinib,NIFEDIPINE|AMPHOTERICIN B|NILOTINIB,5,HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION,Drug tolerance|Hepatic function abnormal|Blood creatine phosphokinase increased|Drug ineffective|Pyrexia|Chills|Oedema peripheral|White blood cell count increased|Acute respiratory failure|Circulatory collapse|Diarrhoea|Therapeutic response decreased|Hyperkalaemia|Malaise,14,1
10141722,20140429,Imatinib,,,,1,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Acute lymphocytic leukaemia,1,5
10142024,20140429,Imatinib,84,801,84.0,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10142220,20140429,Imatinib,67,801,67.0,1,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,GASTRIC CANCER,Cerebrovascular accident|Movement disorder|Blindness|Visual field defect|Hypersomnia|Hypoaesthesia|Tunnel vision,7,5
10142241,20140429,Imatinib,85,801,85.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10142270,20140429,Imatinib,71,801,71.0,2,,1,0,0,0,0,0,1,Imatinib,"IMATINIB MESYLATE|AMLODIPINE|LEVOTHYROXINE SODIUM|CONJUGATED ESTROGENS|ESTROGENS, CONJUGATED",4,CHRONIC MYELOID LEUKAEMIA,Fall|Musculoskeletal chest pain,2,5
10142315,20140429,Imatinib,25,801,25.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10142363,20140429,Imatinib,35,803,0.67,0,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,,Premature baby|Foetal exposure during pregnancy|Low birth weight baby,3,1
10145762,20140501,Imatinib,29,801,29.0,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB|ISONIAZID,3,CHRONIC MYELOID LEUKAEMIA|PULMONARY TUBERCULOSIS|PULMONARY TUBERCULOSIS,Drug level increased|Drug interaction|Drug resistance,3,3
10145832,20140430,Imatinib,60,801,60.0,2,,1,0,1,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Anaemia,1,5
10146047,20140501,Imatinib,15,801,15.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10146369,20140501,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,FUROSEMIDE|AMLODIPINE|LETROZOLE|LETROZOLE TABLETS|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|RAMIPRIL|IMATINIB MESYLATE|IMATINIB,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA,Thrombocytosis,1,1
10147131,20140501,Imatinib,,,,2,,1,1,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,GASTRIC CANCER|SOFT TISSUE SARCOMA,Intestinal obstruction|Post procedural complication|Sepsis,3,5
10148875,20140502,Imatinib,76,801,76.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,4,PRODUCT USED FOR UNKNOWN INDICATION|OSTEOPOROSIS|CHRONIC MYELOID LEUKAEMIA,Vision blurred|Muscle spasms|Mobility decreased|Myalgia|Headache|Photosensitivity reaction|Nausea|Blood pressure increased|Osteoporosis|Weight increased|Diarrhoea|Malaise|Head discomfort|Nasal obstruction,14,5
10148991,20140502,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,METFORMIN HCL|AMLODIPINE|LOSARTAN|RAMIPRIL|LETROZOLE|LETROZOLE TABLETS|FUROSEMIDE,10,METASTATIC PAIN|CHRONIC MYELOID LEUKAEMIA,Thrombocytosis,1,5
10149532,20140502,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,,Neoplasm malignant|Pain,2,5
10149545,20140430,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,AMLODIPINE|FUROSEMIDE|LOSARTAN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|RAMIPRIL|LETROZOLE|LETROZOLE TABLETS,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC PAIN|PRODUCT USED FOR UNKNOWN INDICATION,Thrombocytosis,1,1
10150945,20140502,Imatinib,,,,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10151096,20140502,Imatinib,51,801,51.0,1,,1,0,0,0,0,0,1,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR,Malignant neoplasm progression|Gastrointestinal stromal tumour,2,5
10152022,20140505,Imatinib,48,801,48.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|LISINOPRIL,3,CHRONIC MYELOID LEUKAEMIA,Blister|Rash generalised|Erythema|Pain in extremity,4,5
10152243,20140505,Imatinib,69,801,69.0,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB|IMATINIB,2,GASTROINTESTINAL STROMAL TUMOUR,Pulmonary embolism|Diarrhoea|Decreased appetite,3,1
10152375,20140505,Imatinib,82,801,82.0,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE|NILOTINIB,2,CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Death,1,5
10152659,20140505,Imatinib,,,,0,,1,0,1,1,0,0,0,Imatinib,IMATINIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|RANITIDINE,3,ACUTE LYMPHOCYTIC LEUKAEMIA,Gastric ulcer|Gastric ulcer haemorrhage,2,1
10153022,20140505,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,FUROSEMIDE|LETROZOLE|LETROZOLE TABLETS|LOSARTAN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|RAMIPRIL|AMLODIPINE|IMATINIB,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC PAIN|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA,Thrombocytosis,1,1
10153316,20140505,Imatinib,47,801,47.0,1,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE|LISINOPRIL,2,CHRONIC MYELOID LEUKAEMIA,Acute respiratory distress syndrome|Pneumonia,2,5
10153645,20140505,Imatinib,96,801,96.0,1,85,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Colon cancer,1,3
10155061,20140506,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,,Femur fracture|Impaired healing|Pain|Insomnia,4,1
10155320,20140506,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,GASTROINTESTINAL CARCINOMA,Lung disorder|Cardiac failure,2,5
10155763,20140506,Imatinib,38,801,38.0,1,75,1,1,1,0,0,0,1,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,Neutropenia|Dyspnoea|Malignant neoplasm progression|Leukaemia recurrent|Cardio-respiratory arrest|Acute lymphocytic leukaemia|Second primary malignancy|Chronic myeloid leukaemia|Peritoneal haemorrhage|Appendicitis perforated|Pyrexia|Gastrointestinal oedema,12,5
10155907,20140506,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|AMLODIPINE|FUROSEMIDE|RAMIPRIL|LOSARTAN|IMATINIB|LETROZOLE|LETROZOLE TABLETS,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION,Thrombocytosis,1,3
10155909,20140506,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,AMLODIPINE|FUROSEMIDE|LETROZOLE|LETROZOLE TABLETS|LOSARTAN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|RAMIPRIL|IMATINIB,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA,Thrombocytosis,1,3
10156140,20140506,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Small cell lung cancer recurrent,1,5
10156178,20140506,Imatinib,78,801,78.0,1,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR|GASTROINTESTINAL NEOPLASM,Death,1,5
10156603,20140507,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,LETROZOLE|LETROZOLE TABLETS|FUROSEMIDE|AMLODIPINE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|LOSARTAN|RAMIPRIL,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC PAIN,Thrombocytosis,1,1
10156648,20140507,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,AMLODIPINE|FUROSEMIDE|LETROZOLE|LETROZOLE TABLETS|LOSARTAN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|RAMIPRIL|IMATINIB,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC PAIN|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA,Thrombocytosis,1,3
10157848,20140507,Imatinib,,,,1,104.3,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,GASTRIC CANCER,Hepatic lesion|Asthenia|Dehydration|Diarrhoea|Abdominal pain upper,5,5
10158143,20140507,Imatinib,59,801,59.0,2,42.7,1,1,1,1,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Pneumonia|Respiratory disorder|Bronchitis|Platelet disorder|Haemoglobin abnormal|Feeling abnormal|Influenza|White blood cell disorder,8,5
10158521,20140507,Imatinib,24,801,24.0,2,,1,1,0,0,0,0,0,Imatinib,,1,ACUTE LYMPHOCYTIC LEUKAEMIA,Death,1,5
10159209,20140508,Imatinib,81,801,81.0,1,49.34,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE|SIMVASTATIN|LOSARTAN|PREGABALIN|TIOTROPIUM BROMIDE|FUROSEMIDE,10,GASTROINTESTINAL STROMAL TUMOUR|DIABETES MELLITUS|BLOOD POTASSIUM ABNORMAL,Acute coronary syndrome|Myocardial infarction|Chest pain|Hypoaesthesia|Renal failure chronic|Diabetes mellitus inadequate control|Blood glucose increased|Hyponatraemia|Blood glucose decreased|Essential hypertension|Anxiety|Blood potassium decreased|Dyspepsia,13,5
10159256,20140506,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Thrombocytosis,1,3
10159555,20140508,Imatinib,66,801,66.0,1,108.9,1,1,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,GASTROINTESTINAL NEOPLASM,Fluid retention|Gait disturbance|Death,3,1
10160460,20140508,Imatinib,65,801,65.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10162474,20140509,Imatinib,,,,1,,1,0,1,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE,3,PRODUCT USED FOR UNKNOWN INDICATION,Blood potassium decreased|Vomiting|General physical health deterioration|White blood cell count decreased|Dehydration|Nausea|Malaise|Weight decreased,8,1
10162541,20140509,Imatinib,84,801,84.0,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,SOFT TISSUE NEOPLASM,Cerebrovascular accident,1,5
10162579,20140509,Imatinib,76,801,76.0,1,90,1,0,0,0,0,0,1,Imatinib,BISOPROLOL FUMARATE|PANTOPRAZOLE,4,CHRONIC MYELOID LEUKAEMIA,Pancreatic fistula|Colorectal adenocarcinoma|Second primary malignancy|Post procedural fistula|Papilla of Vater stenosis,5,1
10166287,20140512,Imatinib,76,801,76.0,2,,1,0,0,0,0,0,1,Imatinib,DASATINIB,2,CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Extranodal marginal zone B-cell lymphoma (MALT type)|Pleural effusion,2,5
10167646,20140512,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|IMATINIB MESYLATE,11,GASTROINTESTINAL STROMAL TUMOUR|GASTRIC PH DECREASED,Fistula|Bladder disorder|Feeling abnormal|Haemoglobin decreased|Intestinal perforation|Abdominal pain|Recurrent cancer|Metastasis|Red blood cell count decreased|Renal cancer|Renal disorder|Haematocrit decreased|Second primary malignancy|Gastric fistula|Sunburn|Fistula|Inflammation|Gastrointestinal stromal tumour|Malignant neoplasm progression|Blood iron decreased|Muscle spasms|Metastases to liver|Skin burning sensation|Malaise,24,5
10168336,20140512,Imatinib,35,801,35.0,2,,1,0,0,0,0,0,1,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Maternal exposure during pregnancy|Foetal death,2,5
10168902,20140513,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Myasthenia gravis,1,5
10169538,20140513,Imatinib,42,801,42.0,2,47,1,1,1,0,0,0,1,Imatinib,AMBRISENTAN|FAMOTIDINE|EPOPROSTENOL SODIUM|EPOPROSTENOL SODIUM|AMBRISENTAN|AMBRISENTAN|EPOPROSTENOL SODIUM|AMBRISENTAN|SILDENAFIL CITRATE|AMBRISENTAN|AMBRISENTAN|FUROSEMIDE,22,PULMONARY ARTERIAL HYPERTENSION|PULMONARY ARTERIAL HYPERTENSION|PULMONARY ARTERIAL HYPERTENSION|PULMONARY ARTERIAL HYPERTENSION|PULMONARY ARTERIAL HYPERTENSION,Right ventricular failure|Cystitis|Cardiac failure|Oedema|Iron deficiency anaemia|Off label use,6,5
10170510,20140513,Imatinib,,,,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,GASTRIC CANCER|SOFT TISSUE NEOPLASM,Death,1,1
10170523,20140513,Imatinib,51,801,51.0,1,67,1,1,0,0,0,0,1,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,White blood cell count decreased|Haemorrhage intracranial|Respiratory tract haemorrhage|Bone marrow failure|Dyspnoea|Respiratory failure|Subarachnoid haemorrhage|Chest discomfort,8,3
10170530,20140513,Imatinib,72,801,72.0,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,BONE CANCER,Death,1,5
10170556,20140513,Imatinib,64,801,64.0,2,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR|GASTROINTESTINAL NEOPLASM,Death,1,3
10170999,20140513,Imatinib,58,801,58.0,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,,Pain|Pollakiuria|Weight decreased,3,3
10171143,20140514,Imatinib,,,,0,,1,1,0,0,0,0,0,Imatinib,"RITUXIMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DOXORUBICIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|IMATINIB",6,ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA,Acute myeloid leukaemia|Myelodysplastic syndrome,2,1
10172031,20140515,Imatinib,66,801,66.0,1,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR|GASTROINTESTINAL NEOPLASM,Death,1,3
10172139,20140515,Imatinib,32,801,32.0,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB,1,CHRONIC MYELOMONOCYTIC LEUKAEMIA,Death,1,3
10172147,20140515,Imatinib,,,,0,,1,1,0,0,0,0,1,Imatinib,,1,,Stillbirth|Foetal exposure during pregnancy|Umbilical cord abnormality,3,5
10172184,20140515,Imatinib,81,801,81.0,2,,1,0,0,0,0,0,1,Imatinib,PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,5,GASTROINTESTINAL STROMAL TUMOUR,Nodule|Hypothyroidism|Dysgeusia|Vomiting|Cholecystitis|Gastrointestinal toxicity|Decreased appetite|Diabetes mellitus|Metastases to peritoneum|Rash|Nausea|Metastases to liver|Cholecystitis infective|Hypoaesthesia,14,3
10172593,20140515,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,SITAGLIPTIN|NILOTINIB|IMATINIB MESYLATE|IMATINIB|INSULIN GLARGINE,6,DIABETES MELLITUS|LEUKAEMIA|LEUKAEMIA|DIURETIC THERAPY,Neoplasm malignant|Paraesthesia|Overdose,3,5
10173049,20140515,Imatinib,65,801,65.0,2,,1,0,0,0,0,0,1,Imatinib,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LENALIDOMIDE|LENALIDOMIDE|BORTEZOMIB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|MELPHALAN HYDROCHLORIDE|MELPHALAN|VORINOSTAT|IMATINIB",8,PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PLASMA CELL MYELOMA|PRODUCT USED FOR UNKNOWN INDICATION|PLASMA CELL MYELOMA|CHEMOTHERAPY,Chronic myeloid leukaemia,1,1
10174969,20140515,Imatinib,,,,0,,1,0,1,0,0,0,0,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR|GASTROINTESTINAL STROMAL TUMOUR,Renal impairment,1,1
10175910,20140516,Imatinib,78,801,78.0,2,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10176040,20140516,Imatinib,56,801,56.0,1,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL NEOPLASM|GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10176590,20140516,Imatinib,62,801,62.0,1,,1,1,0,0,0,0,1,Imatinib,IMATINIB,1,GASTROINTESTINAL STROMAL TUMOUR,Pulmonary embolism|Diabetic gangrene,2,1
10176593,20140516,Imatinib,40,801,40.0,0,,1,1,0,0,0,0,0,Imatinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10176599,20140516,Imatinib,45,801,45.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10176601,20140516,Imatinib,39,801,39.0,2,,1,1,0,0,0,0,1,Imatinib,IMATINIB,1,CHRONIC MYELOID LEUKAEMIA,Cerebral haemorrhage|Nervous system disorder|Chronic myeloid leukaemia|Coagulopathy|No therapeutic response|Abdominal pain|Headache|Drug resistance,8,1
10177448,20140516,Imatinib,24,801,24.0,2,,1,0,1,0,0,0,0,Imatinib,NILOTINIB|NILOTINIB|NILOTINIB|NILOTINIB,5,CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Vomiting|Cardiac disorder|Acute tonsillitis,3,5
10177923,20140516,Imatinib,58,801,58.0,1,95.9,1,1,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|NILOTINIB,2,CHRONIC MYELOID LEUKAEMIA,Sudden death|Dyspnoea,2,5
10177925,20140516,Imatinib,58,801,58.0,2,,1,0,0,0,0,0,0,Imatinib,IMATINIB|IMATINIB|NILOTINIB|DASATINIB|DASATINIB|DASATINIB|HYDROXYUREA,8,CHRONIC MYELOID LEUKAEMIA,Therapeutic response decreased,1,3
10178249,20140519,Imatinib,15,801,15.0,0,,1,1,0,0,0,0,0,Imatinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10178259,20140519,Imatinib,12,802,1.0,0,,1,1,0,0,0,0,0,Imatinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10178267,20140519,Imatinib,60,801,60.0,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,SOFT TISSUE NEOPLASM,Death,1,5
10178277,20140519,Imatinib,70,801,70.0,1,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR|GASTROINTESTINAL NEOPLASM,Death,1,3
10178279,20140519,Imatinib,84,801,84.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10178286,20140519,Imatinib,64,801,64.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10185167,20140521,Imatinib,,,,1,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,GASTRIC CANCER|SOFT TISSUE SARCOMA,Dementia Alzheimer^s type,1,5
10185180,20140521,Imatinib,46,801,46.0,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Death,1,5
10185416,20140521,Imatinib,63,801,63.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10186717,20140521,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,,Oesophageal neoplasm|Hepatic neoplasm,2,5
10186745,20140521,Imatinib,66,801,66.0,2,85,1,0,0,0,0,0,1,Imatinib,ALLOPURINOL|ALLOPURINOL,5,HYPERTENSION|HYPERURICAEMIA|CHRONIC MYELOID LEUKAEMIA|HYPERTENSION,Renal failure chronic,1,3
10186753,20140521,Imatinib,48,801,48.0,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB,1,GASTROINTESTINAL STROMAL TUMOUR,Dystrophic calcification|Calcinosis,2,3
10187240,20140522,Imatinib,35,801,35.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Spinal fracture|Fall,2,5
10189504,20140522,Imatinib,70,801,70.0,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE|WARFARIN,2,CHRONIC MYELOID LEUKAEMIA|CARDIAC DISORDER,Myocardial infarction|Muscle spasms|Fatigue|Diarrhoea,4,5
10189653,20140521,Imatinib,,,,1,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,RECTAL CANCER,Pneumonia|Adverse event|Drug intolerance,3,3
10190799,20140523,Imatinib,40,801,40.0,1,,1,0,0,0,0,0,0,Imatinib,NILOTINIB|NILOTINIB,3,CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Gamma-glutamyltransferase increased|Fatigue|Alanine aminotransferase increased|Blood alkaline phosphatase decreased|Blood creatine phosphokinase increased|Hyperbilirubinaemia|Oedema,7,3
10191397,20140523,Imatinib,50,801,50.0,1,96.15,1,0,0,0,0,0,0,Imatinib,SUNITINIB MALATE|IMATINIB MESYLATE|IMATINIB MESYLATE|ALPRAZOLAM|ENALAPRIL MALEATE|ENALAPRIL|METHYLPREDNISOLONE|METOPROLOL SUCCINATE|ONDANSETRON HYDROCHLORIDE|SILDENAFIL CITRATE,11,GASTROINTESTINAL STROMAL TUMOUR|GASTROINTESTINAL STROMAL TUMOUR|NAUSEA,Abdominal pain|Fatigue|Hyperlipidaemia|Hypertension|Metabolic disorder|Blood glucose abnormal|Radiculopathy|Anxiety|Nausea|Rash,10,1
10191489,20140523,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|ATORVASTATIN CALCIUM|GLYBURIDE|GLYBURIDE|IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE,8,BLOOD CHOLESTEROL INCREASED|BLOOD GLUCOSE INCREASED|GASTROINTESTINAL STROMAL TUMOUR|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Gastrointestinal stromal tumour|Bowel movement irregularity|Blood glucose increased|Weight increased|Abdominal pain upper|Dehydration|Pain|Weight decreased|Stress|Asthenia|Fatigue,12,5
10191841,20140522,Imatinib,67,801,67.0,1,,1,0,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Oedema|Arthralgia,2,2
10192309,20140523,Imatinib,70,801,70.0,2,55,1,0,1,0,0,0,1,Imatinib,ESOMEPRAZOLE MAGNESIUM,5,PROPHYLAXIS|GASTROINTESTINAL STROMAL TUMOUR|PROPHYLAXIS|HAEMORRHAGE PROPHYLAXIS|HAEMORRHAGE PROPHYLAXIS,Gastric antral vascular ectasia|Gastrointestinal haemorrhage|Chronic gastritis|Anaemia|Red blood cell count decreased|Oedema|Blood creatinine increased,7,1
10192319,20140523,Imatinib,61,801,61.0,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE,3,GASTROINTESTINAL STROMAL TUMOUR,Hepatic cancer metastatic|Gastrointestinal stromal tumour|Neoplasm recurrence|Abdominal pain,4,1
10192323,20140523,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,,Colon cancer|Hypertension,2,5
10192399,20140523,Imatinib,70,801,70.0,2,88.9,1,0,0,0,0,0,0,Imatinib,BOSUTINIB|BOSUTINIB|IMATINIB MESYLATE|METOPROLOL TARTRATE|METOPROLOL|SERTRALINE|LEVOTHYROXINE|FUROSEMIDE|DEXLANSOPRAZOLE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,10,CHRONIC LEUKAEMIA|CHRONIC LEUKAEMIA,Cough|Laboratory test abnormal,2,5
10192547,20140523,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,SORAFENIB|LAPATINIB|VEMURAFENIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB|PAZOPANIB|PAZOPANIB HYDROCHLORIDE|IMATINIB,8,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|NEOPLASM MALIGNANT,Electrocardiogram QT prolonged,1,5
10195016,20140526,Imatinib,70,801,70.0,1,,1,0,0,0,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Squamous cell carcinoma of skin|Second primary malignancy|Ulcer|Nodule,4,3
10195041,20140526,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,IMATINIB,2,CHRONIC MYELOID LEUKAEMIA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Bronchial carcinoma|Second primary malignancy,2,1
10195349,20140526,Imatinib,71,801,71.0,2,41,1,0,0,0,0,0,1,Imatinib,PITAVASTATIN CALCIUM|SUNITINIB MALATE,6,GASTROINTESTINAL STROMAL TUMOUR|MUSCLE SPASMS|ABDOMINAL PAIN UPPER|HYPERLIPIDAEMIA|CONSTIPATION|GASTROINTESTINAL STROMAL TUMOUR,Atypical mycobacterial infection,1,1
10195367,20140526,Imatinib,72,801,72.0,2,,1,0,1,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,GASTRIC CANCER,Fall|Asthenia|Haemorrhage|Neoplasm|Malignant neoplasm progression,5,1
10195939,20140527,Imatinib,,,,1,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,SOFT TISSUE NEOPLASM,Gastric neoplasm|Staphylococcal infection|Large intestine perforation,3,5
10196819,20140523,Imatinib,3,801,3.0,1,12.5,1,1,0,0,0,0,0,Imatinib,BEVACIZUMAB|IMATINIB MESYLATE,2,PULMONARY VEIN STENOSIS,Tachycardia|Hypotension|Pulse pressure decreased|Pulmonary hypertensive crisis|General physical health deterioration,5,1
10201031,20140528,Imatinib,35,801,35.0,1,,1,0,1,0,0,0,1,Imatinib,HYDROXYUREA|IMATINIB MESYLATE,3,CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Mucosal inflammation|Chronic myeloid leukaemia transformation|Oesophagitis|Blast crisis in myelogenous leukaemia,4,5
10201618,20140528,Imatinib,41,801,41.0,1,68.27,1,0,1,0,0,0,0,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,Myasthenia gravis|Diplopia,2,1
10203113,20140529,Imatinib,55,801,55.0,1,72.9,1,1,0,0,0,0,1,Imatinib,DASATINIB|VINCRISTINE SULFATE|DASATINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METHOTREXATE|METHOTREXATE SODIUM|CYTARABINE|VINCRISTINE SULFATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METHOTREXATE|METHOTREXATE SODIUM|DASATINIB,14,PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION,Dysgeusia|Therapeutic response decreased|Toxicity to various agents|Chronic myeloid leukaemia transformation|Leukaemia recurrent|Hypoaesthesia|Blood creatine phosphokinase increased|Drug ineffective|Malignant neoplasm progression|Central nervous system leukaemia|Oedema|Chronic myeloid leukaemia,12,3
10203939,20140523,Imatinib,17,801,17.0,1,49.9,1,0,1,0,0,0,0,Imatinib,TREPROSTINIL|SILDENAFIL CITRATE|ACETYLCYSTEINE|AMOXICILLIN|DESLORATADINE|DONEPEZIL HYDROCHLORIDE|ESZOPICLONE|FUROSEMIDE|PANTOPRAZOLE,19,COR PULMONALE CHRONIC|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Gastrointestinal haemorrhage|Gastrointestinal infection|Portal hypertension|Anaemia|Intestinal polyp|Pyrexia|Chills|Pain in extremity|Arthralgia|Diarrhoea|Rectal haemorrhage|Bacteraemia|Gastric disorder|Pulmonary oedema,14,3
10206327,20140530,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10206334,20140530,Imatinib,,,,0,,1,0,1,0,0,0,0,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR|NEOPLASM,Abdominal pain|Dyspnoea|Tumour rupture,3,3
10206338,20140530,Imatinib,37,801,37.0,2,78,1,1,1,0,0,0,1,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,Increased bronchial secretion|Haemoglobin decreased|Drug ineffective|Malaria|Pyrexia|Headache|Acute myeloid leukaemia|Dyspnoea exertional|Breast swelling|White blood cell count increased|Cough|Palpitations|Platelet count increased|Haemorrhage,14,5
10207252,20140528,Imatinib,59,801,59.0,1,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Memory impairment|Disturbance in attention,2,3
10209813,20140602,Imatinib,77,801,77.0,2,42,1,0,0,1,0,0,1,Imatinib,FUROSEMIDE|PREGABALIN|OXYCODONE HYDROCHLORIDE,9,FLUID REPLACEMENT|PRODUCT USED FOR UNKNOWN INDICATION|FLUID REPLACEMENT|PRODUCT USED FOR UNKNOWN INDICATION|GASTROINTESTINAL STROMAL TUMOUR|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Chest pain|Pericardial effusion|Dyspnoea|Hypothyroidism,4,1
10211498,20140602,Imatinib,,,,0,,1,1,0,0,0,0,0,Imatinib,DOXORUBICIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METHOTREXATE|METHOTREXATE SODIUM|CYTARABINE|IMATINIB,7,ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA,Death,1,1
10214863,20140603,Imatinib,,,,0,,1,1,0,0,0,0,0,Imatinib,DOXORUBICIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METHOTREXATE|METHOTREXATE SODIUM|CYTARABINE|IMATINIB,7,ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA,Multi-organ failure|Sepsis,2,1
10214897,20140603,Imatinib,61,801,61.0,1,59.2,1,0,0,0,0,0,1,Imatinib,PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|FUROSEMIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|VALACYCLOVIR|VALACYCLOVIR HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|MAGNESIUM HYDROXIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|FUROSEMIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,42,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|OFF LABEL USE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SECONDARY IMMUNODEFICIENCY|CHRONIC GRAFT VERSUS HOST DISEASE|MYELOFIBROSIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pleural effusion|Respiratory tract infection|Scleroderma|Dyspnoea|Hypercapnia|Nausea|Bronchiectasis|Squamous cell carcinoma,8,1
10215210,20140603,Imatinib,41,801,41.0,1,,1,0,0,0,0,0,1,Imatinib,DASATINIB|DASATINIB|DASATINIB,4,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,Liver disorder,1,1
10215215,20140603,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Second primary malignancy|Ovarian cancer,2,5
10215249,20140603,Imatinib,84,801,84.0,1,,1,0,1,0,0,0,1,Imatinib,FUROSEMIDE|BISOPROLOL FUMARATE|IMATINIB MESYLATE|IMATINIB MESYLATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LEVOTHYROXINE|ALLOPURINOL,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Epistaxis|Muscle spasms|Asthenia|Lung neoplasm malignant|Paralysis|Second primary malignancy|Wound|Cerebrovascular accident|Peripheral swelling|Pulmonary oedema|Pain in extremity|Arthralgia|Dyspnoea|Back pain|Stress,15,1
10215684,20140603,Imatinib,73,801,73.0,1,,1,0,0,0,0,0,0,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE|DUTASTERIDE|SIMVASTATIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|DIPHENHYDRAMINE HYDROCHLORIDE,9,MALIGNANT CONNECTIVE TISSUE NEOPLASM|SOFT TISSUE SARCOMA|NEOPLASM MALIGNANT,Eye haemorrhage|Retinal detachment,2,3
10218457,20140605,Imatinib,,,,2,,1,0,1,0,0,0,1,Imatinib,IMATINIB MESYLATE|CARBIDOPA AND LEVODOPA|DIVALPROEX SODIUM|SIMVASTATIN|GABAPENTIN|METOPROLOL SUCCINATE|OMEPRAZOLE MAGNESIUM|ATORVASTATIN CALCIUM|ENOXAPARIN SODIUM|BUPROPION HYDROCHLORIDE|RIVASTIGMINE|TOPIRAMATE|MIRTAZAPINE|ARIPIPRAZOLE,16,LEUKAEMIA,Bipolar disorder,1,5
10218747,20140605,Imatinib,72,801,72.0,1,,1,0,1,0,0,0,1,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,Pancytopenia|Colon cancer|Second primary malignancy|Prostate cancer,4,3
10222972,20140607,Imatinib,,,,1,106,1,0,0,0,0,0,1,Imatinib,NILOTINIB,2,CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION,Pain in extremity|Dyspnoea|Interstitial lung disease|Lung disorder|Polyneuropathy|Obesity,6,3
10222975,20140607,Imatinib,,,,1,80,1,0,0,0,0,0,1,Imatinib,,5,CHRONIC MYELOID LEUKAEMIA,Abdominal pain|Myalgia|Musculoskeletal disorder|Tetany|Muscle spasms,5,1
10223016,20140607,Imatinib,48,801,48.0,1,88,1,0,0,0,0,0,1,Imatinib,IMATINIB|IMATINIB|IMATINIB|REGORAFENIB,4,GASTROINTESTINAL STROMAL TUMOUR,Gastrointestinal stromal tumour|Diarrhoea|Abdominal pain|Neoplasm recurrence|Metastases to liver|Malignant neoplasm progression|Pollakiuria|Dysuria|Abnormal faeces,9,3
10223111,20140607,Imatinib,55,801,55.0,1,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR|GASTROINTESTINAL NEOPLASM,Death,1,5
10223134,20140607,Imatinib,84,801,84.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10224175,20140609,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Second primary malignancy|Chronic myeloid leukaemia|Lung neoplasm malignant|Malignant neoplasm progression,4,5
10224240,20140609,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10224253,20140609,Imatinib,63,801,63.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10224255,20140609,Imatinib,28,801,28.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10224265,20140609,Imatinib,56,801,56.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10224269,20140609,Imatinib,81,801,81.0,1,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL NEOPLASM|GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10224285,20140609,Imatinib,23,801,23.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10227497,20140610,Imatinib,58,801,58.0,1,,1,1,0,0,0,0,1,Imatinib,IMATINIB|MITOMYCIN|CISPLATIN|SORAFENIB,5,THYMIC CANCER METASTATIC,Death|Thymic cancer metastatic|Malignant neoplasm progression|Weight decreased|Abdominal pain,5,3
10227593,20140610,Imatinib,30,801,30.0,2,80,1,0,1,0,0,0,0,Imatinib,,3,CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION,Gestational hypertension|Maternal exposure during pregnancy|Normal newborn,3,5
10229744,20140611,Imatinib,56,801,56.0,2,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,CHRONIC MYELOID LEUKAEMIA,Muscle strain|Abdominal pain lower|Painful defaecation|Cystitis|Dysuria|Diverticulitis|Fistula|Urinary tract infection,8,5
10229760,20140611,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Myocardial infarction|Cerebrovascular accident,2,5
10229767,20140611,Imatinib,69,801,69.0,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Death,1,1
10229771,20140611,Imatinib,69,801,69.0,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Death,1,5
10229867,20140610,Imatinib,28,801,28.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,,Nausea|Vomiting|Bone pain,3,2
10229878,20140611,Imatinib,,,,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE|CELECOXIB|FENOFIBRATE|SIMVASTATIN,6,ABDOMINAL NEOPLASM,Post procedural complication,1,5
10230507,20140611,Imatinib,71,801,71.0,2,63.95,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|RUXOLITINIB|RUXOLITINIB|LEVOTHYROXINE SODIUM|ENOXAPARIN SODIUM|IMATINIB MESYLATE,6,CHRONIC MYELOID LEUKAEMIA|MYELOFIBROSIS|DEEP VEIN THROMBOSIS,Paranasal sinus hypersecretion|Cough|Paranasal sinus discomfort|Injection site haematoma|Fatigue|Migraine|Muscle spasms|Increased tendency to bruise|Chronic myeloid leukaemia|Deep vein thrombosis|Dyspnoea exertional|Blood thyroid stimulating hormone increased|Visual impairment,13,3
10233014,20140612,Imatinib,63,801,63.0,1,102,1,0,1,0,0,0,0,Imatinib,"SUNITINIB MALATE|METOPROLOL TARTRATE|METOPROLOL|IMATINIB|CYCLOBENZAPRINE|METOPROLOL TARTRATE|SIMVASTATIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|SUNITINIB MALATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM",11,GASTROINTESTINAL STROMAL TUMOUR|HEADACHE|MUSCLE SPASMS|BLOOD PRESSURE ABNORMAL,Palmar-plantar erythrodysaesthesia syndrome|Skin odour abnormal|Nausea|Abdominal distension|Foreign body in eye|Toxicity to various agents|Diarrhoea|Depression|Headache|Gastrointestinal stromal tumour|Tongue discolouration|Weight decreased|Skin discolouration|Pruritus|Dizziness|Flatulence|Hyperhidrosis|Weight increased|Disease progression,19,5
10235037,20140613,Imatinib,52,801,52.0,1,,1,1,0,0,0,0,1,Imatinib,NILOTINIB|IMATINIB|IMATINIB,5,GASTROINTESTINAL STROMAL TUMOUR|GASTROINTESTINAL STROMAL TUMOUR|GASTROINTESTINAL STROMAL TUMOUR,Malignant neoplasm progression|Anaemia|Gastrointestinal stromal tumour|General physical health deterioration|Abdominal mass|Drug intolerance|Death|Neoplasm recurrence|Drug resistance|Subileus|Neutropenia,11,
10235060,20140613,Imatinib,59,801,59.0,1,,1,1,0,0,0,0,1,Imatinib,,2,METASTASES TO LIVER|GASTROINTESTINAL STROMAL TUMOUR,Splenic neoplasm malignancy unspecified|Gastrointestinal stromal tumour|Abdominal mass|Malignant neoplasm progression|Drug intolerance,5,3
10235436,20140613,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,MYCOPHENOLATE MOFETIL|MYCOPHENOLATE MOFETIL HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|METHYLPREDNISOLONE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,7,IMMUNOSUPPRESSION|IMMUNOSUPPRESSION|IMMUNOSUPPRESSION|IMMUNOSUPPRESSION|CHRONIC MYELOID LEUKAEMIA,Chronic myeloid leukaemia|Blood creatinine increased|Drug interaction|Kaposi^s sarcoma,4,
10238117,20140616,Imatinib,57,801,57.0,1,,1,0,0,0,0,0,1,Imatinib,NILOTINIB,2,CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Xanthoma|Muscle spasms|Empyema,3,2
10238131,20140616,Imatinib,54,801,54.0,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,ACUTE MYELOID LEUKAEMIA,Death,1,5
10238146,20140616,Imatinib,63,801,63.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10238163,20140616,Imatinib,69,801,69.0,1,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR|GASTROINTESTINAL NEOPLASM,Death,1,3
10238174,20140616,Imatinib,69,801,69.0,1,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR|GASTROINTESTINAL NEOPLASM,Death,1,3
10240298,20140617,Imatinib,,,,2,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,GASTRIC CANCER,Blood glucose abnormal|Lung infection|Pneumonia|Back pain,4,5
10240849,20140617,Imatinib,,,,2,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Renal disorder|Weight decreased,2,5
10240864,20140617,Imatinib,45,801,45.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10240870,20140617,Imatinib,55,801,55.0,1,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL NEOPLASM|GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10240885,20140617,Imatinib,65,801,65.0,1,,1,0,1,0,0,0,0,Imatinib,NILOTINIB|NILOTINIB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CARVEDILOL|DULOXETINE HYDROCHLORIDE|GABAPENTIN|GLIMEPIRIDE|IMATINIB|INSULIN GLARGINE|LORAZEPAM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|RAMIPRIL,14,CHRONIC MYELOID LEUKAEMIA,Pancreatitis|Abdominal pain upper|Nausea|Vomiting|Abdominal distension|Abdominal tenderness|Malaise|Haematochezia|Myalgia,9,5
10241102,20140617,Imatinib,9,801,9.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB,2,CHRONIC MYELOID LEUKAEMIA|PROPHYLAXIS,Pseudoporphyria|Blister|Skin erosion|Skin fragility,4,3
10242538,20140616,Imatinib,57,801,57.0,2,,1,1,0,0,0,0,1,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR,Death|Skin exfoliation|Rash|Anaphylactic shock|Oedema peripheral|Diarrhoea|Skin hyperpigmentation,7,5
10243293,20140618,Imatinib,80,801,80.0,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB|IMATINIB,2,GASTROINTESTINAL STROMAL TUMOUR|MALIGNANT PERITONEAL NEOPLASM,Intra-abdominal haemorrhage|Gastrointestinal stromal tumour|Neoplasm recurrence|Tumour rupture|Drug tolerance decreased,5,3
10243318,20140618,Imatinib,,,,2,111.57,1,0,0,0,0,0,1,Imatinib,NILOTINIB|METHYLPREDNISOLONE ACETATE|MELOXICAM|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM|ESCITALOPRAM OXALATE|ESCITALOPRAM|LOSARTAN POTASSIUM|LOSARTAN|CARVEDILOL|CLONAZEPAM|LISINOPRIL|ALPRAZOLAM|CYCLOSPORINE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FUROSEMIDE|AMLODIPINE BESYLATE|IMATINIB MESYLATE,20,CHRONIC MYELOID LEUKAEMIA,Pulmonary mass|Dyspnoea|Malaise|Nausea|Rash,5,5
10243324,20140618,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10243325,20140618,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,,1,ACUTE LYMPHOCYTIC LEUKAEMIA,Death,1,5
10243353,20140618,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Road traffic accident,1,3
10245971,20140619,Imatinib,83,801,83.0,2,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10245976,20140619,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Death,1,5
10245981,20140619,Imatinib,,,,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE|LISINOPRIL,2,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10245983,20140619,Imatinib,18,801,18.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB|LEVONORGESTREL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|IMATINIB|IMATINIB|ACYCLOVIR,11,PROPHYLAXIS|ACUTE LYMPHOCYTIC LEUKAEMIA|PROPHYLAXIS|PROPHYLAXIS|ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT|ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|PROPHYLAXIS|PROPHYLAXIS,Blister|Ascites|Skin erosion|Pseudoporphyria|Skin fragility|Acute lymphocytic leukaemia recurrent|Purpura,7,3
10245987,20140619,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Death,1,5
10245992,20140619,Imatinib,45,801,45.0,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Death,1,5
10245995,20140619,Imatinib,40,801,40.0,2,,1,1,0,0,0,0,0,Imatinib,,1,ACUTE LYMPHOCYTIC LEUKAEMIA,Death,1,3
10246001,20140619,Imatinib,93,801,93.0,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10246232,20140619,Imatinib,,,,1,,1,0,1,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE|CLONAZEPAM|IMATINIB MESYLATE|IMATINIB|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE,7,GASTROINTESTINAL STROMAL TUMOUR|PRODUCT USED FOR UNKNOWN INDICATION|GASTROINTESTINAL STROMAL TUMOUR|PRODUCT USED FOR UNKNOWN INDICATION,Rib fracture|Nausea|Personality change|Gastrooesophageal reflux disease|Fatigue|Sneezing|Candida infection|Dysphagia|Deafness bilateral|Pruritus|Headache|Hypophagia|Pain|Weight increased|Dyspepsia|Insomnia|Weight decreased|Muscle atrophy|Nasopharyngitis|Contusion,20,1
10246233,20140619,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,,Death,1,5
10246235,20140619,Imatinib,70,801,70.0,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,OFF LABEL USE|BENIGN BONE NEOPLASM,Death,1,5
10246785,20140619,Imatinib,37,801,37.0,1,100.4,1,0,0,0,0,0,1,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,Proteinuria|Oedema peripheral|Protein total decreased|Low density lipoprotein increased|Haematuria|Nephropathy|Blood triglycerides increased|Hypertension|Blood cholesterol increased,9,5
10248813,20140620,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,"DOXORUBICIN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METHOTREXATE|METHOTREXATE SODIUM|CYTARABINE|RITUXIMAB|IMATINIB",9,ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA|ACUTE LYMPHOCYTIC LEUKAEMIA,Myeloid leukaemia|Myelodysplastic syndrome|Off label use,3,1
10249026,20140620,Imatinib,,,,1,,1,1,0,0,0,0,1,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Metastases to central nervous system|Terminal state,2,3
10249029,20140620,Imatinib,92,801,92.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,,Hip fracture|Gait disturbance,2,5
10249032,20140620,Imatinib,68,801,68.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10249037,20140620,Imatinib,87,801,87.0,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Cerebrovascular accident,1,5
10249780,20140620,Imatinib,,,,1,,1,0,1,0,0,0,0,Imatinib,HYDROXYUREA,5,PRODUCT USED FOR UNKNOWN INDICATION,Pneumonia|Pyrexia|Measles|White blood cell count decreased|Splenomegaly|Asthma|Rash|Hypersensitivity|Headache,9,5
10249783,20140620,Imatinib,61,801,61.0,2,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10250316,20140620,Imatinib,,,,1,,1,1,0,0,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death|Chronic kidney disease,2,5
10251878,20140623,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|IMATINIB,2,GASTROOESOPHAGEAL REFLUX DISEASE|CHRONIC MYELOID LEUKAEMIA,Transaminases increased,1,1
10252032,20140623,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,"IMATINIB MESYLATE|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|LORAZEPAM|IMATINIB MESYLATE|IMATINIB MESYLATE",7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ANXIETY|PRODUCT USED FOR UNKNOWN INDICATION|PAIN,Mobility decreased|Muscle spasms|Myalgia|Joint swelling|Hepatic neoplasm|Arthralgia,6,1
10252417,20140623,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,,Cerebrovascular accident,1,5
10252418,20140623,Imatinib,53,801,53.0,2,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10252420,20140623,Imatinib,61,801,61.0,2,,1,1,0,0,0,0,0,Imatinib,,1,ACUTE LYMPHOCYTIC LEUKAEMIA,Death,1,3
10252423,20140623,Imatinib,,,,2,,1,1,0,0,0,0,1,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,General physical health deterioration|Leukopenia|Death,3,5
10252426,20140623,Imatinib,51,801,51.0,2,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10252428,20140623,Imatinib,65,801,65.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10253410,20140623,Imatinib,70,801,70.0,1,,1,0,1,0,0,0,1,Imatinib,NILOTINIB|NILOTINIB,4,CHRONIC MYELOID LEUKAEMIA,Pleural mesothelioma|Oedema peripheral|Pleural effusion|Venous thrombosis|Cough|Pain in extremity|Second primary malignancy,7,1
10254584,20140624,Imatinib,87,801,87.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Cerebrovascular accident|Retching|Nausea|Dysphagia|Malaise|Hypophagia,6,5
10254608,20140624,Imatinib,,,,1,,1,0,1,0,0,0,1,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,Second primary malignancy|Hypokalaemia|Prostate cancer,3,1
10254614,20140624,Imatinib,43,801,43.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10254617,20140624,Imatinib,58,801,58.0,2,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR|NEOPLASM,Death,1,3
10254890,20140624,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,OCTREOTIDE ACETATE|IMATINIB MESYLATE|RAMIPRIL|RAMIPRIL|ROSUVASTATIN|RAMIPRIL,6,PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Muscle spasms|Loss of consciousness|Meralgia paraesthetica|Malaise|Clostridium difficile infection|Blood pressure fluctuation|Clostridium difficile colitis|Tremor|Vomiting|Thrombosis|Pain,11,5
10257517,20140625,Imatinib,71,801,71.0,1,48,1,1,1,0,0,0,1,Imatinib,FUROSEMIDE|FUROSEMIDE|AMIODARONE HYDROCHLORIDE|CLOPIDOGREL|FERROUS SULFATE|FUROSEMIDE,23,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Rash pustular|Pneumonia|Gallbladder disorder|Occult blood positive|Dyspnoea|Pyrexia|Diarrhoea|Cholelithiasis|Haemorrhage|Cardiac failure congestive|Cholecystitis acute|Cyst|Nephrolithiasis|Gallbladder polyp|Haemoglobin decreased|Renal atrophy,16,2
10257530,20140625,Imatinib,91,801,91.0,1,,1,1,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|MORPHINE SULFATE|IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE|MEGESTROL ACETATE|OXYCODONE AND ACETAMINOPHEN|OXYCODONE AND ACETAMINOPHEN|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|OXYCODONE AND ACETAMINOPHEN TABLETS,9,GASTROINTESTINAL STROMAL TUMOUR,Rash|Asthenia|Gastric neoplasm|Malignant neoplasm progression|Pruritus|Abdominal pain|Gastrointestinal stromal tumour|Metastases to spleen|Cancer pain|Anaemia,10,5
10258210,20140625,Imatinib,70,801,70.0,2,,1,0,1,0,0,0,1,Imatinib,IMATINIB MESYLATE|FLUTICASONE PROPIONATE AND SALMETEROL|CLONAZEPAM|FOLIC ACID|LANSOPRAZOLE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|SAXAGLIPTIN|TELMISARTAN|DILTIAZEM HYDROCHLORIDE|ALBUTEROL SULFATE,13,,Lung adenocarcinoma|Pulmonary mass|Malignant neoplasm progression,3,3
10258233,20140625,Imatinib,58,801,58.0,1,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR|NEOPLASM,Death,1,3
10258236,20140625,Imatinib,,,,1,,1,1,0,0,0,0,1,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,White blood cell count increased|Thrombocytopenia|Drug resistance|Anaemia|Hepatosplenomegaly|Chronic myeloid leukaemia|Drug ineffective,7,5
10258273,20140623,Imatinib,,,,2,,1,0,0,0,1,0,0,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|VITAMIN E|CALCIUM|VENLAFAXINE HYDROCHLORIDE|LORAZEPAM,8,,Abasia|Fatigue|Cardiac discomfort,3,2
10258556,20140625,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,SOFT TISSUE SARCOMA,Gastric neoplasm,1,5
10260876,20140626,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,,Blindness,1,1
10260883,20140626,Imatinib,,,,1,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Venous occlusion,1,1
10261557,20140626,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,,1,ACUTE LYMPHOCYTIC LEUKAEMIA,Infection,1,1
10261563,20140626,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES,4,,Cardiac disorder|Pain in extremity|Epigastric discomfort|Peripheral swelling|Muscular weakness,5,1
10263896,20140627,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,CAPECITABINE|CAPECITABINE|IMATINIB,3,NEOPLASM|NEOPLASM,Diarrhoea|Dizziness|Hypophosphataemia|Anaemia|Fatigue|Palmar-plantar erythrodysaesthesia syndrome,6,3
10264609,20140627,Imatinib,,,,1,82,1,0,1,0,0,0,1,Imatinib,"LEVOTHYROXINE SODIUM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",3,GASTROINTESTINAL STROMAL TUMOUR|HYPOTHYROIDISM|HEADACHE,Subdural haematoma|Headache|Platelet disorder,3,1
10264616,20140627,Imatinib,73,801,73.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10264618,20140627,Imatinib,55,801,55.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10264626,20140627,Imatinib,39,801,39.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10264627,20140627,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,,1,ACUTE LYMPHOCYTIC LEUKAEMIA,Death,1,5
10264628,20140627,Imatinib,58,801,58.0,2,,1,0,1,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Depression|Arthralgia|Product physical issue|Joint injury|Weight increased|Hyperlipidaemia|Bone formation increased|Basedow^s disease|Obesity|Hypertension|Gastrooesophageal reflux disease,11,5
10264633,20140627,Imatinib,47,801,47.0,1,,1,1,0,0,0,0,1,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR,Malignant neoplasm progression|Gastrointestinal stromal tumour|Haematemesis,3,5
10267291,20140626,Imatinib,84,801,84.0,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Myocardial infarction|Leukaemia,2,2
10267311,20140630,Imatinib,65,801,65.0,1,64,1,0,1,0,0,0,0,Imatinib,,2,LEIOMYOSARCOMA|OFF LABEL USE,Second primary malignancy|Haematuria|Transitional cell carcinoma|Urinary bladder haemorrhage|Cystitis,5,1
10267348,20140630,Imatinib,47,801,47.0,2,54,1,0,1,0,0,0,1,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION,Metastases to peritoneum|Adenocarcinoma pancreas|Second primary malignancy,3,1
10268212,20140630,Imatinib,69,801,69.0,2,,1,0,0,0,0,0,1,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA|GASTROOESOPHAGEAL REFLUX DISEASE,Transaminases increased,1,5
10270596,20140701,Imatinib,,,,1,83.9,1,0,0,0,0,0,0,Imatinib,POLYETHYLENE GLYCOL 3350|IMATINIB MESYLATE|SIMVASTATIN,3,CONSTIPATION|LEUKAEMIA|BLOOD CHOLESTEROL,Incorrect drug administration duration|Diarrhoea,2,5
10271924,20140702,Imatinib,74,801,74.0,2,62.14,1,0,0,0,0,0,1,Imatinib,LEVOTHYROXINE|IMATINIB MESYLATE|IMATINIB MESYLATE|LORAZEPAM|OLMESARTAN MEDOXOMIL,5,PRODUCT USED FOR UNKNOWN INDICATION|GASTROINTESTINAL STROMAL TUMOUR|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Hypertension|Metastases to liver|Drug intolerance|Swelling face|Haemorrhoids|Anal fissure|Eye swelling,8,1
10271947,20140702,Imatinib,60,801,60.0,2,,1,1,0,0,0,0,1,Imatinib,THIOGUANINE|HYDROXYUREA|CYTARABINE|IMATINIB,5,CHRONIC MYELOID LEUKAEMIA,Death|Myeloblast count increased|General physical health deterioration|Lymphadenopathy|Leukaemia recurrent|Chronic myeloid leukaemia|Drug ineffective,7,3
10271948,20140702,Imatinib,,,,1,85,1,0,0,0,0,0,0,Imatinib,HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,7,CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION,Muscle spasms|Eyelid oedema|Rash|Drug intolerance|Abdominal discomfort|Erythema|Headache|Drug ineffective,8,1
10271972,20140702,Imatinib,63,801,63.0,1,90,1,1,0,0,0,0,1,Imatinib,AMLODIPINE|IMATINIB,3,GASTROINTESTINAL STROMAL TUMOUR,Cardiac failure|Atrial fibrillation|Pneumonia,3,3
10271979,20140702,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,,1,,Haemorrhagic stroke,1,1
10272008,20140702,Imatinib,62,801,62.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10272020,20140702,Imatinib,34,801,34.0,1,,1,1,0,0,0,0,1,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,Leukaemia recurrent|Chronic myeloid leukaemia|Death,3,5
10272023,20140702,Imatinib,79,801,79.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,1
10272029,20140702,Imatinib,64,801,64.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10272036,20140702,Imatinib,38,801,38.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10272037,20140702,Imatinib,61,801,61.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10272045,20140702,Imatinib,,,,0,,1,1,0,0,0,0,1,Imatinib,IMATINIB|IMATINIB,2,MYELOID LEUKAEMIA,Thrombocytopenia|Haematotoxicity|Haemorrhage intracranial|Pancytopenia,4,3
10272047,20140702,Imatinib,,,,0,,1,1,1,1,0,0,1,Imatinib,SILDENAFIL CITRATE|BOSENTAN,8,PULMONARY ARTERIAL HYPERTENSION|PULMONARY ARTERIAL HYPERTENSION|ATRIAL FIBRILLATION|PULMONARY ARTERIAL HYPERTENSION|PULMONARY ARTERIAL HYPERTENSION|PULMONARY ARTERIAL HYPERTENSION|PULMONARY ARTERIAL HYPERTENSION,Pulmonary embolism|Atrial fibrillation|Concomitant disease progression|Atrial flutter|Cardiac failure|Cardiomegaly|Cardiomyopathy|Rash|Lung infiltration|Oedema|Bradycardia,11,1
10272056,20140702,Imatinib,50,801,50.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10272635,20140702,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,,3,GASTROINTESTINAL STROMAL TUMOUR,VIIth nerve paralysis,1,3
10272643,20140702,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|IMATINIB MESYLATE,3,GASTROINTESTINAL STROMAL TUMOUR,Right atrial dilatation|Left atrial dilatation|White blood cell count decreased,3,1
10272671,20140702,Imatinib,70,801,70.0,0,62,1,1,0,0,0,0,1,Imatinib,AMOXICILLIN AND CLAVULANATE POTASSIUM|CIMETIDINE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,4,GASTROINTESTINAL STROMAL TUMOUR,Cystitis|Liver function test abnormal|Malignant neoplasm progression|Septic shock|Pyrexia|Gastrointestinal stromal tumour|Vomiting,7,5
10272673,20140702,Imatinib,67,801,67.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10272674,20140702,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,,3,CHRONIC MYELOID LEUKAEMIA,Second primary malignancy|Testicular seminoma (pure) stage II|Metastases to lymph nodes|Full blood count decreased,4,5
10272679,20140702,Imatinib,77,801,77.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10272682,20140702,Imatinib,34,801,34.0,1,,1,0,0,0,0,0,1,Imatinib,DASATINIB|NILOTINIB|IMATINIB,3,CHRONIC MYELOID LEUKAEMIA,White blood cell count decreased|Rash|Gene mutation|Chronic myeloid leukaemia recurrent|Platelet count decreased,5,3
10273075,20140702,Imatinib,55,801,55.0,1,,1,1,1,0,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,General physical health deterioration|Deep vein thrombosis|Sepsis|Death,4,5
10273080,20140702,Imatinib,49,801,49.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Procalcitonin increased|Death|Blood creatinine increased,3,5
10273081,20140702,Imatinib,43,801,43.0,2,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10273083,20140702,Imatinib,65,801,65.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10273088,20140702,Imatinib,37,801,37.0,1,,1,1,0,0,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death|Blast crisis in myelogenous leukaemia,2,5
10273089,20140702,Imatinib,25,801,25.0,1,,1,1,0,0,0,0,0,Imatinib,,1,ACUTE LYMPHOCYTIC LEUKAEMIA,Death,1,3
10275791,20140703,Imatinib,60,801,60.0,1,,1,0,1,0,0,0,1,Imatinib,"ORLISTAT|IMATINIB MESYLATE|IMATINIB|DEXLANSOPRAZOLE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|IMATINIB MESYLATE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|IRON|DOXEPIN|DOXEPIN HYDROCHLORIDE",14,PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hepatic cirrhosis|Diarrhoea|Fatigue|Drug ineffective|Headache|Abdominal discomfort|Decreased immune responsiveness|Pericardial effusion|Weight increased|Chest discomfort,10,5
10278131,20140704,Imatinib,77,801,77.0,2,50,1,0,1,0,0,0,1,Imatinib,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,6,GASTROINTESTINAL STROMAL TUMOUR|GASTRITIS,Ascites|Renal failure acute|Haemodynamic instability|Drug intolerance|Diarrhoea|Malignant neoplasm progression|Hepatic lesion|Pleural effusion|Gastrointestinal stromal tumour|Dehydration,10,5
10278142,20140704,Imatinib,,,,2,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Uterine cancer|Second primary malignancy,2,1
10278143,20140704,Imatinib,66,801,66.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Thrombocytopenia|Death,2,5
10278149,20140704,Imatinib,40,801,40.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10278152,20140704,Imatinib,79,801,79.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10278154,20140704,Imatinib,68,801,68.0,1,,1,1,1,0,0,0,1,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,Death|Arthritis infective|Tuberculosis of central nervous system,3,5
10278162,20140704,Imatinib,32,801,32.0,1,50,1,1,1,0,0,0,1,Imatinib,,5,BLAST CRISIS IN MYELOGENOUS LEUKAEMIA,White blood cell count decreased|Blast crisis in myelogenous leukaemia|Jaundice|Thrombocytopenia|Nausea|Pneumonia klebsiella|Haemoglobin decreased|Gastrointestinal haemorrhage|Platelet count decreased|Pyrexia|Neutrophil count decreased|Abscess neck|Gingival bleeding|No therapeutic response,14,5
10278320,20140704,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA (IN REMISSION),Second primary malignancy|Bladder cancer,2,1
10278324,20140704,Imatinib,72,801,72.0,2,65,1,0,1,1,0,0,1,Imatinib,HYDROXYUREA|HYDROXYUREA|FUROSEMIDE|INSULIN DETEMIR|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|PREDNISONE|HYDROXYUREA|PREDNISONE|BISOPROLOL FUMARATE|PREDNISONE|PREDNISONE|PREDNISONE|PANTOPRAZOLE|PREDNISONE|PREDNISONE,22,CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,General physical health deterioration|Herpes zoster|Pyrexia|Hyponatraemia|Oral herpes|Vomiting|Diarrhoea|Renal tubular necrosis|Neuropathy peripheral|Micturition disorder|Rash|Tubulointerstitial nephritis|Dehydration|Acute kidney injury|Anuria|Nausea,16,1
10278332,20140704,Imatinib,50,801,50.0,2,,1,1,0,0,0,0,0,Imatinib,,2,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10278474,20140704,Imatinib,58,801,58.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10278475,20140704,Imatinib,53,801,53.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10279377,20140707,Imatinib,74,801,74.0,2,42,1,0,1,0,0,0,1,Imatinib,,4,GASTROINTESTINAL STROMAL TUMOUR,Pulmonary oedema|Dry skin|Neutrophil count decreased|Weight increased|Dyspnoea|Pleural effusion|Pruritus|Rash|Oedema peripheral|Eosinophil count increased,10,1
10279610,20140707,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,GASTROINTESTINAL CARCINOMA,Hand fracture,1,5
10279615,20140707,Imatinib,34,801,34.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10279618,20140707,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,,2,ACUTE LYMPHOCYTIC LEUKAEMIA|CHROMOSOME ANALYSIS ABNORMAL,Death,1,5
10279623,20140707,Imatinib,49,801,49.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10279629,20140707,Imatinib,54,801,54.0,2,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,5
10279864,20140707,Imatinib,19,801,19.0,2,,1,0,1,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Prothrombin level decreased|Coagulation factor V level decreased|Autoimmune hepatitis,3,3
10280544,20140707,Imatinib,,,,2,,1,0,1,0,0,0,0,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE|HYDROXYUREA|ALLOPURINOL|NILOTINIB,6,CHRONIC MYELOID LEUKAEMIA,Nausea|Pain|Thrombocytopenia|Asthenia|Leukocytosis|Full blood count decreased|Decreased appetite|Red blood cell count decreased|Haemoglobin decreased|Weight decreased,10,5
10283196,20140708,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Second primary malignancy|Bladder cancer,2,1
10283198,20140708,Imatinib,58,801,58.0,2,,1,1,1,0,0,0,0,Imatinib,,2,,Hepatitis acute,1,3
10283202,20140708,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,SMALL INTESTINE CARCINOMA|GASTRIC CANCER,Cerebrovascular accident|Muscular weakness,2,5
10283205,20140708,Imatinib,,,,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10283212,20140708,Imatinib,32,801,32.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10283213,20140708,Imatinib,33,801,33.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,1
10283214,20140708,Imatinib,45,801,45.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10283215,20140708,Imatinib,78,801,78.0,2,,1,1,1,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Neoplasm recurrence|Respiratory failure|Metastasis|Small intestinal perforation|Peritonitis|Circulatory collapse|Gastrointestinal stromal tumour,7,3
10283216,20140708,Imatinib,67,801,67.0,2,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,5
10283225,20140708,Imatinib,67,801,67.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10283226,20140708,Imatinib,58,801,58.0,2,,1,1,1,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Abdominal pain|Tumour rupture,2,5
10283698,20120709,Imatinib,53,801,53.0,2,155,1,0,0,0,0,0,1,Imatinib,,4,BRAIN NEOPLASM MALIGNANT|BRAIN NEOPLASM MALIGNANT|BRAIN NEOPLASM MALIGNANT,Thrombocytopenia|White blood cell count decreased|Epistaxis|Fatigue|Diarrhoea|Vomiting|Constipation|Brain neoplasm malignant|Malignant neoplasm progression,9,3
10283802,20120709,Imatinib,86,801,86.0,2,56,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,5,CHROMOSOME ANALYSIS ABNORMAL,Cystitis|Coronary artery disease|Myocardial infarction|Atrial fibrillation|Chromosome analysis abnormal|Gene mutation identification test positive|Blister|Drug intolerance|Diarrhoea|Abdominal discomfort|Vomiting|Nausea|Blood pressure diastolic decreased|Therapeutic response decreased|Dizziness,15,3
10285020,20120709,Imatinib,65,801,65.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,5,CHRONIC MYELOID LEUKAEMIA,Hypertension|Hypokalaemia|Diarrhoea|Muscle spasms|Nausea|Vomiting|Malaise|Panic attack,8,5
10285071,20120709,Imatinib,54,801,54.0,1,,1,0,0,0,0,0,1,Imatinib,,10,CHRONIC MYELOID LEUKAEMIA,Papilloedema|Muscle spasms,2,5
10285934,20140709,Imatinib,,,,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10285946,20140709,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,CHRONIC MYELOID LEUKAEMIA,Blindness unilateral|Visual acuity reduced,2,5
10285948,20140709,Imatinib,45,801,45.0,1,,1,0,0,0,0,0,1,Imatinib,,3,GASTROINTESTINAL STROMAL TUMOUR,Metastases to liver|Malignant neoplasm progression|Hepatic lesion|Protein-losing gastroenteropathy|Liver injury|Gastrointestinal stromal tumour,6,5
10285958,20140709,Imatinib,30,801,30.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10285960,20140709,Imatinib,50,801,50.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death|Pancytopenia,2,5
10285961,20140709,Imatinib,31,801,31.0,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,5
10285967,20140709,Imatinib,76,801,76.0,1,,1,1,0,0,0,0,0,Imatinib,IMATINIB MESYLATE,1,ACUTE MYELOID LEUKAEMIA,Death,1,3
10285968,20140709,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10285970,20140709,Imatinib,51,801,51.0,2,,1,0,1,1,0,0,1,Imatinib,METRONIDAZOLE,9,CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypertension|Conjunctival haemorrhage|Alopecia|Urinary tract infection|Pyrexia|Mitral valve incompetence|Gait disturbance|Pain in extremity|Ear infection|Back pain|Chest pain|Productive cough|Cough|Ear disorder|Abdominal distension|Ocular hyperaemia|Inappropriate schedule of drug administration|Feeling cold|Affective disorder|Anaemia|Lacrimation increased|Fatigue|Vaginal infection|Furuncle|Tonsillitis|Gastrointestinal infection|Vomiting|Uterine leiomyoma|Cardiac murmur|Ovarian cyst|Hot flush|Dizziness|Menstrual disorder|Bone pain|Arthralgia|Headache|Abdominal pain|Dysuria|Pelvic pain|Irritability|Abdominal pain upper|Eye pain|Oedema peripheral|Swelling|Nausea|Influenza,46,1
10285972,20140709,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10285974,20140709,Imatinib,30,801,30.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10285978,20140709,Imatinib,66,801,66.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10286572,20140709,Imatinib,74,801,74.0,1,90,1,0,0,0,0,0,1,Imatinib,QUINAPRIL|QUINAPRIL HYDROCHLORIDE,11,MYOCARDIAL ISCHAEMIA|HYPERTENSION|CHRONIC MYELOID LEUKAEMIA|MYOCARDIAL ISCHAEMIA|MYOCARDIAL ISCHAEMIA,Face oedema|Eyelid oedema|Oedema peripheral|Generalised erythema|Skin exfoliation|Skin lesion,6,1
10286626,20140709,Imatinib,12,801,12.0,1,,1,0,0,0,0,0,0,Imatinib,CARBAMAZEPINE|NILOTINIB,3,CHRONIC MYELOID LEUKAEMIA,Drug level decreased,1,3
10286629,20140709,Imatinib,79,801,79.0,1,,1,0,0,0,0,0,0,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,Platelet count decreased|Malaise,2,3
10289501,20140710,Imatinib,60,801,60.0,1,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE,1,CHRONIC MYELOID LEUKAEMIA,Second primary malignancy|Myelodysplastic syndrome|Plasma cell myeloma,3,1
10295893,20140711,Imatinib,70,801,70.0,1,,1,1,0,0,0,0,0,Imatinib,SUNITINIB MALATE,4,GASTROINTESTINAL STROMAL TUMOUR|GASTROINTESTINAL STROMAL TUMOUR,Death,1,5
10295918,20140711,Imatinib,31,801,31.0,2,,1,1,0,0,0,0,0,Imatinib,,3,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10295926,20140711,Imatinib,38,801,38.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10295935,20140711,Imatinib,33,801,33.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,1
10296534,20140710,Imatinib,62,801,62.0,2,,1,0,1,0,0,0,0,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,Cardiac arrest|Pulmonary infarction|Platelet count decreased,3,3
10296538,20140710,Imatinib,60,801,60.0,1,,1,1,0,0,0,0,1,Imatinib,,3,CHRONIC MYELOID LEUKAEMIA,Death|Rash|Blast crisis in myelogenous leukaemia,3,1
10296552,20140710,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10296558,20140710,Imatinib,,,,2,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10296559,20140710,Imatinib,83,801,83.0,2,,1,0,1,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Cerebral infarction,1,3
10296566,20140710,Imatinib,35,801,35.0,2,,1,0,0,0,0,0,1,Imatinib,,9,CHRONIC MYELOID LEUKAEMIA,Weight increased|Cardiac disorder|Malaise|Pleural effusion|Pain|Electrocardiogram QT prolonged|Pyrexia,7,3
10296568,20140710,Imatinib,87,801,87.0,2,,1,0,0,0,0,0,1,Imatinib,,3,CHRONIC MYELOID LEUKAEMIA,Platelet count decreased|Compression fracture|Dementia,3,3
10296570,20140710,Imatinib,40,801,40.0,2,,1,1,1,1,1,1,1,Imatinib,NILOTINIB|DASATINIB|DASATINIB,5,Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Necrosis|Rash|Diarrhoea,3,3
10296574,20140710,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10296579,20140710,Imatinib,85,801,85.0,2,,1,0,0,0,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Fracture|Fall,2,3
10296586,20140710,Imatinib,,,,1,,1,0,0,0,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Renal impairment|Oedema,2,3
10296589,20140710,Imatinib,76,801,76.0,1,,1,1,1,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death|Colon cancer,2,3
10296593,20140710,Imatinib,84,801,84.0,1,,1,1,1,1,0,0,0,Imatinib,,3,PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION,Infectious pleural effusion|Pneumonia|Jaundice cholestatic,3,3
10296597,20140710,Imatinib,84,801,84.0,1,,1,0,1,0,0,0,0,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,Jaundice cholestatic,1,3
10296614,20140710,Imatinib,86,801,86.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10296618,20140710,Imatinib,85,801,85.0,2,,1,1,0,0,0,0,0,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10296643,20140710,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,,1,GASTROINTESTINAL STROMAL TUMOUR,Death,1,3
10296651,20140710,Imatinib,58,801,58.0,2,,1,0,0,0,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Second primary malignancy|Gastrointestinal carcinoma,2,3
10296667,20140710,Imatinib,36,801,36.0,1,,1,0,0,1,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Blast crisis in myelogenous leukaemia,1,3
10296692,20140710,Imatinib,,,,0,,1,0,0,0,0,0,1,Imatinib,,3,GASTROINTESTINAL STROMAL TUMOUR,Oedema|Tuberculosis,2,1
10297267,20140711,Imatinib,,,,2,,1,0,0,0,0,0,1,Imatinib,"TACROLIMUS|SUMATRIPTAN|DRONABINOL|FLUCONAZOLE|TACROLIMUS|DULOXETINE HYDROCHLORIDE|DULOXETINE|IMATINIB MESYLATE|LOPERAMIDE HYDROCHLORIDE|PREDNISONE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|OXYCODONE|MONTELUKAST SODIUM|AMLODIPINE|CALCIUM CARBONATE|ANTACID|INSULIN ASPART|FOLIC ACID|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|LEVALBUTEROL TARTRATE|ACYCLOVIR|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|SENNOSIDES|SENNA LEAF|SENNA",30,MIGRAINE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ACUTE MYELOID LEUKAEMIA|PAIN|DIARRHOEA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|CONSTIPATION|VOMITING,Abdominal tenderness|Catheter site infection|Diarrhoea|Graft versus host disease,4,5
10297351,20140711,Imatinib,61,801,61.0,1,,1,1,0,0,0,0,1,Imatinib,AZACITIDINE|AZACITIDINE FOR|HYDROXYUREA|IMATINIB,3,PANCYTOPENIA|CHRONIC MYELOID LEUKAEMIA,Chronic myeloid leukaemia|Neutropenia|Chronic myeloid leukaemia transformation|Metastases to skin|Thrombocytopenia|Drug ineffective|Death|Malignant neoplasm progression|Pancytopenia,9,3
10297358,20140711,Imatinib,42,801,42.0,2,,1,1,0,0,0,0,1,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death|Chronic myeloid leukaemia|Leukaemia recurrent,3,5
10297360,20140711,Imatinib,,,,1,,1,1,0,0,0,0,0,Imatinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10297368,20140711,Imatinib,60,801,60.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10297376,20140711,Imatinib,81,801,81.0,2,,1,1,0,0,0,0,0,Imatinib,,2,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10297378,20140711,Imatinib,,,,0,,1,1,0,0,0,0,0,Imatinib,,1,,Death,1,3
10297381,20140711,Imatinib,45,801,45.0,1,53,1,1,1,0,0,0,1,Imatinib,HYDROXYUREA,4,CHRONIC MYELOID LEUKAEMIA|CHRONIC MYELOID LEUKAEMIA,Death|Neutropenia|Haemorrhagic disorder|Drug intolerance|Blast crisis in myelogenous leukaemia|Thrombocytopenia|Pneumonia|Pyrexia|Anaemia,9,5
10297391,20140711,Imatinib,71,801,71.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10297400,20140711,Imatinib,71,801,71.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,5
10297420,20140711,Imatinib,57,801,57.0,1,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10297436,20140711,Imatinib,29,801,29.0,0,,1,1,0,0,0,0,1,Imatinib,,1,GASTROINTESTINAL NEOPLASM,Death|Metastasis|Oedema,3,3
10297563,20140711,Imatinib,87,801,87.0,2,,1,0,0,0,0,0,1,Imatinib,IMATINIB MESYLATE|IMATINIB MESYLATE,2,GASTROINTESTINAL STROMAL TUMOUR,Immune thrombocytopenic purpura|Platelet count decreased,2,1
10297635,20140711,Imatinib,63,801,63.0,2,,1,1,0,0,0,0,0,Imatinib,,1,CHRONIC MYELOID LEUKAEMIA,Death,1,3
10006147,20140313,Erlotinib,71,801,71.0,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|FOLIC ACID|LOSARTAN POTASSIUM|LOSARTAN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|MINOCYCLINE,8,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dizziness|Fatigue|Rash,3,5
10006148,20140313,Erlotinib,69,801,69.0,1,,1,0,0,0,0,0,1,Erlotinib,CISPLATIN,4,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Anaemia|Malignant neoplasm progression|Diarrhoea,3,1
10006149,20140313,Erlotinib,35,801,35.0,2,,1,0,1,0,0,0,0,Erlotinib,ESCITALOPRAM|FOLIC ACID,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Haemorrhage intracranial|Food poisoning|Pneumonia,3,5
10006150,20140313,Erlotinib,70,801,70.0,2,,1,0,1,0,0,0,0,Erlotinib,LATANOPROST|AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM|AMLODIPINE AND ATORVASTATIN|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|VALACYCLOVIR HYDROCHLORIDE|ALBUTEROL SULFATE|FLUTICASONE PROPIONATE AND SALMETEROL|FLUTICASONE PROPIONATE AND SALMETEROL,13,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Haemoptysis|Dyspnoea|Fatigue,3,5
10006151,20140313,Erlotinib,55,801,55.0,1,,1,1,0,0,0,0,0,Erlotinib,METHYLNALTREXONE BROMIDE,2,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Incorrect dose administered|Overdose|Death,3,5
10006152,20140313,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,,5,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Local swelling|Haemorrhage|Erythema|Localised infection|Localised infection|Skin disorder|Pain in extremity|Secretion discharge|Scab|Rash|Pruritus|Rash,12,5
10006153,20140313,Erlotinib,54,801,54.0,2,,1,0,1,0,0,0,0,Erlotinib,ALPRAZOLAM|MORPHINE SULFATE|PREDNISONE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FLUTICASONE PROPIONATE AND SALMETEROL|FOLIC ACID,9,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Nephrolithiasis|Nausea,2,5
10006154,20140313,Erlotinib,69,801,69.0,2,,1,0,0,0,0,0,1,Erlotinib,DOXYCYCLINE|DOXYCYCLINE HYCLATE|ASCORBIC ACID|ERGOCALCIFEROL,10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Neutropenia|Rhinorrhoea|Dermatitis acneiform|Dermatitis acneiform,4,5
10006155,20140313,Erlotinib,61,801,61.0,1,,1,0,0,0,0,0,1,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Epistaxis|Mucosal haemorrhage|Pain|Vomiting|Diarrhoea|Malignant neoplasm progression,6,1
10006156,20140313,Erlotinib,73,801,73.0,1,,1,1,0,0,0,0,0,Erlotinib,"OLANZAPINE|OLANZAPINE PAMOATE|ATORVASTATIN CALCIUM|DIVALPROEX SODIUM|CLONAZEPAM|MAGNESIUM HYDROXIDE|LUBIPROSTONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|BLACK COHOSH, BRYONIA ALBA WHOLE, TOXICODENDRON PUBESCENS WHOLE, ARNICA MONTANA, CAUSTICUM, FERROSOFERRIC PHOSPHATE, SODIUM SULFATE ANHYDROUS, STRYCHNOS NUX-VOMICA SEED, RHODODENDRON AUREUM WHOLE, CITRULLUS COLOCYNTHIS WHOLE, SOLANUM DULCAMARA WHOLE, KALMIA LATIFOLIA WHOLE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, ARSENIC TRIOXIDE, AND TRIBASIC CALCIUM PHOSPHATE|BERBERIS VULGARIS ROOT BARK, BRYONIA ALBA ROOT, PHENOL, MILK THISTLE, CHELIDONIUM MAJUS, JUNIPER BERRY, LYCOPODIUM CLAVATUM SPORE, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, SODIUM SULFATE, STRYCHNOS NUX-VOMICA SEED, PHOSPHORUS, LACTIC ACID, L-, TARAXACUM OFFICINALE, VISCUM ALBUM FRUITING TOP, AND YUCCA FILAMENTOSA|ARTEMISIA CINA PRE-FLOWERING TOP, TANACETUM VULGARE WHOLE, ARTEMISIA VULGARIS WHOLE, DRYOPTERIS FILIX-MAS ROOT, MERCURIC CHLORIDE, AND GRAPHITE|AMBROSIA ARTEMISIAEFOLIA, ARALIA RACEMOSA, ARNICA MONTANA, CALENDULA OFFICINALIS, CHROMICUM ACIDUM, ECHINACEA PURPUREA, EUCALYPTOL, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC VACCINUM, MERCURIUS IODATUS FLAVUS, MERCURIUS SULPHURATUS RUBER, NATRUM ARSENICICUM, ROSA DAMASCENA, SABADILLA, SANGUINARINUM NITRICUM, SYMPHYTUM OFFICINALE|NAJA NAJA WHOLE, SCROPHULARIA NODOSA, LACTIC ACID, DL-, AND RADIUM BROMIDE|APIS MELLIFERA, ASPARAGUS, BERBERIS VULGARIS ROOT BARK, LYTTA VESICATORIA, CHELIDONIUM MAJUS, JUNIPER BERRY, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, POPULUS TREMULOIDES BARK, RHUS AROMATICA ROOT BARK, RUBIA TINCTORUM ROOT, SAW PALMETTO, SOLIDAGO VIRGAUREA FLOWERING TOP, TARAXACUM OFFICINALE, AND ARCTOSTAPHYLOS UVA-URSI LEAF|AVENA SATIVA WHOLE, VALERIANA OFFICINALIS WHOLE, HUMULUS LUPULUS WHOLE, ARABICA COFFEE BEAN, STRYCHNOS IGNATII WHOLE, ZINC VALERATE DIHYDRATE, AMMONIUM BROMIDE, CHAMOMILE, ESCHSCHOLZIA CALIFORNICA, AND PASSIFLORA INCARNATA WHOLE|APIS MELLIFICA, ARGENTUM NITRICUM, BADIAGA, BELLADONNA, CANTHARIS, CAUSTICUM, CHIMAPHILA UMBELLATA, COLOCYNTHIS, CUBEBA OFFICINALIS, CUCURBITA CITRULLUS, CUCURBITA PEPO FLOWER, ECHINACEA ANGUSTIFOLIA, EQUISETUM HYEMALE, ERYNGIUM AQUATICUM, FERRUM PHOSPHORICUM, MITCHELLA REPENS, OLEUM SANTALI, PETROSELINUM SATIVUM, PIPER METHYSTICUM, POPULUS TREMULOIDES BARK, SARSAPARILLA, TEREBINTHINA, UVA URSI|ACHILLEA MILLEFOLIUM, ARNICA MONTANA, HYPERICUM PERFORATUM, HORSE CHESTNUT, AND VISCUM ALBUM WHOLE|ACONITUM NAPELLUS, AMERICAN GINSENG, ARSENICUM IODATUM, BLATTA ORIENTALIS, CALCAREA SULPHURICA, CARPINUS BETULUS FLOWER, CUPRUM METALLICUM, GRINDELIA, HEPAR SULPHURIS CALCAREUM, IPECACUANHA, JUSTICIA ADHATODA, KALI IODATUM, LOBELIA INFLATA, NAPHTHALINUM, NARCISSUS PSEUDONARCISSUS, PINE TAR, POPULUS CANDICANS, TABACUM, THUJA OCCIDENTALIS, THYMUS SERPYLLUM|PASSIFLORA INCARNATA WHOLE, SMILAX ORNATA WHOLE, PHYTOLACCA AMERICANA ROOT, STILLINGIA SYLVATICA ROOT, TRIFOLIUM PRATENSE WHOLE, ARCTIUM LAPPA WHOLE, PRUNUS DULCIS WHOLE, FRANGULA PURSHIANA BARK, BERBERIS VULGARIS WHOLE, GLYCYRRHIZA GLABRA WHOLE, AND LARREA DIVARICATA WHOLE|ALOE, ACTIVATED CHARCOAL, COLCHICUM AUTUMNALE BULB, COLLINSONIA CANADENSIS ROOT, CUCURBITA PEPO FLOWER, DRYOPTERIS FILIX-MAS ROOT, INDOLE, SKIM MILK, LYCOPODIUM CLAVATUM SPORE, ACHILLEA MILLEFOLIUM, SODIUM SULFATE, FRANGULA PURSHIANA BARK, SCROPHULARIA NODOSA, SKATOLE, TARAXACUM OFFICINALE, TARTARIC ACID|ARANEUS DIADEMATUS, ARISAEMA TRIPHYLLUM ROOT, ASTERIAS RUBENS, BAPTISIA TINCTORIA, BARIUM IODIDE, ECHINACEA ANGUSTIFOLIA, FERROUS IODIDE, GOLDENSEAL, LACHESIS MUTA VENOM, PHYTOLACCA AMERICANA ROOT, PINUS SYLVESTRIS FLOWERING TOP, SCROPHULARIA NODOSA, SPONGIA OFFICINALIS SKELETON, ROASTED, AND TEUCRIUM SCORODONIA FLOWERING TOP|ALFALFA, ALLIUM SATIVUM, ASPARAGUS OFFICINALIS, AVENA SATIVA, BELLADONNA, BERBERIS VULGARIS, CHELIDONIUM MAJUS, GLYCYRRHIZA GLABRA, HYDRASTIS CANADENSIS, JUNIPERUS VIRGINIANA, NICCOLUM METALLICUM, PASSIFLORA INCARNATA, SARCOLACTICUM ACIDUM, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE|ALNUS GLUTINOSA, APIS MELLIFICA, BERBERIS VULGARIS, CALCIUM SULFIDE, CROTON TIGLIUM, ECHINACEA ANGUSTIFOLIA, GRAPHITE, GRINDELIA HIRSUTULA, HYDROFLUORIC ACID, JUGLANS REGIA, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, MYRISTICA SEBIFERA, NITRICUM ACIDUM, PHOSPHORUS, RHUS TOXICODENDRON, SCROPHULARIA NODOSA, SOLIDAGO VIRGAUREA, SULPHUR, VINCA MINOR",16,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10006157,20140313,Erlotinib,70,801,70.0,1,,1,1,0,0,0,0,0,Erlotinib,LATANOPROST|SIMVASTATIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|GLIPIZIDE|FLUTICASONE PROPIONATE AND SALMETEROL,12,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10006158,20140313,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,"ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE",8,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pulmonary thrombosis|Thrombosis,2,5
10006159,20140313,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,LISINOPRIL,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Blood disorder|Neoplasm malignant,2,5
10006160,20140313,Erlotinib,,,,1,,1,0,0,0,0,0,1,Erlotinib,PANTOPRAZOLE|PANCRELIPASE|OXYCODONE AND ACETAMINOPHEN|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|OXYCODONE AND ACETAMINOPHEN TABLETS|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|POTASSIUM CHLORIDE,9,NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dyspepsia,1,5
10006161,20140313,Erlotinib,57,801,57.0,1,,1,1,0,0,0,0,0,Erlotinib,OXYCODONE HYDROCHLORIDE|PREDNISONE|LANSOPRAZOLE|METOPROLOL SUCCINATE,9,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Blood urine present|Cholelithiasis|Dizziness|Fatigue|Pneumonia|Decreased appetite|Skin reaction,8,5
10006162,20140313,Erlotinib,89,801,89.0,1,,1,0,0,0,0,0,1,Erlotinib,TEMAZEPAM,6,LUNG NEOPLASM MALIGNANT|HYPOTHYROIDISM|INSOMNIA|PRODUCT USED FOR UNKNOWN INDICATION,Abdominal pain|Flatulence|Muscle spasms|Rash|Flatulence|Eructation|Constipation|Eructation|Vision blurred|Blood pressure increased|Anxiety|Hypophagia|Weight decreased|Rash|Rash|Acne|Pruritus,17,5
10006163,20140313,Erlotinib,59,801,59.0,1,,1,1,0,0,0,0,1,Erlotinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,Death|Ill-defined disorder,2,5
10006164,20140313,Erlotinib,77,801,77.0,2,,1,0,1,0,0,0,0,Erlotinib,"DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE|LANSOPRAZOLE|MONTELUKAST SODIUM|TRIAMTERENE CAPSULES|TRIAMTERENE|CALCIUM|BRIMONIDINE TARTRATE, TIMOLOL MALEATE",11,LUNG NEOPLASM MALIGNANT|NUTRITIONAL SUPPLEMENTATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Fall|Full blood count decreased|Contusion|Fatigue|Diarrhoea|Decreased appetite,6,5
10006165,20140313,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|GLYBURIDE,6,BRONCHIAL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10006166,20140313,Erlotinib,60,801,60.0,1,,1,1,0,0,0,0,0,Erlotinib,MEGESTROL ACETATE|LISINOPRIL,5,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Incorrect dose administered|Death,2,5
10006167,20140313,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,,1,METASTASES TO LUNG,Death,1,5
10006168,20140313,Erlotinib,67,801,67.0,1,,1,0,0,0,0,0,1,Erlotinib,ROSUVASTATIN|MINOCYCLINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CANDESARTAN CILEXETIL|MAGNESIUM,7,PANCREATIC CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Incorrect dose administered|White blood cell count decreased|Rash,3,5
10006169,20140313,Erlotinib,43,801,43.0,1,,1,1,0,0,0,0,0,Erlotinib,EVEROLIMUS|PAZOPANIB HYDROCHLORIDE,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10006170,20140313,Erlotinib,,,,1,,1,0,0,0,0,0,1,Erlotinib,CAPECITABINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,6,SALIVARY GLAND CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Off label use|Atrial fibrillation|Metastases to bone,3,3
10006171,20140313,Erlotinib,73,801,73.0,1,,1,0,1,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Fall,1,5
10006172,20140313,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Incorrect dose administered|Visual acuity reduced|Blood triglycerides increased,3,5
10006178,20140313,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10006180,20140313,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10006182,20140313,Erlotinib,64,801,64.0,2,,1,1,0,0,0,0,1,Erlotinib,ESCITALOPRAM|FOLIC ACID|RIVAROXABAN|ARIPIPRAZOLE,10,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Spinal disorder|Device related infection,3,3
10006191,20140313,Erlotinib,63,801,63.0,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,4,LUNG ADENOCARCINOMA|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION,Interstitial lung disease|Pyrexia|Diarrhoea|Rash,4,5
10006195,20140313,Erlotinib,67,801,67.0,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,2,PRODUCT USED FOR UNKNOWN INDICATION,Abdominal symptom|Conjunctivitis|Dyspnoea|Vomiting|Diarrhoea|Decreased appetite,6,5
10006198,20140313,Erlotinib,62,801,62.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|LOSARTAN,5,LUNG NEOPLASM MALIGNANT|HYPERTENSION|HYPERTENSION,Eye swelling|Rash|Ocular hyperaemia|Incorrect dose administered,4,5
10006200,20140313,Erlotinib,,,,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,NON-SMALL CELL LUNG CANCER,Pleural effusion,1,5
10006203,20140313,Erlotinib,85,801,85.0,1,,1,0,0,0,0,0,1,Erlotinib,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,3,PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Hearing impaired|Epistaxis|Hypertension|Computerised tomogram abnormal|Inappropriate schedule of drug administration|Rash|Hip fracture|Haemorrhagic diathesis|Rash|Dry skin,10,5
10006204,20140313,Erlotinib,80,801,80.0,2,,1,1,0,0,0,0,0,Erlotinib,,1,LUNG ADENOCARCINOMA,Death,1,5
10006232,20140313,Erlotinib,80,801,80.0,2,,1,1,1,0,0,0,1,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Asphyxia|Epilepsy|Metastases to central nervous system|Lung infection,4,5
10011530,20140314,Erlotinib,50,801,50.0,1,,1,1,0,0,0,0,0,Erlotinib,MORPHINE SULFATE|HYDROMORPHONE HYDROCHLORIDE|PANCRELIPASE|PROCHLORPERAZINE|QUETIAPINE|SERTRALINE HYDROCHLORIDE|LORAZEPAM,10,PANCREATIC CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10011531,20140314,Erlotinib,,,,1,,1,0,0,0,0,0,1,Erlotinib,"DULOXETINE HYDROCHLORIDE|CALCIUM CARBONATE, SIMETHICONE|SIMETHICONE|DIGOXIN|QUETIAPINE|SARGRAMOSTIM|FOLIC ACID",10,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Atrial fibrillation|Eructation|Flatulence|Abdominal discomfort|Hyperchlorhydria,5,5
10011542,20140314,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|RIVAROXABAN|PREDNISONE|PREDNISONE,5,CHRONIC LYMPHOCYTIC LEUKAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Off label use|Death,2,5
10011546,20140314,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|PROCHLORPERAZINE MALEATE,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10011548,20140314,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10011550,20140314,Erlotinib,65,801,65.0,2,,1,0,0,0,0,0,1,Erlotinib,DOCETAXEL|DOCETAXEL ANHYDROUS,2,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Neutropenia|Malignant neoplasm progression,2,1
10011558,20140314,Erlotinib,,,,1,,1,1,0,0,1,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression|Deafness|Bone pain|Memory impairment,4,5
10011561,20140314,Erlotinib,49,801,49.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Incorrect dose administered|Death,2,3
10011564,20140314,Erlotinib,48,801,48.0,1,,1,0,0,0,0,0,1,Erlotinib,,2,ADENOID CYSTIC CARCINOMA|LEUKAEMIA,Off label use|Dacryostenosis acquired|Vision blurred,3,5
10011569,20140314,Erlotinib,67,801,67.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|OXYCODONE|AMLODIPINE,4,LUNG NEOPLASM MALIGNANT|PAIN|PAIN|PRODUCT USED FOR UNKNOWN INDICATION,Blood pressure increased|Abdominal discomfort|Vision blurred|Nervousness|Depression|Insomnia|Decreased appetite|Weight decreased|Incorrect dose administered,9,5
10014522,20140317,Erlotinib,63,801,63.0,2,,1,0,1,0,0,0,1,Erlotinib,PEMETREXED DISODIUM|PEMETREXED|CISPLATIN,5,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pain|Hypertension|Investigation|Vomiting|Diarrhoea|Malignant neoplasm progression,6,1
10014523,20140317,Erlotinib,76,801,76.0,2,,1,1,0,0,0,0,0,Erlotinib,,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10014525,20140317,Erlotinib,51,801,51.0,2,,1,1,0,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Syncope,1,5
10014526,20140317,Erlotinib,67,801,67.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10014530,20140317,Erlotinib,54,801,54.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|LEVOTHYROXINE SODIUM|METOPROLOL TARTRATE|METOPROLOL,6,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Incorrect dose administered|Death,2,5
10014532,20140317,Erlotinib,46,801,46.0,2,,1,1,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG ADENOCARCINOMA,Death|Convulsion|Therapeutic response decreased|Metastases to bone|Metastases to central nervous system,5,1
10014544,20140317,Erlotinib,69,801,69.0,1,,1,1,0,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Dyspnoea|Asthenia|Decreased appetite,3,5
10017802,20140318,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10017813,20140318,Erlotinib,68,801,68.0,1,,1,1,0,0,0,0,0,Erlotinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10017829,20140318,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10017830,20140318,Erlotinib,,,,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Pleural fibrosis|Rash|Dry eye|Vision blurred,4,5
10017832,20140318,Erlotinib,55,801,55.0,1,,1,1,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Gait disturbance|Pain in extremity|Immobile|Rash,4,5
10017835,20140318,Erlotinib,57,801,57.0,2,,1,1,0,0,0,0,0,Erlotinib,,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10017840,20140318,Erlotinib,54,801,54.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|FOLIC ACID|CALCIUM|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LEVETIRACETAM|PANTOPRAZOLE|PEMETREXED DISODIUM|CARBOPLATIN,15,NON-SMALL CELL LUNG CANCER|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|NAUSEA|CONVULSION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|GASTROOESOPHAGEAL REFLUX DISEASE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Eye pruritus|Lacrimation increased|Facial pain|Weight fluctuation|Surgical failure|Growth of eyelashes|Hair texture abnormal|Blister|Rash|Dry skin|Wound,11,5
10021012,20140319,Erlotinib,79,801,79.0,2,,1,1,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,LUNG NEOPLASM MALIGNANT,Intestinal obstruction|Death|Neoplasm,3,1
10021016,20140319,Erlotinib,70,801,70.0,2,,1,0,0,0,0,0,1,Erlotinib,ATORVASTATIN CALCIUM,4,NON-SMALL CELL LUNG CANCER|BLOOD CHOLESTEROL|GASTROOESOPHAGEAL REFLUX DISEASE,Incorrect dose administered|Eyelid oedema|Face oedema|Madarosis|Eye pain|Rash|Dry skin|Eyelids pruritus|Skin exfoliation|Pigmentation disorder|Corneal abrasion,11,5
10021018,20140319,Erlotinib,58,801,58.0,2,,1,1,0,0,0,0,0,Erlotinib,,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10021019,20140319,Erlotinib,54,801,54.0,2,,1,0,1,0,0,0,0,Erlotinib,,1,LUNG NEOPLASM MALIGNANT,Foot fracture,1,5
10021021,20140319,Erlotinib,77,801,77.0,2,,1,1,0,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Death,1,5
10021023,20140319,Erlotinib,81,801,81.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Incorrect dose administered|Death,2,5
10021035,20140319,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,,2,LUNG NEOPLASM MALIGNANT|NERVOUS SYSTEM DISORDER,Off label use|Pulmonary thrombosis|Fall|Performance status decreased|Thrombosis|Head injury|Dizziness|Malaise|Diarrhoea,9,3
10021038,20140319,Erlotinib,91,801,91.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,4,LUNG NEOPLASM MALIGNANT,Death|Incorrect dose administered,2,5
10021039,20140319,Erlotinib,52,801,52.0,2,,1,0,1,0,0,0,0,Erlotinib,,3,NON-SMALL CELL LUNG CANCER,Fall|Head injury|Gait disturbance|Rash,4,5
10021040,20140319,Erlotinib,39,801,39.0,1,,1,1,0,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Organ failure,1,5
10021043,20140319,Erlotinib,56,801,56.0,2,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|LEVOTHYROXINE|LEVOTHYROXINE SODIUM|ERLOTINIB HYDROCHLORIDE,4,PRODUCT USED FOR UNKNOWN INDICATION|HYPOTHYROIDISM|LUNG NEOPLASM MALIGNANT,Pain|Abdominal pain|Death,3,5
10021045,20140319,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,VINORELBINE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|CISPLATIN|ETOPOSIDE,4,PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10021047,20140319,Erlotinib,,,,1,,1,1,0,0,0,0,1,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Lung infection|Nasopharyngitis,2,5
10021048,20140319,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10021049,20140319,Erlotinib,87,801,87.0,1,,1,1,0,0,0,0,0,Erlotinib,,1,LUNG NEOPLASM MALIGNANT,Incorrect dose administered|Sepsis|Lung neoplasm malignant,3,3
10021050,20140319,Erlotinib,66,801,66.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PANCREATIC CARCINOMA,Death,1,5
10021057,20140319,Erlotinib,66,801,66.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Pulmonary haemorrhage,1,5
10021059,20140319,Erlotinib,,,,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Pleural effusion|Pneumothorax|Cough|Asthenia,4,5
10021061,20140319,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Organ failure,1,5
10021064,20140319,Erlotinib,47,801,47.0,1,,1,1,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Schizophrenia|Metastases to central nervous system,2,5
10023951,20140320,Erlotinib,56,801,56.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,LUNG NEOPLASM MALIGNANT,Dry eye|Eye pain|Rash|Malignant neoplasm progression|Eye pruritus|Hyperventilation|Dry eye|Sensory disturbance|Diarrhoea|Skin fissures|Skin discolouration|Cough,12,5
10023965,20140320,Erlotinib,61,801,61.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,25,LUNG ADENOCARCINOMA|DIARRHOEA|GASTRITIS|LUNG ADENOCARCINOMA|COLITIS ULCERATIVE|GASTRITIS|TACHYARRHYTHMIA|LUNG ADENOCARCINOMA|DIZZINESS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Respiratory disorder|Nasal congestion|Vomiting|Nausea|Epistaxis|Headache|Dermatitis|Folliculitis,8,2
10023971,20140320,Erlotinib,51,801,51.0,1,,1,0,1,0,0,0,1,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Muscle injury|Limb injury|Injury|Cervical vertebral fracture|Asthenia|Fall,6,5
10023983,20140320,Erlotinib,61,801,61.0,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,LUNG ADENOCARCINOMA,Cough|Pyrexia|Haemoptysis|Diarrhoea|Pneumonia|Nasopharyngitis|White blood cell count decreased,7,5
10023986,20140320,Erlotinib,60,801,60.0,1,,1,1,1,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Blood disorder|Death|Liver disorder,3,5
10023989,20140320,Erlotinib,,,,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Nephrolithiasis|Asthenia,2,5
10023991,20140320,Erlotinib,79,801,79.0,2,,1,0,1,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Fall|Fracture,2,5
10025307,20140320,Erlotinib,70,801,70.0,1,,1,0,1,0,0,0,0,Erlotinib,ATORVASTATIN CALCIUM|ERLOTINIB HYDROCHLORIDE|OLANZAPINE|OLANZAPINE PAMOATE,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pancreatitis|Palmar-plantar erythrodysaesthesia syndrome,2,2
10026989,20140321,Erlotinib,53,801,53.0,1,56,1,0,1,0,0,0,1,Erlotinib,"ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|DACOMITINIB|QUAZEPAM|MIRTAZAPINE|CLOBETASOL PROPIONATE|CLOBETASOL PROPIONATE OINTMENT USP, 0.05%|PREGABALIN",24,CHEST PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DEPRESSION|DERMATITIS ACNEIFORM|HEADACHE|CHEST PAIN|BOWEL MOVEMENT IRREGULARITY|CHEST PAIN|DERMATITIS ACNEIFORM|CHEST PAIN|CONSTIPATION|DERMATITIS ACNEIFORM|NAUSEA|DEPRESSION,Non-small cell lung cancer|Pleural effusion|Decreased appetite|Fluid intake reduced|Nausea|Vomiting,6,1
10027289,20140321,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG CANCER METASTATIC,Death,1,5
10027291,20140321,Erlotinib,,,,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,TRACHEAL CANCER,Off label use|Spinal fracture|Fall,3,5
10027293,20140321,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|DOXYCYCLINE HYCLATE|DOXYCYCLINE|DOXYCLYCLINE HYCLATE|LORAZEPAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|GUAIFENESIN|ERGOCALCIFEROL,10,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Non-small cell lung cancer,1,5
10027295,20140321,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Death,1,1
10027296,20140321,Erlotinib,69,801,69.0,2,,1,0,1,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Urinary tract obstruction,1,5
10027297,20140321,Erlotinib,63,801,63.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|FOLIC ACID|TIOTROPIUM BROMIDE|FLUTICASONE PROPIONATE AND SALMETEROL|MAGNESIUM,11,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10027302,20140321,Erlotinib,71,801,71.0,2,,1,1,0,0,0,0,0,Erlotinib,,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10027308,20140321,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10027317,20140321,Erlotinib,,,,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Blood glucose increased|Rash|Pruritus,3,5
10027318,20140321,Erlotinib,57,801,57.0,1,,1,1,0,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Respiratory failure,1,5
10027319,20140321,Erlotinib,72,801,72.0,2,,1,0,0,0,0,0,1,Erlotinib,"ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERGOCALCIFEROL|CALCIUM CARBONATE, SIMETHICONE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",8,PRODUCT USED FOR UNKNOWN INDICATION|PAIN|VITAMIN D DECREASED|REFLUX GASTRITIS|NON-SMALL CELL LUNG CANCER|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV|PRODUCT USED FOR UNKNOWN INDICATION,Hair texture abnormal|Nasal dryness|Conjunctivitis|Hair texture abnormal|Alopecia|Lip swelling|Tongue eruption|Malignant neoplasm progression|Madarosis|Eye irritation|Eye discharge|Rash|Eye irritation|Pruritus|Acne|Weight increased|Skin burning sensation|Glossodynia|Diarrhoea,19,5
10027320,20140321,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,"GLIPIZIDE|LANSOPRAZOLE|SIMVASTATIN|PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE|ERLOTINIB HYDROCHLORIDE|INSULIN GLULISINE|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|INSULIN GLARGINE|PANCRELIPASE|DOXYCYCLINE HYCLATE|DOXYCYCLINE|DOXYCLYCLINE HYCLATE",15,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Lung cancer metastatic|Constipation|Rash|Decreased appetite|Rash|Asthenia,6,5
10027321,20140321,Erlotinib,66,801,66.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|CARBOPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE,4,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|ATRIAL FIBRILLATION,Thrombocytopenia|Taeniasis,2,1
10027322,20140321,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10027323,20140321,Erlotinib,64,801,64.0,1,,1,1,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,PRODUCT USED FOR UNKNOWN INDICATION,Oedema peripheral|Haemoglobin decreased,2,5
10031468,20140324,Erlotinib,59,801,59.0,2,,1,1,0,0,0,0,0,Erlotinib,,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10031471,20140324,Erlotinib,65,801,65.0,1,,1,0,1,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Hydrocephalus,1,5
10031473,20140324,Erlotinib,58,801,58.0,1,,1,1,1,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Thrombosis|Angiopathy|Oedema|Eating disorder|Oedema peripheral|Back pain|Asthenia,7,5
10031480,20140324,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10031481,20140324,Erlotinib,86,801,86.0,1,,1,0,1,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Hypotension|Dizziness,2,5
10031482,20140324,Erlotinib,63,801,63.0,1,,1,1,0,0,0,0,0,Erlotinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10031483,20140324,Erlotinib,,,,0,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Liver injury|Thrombotic microangiopathy,2,1
10031484,20140324,Erlotinib,71,801,71.0,2,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Dehydration|Dyspepsia|Mouth haemorrhage|Tongue ulceration|Abdominal discomfort|Diarrhoea|Vomiting,7,5
10031488,20140324,Erlotinib,61,801,61.0,2,,1,1,0,0,0,0,0,Erlotinib,OXYCODONE HYDROCHLORIDE|TEMAZEPAM|LEVOTHYROXINE SODIUM|BISOPROLOL FUMARATE|PREGABALIN|TIOTROPIUM BROMIDE,9,LUNG CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10031490,20140324,Erlotinib,64,801,64.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10031493,20140324,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Cardiac failure|Rash|Diarrhoea,3,5
10031500,20140324,Erlotinib,,,,2,,1,1,1,0,0,0,1,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Respiratory failure|Gait disturbance|Lung infection|Nasopharyngitis|Pyrexia,5,5
10034415,20140324,Erlotinib,73,801,73.0,1,92,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,2,LUNG NEOPLASM MALIGNANT,Haematuria,1,3
10034666,20140325,Erlotinib,57,801,57.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,NON-SMALL CELL LUNG CANCER,Death,1,1
10034667,20140325,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10034671,20140325,Erlotinib,73,801,73.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ATORVASTATIN CALCIUM|WARFARIN,5,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10034680,20140325,Erlotinib,79,801,79.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|HYDROCHLOROTHIAZIDE|CLOPIDOGREL,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10034682,20140325,Erlotinib,64,801,64.0,1,,1,1,0,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Cardiac failure|Lung infection|Depression|Dyspnoea|Nasopharyngitis,5,5
10034685,20140325,Erlotinib,53,801,53.0,2,,1,0,1,0,0,0,1,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Ligament sprain|Pulmonary mass|Pyrexia|Cough,4,5
10035432,20140325,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,WARFARIN,4,LUNG NEOPLASM MALIGNANT|ANTICOAGULANT THERAPY|THYROID DISORDER,Death|Rash,2,5
10037526,20140326,Erlotinib,65,801,65.0,2,,1,1,0,0,0,0,0,Erlotinib,,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10037527,20140326,Erlotinib,48,801,48.0,2,,1,1,0,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Death,1,5
10037528,20140326,Erlotinib,,,,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|VORICONAZOLE,2,NON-SMALL CELL LUNG CANCER|ASPERGILLUS INFECTION,Eosinophilia|Drug interaction|Thrombocytopenia|Rash|Leukocytosis|Neutrophilia,6,1
10037533,20140326,Erlotinib,65,801,65.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10037536,20140326,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10037539,20140326,Erlotinib,84,801,84.0,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Fall|Spinal compression fracture|Forearm fracture|Limb injury,4,5
10037546,20140326,Erlotinib,,,,1,,1,1,1,0,0,0,1,Erlotinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,General physical health deterioration|White blood cell count decreased|Platelet count decreased,3,5
10037552,20140326,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|AMLODIPINE BESYLATE,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10037556,20140326,Erlotinib,,,,1,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,2,LUNG NEOPLASM MALIGNANT,Angle closure glaucoma|Visual impairment|Ocular hypertension|Keratitis|Pneumonia|Conjunctivitis,6,1
10037558,20140326,Erlotinib,57,801,57.0,1,,1,1,0,0,0,0,0,Erlotinib,,1,LUNG NEOPLASM MALIGNANT,Death,1,1
10037560,20140326,Erlotinib,,,,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|CLONAZEPAM|CIMETIDINE|ESCITALOPRAM|LISINOPRIL|LORAZEPAM,6,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Suicidal ideation|Oesophagitis,2,1
10037563,20140326,Erlotinib,82,801,82.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|SIMVASTATIN|CLOPIDOGREL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|GABAPENTIN|CLOPIDOGREL|CLOPIDOGREL BISULFATE,7,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Incorrect dose administered|Death|Pruritus generalised,3,5
10037568,20140326,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ATENOLOL|POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL|POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL|HYPROMELLOSE|LIDOCAINE PATCH 5%|OXYCODONE|GEMFIBROZIL|OXYBUTYNIN|ERGOCALCIFEROL|ALPRAZOLAM|MAGNESIUM,21,LUNG NEOPLASM MALIGNANT|BONE CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Incorrect dose administered|Death|Vomiting|Decreased appetite,4,5
10037593,20140325,Erlotinib,73,801,73.0,1,88.8,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,2,LUNG NEOPLASM MALIGNANT,Haematuria,1,3
10041077,20140327,Erlotinib,67,801,67.0,1,,1,1,0,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Death,1,5
10041086,20140327,Erlotinib,69,801,69.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10041087,20140327,Erlotinib,83,801,83.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|LETROZOLE|LETROZOLE TABLETS|ENALAPRIL,3,BREAST CANCER FEMALE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10041088,20140327,Erlotinib,36,801,36.0,2,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Lung cancer metastatic,1,1
10041089,20140327,Erlotinib,76,801,76.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PLASMA CELL MYELOMA,Death,1,5
10041091,20140327,Erlotinib,60,801,60.0,2,,1,1,1,0,0,0,0,Erlotinib,,3,LUNG NEOPLASM MALIGNANT|BRAIN NEOPLASM MALIGNANT|BLOOD PRESSURE,Death|Vision blurred|Vision blurred,3,1
10041097,20140327,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,2,LUNG NEOPLASM MALIGNANT,Death,1,5
10041098,20140327,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10041100,20140327,Erlotinib,,,,1,,1,0,1,0,0,0,0,Erlotinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,Fracture,1,5
10041101,20140327,Erlotinib,61,801,61.0,2,,1,1,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|LISINOPRIL|LORAZEPAM|PREDNISONE|TIOTROPIUM BROMIDE,10,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Haemorrhage,2,5
10041105,20140327,Erlotinib,67,801,67.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,1
10043571,20140328,Erlotinib,51,801,51.0,1,,1,1,0,0,0,0,0,Erlotinib,,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10043577,20140328,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,CITALOPRAM|CITALOPRAM HYDROBROMIDE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE,4,LUNG NEOPLASM MALIGNANT|ANXIETY|DEPRESSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Lung neoplasm malignant,1,3
10044137,20140327,Erlotinib,67,801,67.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|NIFEDIPINE|AMLODIPINE,3,LUNG NEOPLASM MALIGNANT,Rash,1,2
10047430,20140331,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,"ERLOTINIB HYDROCHLORIDE|MINOCYCLINE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE|PHENELZINE SULFATE|PROCHLORPERAZINE MALEATE|TRIAZOLAM|BENZTROPINE MESYLATE|BENZTROPINE|AMLODIPINE BESYLATE|ALENDRONATE SODIUM|AMOXAPINE|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|FINASTERIDE|SIMVASTATIN|ALPRAZOLAM",18,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Rash|Diarrhoea,3,5
10047437,20140331,Erlotinib,58,801,58.0,1,,1,0,0,0,0,0,1,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Oedema|Abdominal pain|Insomnia|Metastases to liver|Cough,5,5
10047439,20140331,Erlotinib,67,801,67.0,2,,1,1,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|CISPLATIN|PEMETREXED DISODIUM,5,LUNG ADENOCARCINOMA METASTATIC|LUNG ADENOCARCINOMA METASTATIC|LUNG ADENOCARCINOMA METASTATIC|LUNG ADENOCARCINOMA METASTATIC,Pancreatic enzymes increased|Malignant neoplasm progression,2,5
10047440,20140331,Erlotinib,90,801,90.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10047444,20140331,Erlotinib,60,801,60.0,2,,1,1,0,0,0,0,0,Erlotinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10047448,20140331,Erlotinib,76,801,76.0,1,,1,0,1,0,0,0,1,Erlotinib,"ERLOTINIB HYDROCHLORIDE|ERLOTINIB|LORATADINE|LORATADINE TABLET|MAGNESIUM|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|MORPHINE SULFATE|CLONAZEPAM|ERGOCALCIFEROL|CLOPIDOGREL|SIMVASTATIN|ALPRAZOLAM|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|CITALOPRAM|CITALOPRAM HYDROBROMIDE|DENOSUMAB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB",20,GLAUCOMA|HYPERSENSITIVITY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|SPINAL PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|TRANSIENT ISCHAEMIC ATTACK|BLOOD CHOLESTEROL|PRODUCT USED FOR UNKNOWN INDICATION|MOOD SWINGS|PRODUCT USED FOR UNKNOWN INDICATION|METASTASES TO SPINE|DEPRESSION|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Pain|Nausea|Diarrhoea|Spinal pain|Drug effect decreased|Eye irritation|Rash|Growth of eyelashes|Interstitial lung disease|Sleep disorder|Abdominal discomfort|Drug hypersensitivity|Muscle spasms|Retching|Decreased appetite|Speech disorder|Depression|Paraesthesia|Emotional distress,20,5
10047450,20140331,Erlotinib,,,,2,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death|Epistaxis|Headache,3,5
10047452,20140331,Erlotinib,72,801,72.0,1,,1,1,1,0,0,0,1,Erlotinib,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,PRODUCT USED FOR UNKNOWN INDICATION|PANCREATIC CARCINOMA,Mechanical ileus|Cholangitis|Malignant neoplasm progression|General physical health deterioration|Vomiting,5,5
10047461,20140331,Erlotinib,82,801,82.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Vision blurred|Confusional state|Stomatitis|Nausea|Fatigue,5,5
10047462,20140331,Erlotinib,73,801,73.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10047463,20140331,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ENOXAPARIN SODIUM,5,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,3
10047464,20140331,Erlotinib,53,801,53.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Eating disorder|Oral mucosal blistering,2,1
10047469,20140331,Erlotinib,64,801,64.0,2,,1,1,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|MORPHINE|LORAZEPAM,4,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA|PAIN|SEDATION,Haemoglobin decreased|General physical health deterioration|Malignant neoplasm progression,3,5
10047474,20140331,Erlotinib,77,801,77.0,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|PROCHLORPERAZINE,2,PANCREATIC CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION,Dehydration,1,5
10047490,20140331,Erlotinib,,,,0,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10049726,20140401,Erlotinib,,,,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,NON-SMALL CELL LUNG CANCER,Pulmonary embolism,1,1
10049750,20140401,Erlotinib,,,,2,,1,0,1,0,0,0,0,Erlotinib,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METOPROLOL TARTRATE|METOPROLOL|ERLOTINIB HYDROCHLORIDE|LOSARTAN|ERLOTINIB HYDROCHLORIDE,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Gastric disorder|Rash|Hypotension|Platelet count decreased,4,1
10049773,20140401,Erlotinib,81,801,81.0,1,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Confusional state|Dehydration|Diarrhoea|Asthenia|Malignant neoplasm progression|Vomiting|Rash,7,5
10051583,20140401,Erlotinib,67,801,67.0,1,71,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|CANDESARTAN CILEXETIL|TIOTROPIUM BROMIDE,7,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|RHEUMATOID ARTHRITIS|BLOOD PRESSURE|COUGH|RHEUMATOID ARTHRITIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Pneumonia,1,5
10052428,20140402,Erlotinib,75,801,75.0,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,2,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA,Pneumatosis,1,3
10052432,20140402,Erlotinib,74,801,74.0,2,,1,1,1,0,0,0,1,Erlotinib,GEMCITABINE HYDROCHLORIDE|RAMIPRIL,5,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA|PROPHYLAXIS|HYPERTENSION|HYPERTENSION,Pain|Hepatic failure|Cholestasis|Cholangitis,4,1
10052434,20140402,Erlotinib,78,801,78.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,3
10052435,20140402,Erlotinib,60,801,60.0,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|PACLITAXEL|DOCETAXEL|DOCETAXEL ANHYDROUS,3,LUNG CANCER METASTATIC|LUNG CANCER METASTATIC|LUNG CANCER METASTATIC,Neuropathy peripheral,1,1
10052443,20140402,Erlotinib,67,801,67.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10052449,20140402,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10052450,20140402,Erlotinib,71,801,71.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,MALIGNANT RESPIRATORY TRACT NEOPLASM,Death,1,5
10052623,20140402,Erlotinib,59,801,59.0,2,,1,0,0,0,0,0,1,Erlotinib,CARBOPLATIN|CARBOPLATIN|CARBOPLATIN|PEMETREXED DISODIUM,8,NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Drug ineffective|Thrombocytopenia|Pancytopenia|Malignant neoplasm progression|Neuropathy peripheral|Myalgia|Anxiety|Depression|Nausea|Vomiting|Decreased appetite|Stomatitis|Skin ulcer|Fatigue|Headache|Glomerular filtration rate decreased,16,5
10053584,20140402,Erlotinib,21765,804,59.63,2,,1,0,1,0,0,0,0,Erlotinib,FULVESTRANT|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Pulmonary embolism|Thrombosis,2,1
10055862,20140402,Erlotinib,73,801,73.0,1,88.8,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,2,LUNG NEOPLASM MALIGNANT,Haematuria,1,3
10056060,20140403,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,ZOLPIDEM TARTRATE|ERLOTINIB HYDROCHLORIDE|DULOXETINE HYDROCHLORIDE|ERGOCALCIFEROL|FISH OIL|SPIRONOLACTONE|MOMETASONE FUROATE|ATENOLOL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,17,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Visual impairment|Ulcer|Thyroid mass|Alopecia|Rash erythematous|Blindness|Scab|Vision blurred,8,5
10056078,20140403,Erlotinib,,,,0,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death|Rash,2,1
10058548,20140404,Erlotinib,49,801,49.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,General physical health deterioration,1,5
10058559,20140404,Erlotinib,81,801,81.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10058564,20140404,Erlotinib,,,,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,2,LUNG NEOPLASM MALIGNANT,Lung operation|Rash|Diarrhoea|Dry skin,4,5
10058569,20140404,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,NON-SMALL CELL LUNG CANCER,Death,1,3
10058570,20140404,Erlotinib,61,801,61.0,1,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|LEVOTHYROXINE|LEVETIRACETAM|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|OMEPRAZOLE MAGNESIUM|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|FUROSEMIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LISINOPRIL,12,PROSTATE CANCER|PROSTATE CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SEIZURE|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|GLUCOSE TOLERANCE IMPAIRED|OEDEMA|PRODUCT USED FOR UNKNOWN INDICATION|BLOOD PRESSURE,Therapeutic product ineffective|Eye irritation|Rash|Cough|Diarrhoea|Oedema|Folliculitis|Respiratory distress|Partial seizures|Herpes zoster|Product use issue|Photopsia|Drug dose omission|Eyelid oedema|Ocular hyperaemia|Pleurisy,16,5
10058571,20140404,Erlotinib,71,801,71.0,1,,1,1,1,0,0,0,0,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Respiratory failure|Rhinorrhoea|Nasopharyngitis|Lung infection,4,1
10058572,20140404,Erlotinib,88,801,88.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10058575,20140404,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|TIOTROPIUM BROMIDE|HYDROCHLOROTHIAZIDE|ALBUTEROL SULFATE,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Decreased appetite|Fatigue,3,5
10060649,20140404,Erlotinib,75,801,75.0,1,,1,1,1,0,0,0,1,Erlotinib,GEMCITABINE HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA,Death|Pneumatosis intestinalis|Ascites|General physical health deterioration|Haematochezia|Decreased appetite|Asthenia,7,3
10061913,20140407,Erlotinib,,,,0,,1,0,0,0,0,0,1,Erlotinib,,2,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA,Anaemia,1,3
10061918,20140407,Erlotinib,,,,1,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,3,LUNG NEOPLASM MALIGNANT|BLOOD PRESSURE|PRODUCT USED FOR UNKNOWN INDICATION,Neuroendocrine tumour|Lung cancer metastatic|Gastric ulcer|Rash,4,5
10061920,20140407,Erlotinib,,,,0,79,1,0,0,0,0,0,1,Erlotinib,,2,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA,Cholangitis acute,1,3
10061927,20140407,Erlotinib,61,801,61.0,1,,1,0,1,0,0,0,0,Erlotinib,INSULIN GLARGINE|RAMIPRIL|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PANCREATIC CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PANCREATIC CARCINOMA,Optic ischaemic neuropathy,1,5
10061933,20140407,Erlotinib,,,,0,,1,0,0,0,0,0,1,Erlotinib,,2,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA,Leukopenia,1,3
10061936,20140407,Erlotinib,,,,0,,1,0,0,0,0,0,1,Erlotinib,,2,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA,Neutropenia,1,3
10061939,20140407,Erlotinib,,,,1,,1,1,0,0,0,0,1,Erlotinib,ALLOPURINOL|AMLODIPINE BESYLATE|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|ENOXAPARIN SODIUM|LEVETIRACETAM|LORAZEPAM|MORPHINE|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|SUCRALFATE|SUCRALFATE ORAL SUSPENSION|SUCRALFATE ORAL,19,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Head injury|Disease progression|Gastrointestinal haemorrhage|Anaemia,4,2
10061951,20140407,Erlotinib,72,801,72.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|FUROSEMIDE|POTASSIUM CHLORIDE|CLOPIDOGREL|INSULIN GLARGINE|SAXAGLIPTIN|ALLOPURINOL,12,TRACHEAL CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Pruritus generalised,2,5
10061955,20140407,Erlotinib,81,801,81.0,1,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Muscular weakness|Rhabdomyolysis|Fall|Dehydration|Pyrexia,5,5
10061957,20140407,Erlotinib,,,,2,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,2,LUNG NEOPLASM MALIGNANT,Respiratory failure|Metabolic acidosis|Hyperkalaemia|Failure to thrive|Malignant neoplasm progression|Ventricular tachycardia|White blood cell count increased|Abdominal pain|Nausea|Diarrhoea,10,5
10061960,20140407,Erlotinib,50,801,50.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|BACLOFEN|LANSOPRAZOLE|FOLIC ACID|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,8,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Drug dose omission|Death|Malaise|Fatigue|Asthenia|Diarrhoea,6,1
10061968,20140407,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|HYDROCODONE BITARTRATE|LEVOTHYROXINE SODIUM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10063184,20140407,Erlotinib,67,801,67.0,2,,1,0,0,0,0,0,1,Erlotinib,SIMVASTATIN|LOSARTAN|LEVOTHYROXINE SODIUM|METOPROLOL TARTRATE|METOPROLOL,6,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|BLOOD CHOLESTEROL|BLOOD PRESSURE|THYROID DISORDER|BLOOD PRESSURE,Conjunctivitis|Eye irritation|Dermatitis acneiform|Rash,4,5
10063187,20140407,Erlotinib,,,,1,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,2,SQUAMOUS CELL CARCINOMA|LUNG NEOPLASM MALIGNANT,Pulmonary haemorrhage|Rash,2,5
10063189,20140407,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Toxicity to various agents|Thirst|Oral discomfort|Chapped lips|Dry mouth|Oral pain,6,5
10063190,20140407,Erlotinib,,,,1,65,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,4,LUNG NEOPLASM MALIGNANT,Cardiac failure congestive|Dehydration|Functional gastrointestinal disorder|Blood count abnormal,4,5
10063197,20140407,Erlotinib,67,801,67.0,2,,1,0,0,0,0,0,1,Erlotinib,,1,LUNG NEOPLASM MALIGNANT,Breast cancer|Heart rate irregular|Rash,3,5
10063354,20140407,Erlotinib,61,801,61.0,1,,1,0,0,0,0,0,1,Erlotinib,TIOTROPIUM BROMIDE|TIOTROPIUM BROMIDE|ERLOTINIB HYDROCHLORIDE,5,CHRONIC OBSTRUCTIVE PULMONARY DISEASE|LUNG NEOPLASM MALIGNANT,Lung neoplasm malignant|Haemorrhage|Memory impairment|Hernial eventration|Incorrect route of drug administration,5,5
10063363,20140407,Erlotinib,42,801,42.0,1,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,2,LUNG NEOPLASM MALIGNANT,Pneumonia,1,1
10064091,20140114,Erlotinib,61,801,61.0,2,74,1,0,0,1,0,0,0,Erlotinib,,3,OVARIAN CANCER|OVARIAN CANCER|OVARIAN CANCER,Thrombocytopenia|Off label use,2,3
10064502,20140408,Erlotinib,71,801,71.0,1,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|LOSARTAN POTASSIUM|LOSARTAN|FOLIC ACID,5,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Meningitis|Cerebrovascular accident|Convulsion|Brain neoplasm malignant|Metastases to central nervous system|Incision site haematoma|Diarrhoea|Rash,8,5
10066252,20140408,Erlotinib,72,801,72.0,2,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ALLOPURINOL|FUROSEMIDE|BAYER ASPIRIN EXTRA STRENGTH|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,11,LUNG NEOPLASM MALIGNANT|DEPRESSION|GOUT|TREMOR|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|THYROID DISORDER,Malignant neoplasm progression|Hyperkeratosis|Hypersomnia|Diarrhoea|Haemolysis|Drug ineffective|Recurrent cancer|Onychomycosis|Pulmonary embolism|Myocardial infarction|Headache|Malignant neoplasm progression|Hair growth abnormal|Haematemesis|Diarrhoea|Growth of eyelashes,16,1
10066253,20140408,Erlotinib,80,801,80.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10066254,20140408,Erlotinib,,,,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ALLOPURINOL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LISINOPRIL|TIOTROPIUM BROMIDE,8,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Rash|Diarrhoea|Catheter placement,3,5
10066444,20140408,Erlotinib,63,801,63.0,2,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,PANCREATIC CARCINOMA|HEPATIC CANCER,Malignant neoplasm progression|Intestinal perforation|Stomatitis,3,5
10066458,20140408,Erlotinib,51,801,51.0,1,,1,0,0,0,0,0,1,Erlotinib,,1,LUNG ADENOCARCINOMA,Pulmonary fibrosis|Pneumonia|Mouth ulceration|Rash,4,5
10066475,20140408,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Death|Memory impairment|Diarrhoea|Nausea,4,5
10066476,20140408,Erlotinib,70,801,70.0,2,,1,1,0,0,0,0,1,Erlotinib,,1,NON-SMALL CELL LUNG CANCER,Death|Anaemia|Alopecia|Diarrhoea|Fatigue|Nausea,6,1
10066487,20140408,Erlotinib,75,801,75.0,2,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,5,METASTASES TO BONE MARROW|PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|BONE CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Lung neoplasm malignant,1,5
10066496,20140408,Erlotinib,44,801,44.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Petit mal epilepsy,1,1
10066498,20140408,Erlotinib,,,,1,,1,0,1,0,0,0,0,Erlotinib,"ERLOTINIB HYDROCHLORIDE|CELECOXIB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FISH OIL|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|ERGOCALCIFEROL|OXYCODONE HYDROCHLORIDE|CALCIUM",11,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pulmonary oedema|Muscle spasms|Dehydration|Dysphagia|Vomiting|Decreased appetite|Nausea|Fatigue,8,5
10066499,20140408,Erlotinib,57,801,57.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,3,NON-SMALL CELL LUNG CANCER|LIVER FUNCTION TEST ABNORMAL,Epilepsy|Convulsion,2,1
10066707,20140408,Erlotinib,53,801,53.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Myalgia,1,1
10066709,20140408,Erlotinib,68,801,68.0,1,,1,1,0,0,0,0,0,Erlotinib,AFATINIB|ERLOTINIB HYDROCHLORIDE,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Lung neoplasm malignant|Liver injury|Off label use,3,1
10066720,20140408,Erlotinib,62,801,62.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,6,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Amylase increased|Rash maculo-papular,2,1
10066721,20140408,Erlotinib,83,801,83.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Pleural fibrosis,1,1
10066722,20140408,Erlotinib,56,801,56.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Malignant melanoma,1,1
10066723,20140408,Erlotinib,67,801,67.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Pleural fibrosis,1,1
10066724,20140408,Erlotinib,63,801,63.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Pleural fibrosis,1,1
10066727,20140408,Erlotinib,82,801,82.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Pulmonary fibrosis,1,1
10066728,20140408,Erlotinib,57,801,57.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Basal cell carcinoma,1,1
10066730,20140408,Erlotinib,56,801,56.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Pulmonary fibrosis,1,1
10066767,20140408,Erlotinib,67,801,67.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Squamous cell carcinoma of skin|Squamous cell carcinoma,2,1
10066768,20140408,Erlotinib,66,801,66.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Prostate cancer stage I,1,1
10066769,20140408,Erlotinib,63,801,63.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Prostate cancer,1,1
10066770,20140408,Erlotinib,68,801,68.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Prostate cancer,1,1
10066771,20140408,Erlotinib,69,801,69.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Thyroid cancer,1,1
10066772,20140408,Erlotinib,61,801,61.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|HYDROCHLOROTHIAZIDE|CANDESARTAN,4,NON-SMALL CELL LUNG CANCER|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|ASTHMA,Prostate cancer,1,1
10066773,20140408,Erlotinib,59,801,59.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Prostate cancer,1,1
10066774,20140408,Erlotinib,61,801,61.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Prostate cancer,1,1
10067629,20140409,Erlotinib,72,801,72.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|LORAZEPAM,3,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,1
10067631,20140409,Erlotinib,72,801,72.0,1,,1,1,0,0,0,0,1,Erlotinib,ESCITALOPRAM|IPRATROPIUM BROMIDE|LEVALBUTEROL TARTRATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|LISINOPRIL|MORPHINE SULFATE,19,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Drug ineffective|Death|Metastases to bone|Pain in extremity|Pain in extremity|Paraesthesia oral|Paraesthesia oral|Tongue disorder|Chapped lips|Hip fracture|Pruritus|Skin exfoliation|Dyspnoea|Rash,14,1
10067634,20140409,Erlotinib,67,801,67.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ATORVASTATIN CALCIUM,2,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Death|Diarrhoea,2,5
10068712,20140409,Erlotinib,65,801,65.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10068713,20140409,Erlotinib,77,801,77.0,2,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Hallucination|Confusional state|White blood cell count increased|Infection|Mental status changes,5,3
10068716,20140409,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10068720,20140409,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10071285,20140410,Erlotinib,45,801,45.0,2,,1,0,0,0,0,0,1,Erlotinib,DULOXETINE HYDROCHLORIDE|DULOXETINE|METOPROLOL TARTRATE|METOPROLOL,6,NON-SMALL CELL LUNG CANCER STAGE IV|PAIN|PRURITUS|SEASONAL ALLERGY|PRODUCT USED FOR UNKNOWN INDICATION,Vision blurred|Dry eye|Eye pruritus|Deafness unilateral|Abdominal discomfort|Rash|Dry skin,7,5
10075471,20140411,Erlotinib,,,,0,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Non-small cell lung cancer|Malignant neoplasm progression|Mental status changes|Dyspnoea|Tachycardia|Tachypnoea|Leukocytosis|Breath sounds abnormal|Wheezing,9,3
10078241,20140415,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,DENOSUMAB|ERLOTINIB HYDROCHLORIDE,2,PRODUCT USED FOR UNKNOWN INDICATION,Disease progression,1,5
10081078,20140416,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE,3,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Diarrhoea,2,1
10081085,20140416,Erlotinib,60,801,60.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10081086,20140416,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Pericardial effusion,1,5
10081089,20140416,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Organ failure|Aphagia,2,5
10082462,20140416,Erlotinib,45,801,45.0,2,,1,0,1,0,1,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Corneal thinning|Corneal disorder|Eye pruritus|Corneal irritation|Eye irritation|Keratitis|Visual impairment|Vision blurred|Vision blurred|Rash,10,5
10084462,20140417,Erlotinib,,,,1,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|RITUXIMAB,2,LUNG ADENOCARCINOMA|CHRONIC LYMPHOCYTIC LEUKAEMIA,Chronic lymphocytic leukaemia,1,5
10084465,20140417,Erlotinib,82,801,82.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,NON-SMALL CELL LUNG CANCER,Death,1,5
10084469,20140417,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10084724,20140417,Erlotinib,66,801,66.0,1,,1,0,1,1,1,0,0,Erlotinib,FONDAPARINUX SODIUM|ERLOTINIB HYDROCHLORIDE,2,DEEP VEIN THROMBOSIS|NON-SMALL CELL LUNG CANCER,Cerebral haemorrhage|Hemiparesis|Hemianopia homonymous|Eye movement disorder|VIIth nerve paralysis,5,1
10084835,20140417,Erlotinib,69,801,69.0,1,,1,0,0,0,0,0,1,Erlotinib,PEMETREXED DISODIUM|ERLOTINIB HYDROCHLORIDE,3,LUNG ADENOCARCINOMA METASTATIC|LUNG ADENOCARCINOMA METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION,Upper gastrointestinal haemorrhage|Hepatic failure|Malignant neoplasm progression|Eastern Cooperative Oncology Group performance status worsened|Off label use,5,5
10085749,20140418,Erlotinib,77,801,77.0,1,67,1,0,0,0,0,0,1,Erlotinib,DENOSUMAB|GEFITINIB|ERLOTINIB HYDROCHLORIDE,4,METASTASES TO BONE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Neuropsychiatric syndrome|Abdominal pain|Abnormal behaviour,3,5
10086453,20140418,Erlotinib,62,801,62.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG ADENOCARCINOMA STAGE IV,Anaemia|Dry skin,2,5
10086503,20140418,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|FAMOTIDINE|PREDNISONE|THEOPHYLLINE|TIOTROPIUM BROMIDE|ALPRAZOLAM|FENTANYL,9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10087129,20140418,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,PRODUCT USED FOR UNKNOWN INDICATION,Death|Dehydration,2,5
10087132,20140418,Erlotinib,50,801,50.0,1,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,SQUAMOUS CELL CARCINOMA OF LUNG,Respiratory failure|Rash,2,5
10089072,20140421,Erlotinib,71,801,71.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PANCREATIC CARCINOMA,Death,1,5
10089354,20140418,Erlotinib,56,801,56.0,1,65,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,,Disease progression,1,
10090289,20140421,Erlotinib,73,801,73.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10090511,20140421,Erlotinib,75,801,75.0,2,,1,1,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|AMLODIPINE BESYLATE AND VALSARTAN|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|METOPROLOL TARTRATE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|FUROSEMIDE|CLOPIDOGREL,7,PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|HYPERTENSION|CEREBROVASCULAR ACCIDENT|CARDIAC FAILURE CONGESTIVE|PRODUCT USED FOR UNKNOWN INDICATION,Fracture|Fall|Laceration|Impaired healing|Cardiac failure congestive|Pneumonia,6,5
10090512,20140421,Erlotinib,,,,0,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10090615,20140421,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,"ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|DOXYCYCLINE|DOXYCYCLINE HYCLATE",9,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pyrexia|Rash pruritic|Hyperaesthesia|White blood cell count decreased|Fatigue,5,5
10093854,20140421,Erlotinib,79,801,79.0,2,,1,0,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|VALSARTAN|SIMVASTATIN|LEVOTHYROXINE|GABAPENTIN,7,COUGH|BLOOD PRESSURE|BLOOD PRESSURE|BLOOD CHOLESTEROL|THYROID DISORDER|PRURITUS,Fatigue|Somnolence,2,5
10094645,20140422,Erlotinib,48,801,48.0,2,,1,1,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|DICLOFENAC|DICLOFENAC SODIUM,7,NON-SMALL CELL LUNG CANCER|PAIN|PAIN|EYE IRRITATION|PAIN|PAIN,Cerebrovascular disorder|Pulmonary embolism|Cerebrovascular accident|Deep vein thrombosis|Dermatitis acneiform|Metastases to bone,6,5
10094727,20140422,Erlotinib,63,801,63.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|GEMFIBROZIL|ERGOCALCIFEROL|DOXYCYCLINE HYCLATE|DOXYCYCLINE|DOXYCLYCLINE HYCLATE|ATENOLOL|ERLOTINIB HYDROCHLORIDE|DOXYCYCLINE HYCLATE|DOXYCYCLINE|DOXYCLYCLINE HYCLATE|MECLIZINE HYDROCHLORIDE|MECLIZINE HCL|MECLIZINE|MECLIZINE HYDROCLORIDE|CALCIUM,12,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Abdominal pain|Rash|Blister|Oral mucosal blistering|Cough,5,5
10094730,20140422,Erlotinib,,,,0,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Haemoglobin abnormal,1,5
10094954,20140422,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|FENTANYL CITRATE|PROCHLORPERAZINE|OXYCODONE HYDROCHLORIDE|OXYCODONE,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10096210,20140422,Erlotinib,,,,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,VIIth nerve paralysis|Back pain,2,5
10097138,20140422,Erlotinib,6,800,60.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,NON-SMALL CELL LUNG CANCER,Dysgeusia,1,5
10097327,20140423,Erlotinib,,,,0,,1,0,0,0,0,0,1,Erlotinib,CARBOPLATIN|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,5,GLIOMA|GLIOMA|GLIOMA|GLIOMA|GLIOMA,Ataxia|Malignant glioma|Malignant neoplasm progression|Hemiparesis,4,3
10098651,20140422,Erlotinib,68,801,68.0,1,92.5,1,1,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,,Disease progression,1,1
10098846,20140423,Erlotinib,64,801,64.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,2
10098855,20140423,Erlotinib,,,,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERGOCALCIFEROL|LEVETIRACETAM|CALCIUM,7,NON-SMALL CELL LUNG CANCER|OSTEOPOROSIS|PROPHYLAXIS|AUTOIMMUNE THYROIDITIS|PROPHYLAXIS|METASTASES TO CENTRAL NERVOUS SYSTEM|PRODUCT USED FOR UNKNOWN INDICATION,Pancytopenia|Dehydration|Infection,3,5
10100786,20140423,Erlotinib,56,801,56.0,1,,1,1,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|BISOPROLOL FUMARATE|BISOPROLOL FUMARATE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE),9,LUNG ADENOCARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hyponatraemia|Nausea|Vomiting|Diarrhoea,4,5
10102015,20140424,Erlotinib,74,801,74.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10102028,20140424,Erlotinib,40,801,40.0,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,3,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,General physical health deterioration|Pain|Decreased appetite|Vomiting|Pyrexia,5,5
10103591,20140424,Erlotinib,51,801,51.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS,2,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Pulmonary embolism|Interstitial lung disease|Disease progression|Hepatic cyst|Platelet count increased|Bronchitis|Diarrhoea|Rash|Liver function test abnormal,9,5
10103678,20140424,Erlotinib,87,801,87.0,2,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|LEVOTHYROXINE SODIUM,2,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Off label use|Diarrhoea|Dehydration|Constipation|Confusional state|Weight decreased,6,5
10104717,20140424,Erlotinib,68,801,68.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Micturition disorder|Incontinence|Pain,3,5
10104729,20140424,Erlotinib,,,,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Discomfort,1,5
10104746,20140424,Erlotinib,75,801,75.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|GABAPENTIN|LEVOTHYROXINE,5,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dry eye|Ocular hyperaemia|Eye irritation,3,5
10108913,20140425,Erlotinib,,,,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|BEVACIZUMAB|PEMETREXED DISODIUM|CARBOPLATIN,4,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Disease progression,1,1
10118744,20140425,Erlotinib,47,801,47.0,1,,1,0,1,0,0,0,1,Erlotinib,ALPRAZOLAM|ZOLPIDEM TARTRATE|OXYCODONE|ERLOTINIB HYDROCHLORIDE|MORPHINE,6,ANXIETY|SLEEP DISORDER|PAIN|PAIN|LUNG NEOPLASM MALIGNANT|PAIN,Anxiety|Arthralgia|Diarrhoea|Decreased appetite|Pain in extremity|Rash|Infection|Diarrhoea|Rash|Pruritus,10,5
10118762,20140425,Erlotinib,65,801,65.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,2,LUNG ADENOCARCINOMA,Conjunctival ulcer|Dry eye,2,3
10118791,20140425,Erlotinib,86,801,86.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Neuropathy peripheral,1,3
10118842,20140425,Erlotinib,63,801,63.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|MORPHINE|OXYCODONE|PREDNISONE,5,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Rash|Skin ulcer|Treatment failure,3,5
10120819,20140425,Erlotinib,56,801,56.0,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Gastroenteritis,1,5
10120828,20140425,Erlotinib,85,801,85.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death|Rash,2,5
10120830,20140425,Erlotinib,,,,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Dizziness|Headache|Nausea,3,5
10128629,20140428,Erlotinib,59,801,59.0,1,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Death|Cough,2,5
10130360,20140428,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Drug ineffective,1,5
10133472,20140428,Erlotinib,64,801,64.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,LUNG ADENOCARCINOMA METASTATIC,Carcinoembryonic antigen increased|Drug resistance,2,5
10133675,20140428,Erlotinib,70,801,70.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Tonsil cancer,1,1
10133754,20140428,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,FOLIC ACID|WARFARIN|FERROUS SULFATE|ERLOTINIB HYDROCHLORIDE,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT,Erythema|Nail bed bleeding|Swelling|Eye infection|Pain,5,3
10136876,20140429,Erlotinib,,,,2,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,PRODUCT USED FOR UNKNOWN INDICATION,Acetabulum fracture|Fall|Muscular weakness|Rash,4,5
10136877,20140429,Erlotinib,64,801,64.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Tonsil cancer,1,1
10141572,20140429,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10141632,20140429,Erlotinib,,,,0,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10141705,20140429,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|SIMVASTATIN|CYCLOBENZAPRINE HYDROCHLORIDE|CYCLOBENZAPRINE|VERAPAMIL HYDROCHLORIDE,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10141817,20140429,Erlotinib,81,801,81.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|WARFARIN|COLESEVELAM HYDROCHLORIDE|LISINOPRIL|PHENYTOIN|SERTRALINE|FINASTERIDE|PREDNISONE|FLUNISOLIDE|MELATONIN|MOMETASONE FUROATE|MOMETASONE,18,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10141822,20140429,Erlotinib,,,,0,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Sepsis|Bradycardia|Septic shock|Pneumonia|Diarrhoea|Dyspnoea|Febrile neutropenia|Nausea|Fatigue|Dermatitis acneiform|Vomiting|Decreased appetite|Respiratory failure|Cough|Rash|Anaemia|Neutropenia|Asthenia,18,
10141828,20140429,Erlotinib,80,801,80.0,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|LOSARTAN POTASSIUM|LOSARTAN|GLIMEPIRIDE,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Urinary retention|Dermatitis acneiform|Rash papular|Diarrhoea|Rash,5,5
10141859,20140429,Erlotinib,83,801,83.0,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,4,LUNG ADENOCARCINOMA,Arthritis|Chondrocalcinosis pyrophosphate|Hepatic function abnormal|Pyrexia|Gastroenteritis|C-reactive protein increased|Arthralgia,7,5
10142027,20140429,Erlotinib,,,,0,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Dyspepsia|Rash|Diarrhoea|Asthenia|Eye disorder,5,5
10142163,20140429,Erlotinib,,,,0,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,3,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Pulmonary embolism,1,5
10142178,20140429,Erlotinib,,,,0,,1,0,0,0,0,0,1,Erlotinib,CARBOPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|CISPLATIN|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,4,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Bone marrow failure,1,5
10142206,20140429,Erlotinib,,,,0,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|CARBOPLATIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|PACLITAXEL|CISPLATIN|ETOPOSIDE|VINORELBINE|DOCETAXEL|DOCETAXEL ANHYDROUS,9,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Febrile neutropenia|Pulmonary embolism|Pleural effusion|Neuropathy peripheral|Thrombocytopenia|Anaemia|Fatigue,7,5
10142699,20140429,Erlotinib,69,801,69.0,2,75.3,1,1,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,,General physical health deterioration,1,
10143146,20140430,Erlotinib,68,801,68.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE,4,LUNG NEOPLASM MALIGNANT|HEPATIC CANCER|PAIN|PRODUCT USED FOR UNKNOWN INDICATION,Death|Ageusia|Nausea,3,5
10143170,20140430,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10143172,20140430,Erlotinib,54,801,54.0,1,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death|Malignant neoplasm progression,2,5
10143604,20140429,Erlotinib,70,801,70.0,2,45.8,1,0,1,0,0,0,0,Erlotinib,,1,,Hospitalisation,1,
10143881,20140430,Erlotinib,85,801,85.0,2,,1,1,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE,3,ADENOCARCINOMA PANCREAS|ADENOCARCINOMA PANCREAS,Pulmonary fibrosis|Hypoxia|Urinary tract infection,3,3
10143884,20140430,Erlotinib,77,801,77.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|PHENYTOIN|LACTULOSE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS,14,BRONCHIAL CARCINOMA|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Oedema peripheral|Acne,2,5
10143885,20140430,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|PROCHLORPERAZINE|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Rash,2,5
10143886,20140430,Erlotinib,58,801,58.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,LUNG NEOPLASM MALIGNANT,Pain in extremity|Gait disturbance|Rash,3,5
10143887,20140430,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|GLIMEPIRIDE|RIVAROXABAN|CARBOPLATIN|VALSARTAN|RANITIDINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PROCHLORPERAZINE|MEMANTINE HYDROCHLORIDE|ATORVASTATIN CALCIUM,11,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Eye pruritus|Eye irritation|Rash,4,5
10143888,20140430,Erlotinib,60,801,60.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Neoplasm|Ligament sprain|Malignant neoplasm progression,3,5
10144213,20140430,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,2,TRACHEAL CANCER|METASTASES TO NERVOUS SYSTEM,Death,1,5
10145590,20140501,Erlotinib,72,801,72.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10145591,20140501,Erlotinib,49,801,49.0,2,,1,0,0,0,0,0,1,Erlotinib,PROCHLORPERAZINE|MINOCYCLINE|MEGESTROL ACETATE|ERLOTINIB HYDROCHLORIDE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|PANTOPRAZOLE,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Drug ineffective|Constipation|Malignant neoplasm progression,3,3
10145595,20140501,Erlotinib,73,801,73.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10145600,20140501,Erlotinib,75,801,75.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|HYDROMORPHONE HYDROCHLORIDE|PREDNISONE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|CARBOPLATIN|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE,8,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Rash|Death,2,5
10145602,20140501,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10146052,20140501,Erlotinib,43,801,43.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|NALTREXONE,5,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hyperhidrosis|Abdominal pain upper|Bone pain|Chills|Vomiting,5,5
10146053,20140501,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|PRAVASTATIN SODIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10146557,20140501,Erlotinib,79,801,79.0,2,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|OXYGEN|0XYGEN,3,NON-SMALL CELL LUNG CANCER|THYROID DISORDER|PRODUCT USED FOR UNKNOWN INDICATION,Ill-defined disorder|Dyspnoea|Dyspnoea|Malaise|Constipation|Dizziness|Disorientation|Heart rate increased|Fatigue|Asthenia|Nausea,11,5
10146558,20140501,Erlotinib,6,800,60.0,1,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|DOCETAXEL|DOCETAXEL ANHYDROUS,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Pneumonia|Neutrophil count decreased|Loss of consciousness|Sepsis,4,5
10146560,20140501,Erlotinib,,,,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,2,LUNG NEOPLASM,Weight increased|Rash|Acne,3,5
10146561,20140501,Erlotinib,61,801,61.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10146563,20140501,Erlotinib,,,,2,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Malignant neoplasm progression,1,5
10146564,20140501,Erlotinib,56,801,56.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,2,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Optic neuritis|Vomiting|Diarrhoea,3,3
10146734,20140501,Erlotinib,79,801,79.0,1,,1,1,0,0,1,0,0,Erlotinib,AFATINIB|AFATINIB|AFATINIB|ERLOTINIB HYDROCHLORIDE|GABAPENTIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FOLIC ACID|ERGOCALCIFEROL|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE,17,NON-SMALL CELL LUNG CANCER,Death|Diarrhoea|Fatigue|Asthenia|Wound|Rash|Nausea|Retching|Decreased appetite|Fatigue,10,1
10147011,20140501,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|WARFARIN SODIUM|WARFARIN|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL,4,PANCREATIC CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10148949,20140502,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|CAPECITABINE,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10148955,20140502,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|BEVACIZUMAB|OMEPRAZOLE MAGNESIUM,5,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Lung neoplasm|Therapeutic product ineffective|Diarrhoea|Dry skin|Disease progression,5,1
10149251,20140502,Erlotinib,58,801,58.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|BEVACIZUMAB,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10149369,20140502,Erlotinib,,,,2,,1,0,1,0,0,0,1,Erlotinib,"ERLOTINIB HYDROCHLORIDE|ALPRAZOLAM|THYROID, PORCINE|ESTRADIOL|ESTRADIOL GEL 0.1%|ESTRADIOL TRANSDERMAL|ESTRADIOL,|ERLOTINIB HYDROCHLORIDE|OXYCODONE",8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Paraesthesia|Drug dose omission|Diarrhoea|Pneumothorax|Rash,5,5
10149373,20140502,Erlotinib,73,801,73.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10149374,20140502,Erlotinib,,,,2,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Fall,1,5
10149376,20140502,Erlotinib,61,801,61.0,1,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Cholangitis acute|Cholecystitis|Cholelithiasis|Abdominal pain upper|Vomiting|Abdominal pain upper,6,5
10149853,20140502,Erlotinib,64,801,64.0,1,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|PREDNISONE|AMOXICILLIN AND CLAVULANATE POTASSIUM|LORATADINE|LORATADINE ORAL,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Lung neoplasm malignant,1,5
10149854,20140502,Erlotinib,67,801,67.0,2,,1,1,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|BISOPROLOL FUMARATE|DIGOXIN|DICLOFENAC|DICLOFENAC SODIUM|METHYLPREDNISOLONE SODIUM SUCCINATE|CARBAMAZEPINE,19,LUNG NEOPLASM MALIGNANT|MYOCARDIAL ISCHAEMIA|PROPHYLAXIS|MYOCARDIAL ISCHAEMIA|DIARRHOEA|PRODUCT USED FOR UNKNOWN INDICATION|MUSCULOSKELETAL PAIN|MUSCULOSKELETAL PAIN|NON-SMALL CELL LUNG CANCER|DIARRHOEA|LUNG NEOPLASM MALIGNANT|ANAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|DIARRHOEA|PRODUCT USED FOR UNKNOWN INDICATION|MUSCULOSKELETAL PAIN|DIARRHOEA|MYOCARDIAL ISCHAEMIA|MYOCARDIAL ISCHAEMIA,Musculoskeletal pain|Cardiac failure,2,5
10149858,20140502,Erlotinib,62,801,62.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,2,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10149859,20140502,Erlotinib,,,,1,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Malignant neoplasm progression,1,1
10149862,20140502,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|RANIBIZUMAB|ATENOLOL|HYDROCHLOROTHIAZIDE|FLUOXETINE HYDROCHLORIDE,5,PRODUCT USED FOR UNKNOWN INDICATION|MACULAR DEGENERATION|HYPERTENSION|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION,Blindness|Macular degeneration,2,1
10149863,20140502,Erlotinib,93,801,93.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10149864,20140502,Erlotinib,79,801,79.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10150996,20140502,Erlotinib,65,801,65.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|FUROSEMIDE|TRIAZOLAM,9,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Hyperbilirubinaemia|Skin disorder,3,5
10150999,20140502,Erlotinib,,,,1,,1,1,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression|Pneumonia|Cough,3,5
10151001,20140502,Erlotinib,88,801,88.0,1,,1,1,0,0,0,0,1,Erlotinib,FUROSEMIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,3,PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Anaemia|Balance disorder|Neoplasm|Weight decreased|Death|Pollakiuria,6,5
10151005,20140502,Erlotinib,69,801,69.0,1,,1,0,1,0,0,0,0,Erlotinib,FUROSEMIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,5,NON-SMALL CELL LUNG CANCER|OEDEMA PERIPHERAL|RASH|NON-SMALL CELL LUNG CANCER|RASH,Cellulitis,1,5
10151008,20140502,Erlotinib,63,801,63.0,2,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|FLUTICASONE PROPIONATE AND SALMETEROL|TIOTROPIUM BROMIDE|ROSUVASTATIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,8,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Malaise,2,1
10151016,20140502,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|FINASTERIDE|LOSARTAN POTASSIUM|LOSARTAN,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10151031,20140502,Erlotinib,,,,1,,1,1,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PANCREATIC CARCINOMA,Death|Bacterial infection,2,5
10151043,20140502,Erlotinib,66,801,66.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,4,SQUAMOUS CELL CARCINOMA OF LUNG|PRODUCT USED FOR UNKNOWN INDICATION|PROSTATIC ADENOMA|PRODUCT USED FOR UNKNOWN INDICATION,Abdominal pain|Nausea|Diarrhoea,3,5
10151414,20140504,Erlotinib,,,,1,,1,0,0,0,1,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,2,NON-SMALL CELL LUNG CANCER,Deafness|Rash|Diarrhoea,3,5
10151418,20140504,Erlotinib,68,801,68.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10151422,20140504,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,LEVOTHYROXINE SODIUM|BUPROPION HYDROCHLORIDE|CLONAZEPAM|GABAPENTIN|CITALOPRAM|CITALOPRAM HYDROBROMIDE|INSULIN DETEMIR|ERLOTINIB HYDROCHLORIDE|OXYCODONE|PANTOPRAZOLE SODIUM|INSULIN LISPRO,15,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Ankle fracture|Herpes zoster|Diarrhoea,3,5
10152101,20140505,Erlotinib,70,801,70.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|PREDNISONE|METOPROLOL TARTRATE|PANTOPRAZOLE SODIUM|ALBUTEROL SULFATE|ALPRAZOLAM,6,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10152105,20140505,Erlotinib,68,801,68.0,1,,1,1,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,2,PRODUCT USED FOR UNKNOWN INDICATION,Death|Drug hypersensitivity,2,5
10152110,20140505,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|HYDROCHLOROTHIAZIDE|ROSUVASTATIN,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10152115,20140505,Erlotinib,73,801,73.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10152116,20140505,Erlotinib,81,801,81.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10152120,20140505,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,3,LUNG NEOPLASM MALIGNANT,Death|Tremor|Tremor|Ocular icterus,4,5
10153027,20140505,Erlotinib,65,801,65.0,2,,1,1,1,1,1,1,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|HYDROCHLOROTHIAZIDE|AMOXICILLIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DOXYCYCLINE HYCLATE|DOXYCYCLINE|DOXYCLYCLINE HYCLATE|DIPHENHYDRAMINE HYDROCHLORIDE|PREDNISONE|PANTOPRAZOLE|ALBUTEROL SULFATE,14,Lung neoplasm malignant|Bronchioloalveolar carcinoma|Bronchial carcinoma|Blood pressure measurement|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication|Product used for unknown indication,Blood potassium decreased|Pruritus|Dry skin|Hyperhidrosis|Hypersensitivity|Hot flush|Pain of skin|Swelling of eyelid|Fungal infection|Dry eye|Diarrhoea|Fatigue|Asthenia|Rash|Rash,15,5
10154131,20140506,Erlotinib,66,801,66.0,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|BEVACIZUMAB|ROSUVASTATIN|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|POTASSIUM CHLORIDE|CLOPIDOGREL|CLOPIDOGREL BISULFATE|CLOTRIMAZOLE|DRS. CLOTRIMAZOLE|FAMILY WELLNESS CLOTRIMAZOLE|CLOTRIMAZOLE TOPICAL|ROSUVASTATIN|CARBOPLATIN,12,LUNG NEOPLASM MALIGNANT|LUNG ADENOCARCINOMA,Hypovolaemia|Nausea|Vomiting|Bone marrow failure|Diarrhoea|Neoplasm|Rash,7,1
10155451,20140506,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10155461,20140506,Erlotinib,47,801,47.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|PREDNISONE|ENOXAPARIN SODIUM|METOPROLOL TARTRATE|METOPROLOL,6,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Convulsion|Brain mass,2,5
10156880,20140507,Erlotinib,83,801,83.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PLEURAL EFFUSION,Death,1,5
10156881,20140507,Erlotinib,58,801,58.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10156882,20140507,Erlotinib,60,801,60.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10156883,20140507,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|CAPECITABINE,2,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10156884,20140507,Erlotinib,72,801,72.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10157821,20140507,Erlotinib,87,801,87.0,1,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,3,LUNG NEOPLASM MALIGNANT|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Food poisoning|Rash|Rash|Diarrhoea|Vomiting|Drug dose omission,6,5
10157824,20140507,Erlotinib,62,801,62.0,2,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,3,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|DUMPING SYNDROME,Squamous cell carcinoma|Dehydration|Alopecia|Fungal skin infection|Nasal mucosal disorder|Gait disturbance|Malaise|Rash|Onychomadesis|Nail disorder|Skin fissures|Diarrhoea|Pruritus,13,5
10157825,20140507,Erlotinib,47,801,47.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|CLOBAZAM,4,LUNG ADENOCARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION,Convulsion|Rash|Blood bilirubin increased,3,5
10157826,20140507,Erlotinib,81,801,81.0,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Peripheral swelling,1,5
10157828,20140507,Erlotinib,79,801,79.0,2,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Apparent death|Malaise,2,5
10157832,20140507,Erlotinib,69,801,69.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|PANTOPRAZOLE|DIGOXIN|DULOXETINE HYDROCHLORIDE|LACTULOSE|LEVOTHYROXINE|PREGABALIN|CELECOXIB|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|FUROSEMIDE|OXYCODONE HYDROCHLORIDE|NITROGLYCERIN,16,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dry skin|Skin fissures|Arthralgia|Headache|Pain in extremity|Confusional state|Disorientation|Skin fissures|Onychomadesis|Onychomadesis,10,5
10159416,20140508,Erlotinib,49,801,49.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Dyspnoea|Palpitations,2,5
10159418,20140508,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,BREAST CANCER,Off label use|Death,2,5
10159420,20140508,Erlotinib,61,801,61.0,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,3,NON-SMALL CELL LUNG CANCER,Mouth ulceration|Investigation abnormal|Diarrhoea|Rash,4,5
10159422,20140508,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|FLUDROCORTISONE ACETATE,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10160700,20140508,Erlotinib,82,801,82.0,2,,1,0,1,0,0,0,1,Erlotinib,"ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|FAMOTIDINE|GOLIMUMAB|ERLOTINIB HYDROCHLORIDE|METHOTREXATE|METHOTREXATE SODIUM|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|MONTELUKAST SODIUM|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|LOSARTAN|ERLOTINIB HYDROCHLORIDE|SERTRALINE HYDROCHLORIDE|SIMVASTATIN|GABAPENTIN|GEMFIBROZIL|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|DOXYCYCLINE|DOXYCYCLINE HYCLATE|METOPROLOL TARTRATE|METOPROLOL|ERLOTINIB HYDROCHLORIDE|LORAZEPAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PREDNISONE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|THYROID|IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA,|THYROID, UNSPECIFIED",29,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Gastrooesophageal reflux disease|Onychoclasis|Rash|Acne|Myasthenia gravis|Rash|Nail bed bleeding|Rhinorrhoea|Onychalgia|Fatigue|Headache|Infection|Lip dry|Intervertebral disc degeneration|Pain in extremity|Eyelids pruritus|Peripheral swelling|Ingrowing nail|Nail disorder|Pain|Vision blurred|Nail bed inflammation|Atrial fibrillation|Nail ridging|Rash erythematous,25,1
10160702,20140508,Erlotinib,59,801,59.0,2,,1,1,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|CARBOPLATIN|PACLITAXEL|PEMETREXED DISODIUM|DOXYCYCLINE|DOXYCYCLINE HYCLATE,5,TRACHEAL CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Middle ear effusion|Dizziness,3,5
10160703,20140508,Erlotinib,,,,0,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10160704,20140508,Erlotinib,,,,2,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,3,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dehydration|Asthenia|Ocular hyperaemia|Eye discharge|Decreased appetite|Peripheral swelling|Vision blurred,7,5
10160707,20140508,Erlotinib,66,801,66.0,1,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CARBOPLATIN|ROSUVASTATIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|POTASSIUM CHLORIDE|CLOPIDOGREL|CLOPIDOGREL BISULFATE|CLOTRIMAZOLE|DRS. CLOTRIMAZOLE|FAMILY WELLNESS CLOTRIMAZOLE|CLOTRIMAZOLE TOPICAL,11,LUNG NEOPLASM MALIGNANT|LUNG ADENOCARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypovolaemia|Bone marrow failure|Neoplasm|Nausea|Vomiting|Diarrhoea|Rash,7,5
10160708,20140508,Erlotinib,74,801,74.0,2,,1,1,1,1,0,0,0,Erlotinib,"ERLOTINIB HYDROCHLORIDE|ERLOTINIB|FONDAPARINUX SODIUM|SIMVASTATIN|AMLODIPINE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|ZOLEDRONIC ACID|GLIMEPIRIDE|METOPROLOL TARTRATE|METOPROLOL|AMIKACIN SULFATE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|AMPHOTERICIN B|MOXIFLOXACIN HYDROCHLORIDE",23,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonia|Pulmonary embolism|Pancytopenia,3,5
10160709,20140508,Erlotinib,,,,2,,1,0,1,0,0,0,0,Erlotinib,ATORVASTATIN CALCIUM|ZOLPIDEM TARTRATE|OXYCODONE HYDROCHLORIDE|OXYCODONE|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|ERLOTINIB HYDROCHLORIDE|CLOPIDOGREL|WARFARIN SODIUM|WARFARIN,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Vomiting|Pleural effusion|Fatigue|Decreased appetite,4,1
10160711,20140508,Erlotinib,56,801,56.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Faecal incontinence|Stevens-Johnson syndrome|Bacterial infection,3,5
10160716,20140508,Erlotinib,74,801,74.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,NEOPLASM MALIGNANT,Death|Rash,2,5
10160835,20140508,Erlotinib,52,801,52.0,2,,1,0,0,1,0,0,1,Erlotinib,PANCRELIPASE|ALPRAZOLAM|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|TRASTUZUMAB,7,PROPHYLAXIS|DEPRESSION|PANCREATIC CARCINOMA METASTATIC|PANCREATIC CARCINOMA METASTATIC|RASH|PANCREATIC CARCINOMA METASTATIC|DEPRESSION,Neutropenia|Accidental overdose,2,
10160836,20140508,Erlotinib,52,801,52.0,2,,1,0,0,1,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|TRASTUZUMAB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|PANCRELIPASE|ALPRAZOLAM,7,PANCREATIC CARCINOMA METASTATIC|PANCREATIC CARCINOMA METASTATIC|PANCREATIC CARCINOMA METASTATIC|RASH|PROPHYLAXIS|DEPRESSION|DEPRESSION,Neutropenia|Accidental overdose,2,
10162339,20140509,Erlotinib,77,801,77.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10162342,20140509,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10162343,20140509,Erlotinib,73,801,73.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|DENOSUMAB|ERLOTINIB HYDROCHLORIDE,6,LUNG NEOPLASM MALIGNANT|OSTEOPOROSIS|PRODUCT USED FOR UNKNOWN INDICATION,Rash generalised|Alopecia|Weight decreased|Acne|Contusion|Bone pain|Diarrhoea|Rash,8,5
10162344,20140509,Erlotinib,85,801,85.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10162346,20140509,Erlotinib,52,801,52.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|FOLIC ACID|FENOFIBRATE|LISINOPRIL|AMOXICILLIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PROCHLORPERAZINE,11,NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Therapeutic product ineffective|Dry mouth|Rash,3,5
10162347,20140509,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10162352,20140509,Erlotinib,66,801,66.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,NON-SMALL CELL LUNG CANCER|LUNG NEOPLASM MALIGNANT,Keratorhexis|Corneal operation|Rash|Rash|Fatigue|Rash|Abdominal discomfort|Weight decreased|Memory impairment,9,5
10162791,20140509,Erlotinib,74,801,74.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|OXYCODONE|DOXYCYCLINE|DOXYCYCLINE HYCLATE,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|RASH,Pain in extremity|Drug dose omission|Rash|Rash|Epistaxis|Dry skin|Intervertebral disc protrusion|Drug hypersensitivity|Skin fissures|Muscle spasms,10,5
10163360,20140509,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|AMLODIPINE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|SIMVASTATIN|TIOTROPIUM BROMIDE|WARFARIN,11,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10163377,20140509,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|SIMVASTATIN|ROTIGOTINE|PANTOPRAZOLE,9,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PARKINSON^S DISEASE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10163914,20140510,Erlotinib,,,,0,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|BEVACIZUMAB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Death|Decreased appetite|Dehydration|Dermatitis acneiform|Fatigue|Diarrhoea|Anaemia|Dyspnoea|Cerebral haemorrhage|Arterial thrombosis|Deep vein thrombosis|Blood creatinine increased|Metabolic acidosis|Hypotension,14,3
10166835,20140512,Erlotinib,67,801,67.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10166836,20140512,Erlotinib,88,801,88.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,PRODUCT USED FOR UNKNOWN INDICATION,Swollen tongue|Lip swelling|Pharyngeal oedema|Dysphagia|Diarrhoea|Rash,6,5
10166837,20140512,Erlotinib,70,801,70.0,1,,1,1,1,1,0,0,1,Erlotinib,"ERLOTINIB HYDROCHLORIDE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|THEOPHYLLINE|THEOPHYLLINE|LORAZEPAM|CEFUROXIME|FLUCONAZOLE|FUROSEMIDE|INSULIN GLARGINE-YFGN|INSULIN GLARGINE|LACTULOSE|LUBIPROSTONE|MAGNESIUM OXIDE|MONTELUKAST|NICOTINE POLACRILEX|NICOTINE|NICOTINE POLACRILEX MINI|NICOTINE POLARILEX|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREDNISONE|TEMAZEPAM",27,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ANXIETY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cardio-respiratory arrest|Lung cancer metastatic|Pneumonia|Sepsis|Malignant neoplasm progression,5,1
10166843,20140512,Erlotinib,81,801,81.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10166844,20140512,Erlotinib,75,801,75.0,2,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,3,LUNG NEOPLASM MALIGNANT,Death|Pulmonary thrombosis|Rash|Cough,4,5
10167616,20140512,Erlotinib,56,801,56.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,2,LUNG NEOPLASM MALIGNANT|BONE CANCER,Death,1,5
10167619,20140512,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10167622,20140512,Erlotinib,75,801,75.0,2,,1,1,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Abasia|Death|Hip surgery|Pruritus|Erythema|Hip fracture,6,5
10167623,20140512,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,4,LUNG NEOPLASM MALIGNANT,Dysgeusia|Macule|Diarrhoea|Mouth ulceration|Alopecia|Dry mouth|Alopecia|Epistaxis|Alopecia|Rash|Dry skin|Decreased appetite|Skin fissures|Hair texture abnormal|Hair disorder|Nail disorder,16,5
10167624,20140512,Erlotinib,71,801,71.0,1,56,1,1,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|DOCETAXEL|DOCETAXEL ANHYDROUS,3,LUNG NEOPLASM MALIGNANT|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Cachexia|Respiratory failure|Fatigue|Malignant neoplasm progression|Epistaxis|Sputum discoloured|Metastases to liver|Hypoxia|Dyspnoea at rest|Cough|Haemorrhagic anaemia|Pneumonia|Haemoptysis|Anaemia,14,5
10167625,20140512,Erlotinib,49,801,49.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10169016,20140513,Erlotinib,82,801,82.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10169017,20140513,Erlotinib,67,801,67.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,TRACHEAL CANCER,Death,1,5
10169018,20140513,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|IRBESARTAN|SIMVASTATIN,6,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION|BLOOD TRIGLYCERIDES INCREASED|PRODUCT USED FOR UNKNOWN INDICATION,Pulmonary embolism,1,5
10169020,20140513,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ZOLPIDEM TARTRATE,4,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Rash,2,5
10169022,20140513,Erlotinib,,,,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,LUNG NEOPLASM MALIGNANT,Swollen tongue|Lip swelling|Pharyngeal oedema|Dysphagia|Diarrhoea|Muscle spasms|Rash|Respiratory tract congestion,8,5
10169024,20140513,Erlotinib,88,801,88.0,2,,1,0,1,1,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|AMLODIPINE BESYLATE|WARFARIN|HYDROXYZINE|CALCIUM|METOPROLOL TARTRATE|METOPROLOL,9,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pulmonary embolism|Eye irritation|Rash|Mucosal inflammation,4,5
10169028,20140513,Erlotinib,33,801,33.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|FENTANYL CITRATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,5,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10169976,20140513,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10171029,20140514,Erlotinib,89,801,89.0,1,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Throat irritation|Dyspepsia|Stomatitis|Rash,4,5
10171033,20140514,Erlotinib,82,801,82.0,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEMCITABINE HYDROCHLORIDE,2,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA,General physical health deterioration|Cholestasis|Cholangitis,3,5
10172994,20140515,Erlotinib,73,801,73.0,1,,1,1,1,0,0,0,1,Erlotinib,INSULIN GLARGINE|MORPHINE SULFATE|BISOPROLOL FUMARATE|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|MORPHINE SULFATE|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,21,PRODUCT USED FOR UNKNOWN INDICATION|TYPE 2 DIABETES MELLITUS|PAIN|GASTRITIS PROPHYLAXIS|HYPERTENSION|OEDEMA PERIPHERAL|DEPRESSION|OEDEMA PERIPHERAL|PRODUCT USED FOR UNKNOWN INDICATION|PANCREATIC CARCINOMA|INFECTION|PROPHYLAXIS|CONSTIPATION|PANCREATIC CARCINOMA|HYPERTENSION|PAIN|INSOMNIA,Pneumonia aspiration|Respiratory failure|Cerebral infarction|Chills|Pyrexia|Infection|General physical health deterioration,7,5
10172996,20140515,Erlotinib,64,801,64.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,NEOPLASM MALIGNANT,Death,1,5
10173707,20140515,Erlotinib,70,801,70.0,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG ADENOCARCINOMA,Oedema peripheral|Thrombosis,2,5
10174183,20140515,Erlotinib,75,801,75.0,2,,1,1,1,0,0,0,1,Erlotinib,"POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PREGABALIN|DENOSUMAB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ERLOTINIB HYDROCHLORIDE|FLUCONAZOLE|CARBOPLATIN|ERLOTINIB HYDROCHLORIDE",18,PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|VOMITING|PRODUCT USED FOR UNKNOWN INDICATION|VOMITING|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER,Diarrhoea|Dehydration|Asthenia|Oral candidiasis|Hypokalaemia|Metastases to central nervous system|Burning sensation|Headache|Weight decreased|Colitis ulcerative|Pulmonary embolism|Lymphoedema|Oedema peripheral|Visual acuity reduced|Decubitus ulcer|Hypotension|Arthralgia|Bone pain|Constipation|Fatigue|Dizziness|VIIth nerve paralysis,22,1
10174395,20140515,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10174931,20140515,Erlotinib,,,,0,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|BEVACIZUMAB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Metabolic acidosis|Hypotension|Fatigue|Dyspnoea|Blood creatinine increased,5,
10174933,20140515,Erlotinib,62,801,62.0,2,,1,1,1,0,0,0,1,Erlotinib,PREDNISONE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,4,PRODUCT USED FOR UNKNOWN INDICATION|METASTATIC NEOPLASM|LUNG NEOPLASM MALIGNANT,Respiratory failure|Dehydration|Urinary tract infection|Blood pressure decreased,4,1
10175927,20140516,Erlotinib,,,,0,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|BEVACIZUMAB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Dehydration,1,
10175929,20140516,Erlotinib,,,,1,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,NON-SMALL CELL LUNG CANCER,Pulmonary embolism|Disease progression,2,5
10175931,20140516,Erlotinib,51,801,51.0,1,,1,1,0,0,0,0,1,Erlotinib,MINOCYCLINE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|DALTEPARIN SODIUM|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|TRACHEAL CANCER,Upper respiratory tract infection|Non-small cell lung cancer metastatic|Pulmonary embolism|Dermatitis acneiform|Pain in extremity,5,1
10175933,20140516,Erlotinib,71,801,71.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10176735,20140515,Erlotinib,58,801,58.0,2,,1,0,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|LEVOTHYROXINE|AMLODIPINE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|HYDROXYZINE|FOLIC ACID|ERGOCALCIFEROL,8,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,Muscle spasms|Abdominal discomfort,2,3
10178087,20140518,Erlotinib,63,801,63.0,1,,1,1,0,0,0,0,0,Erlotinib,CAPECITABINE|CAPECITABINE|ERLOTINIB HYDROCHLORIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ACYCLOVIR|NEBIVOLOL HYDROCHLORIDE|RABEPRAZOLE SODIUM,8,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA,Death|Abdominal pain upper|Rash,3,5
10178351,20140519,Erlotinib,79,801,79.0,1,,1,1,1,0,1,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,9,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Oesophageal fistula|Aorto-oesophageal fistula|Sepsis,3,5
10178354,20140519,Erlotinib,62,801,62.0,1,,1,0,0,1,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,NEUROENDOCRINE CARCINOMA,Chronic hepatitis,1,3
10178355,20140519,Erlotinib,,,,1,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,NON-SMALL CELL LUNG CANCER,Asthma|Pneumonia|Cough|Vomiting|Chest discomfort|Respiration abnormal,6,5
10178698,20140516,Erlotinib,69,801,69.0,1,63.2,1,0,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,,Malnutrition|Weight decreased|Eating disorder,3,
10182074,20140520,Erlotinib,,,,0,,1,0,0,0,0,0,1,Erlotinib,BEVACIZUMAB|ERLOTINIB HYDROCHLORIDE|CARBOPLATIN,4,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Cardiac fibrillation|Diarrhoea|Tachycardia|Disease progression,4,1
10182444,20140520,Erlotinib,72,801,72.0,2,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|AMLODIPINE|FOLIC ACID|LOSARTAN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,6,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Lacrimation increased|Stomatitis|Rash|Diarrhoea|Acne|Skin ulcer|Eye discharge|Dry skin|Skin burning sensation,9,5
10183264,20140520,Erlotinib,83,801,83.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|LOSARTAN POTASSIUM|LOSARTAN|LOVASTATIN|HYDROCHLOROTHIAZIDE|PROCHLORPERAZINE|AMLODIPINE BESYLATE|CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE|CIPROFLOXACIN HYDROCHLORIDE|CIPROFLOXACIN|METOPROLOL TARTRATE|METOPROLOL,8,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10183272,20140520,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10183278,20140520,Erlotinib,63,801,63.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|CAPECITABINE|CAPECITABINE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|NEBIVOLOL HYDROCHLORIDE|RABEPRAZOLE SODIUM|PANCRELIPASE,9,PANCREATIC CARCINOMA|PANCREATIC CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Abdominal pain upper|Rash,3,5
10183755,20140520,Erlotinib,60,801,60.0,1,,1,0,1,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|METOPROLOL TARTRATE|METOPROLOL|SIMVASTATIN|FOLIC ACID|ENALAPRIL MALEATE|ENALAPRIL|OXYCODONE HYDROCHLORIDE|OXYCODONE,6,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV|PRODUCT USED FOR UNKNOWN INDICATION|BLOOD CHOLESTEROL|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypertension|Acne|Hyperaesthesia|Adverse drug reaction|Skin haemorrhage|Hyperhidrosis|Nausea|Pruritus|Skin irritation|Erythema|Rash|Decreased appetite,12,5
10184803,20140520,Erlotinib,62,801,62.0,2,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|LACTULOSE|CALCIUM CARBONATE|ANTACID,4,NEOPLASM MALIGNANT,Haematuria|Jaundice|Alanine aminotransferase increased|Aspartate aminotransferase increased,4,
10184870,20140521,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10184876,20140521,Erlotinib,,,,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10185776,20140521,Erlotinib,,,,0,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|CARBOPLATIN,4,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cardiac fibrillation|Tachycardia|Malignant neoplasm progression|Diarrhoea,4,5
10185779,20140521,Erlotinib,82,801,82.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|AMLODIPINE BESYLATE|ATENOLOL|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|LOSARTAN POTASSIUM|LOSARTAN,6,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Rash,2,5
10185784,20140521,Erlotinib,86,801,86.0,2,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB,1,LUNG NEOPLASM MALIGNANT,Aphasia|Dehydration|Lung neoplasm malignant,3,5
10187121,20140522,Erlotinib,56,801,56.0,2,,1,1,1,1,0,0,1,Erlotinib,MELOXICAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ERLOTINIB HYDROCHLORIDE|GABAPENTIN|ERLOTINIB HYDROCHLORIDE|ADALIMUMAB,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RHEUMATOID ARTHRITIS|PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Staphylococcal infection|Rash|Malignant neoplasm progression|Brain neoplasm,4,5
10187316,20140522,Erlotinib,,,,1,,1,0,0,0,0,0,0,Erlotinib,VORICONAZOLE|ERLOTINIB HYDROCHLORIDE,2,NEOPLASM MALIGNANT,Nausea|Constipation|Rash,3,5
10188179,20140522,Erlotinib,71,801,71.0,1,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PANCREATIC CARCINOMA,Pancreatic carcinoma metastatic,1,3
10190412,20140522,Erlotinib,84,801,84.0,2,,1,0,1,0,0,0,0,Erlotinib,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|ERLOTINIB HYDROCHLORIDE,2,ADENOCARCINOMA PANCREAS,Hypoxia|Urinary tract infection|Heart rate increased|Tachycardia,4,1
10190760,20140523,Erlotinib,44,801,44.0,1,88.53,1,0,0,0,0,0,1,Erlotinib,LAMOTRIGINE|LAMOTRIGINE EXTENDED-RELEASE|LAMOTRIGINE CHEWABLE DISPERSIBLE|LAMOTIRIGINE|ERLOTINIB HYDROCHLORIDE|CLONAZEPAM|ALPRAZOLAM|LAMOTRIGINE|VENLAFAXINE HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|OXYCODONE|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE,10,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Rash|Skin exfoliation|Acne|Deafness unilateral|Dyspepsia|Rash,6,5
10191107,20140521,Erlotinib,87,801,87.0,2,,1,0,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE|FLUOXETINE HYDROCHLORIDE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PREGABALIN|RIVAROXABAN,8,LUNG NEOPLASM MALIGNANT,Nausea,1,1
10191142,20140523,Erlotinib,67,801,67.0,2,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,5
10191837,20140523,Erlotinib,,,,2,,1,1,0,0,0,0,0,Erlotinib,"ERLOTINIB HYDROCHLORIDE|SOLIFENACIN SUCCINATE|LOSARTAN POTASSIUM|LOSARTAN|INSULIN ASPART|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS",7,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Breast pain|Diarrhoea|Rash,4,5
10192498,20140523,Erlotinib,63,801,63.0,2,58.96,1,0,1,0,0,0,0,Erlotinib,TEMSIROLIMUS|TEMSIROLIMUS INJECTION|TEMSIROLIMUS|TEMSIROLIMUS INJECTION|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|ALENDRONATE SODIUM|ALENDRONATE SODIUM TABLET|CALCIUM|FOLIC ACID|OXYCODONE|ERGOCALCIFEROL|MESALAMINE|PREDNISONE|ENOXAPARIN SODIUM|BENZONATATE|ALBUTEROL SULFATE|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE,17,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Muscular weakness|Pyrexia,2,1
10192551,20140523,Erlotinib,70,801,70.0,1,,1,1,0,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10194707,20140526,Erlotinib,,,,0,,1,1,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|BEVACIZUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Death|Rash|Haemorrhage|Interstitial lung disease,4,3
10195877,20140527,Erlotinib,,,,0,,1,0,1,0,0,0,0,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,PRODUCT USED FOR UNKNOWN INDICATION,Investigation,1,2
10195887,20140527,Erlotinib,,,,0,,1,0,0,0,0,0,1,Erlotinib,ERLOTINIB HYDROCHLORIDE,1,LUNG NEOPLASM MALIGNANT,Cerebral atrophy,1,5
10041399,20140327,Gefitinib,68,801,68.0,2,35,1,0,1,0,0,0,0,Gefitinib,DENOSUMAB|PEMETREXED|PEMETREXED DISODIUM|GEFITINIB|OXYCODONE HYDROCHLORIDE|GRANISETRON|GRANISETRON HYDROCHLORIDE,31,METASTASES TO BONE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Platelet count decreased|Disseminated intravascular coagulation|Pyrexia|Pyrexia|Pyrexia|Blood albumin decreased|Back pain|Epistaxis|Nausea|Oedema peripheral|Blood urea increased,11,1
10158137,20140507,Gefitinib,53,801,53.0,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB|GEFITINIB|GEFITINIB|GEFITINIB,6,LUNG ADENOCARCINOMA STAGE IV|LUNG ADENOCARCINOMA STAGE IV|LUNG ADENOCARCINOMA STAGE IV|LUNG ADENOCARCINOMA STAGE IV|LUNG ADENOCARCINOMA STAGE IV|LUNG ADENOCARCINOMA STAGE IV,Prescribed overdose|Somnolence|Transaminases increased|Off label use,4,3
10175832,20140516,Gefitinib,810,802,67.5,2,,1,0,0,0,0,0,1,Gefitinib,ATENOLOL|GEFITINIB,2,HYPERTENSION|LUNG NEOPLASM MALIGNANT,Lung neoplasm malignant|Skin hypertrophy|Acne|Dry skin|Dyspepsia,5,5
10182355,20140520,Gefitinib,67,801,67.0,2,,1,0,0,0,0,0,1,Gefitinib,ATENOLOL|GEFITINIB,2,HYPERTENSION|LUNG NEOPLASM MALIGNANT,Lung neoplasm malignant|Skin hypertrophy|Acne|Dry skin|Dyspepsia,5,5
10204077,20140529,Gefitinib,69,801,69.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|DENOSUMAB,8,LUNG NEOPLASM MALIGNANT,Osteonecrosis of jaw,1,1
10236523,20140613,Gefitinib,24416,804,66.89,2,,1,0,1,0,0,0,1,Gefitinib,FULVESTRANT|GEFITINIB,2,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Condition aggravated|Pleurisy|Dyspnoea|Oedema peripheral,4,1
10244100,20140618,Gefitinib,75,801,75.0,2,,1,0,1,0,0,0,1,Gefitinib,GEFITINIB|ESOMEPRAZOLE MAGNESIUM|PITAVASTATIN CALCIUM|DICLOFENAC SODIUM,15,METASTASES TO BONE,Nephrogenic anaemia|Liver disorder|Tubulointerstitial nephritis,3,2
10264846,20140627,Gefitinib,,,,0,,1,0,1,0,0,0,0,Gefitinib,PREDNISONE|GEFITINIB,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cerebellar ataxia,1,1
10270678,20140701,Gefitinib,983,802,81.92,1,,1,0,1,0,0,0,0,Gefitinib,PEMETREXED DISODIUM|MOMETASONE FUROATE|PREDNISONE|BEVACIZUMAB|GEFITINIB,11,LUNG NEOPLASM MALIGNANT,Cerebellar ataxia,1,1
10300208,20140711,Gefitinib,80,801,80.0,2,55.8,1,1,0,0,0,0,1,Gefitinib,EZETIMIBE AND SIMVASTATIN|GEFITINIB|ATENOLOL,9,LUNG NEOPLASM MALIGNANT|BLOOD PRESSURE ABNORMAL,Pneumonia|Renal failure|Angina pectoris|Blood pressure|Myocardial infarction|Septic shock,6,5
10310936,20140717,Gefitinib,78,801,78.0,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,2,PRODUCT USED FOR UNKNOWN INDICATION|CHRONIC MYELOID LEUKAEMIA,Cytopenia,1,5
10343231,20140725,Gefitinib,73,801,73.0,1,,1,0,0,0,1,0,0,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Vascular insufficiency,1,5
10345027,20140728,Gefitinib,65,801,65.0,1,65,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,2,CHRONIC OBSTRUCTIVE PULMONARY DISEASE|LUNG NEOPLASM MALIGNANT,Neoplasm progression,1,1
10364146,20140806,Gefitinib,59,801,59.0,2,,1,0,1,0,0,0,1,Gefitinib,METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|CALCIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FENTANYL|GEFITINIB|DALTEPARIN SODIUM|HYDRALAZINE HYDROCHLORIDE|DENOSUMAB|ERGOCALCIFEROL|DENOSUMAB|DALTEPARIN SODIUM,14,PAIN|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RENAL VEIN THROMBOSIS|BLOOD PRESSURE INCREASED|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|VENA CAVA THROMBOSIS,Cardiac failure congestive|Stress cardiomyopathy|Dyspnoea|Back pain|Spinal cord compression|Acute myocardial infarction|Blood pressure increased|Myoclonus|Chest pain|Confusional state|Muscular weakness|Arthralgia|Toxicity to various agents|Areflexia,14,1
10368208,20140807,Gefitinib,69,801,69.0,2,,1,0,0,0,0,0,1,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB|PEMETREXED DISODIUM|VINORELBINE,5,LUNG ADENOCARCINOMA STAGE IV|LUNG ADENOCARCINOMA STAGE IV|LUNG ADENOCARCINOMA STAGE IV|LUNG ADENOCARCINOMA STAGE IV|LUNG ADENOCARCINOMA STAGE IV,Pleural effusion|Cardiac failure,2,5
10371134,20140808,Gefitinib,81,801,81.0,2,,1,0,0,0,0,0,1,Gefitinib,DOCETAXEL|DOCETAXEL ANHYDROUS|GEFITINIB|DOCETAXEL|DOCETAXEL ANHYDROUS|GEFITINIB,4,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Neuropathy peripheral|Peroneal nerve palsy,2,1
10379814,20140812,Gefitinib,70,801,70.0,2,46.6,1,0,1,0,0,0,1,Gefitinib,AFATINIB|AFATINIB|GEFITINIB|DOCETAXEL|DOCETAXEL ANHYDROUS,4,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malaise|Skin disorder|Decreased appetite|Rash|Paronychia|Diarrhoea,6,1
10396687,20140820,Gefitinib,73,801,73.0,2,,1,1,0,0,0,0,1,Gefitinib,PEMETREXED|PEMETREXED DISODIUM|GEFITINIB|CISPLATIN,4,NEOPLASM MALIGNANT|NEOPLASM MALIGNANT|METASTASES TO BONE,Malignant neoplasm progression|EGFR gene mutation|Metastases to liver|Metastases to central nervous system|Pathological fracture|Pericardial effusion|Death|Metastases to lung|Decreased appetite|Metastases to bone|Rash,11,1
10397021,20140820,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,CHLORPROMAZINE|GEFITINIB,8,CANCER PAIN|CANCER PAIN,Sedation|Delirium,2,3
10398530,20140821,Gefitinib,73,801,73.0,2,,1,0,1,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,3,METASTASES TO BONE,Ileus|Aspartate aminotransferase increased|Pyrexia|Abdominal distension|Periodontal disease|Hepatic function abnormal|Alanine aminotransferase increased|Diarrhoea|Vomiting,9,1
10399666,20140821,Gefitinib,72,801,72.0,1,62,1,1,1,0,0,0,0,Gefitinib,WARFARIN|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|PACLITAXEL|CARBOPLATIN|WARFARIN|GEFITINIB|BEVACIZUMAB|AFATINIB|WARFARIN|WARFARIN,22,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG ADENOCARCINOMA|PULMONARY EMBOLISM|PRODUCT USED FOR UNKNOWN INDICATION|DIARRHOEA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|PULMONARY EMBOLISM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Gastrointestinal haemorrhage|Peripheral circulatory failure|Constipation|Stomatitis|Diarrhoea|Decreased appetite|Nausea|Acute prerenal failure|Ileal ulcer|Large intestinal ulcer|Dehydration|Seborrhoeic dermatitis|Gastrointestinal erosion|Vomiting,14,1
10402976,20140822,Gefitinib,66,801,66.0,2,44.5,1,1,0,0,0,0,1,Gefitinib,SITAGLIPTIN|GLYBURIDE|OMEPRAZOLE MAGNESIUM|CELECOXIB|GABAPENTIN|GEFITINIB|GABAPENTIN|TRIMETHOPRIM|ESOMEPRAZOLE MAGNESIUM|SOLIFENACIN SUCCINATE,15,DIABETES MELLITUS|HYPERTONIC BLADDER|NON-SMALL CELL LUNG CANCER|ILL-DEFINED DISORDER,Lung neoplasm malignant|Lung carcinoma cell type unspecified recurrent|Adverse drug reaction|Dyspnoea|Growth of eyelashes|Rash generalised|Gastrooesophageal reflux disease|Weight decreased|Drug dose omission|Diarrhoea|Dysuria|Micturition urgency|Urinary tract infection|Nodule,14,
10405958,20140825,Gefitinib,,,,2,,1,1,0,0,0,0,1,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,3,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT RESPIRATORY TRACT NEOPLASM,Diarrhoea|Lung neoplasm malignant|Rash,3,1
10441059,20140909,Gefitinib,,,,1,,1,1,0,1,0,0,1,Gefitinib,BEVACIZUMAB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|CAPECITABINE|BEVACIZUMAB|BEVACIZUMAB|BEVACIZUMAB|THALIDOMIDE,12,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RENAL CANCER|METASTATIC RENAL CELL CARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION,Metastases to the mediastinum|Weight decreased|Off label use|Malaise,4,5
10459333,20140917,Gefitinib,43,801,43.0,1,,1,1,0,0,0,0,1,Gefitinib,GEFITINIB|BEVACIZUMAB|PACLITAXEL|BEVACIZUMAB|DARBEPOETIN ALFA|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|DOXORUBICIN HYDROCHLORIDE|DARBEPOETIN ALFA|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BEVACIZUMAB|DOCETAXEL|DOCETAXEL ANHYDROUS|DIPHENHYDRAMINE HYDROCHLORIDE,21,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BONE CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER MALE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER MALE|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Off label use|Death|Malignant pleural effusion,3,5
10460014,20140917,Gefitinib,,,,2,,1,1,0,0,0,0,1,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,3,MALIGNANT RESPIRATORY TRACT NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER,Malaise|Diarrhoea|Drug ineffective|Vomiting|Thrombocytopenia|Metastases to skin|Lung neoplasm malignant,7,5
10515112,20141014,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,2,NEOPLASM|NEOPLASM,Hypokalaemia,1,3
10515150,20141014,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,2,NEOPLASM|NEOPLASM,Hypokalaemia,1,3
10517752,20141014,Gefitinib,77,801,77.0,2,65,1,0,1,0,0,0,1,Gefitinib,GEFITINIB|DENOSUMAB,2,LUNG ADENOCARCINOMA METASTATIC|METASTASES TO BONE,Osteonecrosis of jaw|Toothache,2,1
10519553,20141015,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB|PEMETREXED DISODIUM,3,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Drug resistance|Shock,2,5
10534062,20141022,Gefitinib,,,,2,52,1,0,0,0,0,0,1,Gefitinib,MELPHALAN HYDROCHLORIDE|MELPHALAN|PACLITAXEL|PEMETREXED DISODIUM|PEMETREXED|PREGABALIN|DENOSUMAB|GEFITINIB|AMLODIPINE BESYLATE|GEMCITABINE HYDROCHLORIDE|ESOMEPRAZOLE MAGNESIUM|CARBOPLATIN|ETOPOSIDE|VINORELBINE,19,METASTASES TO BONE,Renal impairment,1,1
10552907,20141029,Gefitinib,77,801,77.0,2,,1,0,1,0,0,0,1,Gefitinib,ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|BEVACIZUMAB|PEMETREXED|PEMETREXED DISODIUM|GEFITINIB|DOCETAXEL|DOCETAXEL ANHYDROUS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OXYCODONE|CARBOPLATIN,10,CANCER PAIN|METASTASES TO BONE|ADENOCARCINOMA|ADENOCARCINOMA|ADENOCARCINOMA|ADENOCARCINOMA|MALAISE|CANCER PAIN|ADENOCARCINOMA,Metastases to central nervous system|Deep vein thrombosis|Oedema peripheral|Neutropenia|Renal impairment,5,3
10558602,20141031,Gefitinib,74,801,74.0,2,,1,0,1,0,0,0,1,Gefitinib,HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|GEFITINIB,2,HYPOPITUITARISM|LUNG NEOPLASM MALIGNANT,Cellulitis|Pneumococcal infection|Tenosynovitis|Pneumonia,4,1
10634028,20141205,Gefitinib,42,801,42.0,2,,1,1,0,0,0,0,1,Gefitinib,DOCETAXEL|DOCETAXEL ANHYDROUS|CRIZOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|CARBOPLATIN|PEMETREXED|PEMETREXED DISODIUM|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|CISPLATIN|GEFITINIB,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hepatotoxicity|Metastases to meninges|Seizure|Toxicity to various agents,4,3
10656465,20141216,Gefitinib,71,801,71.0,2,,1,1,0,0,0,0,1,Gefitinib,AFATINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB,3,LUNG ADENOCARCINOMA METASTATIC|LUNG ADENOCARCINOMA METASTATIC|LUNG ADENOCARCINOMA METASTATIC,Pneumonia|Diarrhoea|Metastases to central nervous system|Diabetic metabolic decompensation|Skin toxicity,5,3
10664168,20141217,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,4,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Haematotoxicity|Nausea|Mucosal inflammation|Thrombocytopenia|Diarrhoea|Vomiting|Febrile neutropenia,7,1
10664218,20141217,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,4,SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK|SQUAMOUS CELL CARCINOMA OF HEAD AND NECK,Haematotoxicity|Febrile neutropenia|Mucosal inflammation|Vomiting|Nausea|Thrombocytopenia,6,1
10678125,20141229,Gefitinib,,,,0,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB|ANASTROZOLE|ANASTROZOLE TABLETS,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Cardiac failure congestive,1,3
10680161,20141229,Gefitinib,57,801,57.0,2,,1,0,0,0,0,0,1,Gefitinib,CARBOPLATIN|CISPLATIN|DOCETAXEL|DOCETAXEL ANHYDROUS|PACLITAXEL|GEFITINIB,9,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|METASTASES TO CENTRAL NERVOUS SYSTEM|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Dementia|Amnesia|Speech disorder|Gait disturbance|Leukoencephalopathy|Urinary incontinence,6,3
10681393,20141230,Gefitinib,,,,0,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB|ANASTROZOLE|ANASTROZOLE TABLETS,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Renal failure|Dehydration,2,3
10686268,20141231,Gefitinib,25647,804,70.27,2,55,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB,8,PAIN|EGFR GENE MUTATION|EGFR GENE MUTATION|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|DYSLIPIDAEMIA|VERTIGO|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pericardial effusion|Pulmonary hypertension,2,1
10686272,20141231,Gefitinib,46,801,46.0,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,2,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Cystitis,1,1
10686312,20141231,Gefitinib,30925,804,84.73,2,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Mucosal inflammation,1,1
10702556,20150109,Gefitinib,21967,804,60.18,2,68.2,1,1,1,0,0,0,0,Gefitinib,GEFITINIB|OLAPARIB,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Lung infection|Disease progression|Herpes zoster|Genital pain,4,1
10722485,20150119,Gefitinib,61,801,61.0,2,,1,0,1,0,1,0,0,Gefitinib,DENOSUMAB|GEFITINIB|CLOPIDOGREL|CLOPIDOGREL BISULFATE,5,METASTASES TO BONE|INSOMNIA|PROPHYLAXIS|PROPHYLAXIS,Cerebral disorder,1,1
10727084,20150121,Gefitinib,72,801,72.0,1,,1,1,1,0,0,0,1,Gefitinib,GEFITINIB|VALSARTAN|VALSARTAN|VALSARTAN|VALSARTAN|VALSARTAN|AFATINIB|ERLOTINIB HYDROCHLORIDE,15,BRAIN NEOPLASM|BRAIN NEOPLASM|HYPERTENSION|HYPERTENSION|INFLAMMATION|GASTRITIS PROPHYLAXIS|BRAIN NEOPLASM|NONINFECTIVE ENCEPHALITIS|HEADACHE|NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Respiratory arrest|Blood pressure decreased|Blood pressure increased|Gait disturbance|Neoplasm malignant|Blood pressure fluctuation|Depressed mood|Ulcer,8,5
10733167,20150123,Gefitinib,41,801,41.0,1,,1,1,0,0,0,0,1,Gefitinib,"CISPLATIN|PACLITAXEL|CARBOPLATIN|GEFITINIB|DOXORUBICIN|PREDNISONE|IFOSFAMIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|ETOPOSIDE",11,THYMIC CANCER METASTATIC|THYMIC CANCER METASTATIC|THYMIC CANCER METASTATIC|THYMIC CANCER METASTATIC|THYMIC CANCER METASTATIC|THYMIC CANCER METASTATIC|THYMIC CANCER METASTATIC|THYMIC CANCER METASTATIC|THYMIC CANCER METASTATIC|THYMIC CANCER METASTATIC|THYMIC CANCER METASTATIC,Death|Drug effect incomplete|Renal impairment|Anaemia|Fatigue,5,3
10750274,20150129,Gefitinib,90,801,90.0,2,35,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DALTEPARIN SODIUM|SENNOSIDES|SENNA LEAF|SENNA|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PANTOPRAZOLE|RISEDRONATE SODIUM,16,LUNG NEOPLASM MALIGNANT,Candida infection,1,3
10750615,20150130,Gefitinib,27607,804,75.64,2,,1,1,1,0,0,0,0,Gefitinib,OLAPARIB|GEFITINIB,2,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Cardiopulmonary failure|Anaemia|Asthenia|Decreased appetite|Diarrhoea|Renal failure,6,1
10772233,20150206,Gefitinib,945,802,78.75,2,,1,0,1,0,1,0,1,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB|GEFITINIB|LOSARTAN|AMLODIPINE,10,METASTASES TO CENTRAL NERVOUS SYSTEM|LUNG NEOPLASM MALIGNANT|HYPERTENSION|LUNG NEOPLASM MALIGNANT|SEIZURE|BRAIN OEDEMA|METASTASES TO CENTRAL NERVOUS SYSTEM|HYPERTENSION|HYPERTENSION|SEIZURE,Cerebrovascular accident|Hypophagia|Lung neoplasm malignant|Dizziness|Apathy|Circumstance or information capable of leading to medication error|Seizure|Anaemia|Metastases to central nervous system|Gait disturbance|Malignant neoplasm progression|Urinary tract infection|Dementia Alzheimer^s type|Brain oedema|Weight decreased,15,5
10843712,20150220,Gefitinib,,,,2,55.1,1,1,1,0,0,0,0,Gefitinib,"IRON SUCROSE|RIVAROXABAN|AMLODIPINE|GEFITINIB|PEMETREXED DISODIUM|MEGESTROL ACETATE|INSULIN HUMAN|RIVAROXABAN|TAMSULOSIN HYDROCHLORIDE|INSULIN HUMAN|ESOMEPRAZOLE MAGNESIUM|AMLODIPINE|RIVAROXABAN|FLUMAZENIL|FERROUS SULFATE|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|RIVAROXABAN|RIVAROXABAN|PSEUDOEPHEDRINE HYDROCHLORIDE|PSEUDOEPHEDRINE HCL|RIVAROXABAN|COUGH SYRUP|CAMPHOR (NATURAL), ARSENIC TRIOXIDE, BRYONIA ALBA ROOT, DROSERA ROTUNDIFOLIA, IPECAC, POTASSIUM CARBONATE, PHOSPHORUS, ANEMONE PULSATILLA, SPONGIA OFFICINALIS SKELETON, ROASTED, DRIMIA MARITIMA WHOLE|DARBEPOETIN ALFA",34,IRON DEFICIENCY ANAEMIA|ANTICOAGULANT THERAPY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|UPPER RESPIRATORY TRACT INFECTION|DECREASED APPETITE|PRODUCT USED FOR UNKNOWN INDICATION|EMBOLISM VENOUS|PRODUCT USED FOR UNKNOWN INDICATION|DIARRHOEA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|IRON DEFICIENCY ANAEMIA|PRODUCT USED FOR UNKNOWN INDICATION|THROMBOSIS PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|ENDOSCOPY UPPER GASTROINTESTINAL TRACT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|IRON DEFICIENCY ANAEMIA|ENDOSCOPY GASTROINTESTINAL|THROMBOSIS PROPHYLAXIS|EMBOLISM VENOUS|PRODUCT USED FOR UNKNOWN INDICATION|UPPER RESPIRATORY TRACT INFECTION|ANTICOAGULANT THERAPY|PRODUCT USED FOR UNKNOWN INDICATION|UPPER RESPIRATORY TRACT INFECTION|PRODUCT USED FOR UNKNOWN INDICATION,Decreased appetite|Diarrhoea|Influenza|Lung neoplasm malignant|Upper respiratory tract infection|Pneumonia|Chronic gastritis|Duodenal ulcer|Urinary tract infection|Iron deficiency anaemia,10,1
10867587,20150225,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Drug resistance|EGFR gene mutation,2,3
10883809,20150304,Gefitinib,75,801,75.0,2,67,1,0,1,0,0,0,1,Gefitinib,GEFITINIB|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|ENALAPRIL|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|CYCLOBENZAPRINE|GEFITINIB,10,LUNG NEOPLASM MALIGNANT|THYROID DISORDER|PAIN|BLOOD PRESSURE ABNORMAL|HORMONE THERAPY|BLOOD PRESSURE ABNORMAL|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|LUNG NEOPLASM MALIGNANT,Lung neoplasm malignant|Blood pressure increased|Drug dose omission|Pneumonia|Thyroid disorder,5,5
10890529,20150305,Gefitinib,79,801,79.0,1,,1,1,0,0,0,0,0,Gefitinib,FUROSEMIDE|DOXAZOSIN|DOXAZOSIN MESYLATE|FERROUS SULFATE|BEVACIZUMAB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GLIPIZIDE|LISINOPRIL|PIOGLITAZONE|SERTRALINE HYDROCHLORIDE|ESOMEPRAZOLE MAGNESIUM|DARBEPOETIN ALFA|GEFITINIB|MEGESTROL ACETATE|CARVEDILOL,16,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT RESPIRATORY TRACT NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Off label use|Death|Weight increased|Dyspnoea exertional,4,5
10896043,20150308,Gefitinib,,,,0,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|CISPLATIN|PEMETREXED|PEMETREXED DISODIUM|FOLIC ACID,4,NON-SMALL CELL LUNG CANCER STAGE IV,Toxic epidermal necrolysis,1,3
10925815,20150313,Gefitinib,42,801,42.0,2,,1,0,1,0,0,0,0,Gefitinib,CISPLATIN|PEMETREXED|PEMETREXED DISODIUM|GEFITINIB,6,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Toxic epidermal necrolysis,1,
10933799,20150320,Gefitinib,50,801,50.0,2,,1,0,1,0,0,0,0,Gefitinib,AFATINIB|GEFITINIB|DOCETAXEL|DOCETAXEL ANHYDROUS|PLATINUM|PEMETREXED|PEMETREXED DISODIUM|BEVACIZUMAB,6,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Cholecystitis infective,1,1
11040934,20150416,Gefitinib,81,801,81.0,1,127.01,1,0,0,0,0,0,0,Gefitinib,RIVAROXABAN|RIVAROXABAN|GEFITINIB,4,DIABETES MELLITUS|ATRIAL FIBRILLATION|CEREBROVASCULAR ACCIDENT PROPHYLAXIS|BLOOD PRESSURE,Incorrect dose administered,1,5
11060701,20150423,Gefitinib,65,801,65.0,1,,1,1,0,0,0,0,0,Gefitinib,AFATINIB|GEFITINIB|ERLOTINIB HYDROCHLORIDE,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pneumonia,1,1
11097261,20150507,Gefitinib,,,,2,,1,1,0,0,0,0,0,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB,2,MALIGNANT RESPIRATORY TRACT NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION,Diarrhoea|Vomiting|Death,3,5
11105628,20150512,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,PEMETREXED|PEMETREXED DISODIUM|CARBOPLATIN|GEFITINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Interstitial lung disease,1,3
11105629,20150512,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,CARBOPLATIN|GEFITINIB|PEMETREXED|PEMETREXED DISODIUM,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Interstitial lung disease,1,3
11105642,20150512,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,CARBOPLATIN|GEFITINIB|PEMETREXED|PEMETREXED DISODIUM,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Interstitial lung disease,1,3
11105643,20150512,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,PEMETREXED|PEMETREXED DISODIUM|GEFITINIB|CARBOPLATIN,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pneumonitis,1,3
11105644,20150512,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|CARBOPLATIN|PEMETREXED|PEMETREXED DISODIUM,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Interstitial lung disease,1,3
11105729,20150512,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,CARBOPLATIN|GEFITINIB|PEMETREXED|PEMETREXED DISODIUM,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pneumonitis,1,3
11108462,20150513,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,CARBOPLATIN|GEFITINIB|PEMETREXED|PEMETREXED DISODIUM,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pneumonitis,1,3
11108465,20150513,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,CARBOPLATIN|PEMETREXED|PEMETREXED DISODIUM|GEFITINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pneumonitis,1,3
11108471,20150513,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|CARBOPLATIN|PEMETREXED|PEMETREXED DISODIUM,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Paronychia,1,3
11108472,20150513,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|PEMETREXED|PEMETREXED DISODIUM|CARBOPLATIN,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Paronychia,1,3
11135627,20150526,Gefitinib,84,801,84.0,2,,1,1,0,0,0,0,0,Gefitinib,AFATINIB|ERLOTINIB HYDROCHLORIDE|AFATINIB|GEFITINIB|CISPLATIN|ERLOTINIB HYDROCHLORIDE,8,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG NEOPLASM MALIGNANT|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|LUNG ADENOCARCINOMA,Decreased appetite|Malignant neoplasm progression|Diarrhoea,3,3
11151349,20150601,Gefitinib,74,801,74.0,2,34,1,0,1,0,0,0,0,Gefitinib,VORINOSTAT|GEFITINIB,7,INSOMNIA|HEADACHE|NON-SMALL CELL LUNG CANCER|DRY SKIN|HEADACHE|COUGH|NON-SMALL CELL LUNG CANCER,Fall|Lung infection,2,1
11166232,20150605,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,BEVACIZUMAB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Diarrhoea|Rash|Hypertension|Proteinuria|Aspartate aminotransferase increased|Alanine aminotransferase increased,6,1
11171543,20150608,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Haematotoxicity,1,5
11184024,20150612,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|DENOSUMAB,2,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Osteonecrosis of jaw,1,1
11211255,20150623,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,CRIZOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|LAPATINIB|GEFITINIB|AXITINIB|IMATINIB|VEMURAFENIB|NILOTINIB,8,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hepatotoxicity,1,3
11219216,20150625,Gefitinib,86,801,86.0,1,,1,1,0,0,0,0,0,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB,2,MALIGNANT RESPIRATORY TRACT NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION,Drug ineffective|Death,2,5
11221551,20150626,Gefitinib,,,,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT RESPIRATORY TRACT NEOPLASM,Dyspnoea|Death|Malaise|Back pain,4,5
11281084,20150717,Gefitinib,77,801,77.0,2,47,1,0,1,0,0,0,1,Gefitinib,CETIRIZINE HYDROCHLORIDE|GEFITINIB|RANITIDINE|GEFITINIB,12,COUGH|CANCER PAIN|GASTRIC ULCER|GASTRIC ULCER|RASH|LUNG ADENOCARCINOMA|COUGH|RASH|RASH|GASTRITIS|LUNG ADENOCARCINOMA|COUGH,Duodenal ulcer|Pyrexia|Pleural effusion,3,1
11281835,20150717,Gefitinib,30727,804,84.18,2,40,1,1,1,0,0,0,0,Gefitinib,"GEFITINIB|TELMISARTAN|DILTIAZEM HYDROCHLORIDE|ZOLPIDEM TARTRATE|TELMISARTAN|ZOLPIDEM TARTRATE|VALSARTAN|VALSARTAN ORAL|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|DILTIAZEM HYDROCHLORIDE",17,LUNG ADENOCARCINOMA|INSOMNIA|INSOMNIA,Malignant neoplasm progression|Interstitial lung disease,2,2
11281855,20150717,Gefitinib,70,801,70.0,1,,1,1,1,1,0,0,1,Gefitinib,GEFITINIB|CISPLATIN|PEMETREXED|PEMETREXED DISODIUM|PEMETREXED|PEMETREXED DISODIUM|CISPLATIN|CISPLATIN|PEMETREXED|PEMETREXED DISODIUM,14,BRAIN INJURY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERTENSION|BLOOD CREATININE INCREASED|NON-SMALL CELL LUNG CANCER|BLOOD CREATININE INCREASED|PROPHYLAXIS|HYPERTENSION|BLOOD CREATININE INCREASED,Pneumonia,1,3
11284841,20150720,Gefitinib,93,801,93.0,2,,1,0,1,0,0,0,0,Gefitinib,KAOLIN|ZOLPIDEM TARTRATE|QUETIAPINE|QUETIAPINE EXTENDED-RELEASE|GEFITINIB|ALPRAZOLAM|VALSARTAN|VALSARTAN ORAL,9,NON-SMALL CELL LUNG CANCER,Hypokalaemia|Pneumonitis|Diarrhoea,3,1
11288215,20150721,Gefitinib,52,801,52.0,2,59,1,0,1,0,0,0,0,Gefitinib,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|GEFITINIB|PEMETREXED|PEMETREXED DISODIUM|FOLIC ACID|GEFITINIB|PEMETREXED|PEMETREXED DISODIUM,7,PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS,Urinary tract infection,1,1
11293342,20150722,Gefitinib,67,801,67.0,2,,1,0,0,0,0,0,1,Gefitinib,CAPECITABINE|GEFITINIB|CANDESARTAN CILEXETIL|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,12,PRODUCT USED FOR UNKNOWN INDICATION|LUNG ADENOCARCINOMA|MACULAR DEGENERATION|LUNG ADENOCARCINOMA|HYPERTENSION|PRODUCT USED FOR UNKNOWN INDICATION|OSTEOARTHRITIS,Dry eye|Growth of eyelashes|Pyogenic granuloma|Paronychia|Nail disorder|Hair growth abnormal|Alopecia|Dry mouth|Corneal erosion|Gingival bleeding,10,2
11295052,20150723,Gefitinib,65,801,65.0,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB,2,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Respiratory failure|Diarrhoea|Organising pneumonia|Rash,4,1
11295167,20150723,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,,Ileus paralytic,1,1
11308281,20150724,Gefitinib,,,,1,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
11310179,20150724,Gefitinib,57,801,57.0,2,30,1,0,1,1,0,0,0,Gefitinib,GEFITINIB|PEMETREXED DISODIUM|GEFITINIB,9,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Diarrhoea|International normalised ratio increased|Decreased appetite,3,1
11310344,20150724,Gefitinib,30228,804,82.82,1,50,1,1,1,0,1,0,1,Gefitinib,GEFITINIB,15,BRAIN NEOPLASM|PROCTALGIA|ANAL EROSION|PROCTALGIA|HAEMORRHOIDS|LUNG NEOPLASM MALIGNANT,Radiation interaction|Dysphagia|Circulatory collapse|Partial seizures|Tumour marker increased|Diarrhoea|Alanine aminotransferase increased|Gamma-glutamyltransferase increased|Nerve injury|Blood alkaline phosphatase increased|Anal erosion|Blood lactate dehydrogenase increased|Respiratory failure|Gait disturbance|White blood cell count decreased|Neurogenic bladder|Epistaxis|Nervous system disorder|Mouth haemorrhage|Hyponatraemia|Hepatic function abnormal|Aspartate aminotransferase increased,22,1
11318176,20150728,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,CISPLATIN|CARBOPLATIN|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|PEMETREXED|PEMETREXED DISODIUM|GEFITINIB,5,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Anaemia|Thrombocytopenia|Leukopenia|Neutropenia,4,5
11321108,20150729,Gefitinib,59,801,59.0,1,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,5
11321139,20150729,Gefitinib,45,801,45.0,2,,1,0,0,0,0,0,0,Gefitinib,ZOLEDRONIC ACID|GEFITINIB,2,LUNG ADENOCARCINOMA STAGE IV,Diarrhoea|Rash,2,3
11321752,20150729,Gefitinib,56,801,56.0,2,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,,Intervertebral disc protrusion|Pyrexia|Intentional product misuse|Gait disturbance|Pleural effusion|Pain in extremity|Speech disorder|Peripheral coldness|Cough|Hypoaesthesia,10,5
11323277,20150730,Gefitinib,76,801,76.0,1,,1,1,1,1,0,0,1,Gefitinib,GEFITINIB,2,LUNG ADENOCARCINOMA|PAIN,Anaemia|Acute kidney injury|Hepatic function abnormal|Neoplasm malignant|Tumour lysis syndrome,5,1
11324182,20150730,Gefitinib,53,801,53.0,2,,1,0,1,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,5,,Productive cough|Melaena|Interstitial lung disease|Diarrhoea|Malignant neoplasm progression|Vomiting|Hilar lymphadenopathy|Intentional product misuse,8,5
11324396,20150730,Gefitinib,49,801,49.0,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,,Drug resistance|Non-small cell lung cancer,2,3
11327128,20150731,Gefitinib,76,801,76.0,1,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant pleural effusion,1,1
11327315,20150731,Gefitinib,76,801,76.0,2,42,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|GLIMEPIRIDE|TRIAZOLAM|ALOGLIPTIN|DICLOFENAC SODIUM,13,NAUSEA|LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT|DIABETES MELLITUS|POLLAKIURIA|HYPOAESTHESIA|INSOMNIA|POLLAKIURIA|GASTROOESOPHAGEAL REFLUX DISEASE|GASTROINTESTINAL DISORDER|DIABETES MELLITUS|HYPERTENSION|BACK PAIN,Megacolon,1,1
11327374,20150731,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,,Metastases to adrenals,1,1
11328779,20150731,Gefitinib,70,801,70.0,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Dyspnoea|Cough|Interstitial lung disease,3,1
11339530,20150805,Gefitinib,84,801,84.0,2,,1,0,1,0,0,0,1,Gefitinib,GEFITINIB,1,,Lung neoplasm malignant|Pleural effusion,2,5
11342794,20150805,Gefitinib,44,801,44.0,1,74,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|AFATINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Diarrhoea|Malignant neoplasm progression|Rash,3,1
11344163,20150806,Gefitinib,57,801,57.0,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB|GEFITINIB|GEFITINIB|GEFITINIB,6,NON-SMALL CELL LUNG CANCER|NEOPLASM|METASTATIC NEOPLASM|NEOPLASM|NON-SMALL CELL LUNG CANCER|METASTATIC NEOPLASM,Intestinal obstruction,1,3
11359118,20150807,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,,Metastases to bone,1,2
11363936,20150811,Gefitinib,69,801,69.0,1,,1,1,0,0,0,0,0,Gefitinib,DARBEPOETIN ALFA|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|BEVACIZUMAB|GEFITINIB|BEVACIZUMAB|BEVACIZUMAB|GABAPENTIN|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,15,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT RESPIRATORY TRACT NEOPLASM|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT RESPIRATORY TRACT NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT,Depression|Rash|Furuncle|Vocal cord paralysis|Weight decreased|Malaise|Atrial thrombosis|Death|Anxiety|Vomiting|Fungal infection|Chest pain|Diarrhoea|Off label use,14,5
11364063,20150811,Gefitinib,,,,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|BEVACIZUMAB,5,PRODUCT USED FOR UNKNOWN INDICATION|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|PRODUCT USED FOR UNKNOWN INDICATION,Death|Nasal ulcer|Rash|Dry skin|Skin ulcer,5,5
11364543,20150811,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Stevens-Johnson syndrome|Skin exfoliation,2,1
11365932,20150811,Gefitinib,65,801,65.0,1,,1,1,0,0,0,0,1,Gefitinib,CLINDAMYCIN PHOSPHATE|CAPECITABINE|BEVACIZUMAB|GEFITINIB|OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE|METOPROLOL SUCCINATE|BEVACIZUMAB|BEVACIZUMAB|STANDARDIZED SENNA CONCENTRATE|THALIDOMIDE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|AMLODIPINE BESYLATE,17,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|RENAL CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Death|Decreased appetite|Blood pressure increased|Renal failure|Weight decreased|Off label use|Pruritus|Rash|Constipation|Pain|Fatigue|Malignant neoplasm progression|Proteinuria|Asthenia,14,5
11371042,20150812,Gefitinib,,,,1,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,,Death,1,
11375009,20150813,Gefitinib,71,801,71.0,1,45.4,1,0,1,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA,Rash|Pneumatosis intestinalis,2,3
11375291,20150813,Gefitinib,56,801,56.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,2,NON-SMALL CELL LUNG CANCER STAGE IV,Forced vital capacity decreased|Lung cyst|Forced expiratory volume decreased,3,1
11375793,20150813,Gefitinib,87,801,87.0,2,47,1,1,1,0,0,0,0,Gefitinib,GEFITINIB|OXYCODONE|GEFITINIB|LANSOPRAZOLE,5,NON-SMALL CELL LUNG CANCER METASTATIC|EGFR GENE MUTATION|PROPHYLAXIS,Diarrhoea|Sepsis,2,1
11376363,20150813,Gefitinib,71,801,71.0,1,59,1,0,0,0,0,0,1,Gefitinib,ESCITALOPRAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|RIVAROXABAN|FOLIC ACID|GEFITINIB,7,DEPRESSION|PROSTATOMEGALY|MUSCULOSKELETAL CHEST PAIN|GASTRITIS|THROMBOSIS|ANAEMIA PROPHYLAXIS|LUNG NEOPLASM MALIGNANT,Pulmonary thrombosis|Erythema|Prostatomegaly|Lung neoplasm malignant|Depression|Anaemia|Musculoskeletal chest pain,7,5
11381618,20150814,Gefitinib,27035,804,74.07,1,52,1,1,1,0,0,0,0,Gefitinib,PREGABALIN|GEFITINIB|LANSOPRAZOLE,9,SKIN DISORDER|HYPOAESTHESIA|LUNG ADENOCARCINOMA|HYPOAESTHESIA|SKIN DISORDER|APPLICATION SITE ERYTHEMA|HYPOAESTHESIA,Cerebral infarction|Rash|Interstitial lung disease|Diarrhoea,4,1
11387443,20150817,Gefitinib,,,,0,,1,1,0,0,0,0,0,Gefitinib,CISPLATIN|GEFITINIB|PEMETREXED|PEMETREXED DISODIUM,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea,1,3
11387450,20150817,Gefitinib,,,,0,,1,1,0,0,0,0,0,Gefitinib,PEMETREXED|PEMETREXED DISODIUM|GEFITINIB|CISPLATIN,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Pneumonia,1,3
11394911,20150819,Gefitinib,61,801,61.0,1,,1,0,1,0,0,0,0,Gefitinib,ERLOTINIB HYDROCHLORIDE|GEFITINIB|ERLOTINIB HYDROCHLORIDE,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hepatocellular injury,1,3
11398008,20150820,Gefitinib,,,,2,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG CANCER METASTATIC,Cerebral atrophy,1,1
11404314,20150821,Gefitinib,25877,804,70.9,2,40,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|OXYCODONE HYDROCHLORIDE,4,LUNG NEOPLASM MALIGNANT|INSOMNIA|CANCER PAIN|CONSTIPATION,Gastrointestinal haemorrhage|Gastric ulcer,2,1
11404559,20150821,Gefitinib,60,801,60.0,2,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Coma|Secondary hypothyroidism|Hypothalamic pituitary adrenal axis suppression|Cranial nerve disorder|Incontinence|Staring|Metastases to meninges,7,1
11416709,20150825,Gefitinib,29567,804,81.01,2,37,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,9,INSOMNIA|HYPOCALCAEMIA|LUNG ADENOCARCINOMA|HYPERTENSION|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|HYPOTHYROIDISM|HYPOCALCAEMIA|HYPOCALCAEMIA|HYPERURICAEMIA,Cerebral infarction|Rash|Diarrhoea,3,1
11419884,20150826,Gefitinib,21920,804,60.05,2,51,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB|GEFITINIB,10,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS,Diverticulitis,1,1
11424109,20150827,Gefitinib,26970,804,73.89,2,52,1,1,1,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB,15,DIARRHOEA|HYPERTENSION|INSOMNIA|HYPERTENSION|NON-SMALL CELL LUNG CANCER|BRONCHITIS CHRONIC|NON-SMALL CELL LUNG CANCER|DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER|BRONCHITIS CHRONIC,Paronychia|Diarrhoea|Hypoxia|Lung disorder|Interstitial lung disease|Dermatitis acneiform,6,1
11424189,20150827,Gefitinib,,,,2,,1,0,1,0,0,0,1,Gefitinib,BEVACIZUMAB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|LORAZEPAM|BEVACIZUMAB|CARBOPLATIN|PEMETREXED DISODIUM|OXYCODONE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE|GEFITINIB|BEVACIZUMAB|BEVACIZUMAB,23,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT RESPIRATORY TRACT NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MALIGNANT RESPIRATORY TRACT NEOPLASM|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Fatigue|Off label use|Diarrhoea|Febrile neutropenia|Contusion|Rash|Dyspnoea|Pain,9,5
11424247,20150827,Gefitinib,19486,804,53.39,2,,1,0,0,0,1,0,0,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Gastrooesophageal reflux disease,1,1
11432378,20150828,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB|AFATINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Drug resistance|Diarrhoea|Rash,3,3
11432647,20150828,Gefitinib,55,801,55.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,3,LUNG ADENOCARCINOMA,Weight decreased|Neoplasm progression|Pain,3,5
11442900,20150901,Gefitinib,,,,2,,1,1,1,0,0,0,0,Gefitinib,GEFITINIB|NIFEDIPINE|ROSUVASTATIN|CLONAZEPAM|RAMELTEON,12,NON-SMALL CELL LUNG CANCER,Neutrophil count decreased|Septic shock|Interstitial lung disease,3,1
11445776,20150902,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|DIGOXIN,2,,Atrioventricular block complete,1,1
11448171,20150902,Gefitinib,25313,804,69.35,1,55,1,0,1,1,0,0,1,Gefitinib,TIOTROPIUM BROMIDE|AMLODIPINE BESYLATE|GEFITINIB,12,CHRONIC OBSTRUCTIVE PULMONARY DISEASE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|HYPERTENSION|LUNG ADENOCARCINOMA|DECREASED APPETITE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|VITAMIN B COMPLEX DEFICIENCY|HYPERTENSION|HEADACHE|PNEUMONIA,Rash|Hepatic function abnormal|Abdominal discomfort|Acute respiratory failure|Oncologic complication|Interstitial lung disease|Pyrexia,7,1
11455264,20150903,Gefitinib,57,801,57.0,1,,1,0,1,0,0,0,1,Gefitinib,GEFITINIB|SULFADIAZINE|ERLOTINIB HYDROCHLORIDE|LORAZEPAM|DESONIDE|PREDNISONE|ERLOTINIB HYDROCHLORIDE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ZOLPIDEM TARTRATE|BUTALBITAL AND ACETAMINOPHEN|BUTALBITAL AND ACETAMINOPHEN TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ALPRAZOLAM,17,PRODUCT USED FOR UNKNOWN INDICATION|RASH|NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|ANXIETY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|NAUSEA|INSOMNIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|HEADACHE|PRODUCT USED FOR UNKNOWN INDICATION|HYPERSENSITIVITY|VERTIGO,Fatigue|Drug-induced liver injury|Blood creatinine increased|Rash|Burning sensation|Peripheral swelling|Pharyngeal ulceration|Oral pain|Diarrhoea|Stomatitis|Urticaria,11,1
11457045,20150904,Gefitinib,69,801,69.0,2,42,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB|VALSARTAN|VALSARTAN ORAL|PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE,6,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|HYPERTENSION|HEPATITIS C|DEPRESSION,Platelet count decreased|Liver disorder|Coagulation test abnormal,3,1
11457587,20150904,Gefitinib,27392,804,75.05,1,60,1,1,1,0,0,0,0,Gefitinib,GEFITINIB|METOPROLOL TARTRATE|METOPROLOL,4,LUNG NEOPLASM MALIGNANT,Respiratory failure|Oral candidiasis,2,5
11457622,20150904,Gefitinib,53,801,53.0,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,5
11465935,20150907,Gefitinib,24958,804,68.38,1,93,1,0,1,0,0,0,0,Gefitinib,DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|ROSUVASTATIN|GEFITINIB,5,ATRIAL FIBRILLATION|DYSLIPIDAEMIA|LUNG ADENOCARCINOMA METASTATIC|HYPERTENSION|TYPE 2 DIABETES MELLITUS,Anaemia|Melaena|Presyncope,3,1
11468995,20150908,Gefitinib,64,801,64.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG CANCER METASTATIC,Metastases to liver|Malignant neoplasm progression|Paraneoplastic pleural effusion,3,5
11469499,20150908,Gefitinib,37,801,37.0,1,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,5
11472850,20150908,Gefitinib,68,801,68.0,1,93,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|ROSUVASTATIN,5,LUNG ADENOCARCINOMA METASTATIC|ATRIAL FIBRILLATION|DYSLIPIDAEMIA|HYPERTENSION|TYPE 2 DIABETES MELLITUS,Presyncope|Anaemia|Melaena,3,1
11482317,20150909,Gefitinib,59,801,59.0,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB,7,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pneumothorax,1,3
11486959,20150909,Gefitinib,58,801,58.0,2,41,1,0,1,0,0,0,1,Gefitinib,CARBOPLATIN|CARBOPLATIN|ESOMEPRAZOLE MAGNESIUM|GEFITINIB|CARBOPLATIN|AFATINIB|GEFITINIB|GEFITINIB,22,PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS|PROPHYLAXIS|LUNG ADENOCARCINOMA|PROPHYLAXIS|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG ADENOCARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PROPHYLAXIS AGAINST DIARRHOEA|LUNG ADENOCARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|PRODUCT USED FOR UNKNOWN INDICATION,Anaphylactic shock,1,2
11487102,20150909,Gefitinib,27514,804,75.38,2,42,1,1,0,0,0,0,1,Gefitinib,ROSUVASTATIN|GEFITINIB,8,PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|CACHEXIA|HYPERTENSION|VOMITING|CACHEXIA|DYSLIPIDAEMIA|LUNG ADENOCARCINOMA|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER,Drug-induced liver injury|Platelet count decreased,2,1
11489929,20150909,Gefitinib,21085,804,57.77,2,50,1,0,1,0,0,0,0,Gefitinib,PEMETREXED DISODIUM|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Febrile neutropenia,1,1
11490012,20150910,Gefitinib,,,,0,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,2,,Melaena|International normalised ratio increased,2,2
11490767,20150910,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,3,LEUKAEMIA|LUNG NEOPLASM MALIGNANT|LEUKAEMIA,Leukaemia recurrent,1,2
11491673,20150910,Gefitinib,25304,804,69.33,1,60,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Death,1,1
11496334,20150911,Gefitinib,,,,0,,1,1,0,0,0,0,1,Gefitinib,GEFITINIB|CISPLATIN|PEMETREXED|PEMETREXED DISODIUM|DOCETAXEL|DOCETAXEL ANHYDROUS|PACLITAXEL|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|CARBOPLATIN|VINORELBINE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,9,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Lung infection|Haemoptysis|Acute left ventricular failure|Pulmonary embolism,4,5
11501790,20150914,Gefitinib,27077,804,74.18,2,34,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|VORINOSTAT,6,HEADACHE|NON-SMALL CELL LUNG CANCER|INSOMNIA|COUGH|NON-SMALL CELL LUNG CANCER|DRY SKIN,Fall|Pneumonia,2,1
11512530,20150916,Gefitinib,68,801,68.0,2,,1,1,1,1,1,1,1,Gefitinib,GEFITINIB,1,Lung adenocarcinoma,Large intestine perforation|Peritonitis|Sepsis,3,1
11517603,20150917,Gefitinib,75,801,75.0,1,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,"Rash pruritic|Coma|Malignant neoplasm progression|Sleep disorder due to general medical condition, insomnia type|Eye pruritus|Eyelid rash|Therapeutic response unexpected",7,5
11519434,20150918,Gefitinib,,,,2,,1,0,0,0,0,0,0,Gefitinib,GEFITINIB,1,,Flatulence|Gastrooesophageal reflux disease,2,1
11521456,20150918,Gefitinib,909,802,75.75,2,64,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,Malignant neoplasm progression|EGFR gene mutation|Central nervous system lesion,3,2
11541058,20150923,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|PEMETREXED|PEMETREXED DISODIUM,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Febrile neutropenia,1,1
11541576,20150923,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,PEMETREXED|PEMETREXED DISODIUM|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Neutrophil count decreased,1,1
11543712,20150924,Gefitinib,56,801,56.0,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA,Pulmonary air leakage|Infectious pleural effusion,2,3
11553421,20150925,Gefitinib,58,801,58.0,2,60,1,1,1,0,0,0,1,Gefitinib,CISPLATIN|GEFITINIB|ERLOTINIB HYDROCHLORIDE|PEMETREXED DISODIUM|PEMETREXED DISODIUM|DALTEPARIN SODIUM,8,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER,Thrombotic thrombocytopenic purpura|Vitamin K deficiency|Multiple organ dysfunction syndrome|Ascites|Paraneoplastic syndrome|Cholecystitis infective|Pleural effusion|Thrombotic microangiopathy|Hypoventilation|Toxicity to various agents|Respiratory tract infection|Malignant neoplasm progression|Urinary tract obstruction|Pulmonary arterial hypertension|Coagulopathy|Septic shock|Hepatitis|Disseminated intravascular coagulation|Staphylococcal sepsis|Abdominal infection|Vena cava embolism|Cholangitis|Haemolytic uraemic syndrome|Bicytopenia|Device related sepsis,25,5
11553525,20150925,Gefitinib,,,,2,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Metastases to liver|Asthenia|Ocular hyperaemia|Diarrhoea|Vomiting|Back pain|Decreased appetite,7,
11555311,20150925,Gefitinib,30294,804,83.0,2,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Hypersensitivity|Dyspnoea,2,3
11578486,20150930,Gefitinib,69,801,69.0,2,,1,0,0,0,0,0,1,Gefitinib,CISPLATIN|CRIZOTINIB|GEFITINIB,4,ADENOCARCINOMA|ADENOCARCINOMA,Drug ineffective|Metastases to bone,2,1
11584719,20151001,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,2,LUNG NEOPLASM MALIGNANT,Deep vein thrombosis|Skin disorder,2,1
11588931,20151002,Gefitinib,61,801,61.0,1,44.5,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA METASTATIC,Blood alkaline phosphatase increased,1,3
11589433,20151002,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,10,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Rash|Ulcer|Stomatitis,3,1
11590886,20151002,Gefitinib,26514,804,72.64,1,58,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|ZOLPIDEM TARTRATE|BETAMETHASONE VALERATE|BETAMETHASONE VALERATE FOAM|HYDROCHLOROTHIAZIDE|PREGABALIN|TELMISARTAN|NIFEDIPINE|GLIMEPIRIDE|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL,12,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER|NAUSEA|NAUSEA|NON-SMALL CELL LUNG CANCER|NAUSEA,Pleural infection,1,1
11594808,20151005,Gefitinib,15962,804,43.73,1,74,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression,1,
11603400,20151007,Gefitinib,79,801,79.0,1,72,1,0,0,0,0,0,1,Gefitinib,DENOSUMAB|GEFITINIB,2,LUNG ADENOCARCINOMA METASTATIC|LUNG ADENOCARCINOMA METASTATIC,Leukopenia|Thrombocytopenia|Neutropenia,3,3
11603709,20151007,Gefitinib,53,801,53.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB|ERLOTINIB HYDROCHLORIDE,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression|Drug intolerance,2,1
11613387,20151008,Gefitinib,28950,804,79.32,1,72,1,0,0,0,0,0,1,Gefitinib,DENOSUMAB|GEFITINIB,2,LUNG ADENOCARCINOMA METASTATIC|LUNG ADENOCARCINOMA METASTATIC,Thrombocytopenia|Neutropenia,2,1
11613660,20151008,Gefitinib,68,801,68.0,1,,1,1,1,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Death|Dyspnoea,2,5
11613686,20151008,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB|GEFITINIB|GEFITINIB|GEFITINIB,6,NON-SMALL CELL LUNG CANCER|ADENOCARCINOMA|NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION|ADENOCARCINOMA|EGFR GENE MUTATION,Rash generalised|Disease progression,2,1
11617644,20151009,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,PEMETREXED|PEMETREXED DISODIUM|GEFITINIB,2,LUNG ADENOCARCINOMA METASTATIC|LUNG ADENOCARCINOMA METASTATIC,Hepatotoxicity,1,3
11617646,20151009,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,PEMETREXED|PEMETREXED DISODIUM|GEFITINIB,2,LUNG ADENOCARCINOMA METASTATIC|LUNG ADENOCARCINOMA METASTATIC,Hepatotoxicity,1,3
11619593,20151012,Gefitinib,24525,804,67.19,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,2,NON-SMALL CELL LUNG CANCER|TYPE 2 DIABETES MELLITUS,Malignant neoplasm progression,1,1
11621664,20151013,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|BEVACIZUMAB|GEFITINIB|AFATINIB,4,Non-small cell lung cancer|Non-small cell lung cancer|Non-small cell lung cancer|Non-small cell lung cancer,Rash|Paronychia|Anaemia|Hypertension|Decreased appetite|Nausea|Diarrhoea|Thrombocytopenia|Proteinuria|Haemoptysis|Drug resistance,11,3
11626074,20151013,Gefitinib,,,,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB|ATENOLOL,3,LUNG NEOPLASM MALIGNANT|HYPERTENSION|HYPERTENSION,Abdominal pain|Death|Dyspnoea,3,5
11628082,20151014,Gefitinib,83,801,83.0,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,5
11628443,20151014,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Dizziness,1,1
11628454,20151014,Gefitinib,83,801,83.0,1,,1,1,1,1,0,0,0,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Interstitial lung disease|Infection|Pulmonary fibrosis,3,1
11628778,20151014,Gefitinib,48,801,48.0,1,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,5
11634472,20151015,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,BEVACIZUMAB|GEFITINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Anaemia|Hypertension,2,5
11636604,20151016,Gefitinib,59,801,59.0,2,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,3,NON-SMALL CELL LUNG CANCER METASTATIC,Cerebellar syndrome|Nervous system disorder|Disorientation,3,1
11638717,20151016,Gefitinib,22425,804,61.44,1,56,1,1,1,0,0,0,0,Gefitinib,OXYCODONE HYDROCHLORIDE|LANSOPRAZOLE|GEFITINIB,6,CANCER PAIN|CANCER PAIN|GASTRIC ULCER|RHINITIS|CONSTIPATION|NON-SMALL CELL LUNG CANCER RECURRENT,Malignant neoplasm progression|Rash|Lung disorder,3,1
11644619,20151020,Gefitinib,59,801,59.0,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,,Death,1,5
11645628,20151020,Gefitinib,29537,804,80.92,1,,1,1,1,1,1,1,1,Gefitinib,GEFITINIB|LISINOPRIL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ATORVASTATIN CALCIUM|CALCIUM|TIOTROPIUM BROMIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LORAZEPAM,11,Lung neoplasm malignant,Death|Product use in unapproved indication|Off label use,3,5
11646955,20151020,Gefitinib,72,801,72.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,,Malignant neoplasm progression|Rash papular|Transaminases increased,3,1
11647723,20151021,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|TREMELIMUMAB,5,NON-SMALL CELL LUNG CANCER|ATRIAL FIBRILLATION|ATRIAL FIBRILLATION|ATRIAL FIBRILLATION|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
11651423,20151022,Gefitinib,,,,1,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Fall|Nausea|Cerebral infarction|Dehydration,4,3
11652334,20151022,Gefitinib,16938,804,46.41,2,43,1,0,1,0,0,0,1,Gefitinib,GEFITINIB|OXYCODONE|VENLAFAXINE HYDROCHLORIDE|TIOTROPIUM BROMIDE,9,CHRONIC OBSTRUCTIVE PULMONARY DISEASE|DEPRESSION|NON-SMALL CELL LUNG CANCER|PAIN|PAIN|PAIN|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|DEPRESSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Malignant neoplasm progression|Bronchospasm|Dyspnoea exertional,3,1
11654397,20151023,Gefitinib,,,,1,,1,1,1,0,1,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Cardiac failure congestive|Decreased appetite|Oral mucosal blistering|Rash|Respiratory failure|Pleural effusion|Malignant pleural effusion,7,5
11654761,20151023,Gefitinib,78,801,78.0,1,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
11658979,20151026,Gefitinib,77,801,77.0,2,,1,0,0,0,0,0,0,Gefitinib,"GEFITINIB|CALCIUM CARBONATE|ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE|ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE|ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE|DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE AND PHENYLEPHRINE HYDROCHLORIDE",3,NON-SMALL CELL LUNG CANCER|NASOPHARYNGITIS,Diarrhoea|Nasopharyngitis,2,2
11659318,20151026,Gefitinib,43,801,43.0,1,109,1,1,1,0,0,0,0,Gefitinib,MOXIFLOXACIN HYDROCHLORIDE|MOXIFLOXACIN|GEFITINIB,2,,Drug ineffective|Lung adenocarcinoma|Acute respiratory distress syndrome|Interstitial lung disease,4,1
11662508,20151027,Gefitinib,89,801,89.0,0,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,,Fall|Fracture,2,2
11668033,20151027,Gefitinib,790,802,65.83,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Ascites|Liver disorder|Malignant neoplasm progression|Portal vein thrombosis,4,1
11668069,20151027,Gefitinib,59,801,59.0,1,,1,0,1,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Nasopharyngitis|Dizziness|Epilepsy|Vomiting,4,1
11668191,20151027,Gefitinib,,,,2,,1,0,1,0,0,0,1,Gefitinib,GEFITINIB,1,ADENOCARCINOMA,Nausea|Haematemesis|Headache|Coma|Vomiting,5,1
11669807,20151027,Gefitinib,24382,804,66.8,2,81.2,1,0,1,0,0,0,0,Gefitinib,AMLODIPINE|OLAPARIB|FUROSEMIDE|SIMVASTATIN|OLAPARIB|GEFITINIB|GEFITINIB|CITALOPRAM|CITALOPRAM HYDROBROMIDE,9,HYPERTENSION|NON-SMALL CELL LUNG CANCER|DRUG ABUSE|DIABETES MELLITUS|HYPERCHOLESTEROLAEMIA|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ANXIETY,Diarrhoea|Anaemia,2,1
11674658,20151028,Gefitinib,31100,804,85.21,1,,1,1,0,0,0,0,0,Gefitinib,"GEFITINIB|DIPHENHYDRAMINE HYDROCHLORIDE|GABAPENTIN|PREDNISONE|PRAMIPEXOLE|WARFARIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",8,TRACHEAL CANCER,Death|Product use issue|Off label use,3,
11676864,20151028,Gefitinib,82,801,82.0,2,43.8,1,1,0,0,0,0,1,Gefitinib,ERLOTINIB HYDROCHLORIDE|GEFITINIB|OSIMERTINIB|CETUXIMAB|GEFITINIB,5,,Vomiting|Pneumonia aspiration|Respiratory failure|Disease progression|Weight decreased|Dyspnoea|Pleural effusion|Metastases to lymph nodes,8,3
11687554,20151030,Gefitinib,80,801,80.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,,Rash|Gastric ulcer,2,5
11688059,20151030,Gefitinib,72,801,72.0,2,49,1,0,1,0,0,0,0,Gefitinib,MILNACIPRAN HYDROCHLORIDE|GEFITINIB|GLIMEPIRIDE|AMLODIPINE|ESOMEPRAZOLE MAGNESIUM,11,DIABETIC NEUROPATHY|DIABETES MELLITUS|HYPERTENSION|LUNG NEOPLASM MALIGNANT|DIABETES MELLITUS|HYPERTENSION|ARTHRODESIS|GASTROOESOPHAGEAL REFLUX DISEASE|DIABETES MELLITUS|ARTHRODESIS|OSTEOPOROSIS,Polymyalgia rheumatica,1,1
11691616,20151102,Gefitinib,29481,804,80.77,2,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|FUROSEMIDE,4,SMALL CELL LUNG CANCER METASTATIC|HYPOTHYROIDISM,Malignant neoplasm progression|Neutrophil count decreased,2,1
11693735,20151103,Gefitinib,23253,804,63.71,2,52,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB|SELUMETINIB|SELUMETINIB,4,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Visual impairment,1,1
11693752,20151103,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,,Metastases to central nervous system,1,2
11696368,20151104,Gefitinib,27942,804,76.55,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,5,HYPOTHYROIDISM|HYPERTENSION|NON-SMALL CELL LUNG CANCER,Deep vein thrombosis|Blood bilirubin increased|Transaminases increased|Malignant neoplasm progression,4,1
11699137,20151104,Gefitinib,33329,804,91.31,2,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|FULVESTRANT,2,LUNG CANCER METASTATIC|LUNG CANCER METASTATIC,Pleural fistula|Pleural effusion,2,1
11704063,20151106,Gefitinib,60,801,60.0,1,,1,1,1,0,0,0,0,Gefitinib,GEFITINIB,2,LUNG NEOPLASM MALIGNANT,Agitation|Cardiac failure|Dyspnoea,3,5
11704137,20151106,Gefitinib,,,,0,,1,1,0,0,0,0,0,Gefitinib,CARBOPLATIN|PACLITAXEL|GEFITINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Infection,1,3
11705761,20151106,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|CARBOPLATIN|GEFITINIB|AMLODIPINE|GEFITINIB|DENOSUMAB|GEFITINIB|PACLITAXEL,9,EGFR GENE MUTATION|METASTASES TO BONE|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NON-SMALL CELL LUNG CANCER|METASTASES TO BONE|EGFR GENE MUTATION,Renal impairment|Disease progression,2,1
11707927,20151106,Gefitinib,,,,0,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB|CARBOPLATIN|PACLITAXEL,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Infection,1,3
11721198,20151110,Gefitinib,,,,2,,1,0,0,0,0,0,0,Gefitinib,GEFITINIB,1,,Cough|Pleural effusion|Malaise,3,5
11722329,20151111,Gefitinib,81,801,81.0,2,,1,1,1,0,0,0,0,Gefitinib,GEFITINIB,3,LUNG ADENOCARCINOMA METASTATIC,Rash|Pyrexia|Malignant neoplasm progression,3,1
11723044,20151111,Gefitinib,92,801,92.0,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression|Xeroderma,2,2
11726602,20151112,Gefitinib,73,801,73.0,1,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB|ALCOHOL|ETHYL ALCOHOL|ISOPROPYL ALCOHOL,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Hyperammonaemia|Metastases to central nervous system,2,1
11727530,20151112,Gefitinib,25489,804,69.83,1,74,1,0,1,0,0,0,0,Gefitinib,"GEFITINIB|MAGNESIUM OXIDE|CLOBETASOL PROPIONATE|CLOBETASOL PROPIONATE OINTMENT USP, 0.05%|GENTAMICIN SULFATE|GEFITINIB|HYDROCORTISONE BUTYRATE|LEVOCETIRIZINE DIHYDROCHLORIDE|MINOCYCLINE HYDROCHLORIDE|GEFITINIB|POVIDONE-IODINE|BETAMETHASONE VALERATE|BETAMETHASONE VALERATE FOAM|GEFITINIB|BETAMETHASONE VALERATE|BETAMETHASONE VALERATE FOAM|FAMOTIDINE|PREDNISOLONE ACETATE|DIFLUPREDNATE OPHTHALMIC|DIFLUPREDNATE",26,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Gastroenteritis,1,1
11727967,20151112,Gefitinib,70,801,70.0,2,,1,0,0,0,1,0,0,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Vision blurred|Eye discharge|Photopsia,3,3
11733666,20151113,Gefitinib,,,,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,SMALL CELL LUNG CANCER,Death,1,1
11733787,20151113,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Treatment failure,1,1
11734051,20151113,Gefitinib,22947,804,62.87,1,52,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|MINOCYCLINE HYDROCHLORIDE|GEFITINIB|GEFITINIB|CLOPIDOGREL|GEFITINIB|OLMESARTAN MEDOXOMIL,18,NON-SMALL CELL LUNG CANCER|CEREBRAL INFARCTION|RASH|RASH|RASH|DIARRHOEA|RASH|DECREASED APPETITE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CEREBRAL INFARCTION|COUGH|NON-SMALL CELL LUNG CANCER|DECREASED APPETITE|HYPERTENSION|GASTRITIS PROPHYLAXIS|DYSGEUSIA|DECREASED APPETITE,Cerebral infarction,1,1
11734650,20151113,Gefitinib,21689,804,59.42,2,,1,1,0,0,0,0,0,Gefitinib,SIMVASTATIN|ATENOLOL|GEFITINIB|ESCITALOPRAM,5,,Death,1,
11737244,20151113,Gefitinib,49,801,49.0,1,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,2,LUNG ADENOCARCINOMA METASTATIC,Bronchopulmonary aspergillosis,1,3
11738518,20151113,Gefitinib,26359,804,72.22,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression|Mucinous breast carcinoma,2,1
11745463,20151117,Gefitinib,81,801,81.0,2,,1,0,0,0,0,0,0,Gefitinib,GEFITINIB,1,,Rash|Decreased appetite|Diarrhoea|Abdominal pain,4,5
11751970,20151118,Gefitinib,,,,2,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION,Intestinal ischaemia,1,1
11753894,20151119,Gefitinib,,,,2,,1,1,0,0,0,0,0,Gefitinib,LORATADINE|LORATADINE ORAL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|GABAPENTIN|CLOPIDOGREL|CLOPIDOGREL BISULFATE|ERGOCALCIFEROL|SIMVASTATIN|LEVOTHYROXINE|PANTOPRAZOLE|GEFITINIB|METOPROLOL TARTRATE|METOPROLOL|IRON,13,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Death,1,
11758271,20151120,Gefitinib,75,801,75.0,1,48,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,3,LUNG NEOPLASM MALIGNANT,Peritonitis|Gastric perforation|Peptic ulcer,3,1
11761740,20151120,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,EGFR GENE MUTATION|LUNG ADENOCARCINOMA,Treatment failure,1,1
11769321,20151123,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,CETUXIMAB|GEFITINIB|PANITUMUMAB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|CETUXIMAB,5,NEURALGIA|NEURALGIA|NEURALGIA|NEURALGIA,Hepatic enzyme increased|Skin disorder|Off label use|Meningitis aseptic|Hypertrichosis|Hypomagnesaemia|Infection|Alopecia|Diarrhoea|Stomatitis|Nausea,11,5
11771287,20151124,Gefitinib,,,,0,,1,1,0,0,0,0,1,Gefitinib,CELECOXIB|CAPECITABINE|GEFITINIB|PACLITAXEL,4,OESOPHAGEAL CARCINOMA|OESOPHAGEAL ADENOCARCINOMA METASTATIC|OESOPHAGEAL CARCINOMA,Metastasis|Diarrhoea|Disease progression|Hepatic enzyme increased|Hepatic failure|Disease recurrence|Dysphagia|Epistaxis|Blood bilirubin increased|Mucosal inflammation,10,1
11777866,20151125,Gefitinib,63,801,63.0,2,,1,1,1,0,0,0,0,Gefitinib,CLONAZEPAM|PREGABALIN|PREGABALIN|CLONAZEPAM|GEFITINIB|OXYCODONE|FOLIC ACID|CLONAZEPAM,9,PANIC DISORDER|SEIZURE|ANALGESIC THERAPY|ANXIOLYTIC THERAPY|ANALGESIC THERAPY|ANALGESIC THERAPY|SEIZURE,Constipation|Dry skin|Disease progression,3,5
11779114,20151125,Gefitinib,64,801,64.0,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Respiratory failure,1,1
11780906,20151126,Gefitinib,23735,804,65.03,1,69,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Febrile neutropenia|Agranulocytosis|Pyoderma,3,1
11781009,20151126,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,,Lung disorder,1,1
11781067,20151126,Gefitinib,81,801,81.0,2,,1,0,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA STAGE II,Skin lesion,1,1
11781262,20151126,Gefitinib,26268,804,71.97,1,47,1,1,1,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB,7,LUNG ADENOCARCINOMA|NAUSEA|HYPOTHYROIDISM|HYPOCALCAEMIA|LUNG ADENOCARCINOMA|NAUSEA|COUGH,Decreased appetite|Rash|Pruritus|Cough|Lung disorder,5,1
11781274,20151126,Gefitinib,27476,804,75.28,2,37,1,1,0,0,0,0,0,Gefitinib,LANSOPRAZOLE|GEFITINIB,5,GASTRIC ULCER|CANCER PAIN|HYPERTENSION|NON-SMALL CELL LUNG CANCER|DYSLIPIDAEMIA,Interstitial lung disease,1,1
11781667,20151126,Gefitinib,,,,1,,1,0,1,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Malignant neoplasm progression,1,1
11782063,20151126,Gefitinib,29735,804,81.47,2,55.6,1,0,1,0,0,0,0,Gefitinib,"GEFITINIB|GEFITINIB|GEFITINIB|ESZOPICLONE|ALPRAZOLAM|MAGNESIUM|GEFITINIB|GEFITINIB|THYROID|IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA,|THYROID, UNSPECIFIED|NEBIVOLOL HYDROCHLORIDE|GEFITINIB|GEFITINIB|SERTRALINE|GEFITINIB",19,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|ALOPECIA|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Diarrhoea|Abdominal pain|Vulvovaginal discomfort|Dehydration|Urine analysis abnormal|Trichorrhexis|Asthenia|Vomiting|Eye disorder|Abdominal discomfort|Fatigue|Dry skin|Skin exfoliation|Rash pustular|Nausea|Off label use|Decreased appetite|Acne|Weight decreased|Throat irritation|Rash generalised|Alopecia,22,
11783127,20151127,Gefitinib,89,801,89.0,2,,1,0,0,0,0,0,1,Gefitinib,AMLODIPINE|GEFITINIB,2,HYPERTENSION|LUNG NEOPLASM MALIGNANT,Basal cell carcinoma,1,1
11783678,20151127,Gefitinib,62,801,62.0,2,39.8,1,0,1,1,0,0,0,Gefitinib,"LOSARTAN|GEFITINIB|GEFITINIB|AMLODIPINE|LINAGLIPTIN|PREGABALIN|ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE",10,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Sepsis,1,1
11786226,20151130,Gefitinib,,,,1,,1,0,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT,Epistaxis|Acne|Oral pain,3,3
11786695,20151130,Gefitinib,64,801,64.0,2,,1,0,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Gait disturbance|Activities of daily living impaired|Confusional state,3,1
11789996,20151201,Gefitinib,45,801,45.0,1,,1,1,1,0,0,0,1,Gefitinib,GEFITINIB|NIVOLUMAB,3,PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Tumour pain|Cholecystitis|Abdominal pain|Malignant neoplasm progression,4,1
11793130,20151202,Gefitinib,61,801,61.0,2,47,1,0,0,0,0,0,1,Gefitinib,OXYCODONE HYDROCHLORIDE|GEFITINIB,8,METASTASES TO BONE,Osteonecrosis of jaw,1,1
11796801,20151203,Gefitinib,854,802,71.17,2,,1,0,0,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB,2,BRONCHIAL CARCINOMA|LUNG NEOPLASM MALIGNANT,Psoriasis|Skin disorder|Product use issue|Pulmonary congestion|Diarrhoea|Dry skin|Rash pruritic|Cough|Skin disorder|Off label use|Rosacea,11,5
11800703,20151204,Gefitinib,83,801,83.0,2,,1,0,0,0,0,0,0,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Weight decreased|Alopecia|Muscle spasms|Haematochezia|Onychoclasis|Acne|Nausea|Abnormal faeces|Epistaxis|Diarrhoea|Feeling abnormal,11,
11805068,20151206,Gefitinib,,,,1,109.8,1,0,0,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB,3,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Rash pruritic|Epistaxis|Alopecia|Hair texture abnormal|Acne,5,5
11805145,20151206,Gefitinib,20809,804,57.01,2,55,1,1,0,0,1,0,0,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA,Visual impairment|Death|Deafness,3,1
11805282,20151206,Gefitinib,30946,804,84.78,2,45.4,1,0,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Nasal dryness|Nasal discomfort|Dyspnoea|Epistaxis|Oropharyngeal pain|Dry eye,6,3
11811143,20151208,Gefitinib,,,,1,,1,0,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Off label use|Product use issue|Rash generalised,3,5
11813105,20151209,Gefitinib,31068,804,85.12,1,,1,1,0,0,0,0,0,Gefitinib,QUETIAPINE|GEFITINIB,2,,Death,1,
11813595,20151209,Gefitinib,22107,804,60.57,1,58,1,0,0,0,0,0,1,Gefitinib,ETOPOSIDE|CISPLATIN|GEFITINIB,3,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Nausea|Bone marrow failure|Vomiting,3,1
11829035,20151211,Gefitinib,83,801,83.0,2,32,1,1,1,0,0,0,0,Gefitinib,GEFITINIB|LEVETIRACETAM|AFATINIB,11,PROPHYLAXIS|TRANSIENT ISCHAEMIC ATTACK|LUNG ADENOCARCINOMA|EPILEPSY|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG ADENOCARCINOMA|HEPATIC FUNCTION ABNORMAL|PROPHYLAXIS AGAINST DIARRHOEA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Interstitial lung disease|Hepatic cirrhosis,2,1
11829754,20151212,Gefitinib,80,801,80.0,1,45,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|ESOMEPRAZOLE MAGNESIUM,9,LUNG NEOPLASM MALIGNANT,Lung disorder,1,2
11829758,20151212,Gefitinib,63,801,63.0,2,42,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,TARGETED CANCER THERAPY|LUNG ADENOCARCINOMA,Pruritus|Lymphadenitis|Hair growth abnormal|Folliculitis,4,1
11829803,20151212,Gefitinib,65,801,65.0,1,,1,0,1,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB,3,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Rash|Haematemesis|Gastric ulcer,3,1
11829874,20151212,Gefitinib,73,801,73.0,2,40,1,0,0,0,0,0,0,Gefitinib,GEFITINIB|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE),3,NON-SMALL CELL LUNG CANCER,Hypokalaemia,1,1
11829883,20151212,Gefitinib,,,,0,,1,0,0,0,1,0,0,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Renal impairment,1,1
11831248,20151214,Gefitinib,48,801,48.0,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death|Drug dose omission|Dysphagia,3,5
11831900,20151214,Gefitinib,34936,804,95.72,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,7,HYPERTENSION|NON-SMALL CELL LUNG CANCER|HYPERTENSION|EGFR GENE MUTATION|ILL-DEFINED DISORDER|HYPOTHYROIDISM|HYPERTENSION,Blood sodium abnormal|Neutrophil count increased|Malignant neoplasm progression|Electrocardiogram ST segment depression|Electrocardiogram QT shortened|Atrial fibrillation|Blood glucose increased|Blood potassium abnormal|Creatinine renal clearance decreased,9,1
11834657,20151215,Gefitinib,74,801,74.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB,3,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Skin toxicity|Diarrhoea|Malignant neoplasm progression|Hepatotoxicity|Alopecia|Paronychia,6,1
11835942,20151215,Gefitinib,65,801,65.0,2,,1,0,1,0,0,0,0,Gefitinib,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|GEFITINIB|GEFITINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,4,LUNG ADENOCARCINOMA,Emphysematous cystitis,1,3
11836483,20151215,Gefitinib,30159,804,82.63,1,67,1,0,1,0,0,0,0,Gefitinib,TIOTROPIUM BROMIDE|AMLODIPINE|AMLODIPINE|GEFITINIB|ROSUVASTATIN|CLOPIDOGREL,10,CHRONIC OBSTRUCTIVE PULMONARY DISEASE|HYPERTENSION|HYPERTENSION|LUNG ADENOCARCINOMA|HYPERLIPIDAEMIA|TRANSIENT ISCHAEMIC ATTACK|HYPERTENSION,Neutropenia|Dermatitis acneiform|Diarrhoea,3,1
11837353,20151215,Gefitinib,87,801,87.0,2,,1,0,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Rash pustular|Skin disorder|Pruritus|Scratch,4,2
11839196,20151216,Gefitinib,,,,0,,1,1,0,0,0,0,1,Gefitinib,GEFITINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|GEFITINIB|ZOLEDRONIC ACID|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,5,LUNG ADENOCARCINOMA RECURRENT|LUNG ADENOCARCINOMA RECURRENT|LUNG ADENOCARCINOMA RECURRENT|LUNG ADENOCARCINOMA RECURRENT,Emphysematous cystitis|Ascites|Vomiting|Diarrhoea|Hyperglycaemia|Neurological decompensation|Staphylococcus test positive|Immunosuppression|Performance status decreased|Blood sodium decreased|Pneumoperitoneum|Escherichia test positive,12,1
11841135,20151216,Gefitinib,75,801,75.0,1,,1,0,1,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Decreased appetite|Cystitis|Weight decreased|Transaminases increased,4,5
11842743,20151216,Gefitinib,,,,0,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Death,1,1
11845981,20151217,Gefitinib,76,801,76.0,2,,1,0,0,0,0,0,1,Gefitinib,WARFARIN|GEFITINIB,2,ATRIAL FIBRILLATION|LUNG ADENOCARCINOMA,Drug interaction|Activated partial thromboplastin time prolonged|International normalised ratio increased|Anaemia|Gastrointestinal haemorrhage,5,3
11846008,20151217,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|WARFARIN|WARFARIN|GEFITINIB|WARFARIN|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE MAGNESIUM|ESOMEPRAZOLE MAGNESIUM,10,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|DUODENAL ULCER|ABDOMINAL PAIN UPPER|DUODENAL ULCER|ABDOMINAL PAIN UPPER,Diarrhoea|International normalised ratio increased|Contusion|Drug interaction,4,3
11847043,20151217,Gefitinib,,,,2,,1,0,0,0,0,0,0,Gefitinib,GEFITINIB,1,METASTASES TO LUNG,Dizziness|Dysgeusia|Vision blurred,3,
11851764,20151218,Gefitinib,21769,804,59.64,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,MALIGNANT RESPIRATORY TRACT NEOPLASM,Death,1,
11852361,20151218,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Rash|Pneumonitis,2,5
11852693,20151218,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,2,NON-SMALL CELL LUNG CANCER,Drug interaction|Drug level decreased,2,1
11853130,20151218,Gefitinib,29209,804,80.02,1,71,1,0,1,0,0,0,1,Gefitinib,GEFITINIB|AMLODIPINE BESYLATE|SULFASALAZINE,9,RHEUMATOID ARTHRITIS|NON-SMALL CELL LUNG CANCER RECURRENT|RHEUMATOID ARTHRITIS,Duodenal ulcer|Gastrointestinal haemorrhage|Chronic gastritis,3,3
11855372,20151221,Gefitinib,,,,0,,1,0,1,0,0,0,0,Gefitinib,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|GEFITINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ZOLEDRONIC ACID,4,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Emphysematous cystitis|Vomiting|Diarrhoea,3,3
11858949,20151222,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Acne|Disease progression|Aphthous ulcer,3,5
11860052,20151222,Gefitinib,72,801,72.0,1,,1,0,1,1,0,0,0,Gefitinib,GEFITINIB,2,LUNG NEOPLASM MALIGNANT,Interstitial lung disease|Gastrointestinal haemorrhage,2,1
11867231,20151224,Gefitinib,809,802,67.42,2,,1,0,0,0,1,0,1,Gefitinib,CANDESARTAN CILEXETIL|GEFITINIB|GEFITINIB,5,HYPERTENSION|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Paraneoplastic syndrome|Malignant neoplasm progression|Metastases to meninges|Spinal fracture|Impaired healing|Gastritis,6,1
11868066,20151224,Gefitinib,80,801,80.0,1,,1,0,1,0,0,0,0,Gefitinib,SITAGLIPTIN|GEFITINIB,6,NON-SMALL CELL LUNG CANCER,Liver disorder,1,1
11872261,20151228,Gefitinib,65,801,65.0,2,,1,1,0,0,0,0,0,Gefitinib,ZOLEDRONIC ACID|GEFITINIB,4,PRODUCT USED FOR UNKNOWN INDICATION|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Emphysematous cystitis,1,3
11873850,20151229,Gefitinib,26704,804,73.16,1,,1,0,0,0,0,0,1,Gefitinib,OXYCODONE HYDROCHLORIDE|PREGABALIN|GEFITINIB,9,METASTATIC BRONCHIAL CARCINOMA,Dermatitis acneiform|Disease progression|Rash pustular,3,1
11877115,20151229,Gefitinib,,,,1,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,5
11880349,20151230,Gefitinib,23688,804,64.9,2,52,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|PANTOPRAZOLE,6,NON-SMALL CELL LUNG CANCER METASTATIC|DEPRESSION|DIARRHOEA|ABDOMINAL PAIN UPPER|TREMOR|DEEP VEIN THROMBOSIS,Subacute cutaneous lupus erythematosus,1,1
11882152,20151231,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|MIDAZOLAM|MIDAZOLAM HYDROCHLORIDE,2,METASTASIS|SEDATION,Unresponsive to stimuli|Respiratory depression,2,3
11884939,20160104,Gefitinib,3091,803,59.44,1,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,ILL-DEFINED DISORDER,Death,1,
11888229,20160105,Gefitinib,33924,804,92.94,1,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,NEOPLASM MALIGNANT,Death,1,
11889586,20160105,Gefitinib,31050,804,85.07,1,54,1,1,0,1,0,0,0,Gefitinib,GEFITINIB|MAGNESIUM OXIDE,6,RETINAL HAEMORRHAGE|LUNG ADENOCARCINOMA|COUGH|RETINAL HAEMORRHAGE|CONSTIPATION PROPHYLAXIS,Rectal ulcer,1,2
11889603,20160105,Gefitinib,80,801,80.0,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,4,LUNG NEOPLASM MALIGNANT,Death|Decreased appetite|Constipation,3,5
11889813,20160105,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB|PACLITAXEL|ERLOTINIB HYDROCHLORIDE,4,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Small cell lung cancer,1,1
11909252,20160112,Gefitinib,81,801,81.0,1,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
11910158,20160112,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,3
11911348,20160112,Gefitinib,16849,804,46.16,2,69,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA,Deep vein thrombosis,1,1
11916074,20160114,Gefitinib,23974,804,65.68,2,55,1,0,1,0,0,0,0,Gefitinib,CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|GEFITINIB,8,ACNE|ACNE|ACNE|ACNE|ACNE|INSOMNIA|PHARYNGITIS|LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT,Pulmonary artery thrombosis|Deep vein thrombosis,2,1
11918401,20160115,Gefitinib,28272,804,77.46,1,,1,0,0,0,0,0,1,Gefitinib,SOLIFENACIN SUCCINATE|GEFITINIB,2,BLADDER SPASM|NON-SMALL CELL LUNG CANCER,Creatinine renal clearance decreased|Metastases to liver,2,1
11923794,20160118,Gefitinib,,,,0,,1,1,0,0,0,0,1,Gefitinib,PACLITAXEL|DOCETAXEL|DOCETAXEL ANHYDROUS|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB|CARBOPLATIN|DOCETAXEL|DOCETAXEL ANHYDROUS|CISPLATIN|CARBOPLATIN|CISPLATIN|PEMETREXED DISODIUM|PEMETREXED|PEMETREXED DISODIUM|PEMETREXED,12,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DISEASE PROGRESSION|DISEASE PROGRESSION|NON-SMALL CELL LUNG CANCER,Metastases to central nervous system|Metastases to liver|Lung infection|Vomiting|Disease recurrence|Cachexia|Bone marrow failure|Nausea|Cytopenia|Gastrointestinal toxicity,10,3
11930230,20160120,Gefitinib,66,801,66.0,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB|PREGABALIN|GEFITINIB|SIMVASTATIN|LISINOPRIL,5,LUNG NEOPLASM MALIGNANT|BONE CANCER,Death|Acne|Dry skin|Pain,4,
11931847,20160120,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,,Malignant neoplasm progression,1,5
11935307,20160121,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|GEFITINIB,3,HYPERTENSION|ABDOMINAL PAIN UPPER|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
11936447,20160121,Gefitinib,23461,804,64.28,2,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA,Renal failure|Hepatic failure|Coma|Cellulitis,4,1
11938410,20160122,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Conjunctivitis|Pruritus|Transaminases increased|Gastritis|Diarrhoea|Rash|Fatigue,7,5
11939151,20160122,Gefitinib,59,801,59.0,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA,Skin disorder,1,1
11952617,20160126,Gefitinib,59,801,59.0,1,83,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA,Bone marrow failure|Back pain,2,1
11954068,20160126,Gefitinib,69,801,69.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA,Endometrial cancer|Vaginal discharge|Hydrometra|Uterine inflammation,4,5
11968697,20160128,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB|BEVACIZUMAB|GEFITINIB,5,EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION,Malignant neoplasm progression|Drug intolerance,2,1
11979665,20160129,Gefitinib,,,,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB|OSIMERTINIB,2,ADENOCARCINOMA|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
11979810,20160129,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
11980603,20160129,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Neoplasm recurrence,1,5
11980735,20160129,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression,1,1
11980987,20160129,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,3,ANXIETY|NON-SMALL CELL LUNG CANCER|HYPERTENSION,Cataract|Disease progression,2,1
11982865,20160201,Gefitinib,78,801,78.0,1,,1,0,0,0,0,0,0,Gefitinib,GEFITINIB,3,CANCER PAIN|CANCER PAIN,Wrong technique in product usage process|Pain|Off label use,3,5
11983609,20160201,Gefitinib,27030,804,74.05,2,,1,0,0,0,0,0,0,Gefitinib,GEFITINIB|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|DIGOXIN,7,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I,Hair growth abnormal|Diarrhoea|Rash|Dry skin,4,
11986896,20160202,Gefitinib,57,801,57.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB|TRASTUZUMAB|TRASTUZUMAB,4,BREAST CANCER|BREAST CANCER,Alanine aminotransferase increased|Proteinuria|Aspartate aminotransferase increased,3,1
11987580,20160202,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression,1,1
11987638,20160202,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression,1,1
11988295,20160202,Gefitinib,38,801,38.0,2,,1,0,1,0,0,0,0,Gefitinib,CISPLATIN|GEFITINIB|PEMETREXED|PEMETREXED DISODIUM,3,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Headache,1,1
11989269,20160202,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Disease progression,1,1
11989331,20160202,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression,1,1
11989332,20160202,Gefitinib,30753,804,84.25,2,57,1,0,1,0,0,0,1,Gefitinib,GEFITINIB|GABAPENTIN|PREGABALIN|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|LAMOTRIGINE|ZOLPIDEM TARTRATE,9,NON-SMALL CELL LUNG CANCER|TRANSIENT ISCHAEMIC ATTACK,Aspartate aminotransferase increased|Transaminases increased|Alanine aminotransferase increased|Transient ischaemic attack,4,1
11990773,20160202,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression,1,1
11993014,20160203,Gefitinib,31482,804,86.25,1,88.5,1,0,0,0,0,0,0,Gefitinib,"LANSOPRAZOLE|CYCLOBENZAPRINE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|FUROSEMIDE|GEFITINIB|BACITRACIN ZINC, POLYMYXIN B SULFATE|NEOMYCIN SULFATE|BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B|BACITRACIN|NEOMYCIN, POLYMYXIN B, PRAMOXINE HCL|BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE|BACITRACIN ZINC|TRIAMCINOLONE ACETONIDE|TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%|GEFITINIB|ERGOCALCIFEROL|TERAZOSIN|TERAZOSIN HYDROCHLORIDE",13,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Urinary tract infection|Drug interaction|Pain in extremity|Urine output decreased|Chromaturia,5,
11993791,20160203,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
11993794,20160203,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression,1,1
11995887,20160203,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
11999537,20160204,Gefitinib,,,,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB,2,BONE CANCER|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Weight decreased|Decreased appetite|Death,3,
12000771,20160204,Gefitinib,76,801,76.0,2,,1,0,1,0,0,0,1,Gefitinib,GEFITINIB,1,,Dyspnoea|Hypoaesthesia oral|Fibrin D dimer increased|Pleural effusion|Nail bed inflammation|Drug resistance|General physical health deterioration|Fatigue|Malignant neoplasm progression|Metastases to bone|Asthenia|Bone lesion|Back pain|Pancytopenia,14,1
12001484,20160204,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12001907,20160204,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12007618,20160204,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Malignant neoplasm progression,1,
12007874,20160205,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12009768,20160205,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression|Diarrhoea,2,1
12009927,20160205,Gefitinib,40,801,40.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Skin toxicity|Metastases to bone|Gastrointestinal motility disorder,3,1
12013562,20160205,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12047252,20160209,Gefitinib,26660,804,73.04,2,55.2,1,0,0,0,0,0,1,Gefitinib,"FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|LEVOTHYROXINE SODIUM|WARFARIN|GEFITINIB|AMLODIPINE|DIGOXIN|DEXLANSOPRAZOLE|OSIMERTINIB|METOPROLOL SUCCINATE|SIMVASTATIN|EFINACONAZOLE|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL",15,METASTASES TO LUNG|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Fatigue|Onychoclasis|Skin exfoliation|Malignant neoplasm progression|Pruritus|Nausea|Nasopharyngitis|Diarrhoea|Fungal infection|Drug dose omission|Dyspnoea|Decreased appetite|Muscle spasms|Skin burning sensation,14,
12053027,20160209,Gefitinib,923,802,76.92,2,,1,0,0,0,0,0,1,Gefitinib,BISOPROLOL FUMARATE|GEFITINIB|GEFITINIB,7,,Weight decreased|Transaminases increased|Asthenia,3,1
12053045,20160209,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12053076,20160209,Gefitinib,75,801,75.0,2,,1,0,1,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA,Malignant neoplasm progression|Atelectasis|Pleural effusion,3,1
12056737,20160209,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12059541,20160210,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12060134,20160210,Gefitinib,65,801,65.0,2,64,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,2,NON-SMALL CELL LUNG CANCER|CONSTIPATION,Lung disorder,1,2
12061890,20160210,Gefitinib,,,,0,,1,0,0,0,0,0,0,Gefitinib,GEFITINIB,1,,No adverse event,1,1
12065608,20160211,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12067705,20160211,Gefitinib,30588,804,83.8,2,38,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB,4,HYPERTENSION|LUNG ADENOCARCINOMA STAGE III|LUNG ADENOCARCINOMA STAGE III|INSOMNIA,Colitis ischaemic,1,1
12068401,20160211,Gefitinib,66,801,66.0,1,,1,0,0,0,0,0,1,Gefitinib,"FUROSEMIDE|ENALAPRIL|METOPROLOL TARTRATE|METOPROLOL|OXAZEPAM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|GEFITINIB",16,DYSLIPIDAEMIA|HYPERTENSION|HYPERSENSITIVITY|PROPHYLAXIS|ARRHYTHMIA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|ANXIETY|DYSLIPIDAEMIA|PROPHYLAXIS|HYPERLIPIDAEMIA|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|HYPERLIPIDAEMIA|ARRHYTHMIA,Lung neoplasm malignant,1,1
12069447,20160211,Gefitinib,88,801,88.0,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I,Death|Diarrhoea|Rash,3,
12069547,20160211,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12070516,20160211,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12070586,20160211,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12070974,20160211,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12071022,20160211,Gefitinib,66,801,66.0,2,,1,0,1,0,0,0,0,Gefitinib,WARFARIN|GEFITINIB,2,ATRIAL FIBRILLATION|LUNG ADENOCARCINOMA METASTATIC,International normalised ratio increased,1,2
12072933,20160212,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12074775,20160212,Gefitinib,712,802,59.33,2,,1,1,0,0,0,0,1,Gefitinib,GEFITINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER,Metastases to central nervous system|Death,2,5
12089137,20160218,Gefitinib,62,801,62.0,2,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,,Fracture,1,2
12090754,20160218,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12090854,20160218,Gefitinib,88,801,88.0,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Rash generalised|Malignant neoplasm progression,2,1
12091322,20160218,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12095569,20160219,Gefitinib,55,801,55.0,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,5
12096374,20160220,Gefitinib,71,801,71.0,1,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Pulmonary thrombosis|Metastases to central nervous system,2,
12098670,20160222,Gefitinib,74,801,74.0,2,,1,1,1,0,0,0,0,Gefitinib,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|GEFITINIB|GEFITINIB,6,ANTIINFLAMMATORY THERAPY|LUNG NEOPLASM MALIGNANT|ANALGESIC THERAPY|ANTIINFLAMMATORY THERAPY|IRON DEFICIENCY|LUNG NEOPLASM MALIGNANT,Malignant neoplasm progression|Dehydration,2,5
12103926,20160223,Gefitinib,81,801,81.0,1,60,1,0,1,0,1,0,0,Gefitinib,AMOXICILLIN AND CLAVULANATE POTASSIUM|METRONIDAZOLE|GEFITINIB,18,LUNG NEOPLASM MALIGNANT|PAIN,Metastases to meninges|Malignant pleural effusion|Pyogenic granuloma|Decreased appetite|Dysphagia|Pneumonia|Anaemia|Muscular weakness|Fall|General physical health deterioration|Mobility decreased|Abnormal behaviour|Encephalopathy|Cholelithiasis|Cholecystitis acute|Chronic obstructive pulmonary disease|Fatigue|Pyrexia|Abasia|Asthenia|Cystitis pseudomonal|Lung adenocarcinoma stage IV|Diarrhoea|Somnolence,24,1
12103936,20160223,Gefitinib,,,,0,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,,Death,1,1
12105297,20160223,Gefitinib,56,801,56.0,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Nodule,2,5
12105698,20160223,Gefitinib,77,801,77.0,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12108737,20160224,Gefitinib,674,802,56.17,2,92,1,0,0,0,0,0,1,Gefitinib,DENOSUMAB|GEFITINIB|OSIMERTINIB,6,PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER METASTATIC|PAIN,Malignant neoplasm progression|Epistaxis|Acute haemorrhagic conjunctivitis,3,1
12108914,20160224,Gefitinib,,,,0,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,,Skin disorder|Decreased appetite,2,5
12109950,20160224,Gefitinib,70,801,70.0,1,,1,0,0,1,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Acute monocytic leukaemia,1,1
12111127,20160224,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEFITINIB|PACLITAXEL|DOCETAXEL|DOCETAXEL ANHYDROUS|BEVACIZUMAB|CARBOPLATIN|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|PEMETREXED|PEMETREXED DISODIUM,8,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Drug resistance|Neuroendocrine carcinoma,2,3
12111294,20160224,Gefitinib,31813,804,87.16,2,,1,0,1,1,0,0,0,Gefitinib,GEFITINIB,8,LUNG ADENOCARCINOMA,Thyroid disorder|Interstitial lung disease,2,1
12111386,20160224,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression|Aphasia,2,1
12113588,20160225,Gefitinib,28986,804,79.41,2,,1,1,1,0,0,0,0,Gefitinib,PREDNISONE|GEFITINIB|GEFITINIB,3,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Death|Dry skin|Lacrimation increased|Diarrhoea|Pleural effusion|Vomiting,6,
12113714,20160225,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION,Disease progression,1,1
12115201,20160225,Gefitinib,70,801,70.0,2,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Hypoglycaemia|Diarrhoea|Nausea|Vomiting|Decreased appetite,5,1
12116490,20160225,Gefitinib,26738,804,73.25,2,61.2,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,NEOPLASM MALIGNANT,Death,1,
12118141,20160226,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,PEMETREXED|PEMETREXED DISODIUM|GEFITINIB,2,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12124312,20160229,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER RECURRENT,Malignant neoplasm progression,1,1
12131609,20160301,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,CISPLATIN|GEFITINIB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE,3,TRANSITIONAL CELL CARCINOMA|TRANSITIONAL CELL CARCINOMA|TRANSITIONAL CELL CARCINOMA,Leukopenia|Discomfort|Rash|Dyspnoea|Nausea,5,3
12133224,20160301,Gefitinib,72,801,72.0,2,,1,0,0,0,0,0,0,Gefitinib,AMLODIPINE|GEFITINIB,6,LUNG ADENOCARCINOMA,Renal impairment,1,2
12133723,20160301,Gefitinib,991,802,82.58,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Disease progression|Rash generalised|Alopecia|Diarrhoea,4,
12133932,20160301,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEMCITABINE HYDROCHLORIDE|GEMCITABINE|GEFITINIB|CISPLATIN|VINORELBINE|CARBOPLATIN|PACLITAXEL,6,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Second primary malignancy,1,3
12135846,20160302,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB|GEFITINIB,4,EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression|Dry skin|Acne,3,1
12135945,20160302,Gefitinib,24830,804,68.03,1,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|GEFITINIB|GEFITINIB|GEFITINIB,5,BRONCHIAL CARCINOMA|BRONCHIAL CARCINOMA|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Diarrhoea|Death,2,
12136014,20160302,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12136095,20160302,Gefitinib,,,,0,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,,Metastases to central nervous system|Gait disturbance,2,2
12138269,20160302,Gefitinib,68,801,68.0,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Malignant neoplasm progression,1,5
12138532,20160302,Gefitinib,76,801,76.0,2,,1,1,1,0,0,0,1,Gefitinib,AFATINIB|GEFITINIB|AFATINIB|GEFITINIB,4,EGFR GENE MUTATION|EGFR GENE MUTATION|ADENOCARCINOMA|ADENOCARCINOMA,General physical health deterioration|General physical health deterioration|Fibrin D dimer increased|Death|Malignant neoplasm progression|Dyspnoea|Dyspnoea,7,3
12138912,20160302,Gefitinib,58,801,58.0,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA,Metastases to central nervous system,1,1
12138958,20160302,Gefitinib,87,801,87.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA,Malignant neoplasm progression|Alopecia,2,1
12140197,20160303,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Diarrhoea|Disease progression,2,1
12147115,20160304,Gefitinib,68,801,68.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12147337,20160304,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression,1,1
12152826,20160304,Gefitinib,623,802,51.92,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION,Transaminases increased|Gamma-glutamyltransferase increased|Blood alkaline phosphatase increased|Malignant neoplasm progression|Arteriosclerosis coronary artery,5,1
12155288,20160307,Gefitinib,844,802,70.33,2,,1,1,1,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death|Therapy cessation|Adverse event,3,
12155480,20160307,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE|GEFITINIB,3,LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Lung disorder,1,5
12157823,20160308,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,2,NON-SMALL CELL LUNG CANCER,Disease progression,1,3
12160010,20160308,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression,1,1
12160276,20160308,Gefitinib,1039,802,86.58,1,,1,1,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|LUNG NEOPLASM MALIGNANT,Death|Decreased appetite|Fatigue|Weight decreased|Metastasis|Dehydration,6,
12161253,20160308,Gefitinib,942,802,78.5,1,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB|GEFITINIB,4,CHEMOTHERAPY|CHEMOTHERAPY|CHEMOTHERAPY|CHEMOTHERAPY,Liver disorder|Pruritus|Oedema peripheral|Rash|Urticaria,5,1
12166750,20160310,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|RIVAROXABAN|GEFITINIB,4,NON-SMALL CELL LUNG CANCER|EMBOLISM VENOUS|PAIN|EGFR GENE MUTATION,Malignant neoplasm progression,1,1
12167754,20160310,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12167867,20160310,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,EGFR GENE MUTATION,Malignant neoplasm progression,1,1
12168116,20160310,Gefitinib,54,801,54.0,2,,1,1,1,0,0,0,1,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERGOCALCIFEROL|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|FAMOTIDINE|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE,14,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|SPINAL MENINGIOMA MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Metastases to meninges|Pyrexia|Pain|Dry skin|Nausea|Death|Mass|Pruritus|Hypoaesthesia|Wound|Abdominal discomfort|Confusional state|Rash|Amnesia|Skin exfoliation|Diarrhoea|Drug ineffective|Hepatic enzyme increased|Infected skin ulcer|Peripheral coldness|Depression|Rash,22,5
12168495,20160310,Gefitinib,31828,804,87.2,2,50,1,1,0,1,0,0,1,Gefitinib,VALSARTAN|GEFITINIB|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|SULFASALAZINE|DOXAZOSIN|DOXAZOSIN MESYLATE,12,HYPERTENSION|ANXIETY DISORDER|HYPERTENSION|LUNG ADENOCARCINOMA|RHINITIS ALLERGIC|RHEUMATOID ARTHRITIS|RHEUMATOID ARTHRITIS|HYPERTENSION|RHEUMATOID ARTHRITIS,Septic shock|Pneumonia|Interstitial lung disease|Atrial fibrillation|Renal impairment|Blood pressure decreased,6,1
12170691,20160311,Gefitinib,35,801,35.0,2,,1,0,0,0,0,0,0,Gefitinib,CISPLATIN|GEFITINIB|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|DOCETAXEL|DOCETAXEL ANHYDROUS,4,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Therapy non-responder|Exposure during pregnancy,2,3
12171238,20160311,Gefitinib,29,801,29.0,2,,1,1,1,0,0,0,0,Gefitinib,DOCETAXEL|DOCETAXEL ANHYDROUS|BEVACIZUMAB|PEMETREXED|PEMETREXED DISODIUM|CARBOPLATIN|GEFITINIB,5,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Death|Exposure during pregnancy|Premature delivery|Normal newborn|Dermatitis|Cerebral venous thrombosis|Neoplasm progression,7,3
12171552,20160311,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression,1,1
12172379,20160311,Gefitinib,65,801,65.0,2,,1,1,0,1,0,0,0,Gefitinib,GEFITINIB|ZOLEDRONIC ACID|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,4,NON-SMALL CELL LUNG CANCER METASTATIC|EGFR GENE MUTATION|EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER METASTATIC,Emphysematous cystitis|Death,2,3
12172511,20160311,Gefitinib,730,802,60.83,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION,Malignant neoplasm progression,1,1
12173534,20160311,Gefitinib,74,801,74.0,2,,1,0,0,0,1,0,1,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB,3,NON-SMALL CELL LUNG CANCER RECURRENT|NON-SMALL CELL LUNG CANCER RECURRENT|NON-SMALL CELL LUNG CANCER RECURRENT,Neuropathy peripheral|Malignant neoplasm progression|Hepatitis|Toxic skin eruption|Diarrhoea|Off label use,6,1
12173929,20160314,Gefitinib,66,801,66.0,2,27,1,1,1,1,1,1,1,Gefitinib,GEFITINIB|FAMOTIDINE|PREGABALIN|OXYCODONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|MAGNESIUM OXIDE,8,Lung adenocarcinoma|Gastrooesophageal reflux disease|Cancer pain|Neuropathy peripheral|Anxiety|Cancer pain|Cancer pain,Pneumonia aspiration|Disease progression|Pneumatosis intestinalis|Diarrhoea|Vomiting|Constipation|Therapy cessation,7,1
12178631,20160315,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression,1,1
12180659,20160315,Gefitinib,84,801,84.0,2,57,1,0,1,0,0,0,0,Gefitinib,DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|ZOLPIDEM TARTRATE|ZOLPIDEM TARTRATE|LAMOTRIGINE|PREGABALIN|GEFITINIB,11,TRANSIENT ISCHAEMIC ATTACK|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|ATRIAL FIBRILLATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Transaminases increased|Transient ischaemic attack,2,1
12184890,20160316,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12185572,20160316,Gefitinib,,,,2,64,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression,1,
12186879,20160317,Gefitinib,48,801,48.0,2,,1,1,1,0,0,0,0,Gefitinib,GEFITINIB|FENTANYL|OXYCODONE|MELATONIN,4,METASTASES TO LUNG,Death|Spinal cord compression,2,
12189344,20160317,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression,1,1
12189793,20160318,Gefitinib,26003,804,71.24,2,,1,0,1,0,1,0,0,Gefitinib,GEFITINIB|CLOPIDOGREL|GEFITINIB|SIMVASTATIN|RAMIPRIL|ALENDRONATE SODIUM|HYDROCHLOROTHIAZIDE,7,EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER,Haematemesis|Gastrointestinal ulcer|Diarrhoea,3,2
12192991,20160318,Gefitinib,75,801,75.0,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,2,NON-SMALL CELL LUNG CANCER,Atelectasis,1,3
12193857,20160321,Gefitinib,51,801,51.0,2,,1,0,0,0,0,0,1,Gefitinib,CARBOPLATIN|GEFITINIB|AFATINIB|GEFITINIB|GEFITINIB|PEMETREXED|PEMETREXED DISODIUM|AFATINIB,8,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Diarrhoea|Hyperplasia|Disease recurrence|Disease progression|Drug intolerance|Chest pain|Blood creatinine increased|Mouth ulceration|Onychoclasis|Gene mutation|Flatulence,11,3
12195550,20160321,Gefitinib,46,801,46.0,1,,1,1,0,0,0,0,1,Gefitinib,GEFITINIB|MANNITOL|PEMETREXED|PEMETREXED DISODIUM|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,6,SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|INTRACRANIAL PRESSURE INCREASED|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER,Lung infection|Gastrointestinal haemorrhage|Bone marrow failure|Nosocomial infection|Liver injury,5,1
12197624,20160322,Gefitinib,85,801,85.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Invasive ductal breast carcinoma|Lymphadenopathy|Rash maculo-papular,3,1
12198931,20160322,Gefitinib,,,,2,,1,1,1,1,1,1,1,Gefitinib,GEFITINIB,1,,Disease progression,1,1
12203027,20160323,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB|LEVETIRACETAM,5,PHLEBITIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|EPILEPSY|GASTROOESOPHAGEAL REFLUX DISEASE,Disease progression,1,1
12203049,20160323,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,PREGABALIN|ALPRAZOLAM|GEFITINIB,4,NEURALGIA|SLEEP DISORDER|NON-SMALL CELL LUNG CANCER|HYPERTENSION,Malignant neoplasm progression,1,1
12204219,20160323,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,PEMETREXED|PEMETREXED DISODIUM|GEFITINIB|CISPLATIN|GEFITINIB|BEVACIZUMAB,6,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12205624,20160323,Gefitinib,25768,804,70.6,2,,1,1,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Pneumonia|Death|Fatigue,3,
12207664,20160324,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12208130,20160324,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression,1,1
12209843,20160325,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12211386,20160325,Gefitinib,68,801,68.0,2,,1,0,0,0,0,0,1,Gefitinib,CARBOPLATIN|PEMETREXED|PEMETREXED DISODIUM|CITALOPRAM|CITALOPRAM HYDROBROMIDE|GEFITINIB|GEFITINIB,5,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DEPRESSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12211688,20160325,Gefitinib,71,801,71.0,1,,1,1,0,0,0,0,1,Gefitinib,CANDESARTAN CILEXETIL|GEFITINIB,4,MYOCARDIAL ISCHAEMIA|HYPERTENSION|LUNG NEOPLASM MALIGNANT|PRODUCT USED FOR UNKNOWN INDICATION,Disease progression|Myocardial infarction,2,5
12211917,20160325,Gefitinib,21889,804,59.97,1,24,1,1,0,1,0,0,0,Gefitinib,GEFITINIB|CISPLATIN|CARBOPLATIN|PACLITAXEL|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|PACLITAXEL|PACLITAXEL|CARBOPLATIN|CARBOPLATIN|VINORELBINE|CARBOPLATIN|PACLITAXEL|PACLITAXEL,21,NON-SMALL CELL LUNG CANCER|LUNG ADENOCARCINOMA|SPUTUM RETENTION|GASTRITIS|INSOMNIA|GASTRITIS|LUNG ADENOCARCINOMA|METASTASES TO LYMPH NODES,Sepsis|Interstitial lung disease,2,1
12212412,20160326,Gefitinib,46,801,46.0,1,,1,0,0,1,0,0,1,Gefitinib,GEFITINIB|ETOPOSIDE|PEMETREXED|PEMETREXED DISODIUM|METHOTREXATE|METHOTREXATE SODIUM|MANNITOL,6,SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|SMALL CELL LUNG CANCER|INTRACRANIAL PRESSURE INCREASED,Gastrointestinal haemorrhage|Liver injury|Bone marrow failure,3,1
12212519,20160327,Gefitinib,59,801,59.0,2,,1,0,1,0,0,0,0,Gefitinib,DENOSUMAB|DALTEPARIN SODIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|DALTEPARIN SODIUM|GEFITINIB|CALCIUM|HYDRALAZINE HYDROCHLORIDE|FENTANYL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,11,PRODUCT USED FOR UNKNOWN INDICATION|RENAL VEIN THROMBOSIS|VENA CAVA THROMBOSIS|PRODUCT USED FOR UNKNOWN INDICATION|PAIN|BLOOD PRESSURE INCREASED|PRODUCT USED FOR UNKNOWN INDICATION,Dyspnoea|Chest pain|Stress cardiomyopathy,3,3
12213942,20160328,Gefitinib,51,801,51.0,2,,1,0,0,0,0,0,1,Gefitinib,AFATINIB|GEFITINIB|AFATINIB|VINORELBINE|GEFITINIB|GEFITINIB,8,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Onychoclasis|Blood creatinine increased|Hyperplasia|Chest pain|Gene mutation|Drug intolerance|Disease recurrence|Disease progression|Flatulence|Diarrhoea|Mouth ulceration,11,5
12216377,20160329,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Fatigue|Disease progression|Diarrhoea,3,
12218433,20160329,Gefitinib,51,801,51.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|OSIMERTINIB|PEMETREXED|PEMETREXED DISODIUM|GEFITINIB|VINORELBINE|GEFITINIB|CARBOPLATIN,7,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Hyperplasia|Disease recurrence|Chest pain|Diarrhoea|Gene mutation|Malignant neoplasm progression|Flatulence|Blood creatinine increased|Mouth ulceration|Drug intolerance|Onychoclasis,11,3
12218882,20160329,Gefitinib,76,801,76.0,1,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12221605,20160330,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,ADENOCARCINOMA|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression|Nail toxicity,2,1
12222727,20160330,Gefitinib,51,801,51.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|AFATINIB|GEFITINIB|AFATINIB|GEFITINIB|PEMETREXED|PEMETREXED DISODIUM,9,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Drug intolerance|Gene mutation|Chest pain|Mouth ulceration|Onychoclasis|Blood creatine increased|Hyperplasia|Diarrhoea|Disease progression|Flatulence,10,3
12223770,20160330,Gefitinib,51,801,51.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|PEMETREXED|PEMETREXED DISODIUM|AFATINIB|CARBOPLATIN|AFATINIB|GEFITINIB|GEFITINIB,8,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Malignant neoplasm progression|Chest pain|Gene mutation|Disease recurrence|Blood creatinine increased|Drug intolerance|Diarrhoea|Hyperplasia|Mouth ulceration|Onychoclasis|Flatulence,11,3
12225953,20160331,Gefitinib,70,801,70.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA,Malignant neoplasm progression|Metastases to central nervous system|Drug resistance,3,3
12226397,20160331,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Seizure,1,1
12227476,20160331,Gefitinib,51,801,51.0,2,58,1,0,0,0,0,0,1,Gefitinib,PEMETREXED|PEMETREXED DISODIUM|GEFITINIB|GEFITINIB|CARBOPLATIN|GEFITINIB|AFATINIB|AFATINIB,8,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Flatulence|Onychoclasis|Hyperplasia|Drug tolerance|Gene mutation|Disease recurrence|Disease progression|Blood creatinine increased|Mouth ulceration|Diarrhoea|Chest pain,11,3
12228390,20160401,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression,1,1
12230926,20160401,Gefitinib,56,801,56.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|PROPRANOLOL HYDROCHLORIDE|PROPRANOLOL HYDROCHLORIDE,5,NON-SMALL CELL LUNG CANCER|OBSTRUCTION GASTRIC|ANXIETY|HYPERTENSION|HYPERTENSION,Malignant neoplasm progression|Blood alkaline phosphatase increased|Alanine aminotransferase increased|Aspartate aminotransferase increased|Gamma-glutamyltransferase increased,5,1
12231940,20160401,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,VALSARTAN|VALSARTAN ORAL|GEFITINIB,2,HYPERTENSION|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12232692,20160401,Gefitinib,78,801,78.0,2,56,1,1,1,1,0,0,0,Gefitinib,"GEFITINIB|NOREPINEPHRINE (BITARTRATE)|NOREPINEPHRINE|NOREPINEPHRINE BITARTRATE|VALSARTAN|VALSARTAN ORAL|ASCORBIC ACID|DOPAMINE HYDROCHLORIDE|SODIUM ACETATE|SODIUM ACETATE INJECTION, USP, 200 MEQ/100 ML|SODIUM ACETATE INJECTION, USP, 400 MEQ/100 ML|PYRIDOXINE HYDROCHLORIDE|METHYLPREDNISOLONE SODIUM SUCCINATE|METHYLPREDNISOLONE|LANSOPRAZOLE|FUROSEMIDE|CEFUROXIME SODIUM|NIFEDIPINE",16,NON-SMALL CELL LUNG CANCER|HYPOTENSION|HYPERTENSION|CHEST PAIN|SUPPLEMENTATION THERAPY|SHOCK|ACIDOSIS|UPPER-AIRWAY COUGH SYNDROME|SUPPLEMENTATION THERAPY|INFECTION|ASTHMA|ENTERITIS|POLYURIA|HYPERTENSION|INFECTION,Pneumonia,1,1
12233851,20160404,Gefitinib,51,801,51.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|CARBOPLATIN|GEFITINIB|AFATINIB|AFATINIB|GEFITINIB|PEMETREXED|PEMETREXED DISODIUM,8,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Flatulence|Disease recurrence|Gene mutation|Onychoclasis|Disease progression|Diarrhoea|Hyperplasia|Drug intolerance|Blood creatinine increased|Mouth ulceration|Chest pain,11,3
12240839,20160406,Gefitinib,,,,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,,Death|Diarrhoea,2,
12240852,20160406,Gefitinib,24878,804,68.16,2,,1,1,0,0,0,0,0,Gefitinib,POLYETHYLENE GLYCOL 3350|PREGABALIN|HYDROXYZINE|GEFITINIB|MORPHINE SULFATE|PROCHLORPERAZINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES,8,LUNG NEOPLASM MALIGNANT,Drug interaction|Rash|Nausea|Death|Spinal osteoarthritis,5,
12241207,20160406,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,3,NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION|HYPOTHYROIDISM,Disease progression,1,1
12242749,20160406,Gefitinib,63,801,63.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression,1,1
12243447,20160406,Gefitinib,52,801,52.0,2,,1,0,0,0,0,0,1,Gefitinib,CISPLATIN|GEFITINIB,2,LUNG NEOPLASM MALIGNANT,Pyrexia|Palpitations|Thrombosis|Nausea|Ascites|Chest discomfort|Hypoproteinaemia|Anaemia|Tachypnoea,9,1
12248962,20160408,Gefitinib,,,,0,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,,Leukopenia,1,3
12249373,20160408,Gefitinib,74,801,74.0,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12255475,20160412,Gefitinib,31720,804,86.9,2,62.6,1,1,1,0,0,0,1,Gefitinib,"FUROSEMIDE|ALBUTEROL SULFATE|ALBUTEROL|WARFARIN|PANTOPRAZOLE SODIUM|GEFITINIB|GEFITINIB|DIGOXIN|DOXORUBICIN HYDROCHLORIDE|METOPROLOL TARTRATE|METOPROLOL|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|EZETIMIBE AND SIMVASTATIN",17,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Laryngeal cancer|Death|Fatigue|Joint swelling|Cerebrovascular accident|Dyspnoea|Dry skin|Iron deficiency anaemia|Diarrhoea|Decreased appetite|Device related thrombosis|Malignant neoplasm progression|Gastrointestinal haemorrhage|Lymphoedema,14,
12257305,20160412,Gefitinib,46,801,46.0,2,,1,0,0,0,0,0,0,Gefitinib,MINOCYCLINE|GEFITINIB|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN,3,ACNE|NON-SMALL CELL LUNG CANCER|ACNE,Intentional product misuse|Skin haemorrhage|Skin exfoliation|Dry skin|Acne,5,2
12261098,20160412,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,ZOLPIDEM TARTRATE|GEFITINIB,3,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12261247,20160412,Gefitinib,78,801,78.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,2,,Dyspnoea|Malignant neoplasm progression|Asthenia|Malignant pleural effusion|Decreased appetite|Drug ineffective,6,5
12261509,20160412,Gefitinib,21785,804,59.68,2,,1,1,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB,3,LUNG NEOPLASM MALIGNANT|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|NON-SMALL CELL LUNG CANCER,Malaise|Death|Brain neoplasm malignant|Diarrhoea,4,
12261513,20160412,Gefitinib,25742,804,70.53,1,,1,0,0,0,0,0,1,Gefitinib,OSIMERTINIB|GEFITINIB|GEFITINIB|GEFITINIB|GEFITINIB,5,LUNG NEOPLASM MALIGNANT|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|LEUKAEMIA|LEUKAEMIA|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Urinary incontinence|Blood urine present|Rash generalised|Pain in extremity|Back pain|Liver disorder|Dysuria|Purpura|Headache|Product use in unapproved indication|Abdominal pain lower|Bladder pain|Dry skin|Off label use,14,
12261586,20160412,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,ERLOTINIB HYDROCHLORIDE|GEFITINIB,2,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Metastases to central nervous system|Metastases to meninges|Ascites,3,5
12261589,20160412,Gefitinib,31832,804,87.21,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Blood glucose abnormal|Malignant neoplasm progression|Atrial fibrillation,3,1
12263189,20160413,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12266592,20160414,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION,Malignant neoplasm progression,1,1
12272246,20160415,Gefitinib,40,801,40.0,1,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Death,1,1
12272653,20160415,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,FUROSEMIDE|GEFITINIB|ALPRAZOLAM|BISOPROLOL FUMARATE,4,HYPERTENSION|NON-SMALL CELL LUNG CANCER|HYPERTENSION,Metastases to pleura|Malignant neoplasm progression|Pulmonary embolism|Metastases to lung,4,1
12273074,20160415,Gefitinib,,,,1,,1,1,1,0,0,0,1,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Dyspnoea|Respiratory failure,2,5
12273229,20160415,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Metastases to bone|Malignant neoplasm progression,2,1
12273358,20160415,Gefitinib,82,801,82.0,1,,1,0,0,0,0,0,0,Gefitinib,GEFITINIB|ERLOTINIB HYDROCHLORIDE,2,LUNG NEOPLASM MALIGNANT,Pleural adhesion|Drug resistance|Pleural effusion,3,5
12273550,20160415,Gefitinib,,,,2,,1,1,1,0,0,0,0,Gefitinib,GEFITINIB,1,METASTASES TO LUNG,Death|Nausea|Malaise|Vomiting|Eye pruritus,5,
12273593,20160415,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,LOSARTAN POTASSIUM|GEFITINIB|LEVETIRACETAM,5,HYPERCHOLESTEROLAEMIA|TYPE 2 DIABETES MELLITUS|HYPERTENSION|NON-SMALL CELL LUNG CANCER|METASTASES TO CENTRAL NERVOUS SYSTEM,Malignant neoplasm progression,1,1
12274954,20160415,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER,Metastases to liver|Malignant neoplasm progression,2,1
12281947,20160419,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,General physical health deterioration,1,5
12282386,20160419,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12283030,20160419,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12283044,20160419,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12287976,20160420,Gefitinib,26343,804,72.17,1,49,1,0,1,1,0,0,1,Gefitinib,GEFITINIB|RIVAROXABAN|ATORVASTATIN CALCIUM,6,NEUROPATHY PERIPHERAL|NON-SMALL CELL LUNG CANCER RECURRENT|ATRIAL FIBRILLATION|ATRIAL FIBRILLATION|HYPERLIPIDAEMIA|NEUROPATHY PERIPHERAL,Interstitial lung disease|Pneumothorax,2,1
12288081,20160420,Gefitinib,59,801,59.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12288122,20160420,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Metastases to central nervous system,1,1
12295000,20160422,Gefitinib,,,,2,,1,1,1,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12297377,20160422,Gefitinib,24912,804,68.25,1,,1,1,1,0,0,0,1,Gefitinib,GEFITINIB|OSIMERTINIB|LANSOPRAZOLE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION,4,,Dyspnoea|Malignant neoplasm progression|Radiation pneumonitis|Death,4,1
12298051,20160422,Gefitinib,,,,1,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Disease progression,1,1
12300543,20160425,Gefitinib,,,,0,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA,Malignant neoplasm progression,1,5
12305348,20160426,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12305901,20160426,Gefitinib,57,801,57.0,2,,1,0,1,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Neoplasm|Asthenia|Localised infection|Arthralgia|Joint injury|Depression|Malaise|Abdominal neoplasm,8,5
12306525,20160426,Gefitinib,89,801,89.0,1,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|GEFITINIB|GEFITINIB|ERYTHROMYCIN LACTOBIONATE,17,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Gastrointestinal haemorrhage,1,1
12306576,20160426,Gefitinib,,,,0,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT,Chest discomfort|Interstitial lung disease,2,1
12308803,20160427,Gefitinib,67,801,67.0,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,,Thrombocytopenia,1,2
12309024,20160427,Gefitinib,,,,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER,Lung disorder,1,1
12309145,20160427,Gefitinib,,,,2,,1,1,1,0,0,0,1,Gefitinib,GEFITINIB,2,LUNG CANCER METASTATIC,Acute respiratory failure|Malignant neoplasm progression,2,5
12309642,20160427,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,1,LUNG ADENOCARCINOMA,Condition aggravated,1,5
12310161,20160427,Gefitinib,713,802,59.42,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,4,EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER,Hepatitis|Malignant neoplasm progression,2,1
12311460,20160427,Gefitinib,,,,2,,1,1,0,0,0,0,0,Gefitinib,GEFITINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12311994,20160427,Gefitinib,85,801,85.0,1,,1,0,1,0,0,0,1,Gefitinib,GEFITINIB,1,NON-SMALL CELL LUNG CANCER STAGE IV,Diarrhoea|Rectal haemorrhage|Bone pain|Condition aggravated|Asthenia,5,2
12313196,20160428,Gefitinib,24654,804,67.55,2,,1,0,1,0,0,0,0,Gefitinib,GEFITINIB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|GEFITINIB|PREGABALIN|GEFITINIB|GEFITINIB|ALPRAZOLAM|LEVETIRACETAM,18,METASTASES TO CENTRAL NERVOUS SYSTEM|PHLEBITIS|LUNG ADENOCARCINOMA|METASTASES TO CENTRAL NERVOUS SYSTEM|LUNG ADENOCARCINOMA|EPILEPSY,Nausea|Off label use|Prerenal failure|Diarrhoea,4,1
12313218,20160428,Gefitinib,25572,804,70.06,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB,3,HYPOTHYROIDISM|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression|Metastases to lung|Metastases to the mediastinum,3,1
12314187,20160428,Gefitinib,,,,2,,1,0,0,0,0,0,1,Gefitinib,GEFITINIB|GEFITINIB,2,EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
12335317,20160504,Gefitinib,49,801,49.0,1,62.5,1,1,0,1,0,0,1,Gefitinib,OSIMERTINIB|GEFITINIB,2,PRODUCT USED FOR UNKNOWN INDICATION,Interstitial lung disease|Respiratory failure|Pneumonia staphylococcal,3,1
11173275,20150608,Osimertinib,27392,804,75.05,1,75.3,1,0,1,0,0,0,1,Osimertinib,BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|OSIMERTINIB|OSIMERTINIB|LOSARTAN,4,ASTHMA|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|HYPERTENSION,Skin burning sensation|Hair texture abnormal|Erythema|Bladder disorder|Localised infection|Rhinorrhoea|Nail discolouration|Bowel movement irregularity|Diarrhoea|Body height decreased|Malaise|Limb injury|Skin discolouration|Dysgeusia|Weight decreased|Flatulence,16,
11375028,20150813,Osimertinib,68,801,68.0,2,88,1,0,1,0,0,0,1,Osimertinib,"ERGOCALCIFEROL|ENOXAPARIN SODIUM|OSIMERTINIB|ALBUTEROL SULFATE|ALBUTEROL SULFATE|ALBUTEROL|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FOLIC ACID|OXYCODONE HYDROCHLORIDE|OXYCODONE|LISINOPRIL|ALBUTEROL SULFATE|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL|ALBUTEROL SULFATE|FLUOXETINE HYDROCHLORIDE|METHYLPREDNISOLONE|DOXYCYCLINE|DOXYCYCLINE HYCLATE|HYDROXYZINE HYDROCHLORIDE|HYDROXYZINE|HYDROXYZINE HYDROCHLORIDE ORAL|DIAZEPAM|DIAZEPAM|FLUOXETINE HYDROCHLORIDE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|ONDANSETRON HYDROCHLORIDE|CYANOCOBALAMIN|METRONIDAZOLE",29,SUPPLEMENTATION THERAPY|NON-SMALL CELL LUNG CANCER|ASTHMA|PAIN|PAIN|BLOOD CHOLESTEROL INCREASED|DEPRESSION,Arthralgia|Drug ineffective|Hypotension|Bronchitis|Pain in extremity|Swelling face|Chest pain|Drug hypersensitivity|Lung neoplasm malignant|Pneumonia|Abdominal discomfort|Depression|Back pain,13,
11748289,20151117,Osimertinib,27158,804,74.41,2,42.8,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,15,NON-SMALL CELL LUNG CANCER METASTATIC|ANTIVIRAL PROPHYLAXIS|INSOMNIA|DRY SKIN|RASH|HYPERTENSION|NON-SMALL CELL LUNG CANCER METASTATIC|PRURITUS|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|RASH|RASH|RASH|RASH|RASH,Hyponatraemia|Multiple fractures,2,1
11750830,20151118,Osimertinib,76,801,76.0,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,4,HYPERTENSION|VITAMIN B12 DEFICIENCY|NON-SMALL CELL LUNG CANCER METASTATIC|PNEUMONIA,Pneumothorax|Interstitial lung disease,2,1
11752304,20151118,Osimertinib,28893,804,79.16,1,,1,0,1,0,0,0,1,Osimertinib,ATORVASTATIN CALCIUM|OSIMERTINIB|VALSARTAN|VALSARTAN ORAL|ATENOLOL,9,HYPERLIPIDAEMIA|CORONARY ARTERY BYPASS|HYPERTENSION|CORONARY ARTERY BYPASS|CORONARY ARTERY BYPASS|PERIPHERAL ARTERIAL OCCLUSIVE DISEASE|HYPERTENSION|ABDOMINAL DISCOMFORT|CORONARY ARTERY BYPASS,Peripheral arterial occlusive disease,1,1
11752311,20151118,Osimertinib,,,,2,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
11753923,20151119,Osimertinib,22280,804,61.04,2,,1,0,1,0,0,0,0,Osimertinib,CALCIUM|ALPRAZOLAM|ERGOCALCIFEROL|BISOPROLOL FUMARATE|SIMVASTATIN|OSIMERTINIB|MAGNESIUM|DENOSUMAB|OSIMERTINIB|OSIMERTINIB,18,METASTASES TO BONE|ANXIETY|PROPHYLAXIS|METASTASES TO BONE|LEFT VENTRICULAR DYSFUNCTION|ANXIETY|NON-SMALL CELL LUNG CANCER|ANXIETY|MENOPAUSE|MUSCLE SPASMS|MENOPAUSE|METASTASES TO BONE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ARTHRALGIA|PAIN|DIARRHOEA,Acute pulmonary oedema,1,1
11755071,20151119,Osimertinib,918,802,76.5,2,63,1,0,0,0,1,0,0,Osimertinib,OSIMERTINIB|PANTOPRAZOLE,5,DIARRHOEA|NON-SMALL CELL LUNG CANCER METASTATIC|HIATUS HERNIA,Tendonitis,1,2
11755616,20151119,Osimertinib,86,801,86.0,2,,1,1,0,0,0,0,0,Osimertinib,ESOMEPRAZOLE|ESOMEPRAZOLE MAGNESIUM|OSIMERTINIB|SPIRONOLACTONE,5,NON-SMALL CELL LUNG CANCER METASTATIC,Failure to thrive,1,1
11756551,20151119,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression,1,1
11758198,20151120,Osimertinib,,,,0,,1,0,1,0,0,0,0,Osimertinib,ENTECAVIR|ENTECAVIR ANHYDROUS|PROCHLORPERAZINE MALEATE|LANSOPRAZOLE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|LACTULOSE|FLUDROCORTISONE ACETATE|ACETYLCYSTEINE|HYPROMELLOSE|AMOXICILLIN AND CLAVULANATE POTASSIUM|OSIMERTINIB|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE,19,NON-SMALL CELL LUNG CANCER,Dysphagia,1,2
11760130,20151120,Osimertinib,67,801,67.0,1,68,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Hypoxia,1,1
11771999,20151124,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,
11774295,20151124,Osimertinib,60,801,60.0,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL,5,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HEADACHE|CONSTIPATION,Road traffic accident,1,1
11781546,20151126,Osimertinib,23516,804,64.43,2,48,1,0,1,0,0,0,0,Osimertinib,SENNOSIDES|SENNA LEAF|SENNA|OSIMERTINIB|TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HCL|IOHEXOL|OSIMERTINIB|IOVERSOL,23,PROPHYLAXIS|NON-SMALL CELL LUNG CANCER METASTATIC|PROPHYLAXIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER METASTATIC,Pyrexia|Aspartate aminotransferase increased|Alanine aminotransferase increased,3,1
11782503,20151127,Osimertinib,,,,1,,1,0,0,0,0,0,1,Osimertinib,HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|OSIMERTINIB|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|ERLOTINIB HYDROCHLORIDE,6,RADIOTHERAPY|BLOOD PRESSURE ABNORMAL|ADRENALECTOMY|LYMPHADENOPATHY|BLOOD PRESSURE ABNORMAL,Carcinoembryonic antigen increased|Neoplasm recurrence,2,
11797180,20151203,Osimertinib,28005,804,76.73,2,72.8,1,0,1,0,1,0,0,Osimertinib,CETIRIZINE HYDROCHLORIDE|MULTIVITAMIN|CITALOPRAM|OSIMERTINIB|MONTELUKAST SODIUM,8,NON-SMALL CELL LUNG CANCER METASTATIC,Femur fracture,1,1
11798256,20151203,Osimertinib,75,801,75.0,2,56,1,1,1,0,0,0,1,Osimertinib,OSIMERTINIB|GABAPENTIN|OSIMERTINIB,8,TYROSINE KINASE MUTATION|TYROSINE KINASE MUTATION|GASTRITIS,Hydrothorax|Cardiopulmonary failure|Atrial fibrillation|Uveitis|Metastases to bone|Metastases to lymph nodes|Blindness|Pulmonary oedema|Osteoarthritis|Neoplasm progression|Diffuse alveolar damage|Endophthalmitis,12,1
11800341,20151203,Osimertinib,28052,804,76.85,1,,1,0,0,0,0,0,1,Osimertinib,FOLIC ACID|OSIMERTINIB|ROSUVASTATIN|OSIMERTINIB|MULTIVITAMIN|CHLORTHALIDONE,6,SUPPLEMENTATION THERAPY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|SUPPLEMENTATION THERAPY|HYPERTENSION,Blood creatine phosphokinase increased,1,1
11804844,20151205,Osimertinib,29448,804,80.68,2,54.5,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Dyspnoea|Alanine aminotransferase increased,2,1
11808274,20151207,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Therapeutic response unexpected|Lid sulcus deepened|Weight increased|Mucous membrane disorder|Pollakiuria,5,5
11825181,20151211,Osimertinib,22190,804,60.79,2,58,1,1,0,0,0,0,1,Osimertinib,OSIMERTINIB|MINOCYCLINE,7,METASTASES TO CENTRAL NERVOUS SYSTEM|NON-SMALL CELL LUNG CANCER|SKIN DISORDER|C-REACTIVE PROTEIN INCREASED|LUNG INFILTRATION|METASTASES TO CENTRAL NERVOUS SYSTEM,Thrombocytopenia|Anti-platelet antibody|Respiratory failure|Lung disorder,4,1
11829920,20151213,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Death,1,1
11837361,20151215,Osimertinib,22350,804,61.23,2,,1,1,0,0,0,0,0,Osimertinib,PEMETREXED|PEMETREXED DISODIUM|CARBOPLATIN|OSIMERTINIB,3,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Respiratory failure,1,1
11838222,20151215,Osimertinib,22859,804,62.63,1,72,1,0,1,1,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,5,HYPERTENSION|NON-SMALL CELL LUNG CANCER|CORONARY ARTERY DISEASE|NON-SMALL CELL LUNG CANCER|HYPERTENSION,Interstitial lung disease|Pleural neoplasm|Pulmonary embolism,3,1
11841031,20151216,Osimertinib,48,801,48.0,2,,1,0,0,0,0,0,0,Osimertinib,RIVAROXABAN|GABAPENTIN|OSIMERTINIB,3,ANTICOAGULANT THERAPY|MUSCLE SPASMS|LUNG NEOPLASM MALIGNANT,Blister|Erythema|Muscle spasms,3,5
11851962,20151218,Osimertinib,68,801,68.0,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Tachycardia,1,3
11853020,20151218,Osimertinib,23136,804,63.39,1,,1,0,1,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB|AMLODIPINE|FOLIC ACID|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,8,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|HYPERTENSION|PREMEDICATION|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Non-cardiac chest pain,1,1
11860963,20151222,Osimertinib,,,,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,,Transient ischaemic attack,1,2
11865368,20151223,Osimertinib,80,801,80.0,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,
11867716,20151224,Osimertinib,80,801,80.0,1,61,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Hyperkalaemia,1,
11867733,20151224,Osimertinib,29660,804,81.26,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|DENOSUMAB,3,METASTASES TO BONE|NON-SMALL CELL LUNG CANCER METASTATIC|METASTASES TO BONE,Keratitis|Conjunctivitis bacterial,2,1
11868280,20151224,Osimertinib,21965,804,60.18,1,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|ENALAPRIL|NITROGLYCERIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ROSUVASTATIN|BISOPROLOL FUMARATE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FOLIC ACID|APREPITANT|APREPITANT|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,15,NON-SMALL CELL LUNG CANCER METASTATIC|HYPERTENSION|MYOCARDIAL ISCHAEMIA|PERIPHERAL ARTERIAL OCCLUSIVE DISEASE|CHEMOTHERAPY|CHEMOTHERAPY|DYSLIPIDAEMIA|MYOCARDIAL ISCHAEMIA|MYOCARDIAL ISCHAEMIA|CHEMOTHERAPY|CHEMOTHERAPY|CHEMOTHERAPY|CHEMOTHERAPY|CHEMOTHERAPY|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER,Ataxia,1,1
11876765,20151229,Osimertinib,28258,804,77.42,1,,1,0,1,1,0,0,1,Osimertinib,OSIMERTINIB,4,GASTRITIS|RASH|NON-SMALL CELL LUNG CANCER METASTATIC|RASH,Subdural haematoma,1,1
11883884,20160101,Osimertinib,13535,804,37.08,1,,1,0,1,0,0,0,0,Osimertinib,OXYCODONE HYDROCHLORIDE|OXYCODONE|MINOCYCLINE HYDROCHLORIDE|OSIMERTINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ALCLOMETASONE DIPROPIONATE|OSIMERTINIB,50,EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER|CANCER PAIN|DERMATITIS ATOPIC|CANCER PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION|EGFR GENE MUTATION|DERMATITIS ACNEIFORM|EGFR GENE MUTATION|EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION|EGFR GENE MUTATION|EGFR GENE MUTATION|EGFR GENE MUTATION|EGFR GENE MUTATION|EGFR GENE MUTATION|EGFR GENE MUTATION|EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|SKIN DISORDER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION|EGFR GENE MUTATION|EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|STOMATITIS|SKIN DISORDER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DERMATITIS ATOPIC|NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION|EGFR GENE MUTATION|EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|EPILEPSY,Pulmonary embolism,1,1
11894084,20160107,Osimertinib,58,801,58.0,2,50.8,1,0,0,0,0,0,0,Osimertinib,"OSIMERTINIB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE",3,LUNG NEOPLASM MALIGNANT|FALL,Post-traumatic neck syndrome|Nasopharyngitis|Cough|Head injury|Fall,5,5
11896004,20160107,Osimertinib,22495,804,61.63,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Pain|Full blood count decreased|Pyrexia|Headache|Muscular weakness|Malignant neoplasm progression,6,
11910060,20160112,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Disease progression,1,
11910740,20160112,Osimertinib,,,,2,,1,0,1,0,0,0,1,Osimertinib,OSIMERTINIB,1,,Pulmonary embolism|Dyspnoea|Deep vein thrombosis,3,1
11912800,20160113,Osimertinib,25967,804,71.14,1,,1,1,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Cholestasis|Hepatocellular injury|Malignant neoplasm progression,3,2
11917351,20160114,Osimertinib,19418,804,53.2,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Death,1,
11917646,20160114,Osimertinib,27713,804,75.93,2,,1,1,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Death|Haemorrhage intracranial|Fall|Cough,4,
11919612,20160115,Osimertinib,72,801,72.0,1,65,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Disease progression|Diarrhoea|Ill-defined disorder|Pyrexia|Dyspnoea,5,
11920337,20160115,Osimertinib,,,,0,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NEOPLASM MALIGNANT,Death,1,
11920579,20160115,Osimertinib,20291,804,55.59,0,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,,Lung adenocarcinoma,1,
11921398,20160115,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Death,1,
11922031,20160115,Osimertinib,,,,1,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB|ERLOTINIB HYDROCHLORIDE|ERLOTINIB,2,LUNG NEOPLASM MALIGNANT,Pneumonia|Death,2,1
11922145,20160115,Osimertinib,28360,804,77.7,1,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB,7,HEPATOCELLULAR CARCINOMA|HYPERTENSION|ANXIETY|GASTRIC DISORDER|HYPERTENSION|HYPERTENSION|URETHRAL STENOSIS,Acute kidney injury,1,1
11922514,20160115,Osimertinib,76,801,76.0,2,,1,0,1,0,0,0,0,Osimertinib,"RAMIPRIL|BRIMONIDINE TARTRATE|BIMATOPROST|BISOPROLOL FUMARATE|MAGNESIUM|OSIMERTINIB|SIMVASTATIN|ARTIFICIAL TEARS|LUBRICANT EYE DROPS|POLYVINYL ALCOHOL, POVIDONE|GLYCERIN",11,MENOPAUSE|EJECTION FRACTION DECREASED|CONSTIPATION|MENOPAUSE|GLAUCOMA|GLAUCOMA|EJECTION FRACTION DECREASED|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS,Vasculitis,1,1
11923504,20160118,Osimertinib,,,,0,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Back pain|Diarrhoea|Rash|Adverse event,4,2
11926635,20160119,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,
11927371,20160119,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,1
11933878,20160121,Osimertinib,24310,804,66.6,1,,1,0,1,0,0,0,0,Osimertinib,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|CETIRIZINE HCL|CETIRIZINE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|BENZONATATE|HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE|OSIMERTINIB|DENOSUMAB",11,EYE DISORDER|PROCEDURAL PAIN|SEASONAL ALLERGY|PROCEDURAL PAIN|RASH|COUGH|NON-SMALL CELL LUNG CANCER|NAUSEA|COUGH|NON-SMALL CELL LUNG CANCER|METASTASES TO BONE,Dyspnoea,1,1
11934279,20160121,Osimertinib,996,802,83.0,2,,1,0,1,0,0,0,1,Osimertinib,ZOLPIDEM TARTRATE|OSIMERTINIB|OSIMERTINIB|ALENDRONATE SODIUM|OSIMERTINIB|LETROZOLE|LISINOPRIL,10,SMALL CELL LUNG CANCER METASTATIC|SMALL CELL LUNG CANCER METASTATIC|OSTEOPOROTIC FRACTURE|EMBOLISM|SMALL CELL LUNG CANCER METASTATIC|BREAST CANCER FEMALE|ADENOCARCINOMA|HYPERTENSION,Asthenia|Diarrhoea|Oral candidiasis|General physical health deterioration|Weight decreased|Disease progression|Normochromic normocytic anaemia|Food intolerance|Dysphagia|Food aversion|Decreased appetite|Mucosal inflammation|Nausea|Respiratory tract infection,14,1
11938917,20160122,Osimertinib,27693,804,75.87,2,,1,0,1,0,0,0,0,Osimertinib,CARVEDILOL|HYDROCHLOROTHIAZIDE|DRONABINOL|OSIMERTINIB|DRONABINOL|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OSIMERTINIB|ACLIDINIUM BROMIDE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|MUPIROCIN|MUPIROCIN CALCIUM|FERROUS SULFATE|PROMETHAZINE|OXYGEN|0XYGEN|AMLODIPINE|LOSARTAN,34,GASTRITIS PROPHYLAXIS|ATRIAL FIBRILLATION|HYPERTENSION|DECREASED APPETITE|DECREASED APPETITE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|HYPERLIPIDAEMIA|COUGH|HAEMORRHOIDS|MULTIPLE ALLERGIES|DECREASED APPETITE|DIARRHOEA|SKIN ULCER|NAUSEA|NON-SMALL CELL LUNG CANCER|ONYCHOMYCOSIS|DECREASED APPETITE|BONE DISORDER|ASTHMA|GASTROOESOPHAGEAL REFLUX DISEASE|NON-SMALL CELL LUNG CANCER|ASTHMA|DRY MOUTH|INFECTION|ATRIAL FIBRILLATION|ATRIAL FIBRILLATION|ANAEMIA|NAUSEA|DYSPNOEA|NON-SMALL CELL LUNG CANCER|HYPERTENSION|NON-SMALL CELL LUNG CANCER|ATRIAL FIBRILLATION,Pneumonia,1,1
11954072,20160126,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Death,1,2
11954126,20160126,Osimertinib,26634,804,72.97,2,45,1,0,0,0,0,0,1,Osimertinib,OXYCODONE HYDROCHLORIDE|OSIMERTINIB|OSIMERTINIB,4,BONE PAIN|BONE PAIN|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Pancytopenia,1,2
11959318,20160126,Osimertinib,26876,804,73.63,2,,1,1,0,0,0,0,0,Osimertinib,CALCIUM|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|OSIMERTINIB,4,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Lung neoplasm malignant|Cough|Pyrexia,3,
11980931,20160129,Osimertinib,23261,804,63.73,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB|OXYCODONE HYDROCHLORIDE,2,NON-SMALL CELL LUNG CANCER METASTATIC|PAIN,Pneumonia,1,1
11984099,20160201,Osimertinib,26375,804,72.26,1,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Decreased appetite,1,1
11992207,20160203,Osimertinib,701,802,58.42,2,,1,1,1,0,0,0,1,Osimertinib,OSIMERTINIB|MORPHINE SULFATE|FENTANYL|WARFARIN|LEVETIRACETAM|HYDROMORPHONE HYDROCHLORIDE|OSIMERTINIB|DIAZEPAM,11,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Pyrexia|Radiation interaction|Vomiting|Thrombosis|Faeces soft|Fatigue|Skin discolouration|Ligament sprain|Urinary tract infection|Pruritus|Death|Clostridium difficile infection,12,
11994831,20160203,Osimertinib,72,801,72.0,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Neutropenia,1,1
12002048,20160204,Osimertinib,25454,804,69.74,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12004510,20160204,Osimertinib,,,,2,52,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,,Hyporesponsive to stimuli|Pneumonia aspiration|Dyspnoea,3,1
12006072,20160204,Osimertinib,22344,804,61.22,2,41.7,1,1,1,0,0,0,1,Osimertinib,LISINOPRIL|OSIMERTINIB,4,NERVOUS SYSTEM DISORDER|SMALL CELL LUNG CANCER METASTATIC,Superior vena cava syndrome|Pulmonary embolism|Product use issue|Off label use,4,1
12034561,20160207,Osimertinib,,,,1,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Dysuria,1,5
12047473,20160209,Osimertinib,18617,804,51.01,1,80,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Hepatitis,1,1
12053844,20160209,Osimertinib,72,801,72.0,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,5
12054196,20160209,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Malignant neoplasm progression,1,2
12056947,20160209,Osimertinib,,,,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,,Vision blurred|Retinal vascular occlusion,2,1
12058986,20160210,Osimertinib,,,,0,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Death,1,
12060911,20160210,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Ulcerative keratitis,1,1
12061016,20160210,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,PREDNISONE|OSIMERTINIB,2,ASTHMA|LUNG NEOPLASM MALIGNANT,Nausea|Diarrhoea|Musculoskeletal pain|Constipation|Back pain,5,3
12066869,20160211,Osimertinib,59,801,59.0,1,80,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Muscular weakness|Thrombocytopenia|Anaemia,3,1
12067688,20160211,Osimertinib,,,,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,,Hepatic neoplasm,1,3
12067721,20160211,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Nail ridging,1,
12068045,20160211,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|TICAGRELOR|OSIMERTINIB,5,LUNG NEOPLASM MALIGNANT|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|ACUTE CORONARY SYNDROME|LUNG NEOPLASM MALIGNANT,Blepharitis|Onychoclasis|Musculoskeletal pain|Eye pain|Dyspnoea|Skin haemorrhage|Skin fissures|Cardiac failure|Pain in extremity|Nail disorder|Muscular weakness|Oral pain|Muscle spasms,13,
12068508,20160211,Osimertinib,825,802,68.75,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Rash|Diarrhoea,2,2
12068529,20160211,Osimertinib,70,801,70.0,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NEOPLASM MALIGNANT,Dermatitis acneiform,1,3
12068530,20160211,Osimertinib,,,,0,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Thrombosis,1,1
12068531,20160211,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Haemoglobin decreased,1,
12068537,20160211,Osimertinib,,,,1,,1,0,0,0,0,0,0,Osimertinib,LISINOPRIL|GLIPIZIDE|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,5,DIABETES MELLITUS|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Oedema|Fatigue|Sluggishness|Decreased appetite|Back pain|Renal impairment,6,5
12068538,20160211,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Disease progression,1,1
12069822,20160211,Osimertinib,20948,804,57.39,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION,Vomiting|Nausea,2,2
12075241,20160212,Osimertinib,30277,804,82.95,1,,1,0,1,1,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,5,TYPE 2 DIABETES MELLITUS|DIARRHOEA|PAIN|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Hypoglycaemia,1,1
12075275,20160212,Osimertinib,25458,804,69.75,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|MINOCYCLINE|OSIMERTINIB|OSIMERTINIB|PIMECROLIMUS,5,NON-SMALL CELL LUNG CANCER|RASH|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|RASH,Atrial fibrillation,1,1
12076392,20160215,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,BRONCHIAL CARCINOMA|LUNG NEOPLASM MALIGNANT,Rash maculo-papular|Rash,2,
12076953,20160215,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,1
12085375,20160217,Osimertinib,57,801,57.0,1,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|FUROSEMIDE,3,NON-SMALL CELL LUNG CANCER STAGE IV|PROPHYLAXIS|SURGERY,Drug-induced liver injury,1,1
12091391,20160218,Osimertinib,757,802,63.08,2,,1,1,1,0,0,0,0,Osimertinib,OXYCODONE|METHYLPREDNISOLONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ALPRAZOLAM|FUROSEMIDE|OSIMERTINIB,8,PAIN|METASTASES TO CENTRAL NERVOUS SYSTEM|METASTASES TO CENTRAL NERVOUS SYSTEM|PULMONARY EMBOLISM|GASTROINTESTINAL DISORDER|INSOMNIA|OEDEMA PERIPHERAL|NON-SMALL CELL LUNG CANCER METASTATIC,Interstitial lung disease,1,1
12094140,20160219,Osimertinib,,,,1,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Death|Malaise|Drug dose omission,3,
12095593,20160219,Osimertinib,67,801,67.0,2,,1,1,0,0,0,0,0,Osimertinib,VALSARTAN|VALSARTAN ORAL|OSIMERTINIB,3,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Death|Rash|Temperature difference of extremities|Swelling face|Erythema|Dry skin|Vomiting,7,
12096368,20160220,Osimertinib,49,801,49.0,1,94,1,0,1,0,0,0,0,Osimertinib,"PREGABALIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FENTANYL|FENTANYL|FENTANYL|PREGABALIN|PREGABALIN|FENTANYL|OSIMERTINIB|PREGABALIN|FENTANYL|OSIMERTINIB",29,PROPHYLAXIS|NON-SMALL CELL LUNG CANCER METASTATIC|PROPHYLAXIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER METASTATIC|PROPHYLAXIS|PROPHYLAXIS,Vomiting|Gastritis erosive,2,1
12104402,20160223,Osimertinib,20154,804,55.22,1,,1,1,1,1,1,1,1,Osimertinib,OSIMERTINIB,1,Lung carcinoma cell type unspecified stage 0,Death|Chest pain,2,5
12108743,20160224,Osimertinib,29296,804,80.26,2,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Pneumonia|Pulmonary oedema|Death|Fall,4,
12109978,20160224,Osimertinib,23400,804,64.11,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Erythema|Death,2,
12113497,20160225,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Malignant neoplasm progression,1,2
12114269,20160225,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,
12120957,20160226,Osimertinib,26397,804,72.32,2,50,1,0,1,0,0,0,0,Osimertinib,"OSIMERTINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|KETOPROFEN|AMPICILLIN SODIUM AND SULBACTAM SODIUM|DEXTROSE ANHYDROUS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|MAGNESIUM OXIDE|DEXTROMETHORPHAN HYDROBROMIDE|CLOBETASOL PROPIONATE|CLOBETASOL PROPIONATE OINTMENT USP, 0.05%|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|GLYCERIN|GLYCERIN SUPPOSITORIES|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL",25,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Pyrexia,1,1
12122448,20160226,Osimertinib,18938,804,51.88,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Lung infection,1,1
12122493,20160226,Osimertinib,22797,804,62.46,1,,1,1,1,1,0,0,0,Osimertinib,TRAMADOL HYDROCHLORIDE|TRAMADOL HYDROCHLORIDE|LACTULOSE|TRAMADOL HYDROCHLORIDE|TRAMADOL HYDROCHLORIDE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|OSIMERTINIB|UREA|OSIMERTINIB|TRAMADOL HYDROCHLORIDE|TRAMADOL HYDROCHLORIDE|TRAMADOL HYDROCHLORIDE|TRAMADOL HYDROCHLORIDE,15,CANCER PAIN|ARTHRALGIA|CONSTIPATION|BLOOD CALCIUM ABNORMAL|CANCER PAIN|ARTHRALGIA|INSOMNIA|NON-SMALL CELL LUNG CANCER METASTATIC|RASH GENERALISED|NON-SMALL CELL LUNG CANCER METASTATIC|NUTRITIONAL SUPPLEMENTATION|CANCER PAIN|ARTHRALGIA|ARTHRALGIA|CANCER PAIN,Haemoptysis|Dyspnoea,2,1
12125048,20160229,Osimertinib,84,801,84.0,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Dry skin|Lacrimation increased|Increased appetite,3,
12130310,20160301,Osimertinib,18555,804,50.84,2,,1,1,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression|Death|Seizure|Coma,4,1
12135280,20160301,Osimertinib,20948,804,57.39,2,55,1,0,1,0,0,0,0,Osimertinib,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LORAZEPAM|OSIMERTINIB|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,15,PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER METASTATIC|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS|PROPHYLAXIS,Transaminases increased,1,1
12138475,20160302,Osimertinib,,,,1,75.8,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Inappropriate antidiuretic hormone secretion,1,1
12142677,20160303,Osimertinib,78,801,78.0,2,,1,1,1,0,0,0,0,Osimertinib,ENALAPRIL|RANITIDINE|FENTANYL|HALOPERIDOL|HALOPERIDOL LACTATE|TIOTROPIUM BROMIDE|PENTOXIFYLLINE|OSIMERTINIB|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE,13,HYPERTENSION|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|PROPHYLACTIC CHEMOTHERAPY|PAIN|DEPRESSION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|OSTEOPOROSIS PROPHYLAXIS|NON-SMALL CELL LUNG CANCER METASTATIC|DEPRESSION|PAIN|NON-SMALL CELL LUNG CANCER,Acute interstitial pneumonitis,1,1
12160042,20160308,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,3
12164752,20160309,Osimertinib,,,,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Deep vein thrombosis|Decreased appetite|Pulmonary embolism|Nausea|Vomiting,5,5
12165536,20160309,Osimertinib,28121,804,77.04,2,61,1,1,0,1,0,0,0,Osimertinib,OSIMERTINIB|DENOSUMAB|OSIMERTINIB,8,HYPOTHYROIDISM|NON-SMALL CELL LUNG CANCER|HYPERTENSION|METASTASES TO BONE|EGFR GENE MUTATION,Cardiac failure|Renal failure|Hypocalcaemia|Cardiac tamponade,4,1
12165537,20160309,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,5
12169226,20160310,Osimertinib,66,801,66.0,2,,1,0,1,1,1,0,1,Osimertinib,METHYLPREDNISOLONE|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|OSIMERTINIB,6,PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER,Protein-losing gastroenteropathy|Gastric haemorrhage|Gastroduodenal ulcer|Hypothyroidism|Gastrointestinal oedema,5,1
12170786,20160311,Osimertinib,17115,804,46.89,1,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB,6,NON-SMALL CELL LUNG CANCER METASTATIC|CHEST PAIN|CHEST PAIN|DECREASED APPETITE|CHEST PAIN|COUGH,Pneumonitis,1,1
12171216,20160311,Osimertinib,76,801,76.0,2,,1,1,1,0,0,0,1,Osimertinib,NIVOLUMAB|NIVOLUMAB,4,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|METASTASES TO BONE,Embolism venous|Osteomyelitis|Malignant neoplasm progression|Diarrhoea,4,5
12172407,20160311,Osimertinib,73,801,73.0,1,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB|RIVAROXABAN,2,,Dyspnoea|Death,2,
12180884,20160315,Osimertinib,77,801,77.0,2,,1,0,1,0,0,0,0,Osimertinib,VENLAFAXINE HYDROCHLORIDE|OSIMERTINIB|ATENOLOL|OSIMERTINIB,9,AORTIC EMBOLUS|ANXIETY|NON-SMALL CELL LUNG CANCER|ANXIETY|HYPERTENSION|ANXIETY|ANXIETY|NON-SMALL CELL LUNG CANCER|DYSPNOEA,Dyspnoea,1,1
12185531,20160316,Osimertinib,73,801,73.0,2,48,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|CARVEDILOL|ROSUVASTATIN CALCIUM|OLMESARTAN MEDOXOMIL,10,NON-SMALL CELL LUNG CANCER METASTATIC,Cardiac failure chronic|Electrocardiogram QT prolonged,2,1
12187590,20160317,Osimertinib,70,801,70.0,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|DENOSUMAB|CALCIUM|OSIMERTINIB|FOLIC ACID|POLYETHYLENE GLYCOL 3350|OSIMERTINIB|MAGNESIUM OXIDE|MULTIVITAMIN|OSIMERTINIB|LISINOPRIL|LORAZEPAM|BACLOFEN|LORAZEPAM,20,BONE CANCER|LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT|BONE CANCER|LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT,Dry throat|Product dose omission|Dry eye|Fatigue|Genital herpes|Skin reaction|Off label use|Blood creatinine increased|Oropharyngeal pain|Dry skin|Rash|Product use in unapproved indication|Muscle spasms|Malaise|Sneezing|Large intestinal obstruction|Confusional state|Acne|Rhinorrhoea,19,5
12189340,20160317,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12189830,20160318,Osimertinib,,,,0,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,TYROSINE KINASE MUTATION,Urinary retention|Demyelination,2,1
12193124,20160319,Osimertinib,22553,804,61.79,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Urinary tract infection,1,5
12197596,20160322,Osimertinib,,,,0,,1,0,1,0,0,0,1,Osimertinib,OSIMERTINIB,1,NEOPLASM MALIGNANT,Pleural effusion|Pericardial effusion,2,1
12199846,20160322,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,
12202754,20160322,Osimertinib,905,802,75.42,1,,1,1,1,0,0,0,0,Osimertinib,DOXYCYCLINE|DOXYCYCLINE HYCLATE|OSIMERTINIB,2,SKIN DISORDER|NON-SMALL CELL LUNG CANCER,Craniocerebral injury|Somnolence|Productive cough|Asthenia|Oedema peripheral|Nausea|Dyspnoea|Memory impairment|Pelvic pain|Malignant neoplasm progression|Back pain,11,2
12205329,20160323,Osimertinib,28482,804,78.03,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL,2,BRONCHIAL CARCINOMA,Myocardial infarction,1,
12208347,20160324,Osimertinib,21613,804,59.21,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12211392,20160325,Osimertinib,22859,804,62.63,2,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Death|Pneumonitis,2,
12212178,20160325,Osimertinib,,,,1,59,1,1,0,0,0,0,0,Osimertinib,MORPHINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OSIMERTINIB|GABAPENTIN|OSIMERTINIB|OSIMERTINIB|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL,9,LUNG ADENOCARCINOMA STAGE IV|LUNG ADENOCARCINOMA STAGE IV|LUNG ADENOCARCINOMA STAGE IV|PAIN,Back pain|Condition aggravated,2,1
12218253,20160329,Osimertinib,46,801,46.0,2,50,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|DOXYCYCLINE|DOXYCYCLINE HYCLATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|LORAZEPAM,10,NON-SMALL CELL LUNG CANCER|PAIN|SKIN DISORDER|DIARRHOEA|NAUSEA|COUGH|DYSPNOEA|INSOMNIA|DYSPNOEA,Dyspnoea|Pleural effusion|Pneumonitis|Subclavian vein thrombosis|Pneumonia,5,1
12218471,20160329,Osimertinib,938,802,78.17,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV,Pneumonia viral,1,1
12218930,20160329,Osimertinib,,,,2,58.6,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Pneumonitis,1,1
12223600,20160330,Osimertinib,886,802,73.83,2,,1,0,1,0,0,0,0,Osimertinib,PREGABALIN|AMLODIPINE|OSIMERTINIB|PANTOPRAZOLE|MAGNESIUM|TIOTROPIUM BROMIDE|LINAGLIPTIN,16,PAIN|CONSTIPATION|HYPERTENSION|OSTEOARTHRITIS|COAGULOPATHY|NON-SMALL CELL LUNG CANCER METASTATIC|PULMONARY EMBOLISM|REFLUX GASTRITIS|DYSPNOEA|DRY EYE|BONE DISORDER|HYPERCHOLESTEROLAEMIA|DRY EYE|DYSPNOEA|DIABETES MELLITUS|DIABETES MELLITUS,Supraventricular tachycardia,1,1
12230921,20160401,Osimertinib,,,,2,55,1,1,1,1,0,0,1,Osimertinib,OSIMERTINIB|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL,2,LUNG NEOPLASM MALIGNANT|PAIN,Atrial fibrillation|Staphylococcal bacteraemia|Pneumonia|Non-small cell lung cancer stage IV|Lower respiratory tract infection|Respiratory acidosis|Respiratory failure,7,1
12232056,20160401,Osimertinib,78,801,78.0,2,60,1,0,1,0,0,0,0,Osimertinib,INDOMETHACIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|EPINASTINE HYDROCHLORIDE|CANDESARTAN CILEXETIL|CANDESARTAN CILEXETIL|OSIMERTINIB|OSIMERTINIB|LANSOPRAZOLE|FLUOROMETHOLONE|CANDESARTAN CILEXETIL|CANDESARTAN CILEXETIL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OSIMERTINIB,26,PARONYCHIA|DERMATITIS ACNEIFORM|BACK PAIN|PARONYCHIA|PARONYCHIA|CEREBROVASCULAR ACCIDENT PROPHYLAXIS|DERMATITIS ACNEIFORM|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DERMATITIS ACNEIFORM|PROPHYLAXIS|CEREBROVASCULAR ACCIDENT PROPHYLAXIS|NON-SMALL CELL LUNG CANCER,Enterocolitis|Acute kidney injury,2,1
12232690,20160401,Osimertinib,19833,804,54.34,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,EGFR GENE MUTATION,Dyspnoea,1,1
12239526,20160405,Osimertinib,,,,1,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|SIMVASTATIN,2,NON-SMALL CELL LUNG CANCER,Alanine aminotransferase decreased|Aspartate aminotransferase decreased|Liver disorder,3,3
12242521,20160406,Osimertinib,,,,0,,1,0,1,0,0,0,1,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Hyponatraemia,1,1
12242719,20160406,Osimertinib,,,,2,,1,1,1,0,0,0,1,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Neoplasm progression|Medical device site infection|Respiratory tract infection|Sepsis,4,5
12243476,20160406,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,
12243646,20160406,Osimertinib,,,,2,38.6,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,GENE MUTATION,Death,1,
12244534,20160407,Osimertinib,28333,804,77.62,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Tenderness|Rash pruritic|Malignant neoplasm progression|Diarrhoea|Fatigue|Abdominal distension,6,
12244666,20160407,Osimertinib,57,801,57.0,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Pancreatitis,1,1
12246738,20160407,Osimertinib,20744,804,56.83,1,81.5,1,1,0,0,0,0,0,Osimertinib,"OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|SENNOSIDES|SENNA LEAF|SENNA|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|WHITE PETROLATUM|PETROLATUM|SKIN PROTECTANT|OSIMERTINIB|OSIMERTINIB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ALBUTEROL SULFATE|ALBUTEROL|OSIMERTINIB|BISACODYL|SENNOSIDES|DOCUSATE SODIUM AND SENNOSIDES|SENNOSIDES, 25 MG|POLYETHYLENE GLYCOL 3350|BISACODYL 5MG|LAXATIVE|PREDNISONE|LEVOTHYROXINE",19,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|LUNG NEOPLASM MALIGNANT|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|NON-SMALL CELL LUNG CANCER METASTATIC|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Adverse event|Death|Drug dose omission,3,
12248219,20160408,Osimertinib,,,,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,LUNG NEOPLASM MALIGNANT|NEOPLASM MALIGNANT,Malignant neoplasm progression|Hunger|Dyspnoea|Abdominal pain upper|Fatigue|Cough,6,
12248580,20160408,Osimertinib,22476,804,61.58,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CANCER METASTATIC,Decreased appetite|Death|Fatigue,3,
12254000,20160411,Osimertinib,27585,804,75.58,2,,1,0,1,0,0,0,0,Osimertinib,CANDESARTAN CILEXETIL|OSIMERTINIB,3,HYPERTENSION|NON-SMALL CELL LUNG CANCER METASTATIC|HYPERTENSION,Liver function test abnormal,1,1
12261026,20160412,Osimertinib,25055,804,68.64,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Decreased appetite|Death,2,
12265827,20160413,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death|Nausea,2,
12267570,20160414,Osimertinib,30754,804,84.26,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,4,GENE MUTATION|NON-SMALL CELL LUNG CANCER METASTATIC|GENE MUTATION|NON-SMALL CELL LUNG CANCER METASTATIC,Hepatitis,1,2
12267767,20160414,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER STAGE IV|EGFR GENE MUTATION,Death,1,
12269639,20160414,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Death|Fatigue,2,
12273824,20160415,Osimertinib,,,,2,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Malaise|Death,2,
12277101,20160418,Osimertinib,27913,804,76.47,2,,1,0,1,1,0,0,1,Osimertinib,ERGOCALCIFEROL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|ATENOLOL|MULTIVITAMIN,19,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|VITAMIN SUPPLEMENTATION|SUPPLEMENTATION THERAPY|VITAMIN SUPPLEMENTATION|SUPPLEMENTATION THERAPY|COUGH|ISCHAEMIC HEART DISEASE PROPHYLAXIS|HYPERSENSITIVITY|SUPPLEMENTATION THERAPY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|ATRIAL FLUTTER|DYSPNOEA|SUPPLEMENTATION THERAPY|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|SUPPLEMENTATION THERAPY,Dyspnoea,1,1
12281957,20160419,Osimertinib,72,801,72.0,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|ERLOTINIB HYDROCHLORIDE,2,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Central nervous system lesion,1,5
12282753,20160419,Osimertinib,,,,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,,Angina pectoris,1,1
12283351,20160419,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12288036,20160420,Osimertinib,,,,2,46,1,1,0,0,0,0,0,Osimertinib,PANTOPRAZOLE|OSIMERTINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,5,LUNG NEOPLASM MALIGNANT|METASTASES TO CENTRAL NERVOUS SYSTEM|METASTASES TO CENTRAL NERVOUS SYSTEM,Lower respiratory tract infection|Cerebrovascular accident,2,1
12288319,20160420,Osimertinib,25567,804,70.05,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,3,NON-SMALL CELL LUNG CANCER METASTATIC|INSOMNIA|INSOMNIA,Interstitial lung disease,1,1
12289431,20160421,Osimertinib,24461,804,67.02,2,56.7,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Asthenia|Nausea|Vomiting|Diarrhoea|Dehydration,5,1
12289676,20160421,Osimertinib,26044,804,71.35,2,,1,1,0,0,0,0,0,Osimertinib,ATENOLOL|LOSARTAN|AMLODIPINE|OSIMERTINIB,4,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Death|Diarrhoea|Dizziness|Feeling abnormal|Insomnia|Confusional state,6,
12291038,20160421,Osimertinib,22577,804,61.85,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,GENE MUTATION|NON-SMALL CELL LUNG CANCER METASTATIC,Disease progression,1,2
12296157,20160422,Osimertinib,,,,1,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,,Dyspnoea,1,3
12296178,20160422,Osimertinib,907,802,75.58,2,67.6,1,0,1,0,0,0,0,Osimertinib,"OSIMERTINIB|PROCHLORPERAZINE MALEATE|OSIMERTINIB|LISINOPRIL|OSIMERTINIB|MULTIVITAMIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OSIMERTINIB|METOPROLOL TARTRATE|METOPROLOL|ERGOCALCIFEROL|PREGABALIN|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|OSIMERTINIB|PANTOPRAZOLE SODIUM|FENTANYL|OSIMERTINIB|ERLOTINIB HYDROCHLORIDE",19,LUNG NEOPLASM MALIGNANT|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I|LUNG NEOPLASM MALIGNANT|INFLAMMATION|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I|PAIN|LUNG NEOPLASM MALIGNANT|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I,Nausea|Gastrooesophageal reflux disease|Nightmare|Emotional disorder|Abdominal discomfort|Asthenia|Feeling hot|Accidental overdose|Diarrhoea|Nail disorder|Infection|Abdominal pain upper|Rash|Urinary tract infection|Clostridium difficile colitis|Dyspepsia|Musculoskeletal discomfort|Hypokinesia|Drug hypersensitivity|Drug dose omission|Retching|Heart rate irregular|Therapeutic response unexpected,23,
12296979,20160422,Osimertinib,16813,804,46.06,2,,1,1,0,0,0,0,0,Osimertinib,"BEVACIZUMAB|PEMETREXED|PEMETREXED DISODIUM|DIPHENHYDRAMINE HYDROCHLORIDE|APREPITANT|CLINDAMYCIN PHOSPHATE|OSIMERTINIB|METHADONE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|FOLIC ACID|DOXYCYCLINE|DOXYCYCLINE HYCLATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CARBOPLATIN|ZOLPIDEM TARTRATE|METRONIDAZOLE|LORAZEPAM",26,LUNG NEOPLASM MALIGNANT,Death,1,
12301451,20160425,Osimertinib,29223,804,80.06,2,38.3,1,1,1,0,0,0,0,Osimertinib,"OSIMERTINIB|OSIMERTINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LANSOPRAZOLE|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|CYANOCOBALAMIN|UREA|LULICONAZOLE",16,NON-SMALL CELL LUNG CANCER METASTATIC|HYPERTENSION|DIARRHOEA|NON-SMALL CELL LUNG CANCER METASTATIC|DIABETES MELLITUS|HYPERKERATOSIS|STOMATITIS|GASTROOESOPHAGEAL REFLUX DISEASE|DYSLIPIDAEMIA|HYPERKERATOSIS|DYSLIPIDAEMIA|CATARACT|HYPERKERATOSIS|TINEA PEDIS|OSTEOPOROSIS|HYPERKERATOSIS,Aplastic anaemia|Neutrophil count decreased|Platelet count decreased|Anaemia,4,1
12305860,20160426,Osimertinib,24612,804,67.43,2,,1,1,0,0,0,0,0,Osimertinib,"OSIMERTINIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",8,NON-SMALL CELL LUNG CANCER|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I,Dyspnoea|Death|Dry skin|Pruritus,4,5
12309793,20160427,Osimertinib,72,801,72.0,1,61.3,1,1,0,0,0,0,0,Osimertinib,FAMOTIDINE|CETIRIZINE|CETIRIZINE HYDROCHLORIDE|CETIIRIZINE|OSIMERTINIB,4,GASTRODUODENAL ULCER|COUGH|RHINORRHOEA|LUNG NEOPLASM MALIGNANT,Pneumonia,1,1
12311119,20160427,Osimertinib,18862,804,51.68,1,,1,0,1,0,0,0,0,Osimertinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|OSIMERTINIB,2,LUNG ADENOCARCINOMA STAGE IV,Nausea|Vomiting|Diarrhoea,3,1
12322224,20160502,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OMEPRAZOLE MAGNESIUM|OSIMERTINIB|OSIMERTINIB|CITALOPRAM,6,LUNG CANCER METASTATIC|LUNG CANCER METASTATIC,Muscle spasms,1,1
12323877,20160502,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Joint swelling|Nodule,2,5
12328882,20160503,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Death,1,
12329125,20160503,Osimertinib,,,,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Pyrexia|Dry skin|Urinary tract infection|Pain in extremity|Chills,5,
12329929,20160504,Osimertinib,66,801,66.0,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB|METOPROLOL TARTRATE|METOPROLOL,3,PRODUCT USED FOR UNKNOWN INDICATION,Death,1,
12335323,20160504,Osimertinib,75,801,75.0,2,,1,0,0,0,0,0,1,Osimertinib,CALCIUM|BIOTIN|ERGOCALCIFEROL|LISINOPRIL|MOXIFLOXACIN HYDROCHLORIDE|OSIMERTINIB|TAFLUPROST|PREDNISOLONE ACETATE,9,,Cataract,1,1
12335326,20160504,Osimertinib,28970,804,79.37,2,,1,0,1,0,0,0,1,Osimertinib,"OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|ERGOCALCIFEROL|RIVAROXABAN|MAGNESIUM OXIDE|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",13,NON-SMALL CELL LUNG CANCER|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Off label use|Diarrhoea|Skin exfoliation|Malignant neoplasm progression|Vomiting|Electrolyte imbalance,6,
12338509,20160505,Osimertinib,832,802,69.33,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|ERGOCALCIFEROL|ESOMEPRAZOLE MAGNESIUM|LEVOTHYROXINE SODIUM|DICYCLOMINE HYDROCHLORIDE|DESLORATADINE|OMEPRAZOLE MAGNESIUM|OSIMERTINIB,12,NON-SMALL CELL LUNG CANCER|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|GASTROOESOPHAGEAL REFLUX DISEASE|GASTROOESOPHAGEAL REFLUX DISEASE|NON-SMALL CELL LUNG CANCER,Gastrooesophageal reflux disease|Constipation|Diarrhoea|Non-small cell lung cancer|Muscle spasms|Therapy cessation|Pain,7,5
12339204,20160505,Osimertinib,29246,804,80.13,1,,1,0,1,0,1,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,15,GASTRIC ULCER|NON-SMALL CELL LUNG CANCER METASTATIC|ROUTINE HEALTH MAINTENANCE|TINEA INFECTION|ROUTINE HEALTH MAINTENANCE|COUGH|PYREXIA|NON-SMALL CELL LUNG CANCER METASTATIC|GASTRIC ULCER|GASTRIC ULCER|PYREXIA|BENIGN PROSTATIC HYPERPLASIA|RASH|RASH|PRODUCTIVE COUGH,Myelodysplastic syndrome,1,1
12340184,20160506,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Disease progression,1,1
12343547,20160506,Osimertinib,,,,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,,Muscle spasms|Gait disturbance|Foot deformity,3,
12343641,20160506,Osimertinib,55,801,55.0,2,,1,1,1,0,0,0,1,Osimertinib,OSIMERTINIB|GEFITINIB,2,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Death|Colitis|Rash pruritic|Nausea|Stomatitis|Fatigue|Dry skin|Headache|Viral infection|Dizziness|Weight decreased|Decreased appetite|Rash|Urinary tract infection|Glossodynia|Large intestinal haemorrhage|Arrhythmia|Depression|Productive cough|Infection|Dyspnoea|Palpitations|Diarrhoea|Hypotension,24,
12347064,20160509,Osimertinib,,,,1,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|LOSARTAN|ENOXAPARIN SODIUM|SENNOSIDES|SENNA LEAF|SENNA|POLYETHYLENE GLYCOL 3350,8,LUNG NEOPLASM MALIGNANT|CONSTIPATION|CONSTIPATION|CONSTIPATION|CONSTIPATION,Constipation|Diarrhoea|Abdominal pain upper|Dyspnoea,4,
12348285,20160509,Osimertinib,,,,0,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Myalgia,1,1
12349541,20160510,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,
12365100,20160513,Osimertinib,,,,0,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Pneumonia,1,1
12365145,20160513,Osimertinib,70,801,70.0,2,57,1,0,0,0,0,0,1,Osimertinib,GEFITINIB|OSIMERTINIB|DENOSUMAB,3,TYROSINE KINASE MUTATION|BONE DISORDER,Blood alkaline phosphatase increased|Metastases to lung|Spinal pain|Metastases to spine|Pleural effusion|Muscular weakness|Disease progression|Erythema|Transaminases increased|General physical health deterioration,10,1
12365798,20160513,Osimertinib,,,,1,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER,Nightmare|Delirium|Therapy cessation|Metastases to central nervous system,4,1
12366615,20160513,Osimertinib,67,801,67.0,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NEOPLASM MALIGNANT,Death,1,
12368910,20160513,Osimertinib,,,,0,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Aspiration,1,1
12369012,20160513,Osimertinib,,,,1,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Interstitial lung disease|Lung infiltration,2,1
12369901,20160516,Osimertinib,,,,0,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Pneumonia,1,1
12370086,20160516,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Fatigue|Dizziness|Balance disorder|Dysgeusia|Back pain|Death|Nausea,7,
12370168,20160516,Osimertinib,,,,0,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Respiratory failure|Counterfeit drug administered|Rubella,3,5
12370230,20160516,Osimertinib,,,,2,,1,0,0,0,0,0,1,Osimertinib,ERLOTINIB HYDROCHLORIDE|OSIMERTINIB,2,LUNG NEOPLASM MALIGNANT,Malignant neoplasm progression,1,1
12370238,20160516,Osimertinib,46,801,46.0,2,45,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|NIVOLUMAB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,7,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pyrexia|Platelet count decreased|Skin infection|Rash|Liver disorder,5,1
12377444,20160517,Osimertinib,20256,804,55.5,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death|Decreased appetite|Fatigue,3,
12378352,20160517,Osimertinib,763,802,63.58,1,85,1,1,1,0,0,0,1,Osimertinib,OSIMERTINIB|LORAZEPAM|ESOMEPRAZOLE MAGNESIUM|OXAZEPAM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|GEFITINIB,10,LUNG CANCER METASTATIC,Cerebral ischaemia|Pulmonary embolism|Metastases to central nervous system,3,1
12379066,20160517,Osimertinib,59,801,59.0,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Renal failure,1,1
12383468,20160518,Osimertinib,,,,1,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,Heart rate increased|Pyrexia,2,5
12385300,20160519,Osimertinib,55,801,55.0,2,52,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|ZOLEDRONIC ACID,3,LUNG NEOPLASM MALIGNANT,Bone pain|Pain|Sneezing|Product use issue|Off label use|Cough,6,5
12385413,20160519,Osimertinib,78,801,78.0,2,77.1,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Myocardial infarction|Pneumonitis,2,5
12386157,20160519,Osimertinib,77,801,77.0,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NEOPLASM MALIGNANT,Fatigue,1,3
12386158,20160519,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Dermatitis acneiform,1,3
12386159,20160519,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Vision blurred,1,1
12386184,20160519,Osimertinib,21438,804,58.73,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,LUNG NEOPLASM MALIGNANT|NON-SMALL CELL LUNG CANCER METASTATIC,Diarrhoea|Onychoclasis|Dermatitis acneiform|Rash|Herpes zoster,5,5
12386185,20160519,Osimertinib,21870,804,59.92,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|OXYCODONE HYDROCHLORIDE|OSIMERTINIB|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN,4,LUNG NEOPLASM MALIGNANT|NON-SMALL CELL LUNG CANCER,Nausea|Dyspnoea,2,5
12386210,20160519,Osimertinib,70,801,70.0,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Rash,1,1
12386219,20160519,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Constipation,1,2
12386220,20160519,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,GABAPENTIN|OSIMERTINIB,2,EGFR GENE MUTATION,Fatigue,1,
12386221,20160519,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Fatigue|Nausea,2,2
12386237,20160519,Osimertinib,,,,1,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|OSIMERTINIB|IRON|OSIMERTINIB|OSIMERTINIB,7,NON-SMALL CELL LUNG CANCER|DIARRHOEA|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|NON-SMALL CELL LUNG CANCER|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Drug ineffective|Diarrhoea,2,5
12386238,20160519,Osimertinib,31746,804,86.98,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,4,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Malignant neoplasm progression|Constipation|Decreased appetite,3,5
12386239,20160519,Osimertinib,25166,804,68.95,2,,1,0,0,0,0,0,0,Osimertinib,LORAZEPAM|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER METASTATIC,Constipation|Therapy cessation,2,2
12386881,20160519,Osimertinib,26045,804,71.36,2,49,1,1,1,1,1,0,0,Osimertinib,OSIMERTINIB|AMLODIPINE,3,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC,Upper gastrointestinal haemorrhage|Tumour lysis syndrome|Atrial fibrillation,3,1
12387242,20160519,Osimertinib,31410,804,86.05,2,37,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|ERGOCALCIFEROL|OSIMERTINIB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|LOSARTAN,12,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Tracheobronchitis|Diabetic ketoacidosis,2,1
12389767,20160520,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Muscle spasms,1,1
12391165,20160520,Osimertinib,30249,804,82.87,1,50.6,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,7,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER,Pneumonitis,1,1
12398985,20160524,Osimertinib,28178,804,77.2,1,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Heart rate increased|Diarrhoea|Dehydration|Hypotension|Skin lesion|Nail disorder,6,
12403035,20160525,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,5
12404893,20160525,Osimertinib,611,802,50.92,2,,1,1,0,0,0,0,0,Osimertinib,DOXYCYCLINE|DOXYCYCLINE HYCLATE|OSIMERTINIB,2,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Death,1,
12405085,20160525,Osimertinib,28539,804,78.19,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CANCER METASTATIC,Oxygen saturation decreased|Lung disorder|Cardiomyopathy|Dyspnoea at rest,4,5
12406095,20160526,Osimertinib,,,,1,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Ejection fraction decreased,1,
12408786,20160526,Osimertinib,38,801,38.0,2,47,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Interstitial lung disease|Dyspnoea|Dermatitis acneiform|Xeroderma|Diarrhoea,5,1
12412458,20160527,Osimertinib,44,801,44.0,2,62,1,1,0,0,0,0,0,Osimertinib,MORPHINE SULFATE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|OSIMERTINIB,16,NON-SMALL CELL LUNG CANCER|LYMPHANGIOSIS CARCINOMATOSA|CANCER PAIN|SEDATION|GASTRIC ULCER|CANCER PAIN|INFECTION PROPHYLAXIS|DEHYDRATION|LYMPHANGIOSIS CARCINOMATOSA|DEHYDRATION|CANCER PAIN|PHARYNGITIS|DEHYDRATION|NON-SMALL CELL LUNG CANCER|GASTRIC ULCER|CANCER PAIN,Pulmonary embolism|Platelet count decreased,2,1
12412947,20160527,Osimertinib,80,801,80.0,2,52,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,2,ATRIAL FIBRILLATION|NON-SMALL CELL LUNG CANCER,Pulmonary embolism,1,1
12414104,20160527,Osimertinib,77,801,77.0,2,,1,0,0,1,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Acute coronary syndrome,1,3
12416456,20160530,Osimertinib,,,,1,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER,Peripheral swelling|Extremity necrosis,2,1
12418501,20160531,Osimertinib,,,,2,,1,0,0,0,0,0,1,Osimertinib,"OSIMERTINIB|FENTANYL|LANSOPRAZOLE|PREGABALIN|GABAPENTIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|OXYCODONE|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN PHOSPHATE GEL USP, 1%|CLINDAMYCIN PHOSPHATE TOPICAL|DRONABINOL",15,METASTASES TO LUNG,Decreased appetite|Yellow skin|Weight decreased|Contusion|Nausea|Musculoskeletal chest pain|Gingival pain|Onychoclasis|Ingrowing nail|Malignant neoplasm progression|Gastrointestinal pain,11,5
12419000,20160531,Osimertinib,,,,2,47.6,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,2,LUNG NEOPLASM MALIGNANT,Diarrhoea|Vomiting,2,3
12419212,20160531,Osimertinib,78,801,78.0,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Pneumonitis,1,3
12422674,20160601,Osimertinib,30914,804,84.7,2,,1,0,1,0,0,0,0,Osimertinib,ERLOTINIB HYDROCHLORIDE|ERLOTINIB|FUROSEMIDE|OXAZEPAM|CLOPIDOGREL|CLOPIDOGREL BISULFATE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|SPIRONOLACTONE|OSIMERTINIB,14,DISEASE PROGRESSION,Cardiac failure|Hyponatraemia,2,1
12429186,20160602,Osimertinib,71,801,71.0,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Gastrointestinal perforation|Rash,2,1
12429624,20160602,Osimertinib,17056,804,46.73,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12431153,20160603,Osimertinib,27731,804,75.98,2,,1,0,0,0,0,0,1,Osimertinib,LOVASTATIN|PREGABALIN|ERGOCALCIFEROL|OSIMERTINIB|GABAPENTIN|BIOTIN|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|OSIMERTINIB,9,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Neuralgia|Malignant neoplasm progression|Pollakiuria|Oropharyngeal pain|Pruritus|Skin disorder|Weight decreased|Lip dry|Drug dose omission|Dizziness|Lip swelling|Chapped lips|Rash|Urticaria|Early satiety|Diarrhoea,16,5
12435915,20160604,Osimertinib,63,801,63.0,2,56.8,1,1,0,0,0,0,1,Osimertinib,OSIMERTINIB|GEFITINIB,3,LUNG NEOPLASM MALIGNANT|SKIN REACTION,Klebsiella test positive|Acute hepatic failure|Sepsis|Rash,4,1
12435940,20160604,Osimertinib,,,,2,42.6,1,0,0,0,0,0,1,Osimertinib,MORPHINE SULFATE|OSIMERTINIB|ERLOTINIB HYDROCHLORIDE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|CITALOPRAM|CITALOPRAM HYDROBROMIDE,8,PAIN|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|THYROID DISORDER|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|ANTIDEPRESSANT THERAPY,Rash pustular|Skin cancer|Lymphadenopathy|Pain|Drug ineffective|Breast mass|Weight decreased|Pruritus,8,
12436283,20160605,Osimertinib,28655,804,78.51,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,4,METASTASES TO CENTRAL NERVOUS SYSTEM|METASTASES TO CENTRAL NERVOUS SYSTEM|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Blood chloride decreased|Blood sodium decreased|Platelet count decreased|Drug dose omission|Off label use|Pneumonia|Product use issue,7,5
12437837,20160606,Osimertinib,19236,804,52.7,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|LUNG NEOPLASM MALIGNANT,Adverse drug reaction|Onychoclasis|Abdominal discomfort|Erythema|Intentional product misuse,5,
12446917,20160608,Osimertinib,,,,1,,1,0,0,0,0,0,0,Osimertinib,LOSARTAN|ESCITALOPRAM|FINASTERIDE|SILODOSIN|OSIMERTINIB|MORPHINE|CLOPIDOGREL|GUAIFENESIN|GABAPENTIN,9,LUNG NEOPLASM MALIGNANT,Prostatic disorder|Peripheral swelling|Fatigue|Pollakiuria,4,3
12449067,20160608,Osimertinib,,,,1,,1,1,0,1,0,0,1,Osimertinib,OSIMERTINIB,1,,Pneumonia|Myocardial infarction|Arrhythmia|Pneumonitis|Cardiac arrest,5,1
12449288,20160608,Osimertinib,649,802,54.08,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|PANTOPRAZOLE|OSIMERTINIB,5,NON-SMALL CELL LUNG CANCER|ABDOMINAL DISCOMFORT|HYPOTHYROIDISM|DECREASED APPETITE|NON-SMALL CELL LUNG CANCER,Breath odour|Aspartate aminotransferase abnormal|Hypophagia|Haematocrit decreased|Platelet count abnormal|Vomiting|General physical health deterioration|Mean cell haemoglobin concentration increased|Haemoglobin decreased|Mean cell volume increased|Salivary hypersecretion,11,1
12453808,20160609,Osimertinib,71,801,71.0,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Product use issue|Asthenia|Blood urine present,3,5
12453935,20160609,Osimertinib,77,801,77.0,2,54,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Cardiac failure congestive,1,1
12453975,20160610,Osimertinib,67,801,67.0,1,,1,1,1,1,0,0,1,Osimertinib,OSIMERTINIB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|LANSOPRAZOLE,6,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Malignant neoplasm progression|Thoracic cavity lavage|Infectious pleural effusion|Interstitial lung disease|Blood thyroid stimulating hormone increased|Thoracic cavity drainage,6,5
12459427,20160610,Osimertinib,78,801,78.0,2,80.5,1,0,0,1,0,0,1,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER STAGE IV,Platelet count decreased,1,2
12462416,20160614,Osimertinib,687,802,57.25,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Arthralgia|Rash,2,5
12462423,20160614,Osimertinib,60,801,60.0,2,,1,0,0,0,0,0,1,Osimertinib,RIVAROXABAN|OSIMERTINIB|OSIMERTINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Thrombocytopenia|White blood cell count decreased,2,1
12462444,20160614,Osimertinib,,,,1,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Thrombocytopenia|Liver function test increased,2,1
12463279,20160614,Osimertinib,,,,0,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,3,,Off label use|Pruritus,2,1
12466425,20160615,Osimertinib,741,802,61.75,2,70,1,0,1,0,1,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|CANDESARTAN CILEXETIL,12,NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|NON-SMALL CELL LUNG CANCER METASTATIC|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION|INSOMNIA,Nausea|Malignant neoplasm progression|Thrombocytopenia|Weight decreased|Pyrexia|Adverse event|Decreased appetite|Gastrooesophageal reflux disease|Hypokalaemia,9,3
12466561,20160615,Osimertinib,,,,2,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,BRONCHIAL CARCINOMA|LUNG NEOPLASM MALIGNANT,Hyponatraemia|Nausea|Haematemesis|Dehydration|Fatigue|Gastrointestinal haemorrhage,6,5
12468366,20160615,Osimertinib,29390,804,80.52,1,71.8,1,0,1,0,0,0,1,Osimertinib,DOXYCYCLINE|DOXYCYCLINE HYCLATE|SENNOSIDES|SENNA LEAF|SENNA|FOLIC ACID|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|POLYETHYLENE GLYCOL 3350|OSIMERTINIB,7,CONJUNCTIVITIS|CONSTIPATION|PREMEDICATION|PULMONARY EMBOLISM|PREMEDICATION|CONSTIPATION|NON-SMALL CELL LUNG CANCER,Periorbital cellulitis,1,1
12469729,20160615,Osimertinib,28601,804,78.36,2,,1,0,0,0,0,0,1,Osimertinib,ALPRAZOLAM|OSIMERTINIB|OSIMERTINIB|ATENOLOL,8,ANXIETY|PULMONARY EMBOLISM|ERYTHEMA|EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER|DIABETES MELLITUS|INSOMNIA|HYPERTENSION,Blood glucose increased|Lymphocyte count decreased|Creatinine renal clearance decreased|Breath sounds abnormal|Renal impairment|Platelet count decreased,6,1
12472392,20160616,Osimertinib,21493,804,58.88,1,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Cerebrovascular accident|Death,2,
12472417,20160616,Osimertinib,76,801,76.0,1,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,No adverse event,1,1
12473316,20160616,Osimertinib,54,801,54.0,1,64,1,0,0,0,0,0,0,Osimertinib,ALPRAZOLAM|ROPINIROLE|LISINOPRIL|ALPRAZOLAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|OSIMERTINIB|SIMVASTATIN|INSULIN GLARGINE,9,NAUSEA|RESTLESS LEGS SYNDROME|HYPERTENSION|ANXIETY|GASTROOESOPHAGEAL REFLUX DISEASE|NON-SMALL CELL LUNG CANCER METASTATIC|DIABETES MELLITUS|DEPRESSION,Liver function test increased,1,1
12473610,20160616,Osimertinib,,,,2,32.7,1,0,0,1,0,0,1,Osimertinib,OSIMERTINIB|ENTECAVIR|ENTECAVIR ANHYDROUS|OSIMERTINIB|AMLODIPINE,7,PAIN PROPHYLAXIS|EGFR GENE MUTATION|VIRAL HEPATITIS CARRIER|COUGH|COUGH|LUNG ADENOCARCINOMA STAGE IV|HYPERTENSION,Decreased appetite|Diarrhoea|Insomnia|Weight decreased|Cough,5,1
12474064,20160616,Osimertinib,,,,0,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Urticaria|Hair disorder|Nail disorder|Skin disorder,4,5
12474066,20160616,Osimertinib,,,,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,,Asthenia,1,1
12474959,20160617,Osimertinib,59,801,59.0,1,,1,0,1,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Anaemia|Infectious pleural effusion|Delirium,3,1
12475251,20160617,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death|Eye irritation,2,
12477203,20160617,Osimertinib,,,,1,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,LUNG NEOPLASM MALIGNANT|BRONCHIAL NEOPLASM,Malaise|Death,2,
12478330,20160617,Osimertinib,68,801,68.0,1,56,1,1,0,0,0,0,1,Osimertinib,OXYGEN|0XYGEN|OSIMERTINIB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB,7,CANCER PAIN|NON-SMALL CELL LUNG CANCER|CANCER PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pericardial effusion|Interstitial lung disease|Respiratory failure|Ventricular arrhythmia,4,1
12478469,20160618,Osimertinib,56,801,56.0,1,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|PRASUGREL HYDROCHLORIDE|LEVOTHYROXINE SODIUM,5,LUNG NEOPLASM MALIGNANT,Unevaluable event|Dyspnoea,2,1
12478497,20160618,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|DOXYCYCLINE HYCLATE|DOXYCYCLINE|DOXYCLYCLINE HYCLATE|ESOMEPRAZOLE MAGNESIUM|MUPIROCIN|MUPIROCIN CALCIUM,6,LUNG NEOPLASM MALIGNANT|NON-SMALL CELL LUNG CANCER|ABDOMINAL DISCOMFORT|FLATULENCE,Onychoclasis|Vomiting|Sinusitis|Hair growth abnormal|Flatulence|Nail growth abnormal|Diarrhoea|Dry skin|Dry mouth,9,5
12478549,20160619,Osimertinib,25762,804,70.58,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|BRONCHIAL CARCINOMA,Contusion|Asthenia|Feeling cold|Weight decreased|Decreased appetite|Fatigue,6,3
12481227,20160620,Osimertinib,31457,804,86.18,2,48.1,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Drug ineffective|Constipation,2,
12483158,20160620,Osimertinib,26241,804,71.89,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,ONCOLOGIC COMPLICATION,Joint swelling|Peripheral swelling,2,3
12483168,20160620,Osimertinib,,,,1,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Asthenia|Hypersomnia,2,5
12483171,20160620,Osimertinib,668,802,55.67,2,,1,0,0,0,0,0,0,Osimertinib,"OSIMERTINIB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",2,LUNG NEOPLASM MALIGNANT|HEADACHE,Headache|Visual impairment|Fatigue|Neoplasm progression,4,5
12483384,20160621,Osimertinib,71,801,71.0,2,65,1,0,1,0,0,0,1,Osimertinib,BIMATOPROST|NIVOLUMAB|BRIMONIDINE TARTRATE|OSIMERTINIB,13,CONVULSION PROPHYLAXIS|GLAUCOMA|GLAUCOMA|NON-SMALL CELL LUNG CANCER|INSOMNIA|GLAUCOMA|DRY SKIN|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|ANALGESIC THERAPY|GLAUCOMA|NON-SMALL CELL LUNG CANCER|DRY SKIN,Pulmonary embolism|Interstitial lung disease,2,1
12486317,20160621,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Death,1,
12486550,20160621,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12486729,20160621,Osimertinib,21916,804,60.04,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,3
12487155,20160622,Osimertinib,25245,804,69.16,2,,1,0,1,0,0,0,1,Osimertinib,OSIMERTINIB|MINOCYCLINE HYDROCHLORIDE|OSIMERTINIB,11,NON-SMALL CELL LUNG CANCER|PNEUMONIA|NON-SMALL CELL LUNG CANCER|DIARRHOEA|PNEUMONIA|PNEUMONIA|RASH|PNEUMONIA|RASH|NON-SMALL CELL LUNG CANCER|PNEUMONIA,Anaphylactic reaction,1,1
12488354,20160622,Osimertinib,68,801,68.0,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,
12489131,20160622,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Arthralgia,1,3
12490828,20160622,Osimertinib,81,801,81.0,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,4,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|THROMBOLYSIS|NON-SMALL CELL LUNG CANCER,Cardiac failure congestive|Anaemia,2,1
12492371,20160623,Osimertinib,66,801,66.0,2,57,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,9,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Rash|Diarrhoea|Liver disorder,3,1
12492460,20160623,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,LACTULOSE|OSIMERTINIB|METOPROLOL TARTRATE|METOPROLOL|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FUROSEMIDE,7,LUNG NEOPLASM MALIGNANT,Death,1,
12492999,20160623,Osimertinib,,,,1,,1,1,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Metastases to central nervous system|Death|Weight decreased|Chromaturia,4,
12493097,20160623,Osimertinib,65,801,65.0,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression,1,1
12496052,20160624,Osimertinib,,,,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER,Pneumonitis|Metastases to bone,2,1
12497075,20160624,Osimertinib,74,801,74.0,1,64,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Rash|Weight decreased|Acute myocardial infarction|Decreased appetite,4,1
12498039,20160626,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12501300,20160627,Osimertinib,21846,804,59.85,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|ERLOTINIB HYDROCHLORIDE,3,NAUSEA|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Nausea|Dry skin|Nasopharyngitis|Skin fissures|Lymphadenopathy|Lymphadenopathy,6,
12503904,20160628,Osimertinib,788,802,65.67,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER RECURRENT,Renal impairment|Abdominal pain|Nausea|Decreased appetite|Decubitus ulcer|Rash,6,1
12505392,20160628,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,GABAPENTIN|MORPHINE SULFATE|OSIMERTINIB,3,LUNG NEOPLASM MALIGNANT,Death,1,
12506032,20160628,Osimertinib,65,801,65.0,2,41,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Hepatic function abnormal|Vomiting|Metastases to meninges|Stress cardiomyopathy,4,1
12508928,20160629,Osimertinib,,,,2,54.4,1,0,0,0,0,0,0,Osimertinib,FUROSEMIDE|OSIMERTINIB|OSIMERTINIB|ALENDRONATE SODIUM,4,FLUID RETENTION|LUNG CANCER METASTATIC|LUNG CANCER METASTATIC,Alanine aminotransferase increased|Oedema peripheral|Aspartate aminotransferase increased|Ascites,4,
12517027,20160630,Osimertinib,30172,804,82.66,2,86,1,0,1,0,0,0,0,Osimertinib,FUROSEMIDE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|LOSARTAN|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ATENOLOL|OSIMERTINIB|OSIMERTINIB,11,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Decreased appetite|Asthenia,2,1
12517662,20160630,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
12518384,20160630,Osimertinib,24843,804,68.06,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Decreased appetite|Nausea|Productive cough|Cough|Pleural effusion|Chest pain|Flank pain|Death|Vomiting|Respiratory tract congestion|Musculoskeletal chest pain,11,
12519158,20160630,Osimertinib,80,801,80.0,1,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,3,BRAIN CANCER METASTATIC|NEOPLASM MALIGNANT|VENTRICULAR FIBRILLATION,Autoimmune retinopathy|Malignant melanoma|Blindness|Pain in extremity|Insomnia|Vision blurred|Nail disorder|Drug dose omission|Malignant neoplasm progression|Cardiac fibrillation,10,5
12520408,20160701,Osimertinib,,,,2,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death|Pneumonia,2,
12523031,20160701,Osimertinib,78,801,78.0,2,38,1,0,0,0,0,0,1,Osimertinib,GEFITINIB|OSIMERTINIB|OSIMERTINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pyrexia|Liver disorder|Bone marrow failure|Cardiac failure|Neutrophil count decreased,5,1
12523583,20160703,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Asthenia|Fatigue,2,3
12525168,20160704,Osimertinib,,,,2,,1,0,0,1,0,0,0,Osimertinib,OSIMERTINIB,1,NEOPLASM MALIGNANT,Haemoglobin decreased|Red blood cell count decreased|White blood cell count decreased,3,5
12525507,20160704,Osimertinib,24432,804,66.94,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NEOPLASM MALIGNANT,Dry mouth|Skin fissures|Dry skin|Fatigue|Tongue dry|Dry throat,6,
12525821,20160705,Osimertinib,82,801,82.0,2,37,1,1,0,0,0,0,0,Osimertinib,NIVOLUMAB|OSIMERTINIB,11,BRAIN OEDEMA|NON-SMALL CELL LUNG CANCER|HYPERTENSION|GASTRIC ULCER|TYPE 2 DIABETES MELLITUS|ANGINA PECTORIS|GENERAL PHYSICAL HEALTH DETERIORATION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|BACK PAIN|NON-SMALL CELL LUNG CANCER|BACK PAIN,Interstitial lung disease,1,1
12528515,20160705,Osimertinib,,,,0,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Pulmonary embolism,1,1
12530330,20160706,Osimertinib,61,801,61.0,1,72,1,0,1,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression|Chest pain|Cardiomyopathy,3,1
12530617,20160705,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Palpitations|Heart rate increased,2,
12538368,20160707,Osimertinib,648,802,54.0,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Drug-induced liver injury,1,1
12538830,20160708,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death|Diarrhoea,2,
12539221,20160708,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB|GEFITINIB,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Death|Fatigue|Pain in extremity|Hypertension|Diarrhoea,5,
12540202,20160708,Osimertinib,67,801,67.0,2,,1,0,1,0,0,0,0,Osimertinib,DENOSUMAB|CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE|OSIMERTINIB,12,METASTASIS|CONSTIPATION|PAIN|METASTASIS|GASTRITIS PROPHYLAXIS|PAIN|HYPERTENSION|DEPRESSION|NON-SMALL CELL LUNG CANCER METASTATIC|HYPERTENSION|INSOMNIA|PAIN,Gastritis,1,1
12547781,20160712,Osimertinib,30062,804,82.36,1,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Nail disorder|Pleural effusion|Rhinitis allergic|Productive cough|Dyspnoea,5,
12547858,20160712,Osimertinib,70,801,70.0,2,59,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,5,NON-SMALL CELL LUNG CANCER|ANALGESIC THERAPY|PRODUCTIVE COUGH|NON-SMALL CELL LUNG CANCER|PRODUCTIVE COUGH,Nausea|Adjustment disorder|Pruritus|Rash|Erythema|Diarrhoea,6,1
12549005,20160712,Osimertinib,53,801,53.0,1,63,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Hydrocephalus|Malignant neoplasm progression,2,1
12549912,20160712,Osimertinib,66,801,66.0,1,69,1,1,1,0,0,0,1,Osimertinib,FUROSEMIDE|OSIMERTINIB|WARFARIN|GEMCITABINE HYDROCHLORIDE|GEMCITABINE|MAGNESIUM OXIDE|PREGABALIN|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,15,HYPERTENSION|HYPERTENSION|HYPOAESTHESIA|NON-SMALL CELL LUNG CANCER|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|THROMBOSIS PROPHYLAXIS|CONSTIPATION|CANCER PAIN|HEPATIC ENZYME INCREASED|CANCER PAIN|CANCER PAIN,Dyspnoea exertional|Allergic eosinophilia|Lung disorder|Alveolitis allergic,4,1
12549917,20160712,Osimertinib,64,801,64.0,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER STAGE IV,Cardiac failure|Pericardial effusion,2,1
12550155,20160712,Osimertinib,62,801,62.0,1,65,1,1,1,0,0,0,0,Osimertinib,RAMELTEON|OSIMERTINIB|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|MAGNESIUM OXIDE|QUETIAPINE|OSIMERTINIB|MAGNESIUM OXIDE|QUETIAPINE|ESOMEPRAZOLE MAGNESIUM|NIVOLUMAB,28,GASTROINTESTINAL DISORDER THERAPY|INSOMNIA|NON-SMALL CELL LUNG CANCER|SEIZURE|INTERSTITIAL LUNG DISEASE|PAIN|BRAIN OEDEMA|BRAIN OEDEMA|EPILEPSY|CONSTIPATION|INSOMNIA|PNEUMOCYSTIS JIROVECII PNEUMONIA|NON-SMALL CELL LUNG CANCER|PAIN|CONSTIPATION|INSOMNIA|SEIZURE|PAIN|PULMONARY EMBOLISM|BRAIN OEDEMA|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|PULMONARY EMBOLISM|PAIN|OSTEOPOROSIS,Hypotension|Diarrhoea|Interstitial lung disease|Altered state of consciousness|Pneumocystis jirovecii pneumonia,5,1
12550632,20160712,Osimertinib,67,801,67.0,2,,1,0,1,0,0,0,0,Osimertinib,CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE|OSIMERTINIB|DENOSUMAB,12,HYPERTENSION|HYPERTENSION|PAIN|GASTRITIS PROPHYLAXIS|DEPRESSION|PAIN|METASTASIS|NON-SMALL CELL LUNG CANCER METASTATIC|PAIN|INSOMNIA|METASTASIS|CONSTIPATION,Gastritis,1,1
12552534,20160713,Osimertinib,982,802,81.83,2,,1,0,1,0,0,0,0,Osimertinib,DOXYCYCLINE|DOXYCYCLINE HYCLATE|OSIMERTINIB|OSIMERTINIB,3,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Choking|Dyspnoea,2,5
12552971,20160713,Osimertinib,38,801,38.0,1,46,1,0,1,0,0,0,1,Osimertinib,OSIMERTINIB|ETODOLAC|OSIMERTINIB|OSIMERTINIB|OXYCODONE HYDROCHLORIDE|OSIMERTINIB|NIVOLUMAB,10,NON-SMALL CELL LUNG CANCER|CANCER PAIN|GASTROINTESTINAL HAEMORRHAGE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CANCER PAIN|NON-SMALL CELL LUNG CANCER|GASTROINTESTINAL DISORDER|CANCER PAIN|NON-SMALL CELL LUNG CANCER,Diarrhoea|Liver disorder|Cough|Acne|Eosinophilic pneumonia|Pulmonary alveolar haemorrhage,6,1
12553193,20160713,Osimertinib,79,801,79.0,2,36,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Hypoxia,1,1
12553409,20160713,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NEOPLASM MALIGNANT,Sleep disorder|Fatigue,2,5
12554753,20160713,Osimertinib,25981,804,71.18,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,4,COUGH|COUGH|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER,Cardiac failure,1,1
12554803,20160713,Osimertinib,,,,0,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Malaise,1,3
12556292,20160714,Osimertinib,50,801,50.0,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,2,ADENOCARCINOMA,Metastasis|Metastases to lymph nodes|Metastases to liver,3,5
12556743,20160714,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Pain|Fatigue|Dyspnoea|Eating disorder,4,
12558159,20160714,Osimertinib,69,801,69.0,1,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Asthenia,1,1
12561021,20160715,Osimertinib,,,,1,,1,0,0,0,0,0,1,Osimertinib,SOLIFENACIN SUCCINATE|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER,Weight increased|Brain neoplasm,2,3
12563449,20160715,Osimertinib,47,801,47.0,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|LEVETIRACETAM,10,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CHEST PAIN|CHEST PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|SEIZURE|NON-SMALL CELL LUNG CANCER|SEIZURE,Neutrophil count decreased|Pyrexia,2,1
12563606,20160715,Osimertinib,22844,804,62.59,1,,1,1,1,0,0,0,0,Osimertinib,FUROSEMIDE|DULOXETINE HYDROCHLORIDE|OSIMERTINIB|FUROSEMIDE|RIVAROXABAN|AMOXICILLIN AND CLAVULANATE POTASSIUM,7,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Dyspnoea|Wheezing|Death|Cough|Diarrhoea,5,
12563909,20160716,Osimertinib,827,802,68.92,2,,1,1,1,1,0,0,0,Osimertinib,OSIMERTINIB,2,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|DIARRHOEA,Cardiac tamponade|Death|Muscle spasms|Visual impairment|Nail infection|Diarrhoea|Nail disorder|Dacryostenosis acquired,8,5
12564531,20160718,Osimertinib,741,802,61.75,2,90.7,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|CLINDAMYCIN PHOSPHATE|CLINDAMYCIN|SPIRONOLACTONE|ALPRAZOLAM|GEFITINIB|GEFITINIB|RABEPRAZOLE SODIUM|BUPROPION|ZOLPIDEM TARTRATE|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|OXYCODONE|CEFDINIR|HYDROCHLOROTHIAZIDE|OXYCODONE|ALPRAZOLAM|TIZANIDINE|PHENAZOPYRIDINE|ESTRADIOL ACETATE,21,LUNG ADENOCARCINOMA|ACNE|BLOOD PRESSURE DIASTOLIC ABNORMAL|OEDEMA|ANXIETY|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|MENOPAUSE|SLEEP DISORDER|VOMITING|PAIN|URINARY TRACT INFECTION|OEDEMA|PAIN|SLEEP DISORDER|MUSCLE SPASMS|URINARY TRACT PAIN|NAUSEA,Malignant neoplasm progression|Oedema peripheral|Weight fluctuation|Klebsiella infection|Pain|Blister|Swollen tongue|Oropharyngeal pain|Urinary tract infection|Fluid retention|Skin atrophy|Ocular hyperaemia|Muscle twitching|Lymph node pain|Metastases to lymph nodes|Cough|Pain|Dry eye|Nausea|Vomiting|Insomnia|Photosensitivity reaction|Gastrointestinal disorder|Hair disorder|Genital haemorrhage|Cystitis|Alopecia|Aphasia|Feeling abnormal|Dyspnoea|Rash|Diarrhoea|Oral herpes|Basal cell carcinoma|Migraine|Memory impairment|Dyspareunia|Myalgia|Pain in extremity|Fatigue|Back pain|Abdominal pain upper|Pain of skin|Chest pain|Arthralgia|Ear pain|Feeling abnormal|Genital injury|Chills|Dry skin|Stomatitis|Sinus pain|Cyst,53,
12565403,20160718,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Stomatitis,1,1
12566320,20160718,Osimertinib,,,,1,,1,1,0,0,0,0,1,Osimertinib,DENOSUMAB|OSIMERTINIB|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE,5,METASTASES TO BONE|METASTASES TO BONE|LIVER DISORDER|BRONCHIAL CARCINOMA,Cardiopulmonary failure|Atrial fibrillation|Lung infection|Metastasis|Pericardial effusion|Disease progression,6,1
12566321,20160718,Osimertinib,,,,1,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Stomatitis,1,1
12566714,20160718,Osimertinib,,,,1,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Haemoptysis,1,5
12568314,20160718,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Nasopharyngitis|Decreased appetite|Weight decreased|Death|Dry skin,5,
12568431,20160718,Osimertinib,,,,1,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Stomatitis,1,1
12568955,20160719,Osimertinib,75,801,75.0,1,,1,0,0,0,0,0,0,Osimertinib,"LISINOPRIL|CALCIUM POLYCARBOPHIL|OSIMERTINIB|ALLOPURINOL|BRIMONIDINE TARTRATE|BIMATOPROST|OMEPRAZOLE MAGNESIUM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LEVOTHYROXINE SODIUM|AMOXICILLIN|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SIMVASTATIN|SIMVASTATIN",19,LUNG NEOPLASM MALIGNANT,Nasopharyngitis|Dry skin|Dizziness,3,
12570321,20160719,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12570340,20160719,Osimertinib,83,801,83.0,1,50,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|FUROSEMIDE,2,NON-SMALL CELL LUNG CANCER|GENERALISED OEDEMA,Ventricular extrasystoles,1,1
12575278,20160720,Osimertinib,65,801,65.0,1,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Depressive symptom|Malaise|Decreased appetite,3,1
12575661,20160720,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12576416,20160720,Osimertinib,26930,804,73.78,2,,1,1,0,0,0,0,0,Osimertinib,OLANZAPINE|ERGOCALCIFEROL|MULTIVITAMIN|OSIMERTINIB|LISINOPRIL,9,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Drug hypersensitivity|Death|Nausea,3,
12576633,20160720,Osimertinib,78,801,78.0,1,58,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Pyrexia,1,1
12577504,20160720,Osimertinib,76,801,76.0,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,LUNG NEOPLASM MALIGNANT|EGFR GENE MUTATION,Malignant neoplasm progression|Cardiopulmonary failure,2,1
12578071,20160721,Osimertinib,751,802,62.58,2,,1,1,0,0,0,0,0,Osimertinib,OXYGEN|0XYGEN|OSIMERTINIB,4,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Vomiting|Nausea|Lip disorder|Death|Cheilitis|Diarrhoea|Malaise|Intentional product misuse,8,
12578552,20160721,Osimertinib,16107,804,44.13,1,,1,0,1,0,0,0,0,Osimertinib,TESTOSTERONE|OSIMERTINIB|OXYCODONE|OMEPRAZOLE MAGNESIUM,4,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I|PAIN,Fatigue|Rash|Pulmonary embolism|Arthralgia|Abdominal pain upper,5,
12579565,20160721,Osimertinib,81,801,81.0,2,40,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Cardiac failure|Atrial fibrillation|Lacunar infarction|Hepatic function abnormal,4,1
12579996,20160721,Osimertinib,57,801,57.0,1,68,1,0,0,0,0,0,0,Osimertinib,BUDESONIDE|BUDESONIDE|BUDESONIDE|OSIMERTINIB|BUDESONIDE|BUDESONIDE|BUDESONIDE|OSIMERTINIB,8,PROPHYLAXIS|BRONCHITIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|LUNG NEOPLASM MALIGNANT|PROPHYLAXIS|BRONCHITIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|LUNG NEOPLASM MALIGNANT,Bronchitis|Hypotrichosis|Insomnia|Fatigue|Arthralgia|Tendonitis|Off label use|Myalgia,8,
12582032,20160722,Osimertinib,,,,2,58.1,1,1,0,0,0,0,0,Osimertinib,"OSIMERTINIB|FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE|FOLIC ACID|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|DIGOXIN|METOPROLOL SUCCINATE|HYDROCHLOROTHIAZIDE|FENTANYL|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED",15,LUNG NEOPLASM MALIGNANT,Death|Musculoskeletal chest pain|Vomiting|Nausea,4,
12583225,20160722,Osimertinib,26180,804,71.73,2,,1,1,0,0,0,0,1,Osimertinib,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OSIMERTINIB|AMLODIPINE|CALCIUM CARBONATE|ANTACID|PANTOPRAZOLE,7,SUPERIOR VENA CAVA OCCLUSION|NON-SMALL CELL LUNG CANCER STAGE IV|HYPERTENSION|JUGULAR VEIN THROMBOSIS|MINERAL SUPPLEMENTATION|MINERAL SUPPLEMENTATION|GASTROOESOPHAGEAL REFLUX DISEASE,Vocal cord paralysis|Pneumonia aspiration|Jugular vein thrombosis|Malignant neoplasm progression,4,1
12583439,20160722,Osimertinib,61,801,61.0,2,,1,0,1,0,0,0,1,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Metastases to bone|Malignant neoplasm progression|Lymphangiosis carcinomatosa|Pleural effusion,4,1
12585680,20160725,Osimertinib,46,801,46.0,1,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Dyspnoea,1,5
12589742,20160725,Osimertinib,787,802,65.58,1,,1,1,1,0,0,0,1,Osimertinib,"ENOXAPARIN SODIUM|GABAPENTIN|FINASTERIDE|OSIMERTINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|MIRTAZAPINE|OSIMERTINIB|CITALOPRAM|CITALOPRAM HYDROBROMIDE|DOCUSATE SODIUM 50 MG AND SENNOSIDES 8.6 MG|DOCUSATE SODIUM, SENNOSIDES|DOCUSATE SODIUM, 50 MG SENNOSIDES, 8.6 MG|PANTOPRAZOLE|CITALOPRAM",14,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Burning sensation|Muscular weakness|Insomnia|Tumour marker increased|Neoplasm|Brain neoplasm|Decreased appetite|Weight decreased|Drug dose omission|Thrombosis|Tumour compression|Death|Cellulitis|Platelet disorder|Fatigue|Gait disturbance|Fall|Wound|Pain in extremity|Swelling|Positron emission tomogram abnormal|Oedema peripheral,22,
12590576,20160725,Osimertinib,26,801,26.0,2,,1,1,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression|Lymphangiosis carcinomatosa,2,1
12594671,20160726,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12597038,20160726,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Dizziness|Anxiety|Paraesthesia,3,1
12598370,20160727,Osimertinib,63,801,63.0,2,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pleural effusion|Heart rate increased|Intentional product misuse|Pneumonia|Pyrexia,5,2
12598885,20160726,Osimertinib,21975,804,60.21,2,51,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Hepatitis C,1,1
12599060,20160727,Osimertinib,52,801,52.0,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Herpes zoster,1,1
12599172,20160727,Osimertinib,942,802,78.5,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Decreased appetite|Nausea|Death|Delusion,4,
12599280,20160727,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Death,1,
12599545,20160727,Osimertinib,26360,804,72.22,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,
12600510,20160727,Osimertinib,551,802,45.92,1,,1,0,1,0,0,0,0,Osimertinib,"LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|ACETYLCYSTEINE|PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM|PIPERACILLIN AND TAZOBACTAM|PIPERACILLIN SODIUM,TAZOBACTAM SODIUM|OSIMERTINIB|OSIMERTINIB|LANSOPRAZOLE",17,DYSPNOEA|ANTIBIOTIC THERAPY|DYSPNOEA|ANTIBIOTIC THERAPY|DYSPNOEA|ANTIBIOTIC THERAPY|NON-SMALL CELL LUNG CANCER|ANTIBIOTIC THERAPY|DECREASED APPETITE|BRONCHIAL DISORDER|NON-SMALL CELL LUNG CANCER|ANTITUSSIVE THERAPY|DYSPNOEA|DYSPNOEA|GASTRITIS|ANTITUSSIVE THERAPY|ANTIBIOTIC THERAPY,Pneumonia fungal,1,1
12607511,20160729,Osimertinib,,,,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,METASTASES TO CENTRAL NERVOUS SYSTEM,Malignant neoplasm progression,1,1
12608825,20160729,Osimertinib,20628,804,56.52,2,66,1,0,1,1,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Acute myocardial infarction,1,1
12616747,20160802,Osimertinib,21488,804,58.87,2,65,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER,Respiratory failure|Interstitial lung disease,2,1
12617409,20160803,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB|MORPHINE SULFATE|PAROXETINE HYDROCHLORIDE|ZOLPIDEM TARTRATE|DABIGATRAN ETEXILATE MESYLATE|DABIGATRAN ETEXILATE|LORAZEPAM,7,,Death,1,
12617997,20160803,Osimertinib,78,801,78.0,1,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Pancreatitis,1,1
12618168,20160803,Osimertinib,64,801,64.0,2,,1,0,1,0,0,0,0,Osimertinib,NIVOLUMAB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER,Pneumonitis,1,1
12618941,20160803,Osimertinib,81,801,81.0,2,31,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Metastases to central nervous system|Erythema multiforme,2,1
12622274,20160804,Osimertinib,66,801,66.0,1,51,1,0,1,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB|OXYCODONE HYDROCHLORIDE|MINOCYCLINE HYDROCHLORIDE|WHITE PETROLATUM|PETROLATUM|SKIN PROTECTANT|OSIMERTINIB|OSIMERTINIB|FEXOFENADINE HYDROCHLORIDE|FEXOFENADINE HYDROCHLORIDE ORAL|FEXOFENADINE HCL|MINOCYCLINE HYDROCHLORIDE|MAGNESIUM OXIDE|OSIMERTINIB,24,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|RASH|METASTASIS|NON-SMALL CELL LUNG CANCER|RASH,Hypocalcaemia|Electrocardiogram QT prolonged,2,1
12622280,20160804,Osimertinib,,,,0,,1,1,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,GENE MUTATION IDENTIFICATION TEST POSITIVE|NON-SMALL CELL LUNG CANCER,Small cell lung cancer,1,1
12622794,20160804,Osimertinib,72,801,72.0,2,50,1,0,1,1,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Liver disorder,1,1
12624853,20160805,Osimertinib,76,801,76.0,1,71,1,1,1,0,0,0,0,Osimertinib,PREGABALIN|LANSOPRAZOLE|VALSARTAN|VALSARTAN ORAL|ZOLPIDEM TARTRATE|NIFEDIPINE|PREDNISOLONE|PREDNISOLONE ORAL|PREDNISOLONE ORAL SOLUTION|OSIMERTINIB,14,GASTRITIS|NEURALGIA|GASTROOESOPHAGEAL REFLUX DISEASE|DIABETES MELLITUS|HYPERTENSION|DIABETES MELLITUS|INSOMNIA|HYPERTENSION|RADIATION PNEUMONITIS|NON-SMALL CELL LUNG CANCER|RASH|INSOMNIA|DYSLIPIDAEMIA,Interstitial lung disease|Hypoglycaemia|Lung infection,3,1
12625118,20160805,Osimertinib,60,801,60.0,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,EGFR GENE MUTATION,Interstitial lung disease,1,1
12630110,20160808,Osimertinib,,,,1,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,,Myocardial infarction,1,2
12634300,20160809,Osimertinib,52,801,52.0,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|ESOMEPRAZOLE MAGNESIUM|KETAMINE HYDROCHLORIDE|OSIMERTINIB,11,NON-SMALL CELL LUNG CANCER|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|PAIN|COUGH|CONSTIPATION|PAIN|PAIN|NON-SMALL CELL LUNG CANCER,Electrocardiogram QT prolonged,1,1
12634352,20160809,Osimertinib,64,801,64.0,1,55,1,0,0,1,0,0,0,Osimertinib,SITAGLIPTIN|NIVOLUMAB|OSIMERTINIB,7,DIABETES MELLITUS|COUGH|NON-SMALL CELL LUNG CANCER|HYPOCALCAEMIA|COUGH|DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER,Interstitial lung disease,1,1
12635015,20160809,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,LAMOTRIGINE|LAMOTRIGINE EXTENDED-RELEASE|LAMOTRIGINE CHEWABLE DISPERSIBLE|LAMOTIRIGINE|OSIMERTINIB|HYDROXYCHLOROQUINE|OSIMERTINIB|LORAZEPAM|OXYCODONE,6,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Death|Drug intolerance,2,5
12635312,20160808,Osimertinib,,,,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I,Gait disturbance,1,
12638666,20160809,Osimertinib,63,801,63.0,1,51,1,1,0,1,0,0,0,Osimertinib,OSIMERTINIB|NIVOLUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pneumothorax|Interstitial lung disease,2,1
12639606,20160810,Osimertinib,80,801,80.0,2,38,1,1,0,0,0,0,1,Osimertinib,ALLOPURINOL|GEFITINIB|OSIMERTINIB|SPIRONOLACTONE|GEFITINIB,9,HYPERURICAEMIA|THROMBOSIS PROPHYLAXIS|CARDIAC FAILURE CHRONIC|GASTRITIS|NON-SMALL CELL LUNG CANCER|CARDIAC FAILURE CHRONIC|DIABETES MELLITUS,Cardiac failure chronic|Prerenal failure|Pulmonary congestion|Atrial fibrillation|Cardiac valve disease|Hemiparesis|Blood pressure decreased|Multiple organ dysfunction syndrome|Interstitial lung disease|Cerebral infarction|Facial paralysis,11,1
12642394,20160810,Osimertinib,26482,804,72.55,2,54.4,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|AMLODIPINE BESYLATE|OSIMERTINIB|NIVOLUMAB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,10,EGFR GENE MUTATION|PAIN|NON-SMALL CELL LUNG CANCER|PAIN|PYREXIA|NAUSEA,Product use issue|Hepatitis cholestatic|Off label use,3,
12643096,20160811,Osimertinib,61,801,61.0,1,51,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|PACLITAXEL,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pneumothorax,1,1
12644653,20160811,Osimertinib,80,801,80.0,2,,1,1,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Rash macular|Death,2,1
12644909,20160811,Osimertinib,22805,804,62.48,2,58.5,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,2,LUNG NEOPLASM MALIGNANT,Pleurisy,1,
12645052,20160811,Osimertinib,51,801,51.0,2,,1,0,0,0,0,0,0,Osimertinib,AFATINIB|CARBOPLATIN|GEFITINIB|GEFITINIB|GEFITINIB|PEMETREXED|PEMETREXED DISODIUM|AFATINIB|OSIMERTINIB,9,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Mouth ulceration|Drug intolerance|Chest pain|Lung neoplasm|Lung neoplasm|Flatulence|Onychoclasis|Disease progression|Diarrhoea|Disease recurrence|Blood creatinine increased|Hyperplasia|Gene mutation,13,5
12646000,20160811,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER,Pain in extremity|Muscle spasms,2,1
12646082,20160811,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,2,LUNG NEOPLASM MALIGNANT,Death|Acne,2,
12646841,20160812,Osimertinib,60,801,60.0,2,44,1,0,1,0,0,0,1,Osimertinib,OLANZAPINE|OLANZAPINE PAMOATE|OSIMERTINIB|LUBIPROSTONE|LORAZEPAM,11,GASTRIC DISORDER|DRY SKIN PROPHYLAXIS|PAIN|PAIN|CONSTIPATION|NAUSEA|ANXIETY|NON-SMALL CELL LUNG CANCER|CONSTIPATION|ANXIETY|PAIN,Lymphangiosis carcinomatosa|Interstitial lung disease|Lymphadenopathy,3,1
12650644,20160815,Osimertinib,72,801,72.0,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,SMALL CELL LUNG CANCER,Rash,1,1
12653787,20160816,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,3,LUNG NEOPLASM MALIGNANT,Blood glucose increased,1,5
12654137,20160816,Osimertinib,77,801,77.0,2,42,1,1,0,1,1,0,0,Osimertinib,METHYLPREDNISOLONE|METHYLPREDNISOLONE|METHYLPREDNISOLONE|OSIMERTINIB|METHYLPREDNISOLONE|NIVOLUMAB,13,LUNG DISORDER|MALAISE|LUNG DISORDER|LUNG DISORDER|PROPHYLAXIS|NON-SMALL CELL LUNG CANCER|NAUSEA|CONSTIPATION|LUNG DISORDER|NON-SMALL CELL LUNG CANCER|MALAISE|MALAISE|PROPHYLAXIS,Malignant neoplasm progression|Lung disorder|Liver disorder,3,1
12654908,20160816,Osimertinib,19364,804,53.05,1,39.1,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|GABAPENTIN|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OSIMERTINIB|PANTOPRAZOLE,8,NON-SMALL CELL LUNG CANCER|NAUSEA|NEURALGIA|SPINAL CORD COMPRESSION|VOMITING|NON-SMALL CELL LUNG CANCER|CANCER PAIN|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER,Escherichia sepsis|Urosepsis|Thrombocytopenia,3,1
12656898,20160816,Osimertinib,63,801,63.0,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB|MAGNESIUM OXIDE|OXYCODONE HYDROCHLORIDE,5,NON-SMALL CELL LUNG CANCER|GASTRITIS PROPHYLAXIS|CANCER PAIN|CONSTIPATION|CANCER PAIN,Interstitial lung disease,1,1
12657517,20160816,Osimertinib,53,801,53.0,1,60,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Haemorrhoidal haemorrhage|Dermatitis acneiform|Pyrexia|Pollakiuria,4,1
12658097,20160817,Osimertinib,,,,2,,1,1,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Death|Fatigue|Disease progression|Metastases to bone,4,
12658313,20160817,Osimertinib,616,802,51.33,2,64,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Aphasia,1,1
12659612,20160817,Osimertinib,,,,1,,1,1,1,0,0,0,1,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Urinary tract infection|Back pain|Death|Cerebrovascular accident|Fatigue|Onychoclasis,6,
12660483,20160817,Osimertinib,75,801,75.0,2,50,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|PEMETREXED DISODIUM|PACLITAXEL|CISPLATIN|AFATINIB|NIVOLUMAB|GEFITINIB,9,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Cholestasis,1,1
12664411,20160818,Osimertinib,24765,804,67.85,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,3,LUNG NEOPLASM MALIGNANT|LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT,Death|Platelet count decreased,2,
12664824,20160818,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12666008,20160818,Osimertinib,28591,804,78.33,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,
12668596,20160819,Osimertinib,67,801,67.0,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12669174,20160820,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Death,1,
12669607,20160820,Osimertinib,628,802,52.33,2,,1,1,1,1,0,0,0,Osimertinib,MAGNESIUM OXIDE|OSIMERTINIB,3,CANCER PAIN|CONSTIPATION PROPHYLAXIS|NON-SMALL CELL LUNG CANCER METASTATIC,Pneumonia,1,1
12674486,20160822,Osimertinib,30350,804,83.15,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Death,1,
12674979,20160822,Osimertinib,67,801,67.0,1,,1,1,1,0,0,0,1,Osimertinib,NIVOLUMAB|OSIMERTINIB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB|NIVOLUMAB,6,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Malignant neoplasm progression|Lung disorder,2,5
12675310,20160822,Osimertinib,87,801,87.0,2,45,1,0,1,0,0,0,0,Osimertinib,LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|OSIMERTINIB,2,EPILEPSY|NON-SMALL CELL LUNG CANCER,Hyponatraemia|Hypokalaemia|Decreased appetite,3,1
12677930,20160823,Osimertinib,41,801,41.0,2,,1,0,1,0,0,0,1,Osimertinib,NIVOLUMAB|NIVOLUMAB|OSIMERTINIB|NIVOLUMAB|NIVOLUMAB|OSIMERTINIB|NIVOLUMAB|OSIMERTINIB|NIVOLUMAB,9,NON-SMALL CELL LUNG CANCER RECURRENT|NON-SMALL CELL LUNG CANCER RECURRENT,Interstitial lung disease|Cardiac tamponade,2,5
12678122,20160823,Osimertinib,22509,804,61.67,1,,1,1,0,0,0,0,0,Osimertinib,RIVAROXABAN|OSIMERTINIB|VENLAFAXINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,8,METASTASES TO CENTRAL NERVOUS SYSTEM,Gait disturbance|Onychalgia|Off label use|Death,4,
12678161,20160823,Osimertinib,55,801,55.0,2,59,1,0,1,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Haemoglobin decreased|Mucosal inflammation|Haematuria|Renal impairment,4,1
12678486,20160823,Osimertinib,22564,804,61.82,1,,1,1,0,0,0,0,0,Osimertinib,MELATONIN|OSIMERTINIB|FOLIC ACID|LORATADINE|LORATADINE TABLET|ERGOCALCIFEROL,7,NON-SMALL CELL LUNG CANCER,Decreased appetite|Death|Dyspnoea|Vomiting|Malaise|Nail infection|Chest pain|Vocal cord paralysis|Fatigue,9,
12678673,20160823,Osimertinib,24784,804,67.9,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,10,CONSTIPATION|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|CONSTIPATION|STOMATITIS|BACK PAIN|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Diarrhoea|Dehydration,2,1
12678818,20160824,Osimertinib,28838,804,79.01,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE I,Death,1,
12681461,20160824,Osimertinib,23963,804,65.65,1,51.8,1,0,1,0,0,0,0,Osimertinib,ENTECAVIR|ENTECAVIR ANHYDROUS|OSIMERTINIB|GABAPENTIN,6,PROPHYLAXIS|PROPHYLAXIS|VIRAL HEPATITIS CARRIER|PAIN|NON-SMALL CELL LUNG CANCER|PAIN,Seizure,1,1
12682447,20160825,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Death,1,
12683841,20160825,Osimertinib,549,802,45.75,1,74.4,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|VITAMIN,2,LUNG ADENOCARCINOMA STAGE IV,Foot fracture|Femur fracture|Road traffic accident|Faeces hard|Tibia fracture,5,
12685619,20160825,Osimertinib,27549,804,75.48,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Nausea|Diarrhoea|Agitation,3,3
12686249,20160825,Osimertinib,71,801,71.0,1,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Haematotoxicity|Platelet count decreased,2,1
12686607,20160825,Osimertinib,80,801,80.0,2,,1,1,1,1,0,0,1,Osimertinib,NIVOLUMAB|NIVOLUMAB|GEFITINIB|ALLOPURINOL|SPIRONOLACTONE|NIVOLUMAB|OSIMERTINIB,12,NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION,Cardiac failure chronic|Multiple organ dysfunction syndrome|Pneumonia,3,5
12688356,20160826,Osimertinib,78,801,78.0,2,47,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,4,RASH|RASH|NON-SMALL CELL LUNG CANCER|RASH,Pneumonitis,1,1
12688421,20160826,Osimertinib,23753,804,65.08,2,54.4,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,6,METASTASES TO CENTRAL NERVOUS SYSTEM|NON-SMALL CELL LUNG CANCER STAGE IV|METASTASES TO CENTRAL NERVOUS SYSTEM|NON-SMALL CELL LUNG CANCER STAGE IV|NON-SMALL CELL LUNG CANCER STAGE IV|METASTASES TO CENTRAL NERVOUS SYSTEM,Intentional product misuse|Interstitial lung disease|Off label use,3,1
12688597,20160826,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,2,,Death,1,
12690079,20160826,Osimertinib,86,801,86.0,2,37,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pulmonary embolism|Platelet count decreased|Disseminated intravascular coagulation|Death|Skin disorder|Embolism|Deep vein thrombosis|Diarrhoea,8,1
12690595,20160826,Osimertinib,77,801,77.0,2,49,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Liver disorder|Anaemia|Stomatitis|Platelet count decreased|Liver disorder,5,1
12690826,20160826,Osimertinib,3909,803,75.17,2,,1,0,1,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,LUNG ADENOCARCINOMA|LUNG NEOPLASM MALIGNANT,Oedema peripheral|Acute kidney injury|Dehydration|Diarrhoea,4,
12691856,20160827,Osimertinib,84,801,84.0,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|VENLAFAXINE HYDROCHLORIDE|CLOPIDOGREL|OSIMERTINIB|OSIMERTINIB,12,ASTHMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Product blister packaging issue|Respiratory distress|Cardiac failure|Poor quality drug administered,4,1
12692185,20160828,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,EGFR GENE MUTATION|EGFR GENE MUTATION,Pleural effusion|Dyspnoea,2,1
12697565,20160830,Osimertinib,22912,804,62.77,1,,1,0,1,0,0,0,0,Osimertinib,PANTOPRAZOLE|AMLODIPINE|FONDAPARINUX SODIUM|OSIMERTINIB,4,GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION|CEREBROVASCULAR ACCIDENT PROPHYLAXIS|NON-SMALL CELL LUNG CANCER,Atrial fibrillation,1,1
12700892,20160830,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NEOPLASM MALIGNANT,Malignant neoplasm progression,1,2
12700897,20160830,Osimertinib,30064,804,82.37,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,SMALL CELL LUNG CANCER|BRONCHIAL CARCINOMA,Death|Diarrhoea,2,5
12700934,20160830,Osimertinib,,,,2,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Neutrophil count decreased|Platelet count decreased,2,1
12705083,20160831,Osimertinib,62,801,62.0,1,44,1,1,0,0,0,0,0,Osimertinib,FAMOTIDINE|RIVAROXABAN|OSIMERTINIB,7,ATRIAL FIBRILLATION|ATRIAL FIBRILLATION|NON-SMALL CELL LUNG CANCER|ATRIAL FIBRILLATION|EATING DISORDER,Interstitial lung disease|Malignant neoplasm progression,2,2
12705449,20160901,Osimertinib,895,802,74.58,1,64.9,1,0,0,0,0,0,0,Osimertinib,"GABAPENTIN|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|ANASTROZOLE|ERGOCALCIFEROL|OSIMERTINIB|SIMVASTATIN|GABAPENTIN|OSIMERTINIB|METHADONE|MINOCYCLINE",18,NEURALGIA|PROSTATIC DISORDER|LUNG NEOPLASM MALIGNANT|CARDIAC DISORDER|BACK PAIN|ATRIAL FIBRILLATION|NECK PAIN|MUSCULOSKELETAL PAIN|INFLAMMATION|LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT|SLEEP DISORDER|RASH,Tongue disorder|Oral mucosal eruption|Dysgeusia|Oral pain|Rash|Intentional product misuse|Weight decreased,7,
12706333,20160901,Osimertinib,27632,804,75.7,2,,1,1,0,0,0,0,0,Osimertinib,"METRONIDAZOLE|METRONIDAZOLE TOPICAL|BACITRACIN ZINC, POLYMYXIN B SULFATE|NEOMYCIN SULFATE|BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B|BACITRACIN|NEOMYCIN, POLYMYXIN B, PRAMOXINE HCL|BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE|BACITRACIN ZINC|RIVAROXABAN|CLONAZEPAM|OSIMERTINIB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE",6,URINARY TRACT INFECTION|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Constipation|Urinary tract infection|Death|Diarrhoea,4,
12706372,20160901,Osimertinib,63,801,63.0,1,58.2,1,0,0,1,0,0,0,Osimertinib,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|OSIMERTINIB|PREGABALIN|FOLIC ACID|PEMETREXED|PEMETREXED DISODIUM|LANSOPRAZOLE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,12,LUNG ADENOCARCINOMA|CHEMOTHERAPY,Myocardial infarction,1,3
12706583,20160901,Osimertinib,16614,804,45.52,2,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Dyspnoea|Death|Pulmonary embolism,3,
12708765,20160901,Osimertinib,70,801,70.0,2,43,1,0,0,1,1,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Disseminated intravascular coagulation|Cerebral infarction,2,1
12710026,20160902,Osimertinib,77,801,77.0,2,,1,0,1,0,0,0,0,Osimertinib,NIVOLUMAB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Diarrhoea|Melaena|Colitis|Feeding disorder,4,1
12713140,20160902,Osimertinib,72,801,72.0,2,39,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|ESOMEPRAZOLE MAGNESIUM|OSIMERTINIB,5,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Duodenal ulcer|Duodenal stenosis|Iron deficiency anaemia,3,1
12713268,20160902,Osimertinib,616,802,51.33,1,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|COUGH,Pneumonitis,1,1
12713311,20160902,Osimertinib,82,801,82.0,2,37,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OXYCODONE HYDROCHLORIDE|AMLODIPINE BESYLATE AND VALSARTAN|TRIAZOLAM,11,CANCER PAIN|NON-SMALL CELL LUNG CANCER|CANCER PAIN|PRODUCTIVE COUGH|HYPERTENSION|CONSTIPATION|CUTANEOUS SYMPTOM|ANXIETY DISORDER|PRODUCTIVE COUGH|INSOMNIA|STOMATITIS,Interstitial lung disease,1,1
12713813,20160904,Osimertinib,,,,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Malaise|Pleural effusion,2,
12716973,20160906,Osimertinib,,,,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,MALIGNANT RESPIRATORY TRACT NEOPLASM,Death,1,
12718639,20160906,Osimertinib,62,801,62.0,2,57,1,1,0,0,0,0,0,Osimertinib,"OSIMERTINIB|VALERIAN ROOT, PASSIFLORA, MAGNESIUM CARBONATE|VALERIAN ROOT, PASSIFLORA, MAGNESIUM CARBONATE|OSIMERTINIB",4,NON-SMALL CELL LUNG CANCER|SEIZURE|SEIZURE|NON-SMALL CELL LUNG CANCER,Hepatic function abnormal,1,1
12718666,20160906,Osimertinib,,,,2,59,1,0,0,0,0,0,0,Osimertinib,MAGNESIUM|LOSARTAN|OSIMERTINIB|MAGNESIUM|TEMAZEPAM|CITALOPRAM|CITALOPRAM HYDROBROMIDE|LORAZEPAM|WARFARIN,9,BLOOD MAGNESIUM DECREASED|SMALL CELL LUNG CANCER|HYPOTENSION|SLEEP DISORDER|ILL-DEFINED DISORDER|NAUSEA|INSOMNIA|ANTICOAGULANT THERAPY,Off label use|Oral pain|Product use issue,3,
12718948,20160906,Osimertinib,75,801,75.0,1,56,1,1,1,0,0,0,0,Osimertinib,ESOMEPRAZOLE MAGNESIUM|OSIMERTINIB|OSIMERTINIB|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS,8,DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|DIABETES MELLITUS|DIABETES MELLITUS,Pyrexia|Malaise|Renal impairment|Hepatic function abnormal|Rash|Hypophagia,6,2
12721570,20160907,Osimertinib,72,801,72.0,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB,4,OVARIAN CANCER|NON-SMALL CELL LUNG CANCER|OVARIAN CANCER|NON-SMALL CELL LUNG CANCER,Diarrhoea|Paronychia|Ovarian cancer|Onychoclasis|Platelet count decreased,5,1
12725274,20160908,Osimertinib,26605,804,72.89,2,62.6,1,1,1,1,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OSIMERTINIB,4,NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION|LUNG NEOPLASM MALIGNANT,Pulmonary embolism|Pulseless electrical activity|Microangiopathic haemolytic anaemia,3,1
12726688,20160908,Osimertinib,20640,804,56.55,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,
12727921,20160909,Osimertinib,84,801,84.0,1,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|NIVOLUMAB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Adrenal insufficiency,1,1
12729090,20160909,Osimertinib,58,801,58.0,1,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|QUETIAPINE,4,MALAISE|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Liver disorder|Sepsis,2,1
12729902,20160909,Osimertinib,,,,2,,1,1,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,MALIGNANT RESPIRATORY TRACT NEOPLASM,Diarrhoea|Pruritus|Rash|Red blood cell count decreased|Gallbladder disorder|Hepatic function abnormal|Death|Skin discolouration|Renal disorder,9,
12730094,20160909,Osimertinib,62,801,62.0,2,38,1,0,1,0,0,0,0,Osimertinib,NIVOLUMAB|OSIMERTINIB,14,INTERSTITIAL LUNG DISEASE|PAIN|INTERSTITIAL LUNG DISEASE|PROPHYLAXIS|ENTEROCOLITIS|INTERSTITIAL LUNG DISEASE|INTERSTITIAL LUNG DISEASE|INTERSTITIAL LUNG DISEASE|METASTASES TO BONE|NON-SMALL CELL LUNG CANCER|INTERSTITIAL LUNG DISEASE|NON-SMALL CELL LUNG CANCER|INTERSTITIAL LUNG DISEASE|INTERSTITIAL LUNG DISEASE,Oral candidiasis|Interstitial lung disease,2,1
12730377,20160909,Osimertinib,77,801,77.0,1,,1,0,1,0,0,0,1,Osimertinib,OSIMERTINIB|GEFITINIB|GEFITINIB,4,BRONCHIAL CARCINOMA|BRONCHIAL CARCINOMA|BRONCHIAL CARCINOMA,Radiation injury|Encephalopathy|Malignant neoplasm progression|Metastases to central nervous system,4,1
12730498,20160909,Osimertinib,89,801,89.0,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,LUNG ADENOCARCINOMA,Malignant neoplasm progression,1,1
12736750,20160913,Osimertinib,,,,1,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,GENE MUTATION,Cardiac disorder|Ascites|Liver disorder,3,1
12736758,20160912,Osimertinib,55,801,55.0,1,72,1,1,1,1,1,1,1,Osimertinib,NIVOLUMAB|OSIMERTINIB,2,Non-small cell lung cancer recurrent|Product used for unknown indication,Fulminant type 1 diabetes mellitus|Weight decreased|Platelet count decreased|Hepatic function abnormal,4,1
12737090,20160913,Osimertinib,,,,2,,1,1,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Small cell lung cancer|Death|Metastases to liver,3,1
12742241,20160914,Osimertinib,,,,2,65.8,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Drug intolerance|Activities of daily living impaired|Malaise,3,
12742613,20160914,Osimertinib,57,801,57.0,2,67,1,0,1,0,0,0,0,Osimertinib,ZOLPIDEM TARTRATE|AMLODIPINE|OSIMERTINIB,4,HYPERURICAEMIA|INSOMNIA|HYPERTENSION|NON-SMALL CELL LUNG CANCER,Interstitial lung disease,1,1
12746312,20160915,Osimertinib,,,,2,52,1,1,0,0,0,0,0,Osimertinib,LISINOPRIL|OSIMERTINIB|LORATADINE|LORATADINE TABLET|FLUTICASONE PROPIONATE|FLUTICASONE PROPIONATE NASAL|AMLODIPINE BESYLATE|ATENOLOL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DOCUSATE CALCIUM|STOOL SOFTENER,9,LUNG NEOPLASM MALIGNANT,Death,1,
12746666,20160915,Osimertinib,786,802,65.5,1,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,BRONCHIAL CARCINOMA,Psychomotor retardation|Leukoencephalopathy,2,1
12749652,20160915,Osimertinib,62,801,62.0,1,,1,1,1,0,0,0,1,Osimertinib,NIVOLUMAB|QUETIAPINE|NIVOLUMAB|OSIMERTINIB|MAGNESIUM OXIDE|NIVOLUMAB|OSIMERTINIB,15,BRAIN OEDEMA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|INSOMNIA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER|PRODUCT USED FOR UNKNOWN INDICATION|NON-SMALL CELL LUNG CANCER RECURRENT|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Interstitial lung disease|Diarrhoea|Hypotension|Altered state of consciousness|Malignant neoplasm progression,5,5
12755664,20160916,Osimertinib,72,801,72.0,1,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,,Pneumocystis jirovecii pneumonia,1,1
12756117,20160916,Osimertinib,29765,804,81.55,2,48.8,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|AMLODIPINE|SIMVASTATIN,5,NON-SMALL CELL LUNG CANCER|BLOOD CHOLESTEROL|BLOOD CHOLESTEROL|HYPERTENSION|BLOOD CHOLESTEROL,Pulmonary sepsis|Dyspnoea,2,1
12756163,20160916,Osimertinib,77,801,77.0,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death|Herpes zoster,2,
12757474,20160919,Osimertinib,63,801,63.0,2,,1,0,1,0,0,0,0,Osimertinib,LEVETIRACETAM|OSIMERTINIB,2,LUNG NEOPLASM MALIGNANT,Memory impairment|Lung disorder|Pneumothorax|Mobility decreased,4,
12760572,20160919,Osimertinib,72,801,72.0,1,66,1,1,1,0,0,0,0,Osimertinib,AMLODIPINE|CARVEDILOL|LEVOCETIRIZINE DIHYDROCHLORIDE|OSIMERTINIB,5,HYPERTENSION|HYPERTENSION|RHINITIS ALLERGIC|NON-SMALL CELL LUNG CANCER|ATRIAL FIBRILLATION,Interstitial lung disease,1,1
12760787,20160919,Osimertinib,,,,0,,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Vocal cord disorder,1,5
12760961,20160919,Osimertinib,85,801,85.0,2,37,1,1,0,0,0,0,0,Osimertinib,SUVOREXANT|ZINC OXIDE|PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/LIGHT|ZINC OXIDE OINTMENT|PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 WARM/TAN|SKIN PROTECTANT|PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 NATURAL/MEDIUM|PACIFICA ULTRA CC CREAM RADIANT FOUNDATION SPF 30 COOL/DEEP|MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN|OSIMERTINIB|CALCITRIOL|CALCITRIOL CAPSULES 0.25 MCG|CALCITRIOL CAPSULES 0.5 MCG|KETOPROFEN|AMLODIPINE,28,HYPERURICAEMIA|BACK PAIN|BRONCHITIS CHRONIC|HYPERTENSION|BRONCHITIS CHRONIC|INSOMNIA|BACK PAIN|NUTRITIONAL SUPPLEMENTATION|ANXIETY|SKIN DISORDER|GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION|NON-SMALL CELL LUNG CANCER|PERIPHERAL ARTERIAL OCCLUSIVE DISEASE|INTERCOSTAL NEURALGIA|SKIN DISORDER|OSTEOPOROSIS|GASTRITIS PROPHYLAXIS|SKIN DISORDER|SKIN DISORDER|OROPHARYNGEAL DISCOMFORT|HYPERTENSION|PNEUMONIA|DECREASED APPETITE|PERIPHERAL ARTERIAL OCCLUSIVE DISEASE|HYPERTENSION|BACK PAIN,Interstitial lung disease|Stomatitis,2,1
12760996,20160919,Osimertinib,31258,804,85.64,0,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,,Death,1,
12764546,20160920,Osimertinib,,,,0,,1,1,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Pneumonitis,1,3
12767351,20160921,Osimertinib,68,801,68.0,1,48,1,0,0,0,1,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Thrombotic cerebral infarction,1,1
12769419,20160921,Osimertinib,,,,0,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|AFATINIB|AFATINIB|AFATINIB|CARBOPLATIN,9,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Paronychia|Diarrhoea|Malignant neoplasm progression,3,1
12769437,20160921,Osimertinib,,,,0,,1,0,0,0,0,0,1,Osimertinib,AFATINIB|AFATINIB|OSIMERTINIB,3,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Stomatitis|Malignant neoplasm progression,2,1
12769720,20160922,Osimertinib,54,801,54.0,2,51.3,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB|ATENOLOL|ERLOTINIB HYDROCHLORIDE|ERLOTINIB HYDROCHLORIDE,6,LUNG NEOPLASM MALIGNANT|MITRAL VALVE PROLAPSE|METASTASIS|LUNG NEOPLASM MALIGNANT,Body height decreased|Nasal discharge discolouration|Hypotension|Metastasis|Muscle spasms|Cough|Diarrhoea|Epistaxis|Lung neoplasm malignant|Osteoporosis|Influenza like illness|Nail discolouration|Rash|Nasal dryness|Nail disorder,15,
12770605,20160922,Osimertinib,18922,804,51.84,1,65,1,1,0,0,0,0,0,Osimertinib,POLYETHYLENE GLYCOL 3350|SENNOSIDES|SENNA LEAF|SENNA|OSIMERTINIB|BENZONATATE|MULTIVITAMIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|VITAMIN E|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|LORAZEPAM|ALBUTEROL SULFATE|ALBUTEROL|FUROSEMIDE|LACTULOSE|OSIMERTINIB|CALCIUM CARBONATE|ANTACID|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|PANTOPRAZOLE|PROCHLORPERAZINE,19,CONSTIPATION|CONSTIPATION|NON-SMALL CELL LUNG CANCER|COUGH|DRUG THERAPY|NAUSEA|DRUG THERAPY|CONSTIPATION|SEIZURE|ANXIETY|DYSPNOEA|OEDEMA|CONSTIPATION|EGFR GENE MUTATION|ABDOMINAL DISCOMFORT|PAIN|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|NAUSEA,Pneumonitis,1,1
12770740,20160922,Osimertinib,76,801,76.0,2,,1,1,1,0,0,0,1,Osimertinib,"MORPHINE SULFATE|GABAPENTIN|HYDROMORPHONE HYDROCHLORIDE|LEVOTHYROXINE SODIUM|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE|ATENOLOL|OMEPRAZOLE MAGNESIUM|POLYETHYLENE GLYCOL 3350|OSIMERTINIB|ACETAMINOPHEN, CAFFEINE|CITALOPRAM|TRIAMTERENE CAPSULES|TRIAMTERENE|OSIMERTINIB|CLOPIDOGREL|OMEPRAZOLE MAGNESIUM|ERGOCALCIFEROL|LORAZEPAM",21,BONE PAIN|PAIN|LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0|NON-SMALL CELL LUNG CANCER,Death|Vision blurred|Urinary tract infection|Metastases to bone|Cancer pain|Skin burning sensation|Gastrooesophageal reflux disease|Skin atrophy|Dysphagia|Ocular discomfort|Constipation|Dysgeusia|Cough|Dehydration|Metastases to central nervous system|Asthenia|Diarrhoea|Muscular weakness|Nausea|Dysphonia|Pleural effusion|Abdominal discomfort|Fatigue|Swelling|Dyspnoea|Decreased appetite|Pneumonia|Rash|Chest discomfort,29,3
12775140,20160923,Osimertinib,63,801,63.0,1,58,1,0,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,No adverse event,1,1
12776094,20160923,Osimertinib,74,801,74.0,2,41,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Pneumobilia|Pneumatosis intestinalis,2,1
12787114,20160927,Osimertinib,82,801,82.0,2,,1,0,1,0,0,0,0,Osimertinib,LORAZEPAM|ACLIDINIUM BROMIDE|OSIMERTINIB|FUROSEMIDE|CARVEDILOL|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|ALLOPURINOL,9,DRUG ABUSE|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|NON-SMALL CELL LUNG CANCER METASTATIC|DIURETIC THERAPY|HYPERTENSION|ATRIAL FIBRILLATION|ANTIDEPRESSANT THERAPY|BLOOD URIC ACID|NON-SMALL CELL LUNG CANCER METASTATIC,Hypertensive heart disease,1,1
12788041,20160928,Osimertinib,80,801,80.0,2,,1,0,1,0,1,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Head injury,1,1
12788242,20160928,Osimertinib,79,801,79.0,2,34,1,0,1,1,1,0,1,Osimertinib,PREGABALIN|DICLOFENAC SODIUM|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|OSIMERTINIB|ESOMEPRAZOLE MAGNESIUM|LANSOPRAZOLE|OXYCODONE HYDROCHLORIDE,18,NEURALGIA|ANALGESIC THERAPY|URINARY TRACT INFECTION|CANCER PAIN|CHEST PAIN|NON-SMALL CELL LUNG CANCER|CONSTIPATION|IRON DEFICIENCY ANAEMIA|GASTRIC ULCER|VOMITING|CHEST PAIN|HYPOPHAGIA|GASTRIC ULCER|CANCER PAIN|URINARY TRACT INFECTION|URINARY TRACT INFECTION|BACK PAIN|CONSTIPATION,Back pain|Nausea|Hypophagia|Chest pain|Urinary tract infection|Myocardial infarction|Electrocardiogram QT prolonged,7,1
12788524,20160928,Osimertinib,,,,2,,1,0,1,0,0,0,0,Osimertinib,OSIMERTINIB,1,NON-SMALL CELL LUNG CANCER,Neck pain|Malaise|Urine analysis abnormal|Musculoskeletal stiffness|Hypersensitivity|Urinary tract inflammation|Facial pain|Headache|Urticaria,9,5
12789654,20160928,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Death,1,
12789945,20160928,Osimertinib,,,,2,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB,1,LUNG NEOPLASM MALIGNANT,Death|Epistaxis,2,
12790191,20160928,Osimertinib,63,801,63.0,2,67,1,0,1,0,0,0,1,Osimertinib,OSIMERTINIB|OSIMERTINIB|OSIMERTINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Dehydration|Diarrhoea|Pyrexia|Deep vein thrombosis,4,1
12791194,20160929,Osimertinib,63,801,63.0,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,,Hepatocellular injury,1,1
12791889,20160929,Osimertinib,,,,2,,1,0,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,,Disease progression,1,1
12798842,20160930,Osimertinib,80,801,80.0,2,,1,1,0,0,0,0,1,Osimertinib,OSIMERTINIB,1,,Atrial fibrillation|Weight decreased|Malignant pleural effusion|Chest pain|Death|Malignant neoplasm progression|Decreased appetite,7,1
12800017,20160930,Osimertinib,1029,802,85.75,1,,1,1,0,0,0,0,0,Osimertinib,OSIMERTINIB|OSIMERTINIB,2,LUNG NEOPLASM MALIGNANT|BRONCHIAL CARCINOMA,Death|Cough|Blood potassium increased,3,
12800108,20160930,Osimertinib,18912,804,51.81,1,65,1,1,1,0,0,0,0,Osimertinib,MORPHINE|LORAZEPAM|LORAZEPAM|ALBUTEROL SULFATE|ALBUTEROL|BENZONATATE|FUROSEMIDE|MULTIVITAMIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PANTOPRAZOLE|CALCIUM CARBONATE|ANTACID|PROCHLORPERAZINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LACTULOSE|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|OSIMERTINIB|OSIMERTINIB|SENNOSIDES|SENNA LEAF|SENNA|LEVETIRACETAM|BISACODYL|BISACODYL SUPPOSITORIES|BISCODYL|POLYETHYLENE GLYCOL 3350|VITAMIN E,22,ANXIETY|FEELING OF RELAXATION|DYSPNOEA|COUGH|OEDEMA|PAIN|DRUG THERAPY|NAUSEA|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|ABDOMINAL DISCOMFORT|NAUSEA|CONSTIPATION|SEIZURE|NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION|CONSTIPATION|PROPHYLAXIS|CONSTIPATION|CONSTIPATION|DRUG THERAPY,Seizure|Hypoxia|Pneumonitis|Metastases to central nervous system|Condition aggravated,5,5
12800230,20160930,Osimertinib,,,,2,,1,1,0,0,0,0,1,Osimertinib,GEFITINIB|GEFITINIB|GEFITINIB|OSIMERTINIB|OSIMERTINIB|GEFITINIB|GEFITINIB|GEFITINIB,8,EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION|EGFR GENE MUTATION|NON-SMALL CELL LUNG CANCER|EGFR GENE MUTATION,Death|Product use issue|Metastases to skin|Malignant neoplasm progression|Off label use,5,1
10004291,20140312,Crizotinib,68,801,68.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dizziness,1,5
10004833,20140312,Crizotinib,50,801,50.0,2,44,1,0,1,0,0,0,1,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB,13,NON-SMALL CELL LUNG CANCER,Renal abscess|Enterocolitis,2,1
10006221,20140313,Crizotinib,68,801,68.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10006227,20140313,Crizotinib,68,801,68.0,1,,1,1,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Hypotension|Pyrexia|Pulmonary oedema|Death,4,3
10006653,20140313,Crizotinib,73,801,73.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Upper respiratory tract infection,1,3
10007127,20140313,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Dysphagia|Intentional drug misuse,2,1
10007135,20140313,Crizotinib,57,801,57.0,2,,1,0,1,0,0,0,1,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Pneumonitis|Jugular vein thrombosis|Disease progression|Lung neoplasm malignant,4,1
10007650,20140313,Crizotinib,51,801,51.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB|MORPHINE SULFATE|OXYCODONE HYDROCHLORIDE|OXYCODONE|ALBUTEROL SULFATE|PREDNISONE|OXYCODONE|FUROSEMIDE,8,LUNG CANCER METASTATIC,Death,1,3
10007937,20140313,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Local swelling|Secretion discharge,2,5
10008097,20140313,Crizotinib,69,801,69.0,2,52.3,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,7,NON-SMALL CELL LUNG CANCER,Oesophageal ulcer,1,1
10009369,20140313,Crizotinib,65,801,65.0,1,55.28,1,1,1,0,0,0,1,Crizotinib,DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CRIZOTINIB|LEVETIRACETAM|LEVETIRACETAM ORAL|LEVETIRACETAM INJECTION|LEVETIRACETAM IN SODIUM CHLORIDE|LEVOTHYROXINE SODIUM|LEVOTHYROXINE SODIUM ANHYDROUS|LORAZEPAM|PAROXETINE HYDROCHLORIDE,8,METASTASES TO CENTRAL NERVOUS SYSTEM|NON-SMALL CELL LUNG CANCER,Bronchopulmonary aspergillosis|Hypoxia|Renal failure acute|Endotracheal intubation|Disseminated intravascular coagulation|Platelet transfusion|Platelet count decreased,7,5
10011951,20140314,Crizotinib,72,801,72.0,2,50.3,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|LORAZEPAM|METOCLOPRAMIDE HYDROCHLORIDE|IRON|POLYETHYLENE GLYCOL 3350|HYDROMORPHONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE,10,GASTRIC NEOPLASM|NUTRITIONAL SUPPLEMENTATION|INSOMNIA|ANAEMIA|CONSTIPATION|CONSTIPATION|TUMOUR PAIN|TUMOUR PAIN|NUTRITIONAL SUPPLEMENTATION,Oedema peripheral,1,1
10012047,20140314,Crizotinib,79,801,79.0,1,,1,1,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Death|Fall|Fracture,3,5
10012250,20140314,Crizotinib,73,801,73.0,2,,1,0,1,0,0,0,0,Crizotinib,RIFAMPIN|CRIZOTINIB|LORAZEPAM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|POLYETHYLENE GLYCOL|HYDROMORPHONE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|MIRTAZAPINE,9,GASTRIC CANCER|GASTRIC CANCER|INSOMNIA|PRODUCT USED FOR UNKNOWN INDICATION|CONSTIPATION|PAIN|PAIN|PRODUCT USED FOR UNKNOWN INDICATION,Intestinal obstruction,1,
10012426,20140312,Crizotinib,61,801,61.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Vomiting|Nausea,2,2
10012572,20140312,Crizotinib,,,,0,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Bradycardia,1,1
10012989,20140314,Crizotinib,66,801,66.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,TRACHEAL CANCER,Off label use|Nausea|Vomiting,3,5
10012996,20140314,Crizotinib,64,801,64.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Peripheral swelling|Diarrhoea|Nausea|Throat irritation|Oropharyngeal pain|Eczema,6,3
10013005,20140314,Crizotinib,77,801,77.0,1,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Peripheral swelling,1,5
10013054,20140314,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|ALPRAZOLAM,2,,Platelet count decreased,1,5
10014828,20140317,Crizotinib,54,801,54.0,1,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Confusional state|Agitation|Dyspnoea|Fluid retention|Pneumonitis,5,3
10015087,20140317,Crizotinib,,,,0,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Optic neuropathy,1,1
10015285,20140317,Crizotinib,69,801,69.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant|Nausea|Visual impairment,4,5
10015288,20140317,Crizotinib,61,801,61.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,NON-SMALL CELL LUNG CANCER,Diarrhoea|Epistaxis|Peripheral swelling|Constipation|Nausea|Fatigue|Asthenia|Decreased appetite|Pain|Skin warm|Chills|Back pain|Abdominal tenderness|Dysgeusia,14,3
10015305,20140317,Crizotinib,,,,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Disease progression|Non-small cell lung cancer metastatic,2,1
10015309,20140317,Crizotinib,45,801,45.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Vision blurred,1,2
10015493,20140317,Crizotinib,65,801,65.0,2,45.2,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,5,NON-SMALL CELL LUNG CANCER,Toxic skin eruption|Hepatic function abnormal,2,1
10016213,20140317,Crizotinib,61,801,61.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Fall|Thrombosis,2,2
10016687,20140317,Crizotinib,33,801,33.0,1,,1,0,1,0,0,0,1,Crizotinib,DENOSUMAB|CRIZOTINIB|OXYCODONE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|ENOXAPARIN SODIUM,8,METASTASES TO BONE|PROPHYLAXIS,Cerebrovascular accident|Thrombosis,2,5
10016852,20140318,Crizotinib,,,,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,1
10018711,20140318,Crizotinib,58,801,58.0,1,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Pulmonary embolism|Dyspnoea|Diarrhoea|Fatigue,4,3
10019494,20140318,Crizotinib,64,801,64.0,2,75.19,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|FOLIC ACID|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|LEVOTHYROXINE|ROSUVASTATIN|MAGNESIUM|MONTELUKAST SODIUM|ACLIDINIUM BROMIDE,10,LUNG CANCER METASTATIC|NAUSEA,Cerebrovascular accident,1,3
10021094,20140319,Crizotinib,59,801,59.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Vitreous floaters|Hepatic enzyme increased|White blood cell count decreased|Vomiting|Throat irritation|Cough|Constipation|Vision blurred,8,3
10021113,20140319,Crizotinib,,,,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Pneumonia,1,3
10021719,20140319,Crizotinib,4,801,4.0,1,16.4,1,0,1,0,0,0,1,Crizotinib,CRIZOTINIB|CRIZOTINIB|TOPOTECAN HYDROCHLORIDE|TOPOTECAN HYDROCHLORIDE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DIPHENHYDRAMINE HYDROCHLORIDE|POLYETHYLENE GLYCOL 3350|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,12,PRIMITIVE NEUROECTODERMAL TUMOUR|PRIMITIVE NEUROECTODERMAL TUMOUR|PRIMITIVE NEUROECTODERMAL TUMOUR|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Sepsis|Hypoxia,2,1
10021884,20140319,Crizotinib,58,801,58.0,1,62,1,0,0,1,0,0,0,Crizotinib,CRIZOTINIB|LANSOPRAZOLE|CRIZOTINIB|MAGNESIUM OXIDE|CRIZOTINIB|OXYCODONE HYDROCHLORIDE,10,NON-SMALL CELL LUNG CANCER,Gastrointestinal toxicity,1,1
10022155,20140319,Crizotinib,10,801,10.0,2,46.2,1,0,1,0,0,0,0,Crizotinib,"TOPOTECAN HYDROCHLORIDE|CRIZOTINIB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",3,EWING^S SARCOMA|EWING^S SARCOMA|EWING^S SARCOMA,Dehydration,1,3
10022410,20140319,Crizotinib,50,801,50.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression|Non-small cell lung cancer,2,1
10022415,20140319,Crizotinib,76,801,76.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,3
10022417,20140319,Crizotinib,73,801,73.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Death,1,3
10022700,20140319,Crizotinib,60,801,60.0,1,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dyspepsia|Abdominal discomfort,2,5
10022857,20140319,Crizotinib,54,801,54.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,COLON CANCER,Disease progression|Colon cancer|Off label use,3,1
10023931,20140320,Crizotinib,69,801,69.0,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Optic neuropathy|Blindness,2,3
10024095,20140320,Crizotinib,75,801,75.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Oedema peripheral,1,3
10024120,20140320,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Muscle tightness,1,1
10024129,20140320,Crizotinib,,,,1,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Joint swelling,1,5
10024293,20140320,Crizotinib,59,801,59.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,3
10024301,20140320,Crizotinib,69,801,69.0,1,45,1,1,1,0,0,0,0,Crizotinib,CRIZOTINIB|LAMIVUDINE|LAMIVUDINE ORAL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,,Pulmonary embolism|Hepatic function abnormal,2,1
10025028,20140320,Crizotinib,11,801,11.0,2,46.2,1,0,1,0,0,0,0,Crizotinib,"TOPOTECAN|CRIZOTINIB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",3,EWING^S SARCOMA|EWING^S SARCOMA|EWING^S SARCOMA,Nausea|Hypophagia|Dehydration|Vomiting,4,3
10026464,20140321,Crizotinib,66,801,66.0,1,58,1,1,1,0,0,0,0,Crizotinib,CRIZOTINIB|LEVODOPA|CARBIDOPA|CARBIDOPA TABLETS,4,LUNG ADENOCARCINOMA,Lymphadenopathy|Biliary tract disorder|Pleural effusion|Pyrexia,4,1
10026469,20140321,Crizotinib,73,801,73.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10027407,20140321,Crizotinib,,,,1,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Pneumonia,1,1
10027465,20140321,Crizotinib,67,801,67.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Diarrhoea,1,3
10027531,20140321,Crizotinib,63,801,63.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Vomiting|Malaise,2,3
10028757,20140321,Crizotinib,41,801,41.0,2,,1,1,0,0,0,0,1,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CARBOPLATIN|PACLITAXEL,5,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Deafness|Disease progression|Lung adenocarcinoma|Pulmonary embolism|Decreased appetite|Dysphagia|Anosmia|Diplopia|Headache|Hypoaesthesia|Abdominal distension,11,1
10031583,20140324,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dyspnoea|Wheezing,2,3
10031589,20140324,Crizotinib,76,801,76.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,2
10032187,20140324,Crizotinib,61,801,61.0,1,75,1,1,1,1,0,0,0,Crizotinib,CRIZOTINIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|SITAGLIPTIN AND METFORMIN HYDROCHLORIDE|TIOTROPIUM BROMIDE,4,INFLAMMATORY MYOFIBROBLASTIC TUMOUR|DIABETES MELLITUS|BRONCHITIS CHRONIC,Pyopneumothorax,1,1
10032233,20140324,Crizotinib,,,,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,1
10032251,20140324,Crizotinib,72,801,72.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,2
10033156,20140324,Crizotinib,10,801,10.0,2,46.2,1,0,1,0,0,0,0,Crizotinib,"CRIZOTINIB|CRIZOTINIB|TOPOTECAN HYDROCHLORIDE|PROMETHAZINE|ONDANSETRON HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED",7,EWING^S SARCOMA|EWING^S SARCOMA|EWING^S SARCOMA|VOMITING|VOMITING|VOMITING,Dehydration|Vomiting|Nausea,3,1
10035959,20140325,Crizotinib,27,801,27.0,2,51.7,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,3,NON-SMALL CELL LUNG CANCER,Oesophagitis,1,1
10035970,20140325,Crizotinib,62,801,62.0,1,123,1,0,0,0,0,0,1,Crizotinib,"CRIZOTINIB|ALBUTEROL SULFATE|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|ALBUTEROL SULFATE|METHYLPREDNISOLONE|CLONIDINE|HYDROCHLOROTHIAZIDE|LISINOPRIL|OXYCODONE HYDROCHLORIDE|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|TEMAZEPAM",15,LUNG ADENOCARCINOMA,Blood pressure decreased|Syncope|Urinary retention|Blood glucose increased|Fatigue|Asthenia|Pleural effusion|Anaemia|Paraesthesia|Prostatitis|Blood sodium decreased,11,5
10037696,20140326,Crizotinib,50,801,50.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Disease progression|Neoplasm malignant,2,1
10037735,20140326,Crizotinib,41,801,41.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,SOFT TISSUE NEOPLASM,Diarrhoea|Off label use,2,3
10038520,20140326,Crizotinib,,,,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB|ALBUMIN HUMAN,3,INFLAMMATORY MYOFIBROBLASTIC TUMOUR|RENAL FAILURE|RENAL FAILURE,Death|Off label use,2,3
10039764,20140326,Crizotinib,77,801,77.0,2,,1,0,1,0,0,0,1,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Chylothorax|Embolism|Pleural effusion|Fluid retention|Dizziness|Nausea|Dysgeusia,7,1
10040880,20140327,Crizotinib,73,801,73.0,2,63.9,1,0,1,0,0,0,1,Crizotinib,ESOMEPRAZOLE MAGNESIUM|LISINOPRIL|CRIZOTINIB|CRIZOTINIB,4,GASTROOESOPHAGEAL REFLUX DISEASE|HYPERTENSION|LUNG NEOPLASM MALIGNANT,Hepatic enzyme increased|Hypersensitivity,2,5
10040902,20140327,Crizotinib,66,801,66.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB,3,LUNG NEOPLASM MALIGNANT,Dizziness|Visual impairment|Pyrexia|Infection|Myalgia,5,5
10040943,20140327,Crizotinib,69,801,69.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,2
10041064,20140327,Crizotinib,44,801,44.0,1,,1,1,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression|Non-small cell lung cancer|Neurosis|Asthenia,4,2
10041069,20140327,Crizotinib,42,801,42.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|ENOXAPARIN SODIUM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|ESCITALOPRAM|DIAZEPAM|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|METOCLOPRAMIDE HYDROCHLORIDE|MORPHINE SULFATE,12,LUNG ADENOCARCINOMA METASTATIC|PAIN,Disease progression|Lung adenocarcinoma metastatic,2,3
10041172,20140327,Crizotinib,41,801,41.0,2,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Brain oedema|Vomiting,2,3
10041187,20140327,Crizotinib,56,801,56.0,2,83,1,0,1,0,0,0,0,Crizotinib,INSULIN GLARGINE|LOSARTAN POTASSIUM|LOSARTAN|METFORMIN HYDROCHLORIDE|METFORMIN|METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS|METFORMIN HYDROCHLORIDE TABLET|METFORMIN HYDROCHLORIDE TABLETS|CRIZOTINIB,11,HYPERCHOLESTEROLAEMIA|DIABETES MELLITUS|DYSPNOEA|PAIN|HYPERTENSION|OEDEMA|DIABETES MELLITUS|NON-SMALL CELL LUNG CANCER|PULMONARY EMBOLISM|DIABETES MELLITUS|PNEUMONIA,Acute kidney injury,1,1
10041202,20140327,Crizotinib,63,801,63.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10041275,20140327,Crizotinib,67,801,67.0,2,,1,1,1,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT|LIP NEOPLASM MALIGNANT STAGE UNSPECIFIED,Respiratory distress|Haemoptysis|Disease progression|Lung neoplasm malignant,4,3
10041415,20140326,Crizotinib,13,801,13.0,1,39.1,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LYMPHOMA,Electrocardiogram QT prolonged,1,2
10043458,20140328,Crizotinib,40,801,40.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,TRACHEAL CANCER,Off label use|Cough,2,3
10047618,20140331,Crizotinib,45,801,45.0,2,60,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,LUNG ADENOCARCINOMA,Leukopenia|Neutropenia,2,1
10048068,20140331,Crizotinib,65,801,65.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Visual impairment|Dysgeusia|Abnormal faeces,3,2
10048094,20140331,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Hypersensitivity|Rash|Swelling,3,1
10048104,20140331,Crizotinib,,,,0,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Rash|Lip swelling,2,1
10048110,20140331,Crizotinib,77,801,77.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,2
10048124,20140331,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Non-cardiac chest pain|Oesophageal disorder|Hypophagia|Oesophagitis,4,1
10048126,20140331,Crizotinib,70,801,70.0,2,,1,0,0,0,0,0,0,Crizotinib,"CRIZOTINIB|FUROSEMIDE|GABAPENTIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LANSOPRAZOLE|ATORVASTATIN CALCIUM|LOSARTAN POTASSIUM|LOSARTAN|PROCHLORPERAZINE|SERTRALINE HYDROCHLORIDE|ERGOCALCIFEROL|ZOLPIDEM TARTRATE|MORPHINE SULFATE",14,LUNG NEOPLASM MALIGNANT,Oedema peripheral,1,5
10048127,20140331,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Rash|Lip swelling,2,1
10048885,20140331,Crizotinib,61,801,61.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Pyrexia|Decreased appetite|Nausea|Eructation|Pyrexia,5,3
10049165,20140401,Crizotinib,69,801,69.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,3
10050200,20140401,Crizotinib,68,801,68.0,2,45.5,1,0,1,0,0,0,1,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB,6,NON-SMALL CELL LUNG CANCER,Muscle abscess|Renal abscess,2,1
10050438,20140401,Crizotinib,43,801,43.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10050857,20140401,Crizotinib,42,801,42.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Malaise,1,3
10051277,20140401,Crizotinib,15,801,15.0,1,88,1,0,1,0,0,0,1,Crizotinib,"CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|TOPOTECAN HYDROCHLORIDE|TOPOTECAN HYDROCHLORIDE|LORAZEPAM|PROMETHAZINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DRONABINOL|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED|PROMETHAZINE HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DRONABINOL|LORAZEPAM|DIPHENHYDRAMINE HYDROCHLORIDE|DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED",22,NEOPLASM|NEOPLASM|NEOPLASM|ANTIEMETIC SUPPORTIVE CARE|PRODUCT USED FOR UNKNOWN INDICATION|ANTIEMETIC SUPPORTIVE CARE|ANTIEMETIC SUPPORTIVE CARE|ANTIEMETIC SUPPORTIVE CARE|ANTIEMETIC SUPPORTIVE CARE|ANTIEMETIC SUPPORTIVE CARE|PRODUCT USED FOR UNKNOWN INDICATION|ANTIEMETIC SUPPORTIVE CARE|ANTIEMETIC SUPPORTIVE CARE|ANTIEMETIC SUPPORTIVE CARE|ANTIEMETIC SUPPORTIVE CARE|ANTIEMETIC SUPPORTIVE CARE|ANTIEMETIC SUPPORTIVE CARE,Dehydration|Hypoxia|Nausea|Diarrhoea,4,1
10051323,20140401,Crizotinib,70,801,70.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Blood potassium decreased,1,3
10051351,20140401,Crizotinib,58,801,58.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CLONAZEPAM|SERTRALINE HYDROCHLORIDE|ZOLPIDEM TARTRATE,4,LUNG NEOPLASM MALIGNANT,Face oedema,1,1
10051358,20140401,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG CANCER METASTATIC,Oesophageal pain|Dysphagia|Inflammation,3,1
10051360,20140401,Crizotinib,58,801,58.0,2,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB,3,LUNG NEOPLASM MALIGNANT,Dizziness|Dyspnoea|Swelling|Cardiac disorder|Fluid retention|Weight increased,6,3
10052650,20140402,Crizotinib,15,801,15.0,1,88,1,0,1,0,0,0,1,Crizotinib,"CRIZOTINIB|TOPOTECAN|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|LORAZEPAM|DIPHENHYDRAMINE HYDROCHLORIDE|DRONABINOL|PROMETHAZINE HYDROCHLORIDE|SCOPOLAMINE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",10,DESMOPLASTIC SMALL ROUND CELL TUMOUR|DESMOPLASTIC SMALL ROUND CELL TUMOUR|DESMOPLASTIC SMALL ROUND CELL TUMOUR,Dehydration|Hypoxia,2,1
10053289,20140402,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CANDESARTAN CILEXETIL|CRIZOTINIB,4,,Fatigue|Nausea|Constipation|Renal impairment,4,
10053390,20140402,Crizotinib,52,801,52.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dyspepsia|Diarrhoea,2,5
10053394,20140402,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,5
10053395,20140402,Crizotinib,75,801,75.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,METASTASES TO LUNG,Dehydration|Memory impairment|Off label use|Confusional state,4,3
10053530,20140402,Crizotinib,75,801,75.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Diarrhoea|Nausea|Vomiting,3,3
10053578,20140402,Crizotinib,71,801,71.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Heart rate decreased,1,5
10055958,20140403,Crizotinib,41,801,41.0,1,89.88,1,0,0,0,0,0,0,Crizotinib,"CRIZOTINIB|CRIZOTINIB|IBUPROFEN|IBUPROFEN AND DIPHENHYDRAMINE CITRATE|POLYETHYLENE GLYCOL 3350|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|STANDARDIZED SENNA CONCENTRATE|STANDARDIZED SENNA CONCENTRATE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",16,LUNG NEOPLASM MALIGNANT|PAIN|CONSTIPATION|NAUSEA,Disease progression|Lung neoplasm malignant,2,3
10055982,20140403,Crizotinib,69,801,69.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Disease progression|Neoplasm malignant,2,2
10055988,20140403,Crizotinib,70,801,70.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Fatigue|Dysgeusia|Decreased appetite|Nausea|Vomiting,5,3
10056106,20140403,Crizotinib,22024,804,60.34,1,,1,0,1,0,0,0,0,Crizotinib,OMEPRAZOLE MAGNESIUM|CRIZOTINIB,3,,Dyspepsia|Abdominal discomfort|Drug ineffective,3,
10057358,20140403,Crizotinib,17,801,17.0,2,48.3,1,0,1,0,0,0,1,Crizotinib,CRIZOTINIB|TOPOTECAN HYDROCHLORIDE,4,EWING^S SARCOMA|EWING^S SARCOMA|EWING^S SARCOMA|PRODUCT USED FOR UNKNOWN INDICATION,Syncope|Pyrexia,2,1
10058385,20140403,Crizotinib,13,801,13.0,2,40,1,0,1,0,0,0,1,Crizotinib,"CRIZOTINIB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|ACYCLOVIR|MUPIROCIN|MUPIROCIN CALCIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|FAMOTIDINE|DOXORUBICIN|METHOTREXATE|METHOTREXATE SODIUM|AMLODIPINE",12,NON-HODGKIN^S LYMPHOMA,Generalised tonic-clonic seizure|Posterior reversible encephalopathy syndrome,2,2
10058523,20140404,Crizotinib,54,801,54.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,5
10058645,20140404,Crizotinib,79,801,79.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,5
10058656,20140404,Crizotinib,65,801,65.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10059701,20140404,Crizotinib,68,801,68.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Diarrhoea,1,2
10062493,20140407,Crizotinib,52,801,52.0,1,70,1,1,1,1,1,1,1,Crizotinib,CRIZOTINIB,1,Non-small cell lung cancer,Death,1,1
10062824,20140407,Crizotinib,48,801,48.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Nausea,1,3
10063416,20140407,Crizotinib,51,801,51.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression|Non-small cell lung cancer,2,5
10063418,20140407,Crizotinib,72,801,72.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Disease progression|Neoplasm malignant,2,3
10063790,20140408,Crizotinib,15,801,15.0,1,88,1,0,1,0,0,0,1,Crizotinib,"DIPHENHYDRAMINE HYDROCHLORIDE|CRIZOTINIB|TOPOTECAN HYDROCHLORIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|LORAZEPAM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SCOPOLAMINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|DRONABINOL|PROMETHAZINE",10,ANTIEMETIC SUPPORTIVE CARE|DESMOPLASTIC SMALL ROUND CELL TUMOUR|DESMOPLASTIC SMALL ROUND CELL TUMOUR|DESMOPLASTIC SMALL ROUND CELL TUMOUR|ANTIEMETIC SUPPORTIVE CARE|ANTIEMETIC SUPPORTIVE CARE|ANTIEMETIC SUPPORTIVE CARE|ANTIEMETIC SUPPORTIVE CARE|ANTIEMETIC SUPPORTIVE CARE|ANTIEMETIC SUPPORTIVE CARE,Dehydration|Decreased appetite|Hypoxia|Diarrhoea|Nausea|Faecal incontinence,6,3
10064112,20140408,Crizotinib,58,801,58.0,1,,1,1,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death|Pneumonia|Thrombosis,3,3
10065222,20140408,Crizotinib,36,801,36.0,2,58,1,1,1,0,0,0,0,Crizotinib,CRIZOTINIB|WARFARIN,3,LUNG NEOPLASM MALIGNANT|DEEP VEIN THROMBOSIS|METASTATIC PAIN,Disease progression|Lung neoplasm malignant|Deep vein thrombosis,3,1
10065649,20140408,Crizotinib,55,801,55.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Paraesthesia|Oedema peripheral,2,3
10067983,20140409,Crizotinib,67,801,67.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression|Non-small cell lung cancer,2,3
10067995,20140409,Crizotinib,,,,1,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Pneumonia|Obstructive airways disorder,2,5
10068180,20140409,Crizotinib,68,801,68.0,2,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Constipation|Oedema peripheral,2,3
10068260,20140409,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Disease progression|Neoplasm malignant,2,5
10068286,20140409,Crizotinib,56,801,56.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Toothache|Dyspnoea|Swelling,3,3
10069768,20140410,Crizotinib,56,801,56.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|BISMUTH SUBSALICYLATE,4,LUNG NEOPLASM MALIGNANT,Deep vein thrombosis|Fatigue,2,3
10069772,20140410,Crizotinib,63,801,63.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10069870,20140410,Crizotinib,65,801,65.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Chest pain|Flatulence|Vision blurred|Vertigo|Abdominal pain upper,5,2
10070361,20140410,Crizotinib,70,801,70.0,1,49.7,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|WARFARIN|CRIZOTINIB,7,NON-SMALL CELL LUNG CANCER,Kidney infection|Decreased appetite|Acute kidney injury,3,2
10072496,20140411,Crizotinib,72,801,72.0,1,77,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|ATENOLOL|BICALUTAMIDE|REPAGLINIDE,6,COLORECTAL CANCER,Renal failure,1,1
10072590,20140411,Crizotinib,73,801,73.0,2,73,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Sepsis,1,3
10072652,20140411,Crizotinib,64,801,64.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Dizziness|Diarrhoea|Pollakiuria|Vitreous floaters,4,2
10073024,20140411,Crizotinib,,,,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,2
10073120,20140411,Crizotinib,59,801,59.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB|PROCHLORPERAZINE MALEATE|CITALOPRAM|CITALOPRAM HYDROBROMIDE|INSULIN LISPRO,4,LUNG NEOPLASM MALIGNANT,Death,1,3
10076068,20140414,Crizotinib,64,801,64.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Dysphagia,1,3
10076072,20140414,Crizotinib,86,801,86.0,1,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Constipation,1,3
10076099,20140414,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Product quality issue|Product physical issue|Hepatitis,3,5
10076528,20140414,Crizotinib,51,801,51.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Drug intolerance|Malaise,2,2
10076533,20140414,Crizotinib,57,801,57.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Oesophagitis|Oropharyngeal pain|Throat irritation,3,2
10076556,20140414,Crizotinib,58,801,58.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10076585,20140414,Crizotinib,51,801,51.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Disease progression|Neoplasm malignant,2,1
10076770,20140414,Crizotinib,4,801,4.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEUROBLASTOMA,Disease progression|Neuroblastoma|Off label use,3,2
10078758,20140415,Crizotinib,85,801,85.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB,3,BRONCHIAL NEOPLASM|LUNG NEOPLASM|BONE CANCER,Death,1,2
10078767,20140415,Crizotinib,70,801,70.0,2,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION,4,,Thrombosis,1,3
10078807,20140415,Crizotinib,56,801,56.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,3
10079494,20140415,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,OVARIAN CANCER,Off label use|Disease progression|Ovarian cancer,3,5
10080469,20140416,Crizotinib,,,,2,,1,0,0,0,0,0,1,Crizotinib,DENOSUMAB|CRIZOTINIB,2,METASTASES TO BONE,Impaired gastric emptying|Myalgia,2,5
10081038,20140416,Crizotinib,78,801,78.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Local swelling,1,3
10081100,20140416,Crizotinib,,,,0,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,5
10081139,20140416,Crizotinib,,,,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,1
10081180,20140416,Crizotinib,39,801,39.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,2,LUNG NEOPLASM MALIGNANT,Abdominal distension|Abnormal faeces|Flatulence,3,2
10081194,20140416,Crizotinib,83,801,83.0,1,,1,0,0,0,0,0,0,Crizotinib,"ALLOPURINOL|FUROSEMIDE|NEBIVOLOL HYDROCHLORIDE|FINASTERIDE|ATORVASTATIN CALCIUM|ATORVASTATIN CALCIUM, FILM COATED|CLONAZEPAM|ERGOCALCIFEROL|PANTOPRAZOLE SODIUM|PANTOPRAZOLE|PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE|PANTOPRAZOLE SODIUM INJECTION|CLOPIDOGREL|CRIZOTINIB",13,LUNG NEOPLASM MALIGNANT,Diarrhoea|Rash,2,5
10081258,20140416,Crizotinib,66,801,66.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10081471,20140416,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Disease progression|Neoplasm malignant,2,5
10081513,20140416,Crizotinib,82,801,82.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,3
10082869,20140416,Crizotinib,36,801,36.0,2,,1,1,0,0,0,0,1,Crizotinib,CARBOPLATIN|VINORELBINE|PEMETREXED|PEMETREXED DISODIUM|CRIZOTINIB,6,METASTASES TO BONE|CHEMOTHERAPY|CHEMOTHERAPY|CHEMOTHERAPY,Death|Metastases to bone|Disease progression|Malignant neoplasm progression,4,3
10082964,20140417,Crizotinib,66,801,66.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Lung neoplasm malignant|Disease progression,2,2
10082967,20140417,Crizotinib,63,801,63.0,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,LUNG ADENOCARCINOMA,Leukopenia|Neutropenia|Lymphopenia|Liver function test abnormal|Decreased appetite|Diarrhoea|Diplopia,7,1
10082969,20140417,Crizotinib,,,,0,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,1
10083643,20140417,Crizotinib,,,,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Pneumonia|Pneumonitis,2,1
10083933,20140417,Crizotinib,53,801,53.0,1,88,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB,6,LUNG ADENOCARCINOMA,Disease progression|Oedema|Decreased appetite|Hypoproteinaemia|Lung adenocarcinoma|Hepatotoxicity|Weight decreased|Nausea|Vomiting,9,1
10084274,20140417,Crizotinib,51,801,51.0,2,57.8,1,1,1,1,0,0,0,Crizotinib,CRIZOTINIB|GABAPENTIN|RIVAROXABAN,4,NON-SMALL CELL LUNG CANCER|INFECTION|DYSAESTHESIA|THROMBOSIS PROPHYLAXIS,Disease progression|Non-small cell lung cancer|Renal cyst|Renal failure acute|Posterior reversible encephalopathy syndrome|Fatigue,6,1
10084276,20140417,Crizotinib,27,801,27.0,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB|CRIZOTINIB|ZOLEDRONIC ACID,3,LUNG ADENOCARCINOMA,Neutropenia|Lung adenocarcinoma|Liver function test abnormal|Disease progression|Leukopenia,5,1
10084402,20140417,Crizotinib,51,801,51.0,0,84,1,1,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression|Non-small cell lung cancer|Haemorrhage|Haemoptysis,4,1
10085657,20140416,Crizotinib,15,801,15.0,1,88,1,0,1,0,0,0,1,Crizotinib,CRIZOTINIB|TOPOTECAN HYDROCHLORIDE|DRONABINOL,10,NAUSEA|DESMOPLASTIC SMALL ROUND CELL TUMOUR|DESMOPLASTIC SMALL ROUND CELL TUMOUR|DESMOPLASTIC SMALL ROUND CELL TUMOUR|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Hypoxia|Nausea|Decreased appetite|Weight decreased|Impaired gastric emptying|Dehydration|Diarrhoea|Faecal incontinence,8,1
10085771,20140418,Crizotinib,67,801,67.0,1,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|EZETIMIBE|DENOSUMAB,7,NON-SMALL CELL LUNG CANCER METASTATIC|HYPERLIPIDAEMIA|METASTASES TO BONE,Hepatotoxicity|Dysgeusia|Nausea,3,3
10085804,20140418,Crizotinib,,,,0,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Aspartate aminotransferase increased|Alanine aminotransferase increased,2,1
10085838,20140418,Crizotinib,66,801,66.0,1,72,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,Pneumonia,1,2
10085853,20140418,Crizotinib,81,801,81.0,1,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB,3,LUNG NEOPLASM MALIGNANT,Nausea|Decreased appetite|Diarrhoea|Dysgeusia|Asthenia|Dysphagia|Dyspepsia|Weight decreased|Constipation|Abdominal discomfort,10,3
10085859,20140418,Crizotinib,45,801,45.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Chest pain|Pyrexia,2,3
10086364,20140418,Crizotinib,76,801,76.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG CANCER METASTATIC,Death,1,2
10094478,20140422,Crizotinib,69,801,69.0,1,59,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|RAMIPRIL|ESCITALOPRAM|ESCITALOPRAM OXALATE|ESCITSLOPRAM|LORAZEPAM|FUROSEMIDE,10,LUNG ADENOCARCINOMA RECURRENT|HYPERTENSION,Renal impairment,1,3
10095576,20140422,Crizotinib,58,801,58.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10097933,20140423,Crizotinib,66,801,66.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,3
10099257,20140423,Crizotinib,88,801,88.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Malaise,1,5
10099258,20140423,Crizotinib,54,801,54.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dehydration|Dyspepsia,2,3
10099262,20140423,Crizotinib,24,801,24.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10099274,20140423,Crizotinib,55,801,55.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|FOLIC ACID,4,LUNG NEOPLASM MALIGNANT,Drug intolerance,1,3
10100532,20140423,Crizotinib,10,801,10.0,2,43.7,1,0,1,0,0,0,0,Crizotinib,"TOPOTECAN HYDROCHLORIDE|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|CRIZOTINIB",3,EWING^S SARCOMA|EWING^S SARCOMA|EWING^S SARCOMA,Abdominal pain|Lung infection,2,5
10100986,20140424,Crizotinib,40,801,40.0,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,2,ADENOCARCINOMA|PAIN,Neutropenia|Hepatocellular injury|Thrombocytopenia,3,1
10101272,20140424,Crizotinib,75,801,75.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,2
10101282,20140424,Crizotinib,69,801,69.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|FAMOTIDINE|MONTELUKAST SODIUM|MONTELUKAST SODIUM|GABAPENTIN|FENOFIBRATE|ERGOCALCIFEROL,11,LUNG NEOPLASM MALIGNANT|GASTROOESOPHAGEAL REFLUX DISEASE,Oropharyngeal pain|Throat tightness|Odynophagia,3,3
10101295,20140424,Crizotinib,78,801,78.0,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Hepatotoxicity|Nausea,2,1
10101321,20140424,Crizotinib,,,,0,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Tongue disorder,1,1
10102074,20140424,Crizotinib,41,801,41.0,2,68,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,3,ALVEOLAR SOFT PART SARCOMA|DIARRHOEA|DIARRHOEA,Abdominal distension|Abdominal pain,2,1
10102170,20140424,Crizotinib,42,801,42.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Diarrhoea|Transaminases increased,2,3
10102172,20140424,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Nausea,1,3
10102190,20140424,Crizotinib,,,,0,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Disease progression|Neoplasm malignant,2,1
10102357,20140424,Crizotinib,40,801,40.0,1,,1,0,0,0,0,0,1,Crizotinib,"CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|DIVALPROEX SODIUM|DIVALPROEX SODIUM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|IBUPROFEN|IBUPROFEN AND DIPHENHYDRAMINE CITRATE|POLYETHYLENE GLYCOL 3350|OMEPRAZOLE MAGNESIUM|OMEPRAZOLE MAGNESIUM|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES|STANDARDIZED SENNA CONCENTRATE|DOCUSATE CALCIUM|DOCUSATE SODIUM|MARC GLASSMAN|DOCUSATE SODIUM SENNOSIDES|DOCUSATE SODIUM AND SENNOSIDES|STOOL SOFTENER|DOCUSATE SODIUM 100MG|COUGH SYRUP|CAMPHOR (NATURAL), ARSENIC TRIOXIDE, BRYONIA ALBA ROOT, DROSERA ROTUNDIFOLIA, IPECAC, POTASSIUM CARBONATE, PHOSPHORUS, ANEMONE PULSATILLA, SPONGIA OFFICINALIS SKELETON, ROASTED, DRIMIA MARITIMA WHOLE",32,LUNG ADENOCARCINOMA STAGE IV|PAIN|NAUSEA|VOMITING,Pulmonary embolism|Syncope|Nasopharyngitis|Muscle spasms|Constipation|Alanine aminotransferase increased|Asthenia|Fatigue,8,3
10108270,20140425,Crizotinib,69,801,69.0,1,,1,0,1,0,0,0,1,Crizotinib,CRIZOTINIB,1,LUNG ADENOCARCINOMA METASTATIC,General physical health deterioration|Pneumonitis,2,1
10109746,20140416,Crizotinib,72,801,72.0,1,,1,0,1,0,0,0,0,Crizotinib,LISINOPRIL|CRIZOTINIB,2,HYPERTENSION|LUNG NEOPLASM MALIGNANT,Renal failure|Vomiting|Nausea|Dehydration,4,3
10119392,20140425,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Joint swelling,1,2
10119559,20140425,Crizotinib,57,801,57.0,1,76,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB|CRIZOTINIB|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|CIPROFLOXACIN HYDROCHLORIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LISINOPRIL|ONDANSETRON HYDROCHLORIDE|PREDNISONE|PROCHLORPERAZINE MALEATE|PANTOPRAZOLE SODIUM|SIMVASTATIN,14,NON-SMALL CELL LUNG CANCER METASTATIC|PAIN|OCULAR HYPERAEMIA|OCULAR HYPERAEMIA|PAIN|NAUSEA|NAUSEA,Liver function test abnormal|Diarrhoea|Nausea|Vomiting|Malaise|Insomnia|Fatigue|Asthenia|Dizziness|Disease progression|Non-small cell lung cancer metastatic,11,3
10119604,20140425,Crizotinib,46,801,46.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Hypoaesthesia|Chest pain|Vomiting|Nausea|Myalgia,5,3
10120080,20140425,Crizotinib,,,,0,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Oedema peripheral,1,3
10120208,20140425,Crizotinib,,,,0,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death|Oedema peripheral,2,1
10120211,20140425,Crizotinib,63,801,63.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CARVEDILOL|ENOXAPARIN SODIUM|RANITIDINE,5,LUNG NEOPLASM MALIGNANT,Amnesia|Off label use,2,1
10120258,20140425,Crizotinib,70,801,70.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Disease progression|Neoplasm malignant,2,5
10120271,20140425,Crizotinib,59,801,59.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Arthralgia,1,2
10120421,20140425,Crizotinib,43,801,43.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,PAPILLARY THYROID CANCER,Off label use|Dyspnoea|Dysphagia,3,1
10130071,20140428,Crizotinib,68,801,68.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Oedema peripheral|Dizziness,2,2
10131288,20140428,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,2,NAUSEA|LUNG NEOPLASM MALIGNANT,Drug ineffective,1,5
10133381,20140428,Crizotinib,79,801,79.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,2
10137348,20140429,Crizotinib,69,801,69.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Cardio-respiratory arrest|Disease progression|Non-small cell lung cancer metastatic,3,5
10138191,20140429,Crizotinib,43,801,43.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Dysphagia|Diplopia|Memory impairment|Gastrooesophageal reflux disease,4,2
10138195,20140429,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Vitreous floaters,1,3
10138199,20140429,Crizotinib,,,,0,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Vision blurred,1,1
10138272,20140429,Crizotinib,,,,0,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Diplopia,1,2
10138548,20140429,Crizotinib,65,801,65.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|BUPROPION HYDROCHLORIDE|OXYCODONE|FOLIC ACID,4,LUNG NEOPLASM MALIGNANT|DEPRESSION|PAIN|VITAMIN SUPPLEMENTATION,Disease progression|Lung neoplasm malignant,2,2
10140217,20140429,Crizotinib,,,,0,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,1
10142633,20140430,Crizotinib,70,801,70.0,2,47.8,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|ESOMEPRAZOLE MAGNESIUM,10,NON-SMALL CELL LUNG CANCER,Ileus,1,1
10143023,20140430,Crizotinib,57,801,57.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,3
10143651,20140430,Crizotinib,,,,0,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Vision blurred,1,3
10143658,20140430,Crizotinib,60,801,60.0,2,80.73,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|DIPHENHYDRAMINE HYDROCHLORIDE|LISINOPRIL,4,LUNG NEOPLASM MALIGNANT,Nausea|Rash|Pruritus|Joint swelling,4,3
10144062,20140430,Crizotinib,,,,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Pneumonia|General physical health deterioration,2,1
10144561,20140430,Crizotinib,43,801,43.0,2,72.1,1,0,1,0,0,0,0,Crizotinib,"ENOXAPARIN SODIUM|ENOXAPARIN SODIUM|CRIZOTINIB|CRIZOTINIB|FUROSEMIDE|LORAZEPAM|ZOLPIDEM TARTRATE|CLONAZEPAM|CLONAZEPAM|DAPSONE GEL, 5%|DAPSONE|DASPONE|DAPSONE GEL, 5%|DAPSONE|DASPONE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|OLANZAPINE|OLANZAPINE PAMOATE",16,PULMONARY EMBOLISM|PULMONARY EMBOLISM|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NAUSEA|OEDEMA|ANXIETY|NUTRITIONAL SUPPLEMENTATION|INSOMNIA|DEPRESSION|ANXIETY|STEROID THERAPY|PROPHYLAXIS|METASTASES TO CENTRAL NERVOUS SYSTEM|HEADACHE,Brain stem haemorrhage|Diplopia|Confusional state|Speech disorder|Nystagmus|Hypoaesthesia,6,1
10146180,20140501,Crizotinib,76,801,76.0,1,,1,1,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Cerebrovascular accident|Death|Disease progression|Non-small cell lung cancer,4,2
10146263,20140501,Crizotinib,67,801,67.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Abdominal pain upper|Vomiting|Decreased appetite,3,3
10146267,20140501,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Vision blurred,1,1
10146269,20140501,Crizotinib,58,801,58.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,5
10146272,20140501,Crizotinib,29,801,29.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dysgeusia,1,2
10146401,20140501,Crizotinib,76,801,76.0,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Syncope,1,1
10146408,20140501,Crizotinib,,,,1,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Respiratory disorder,1,5
10146701,20140501,Crizotinib,84,801,84.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|ENALAPRIL MALEATE|ENALAPRIL|ATORVASTATIN CALCIUM|RIVASTIGMINE TARTRATE|LEVOTHYROXINE SODIUM|WARFARIN SODIUM|WARFARIN,6,LUNG NEOPLASM MALIGNANT,Diarrhoea,1,5
10149498,20140502,Crizotinib,54,801,54.0,1,,1,1,1,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB,3,LUNG NEOPLASM MALIGNANT,Osteomyelitis|Sepsis|General physical health deterioration,3,3
10149503,20140502,Crizotinib,49,801,49.0,1,77,1,0,1,0,0,0,1,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,BRONCHIAL CARCINOMA,Renal failure acute,1,3
10149568,20140502,Crizotinib,69,801,69.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,2,METASTASES TO CENTRAL NERVOUS SYSTEM|NAUSEA,Nausea|Diarrhoea|Decreased appetite|Dysgeusia|Local swelling|Oral mucosal blistering|Petechiae,7,5
10149587,20140502,Crizotinib,57,801,57.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10149612,20140502,Crizotinib,,,,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Interstitial lung disease,1,3
10149617,20140502,Crizotinib,80,801,80.0,2,52.6,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|ESOMEPRAZOLE MAGNESIUM|DIGOXIN|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|GABAPENTIN|POLYETHYLENE GLYCOL 3350|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES,8,LUNG NEOPLASM MALIGNANT,Dyspepsia|Local swelling|Visual impairment|Dysgeusia|Fatigue|Nausea|Abdominal discomfort,7,3
10149624,20140502,Crizotinib,83,801,83.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CITALOPRAM|CITALOPRAM HYDROBROMIDE|FERROUS SULFATE|MIRTAZAPINE|ERGOCALCIFEROL,9,LUNG NEOPLASM MALIGNANT,Nausea|Chromaturia,2,3
10149625,20140502,Crizotinib,65,801,65.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Abdominal pain|Constipation,2,5
10150707,20140502,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Pneumonitis,1,1
10150938,20140502,Crizotinib,73,801,73.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|TURMERIC,5,LUNG CANCER METASTATIC,Disease progression|Lung cancer metastatic|Heart rate decreased|Hypotension,4,5
10151274,20140504,Crizotinib,3,801,3.0,1,15,1,0,1,0,0,0,0,Crizotinib,"TOPOTECAN|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|SULFAMETHOXAZOLE AND TRIMETHOPRIM",8,NEUROBLASTOMA|NEUROBLASTOMA|NEUROBLASTOMA|NEUROBLASTOMA|NEUROBLASTOMA|PROPHYLAXIS|VITAMIN SUPPLEMENTATION,Febrile neutropenia|Thrombocytopenia|White blood cell count decreased|Anaemia|Fatigue|Weight decreased|Transaminases increased|Blood lactate dehydrogenase increased|Hypocalcaemia,9,3
10151394,20140502,Crizotinib,,,,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Death,1,1
10151781,20140505,Crizotinib,75,801,75.0,2,43.7,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|SOLIFENACIN SUCCINATE|ESOMEPRAZOLE MAGNESIUM|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB,15,NON-SMALL CELL LUNG CANCER,Pyrexia|Nausea|Renal function test abnormal|C-reactive protein increased|Herpes zoster,5,1
10152785,20140505,Crizotinib,61,801,61.0,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,NEOPLASM,Impaired gastric emptying|Nausea|Oedema peripheral,3,3
10152792,20140505,Crizotinib,75,801,75.0,1,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Femur fracture,1,3
10154188,20140506,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Dizziness,1,3
10154232,20140506,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Diarrhoea|Malaise,2,3
10154238,20140506,Crizotinib,68,801,68.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,BRONCHIAL NEOPLASM|LUNG NEOPLASM,Diarrhoea|Nausea|Vomiting|Fatigue,4,3
10154242,20140506,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Vision blurred,1,1
10154244,20140506,Crizotinib,76,801,76.0,2,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|POTASSIUM CHLORIDE|LOPERAMIDE HYDROCHLORIDE|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|BISMUTH SUBSALICYLATE|MIRTAZAPINE|TIMOLOL,9,NON-SMALL CELL LUNG CANCER,Vomiting|Nausea|Hypovolaemia,3,3
10154408,20140506,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Gastrooesophageal reflux disease,1,5
10154417,20140506,Crizotinib,46,801,46.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Oedema peripheral,1,2
10154507,20140506,Crizotinib,62,801,62.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Peripheral swelling|Hypoaesthesia|Paraesthesia,3,3
10154526,20140506,Crizotinib,48,801,48.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10154531,20140506,Crizotinib,69,801,69.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Swollen tongue,1,2
10154566,20140506,Crizotinib,64,801,64.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Body temperature decreased|Peripheral coldness,2,3
10155038,20140506,Crizotinib,7,800,70.0,2,,1,0,1,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Cerebral haemorrhage|Platelet count decreased,2,1
10156335,20140507,Crizotinib,49,801,49.0,2,54,1,0,0,0,1,0,0,Crizotinib,CRIZOTINIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM,2,LUNG NEOPLASM MALIGNANT,Periodontitis|Tooth loss|Dental caries,3,1
10157156,20140507,Crizotinib,88,801,88.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant|Peripheral swelling|Fluid retention|Weight increased,5,2
10157169,20140507,Crizotinib,,,,1,,1,1,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant|Pneumonitis|Pulmonary embolism,4,2
10160136,20140508,Crizotinib,,,,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,1
10160500,20140508,Crizotinib,41,801,41.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Death,1,2
10161010,20140508,Crizotinib,62,801,62.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10162626,20140509,Crizotinib,69,801,69.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Nausea|Vomiting,2,3
10162733,20140509,Crizotinib,,,,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10162739,20140509,Crizotinib,65,801,65.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,3
10162966,20140509,Crizotinib,54,801,54.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Nausea|Fatigue|Diarrhoea|Visual impairment|Constipation,5,3
10162977,20140509,Crizotinib,56,801,56.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Rash|Pruritus,2,3
10162981,20140509,Crizotinib,78,801,78.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Swelling face|Skin exfoliation|Peripheral swelling|Pruritus|Eye swelling,5,2
10163034,20140509,Crizotinib,72,801,72.0,1,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Pneumonia,1,3
10163785,20140509,Crizotinib,60,801,60.0,2,55,1,0,1,1,0,0,0,Crizotinib,DALTEPARIN SODIUM|CRIZOTINIB|CARBOPLATIN|PEMETREXED|PEMETREXED DISODIUM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|ACETYLCYSTEINE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,7,THROMBOPHLEBITIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NAUSEA|NASOPHARYNGITIS|VOMITING,Subarachnoid haemorrhage,1,1
10166912,20140512,Crizotinib,57,801,57.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Abdominal discomfort,1,5
10166916,20140512,Crizotinib,65,801,65.0,1,,1,1,1,0,0,0,0,Crizotinib,BUPROPION HYDROCHLORIDE|SIMVASTATIN|FUROSEMIDE|CRIZOTINIB|OMEPRAZOLE MAGNESIUM|LORAZEPAM|CARVEDILOL|LORAZEPAM|CRIZOTINIB|CLONAZEPAM|DILTIAZEM HYDROCHLORIDE|BUPROPION HYDROCHLORIDE|FENOFIBRATE,22,WHEEZING|HYPERCHOLESTEROLAEMIA|NAUSEA|PAIN|CONSTIPATION|ANXIETY|INSOMNIA|NON-SMALL CELL LUNG CANCER|VOMITING|MUSCLE SPASMS,Pneumothorax|Ataxia|Dyspnoea|Confusional state|Dizziness,5,3
10167051,20140512,Crizotinib,59,801,59.0,1,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB|CRIZOTINIB|CARBOPLATIN|PEMETREXED|PEMETREXED DISODIUM|PEMETREXED|PEMETREXED DISODIUM,6,NON-SMALL CELL LUNG CANCER METASTATIC|LUNG ADENOCARCINOMA METASTATIC,Spleen disorder|Prostatomegaly|Cholelithiasis|Pleural effusion|Malignant neoplasm progression|Metastases to central nervous system|Central nervous system lesion|Thirst|Diarrhoea|Decreased appetite,10,1
10167243,20140512,Crizotinib,82,801,82.0,2,56.7,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Peripheral swelling|Hypoaesthesia,2,5
10167280,20140512,Crizotinib,50,801,50.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10167386,20140512,Crizotinib,85,801,85.0,1,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Blindness transient,1,3
10167702,20140512,Crizotinib,57,801,57.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,3
10169483,20140513,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,,Drug intolerance,1,3
10169676,20140513,Crizotinib,58,801,58.0,2,62,1,1,1,1,0,0,0,Crizotinib,OXYCODONE HYDROCHLORIDE|CRIZOTINIB|DEXAMETHASONE|DEXAMETHASONE 1.5 MG,3,PAIN|NON-SMALL CELL LUNG CANCER METASTATIC|METASTATIC PAIN,Haemorrhagic stroke|Hemiplegia,2,2
10169679,20140513,Crizotinib,50,801,50.0,1,65,1,0,1,0,0,0,0,Crizotinib,PREGABALIN|OXYCODONE HYDROCHLORIDE|CRIZOTINIB|PREGABALIN|PREGABALIN|PREGABALIN|DICLOFENAC SODIUM,13,NON-SMALL CELL LUNG CANCER,Venous thrombosis limb|Pulmonary embolism,2,1
10171192,20140512,Crizotinib,60,801,60.0,2,55,1,0,1,1,0,0,0,Crizotinib,CRIZOTINIB|PEMETREXED|PEMETREXED DISODIUM|CARBOPLATIN,6,THROMBOPHLEBITIS|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Subarachnoid haemorrhage|Ruptured cerebral aneurysm,2,1
10171215,20140514,Crizotinib,,,,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10171240,20140514,Crizotinib,59,801,59.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Diarrhoea|Hypoaesthesia|Joint swelling,3,3
10171498,20140514,Crizotinib,23,801,23.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,3
10173273,20140515,Crizotinib,74,801,74.0,2,68.9,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Diarrhoea|Cough|Dysgeusia|Malaise|Nasopharyngitis|Fatigue,6,5
10176258,20140516,Crizotinib,36,801,36.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10176266,20140516,Crizotinib,60,801,60.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10176322,20140516,Crizotinib,64,801,64.0,2,,1,0,0,0,0,0,0,Crizotinib,FUROSEMIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|CRIZOTINIB|METOPROLOL SUCCINATE|METOPROLOL SUCCINATE ER TABLETS|AMLODIPINE|LORATADINE|LORATADINE ORAL|CITALOPRAM|CITALOPRAM HYDROBROMIDE,10,LUNG NEOPLASM MALIGNANT,Peripheral swelling|Rash,2,3
10176435,20140516,Crizotinib,59,801,59.0,2,84.8,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB|EXTENDED PHENYTOIN SODIUM,3,NON-SMALL CELL LUNG CANCER|EPILEPSY,Gastrooesophageal reflux disease|Barrett^s oesophagus,2,1
10176464,20140516,Crizotinib,64,801,64.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|SIMVASTATIN|LOSARTAN|ATENOLOL|AMLODIPINE|BUMETANIDE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG,11,LUNG ADENOCARCINOMA METASTATIC|ANTICOAGULANT THERAPY,Disease progression|Lung adenocarcinoma metastatic,2,5
10176498,20140516,Crizotinib,16,801,16.0,2,72.3,1,0,1,0,0,0,0,Crizotinib,"CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|CYTARABINE|CYTARABINE|METHOTREXATE SODIUM|ETOPOSIDE|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|SULFAMETHOXAZOLE AND TRIMETHOPRIM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|IFOSFAMIDE|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|METHOTREXATE SODIUM",15,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES|ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES|ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES|ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES|ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES|ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES|ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES|NAUSEA|ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,Vomiting|Seizure|Ileus|Posterior reversible encephalopathy syndrome|Neutropenic colitis,5,1
10176504,20140516,Crizotinib,71,801,71.0,1,60,1,1,0,1,0,0,0,Crizotinib,CRIZOTINIB,10,NON-SMALL CELL LUNG CANCER,Disease progression|Non-small cell lung cancer|Hyperkalaemia,3,2
10177144,20140515,Crizotinib,72,801,72.0,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Adverse drug reaction,1,2
10182907,20140520,Crizotinib,51,801,51.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Visual brightness,1,2
10182989,20140520,Crizotinib,57,801,57.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Decreased appetite|Neuropathy peripheral,2,3
10182994,20140520,Crizotinib,41,801,41.0,2,68.9,1,0,0,0,0,0,0,Crizotinib,LORATADINE|LORATADINE TABLET|CRIZOTINIB,2,NON-SMALL CELL LUNG CANCER,Headache|Fatigue|Vision blurred|Rash,4,3
10185289,20140521,Crizotinib,60,801,60.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB,4,NON-SMALL CELL LUNG CANCER,Nausea|Vomiting|Rash|Palpitations|Photopsia|Joint swelling|Liver function test abnormal|Fatigue,8,5
10185428,20140521,Crizotinib,56,801,56.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Peripheral swelling,1,2
10185448,20140521,Crizotinib,36,801,36.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Deep vein thrombosis,1,3
10185450,20140521,Crizotinib,44,801,44.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Dizziness,1,1
10185476,20140521,Crizotinib,71,801,71.0,2,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dysphagia|Vocal cord paralysis|Dyspnoea|Increased bronchial secretion,4,3
10185478,20140521,Crizotinib,,,,2,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Epilepsy,1,5
10185487,20140521,Crizotinib,49,801,49.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,3
10185543,20140521,Crizotinib,59,801,59.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0,Peripheral swelling|Back pain|Vitreous floaters|Anxiety,4,1
10185974,20140521,Crizotinib,16,801,16.0,2,72.3,1,0,1,0,0,0,0,Crizotinib,"METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CYTARABINE|IFOSFAMIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|CRIZOTINIB|CRIZOTINIB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",11,NAUSEA,Posterior reversible encephalopathy syndrome|Vasogenic cerebral oedema|Generalised tonic-clonic seizure|Loss of consciousness|Enuresis|Headache|Cyanosis|Confusional state|Asthenia|Eye movement disorder|Musculoskeletal stiffness|Ileus|Abdominal distension|Vomiting|Colitis|Abdominal pain|Nausea,17,3
10188287,20140522,Crizotinib,36,801,36.0,1,73,1,0,0,0,0,0,0,Crizotinib,BISOPROLOL FUMARATE|CRIZOTINIB|PANTOPRAZOLE,3,HYPERTENSION|ALVEOLAR SOFT PART SARCOMA,Disease progression|Alveolar soft part sarcoma,2,1
10189444,20140522,Crizotinib,,,,1,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Renal disorder|Renal impairment|Coagulopathy,3,5
10191214,20140523,Crizotinib,18,801,18.0,2,41,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|DICLOFENAC SODIUM|FUROSEMIDE,13,NON-SMALL CELL LUNG CANCER,Non-small cell lung cancer|Disease progression|Pneumocystis jirovecii pneumonia,3,1
10191218,20140523,Crizotinib,46,801,46.0,2,47,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,17,NON-SMALL CELL LUNG CANCER,Hyperglycaemia,1,1
10191406,20140523,Crizotinib,72,801,72.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Dizziness|Neuropathy peripheral|Oedema peripheral,3,2
10191415,20140523,Crizotinib,55,801,55.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Nausea|Reflux gastritis,2,3
10192054,20140523,Crizotinib,,,,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,1
10192073,20140523,Crizotinib,71,801,71.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10192381,20140523,Crizotinib,72,801,72.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,5
10194683,20140526,Crizotinib,2,801,2.0,1,10,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEUROBLASTOMA RECURRENT,Disease progression|Neuroblastoma,2,1
10195165,20140526,Crizotinib,48,801,48.0,2,53.2,1,0,1,0,0,0,0,Crizotinib,OXYCODONE|PEMETREXED DISODIUM|PEMETREXED|CRIZOTINIB|ALBUTEROL SULFATE|ALBUTEROL|ESTRADIOL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CARBOPLATIN|ENOXAPARIN SODIUM,10,PAIN|CHEMOTHERAPY|NON-SMALL CELL LUNG CANCER|NAUSEA|WHEEZING|HEADACHE|CHEMOTHERAPY|PULMONARY EMBOLISM,Oesophageal candidiasis,1,5
10196034,20140527,Crizotinib,,,,0,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Thrombosis,1,1
10196040,20140527,Crizotinib,76,801,76.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB,3,LUNG NEOPLASM MALIGNANT,Cough|Oedema|Insomnia,3,3
10196060,20140527,Crizotinib,,,,0,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|ENOXAPARIN SODIUM,2,ANTICOAGULANT THERAPY,Alanine aminotransferase increased|Aspartate aminotransferase increased,2,1
10196081,20140527,Crizotinib,60,801,60.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Vitreous floaters,1,5
10196168,20140527,Crizotinib,55,801,55.0,1,54.7,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|VALSARTAN,8,NON-SMALL CELL LUNG CANCER,Oesophagitis,1,1
10196670,20140527,Crizotinib,56,801,56.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,3
10201145,20140528,Crizotinib,51,801,51.0,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,2,LUNG CANCER METASTATIC|DEEP VEIN THROMBOSIS,Transaminases increased,1,1
10201151,20140528,Crizotinib,67,801,67.0,2,53.4,1,0,1,0,0,0,0,Crizotinib,OLANZAPINE|OLANZAPINE PAMOATE|ROSUVASTATIN|CRIZOTINIB|SENNOSIDES,21,SCHIZOPHRENIA|RIB FRACTURE|CONSTIPATION|RIB FRACTURE|NON-SMALL CELL LUNG CANCER,Deep vein thrombosis|Pulmonary embolism,2,1
10203853,20140529,Crizotinib,61,801,61.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Dysphagia|Sensation of foreign body,2,2
10204710,20140529,Crizotinib,49,801,49.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Malaise,1,3
10206061,20140530,Crizotinib,5,801,5.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEUROBLASTOMA,Off label use|Pharyngitis streptococcal,2,5
10206075,20140530,Crizotinib,54,801,54.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dysgeusia|Diarrhoea|Rash,3,3
10206678,20140530,Crizotinib,75,801,75.0,2,54.7,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|ATORVASTATIN CALCIUM,5,LUNG NEOPLASM MALIGNANT,Renal disorder|Blood creatinine increased|Vomiting,3,2
10210285,20140602,Crizotinib,51,801,51.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Deep vein thrombosis,1,1
10214045,20140603,Crizotinib,,,,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Disease progression|Neoplasm malignant|Pleural effusion|Respiratory failure,4,1
10214158,20140603,Crizotinib,43,801,43.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Deep vein thrombosis|Nausea|Constipation,3,3
10214196,20140603,Crizotinib,87,801,87.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Constipation,1,3
10214679,20140603,Crizotinib,54,801,54.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Diarrhoea,1,5
10215651,20140604,Crizotinib,,,,0,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Renal haematoma|Perinephritis|Renal failure,3,1
10215652,20140604,Crizotinib,49,801,49.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10216488,20140604,Crizotinib,59,801,59.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dyspepsia|Gastrointestinal disorder,2,3
10216512,20140604,Crizotinib,65,801,65.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dyspnoea|Breath sounds abnormal,2,5
10216516,20140604,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Disease progression|Neoplasm malignant,2,5
10216634,20140604,Crizotinib,54,801,54.0,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,4,PAIN|NAUSEA|HYPOTHYROIDISM|LUNG NEOPLASM MALIGNANT,Hepatic enzyme increased|Dyspepsia|Gastrooesophageal reflux disease,3,3
10216639,20140604,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Disease progression|Neoplasm malignant,2,1
10216741,20140604,Crizotinib,61,801,61.0,1,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG ADENOCARCINOMA STAGE IV,Interstitial lung disease|Dyspnoea|Hypoxia,3,3
10216742,20140604,Crizotinib,52,801,52.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,3
10216775,20140604,Crizotinib,49,801,49.0,2,44,1,1,1,0,0,0,0,Crizotinib,CRIZOTINIB,14,NON-SMALL CELL LUNG CANCER,Disease progression|Non-small cell lung cancer|Organising pneumonia,3,1
10219044,20140605,Crizotinib,,,,0,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Aspartate aminotransferase increased|Alanine aminotransferase increased,2,3
10219732,20140605,Crizotinib,65,801,65.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,3
10220480,20140606,Crizotinib,79,801,79.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,5
10220704,20140606,Crizotinib,62,801,62.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|VALSARTAN|RABEPRAZOLE SODIUM|CRIZOTINIB|CRIZOTINIB|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|RABEPRAZOLE SODIUM,8,NON-SMALL CELL LUNG CANCER|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|HYPERTENSION|BARRETT^S OESOPHAGUS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|GASTROOESOPHAGEAL REFLUX DISEASE,Arthralgia|Foreign body|Nausea|Dizziness|Joint swelling|Visual impairment,6,3
10220779,20140606,Crizotinib,66,801,66.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression|Non-small cell lung cancer|Visual impairment,3,1
10220785,20140606,Crizotinib,57,801,57.0,1,71.2,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|ALPRAZOLAM,2,LUNG NEOPLASM MALIGNANT,Blood creatine phosphokinase increased|Blood lactate dehydrogenase increased,2,5
10221139,20140606,Crizotinib,,,,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Acute myocardial infarction,1,1
10221445,20140606,Crizotinib,54,801,54.0,2,54.8,1,0,1,1,0,0,0,Crizotinib,CRIZOTINIB|FUROSEMIDE|OSELTAMIVIR PHOSPHATE|DEXTROSE MONOHYDRATE|DEXTROSE|ETODOLAC,16,NON-SMALL CELL LUNG CANCER|UPPER RESPIRATORY TRACT INFLAMMATION,Interstitial lung disease|Bronchitis,2,1
10221486,20140606,Crizotinib,63,801,63.0,1,104,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|METOPROLOL TARTRATE|METOPROLOL|METOPROLOL TARTRATE|METOPROLOL|OMEPRAZOLE MAGNESIUM|OXYCODONE|LORAZEPAM|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|PROCHLORPERAZINE|WARFARIN SODIUM|WARFARIN|NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE|DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE,14,HEPATIC CANCER|HYPERTENSION|PAIN|NAUSEA|NAUSEA|URINARY TRACT INFECTION|DIARRHOEA|PAIN|SOFT TISSUE INFECTION,Sepsis,1,1
10223979,20140609,Crizotinib,51,801,51.0,2,41,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|FUROSEMIDE,8,NON-SMALL CELL LUNG CANCER,Disease progression|Non-small cell lung cancer,2,1
10223983,20140609,Crizotinib,82,801,82.0,1,51.5,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Pulmonary oedema,1,1
10224042,20140609,Crizotinib,60,801,60.0,2,60,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Renal impairment,1,1
10224164,20140609,Crizotinib,68,801,68.0,2,,1,0,0,0,0,0,0,Crizotinib,SERTRALINE HYDROCHLORIDE|INSULIN ASPART|HYDROCHLOROTHIAZIDE|LOSARTAN POTASSIUM|LOSARTAN|CRIZOTINIB|INSULIN GLARGINE|CRIZOTINIB,7,LUNG NEOPLASM MALIGNANT,Paraesthesia|Hypoaesthesia|Abdominal discomfort,3,3
10224177,20140609,Crizotinib,55,801,55.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Abdominal distension,1,3
10224182,20140609,Crizotinib,59,801,59.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Peripheral swelling|Rash,2,2
10224315,20140609,Crizotinib,79,801,79.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Lung neoplasm malignant|Disease progression,2,3
10224359,20140609,Crizotinib,49,801,49.0,2,62.5,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,2,LEIOMYOSARCOMA,Off label use|Nausea,2,3
10224479,20140609,Crizotinib,61,801,61.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Bacterial sepsis|Respiratory failure,2,3
10224650,20140609,Crizotinib,55,801,55.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10227873,20140610,Crizotinib,,,,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,SARCOMA,Off label use|Pancytopenia|Bone marrow failure,3,1
10227874,20140610,Crizotinib,,,,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,SARCOMA,Off label use|Pancytopenia|Aplastic anaemia,3,1
10229988,20140611,Crizotinib,34,801,34.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Death,1,1
10230090,20140611,Crizotinib,71,801,71.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dysphagia|Vomiting,2,3
10230098,20140611,Crizotinib,73,801,73.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB,3,NEOPLASM MALIGNANT,Visual impairment|Rash|Liver function test abnormal|Neoplasm malignant|Vomiting|Dizziness|Neck mass|Nausea|Thrombosis|Disease progression|Headache,11,3
10230128,20140611,Crizotinib,48,801,48.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Rash|Vitreous floaters|Acne,3,3
10230630,20140611,Crizotinib,69,801,69.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,TRACHEAL CANCER,Death|Off label use,2,3
10230702,20140611,Crizotinib,52,801,52.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10230961,20140611,Crizotinib,6,801,6.0,1,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|ISOTRETINOIN,2,,Insomnia|Hallucination|Memory impairment|Constipation,4,3
10232427,20140612,Crizotinib,77,801,77.0,1,90.7,1,1,1,0,0,0,1,Crizotinib,CARBOPLATIN|CARBOPLATIN|PEMETREXED|PEMETREXED DISODIUM|PEMETREXED|PEMETREXED DISODIUM|CRIZOTINIB,5,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Disease progression|Non-small cell lung cancer|Transaminases increased|Dyspnoea exertional|Confusional state|Pain|General physical health deterioration|Thrombocytopenia|Asthenia|Decreased appetite|Generalised oedema|Oedema,12,3
10232988,20140612,Crizotinib,63,801,63.0,1,107,1,0,0,0,0,0,0,Crizotinib,LISINOPRIL|FOLIC ACID|LEVOTHYROXINE SODIUM|CRIZOTINIB|AMLODIPINE BESYLATE|CARVEDILOL,7,HYPOTHYROIDISM|LUNG NEOPLASM MALIGNANT,Semen discolouration,1,1
10233003,20140612,Crizotinib,81,801,81.0,1,47.6,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|SIMVASTATIN,2,LUNG NEOPLASM MALIGNANT,Blood potassium increased|Blood potassium decreased,2,5
10233030,20140612,Crizotinib,53,801,53.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Oedema,1,3
10233054,20140612,Crizotinib,31,801,31.0,1,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Pneumonia|Hallucination,2,5
10234350,20140612,Crizotinib,16,801,16.0,2,72.29,1,0,1,0,0,0,0,Crizotinib,"DEXAMETHASONE|DEXAMETHASONE 1.5 MG|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|CRIZOTINIB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|CYTARABINE|IFOSFAMIDE|METHOTREXATE|METHOTREXATE SODIUM|METHOTREXATE|METHOTREXATE SODIUM|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",10,ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES|ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES|ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES|ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES|ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES|ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES,Convulsion|Posterior reversible encephalopathy syndrome,2,5
10235389,20140613,Crizotinib,48,801,48.0,2,90.2,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT|PAIN,Disease progression|Lung neoplasm malignant,2,5
10235416,20140613,Crizotinib,66,801,66.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Death,1,3
10235422,20140613,Crizotinib,71,801,71.0,1,59,1,1,1,1,0,0,1,Crizotinib,PREGABALIN|CRIZOTINIB,8,NON-SMALL CELL LUNG CANCER,Pneumonia cytomegaloviral|Interstitial lung disease,2,1
10236653,20140613,Crizotinib,66,801,66.0,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Hemiparesis|Chest pain|Gait disturbance,3,2
10236656,20140613,Crizotinib,61,801,61.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,3
10238272,20140616,Crizotinib,78,801,78.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dyspnoea|Hypersensitivity,2,3
10238300,20140616,Crizotinib,67,801,67.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Vomiting,1,3
10238535,20140613,Crizotinib,46,801,46.0,2,71,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Alanine aminotransferase increased|Aspartate aminotransferase increased,2,1
10238587,20140616,Crizotinib,42,801,42.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,3
10238865,20140616,Crizotinib,6,801,6.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,RENAL CANCER,Nausea,1,1
10241172,20140617,Crizotinib,71,801,71.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,2
10241289,20140617,Crizotinib,43,801,43.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Abdominal pain upper|Abdominal discomfort|Swelling|Hepatic enzyme increased,4,2
10241294,20140617,Crizotinib,49,801,49.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,NON-SMALL CELL LUNG CANCER,Diarrhoea|Rash,2,3
10241346,20140617,Crizotinib,70,801,70.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Muscle strain,1,3
10242173,20140617,Crizotinib,76,801,76.0,1,63,1,0,1,0,0,0,1,Crizotinib,CRIZOTINIB,2,NON-SMALL CELL LUNG CANCER,Proctitis|Lower gastrointestinal haemorrhage,2,1
10242298,20140617,Crizotinib,66,801,66.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,3
10242305,20140617,Crizotinib,72,801,72.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10242334,20140617,Crizotinib,47,801,47.0,2,,1,0,0,0,0,0,1,Crizotinib,"CRIZOTINIB|CRIZOTINIB|HYDROMORPHONE HYDROCHLORIDE|ERGOCALCIFEROL|DRONABINOL|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|ZINC|ZINC GLUCONATE|ZINC CHLORIDE|LORAZEPAM|LEVOTHYROXINE SODIUM|CRIZOTINIB",16,LUNG NEOPLASM MALIGNANT,Fatigue|Vomiting|Lung neoplasm malignant|Paraesthesia|Oesophageal pain|Dyspepsia|Nausea|Convulsion|Gastrooesophageal reflux disease|Vitreous floaters|Yellow skin|Pruritus|Disease progression,13,2
10242417,20140617,Crizotinib,59,801,59.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10242476,20140617,Crizotinib,42,801,42.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10243555,20140618,Crizotinib,40,801,40.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10244095,20140618,Crizotinib,,,,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10244728,20140618,Crizotinib,82,801,82.0,1,67.1,1,1,0,0,0,0,0,Crizotinib,CITALOPRAM|INSULIN GLARGINE|INSULIN LISPRO|INSULIN LISPRO|CRIZOTINIB|SENNOSIDES|SENNA LEAF|SENNA,9,PAIN|LUNG ADENOCARCINOMA,Disease progression|Lung adenocarcinoma,2,5
10246449,20140619,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,,Liver function test abnormal,1,1
10246524,20140619,Crizotinib,73,801,73.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Photophobia|Death,2,5
10248235,20140620,Crizotinib,72,801,72.0,2,,1,0,0,0,0,0,1,Crizotinib,CARBOPLATIN|GEMCITABINE HYDROCHLORIDE|CRIZOTINIB,3,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER,Toxicity to various agents,1,1
10249523,20140620,Crizotinib,61,801,61.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Lung neoplasm malignant|Disease progression|Nausea,3,2
10249794,20140620,Crizotinib,55,801,55.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Disease progression|Non-small cell lung cancer,2,2
10252275,20140623,Crizotinib,62,801,62.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Nausea|Joint swelling|Dizziness|Eye movement disorder|Dyspnoea,5,3
10252627,20140623,Crizotinib,,,,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,2
10252633,20140623,Crizotinib,41,801,41.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10252799,20140623,Crizotinib,51,801,51.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Neoplasm malignant|Fatigue|Hepatic enzyme increased|Disease progression|Vision blurred|Diarrhoea,6,3
10253071,20140623,Crizotinib,52,801,52.0,2,58.6,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,4,NON-SMALL CELL LUNG CANCER,Posterior reversible encephalopathy syndrome,1,1
10255085,20140624,Crizotinib,57,801,57.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Death,1,3
10255091,20140624,Crizotinib,45,801,45.0,1,,1,1,1,0,0,0,1,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death|Dysuria|Hyperpyrexia,3,5
10255138,20140624,Crizotinib,72,801,72.0,1,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,BRONCHIAL CARCINOMA,Interstitial lung disease|Alveolitis,2,1
10255276,20140624,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Fatigue,1,1
10257947,20140625,Crizotinib,71,801,71.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG ADENOCARCINOMA,Fatigue|Disease progression|Lung adenocarcinoma|Dizziness|Decreased appetite|Vertigo,6,2
10258033,20140625,Crizotinib,69,801,69.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,2
10259495,20140625,Crizotinib,63,801,63.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,3
10261683,20140626,Crizotinib,54,801,54.0,2,43,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|WARFARIN|PREGABALIN,11,DEHYDRATION|NON-SMALL CELL LUNG CANCER|CONSTIPATION|CANCER PAIN|CONSTIPATION|DEEP VEIN THROMBOSIS|CANCER PAIN|CANCER PAIN|CANCER PAIN,Malaise|Nausea|Vomiting,3,1
10262223,20140626,Crizotinib,33,801,33.0,2,41.8,1,0,1,0,0,0,0,Crizotinib,ZOLPIDEM TARTRATE|OXYCODONE HYDROCHLORIDE|CRIZOTINIB|LANSOPRAZOLE|LUBIPROSTONE|OXYCODONE HYDROCHLORIDE|PREGABALIN,17,NON-SMALL CELL LUNG CANCER|CANCER PAIN,Drug-induced liver injury,1,1
10262494,20140626,Crizotinib,78,801,78.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,3
10264613,20140625,Crizotinib,58,801,58.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,5
10264943,20140627,Crizotinib,72,801,72.0,2,87.75,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Nasopharyngitis|Constipation|Peripheral swelling,3,5
10264989,20140627,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Swelling,1,2
10265039,20140627,Crizotinib,77,801,77.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|LEVOTHYROXINE SODIUM|COLCHICINE,5,LUNG NEOPLASM MALIGNANT,Diarrhoea,1,5
10265931,20140627,Crizotinib,93,801,93.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death,1,3
10265941,20140627,Crizotinib,,,,1,,1,1,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Off label use|Death|Electrolyte imbalance,3,1
10267531,20140630,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Creatinine renal clearance decreased,1,1
10267565,20140630,Crizotinib,90,801,90.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dizziness|Vision blurred,2,3
10267580,20140630,Crizotinib,,,,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Pneumonia,1,3
10268189,20140630,Crizotinib,55,801,55.0,2,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,Bronchopulmonary aspergillosis,1,1
10270287,20140701,Crizotinib,14,801,14.0,1,44.1,1,1,1,0,0,0,0,Crizotinib,ESCITALOPRAM|POLYETHYLENE GLYCOL 3350|CRIZOTINIB|METRONIDAZOLE|MORPHINE SULFATE|MORPHINE SULFATE|METHADONE|METHADONE|LEVOTHYROXINE SODIUM|CETIRIZINE HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE|METHYLPHENIDATE HYDROCHLORIDE|GABAPENTIN,18,PAIN|PAIN|CLEAR CELL SARCOMA OF SOFT TISSUE|PAIN,Disease progression|Clear cell sarcoma of soft tissue|Pain in extremity|Hypoxia,4,1
10270441,20140701,Crizotinib,63,801,63.0,2,77.1,1,0,0,0,0,0,0,Crizotinib,FOLIC ACID|LORAZEPAM|FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|FUROSEMIDE|LORAZEPAM|FAMOTIDINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|CRIZOTINIB|CRIZOTINIB|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|ALBUTEROL SULFATE,13,NAUSEA|NAUSEA|OEDEMA|VOMITING|NAUSEA|VOMITING|LUNG ADENOCARCINOMA|PAIN|DYSPNOEA,Oedema peripheral|Hepatotoxicity|Dyspnoea|Nasal congestion|Abdominal pain upper|Cough|Wheezing|Fatigue|Visual impairment,9,3
10270456,20140701,Crizotinib,58,801,58.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10270658,20140701,Crizotinib,14,801,14.0,1,44,1,1,1,0,0,0,1,Crizotinib,ESCITALOPRAM|CRIZOTINIB|METRONIDAZOLE|MORPHINE|MORPHINE|OXYCODONE|LEVOTHYROXINE SODIUM|METHYLPHENIDATE HYDROCHLORIDE|POLYETHYLENE GLYCOL 3350|GABAPENTIN|METHADONE|CETIRIZINE HYDROCHLORIDE,17,PRODUCT USED FOR UNKNOWN INDICATION|PAIN|PAIN|PAIN|CLEAR CELL SARCOMA OF SOFT TISSUE,Disease progression|Hypoxia|Mental status changes|Malignant neoplasm progression|Asthenia|Pain,6,1
10271482,20140701,Crizotinib,,,,1,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Osteonecrosis,1,1
10273592,20140702,Crizotinib,68,801,68.0,2,49.6,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,6,DIARRHOEA|DECREASED APPETITE|NAUSEA|NON-SMALL CELL LUNG CANCER|GASTROOESOPHAGEAL REFLUX DISEASE|PYREXIA,Mediastinitis,1,1
10274045,20140702,Crizotinib,74,801,74.0,2,49,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|MAGNESIUM OXIDE|FAMOTIDINE|GINKGO BILOBA|MELOXICAM|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE,8,NON-SMALL CELL LUNG CANCER|CONSTIPATION|PAIN|ARTHRALGIA|COUGH|ARTHRALGIA|PAIN|NAUSEA,Vertebral column mass,1,1
10274271,20140702,Crizotinib,71,801,71.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Vomiting,1,3
10274506,20140702,Crizotinib,79,801,79.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER,White blood cell count decreased,1,3
10274566,20140702,Crizotinib,68,801,68.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Death,1,5
10274578,20140702,Crizotinib,,,,2,,1,0,1,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Performance status decreased|Diarrhoea|Vomiting,3,1
10275893,20140703,Crizotinib,64,801,64.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|PEMETREXED DISODIUM,2,LUNG ADENOCARCINOMA|LUNG ADENOCARCINOMA,Disease progression|Iron deficiency anaemia|Peripheral arterial occlusive disease|Lung adenocarcinoma,4,1
10275942,20140703,Crizotinib,80,801,80.0,2,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Pleural effusion|Photopsia|Nausea|Diarrhoea,4,3
10278219,20140704,Crizotinib,66,801,66.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,BRONCHIAL CARCINOMA,Dysgeusia,1,2
10278233,20140704,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,THYMOMA MALIGNANT,Nausea|Vomiting|Off label use,3,2
10278273,20140704,Crizotinib,,,,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM,Nausea|Vitreous floaters|Insomnia,3,5
10279943,20140707,Crizotinib,83,801,83.0,2,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dehydration,1,5
10279947,20140707,Crizotinib,63,801,63.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant|Cardiac failure|Respiratory failure,4,5
10279954,20140707,Crizotinib,40,801,40.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Coma hepatic|Disease progression|Lung neoplasm malignant,3,5
10280370,20140707,Crizotinib,67,801,67.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Lung neoplasm malignant|Cardiac arrest|Disease progression,3,5
10280387,20140707,Crizotinib,56,801,56.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10281911,20140707,Crizotinib,61,801,61.0,2,,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Renal disorder,1,3
10284054,20140708,Crizotinib,61,801,61.0,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB,3,NON-SMALL CELL LUNG CANCER,Pericardial effusion|Non-small cell lung cancer|Oedema peripheral|Disease progression,4,3
10284064,20140708,Crizotinib,66,801,66.0,2,77.1,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dysgeusia,1,5
10284086,20140708,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|PACLITAXEL,2,LUNG NEOPLASM MALIGNANT|LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,5
10284129,20140708,Crizotinib,65,801,65.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB,4,LUNG NEOPLASM MALIGNANT,Lung neoplasm malignant|Death|Disease progression,3,3
10284175,20140708,Crizotinib,,,,0,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Visual impairment,1,1
10284283,20140708,Crizotinib,,,,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Death|Dysgeusia,2,1
10286377,20140709,Crizotinib,49,801,49.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,NON-SMALL CELL LUNG CANCER,Vomiting|Diarrhoea|Dizziness|Disease progression|Nausea|Non-small cell lung cancer,6,3
10286390,20140709,Crizotinib,60,801,60.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,,Neoplasm malignant|Disease progression,2,3
10286395,20140709,Crizotinib,68,801,68.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10286420,20140709,Crizotinib,80,801,80.0,1,,1,1,1,0,0,0,0,Crizotinib,CRIZOTINIB|FOLIC ACID|TAMSULOSIN HYDROCHLORIDE|OXYCODONE HYDROCHLORIDE|OXYCODONE|LORAZEPAM|DUTASTERIDE|CRIZOTINIB|ALBUTEROL SULFATE,8,LUNG NEOPLASM MALIGNANT,Death|Pulmonary embolism,2,3
10286432,20140709,Crizotinib,78,801,78.0,1,61,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Weight decreased|Dysphagia|Diarrhoea|Constipation|Visual field defect|Gastrooesophageal reflux disease|Peripheral swelling|Fluid retention,8,3
10286458,20140709,Crizotinib,57,801,57.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Lung neoplasm malignant|Disease progression,2,2
10286755,20140709,Crizotinib,42,801,42.0,1,,1,0,1,0,0,0,1,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Non-small cell lung cancer metastatic|Pyrexia|Abdominal pain upper|Joint swelling|Photopsia|Hepatic enzyme increased|Disease progression|Diarrhoea|Lower respiratory tract infection|Cardiac tamponade|Rash,11,5
10287362,20140709,Crizotinib,80,801,80.0,2,44,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Oedema peripheral|Vomiting,2,5
10288296,20140709,Crizotinib,,,,0,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Dementia,1,3
10288313,20140709,Crizotinib,46,801,46.0,1,79.7,1,0,1,1,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB|CRIZOTINIB,7,NON-SMALL CELL LUNG CANCER,Cerebral haemorrhage,1,1
10288327,20140709,Crizotinib,87,801,87.0,2,,1,0,0,0,0,0,1,Crizotinib,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CRIZOTINIB,2,DYSPEPSIA|LUNG NEOPLASM MALIGNANT,Dementia,1,3
10289500,20140710,Crizotinib,71,801,71.0,1,65,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,2,,Pericarditis|Hyperglycaemia|Hepatic function abnormal,3,1
10290767,20140710,Crizotinib,,,,1,,1,1,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Pneumonia|Death,2,1
10296256,20140711,Crizotinib,52,801,52.0,1,74,1,1,1,0,0,0,0,Crizotinib,GLYCERIN|GLYCERIN SUPPOSITORIES|TELMISARTAN|CRIZOTINIB|DICLOFENAC SODIUM|GLYCERIN|GLYCERIN SUPPOSITORIES|SENNOSIDES|SENNA LEAF|SENNA|MORPHINE SULFATE|MISOPROSTOL|GLYCERIN|GLYCERIN SUPPOSITORIES,23,NON-SMALL CELL LUNG CANCER,Abdominal pain upper|Nausea|Non-small cell lung cancer|Disease progression|Decreased appetite,5,1
10296284,20140711,Crizotinib,,,,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG CANCER METASTATIC,Death,1,1
10296508,20140710,Crizotinib,,,,0,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Diverticular perforation,1,1
10297361,20140711,Crizotinib,45,801,45.0,2,61,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,COLORECTAL CANCER,Pyrexia,1,1
10297580,20140711,Crizotinib,,,,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Diarrhoea|Decreased appetite,2,2
10297590,20140711,Crizotinib,,,,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,,Abasia,1,3
10297625,20140711,Crizotinib,51,801,51.0,2,,1,0,0,0,0,0,1,Crizotinib,LORATADINE PSEUDOEPHEDRINE SULFATE|LORATADINE AND PSEUDOEPHEDRINE SULFATE|ENOXAPARIN SODIUM|CRIZOTINIB,4,DEEP VEIN THROMBOSIS|LUNG CANCER METASTATIC,Hepatic enzyme increased,1,2
10298307,20140711,Crizotinib,53,801,53.0,2,44.9,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,3,NON-SMALL CELL LUNG CANCER|PROPHYLAXIS OF NAUSEA AND VOMITING|ABDOMINAL PAIN UPPER,White blood cell count decreased|Neutropenia,2,1
10298384,20140711,Crizotinib,64,801,64.0,2,36.6,1,1,1,0,0,0,0,Crizotinib,RISPERIDONE|AMIKACIN SULFATE|WHITE PETROLATUM|PETROLATUM|SKIN PROTECTANT|CRIZOTINIB|HUMAN INSULIN|DEXTROSE ANHYDROUS|DEXTROSE ANHYDROUS,41,NON-SMALL CELL LUNG CANCER,Non-small cell lung cancer|Depressed level of consciousness|Disease progression,3,1
10298726,20140711,Crizotinib,41,801,41.0,2,47.17,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV,Oesophagitis|Dysphagia,2,3
10299318,20140711,Crizotinib,45,801,45.0,1,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Vision blurred|Joint swelling|Peripheral swelling,3,5
10300940,20140714,Crizotinib,58,801,58.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Lung neoplasm malignant|Disease progression,2,3
10300947,20140714,Crizotinib,58,801,58.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Non-small cell lung cancer metastatic|Disease progression,2,3
10300965,20140714,Crizotinib,69,801,69.0,1,,1,0,0,0,0,0,0,Crizotinib,FUROSEMIDE|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|CRIZOTINIB|LISINOPRIL|MAGNESIUM OXIDE|PRASUGREL HYDROCHLORIDE|CARVEDILOL,9,LUNG NEOPLASM MALIGNANT|NAUSEA,Epistaxis,1,3
10300983,20140714,Crizotinib,55,801,55.0,2,,1,0,0,0,0,0,1,Crizotinib,MEMANTINE HYDROCHLORIDE|TRIAZOLAM|CRIZOTINIB|OXYCODONE|CRIZOTINIB,7,SLEEP DISORDER|COUGH|NON-SMALL CELL LUNG CANCER STAGE IV,Somnolence|Asthenia|Gait disturbance|General physical health deterioration|Dizziness|Lethargy|Oesophageal food impaction|Balance disorder|Decreased appetite|Off label use|Alopecia|Blood glucose increased|Fatigue,13,3
10301148,20140714,Crizotinib,54,801,54.0,1,95,1,1,1,0,0,0,0,Crizotinib,HYDROCORTISONE|CRIZOTINIB|CRIZOTINIB,4,NON-SMALL CELL LUNG CANCER METASTATIC,Respiratory failure|Oedema,2,1
10301162,20140714,Crizotinib,70,801,70.0,2,,1,0,1,0,0,0,0,Crizotinib,RIVAROXABAN|CRIZOTINIB,2,THROMBOSIS PROPHYLAXIS|NON-SMALL CELL LUNG CANCER,Thrombocytopenia,1,1
10301170,20140714,Crizotinib,75,801,75.0,1,63.2,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB|FUROSEMIDE|FUROSEMIDE|FUROSEMIDE|ESOMEPRAZOLE MAGNESIUM|FUROSEMIDE,24,NON-SMALL CELL LUNG CANCER|OEDEMA,Dermatitis|Pneumonia|Renal impairment|Oedema peripheral,4,1
10305371,20140715,Crizotinib,46,801,46.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG ADENOCARCINOMA,Oesophageal ulcer,1,1
10305384,20140715,Crizotinib,39,801,39.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Glomerular filtration rate decreased,1,1
10305497,20140715,Crizotinib,58,801,58.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Death,1,2
10305509,20140715,Crizotinib,60,801,60.0,2,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB|FOLIC ACID|LEVETIRACETAM|METOPROLOL TARTRATE|METOROPROLOL TARTRATE|METOPROLOL|FENTANYL,9,LUNG NEOPLASM MALIGNANT,Disease progression|Lung neoplasm malignant,2,3
10305623,20140715,Crizotinib,73,801,73.0,2,87.5,1,0,1,0,0,0,0,Crizotinib,CRIZOTINIB,1,INFLAMMATORY MYOFIBROBLASTIC TUMOUR,Off label use|Biliary tract infection|Bile duct obstruction|Photopsia,4,5
10306677,20140715,Crizotinib,71,801,71.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Dyspnoea,1,2
10306686,20140715,Crizotinib,66,801,66.0,1,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Hypersensitivity,1,3
10308148,20140716,Crizotinib,24,801,24.0,1,,1,1,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Lung neoplasm malignant|Renal failure|Disease progression|Cardiac failure,4,5
10308153,20140716,Crizotinib,50,801,50.0,2,,1,0,0,0,0,0,1,Crizotinib,CRIZOTINIB,1,NON-SMALL CELL LUNG CANCER METASTATIC,Off label use|Erosive oesophagitis,2,1
10310257,20140717,Crizotinib,76,801,76.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,LUNG NEOPLASM MALIGNANT,Peripheral swelling|Liver disorder|Constipation,3,3
10310293,20140717,Crizotinib,50,801,50.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB|CRIZOTINIB,2,LUNG NEOPLASM MALIGNANT,Thyroid function test abnormal|Pain|Anxiety|Gastrointestinal disorder|Cough|Vomiting|Insomnia|Dysphonia|Visual impairment|Diarrhoea,10,3
10310625,20140717,Crizotinib,57,801,57.0,2,,1,0,0,0,0,0,0,Crizotinib,CRIZOTINIB,1,NEOPLASM MALIGNANT,Disease progression|Neoplasm malignant,2,1
10240907,20140617,Palbociclib,45,801,45.0,2,77.1,1,0,1,0,0,0,1,Palbociclib,NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|ESCITALOPRAM|CALCIUM CARBONATE|PALBOCICLIB|CETIRIZINE HYDROCHLORIDE|MULTIVITAMIN|LETROZOLE|LETROZOLE TABLETS|DENOSUMAB,9,BONE PAIN|SUPPLEMENTATION THERAPY|DEPRESSION|GASTROOESOPHAGEAL REFLUX DISEASE|BREAST CANCER|SEASONAL ALLERGY|SUPPLEMENTATION THERAPY|BREAST CANCER METASTATIC,Pancreatitis acute,1,1
10332289,20140722,Palbociclib,86,801,86.0,1,76.8,1,0,0,0,0,0,1,Palbociclib,ALLOPURINOL|LEVOTHYROXINE|POTASSIUM CHLORIDE|BUMETANIDE|FILGRASTIM|METOPROLOL TARTRATE|METOPROLOL|CITALOPRAM|CITALOPRAM HYDROBROMIDE|ERYTHROPOIETIN|PALBOCICLIB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,12,NEPHROLITHIASIS|HYPOTHYROIDISM|MINERAL SUPPLEMENTATION|MINERAL SUPPLEMENTATION|PRODUCT USED FOR UNKNOWN INDICATION|HYPERTENSION|DEPRESSION|MYELODYSPLASTIC SYNDROME|POLLAKIURIA|NEOPLASM MALIGNANT|ANTICOAGULANT THERAPY,Thrombocytopenia|Pruritus,2,3
10367198,20140807,Palbociclib,,,,0,,1,0,0,1,0,0,1,Palbociclib,PALBOCICLIB|SIMVASTATIN|PALBOCICLIB,3,NON-SMALL CELL LUNG CANCER RECURRENT|NON-SMALL CELL LUNG CANCER,Rhabdomyolysis|Transaminases increased,2,3
10403214,20140822,Palbociclib,76,801,76.0,2,59.9,1,0,1,0,0,0,0,Palbociclib,TRAMETINIB|PALBOCICLIB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN,5,NON-SMALL CELL LUNG CANCER|NON-SMALL CELL LUNG CANCER|PAIN|ABDOMINAL PAIN,Alanine aminotransferase increased|Lipase increased|Blood culture positive|Troponin T increased|Ejection fraction decreased|Aspartate aminotransferase increased,6,1
10438558,20140908,Palbociclib,64,801,64.0,1,95.4,1,0,1,0,0,0,1,Palbociclib,PALBOCICLIB|TRAMETINIB|TRAMETINIB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Diarrhoea|Small intestinal obstruction|Pneumonia|Blood creatine phosphokinase increased|Vomiting|Lipase increased|Blood creatine phosphokinase MB increased|Amylase increased,8,1
10448211,20140911,Palbociclib,65,801,65.0,1,108.5,1,0,1,0,0,0,1,Palbociclib,PALBOCICLIB|TRAMETINIB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Staphylococcal sepsis,1,1
10494840,20141003,Palbociclib,72,801,72.0,2,76,1,1,0,0,0,0,1,Palbociclib,FULVESTRANT|SERTRALINE|METOCLOPRAMIDE|METOCLOPRAMIDE HYDROCHLORIDE|PALBOCICLIB,7,CARDIOVASCULAR EVENT PROPHYLAXIS|BREAST CANCER METASTATIC|DEPRESSION|HYPERTENSION|NAUSEA|BREAST CANCER METASTATIC|HYPERTENSION,Thinking abnormal|Nausea|Metastases to central nervous system|Headache|Fatigue|Mucosal inflammation|Oedema peripheral|Breast cancer metastatic|Seizure|Cough|Abdominal distension|Unresponsive to stimuli|Dyspnoea|Metastases to liver|Type 2 diabetes mellitus|Hypertension|Hydrocephalus|Vomiting|Back pain|Cerebral haemorrhage,20,5
10535314,20141022,Palbociclib,46,801,46.0,2,120.4,1,0,1,0,0,0,1,Palbociclib,PROCHLORPERAZINE MALEATE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|POLYETHYLENE GLYCOL 3350|SENNOSIDES|SENNA LEAF|SENNA|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|TRAMETINIB|PALBOCICLIB|LOPERAMIDE HYDROCHLORIDE|LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE|DOCUSATE SODIUM|DOCUSATE SODIUM - SENNOSIDES,10,NAUSEA|BLOOD MAGNESIUM DECREASED|HYPOKALAEMIA|CONSTIPATION|CONSTIPATION|PAIN|COLORECTAL ADENOCARCINOMA|COLORECTAL ADENOCARCINOMA|DIARRHOEA|CONSTIPATION,Thrombosis in device,1,1
10564770,20141105,Palbociclib,,,,2,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB|VEMURAFENIB,2,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Interstitial lung disease,1,1
10572098,20141107,Palbociclib,68,801,68.0,2,82.6,1,0,1,0,0,0,0,Palbociclib,TRAMETINIB|PALBOCICLIB,2,NEOPLASM|NEOPLASM,Troponin I increased|Dyspnoea|Ejection fraction decreased,3,1
10578833,20141112,Palbociclib,78,801,78.0,2,49,1,0,0,0,1,0,1,Palbociclib,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FULVESTRANT|DENOSUMAB|FULVESTRANT|PALBOCICLIB|ALPRAZOLAM|ALPRAZOLAM|PALBOCICLIB,13,GASTROOESOPHAGEAL REFLUX DISEASE|BREAST CANCER METASTATIC|BLOOD CHOLESTEROL INCREASED|INSOMNIA|METASTASES TO BONE|BREAST CANCER METASTATIC|BREAST CANCER STAGE IV|PAIN|INSOMNIA|PAIN|BREAST CANCER STAGE IV|CLOSTRIDIUM DIFFICILE INFECTION|CLOSTRIDIUM DIFFICILE INFECTION,Asthenia|Visual impairment|Bone pain|Fatigue|Insomnia|Ataxia|Cough,7,1
10608810,20141125,Palbociclib,30,801,30.0,2,,1,0,1,0,0,0,1,Palbociclib,,2,COLORECTAL CANCER METASTATIC|COLORECTAL CANCER METASTATIC,Alanine aminotransferase increased|Small intestinal obstruction|Abdominal pain|Vomiting|Aspartate aminotransferase increased|Nausea,6,1
10627187,20141204,Palbociclib,49,801,49.0,1,89.4,1,0,1,0,0,0,0,Palbociclib,FENTANYL CITRATE|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER,9,NEOPLASM|PAIN|PAIN|PAIN|PAIN|FLUSHING|NEOPLASM|PAIN|PAIN,Epistaxis,1,1
10643344,20141128,Palbociclib,,,,2,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB,2,COLORECTAL CANCER|COLORECTAL CANCER,Intra-abdominal haemorrhage,1,
10655395,20141216,Palbociclib,49,801,49.0,1,89.4,1,0,1,0,0,0,0,Palbociclib,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,3,NEUROENDOCRINE TUMOUR|NEUROENDOCRINE TUMOUR|ANEURYSM,Epistaxis,1,1
10681067,20141229,Palbociclib,81,801,81.0,2,75.7,1,0,1,0,0,0,1,Palbociclib,"LETROZOLE|LETROZOLE TABLETS|ATORVASTATIN CALCIUM|FILGRASTIM|NIFEDIPINE|ALPRAZOLAM|LORATADINE PSEUDOEPHEDRINE SULFATE|LORATADINE AND PSEUDOEPHEDRINE SULFATE|FAMOTIDINE|FILGRASTIM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PALBOCICLIB|PALBOCICLIB",17,BREAST CANCER|HYPERLIPIDAEMIA|PROPHYLAXIS|HYPERTENSION|INSOMNIA|RHINITIS ALLERGIC|GASTROOESOPHAGEAL REFLUX DISEASE|PROPHYLAXIS|PROPHYLAXIS|MYALGIA|PROPHYLAXIS|BREAST CANCER STAGE IV|MYALGIA|MYALGIA|GASTROOESOPHAGEAL REFLUX DISEASE,Neutropenia|Electrocardiogram QT prolonged|Alopecia|Gastrooesophageal reflux disease|Oedema peripheral|Asthenia|Chest pain|Constipation,8,1
10681756,20141230,Palbociclib,63,801,63.0,2,87,1,0,1,0,0,0,0,Palbociclib,DIAZEPAM|PALBOCICLIB|PROMETHAZINE HYDROCHLORIDE|PROMETHAZINE|METHYLPREDNISOLONE|FULVESTRANT,7,ANXIETY|BREAST CANCER METASTATIC|PROPHYLAXIS OF NAUSEA AND VOMITING|BREAST CANCER METASTATIC|MIGRAINE,Chronic obstructive pulmonary disease|Troponin increased|Sedation,3,1
10707357,20150112,Palbociclib,37,801,37.0,2,45.02,1,0,1,0,0,0,0,Palbociclib,"LEVOTHYROXINE SODIUM|BACLOFEN|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|VITAMIN E|CETUXIMAB|AZITHROMYCIN DIHYDRATE|FENTANYL|GABAPENTIN|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|NIACIN|FLUCONAZOLE|TRIAMCINOLONE ACETONIDE|TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%|PALBOCICLIB|SENNOSIDES|SENNA LEAF|SENNA|MINOCYCLINE|MULTIVITAMIN|BENZONATATE|MIRTAZAPINE|GUAIFENESIN|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|SALSALATE",29,SQUAMOUS CELL CARCINOMA|SQUAMOUS CELL CARCINOMA,Tumour pain|Pneumonia|Malignant neoplasm progression|Lethargy|Squamous cell carcinoma,5,3
10716094,20150115,Palbociclib,37,801,37.0,2,45.02,1,1,1,0,0,0,0,Palbociclib,"LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|SALSALATE|MIRTAZAPINE|VITAMIN E|AZITHROMYCIN DIHYDRATE|BENZONATATE|FENTANYL|FLUCONAZOLE|NIACIN|PALBOCICLIB|BACLOFEN|SENNOSIDES|SENNA LEAF|SENNA|TRIAMCINOLONE ACETONIDE|TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|GUAIFENESIN|MINOCYCLINE|GABAPENTIN|HYDROCODONE BITARTRATE AND ACETAMINOPHEN|MULTIVITAMIN|LEVOTHYROXINE SODIUM|CETUXIMAB",29,SQUAMOUS CELL CARCINOMA|SQUAMOUS CELL CARCINOMA,Pneumonia|Tumour pain|Lung infection|Disease progression,4,3
10716270,20150115,Palbociclib,37,801,37.0,2,45.02,1,0,1,0,0,0,0,Palbociclib,"CETUXIMAB|LEVOFLOXACIN|LEVOFLOXACIN IN 5% DEXTROSE|VITAMIN E|FENTANYL|BACLOFEN|MIRTAZAPINE|MULTIVITAMIN|AZITHROMYCIN DIHYDRATE|LEVOTHYROXINE SODIUM|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|GUAIFENESIN|BENZONATATE|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|SENNOSIDES|SENNA LEAF|SENNA|FLUCONAZOLE|GABAPENTIN|MINOCYCLINE|NIACIN|SALSALATE",28,SQUAMOUS CELL CARCINOMA|SQUAMOUS CELL CARCINOMA,Tumour pain|Pneumonia|Lethargy|Lung infection,4,3
10749771,20150129,Palbociclib,71,801,71.0,1,84.4,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB|TRAMETINIB|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE,4,NEOPLASM|NEOPLASM|FATIGUE|MALAISE,Fatigue,1,1
10770033,20150206,Palbociclib,59,801,59.0,2,59,1,0,1,0,0,0,0,Palbociclib,LETROZOLE|PALBOCICLIB|AZITHROMYCIN|AZITHROMYCIN MONOHYDRATE|AZITHROMYCIN DIHYDRATE,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|SINUSITIS,Hepatic enzyme abnormal|Intestinal dilatation|Gastrointestinal toxicity|Clostridium difficile colitis,4,3
10791390,20150213,Palbociclib,58,801,58.0,2,67,1,0,1,0,0,0,0,Palbociclib,EXEMESTANE|OXYCODONE|RANITIDINE|TIOTROPIUM BROMIDE|DICLOFENAC|DICLOFENAC SODIUM|CAPSAICIN|ARTHRITIS PAIN RELIEF|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|PALBOCICLIB|FULVESTRANT|ALPRAZOLAM|ERGOCALCIFEROL,18,BREAST CANCER METASTATIC,Renal impairment,1,3
10791394,20150213,Palbociclib,79,801,79.0,2,54,1,0,1,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|QUININE|TEMAZEPAM|DALTEPARIN SODIUM|OXYCODONE|METOPROLOL SUCCINATE|PALBOCICLIB|CELECOXIB,9,BREAST CANCER METASTATIC|MUSCLE SPASMS|SLEEP DISORDER|PULMONARY EMBOLISM|PAIN|HYPERTENSION|BREAST CANCER METASTATIC|PAIN|VITAMIN SUPPLEMENTATION,Pulmonary embolism,1,3
10792732,20150211,Palbociclib,63,801,63.0,2,87.18,1,0,1,0,0,0,0,Palbociclib,"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE|BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE|BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES",2,MIGRAINE,Sedation|Troponin increased|Chronic obstructive pulmonary disease,3,1
10793180,20150213,Palbociclib,51,801,51.0,2,70,1,0,0,0,0,0,1,Palbociclib,"PALBOCICLIB|PREDNISONE|CALCIUM|FULVESTRANT|DIPHENHYDRAMINE|DIPHENHYDRAMINE HYDROCHLORIDE|STANDARDIZED SENNA CONCENTRATE|GOSERELIN|ERGOCALCIFEROL|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN",10,BREAST CANCER METASTATIC|PROPHYLAXIS|SUPPLEMENTATION THERAPY|BREAST CANCER METASTATIC|PROPHYLAXIS|CONSTIPATION|BREAST CANCER METASTATIC|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY|ARTHRALGIA,Alanine aminotransferase increased,1,3
10793230,20150213,Palbociclib,73,801,73.0,2,69.39,1,0,1,0,0,0,0,Palbociclib,LORAZEPAM|LORAZEPAM|GABAPENTIN|FENTANYL|LOSARTAN POTASSIUM|LOSARTAN|ALLOPURINOL|MORPHINE SULFATE|PALBOCICLIB|FUROSEMIDE|LETROZOLE|LETROZOLE TABLETS,11,NAUSEA|VOMITING|NEUROPATHY PERIPHERAL|PAIN|PAIN|HYPERTENSION|GOUT|PAIN|BREAST CANCER METASTATIC|OEDEMA PERIPHERAL|BREAST CANCER METASTATIC,Acute kidney injury,1,1
10802745,20150217,Palbociclib,68,801,68.0,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER|BREAST CANCER,Urinary tract infection,1,3
10803349,20150217,Palbociclib,62,801,62.0,2,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB|LISINOPRIL,5,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Electrocardiogram QT prolonged|Anaemia|Nausea|Liver function test abnormal|Low density lipoprotein increased|Bone marrow failure|Blood glucose increased,7,3
10815821,20150218,Palbociclib,73,801,73.0,2,65,1,0,1,0,0,0,1,Palbociclib,PALBOCICLIB|FULVESTRANT|RAMIPRIL|BISOPROLOL FUMARATE,8,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|NAUSEA|COUGH|HYPERTENSION|HYPERTENSION|PROPHYLAXIS|PROPHYLAXIS,Pericarditis|Electrocardiogram QT prolonged,2,1
10818601,20150218,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Nausea,1,5
10830675,20150219,Palbociclib,73,801,73.0,2,64,1,0,1,0,0,0,0,Palbociclib,ZOLEDRONIC ACID|VALSARTAN|VALSARTAN ORAL|LATANOPROST|FULVESTRANT|BUPRENORPHINE|DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|PALBOCICLIB,8,METASTASES TO BONE|HYPERTENSION|GLAUCOMA|BREAST CANCER METASTATIC|PAIN|GLAUCOMA|DIABETES MELLITUS|BREAST CANCER METASTATIC,Deep vein thrombosis,1,1
10844787,20150220,Palbociclib,48,801,48.0,2,35.7,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|PAMIDRONATE DISODIUM|FULVESTRANT,5,BREAST CANCER METASTATIC|BACK PAIN|METASTASES TO BONE|BREAST CANCER METASTATIC|PREMEDICATION,Otitis media acute|Pharyngitis,2,3
10853662,20150223,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Dysphagia,1,2
10855425,20150223,Palbociclib,66,801,66.0,2,65,1,0,1,0,0,0,0,Palbociclib,DENOSUMAB|PALBOCICLIB|FULVESTRANT|AMLODIPINE,8,OSTEOPOROSIS|OSTEOPOROSIS|METASTASES TO BONE|CONJUNCTIVITIS|BREAST CANCER METASTATIC|GLAUCOMA|BREAST CANCER METASTATIC|HYPERTENSION,Small intestinal obstruction,1,3
10856075,20150223,Palbociclib,71,801,71.0,1,81,1,1,1,0,0,0,0,Palbociclib,ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PALBOCICLIB|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|ALBUTEROL SULFATE|ALBUTEROL|LORAZEPAM|TERAZOSIN|TERAZOSIN HYDROCHLORIDE|ALBUTEROL SULFATE|ALBUTEROL|TIOTROPIUM BROMIDE|PREDNISONE|ALBUTEROL SULFATE|ALBUTEROL|LORAZEPAM|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,15,ASTHMA|NAUSEA|SQUAMOUS CELL CARCINOMA OF LUNG|DEPRESSION|WHEEZING|SLEEP DISORDER|COUGH|BENIGN PROSTATIC HYPERPLASIA|COUGH|COUGH|DYSPNOEA|ASTHMA PROPHYLAXIS|NAUSEA|VOMITING,Dyspnoea,1,3
10874092,20150227,Palbociclib,62,801,62.0,2,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB|LISINOPRIL|LETROZOLE|LETROZOLE TABLETS,5,,Electrocardiogram QT prolonged|Anaemia|Bone marrow failure|Aspartate aminotransferase increased|Nausea|Gamma-glutamyltransferase increased,6,1
10874766,20150227,Palbociclib,64,801,64.0,1,95,1,0,1,0,0,0,1,Palbociclib,PALBOCICLIB|TRAMETINIB|TRAMETINIB,3,MALIGNANT MELANOMA|MALIGNANT MELANOMA,Small intestinal obstruction|Blood creatine phosphokinase MB increased|Lipase increased|Vomiting|Pneumonia|Blood creatine phosphokinase increased|Amylase increased|Diarrhoea,8,1
10880982,20150303,Palbociclib,67,801,67.0,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER METASTATIC,Breast cancer metastatic|Disease progression,2,1
10886036,20150304,Palbociclib,68,801,68.0,2,68,1,0,1,0,0,0,0,Palbociclib,"PALBOCICLIB|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|SENNOSIDES|SENNA LEAF|SENNA|DENOSUMAB|LETROZOLE|LETROZOLE TABLETS|KETOPROFEN|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%",11,BREAST CANCER|CANCER PAIN|CANCER PAIN|HYPERTENSION|CONSTIPATION|PROPHYLAXIS|BREAST CANCER|BREAST CANCER|CANCER PAIN|CANCER PAIN|GASTRITIS PROPHYLAXIS,Urinary tract infection,1,1
10886987,20150304,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Malaise,1,5
10889212,20150305,Palbociclib,81,801,81.0,2,51,1,0,1,0,0,0,1,Palbociclib,"CARVEDILOL|IPRATROPIUM BROMIDE|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|CARVEDILOL|GABAPENTIN|LORAZEPAM|IRBESARTAN|ERGOCALCIFEROL|SENNOSIDES|SENNA LEAF|SENNA|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|HYDROMORPHONE HYDROCHLORIDE|LORAZEPAM|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|ATORVASTATIN CALCIUM|LORAZEPAM|METHYLPHENIDATE HYDROCHLORIDE",25,ASTHMA|CARDIOPULMONARY FAILURE|OSTEOPOROSIS|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|BREAST CANCER|BREAST CANCER|HYPERTENSION|CHRONIC OBSTRUCTIVE PULMONARY DISEASE|SLEEP DISORDER|HYPERTENSION|SUPPLEMENTATION THERAPY|VITAMIN B12 DEFICIENCY|CONSTIPATION|ASTHMA|PAIN|NAUSEA|PROPHYLAXIS|COUGH|COUGH|NAUSEA|PAIN|HYPERLIPIDAEMIA|ANXIETY|DEPRESSION,Acute kidney injury|Anaemia,2,3
10891981,20150306,Palbociclib,45,801,45.0,2,84,1,0,1,0,0,0,0,Palbociclib,"ERGOCALCIFEROL|PALBOCICLIB|DIAZEPAM|LORAZEPAM|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|BUPROPION HYDROCHLORIDE|LETROZOLE|LETROZOLE TABLETS|GRANISETRON|GRANISETRON HYDROCHLORIDE|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|ALPRAZOLAM|BUPROPION HYDROCHLORIDE|CYCLOBENZAPRINE|CLONAZEPAM|TEMAZEPAM|ADRENALINUM, ARGENTUM NITRICUM, BOS TAURUS PITUITARUM POSTERIUM, GLYCERINUM, GLYCYRRHIZA GLABRA, KALI CARBONICUM, LACTICUM ACIDUM, MAGNESIA SULPHURICA, NICCOLUM METALLICUM, PANCREATINUM, PHOSPHORICUM ACIDUM, SACCHARINUM, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, SELENIUM METALLICUM, SYZYGIUM JAMBOLANUM, THYROIDINUM, ZINCUM METALLICUM|ACONITUM NAPELLUS, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA ALBA, CALENDULA OFFICINALIS, CHAMOMILLA, CHERRY PLUM, CLEMATIS, COLOCYNTHIS, DULCAMARA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPATORIUM PERFOLIATUM, FERRUM PHOSPHORICUM, HAMAMELIS VIRGINIANA, HISTAMINUM, HYPERICUM PERFORATUM, IMPATIENS, MILLEFOLIUM, RHUS TOXICODENDRON, ROCK ROSE, STAR OF BETHLEHEM, SULPHUR, SYMPHYTUM OFFICINALE, VERATRUM ALBUM|ACONITUM NAPELLUS,APIS MELLIFICA,ARNICA MONTANA,ARSENICUM ALBUM,BELLADONNA,BELLIS PERENNIS,BRYONIA,CALENDULA OFFICINALIS,CHAMOMILLA,CHERRY PLUM,CLEMATIS VITALBA,COLOCYNTHIS,COMFREY,DULCAMARA LIGNOSA,ECHINACEA ANGUSTIFOLIA,ECHINACEA PURPUREA,EUPATORIUM PERFOLIATUM,FERRUM PHOSPHORICUM,HAMAMELIS VIRGINIANA,HISTAMINUM,HYPERICUM PERFORATUM,IMPATIENS GLANDULIFERA,LEDUM PALUSTRE,MENTHA PIPERITA,MILLEFOLIUM,ORNITHOGALUM UMBELLATUM,PLANTAGO MAJOR,RHUS TOXICODENDRON,ROCKROSE,SULPHUR,VERATRUM ALBUM,VERBASCUM THAPSUS|ALFALFA, ANTIMONIUM CRUDUM, AVENA SATIVA, BERBERIS VULGARIS, CAJUPUTUM, CARBO ANIMALIS, CARBO VEGETABILIS, CHELIDONIUM MAJUS, FEL TAURI, GENTIANA LUTEA, GLYCYRRHIZA GLABRA, ILLICIUM ANISATUM, INDOLUM, KALI CARBONICUM, LYCOPODIUM CLAVATUM, MAGNESIA PHOSPHORICA, NUX VOMICA, PANCREATINUM, PEPSINUM, RAPHANUS SATIVUS, RHAMNUS PURSHIANA, SKATOLUM|ALLIUM SATIVUM, AVENA SATIVA, CALCAREA CARBONICA, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CALCAREA SULPHURICA, CARBO VEGETABILIS, FERRUM IODATUM, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LACTICUM ACIDUM, MAGNESIA PHOSPHORICA, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, PHOSPHORICUM ACIDUM, URTICA URENS|AVENA SATIVA, CHAMOMILLA, CHERRY PLUM, CLEMATIS VITALBA, COFFEA CRUDA, ENGLISH OAK, ESCHSCHOLTZIA CALIFORNICA, EUROPEAN HORNBEAM, FICUS CARICA, HUMULUS LUPULUS, IGNATIA AMARA, IMPATIENS GLANDULIFERA, KALI PHOSPHORICUM, KALI SILICATUM, MELISSA OFFICINALIS, PASSIFLORA INCARNATA, PHOSPHORICUM ACIDUM, PYRENEES STAR OF BETHLEHEM, ROCKROSE, SUS SCROFA PARASYMPATHETIC NERVE, PINEAL GLAND, SYMPATHETIC NERVE, VALERIANA OFFICINALIS, VERBENA OFFICINALIS, ZINCUM VALERIANICUM|ADRENALINUM, AETHUSA CYNAPIUM, AGNUS CASTUS, ALFALFA, ARGENTUM NITRICUM, AURUM METALLICUM, AVENA SATIVA, CERATOSTIGMA WILLMOTTIANUM FLOWER, CHERRY PLUM FLOWER, DAMIANA, EUROPEAN ASPEN FLOWER, EUROPEAN HORNBEAM FLOWER, GORSE FLOWER, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MANDRAGORA OFFICINARUM, NATRUM MURIATICUM, PASSIFLORA INCARNATA, ROSA CANINA FLOWER, SEPIA, SWEET CHESTNUT FLOWER, THYROIDINUM, WILD MUSTARD FLOWER|BELLADONNA, BLATTA ORIENTALIS, COCCUS CACTI, CORALLIUM RUBRUM, CUPRUM METALLICUM, DROSERA ROTUNDIFOLIA, ECHINACEA ANGUSTIFOLIA, HEDERA HELIX, HYDRASTIS CANADENSIS, IPECACUANHA, KALI NITRICUM, LAC VACCINUM, LOBELIA INFLATA, PASSIFLORA INCARNATA, PERTUSSINUM, SAMBUCUS NIGRA, THYMUS SERPYLLUM, VALERIANA OFFICINALIS|BALSAMUM PERUVIANUM, BORAX, BRYONIA, CALCAREA ACETICA, COCCUS CACTI, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUCALYPTUS GLOBULUS, EUPHORBIUM OFFICINARUM, EUPHRASIA OFFICINALIS, HISTAMINUM HYDROCHLORICUM, IPECACUANHA, KALI BICHROMICUM, LUFFA OPERCULATA, MERCURIUS CYANATUS, MERCURIUS DULCIS, MERCURIUS SULPHURATUS RUBER, NATRUM ARSENICICUM, PANCREATINUM, SAMBUCUS NIGRA, SANGUINARINUM NITRICUM, SAPONARIA OFFICINALIS|ALLIUM CEPA, CALCAREA IODATA, CALCAREA SULPHURICA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPHORBIUM OFFICINARUM, HEPAR SULPHURIS CALCAREUM, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC DEFLORATUM, LUFFA OPERCULATA, MERCURIUS SULPHURATUS RUBER, PHOSPHORUS, PULSATILLA VULGARIS, SACCHARUM LACTIS, THUJA OCCIDENTALIS|ACONITUM NAPELLUS, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BELLADONNA, BRYONIA, CHERRY PLUM, CLEMATIS VITALBA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUCALYPTUS GLOBULUS, EUPATORIUM PERFOLIATUM, EUROPEAN OLIVE, FERRUM PHOSPHORICUM, GENTIANA LUTEA, IMPATIENS GLANDULIFERA, INFLUENZA A VIRUS, LACHESIS MUTUS, LUFFA OPERCULATA, ORNITHOGALUM UMBELLATUM, PHOSPHORUS, ROCKROSE, SARCOLACTICUM ACIDUM, VERATRUM ALBUM, YELLOW JASMINE|ARISTOLOCHIA MILHOMENS, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA, CALENDULA OFFICINALIS, CARBO VEGETABILIS, CHAMOMILLA, CHERRY PLUM FLOWER, CLEMATIS VITALBA FLOWER, ECHINACEA ANGUSTIFOLIA, HAMAMELIS VIRGINIANA, HEPAR SULPHURIS CALCAREUM, HYPERICUM PERFORATUM, IMPATIENS GLANDULIFERA FLOWER, LACHESIS MUTUS, MILLEFOLIUM, PYRENEES STAR OF BETHLEHEM, RHUS TOXICODENDRON, ROCKROSE FLOWER, RUTA GRAVEOLENS, SARCOLACTICUM ACIDUM, SULPHUR IODATUM, SYMPHYTUM OFFICINALE, VERATRUM ALBUM|ACONITUM NAPELLUS, APIS MELLIFICA, ARNICA MONTANA, ARSENICUM ALBUM, BELLADONNA, BELLIS PERENNIS, BRYONIA, CALENDULA, CHAMOMILLA, CHERRY PLUM, CLEMATIS VITALBA, COLOCYNTHIS, DULCAMARA LIGNOSA, ECHINACEA, EUPATORIUM, FERRUM PHOSPHORICUM, HAMAMELIS VIRGINIANA, HISTAMINUM, HYPERICUM PERFORATUM, IMPATIENS GLANDULIFERA, LEDUM PALUSTRE, MENTHA PIPERITA, MILLEFOLIUM, PLANTAGO MAJOR, PYRENEES STAR OF BETHLEHEM, RHUS TOXICODENDRON, ROCKROSE, SULFUR, COMFREY, VERATRUM ALBUM, VERBASCUM THAPSUS|ACETICUM ACIDUM, ADRENALINUM, AMERICAN GINSENG, ARNICA MONTANA, BALSAMUM PERUVIANUM, BOS TAURUS PITUITARUM POSTERIUM, CHERRY PLUM FLOWER, CHININUM ARSENICOSUM, CINCHONA OFFICINALIS, CLEMATIS VITALBA FLOWER, DAMIANA, EUROPEAN HORNBEAM FLOWER, EUROPEAN OLIVE FLOWER, GLYCYRRHIZA GLABRA, IMPATIENS GLANDULIFERA FLOWER, KALI PHOSPHORICUM, LYCOPODIUM CLAVATUM, MAGNESIA PHOSPHORICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, PYRENEES STAR OF BETHLEHEM, ROCKROSE FLOWER, SELENIUM METALLICUM, THYROIDINUM",21,SUPPLEMENTATION THERAPY|BREAST CANCER METASTATIC|ANXIETY|ANXIETY|ARTHRALGIA|ARTHRALGIA|ARTHRALGIA|ARTHRALGIA|ANXIETY|BREAST CANCER METASTATIC|NAUSEA|NAUSEA|ARTHRALGIA|ANXIETY|HOT FLUSH|BACK PAIN|NAUSEA|INSOMNIA|INSOMNIA|SUPPLEMENTATION THERAPY|SUPPLEMENTATION THERAPY,Neutrophil count decreased|Cellulitis,2,3
10897111,20150309,Palbociclib,78,801,78.0,2,61.22,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER FEMALE,Feeling hot|Abdominal pain|Alopecia,3,5
10897218,20150309,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,2,,International normalised ratio abnormal,1,1
10897243,20150309,Palbociclib,24,801,24.0,1,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,RHABDOMYOSARCOMA,Product use issue|Scrotal oedema|Pneumonia,3,3
10899256,20150309,Palbociclib,41,801,41.0,2,,1,1,1,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,BREAST CANCER METASTATIC,Acute hepatic failure|Disease progression|Sepsis|Malaise|Abdominal pain upper|Ascites|Breast cancer metastatic|Jaundice,8,1
10899477,20150309,Palbociclib,73,801,73.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Stomatitis|Dizziness|Oropharyngeal pain,3,5
10900622,20150303,Palbociclib,79,801,79.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Anger|Agitation,2,2
10900818,20150310,Palbociclib,63,801,63.0,2,74,1,0,0,0,0,0,0,Palbociclib,ERGOCALCIFEROL|GEMFIBROZIL|PALBOCICLIB|GABAPENTIN|PALBOCICLIB|QUINAPRIL|QUINAPRIL HYDROCHLORIDE|LETROZOLE|LETROZOLE TABLETS|ROMIPLOSTIM,10,VITAMIN D DEFICIENCY|HYPERLIPIDAEMIA|BREAST CANCER METASTATIC|NEUROPATHY PERIPHERAL|NEUTROPENIA|PROPHYLAXIS|HYPERTENSION|BREAST CANCER|THROMBOCYTOPENIA,Sinusitis,1,3
10900840,20150310,Palbociclib,71,801,71.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,PANCREATIC CARCINOMA METASTATIC,Fatigue|Depression|Amnesia|Appetite disorder|Product use in unapproved indication|Nausea|Neoplasm progression,7,2
10900943,20150310,Palbociclib,55,801,55.0,2,51,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,BREAST CANCER METASTATIC|NEOPLASM,Pleural effusion|Neutropenia|Neutropenia,3,1
10905543,20150311,Palbociclib,72,801,72.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LEVOTHYROXINE|LETROZOLE|LETROZOLE TABLETS|FUROSEMIDE,4,BREAST CANCER,Fatigue,1,3
10905592,20150311,Palbociclib,69,801,69.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,3
10907634,20150312,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutrophil count decreased,1,2
10911084,20150312,Palbociclib,,,,1,,1,0,0,0,0,0,1,Palbociclib,TRAMETINIB|TRAMETINIB|PALBOCICLIB|RILUZOLE,4,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Rash macular|Rash generalised|Pharyngitis|Candida infection|Staphylococcal infection,5,5
10911985,20150313,Palbociclib,57,801,57.0,1,73,1,1,1,0,0,0,0,Palbociclib,OXYCODONE HYDROCHLORIDE|PALBOCICLIB|LORAZEPAM,8,PAIN MANAGEMENT|SQUAMOUS CELL CARCINOMA OF LUNG,Platelet count decreased|Squamous cell carcinoma of lung|Leukocytosis|Nausea|Disease progression|Vomiting,6,3
10912715,20150313,Palbociclib,83,801,83.0,2,,1,0,1,0,0,0,0,Palbociclib,EXEMESTANE|PALBOCICLIB,6,BREAST CANCER|BREAST CANCER,Cardiac failure congestive|Respiratory tract infection,2,3
10915381,20150316,Palbociclib,71,801,71.0,2,,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Death,1,1
10915558,20150316,Palbociclib,71,801,71.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Heart rate increased|Fatigue,2,5
10915575,20150316,Palbociclib,58,801,58.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|EXEMESTANE,2,BREAST CANCER|BREAST CANCER,Photosensitivity reaction,1,1
10915595,20150316,Palbociclib,68,801,68.0,2,83,1,0,0,0,0,0,1,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|PALBOCICLIB,3,BREAST CANCER FEMALE,White blood cell count decreased|Neoplasm progression|Neutrophil count decreased|Myocardial infarction,4,5
10917800,20150316,Palbociclib,54,801,54.0,1,98.1,1,0,1,0,0,0,1,Palbociclib,TRAMETINIB|PALBOCICLIB,2,SARCOMA|SARCOMA,Retinal haemorrhage|Herpes zoster disseminated,2,1
10920845,20150317,Palbociclib,,,,2,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Nausea,1,3
10920864,20150317,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Thrombocytopenia|Neutropenia,2,3
10920869,20150317,Palbociclib,,,,2,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Nausea,1,3
10920919,20150317,Palbociclib,70,801,70.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Dyspnoea,1,1
10922512,20150317,Palbociclib,72,801,72.0,2,64,1,0,0,0,0,0,1,Palbociclib,PREGABALIN|PREGABALIN|EXEMESTANE|WARFARIN|LEVOTHYROXINE SODIUM|EZETIMIBE AND SIMVASTATIN|EXEMESTANE|SERTRALINE HYDROCHLORIDE|PREGABALIN|PALBOCICLIB|PANTOPRAZOLE SODIUM|FULVESTRANT|APREPITANT|FOSAPREPITANT DIMEGLUMINE|CAPECITABINE,20,NEUROPATHY PERIPHERAL|HERPES ZOSTER|ANTICOAGULANT THERAPY|THYROID DISORDER|BREAST CANCER FEMALE|NEURALGIA|GASTROOESOPHAGEAL REFLUX DISEASE|PROPHYLACTIC CHEMOTHERAPY,Breast cancer metastatic|Metastases to bone|Lung neoplasm malignant,3,5
10930191,20150319,Palbociclib,75,801,75.0,2,,1,0,0,0,0,0,1,Palbociclib,EXEMESTANE|PALBOCICLIB,2,HEPATIC CANCER,Abdominal distension|Product use issue|Somnolence|Road traffic accident|Fluid retention,5,5
10930221,20150319,Palbociclib,58,801,58.0,2,,1,0,0,0,0,0,1,Palbociclib,"PALBOCICLIB|ASPIRIN|OXYCODONE HYDROCHLORIDE|OXYCODONE|PALBOCICLIB|ZOLPIDEM TARTRATE|AMOXICILLIN AND CLAVULANATE POTASSIUM|LETROZOLE|GOSERELIN|IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|ERGOCALCIFEROL|DENOSUMAB|PALBOCICLIB",14,BREAST CANCER METASTATIC|PAIN|SLEEP DISORDER|PAIN,Hepatic enzyme increased|Neutropenia|Breast cancer metastatic|Pyrexia|Chills|Disease progression|Fatigue,7,3
10930245,20150319,Palbociclib,70,801,70.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|AMOXICILLIN|METRONIDAZOLE|WARFARIN SODIUM|WARFARIN|VENLAFAXINE HYDROCHLORIDE|PREGABALIN|OXYCODONE HYDROCHLORIDE|LIOTHYRONINE SODIUM|POTASSIUM CHLORIDE|LEVOTHYROXINE SODIUM,11,,Vision blurred|Somnolence,2,5
10930257,20150319,Palbociclib,45,801,45.0,2,66,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Fatigue,1,5
10930302,20150319,Palbociclib,68,801,68.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Haemoglobin decreased|Fatigue|Nausea,3,5
10932696,20150319,Palbociclib,71,801,71.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|VENLAFAXINE HYDROCHLORIDE|MULTIVITAMIN|LETROZOLE|LETROZOLE TABLETS,5,MALIGNANT NIPPLE NEOPLASM FEMALE,Brain neoplasm,1,3
10934530,20150320,Palbociclib,72,801,72.0,2,54,1,0,0,0,0,0,1,Palbociclib,"PALBOCICLIB|GLIPIZIDE|SIMVASTATIN|SODIUM CHLORIDE|SODIUM CHLORIDE INJECTION|SODIUM CHLORIDE TABLET|SODIUM CHLORIDE TABLETS|DEXAMETHASONE SODIUM PHOSPHATE|EPOETIN ALFA|FULVESTRANT|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET|PALBOCICLIB|ERIBULIN MESYLATE|FILGRASTIM|ERYTHROPOIETIN|LETROZOLE|LETROZOLE TABLETS|METFORMIN HCL|PEGFILGRASTIM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL",19,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Red blood cell count decreased|Neutropenia|Thrombocytopenia,3,3
10948898,20150324,Palbociclib,71,801,71.0,2,74,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|LETROZOLE|FISH OIL|PALBOCICLIB,5,BREAST CANCER|BREAST CANCER METASTATIC,Neutropenia|Breast cancer metastatic|Nasopharyngitis|Thrombocytopenia|Pleural effusion|Lung disorder|Disease progression|Fatigue,8,3
10948912,20150324,Palbociclib,73,801,73.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB,8,BREAST CANCER METASTATIC,Diarrhoea|Memory impairment|Pruritus|Visual impairment|Blood glucose increased|Arthritis|Rhinorrhoea|Upper respiratory tract infection|Headache|Abdominal pain upper|Cough|Contusion|Body temperature abnormal|Arthralgia|Fatigue|Epistaxis|Cataract|Night sweats,18,3
10948923,20150324,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
10949398,20150324,Palbociclib,72,801,72.0,2,,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Thrombocytopenia|Death,2,1
10949546,20150323,Palbociclib,47,801,47.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER FEMALE,Abdominal discomfort|Dysgeusia|Fatigue,3,5
10949740,20150323,Palbociclib,66,801,66.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Dizziness|Vomiting|Fatigue,3,2
10953104,20150325,Palbociclib,66,801,66.0,2,,1,0,1,0,0,0,0,Palbociclib,"NEBIVOLOL HYDROCHLORIDE|SIMVASTATIN|ENALAPRIL MALEATE|ERGOCALCIFEROL|PREDNISONE|PALBOCICLIB|TICAGRELOR|LOVASTATIN|ASPIRIN|ERYTHROPOIETIN|TOLTERODINE TARTRATE|MONTELUKAST|DIPHENHYDRAMINE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|LETROZOLE|PANTOPRAZOLE SODIUM|MONTELUKAST SODIUM|RALOXIFENE HYDROCHLORIDE|DEFEROXAMINE MESYLATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE|MAGNESIUM SULFATE|MAGNESIUM SULFATE HEPTAHYDRATE|MAGNESIUM SULFATE IN WATER FOR|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|TOLTERODINE TARTRATE|DENOSUMAB",30,,Abdominal pain|Gastrointestinal haemorrhage|Vomiting|Fatigue|Nausea|Asthenia|Headache,7,1
10953258,20150325,Palbociclib,62,801,62.0,2,66,1,0,0,0,0,0,1,Palbociclib,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|VENLAFAXINE HYDROCHLORIDE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|LORAZEPAM|DIPHENHYDRAMINE HYDROCHLORIDE|POLYETHYLENE GLYCOL 3350|PROCHLORPERAZINE MALEATE|ERGOCALCIFEROL|LORAZEPAM|OXYCODONE HYDROCHLORIDE|OXYCODONE|OXYCODONE HYDROCHLORIDE|CALCIUM CARBONATE|ANTACID|LISINOPRIL AND HYDROCHLOROTHIAZIDE|LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS|METFORMIN HCL|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|SIMVASTATIN",20,PAIN|DEPRESSION|PAIN|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|CLAUSTROPHOBIA|SEASONAL ALLERGY|SUPPLEMENTATION THERAPY|CONSTIPATION|NAUSEA|SUPPLEMENTATION THERAPY|NAUSEA|PAIN|MUSCLE SPASMS|SUPPLEMENTATION THERAPY|HYPERTENSION|TYPE 2 DIABETES MELLITUS|SUPPLEMENTATION THERAPY|HYPERCHOLESTEROLAEMIA,Fatigue|Pruritus|Anaemia|Neutropenia|Insomnia,5,1
10953308,20150325,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,,Fatigue|Alopecia,2,5
10953792,20150325,Palbociclib,50,801,50.0,2,47,1,0,0,0,0,0,1,Palbociclib,"PALBOCICLIB|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB",6,PAIN|BREAST CANCER|BREAST CANCER|METASTASES TO BONE|PAIN,Alanine aminotransferase increased|Aspartate aminotransferase increased,2,3
10956258,20150325,Palbociclib,65,801,65.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|FESOTERODINE FUMARATE|PROMETHAZINE|DRONABINOL|LETROZOLE|LETROZOLE TABLETS|DEXAMETHASONE|DEXAMETHASONE 1.5 MG|LEVOTHYROXINE SODIUM,11,BREAST CANCER,Vomiting,1,3
10956279,20150325,Palbociclib,72,801,72.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|LEVOTHYROXINE SODIUM|SIMVASTATIN,4,BREAST CANCER,Oral pain,1,3
10957023,20150326,Palbociclib,61,801,61.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Muscle spasms,1,5
10957087,20150326,Palbociclib,79,801,79.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,NEOPLASM MALIGNANT,Fatigue|Nausea,2,5
10957924,20150326,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|ANASTROZOLE,2,,Breast cancer metastatic,1,2
10957988,20150326,Palbociclib,62,801,62.0,2,66,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER FEMALE,Epistaxis|Rhinorrhoea|Nausea|Lacrimation increased|Feeling abnormal|Depression,6,5
10960440,20150327,Palbociclib,59,801,59.0,2,72,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,,Atrial fibrillation,1,3
10960569,20150327,Palbociclib,73,801,73.0,2,,1,0,0,0,0,0,1,Palbociclib,"PALBOCICLIB|DENOSUMAB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|LETROZOLE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|PANTOPRAZOLE SODIUM",7,BREAST CANCER|BREAST CANCER FEMALE|BREAST CANCER FEMALE|PAIN,Pancytopenia,1,5
10960817,20150327,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,No adverse event,1,5
10960846,20150327,Palbociclib,53,801,53.0,2,87,1,1,0,0,0,0,1,Palbociclib,ALPRAZOLAM|OXYCODONE HYDROCHLORIDE|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,6,ANXIETY|CONSTIPATION|PAIN|PAIN|BREAST CANCER METASTATIC,Asthenia|General physical health deterioration|Fatigue|Pain|Disease progression|Breast cancer metastatic|Dyspnoea,7,1
10961837,20150327,Palbociclib,55,801,55.0,2,37.9,1,0,1,0,0,0,1,Palbociclib,"OXYCODONE HYDROCHLORIDE|LIDOCAINE|LIDOCAINE HYDROCHLORIDE|BURN RELIEF|MAXIMUM STRENGTH PAIN RELIEVER|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE|LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE|LIDOCAINE 4%|LIDOCAINE, MENTHOL|LETROZOLE|LORAZEPAM|FAMOTIDINE|METRONIDAZOLE|IBUPROFEN|OXYCODONE HYDROCHLORIDE|PALBOCICLIB",10,PAIN|PAIN|METASTASES TO BONE|BREAST CANCER|ANXIETY|ABDOMINAL DISCOMFORT|HEADACHE|PAIN|BREAST CANCER METASTATIC,Pancytopenia,1,3
10961937,20150327,Palbociclib,79,801,79.0,2,81.7,1,0,1,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|VALSARTAN|PALBOCICLIB|PALBOCICLIB|FAMOTIDINE|PALBOCICLIB|METOPROLOL SUCCINATE|AMLODIPINE BESYLATE,10,BREAST CANCER|HYPERTENSION|DIABETES MELLITUS|DYSPEPSIA|BREAST CANCER|HYPERTENSION|HYPERTENSION,Dermatitis,1,1
10962062,20150327,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Product size issue|Dysphagia,2,3
10962132,20150327,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,,Oral pain,1,1
10962138,20150327,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
10962447,20150327,Palbociclib,58,801,58.0,1,104.3,1,0,0,0,0,0,1,Palbociclib,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|TRAMETINIB|LABETALOL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|TRAMETINIB|FERROUS SULFATE|PALBOCICLIB|GLIPIZIDE|LISINOPRIL|PALBOCICLIB,13,DIABETES MELLITUS|HYPERTENSION|DIABETES MELLITUS|HYPERTENSION|NEOPLASM|HYPERTENSION|MICROCYTIC ANAEMIA|DIABETES MELLITUS|HYPERTENSION|NEOPLASM|HYPERTENSION,Vitreous haemorrhage,1,1
10963371,20150327,Palbociclib,64,801,64.0,2,78,1,0,0,0,0,0,1,Palbociclib,"GLIPIZIDE|LORAZEPAM|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|FULVESTRANT|FAMOTIDINE|MAGNESIUM HYDROXIDE|MORPHINE SULFATE|PROMETHAZINE|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|CAPECITABINE|DENOSUMAB|GABAPENTIN|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|PALBOCICLIB|PROMETHAZINE|SUMATRIPTAN|SUMATRIPTAN SUCCINATE|EXEMESTANE|OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|EXEMESTANE|ATENOLOL|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|FUROSEMIDE|PROMETHAZINE|ZOLPIDEM TARTRATE|FLUOCINONIDE|FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%|FUROSEMIDE|POLYETHYLENE GLYCOL|PROMETHAZINE|EXEMESTANE|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|SENNOSIDES|SENNA LEAF|SENNA",44,NAUSEA|MUSCLE SPASMS|VOMITING|VOMITING|VOMITING|NAUSEA|VOMITING|NEOADJUVANT THERAPY|NAUSEA|NAUSEA|NAUSEA,Embolic stroke|Cardiac valve disease|Clostridium difficile colitis,3,3
10965250,20150330,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Blood test abnormal,1,3
10965271,20150330,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Upper respiratory tract infection|Neutropenia,2,1
10966492,20150330,Palbociclib,71,801,71.0,2,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB|PALBOCICLIB,2,METASTASES TO BONE MARROW|METASTASES TO BONE,Second primary malignancy|Brain neoplasm,2,5
10969871,20150331,Palbociclib,52,801,52.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,NEOPLASM MALIGNANT,Fatigue|Disease progression|Lacrimation increased|Neoplasm malignant,4,5
10970764,20150331,Palbociclib,54,801,54.0,1,98,1,0,1,0,0,0,1,Palbociclib,TRAMETINIB|PALBOCICLIB,2,SARCOMA|SARCOMA,Herpes zoster disseminated|Retinal haemorrhage,2,1
10970870,20150331,Palbociclib,,,,2,52.18,1,0,0,0,0,0,1,Palbociclib,FULVESTRANT|PERTUZUMAB|PALBOCICLIB|LETROZOLE|LETROZOLE|TRASTUZUMAB|EXEMESTANE|TRASTUZUMAB,10,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC,Breast cancer recurrent|Metastases to pituitary gland|Metastases to liver|Tumour marker increased|Malignant neoplasm progression|Metastases to lung|Diabetes insipidus|Breast cancer metastatic|Back pain|Arthralgia|No therapeutic response|Metastases to bone|Fatigue|Metastases to lymph nodes|Metastases to the mediastinum,15,5
10970987,20150331,Palbociclib,58,801,58.0,2,43,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE,2,BREAST CANCER METASTATIC,Nausea|Diarrhoea,2,1
10971280,20150331,Palbociclib,41,801,41.0,2,60.7,1,1,1,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Respiratory failure|Dyspnoea,2,3
10971421,20150331,Palbociclib,57,801,57.0,1,124,1,0,0,0,0,0,1,Palbociclib,"OXYCODONE|PALBOCICLIB|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FENTANYL",6,PHANTOM PAIN|LIPOSARCOMA METASTATIC|DIABETES MELLITUS|PAIN|PAIN|DIABETES MELLITUS,Pneumonia|Lymphocyte count decreased|Depression|Hyponatraemia,4,3
10974336,20150331,Palbociclib,60,801,60.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Bone operation|White blood cell count decreased,2,3
10975502,20150401,Palbociclib,74,801,74.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Fatigue|Asthenia|Vomiting,3,5
10975512,20150401,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER FEMALE,Hypersomnia,1,5
10975518,20150401,Palbociclib,57,801,57.0,2,70,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Asthenia|Fatigue|Nausea|Blood count abnormal|Dyspnoea,5,5
10975527,20150401,Palbociclib,77,801,77.0,2,,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB|PALBOCICLIB,2,BREAST CANCER,Asthenia|Nausea|Death|Vomiting,4,3
10978375,20150401,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,MULTIVITAMIN|BUPROPION HYDROCHLORIDE|PALBOCICLIB|ERGOCALCIFEROL|LETROZOLE|LETROZOLE TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,11,,Stomatitis|Alopecia|Fatigue|Malaise,4,5
10978698,20150401,Palbociclib,63,801,63.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|PALBOCICLIB|PROCHLORPERAZINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ANASTROZOLE|ANASTROZOLE TABLETS,6,BREAST CANCER,Asthenia|Hypoaesthesia oral|Epistaxis,3,5
10979197,20150402,Palbociclib,60,801,60.0,2,,1,0,1,0,0,0,1,Palbociclib,TIOTROPIUM BROMIDE|IRON|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,6,MINERAL SUPPLEMENTATION|EMPHYSEMA|BREAST CANCER|BREAST CANCER,Pulmonary haemorrhage|Nausea|Haemoptysis,3,5
10982323,20150403,Palbociclib,49,801,49.0,2,62,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|BUPROPION HYDROCHLORIDE,3,BREAST CANCER,Fatigue|Back pain,2,3
10982340,20150403,Palbociclib,77,801,77.0,2,53,1,0,1,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER|BREAST CANCER,Headache|Fatigue|Hypoaesthesia|Asthenia|Blood count abnormal|Alopecia|Contusion|Chills|Arthralgia|Dizziness,10,5
10982706,20150402,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased,1,5
10982807,20150402,Palbociclib,79,801,79.0,2,,1,0,0,0,0,0,0,Palbociclib,HYDROCHLOROTHIAZIDE|LISINOPRIL|PALBOCICLIB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,5,BREAST CANCER,Gastrooesophageal reflux disease,1,5
10983193,20150403,Palbociclib,64,801,64.0,2,76.6,1,0,1,0,0,0,1,Palbociclib,"ATENOLOL|VENLAFAXINE|VENLAFAXINE HYDROCHLORIDE|FULVESTRANT|PALBOCICLIB|MAGNESIUM HYDROXIDE|PROMETHAZINE|SENNOSIDES|SENNA LEAF|SENNA|FUROSEMIDE|DENOSUMAB|CAPECITABINE|GABAPENTIN|GLIPIZIDE|HYDROCORTISONE|ANTIPRURITIC (ANTI-ITCH)|ANTI-ITCH CREAM|HYDROCORTISONE CREAM|HYDROCORTISONE 1%|HYDROCORTISONE CONTINUOUS SPRAY|ANTI-PRURITIC|HYDROCORTISONE LOTION|HYDROCORTISONE ACETATE|HYDROCORTISONE LOTION KIT|ANTI ITCH|ANTI-ITCH|COOL RELIEF GEL WITH ALOE|HYDROCORTISONE CREAM 1%|HYDROCORTISONE SPRAY|DRS. HYDROCORTISONE|LORAZEPAM|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|VANCOMYCIN HYDROCHLORIDE|VANCOMYCIN|POLYETHYLENE GLYCOL|SUMATRIPTAN|SUMATRIPTAN SUCCINATE|FLUOCINONIDE|FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|EXEMESTANE|DOCUSATE SODIUM|DOCUSATE SODIUM 100MG|MORPHINE|ZOLPIDEM TARTRATE",34,NAUSEA|VOMITING|NAUSEA|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|VOMITING,Nausea|Vomiting|Visual impairment|Clostridium difficile colitis|Muscle spasms|Anxiety|Pain in extremity,7,1
10983307,20150403,Palbociclib,64,801,64.0,2,77.98,1,0,0,0,0,0,0,Palbociclib,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|ERGOCALCIFEROL|PALBOCICLIB|LORAZEPAM|CARVEDILOL|BUPROPION HYDROCHLORIDE|LETROZOLE|LETROZOLE TABLETS|INSULIN ASPART|MORPHINE SULFATE|ACETYLCYSTEINE|EXEMESTANE|SENNOSIDES|SENNA LEAF|SENNA,14,BREAST CANCER STAGE IV|BREAST CANCER STAGE IV|CONSTIPATION,White blood cell count decreased|Fatigue,2,3
10983445,20150403,Palbociclib,64,801,64.0,1,141,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|PALBOCICLIB|DENOSUMAB,11,BREAST CANCER MALE|BREAST CANCER MALE,Neutropenia|Herpes zoster|Dyspnoea|Rash|Vomiting|Confusional state|Depression|Dyspnoea|Diarrhoea|Pneumonia|Hyperglycaemia|Product use issue|White blood cell count decreased|Neoplasm progression|Nausea|Weight increased|Fluid retention|Pain|Anaemia|Eating disorder|Night sweats,21,3
10983540,20150403,Palbociclib,66,801,66.0,1,70,1,1,0,0,0,0,1,Palbociclib,PALBOCICLIB|BISOPROLOL FUMARATE,2,GASTROINTESTINAL STROMAL TUMOUR|HYPERTENSION,Renal failure|Sudden death,2,1
10983560,20150402,Palbociclib,74,801,74.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased|Nausea,2,2
10983709,20150403,Palbociclib,76,801,76.0,2,55,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB|BUDESONIDE|ALBUTEROL SULFATE|ALBUTEROL,3,SQUAMOUS CELL CARCINOMA OF LUNG,Haemoptysis,1,1
10983712,20150403,Palbociclib,77,801,77.0,2,42,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,5,BREAST CANCER|BREAST CANCER,Deep vein thrombosis,1,1
10993439,20150406,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,2,BREAST CANCER,Dyspnoea,1,2
10994015,20150407,Palbociclib,,,,2,,1,1,1,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Pneumonia|Sepsis|Death,3,1
10994086,20150406,Palbociclib,63,801,63.0,2,,1,0,0,0,0,0,1,Palbociclib,PROCHLORPERAZINE|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|ANASTROZOLE|ANASTROZOLE TABLETS|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,5,BREAST CANCER FEMALE,White blood cell count decreased,1,1
10994308,20150407,Palbociclib,77,801,77.0,2,70,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER,Epistaxis|Disturbance in attention|Abdominal discomfort,3,5
10994311,20150407,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Alopecia|Nausea|Nail disorder,3,1
10994317,20150407,Palbociclib,45,801,45.0,2,,1,0,0,0,0,0,0,Palbociclib,OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|ERGOCALCIFEROL|PALBOCICLIB|DENOSUMAB|FULVESTRANT|PALBOCICLIB|ALPRAZOLAM|OXYCODONE HYDROCHLORIDE|ANASTROZOLE|ANASTROZOLE TABLETS|LETROZOLE|LETROZOLE TABLETS,12,BREAST CANCER,Mucosal inflammation|Nasal discomfort|Red blood cell count decreased|Tumour marker increased|Weight increased|Weight decreased|Rash,7,3
10994435,20150407,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Fatigue|Asthenia,2,1
10994651,20150407,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Leukopenia|Neutropenia,2,1
10994657,20150407,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|PALBOCICLIB,2,,Neutropenia|Leukopenia,2,1
10996540,20150407,Palbociclib,77,801,77.0,2,53.07,1,0,0,0,0,0,0,Palbociclib,"ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|CALCIUM|FAMOTIDINE|SIMVASTATIN|ERGOCALCIFEROL",7,BREAST CANCER,Fatigue|Alopecia|Dizziness|Pain|Headache|Chills|Full blood count decreased,7,
10996851,20150407,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,4,,Dyspnoea|Full blood count decreased,2,5
10996943,20150407,Palbociclib,56,801,56.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Nausea,1,
10997433,20150408,Palbociclib,68,801,68.0,2,43,1,0,1,0,0,0,0,Palbociclib,FUROSEMIDE|PALBOCICLIB|LEVOTHYROXINE SODIUM|INSULIN GLARGINE|INSULIN LISPRO|SIMVASTATIN|MAGNESIUM HYDROXIDE|POLYETHYLENE GLYCOL 3350|LACTULOSE,9,OEDEMA|BREAST CANCER STAGE IV|HYPOTHYROIDISM|DIABETES MELLITUS|DIABETES MELLITUS|HYPERLIPIDAEMIA|CONSTIPATION|CONSTIPATION|OSTEOPOROSIS,Pleural effusion,1,3
10997464,20150408,Palbociclib,66,801,66.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|AMLODIPINE BESYLATE|LETROZOLE|LETROZOLE TABLETS|WARFARIN SODIUM|WARFARIN|PALBOCICLIB|ERGOCALCIFEROL,7,PULMONARY EMBOLISM|BLOOD PRESSURE ABNORMAL|BREAST CANCER|PULMONARY EMBOLISM|BREAST CANCER|VITAMIN D DEFICIENCY,Neutropenia|Neutropenia|Fatigue|Muscle spasms|Phlebitis|Thrombophlebitis,6,1
10997467,20150408,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutrophil count decreased,1,3
10997468,20150408,Palbociclib,71,801,71.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE|LETROZOLE TABLETS,4,BREAST CANCER,Nausea|Fatigue,2,3
10997475,20150408,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia|Leukopenia,2,1
10997587,20150408,Palbociclib,64,801,64.0,2,62.59,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB,7,BREAST CANCER METASTATIC,Insomnia|Nasopharyngitis|Pharyngeal disorder|Pain|Arthralgia|White blood cell count decreased|Nasal discomfort|Vision blurred|Lacrimation increased|Arthralgia|Stomatitis|Epistaxis|Tendonitis|Sinusitis|Condition aggravated|Glossodynia,16,3
10997648,20150407,Palbociclib,44,801,44.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased,1,2
11001637,20150408,Palbociclib,71,801,71.0,1,84,1,0,1,0,0,0,0,Palbociclib,TRAMETINIB|PREDNISONE|TRAMETINIB|PREDNISONE|PALBOCICLIB,5,NEOPLASM|NEOPLASM,Dehydration|Mucosal inflammation,2,1
11003977,20150408,Palbociclib,63,801,63.0,2,,1,0,0,0,0,0,1,Palbociclib,ANASTROZOLE|ANASTROZOLE TABLETS|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|PROCHLORPERAZINE|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,5,BREAST CANCER FEMALE,White blood cell count decreased,1,2
11003993,20150408,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased,1,2
11004374,20150409,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Leukopenia|Neutropenia,2,1
11004763,20150409,Palbociclib,83,801,83.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Nausea|Fatigue,2,1
11004806,20150409,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,NEOPLASM MALIGNANT,Neoplasm malignant|Disease progression,2,2
11006019,20150409,Palbociclib,60,801,60.0,2,,1,0,1,0,0,0,0,Palbociclib,MULTIVITAMIN|TIOTROPIUM BROMIDE|IRON|BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,7,PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|MINERAL SUPPLEMENTATION|EMPHYSEMA|NEOPLASM MALIGNANT|BREAST CANCER FEMALE,Arterial haemorrhage|Haemoptysis|Nausea,3,2
11008596,20150410,Palbociclib,51,801,51.0,2,90,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|BISOPROLOL FUMARATE|BISOPROLOL FUMARATE,7,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|METASTASES TO BONE|CORONARY ARTERY DISEASE|ANGINA PECTORIS|ANGINA PECTORIS|CORONARY ARTERY DISEASE,Myocardial infarction,1,3
11009162,20150410,Palbociclib,81,801,81.0,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER,Decreased appetite|Headache|Dizziness|Abdominal discomfort|Nausea|Fatigue,6,3
11009170,20150410,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,3
11009178,20150410,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Epistaxis,1,2
11009185,20150410,Palbociclib,72,801,72.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,White blood cell count decreased,1,5
11009190,20150410,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Alopecia,1,5
11009235,20150410,Palbociclib,84,801,84.0,2,99,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB,10,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Neutropenia|Platelet count decreased|Breast cancer metastatic|Drug intolerance|Anaemia|Disease progression|White blood cell count decreased|Pancytopenia|Erythema|Alopecia|Skin lesion,11,3
11009255,20150410,Palbociclib,72,801,72.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|PALBOCICLIB,4,BREAST CANCER,Headache|Paraesthesia|Dry mouth|Pruritus generalised|Alopecia|Neutropenia|Dizziness|White blood cell count decreased|Pain in extremity|Colitis|Red blood cell count decreased|Fatigue|Dry eye,13,3
11009262,20150410,Palbociclib,65,801,65.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Fatigue|Neutrophil count decreased,2,1
11009265,20150410,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,OESTROGEN RECEPTOR POSITIVE BREAST CANCER,Fatigue,1,5
11009408,20150409,Palbociclib,62,801,62.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased,1,3
11009605,20150409,Palbociclib,61,801,61.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Platelet count decreased,1,3
11010475,20150410,Palbociclib,61,801,61.0,2,75,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|ALPRAZOLAM|LORAZEPAM,4,BREAST CANCER|BREAST CANCER|PROPHYLAXIS|PROPHYLAXIS,Haemorrhoids,1,1
11010480,20150410,Palbociclib,67,801,67.0,2,77.4,1,0,1,0,0,0,0,Palbociclib,PAROXETINE HYDROCHLORIDE|ALPRAZOLAM|PAROXETINE HYDROCHLORIDE|BIMATOPROST|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|ALPRAZOLAM|INSULIN GLARGINE,11,PAIN|DEPRESSION|ANXIETY|ANXIETY|PROPHYLAXIS|GLAUCOMA|PROPHYLAXIS|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|DEPRESSION|TYPE 2 DIABETES MELLITUS,Localised infection,1,3
11010974,20150410,Palbociclib,60,801,60.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Hypoaesthesia|Wound secretion|Paraesthesia|Nausea|Impaired healing,5,5
11011234,20150410,Palbociclib,42,801,42.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,BREAST CANCER,Anxiety|Pain|Alopecia|Abdominal discomfort,4,3
11012223,20150410,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,ETODOLAC|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,3,BREAST CANCER,Stomatitis|Oral pain,2,2
11012258,20150410,Palbociclib,86,801,86.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Rash,1,2
11012288,20150410,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased,1,3
11023352,20150413,Palbociclib,63,801,63.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|DENOSUMAB,3,BREAST CANCER,Oral mucosal blistering|Genital blister|Chest pain|Fatigue|Abdominal pain upper|Flatulence,6,3
11023397,20150413,Palbociclib,65,801,65.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Dyspnoea|Pleural effusion,2,3
11023442,20150413,Palbociclib,85,801,85.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Vomiting,1,5
11023759,20150413,Palbociclib,72,801,72.0,2,,1,0,1,0,0,0,1,Palbociclib,"ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|METOPROLOL TARTRATE|METOPROLOL|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|PROMETHAZINE HYDROCHLORIDE|PALBOCICLIB|FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE|METFORMIN|METFORMIN ER 500 MG|METFORMIN ER 750 MG|SENNOSIDES|SENNA LEAF|SENNA|PALBOCICLIB|PALBOCICLIB|POTASSIUM CHLORIDE|POTASSIUM CHLORIDE EXTENDED-RELEASE|POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE|POTASSIUM CHLORIDE ORAL|PROMETHAZINE|LORAZEPAM|AMLODIPINE|THEOPHYLLINE|BUMETANIDE|PSYLLIUM HUSK|FULVESTRANT|PALBOCICLIB|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|CALCIUM|PANTOPRAZOLE|PALBOCICLIB|OLMESARTAN MEDOXOMIL|DEXAMETHASONE|DEXAMETHASONE 1.5 MG",30,NEOPLASM MALIGNANT|BREAST CANCER|BREAST CANCER FEMALE|BREAST CANCER FEMALE|BREAST CANCER METASTATIC,White blood cell count decreased|Drug dose omission|Erythema|Intestinal obstruction|Pain in extremity,5,3
11025496,20150414,Palbociclib,57,801,57.0,2,64,1,0,0,0,0,0,1,Palbociclib,MORPHINE SULFATE|ERGOCALCIFEROL|STANDARDIZED SENNA CONCENTRATE|LETROZOLE|LETROZOLE TABLETS|LORAZEPAM|PROCHLORPERAZINE MALEATE|GABAPENTIN|PALBOCICLIB|MORPHINE,10,ARTHRITIS|SUPPLEMENTATION THERAPY|CONSTIPATION|BREAST CANCER METASTATIC|ANXIETY|NAUSEA|SUPPLEMENTATION THERAPY|PAIN|BREAST CANCER METASTATIC|DYSPNOEA,Neutropenia,1,1
11025630,20150414,Palbociclib,64,801,64.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased,1,5
11025679,20150414,Palbociclib,71,801,71.0,2,75,1,0,0,0,0,0,1,Palbociclib,LETROZOLE|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,6,BREAST CANCER|BREAST CANCER,Neutropenia|Thrombocytopenia|Fatigue,3,3
11025683,20150414,Palbociclib,76,801,76.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Alopecia|Fatigue|White blood cell count decreased,3,5
11025701,20150414,Palbociclib,57,801,57.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,NEOPLASM MALIGNANT,Neoplasm malignant|Disease progression,2,3
11025703,20150414,Palbociclib,53,801,53.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased,1,3
11026007,20150413,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,4,,Full blood count decreased|Dyspnoea,2,
11026033,20150414,Palbociclib,,,,0,,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Death,1,3
11026169,20150413,Palbociclib,,,,1,,1,0,0,0,0,0,0,Palbociclib,FLUTICASONE PROPIONATE AND SALMETEROL|SARGRAMOSTIM|PALBOCICLIB|TESTOSTERONE|AMOXICILLIN,14,BREAST CANCER,Neutropenia,1,
11026727,20150414,Palbociclib,46,801,46.0,2,72.6,1,0,0,0,0,0,0,Palbociclib,"PAROXETINE HYDROCHLORIDE HEMIHYDRATE|PAROXETINE|PAROXETINE HYDROCHLORIDE|MULTIVITAMIN|ANASTROZOLE|ANASTROZOLE TABLETS|ZOLPIDEM TARTRATE|LETROZOLE|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|PALBOCICLIB|CYANOCOBALAMIN",13,BREAST CANCER|DEPRESSION|NUTRITIONAL SUPPLEMENTATION|NUTRITIONAL SUPPLEMENTATION|BREAST CANCER|INSOMNIA|BREAST CANCER|NUTRITIONAL SUPPLEMENTATION|THROMBOSIS|PAIN|ANXIETY|BREAST CANCER|NUTRITIONAL SUPPLEMENTATION,Drug intolerance|Adverse drug reaction,2,3
11029782,20150414,Palbociclib,60,801,60.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased,1,3
11029794,20150414,Palbociclib,67,801,67.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Stomatitis|Oesophageal ulcer,2,2
11031364,20150415,Palbociclib,38,801,38.0,2,,1,0,0,0,0,0,0,Palbociclib,MORPHINE|PALBOCICLIB|DENOSUMAB|LETROZOLE,7,BREAST CANCER STAGE IV,Blood bilirubin increased,1,3
11033543,20150415,Palbociclib,46,801,46.0,2,53,1,0,1,0,0,0,0,Palbociclib,FULVESTRANT|PALBOCICLIB,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pyrexia,1,3
11037318,20150416,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,NEOPLASM MALIGNANT,Neoplasm malignant|Disease progression,2,1
11037337,20150416,Palbociclib,56,801,56.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Nausea|Muscle spasms,2,3
11037954,20150416,Palbociclib,68,801,68.0,2,61,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|PALBOCICLIB|RIVAROXABAN,4,BREAST CANCER|BREAST CANCER|ANTICOAGULANT THERAPY,Nausea|Dysphonia,2,5
11038125,20150416,Palbociclib,54,801,54.0,2,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Haemoglobin decreased,1,5
11038251,20150416,Palbociclib,70,801,70.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Blood count abnormal,1,3
11038766,20150416,Palbociclib,48,801,48.0,2,,1,1,1,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Dyspnoea|Breast cancer metastatic|Disease progression|Fluid retention,4,3
11044142,20150417,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,NEOPLASM MALIGNANT,Neoplasm malignant|Disease progression,2,5
11044167,20150417,Palbociclib,86,801,86.0,2,53.1,1,0,0,0,0,0,1,Palbociclib,ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG|ERGOCALCIFEROL|PALBOCICLIB|SIMVASTATIN|LEVOTHYROXINE SODIUM|LETROZOLE|LOSARTAN POTASSIUM|SIMVASTATIN|CARVEDILOL|ERGOCALCIFEROL,13,BREAST CANCER|BREAST CANCER,Rash|Neutropenia,2,2
11044386,20150417,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11044886,20150417,Palbociclib,56,801,56.0,2,,1,0,0,0,0,0,0,Palbociclib,"ANASTROZOLE|AMOXICILLIN|IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FULVESTRANT|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|ARIPIPRAZOLE|LORAZEPAM|ZOLPIDEM TARTRATE|EXEMESTANE|AMOXICILLIN AND CLAVULANATE POTASSIUM|GABAPENTIN|EVEROLIMUS|EVEROLIMUS TABLETS|CAPECITABINE|SERTRALINE HYDROCHLORIDE|LETROZOLE|LETROZOLE TABLETS|PACLITAXEL|ZOLPIDEM TARTRATE|GABAPENTIN|OXYCODONE HCL",27,BREAST CANCER METASTATIC,Depression|Drug hypersensitivity|Musculoskeletal chest pain|Disease progression|Anaemia vitamin B12 deficiency|Toxicity to various agents,6,
11044984,20150417,Palbociclib,75,801,75.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|CYCLOBENZAPRINE|PALBOCICLIB|ERGOCALCIFEROL|DENOSUMAB|CALCIUM,7,BREAST CANCER|HYPERTENSION|MUSCLE SPASMS|BONE DISORDER|BONE DISORDER|BONE DISORDER,Taste disorder|Urine analysis abnormal|Fatigue|Alopecia|Tooth loss|Vision blurred,6,5
11044986,20150417,Palbociclib,61,801,61.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Paraesthesia|Pruritus generalised,2,5
11047288,20150417,Palbociclib,61,801,61.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Stomatitis|Blood count abnormal,2,2
11047297,20150417,Palbociclib,64,801,64.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Stomatitis,1,2
11047879,20150420,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Breast cancer metastatic|Disease progression,2,3
11047881,20150420,Palbociclib,63,801,63.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Oral herpes|White blood cell count decreased|Fatigue,3,5
11047889,20150420,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,BREAST CANCER|BREAST CANCER,Weight decreased|Fatigue,2,1
11047891,20150420,Palbociclib,67,801,67.0,2,,1,0,0,0,0,0,1,Palbociclib,"THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE|LETROZOLE|ERGOCALCIFEROL|ERGOCALCIFEROL|FLUCONAZOLE|PALBOCICLIB|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ASPIRIN|PREDNISONE|FLUTICASONE PROPIONATE|TRIPROLIDINE HCL|ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL|PALBOCICLIB|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ASPIRIN|ERGOCALCIFEROL|ASPIRIN|ERGOCALCIFEROL|NYSTATIN|NYSTATIN OINTMENT|NYSTATIN CREAM|ASPIRIN|PRAVASTATIN SODIUM|PRAVASTATIN SODIUM|PRAVASTATIN SODIUM|PRAVASTATIN SODIUM|PREDNISONE",41,HORMONE THERAPY|BREAST CANCER METASTATIC|MUCOSAL INFLAMMATION|HYPERSENSITIVITY,Erythema|Sensory loss|Oral candidiasis|White blood cell count decreased|Fatigue|Deafness unilateral|Vertigo|Sinusitis|Pneumonia|Fungal infection,10,3
11047893,20150420,Palbociclib,63,801,63.0,2,,1,0,0,0,0,0,1,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER|BREAST CANCER RECURRENT,Neutropenia,1,3
11047910,20150420,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Fatigue|Weight decreased,2,1
11047995,20150420,Palbociclib,82,801,82.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia|Upper respiratory tract infection|Dehydration,3,1
11048022,20150420,Palbociclib,66,801,66.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,White blood cell count decreased,1,5
11048093,20150420,Palbociclib,43,801,43.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Fatigue,1,5
11048125,20150420,Palbociclib,78,801,78.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Nausea,1,5
11051490,20150421,Palbociclib,55,801,55.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,METASTATIC NEOPLASM,Febrile neutropenia,1,1
11051604,20150420,Palbociclib,65,801,65.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Full blood count decreased,1,2
11051689,20150420,Palbociclib,69,801,69.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,NEOPLASM MALIGNANT,Nausea,1,2
11054754,20150422,Palbociclib,59,801,59.0,2,160,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Urticaria,1,3
11054831,20150422,Palbociclib,73,801,73.0,2,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Pleural effusion,1,3
11055238,20150421,Palbociclib,61,801,61.0,2,50,1,0,0,0,1,0,0,Palbociclib,PALBOCICLIB,2,BREAST CANCER METASTATIC,VIIth nerve paralysis|Thrombocytopenia,2,1
11055311,20150422,Palbociclib,,,,1,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Product use issue|Fatigue,2,1
11055317,20150422,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,FULVESTRANT|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,3,,Blood count abnormal|Lung disorder,2,5
11055483,20150422,Palbociclib,66,801,66.0,2,78.46,1,0,1,0,0,0,1,Palbociclib,METOPROLOL TARTRATE|METOPROLOL|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|METOPROLOL TARTRATE|METOPROLOL|MAGNESIUM|PALBOCICLIB|LETROZOLE,12,BONE DISORDER|BREAST CANCER STAGE IV|ATRIAL FIBRILLATION|NEOPLASM MALIGNANT,White blood cell count decreased|Infection|Oropharyngeal pain|Seasonal allergy|Platelet count decreased|Tremor|Fatigue|Ear pain|Constipation|Neutrophil count decreased|Neutropenia,11,3
11055509,20150422,Palbociclib,59,801,59.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|DENOSUMAB,2,,Hypokalaemia,1,3
11055596,20150421,Palbociclib,70,801,70.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Fatigue|Neuropathy peripheral|Diarrhoea|Arthralgia|Decreased appetite|Myalgia,6,2
11058080,20150422,Palbociclib,67,801,67.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Aphthous stomatitis,1,2
11058104,20150422,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,MALIGNANT NIPPLE NEOPLASM,Weight decreased|Stomatitis|Skin ulcer,3,2
11058245,20150422,Palbociclib,63,801,63.0,2,,1,0,0,0,0,0,0,Palbociclib,"EXEMESTANE|HYDROCHLOROTHIAZIDE|PALBOCICLIB|ESTRADIOL|ESTRADIOL GEL 0.1%|ESTRADIOL TRANSDERMAL|ESTRADIOL,|FULVESTRANT",10,,Unevaluable event,1,2
11058458,20150422,Palbociclib,83,801,83.0,2,,1,0,0,0,0,0,1,Palbociclib,LETROZOLE|LETROZOLE TABLETS|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|PROCHLORPERAZINE|LORAZEPAM|PALBOCICLIB|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS,7,BREAST CANCER,Malaise|Nausea|White blood cell count decreased,3,2
11058468,20150422,Palbociclib,47,801,47.0,2,,1,0,0,0,0,0,1,Palbociclib,"ERGOCALCIFEROL|PALBOCICLIB|VENLAFAXINE HYDROCHLORIDE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|NAPROXEN SODIUM|NAPROXEN SODIUM TABLET",5,,White blood cell count decreased,1,2
11059613,20150423,Palbociclib,53,801,53.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Pancytopenia|Bone marrow failure,2,1
11059835,20150423,Palbociclib,66,801,66.0,2,,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Death,1,5
11061384,20150424,Palbociclib,66,801,66.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count abnormal|Decreased appetite|Fatigue|Dyspnoea,4,5
11061387,20150424,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11061388,20150424,Palbociclib,49,801,49.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Neutropenia|Nausea,2,1
11061391,20150424,Palbociclib,55,801,55.0,2,,1,0,0,0,0,0,1,Palbociclib,PREDNISONE|GABAPENTIN|MAGNESIUM|METHADONE|LORAZEPAM|LETROZOLE|ESOMEPRAZOLE MAGNESIUM|PALBOCICLIB,13,NEUROPATHY PERIPHERAL|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Neutropenia|Thrombocytopenia,2,2
11061426,20150424,Palbociclib,69,801,69.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER FEMALE,Nausea|Fatigue,2,1
11061487,20150424,Palbociclib,74,801,74.0,2,68,1,0,0,0,0,0,0,Palbociclib,"PALBOCICLIB|DICLOFENAC SODIUM|DICLOFENAC SODIUM TOPICAL|DICLOFENAC SODIUM TOPICAL GEL, 1%|DICLOFENAC|DICLOFENAC SODIUM 1%|LETROZOLE|LETROZOLE TABLETS|DULOXETINE HYDROCHLORIDE",5,BREAST CANCER METASTATIC|MUSCULOSKELETAL DISCOMFORT|ANXIETY,White blood cell count decreased|Disease progression|Breast cancer metastatic,3,5
11061591,20150424,Palbociclib,74,801,74.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Malaise|Vomiting|Nausea,3,5
11061596,20150424,Palbociclib,71,801,71.0,2,99.77,1,0,0,0,0,0,0,Palbociclib,EXEMESTANE|LETROZOLE|DENOSUMAB|DENOSUMAB|PALBOCICLIB,5,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BONE CANCER|RIB FRACTURE|BREAST CANCER METASTATIC,Rash,1,5
11061601,20150424,Palbociclib,71,801,71.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutrophil count decreased|Platelet count decreased|White blood cell count decreased,3,1
11061611,20150424,Palbociclib,52,801,52.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,White blood cell count decreased,1,5
11062192,20150424,Palbociclib,63,801,63.0,2,41,1,0,0,0,0,0,1,Palbociclib,EVEROLIMUS|EVEROLIMUS|LETROZOLE|LETROZOLE TABLETS|FULVESTRANT|EXEMESTANE|DENOSUMAB|VANCOMYCIN HYDROCHLORIDE|EVEROLIMUS|ANASTROZOLE|ANASTROZOLE TABLETS|TAMOXIFEN CITRATE|PALBOCICLIB|EVEROLIMUS|EVEROLIMUS|CAPECITABINE,15,BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER|BREAST CANCER,Conjunctivitis|Thrombocytopenia|Clostridium difficile infection|Disease progression|Breast cancer|Dental discomfort|Nystagmus|Malignant ascites|Osteonecrosis of jaw|Abdominal pain|Mucosal inflammation|Dyslipidaemia|Gait disturbance,13,1
11062451,20150423,Palbociclib,73,801,73.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Hepatic enzyme increased,1,2
11062461,20150423,Palbociclib,60,801,60.0,2,68.2,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB|FENTANYL,4,NEOPLASM MALIGNANT,Hospitalisation,1,3
11063982,20150424,Palbociclib,81,801,81.0,2,63,1,0,1,0,0,0,0,Palbociclib,DENOSUMAB|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,3,BREAST CANCER,Osteomyelitis,1,3
11064517,20150424,Palbociclib,64,801,64.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Vision blurred|Malaise|Dizziness,3,5
11067379,20150427,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,ETHANOL|DERMA FOAM EXCEL HAND SANITIZER|ALCOHOL|EVEROLIMUS|EVEROLIMUS TABLETS|EXEMESTANE|FULVESTRANT|EXEMESTANE|EVEROLIMUS|EVEROLIMUS TABLETS|EVEROLIMUS|EVEROLIMUS TABLETS|EVEROLIMUS|EVEROLIMUS TABLETS|ANASTROZOLE|ANASTROZOLE TABLETS|EVEROLIMUS|EVEROLIMUS TABLETS|PALBOCICLIB,11,,Osteonecrosis of jaw|Gait disturbance|Hyperlipidaemia|Mucosal inflammation|Dyslipidaemia|Disease progression|Thrombocytopenia|Nystagmus,8,5
11068014,20150424,Palbociclib,44,801,44.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|CETIRIZINE HYDROCHLORIDE|LETROZOLE|LETROZOLE TABLETS,4,BREAST CANCER,Decreased appetite|Muscle spasms|Dysgeusia,3,2
11068493,20150427,Palbociclib,66,801,66.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER FEMALE,White blood cell count decreased,1,1
11068513,20150427,Palbociclib,68,801,68.0,2,,1,0,1,0,0,0,1,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|PALBOCICLIB,3,BREAST CANCER|BREAST CANCER,Neutrophil count decreased|Neutrophil count decreased|Breast cancer|White blood cell count decreased|Disease progression,5,3
11068555,20150427,Palbociclib,57,801,57.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB,5,BREAST CANCER METASTATIC,Thrombosis|Fatigue|Hypoaesthesia|Memory impairment|Abdominal pain|Nausea|Cystitis|Depression|Insomnia|Pain in extremity|Abdominal distension|Constipation|Asthenia|White blood cell count decreased|Peripheral swelling|Anxiety|Pain in extremity|Pain,18,3
11068560,20150427,Palbociclib,72,801,72.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Epistaxis|Joint swelling|Fatigue|Stomatitis,4,5
11071242,20150427,Palbociclib,40,801,40.0,2,,1,0,1,0,0,0,0,Palbociclib,CEPHALEXIN|LANSOPRAZOLE|ACYCLOVIR|LETROZOLE|LETROZOLE TABLETS|LORAZEPAM|PALBOCICLIB|GOSERELIN|CALCIUM,9,BREAST CANCER,Infection,1,2
11071427,20150428,Palbociclib,72,801,72.0,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|WARFARIN|PALBOCICLIB,4,BREAST CANCER FEMALE,Fatigue|Arthritis|White blood cell count decreased|Arthralgia|Dizziness|Diarrhoea|Bone pain,7,1
11071437,20150428,Palbociclib,56,801,56.0,1,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,MALIGNANT NEOPLASM OF CHOROID,Rash|Off label use,2,5
11071499,20150428,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Blood creatinine increased|Neutropenia|Glomerular filtration rate decreased|Fatigue|Weight decreased|Nausea,6,5
11072881,20150428,Palbociclib,60,801,60.0,2,104,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,,Musculoskeletal stiffness,1,5
11075075,20150429,Palbociclib,69,801,69.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Hepatic function abnormal|Diarrhoea|Asthenia|Frequent bowel movements|Rash pruritic|Weight decreased|Abdominal discomfort|Dizziness,8,1
11075216,20150428,Palbociclib,61,801,61.0,2,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER FEMALE,Thrombocytopenia|Anaemia|Respiratory tract infection|Neutropenia,4,3
11075634,20150429,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11075636,20150429,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Vomiting,1,3
11078990,20150430,Palbociclib,72,801,72.0,2,76.2,1,0,1,0,0,0,1,Palbociclib,FULVESTRANT|PALBOCICLIB|METOPROLOL TARTRATE|METOPROLOL|ANASTROZOLE|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,7,ANTIOESTROGEN THERAPY|BLOOD PRESSURE ABNORMAL|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|ANTIOESTROGEN THERAPY,Gastrointestinal necrosis|Hernia repair|Hypoacusis|Feeling abnormal|Polyuria|Pain|Parathyroid disorder|Fear|Malaise|Memory impairment|Arthralgia|Blood magnesium abnormal|Hypercalcaemia|Fatigue|Nervousness|Confusional state|Gastrointestinal disorder|Tumour marker increased|Dyspepsia|Nightmare|Respiratory tract infection|White blood cell count decreased,22,5
11078995,20150430,Palbociclib,74,801,74.0,2,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Diarrhoea|White blood cell disorder|Hypotension,3,5
11081599,20150501,Palbociclib,72,801,72.0,2,,1,0,0,0,0,0,0,Palbociclib,PREDNISONE|LORATADINE|LORATADINE TABLET|MONTELUKAST|PALBOCICLIB|ATORVASTATIN CALCIUM|PREDNISONE,7,BREAST CANCER METASTATIC,Muscle spasms|White blood cell count decreased|Platelet count decreased,3,5
11081603,20150501,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,,Fatigue,1,5
11081637,20150501,Palbociclib,79,801,79.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Fatigue,1,3
11081798,20150501,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,3
11082290,20150501,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11082330,20150501,Palbociclib,67,801,67.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Chest pain,1,5
11082338,20150501,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11082359,20150430,Palbociclib,50,801,50.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased|Alopecia,2,2
11087178,20150504,Palbociclib,61,801,61.0,2,70,1,0,0,0,0,0,0,Palbociclib,OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN|PALBOCICLIB,2,PAIN|BREAST CANCER STAGE IV,Breast cancer stage IV|Disease progression|Fall|White blood cell count decreased,4,5
11087196,20150504,Palbociclib,68,801,68.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Skin lesion|Decreased appetite|Constipation|Epistaxis|Arthralgia,5,5
11087224,20150504,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Neutropenia,1,2
11089872,20150504,Palbociclib,59,801,59.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Full blood count decreased,1,2
11089900,20150504,Palbociclib,72,801,72.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Fatigue,1,2
11090252,20150505,Palbociclib,71,801,71.0,2,,1,1,1,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Abdominal pain upper|Death|Large intestinal obstruction|Disease progression|Infection|Breast cancer,6,5
11090253,20150505,Palbociclib,51,801,51.0,2,,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Death,1,5
11090519,20150505,Palbociclib,67,801,67.0,2,40.82,1,0,0,0,0,0,1,Palbociclib,EVEROLIMUS|EXEMESTANE|DENOSUMAB|CAPECITABINE|DENOSUMAB|PALBOCICLIB|EVEROLIMUS|EVEROLIMUS|EVEROLIMUS|ANASTROZOLE|ANASTROZOLE TABLETS|LETROZOLE|LETROZOLE TABLETS|FULVESTRANT,14,BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC|METASTASES TO BONE|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Clostridium difficile infection|Nystagmus|Breast cancer metastatic|Hyperlipidaemia|Platelet count decreased|Osteonecrosis of jaw|Conjunctivitis|Malignant ascites|Eye discharge|Soft tissue mass|Dyslipidaemia|Abdominal pain|Lymphadenopathy mediastinal|Mucosal inflammation|Gait disturbance|Metastases to bone|Ascites|Pupils unequal|Thrombocytopenia|Adenocarcinoma|Jaw disorder|Pulmonary mass|Malignant neoplasm progression,23,5
11090689,20150505,Palbociclib,57,801,57.0,2,59.2,1,0,0,0,0,0,0,Palbociclib,FULVESTRANT|PALBOCICLIB,2,BREAST CANCER METASTATIC,Hepatic lesion|Depression|Musculoskeletal chest pain,3,3
11091096,20150505,Palbociclib,64,801,64.0,1,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased|Product use issue|Vomiting,3,3
11091102,20150505,Palbociclib,46,801,46.0,2,61,1,0,0,0,0,0,0,Palbociclib,LACTULOSE|LIDOCAINE PATCH 5%|LORAZEPAM|BACLOFEN|LETROZOLE|LETROZOLE TABLETS|LUBIPROSTONE|BACLOFEN|LACTULOSE|PREGABALIN|OXYCODONE HCL|MILNACIPRAN HYDROCHLORIDE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|HYDROCODONE BITARTRATE|LIDOCAINE PATCH 5%|MORPHINE|PALBOCICLIB|LUBIPROSTONE|MORPHINE SULFATE|BUPIVACAINE|BUPIVACAINE HYDROCHLORIDE IN DEXTROSE|CALCIUM|PREGABALIN|MORPHINE SULFATE|CLONIDINE,31,PAIN|CONSTIPATION|NAUSEA|NAUSEA|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Platelet count decreased|Malaise|Neutrophil count decreased,3,2
11091164,20150505,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,,Constipation,1,5
11091173,20150505,Palbociclib,58,801,58.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Diarrhoea|Arthralgia,2,5
11091177,20150505,Palbociclib,67,801,67.0,2,54.4,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER FEMALE,Alopecia,1,5
11091192,20150505,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Fatigue|Onychoclasis,2,5
11091405,20150505,Palbociclib,4,800,40.0,2,,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,METASTATIC NEOPLASM,Pleural effusion|Product use issue|Death|Disease progression|Metastatic neoplasm,5,1
11091452,20150505,Palbociclib,53,801,53.0,1,92.5,1,0,1,0,0,0,1,Palbociclib,TRAMETINIB|TRAMETINIB|PALBOCICLIB,3,RECTAL ADENOCARCINOMA|RECTAL ADENOCARCINOMA,Hypoxia,1,1
11091525,20150505,Palbociclib,56,801,56.0,2,69,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB,4,BREAST CANCER METASTATIC,Rash|Neutropenia|Irritability|Full blood count decreased|Alopecia,5,3
11093125,20150506,Palbociclib,62,801,62.0,2,41,1,1,1,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|ERGOCALCIFEROL,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Renal failure|Sepsis|Fatigue|Pancytopenia|Pneumonia|Atrial fibrillation|Abdominal pain,7,1
11093299,20150506,Palbociclib,,,,2,,1,0,1,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia|Pneumonia,2,1
11093554,20150506,Palbociclib,65,801,65.0,2,73,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|FULVESTRANT|GABAPENTIN|LETROZOLE|LORAZEPAM|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|DENOSUMAB|CAPECITABINE,13,,Metastases to bone|Drug intolerance|Lumbar spinal stenosis|Muscle mass|Osteopenia|Arthritis|Osteoarthritis|Pathological fracture|Malignant neoplasm progression|Arrhythmia|Gastrooesophageal reflux disease|Spinal osteoarthritis,12,5
11093741,20150506,Palbociclib,73,801,73.0,2,55,1,1,1,0,0,0,0,Palbociclib,AMLODIPINE|LETROZOLE|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB,14,HYPERTENSION|BREAST CANCER|PROPHYLAXIS|SKIN FISSURES|OSTEOPOROSIS|BREAST CANCER|SKIN FISSURES|INSOMNIA|PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER|CONSTIPATION|NASOPHARYNGITIS|HYPERLIPIDAEMIA,Subarachnoid haemorrhage|Dizziness|Malaise|Vomiting,4,1
11093773,20150506,Palbociclib,54,801,54.0,2,75,1,0,0,0,0,0,1,Palbociclib,"IBUPROFEN|IBUPROFEN CAPSULES 200 MG|IBUPROFEN TABLETS USP, 200MG|IBUPROFEN ORAL|IBUPROFEN 200MG|IBUPFROFEN|IBUPROFEN TABLET, FILM-COATED|IBUPROFEN 200 MG|IBUPROFEN CAPSULE|FOLIC ACID|SIMVASTATIN|CLOPIDOGREL|CLOPIDOGREL BISULFATE|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|RAMIPRIL|HYPROMELLOSE",15,ARTHRALGIA|MEAN CELL VOLUME INCREASED|ROUTINE HEALTH MAINTENANCE|HYPERCHOLESTEROLAEMIA|BLOOD DISORDER|RASH|BREAST CANCER|ROUTINE HEALTH MAINTENANCE|BREAST CANCER|ROUTINE HEALTH MAINTENANCE|CEREBROVASCULAR ACCIDENT PROPHYLAXIS|METASTASES TO BONE|EYE INFECTION|LACRIMATION INCREASED|DYSPEPSIA,Cataract,1,1
11094446,20150506,Palbociclib,74,801,74.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Nausea|Vomiting,2,5
11094447,20150506,Palbociclib,71,801,71.0,1,58,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB|PANCRELIPASE|RIFAMPIN|PALBOCICLIB|PALBOCICLIB|METHYLTESTOSTERONE|ESTRADIOL,7,LUNG NEOPLASM MALIGNANT|PANCREATIC CARCINOMA METASTATIC,Product use issue|Insomnia|Pancreatic carcinoma metastatic|Death|Disease progression|Nausea|Skin burning sensation|Depression|Lung neoplasm malignant,9,5
11094449,20150506,Palbociclib,81,801,81.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,BREAST CANCER FEMALE,Sensitivity of teeth|Paranasal sinus discomfort,2,1
11094451,20150506,Palbociclib,72,801,72.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER FEMALE,Disease progression|Breast cancer,2,5
11094459,20150506,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Fatigue|Oral pain,2,5
11094462,20150506,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Mood swings|Abdominal discomfort|Oropharyngeal pain|Blood count abnormal,4,5
11094464,20150506,Palbociclib,62,801,62.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Decreased appetite|Hypersomnia,2,5
11094465,20150506,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,3
11094466,20150506,Palbociclib,58,801,58.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased,1,5
11094467,20150506,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Fatigue,1,5
11094469,20150506,Palbociclib,67,801,67.0,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER METASTATIC,Product use issue,1,1
11094470,20150506,Palbociclib,75,801,75.0,2,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,3,MALIGNANT NIPPLE NEOPLASM,Pain in extremity|White blood cell count decreased|Vertigo|Chest pain|Stomatitis|Platelet count decreased,6,3
11094472,20150506,Palbociclib,68,801,68.0,2,57.6,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LEVOTHYROXINE|OMEPRAZOLE MAGNESIUM|DENOSUMAB|DENOSUMAB|WARFARIN SODIUM|WARFARIN|DENOSUMAB|LETROZOLE|LETROZOLE TABLETS,13,BONE CANCER|THYROID DISORDER|GASTROOESOPHAGEAL REFLUX DISEASE|BONE CANCER|BONE CANCER|BLOOD CHOLESTEROL|HEADACHE|ANTICOAGULANT THERAPY|GASTROOESOPHAGEAL REFLUX DISEASE|BONE CANCER|SUPPLEMENTATION THERAPY,Product use issue|Stomatitis|Rash macular|Dysphagia,4,5
11094473,20150506,Palbociclib,78,801,78.0,2,67,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|PALBOCICLIB|PALBOCICLIB,3,BREAST CANCER METASTATIC,Muscle spasms|Dry throat|Dry skin|Joint swelling|Asthenia|Peripheral swelling|Platelet count abnormal,7,3
11094474,20150506,Palbociclib,67,801,67.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER FEMALE,Vomiting|Fatigue|Nausea|Dyspepsia,4,5
11096791,20150507,Palbociclib,72,801,72.0,2,61,1,0,1,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Thyroid disorder|Lower limb fracture|Scar|Fatigue|Dysphagia,5,5
11096793,20150507,Palbociclib,,,,0,,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11096801,20150507,Palbociclib,,,,2,,1,1,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Sepsis|Pancytopenia|Renal failure|Death|Streptococcal bacteraemia,5,1
11097219,20150506,Palbociclib,45,801,45.0,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER,Heart rate increased|Pallor|Dizziness|Nausea|Asthenia,5,2
11097843,20150507,Palbociclib,52,801,52.0,2,76,1,1,1,0,0,0,1,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|CEFEPIME HYDROCHLORIDE|CEFEPIME,3,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Pyrexia|Anaemia|Spinal pain|Death|Tachycardia|Breast cancer metastatic|Pain|Febrile neutropenia|Gait disturbance|Hypophagia|Feeling abnormal|Neutropenia|Fatigue|Depression|Abdominal pain upper|Abdominal tenderness|Nausea|Constipation|Disease progression|Dizziness|Neck pain,21,3
11097937,20150507,Palbociclib,62,801,62.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|LISINOPRIL,3,,Oropharyngeal pain|Nasal congestion|Dyspnoea|Nasopharyngitis,4,2
11097943,20150507,Palbociclib,71,801,71.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|PALBOCICLIB,4,BREAST CANCER FEMALE,Blister|Fatigue|Product use issue|Poor quality sleep|Anxiety|Constipation|Vomiting|Pain,8,3
11098077,20150507,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Stomatitis,1,3
11099957,20150508,Palbociclib,54,801,54.0,2,,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Death,1,5
11099960,20150508,Palbociclib,57,801,57.0,2,,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER FEMALE,Death,1,5
11100119,20150508,Palbociclib,53,801,53.0,1,92.5,1,0,1,0,0,0,1,Palbociclib,PALBOCICLIB|TRAMETINIB|TRAMETINIB,3,RECTAL ADENOCARCINOMA|RECTAL ADENOCARCINOMA,Hypoxia,1,1
11101202,20150508,Palbociclib,85,801,85.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Fatigue|Skin exfoliation|Rash|Cough|Dizziness|Lip exfoliation,6,5
11101312,20150508,Palbociclib,67,801,67.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Fatigue|Headache,2,5
11101319,20150508,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Proteinuria,1,1
11101551,20150508,Palbociclib,57,801,57.0,1,73.16,1,1,1,0,0,0,1,Palbociclib,PALBOCICLIB|LORAZEPAM|PALBOCICLIB|OXYCODONE HYDROCHLORIDE,11,SQUAMOUS CELL CARCINOMA OF LUNG|PAIN MANAGEMENT,Sudden death|Liver disorder|Coma|Vomiting|Constipation|Leukocytosis|Dyspepsia|Hypoalbuminaemia|Squamous cell carcinoma of lung|Flatulence|Nausea|Platelet count decreased|Diarrhoea,13,5
11102304,20150508,Palbociclib,61,801,61.0,2,,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Death,1,2
11103734,20150511,Palbociclib,59,801,59.0,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|PALBOCICLIB,2,BREAST CANCER,Fatigue|Oedema peripheral,2,5
11103742,20150511,Palbociclib,75,801,75.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE,2,METASTATIC NEOPLASM|METASTATIC NEOPLASM,Nasopharyngitis|Nasal congestion,2,5
11103795,20150511,Palbociclib,60,801,60.0,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,,Asthenia|Hypoaesthesia,2,5
11103816,20150511,Palbociclib,83,801,83.0,2,,1,1,0,0,0,0,1,Palbociclib,LETROZOLE|PALBOCICLIB|PALBOCICLIB,3,BREAST CANCER|BREAST CANCER METASTATIC|BREAST CANCER FEMALE,Fatigue|Death|Leukopenia,3,5
11106609,20150512,Palbociclib,63,801,63.0,2,78,1,0,1,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,3,METASTASES TO BONE|BREAST CANCER|BREAST CANCER,Jaw disorder,1,5
11106714,20150511,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Skin lesion,1,2
11106755,20150512,Palbociclib,64,801,64.0,2,,1,0,0,0,0,0,1,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,3,BREAST CANCER|BREAST CANCER METASTATIC,Anaemia,1,1
11106791,20150512,Palbociclib,80,801,80.0,2,,1,0,1,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER FEMALE|BREAST CANCER FEMALE,Gingival pain|Laryngeal disorder|Dehydration|Abdominal pain upper|Constipation|Abdominal pain|Peripheral swelling|Dizziness|Nausea|Oral pain|White blood cell count decreased|Renal impairment|Sleep disorder|Eye pruritus|Diarrhoea|Platelet count decreased|Somnolence,17,5
11106815,20150512,Palbociclib,69,801,69.0,2,79,1,0,1,0,0,0,1,Palbociclib,PALBOCICLIB|PALBOCICLIB|PALBOCICLIB,3,,Seizure|Malaise|Muscle spasms|Pain in extremity|Headache|Bacterial infection|Full blood count decreased|Contusion|Bone pain|White blood cell count decreased,10,5
11106921,20150512,Palbociclib,93,801,93.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|PALBOCICLIB,2,BREAST CANCER,Fatigue|Dysuria|Constipation,3,3
11109333,20150513,Palbociclib,,,,0,,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Disease progression|Breast cancer metastatic,2,1
11109399,20150513,Palbociclib,41,801,41.0,2,,1,1,1,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Sepsis|Pneumonia|Urinary tract infection,3,1
11109841,20150513,Palbociclib,69,801,69.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Hypertension|Neutropenia|White blood cell count decreased|Alanine aminotransferase abnormal|Haemoglobin decreased,5,5
11109941,20150512,Palbociclib,45,801,45.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,BREAST CANCER,Therapy change,1,2
11110049,20150513,Palbociclib,65,801,65.0,2,,1,0,0,0,0,0,1,Palbociclib,"IBUPROFEN SODIUM|IBUPROFEN|IBUPROFEN TABLETS, COATED|IBUPROFEN TABLET COATED|PALBOCICLIB|OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|FESOTERODINE FUMARATE|LETROZOLE|LETROZOLE TABLETS",6,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Asthenia|Anaemia,2,1
11110066,20150513,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Neutropenia,1,1
11110298,20150513,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Rash,1,1
11110348,20150512,Palbociclib,38,801,38.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Abdominal pain,1,2
11110356,20150512,Palbociclib,53,801,53.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased,1,2
11111969,20150513,Palbociclib,82,801,82.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Therapy cessation|Blood count abnormal,2,2
11112061,20150514,Palbociclib,88,801,88.0,2,,1,1,0,0,0,0,0,Palbociclib,SIMVASTATIN|PALBOCICLIB,6,,Death,1,5
11112093,20150514,Palbociclib,,,,0,,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Breast cancer metastatic|Disease progression,2,1
11112187,20150513,Palbociclib,45,801,45.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,BREAST CANCER,Red blood cell count decreased|White blood cell count decreased,2,2
11112246,20150514,Palbociclib,84,801,84.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Platelet count decreased|White blood cell count decreased|Skin lesion|Anaemia|Pancytopenia|Neutropenia|Erythema,7,3
11112270,20150514,Palbociclib,87,801,87.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,NEOPLASM MALIGNANT,Fatigue|Musculoskeletal pain|Arthralgia|Contusion|Fall|Back pain|Dyspnoea|Fatigue|Dizziness,9,5
11112273,20150514,Palbociclib,56,801,56.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Muscle spasms,1,5
11112304,20150514,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER FEMALE,Rash,1,1
11112316,20150514,Palbociclib,55,801,55.0,1,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|PALBOCICLIB,2,NEOPLASM MALIGNANT,Vomiting|Paraesthesia|Rash pruritic|Product use issue|Disease progression|Neoplasm malignant|Dizziness,7,5
11112321,20150514,Palbociclib,57,801,57.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,HORMONE REPLACEMENT THERAPY,Product use issue|Rash,2,5
11112798,20150514,Palbociclib,59,801,59.0,2,59,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB,4,BREAST CANCER METASTATIC|SINUSITIS|BREAST CANCER METASTATIC|NAUSEA,Hepatic enzyme abnormal|Diarrhoea|Metastases to liver|Abdominal pain|Gastrointestinal toxicity|Clostridium difficile colitis|Malignant neoplasm progression|Breast cancer metastatic|Urinary tract infection|Intestinal dilatation|Pyrexia|Abdominal distension|Ascites,13,5
11115731,20150515,Palbociclib,56,801,56.0,1,,1,0,0,0,0,0,1,Palbociclib,RILUZOLE|TRAMETINIB|PALBOCICLIB,3,CHOROID MELANOMA,Product use issue|Candida infection|Rash|Staphylococcal infection,4,5
11115752,20150514,Palbociclib,64,801,64.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Urticaria|Therapy cessation|Rash,3,2
11115800,20150515,Palbociclib,63,801,63.0,2,84.5,1,0,1,0,0,0,1,Palbociclib,OMEPRAZOLE|OMEPRAZOLE MAGNESIUM|CALCIUM|EXEMESTANE|PALBOCICLIB,7,ANALGESIC THERAPY|PROPHYLAXIS|OSTEOPOROSIS PROPHYLAXIS|BREAST CANCER METASTATIC|PAIN PROPHYLAXIS|PAIN PROPHYLAXIS|BREAST CANCER METASTATIC,Dyspnoea|Pneumonia,2,1
11117115,20150515,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Inappropriate schedule of drug administration|White blood cell count decreased,2,1
11117147,20150515,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Arthralgia|Leukopenia|Anaemia|Fatigue,4,1
11118030,20150515,Palbociclib,70,801,70.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Retching,1,2
11119102,20150518,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Pancytopenia,1,1
11119184,20150518,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Fatigue,1,1
11119186,20150518,Palbociclib,50,801,50.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER STAGE IV,Urinary tract infection,1,5
11119224,20150518,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|PALBOCICLIB,2,,Neutropenia,1,1
11119229,20150518,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11119251,20150518,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Fatigue,1,3
11119252,20150518,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|PALBOCICLIB,2,,Neutropenia,1,1
11119270,20150518,Palbociclib,66,801,66.0,2,80,1,0,1,0,0,0,1,Palbociclib,PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB,14,BREAST CANCER METASTATIC,Cardiac disorder|Nausea|White blood cell count decreased|Blood count abnormal|Tumour marker increased|Blood potassium decreased|Red blood cell count decreased|Bone pain|Pain in extremity|Pleural effusion|Full blood count decreased|Neoplasm progression|Cough|Pain|Pyrexia|Haemoglobin decreased|Platelet count decreased|Fatigue|Cardiac failure congestive|Neutropenia|Muscle spasms|Neuropathy peripheral|Blood magnesium decreased,23,3
11119314,20150515,Palbociclib,66,801,66.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Paraesthesia|Oral pain,2,2
11119351,20150518,Palbociclib,64,801,64.0,0,,1,1,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Death,1,1
11119380,20150518,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Rash|Pain of skin,2,5
11119542,20150515,Palbociclib,54,801,54.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Fatigue|Paraesthesia,2,2
11119876,20150518,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,NEOPLASM MALIGNANT,Neoplasm malignant|Disease progression,2,3
11121833,20150518,Palbociclib,45,801,45.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Blood count abnormal,1,2
11122143,20150519,Palbociclib,,,,2,,1,0,1,0,0,0,1,Palbociclib,FUROSEMIDE|DOFETILIDE|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|ACETAMINOPHEN|ACETAMINOPHEN ORAL SOLUTION|ACETAMINOPHEN 500MG|ACETAMINOPHEN TABLET EXTENDED RELEASE|PAIN RELIEVER|LORATADINE|LORATADINE ORAL|RIVAROXABAN|VALSARTAN|ALPRAZOLAM|DOFETILIDE|DENOSUMAB,12,ATRIAL FIBRILLATION,Drug interaction|Electrocardiogram QT prolonged,2,1
11122767,20150519,Palbociclib,68,801,68.0,2,70,1,0,0,0,0,0,0,Palbociclib,LEVOTHYROXINE SODIUM|PALBOCICLIB|LETROZOLE,3,NEOPLASM MALIGNANT,White blood cell count decreased,1,5
11122771,20150519,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Pulmonary embolism,1,1
11122808,20150519,Palbociclib,38,801,38.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Fatigue|Pain|Chills|Feeling hot,4,5
11122822,20150519,Palbociclib,43,801,43.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased,1,1
11122845,20150519,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,METASTATIC NEOPLASM,No adverse event,1,1
11122866,20150519,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,No adverse event,1,1
11122868,20150519,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,3
11122875,20150519,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11122879,20150519,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,NEOPLASM MALIGNANT,Back pain|Neoplasm malignant|Disease progression|Fatigue|Nausea,5,1
11122908,20150519,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11122920,20150519,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Mucosal inflammation,1,1
11122955,20150519,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Diarrhoea,1,3
11124353,20150519,Palbociclib,69,801,69.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Skin fissures,1,2
11124571,20150519,Palbociclib,48,801,48.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Tumour marker increased,1,2
11124931,20150520,Palbociclib,77,801,77.0,2,73,1,0,0,0,0,0,1,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|PALBOCICLIB,3,BREAST CANCER|BREAST CANCER METASTATIC,Anaemia|Cancer pain|Nausea|Neuropathy peripheral|White blood cell count decreased,5,3
11125453,20150520,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Breast cancer metastatic|Disease progression,2,5
11125462,20150520,Palbociclib,6,800,60.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Neutropenia,1,1
11125469,20150520,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Mucosal inflammation,1,1
11125470,20150520,Palbociclib,66,801,66.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Nausea,1,5
11125482,20150520,Palbociclib,51,801,51.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|PALBOCICLIB,4,NEOPLASM MALIGNANT,Dyspnoea|Disease recurrence|Bone pain|Glossodynia|Diarrhoea|Fibromyalgia|Drug dose omission|Neoplasm malignant|Abdominal pain upper,9,3
11125523,20150520,Palbociclib,52,801,52.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Headache|Hyperhidrosis|White blood cell count decreased,3,5
11125530,20150520,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Abdominal discomfort,1,1
11125547,20150520,Palbociclib,63,801,63.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Alopecia,1,5
11125553,20150520,Palbociclib,,,,1,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Thrombocytopenia|Product use issue|Diarrhoea|Neutropenia,4,1
11125556,20150520,Palbociclib,83,801,83.0,2,52,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|PALBOCICLIB,2,BREAST CANCER METASTATIC,White blood cell count decreased|Nausea|Disease progression|Pyrexia|Breast cancer metastatic|Laboratory test abnormal|Fatigue,7,3
11125563,20150520,Palbociclib,56,801,56.0,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,,Fatigue|Arthralgia,2,1
11125598,20150520,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11127454,20150520,Palbociclib,76,801,76.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,NEOPLASM MALIGNANT,Drug ineffective,1,2
11127738,20150520,Palbociclib,31,801,31.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased|Therapy cessation,2,2
11127789,20150520,Palbociclib,56,801,56.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Platelet count decreased|White blood cell count decreased,2,2
11128232,20150521,Palbociclib,55,801,55.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Deep vein thrombosis,1,1
11128345,20150520,Palbociclib,51,801,51.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Muscle spasms|Fatigue|Feeling hot|Panic attack|Pruritus|Activities of daily living impaired|White blood cell count decreased|Pain of skin|Pain in extremity|Depressed mood|Hyperhidrosis,11,2
11128346,20150520,Palbociclib,44,801,44.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Fatigue|Vomiting,2,2
11129103,20150521,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Rash maculo-papular,1,3
11129251,20150521,Palbociclib,51,801,51.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|PALBOCICLIB,2,BREAST CANCER METASTATIC,Neutropenia|Platelet count decreased|Breast cancer metastatic|Laboratory test abnormal|Disease progression,5,5
11129259,20150521,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,3
11129260,20150521,Palbociclib,75,801,75.0,2,82,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|PALBOCICLIB|RIVAROXABAN|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB,8,ATRIAL FIBRILLATION|BREAST CANCER METASTATIC,Neutropenia|White blood cell count decreased|Stomatitis|Tongue exfoliation|Neoplasm progression|Full blood count abnormal|Glossodynia|Hypertension|Atrial fibrillation,9,3
11129281,20150521,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Febrile neutropenia,1,1
11129296,20150521,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Diarrhoea,1,5
11129298,20150521,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11129306,20150521,Palbociclib,63,801,63.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|PALBOCICLIB,2,BREAST CANCER,Neutropenia|Leukopenia|Herpes zoster|Full blood count decreased,4,3
11129310,20150521,Palbociclib,54,801,54.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Feeling cold|Faeces soft|Fatigue|Blood count abnormal,4,5
11129312,20150521,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11129315,20150521,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11129329,20150521,Palbociclib,65,801,65.0,2,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Asthenia|Oedema peripheral|Stomatitis|Muscular weakness|Breast cancer|Fatigue|Disease progression,7,5
11130219,20150522,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,"PALBOCICLIB|DOXORUBICIN HYDROCHLORIDE|TRASTUZUMAB|CYCLOPHOSPHAMIDE FOR INJECTION|CYCLOPHOSPHAMIDE|CYCLOPHOSPHAMIDE INJECTION, SOLUTION",6,PRODUCT USED FOR UNKNOWN INDICATION,Metastases to central nervous system,1,1
11131522,20150522,Palbociclib,66,801,66.0,1,111,1,0,1,0,0,0,0,Palbociclib,METOPROLOL TARTRATE|METOPROLOL|GABAPENTIN|FUROSEMIDE|GLIPIZIDE|PALBOCICLIB|ASPIRIN|ASPIRIN 81 MG|ASPIRIN 325 MG,7,HYPERTENSION|NEUROPATHY PERIPHERAL|ASCITES|DIABETES MELLITUS|CARDIOVASCULAR EVENT PROPHYLAXIS|BLOOD CHOLESTEROL INCREASED,Pneumonia,1,3
11131576,20150521,Palbociclib,31,801,31.0,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|LORAZEPAM|MORPHINE|CALCIUM|PALBOCICLIB|LAMOTRIGINE,8,BREAST CANCER,Fatigue,1,2
11132796,20150522,Palbociclib,52,801,52.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Alopecia|Oropharyngeal pain,2,5
11132812,20150522,Palbociclib,56,801,56.0,1,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LORAZEPAM|MORPHINE,7,PANCREATIC CARCINOMA METASTATIC,Disease progression|Product use issue|Pancreatic carcinoma metastatic,3,3
11132835,20150522,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia|Fatigue,2,1
11132849,20150522,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Haemoglobin decreased,1,1
11132862,20150522,Palbociclib,61,801,61.0,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,3
11132866,20150522,Palbociclib,46,801,46.0,2,68,1,1,0,0,0,0,0,Palbociclib,"PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|CALCIUM|OXYGEN|0XYGEN|PALBOCICLIB|THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE",6,BREAST CANCER,Disease progression|Breast cancer|Malaise,3,5
11132867,20150522,Palbociclib,60,801,60.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|PALBOCICLIB,2,BREAST CANCER,Mood altered|Fatigue|Crying|Hot flush|Neutropenia,5,3
11132895,20150522,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Diarrhoea,1,5
11133343,20150522,Palbociclib,,,,2,43.84,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|PALBOCICLIB,4,NAUSEA|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|DIARRHOEA,Off label use|Drug ineffective,2,5
11135563,20150522,Palbociclib,45,801,45.0,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER,Decreased appetite|Contusion|Platelet count decreased|White blood cell count decreased|Red blood cell count decreased,5,2
11135740,20150522,Palbociclib,53,801,53.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Platelet count decreased|Immunosuppression,2,2
11137295,20150526,Palbociclib,55,801,55.0,2,61,1,0,1,0,0,0,1,Palbociclib,TRAMETINIB|PALBOCICLIB,2,LIP SQUAMOUS CELL CARCINOMA|LIP SQUAMOUS CELL CARCINOMA,Pneumonia,1,1
11137401,20150526,Palbociclib,70,801,70.0,1,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia|Product use issue|Mucosal inflammation,3,1
11137416,20150526,Palbociclib,51,801,51.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|PALBOCICLIB,5,BREAST CANCER,Pruritus|Panic attack|Muscle spasms|Pain in extremity|White blood cell count decreased|Anxiety|Malaise|Fatigue|Pain of skin|Diarrhoea|Abdominal pain upper|Dizziness|Hyperhidrosis|Depression|Faeces discoloured,15,2
11137417,20150526,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,3
11137454,20150526,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Fatigue,1,5
11138146,20150526,Palbociclib,67,801,67.0,2,70,1,0,1,0,0,0,1,Palbociclib,PALBOCICLIB|FULVESTRANT|CAPECITABINE|EXEMESTANE|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|CAPECITABINE|LETROZOLE|LETROZOLE TABLETS|EXEMESTANE|PALBOCICLIB|ALENDRONATE SODIUM|EVEROLIMUS|EVEROLIMUS TABLETS|FULVESTRANT,13,BREAST CANCER RECURRENT|BREAST CANCER RECURRENT|METASTASES TO BONE|BREAST CANCER RECURRENT|BREAST CANCER METASTATIC|METASTASES TO BONE|BREAST CANCER METASTATIC|BREAST CANCER RECURRENT|METASTASES TO BONE|BREAST CANCER RECURRENT|METASTASES TO BONE,Oedema peripheral|Neutropenia|Drug effect incomplete|Tumour marker increased|Bone lesion|Deep vein thrombosis,6,1
11138802,20150526,Palbociclib,56,801,56.0,2,,1,0,0,0,0,0,0,Palbociclib,MUPIROCIN|MUPIROCIN CALCIUM|WARFARIN|ONDANSETRON HYDROCHLORIDE|ONDANSETRON|ONDANSETRON TABLETS|LOSARTAN|MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE|MORPHINE|LORAZEPAM|PALBOCICLIB,11,BREAST CANCER,Anaemia,1,2
11138821,20150526,Palbociclib,57,801,57.0,2,,1,0,0,0,0,0,0,Palbociclib,BUPROPION HYDROCHLORIDE|PALBOCICLIB,2,BREAST CANCER,Fatigue|Stomatitis|Vomiting|Arthralgia|Hot flush|Feeling cold|Nausea,7,2
11139543,20150526,Palbociclib,80,801,80.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,NEOPLASM MALIGNANT,Fatigue|Mobility decreased,2,2
11139560,20150526,Palbociclib,59,801,59.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Joint swelling|Peripheral swelling|Alopecia|Neuropathy peripheral|Fatigue,5,2
11139592,20150526,Palbociclib,45,801,45.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Therapy cessation,1,2
11139726,20150526,Palbociclib,63,801,63.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Neutropenia,1,2
11140084,20150526,Palbociclib,59,801,59.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Fatigue|Alopecia|Peripheral swelling|Joint swelling|Neuropathy peripheral,5,2
11142339,20150527,Palbociclib,71,801,71.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,5,INVASIVE DUCTAL BREAST CARCINOMA|BREAST CANCER METASTATIC|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION|PRODUCT USED FOR UNKNOWN INDICATION,Thrombocytopenia|Disease progression|Neutropenia|No therapeutic response|Pleural effusion,5,3
11143136,20150528,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Pneumonia,1,1
11143483,20150527,Palbociclib,35,801,35.0,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER|BREAST CANCER,Blood pressure increased,1,2
11144603,20150528,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia|Pneumonia,2,3
11144683,20150526,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,NEOPLASM MALIGNANT,Disease progression|Neoplasm malignant,2,1
11145753,20150528,Palbociclib,,,,2,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Hepatic enzyme increased,1,1
11145850,20150528,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Stomatitis,1,3
11145870,20150528,Palbociclib,45,801,45.0,2,63,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|LUBIPROSTONE|HYDROCODONE BITARTRATE AND ACETAMINOPHEN|LACTULOSE|DIAZEPAM|DIAZEPAM ORAL|DIAZEPAM ORAL SOLUTION (CONCENTRATE)|MORPHINE SULFATE|CALCIUM CARBONATE|ANTACID|HYDROCODONE BITARTRATE|LETROZOLE|LETROZOLE TABLETS|OXYCODONE HCL|MILNACIPRAN HYDROCHLORIDE|LORAZEPAM|PREGABALIN|PALBOCICLIB|FULVESTRANT|BACLOFEN|LIDOCAINE PATCH 5%,21,BREAST CANCER METASTATIC|PAIN|CONSTIPATION|NAUSEA|NAUSEA|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Gait disturbance|Multiple sclerosis|Osteonecrosis|Neck deformity|Malaise|Metastases to bone|Paraesthesia|Muscular weakness|Musculoskeletal discomfort|Cervical cord compression|Product use issue|Pain,12,2
11145951,20150528,Palbociclib,56,801,56.0,1,,1,0,0,0,0,0,1,Palbociclib,RILUZOLE|TRAMETINIB|PALBOCICLIB|PALBOCICLIB,4,PRODUCT USED FOR UNKNOWN INDICATION|METASTASES TO LIVER|MALIGNANT MELANOMA,Staphylococcal infection|Candida infection|Infection|Rash,4,5
11146187,20150528,Palbociclib,30,801,30.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,BREAST CANCER METASTATIC,Wrong technique in drug usage process|Dysphagia,2,5
11146222,20150528,Palbociclib,52,801,52.0,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER,Purulent discharge|Paraesthesia|Umbilical discharge,3,5
11146279,20150528,Palbociclib,67,801,67.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,5,,Constipation|Fatigue|Pain in extremity|Anxiety|Full blood count decreased|White blood cell count decreased|Skin discolouration|Dry skin|Decreased appetite|Diarrhoea|Sinusitis|Nail growth abnormal,12,3
11146281,20150528,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|PALBOCICLIB,2,,Neutropenia,1,1
11146283,20150528,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|PALBOCICLIB,2,,White blood cell count decreased,1,1
11146284,20150528,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11146285,20150528,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Retching|Cough,2,3
11146287,20150528,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Viral infection|Febrile neutropenia,2,1
11146288,20150528,Palbociclib,76,801,76.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Constipation|Fatigue,2,5
11146293,20150528,Palbociclib,66,801,66.0,2,,1,0,0,0,0,0,0,Palbociclib,"FAMOTIDINE|NYSTATIN|MORPHINE SULFATE|CALCIUM CARBONATE, SIMETHICONE|ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE|ACETAMINOPHEN|CHOLESTYRAMINE|PALBOCICLIB|FENTANYL|WARFARIN SODIUM|WARFARIN",12,,Abdominal pain|Nausea|Vomiting,3,5
11146325,20150528,Palbociclib,72,801,72.0,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Haemoglobin decreased|Platelet count decreased|Pain|Drug prescribing error,4,3
11146327,20150528,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Pneumonitis,1,3
11146339,20150528,Palbociclib,85,801,85.0,1,72.56,1,0,0,0,0,0,1,Palbociclib,LISINOPRIL|ERGOCALCIFEROL|DIPHENHYDRAMINE HYDROCHLORIDE|PALBOCICLIB|TRAZODONE HYDROCHLORIDE|CALCIUM CARBONATE|FISH OIL|ATORVASTATIN CALCIUM,11,PLEOMORPHIC LIPOSARCOMA,Product use issue|Neutrophil count decreased,2,3
11146341,20150528,Palbociclib,62,801,62.0,2,,1,0,0,0,0,0,1,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC,Neutrophil count decreased,1,1
11146347,20150528,Palbociclib,70,801,70.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB,5,BREAST CANCER,Scar pain|Weight increased|Increased appetite|Neuropathy peripheral|Musculoskeletal chest pain|White blood cell count decreased|Back pain|Paraesthesia|Arthralgia|Fatigue|Musculoskeletal pain,11,3
11146349,20150528,Palbociclib,68,801,68.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS,2,,Dyspnoea|Chills,2,5
11146350,20150528,Palbociclib,,,,0,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,3
11146351,20150528,Palbociclib,69,801,69.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Stomatitis|Retching|Nausea,3,5
11146352,20150528,Palbociclib,55,801,55.0,1,74.83,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,2,BREAST CANCER METASTATIC|DIABETES MELLITUS,Blood glucose increased,1,5
11146353,20150528,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB,2,,Alopecia,1,1
11146361,20150528,Palbociclib,57,801,57.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,Vomiting|Dyspnoea|Rash|Alopecia,4,5
11147730,20150529,Palbociclib,46,801,46.0,2,64,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|VEMURAFENIB|PALBOCICLIB|VEMURAFENIB,9,HYPOTHYROIDISM|HYPERCHOLESTEROLAEMIA|CONTRACEPTION|INFECTION PROPHYLAXIS|METASTATIC MALIGNANT MELANOMA|METASTATIC MALIGNANT MELANOMA|DRY EYE,Gamma-glutamyltransferase increased,1,1
11147784,20150528,Palbociclib,55,801,55.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|LETROZOLE|LETROZOLE TABLETS|ETODOLAC,3,BREAST CANCER,Coating in mouth|Stomatitis,2,2
11147789,20150528,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Fatigue|Neuropathy peripheral|Dyspnoea|Alopecia|Stomatitis|Nausea|Epistaxis|Decreased appetite,8,3
11148209,20150529,Palbociclib,63,801,63.0,2,64,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|FLUOXETINE HYDROCHLORIDE|FLUOXETINE|FULVESTRANT|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL|CETIRIZINE HYDROCHLORIDE|ACETAMINOPHEN AND DIPHENHYDRAMINE HCL|ACETAMINOPHEN|ACETAMINOPHEN AND CAFFEINE|ACETAMINOPHEN AND PHENYLEPRINE HCL,12,METASTASES TO BONE|BREAST CANCER METASTATIC|CATHETER MANAGEMENT|SUPPLEMENTATION THERAPY|OSTEOPOROSIS|DEPRESSION|BREAST CANCER METASTATIC|PAIN|SEASONAL ALLERGY|NECK PAIN|NECK PAIN|CHEST PAIN,Cataract,1,3
11148529,20150529,Palbociclib,52,801,52.0,2,,1,0,1,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Neutropenia|Nausea|Dehydration|Disease progression|Breast cancer metastatic,5,5
11148565,20150529,Palbociclib,72,801,72.0,2,72.56,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB|PALBOCICLIB,2,BREAST CANCER METASTATIC,Fatigue|Muscle spasms|Neutropenia|Neoplasm progression|Pain in extremity,5,3
11148612,20150529,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Nausea|Product use issue,2,3
11148617,20150529,Palbociclib,,,,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Rash,1,3
11148632,20150529,Palbociclib,,,,2,,1,0,0,0,0,0,1,Palbociclib,PALBOCICLIB,1,BREAST CANCER METASTATIC,Neutropenia,1,5
11148676,20150529,Palbociclib,74,801,74.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|PALBOCICLIB,2,,Red blood cell count decreased|White blood cell count decreased|Peripheral swelling|Fatigue|Nausea,5,5
11148679,20150529,Palbociclib,66,801,66.0,2,75,1,0,0,0,0,0,1,Palbociclib,LETROZOLE|LETROZOLE TABLETS|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB,4,BREAST CANCER STAGE IV,Neutropenia|Disease progression|Breast cancer|Hypoaesthesia,4,3
11148910,20150529,Palbociclib,78,801,78.0,2,73,1,1,1,0,0,0,0,Palbociclib,LETROZOLE|LETROZOLE TABLETS|DENOSUMAB|METHYLPREDNISOLONE|PALBOCICLIB|CALCIUM|METHYLPREDNISOLONE|DICLOFENAC SODIUM,16,HYPERCHOLESTEROLAEMIA|PERIPHERAL VENOUS DISEASE|BREAST CANCER|OSTEOPOROSIS|NAUSEA|BRONCHITIS|HYPERTENSION|HYPERTENSION|NAUSEA|BREAST CANCER|PROPHYLAXIS|GASTRIC DISORDER|OSTEOPOROSIS|PULMONARY EMBOLISM|VOMITING|GOUT,Respiratory failure|Anaemia|Pneumonia,3,3
11151819,20150601,Palbociclib,,,,0,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11151826,20150601,Palbociclib,,,,0,,1,0,1,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Neutropenia,1,1
11152279,20150529,Palbociclib,55,801,55.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,BREAST CANCER,White blood cell count decreased,1,2
11152359,20150529,Palbociclib,64,801,64.0,2,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB|RIVAROXABAN,3,BREAST CANCER FEMALE,Rash erythematous|Vomiting|Rash pruritic,3,2
11152949,20150601,Palbociclib,72,801,72.0,2,74.3,1,0,0,0,0,0,1,Palbociclib,LETROZOLE|LETROZOLE TABLETS|FISH OIL|ASPIRIN|PALBOCICLIB|PALBOCICLIB|PALBOCICLIB|ASPIRIN,9,BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|BREAST CANCER METASTATIC|CHEMOTHERAPY|CHEMOTHERAPY,Metastases to liver|Alopecia|Pleural effusion|Lacrimation increased|Thrombocytopenia|Neutropenia,6,5
11155230,20150602,Palbociclib,,,,0,,1,0,0,0,0,0,0,Palbociclib,PALBOCICLIB,1,,Dysphagia,1,2
